{"4590596": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g001.jpg", "caption": "RIPK1 is upregulated in human melanoma cells under ER stress induced by TM or TG. (A) Whole cell lysates from Mel-RM and MM200 cells with or without treatment with tunicamycin (TM) (3 \u03bcM) (left panel) or thapsigargin (TG) (1 \u03bcM) (right panel) for the indicated periods were subjected to western blot analysis of RIPK1, HSPA5, and GAPDH (as a loading control). The numbers represent fold changes of HSPA5. The data shown are representative of 3 individual experiments. (B) Total RNA from Mel-RM and MM200 cells with or without treatment with TM (3 \u03bcM) (left panel) or TG (1 \u03bcM) (right panel) for the indicated periods were subjected to qPCR analysis of RIPK1 mRNA expression. The relative abundance of the RIPK1 mRNA before treatment was arbitrarily designated as 1 (n = 3, mean \u00b1SEM). (C) Total RNA from Mel-RM and MM200 cells treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h followed by treatment with actinomycin D (100 ng/ml) for the indicated period was subjected to qPCR analysis for the expression of RIPK1 mRNA. The relative abundance of the RIPK1 mRNA without actinomycin D treatment was arbitrarily designated as 1 (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (D) Whole cell lysates from ME4405, Sk-Mel-28, Mel-CV, IgR3 and Mel-RMu melanoma cells and HEMn-MP melanocytes treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h were subjected to western blot analysis of RIPK1, HSPA5, and GAPDH (as a loading control). The numbers represent fold changes of HSPA5. The data shown are representative of 3 individual experiments.", "co_occurrence": [{"body": 133, "word": "RIPK1", "fig": 7}, {"body": 146, "word": "cells", "fig": 5}, {"body": 59, "word": "TM", "fig": 5}, {"body": 58, "word": "TG", "fig": 5}, {"body": 41, "word": "The", "fig": 6}, {"body": 94, "word": "melanoma", "fig": 2}, {"body": 121, "word": "ER", "fig": 1}, {"body": 18, "word": "treatment", "fig": 5}, {"body": 87, "word": "stress", "fig": 1}, {"body": 40, "word": "cell", "fig": 2}, {"body": 24, "word": "Mel-RM", "fig": 3}, {"body": 24, "word": "MM200", "fig": 3}, {"body": 11, "word": "mRNA", "fig": 4}, {"body": 10, "word": "expression", "fig": 2}, {"body": 5, "word": "analysis", "fig": 4}, {"body": 9, "word": "shown", "fig": 2}, {"body": 18, "word": "induced", "fig": 1}, {"body": 4, "word": "HSPA5", "fig": 4}, {"body": 2, "word": "\u03bcM", "fig": 8}, {"body": 8, "word": "control", "fig": 2}, {"body": 11, "word": "Mel-RMu", "fig": 1}, {"body": 5, "word": "RNA", "fig": 2}, {"body": 9, "word": "human", "fig": 1}, {"body": 3, "word": "D", "fig": 3}, {"body": 9, "word": "upregulated", "fig": 1}, {"body": 3, "word": "without", "fig": 3}, {"body": 4, "word": "data", "fig": 2}, {"body": 4, "word": "changes", "fig": 2}, {"body": 3, "word": "blot", "fig": 2}, {"body": 6, "word": "C", "fig": 1}, {"body": 6, "word": "B", "fig": 1}, {"body": 3, "word": "qPCR", "fig": 2}, {"body": 3, "word": "western", "fig": 2}, {"body": 1, "word": "subjected", "fig": 4}, {"body": 2, "word": "h", "fig": 2}, {"body": 4, "word": "melanocytes", "fig": 1}, {"body": 2, "word": "actinomycin", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "followed", "fig": 1}, {"body": 3, "word": "tunicamycin", "fig": 1}, {"body": 1, "word": "indicated", "fig": 3}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 1, "word": "represent", "fig": 2}, {"body": 1, "word": "experiments", "fig": 2}, {"body": 2, "word": "Mel-CV", "fig": 1}, {"body": 1, "word": "designated", "fig": 2}, {"body": 1, "word": "GAPDH", "fig": 2}, {"body": 1, "word": "relative", "fig": 2}, {"body": 1, "word": "fold", "fig": 2}, {"body": 1, "word": "individual", "fig": 2}, {"body": 1, "word": "lysates", "fig": 2}, {"body": 2, "word": "ME4405", "fig": 1}, {"body": 2, "word": "IgR3", "fig": 1}, {"body": 1, "word": "abundance", "fig": 2}, {"body": 1, "word": "treated", "fig": 2}, {"body": 1, "word": "arbitrarily", "fig": 2}, {"body": 1, "word": "Total", "fig": 2}, {"body": 1, "word": "HEMn-MP", "fig": 1}, {"body": 1, "word": "Sk-Mel-28", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g002.jpg", "caption": "RIPK1 protects melanoma cells from killing by TM or TG. (A) Whole cell lysates from Mel-RM and MM200 cells transduced with the control or RIPK1 shRNA treated with tunicamycin (TM) (3 \u03bcM) or thapsigargin (TG) (1 \u03bcM) for 16 h were subjected to western blot analysis of RIPK1, HSPA5, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. The numbers represent fold changes of HSPA5. (B) Mel-RM and MM200 cells transduced with the control or RIPK1 shRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (C) Mel-RM and MM200 cells transduced with the control or RIPK1 shRNA were seeded onto 6-well plates at 2000 cells per well in medium containing TM (1 \u03bcM) or TG (0.3 \u03bcM). Twelve d later, cells were fixed and stained with crystal violet. The data shown are representative of 3 individual experiments. (D) Mel-RM and MM200 cells stably transduced with the control or RIPK1 shRNA were transiently transfected with a shRNA-resistant mutant form of RIPK1 (pCMV-MYC-mut-RIPK1). Twenty-four h later, whole cell lysates were subjected to western blot analysis of RIPK1 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (E) Mel-RM and MM200 cells stably transduced with the control or RIPK1 shRNA were transiently transfected with a shRNA-resistant mutant form of RIPK1 (pCMV-MYC-mut-RIPK1). Twenty-four h later, cells were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for another 48 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05; Student t test). (F) Whole cell lysates from HEMn-MP melanocytes transfected with the pCMV-MYC or pCMV-MYC-RIPK1 were subjected to western blot analysis of RIPK1 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (G) HEMn-MP melanocytes transfected with pCMV-MYC or pCMV-MYC-RIPK1 were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05, Student t test).", "co_occurrence": [{"body": 133, "word": "RIPK1", "fig": 11}, {"body": 146, "word": "cells", "fig": 9}, {"body": 59, "word": "TM", "fig": 6}, {"body": 58, "word": "TG", "fig": 6}, {"body": 41, "word": "The", "fig": 5}, {"body": 40, "word": "cell", "fig": 3}, {"body": 24, "word": "Mel-RM", "fig": 5}, {"body": 24, "word": "MM200", "fig": 5}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 8, "word": "control", "fig": 8}, {"body": 9, "word": "shRNA", "fig": 5}, {"body": 9, "word": "shown", "fig": 4}, {"body": 2, "word": "\u03bcM", "fig": 10}, {"body": 6, "word": "Cell", "fig": 3}, {"body": 4, "word": "transfected", "fig": 4}, {"body": 4, "word": "data", "fig": 4}, {"body": 5, "word": "viability", "fig": 3}, {"body": 5, "word": "assays", "fig": 3}, {"body": 5, "word": "analysis", "fig": 3}, {"body": 4, "word": "h.", "fig": 3}, {"body": 6, "word": "form", "fig": 2}, {"body": 3, "word": "blot", "fig": 3}, {"body": 3, "word": "western", "fig": 3}, {"body": 4, "word": "HSPA5", "fig": 2}, {"body": 4, "word": "melanocytes", "fig": 2}, {"body": 8, "word": "killing", "fig": 1}, {"body": 2, "word": "h", "fig": 3}, {"body": 6, "word": "C", "fig": 1}, {"body": 6, "word": "B", "fig": 1}, {"body": 6, "word": "E", "fig": 1}, {"body": 5, "word": "protects", "fig": 1}, {"body": 1, "word": "experiments", "fig": 4}, {"body": 1, "word": "individual", "fig": 4}, {"body": 4, "word": "fixed", "fig": 1}, {"body": 2, "word": "transiently", "fig": 2}, {"body": 1, "word": "treated", "fig": 4}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "changes", "fig": 1}, {"body": 1, "word": "subjected", "fig": 3}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 3}, {"body": 3, "word": "onto", "fig": 1}, {"body": 1, "word": "lysates", "fig": 3}, {"body": 1, "word": "measured", "fig": 3}, {"body": 3, "word": "tunicamycin", "fig": 1}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 2, "word": "plates", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "pCMV-MYC-RIPK1", "fig": 2}, {"body": 2, "word": "G", "fig": 1}, {"body": 1, "word": "HEMn-MP", "fig": 2}, {"body": 1, "word": "stably", "fig": 2}, {"body": 2, "word": "another", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 1, "word": "pCMV-MYC", "fig": 2}, {"body": 2, "word": "seeded", "fig": 1}, {"body": 1, "word": "mutant", "fig": 2}, {"body": 1, "word": "shRNA-resistant", "fig": 2}, {"body": 2, "word": "containing", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}, {"body": 1, "word": "fold", "fig": 1}, {"body": 1, "word": "violet", "fig": 1}, {"body": 1, "word": "6-well", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "crystal", "fig": 1}, {"body": 1, "word": "medium", "fig": 1}, {"body": 1, "word": "well", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g003.jpg", "caption": "RIPK1 protects melanoma cells from TM- or TG-induced apoptosis by activation of autophagy. (A) Whole cell lysates from Mel-RM and MM200 cells transduced with the control or RIPK1 shRNA were subjected to western blot analysis of RIPK1 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (B) Mel-RM and MM200 cells transduced with the control or RIPK1 shRNA were treated with tunicamycin (TM) (3 \u03bcM) (upper panel) or thapsigargin (TG) (1 \u03bcM) (lower panel) for 16 h. Whole cell lysates were subjected to western blot analysis of SQSTM1, MAP1LC3A, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (C) Electron microscopy images showing ultrastructures of Mel-RM cells transduced with the control or RIPK1 shRNA 1 treated with TM (3 \u03bcM) for 24 h. Arrowheads point to double-membraned autophagosomes. The data shown are representative of 3 individual experiments. (D and E) Mel-RM and MM200 cells with or without pretreatment with bafilomycin A1 (Baf A1) (10 nM) (D) or 3-methyladenine (3-MA) (5 mM) (E) for 1 h were treated TM (3 \u03bcM) or (TG) (1 \u03bcM) for another 48 h. Cell viability was measured by CellTiter-Glo (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (F) Whole cell lysates from Mel-RM and MM200 cells transfected with the control or ATG5 siRNA were subjected to western blot analysis of ATG5 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (G) Mel-RM and MM200 cells transfected with the control or ATG5 siRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h. Cell viability was measured by CellTiter-Glo (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (H) Whole cell lysates from Mel-RM and MM200 cells transfected with the control or ATG7 siRNA were subjected to western blot analysis of ATG7 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (I) Mel-RM and MM200 cells transfected with the control or ATG7 siRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h. Cell viability was measured by CellTiter-Glo (n = 3, mean \u00b1SEM, *P < 0.05, Student t test).", "co_occurrence": [{"body": 146, "word": "cells", "fig": 9}, {"body": 133, "word": "RIPK1", "fig": 5}, {"body": 59, "word": "TM", "fig": 5}, {"body": 58, "word": "TG", "fig": 4}, {"body": 41, "word": "The", "fig": 5}, {"body": 24, "word": "Mel-RM", "fig": 8}, {"body": 24, "word": "MM200", "fig": 7}, {"body": 40, "word": "cell", "fig": 4}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 8, "word": "control", "fig": 11}, {"body": 80, "word": "autophagy", "fig": 1}, {"body": 60, "word": "activation", "fig": 1}, {"body": 9, "word": "shown", "fig": 5}, {"body": 9, "word": "shRNA", "fig": 3}, {"body": 23, "word": "apoptosis", "fig": 1}, {"body": 4, "word": "h.", "fig": 5}, {"body": 4, "word": "data", "fig": 5}, {"body": 5, "word": "analysis", "fig": 4}, {"body": 2, "word": "\u03bcM", "fig": 9}, {"body": 18, "word": "TM-", "fig": 1}, {"body": 6, "word": "Cell", "fig": 3}, {"body": 4, "word": "transfected", "fig": 4}, {"body": 4, "word": "siRNA", "fig": 4}, {"body": 16, "word": "TG-induced", "fig": 1}, {"body": 5, "word": "viability", "fig": 3}, {"body": 3, "word": "blot", "fig": 4}, {"body": 3, "word": "western", "fig": 4}, {"body": 6, "word": "A1", "fig": 2}, {"body": 4, "word": "ATG7", "fig": 3}, {"body": 4, "word": "ATG5", "fig": 3}, {"body": 6, "word": "E", "fig": 2}, {"body": 3, "word": "D", "fig": 2}, {"body": 6, "word": "C", "fig": 1}, {"body": 6, "word": "B", "fig": 1}, {"body": 1, "word": "experiments", "fig": 5}, {"body": 1, "word": "individual", "fig": 5}, {"body": 1, "word": "treated", "fig": 5}, {"body": 5, "word": "protects", "fig": 1}, {"body": 1, "word": "subjected", "fig": 4}, {"body": 1, "word": "GAPDH", "fig": 4}, {"body": 4, "word": "3-MA", "fig": 1}, {"body": 1, "word": "lysates", "fig": 4}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "Baf", "fig": 1}, {"body": 1, "word": "measured", "fig": 3}, {"body": 3, "word": "tunicamycin", "fig": 1}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 3, "word": "without", "fig": 1}, {"body": 2, "word": "h", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 2, "word": "autophagosomes", "fig": 1}, {"body": 2, "word": "3-methyladenine", "fig": 1}, {"body": 2, "word": "another", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "bafilomycin", "fig": 1}, {"body": 1, "word": "MAP1LC3A", "fig": 1}, {"body": 1, "word": "point", "fig": 1}, {"body": 1, "word": "I", "fig": 1}, {"body": 1, "word": "H", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g004.jpg", "caption": "RIPK1 protects melanoma cells from TM- or TG-induced apoptosis by activation of autophagy. (A) Whole cell lysates from Mel-RMu cells stably transfected with pCMV-MYC or pCMV-MYC-RIPK1 were subjected to western blot analysis of RIPK1 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (B) Mel-RMu cells stably transfected with pCMV-MYC or pCMV-MYC-RIPK1 were treated with tunicamycin (TM) (3 \u03bcM) or thapsigargin (TG) (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of SQSTM1, MAP1LC3A and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (C) Mel-RMu cells stably transfected with pCMV-MYC or pCMV-MYC-RIPK1 were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h with or without pretreatment with bafilomycin A1 (Baf A1) (10 nM) for 1 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (D) Mel-RMu cells stably transfected with pCMV-MYC or pCMV-MYC-RIPK1 were transiently transfected with the control or ATG5 siRNA followed by treatment with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (E) Mel-RM (left panel) and MM200 (right panel) cells transduced with the control or RIPK1 shRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h with or without pretreatment with Baf A1 (10 nM) for 1 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (F) Mel-RM and MM200 cells transduced with the control or RIPK1 shRNA were treated with TM (3 \u03bcM) (upper panel) or TG (1 \u03bcM) (lower panel) with or without pretreatment with Baf A1 (10 nM) for 1 h. Whole cell lysates were subjected to western blot analysis of MAP1LC3A and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (G) Whole cell lysates from Mel-RM and MM200 cells treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h with or without pretreatment with Baf A1 (10 nM) for 1 h were subjected to western blot analysis of RIPK1 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments.", "co_occurrence": [{"body": 146, "word": "cells", "fig": 8}, {"body": 133, "word": "RIPK1", "fig": 5}, {"body": 59, "word": "TM", "fig": 6}, {"body": 58, "word": "TG", "fig": 6}, {"body": 41, "word": "The", "fig": 4}, {"body": 40, "word": "cell", "fig": 4}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 80, "word": "autophagy", "fig": 1}, {"body": 24, "word": "Mel-RM", "fig": 3}, {"body": 24, "word": "MM200", "fig": 3}, {"body": 60, "word": "activation", "fig": 1}, {"body": 8, "word": "control", "fig": 7}, {"body": 11, "word": "Mel-RMu", "fig": 4}, {"body": 9, "word": "shown", "fig": 4}, {"body": 6, "word": "A1", "fig": 5}, {"body": 2, "word": "\u03bcM", "fig": 12}, {"body": 23, "word": "apoptosis", "fig": 1}, {"body": 4, "word": "transfected", "fig": 5}, {"body": 4, "word": "h.", "fig": 5}, {"body": 5, "word": "analysis", "fig": 4}, {"body": 18, "word": "treatment", "fig": 1}, {"body": 9, "word": "shRNA", "fig": 2}, {"body": 18, "word": "TM-", "fig": 1}, {"body": 6, "word": "Cell", "fig": 3}, {"body": 16, "word": "TG-induced", "fig": 1}, {"body": 4, "word": "data", "fig": 4}, {"body": 5, "word": "viability", "fig": 3}, {"body": 5, "word": "assays", "fig": 3}, {"body": 3, "word": "blot", "fig": 4}, {"body": 3, "word": "Baf", "fig": 4}, {"body": 3, "word": "western", "fig": 4}, {"body": 3, "word": "without", "fig": 4}, {"body": 2, "word": "h", "fig": 4}, {"body": 6, "word": "C", "fig": 1}, {"body": 6, "word": "B", "fig": 1}, {"body": 6, "word": "E", "fig": 1}, {"body": 1, "word": "treated", "fig": 5}, {"body": 5, "word": "protects", "fig": 1}, {"body": 1, "word": "experiments", "fig": 4}, {"body": 1, "word": "subjected", "fig": 4}, {"body": 1, "word": "stably", "fig": 4}, {"body": 1, "word": "GAPDH", "fig": 4}, {"body": 1, "word": "individual", "fig": 4}, {"body": 1, "word": "pCMV-MYC-RIPK1", "fig": 4}, {"body": 1, "word": "lysates", "fig": 4}, {"body": 1, "word": "pCMV-MYC", "fig": 4}, {"body": 4, "word": "siRNA", "fig": 1}, {"body": 4, "word": "ATG5", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "followed", "fig": 1}, {"body": 1, "word": "measured", "fig": 3}, {"body": 3, "word": "tunicamycin", "fig": 1}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 1, "word": "MAP1LC3A", "fig": 2}, {"body": 2, "word": "G", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "transiently", "fig": 1}, {"body": 2, "word": "bafilomycin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g005.jpg", "caption": "RIPK1-mediated activation of MAPK8/9 contributes to induction of autophagy by ER stress in melanoma cells. (A) Mel-RM and MM200 cells transduced with the control or RIPK1 shRNA were treated with tunicamycin (TM) (3 \u03bcM) or thapsigargin (TG) (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of RIPK1, pMAPK8/9, MAPK8/9, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (B) Whole cell lysates from Mel-RM and MM200 cells transfected with the control or MAPK8/9 siRNA were subjected to western blot analysis of MAPK8, MAPK9 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (C) Mel-RM and MM200 cells transfected with the control or MAPK8/9 siRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of RIPK1, SQSTM1, MAP1LC3A, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (D) Mel-RM and MM200 cells were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h with or without pretreatment with the MAPK8/9 inhibitor SP600125 (10 \u03bcM) for 1 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (E) Mel-RM and MM200 cells transfected with the control or MAPK8/9 siRNA 1 were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h. Cell viability was measured by CellTiter-Glo assays (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (F) Mel-RMu cells stably transfected with pCMV-MYC or pCMV-MYC-RIPK1 were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h with or without pretreatement with SP600125 (10 \u03bcM) for 1 h. Whole cell lysates were subjected to western blot analysis of pMAPK8/9, MAPK8/9, SQSTM1, MAP1LC3A, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (G) Whole cell lysates from Mel-RM cells treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h were immunoprecipitated by RIPK1 antibody. The resulting precipitates were subjected to western blot analysis of RIPK1 and MAPK8/9. The data shown are representative of 3 individual experiments.", "co_occurrence": [{"body": 146, "word": "cells", "fig": 8}, {"body": 133, "word": "RIPK1", "fig": 5}, {"body": 59, "word": "TM", "fig": 6}, {"body": 58, "word": "TG", "fig": 6}, {"body": 40, "word": "MAPK8/9", "fig": 8}, {"body": 41, "word": "The", "fig": 6}, {"body": 40, "word": "cell", "fig": 5}, {"body": 24, "word": "Mel-RM", "fig": 6}, {"body": 121, "word": "ER", "fig": 1}, {"body": 24, "word": "MM200", "fig": 5}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 87, "word": "stress", "fig": 1}, {"body": 80, "word": "autophagy", "fig": 1}, {"body": 8, "word": "control", "fig": 8}, {"body": 60, "word": "activation", "fig": 1}, {"body": 9, "word": "shown", "fig": 5}, {"body": 32, "word": "induction", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 14}, {"body": 5, "word": "analysis", "fig": 5}, {"body": 4, "word": "h.", "fig": 5}, {"body": 4, "word": "data", "fig": 5}, {"body": 4, "word": "transfected", "fig": 4}, {"body": 3, "word": "blot", "fig": 5}, {"body": 3, "word": "western", "fig": 5}, {"body": 6, "word": "Cell", "fig": 2}, {"body": 4, "word": "siRNA", "fig": 3}, {"body": 11, "word": "Mel-RMu", "fig": 1}, {"body": 10, "word": "RIPK1-mediated", "fig": 1}, {"body": 5, "word": "viability", "fig": 2}, {"body": 5, "word": "assays", "fig": 2}, {"body": 9, "word": "shRNA", "fig": 1}, {"body": 8, "word": "inhibitor", "fig": 1}, {"body": 3, "word": "SP600125", "fig": 2}, {"body": 2, "word": "h", "fig": 3}, {"body": 6, "word": "C", "fig": 1}, {"body": 6, "word": "B", "fig": 1}, {"body": 1, "word": "treated", "fig": 6}, {"body": 6, "word": "E", "fig": 1}, {"body": 3, "word": "without", "fig": 2}, {"body": 1, "word": "subjected", "fig": 5}, {"body": 1, "word": "experiments", "fig": 5}, {"body": 1, "word": "individual", "fig": 5}, {"body": 5, "word": "contributes", "fig": 1}, {"body": 1, "word": "lysates", "fig": 5}, {"body": 1, "word": "GAPDH", "fig": 4}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "antibody", "fig": 1}, {"body": 3, "word": "tunicamycin", "fig": 1}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 1, "word": "MAP1LC3A", "fig": 2}, {"body": 2, "word": "G", "fig": 1}, {"body": 1, "word": "measured", "fig": 2}, {"body": 2, "word": "F", "fig": 1}, {"body": 1, "word": "stably", "fig": 1}, {"body": 1, "word": "pCMV-MYC-RIPK1", "fig": 1}, {"body": 1, "word": "MAPK8", "fig": 1}, {"body": 1, "word": "MAPK9", "fig": 1}, {"body": 1, "word": "pCMV-MYC", "fig": 1}, {"body": 1, "word": "resulting", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g006.jpg", "caption": "MAPK8/9 activation phosphorylates BCL2L11 and dissociates it from BECN1 in melanoma cells undergoing ER stress. (A) Whole cell lysates from Mel-RM cells transduced with control or RIPK1 shRNA 1 cells treated with tunicamycin (TM) (3 \u03bcM) for 16 h were immunoprecipitated by BECN1 antibody. The resulting precipitates were subjected to western blot analysis of BECN1, BCL2L1, BCL2, and MCL1. The data shown are representative of 3 individual experiments. (B) Whole cell lysates from Mel-RM cells treated with TM (3 \u03bcM) for 16 h with or without pretreatment with the MAPK8/9 inhibitor SP600125 (10 \u03bcM) for 1 h were subjected to western blot analysis of RIPK1, pMAPK8/9, MAPK8/9, pBCL2L11 (using a phosphorylated BCL2L11-specific antibody), and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (C) Whole cell lysates from Mel-RM cells treated with TM (3 \u03bcM) for 16 h with or without pretreatment with the MAPK8/9 inhibitor SP600125 (10 \u03bcM) for 1 h were subjected to immunoprecipitation with an antibody against BECN1. The resulting precipitates were subjected to western blot analysis of BECN1 and BCL2L11. The data shown are representative of 3 individual experiments. (D) Whole cell lysates from Mel-RM and MM200 cells transduced with the control or BCL2L11 shRNA were subjected to western blot analysis of BCL2L11 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (E) Mel-RM and MM200 cells stably transduced with the control or BCL2L11 shRNA were transduced with RIPK1 shRNA 1 and treated with TM (3 \u03bcM) or thapsigargin (TG) (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of SQSTM1, MAP1LC3A, or GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (F) Mel-RM and MM200 cells stably transduced with the control or BCL2L11 shRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h with or without pretreatment with the MAPK8/9 inhibitor SP600125 (10 \u03bcM) for 1 h were subjected to western blot analysis of SQSTM1, MAP1LC3A, or GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (G) Mel-RM and MM200 cells with BCL2L11 stably knocked down were transduced with the control or BECN1 shRNA. Twenty-four h later, whole cell lysates were subjected to western blot analysis of BECN1 or GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (H) Mel-RM and MM200 cells with or without BCL2L11 and BECN1 co-knocked down were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of SQSTM1, MAP1LC3A, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments.", "co_occurrence": [{"body": 146, "word": "cells", "fig": 10}, {"body": 41, "word": "The", "fig": 10}, {"body": 133, "word": "RIPK1", "fig": 3}, {"body": 59, "word": "TM", "fig": 6}, {"body": 40, "word": "cell", "fig": 7}, {"body": 34, "word": "BCL2L11", "fig": 8}, {"body": 33, "word": "BECN1", "fig": 8}, {"body": 40, "word": "MAPK8/9", "fig": 5}, {"body": 24, "word": "Mel-RM", "fig": 8}, {"body": 58, "word": "TG", "fig": 3}, {"body": 121, "word": "ER", "fig": 1}, {"body": 24, "word": "MM200", "fig": 5}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 8, "word": "control", "fig": 11}, {"body": 87, "word": "stress", "fig": 1}, {"body": 9, "word": "shown", "fig": 8}, {"body": 60, "word": "activation", "fig": 1}, {"body": 9, "word": "shRNA", "fig": 6}, {"body": 5, "word": "analysis", "fig": 8}, {"body": 4, "word": "data", "fig": 8}, {"body": 3, "word": "blot", "fig": 8}, {"body": 2, "word": "\u03bcM", "fig": 12}, {"body": 8, "word": "inhibitor", "fig": 3}, {"body": 3, "word": "western", "fig": 8}, {"body": 2, "word": "h", "fig": 8}, {"body": 16, "word": "BCL2", "fig": 1}, {"body": 15, "word": "using", "fig": 1}, {"body": 3, "word": "without", "fig": 4}, {"body": 10, "word": "undergoing", "fig": 1}, {"body": 1, "word": "subjected", "fig": 9}, {"body": 3, "word": "SP600125", "fig": 3}, {"body": 3, "word": "antibody", "fig": 3}, {"body": 1, "word": "experiments", "fig": 8}, {"body": 1, "word": "individual", "fig": 8}, {"body": 4, "word": "h.", "fig": 2}, {"body": 8, "word": "knocked", "fig": 1}, {"body": 8, "word": "MCL1", "fig": 1}, {"body": 1, "word": "lysates", "fig": 7}, {"body": 1, "word": "GAPDH", "fig": 6}, {"body": 6, "word": "C", "fig": 1}, {"body": 6, "word": "B", "fig": 1}, {"body": 1, "word": "treated", "fig": 6}, {"body": 6, "word": "E", "fig": 1}, {"body": 5, "word": "BCL2L1", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 1, "word": "stably", "fig": 3}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "MAP1LC3A", "fig": 3}, {"body": 3, "word": "phosphorylated", "fig": 1}, {"body": 3, "word": "tunicamycin", "fig": 1}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 1, "word": "resulting", "fig": 2}, {"body": 2, "word": "F", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "phosphorylates", "fig": 1}, {"body": 1, "word": "immunoprecipitation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g007.jpg", "caption": "XBP1 plays an important role in RIPK1 upregulation in melanoma cells upon ER stress. (A) Whole cell lysates from Mel-RM and MM200 cells transduced with the control, ERN1, ATF6, or EIF2AK3 shRNA were subjected to western blot analysis of ERN1 (left panel), ATF6 (middle panel) or EIF2AK3 (right panel) and GAPDH (as a loading control). The numbers represent knockdown efficiencies. The data shown are representative of 3 individual western blot analyses. (B) Mel-RM and MM200 cells transduced with the control, ERN1, ATF6, or EIF2AK3 shRNA were treated with tunicamcyin (TM) (3 \u03bcM) or thapsigargin (TG) (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of HSF1, RIPK1, SQSTM1, MAP1LC3A, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (C) Mel-RM and MM200 cells transfected with the control or XBP1 siRNA were subjected to RT-PCR for the analysis of XBP1 mRNA. GAPDH was used as a loading control. The data shown are representative of 3 individual qPCR analyses. (D) Mel-RM and MM200 cells transfected with the control or XBP1 siRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of HSF1, RIPK1, SQSTM1, MAP1LC3A, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments.", "co_occurrence": [{"body": 146, "word": "cells", "fig": 5}, {"body": 133, "word": "RIPK1", "fig": 3}, {"body": 41, "word": "The", "fig": 5}, {"body": 121, "word": "ER", "fig": 1}, {"body": 40, "word": "cell", "fig": 3}, {"body": 30, "word": "XBP1", "fig": 4}, {"body": 59, "word": "TM", "fig": 2}, {"body": 58, "word": "TG", "fig": 2}, {"body": 24, "word": "MM200", "fig": 4}, {"body": 24, "word": "Mel-RM", "fig": 4}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 87, "word": "stress", "fig": 1}, {"body": 43, "word": "HSF1", "fig": 2}, {"body": 8, "word": "control", "fig": 8}, {"body": 13, "word": "ATF6", "fig": 3}, {"body": 38, "word": "knockdown", "fig": 1}, {"body": 9, "word": "shown", "fig": 4}, {"body": 30, "word": "role", "fig": 1}, {"body": 10, "word": "ERN1", "fig": 3}, {"body": 27, "word": "upregulation", "fig": 1}, {"body": 5, "word": "analysis", "fig": 4}, {"body": 19, "word": "upon", "fig": 1}, {"body": 9, "word": "shRNA", "fig": 2}, {"body": 4, "word": "data", "fig": 4}, {"body": 14, "word": "plays", "fig": 1}, {"body": 4, "word": "EIF2AK3", "fig": 3}, {"body": 3, "word": "blot", "fig": 4}, {"body": 3, "word": "western", "fig": 4}, {"body": 11, "word": "used", "fig": 1}, {"body": 11, "word": "mRNA", "fig": 1}, {"body": 10, "word": "important", "fig": 1}, {"body": 4, "word": "h.", "fig": 2}, {"body": 4, "word": "siRNA", "fig": 2}, {"body": 2, "word": "\u03bcM", "fig": 4}, {"body": 4, "word": "transfected", "fig": 2}, {"body": 6, "word": "C", "fig": 1}, {"body": 6, "word": "B", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 4}, {"body": 1, "word": "individual", "fig": 4}, {"body": 1, "word": "subjected", "fig": 4}, {"body": 4, "word": "A", "fig": 1}, {"body": 1, "word": "lysates", "fig": 3}, {"body": 3, "word": "qPCR", "fig": 1}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 2, "word": "RT-PCR", "fig": 1}, {"body": 1, "word": "MAP1LC3A", "fig": 2}, {"body": 1, "word": "experiments", "fig": 2}, {"body": 1, "word": "treated", "fig": 2}, {"body": 1, "word": "represent", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g008.jpg", "caption": "Heat shock factor protein 1 (HSF1) is responsible for transcriptional upregulation of RIPK1 in melanoma cells upon ER stress. (A) Mel-RM (left panel) and MM200 (right panel) cells transfected with the indicated pGL3-basic based reporter constructs were treated with tunicamycin (TM) (3 \u03bcM) for 16 h followed by measurement of the luciferase activity (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (B) Formaldehyde-cross-linked chromatin of Mel-RM and MM200 with or without treatment with TM (3 \u03bcM) for 16 h was subjected to immunoprecipitation with antibody against HSF1 (top panel) or XBP1 (bottom panel). The precipitates were subjected to PCR amplification using primers for the \u2212168 to +25 region of the RIPK1 promoter. The data shown are representative of 3 individual experiments. (C) Formaldehyde-cross-linked chromatin of Mel-RM and MM200 with or without treatment with TM (3 \u03bcM) for 16 h was subjected to immunoprecipitation with antibody against HSF1. The precipitates were subjected to PCR amplification using primers for the HSP70-1 promoter. The data shown are representative of 3 individual experiments. (D) Mel-RM and MM200 cells transfected with indicated pGL3-basic based reporter constructs were treated with TM (3 \u03bcM) for 16 h followed by measurement of the luciferase activity (n = 3, mean \u00b1SEM, *P < 0.05, Student t test). (E) Whole cell lysates of Mel-RM and MM200 cells transfected with the control or HSF1 siRNA were subjected to western blot analysis of HSF1 and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (F) Mel-RM and MM200 cells transfected with the control or HSF1 siRNA were treated with TM (3 \u03bcM) or thapsigargin (TG) (1 \u03bcM) for 16 h. Whole cell lysates were subjected to western blot analysis of RIPK1, SQSTM1, MAP1LC3A, pMAPK8/9, MAPK8/9, and GAPDH (as a loading control). The data shown are representative of 3 individual experiments. (G) Mel-RM and MM200 cells transfected with the control or HSF1 siRNA were treated with TM (3 \u03bcM) or TG (1 \u03bcM) for 48 h. Cell viability was measured by CellTiter-Glo (n = 3, mean \u00b1SEM, *P < 0.05, Student t test).", "co_occurrence": [{"body": 146, "word": "cells", "fig": 6}, {"body": 133, "word": "RIPK1", "fig": 3}, {"body": 59, "word": "TM", "fig": 6}, {"body": 43, "word": "HSF1", "fig": 7}, {"body": 41, "word": "The", "fig": 6}, {"body": 24, "word": "Mel-RM", "fig": 7}, {"body": 24, "word": "MM200", "fig": 7}, {"body": 121, "word": "ER", "fig": 1}, {"body": 58, "word": "TG", "fig": 2}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 87, "word": "stress", "fig": 1}, {"body": 40, "word": "cell", "fig": 2}, {"body": 40, "word": "MAPK8/9", "fig": 1}, {"body": 8, "word": "control", "fig": 5}, {"body": 40, "word": "protein", "fig": 1}, {"body": 18, "word": "treatment", "fig": 2}, {"body": 9, "word": "shown", "fig": 4}, {"body": 16, "word": "promoter", "fig": 2}, {"body": 15, "word": "using", "fig": 2}, {"body": 30, "word": "XBP1", "fig": 1}, {"body": 27, "word": "upregulation", "fig": 1}, {"body": 4, "word": "transfected", "fig": 5}, {"body": 19, "word": "upon", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 8}, {"body": 4, "word": "data", "fig": 4}, {"body": 15, "word": "factor", "fig": 1}, {"body": 6, "word": "PCR", "fig": 2}, {"body": 4, "word": "siRNA", "fig": 3}, {"body": 11, "word": "transcriptional", "fig": 1}, {"body": 5, "word": "activity", "fig": 2}, {"body": 5, "word": "constructs", "fig": 2}, {"body": 5, "word": "analysis", "fig": 2}, {"body": 4, "word": "luciferase", "fig": 2}, {"body": 2, "word": "h", "fig": 4}, {"body": 4, "word": "h.", "fig": 2}, {"body": 4, "word": "primers", "fig": 2}, {"body": 7, "word": "shock", "fig": 1}, {"body": 1, "word": "subjected", "fig": 6}, {"body": 3, "word": "blot", "fig": 2}, {"body": 6, "word": "C", "fig": 1}, {"body": 3, "word": "antibody", "fig": 2}, {"body": 3, "word": "followed", "fig": 2}, {"body": 6, "word": "Cell", "fig": 1}, {"body": 3, "word": "western", "fig": 2}, {"body": 6, "word": "B", "fig": 1}, {"body": 6, "word": "responsible", "fig": 1}, {"body": 6, "word": "E", "fig": 1}, {"body": 3, "word": "without", "fig": 2}, {"body": 5, "word": "viability", "fig": 1}, {"body": 1, "word": "experiments", "fig": 4}, {"body": 1, "word": "individual", "fig": 4}, {"body": 2, "word": "reporter", "fig": 2}, {"body": 4, "word": "region", "fig": 1}, {"body": 1, "word": "treated", "fig": 4}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "thapsigargin", "fig": 1}, {"body": 3, "word": "tunicamycin", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 2}, {"body": 2, "word": "G", "fig": 1}, {"body": 1, "word": "lysates", "fig": 2}, {"body": 2, "word": "F", "fig": 1}, {"body": 1, "word": "indicated", "fig": 2}, {"body": 1, "word": "immunoprecipitation", "fig": 2}, {"body": 1, "word": "MAP1LC3A", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590596/bin/kaup-11-07-1049800-g009.jpg", "caption": "Induction of autophagy by RIPK1 in melanoma cells upon pharmacological ER stress was due to activation of BECN1 as a result of its disassociation from BCL2L11. A schematic illustration of the proposed pharmacological ER stress-XBP1-HSF1-RIPK1-MAPK8/9-autophagy pathway.", "co_occurrence": [{"body": 121, "word": "ER", "fig": 2}, {"body": 146, "word": "cells", "fig": 1}, {"body": 133, "word": "RIPK1", "fig": 1}, {"body": 94, "word": "melanoma", "fig": 1}, {"body": 87, "word": "stress", "fig": 1}, {"body": 80, "word": "autophagy", "fig": 1}, {"body": 60, "word": "activation", "fig": 1}, {"body": 22, "word": "pharmacological", "fig": 2}, {"body": 34, "word": "BCL2L11", "fig": 1}, {"body": 33, "word": "BECN1", "fig": 1}, {"body": 19, "word": "upon", "fig": 1}, {"body": 6, "word": "disassociation", "fig": 1}, {"body": 5, "word": "due", "fig": 1}, {"body": 4, "word": "pathway", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 1, "word": "result", "fig": 1}, {"body": 1, "word": "Induction", "fig": 1}]}], "4991769": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991769/bin/cddiscovery201523-f1.jpg", "caption": "Overexpression of mZac1 in the embryonic chicken retina. Quantitative RT-PCR and immunohistochemistry was used to analyse mRNA and protein expression. (a) Relative mZac1 mRNA levels 24 and 48 h after electroporation of mZac1 or control vectors of st22 retinas. (b) Relative mRNA levels of mZac1 and GFP 24 and 48 h after electroporation. (c and d) Fluorescence micrographs of retinas electroporated with mZac1 at st22 and analysed after 24 and 48 h showing mZac1 and GFP IR. Dashed line marks border to mZac1 electroporated region. (e and f) Fluorescence micrographs of retinas electroporated with the control vector at st22 and analysed after 24 or 48 h. Control: GFP vector, gcl: ganglion cell layer (basal side). Student\u2019s t-test, *P<0.05, **P<0.01, ***P<0.001, N\u22654, mean\u00b1S.D.", "co_occurrence": [{"body": 72, "word": "mZac1", "fig": 7}, {"body": 29, "word": "h", "fig": 3}, {"body": 24, "word": "mRNA", "fig": 3}, {"body": 22, "word": "retinas", "fig": 3}, {"body": 56, "word": "cell", "fig": 1}, {"body": 22, "word": "analysed", "fig": 2}, {"body": 14, "word": "electroporated", "fig": 3}, {"body": 19, "word": "levels", "fig": 2}, {"body": 34, "word": "expression", "fig": 1}, {"body": 28, "word": "retina", "fig": 1}, {"body": 13, "word": "control", "fig": 2}, {"body": 13, "word": "electroporation", "fig": 2}, {"body": 7, "word": "GFP", "fig": 3}, {"body": 9, "word": "vector", "fig": 2}, {"body": 17, "word": "chicken", "fig": 1}, {"body": 14, "word": "used", "fig": 1}, {"body": 12, "word": "protein", "fig": 1}, {"body": 12, "word": "IR", "fig": 1}, {"body": 9, "word": "embryonic", "fig": 1}, {"body": 7, "word": "d", "fig": 1}, {"body": 5, "word": "side", "fig": 1}, {"body": 5, "word": "basal", "fig": 1}, {"body": 3, "word": "Overexpression", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 2, "word": "h.", "fig": 1}, {"body": 2, "word": "immunohistochemistry", "fig": 1}, {"body": 2, "word": "analyse", "fig": 1}, {"body": 2, "word": "line", "fig": 1}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "layer", "fig": 1}, {"body": 1, "word": "Control", "fig": 1}, {"body": 1, "word": "ganglion", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "b", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991769/bin/cddiscovery201523-f2.jpg", "caption": "The effect of mZac1 overexpression on the cell cycle regulators p21 and p27. Quantitative RT-PCR analysis of mRNA expression. (a) Relative levels of p21 mRNA in non-treated or electroporated (mZac1 or control vector) st22 retinas after 24 and 48 h. (b) Relative levels of p21 mRNA in non-treated, electroporated (mZac1 or control vector) and cyclic Pifithrin-\u03b1-treated st22 retinas after 24 h. (c) Relative levels of mZac1 mRNA in non-treated, electroporated (mZac1- or control vector) and cyclic Pifithrin-\u03b1 treated st22 retinas after 24 h. (d) Relative levels of p27 mRNA in electroporated st22 retinas after 24 and 48 h. Control: GFP vector, PFT: cyclic Pifithrin-\u03b1. One-way analysis of variance followed by Tukey\u2019s multiple comparison post-hoc test (a\u2013c) or Student\u2019s t-test (d), *P<0.05, **P<0.01, ***P<0.001, N\u22654, mean\u00b1S.D.", "co_occurrence": [{"body": 72, "word": "mZac1", "fig": 4}, {"body": 24, "word": "mRNA", "fig": 5}, {"body": 22, "word": "retinas", "fig": 4}, {"body": 19, "word": "levels", "fig": 4}, {"body": 23, "word": "p21", "fig": 3}, {"body": 56, "word": "cell", "fig": 1}, {"body": 14, "word": "electroporated", "fig": 4}, {"body": 51, "word": "The", "fig": 1}, {"body": 40, "word": "cycle", "fig": 1}, {"body": 13, "word": "control", "fig": 3}, {"body": 9, "word": "vector", "fig": 4}, {"body": 34, "word": "expression", "fig": 1}, {"body": 7, "word": "cyclic", "fig": 3}, {"body": 20, "word": "overexpression", "fig": 1}, {"body": 7, "word": "Pifithrin-\u03b1", "fig": 2}, {"body": 7, "word": "d", "fig": 2}, {"body": 7, "word": "analysis", "fig": 2}, {"body": 9, "word": "effect", "fig": 1}, {"body": 4, "word": "p27", "fig": 2}, {"body": 2, "word": "h.", "fig": 4}, {"body": 7, "word": "GFP", "fig": 1}, {"body": 2, "word": "non-treated", "fig": 3}, {"body": 4, "word": "followed", "fig": 1}, {"body": 3, "word": "treated", "fig": 1}, {"body": 3, "word": "multiple", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "post-hoc", "fig": 1}, {"body": 1, "word": "Tukey\u2019s", "fig": 1}, {"body": 1, "word": "test", "fig": 1}, {"body": 1, "word": "mZac1-", "fig": 1}, {"body": 1, "word": "Control", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "b", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991769/bin/cddiscovery201523-f3.jpg", "caption": "Overexpression of mZac1 induced apoptosis. Apoptosis was analysed by immunohistochemical detection of C-Casp-3+ and TUNEL in mZac1 or control electroporated retinas. C-casp-3+ IR cells were counted. (a) Relative density of C-Casp-3+ cells in retinas counted at 24, 48 and 72 h after electroporation. (b and c) Fluorescence micrographs showing mZac1 and C-Casp-3 IR in mZac1 electroporated st22 retinas, and GFP and C-Casp3 IR in control electroporated st22 retinas, analysed after 72 h. (d) mZac1 IR and TUNEL staining in retinas electroporated at st22 and analysed after 72 h. Arrow heads indicate double-positive cells. Control: GFP vector, gcl: ganglion cell layer. Student\u2019s t-test, *P<0.05, ***P<0.001, N\u22654, mean\u00b1S.D.", "co_occurrence": [{"body": 72, "word": "mZac1", "fig": 5}, {"body": 83, "word": "cells", "fig": 3}, {"body": 22, "word": "retinas", "fig": 5}, {"body": 22, "word": "analysed", "fig": 3}, {"body": 56, "word": "cell", "fig": 1}, {"body": 14, "word": "electroporated", "fig": 4}, {"body": 25, "word": "counted", "fig": 2}, {"body": 12, "word": "IR", "fig": 4}, {"body": 29, "word": "h", "fig": 1}, {"body": 13, "word": "control", "fig": 2}, {"body": 7, "word": "GFP", "fig": 2}, {"body": 13, "word": "electroporation", "fig": 1}, {"body": 10, "word": "apoptosis", "fig": 1}, {"body": 9, "word": "vector", "fig": 1}, {"body": 4, "word": "TUNEL", "fig": 2}, {"body": 7, "word": "d", "fig": 1}, {"body": 6, "word": "induced", "fig": 1}, {"body": 5, "word": "C-Casp-3", "fig": 1}, {"body": 5, "word": "double-positive", "fig": 1}, {"body": 2, "word": "h.", "fig": 2}, {"body": 3, "word": "Overexpression", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "heads", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "layer", "fig": 1}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "ganglion", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "immunohistochemical", "fig": 1}, {"body": 1, "word": "Control", "fig": 1}, {"body": 1, "word": "b", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991769/bin/cddiscovery201523-f4.jpg", "caption": "The effect of mZac1 overexpression on the PRs and the Lim1+ HCs. PRs (Visinin) and HCs (Lim1) were analysed using immunohistochemistry in mZac1 and control electroporated st22 retinas. (a) Relative density of Visinin+ cells 48 h after electroporation. (b and c) Fluorescence micrographs showing Visinin+ and GFP+ cells in mZac1 and control electroporated retinas after 48 h. (d) Relative density of Lim1+ cells in electroporated retinas after 48 h. (e and f) Fluorescence micrographs showing Lim1+ and GFP+ cells in mZac1 and control electroporated retinas after 48 h. Control: GFP vector, gcl: ganglion cell layer, Student\u2019s t-test, *P<0.05, N\u22654, mean\u00b1S.D.", "co_occurrence": [{"body": 83, "word": "cells", "fig": 4}, {"body": 72, "word": "mZac1", "fig": 4}, {"body": 22, "word": "retinas", "fig": 4}, {"body": 56, "word": "cell", "fig": 1}, {"body": 14, "word": "electroporated", "fig": 4}, {"body": 51, "word": "The", "fig": 1}, {"body": 23, "word": "HCs", "fig": 2}, {"body": 14, "word": "Lim1+", "fig": 3}, {"body": 13, "word": "control", "fig": 3}, {"body": 29, "word": "h", "fig": 1}, {"body": 22, "word": "analysed", "fig": 1}, {"body": 20, "word": "overexpression", "fig": 1}, {"body": 8, "word": "PRs", "fig": 2}, {"body": 13, "word": "electroporation", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 9, "word": "effect", "fig": 1}, {"body": 9, "word": "vector", "fig": 1}, {"body": 4, "word": "Visinin+", "fig": 2}, {"body": 4, "word": "GFP+", "fig": 2}, {"body": 7, "word": "d", "fig": 1}, {"body": 7, "word": "GFP", "fig": 1}, {"body": 2, "word": "h.", "fig": 3}, {"body": 6, "word": "Lim1", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 2, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "showing", "fig": 2}, {"body": 2, "word": "f", "fig": 1}, {"body": 1, "word": "layer", "fig": 1}, {"body": 1, "word": "Visinin", "fig": 1}, {"body": 1, "word": "Control", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "ganglion", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991769/bin/cddiscovery201523-f5.jpg", "caption": "The effect of mZac1 overexpression on cell cycle progression of retinal progenitor cells. The cell cycle progression was analysed using EdU incorporation and PH3 IR in mZac1 and control electroporated retinas. (a) Relative density of EdU+ cells in electroporated st22 retinas after 24 h. (b and c) Fluorescence micrographs showing EdU+ cells in retinas electroporated at st22 with mZac1 or the control vector. (d) Relative density of PH3+ cells in electroporated st22 retinas after 24 h. (e) Fluorescence micrographs showing PH3+ cells in retinas electroporated at st22 with the mZac1 vector. (f) Fluorescence micrographs showing Myc-tag (mZac1), Lim1, EdU IR or in retinas electroporated at st25 with the mZac1 overexpression vector. (g) Fluorescence micrographs showing Myc-tag (mZac1), Lim1, PH3 IR in retinas electroporated at st27 with the mZac1 overexpression vector. Arrow heads denote double- or triple-positive cells. Control: GFP vector, gcl: ganglion cell layer. Student\u2019s t-test, *P<0.05, **P<0.01, N\u22654, mean\u00b1S.D.", "co_occurrence": [{"body": 72, "word": "mZac1", "fig": 8}, {"body": 83, "word": "cells", "fig": 6}, {"body": 56, "word": "cell", "fig": 3}, {"body": 22, "word": "retinas", "fig": 7}, {"body": 51, "word": "The", "fig": 2}, {"body": 14, "word": "electroporated", "fig": 7}, {"body": 40, "word": "cycle", "fig": 2}, {"body": 20, "word": "overexpression", "fig": 3}, {"body": 9, "word": "vector", "fig": 5}, {"body": 12, "word": "IR", "fig": 3}, {"body": 13, "word": "control", "fig": 2}, {"body": 26, "word": "retinal", "fig": 1}, {"body": 22, "word": "analysed", "fig": 1}, {"body": 10, "word": "EdU", "fig": 2}, {"body": 7, "word": "PH3", "fig": 2}, {"body": 7, "word": "Myc-tag", "fig": 2}, {"body": 6, "word": "Lim1", "fig": 2}, {"body": 10, "word": "progenitor", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 9, "word": "effect", "fig": 1}, {"body": 7, "word": "d", "fig": 1}, {"body": 7, "word": "GFP", "fig": 1}, {"body": 2, "word": "h.", "fig": 2}, {"body": 1, "word": "showing", "fig": 4}, {"body": 2, "word": "progression", "fig": 2}, {"body": 3, "word": "st27", "fig": 1}, {"body": 2, "word": "heads", "fig": 1}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "EdU+", "fig": 2}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "layer", "fig": 1}, {"body": 1, "word": "ganglion", "fig": 1}, {"body": 1, "word": "st25", "fig": 1}, {"body": 1, "word": "Control", "fig": 1}, {"body": 1, "word": "g", "fig": 1}, {"body": 1, "word": "incorporation", "fig": 1}, {"body": 1, "word": "b", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991769/bin/cddiscovery201523-f6.jpg", "caption": "Low expression of chZac1 in the developing and injured retina. Expression of endogenous chZac1 was analysed using qRT-PCR and immunohistochemistry in normally developing and Cisplatin-injured retinas. (a) Relative chZac1 mRNA levels in developing retinas of st18\u201345 chickens. (b and c) Fluorescence micrographs of chZac1+ cells in st20 embryonic retina and in postnatal day 19 chicken cerebellum. (d) Relative chZac1 mRNA levels in non-treated and Cisplatin-treated st29 retinas after 2, 4 and 6 h. (e and f) Fluorescence micrographs showing absence of chZac1 IR in retinas treated at st29 with Cisplatin or vehicle, and analysed after 6 h. LE: lens, gcl: ganglion cell layer, N\u22654, mean\u00b1S.D.", "co_occurrence": [{"body": 22, "word": "retinas", "fig": 4}, {"body": 83, "word": "cells", "fig": 1}, {"body": 14, "word": "chZac1", "fig": 5}, {"body": 56, "word": "cell", "fig": 1}, {"body": 28, "word": "retina", "fig": 2}, {"body": 24, "word": "mRNA", "fig": 2}, {"body": 22, "word": "analysed", "fig": 2}, {"body": 19, "word": "levels", "fig": 2}, {"body": 34, "word": "expression", "fig": 1}, {"body": 17, "word": "chicken", "fig": 1}, {"body": 5, "word": "developing", "fig": 3}, {"body": 12, "word": "IR", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 9, "word": "embryonic", "fig": 1}, {"body": 7, "word": "d", "fig": 1}, {"body": 6, "word": "Cisplatin", "fig": 1}, {"body": 3, "word": "st29", "fig": 2}, {"body": 6, "word": "qRT-PCR", "fig": 1}, {"body": 2, "word": "h.", "fig": 2}, {"body": 3, "word": "treated", "fig": 1}, {"body": 2, "word": "non-treated", "fig": 1}, {"body": 2, "word": "immunohistochemistry", "fig": 1}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "st20", "fig": 1}, {"body": 1, "word": "layer", "fig": 1}, {"body": 1, "word": "endogenous", "fig": 1}, {"body": 1, "word": "ganglion", "fig": 1}, {"body": 1, "word": "injured", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "cerebellum", "fig": 1}, {"body": 1, "word": "Expression", "fig": 1}, {"body": 1, "word": "day", "fig": 1}, {"body": 1, "word": "b", "fig": 1}]}], "4203552": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203552/bin/auto-10-1272-g1.jpg", "caption": "Figure 1. Autophagy causes a decrease in the dNTP pool. (A and B) EBSS and rapamycin decreased dNTP pool levels in Huh-7 cells. Huh-7 cells were treated with EBSS (A) or rapamycin (10 \u03bcM) (B) for 24 h. Cells were harvested and subjected to dNTP analysis. (C) EBSS and rapamycin decreased RNR activity in Huh-7 cells. Huh-7 cells were treated as described in (A) and analyzed for RNR activity. Mean \u00b1 SD from 3 independent experiments was shown. (*P < 0.05 vs. control). (D and E) EBSS and rapamycin induced autophagy in Huh-7 cells. Huh-7 cells were treated with EBSS (D) or rapamycin (10 \u03bcM) (E) for 24 h. The whole-cell lysates were subjected to western blotting to assess the expression of SQSTM1 and MAP1LC3. ACTB was used as a control to ensure equal loading in each lane. Ctrl, control; Rap, rapamycin.", "co_occurrence": [{"body": 88, "word": "cells", "fig": 6}, {"body": 24, "word": "rapamycin", "fig": 6}, {"body": 44, "word": "dNTP", "fig": 3}, {"body": 19, "word": "Huh-7", "fig": 6}, {"body": 77, "word": "autophagy", "fig": 1}, {"body": 19, "word": "control", "fig": 3}, {"body": 23, "word": "activity", "fig": 2}, {"body": 9, "word": "EBSS", "fig": 5}, {"body": 22, "word": "RNR", "fig": 2}, {"body": 42, "word": "The", "fig": 1}, {"body": 18, "word": "pool", "fig": 2}, {"body": 34, "word": "levels", "fig": 1}, {"body": 9, "word": "treated", "fig": 3}, {"body": 7, "word": "A", "fig": 3}, {"body": 19, "word": "decrease", "fig": 1}, {"body": 8, "word": "decreased", "fig": 2}, {"body": 7, "word": "h.", "fig": 2}, {"body": 6, "word": "\u03bcM", "fig": 2}, {"body": 9, "word": "shown", "fig": 1}, {"body": 9, "word": "SQSTM1", "fig": 1}, {"body": 8, "word": "lane", "fig": 1}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "Figure", "fig": 1}, {"body": 5, "word": "expression", "fig": 1}, {"body": 5, "word": "Autophagy", "fig": 1}, {"body": 4, "word": "vs.", "fig": 1}, {"body": 4, "word": "induced", "fig": 1}, {"body": 3, "word": "MAP1LC3", "fig": 1}, {"body": 3, "word": "ACTB", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 1, "word": "E", "fig": 2}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "ensure", "fig": 1}, {"body": 1, "word": "described", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203552/bin/auto-10-1272-g2.jpg", "caption": "Figure 2. RNR inhibition by knockdown of RRM2 or hydroxyurea treatment induces autophagy in human cancer cells. (A) Knockdown of RRM2 induced autophagy in Huh-7, KB, H460, and Tu212 cells. Western blotting was performed to determine RRM2 expression, SQSTM1 degradation, and MAP1LC3-II accumulation in Huh-7, KB, H460, and Tu212 cells by depletion of RRM2 with specific siRNAs for 48 h. ACTB was used as an internal control to ensure that equal amounts of proteins were loaded in each lane. Ctrl, control. (B and C) Knockdown of RRM2 decreased dNTP pool levels and RNR activity in Huh-7 cells. Huh-7 cells were treated with control siRNA or RRM2 siRNA for 48 h. Cells were harvested for dNTPs (B) and RR activity (C) analysis. (D) Hydroxyurea treatment upregulated MAP1LC3-II and downregulated SQSTM1 in Huh-7 cells. Huh-7 cells were treated with hydroxyurea (0.5 mM, 24 h) and then whole-cell lysates were subjected to western blotting to assess the expression of MAP1LC3 and SQSTM1. ACTB was used as an internal control to ensure equal loading in each lane. (E and F) Hydroxyurea decreased dNTP pool levels and RNR activity in Huh-7 cells. Huh-7 cells were treated with hydroxyurea (0.5 mM, 24 h), and dNTP levels (E) and RNR activity (F) were analyzed. (G) Knockdown of RRM2 induced GFP-LC3 puncta in Huh7 cells. GFP-LC3 expressing cells derived from Huh-7 cell line were transfected with non-silencing control-siRNA or RRM2-siRNA and incubated at 37 \u00b0C for 48 h. Cells were fixed, stained with DAPI and examined by fluorescence microscopy. Representative merged photographs are shown. (H) TEM images verified autophagic vesicles or autophagosomes induced by si-RRM2 in Huh-7 cells. TEM images were collected by electron microscopy at 48 h post si-RRM2 transfection. The enlarged view shows the presence of typical autophagic vesicles (indicated by an arrow) in si-RRM2-transfected Huh-7 cells. (I) Detection of autophagic flux in RRM2-silenced Huh-7 cells. GFP-LC3 expressing cells derived from Huh-7 cell line were transfected with control-siRNA or RRM2-siRNA. Cells were treated with BafA1 24 h after transfection and incubated for additional 24 h. Fluorescent intensity of GFP-LC3 was measured by FACS analysis 48 h post-transfection.", "co_occurrence": [{"body": 88, "word": "cells", "fig": 15}, {"body": 62, "word": "RRM2", "fig": 7}, {"body": 19, "word": "Huh-7", "fig": 13}, {"body": 77, "word": "autophagy", "fig": 2}, {"body": 44, "word": "dNTP", "fig": 3}, {"body": 34, "word": "levels", "fig": 3}, {"body": 23, "word": "activity", "fig": 4}, {"body": 22, "word": "RNR", "fig": 4}, {"body": 41, "word": "cell", "fig": 2}, {"body": 19, "word": "control", "fig": 4}, {"body": 14, "word": "h", "fig": 5}, {"body": 42, "word": "The", "fig": 1}, {"body": 19, "word": "treatment", "fig": 2}, {"body": 19, "word": "siRNA", "fig": 2}, {"body": 9, "word": "treated", "fig": 4}, {"body": 18, "word": "pool", "fig": 2}, {"body": 8, "word": "GFP-LC3", "fig": 4}, {"body": 14, "word": "incubated", "fig": 2}, {"body": 7, "word": "h.", "fig": 4}, {"body": 14, "word": "mM", "fig": 2}, {"body": 9, "word": "SQSTM1", "fig": 3}, {"body": 7, "word": "autophagic", "fig": 3}, {"body": 20, "word": "cancer", "fig": 1}, {"body": 10, "word": "KB", "fig": 2}, {"body": 19, "word": "dNTPs", "fig": 1}, {"body": 16, "word": "human", "fig": 1}, {"body": 8, "word": "decreased", "fig": 2}, {"body": 8, "word": "used", "fig": 2}, {"body": 8, "word": "lane", "fig": 2}, {"body": 8, "word": "analysis", "fig": 2}, {"body": 7, "word": "Tu212", "fig": 2}, {"body": 13, "word": "\u00b0C", "fig": 1}, {"body": 6, "word": "si-RRM2", "fig": 2}, {"body": 4, "word": "hydroxyurea", "fig": 3}, {"body": 4, "word": "induced", "fig": 3}, {"body": 6, "word": "transfected", "fig": 2}, {"body": 11, "word": "degradation", "fig": 1}, {"body": 5, "word": "microscopy", "fig": 2}, {"body": 5, "word": "expression", "fig": 2}, {"body": 9, "word": "shown", "fig": 1}, {"body": 4, "word": "MAP1LC3-II", "fig": 2}, {"body": 4, "word": "line", "fig": 2}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "Figure", "fig": 1}, {"body": 2, "word": "Cells", "fig": 3}, {"body": 3, "word": "ACTB", "fig": 2}, {"body": 6, "word": "presence", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 5, "word": "inhibition", "fig": 1}, {"body": 5, "word": "autophagosomes", "fig": 1}, {"body": 5, "word": "BafA1", "fig": 1}, {"body": 2, "word": "H460", "fig": 2}, {"body": 4, "word": "fixed", "fig": 1}, {"body": 4, "word": "induces", "fig": 1}, {"body": 2, "word": "expressing", "fig": 2}, {"body": 2, "word": "ensure", "fig": 2}, {"body": 4, "word": "determine", "fig": 1}, {"body": 2, "word": "TEM", "fig": 2}, {"body": 4, "word": "knockdown", "fig": 1}, {"body": 2, "word": "control-siRNA", "fig": 2}, {"body": 2, "word": "RRM2-siRNA", "fig": 2}, {"body": 3, "word": "stained", "fig": 1}, {"body": 3, "word": "electron", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "accumulation", "fig": 1}, {"body": 3, "word": "intensity", "fig": 1}, {"body": 3, "word": "depletion", "fig": 1}, {"body": 3, "word": "MAP1LC3", "fig": 1}, {"body": 3, "word": "additional", "fig": 1}, {"body": 3, "word": "puncta", "fig": 1}, {"body": 3, "word": "fluorescence", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 2, "word": "H", "fig": 1}, {"body": 2, "word": "flux", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "upregulated", "fig": 1}, {"body": 1, "word": "F", "fig": 2}, {"body": 2, "word": "post-transfection", "fig": 1}, {"body": 1, "word": "transfection", "fig": 2}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "derived", "fig": 2}, {"body": 1, "word": "Fluorescent", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "RRM2-silenced", "fig": 1}, {"body": 1, "word": "si-RRM2-transfected", "fig": 1}, {"body": 1, "word": "collected", "fig": 1}, {"body": 1, "word": "Detection", "fig": 1}, {"body": 1, "word": "examined", "fig": 1}, {"body": 1, "word": "I", "fig": 1}, {"body": 1, "word": "FACS", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203552/bin/auto-10-1272-g3.jpg", "caption": "Figure 3. Cancer cells with higher levels of the intracellular dNTPs pool are less responsive to autophagy inducers. (A) Overexpression of RRM2 in KB-M2D and KB-Hur cells. Western blot analysis was performed to determine RRM2 expression in KB, KB-M2D, and KB-Hur cells. (B and C) Increased dNTP pool levels in KB-M2 cells (B) and KB-Hur cells (C). (D) Increased RNR activity in KB-M2 cells and KB-Hur cells. (E and F) KB-M2D (E) and KB-Hur (F) were relatively resistant to rapamycin-treatment. Western blot analysis was performed to determine RRM2 expression, SQSTM1 degradation, and MAP1LC3-II accumulation in KB, KB-M2D, and KB-Hur cells with or without rapamycin-treatment (10 \u03bcM, 24 h). (G) Cell cycle analysis in KB cells with or without rapamycin-treatment (10 \u03bcM, 24 h) (n = 3, Mean \u00b1 SD). (H) The effect of autolysosome or proteasome inhibitors on RRM2 protein level upon autophagy induction by EBSS. Huh-7 cells were treated with BafA1 (10 nM) or MG132 (2 or 10 \u03bcM) in the cells that were treated or untreated with EBSS. Whole-cell lysates were subjected to western blotting to assess the expression of RRM2 and MAP1LC3. ACTB was used as an internal control to ensure equal loading in each lane.", "co_occurrence": [{"body": 88, "word": "cells", "fig": 11}, {"body": 62, "word": "RRM2", "fig": 5}, {"body": 77, "word": "autophagy", "fig": 2}, {"body": 34, "word": "levels", "fig": 2}, {"body": 8, "word": "KB-Hur", "fig": 6}, {"body": 44, "word": "dNTP", "fig": 1}, {"body": 42, "word": "The", "fig": 1}, {"body": 18, "word": "pool", "fig": 2}, {"body": 8, "word": "KB-M2D", "fig": 4}, {"body": 10, "word": "KB", "fig": 3}, {"body": 14, "word": "h", "fig": 2}, {"body": 8, "word": "analysis", "fig": 3}, {"body": 23, "word": "activity", "fig": 1}, {"body": 22, "word": "RNR", "fig": 1}, {"body": 19, "word": "Huh-7", "fig": 1}, {"body": 19, "word": "control", "fig": 1}, {"body": 19, "word": "dNTPs", "fig": 1}, {"body": 6, "word": "\u03bcM", "fig": 3}, {"body": 9, "word": "EBSS", "fig": 2}, {"body": 9, "word": "treated", "fig": 2}, {"body": 16, "word": "level", "fig": 1}, {"body": 16, "word": "intracellular", "fig": 1}, {"body": 15, "word": "induction", "fig": 1}, {"body": 5, "word": "expression", "fig": 3}, {"body": 7, "word": "performed", "fig": 2}, {"body": 13, "word": "protein", "fig": 1}, {"body": 12, "word": "Cell", "fig": 1}, {"body": 11, "word": "degradation", "fig": 1}, {"body": 11, "word": "cycle", "fig": 1}, {"body": 9, "word": "SQSTM1", "fig": 1}, {"body": 4, "word": "blot", "fig": 2}, {"body": 4, "word": "determine", "fig": 2}, {"body": 8, "word": "used", "fig": 1}, {"body": 8, "word": "lane", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "Figure", "fig": 1}, {"body": 3, "word": "without", "fig": 2}, {"body": 5, "word": "BafA1", "fig": 1}, {"body": 2, "word": "Western", "fig": 2}, {"body": 4, "word": "MAP1LC3-II", "fig": 1}, {"body": 2, "word": "Increased", "fig": 2}, {"body": 4, "word": "effect", "fig": 1}, {"body": 3, "word": "ACTB", "fig": 1}, {"body": 3, "word": "accumulation", "fig": 1}, {"body": 3, "word": "MAP1LC3", "fig": 1}, {"body": 3, "word": "upon", "fig": 1}, {"body": 2, "word": "proteasome", "fig": 1}, {"body": 2, "word": "H", "fig": 1}, {"body": 2, "word": "MG132", "fig": 1}, {"body": 2, "word": "ensure", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 1, "word": "F", "fig": 2}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "nM", "fig": 1}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "untreated", "fig": 1}, {"body": 1, "word": "inhibitors", "fig": 1}, {"body": 1, "word": "resistant", "fig": 1}, {"body": 1, "word": "autolysosome", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203552/bin/auto-10-1272-g4.jpg", "caption": "Figure 4. Exogenous supplementation of dNTPs attenuates autophagy induced by rapamycin. (A) Elevated levels of dNTPs rescued the RRM2 level in response to rapamycin. KB cells were treated with rapamycin (Rap 10 \u03bcM) for 24 h, with or without dNMPs (0.02\u20130.2 \u03bcM) pretreatment for 30 min, and then whole-cell lysates were subjected to western blot analysis to assess the expression of MAP1LC3 and RRM2. ACTB was used as an internal control to ensure that equal amounts of proteins were loaded in each lane. (B) Incubation with dNMP increased dNTP pool levels in KB cells in the presence of rapamycin. KB cells were treated with rapamycin (10 \u03bcM) for 24 h, with or without dNMPs (0.2 \u03bcM) pretreatment for 30 min. Cells were then harvested for the dNTP pool assay. Data represents means \u00b1 SD of 3 independent experiments, P represents significant differences between conditions where P < 0.05. (C) dNMP supplements partially reversed phosphorylation of EIF4EBP1 by rapamycin. KB cells were treated with rapamycin (rap 10 \u03bcM) for 24 h, with or without dNMPs (0.2 \u03bcM) pretreatment for 30 min, and whole-cell lysates were subjected to western blot analysis to assess the expression of Phospho-EIF4EBP1, Thr70 (p-EIF4EBP1, Thr70), Phospho-EIF4EBP1, Thr37 and Thr46 (p-EIF4EBP1, Thr37 and Thr46), and total EIF4EBP1. ACTB was used as an internal control to ensure that equal amounts of proteins were loaded in each lane.", "co_occurrence": [{"body": 88, "word": "cells", "fig": 4}, {"body": 24, "word": "rapamycin", "fig": 7}, {"body": 64, "word": "P", "fig": 2}, {"body": 62, "word": "RRM2", "fig": 2}, {"body": 44, "word": "dNTP", "fig": 2}, {"body": 77, "word": "autophagy", "fig": 1}, {"body": 34, "word": "levels", "fig": 2}, {"body": 15, "word": "min", "fig": 3}, {"body": 14, "word": "h", "fig": 3}, {"body": 10, "word": "KB", "fig": 4}, {"body": 19, "word": "control", "fig": 2}, {"body": 19, "word": "dNTPs", "fig": 2}, {"body": 6, "word": "\u03bcM", "fig": 6}, {"body": 18, "word": "pool", "fig": 2}, {"body": 9, "word": "treated", "fig": 3}, {"body": 16, "word": "level", "fig": 1}, {"body": 8, "word": "used", "fig": 2}, {"body": 8, "word": "lane", "fig": 2}, {"body": 8, "word": "analysis", "fig": 2}, {"body": 4, "word": "dNMPs", "fig": 3}, {"body": 5, "word": "expression", "fig": 2}, {"body": 5, "word": "EIF4EBP1", "fig": 2}, {"body": 3, "word": "without", "fig": 3}, {"body": 4, "word": "blot", "fig": 2}, {"body": 8, "word": "increased", "fig": 1}, {"body": 8, "word": "significant", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "Figure", "fig": 1}, {"body": 6, "word": "assay", "fig": 1}, {"body": 3, "word": "proteins", "fig": 2}, {"body": 3, "word": "ACTB", "fig": 2}, {"body": 3, "word": "dNMP", "fig": 2}, {"body": 6, "word": "presence", "fig": 1}, {"body": 2, "word": "Thr46", "fig": 2}, {"body": 4, "word": "induced", "fig": 1}, {"body": 2, "word": "ensure", "fig": 2}, {"body": 2, "word": "Thr37", "fig": 2}, {"body": 2, "word": "Thr70", "fig": 2}, {"body": 2, "word": "western", "fig": 2}, {"body": 3, "word": "MAP1LC3", "fig": 1}, {"body": 1, "word": "pretreatment", "fig": 3}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 2, "word": "phosphorylation", "fig": 1}, {"body": 2, "word": "supplements", "fig": 1}, {"body": 2, "word": "reversed", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "attenuates", "fig": 1}, {"body": 1, "word": "supplementation", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "differences", "fig": 1}, {"body": 1, "word": "partially", "fig": 1}, {"body": 1, "word": "response", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203552/bin/auto-10-1272-g5.jpg", "caption": "Figure 5. The rapamycin-induced reduction of dNTP levels was alleviated by inhibition of autophagy. Huh-7 cells were transduced with lentiviruses expressing non-silencing shRNA (shNS) or shBECN1. Stable cell lines were established after puromycin selection. Cells were treated with 10 \u03bcM rapamycin or DMSO (control) for 24 h. Concentration of each dNTP in (A) shNS or (B) shBECN1 cells was measured and plotted as % of DMSO control. (n = 4, mean \u00b1 SD).", "co_occurrence": [{"body": 88, "word": "cells", "fig": 2}, {"body": 44, "word": "dNTP", "fig": 2}, {"body": 77, "word": "autophagy", "fig": 1}, {"body": 42, "word": "The", "fig": 1}, {"body": 41, "word": "cell", "fig": 1}, {"body": 19, "word": "control", "fig": 2}, {"body": 34, "word": "levels", "fig": 1}, {"body": 24, "word": "rapamycin", "fig": 1}, {"body": 19, "word": "Huh-7", "fig": 1}, {"body": 13, "word": "reduction", "fig": 1}, {"body": 9, "word": "treated", "fig": 1}, {"body": 7, "word": "h.", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "Figure", "fig": 1}, {"body": 6, "word": "rapamycin-induced", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 6, "word": "\u03bcM", "fig": 1}, {"body": 3, "word": "DMSO", "fig": 2}, {"body": 5, "word": "inhibition", "fig": 1}, {"body": 1, "word": "shNS", "fig": 2}, {"body": 2, "word": "established", "fig": 1}, {"body": 1, "word": "shBECN1", "fig": 2}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "shRNA", "fig": 1}, {"body": 1, "word": "transduced", "fig": 1}, {"body": 1, "word": "lines", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203552/bin/auto-10-1272-g6.jpg", "caption": "Figure 6. Treatment of RRM2 siRNA induced autophagy in human cancers grafted in NOD-SCID mice. (A) RRM2 siRNA induces autophagy in vivo. RRM2, MKI67, and MAP1LC3B levels in xenografted tumor sections of vehicle-, scrambled siRNA-, and RRM2 siRNA-treated mice were visualized by immunohistochemical analyses. (B) Knockdown of RRM2 upregulates selected ATG gene transcript abundance in xenograft tumors. Selected mRNA expression levels of RRM2, MAP1LC3B, SQSTM1, ATG5, BECN1, ATG7, and ATG12 in xenografted tumor tissues of vehicle-, scrambled siRNA-, and RRM2 siRNA-treated mice were assayed by qRT-PCR analyses. (C) Decreased RNR activity in tumor xenografts treated with RRM2 siRNA. RNR activity in respective xenografted tumor tissues of vehicle-, scrambled siRNA-, and siRNA-treated mouse was assayed. (D) Decreased dNTP pool levels in tumor xenografts treated with RRM2 siRNA. Levels of dNTPs in tumor tissues of vehicle-, scrambled siRNA-, and RRM2 siRNA-treated mice were analyzed and compared. Data of column represents means \u00b1 SD of 3 independent experiments (*P < 0.05 vs. vehicle-treated group).", "co_occurrence": [{"body": 62, "word": "RRM2", "fig": 10}, {"body": 77, "word": "autophagy", "fig": 2}, {"body": 34, "word": "levels", "fig": 3}, {"body": 19, "word": "siRNA", "fig": 4}, {"body": 10, "word": "tumor", "fig": 6}, {"body": 23, "word": "activity", "fig": 2}, {"body": 44, "word": "dNTP", "fig": 1}, {"body": 22, "word": "RNR", "fig": 2}, {"body": 8, "word": "mice", "fig": 4}, {"body": 19, "word": "dNTPs", "fig": 1}, {"body": 9, "word": "treated", "fig": 2}, {"body": 18, "word": "pool", "fig": 1}, {"body": 16, "word": "human", "fig": 1}, {"body": 6, "word": "MAP1LC3B", "fig": 2}, {"body": 3, "word": "siRNA-treated", "fig": 4}, {"body": 5, "word": "analyses", "fig": 2}, {"body": 10, "word": "compared", "fig": 1}, {"body": 3, "word": "xenografted", "fig": 3}, {"body": 3, "word": "tissues", "fig": 3}, {"body": 9, "word": "SQSTM1", "fig": 1}, {"body": 8, "word": "vivo", "fig": 1}, {"body": 7, "word": "BECN1", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "Figure", "fig": 1}, {"body": 6, "word": "group", "fig": 1}, {"body": 3, "word": "xenografts", "fig": 2}, {"body": 5, "word": "tumors", "fig": 1}, {"body": 5, "word": "expression", "fig": 1}, {"body": 4, "word": "induces", "fig": 1}, {"body": 4, "word": "induced", "fig": 1}, {"body": 4, "word": "mRNA", "fig": 1}, {"body": 4, "word": "vs.", "fig": 1}, {"body": 1, "word": "scrambled", "fig": 4}, {"body": 3, "word": "ATG12", "fig": 1}, {"body": 3, "word": "qRT-PCR", "fig": 1}, {"body": 3, "word": "xenograft", "fig": 1}, {"body": 3, "word": "sections", "fig": 1}, {"body": 3, "word": "ATG5", "fig": 1}, {"body": 2, "word": "visualized", "fig": 1}, {"body": 2, "word": "ATG7", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "NOD-SCID", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "column", "fig": 1}, {"body": 2, "word": "gene", "fig": 1}, {"body": 1, "word": "assayed", "fig": 2}, {"body": 2, "word": "transcript", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "MKI67", "fig": 1}, {"body": 1, "word": "upregulates", "fig": 1}, {"body": 1, "word": "mouse", "fig": 1}, {"body": 1, "word": "immunohistochemical", "fig": 1}]}], "4764856": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764856/bin/srep21602-f1.jpg", "caption": "Smad3 is preferentially localized in the nucleus. (a) Subcellular localization of GFP-Smad2 and GFP-Smad3 in human embryonic stem cells, HEK 293 cells and human embryonic fibroblast cells. Scale bar, 10 \u03bcm. (b\u2013d) Western blot for cytosolic and nuclear expression level of endogenous Smad2 and Smad3 in hESCs (b), HEK 293 cells (c), human skin fibroblasts (d). \u03b2-Tubulin and LaminA/C represent cytosolic and nuclear protein control, respectively. A representative image of three independent experiments is shown. (e\u2013g), Quantification data from 3 blots from (b\u2013d), respectively. Data are represented as mean +/\u2212 SEM. Unpaired two-tailed Student\u2019s t-test. *p < 0.05, **p < 0.01. (H), Western blot for cytosolic and nuclear expression of total Smad2/3 in wild type (WT), Smad2 or Smad3 knockout (KO) HEK 293 cell lines. \u03b2-Tubulin and LaminA/C represent cytosolic and nuclear protein control, respectively.", "co_occurrence": [{"body": 125, "word": "Smad3", "fig": 3}, {"body": 92, "word": "Smad2", "fig": 2}, {"body": 41, "word": "cells", "fig": 4}, {"body": 29, "word": "nuclear", "fig": 4}, {"body": 12, "word": "HEK", "fig": 3}, {"body": 10, "word": "human", "fig": 3}, {"body": 11, "word": "embryonic", "fig": 2}, {"body": 21, "word": "nucleus", "fig": 1}, {"body": 18, "word": "GFP-Smad3", "fig": 1}, {"body": 18, "word": "knockout", "fig": 1}, {"body": 9, "word": "expression", "fig": 2}, {"body": 16, "word": "GFP-Smad2", "fig": 1}, {"body": 12, "word": "localization", "fig": 1}, {"body": 6, "word": "protein", "fig": 2}, {"body": 10, "word": "cell", "fig": 1}, {"body": 9, "word": "three", "fig": 1}, {"body": 4, "word": "Western", "fig": 2}, {"body": 7, "word": "data", "fig": 1}, {"body": 6, "word": "localized", "fig": 1}, {"body": 6, "word": "endogenous", "fig": 1}, {"body": 6, "word": "level", "fig": 1}, {"body": 6, "word": "WT", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "type", "fig": 1}, {"body": 6, "word": "lines", "fig": 1}, {"body": 5, "word": "experiments", "fig": 1}, {"body": 4, "word": "c", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 1, "word": "respectively", "fig": 3}, {"body": 3, "word": "stem", "fig": 1}, {"body": 3, "word": "preferentially", "fig": 1}, {"body": 3, "word": "Smad2/3", "fig": 1}, {"body": 2, "word": "skin", "fig": 1}, {"body": 2, "word": "H", "fig": 1}, {"body": 1, "word": "\u03b2-Tubulin", "fig": 2}, {"body": 2, "word": "fibroblasts", "fig": 1}, {"body": 1, "word": "control", "fig": 2}, {"body": 2, "word": "fibroblast", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "wild", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "total", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "hESCs", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764856/bin/srep21602-f2.jpg", "caption": "Nuclear localization of Smad3 is TGF\u03b2 signaling- and Smad4-independent. (a) Western blot for cytosolic and nuclear expression of total Smad2/3, phospho-Smad2 or Smad4 in HEK 293 cells. Cells were infected with Luc or Smad4 RNAi lentivirus to build stable knockdown lines, and were then depleted from serum for 5 hrs, further stimulated with Activin in the presence or absence of SB431542 for 1 hr. A representative image of three independent experiments is shown. (b) Quantification data of the nuclear to cytoplasmic ratio of Smad3. 3 blots. Mean +/\u2212 SEM. Unpaired two-tailed Student\u2019s t-test. (c) Western blot for cytosolic and nuclear expression of total Smad2/3 and phospho-Smad1/5/8 in HEK 293 cells in the presence of SB431542, DMH1 or LDN193189 for 5 hrs. A representative image of three independent experiments is shown. (d) Quantification data of the nuclear to cytoplasmic ratio of Smad2 and Smad3 upon SB431542, DMH1 or LDN193189 treatment. 3 blots. Mean +/\u2212 SEM. Unpaired two-tailed Student\u2019s t-test. **p < 0.01. (e) Confocal images show nuclear accumulation of GFP-Smad3, GFP-Smad3 AAVA mutant (3A) and GFP-Smad3 DDVD mutant (3D). Scale bar, 25 \u03bcm.", "co_occurrence": [{"body": 125, "word": "Smad3", "fig": 3}, {"body": 29, "word": "nuclear", "fig": 5}, {"body": 92, "word": "Smad2", "fig": 1}, {"body": 41, "word": "cells", "fig": 2}, {"body": 29, "word": "Smad4", "fig": 2}, {"body": 18, "word": "GFP-Smad3", "fig": 3}, {"body": 50, "word": "TGF\u03b2", "fig": 1}, {"body": 12, "word": "HEK", "fig": 2}, {"body": 11, "word": "cytoplasmic", "fig": 2}, {"body": 9, "word": "expression", "fig": 2}, {"body": 9, "word": "three", "fig": 2}, {"body": 7, "word": "data", "fig": 2}, {"body": 6, "word": "shown", "fig": 2}, {"body": 12, "word": "localization", "fig": 1}, {"body": 11, "word": "Activin", "fig": 1}, {"body": 10, "word": "show", "fig": 1}, {"body": 5, "word": "experiments", "fig": 2}, {"body": 5, "word": "hrs", "fig": 2}, {"body": 4, "word": "Western", "fig": 2}, {"body": 4, "word": "mutant", "fig": 2}, {"body": 3, "word": "ratio", "fig": 2}, {"body": 3, "word": "Smad2/3", "fig": 2}, {"body": 6, "word": "lines", "fig": 1}, {"body": 2, "word": "SB431542", "fig": 3}, {"body": 5, "word": "upon", "fig": 1}, {"body": 4, "word": "absence", "fig": 1}, {"body": 2, "word": "DMH1", "fig": 2}, {"body": 4, "word": "c", "fig": 1}, {"body": 4, "word": "treatment", "fig": 1}, {"body": 2, "word": "independent", "fig": 2}, {"body": 3, "word": "Smad4-independent", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "RNAi", "fig": 1}, {"body": 3, "word": "hr", "fig": 1}, {"body": 3, "word": "serum", "fig": 1}, {"body": 3, "word": "stimulated", "fig": 1}, {"body": 3, "word": "e", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 1, "word": "LDN193189", "fig": 2}, {"body": 1, "word": "presence", "fig": 2}, {"body": 1, "word": "total", "fig": 2}, {"body": 2, "word": "signaling-", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 1, "word": "A", "fig": 2}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "knockdown", "fig": 1}, {"body": 1, "word": "depleted", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764856/bin/srep21602-f3.jpg", "caption": "Sequestering of Smad3 in the nucleus hinders its role in mediating TGF\u03b2 signals. (a) HEK 293 cells stably expressing GFP, GFP-Smad2 or GFP-Smad3 were stimulated with Activin for 1 hr before lysed for GFP immunoprecipitation. The immunocomplexes as well as the lysates were analyzed by Western blotting with anti-Smad4, anti-phospho-Smad2/3 and anti-GFP, respectively. A representative image of three independent experiments is shown. (b) Confocal images represent N-terminal Flag tagged Smad2 or Smad3, C-terminal Flag tagged Smad2 or Smad3 subcellular distribution. Scale bar, 25 \u03bcm. (c) HEK 293 cells were transiently transfected with Flag-Smad2 or Flag-Smad3 and were stimulated with Activin for 1 hr before immunoprecipitation with the M2 beads. The immunocomplexes as well as the lysates were analyzed by Western blotting with anti-Smad4, anti-phospho-Smad2/3 or anti-Flag, respectively. A representative image of three independent experiments is shown. (d) Wild type, Smad2 knockout and Smad3 knockout HEK 293 FT cells were stimulated with Activin or TGF\u03b21 for 1 hr and cell lysates were analyzed through Western blotting. *represents the nonspecific band. (e,f) Western blot for phospho-Smad2/3 and Smad2/3 expression in human (e) or mouse (f) ESCs derived neuroepithelial cells treated with Activin or TGF\u03b21.", "co_occurrence": [{"body": 125, "word": "Smad3", "fig": 4}, {"body": 92, "word": "Smad2", "fig": 3}, {"body": 41, "word": "cells", "fig": 4}, {"body": 26, "word": "The", "fig": 2}, {"body": 50, "word": "TGF\u03b2", "fig": 1}, {"body": 11, "word": "Activin", "fig": 4}, {"body": 18, "word": "knockout", "fig": 2}, {"body": 12, "word": "HEK", "fig": 3}, {"body": 21, "word": "nucleus", "fig": 1}, {"body": 19, "word": "signals", "fig": 1}, {"body": 19, "word": "distribution", "fig": 1}, {"body": 18, "word": "GFP-Smad3", "fig": 1}, {"body": 9, "word": "three", "fig": 2}, {"body": 18, "word": "ESCs", "fig": 1}, {"body": 9, "word": "GFP", "fig": 2}, {"body": 4, "word": "Western", "fig": 4}, {"body": 16, "word": "GFP-Smad2", "fig": 1}, {"body": 6, "word": "shown", "fig": 2}, {"body": 4, "word": "blotting", "fig": 3}, {"body": 4, "word": "analyzed", "fig": 3}, {"body": 11, "word": "subcellular", "fig": 1}, {"body": 5, "word": "experiments", "fig": 2}, {"body": 10, "word": "human", "fig": 1}, {"body": 10, "word": "cell", "fig": 1}, {"body": 9, "word": "expression", "fig": 1}, {"body": 3, "word": "hr", "fig": 3}, {"body": 9, "word": "mouse", "fig": 1}, {"body": 3, "word": "stimulated", "fig": 3}, {"body": 7, "word": "role", "fig": 1}, {"body": 7, "word": "C-terminal", "fig": 1}, {"body": 6, "word": "beads", "fig": 1}, {"body": 3, "word": "Flag", "fig": 2}, {"body": 6, "word": "type", "fig": 1}, {"body": 3, "word": "e", "fig": 2}, {"body": 6, "word": "mediating", "fig": 1}, {"body": 4, "word": "c", "fig": 1}, {"body": 2, "word": "immunoprecipitation", "fig": 2}, {"body": 2, "word": "independent", "fig": 2}, {"body": 2, "word": "well", "fig": 2}, {"body": 2, "word": "TGF\u03b21", "fig": 2}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "Smad2/3", "fig": 1}, {"body": 1, "word": "lysates", "fig": 3}, {"body": 3, "word": "lysed", "fig": 1}, {"body": 3, "word": "Flag-Smad3", "fig": 1}, {"body": 2, "word": "M2", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 1, "word": "respectively", "fig": 2}, {"body": 2, "word": "FT", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 1, "word": "f", "fig": 2}, {"body": 2, "word": "neuroepithelial", "fig": 1}, {"body": 1, "word": "A", "fig": 2}, {"body": 2, "word": "derived", "fig": 1}, {"body": 1, "word": "stably", "fig": 1}, {"body": 1, "word": "Sequestering", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "N-terminal", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "transiently", "fig": 1}, {"body": 1, "word": "Flag-Smad2", "fig": 1}, {"body": 1, "word": "anti-Flag", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764856/bin/srep21602-f4.jpg", "caption": "The impaired ability of Smad3 in relaying TGF\u03b2 signals results from its distinct MH1 domain and linker region. (a) Schematic representation of Smad2, Smad2 V3 and Smad3 protein alignments. (b,c) Confocal images of GFP-Smad2, GFP-Smad3 and their chimera mutants. Removal of the TID domain, but not the GAG domain, results in Smad2 nuclear accumulation. Insertion of the TID domain in the MH1 region of Smad3 is sufficient to switch the nuclear localized Smad3 into the cytoplasm. Scale bar, 25 \u03bcm. (d,e) HEK 293 cells stably expressing GFP-Smad2, GFP-Smad3 or their chimera mutants were stimulated with Activin for 1 hr before immunoprecipitation with the GFP antibody. The immunocomplexes as well as the lysates were analyzed by Western blotting with anti-phospho-Smad2/3, anti-Smad2/3 or anti-Smad4, respectively. Two representative images from three independent experiments are shown.", "co_occurrence": [{"body": 125, "word": "Smad3", "fig": 4}, {"body": 92, "word": "Smad2", "fig": 3}, {"body": 29, "word": "nuclear", "fig": 2}, {"body": 26, "word": "The", "fig": 2}, {"body": 50, "word": "TGF\u03b2", "fig": 1}, {"body": 11, "word": "domain", "fig": 4}, {"body": 41, "word": "cells", "fig": 1}, {"body": 18, "word": "GFP-Smad3", "fig": 2}, {"body": 16, "word": "TID", "fig": 2}, {"body": 16, "word": "GFP-Smad2", "fig": 2}, {"body": 19, "word": "signals", "fig": 1}, {"body": 9, "word": "region", "fig": 2}, {"body": 6, "word": "results", "fig": 2}, {"body": 6, "word": "MH1", "fig": 2}, {"body": 12, "word": "HEK", "fig": 1}, {"body": 11, "word": "Activin", "fig": 1}, {"body": 11, "word": "linker", "fig": 1}, {"body": 9, "word": "three", "fig": 1}, {"body": 9, "word": "relaying", "fig": 1}, {"body": 9, "word": "GFP", "fig": 1}, {"body": 8, "word": "cytoplasm", "fig": 1}, {"body": 7, "word": "distinct", "fig": 1}, {"body": 6, "word": "localized", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 3, "word": "chimera", "fig": 2}, {"body": 6, "word": "protein", "fig": 1}, {"body": 6, "word": "GAG", "fig": 1}, {"body": 5, "word": "experiments", "fig": 1}, {"body": 5, "word": "ability", "fig": 1}, {"body": 5, "word": "antibody", "fig": 1}, {"body": 5, "word": "V3", "fig": 1}, {"body": 4, "word": "Western", "fig": 1}, {"body": 4, "word": "blotting", "fig": 1}, {"body": 4, "word": "analyzed", "fig": 1}, {"body": 4, "word": "c", "fig": 1}, {"body": 2, "word": "mutants", "fig": 2}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "hr", "fig": 1}, {"body": 3, "word": "e", "fig": 1}, {"body": 3, "word": "stimulated", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "immunoprecipitation", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "well", "fig": 1}, {"body": 1, "word": "Removal", "fig": 1}, {"body": 1, "word": "stably", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "Insertion", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764856/bin/srep21602-f5.jpg", "caption": "Smad2, but not Smad3, is required for TGF\u03b2 signaling regulated epiblast development. (a,b) Western blots for expression of total Smad2/3 from WT, Smad2\u2212/\u2212 or Smad3\u2212/\u2212 mouse ESCs derivatives. (c\u2013e) Representative H&E staining images of teratomas generated from WT, Smad2\u2212/\u2212 and Smad3\u2212/\u2212 mouse ESCs. High magnification images are presented at the right three panels. C, cartilage; G, glomeruli; NT, neurotube; M, muscle; F, fibroblast. (f\u2013h) Quantitative RT-PCR data show loss of FGF5, N-Cadherin, while upregulated E-Cadherin expression in Smad2\u2212/\u2212 teratomas. WT, 7 samples; Smad2\u2212/\u2212, 7 samples; Smad3\u2212/\u2212, 9 Samples. Horizontal line, mean. Unpaired two-tailed Student\u2019s t-test.", "co_occurrence": [{"body": 125, "word": "Smad3", "fig": 1}, {"body": 92, "word": "Smad2", "fig": 1}, {"body": 50, "word": "TGF\u03b2", "fig": 1}, {"body": 18, "word": "ESCs", "fig": 2}, {"body": 12, "word": "Smad3\u2212/\u2212", "fig": 3}, {"body": 6, "word": "Smad2\u2212/\u2212", "fig": 4}, {"body": 23, "word": "signaling", "fig": 1}, {"body": 10, "word": "teratomas", "fig": 2}, {"body": 6, "word": "WT", "fig": 3}, {"body": 9, "word": "mouse", "fig": 2}, {"body": 9, "word": "expression", "fig": 2}, {"body": 11, "word": "development", "fig": 1}, {"body": 10, "word": "show", "fig": 1}, {"body": 9, "word": "three", "fig": 1}, {"body": 8, "word": "epiblast", "fig": 1}, {"body": 7, "word": "data", "fig": 1}, {"body": 4, "word": "Western", "fig": 1}, {"body": 3, "word": "N-Cadherin", "fig": 1}, {"body": 3, "word": "RT-PCR", "fig": 1}, {"body": 3, "word": "E-Cadherin", "fig": 1}, {"body": 3, "word": "presented", "fig": 1}, {"body": 3, "word": "Smad2/3", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "H", "fig": 1}, {"body": 2, "word": "generated", "fig": 1}, {"body": 2, "word": "FGF5", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "required", "fig": 1}, {"body": 2, "word": "fibroblast", "fig": 1}, {"body": 1, "word": "M", "fig": 1}, {"body": 1, "word": "total", "fig": 1}, {"body": 1, "word": "glomeruli", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "muscle", "fig": 1}, {"body": 1, "word": "cartilage", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764856/bin/srep21602-f6.jpg", "caption": "Nuclear localized Smad3 contributes to in vivo neural specification. (a) Quantitative RT-PCR data show lower neural lineage gene expression while higher mesendoderm gene expression in Smad3\u2212/\u2212 teratomas. Quantification data are represented as mean +/\u2212 SEM. Unpaired two-tailed Student\u2019s t-test. *p < 0.05, **p < 0.01. (b) Schematic strategy for Rosa26 locus knockin. SA, splicing acceptor; Puro, puromycin selection sequence; pA, poly A signal; CAG, cytomegalovirus (CMV) enhancer fused to the chicken \u03b2-actin promoter. (c) Representative images of expression efficiency and subcellular localization of GFP-Smad2, GFP-Smad2 V3, GFP-Smad3 and GFP-Smad3 W/TID in Smad3\u2212/\u2212 mouse ESCs. Scale bar, 50 \u03bcm. (d) Confocal images of GFP-Smad2 and GFP-Smad3 W/TID show cytoplasmic distribution pattern, while GFP-Smad3 shows nuclear expression pattern. Hoechst stains for nucleus. Scale bar, 25 \u03bcm. (e\u2013i) Lineage gene expression in teratomas obtained from GFP, GFP-Smad2, GFP-Smad2 V3, GFP-Smad3 and GFP-Smad3 W/TID expressed Smad3\u2212/\u2212 mouse ESCs. Quantification data are represented as mean +/\u2212 SEM. Unpaired two-tailed Student\u2019s t-test. *p < 0.05, **p < 0.01.", "co_occurrence": [{"body": 125, "word": "Smad3", "fig": 1}, {"body": 18, "word": "GFP-Smad3", "fig": 6}, {"body": 16, "word": "GFP-Smad2", "fig": 5}, {"body": 29, "word": "neural", "fig": 2}, {"body": 9, "word": "expression", "fig": 5}, {"body": 13, "word": "gene", "fig": 3}, {"body": 18, "word": "ESCs", "fig": 2}, {"body": 12, "word": "Smad3\u2212/\u2212", "fig": 3}, {"body": 29, "word": "nuclear", "fig": 1}, {"body": 21, "word": "nucleus", "fig": 1}, {"body": 7, "word": "data", "fig": 3}, {"body": 10, "word": "show", "fig": 2}, {"body": 10, "word": "teratomas", "fig": 2}, {"body": 19, "word": "distribution", "fig": 1}, {"body": 9, "word": "mouse", "fig": 2}, {"body": 12, "word": "specification", "fig": 1}, {"body": 12, "word": "localization", "fig": 1}, {"body": 4, "word": "W/TID", "fig": 3}, {"body": 11, "word": "cytoplasmic", "fig": 1}, {"body": 11, "word": "subcellular", "fig": 1}, {"body": 5, "word": "V3", "fig": 2}, {"body": 9, "word": "lineage", "fig": 1}, {"body": 9, "word": "GFP", "fig": 1}, {"body": 6, "word": "localized", "fig": 1}, {"body": 5, "word": "sequence", "fig": 1}, {"body": 4, "word": "vivo", "fig": 1}, {"body": 4, "word": "mesendoderm", "fig": 1}, {"body": 4, "word": "c", "fig": 1}, {"body": 3, "word": "RT-PCR", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "expressed", "fig": 1}, {"body": 3, "word": "obtained", "fig": 1}, {"body": 3, "word": "higher", "fig": 1}, {"body": 3, "word": "lower", "fig": 1}, {"body": 2, "word": "selection", "fig": 1}, {"body": 2, "word": "puromycin", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 1, "word": "pattern", "fig": 2}, {"body": 2, "word": "efficiency", "fig": 1}, {"body": 2, "word": "locus", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "Rosa26", "fig": 1}, {"body": 1, "word": "knockin", "fig": 1}, {"body": 1, "word": "signal", "fig": 1}, {"body": 1, "word": "contributes", "fig": 1}, {"body": 1, "word": "fused", "fig": 1}, {"body": 1, "word": "Hoechst", "fig": 1}, {"body": 1, "word": "A", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764856/bin/srep21602-f7.jpg", "caption": "Smad2 and Smad3 share similar DNA binding motifs but show different transcriptional activities. (a\u2013c) GFP, GFP-Smad2 and GFP-Smad3 constitutively expressed Smad3\u2212/\u2212 mouse ESCs were differentiated to day6 neuroepithelia and collected for Chip-Seq with an anti-GFP antibody. Numbers of aligned peaks are shown in (a). GO analysis is shown in (b). Top matched de novo motifs surrounding Smad2- and Smad3-bound peaks are show in (c), and both Smad2 and Smad3 share similar binding sequence preference. (d) Basal 4 \u00d7 SBE luciferase activity in wild type, Smad2 knockout and Smad3 knockout HEK293 cells. Quantification data are represented as mean +/\u2212 SEM. (e) Basal 4 x SBE luciferase activity in Smad4 knockout HEK293 cells overexpressed with GFP, GFP-Smad2, GFP-Smad3 or their related mutants. Quantification data are represented as mean +/\u2212 SEM. Unpaired two-tailed Student\u2019s t-test. **p < 0.01.", "co_occurrence": [{"body": 125, "word": "Smad3", "fig": 3}, {"body": 92, "word": "Smad2", "fig": 3}, {"body": 41, "word": "cells", "fig": 2}, {"body": 18, "word": "knockout", "fig": 3}, {"body": 18, "word": "GFP-Smad3", "fig": 2}, {"body": 16, "word": "GFP-Smad2", "fig": 2}, {"body": 15, "word": "binding", "fig": 2}, {"body": 29, "word": "Smad4", "fig": 1}, {"body": 10, "word": "show", "fig": 2}, {"body": 9, "word": "activity", "fig": 2}, {"body": 18, "word": "ESCs", "fig": 1}, {"body": 9, "word": "GFP", "fig": 2}, {"body": 7, "word": "similar", "fig": 2}, {"body": 7, "word": "peaks", "fig": 2}, {"body": 7, "word": "data", "fig": 2}, {"body": 6, "word": "shown", "fig": 2}, {"body": 12, "word": "Smad3\u2212/\u2212", "fig": 1}, {"body": 5, "word": "SBE", "fig": 2}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 9, "word": "related", "fig": 1}, {"body": 9, "word": "transcriptional", "fig": 1}, {"body": 9, "word": "mouse", "fig": 1}, {"body": 4, "word": "luciferase", "fig": 2}, {"body": 4, "word": "HEK293", "fig": 2}, {"body": 6, "word": "type", "fig": 1}, {"body": 5, "word": "sequence", "fig": 1}, {"body": 5, "word": "antibody", "fig": 1}, {"body": 5, "word": "DNA", "fig": 1}, {"body": 2, "word": "motifs", "fig": 2}, {"body": 4, "word": "c", "fig": 1}, {"body": 4, "word": "collected", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "expressed", "fig": 1}, {"body": 3, "word": "aligned", "fig": 1}, {"body": 3, "word": "Chip-Seq", "fig": 1}, {"body": 3, "word": "different", "fig": 1}, {"body": 3, "word": "e", "fig": 1}, {"body": 2, "word": "overexpressed", "fig": 1}, {"body": 2, "word": "differentiated", "fig": 1}, {"body": 2, "word": "Smad2-", "fig": 1}, {"body": 2, "word": "x", "fig": 1}, {"body": 2, "word": "surrounding", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "wild", "fig": 1}, {"body": 2, "word": "mutants", "fig": 1}, {"body": 2, "word": "Smad3-bound", "fig": 1}, {"body": 1, "word": "activities", "fig": 1}, {"body": 1, "word": "de", "fig": 1}, {"body": 1, "word": "GO", "fig": 1}, {"body": 1, "word": "novo", "fig": 1}]}], "3774611": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g001.jpg", "caption": "Low glucose induces 661W cell death via the BCL2/BAX pathway. 661W cells were cultured as mentioned in material & methods and then incubated at 1 mM glucose for different time periods (2, 4, 8, 24 and 48 h) or for 48 h at high (25 mM) glucose concentrations. A) Graphic representation of Bcl2, Bcl-XL and Bax mRNA expression normalized by housekeeping genes. Results are expressed as mean \u00b1 SEM of 2 experiments performed in triplicate. B) Western blot of BCL2, BCL-XL and BAX proteins after exposure to 1 mM or 25 mM glucose concentration during 24 or 48 h. Protein amounts were normalized with TUBULIN and compared to 25 mM condition set to 100%. Results are expressed as mean \u00b1 SEM of 3 experiments, *p<0.040. C) Immunoprecipitation analysis of active BAX from cells exposed to 1 mM or 25 mM glucose during 48 h. Left panel showed the expression of total BAX in whole cell lysates, while right panel showed the expression of immunoprecipitated active BAX (black arrow). Immunofluorescence of active BAX (green) is observed in cells incubated at low glucose during 48 h but not at high glucose conditions.", "co_occurrence": [{"body": 57, "word": "glucose", "fig": 7}, {"body": 29, "word": "mM", "fig": 7}, {"body": 56, "word": "cells", "fig": 3}, {"body": 39, "word": "661W", "fig": 2}, {"body": 20, "word": "h", "fig": 3}, {"body": 55, "word": "low", "fig": 1}, {"body": 26, "word": "cell", "fig": 2}, {"body": 26, "word": "showed", "fig": 2}, {"body": 16, "word": "expression", "fig": 3}, {"body": 6, "word": "BAX", "fig": 5}, {"body": 26, "word": "conditions", "fig": 1}, {"body": 19, "word": "death", "fig": 1}, {"body": 5, "word": "active", "fig": 3}, {"body": 15, "word": "cultured", "fig": 1}, {"body": 13, "word": "proteins", "fig": 1}, {"body": 13, "word": "observed", "fig": 1}, {"body": 13, "word": "pathway", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 5, "word": "expressed", "fig": 2}, {"body": 5, "word": "high", "fig": 2}, {"body": 10, "word": "BCL2", "fig": 1}, {"body": 9, "word": "analysis", "fig": 1}, {"body": 4, "word": "incubated", "fig": 2}, {"body": 4, "word": "SEM", "fig": 2}, {"body": 4, "word": "Results", "fig": 2}, {"body": 3, "word": "mean", "fig": 2}, {"body": 3, "word": "panel", "fig": 2}, {"body": 6, "word": "via", "fig": 1}, {"body": 6, "word": "BCL-XL", "fig": 1}, {"body": 6, "word": "concentration", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 5, "word": "exposure", "fig": 1}, {"body": 4, "word": "Western", "fig": 1}, {"body": 4, "word": "different", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "condition", "fig": 1}, {"body": 3, "word": "Low", "fig": 1}, {"body": 3, "word": "exposed", "fig": 1}, {"body": 3, "word": "periods", "fig": 1}, {"body": 3, "word": "*p", "fig": 1}, {"body": 3, "word": "performed", "fig": 1}, {"body": 1, "word": "h.", "fig": 2}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "genes", "fig": 1}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 2, "word": "BCL2/BAX", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "normalized", "fig": 2}, {"body": 2, "word": "compared", "fig": 1}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "material", "fig": 1}, {"body": 1, "word": "Bax", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g002.jpg", "caption": "Autophagosomes formation is induced by low glucose in 661W cells and retinal explants. 661W cells and retinal explants were cultured as mentioned in material & methods and then incubated at 1 mM glucose for different time periods (2, 4, 8, 24 and 48 h) or for 48 h at high (25 mM) glucose concentrations. A) Western blot of the LC3-II marker of autophagy is representative of 3 different experiments. B) Western blot and quantification of LC3-II expression in retinal explants, cultured at 1 mM or 25 mM glucose. Western blot is representative of 2\u20133 experiments and results are expressed as mean \u00b1 SEM of 5 different retinas for each condition, * p<0.03 and # p<0.0001. C) Electron micrographs showing the effect of low glucose-induced autophagosome accumulation in 661W photoreceptor cells treated 48 h with 1 mM glucose concentration (arrows) compared to normal glucose concentration (25 mM).", "co_occurrence": [{"body": 57, "word": "glucose", "fig": 6}, {"body": 29, "word": "mM", "fig": 6}, {"body": 56, "word": "cells", "fig": 3}, {"body": 39, "word": "661W", "fig": 3}, {"body": 55, "word": "low", "fig": 2}, {"body": 20, "word": "h", "fig": 3}, {"body": 50, "word": "autophagy", "fig": 1}, {"body": 16, "word": "LC3-II", "fig": 2}, {"body": 15, "word": "cultured", "fig": 2}, {"body": 10, "word": "retinal", "fig": 3}, {"body": 16, "word": "expression", "fig": 1}, {"body": 5, "word": "blot", "fig": 3}, {"body": 5, "word": "explants", "fig": 3}, {"body": 13, "word": "induced", "fig": 1}, {"body": 13, "word": "photoreceptor", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 4, "word": "Western", "fig": 3}, {"body": 6, "word": "concentration", "fig": 2}, {"body": 4, "word": "different", "fig": 3}, {"body": 11, "word": "accumulation", "fig": 1}, {"body": 11, "word": "glucose-induced", "fig": 1}, {"body": 9, "word": "normal", "fig": 1}, {"body": 8, "word": "results", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "showing", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "high", "fig": 1}, {"body": 4, "word": "formation", "fig": 1}, {"body": 4, "word": "incubated", "fig": 1}, {"body": 4, "word": "SEM", "fig": 1}, {"body": 4, "word": "effect", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "condition", "fig": 1}, {"body": 3, "word": "periods", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "treated", "fig": 1}, {"body": 3, "word": "Electron", "fig": 1}, {"body": 1, "word": "p", "fig": 2}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 2, "word": "marker", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "compared", "fig": 1}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "autophagosome", "fig": 1}, {"body": 1, "word": "material", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "retinas", "fig": 1}, {"body": 1, "word": "Autophagosomes", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g003.jpg", "caption": "Low glucose induces autophagic flux through AMPK/RAPTOR/mTOR pathway. 661W cells were cultured as mentioned in material & methods, and then incubated at low (1 mM) or high (25 mM) glucose for 24 or 48 h. A) Western blot showed the phosphorylation and the expression of mTOR and is representative of three different experiments. B) Western blot showed the phosphorylation and the expression of AMPK. Quantifications of pAMPK/AMPK ratio are expressed as mean \u00b1 SEM of 3 experiments (n = 8), * p<0.035. C) Western blot showed the phosphorylation and the expression of RAPTOR. Oligomycin (Olig) was used at for positive control induction of pRAPTOR. Quantifications of pRAPTOR/TUBULIN ratio are expressed as mean \u00b1 SEM of 3 experiments (n = 8), # p<0.019.", "co_occurrence": [{"body": 57, "word": "glucose", "fig": 2}, {"body": 26, "word": "showed", "fig": 3}, {"body": 29, "word": "mM", "fig": 2}, {"body": 56, "word": "cells", "fig": 1}, {"body": 55, "word": "low", "fig": 1}, {"body": 16, "word": "expression", "fig": 3}, {"body": 39, "word": "661W", "fig": 1}, {"body": 8, "word": "phosphorylation", "fig": 3}, {"body": 6, "word": "experiments", "fig": 3}, {"body": 17, "word": "autophagic", "fig": 1}, {"body": 5, "word": "blot", "fig": 3}, {"body": 15, "word": "cultured", "fig": 1}, {"body": 13, "word": "pathway", "fig": 1}, {"body": 13, "word": "used", "fig": 1}, {"body": 4, "word": "Western", "fig": 3}, {"body": 11, "word": "mTOR", "fig": 1}, {"body": 5, "word": "expressed", "fig": 2}, {"body": 10, "word": "AMPK", "fig": 1}, {"body": 4, "word": "SEM", "fig": 2}, {"body": 6, "word": "positive", "fig": 1}, {"body": 3, "word": "ratio", "fig": 2}, {"body": 3, "word": "mean", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 5, "word": "high", "fig": 1}, {"body": 5, "word": "induction", "fig": 1}, {"body": 5, "word": "flux", "fig": 1}, {"body": 4, "word": "different", "fig": 1}, {"body": 4, "word": "incubated", "fig": 1}, {"body": 3, "word": "Low", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "p", "fig": 2}, {"body": 2, "word": "AMPK/RAPTOR/mTOR", "fig": 1}, {"body": 2, "word": "RAPTOR", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "pRAPTOR/TUBULIN", "fig": 1}, {"body": 1, "word": "material", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "pAMPK/AMPK", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g004.jpg", "caption": "Low glucose induces a decrease in LAMP2 expression. 661W cells were cultured as mentioned in material & methods, and then incubated at low (1 mM) or high (25 mM) glucose for diverse periods of time. A) Quantification of Lamp2 mRNA by qPCR analysis, RL8 gene was used to normalize gene expression. Results are expressed as mean \u00b1 SEM of 3 experiments, * p<0.02 and # p<0.0008. B) Western blot analysis of LAMP2a protein expression. Results are expressed as mean \u00b1 SEM of 3 experiments, * p<0.03 and #p<0.001. C) Immunofluorescence staining of LAMP2a (green) in 661W cells cultured at 1 mM and 25 mM glucose concentration. D) Western blot analysis and quantification of p62 in 661W cells, western blot is representative of three experiments performed in triplicate and results are expressed as mean \u00b1 SEM, ** p<0.0011. E) Western blot and quantification of p62 expression in retinal explants, cultured at 1 mM or 25 mM glucose. Western blot is representative of 2\u20133 experiments and results are expressed as mean \u00b1 SEM of 5 different retinas for each condition, * p<0.002.", "co_occurrence": [{"body": 57, "word": "glucose", "fig": 4}, {"body": 29, "word": "mM", "fig": 6}, {"body": 56, "word": "cells", "fig": 3}, {"body": 39, "word": "661W", "fig": 3}, {"body": 16, "word": "expression", "fig": 4}, {"body": 55, "word": "low", "fig": 1}, {"body": 15, "word": "cultured", "fig": 3}, {"body": 9, "word": "analysis", "fig": 3}, {"body": 5, "word": "blot", "fig": 5}, {"body": 6, "word": "experiments", "fig": 4}, {"body": 21, "word": "decrease", "fig": 1}, {"body": 5, "word": "expressed", "fig": 4}, {"body": 17, "word": "protein", "fig": 1}, {"body": 8, "word": "results", "fig": 2}, {"body": 4, "word": "Western", "fig": 4}, {"body": 4, "word": "SEM", "fig": 4}, {"body": 13, "word": "used", "fig": 1}, {"body": 3, "word": "mean", "fig": 4}, {"body": 10, "word": "retinal", "fig": 1}, {"body": 5, "word": "p62", "fig": 2}, {"body": 5, "word": "LAMP2a", "fig": 2}, {"body": 8, "word": "LAMP2", "fig": 1}, {"body": 4, "word": "Results", "fig": 2}, {"body": 1, "word": "p", "fig": 6}, {"body": 6, "word": "concentration", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 5, "word": "Quantification", "fig": 1}, {"body": 5, "word": "explants", "fig": 1}, {"body": 5, "word": "high", "fig": 1}, {"body": 4, "word": "incubated", "fig": 1}, {"body": 4, "word": "western", "fig": 1}, {"body": 4, "word": "different", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "condition", "fig": 1}, {"body": 3, "word": "Low", "fig": 1}, {"body": 3, "word": "periods", "fig": 1}, {"body": 3, "word": "diverse", "fig": 1}, {"body": 3, "word": "performed", "fig": 1}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "qPCR", "fig": 1}, {"body": 1, "word": "quantification", "fig": 2}, {"body": 1, "word": "gene", "fig": 2}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "material", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "Lamp2", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "retinas", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g005.jpg", "caption": "Low glucose-induced LC3-II and p62 accumulation is principally due to a defect of autophagosome/lysosome fusion. 661W cells were cultured as mentioned in material & methods, and then incubated at low (1 mM) or high (25 mM) glucose for 48 h in absence or in presence of fusion inhibitors (10 \u00b5g/ml Pepstatin/E64 and 75 \u00b5M Chloroquine) during the last 4 h. A) Representative western blot analysis of LC3-II protein expression and quantification. Results are expressed as mean \u00b1 SEM of 4 experiments, *p<0.03 (1 mM vs. 25 mM without inhibitors). B) Transfection of 661W cells with a lentivirus expressing the GFP-LC3 chimeric protein and incubation for 48 hrs at 1 mM (a-d) and 25 mM (e-h) glucose in absence (a and e) or in presence of 50 nM Bafilomycin (b and f), 10 \u00b5g/ml Pepstatine/E64 (c and g) and 75 \u00b5M Chloroquine (d and h) for the last 4 h. C) Transfection of 661W cells with a lentivirus vector expressing the mRFP-GFP-LC3 chimeric protein and incubation for 48 h at 1 mM (a\u2013f) and 25 mM (g\u2013l) glucose in absence (a\u2013c and g\u2013i) or in presence (d\u2013f and j\u2013l) of 75 \u00b5M chloroquine during the last 4 h.", "co_occurrence": [{"body": 29, "word": "mM", "fig": 8}, {"body": 57, "word": "glucose", "fig": 3}, {"body": 56, "word": "cells", "fig": 3}, {"body": 39, "word": "661W", "fig": 3}, {"body": 20, "word": "h", "fig": 4}, {"body": 55, "word": "low", "fig": 1}, {"body": 17, "word": "protein", "fig": 3}, {"body": 16, "word": "fusion", "fig": 2}, {"body": 16, "word": "LC3-II", "fig": 2}, {"body": 16, "word": "expression", "fig": 1}, {"body": 15, "word": "cultured", "fig": 1}, {"body": 4, "word": "\u00b5M", "fig": 3}, {"body": 11, "word": "accumulation", "fig": 1}, {"body": 11, "word": "glucose-induced", "fig": 1}, {"body": 11, "word": "defect", "fig": 1}, {"body": 5, "word": "inhibitors", "fig": 2}, {"body": 3, "word": "absence", "fig": 3}, {"body": 3, "word": "presence", "fig": 3}, {"body": 9, "word": "analysis", "fig": 1}, {"body": 4, "word": "expressing", "fig": 2}, {"body": 7, "word": "vector", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 6, "word": "mRFP-GFP-LC3", "fig": 1}, {"body": 3, "word": "\u00b5g/ml", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "p62", "fig": 1}, {"body": 5, "word": "GFP-LC3", "fig": 1}, {"body": 5, "word": "high", "fig": 1}, {"body": 4, "word": "autophagosome/lysosome", "fig": 1}, {"body": 4, "word": "incubated", "fig": 1}, {"body": 4, "word": "SEM", "fig": 1}, {"body": 2, "word": "lentivirus", "fig": 2}, {"body": 4, "word": "western", "fig": 1}, {"body": 4, "word": "Results", "fig": 1}, {"body": 4, "word": "without", "fig": 1}, {"body": 2, "word": "chimeric", "fig": 2}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "Low", "fig": 1}, {"body": 3, "word": "*p", "fig": 1}, {"body": 3, "word": "Bafilomycin", "fig": 1}, {"body": 1, "word": "h.", "fig": 2}, {"body": 1, "word": "Chloroquine", "fig": 2}, {"body": 2, "word": "due", "fig": 1}, {"body": 1, "word": "incubation", "fig": 2}, {"body": 2, "word": "chloroquine", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "nM", "fig": 1}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "material", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "Representative", "fig": 1}, {"body": 1, "word": "vs.", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "g", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}, {"body": 1, "word": "Pepstatine/E64", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g006.jpg", "caption": "3-MA chemical inhibition of autophagy increases low glucose-induced cell death and caspase 3 activity. 661W cells were cultured as mentioned in material & methods, and then incubated at low (1 mM) or high (25 mM) glucose for different periods of time (8 or 48 h). A) TUNEL assay was performed in absence (a, d) or in presence (b, c and e, f) of 600 \u00b5M 3-MA, at 1 mM (a, b, c) or 25 mM (d, e, f) glucose concentrations, for different periods of time as indicated to the left. White arrows show TUNEL positive cells. Quantification of TUNEL positive cells was performed in three different experiments, *p<0.05; #p<0.0001 and **p<0.002 B) Measures of Caspase 3 activity, results are expressed as mean \u00b1 SEM of 3 experiments (n = 13), *p<0.04 and #p<0.0002, and immunostaining of cleaved Caspase 3 in 661W cells incubated at 1 mM (a and b) or 25 mM (c and d) glucose concentrations in absence (a and c) or presence of 600 \u00b5M 3-MA (b and d).", "co_occurrence": [{"body": 56, "word": "cells", "fig": 4}, {"body": 29, "word": "mM", "fig": 6}, {"body": 57, "word": "glucose", "fig": 3}, {"body": 55, "word": "low", "fig": 2}, {"body": 39, "word": "661W", "fig": 2}, {"body": 50, "word": "autophagy", "fig": 1}, {"body": 12, "word": "3-MA", "fig": 3}, {"body": 26, "word": "cell", "fig": 1}, {"body": 12, "word": "activity", "fig": 2}, {"body": 20, "word": "h", "fig": 1}, {"body": 19, "word": "death", "fig": 1}, {"body": 6, "word": "TUNEL", "fig": 3}, {"body": 15, "word": "cultured", "fig": 1}, {"body": 7, "word": "Caspase", "fig": 2}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 12, "word": "inhibition", "fig": 1}, {"body": 12, "word": "caspase", "fig": 1}, {"body": 6, "word": "positive", "fig": 2}, {"body": 4, "word": "different", "fig": 3}, {"body": 11, "word": "glucose-induced", "fig": 1}, {"body": 8, "word": "results", "fig": 1}, {"body": 4, "word": "\u00b5M", "fig": 2}, {"body": 4, "word": "incubated", "fig": 2}, {"body": 4, "word": "time", "fig": 2}, {"body": 3, "word": "absence", "fig": 2}, {"body": 3, "word": "periods", "fig": 2}, {"body": 3, "word": "presence", "fig": 2}, {"body": 3, "word": "performed", "fig": 2}, {"body": 3, "word": "*p", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "Quantification", "fig": 1}, {"body": 5, "word": "high", "fig": 1}, {"body": 1, "word": "c", "fig": 4}, {"body": 2, "word": "concentrations", "fig": 2}, {"body": 4, "word": "SEM", "fig": 1}, {"body": 1, "word": "b", "fig": 4}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 3, "word": "cleaved", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 1, "word": "p", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "**p", "fig": 1}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "material", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "n", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g007.jpg", "caption": "Specific inhibition of ATG5 and ATG7 decrease low glucose-induced LC3-II accumulation. Lentiviruses expressing specific shRNA were used to decrease the expression of ATG5 and ATG7 as described in material & methods, then each clonal cell colony was treated and cultured as mentioned in material & methods. A) Representative western blot analysis of ATG7, and quantification. Results are expressed as mean \u00b1 SEM of 3 experiments performed in triplicate, *p<0.0001. B) Quantification of Atg5 mRNA expression was performed by PCR and results expressed as mean \u00b1 SEM of 2 experiments performed in duplicate, *p<0.002. C) Representative western blot analysis of LC3-II expression in specific ATG7 and ATG5 knockdown cells cultured at 1 mM and 25 mM glucose during 48 h and quantification. Results are expressed as mean \u00b1 SEM of 3\u20134 experiments performed in triplicate, #p<0.0001.", "co_occurrence": [{"body": 29, "word": "mM", "fig": 2}, {"body": 57, "word": "glucose", "fig": 1}, {"body": 56, "word": "cells", "fig": 1}, {"body": 55, "word": "low", "fig": 1}, {"body": 16, "word": "expression", "fig": 3}, {"body": 11, "word": "ATG7", "fig": 4}, {"body": 21, "word": "decrease", "fig": 2}, {"body": 12, "word": "ATG5", "fig": 3}, {"body": 16, "word": "LC3-II", "fig": 2}, {"body": 15, "word": "cultured", "fig": 2}, {"body": 26, "word": "cell", "fig": 1}, {"body": 20, "word": "h", "fig": 1}, {"body": 6, "word": "experiments", "fig": 3}, {"body": 9, "word": "analysis", "fig": 2}, {"body": 5, "word": "expressed", "fig": 3}, {"body": 7, "word": "specific", "fig": 2}, {"body": 13, "word": "used", "fig": 1}, {"body": 12, "word": "described", "fig": 1}, {"body": 4, "word": "SEM", "fig": 3}, {"body": 3, "word": "performed", "fig": 4}, {"body": 12, "word": "inhibition", "fig": 1}, {"body": 11, "word": "glucose-induced", "fig": 1}, {"body": 11, "word": "accumulation", "fig": 1}, {"body": 5, "word": "blot", "fig": 2}, {"body": 3, "word": "mean", "fig": 3}, {"body": 8, "word": "results", "fig": 1}, {"body": 4, "word": "western", "fig": 2}, {"body": 4, "word": "Results", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 3, "word": "*p", "fig": 2}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 5, "word": "Quantification", "fig": 1}, {"body": 4, "word": "expressing", "fig": 1}, {"body": 4, "word": "Atg5", "fig": 1}, {"body": 3, "word": "treated", "fig": 1}, {"body": 2, "word": "clonal", "fig": 1}, {"body": 1, "word": "methods", "fig": 2}, {"body": 2, "word": "PCR", "fig": 1}, {"body": 1, "word": "quantification", "fig": 2}, {"body": 1, "word": "Representative", "fig": 2}, {"body": 1, "word": "material", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "colony", "fig": 1}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "Specific", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g008.jpg", "caption": "Specific ATG5 or ATG7 inhibition induces cell death and caspase 3 activity. 661W cells were cultured as mentioned in material & methods. A) Each clonal cell colony was cultured at 1 mM (g, h, i) or 25 mM (j, k, l) glucose for 48 h prior cell death analysis by TUNEL assay. White arrows show TUNEL positive dying cells and quantification is representative of three distinct experiments, *p<0.005; and #p<0.0001. B) Representative western blot and quantification showing cleaved Caspase 3 expression in ATG5 and ATG7 down-regulated clonal cell cultured at 1 mM and 25 mM glucose concentrations. Western blot is representative of three distinct experiments and quantification expressed as 100% of control (25 mM), **p<0.005 and #p<0.0001.", "co_occurrence": [{"body": 29, "word": "mM", "fig": 5}, {"body": 57, "word": "glucose", "fig": 2}, {"body": 56, "word": "cells", "fig": 2}, {"body": 26, "word": "cell", "fig": 4}, {"body": 15, "word": "cultured", "fig": 3}, {"body": 20, "word": "h", "fig": 2}, {"body": 39, "word": "661W", "fig": 1}, {"body": 19, "word": "death", "fig": 2}, {"body": 12, "word": "ATG5", "fig": 2}, {"body": 11, "word": "ATG7", "fig": 2}, {"body": 16, "word": "expression", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 12, "word": "activity", "fig": 1}, {"body": 6, "word": "TUNEL", "fig": 2}, {"body": 12, "word": "caspase", "fig": 1}, {"body": 12, "word": "inhibition", "fig": 1}, {"body": 5, "word": "blot", "fig": 2}, {"body": 9, "word": "analysis", "fig": 1}, {"body": 7, "word": "Caspase", "fig": 1}, {"body": 6, "word": "positive", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "showing", "fig": 1}, {"body": 5, "word": "prior", "fig": 1}, {"body": 4, "word": "Western", "fig": 1}, {"body": 2, "word": "clonal", "fig": 2}, {"body": 4, "word": "western", "fig": 1}, {"body": 1, "word": "quantification", "fig": 3}, {"body": 3, "word": "*p", "fig": 1}, {"body": 3, "word": "cleaved", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 1, "word": "three", "fig": 2}, {"body": 2, "word": "induces", "fig": 1}, {"body": 1, "word": "p", "fig": 2}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "colony", "fig": 1}, {"body": 1, "word": "Representative", "fig": 1}, {"body": 1, "word": "mentioned", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "material", "fig": 1}, {"body": 1, "word": "Specific", "fig": 1}, {"body": 1, "word": "Each", "fig": 1}, {"body": 1, "word": "**p", "fig": 1}, {"body": 1, "word": "g", "fig": 1}, {"body": 1, "word": "j", "fig": 1}, {"body": 1, "word": "l", "fig": 1}, {"body": 1, "word": "k", "fig": 1}, {"body": 1, "word": "down-regulated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774611/bin/pone.0074162.g009.jpg", "caption": "Diagrammatic pathways involved in low glucose-induced autophagy defect. In high (25 mM) glucose concentration, the BCL-2/BAX ratio is not modified, this lead to very low apoptosis; Moreover, AMPK is inactivated and the mTOR complex is able to inhibit autophagosomes formation. On the opposite, in low glucose (1 mM) condition and after 24 h, the autophagic flux is activated via the AMPK/RAPTOR/mTOR pathway. Moreover, low glucose decreases BCL-XL protein expression, which freeing BAX and leads to apoptosis. Direct implication of BCL-2 family proteins in autophagy was not described in this study (dotted lines), but has been described in literature as modulator of free BECLIN1. Longer exposition to low glucose (48 h) induced a decrease in BCL-2 protein expression, which enhanced the effect on BAX (and possibly on BECLIN1). In parallel low glucose induces a decrease in LAMP2 expression, which impaired the autophagosomes/lysosomes fusion process that normally ends autophagy. Inhibition of elongation/maturation process, either chemically (3-MA) or genetically (ATG5/ATG7 KD) led to apoptosis via an increase of Caspase 3. Low glucose. Lysosomal degradation inhibitors (Chloroquine, Bafilomycin and Pepstatin/E64) induce similar pattern than low glucose. Adapted and modified from [21], [51] and [52].", "co_occurrence": [{"body": 57, "word": "glucose", "fig": 7}, {"body": 55, "word": "low", "fig": 7}, {"body": 50, "word": "autophagy", "fig": 3}, {"body": 29, "word": "mM", "fig": 2}, {"body": 16, "word": "expression", "fig": 3}, {"body": 21, "word": "decrease", "fig": 2}, {"body": 20, "word": "h", "fig": 2}, {"body": 17, "word": "protein", "fig": 2}, {"body": 9, "word": "apoptosis", "fig": 3}, {"body": 12, "word": "described", "fig": 2}, {"body": 11, "word": "process", "fig": 2}, {"body": 10, "word": "In", "fig": 2}, {"body": 19, "word": "increase", "fig": 1}, {"body": 17, "word": "autophagic", "fig": 1}, {"body": 16, "word": "fusion", "fig": 1}, {"body": 13, "word": "proteins", "fig": 1}, {"body": 13, "word": "induced", "fig": 1}, {"body": 13, "word": "autophagosomes", "fig": 1}, {"body": 13, "word": "pathway", "fig": 1}, {"body": 12, "word": "3-MA", "fig": 1}, {"body": 6, "word": "via", "fig": 2}, {"body": 6, "word": "modified", "fig": 2}, {"body": 6, "word": "BAX", "fig": 2}, {"body": 11, "word": "mTOR", "fig": 1}, {"body": 11, "word": "glucose-induced", "fig": 1}, {"body": 11, "word": "defect", "fig": 1}, {"body": 10, "word": "either", "fig": 1}, {"body": 10, "word": "AMPK", "fig": 1}, {"body": 4, "word": "Moreover", "fig": 2}, {"body": 8, "word": "study", "fig": 1}, {"body": 8, "word": "LAMP2", "fig": 1}, {"body": 7, "word": "Caspase", "fig": 1}, {"body": 7, "word": "pathways", "fig": 1}, {"body": 6, "word": "involved", "fig": 1}, {"body": 6, "word": "similar", "fig": 1}, {"body": 6, "word": "BCL-XL", "fig": 1}, {"body": 6, "word": "concentration", "fig": 1}, {"body": 5, "word": "leads", "fig": 1}, {"body": 5, "word": "degradation", "fig": 1}, {"body": 5, "word": "flux", "fig": 1}, {"body": 5, "word": "inhibitors", "fig": 1}, {"body": 5, "word": "family", "fig": 1}, {"body": 5, "word": "high", "fig": 1}, {"body": 4, "word": "activated", "fig": 1}, {"body": 2, "word": "BECLIN1", "fig": 2}, {"body": 4, "word": "led", "fig": 1}, {"body": 4, "word": "formation", "fig": 1}, {"body": 4, "word": "effect", "fig": 1}, {"body": 3, "word": "ratio", "fig": 1}, {"body": 3, "word": "condition", "fig": 1}, {"body": 3, "word": "Low", "fig": 1}, {"body": 3, "word": "Bafilomycin", "fig": 1}, {"body": 2, "word": "pattern", "fig": 1}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "able", "fig": 1}, {"body": 2, "word": "AMPK/RAPTOR/mTOR", "fig": 1}, {"body": 2, "word": "parallel", "fig": 1}, {"body": 1, "word": "decreases", "fig": 1}, {"body": 1, "word": "Inhibition", "fig": 1}, {"body": 1, "word": "induce", "fig": 1}, {"body": 1, "word": "Lysosomal", "fig": 1}, {"body": 1, "word": "implication", "fig": 1}, {"body": 1, "word": "enhanced", "fig": 1}, {"body": 1, "word": "lead", "fig": 1}, {"body": 1, "word": "inactivated", "fig": 1}, {"body": 1, "word": "chemically", "fig": 1}, {"body": 1, "word": "Chloroquine", "fig": 1}, {"body": 1, "word": "inhibit", "fig": 1}, {"body": 1, "word": "complex", "fig": 1}, {"body": 1, "word": "genetically", "fig": 1}, {"body": 1, "word": "opposite", "fig": 1}, {"body": 1, "word": "lines", "fig": 1}]}], "3101807": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101807/bin/cddis201110f1.jpg", "caption": "NPR-A small-interfering RNA (siRNA) induces efficient knockdown of NPR-A in murine ES cells. (a) RT-PCR analysis of ES cells transfected with control siRNA or NPR-A siRNAs, showing knockdown of the NPR-A gene 48 h after siRNA transfection. GAPDH was used as the internal control. (b) Real-time PCR analysis of ES cells treated with control siRNA or NPR-A siRNA2. (c) Western blot analysis of ES cells treated as described in panel a, showing a reduced level of the NPR-A protein 48 h after siRNA transfection. \u03b2-Actin was used as a loading control. Data represent mean\u00b1S.D. (n=3); *P<0.05 (two-tailed t-test)", "co_occurrence": [{"body": 95, "word": "NPR-A", "fig": 6}, {"body": 132, "word": "cells", "fig": 4}, {"body": 127, "word": "ES", "fig": 4}, {"body": 26, "word": "siRNA", "fig": 5}, {"body": 23, "word": "control", "fig": 4}, {"body": 26, "word": "knockdown", "fig": 2}, {"body": 13, "word": "treated", "fig": 2}, {"body": 8, "word": "analysis", "fig": 3}, {"body": 11, "word": "transfection", "fig": 2}, {"body": 11, "word": "h", "fig": 2}, {"body": 8, "word": "used", "fig": 2}, {"body": 13, "word": "murine", "fig": 1}, {"body": 11, "word": "reduced", "fig": 1}, {"body": 8, "word": "PCR", "fig": 1}, {"body": 7, "word": "RT-PCR", "fig": 1}, {"body": 7, "word": "level", "fig": 1}, {"body": 7, "word": "RNA", "fig": 1}, {"body": 6, "word": "protein", "fig": 1}, {"body": 4, "word": "gene", "fig": 1}, {"body": 4, "word": "siRNAs", "fig": 1}, {"body": 3, "word": "b", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 2, "word": "induces", "fig": 1}, {"body": 1, "word": "showing", "fig": 2}, {"body": 2, "word": "c", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "Real-time", "fig": 1}, {"body": 1, "word": "siRNA2", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "small-interfering", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "described", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101807/bin/cddis201110f2.jpg", "caption": "Knockdown of NPR-A reduces the potential for ES cell self-renewal. (a) Morphology of ES cells treated with control siRNA or NPR-A siRNAs at 2 days after transfection in the presence of LIF. (b) Self-renewal assay, AP-staining of ES cells treated as described in panel a, 4 days after transfection. (c) Immunofluorescence images of ES cells treated as in panel a for 72 h, stained with antibodies against Oct4 and counterstained with Hoechst reagent. (d) Western blot analysis of ES cells treated as in panel a, showing reduced protein levels of Oct4 and Nanog 72 h after siRNA transfection. \u03b2-Actin was used as a loading control. (e) Left panels, photographs of the formed colonies after 6 days from culturing at low density in the presence of LIF, stained with AP. AP staining of cells treated as in panel a. It must be noted that the staining intensity of NPR-A siRNA-treated cells is decreased. Right panels, high-magnification images of AP staining. (f) Graph showing quantification of the percentages of AP-positive colonies treated as described in panel e. Data represent mean\u00b1S.D. (n=2) and significant values are indicated; **P<0.01, compared with control (two-tailed t-test). Scale bar=50 \u03bcm", "co_occurrence": [{"body": 132, "word": "cells", "fig": 6}, {"body": 127, "word": "ES", "fig": 5}, {"body": 95, "word": "NPR-A", "fig": 3}, {"body": 13, "word": "treated", "fig": 6}, {"body": 35, "word": "Oct4", "fig": 2}, {"body": 23, "word": "control", "fig": 3}, {"body": 26, "word": "siRNA", "fig": 2}, {"body": 47, "word": "cell", "fig": 1}, {"body": 38, "word": "Nanog", "fig": 1}, {"body": 11, "word": "transfection", "fig": 3}, {"body": 16, "word": "presence", "fig": 2}, {"body": 10, "word": "days", "fig": 3}, {"body": 14, "word": "LIF", "fig": 2}, {"body": 8, "word": "AP", "fig": 3}, {"body": 11, "word": "h", "fig": 2}, {"body": 19, "word": "self-renewal", "fig": 1}, {"body": 9, "word": "colonies", "fig": 2}, {"body": 5, "word": "staining", "fig": 3}, {"body": 15, "word": "siRNA-treated", "fig": 1}, {"body": 14, "word": "levels", "fig": 1}, {"body": 11, "word": "reduced", "fig": 1}, {"body": 9, "word": "compared", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 6, "word": "protein", "fig": 1}, {"body": 2, "word": "stained", "fig": 2}, {"body": 4, "word": "Knockdown", "fig": 1}, {"body": 4, "word": "significant", "fig": 1}, {"body": 4, "word": "siRNAs", "fig": 1}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 3, "word": "culturing", "fig": 1}, {"body": 3, "word": "AP-positive", "fig": 1}, {"body": 3, "word": "b", "fig": 1}, {"body": 2, "word": "decreased", "fig": 1}, {"body": 1, "word": "showing", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "images", "fig": 2}, {"body": 1, "word": "described", "fig": 2}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "low", "fig": 1}, {"body": 2, "word": "formed", "fig": 1}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "potential", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "density", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "counterstained", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "Self-renewal", "fig": 1}, {"body": 1, "word": "Hoechst", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "It", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101807/bin/cddis201110f3.jpg", "caption": "NPR-A knockdown decreases ES pluripotency genes and upregulates differentiation genes. (a) Real-time PCR of mRNA levels of pluripotency genes (Oct4, Nanog and Sox2) after treatment of ES cells with control siRNA or NPR-A siRNA. (b) RT-PCR analysis of ES cells treated as described in panel a, showing expression of stem cell marker genes. GAPDH was used as the internal control. (c) Real-time PCR of ES cells treated as described in panel a, showing mRNA levels of the early differentiation genes, GATA-4 (GATA-binding protein 4), GATA-6 (GATA-binding protein 6), AFP (\u03b1-fetoprotein), Brachyury, nestin, Cdx2 (caudal-type homeobox 2), Hand1 (heart and neural crest derivatives expressed transcript 1) and Eomes (eomesodermin homolog). (d) RT-PCR analysis of ES cells treated as described in panel a, showing mRNA levels of the early differentiation genes. GAPDH was used as the internal control. Data represent mean\u00b1S.D. (n=3); *P<0.05 (two-tailed t-test)", "co_occurrence": [{"body": 127, "word": "ES", "fig": 5}, {"body": 132, "word": "cells", "fig": 4}, {"body": 95, "word": "NPR-A", "fig": 2}, {"body": 29, "word": "differentiation", "fig": 3}, {"body": 12, "word": "genes", "fig": 6}, {"body": 23, "word": "control", "fig": 3}, {"body": 34, "word": "pluripotency", "fig": 2}, {"body": 26, "word": "siRNA", "fig": 2}, {"body": 49, "word": "expression", "fig": 1}, {"body": 47, "word": "cell", "fig": 1}, {"body": 14, "word": "levels", "fig": 3}, {"body": 13, "word": "treated", "fig": 3}, {"body": 38, "word": "Nanog", "fig": 1}, {"body": 35, "word": "Oct4", "fig": 1}, {"body": 26, "word": "knockdown", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 3}, {"body": 8, "word": "PCR", "fig": 2}, {"body": 8, "word": "used", "fig": 2}, {"body": 8, "word": "analysis", "fig": 2}, {"body": 7, "word": "RT-PCR", "fig": 2}, {"body": 13, "word": "expressed", "fig": 1}, {"body": 6, "word": "protein", "fig": 2}, {"body": 4, "word": "early", "fig": 2}, {"body": 6, "word": "treatment", "fig": 1}, {"body": 4, "word": "upregulates", "fig": 1}, {"body": 4, "word": "Sox2", "fig": 1}, {"body": 3, "word": "Cdx2", "fig": 1}, {"body": 3, "word": "marker", "fig": 1}, {"body": 3, "word": "Eomes", "fig": 1}, {"body": 3, "word": "Hand1", "fig": 1}, {"body": 1, "word": "showing", "fig": 3}, {"body": 1, "word": "described", "fig": 3}, {"body": 3, "word": "b", "fig": 1}, {"body": 2, "word": "nestin", "fig": 1}, {"body": 2, "word": "AFP", "fig": 1}, {"body": 1, "word": "Real-time", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "GATA-4", "fig": 1}, {"body": 2, "word": "GATA-6", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "Brachyury", "fig": 1}, {"body": 1, "word": "transcript", "fig": 1}, {"body": 1, "word": "stem", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101807/bin/cddis201110f4.jpg", "caption": "NPR-A knockdown reduced ES cell propagation, prolonged the G1 phase and upregulated phosphorylated Akt in murine ES cells. (a) Quantification of ES cells 48 h after transfection with control siRNA or NPR-A siRNA (n=4). (b) Effect of NPR-A knockdown on cell-cycle progression, showing the percentages of cells in the G1, S and G2/M phases of the cell cycle. (c) Quantification of cell-cycle phases (n=3). (d) RT-PCR analysis of p21 and cyclin D1 mRNA 48 h after ES cell transfection with control siRNA or NPR-A siRNA. (e) Real-time PCR analysis of ES cells treated as described in panel d. (f) Western blot analysis for p21 48 h after siRNA transfection. (g) Western blot analysis for phosphorylated Akt (Ser473; p-Akt) and total Akt 48 h after siRNA transfection. \u03b2-Actin was used as a loading control. (h) Relative levels of the p-Akt protein were quantified after normalization to total Akt. Data represent mean\u00b1S.D. (n=3); *P<0.05 or **P<0.01 (two-tailed t-test)", "co_occurrence": [{"body": 127, "word": "ES", "fig": 5}, {"body": 132, "word": "cells", "fig": 4}, {"body": 95, "word": "NPR-A", "fig": 4}, {"body": 26, "word": "siRNA", "fig": 6}, {"body": 47, "word": "cell", "fig": 3}, {"body": 23, "word": "control", "fig": 3}, {"body": 11, "word": "h", "fig": 5}, {"body": 26, "word": "knockdown", "fig": 2}, {"body": 11, "word": "transfection", "fig": 4}, {"body": 9, "word": "Akt", "fig": 4}, {"body": 8, "word": "analysis", "fig": 4}, {"body": 14, "word": "levels", "fig": 1}, {"body": 13, "word": "murine", "fig": 1}, {"body": 13, "word": "treated", "fig": 1}, {"body": 6, "word": "phosphorylated", "fig": 2}, {"body": 11, "word": "reduced", "fig": 1}, {"body": 5, "word": "p21", "fig": 2}, {"body": 8, "word": "PCR", "fig": 1}, {"body": 4, "word": "cell-cycle", "fig": 2}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "RT-PCR", "fig": 1}, {"body": 3, "word": "G1", "fig": 2}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "protein", "fig": 1}, {"body": 6, "word": "phase", "fig": 1}, {"body": 6, "word": "cycle", "fig": 1}, {"body": 3, "word": "progression", "fig": 1}, {"body": 3, "word": "b", "fig": 1}, {"body": 3, "word": "cyclin", "fig": 1}, {"body": 3, "word": "D1", "fig": 1}, {"body": 1, "word": "blot", "fig": 2}, {"body": 1, "word": "Western", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "phases", "fig": 2}, {"body": 2, "word": "S", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 2}, {"body": 1, "word": "total", "fig": 2}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "Ser473", "fig": 1}, {"body": 2, "word": "upregulated", "fig": 1}, {"body": 1, "word": "Real-time", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "described", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101807/bin/cddis201110f5.jpg", "caption": "ANP is expressed in murine ES cells, and exogenous ANP stimulates ES cell pluripotency factors. (a) Upper panels, double-immunofluorescence images of ES cells cultured in the presence of LIF, stained with antibodies against the ES cell markers, Oct4 and ANP. Lower panels, double-immunofluorescence images of ES cells cultured in the absence of LIF for 5 days, stained with antibodies against Nanog and ANP. It must be noted that ANP signals are downregulated upon differentiation. (b) Western blot analysis for ANP of ES cells treated as described in panels a and b. (c) Real-time PCR analysis of mRNA levels for pluripotency genes 12 h after treatment of ES cells with 2.5 \u03bc ANP. (d) Western blot analysis of Oct4 and Nanog in ES cells treated with ANP for 12 or 24 h. \u03b2-Actin is shown as a control for loading. (e) Western blot analysis for phosphorylated Akt (Ser473; p-Akt) and total Akt 12 h after treatment of ES cells with ANP. (f) Relative levels of the p-Akt protein were quantified after normalized to total Akt. (g) ES cells were treated with LY294002, ANP or ANP+LY294002 for 3 days, followed by staining for alkaline phosphatase (AP). (h) Western blot analysis of Nanog in ES cells treated with LY294002 or ANP+LY294002 for 18 h. (i) Quantitative analysis of the western blots as shown in panel h. Data represent mean\u00b1S.D. (n=3). *P<0.05 or **P<0.01 (two-tailed t-test)", "co_occurrence": [{"body": 127, "word": "ES", "fig": 11}, {"body": 132, "word": "cells", "fig": 9}, {"body": 42, "word": "ANP", "fig": 10}, {"body": 38, "word": "Nanog", "fig": 3}, {"body": 47, "word": "cell", "fig": 2}, {"body": 35, "word": "Oct4", "fig": 2}, {"body": 34, "word": "pluripotency", "fig": 2}, {"body": 13, "word": "treated", "fig": 4}, {"body": 8, "word": "analysis", "fig": 6}, {"body": 11, "word": "h", "fig": 3}, {"body": 29, "word": "differentiation", "fig": 1}, {"body": 14, "word": "LIF", "fig": 2}, {"body": 14, "word": "levels", "fig": 2}, {"body": 9, "word": "Akt", "fig": 3}, {"body": 23, "word": "control", "fig": 1}, {"body": 10, "word": "days", "fig": 2}, {"body": 10, "word": "cultured", "fig": 2}, {"body": 16, "word": "presence", "fig": 1}, {"body": 8, "word": "LY294002", "fig": 2}, {"body": 13, "word": "murine", "fig": 1}, {"body": 13, "word": "expressed", "fig": 1}, {"body": 6, "word": "shown", "fig": 2}, {"body": 12, "word": "genes", "fig": 1}, {"body": 6, "word": "treatment", "fig": 2}, {"body": 9, "word": "factors", "fig": 1}, {"body": 8, "word": "PCR", "fig": 1}, {"body": 8, "word": "AP", "fig": 1}, {"body": 4, "word": "antibodies", "fig": 2}, {"body": 7, "word": "markers", "fig": 1}, {"body": 3, "word": "b", "fig": 2}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "phosphorylated", "fig": 1}, {"body": 6, "word": "protein", "fig": 1}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "western", "fig": 1}, {"body": 1, "word": "blot", "fig": 4}, {"body": 2, "word": "stained", "fig": 2}, {"body": 1, "word": "Western", "fig": 4}, {"body": 4, "word": "downregulated", "fig": 1}, {"body": 4, "word": "exogenous", "fig": 1}, {"body": 1, "word": "h.", "fig": 3}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "images", "fig": 2}, {"body": 2, "word": "c", "fig": 1}, {"body": 1, "word": "total", "fig": 2}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "Ser473", "fig": 1}, {"body": 2, "word": "upon", "fig": 1}, {"body": 1, "word": "absence", "fig": 1}, {"body": 1, "word": "Real-time", "fig": 1}, {"body": 1, "word": "blots", "fig": 1}, {"body": 1, "word": "phosphatase", "fig": 1}, {"body": 1, "word": "alkaline", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "described", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "stimulates", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "It", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101807/bin/cddis201110f6.jpg", "caption": "ANP upregulates Oct4 and Nanog through the NPR-A/PKG-dependent pathway. (a) Representative protein blot of Oct4 and Nanog proteins in ES cells treated with vehicle, ANP alone or ANP and anantin. (b) Quantitative analysis of the western blots as shown in panel a. (c) Representative protein blot of Oct4 and Nanog proteins in ES cells treated with vehicle, ANP alone or ANP and a PKG inhibitor (KT5823). (d) Quantitative analysis of the western blots as shown in panel c. (e) Western blot analysis of Oct4 and Nanog in ES cells treated with anantin for 3 days. (f) Western blot analysis of Oct4 and Nanog in ES cells treated with KT5823 for 3 days. Data represent mean\u00b1S.D. (n=3). *P<0.05 or **P<0.01 (two-tailed t-test)", "co_occurrence": [{"body": 132, "word": "cells", "fig": 4}, {"body": 127, "word": "ES", "fig": 4}, {"body": 42, "word": "ANP", "fig": 5}, {"body": 38, "word": "Nanog", "fig": 5}, {"body": 35, "word": "Oct4", "fig": 5}, {"body": 13, "word": "treated", "fig": 4}, {"body": 8, "word": "analysis", "fig": 4}, {"body": 10, "word": "days", "fig": 2}, {"body": 6, "word": "protein", "fig": 2}, {"body": 6, "word": "shown", "fig": 2}, {"body": 12, "word": "pathway", "fig": 1}, {"body": 5, "word": "anantin", "fig": 2}, {"body": 5, "word": "western", "fig": 2}, {"body": 8, "word": "inhibitor", "fig": 1}, {"body": 3, "word": "KT5823", "fig": 2}, {"body": 3, "word": "alone", "fig": 2}, {"body": 5, "word": "PKG", "fig": 1}, {"body": 4, "word": "upregulates", "fig": 1}, {"body": 1, "word": "blot", "fig": 4}, {"body": 2, "word": "vehicle", "fig": 2}, {"body": 3, "word": "b", "fig": 1}, {"body": 1, "word": "Western", "fig": 2}, {"body": 1, "word": "blots", "fig": 2}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "f", "fig": 1}, {"body": 1, "word": "proteins", "fig": 2}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101807/bin/cddis201110f7.jpg", "caption": "Proposed model of NPR-A signaling-mediated maintenance of ES cell self-renewal and pluripotency. Activation of NPR-A by ANP stimulates the cGMP/PKG signaling pathway, leading to increased expressions of Oct4 and Nanog, and reduced expression of p21, which in turn suppresses ES cell differentiation and maintains ES cell pluripotency. In another pathway, binding of ANP to NPR-A activates the phosphoinositide 3-kinase (PI3K) signaling pathway, which enhances G1-to-S progression through induction of cyclin D1, and maintains pluripotency by activation of Nanog expression", "co_occurrence": [{"body": 127, "word": "ES", "fig": 3}, {"body": 95, "word": "NPR-A", "fig": 3}, {"body": 47, "word": "cell", "fig": 3}, {"body": 34, "word": "pluripotency", "fig": 3}, {"body": 49, "word": "expression", "fig": 2}, {"body": 42, "word": "ANP", "fig": 2}, {"body": 38, "word": "Nanog", "fig": 2}, {"body": 12, "word": "pathway", "fig": 3}, {"body": 35, "word": "Oct4", "fig": 1}, {"body": 16, "word": "signaling", "fig": 2}, {"body": 29, "word": "differentiation", "fig": 1}, {"body": 19, "word": "self-renewal", "fig": 1}, {"body": 15, "word": "In", "fig": 1}, {"body": 11, "word": "PI3K", "fig": 1}, {"body": 11, "word": "reduced", "fig": 1}, {"body": 5, "word": "p21", "fig": 1}, {"body": 4, "word": "binding", "fig": 1}, {"body": 4, "word": "maintenance", "fig": 1}, {"body": 3, "word": "cyclin", "fig": 1}, {"body": 3, "word": "activation", "fig": 1}, {"body": 3, "word": "progression", "fig": 1}, {"body": 3, "word": "D1", "fig": 1}, {"body": 2, "word": "suppresses", "fig": 1}, {"body": 1, "word": "cGMP/PKG", "fig": 1}, {"body": 1, "word": "stimulates", "fig": 1}, {"body": 1, "word": "leading", "fig": 1}, {"body": 1, "word": "3-kinase", "fig": 1}, {"body": 1, "word": "turn", "fig": 1}, {"body": 1, "word": "phosphoinositide", "fig": 1}]}], "3759895": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759895/bin/ijms-14-15959f1.jpg", "caption": "Effect of DOR activation on the expression of BDNF and DOR in the cortex and hippocampus exposed to hypoxia. (A) Effect of DOR activation on cortical expression of BDNF and DOR in hypoxia. I, Representative blots of Western blot analysis of the cortical tissues. II, Relative levels of BDNF. III, Relative levels of DOR. C, Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 under normoxic conditions. H + U (UFP-512), DOR activation with UFP-512 under hypoxia. N = 4, 5 and 6 for 1, 3 and 10 days hypoxic exposure groups, respectively. * p < 0.05 vs. the control. #p < 0.05 vs. C + U (UFP-512). &p < 0.05 vs. H + U. Note that prolonged (3\u201310 days), but not relatively short-term (1 day), hypoxia significantly reduced the expression of BDNF but not of DOR, Furthermore, DOR activation with UFP-512 partially reversed the hypoxic reduction of BDNF expression; (B) Effect of DOR activation on hippocampal expression of BDNF and DOR in hypoxia. I, Representative blots of Western blot analysis of the cortical tissues. II, Relative levels of BDNF. III, Relative levels of DOR. C, Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 in normoxic condition. H + U (UFP-512), DOR activation with UFP-512 in hypoxic condition. N = 4, 5 and 6 for 1, 3 and 10 days groups, respectively. * p < 0.05 vs. the control. Note that 1 day hypoxia significantly reduced the expression of BDNF in the hippocampus, while DOR activation partially reversed this hypoxic effect.", "co_occurrence": [{"body": 58, "word": "DOR", "fig": 15}, {"body": 69, "word": "BDNF", "fig": 8}, {"body": 63, "word": "expression", "fig": 6}, {"body": 56, "word": "hypoxia", "fig": 6}, {"body": 24, "word": "UFP-512", "fig": 10}, {"body": 25, "word": "activation", "fig": 9}, {"body": 46, "word": "hypoxic", "fig": 4}, {"body": 27, "word": "p", "fig": 4}, {"body": 36, "word": "days", "fig": 3}, {"body": 27, "word": "control", "fig": 4}, {"body": 16, "word": "levels", "fig": 4}, {"body": 14, "word": "cortical", "fig": 3}, {"body": 34, "word": "exposure", "fig": 1}, {"body": 23, "word": "cortex", "fig": 1}, {"body": 7, "word": "Effect", "fig": 3}, {"body": 9, "word": "day", "fig": 2}, {"body": 9, "word": "significantly", "fig": 2}, {"body": 9, "word": "partially", "fig": 2}, {"body": 8, "word": "hippocampus", "fig": 2}, {"body": 8, "word": "II", "fig": 2}, {"body": 7, "word": "respectively", "fig": 2}, {"body": 7, "word": "groups", "fig": 2}, {"body": 7, "word": "reversed", "fig": 2}, {"body": 12, "word": "prolonged", "fig": 1}, {"body": 12, "word": "reduction", "fig": 1}, {"body": 5, "word": "tissues", "fig": 2}, {"body": 4, "word": "Hypoxia", "fig": 2}, {"body": 8, "word": "B", "fig": 1}, {"body": 4, "word": "III", "fig": 2}, {"body": 6, "word": "conditions", "fig": 1}, {"body": 6, "word": "effect", "fig": 1}, {"body": 1, "word": "H", "fig": 5}, {"body": 1, "word": "C", "fig": 5}, {"body": 2, "word": "reduced", "fig": 2}, {"body": 1, "word": "vs.", "fig": 4}, {"body": 2, "word": "normoxic", "fig": 2}, {"body": 3, "word": "exposed", "fig": 1}, {"body": 3, "word": "short-term", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "condition", "fig": 2}, {"body": 1, "word": "Western", "fig": 2}, {"body": 2, "word": "Furthermore", "fig": 1}, {"body": 2, "word": "relatively", "fig": 1}, {"body": 2, "word": "hippocampal", "fig": 1}, {"body": 1, "word": "analysis", "fig": 2}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759895/bin/ijms-14-15959f2.jpg", "caption": "Effect of DOR activation on the expression of BDNF and DOR in the subcortical and cerebellar regions exposed to prolonged hypoxia. (A) Effect of DOR activation on BDNF and DOR expression in the subcortical region in hypoxia. I, Representative blots of Western blot analysis of the cortical tissues. II, Relative levels of BDNF. III, Relative levels of DOR. C, Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 in normoxic condition. H + U (UFP-512), DOR activation with UFP-512 in hypoxic condition. Note that neither hypoxia nor DOR activation had any significant effect on the expression of BDNF and DOR in the subcortical region; (B) Effect of DOR activation on cerebellar expression of BDNF and DOR in hypoxia. I, Representative blots of Western blot analysis of the cortical tissues. II, Relative levels of BDNF. III, Relative levels of DOR. C, Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 treatment under normoxic conditions. H + U (UFP-512), DOR activation with UFP-512 treatment under hypoxic conditions. N = 4, 5 and 6 for 1, 3 and 10 days groups, respectively. Note that neither hypoxia nor DOR activation had any significant effect on the expression of BDNF and DOR in the cerebellum.", "co_occurrence": [{"body": 58, "word": "DOR", "fig": 16}, {"body": 69, "word": "BDNF", "fig": 7}, {"body": 63, "word": "expression", "fig": 5}, {"body": 56, "word": "hypoxia", "fig": 5}, {"body": 25, "word": "activation", "fig": 9}, {"body": 24, "word": "UFP-512", "fig": 8}, {"body": 46, "word": "hypoxic", "fig": 2}, {"body": 16, "word": "levels", "fig": 4}, {"body": 27, "word": "control", "fig": 2}, {"body": 36, "word": "days", "fig": 1}, {"body": 17, "word": "significant", "fig": 2}, {"body": 14, "word": "cortical", "fig": 2}, {"body": 7, "word": "Effect", "fig": 3}, {"body": 8, "word": "II", "fig": 2}, {"body": 5, "word": "subcortical", "fig": 3}, {"body": 6, "word": "conditions", "fig": 2}, {"body": 6, "word": "effect", "fig": 2}, {"body": 12, "word": "prolonged", "fig": 1}, {"body": 5, "word": "tissues", "fig": 2}, {"body": 5, "word": "cerebellar", "fig": 2}, {"body": 4, "word": "Hypoxia", "fig": 2}, {"body": 8, "word": "B", "fig": 1}, {"body": 4, "word": "III", "fig": 2}, {"body": 4, "word": "region", "fig": 2}, {"body": 7, "word": "groups", "fig": 1}, {"body": 7, "word": "respectively", "fig": 1}, {"body": 3, "word": "treatment", "fig": 2}, {"body": 4, "word": "regions", "fig": 1}, {"body": 1, "word": "C", "fig": 4}, {"body": 1, "word": "H", "fig": 4}, {"body": 4, "word": "cerebellum", "fig": 1}, {"body": 2, "word": "normoxic", "fig": 2}, {"body": 3, "word": "exposed", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "Western", "fig": 2}, {"body": 1, "word": "condition", "fig": 2}, {"body": 1, "word": "analysis", "fig": 2}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759895/bin/ijms-14-15959f3.jpg", "caption": "Effect of DOR activation on cortical TrkB expression in hypoxia. (A) Representative blots of Western blot analysis of the cortical tissues; (B) Relative levels of 140 kDa TrkB. C, Relative levels of 90/140 kDa TrkB; (C) Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 treatment under normoxic conditions. H + U (UFP-512), DOR activation with UFP-512 treatment under hypoxic conditions. N = 4, 5 and 6 for 1, 3 and 10 days groups, respectively. * p < 0.05 vs. the control. #p < 0.05 vs. C + U (UFP-512). &p < 0.05 vs. H + U (UFP-512). Note that 3 or 10 days hypoxia significantly reduced the level of 140 KDa TrkB and increased that of 90/140 kDa TrkB in the cortex, while DOR activation largely reversed these hypoxia-induced changes.", "co_occurrence": [{"body": 58, "word": "DOR", "fig": 4}, {"body": 38, "word": "TrkB", "fig": 5}, {"body": 24, "word": "UFP-512", "fig": 6}, {"body": 56, "word": "hypoxia", "fig": 2}, {"body": 25, "word": "activation", "fig": 4}, {"body": 27, "word": "p", "fig": 3}, {"body": 36, "word": "days", "fig": 2}, {"body": 63, "word": "expression", "fig": 1}, {"body": 27, "word": "control", "fig": 2}, {"body": 46, "word": "hypoxic", "fig": 1}, {"body": 13, "word": "kDa", "fig": 3}, {"body": 16, "word": "levels", "fig": 2}, {"body": 14, "word": "cortical", "fig": 2}, {"body": 23, "word": "cortex", "fig": 1}, {"body": 20, "word": "level", "fig": 1}, {"body": 14, "word": "hypoxia-induced", "fig": 1}, {"body": 6, "word": "conditions", "fig": 2}, {"body": 9, "word": "significantly", "fig": 1}, {"body": 8, "word": "B", "fig": 1}, {"body": 7, "word": "reversed", "fig": 1}, {"body": 7, "word": "Effect", "fig": 1}, {"body": 7, "word": "groups", "fig": 1}, {"body": 7, "word": "respectively", "fig": 1}, {"body": 3, "word": "treatment", "fig": 2}, {"body": 5, "word": "tissues", "fig": 1}, {"body": 5, "word": "increased", "fig": 1}, {"body": 4, "word": "Hypoxia", "fig": 1}, {"body": 1, "word": "C", "fig": 4}, {"body": 3, "word": "changes", "fig": 1}, {"body": 1, "word": "H", "fig": 3}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "vs.", "fig": 3}, {"body": 2, "word": "KDa", "fig": 1}, {"body": 2, "word": "normoxic", "fig": 1}, {"body": 2, "word": "reduced", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "analysis", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759895/bin/ijms-14-15959f4.jpg", "caption": "Effect of DOR activation on cortical TNF-\u03b1 expression in hypoxia. (A) Representative blots of Western blot analysis of the cortical tissues; (B) Relative levels of TNF-\u03b1. C, Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 in normoxic condition. H + U (UFP-512), DOR activation with UFP-512 in hypoxic condition. N = 4, 5 and 6 for 1, 3 and 10 days groups, respectively. * p < 0.05 vs. the control. #p < 0.05 vs. C + U (UFP-512). &p < 0.05 vs. H + U (UFP-512). Note that 10 days hypoxia significantly increased the level of TNF-\u03b1, while DOR activation completely inhibited such increase.", "co_occurrence": [{"body": 58, "word": "DOR", "fig": 4}, {"body": 24, "word": "UFP-512", "fig": 6}, {"body": 56, "word": "hypoxia", "fig": 2}, {"body": 25, "word": "activation", "fig": 4}, {"body": 29, "word": "TNF-\u03b1", "fig": 3}, {"body": 27, "word": "p", "fig": 3}, {"body": 36, "word": "days", "fig": 2}, {"body": 63, "word": "expression", "fig": 1}, {"body": 27, "word": "control", "fig": 2}, {"body": 46, "word": "hypoxic", "fig": 1}, {"body": 14, "word": "cortical", "fig": 2}, {"body": 20, "word": "level", "fig": 1}, {"body": 16, "word": "levels", "fig": 1}, {"body": 12, "word": "increase", "fig": 1}, {"body": 9, "word": "significantly", "fig": 1}, {"body": 8, "word": "B", "fig": 1}, {"body": 7, "word": "Effect", "fig": 1}, {"body": 7, "word": "groups", "fig": 1}, {"body": 7, "word": "respectively", "fig": 1}, {"body": 5, "word": "tissues", "fig": 1}, {"body": 5, "word": "increased", "fig": 1}, {"body": 4, "word": "Hypoxia", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "C", "fig": 3}, {"body": 1, "word": "vs.", "fig": 3}, {"body": 1, "word": "H", "fig": 3}, {"body": 2, "word": "normoxic", "fig": 1}, {"body": 1, "word": "condition", "fig": 2}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "completely", "fig": 1}, {"body": 1, "word": "analysis", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759895/bin/ijms-14-15959f5.jpg", "caption": "Effect of DOR activation on cortical CD11b expression in hypoxia. (A) Representative blots of Western blot analysis of the cortical tissues; (B) Relative levels of CD11b. C, Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 treatment under normoxic conditions. H + U (UFP-512), DOR activation with UFP-512 treatment under hypoxic conditions. N = 4, 5 and 6 for 1, 3 and 10 days groups, respectively. * p < 0.05 vs. the control. #p < 0.05 vs. C + U (UFP-512). &p < 0.05 vs. H + U (UFP-512). Note that 3 or 10 days hypoxia significantly reduced the level of CD11b, while DOR activation with UFP-512 reversed this hypoxic reduction.", "co_occurrence": [{"body": 58, "word": "DOR", "fig": 4}, {"body": 24, "word": "UFP-512", "fig": 7}, {"body": 56, "word": "hypoxia", "fig": 2}, {"body": 25, "word": "activation", "fig": 4}, {"body": 46, "word": "hypoxic", "fig": 2}, {"body": 27, "word": "p", "fig": 3}, {"body": 36, "word": "days", "fig": 2}, {"body": 63, "word": "expression", "fig": 1}, {"body": 27, "word": "control", "fig": 2}, {"body": 11, "word": "CD11b", "fig": 3}, {"body": 14, "word": "cortical", "fig": 2}, {"body": 20, "word": "level", "fig": 1}, {"body": 16, "word": "levels", "fig": 1}, {"body": 6, "word": "conditions", "fig": 2}, {"body": 12, "word": "reduction", "fig": 1}, {"body": 9, "word": "significantly", "fig": 1}, {"body": 8, "word": "B", "fig": 1}, {"body": 7, "word": "reversed", "fig": 1}, {"body": 7, "word": "Effect", "fig": 1}, {"body": 7, "word": "groups", "fig": 1}, {"body": 7, "word": "respectively", "fig": 1}, {"body": 3, "word": "treatment", "fig": 2}, {"body": 5, "word": "tissues", "fig": 1}, {"body": 4, "word": "Hypoxia", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "C", "fig": 3}, {"body": 1, "word": "H", "fig": 3}, {"body": 1, "word": "vs.", "fig": 3}, {"body": 2, "word": "normoxic", "fig": 1}, {"body": 2, "word": "reduced", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "analysis", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759895/bin/ijms-14-15959f6.jpg", "caption": "Effect of DOR activation on cortical pCREB and pATF-1 expression in hypoxia. (A) Representative blots of Western blot analysis of the cortical tissues; (B) Relative levels of pCREB. C, Relative levels of pATF-1; (C) Normoxic control. H, Hypoxia. C + U (UFP-512), DOR activation with UFP-512 treatment under normoxic conditions. H + U (UFP-512), DOR activation with UFP-512 treatment under hypoxic conditions. N = 4, 5 and 6 for 1, 3 and 10 days groups, respectively. Note that neither hypoxia nor DOR activation had any significant effect on the expression of pCREB and pATF-1 in the cortex.", "co_occurrence": [{"body": 58, "word": "DOR", "fig": 4}, {"body": 63, "word": "expression", "fig": 2}, {"body": 56, "word": "hypoxia", "fig": 2}, {"body": 25, "word": "activation", "fig": 4}, {"body": 24, "word": "UFP-512", "fig": 4}, {"body": 46, "word": "hypoxic", "fig": 1}, {"body": 36, "word": "days", "fig": 1}, {"body": 16, "word": "levels", "fig": 2}, {"body": 14, "word": "cortical", "fig": 2}, {"body": 27, "word": "control", "fig": 1}, {"body": 23, "word": "cortex", "fig": 1}, {"body": 6, "word": "pATF-1", "fig": 3}, {"body": 17, "word": "significant", "fig": 1}, {"body": 6, "word": "conditions", "fig": 2}, {"body": 4, "word": "pCREB", "fig": 3}, {"body": 8, "word": "B", "fig": 1}, {"body": 7, "word": "Effect", "fig": 1}, {"body": 7, "word": "groups", "fig": 1}, {"body": 7, "word": "respectively", "fig": 1}, {"body": 3, "word": "treatment", "fig": 2}, {"body": 6, "word": "effect", "fig": 1}, {"body": 5, "word": "tissues", "fig": 1}, {"body": 4, "word": "Hypoxia", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "C", "fig": 3}, {"body": 1, "word": "H", "fig": 2}, {"body": 2, "word": "normoxic", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "analysis", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759895/bin/ijms-14-15959f7.jpg", "caption": "Schematic demonstration of the DOR-BDNF-TrkB pathway in brain protection against hypoxic injury. Prolonged hypoxia causes a down-regulation of BDNF-TrkB signals resulting in an increased cortical TNF-\u03b1, while DOR activation up-regulates BDNF-TrkB signals thereby decreasing the level of TNF-\u03b1 in the hypoxic cortex.", "co_occurrence": [{"body": 46, "word": "hypoxic", "fig": 2}, {"body": 58, "word": "DOR", "fig": 1}, {"body": 29, "word": "TNF-\u03b1", "fig": 2}, {"body": 56, "word": "hypoxia", "fig": 1}, {"body": 25, "word": "activation", "fig": 1}, {"body": 12, "word": "BDNF-TrkB", "fig": 2}, {"body": 23, "word": "cortex", "fig": 1}, {"body": 20, "word": "level", "fig": 1}, {"body": 16, "word": "injury", "fig": 1}, {"body": 14, "word": "cortical", "fig": 1}, {"body": 13, "word": "brain", "fig": 1}, {"body": 4, "word": "signals", "fig": 2}, {"body": 8, "word": "pathway", "fig": 1}, {"body": 5, "word": "increased", "fig": 1}, {"body": 4, "word": "thereby", "fig": 1}, {"body": 3, "word": "causes", "fig": 1}, {"body": 3, "word": "protection", "fig": 1}, {"body": 2, "word": "down-regulation", "fig": 1}, {"body": 2, "word": "decreasing", "fig": 1}, {"body": 1, "word": "Prolonged", "fig": 1}, {"body": 1, "word": "DOR-BDNF-TrkB", "fig": 1}, {"body": 1, "word": "resulting", "fig": 1}]}], "3492294": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492294/bin/pone.0049204.g001.jpg", "caption": "Expression of AHCYL1 in chickens. [A and B] Expression of AHCYL1 in various organs of male and female of chickens. Results of RT-PCR analysis using cDNA templates from different organs of male [A] and female [B] chickens with chicken AHCYL1 and chicken GAPDH-specific primers. [C] In situ hybridization analyses of AHCYL1 mRNAs in the chicken oviduct. Cross-sections of the four components of the chicken oviduct (infundibulum, magnum, isthmus and shell gland) were hybridized with antisense or sense chicken AHCYL1 cRNA probes. [D] Immunoreactive AHCYL1 protein in the chicken oviduct. For the IgG control, normal mouse IgG was substituted for the primary antibody. Sections were not counterstained. Legend: LE, luminal epithelium; GE, glandular epithelium; Scale bar represents 100 \u00b5m. See Materials and Methods for complete description.", "co_occurrence": [{"body": 128, "word": "AHCYL1", "fig": 6}, {"body": 41, "word": "chicken", "fig": 6}, {"body": 77, "word": "oviduct", "fig": 3}, {"body": 39, "word": "using", "fig": 1}, {"body": 33, "word": "protein", "fig": 1}, {"body": 9, "word": "chickens", "fig": 3}, {"body": 23, "word": "In", "fig": 1}, {"body": 18, "word": "control", "fig": 1}, {"body": 17, "word": "shell", "fig": 1}, {"body": 6, "word": "IgG", "fig": 2}, {"body": 12, "word": "gland", "fig": 1}, {"body": 12, "word": "magnum", "fig": 1}, {"body": 10, "word": "analyses", "fig": 1}, {"body": 5, "word": "female", "fig": 2}, {"body": 5, "word": "organs", "fig": 2}, {"body": 9, "word": "GE", "fig": 1}, {"body": 9, "word": "LE", "fig": 1}, {"body": 4, "word": "A", "fig": 2}, {"body": 8, "word": "For", "fig": 1}, {"body": 8, "word": "isthmus", "fig": 1}, {"body": 4, "word": "Expression", "fig": 2}, {"body": 8, "word": "infundibulum", "fig": 1}, {"body": 6, "word": "various", "fig": 1}, {"body": 6, "word": "RT-PCR", "fig": 1}, {"body": 6, "word": "antibody", "fig": 1}, {"body": 5, "word": "hybridization", "fig": 1}, {"body": 5, "word": "primary", "fig": 1}, {"body": 5, "word": "primers", "fig": 1}, {"body": 5, "word": "Results", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "mRNAs", "fig": 1}, {"body": 2, "word": "epithelium", "fig": 2}, {"body": 2, "word": "B", "fig": 2}, {"body": 4, "word": "situ", "fig": 1}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 4, "word": "mouse", "fig": 1}, {"body": 3, "word": "different", "fig": 1}, {"body": 2, "word": "antisense", "fig": 1}, {"body": 2, "word": "four", "fig": 1}, {"body": 2, "word": "Immunoreactive", "fig": 1}, {"body": 1, "word": "male", "fig": 2}, {"body": 2, "word": "sense", "fig": 1}, {"body": 2, "word": "probes", "fig": 1}, {"body": 1, "word": "glandular", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "luminal", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "components", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492294/bin/pone.0049204.g002.jpg", "caption": "Effect of DES on tissue specific expression of chicken AHCYL1. Both RT-PCR [A and B] and q-PCR [C and D] analyses were performed using cDNA templates from DES-treated and untreated oviducts. These experiments were conducted in triplicate and normalized to control GAPDH expression. [E] In situ hybridization analyses revealed cell-specific expression of AHCYL1 mRNA in oviducts of DES-treated and untreated chicks. Cross-sections of the four segments of chicken oviduct (infundibulum, magnum, isthmus, and shell gland) treated with DES or vehicle were hybridized with antisense or sense chicken AHCYL1 cRNA probes. [F] Immunoreactive AHCYL1 protein in oviducts of DES-treated and untreated chicks. For the IgG control, normal goat IgG was substituted for the primary antibody. Sections were not counterstained. See Materials and Methods for complete description. Legend: Untreated oviduct, non-treated whole oviduct; DES Treatment, DES treated whole oviduct; LE, luminal epithelium; GE, glandular epithelium; Scale bar represents 100 \u00b5m. The asterisks denote statistically significant differences (***P<0.001 and **P<0.01).", "co_occurrence": [{"body": 128, "word": "AHCYL1", "fig": 4}, {"body": 77, "word": "oviduct", "fig": 4}, {"body": 49, "word": "DES", "fig": 4}, {"body": 55, "word": "expression", "fig": 3}, {"body": 41, "word": "chicken", "fig": 3}, {"body": 39, "word": "using", "fig": 1}, {"body": 39, "word": "The", "fig": 1}, {"body": 18, "word": "control", "fig": 2}, {"body": 33, "word": "protein", "fig": 1}, {"body": 16, "word": "chicks", "fig": 2}, {"body": 14, "word": "treated", "fig": 2}, {"body": 23, "word": "In", "fig": 1}, {"body": 22, "word": "mRNA", "fig": 1}, {"body": 10, "word": "analyses", "fig": 2}, {"body": 6, "word": "untreated", "fig": 3}, {"body": 17, "word": "shell", "fig": 1}, {"body": 5, "word": "oviducts", "fig": 3}, {"body": 6, "word": "IgG", "fig": 2}, {"body": 12, "word": "gland", "fig": 1}, {"body": 12, "word": "magnum", "fig": 1}, {"body": 9, "word": "GE", "fig": 1}, {"body": 3, "word": "DES-treated", "fig": 3}, {"body": 9, "word": "LE", "fig": 1}, {"body": 8, "word": "For", "fig": 1}, {"body": 8, "word": "isthmus", "fig": 1}, {"body": 8, "word": "These", "fig": 1}, {"body": 8, "word": "performed", "fig": 1}, {"body": 8, "word": "infundibulum", "fig": 1}, {"body": 6, "word": "RT-PCR", "fig": 1}, {"body": 6, "word": "antibody", "fig": 1}, {"body": 5, "word": "hybridization", "fig": 1}, {"body": 5, "word": "primary", "fig": 1}, {"body": 5, "word": "revealed", "fig": 1}, {"body": 4, "word": "segments", "fig": 1}, {"body": 4, "word": "specific", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "epithelium", "fig": 2}, {"body": 4, "word": "tissue", "fig": 1}, {"body": 4, "word": "situ", "fig": 1}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "antisense", "fig": 1}, {"body": 2, "word": "four", "fig": 1}, {"body": 1, "word": "whole", "fig": 2}, {"body": 2, "word": "Immunoreactive", "fig": 1}, {"body": 2, "word": "conducted", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "Treatment", "fig": 1}, {"body": 2, "word": "sense", "fig": 1}, {"body": 2, "word": "significant", "fig": 1}, {"body": 2, "word": "probes", "fig": 1}, {"body": 2, "word": "cell-specific", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "glandular", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "statistically", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "luminal", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "differences", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "q-PCR", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492294/bin/pone.0049204.g003.jpg", "caption": "DES-induced phosphorylation of ERK1/2, stimulation of AHCYL1 and calcium release in chicken oviduct epithelial cells. [A and B] Dose-dependent and time-dependent expression of phosphorylated ERK1/2 in DES-treated chicken oviduct epithelial cells. Blots were imaged to calculate normalized values presented in graphs (bottom) by measurements of levels of phosphorylated protein relative to total protein. [C] In the DES-treated (2 \u00b5g/ml) and non-treated chicken oviduct cells, AHCYL1 protein levels were investigated to determine time-dependent effects of DES. [D] In chicken oviduct cells treated with DES (2 \u00b5g/ml) or both DES and an ERK1/2 inhibitor (U0126) for 24 h, according to results of a preliminary study to optimize time-dependent treatment effects, AHCYL1 protein decreased due to effects of U0126. In [C and D], blots were imaged to calculate the normalized values presented in graphs (bottom) for relative abundance of AHCYL1 protein and alpha-tubulin (TUBA) protein. [E] Immunofluorescence microscopy detected AHCYL1 protein in chicken oviduct epithelial cells treated with DES or both DES and an ERK1/2 inhibitor. AHCYL1 protein was barely detectable in untreated, as well as DES- and ERK1/2 inhibitor-treated cells, but abundant in cytoplasm of DES-treated oviduct epithelial cells. Cell nuclei were stained with DAPI (blue). All images were captured at 40X objective magnification. [F and G] Cells were grown in media with various concentration of DES for 24 h or both DES and an ERK1/2 inhibitor. Then, calcium concentration from the cells was measured. The asterisk denotes a significant effect (***P<0.001, **P<0.01 and *P<0.05). See Materials and Methods for complete description.", "co_occurrence": [{"body": 128, "word": "AHCYL1", "fig": 6}, {"body": 77, "word": "oviduct", "fig": 6}, {"body": 49, "word": "DES", "fig": 7}, {"body": 41, "word": "cells", "fig": 8}, {"body": 33, "word": "protein", "fig": 8}, {"body": 41, "word": "chicken", "fig": 5}, {"body": 15, "word": "ERK1/2", "fig": 6}, {"body": 23, "word": "In", "fig": 3}, {"body": 55, "word": "expression", "fig": 1}, {"body": 39, "word": "The", "fig": 1}, {"body": 16, "word": "h", "fig": 2}, {"body": 14, "word": "calcium", "fig": 2}, {"body": 14, "word": "treated", "fig": 2}, {"body": 6, "word": "epithelial", "fig": 4}, {"body": 19, "word": "results", "fig": 1}, {"body": 6, "word": "effects", "fig": 3}, {"body": 5, "word": "inhibitor", "fig": 3}, {"body": 7, "word": "U0126", "fig": 2}, {"body": 13, "word": "release", "fig": 1}, {"body": 13, "word": "study", "fig": 1}, {"body": 11, "word": "treatment", "fig": 1}, {"body": 5, "word": "levels", "fig": 2}, {"body": 9, "word": "detected", "fig": 1}, {"body": 3, "word": "DES-treated", "fig": 3}, {"body": 7, "word": "decreased", "fig": 1}, {"body": 6, "word": "abundant", "fig": 1}, {"body": 6, "word": "untreated", "fig": 1}, {"body": 6, "word": "various", "fig": 1}, {"body": 6, "word": "determine", "fig": 1}, {"body": 3, "word": "\u00b5g/ml", "fig": 2}, {"body": 3, "word": "phosphorylated", "fig": 2}, {"body": 5, "word": "abundance", "fig": 1}, {"body": 5, "word": "cytoplasm", "fig": 1}, {"body": 2, "word": "relative", "fig": 2}, {"body": 2, "word": "concentration", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "effect", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "microscopy", "fig": 1}, {"body": 3, "word": "phosphorylation", "fig": 1}, {"body": 3, "word": "according", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "due", "fig": 1}, {"body": 3, "word": "well", "fig": 1}, {"body": 2, "word": "Cell", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "normalized", "fig": 2}, {"body": 1, "word": "values", "fig": 2}, {"body": 2, "word": "significant", "fig": 1}, {"body": 1, "word": "captured", "fig": 1}, {"body": 1, "word": "Blots", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "measurements", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "detectable", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "grown", "fig": 1}, {"body": 1, "word": "investigated", "fig": 1}, {"body": 1, "word": "preliminary", "fig": 1}, {"body": 1, "word": "All", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492294/bin/pone.0049204.g004.jpg", "caption": "AHCYL1 knockdown decreased expression of genes associated with oviduct development and production of egg white proteins. [A] In the control group (na\u00efve, sham and control siRNA treatment) and AHCYL1 silencing group (dose-dependent manner), AHCYL1 mRNA levels were quantified by RT-PCR and quantitative RT-PCR analyses. [B] In the control group (na\u00efve, sham and control siRNA treatment) and AHCYL1 silencing group (dose-dependent), immunoreactive AHCYL1 protein was quantified by western blotting. [C] The effects of DES treatment (time-dependent manner) on control cells and cells in which AHCYL1 was silenced is shown in Panels D to F. Total RNA isolated from chicken oviduct epithelial cells treated with AHCYL1 siRNA (100nM) affected expression of CTSB, CTSC, CTSS, ERRFI1, PTN, GAL11, ovalbumin, LYZ and LYZ2 mRNAs as determined using quantitative RT-PCR analyses. Legend: CTSB, cathepsin B; CTSC, cathepsin C; CTSS, cathepsin S; ERRFI1, ERBB receptor feedback inhibitor 1; PTN, pleiotrophin, GAL11; gallinacin 11, LYZ; lysozyme. [G] Cells were grown in medium with the absence and presence of DES with siRNAs and then changes in amount of calcium released from the cells was measured. [H] Immunofluorescence microscopy detected AHCYL1 protein in chicken oviduct epithelial cells treated with DES with siRNAs. Cell nuclei were stained with DAPI (blue). All images were captured at 40X objective magnification. The asterisks denote statistically significant differences (***P<0.001, **P<0.01 and *P<0.05). See Materials and Methods for complete description.", "co_occurrence": [{"body": 128, "word": "AHCYL1", "fig": 8}, {"body": 77, "word": "oviduct", "fig": 3}, {"body": 41, "word": "cells", "fig": 5}, {"body": 49, "word": "DES", "fig": 3}, {"body": 55, "word": "expression", "fig": 2}, {"body": 18, "word": "control", "fig": 5}, {"body": 41, "word": "chicken", "fig": 2}, {"body": 39, "word": "The", "fig": 2}, {"body": 33, "word": "protein", "fig": 2}, {"body": 18, "word": "siRNA", "fig": 3}, {"body": 23, "word": "In", "fig": 2}, {"body": 39, "word": "using", "fig": 1}, {"body": 11, "word": "treatment", "fig": 3}, {"body": 14, "word": "treated", "fig": 2}, {"body": 24, "word": "development", "fig": 1}, {"body": 22, "word": "mRNA", "fig": 1}, {"body": 10, "word": "analyses", "fig": 2}, {"body": 6, "word": "RT-PCR", "fig": 3}, {"body": 18, "word": "genes", "fig": 1}, {"body": 17, "word": "proteins", "fig": 1}, {"body": 14, "word": "calcium", "fig": 1}, {"body": 6, "word": "epithelial", "fig": 2}, {"body": 11, "word": "egg", "fig": 1}, {"body": 5, "word": "ERRFI1", "fig": 2}, {"body": 5, "word": "CTSB", "fig": 2}, {"body": 5, "word": "CTSC", "fig": 2}, {"body": 5, "word": "CTSS", "fig": 2}, {"body": 5, "word": "PTN", "fig": 2}, {"body": 5, "word": "quantitative", "fig": 2}, {"body": 9, "word": "RNA", "fig": 1}, {"body": 9, "word": "detected", "fig": 1}, {"body": 4, "word": "LYZ", "fig": 2}, {"body": 4, "word": "quantified", "fig": 2}, {"body": 4, "word": "GAL11", "fig": 2}, {"body": 4, "word": "sham", "fig": 2}, {"body": 7, "word": "decreased", "fig": 1}, {"body": 7, "word": "knockdown", "fig": 1}, {"body": 6, "word": "effects", "fig": 1}, {"body": 2, "word": "cathepsin", "fig": 3}, {"body": 6, "word": "presence", "fig": 1}, {"body": 3, "word": "na\u00efve", "fig": 2}, {"body": 6, "word": "determined", "fig": 1}, {"body": 3, "word": "manner", "fig": 2}, {"body": 5, "word": "receptor", "fig": 1}, {"body": 5, "word": "ovalbumin", "fig": 1}, {"body": 5, "word": "inhibitor", "fig": 1}, {"body": 5, "word": "levels", "fig": 1}, {"body": 4, "word": "mRNAs", "fig": 1}, {"body": 2, "word": "dose-dependent", "fig": 2}, {"body": 1, "word": "group", "fig": 4}, {"body": 2, "word": "B", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "LYZ2", "fig": 1}, {"body": 3, "word": "production", "fig": 1}, {"body": 3, "word": "microscopy", "fig": 1}, {"body": 3, "word": "lysozyme", "fig": 1}, {"body": 3, "word": "white", "fig": 1}, {"body": 3, "word": "isolated", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 2, "word": "feedback", "fig": 1}, {"body": 2, "word": "blotting", "fig": 1}, {"body": 2, "word": "absence", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "siRNAs", "fig": 2}, {"body": 2, "word": "Cell", "fig": 1}, {"body": 2, "word": "pleiotrophin", "fig": 1}, {"body": 2, "word": "immunoreactive", "fig": 1}, {"body": 2, "word": "gallinacin", "fig": 1}, {"body": 2, "word": "associated", "fig": 1}, {"body": 2, "word": "medium", "fig": 1}, {"body": 2, "word": "ERBB", "fig": 1}, {"body": 2, "word": "significant", "fig": 1}, {"body": 2, "word": "changes", "fig": 1}, {"body": 2, "word": "Total", "fig": 1}, {"body": 1, "word": "silencing", "fig": 2}, {"body": 1, "word": "captured", "fig": 1}, {"body": 1, "word": "affected", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "statistically", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "amount", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "differences", "fig": 1}, {"body": 1, "word": "western", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "grown", "fig": 1}, {"body": 1, "word": "All", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492294/bin/pone.0049204.g005.jpg", "caption": "In vitro target assay of miR-124a, miR-1602, miR-1612, miR-1669, miR-1710 and miR-1782 on AHCYL1 transcript. [A] Diagram of miR-124a, miR-1669, miR-1710 and miR-1782 binding sites in AHCYL1 3\u2032-UTR. [B] Expression vector maps for eGFP with AHCYL1 3\u2032UTR and Ds-Red with each miRNA. The 3\u2032-UTR of the AHCYL1 transcript was subcloned between the eGFP gene and the polyA tail to generate the fusion construct of the GFP transcript following the miRNA target 3\u2032-UTR (pcDNA-eGFP-3\u2032UTR) (upper panel) and miRNA expression vector was designed to co-express DsRed and each miRNA (pcDNA-DsRed-miRNA) (lower panel). [C and D] After co-transfection of pcDNA-eGFP-3\u2032UTR for the AHCYL1 transcript and pcDNA-DsRed-miRNA for the miR-124a, miR-1669, miR-1710 and miR-1782, the fluorescence signals of GFP and DsRed were detected using fluorescent microscopy [C] and FACS [D]. [E] q-PCR analyses were performed using cDNA templates from DES-treated and untreated chicken oviducts (mean \u00b1 SEM). These experiments were conducted in triplicate and normalized to control U6 snRNA expression. See Materials and Methods for complete description. The asterisks denote statistically significant differences (**P<0.01 and *P<0.05).", "co_occurrence": [{"body": 128, "word": "AHCYL1", "fig": 5}, {"body": 55, "word": "expression", "fig": 2}, {"body": 39, "word": "using", "fig": 2}, {"body": 39, "word": "The", "fig": 2}, {"body": 41, "word": "chicken", "fig": 1}, {"body": 12, "word": "3\u2032-UTR", "fig": 3}, {"body": 9, "word": "miR-1710", "fig": 3}, {"body": 9, "word": "miR-124a", "fig": 3}, {"body": 9, "word": "miR-1669", "fig": 3}, {"body": 8, "word": "miR-1782", "fig": 3}, {"body": 23, "word": "In", "fig": 1}, {"body": 11, "word": "target", "fig": 2}, {"body": 5, "word": "transcript", "fig": 4}, {"body": 19, "word": "gene", "fig": 1}, {"body": 18, "word": "control", "fig": 1}, {"body": 4, "word": "miRNA", "fig": 4}, {"body": 10, "word": "analyses", "fig": 1}, {"body": 5, "word": "GFP", "fig": 2}, {"body": 9, "word": "detected", "fig": 1}, {"body": 8, "word": "These", "fig": 1}, {"body": 8, "word": "performed", "fig": 1}, {"body": 8, "word": "fluorescence", "fig": 1}, {"body": 6, "word": "untreated", "fig": 1}, {"body": 6, "word": "sites", "fig": 1}, {"body": 5, "word": "binding", "fig": 1}, {"body": 5, "word": "oviducts", "fig": 1}, {"body": 5, "word": "lower", "fig": 1}, {"body": 2, "word": "pcDNA-DsRed-miRNA", "fig": 2}, {"body": 4, "word": "assay", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "miR-1602", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 4, "word": "miR-1612", "fig": 1}, {"body": 2, "word": "pcDNA-eGFP-3\u2032UTR", "fig": 2}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 4, "word": "After", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "microscopy", "fig": 1}, {"body": 3, "word": "DES-treated", "fig": 1}, {"body": 3, "word": "fluorescent", "fig": 1}, {"body": 3, "word": "vitro", "fig": 1}, {"body": 2, "word": "fusion", "fig": 1}, {"body": 1, "word": "vector", "fig": 2}, {"body": 1, "word": "DsRed", "fig": 2}, {"body": 2, "word": "co-transfection", "fig": 1}, {"body": 1, "word": "eGFP", "fig": 2}, {"body": 2, "word": "conducted", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "significant", "fig": 1}, {"body": 1, "word": "tail", "fig": 1}, {"body": 1, "word": "subcloned", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "statistically", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "generate", "fig": 1}, {"body": 1, "word": "differences", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "q-PCR", "fig": 1}, {"body": 1, "word": "designed", "fig": 1}, {"body": 1, "word": "FACS", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492294/bin/pone.0049204.g006.jpg", "caption": "Schematic illustrating the current working hypothesis on estrogen-induced ERK1/2 MAPK signaling cascades in chicken oviduct cells. Evidence from the present study indicates that estrogen stimulates the classical estrogen- and alternative ERK1/2 MAPK signaling pathways. Legend: RTK, receptor tyrosine kinase; RAS, synaptic Ras-GTPase-activating protein; RAF (also known as MAPK3), mitogen-activated protein kinase (MAPK) kinase kinase; MEK (also known as MAPK2), MAPK kinase; ERK1/2, extracellular signal-regulated kinase; ERE, estrogen response element; ER, endoplasmic reticulum.", "co_occurrence": [{"body": 77, "word": "oviduct", "fig": 1}, {"body": 33, "word": "protein", "fig": 2}, {"body": 15, "word": "ERK1/2", "fig": 3}, {"body": 41, "word": "chicken", "fig": 1}, {"body": 41, "word": "cells", "fig": 1}, {"body": 20, "word": "estrogen", "fig": 2}, {"body": 6, "word": "MAPK", "fig": 4}, {"body": 9, "word": "signaling", "fig": 2}, {"body": 13, "word": "study", "fig": 1}, {"body": 6, "word": "known", "fig": 2}, {"body": 11, "word": "response", "fig": 1}, {"body": 5, "word": "also", "fig": 2}, {"body": 8, "word": "present", "fig": 1}, {"body": 1, "word": "kinase", "fig": 6}, {"body": 5, "word": "receptor", "fig": 1}, {"body": 4, "word": "stimulates", "fig": 1}, {"body": 4, "word": "hypothesis", "fig": 1}, {"body": 4, "word": "pathways", "fig": 1}, {"body": 3, "word": "estrogen-induced", "fig": 1}, {"body": 2, "word": "extracellular", "fig": 1}, {"body": 2, "word": "cascades", "fig": 1}, {"body": 2, "word": "RTK", "fig": 1}, {"body": 2, "word": "current", "fig": 1}, {"body": 1, "word": "working", "fig": 1}, {"body": 1, "word": "tyrosine", "fig": 1}, {"body": 1, "word": "reticulum", "fig": 1}, {"body": 1, "word": "endoplasmic", "fig": 1}]}], "4154686": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g001.jpg", "caption": "Establishing branching phenotype of endothelial cells and media for coculture with neural stem cells. (A) Matrigel branching morphogenesis assay confirmed the potential for endothelial morphogenesis in D3 human cerebral microvasculature endothelial cells (hCMECs) and HMEC-1 dermal EC lines. (B) D3 hCMECs in EC medium formed a cobblestone-like monolayer on collagen-coated surfaces. D3 hCMECs in NSC medium started to detach from culture surfaces, and STROC05 human neural stem cells (hNSCs) in EC medium lost bipolar elongated morphology. In comparison, morphology of D3 hCMECs and STROC05 hNSCs was maintained in a 50\u223650 mix of EC:NSC medium. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bars represent 200 \u00b5m.", "co_occurrence": [{"body": 77, "word": "cells", "fig": 4}, {"body": 38, "word": "hCMECs", "fig": 4}, {"body": 45, "word": "endothelial", "fig": 3}, {"body": 40, "word": "hNSCs", "fig": 2}, {"body": 14, "word": "medium", "fig": 4}, {"body": 22, "word": "neural", "fig": 2}, {"body": 11, "word": "D3", "fig": 4}, {"body": 20, "word": "human", "fig": 2}, {"body": 9, "word": "EC", "fig": 4}, {"body": 16, "word": "morphogenesis", "fig": 2}, {"body": 11, "word": "STROC05", "fig": 2}, {"body": 17, "word": "coculture", "fig": 1}, {"body": 17, "word": "In", "fig": 1}, {"body": 8, "word": "NSC", "fig": 2}, {"body": 16, "word": "assay", "fig": 1}, {"body": 7, "word": "stem", "fig": 2}, {"body": 11, "word": "media", "fig": 1}, {"body": 5, "word": "morphology", "fig": 2}, {"body": 5, "word": "branching", "fig": 2}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "culture", "fig": 1}, {"body": 8, "word": "formed", "fig": 1}, {"body": 7, "word": "Matrigel", "fig": 1}, {"body": 7, "word": "lines", "fig": 1}, {"body": 5, "word": "\u00b5m", "fig": 1}, {"body": 3, "word": "mix", "fig": 1}, {"body": 3, "word": "monolayer", "fig": 1}, {"body": 3, "word": "potential", "fig": 1}, {"body": 3, "word": "phenotype", "fig": 1}, {"body": 3, "word": "HMEC-1", "fig": 1}, {"body": 3, "word": "cerebral", "fig": 1}, {"body": 2, "word": "cobblestone-like", "fig": 1}, {"body": 2, "word": "collagen-coated", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 2, "word": "elongated", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "maintained", "fig": 1}, {"body": 1, "word": "confirmed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g002.jpg", "caption": "Protocols for EC/NSC coculture. (A) Schematic description of the protocols for monoculture and coculture of D3 human cerebral microvascular endothelial cells (hCMECs) and STROC05 human neural stem cells (hNSCs). (B) 1. hCMECs (CD31+ cells) formed a dense monolayer on the collagen-coated surface, but did not form vasculature-like structures (VLS). hNSCS (polyclonal GFAP+ cells) did not form any VLS. 2. In a transwell coculture, only a dense monolayer of hCMECs without significant VLS could be found at the bottom of the lower chamber after 7 days of coculture. 3. No significant VLS was found when hCMECs were seeded in combination with hNSCs. 4. No VLS emerged when hCMECs were seeded on 7-day differentiated STROC05 cells. 5. A distinctive cytoarchitecture composed of CD31+ VLS and GFAP+ cells was observed when hNSCs were seeded on 7-day differentiated hCMECs for a further 7 days of coculture. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bars represent 200 \u00b5m.", "co_occurrence": [{"body": 77, "word": "cells", "fig": 6}, {"body": 58, "word": "VLS", "fig": 6}, {"body": 38, "word": "hCMECs", "fig": 6}, {"body": 40, "word": "hNSCs", "fig": 3}, {"body": 17, "word": "coculture", "fig": 5}, {"body": 45, "word": "endothelial", "fig": 1}, {"body": 20, "word": "human", "fig": 2}, {"body": 18, "word": "form", "fig": 2}, {"body": 15, "word": "differentiated", "fig": 2}, {"body": 14, "word": "days", "fig": 2}, {"body": 11, "word": "STROC05", "fig": 2}, {"body": 22, "word": "neural", "fig": 1}, {"body": 7, "word": "seeded", "fig": 3}, {"body": 9, "word": "A", "fig": 2}, {"body": 17, "word": "In", "fig": 1}, {"body": 16, "word": "structures", "fig": 1}, {"body": 11, "word": "D3", "fig": 1}, {"body": 10, "word": "vasculature-like", "fig": 1}, {"body": 9, "word": "transwell", "fig": 1}, {"body": 8, "word": "formed", "fig": 1}, {"body": 7, "word": "microvascular", "fig": 1}, {"body": 7, "word": "observed", "fig": 1}, {"body": 7, "word": "stem", "fig": 1}, {"body": 3, "word": "monolayer", "fig": 2}, {"body": 6, "word": "monoculture", "fig": 1}, {"body": 5, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "found", "fig": 2}, {"body": 2, "word": "GFAP+", "fig": 2}, {"body": 3, "word": "cerebral", "fig": 1}, {"body": 3, "word": "without", "fig": 1}, {"body": 2, "word": "combination", "fig": 1}, {"body": 1, "word": "dense", "fig": 2}, {"body": 2, "word": "collagen-coated", "fig": 1}, {"body": 1, "word": "CD31+", "fig": 2}, {"body": 2, "word": "polyclonal", "fig": 1}, {"body": 1, "word": "7-day", "fig": 2}, {"body": 1, "word": "emerged", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "cytoarchitecture", "fig": 1}, {"body": 1, "word": "composed", "fig": 1}, {"body": 1, "word": "could", "fig": 1}, {"body": 1, "word": "surface", "fig": 1}, {"body": 1, "word": "bottom", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g003.jpg", "caption": "Immunohistochemistry of junctional markers on endothelial cells. Localization of ZO1 expression/detection was heterogeneous, with it being only visible as part of the membrane (i.e. cellular junctions) on elongated and arranged endothelial cells (red arrows), but being mostly cytoplasmic in clumped and non-elongated cells (yellow arrows). As the cytoplasmic expression is decreased (grey arrow), it gradually shifts towards being exclusively present in the membrane.", "co_occurrence": [{"body": 77, "word": "cells", "fig": 3}, {"body": 45, "word": "endothelial", "fig": 2}, {"body": 7, "word": "membrane", "fig": 2}, {"body": 11, "word": "cellular", "fig": 1}, {"body": 5, "word": "junctions", "fig": 1}, {"body": 2, "word": "cytoplasmic", "fig": 2}, {"body": 4, "word": "mostly", "fig": 1}, {"body": 4, "word": "markers", "fig": 1}, {"body": 4, "word": "present", "fig": 1}, {"body": 3, "word": "ZO1", "fig": 1}, {"body": 3, "word": "i.e", "fig": 1}, {"body": 3, "word": "As", "fig": 1}, {"body": 2, "word": "junctional", "fig": 1}, {"body": 2, "word": "gradually", "fig": 1}, {"body": 2, "word": "expression", "fig": 1}, {"body": 2, "word": "elongated", "fig": 1}, {"body": 1, "word": "towards", "fig": 1}, {"body": 1, "word": "heterogeneous", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g004.jpg", "caption": "Quantification of endothelial morphogenesis. (A) A distinctive neurovascular cytoarchitecture emerged in which hCMECs (CD31+) formed vasculature-like structures (VLS) resembling a vascular network in between patches of hNSCs (polyclonal GFAP+). (B) The efficiency of VLS formation was quantified by measuring the length of segments between VLS branching points. (C) In a few samples, singular capillary-like structures comprising single layers of CD31+ cells between which a lumen-like space formation was observed. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bars represent 50 \u00b5m.", "co_occurrence": [{"body": 58, "word": "VLS", "fig": 3}, {"body": 77, "word": "cells", "fig": 1}, {"body": 32, "word": "formation", "fig": 2}, {"body": 45, "word": "endothelial", "fig": 1}, {"body": 40, "word": "hNSCs", "fig": 1}, {"body": 38, "word": "hCMECs", "fig": 1}, {"body": 38, "word": "The", "fig": 1}, {"body": 16, "word": "structures", "fig": 2}, {"body": 19, "word": "neurovascular", "fig": 1}, {"body": 9, "word": "A", "fig": 2}, {"body": 17, "word": "In", "fig": 1}, {"body": 16, "word": "morphogenesis", "fig": 1}, {"body": 14, "word": "vascular", "fig": 1}, {"body": 10, "word": "vasculature-like", "fig": 1}, {"body": 9, "word": "length", "fig": 1}, {"body": 8, "word": "formed", "fig": 1}, {"body": 7, "word": "observed", "fig": 1}, {"body": 7, "word": "patches", "fig": 1}, {"body": 7, "word": "points", "fig": 1}, {"body": 6, "word": "network", "fig": 1}, {"body": 5, "word": "segments", "fig": 1}, {"body": 5, "word": "\u00b5m", "fig": 1}, {"body": 5, "word": "efficiency", "fig": 1}, {"body": 5, "word": "branching", "fig": 1}, {"body": 4, "word": "single", "fig": 1}, {"body": 3, "word": "capillary-like", "fig": 1}, {"body": 3, "word": "space", "fig": 1}, {"body": 2, "word": "GFAP+", "fig": 1}, {"body": 2, "word": "polyclonal", "fig": 1}, {"body": 1, "word": "CD31+", "fig": 2}, {"body": 1, "word": "measuring", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "lumen-like", "fig": 1}, {"body": 1, "word": "emerged", "fig": 1}, {"body": 1, "word": "cytoarchitecture", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g005.jpg", "caption": "Comparison of efficiency to form vasculature-like structures. Total length of VLS in hCMEC/hNSC coculture was more efficient than any of the other culture conditions, including hCMEC monoculture (hCMEC only), the transwell coculture (hCMEC-hNSC), seeding of hCMECs and hNSCs simultaneously (hCMEC:hNSC), and seeding hCMECs on differentiated hNSCs (hNSC/hCMEC). Data points on the graph represent the median with bars reflecting the value range (post-hoc pairwise comparisons: * p<.05; **p<.01).", "co_occurrence": [{"body": 40, "word": "hNSCs", "fig": 2}, {"body": 38, "word": "hCMECs", "fig": 2}, {"body": 58, "word": "VLS", "fig": 1}, {"body": 17, "word": "coculture", "fig": 2}, {"body": 10, "word": "hCMEC", "fig": 3}, {"body": 18, "word": "form", "fig": 1}, {"body": 16, "word": "structures", "fig": 1}, {"body": 15, "word": "differentiated", "fig": 1}, {"body": 12, "word": "conditions", "fig": 1}, {"body": 10, "word": "vasculature-like", "fig": 1}, {"body": 10, "word": "hNSC", "fig": 1}, {"body": 9, "word": "transwell", "fig": 1}, {"body": 9, "word": "length", "fig": 1}, {"body": 8, "word": "culture", "fig": 1}, {"body": 7, "word": "points", "fig": 1}, {"body": 6, "word": "p", "fig": 1}, {"body": 6, "word": "monoculture", "fig": 1}, {"body": 5, "word": "efficiency", "fig": 1}, {"body": 4, "word": "hCMEC/hNSC", "fig": 1}, {"body": 3, "word": "reflecting", "fig": 1}, {"body": 1, "word": "seeding", "fig": 2}, {"body": 2, "word": "value", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "hCMEC-hNSC", "fig": 1}, {"body": 1, "word": "range", "fig": 1}, {"body": 1, "word": "hNSC/hCMEC", "fig": 1}, {"body": 1, "word": "post-hoc", "fig": 1}, {"body": 1, "word": "median", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g006.jpg", "caption": "3-dimensional cytoarchitecture of vasculature-like structures. (A) A 3-dimensional cytoarchitecture composed of hCMECs (CD31+ cells in red) and hNSCs (polyclonal GFAP+ cells in green) was visualized using confocal microscopy. (B) At the base of the coculture, hNSCs were seen in a monolayer on which hCMECs formed VLS that was characterized by a multicellular organization that extended beyond the monolayer to form a unique structure. (C) Some hNSCs with an astrocytic phenotype were associated with these VLS by forming a layer of cells around the tubular walls in some cases with an elongated morphology and endfeet on the VLS (yellow arrows). The astrocytes were ensheathing the VLS. (D) A higher magnification 3D confocal image clearly demonstrates structural differences in astrocytes\u2019 morphology upon interfacing with the VLS rather than being inside the neural patch. (E) A 3-dimensional cut through this area further indicates that astrocytes provide structural support (white arrows) to the VLS. The orange line indicates the monolayer formed by hNSCs onto which the VLS rests. Nevertheless, no hollow lumen is formed by the VLS. It hence here remains unclear if a 3-dimensional support structure is required to create a lumen and if they are inflatable in a flow system. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bars represent 100 \u00b5m.", "co_occurrence": [{"body": 58, "word": "VLS", "fig": 8}, {"body": 77, "word": "cells", "fig": 3}, {"body": 40, "word": "hNSCs", "fig": 4}, {"body": 38, "word": "hCMECs", "fig": 2}, {"body": 38, "word": "The", "fig": 2}, {"body": 9, "word": "A", "fig": 4}, {"body": 8, "word": "formed", "fig": 3}, {"body": 11, "word": "structure", "fig": 2}, {"body": 22, "word": "neural", "fig": 1}, {"body": 18, "word": "form", "fig": 1}, {"body": 17, "word": "coculture", "fig": 1}, {"body": 16, "word": "structures", "fig": 1}, {"body": 8, "word": "astrocytes", "fig": 2}, {"body": 12, "word": "provide", "fig": 1}, {"body": 11, "word": "line", "fig": 1}, {"body": 11, "word": "using", "fig": 1}, {"body": 5, "word": "morphology", "fig": 2}, {"body": 10, "word": "vasculature-like", "fig": 1}, {"body": 3, "word": "monolayer", "fig": 3}, {"body": 9, "word": "forming", "fig": 1}, {"body": 8, "word": "Nevertheless", "fig": 1}, {"body": 8, "word": "hence", "fig": 1}, {"body": 7, "word": "required", "fig": 1}, {"body": 7, "word": "It", "fig": 1}, {"body": 3, "word": "lumen", "fig": 2}, {"body": 6, "word": "layer", "fig": 1}, {"body": 5, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "indicates", "fig": 2}, {"body": 4, "word": "rather", "fig": 1}, {"body": 3, "word": "unclear", "fig": 1}, {"body": 3, "word": "remains", "fig": 1}, {"body": 3, "word": "system", "fig": 1}, {"body": 3, "word": "phenotype", "fig": 1}, {"body": 3, "word": "organization", "fig": 1}, {"body": 1, "word": "structural", "fig": 2}, {"body": 2, "word": "tubular", "fig": 1}, {"body": 2, "word": "3D", "fig": 1}, {"body": 2, "word": "astrocytic", "fig": 1}, {"body": 1, "word": "cytoarchitecture", "fig": 2}, {"body": 1, "word": "confocal", "fig": 2}, {"body": 2, "word": "elongated", "fig": 1}, {"body": 2, "word": "GFAP+", "fig": 1}, {"body": 2, "word": "area", "fig": 1}, {"body": 1, "word": "support", "fig": 2}, {"body": 2, "word": "differences", "fig": 1}, {"body": 2, "word": "polyclonal", "fig": 1}, {"body": 1, "word": "around", "fig": 1}, {"body": 1, "word": "astrocytes\u2019", "fig": 1}, {"body": 1, "word": "characterized", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "beyond", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "inside", "fig": 1}, {"body": 1, "word": "endfeet", "fig": 1}, {"body": 1, "word": "onto", "fig": 1}, {"body": 1, "word": "create", "fig": 1}, {"body": 1, "word": "composed", "fig": 1}, {"body": 1, "word": "image", "fig": 1}, {"body": 1, "word": "hollow", "fig": 1}, {"body": 1, "word": "cases", "fig": 1}, {"body": 1, "word": "associated", "fig": 1}, {"body": 1, "word": "flow", "fig": 1}, {"body": 1, "word": "clearly", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "CD31+", "fig": 1}, {"body": 1, "word": "At", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g007.jpg", "caption": "Cytoarchitectural characterization of vessel-like structures. (A) Astrocytes (monoclonal GFAP+ cells) form a layer of support around endothelial cells that organize into tubular structures readily identified by phalloidin. (B) Tubular structures are tightly packed with endothelial cells expressing intercellular adhesion molecule-2 (ICAM-2), although there is a degree of inconsistency in along the VLS indicating different stages of development/maturity. (C) Endothelial cells organized into VLS are polarizing as indicated by the expression of the apical marker podocalyxin that influences astrocytes positioning of endfeet. (D) Endothelial cells within the VLS also express markers indicative of tight junctions, such as Claudin-5 and Occludin.", "co_occurrence": [{"body": 77, "word": "cells", "fig": 5}, {"body": 58, "word": "VLS", "fig": 3}, {"body": 45, "word": "endothelial", "fig": 2}, {"body": 16, "word": "structures", "fig": 3}, {"body": 18, "word": "form", "fig": 1}, {"body": 17, "word": "also", "fig": 1}, {"body": 13, "word": "different", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "astrocytes", "fig": 1}, {"body": 7, "word": "although", "fig": 1}, {"body": 6, "word": "layer", "fig": 1}, {"body": 6, "word": "indicating", "fig": 1}, {"body": 5, "word": "within", "fig": 1}, {"body": 5, "word": "junctions", "fig": 1}, {"body": 5, "word": "intercellular", "fig": 1}, {"body": 4, "word": "organize", "fig": 1}, {"body": 4, "word": "adhesion", "fig": 1}, {"body": 4, "word": "markers", "fig": 1}, {"body": 2, "word": "Endothelial", "fig": 2}, {"body": 4, "word": "ICAM-2", "fig": 1}, {"body": 3, "word": "tight", "fig": 1}, {"body": 3, "word": "organized", "fig": 1}, {"body": 3, "word": "tightly", "fig": 1}, {"body": 2, "word": "GFAP+", "fig": 1}, {"body": 2, "word": "identified", "fig": 1}, {"body": 2, "word": "expression", "fig": 1}, {"body": 2, "word": "tubular", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 1, "word": "characterization", "fig": 1}, {"body": 1, "word": "Claudin-5", "fig": 1}, {"body": 1, "word": "marker", "fig": 1}, {"body": 1, "word": "packed", "fig": 1}, {"body": 1, "word": "readily", "fig": 1}, {"body": 1, "word": "support", "fig": 1}, {"body": 1, "word": "monoclonal", "fig": 1}, {"body": 1, "word": "endfeet", "fig": 1}, {"body": 1, "word": "around", "fig": 1}, {"body": 1, "word": "apical", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "Occludin", "fig": 1}, {"body": 1, "word": "indicative", "fig": 1}, {"body": 1, "word": "Cytoarchitectural", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g008.jpg", "caption": "Deposition of a basement membrane and presence of tight junction molecules. Characteristic extracellular matrix molecules, such as laminin, vitronectin, collagen I and IV, delineate the basement membrane which separates the vascular-like structures from the neural environment.", "co_occurrence": [{"body": 22, "word": "neural", "fig": 1}, {"body": 9, "word": "molecules", "fig": 2}, {"body": 16, "word": "structures", "fig": 1}, {"body": 14, "word": "environment", "fig": 1}, {"body": 7, "word": "membrane", "fig": 2}, {"body": 8, "word": "presence", "fig": 1}, {"body": 8, "word": "I", "fig": 1}, {"body": 4, "word": "basement", "fig": 2}, {"body": 7, "word": "collagen", "fig": 1}, {"body": 7, "word": "laminin", "fig": 1}, {"body": 3, "word": "tight", "fig": 1}, {"body": 3, "word": "extracellular", "fig": 1}, {"body": 3, "word": "junction", "fig": 1}, {"body": 2, "word": "matrix", "fig": 1}, {"body": 2, "word": "IV", "fig": 1}, {"body": 2, "word": "vitronectin", "fig": 1}, {"body": 1, "word": "separates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g009.jpg", "caption": "Time-lapse of vasculature-like structure formation. Time-lapse images revealed the gradual development of a neurovascular cytoarchitecture in hCMEC/hNSC coculture. Arrowheads indicate the border of VLS that became prominent after coculture for 72 h. This solid cytoarchitecture was fixed after an observation period of 168 h. The contrast at borders between hCMECs (CD31+ in red) and hNSCs (polyclonal GFAP+ in green) areas was enhanced computationally. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bar, 200 \u00b5m.", "co_occurrence": [{"body": 58, "word": "VLS", "fig": 1}, {"body": 40, "word": "hNSCs", "fig": 1}, {"body": 38, "word": "hCMECs", "fig": 1}, {"body": 38, "word": "The", "fig": 1}, {"body": 17, "word": "coculture", "fig": 2}, {"body": 32, "word": "formation", "fig": 1}, {"body": 19, "word": "neurovascular", "fig": 1}, {"body": 11, "word": "structure", "fig": 1}, {"body": 10, "word": "vasculature-like", "fig": 1}, {"body": 8, "word": "This", "fig": 1}, {"body": 5, "word": "images", "fig": 1}, {"body": 5, "word": "\u00b5m", "fig": 1}, {"body": 4, "word": "contrast", "fig": 1}, {"body": 4, "word": "hCMEC/hNSC", "fig": 1}, {"body": 3, "word": "gradual", "fig": 1}, {"body": 3, "word": "areas", "fig": 1}, {"body": 2, "word": "GFAP+", "fig": 1}, {"body": 1, "word": "h.", "fig": 2}, {"body": 2, "word": "development", "fig": 1}, {"body": 1, "word": "cytoarchitecture", "fig": 2}, {"body": 2, "word": "polyclonal", "fig": 1}, {"body": 2, "word": "fixed", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "CD31+", "fig": 1}, {"body": 1, "word": "revealed", "fig": 1}, {"body": 1, "word": "observation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g010.jpg", "caption": "Time course of endothelial morphogenesis. Immunocytochemistry using antibodies against CD31 (red) and polyclonal GFAP (green) revealed vascular morphogenesis in hCMEC/hNSC coculture with different culture durations of 1 to 7 days. The efficiency of endothelial morphogenesis that produced vasculature-like structures, where hCMECs (CD31+) align to form rods, was assessed by measuring the length of these rods (white lines), as well as the number of branching points between these for each image. Based on these quantifications, it was evident that total length of all individual rods and the number of branching points increased over 7 days in a linear fashion. A linear regression allowed the calculation of the slope of this progression and afforded a statistical comparison between both to indicate a significant difference in slope between VLS length and branching points. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bar, 100 \u00b5m. Data points on the graph represent the median with bars reflecting the value range.", "co_occurrence": [{"body": 45, "word": "endothelial", "fig": 2}, {"body": 58, "word": "VLS", "fig": 1}, {"body": 16, "word": "morphogenesis", "fig": 3}, {"body": 38, "word": "hCMECs", "fig": 1}, {"body": 38, "word": "The", "fig": 1}, {"body": 14, "word": "days", "fig": 2}, {"body": 7, "word": "points", "fig": 4}, {"body": 9, "word": "length", "fig": 3}, {"body": 18, "word": "form", "fig": 1}, {"body": 17, "word": "coculture", "fig": 1}, {"body": 17, "word": "well", "fig": 1}, {"body": 16, "word": "structures", "fig": 1}, {"body": 5, "word": "branching", "fig": 3}, {"body": 14, "word": "vascular", "fig": 1}, {"body": 13, "word": "different", "fig": 1}, {"body": 6, "word": "number", "fig": 2}, {"body": 11, "word": "using", "fig": 1}, {"body": 10, "word": "vasculature-like", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "culture", "fig": 1}, {"body": 7, "word": "evident", "fig": 1}, {"body": 7, "word": "lines", "fig": 1}, {"body": 5, "word": "\u00b5m", "fig": 1}, {"body": 5, "word": "efficiency", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 4, "word": "CD31", "fig": 1}, {"body": 4, "word": "hCMEC/hNSC", "fig": 1}, {"body": 3, "word": "reflecting", "fig": 1}, {"body": 3, "word": "allowed", "fig": 1}, {"body": 3, "word": "GFAP", "fig": 1}, {"body": 1, "word": "slope", "fig": 2}, {"body": 2, "word": "course", "fig": 1}, {"body": 2, "word": "increased", "fig": 1}, {"body": 1, "word": "linear", "fig": 2}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 2, "word": "value", "fig": 1}, {"body": 2, "word": "polyclonal", "fig": 1}, {"body": 1, "word": "median", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "individual", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "measuring", "fig": 1}, {"body": 1, "word": "image", "fig": 1}, {"body": 1, "word": "total", "fig": 1}, {"body": 1, "word": "CD31+", "fig": 1}, {"body": 1, "word": "Time", "fig": 1}, {"body": 1, "word": "align", "fig": 1}, {"body": 1, "word": "Immunocytochemistry", "fig": 1}, {"body": 1, "word": "range", "fig": 1}, {"body": 1, "word": "revealed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154686/bin/pone.0106346.g011.jpg", "caption": "Differentiation status in hCMEC/hNSC coculture. To determine the phenotypic effects of the coculture of hCMECs with hNSCs, specific markers relevant to the differentiation of hNSCs into neurons (MAP2+), astrocytes (monoclonal GFAP+) and oligodendrocytes (GalC+), as well as junction proteins in hCMECs (CD31, VE-cadherin, ZO1) were measured. There was a 3-fold increase in neuronal differentiation in coculture versus monoculture, but no significant effect on astrocytic or oligodendrocyte differentiation. Apart of ZO1, the percentage of hCMECs expressing CD31 and VE-cadherin was significantly reduced in coculture with hNSCs.", "co_occurrence": [{"body": 40, "word": "hNSCs", "fig": 3}, {"body": 38, "word": "hCMECs", "fig": 3}, {"body": 17, "word": "coculture", "fig": 4}, {"body": 14, "word": "differentiation", "fig": 3}, {"body": 17, "word": "well", "fig": 1}, {"body": 13, "word": "To", "fig": 1}, {"body": 12, "word": "specific", "fig": 1}, {"body": 8, "word": "astrocytes", "fig": 1}, {"body": 8, "word": "determine", "fig": 1}, {"body": 4, "word": "CD31", "fig": 2}, {"body": 7, "word": "increase", "fig": 1}, {"body": 3, "word": "ZO1", "fig": 2}, {"body": 6, "word": "effects", "fig": 1}, {"body": 6, "word": "monoculture", "fig": 1}, {"body": 5, "word": "proteins", "fig": 1}, {"body": 5, "word": "oligodendrocytes", "fig": 1}, {"body": 4, "word": "significantly", "fig": 1}, {"body": 4, "word": "markers", "fig": 1}, {"body": 4, "word": "hCMEC/hNSC", "fig": 1}, {"body": 2, "word": "VE-cadherin", "fig": 2}, {"body": 4, "word": "neuronal", "fig": 1}, {"body": 3, "word": "neurons", "fig": 1}, {"body": 3, "word": "junction", "fig": 1}, {"body": 2, "word": "GFAP+", "fig": 1}, {"body": 2, "word": "reduced", "fig": 1}, {"body": 2, "word": "astrocytic", "fig": 1}, {"body": 1, "word": "GalC+", "fig": 1}, {"body": 1, "word": "MAP2+", "fig": 1}, {"body": 1, "word": "oligodendrocyte", "fig": 1}, {"body": 1, "word": "monoclonal", "fig": 1}, {"body": 1, "word": "Apart", "fig": 1}, {"body": 1, "word": "status", "fig": 1}, {"body": 1, "word": "There", "fig": 1}, {"body": 1, "word": "effect", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "phenotypic", "fig": 1}]}], "4741546": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741546/bin/oncotarget-06-30487-g001.jpg", "caption": "The expression of p53 and MDM2 in samples from BC CML patients A. Expression of p53 and Bax in blast cells obtained from BC CML patients by western blot. *, TP53 mutation status was determined by cDNA sequencing. B. Expression of p53 and MDM2 in CD34+ proliferating and quiescent cells in samples obtained from patients with BC CML and normal controls by real-time RT-PCR. P, proliferating and Q, quiescent.", "co_occurrence": [{"body": 67, "word": "CML", "fig": 3}, {"body": 92, "word": "cells", "fig": 2}, {"body": 37, "word": "p53", "fig": 3}, {"body": 31, "word": "BC", "fig": 3}, {"body": 37, "word": "quiescent", "fig": 2}, {"body": 20, "word": "patients", "fig": 3}, {"body": 28, "word": "proliferating", "fig": 2}, {"body": 25, "word": "samples", "fig": 2}, {"body": 24, "word": "MDM2", "fig": 2}, {"body": 32, "word": "CD34+", "fig": 1}, {"body": 8, "word": "obtained", "fig": 2}, {"body": 14, "word": "expression", "fig": 1}, {"body": 9, "word": "TP53", "fig": 1}, {"body": 7, "word": "The", "fig": 1}, {"body": 6, "word": "normal", "fig": 1}, {"body": 6, "word": "Bax", "fig": 1}, {"body": 6, "word": "RT-PCR", "fig": 1}, {"body": 5, "word": "determined", "fig": 1}, {"body": 4, "word": "blot", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 4, "word": "P", "fig": 1}, {"body": 3, "word": "mutation", "fig": 1}, {"body": 2, "word": "cDNA", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "Q", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "sequencing", "fig": 1}, {"body": 1, "word": "blast", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741546/bin/oncotarget-06-30487-g002.jpg", "caption": "Activation of p53 by nutlin3a induces apoptosis in bulk and CD34+CD38\u2212 CML cells, synergizes with ABT-737 and nilotinib, and has minimal toxicity to normal CD34+ cells Blast cells from BC CML patients or cells from normal BM controls were treated with nutlin3a, ABT-737, nilotinib, nutlin3a plus ABT-737, or nutlin3a plus nilotinib for 48 h. Apoptosis induction was determined in bulk and CD34+CD38\u2212 CML cells A. or CD34+ cells from normal BM controls B. by flow cytometry after cells were stained with annexin V. N3a, nutlin3a; ABT, ABT-737; and Nil, nilotinib.", "co_occurrence": [{"body": 92, "word": "cells", "fig": 7}, {"body": 67, "word": "CML", "fig": 3}, {"body": 39, "word": "nutlin3a", "fig": 5}, {"body": 36, "word": "nilotinib", "fig": 4}, {"body": 27, "word": "ABT-737", "fig": 4}, {"body": 32, "word": "CD34+", "fig": 2}, {"body": 37, "word": "p53", "fig": 1}, {"body": 31, "word": "BC", "fig": 1}, {"body": 25, "word": "apoptosis", "fig": 1}, {"body": 12, "word": "CD34+CD38\u2212", "fig": 2}, {"body": 10, "word": "bulk", "fig": 2}, {"body": 20, "word": "patients", "fig": 1}, {"body": 9, "word": "BM", "fig": 2}, {"body": 6, "word": "normal", "fig": 3}, {"body": 17, "word": "treated", "fig": 1}, {"body": 7, "word": "plus", "fig": 2}, {"body": 11, "word": "N3a", "fig": 1}, {"body": 11, "word": "ABT", "fig": 1}, {"body": 4, "word": "controls", "fig": 2}, {"body": 6, "word": "stained", "fig": 1}, {"body": 5, "word": "induces", "fig": 1}, {"body": 5, "word": "determined", "fig": 1}, {"body": 4, "word": "Apoptosis", "fig": 1}, {"body": 3, "word": "induction", "fig": 1}, {"body": 3, "word": "annexin", "fig": 1}, {"body": 3, "word": "flow", "fig": 1}, {"body": 2, "word": "Activation", "fig": 1}, {"body": 2, "word": "toxicity", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "minimal", "fig": 1}, {"body": 1, "word": "Blast", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741546/bin/oncotarget-06-30487-g003.jpg", "caption": "Activation of p53 by nutlin3a induces cell death in both proliferating and quiescent CD34+ progenitor cells from patients with BC CML cultured alone or co-cultured with MSCs CSFE stained CML cells were treated with nutlin3a for 48 h with or without MSC co-culture. Apoptotic cell death in CD34+ primitive CML cells was determined in proliferating (CSFEdim) and quiescent (CSFEbright) cells after cells were stained with CD34 antibody and annexin V in 7AAD negative cells. N3a, nutlin3a and cocx, co-culture. *, P < 0.05.", "co_occurrence": [{"body": 92, "word": "cells", "fig": 6}, {"body": 67, "word": "CML", "fig": 3}, {"body": 39, "word": "nutlin3a", "fig": 3}, {"body": 37, "word": "quiescent", "fig": 2}, {"body": 32, "word": "CD34+", "fig": 2}, {"body": 28, "word": "proliferating", "fig": 2}, {"body": 23, "word": "cell", "fig": 2}, {"body": 37, "word": "p53", "fig": 1}, {"body": 31, "word": "BC", "fig": 1}, {"body": 20, "word": "patients", "fig": 1}, {"body": 9, "word": "death", "fig": 2}, {"body": 17, "word": "treated", "fig": 1}, {"body": 16, "word": "progenitor", "fig": 1}, {"body": 13, "word": "MSCs", "fig": 1}, {"body": 6, "word": "stained", "fig": 2}, {"body": 6, "word": "co-culture", "fig": 2}, {"body": 11, "word": "N3a", "fig": 1}, {"body": 6, "word": "co-cultured", "fig": 1}, {"body": 6, "word": "without", "fig": 1}, {"body": 5, "word": "determined", "fig": 1}, {"body": 5, "word": "induces", "fig": 1}, {"body": 5, "word": "alone", "fig": 1}, {"body": 4, "word": "P", "fig": 1}, {"body": 3, "word": "annexin", "fig": 1}, {"body": 2, "word": "antibody", "fig": 1}, {"body": 2, "word": "CD34", "fig": 1}, {"body": 2, "word": "MSC", "fig": 1}, {"body": 2, "word": "Activation", "fig": 1}, {"body": 2, "word": "Apoptotic", "fig": 1}, {"body": 2, "word": "V", "fig": 1}, {"body": 1, "word": "primitive", "fig": 1}, {"body": 1, "word": "7AAD", "fig": 1}, {"body": 1, "word": "cultured", "fig": 1}, {"body": 1, "word": "h", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741546/bin/oncotarget-06-30487-g004.jpg", "caption": "Activation of p53 sensitizes with ABT-737 and nilotinib in both proliferating and quiescent CD34+ progenitor cells from patients with BC CML cultured alone or co-cultured with MSCs A. CFSE stained cells from a CML patient were treated with nutlin3a, ABT-737, nilotinib, nultin3a plus ABT-737, or nutlin3a plus nilotinib. B. CFSE stained cells were treated with nutlin3a, ABT-737, and nutlin3a plus ABT-737 (n = 8) or C. with nutlin3a, nilotinib, and nutlin3a plus nilotinib (n = 6) with or without MSC co-culture. Cell death was determined at 48 h in CD34+ proliferating and quiescent cells after cells were stained with annexin V. N3a, nutlin3a; ABT, ABT-737; Nil, nilotinib; cocx, co-culture; P, proliferating; and Q, quiescent. *, P < 0.05 and **, P < 0.001.", "co_occurrence": [{"body": 92, "word": "cells", "fig": 5}, {"body": 39, "word": "nutlin3a", "fig": 7}, {"body": 36, "word": "nilotinib", "fig": 6}, {"body": 27, "word": "ABT-737", "fig": 6}, {"body": 67, "word": "CML", "fig": 2}, {"body": 37, "word": "quiescent", "fig": 3}, {"body": 28, "word": "proliferating", "fig": 3}, {"body": 32, "word": "CD34+", "fig": 2}, {"body": 37, "word": "p53", "fig": 1}, {"body": 17, "word": "treated", "fig": 2}, {"body": 31, "word": "BC", "fig": 1}, {"body": 7, "word": "plus", "fig": 4}, {"body": 20, "word": "patients", "fig": 1}, {"body": 6, "word": "stained", "fig": 3}, {"body": 16, "word": "progenitor", "fig": 1}, {"body": 13, "word": "MSCs", "fig": 1}, {"body": 6, "word": "co-culture", "fig": 2}, {"body": 4, "word": "P", "fig": 3}, {"body": 6, "word": "n", "fig": 2}, {"body": 11, "word": "N3a", "fig": 1}, {"body": 11, "word": "ABT", "fig": 1}, {"body": 9, "word": "death", "fig": 1}, {"body": 4, "word": "CFSE", "fig": 2}, {"body": 6, "word": "patient", "fig": 1}, {"body": 6, "word": "co-cultured", "fig": 1}, {"body": 6, "word": "without", "fig": 1}, {"body": 5, "word": "determined", "fig": 1}, {"body": 5, "word": "alone", "fig": 1}, {"body": 3, "word": "annexin", "fig": 1}, {"body": 2, "word": "Cell", "fig": 1}, {"body": 2, "word": "MSC", "fig": 1}, {"body": 2, "word": "Activation", "fig": 1}, {"body": 2, "word": "sensitizes", "fig": 1}, {"body": 2, "word": "Q", "fig": 1}, {"body": 1, "word": "nultin3a", "fig": 1}, {"body": 1, "word": "cultured", "fig": 1}, {"body": 1, "word": "h", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741546/bin/oncotarget-06-30487-g005.jpg", "caption": "Induction of pro-apoptotic and suppression of anti-apoptotic Bcl-2 family proteins as mechanisms of synergy A. Cells from BC CML samples were treated with nutlin3a for 24 h and protein levels were determined by western blot. B. Cells from BC CML samples were treated with nilotinib for 24 h. RNA levels were determined by real time RT-PCR and protein levels by western blot. Cell viability was shown at the bottom of each graph. C. Cells from BC CML samples were treated with nutlin3a or nilotinib for 24 h. p-CrkL levels were determined by western blot. D. A schema representing the mechanisms of synergistic cell killing by nutlin, ABT-737, and nilotinib.", "co_occurrence": [{"body": 67, "word": "CML", "fig": 3}, {"body": 36, "word": "nilotinib", "fig": 3}, {"body": 31, "word": "BC", "fig": 3}, {"body": 39, "word": "nutlin3a", "fig": 2}, {"body": 25, "word": "samples", "fig": 3}, {"body": 15, "word": "levels", "fig": 4}, {"body": 17, "word": "treated", "fig": 3}, {"body": 27, "word": "ABT-737", "fig": 1}, {"body": 23, "word": "cell", "fig": 1}, {"body": 19, "word": "Bcl-2", "fig": 1}, {"body": 5, "word": "determined", "fig": 3}, {"body": 12, "word": "shown", "fig": 1}, {"body": 4, "word": "blot", "fig": 3}, {"body": 5, "word": "protein", "fig": 2}, {"body": 10, "word": "proteins", "fig": 1}, {"body": 8, "word": "anti-apoptotic", "fig": 1}, {"body": 6, "word": "family", "fig": 1}, {"body": 2, "word": "Cells", "fig": 3}, {"body": 3, "word": "mechanisms", "fig": 2}, {"body": 2, "word": "western", "fig": 3}, {"body": 6, "word": "RT-PCR", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 4, "word": "synergistic", "fig": 1}, {"body": 4, "word": "p-CrkL", "fig": 1}, {"body": 4, "word": "pro-apoptotic", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 1, "word": "h.", "fig": 2}, {"body": 2, "word": "viability", "fig": 1}, {"body": 2, "word": "Cell", "fig": 1}, {"body": 1, "word": "synergy", "fig": 1}, {"body": 1, "word": "h", "fig": 1}, {"body": 1, "word": "time", "fig": 1}, {"body": 1, "word": "killing", "fig": 1}, {"body": 1, "word": "suppression", "fig": 1}]}], "2828961": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660001.jpg", "caption": "Induction of \u03b3H2AX in Chk1-depleted cells upon replication stress coincides with RPA34 hyperphosphorylation and precedes apoptosis. Western blot analysis of \u03b3H2AX, RPA34, and cleaved caspase-3 in extracts obtained from HCT116 cells transfected with control or Chk1 siRNAs treated or not treated with 2 mM thymidine (TdR) (A) or 2 mM hydroxyurea (HU; B) for the indicated times. The band showing slower mobility on panel probed with the RPA34 antibody represents hyperphosphorylated forms of the protein. (C) Western blot analysis of \u03b3H2AX and RPA34 in extracts obtained from HCT116 cells transfected with control or Chk1 siRNAs after a 24-h treatment with 2 mM thymidine or exposure to 10 Gy of IR. Cells exposed to IR were harvested 1 h after treatment. \u03b2-Actin levels are presented as loading controls. The percent depletions of Chk1 for cultures treated with the Chk1 siRNAs are presented. These values were normalized to the \u03b2-actin levels loading controls.", "co_occurrence": [{"body": 220, "word": "cells", "fig": 3}, {"body": 119, "word": "\u03b3H2AX", "fig": 3}, {"body": 64, "word": "Chk1", "fig": 4}, {"body": 67, "word": "thymidine", "fig": 2}, {"body": 34, "word": "treated", "fig": 3}, {"body": 66, "word": "replication", "fig": 1}, {"body": 62, "word": "Chk1-depleted", "fig": 1}, {"body": 30, "word": "HCT116", "fig": 2}, {"body": 29, "word": "control", "fig": 2}, {"body": 28, "word": "treatment", "fig": 2}, {"body": 52, "word": "h", "fig": 1}, {"body": 9, "word": "RPA34", "fig": 4}, {"body": 18, "word": "The", "fig": 2}, {"body": 15, "word": "levels", "fig": 2}, {"body": 8, "word": "siRNAs", "fig": 3}, {"body": 11, "word": "IR", "fig": 2}, {"body": 21, "word": "caspase-3", "fig": 1}, {"body": 10, "word": "analysis", "fig": 2}, {"body": 19, "word": "apoptosis", "fig": 1}, {"body": 18, "word": "Cells", "fig": 1}, {"body": 6, "word": "mM", "fig": 3}, {"body": 17, "word": "exposed", "fig": 1}, {"body": 17, "word": "stress", "fig": 1}, {"body": 16, "word": "A", "fig": 1}, {"body": 15, "word": "cultures", "fig": 1}, {"body": 7, "word": "Western", "fig": 2}, {"body": 14, "word": "B", "fig": 1}, {"body": 14, "word": "exposure", "fig": 1}, {"body": 12, "word": "showing", "fig": 1}, {"body": 5, "word": "obtained", "fig": 2}, {"body": 9, "word": "HU", "fig": 1}, {"body": 7, "word": "C", "fig": 1}, {"body": 7, "word": "times", "fig": 1}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 7, "word": "hyperphosphorylation", "fig": 1}, {"body": 3, "word": "extracts", "fig": 2}, {"body": 3, "word": "transfected", "fig": 2}, {"body": 5, "word": "24-h", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 2, "word": "presented", "fig": 2}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "slower", "fig": 1}, {"body": 1, "word": "blot", "fig": 2}, {"body": 2, "word": "panel", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "These", "fig": 1}, {"body": 1, "word": "forms", "fig": 1}, {"body": 1, "word": "hydroxyurea", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "upon", "fig": 1}, {"body": 1, "word": "cleaved", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660002.jpg", "caption": "Kinetics of \u03b3H2AX induction after thymidine treatment of HCT116 cells transfected with control or Chk1 siRNAs. (A) Percentages (%) of \u03b3H2AX positive cells or cells with subG1 DNA contents at indicated times of 2 mM thymidine (TdR)-treatment of siRNA-transfected HCT116 cells, as measured by flow cytometry. Results in A represent the means of three independent experiments \u00b1 SDs. (B and C) Scatter plots presenting flow cytometric analysis of \u03b3H2AX fluorescence intensity and PI staining in control (B) or Chk1 (C) siRNA-transfected cells exposed to thymidine for the indicated times. Cell cycle profiles are also presented, below the corresponding \u03b3H2AX assay, for either total cells (middle panels) or cells gated for increased \u03b3H2AX staining (upper right or UR) region in the plots, lower panels). Cells with a subG1 DNA content are boxed on the left of each panel with the \u03b3H2AX-positive cells having a subG1 DNA content on the upper left (UL).", "co_occurrence": [{"body": 220, "word": "cells", "fig": 8}, {"body": 119, "word": "\u03b3H2AX", "fig": 5}, {"body": 67, "word": "thymidine", "fig": 3}, {"body": 51, "word": "DNA", "fig": 3}, {"body": 64, "word": "Chk1", "fig": 2}, {"body": 30, "word": "HCT116", "fig": 2}, {"body": 29, "word": "control", "fig": 2}, {"body": 27, "word": "staining", "fig": 2}, {"body": 19, "word": "content", "fig": 2}, {"body": 16, "word": "A", "fig": 2}, {"body": 28, "word": "treatment", "fig": 1}, {"body": 14, "word": "B", "fig": 2}, {"body": 9, "word": "subG1", "fig": 3}, {"body": 18, "word": "Cells", "fig": 1}, {"body": 18, "word": "induction", "fig": 1}, {"body": 17, "word": "exposed", "fig": 1}, {"body": 15, "word": "also", "fig": 1}, {"body": 7, "word": "C", "fig": 2}, {"body": 7, "word": "times", "fig": 2}, {"body": 13, "word": "Cell", "fig": 1}, {"body": 13, "word": "cycle", "fig": 1}, {"body": 6, "word": "flow", "fig": 2}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 9, "word": "measured", "fig": 1}, {"body": 8, "word": "experiments", "fig": 1}, {"body": 8, "word": "siRNAs", "fig": 1}, {"body": 4, "word": "left", "fig": 2}, {"body": 7, "word": "increased", "fig": 1}, {"body": 6, "word": "total", "fig": 1}, {"body": 6, "word": "mM", "fig": 1}, {"body": 5, "word": "represent", "fig": 1}, {"body": 5, "word": "PI", "fig": 1}, {"body": 2, "word": "panels", "fig": 2}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "cytometry", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 2, "word": "panel", "fig": 1}, {"body": 2, "word": "\u03b3H2AX-positive", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "UL", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "middle", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "lower", "fig": 1}, {"body": 1, "word": "fluorescence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660003.jpg", "caption": "Nuclear distribution of \u03b3H2AX and RPA34 in HCT116 cells transfected with control or Chk1 siRNAs after thymidine treatment. (A) Percentages of HCT116 cells treated with the indicated siRNAs presenting low (1\u201310 foci/cell) or high (>10 foci/cell) levels of \u03b3H2AX foci or showing pan-nuclear staining after exposure to 2 mM thymidine (TdR) for the indicated times. Results represent the means of three independent experiments \u00b1 SDs. (B) Representative immunofluorescence images reveal colocalization of \u03b3H2AX and RPA foci. Colocalization of \u03b3H2AX (green) and RPA34 (red) appears as yellow in merged images. (C) HCT116 cells transfected with control or Chk1 siRNAs and exposed to 2 mM thymidine for the indicated times were stained for \u03b3H2AX or TUNEL. Most of the Chk1-depleted cells with strong \u03b3H2AX staining after 48-h exposure to thymidine were negative for TUNEL staining. TUNEL staining was only observed in cells with clear signs of apoptotic nuclear morphology. Cells were also DAPI stained for DNA (blue).", "co_occurrence": [{"body": 220, "word": "cells", "fig": 5}, {"body": 119, "word": "\u03b3H2AX", "fig": 6}, {"body": 67, "word": "thymidine", "fig": 4}, {"body": 64, "word": "Chk1", "fig": 2}, {"body": 56, "word": "foci", "fig": 2}, {"body": 27, "word": "staining", "fig": 4}, {"body": 30, "word": "HCT116", "fig": 3}, {"body": 62, "word": "Chk1-depleted", "fig": 1}, {"body": 29, "word": "control", "fig": 2}, {"body": 51, "word": "DNA", "fig": 1}, {"body": 34, "word": "treated", "fig": 1}, {"body": 28, "word": "treatment", "fig": 1}, {"body": 14, "word": "exposure", "fig": 2}, {"body": 8, "word": "siRNAs", "fig": 3}, {"body": 11, "word": "stained", "fig": 2}, {"body": 9, "word": "RPA34", "fig": 2}, {"body": 18, "word": "Cells", "fig": 1}, {"body": 18, "word": "RPA", "fig": 1}, {"body": 17, "word": "exposed", "fig": 1}, {"body": 16, "word": "A", "fig": 1}, {"body": 15, "word": "also", "fig": 1}, {"body": 15, "word": "levels", "fig": 1}, {"body": 7, "word": "times", "fig": 2}, {"body": 14, "word": "B", "fig": 1}, {"body": 6, "word": "mM", "fig": 2}, {"body": 12, "word": "showing", "fig": 1}, {"body": 11, "word": "pan-nuclear", "fig": 1}, {"body": 8, "word": "experiments", "fig": 1}, {"body": 7, "word": "C", "fig": 1}, {"body": 7, "word": "high", "fig": 1}, {"body": 3, "word": "transfected", "fig": 2}, {"body": 2, "word": "indicated", "fig": 3}, {"body": 2, "word": "TUNEL", "fig": 3}, {"body": 5, "word": "represent", "fig": 1}, {"body": 5, "word": "colocalization", "fig": 1}, {"body": 5, "word": "low", "fig": 1}, {"body": 5, "word": "distribution", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 3, "word": "observed", "fig": 1}, {"body": 3, "word": "appears", "fig": 1}, {"body": 3, "word": "immunofluorescence", "fig": 1}, {"body": 3, "word": "48-h", "fig": 1}, {"body": 2, "word": "apoptotic", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "clear", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660004.jpg", "caption": "Cdc45 and p21 are effectors of the enhanced induction of H2AX phosphorylation or the formation of \u03b3H2AX foci during DNA replication stress in the absence of Chk1. (A) Western blot analysis of \u03b3H2AX and RPA34 in extracts obtained from HCT116 cells transfected with the indicated siRNAs and treated or not treated with 2 mM thymidine for 48 h. The levels of Chk1 and Cdc45 proteins in the cells also are presented, whereas \u03b2-actin levels are presented as loading controls. (B) Percentages of HCT116 cells treated with the indicated siRNAs presenting low (1\u201310 foci/cell) or high (>10 foci/cell) levels of \u03b3H2AX foci or pan-nuclear staining after exposure to 2 mM thymidine for 24 h. Results represent the means of three independent experiments \u00b1 SDs. (C) Representative images of \u03b3H2AX immunostaining of HCT116 cells treated with the indicated siRNAs after a 24-h thymidine arrest. (D) Western blot analysis of \u03b3H2AX and RPA34 in extracts prepared from p21+/+ or p21\u2212/\u2212 HCT116 cells treated with control or Chk1 siRNAs or the Chk1 inhibitor G\u00f66976 and exposed or not exposed to 2 mM thymidine for 24 h. The band showing slower mobility on panel probed with the RPA34 antibody represents hyperphosphorylated forms of the protein. The levels of Chk1 in the cells treated with the indicated siRNAs are presented. Phosphorylation of Chk1 at the Ser296 autophosphorylation site was measured (lower band) to determine the effectiveness of G\u00f66976 treatment. \u03b2-actin levels are presented as loading control.", "co_occurrence": [{"body": 220, "word": "cells", "fig": 6}, {"body": 119, "word": "\u03b3H2AX", "fig": 5}, {"body": 64, "word": "Chk1", "fig": 6}, {"body": 67, "word": "thymidine", "fig": 4}, {"body": 34, "word": "treated", "fig": 6}, {"body": 30, "word": "HCT116", "fig": 4}, {"body": 56, "word": "foci", "fig": 2}, {"body": 15, "word": "levels", "fig": 5}, {"body": 66, "word": "replication", "fig": 1}, {"body": 29, "word": "control", "fig": 2}, {"body": 18, "word": "The", "fig": 3}, {"body": 51, "word": "DNA", "fig": 1}, {"body": 8, "word": "siRNAs", "fig": 5}, {"body": 20, "word": "Cdc45", "fig": 2}, {"body": 17, "word": "exposed", "fig": 2}, {"body": 28, "word": "treatment", "fig": 1}, {"body": 9, "word": "RPA34", "fig": 3}, {"body": 27, "word": "staining", "fig": 1}, {"body": 8, "word": "h.", "fig": 3}, {"body": 21, "word": "phosphorylation", "fig": 1}, {"body": 20, "word": "H2AX", "fig": 1}, {"body": 10, "word": "analysis", "fig": 2}, {"body": 18, "word": "induction", "fig": 1}, {"body": 6, "word": "mM", "fig": 3}, {"body": 17, "word": "formation", "fig": 1}, {"body": 17, "word": "stress", "fig": 1}, {"body": 16, "word": "A", "fig": 1}, {"body": 15, "word": "absence", "fig": 1}, {"body": 15, "word": "also", "fig": 1}, {"body": 7, "word": "Western", "fig": 2}, {"body": 14, "word": "B", "fig": 1}, {"body": 14, "word": "exposure", "fig": 1}, {"body": 13, "word": "inhibitor", "fig": 1}, {"body": 12, "word": "showing", "fig": 1}, {"body": 11, "word": "pan-nuclear", "fig": 1}, {"body": 10, "word": "enhanced", "fig": 1}, {"body": 5, "word": "G\u00f66976", "fig": 2}, {"body": 9, "word": "measured", "fig": 1}, {"body": 8, "word": "experiments", "fig": 1}, {"body": 2, "word": "presented", "fig": 4}, {"body": 2, "word": "indicated", "fig": 4}, {"body": 7, "word": "C", "fig": 1}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 7, "word": "high", "fig": 1}, {"body": 3, "word": "extracts", "fig": 2}, {"body": 6, "word": "arrest", "fig": 1}, {"body": 6, "word": "whereas", "fig": 1}, {"body": 5, "word": "represent", "fig": 1}, {"body": 5, "word": "p21", "fig": 1}, {"body": 5, "word": "obtained", "fig": 1}, {"body": 5, "word": "low", "fig": 1}, {"body": 5, "word": "24-h", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 2}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "determine", "fig": 1}, {"body": 1, "word": "blot", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "proteins", "fig": 1}, {"body": 2, "word": "slower", "fig": 1}, {"body": 2, "word": "panel", "fig": 1}, {"body": 2, "word": "site", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 1, "word": "forms", "fig": 1}, {"body": 1, "word": "lower", "fig": 1}, {"body": 1, "word": "Phosphorylation", "fig": 1}, {"body": 1, "word": "p21+/+", "fig": 1}, {"body": 1, "word": "three", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660005.jpg", "caption": "Chk1-depleted HCT116 cells released from thymidine treatment remain committed to apoptosis and show suppressed reentry into S-phase. (A) HCT116 cells transfected with control or Chk1 siRNAs and exposed to 2 mM thymidine for 24 h were washed (W) with thymidine-free medium and transferred to medium containing 10 \u03bcM BrdU. After 1 h these cells were washed with BrdU-free medium and harvested for FACS analysis at the indicated times. (B and C) Representative scatter plots (top panels) show BrdU incorporation and DNA content (PI staining) in cells transfected with control (B) or Chk1 siRNAs (C) as described above. Cells incorporating BrdU have been gated (as indicated) to determine the percentages with G1, S, or G2 DNA content. Cells with a G1 DNA content incorporating BrdU at early times after the pulse most likely represent cells at the G1/S border, although at 20 h these are likely to represent cells that have traversed the cell cycle and reentered G1. Bottom panels present DNA content (PI staining) of all the cells in the cultures (gated and ungated). Cells indicated as untreated present BrdU incorporation of cells before thymidine treatment. (D) Table summarizing the cell cycle distributions and total cells incorporating BrdU treated as described in B and C. Results represent the means of three independent experiments \u00b1 SDs.", "co_occurrence": [{"body": 220, "word": "cells", "fig": 9}, {"body": 51, "word": "DNA", "fig": 4}, {"body": 67, "word": "thymidine", "fig": 3}, {"body": 28, "word": "BrdU", "fig": 6}, {"body": 52, "word": "h", "fig": 3}, {"body": 64, "word": "Chk1", "fig": 2}, {"body": 19, "word": "content", "fig": 4}, {"body": 62, "word": "Chk1-depleted", "fig": 1}, {"body": 30, "word": "HCT116", "fig": 2}, {"body": 29, "word": "control", "fig": 2}, {"body": 28, "word": "cell", "fig": 2}, {"body": 28, "word": "treatment", "fig": 2}, {"body": 27, "word": "staining", "fig": 2}, {"body": 18, "word": "Cells", "fig": 3}, {"body": 14, "word": "B", "fig": 3}, {"body": 14, "word": "medium", "fig": 3}, {"body": 34, "word": "treated", "fig": 1}, {"body": 29, "word": "S-phase", "fig": 1}, {"body": 13, "word": "incorporation", "fig": 2}, {"body": 13, "word": "cycle", "fig": 2}, {"body": 12, "word": "show", "fig": 2}, {"body": 10, "word": "described", "fig": 2}, {"body": 19, "word": "apoptosis", "fig": 1}, {"body": 17, "word": "exposed", "fig": 1}, {"body": 17, "word": "containing", "fig": 1}, {"body": 8, "word": "washed", "fig": 2}, {"body": 16, "word": "released", "fig": 1}, {"body": 8, "word": "siRNAs", "fig": 2}, {"body": 16, "word": "A", "fig": 1}, {"body": 5, "word": "represent", "fig": 3}, {"body": 15, "word": "cultures", "fig": 1}, {"body": 7, "word": "C", "fig": 2}, {"body": 7, "word": "times", "fig": 2}, {"body": 12, "word": "After", "fig": 1}, {"body": 5, "word": "PI", "fig": 2}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 3, "word": "incorporating", "fig": 3}, {"body": 8, "word": "experiments", "fig": 1}, {"body": 8, "word": "G2", "fig": 1}, {"body": 4, "word": "likely", "fig": 2}, {"body": 7, "word": "thymidine-free", "fig": 1}, {"body": 2, "word": "G1", "fig": 3}, {"body": 6, "word": "suppressed", "fig": 1}, {"body": 3, "word": "transfected", "fig": 2}, {"body": 6, "word": "although", "fig": 1}, {"body": 6, "word": "total", "fig": 1}, {"body": 6, "word": "mM", "fig": 1}, {"body": 2, "word": "indicated", "fig": 3}, {"body": 5, "word": "early", "fig": 1}, {"body": 4, "word": "committed", "fig": 1}, {"body": 2, "word": "panels", "fig": 2}, {"body": 4, "word": "FACS", "fig": 1}, {"body": 3, "word": "pulse", "fig": 1}, {"body": 3, "word": "determine", "fig": 1}, {"body": 2, "word": "reentry", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "untreated", "fig": 1}, {"body": 2, "word": "traversed", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 2, "word": "S", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "remain", "fig": 1}, {"body": 2, "word": "BrdU-free", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "reentered", "fig": 1}, {"body": 1, "word": "W", "fig": 1}, {"body": 1, "word": "G1/S", "fig": 1}, {"body": 1, "word": "C.", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "border", "fig": 1}, {"body": 1, "word": "percentages", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660006.jpg", "caption": "Persistence of \u03b3H2AX and other DNA damage response proteins in Chk1-depleted cells after release from thymidine arrest. (A) Western blot analysis of \u03b3H2AX, RPA34, phospho-ATM (pSer1981), and phospho-Chk2 (pThr68) in extracts obtained from HCT116 cells transfected with control or Chk1 siRNAs and treated or not treated with 2 mM thymidine (TdR) for 24 h before release into thymidine-free medium for the indicated times. The levels of Chk1 protein in the cells also are presented, whereas \u03b2-actin levels are presented as loading controls. (B) Representative immunofluorescence images of \u03b3H2AX nuclear distribution in siRNA-transfected HCT116 cells treated with thymidine for 24 h or treated and released from thymidine for 24 h. (C) Percentages of HCT116 cells treated with control or Chk1 siRNAs presenting low (1\u201310 foci/cell) or high (>10 foci/cell) levels of \u03b3H2AX foci or showing pan-nuclear staining for \u03b3H2AX during and after exposure to thymidine for the indicated times. Results presented are the means of three independent experiments \u00b1 SDs. (D) Representative scatter plots illustrating flow cytometric analysis of \u03b3H2AX levels and DNA content of siRNA-transfected HCT116 cells treated with 2 mM thymidine for 24 h and then released for 24 or 40 h before harvest. \u03b3H2AX+ cells with subG1, G1, S, or G2 DNA contents are gated. \u03b3H2AX+ cells having a subG1 DNA content are in the top left boxes, whereas the total cells with a subG1 DNA content are present in the top left and bottom left boxes. The table summarizes the cell cycle distributions of the \u03b3H2AX+ cells and the total cells with a subG1 DNA content. Values represent the means of three independent experiments \u00b1 SDs. (E) Percentages (%) of \u03b3H2AX+ cells, \u03b3H2AX+ cells with a subG1 DNA content, and total cells with a subG1 DNA content in siRNA-transfected HCT116 cultures as measured by flow cytometry in D. Results represent the means of three independent experiments \u00b1 SDs.", "co_occurrence": [{"body": 220, "word": "cells", "fig": 14}, {"body": 119, "word": "\u03b3H2AX", "fig": 6}, {"body": 51, "word": "DNA", "fig": 8}, {"body": 67, "word": "thymidine", "fig": 6}, {"body": 52, "word": "h", "fig": 4}, {"body": 34, "word": "treated", "fig": 6}, {"body": 64, "word": "Chk1", "fig": 3}, {"body": 30, "word": "HCT116", "fig": 5}, {"body": 19, "word": "content", "fig": 6}, {"body": 62, "word": "Chk1-depleted", "fig": 1}, {"body": 15, "word": "levels", "fig": 4}, {"body": 29, "word": "control", "fig": 2}, {"body": 56, "word": "foci", "fig": 1}, {"body": 9, "word": "subG1", "fig": 6}, {"body": 18, "word": "release", "fig": 2}, {"body": 18, "word": "The", "fig": 2}, {"body": 16, "word": "released", "fig": 2}, {"body": 28, "word": "cell", "fig": 1}, {"body": 27, "word": "staining", "fig": 1}, {"body": 8, "word": "experiments", "fig": 3}, {"body": 10, "word": "analysis", "fig": 2}, {"body": 6, "word": "total", "fig": 3}, {"body": 8, "word": "siRNAs", "fig": 2}, {"body": 16, "word": "A", "fig": 1}, {"body": 15, "word": "cultures", "fig": 1}, {"body": 15, "word": "also", "fig": 1}, {"body": 14, "word": "response", "fig": 1}, {"body": 7, "word": "times", "fig": 2}, {"body": 14, "word": "B", "fig": 1}, {"body": 14, "word": "medium", "fig": 1}, {"body": 14, "word": "exposure", "fig": 1}, {"body": 13, "word": "cycle", "fig": 1}, {"body": 12, "word": "showing", "fig": 1}, {"body": 6, "word": "mM", "fig": 2}, {"body": 6, "word": "whereas", "fig": 2}, {"body": 6, "word": "flow", "fig": 2}, {"body": 4, "word": "left", "fig": 3}, {"body": 11, "word": "pan-nuclear", "fig": 1}, {"body": 5, "word": "represent", "fig": 2}, {"body": 9, "word": "RPA34", "fig": 1}, {"body": 9, "word": "measured", "fig": 1}, {"body": 8, "word": "G2", "fig": 1}, {"body": 8, "word": "h.", "fig": 1}, {"body": 7, "word": "Western", "fig": 1}, {"body": 7, "word": "C", "fig": 1}, {"body": 7, "word": "high", "fig": 1}, {"body": 7, "word": "thymidine-free", "fig": 1}, {"body": 6, "word": "arrest", "fig": 1}, {"body": 2, "word": "presented", "fig": 3}, {"body": 2, "word": "independent", "fig": 3}, {"body": 5, "word": "obtained", "fig": 1}, {"body": 5, "word": "low", "fig": 1}, {"body": 5, "word": "distribution", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 4, "word": "damage", "fig": 1}, {"body": 3, "word": "extracts", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 1, "word": "three", "fig": 3}, {"body": 3, "word": "immunofluorescence", "fig": 1}, {"body": 3, "word": "cytometry", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "G1", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "proteins", "fig": 1}, {"body": 2, "word": "bottom", "fig": 1}, {"body": 2, "word": "S", "fig": 1}, {"body": 1, "word": "top", "fig": 2}, {"body": 2, "word": "harvest", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "phospho-ATM", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "phospho-Chk2", "fig": 1}, {"body": 1, "word": "pThr68", "fig": 1}, {"body": 1, "word": "pSer1981", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660007.jpg", "caption": "BrdU incorporation does not coincide with \u03b3H2AX or RPA foci after release of Chk1-depleted HCT116 cells from thymidine. (A) HCT116 or SW480 cells transfected with the Chk1 siRNA were treated or not treated with 2 mM thymidine (TdR) for 16 h before release into thymidine-free medium containing 10 \u03bcM BrdU for 1 h. Cells were fixed and stained for BrdU incorporation or \u03b3H2AX, immunofluorescence images of BrdU incorporation with \u03b3H2AX distribution in HCT116 (B), or SW480 (C) cells treated as above. The adjacent graphs show the percentages of Chk1-depleted cells showing \u03b3H2AX or BrdU staining or both. Notably, BrdU incorporation was not detected at the sites of \u03b3H2AX foci in either cell line. (D) HCT116 cells treated as in A were stained for BrdU incorporation and RPA34. BrdU incorporation was not detected at nuclear sites of RPA34 foci. (E) Representative immunofluorescence images showing colocalization of \u03b3H2AX and RPA34 foci in Chk1-depleted HCT116 cells treated with thymidine for 16 h before release as above.", "co_occurrence": [{"body": 220, "word": "cells", "fig": 6}, {"body": 119, "word": "\u03b3H2AX", "fig": 6}, {"body": 28, "word": "BrdU", "fig": 8}, {"body": 56, "word": "foci", "fig": 4}, {"body": 67, "word": "thymidine", "fig": 3}, {"body": 62, "word": "Chk1-depleted", "fig": 3}, {"body": 34, "word": "treated", "fig": 5}, {"body": 30, "word": "HCT116", "fig": 5}, {"body": 52, "word": "h", "fig": 2}, {"body": 13, "word": "incorporation", "fig": 6}, {"body": 64, "word": "Chk1", "fig": 1}, {"body": 18, "word": "release", "fig": 3}, {"body": 18, "word": "detected", "fig": 2}, {"body": 16, "word": "A", "fig": 2}, {"body": 28, "word": "cell", "fig": 1}, {"body": 27, "word": "staining", "fig": 1}, {"body": 9, "word": "RPA34", "fig": 3}, {"body": 12, "word": "showing", "fig": 2}, {"body": 12, "word": "SW480", "fig": 2}, {"body": 11, "word": "stained", "fig": 2}, {"body": 18, "word": "siRNA", "fig": 1}, {"body": 18, "word": "RPA", "fig": 1}, {"body": 18, "word": "Cells", "fig": 1}, {"body": 18, "word": "The", "fig": 1}, {"body": 17, "word": "containing", "fig": 1}, {"body": 8, "word": "sites", "fig": 2}, {"body": 14, "word": "B", "fig": 1}, {"body": 14, "word": "medium", "fig": 1}, {"body": 12, "word": "show", "fig": 1}, {"body": 10, "word": "fixed", "fig": 1}, {"body": 8, "word": "h.", "fig": 1}, {"body": 7, "word": "C", "fig": 1}, {"body": 7, "word": "thymidine-free", "fig": 1}, {"body": 6, "word": "mM", "fig": 1}, {"body": 3, "word": "immunofluorescence", "fig": 2}, {"body": 5, "word": "colocalization", "fig": 1}, {"body": 5, "word": "distribution", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 1, "word": "percentages", "fig": 1}, {"body": 1, "word": "either", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828961/bin/zmk0051093660008.jpg", "caption": "Cells with persistent \u03b3H2AX foci do not contain activated caspase-3. (A) HCT116 transfected with control or Chk1 siRNAs were exposed to 2 mM thymidine for the indicated times or exposed to thymidine for 24 h followed by a 24-h release into thymidine-free medium. Cells were then fixed and stained for \u03b3H2AX and active caspase-3. Cells staining for \u03b3H2AX foci did not show activated caspase-3. Similarly cells staining for caspase-3 (that also showed a nuclear structure characteristic of apoptotic cells) did not stain for \u03b3H2AX. (B) Proposed model for the role of \u03b3H2AX in the Chk1 suppressed death pathway responding to DNA replication stress. ATR-mediated Chk1 activation is crucial to maintain cell viability and genome stability upon replication stress, by regulating fork integrity, replication restart, and inappropriate origin firing in response to replication inhibitors (RIs, left). In the absence of Chk1, the action of Cdc45 on origin firing and helicase unwinding increases the level ssDNA in cells, triggering a caspase-3\u2013dependent apoptotic pathway in S-phase cells (middle). The data presented here suggest that \u03b3H2AX formation is enhanced in Chk1-depleted cells in response to persistent stress at DNA replication forks that also leads to prolonged ATM and Chk2 activation. The accumulation of \u03b3H2AX is also dependent on Cdc45, but the signal triggering H2AX phosphorylation is not clear (right). Our results suggest that \u03b3H2AX may help protect some cells from apoptosis, perhaps through maintaining S-phase checkpoints. However, H2AX phosphorylation does not appear to be sufficient for the restart of DNA replication in the absence of Chk1 as DNA replication is not detected at sites of \u03b3H2AX foci after release from the replication inhibitor.", "co_occurrence": [{"body": 220, "word": "cells", "fig": 6}, {"body": 119, "word": "\u03b3H2AX", "fig": 9}, {"body": 66, "word": "replication", "fig": 8}, {"body": 64, "word": "Chk1", "fig": 5}, {"body": 51, "word": "DNA", "fig": 4}, {"body": 56, "word": "foci", "fig": 3}, {"body": 67, "word": "thymidine", "fig": 2}, {"body": 21, "word": "caspase-3", "fig": 4}, {"body": 62, "word": "Chk1-depleted", "fig": 1}, {"body": 29, "word": "S-phase", "fig": 2}, {"body": 27, "word": "staining", "fig": 2}, {"body": 18, "word": "Cells", "fig": 3}, {"body": 52, "word": "h", "fig": 1}, {"body": 17, "word": "stress", "fig": 3}, {"body": 15, "word": "also", "fig": 3}, {"body": 21, "word": "phosphorylation", "fig": 2}, {"body": 20, "word": "H2AX", "fig": 2}, {"body": 20, "word": "Cdc45", "fig": 2}, {"body": 18, "word": "release", "fig": 2}, {"body": 18, "word": "The", "fig": 2}, {"body": 17, "word": "exposed", "fig": 2}, {"body": 16, "word": "activation", "fig": 2}, {"body": 15, "word": "absence", "fig": 2}, {"body": 30, "word": "HCT116", "fig": 1}, {"body": 29, "word": "control", "fig": 1}, {"body": 28, "word": "showed", "fig": 1}, {"body": 14, "word": "response", "fig": 2}, {"body": 28, "word": "cell", "fig": 1}, {"body": 19, "word": "apoptosis", "fig": 1}, {"body": 19, "word": "In", "fig": 1}, {"body": 9, "word": "firing", "fig": 2}, {"body": 18, "word": "detected", "fig": 1}, {"body": 17, "word": "formation", "fig": 1}, {"body": 8, "word": "activated", "fig": 2}, {"body": 16, "word": "A", "fig": 1}, {"body": 15, "word": "inhibitors", "fig": 1}, {"body": 15, "word": "may", "fig": 1}, {"body": 14, "word": "ATM", "fig": 1}, {"body": 14, "word": "B", "fig": 1}, {"body": 14, "word": "medium", "fig": 1}, {"body": 13, "word": "inhibitor", "fig": 1}, {"body": 12, "word": "show", "fig": 1}, {"body": 12, "word": "level", "fig": 1}, {"body": 12, "word": "forks", "fig": 1}, {"body": 6, "word": "persistent", "fig": 2}, {"body": 11, "word": "stained", "fig": 1}, {"body": 5, "word": "pathway", "fig": 2}, {"body": 10, "word": "fixed", "fig": 1}, {"body": 10, "word": "enhanced", "fig": 1}, {"body": 5, "word": "origin", "fig": 2}, {"body": 9, "word": "death", "fig": 1}, {"body": 8, "word": "sites", "fig": 1}, {"body": 8, "word": "Chk2", "fig": 1}, {"body": 4, "word": "restart", "fig": 2}, {"body": 8, "word": "However", "fig": 1}, {"body": 8, "word": "siRNAs", "fig": 1}, {"body": 7, "word": "times", "fig": 1}, {"body": 7, "word": "thymidine-free", "fig": 1}, {"body": 7, "word": "data", "fig": 1}, {"body": 6, "word": "active", "fig": 1}, {"body": 6, "word": "suppressed", "fig": 1}, {"body": 6, "word": "mM", "fig": 1}, {"body": 3, "word": "suggest", "fig": 2}, {"body": 6, "word": "role", "fig": 1}, {"body": 5, "word": "24-h", "fig": 1}, {"body": 4, "word": "accumulation", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 4, "word": "fork", "fig": 1}, {"body": 2, "word": "apoptotic", "fig": 2}, {"body": 2, "word": "triggering", "fig": 2}, {"body": 4, "word": "left", "fig": 1}, {"body": 3, "word": "integrity", "fig": 1}, {"body": 3, "word": "dependent", "fig": 1}, {"body": 3, "word": "results", "fig": 1}, {"body": 3, "word": "appear", "fig": 1}, {"body": 3, "word": "inappropriate", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "helicase", "fig": 1}, {"body": 3, "word": "genome", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 2, "word": "ssDNA", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "Similarly", "fig": 1}, {"body": 1, "word": "help", "fig": 1}, {"body": 1, "word": "stability", "fig": 1}, {"body": 1, "word": "stain", "fig": 1}, {"body": 1, "word": "leads", "fig": 1}, {"body": 1, "word": "signal", "fig": 1}, {"body": 1, "word": "prolonged", "fig": 1}, {"body": 1, "word": "contain", "fig": 1}, {"body": 1, "word": "crucial", "fig": 1}, {"body": 1, "word": "viability", "fig": 1}, {"body": 1, "word": "protect", "fig": 1}, {"body": 1, "word": "action", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "caspase-3\u2013dependent", "fig": 1}, {"body": 1, "word": "unwinding", "fig": 1}, {"body": 1, "word": "responding", "fig": 1}, {"body": 1, "word": "Our", "fig": 1}, {"body": 1, "word": "middle", "fig": 1}, {"body": 1, "word": "upon", "fig": 1}, {"body": 1, "word": "clear", "fig": 1}, {"body": 1, "word": "ATR-mediated", "fig": 1}, {"body": 1, "word": "perhaps", "fig": 1}, {"body": 1, "word": "maintain", "fig": 1}]}], "3670853": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/bin/pone.0065251.g001.jpg", "caption": "TNF-\u03b1 deficiency reduced liver fibrosis after CBDL+CDL. TNF-\u03b1+/+ and TNF-\u03b1\u2212/\u2212 mice received CBDL+CDL. The animals were sacrificed on 3 (A) or 21 (B, C) days after the surgery. (A) Serum TNF-\u03b1 levels were measured by ELISA. (B, C) Collagen deposition was assessed by Sirius red staining (B, original magnification: 40\u00d7, graph in right panel) and measurement of hydroxyproline content (C). Data are mean \u00b1 SD from at least 5 independent experiments. *, P<0.05 using a 2-tailed Student\u2019s t-test.", "co_occurrence": [{"body": 54, "word": "TNF-\u03b1", "fig": 2}, {"body": 104, "word": "liver", "fig": 1}, {"body": 84, "word": "mice", "fig": 1}, {"body": 37, "word": "CBDL+CDL", "fig": 2}, {"body": 52, "word": "fibrosis", "fig": 1}, {"body": 32, "word": "TNF-\u03b1\u2212/\u2212", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 18, "word": "reduced", "fig": 1}, {"body": 13, "word": "TNF-\u03b1+/+", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 6, "word": "surgery", "fig": 1}, {"body": 2, "word": "C", "fig": 3}, {"body": 6, "word": "received", "fig": 1}, {"body": 5, "word": "Sirius", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "days", "fig": 1}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "Student\u2019s", "fig": 1}, {"body": 4, "word": "2-tailed", "fig": 1}, {"body": 4, "word": "least", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 4, "word": "independent", "fig": 1}, {"body": 4, "word": "P", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 3, "word": "deficiency", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "Serum", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 3, "word": "Data", "fig": 1}, {"body": 2, "word": "content", "fig": 1}, {"body": 2, "word": "hydroxyproline", "fig": 1}, {"body": 2, "word": "animals", "fig": 1}, {"body": 2, "word": "sacrificed", "fig": 1}, {"body": 2, "word": "Collagen", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "ELISA", "fig": 1}, {"body": 1, "word": "deposition", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/bin/pone.0065251.g002.jpg", "caption": "TNF-\u03b1 deficiency did not affect CBDL+CDL-induced liver injury. TNF-\u03b1+/+ and TNF-\u03b1\u2212/\u2212 mice received CBDL+CDL. The animals were sacrificed at the indicated times. (A) The injured lesion in the livers was assessed by H&E staining (original magnification: 40\u00d7). (B) Serum ALT and total bilirubin levels were compared at the indicated times. (C) Expression of F4/80 in the livers was examined by immunohistochemistry (original magnification: 200\u00d7). F4/80 positive area was compared (right panel). (D) CD3+ cells in the livers were examined by immunohistochemistry (original magnification: 200\u00d7). Number of CD3+ cells was compared. Data are mean \u00b1 SD from at least 5 independent experiments. *, P<0.05 vs. sham using a 2-tailed Student\u2019s t-test.", "co_occurrence": [{"body": 104, "word": "liver", "fig": 1}, {"body": 84, "word": "mice", "fig": 1}, {"body": 54, "word": "TNF-\u03b1", "fig": 1}, {"body": 22, "word": "The", "fig": 2}, {"body": 42, "word": "injury", "fig": 1}, {"body": 37, "word": "CBDL+CDL", "fig": 1}, {"body": 32, "word": "TNF-\u03b1\u2212/\u2212", "fig": 1}, {"body": 8, "word": "livers", "fig": 3}, {"body": 8, "word": "cells", "fig": 2}, {"body": 13, "word": "TNF-\u03b1+/+", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 4, "word": "compared", "fig": 3}, {"body": 9, "word": "levels", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 6, "word": "positive", "fig": 1}, {"body": 6, "word": "received", "fig": 1}, {"body": 6, "word": "area", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "2-tailed", "fig": 1}, {"body": 4, "word": "total", "fig": 1}, {"body": 4, "word": "least", "fig": 1}, {"body": 4, "word": "independent", "fig": 1}, {"body": 4, "word": "P", "fig": 1}, {"body": 4, "word": "ALT", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 2, "word": "F4/80", "fig": 2}, {"body": 4, "word": "Student\u2019s", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "deficiency", "fig": 1}, {"body": 3, "word": "Serum", "fig": 1}, {"body": 3, "word": "Data", "fig": 1}, {"body": 2, "word": "CBDL+CDL-induced", "fig": 1}, {"body": 1, "word": "examined", "fig": 2}, {"body": 2, "word": "sham", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "bilirubin", "fig": 1}, {"body": 2, "word": "animals", "fig": 1}, {"body": 2, "word": "sacrificed", "fig": 1}, {"body": 1, "word": "CD3+", "fig": 2}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}, {"body": 1, "word": "Expression", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/bin/pone.0065251.g003.jpg", "caption": "TNF-\u03b1-mediated increase of liver injury and hepatocyte apoptosis after CBDL+CDL was induced only in GalN sensitized mice. TNF-\u03b1+/+ and TNF-\u03b1\u2212/\u2212 mice were treated with or without GalN (20 mg) and subjected to CBDL+CDL. The animals were sacrificed 24 h after the surgery. (A) The injured lesions in the livers were assessed by H&E staining (original magnification: 40\u00d7). (B) Serum ALT and total bilirubin levels were compared. (C) Apoptotic nuclei were identified by TUNEL staining (original magnification: 400\u00d7). Numbers of TUNEL-positive cells were compared (right panel). Data are mean \u00b1 SD from at least 5 independent experiments. *, P<0.05 using a 2-tailed Student\u2019s t-test.", "co_occurrence": [{"body": 84, "word": "mice", "fig": 2}, {"body": 104, "word": "liver", "fig": 1}, {"body": 37, "word": "CBDL+CDL", "fig": 2}, {"body": 22, "word": "The", "fig": 2}, {"body": 42, "word": "injury", "fig": 1}, {"body": 32, "word": "TNF-\u03b1\u2212/\u2212", "fig": 1}, {"body": 10, "word": "GalN", "fig": 2}, {"body": 16, "word": "induced", "fig": 1}, {"body": 14, "word": "hepatocyte", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 13, "word": "TNF-\u03b1+/+", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 8, "word": "h", "fig": 1}, {"body": 8, "word": "cells", "fig": 1}, {"body": 8, "word": "livers", "fig": 1}, {"body": 4, "word": "compared", "fig": 2}, {"body": 8, "word": "without", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 3, "word": "staining", "fig": 2}, {"body": 6, "word": "surgery", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 4, "word": "P", "fig": 1}, {"body": 4, "word": "Student\u2019s", "fig": 1}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "2-tailed", "fig": 1}, {"body": 4, "word": "total", "fig": 1}, {"body": 4, "word": "least", "fig": 1}, {"body": 4, "word": "ALT", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 4, "word": "independent", "fig": 1}, {"body": 3, "word": "Data", "fig": 1}, {"body": 3, "word": "Serum", "fig": 1}, {"body": 2, "word": "TUNEL", "fig": 1}, {"body": 2, "word": "apoptosis", "fig": 1}, {"body": 2, "word": "sacrificed", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "animals", "fig": 1}, {"body": 2, "word": "bilirubin", "fig": 1}, {"body": 1, "word": "sensitized", "fig": 1}, {"body": 1, "word": "increase", "fig": 1}, {"body": 1, "word": "TUNEL-positive", "fig": 1}, {"body": 1, "word": "TNF-\u03b1-mediated", "fig": 1}, {"body": 1, "word": "Numbers", "fig": 1}, {"body": 1, "word": "treated", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/bin/pone.0065251.g004.jpg", "caption": "TNF-\u03b1 deficiency did not affect hepatocyte regeneration after CBDL+CDL. TNF-\u03b1+/+ and TNF-\u03b1\u2212/\u2212 mice received CBDL+CDL. The animals were sacrificed 7 days after the surgery. (A) Expression of Ki67 in the livers was examined by immunohistochemistry (original magnification: 40\u00d7). Number of Ki67+ cells was compared (right panel). Data are mean \u00b1 SD from at least 5 independent experiments. *, P<0.05 using a 2-tailed Student\u2019s t-test. (B) The protein extracts from the livers were subjected to SDS-PAGE and immunoblotting was performed with anti-cyclin E and -GAPDH antibodies. The results shown are representative of at least 3 independent experiments.", "co_occurrence": [{"body": 84, "word": "mice", "fig": 1}, {"body": 37, "word": "CBDL+CDL", "fig": 2}, {"body": 22, "word": "The", "fig": 3}, {"body": 54, "word": "TNF-\u03b1", "fig": 1}, {"body": 32, "word": "TNF-\u03b1\u2212/\u2212", "fig": 1}, {"body": 8, "word": "livers", "fig": 2}, {"body": 14, "word": "hepatocyte", "fig": 1}, {"body": 13, "word": "TNF-\u03b1+/+", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 9, "word": "results", "fig": 1}, {"body": 8, "word": "protein", "fig": 1}, {"body": 4, "word": "least", "fig": 2}, {"body": 4, "word": "independent", "fig": 2}, {"body": 8, "word": "cells", "fig": 1}, {"body": 7, "word": "regeneration", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 6, "word": "surgery", "fig": 1}, {"body": 6, "word": "received", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 5, "word": "days", "fig": 1}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "2-tailed", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "compared", "fig": 1}, {"body": 4, "word": "P", "fig": 1}, {"body": 4, "word": "Student\u2019s", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 3, "word": "deficiency", "fig": 1}, {"body": 3, "word": "Data", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "animals", "fig": 1}, {"body": 2, "word": "sacrificed", "fig": 1}, {"body": 2, "word": "Ki67", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "examined", "fig": 1}, {"body": 1, "word": "Ki67+", "fig": 1}, {"body": 1, "word": "extracts", "fig": 1}, {"body": 1, "word": "Expression", "fig": 1}, {"body": 1, "word": "anti-cyclin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/bin/pone.0065251.g005.jpg", "caption": "TNF-\u03b1 deficiency did not affect collagen \u03b11(I) mRNA expression and HSC activation in the livers of mice after CBDL+CDL.", "co_occurrence": [{"body": 84, "word": "mice", "fig": 1}, {"body": 54, "word": "TNF-\u03b1", "fig": 1}, {"body": 37, "word": "CBDL+CDL", "fig": 1}, {"body": 28, "word": "mRNA", "fig": 1}, {"body": 20, "word": "collagen", "fig": 1}, {"body": 16, "word": "expression", "fig": 1}, {"body": 12, "word": "I", "fig": 1}, {"body": 12, "word": "\u03b11", "fig": 1}, {"body": 10, "word": "activation", "fig": 1}, {"body": 8, "word": "livers", "fig": 1}, {"body": 5, "word": "HSC", "fig": 1}, {"body": 3, "word": "deficiency", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/bin/pone.0065251.g006.jpg", "caption": "CBDL+CDL increased TIMP-1 in a TNF-\u03b1 dependent manner. TNF-\u03b1+/+ and TNF-\u03b1\u2212/\u2212 mice received CBDL+CDL. The animals were sacrificed at the indicated times. (A) mRNA levels of TIMP-1 in the livers were determined by quantitative real time RT-PCR. (B) The protein extracts from the livers were analyzed by SDS-PAGE, and immunoblotting was performed with anti-TIMP-1 and -GAPDH antibodies. The results shown are representative of at least 5 independent experiments. Relative densitometric intensity of TIMP-1 was determined for each protein band and normalized to GAPDH (bottom panels). (C) Collagenase activities in the protein extracts were measured by gelatin zymography. (D) Expression of TIMP-1 in the livers was examined by immunohistochemistry (original magnification: 400\u00d7). (E) Expression of desmin (green) and TIMP-1 (red) around the interstitial space around dilated bile ducts was examined by immunofluorescent staining. The results shown are representative of at least 3 independent experiments. Data are mean \u00b1 SD from at least 5 independent experiments. *, P<0.05 using a 2-tailed Student\u2019s t-test.", "co_occurrence": [{"body": 48, "word": "TIMP-1", "fig": 5}, {"body": 22, "word": "The", "fig": 4}, {"body": 84, "word": "mice", "fig": 1}, {"body": 37, "word": "CBDL+CDL", "fig": 2}, {"body": 54, "word": "TNF-\u03b1", "fig": 1}, {"body": 32, "word": "TNF-\u03b1\u2212/\u2212", "fig": 1}, {"body": 28, "word": "mRNA", "fig": 1}, {"body": 8, "word": "livers", "fig": 3}, {"body": 8, "word": "protein", "fig": 3}, {"body": 9, "word": "results", "fig": 2}, {"body": 6, "word": "experiments", "fig": 3}, {"body": 17, "word": "bile", "fig": 1}, {"body": 17, "word": "increased", "fig": 1}, {"body": 15, "word": "desmin", "fig": 1}, {"body": 7, "word": "determined", "fig": 2}, {"body": 13, "word": "using", "fig": 1}, {"body": 13, "word": "TNF-\u03b1+/+", "fig": 1}, {"body": 4, "word": "least", "fig": 3}, {"body": 4, "word": "independent", "fig": 3}, {"body": 9, "word": "levels", "fig": 1}, {"body": 4, "word": "shown", "fig": 2}, {"body": 7, "word": "performed", "fig": 1}, {"body": 6, "word": "received", "fig": 1}, {"body": 5, "word": "RT-PCR", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 4, "word": "Student\u2019s", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 4, "word": "2-tailed", "fig": 1}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "P", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "real", "fig": 1}, {"body": 3, "word": "Data", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 3, "word": "quantitative", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "sacrificed", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "around", "fig": 2}, {"body": 2, "word": "zymography", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "extracts", "fig": 2}, {"body": 1, "word": "Expression", "fig": 2}, {"body": 2, "word": "animals", "fig": 1}, {"body": 1, "word": "examined", "fig": 2}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "gelatin", "fig": 1}, {"body": 1, "word": "interstitial", "fig": 1}, {"body": 1, "word": "ducts", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "dilated", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "space", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/bin/pone.0065251.g007.jpg", "caption": "TIMP-1 deficiency reduced liver fibrosis after BDL. TIMP-1+/+ and TIMP-1\u2212/\u2212 mice received CBDL+CDL (A, B) or PBDL (C). The animals were sacrificed at the indicated times. (A) The injured lesions in the livers were assessed by H&E staining (original magnification: 40\u00d7, left panel). Serum ALT levels were compared (right panel). (B) Survival curves for animals with CBDL+CDL. (C) Collagen deposition in the ligated left robes was assessed by Sirius red staining (original magnification: 40\u00d7). Sirius red positive area was compared (right panel). Data are mean \u00b1 SD from at least 5 independent experiments. *, P<0.05 using a 2-tailed Student\u2019s t-test.", "co_occurrence": [{"body": 104, "word": "liver", "fig": 1}, {"body": 84, "word": "mice", "fig": 1}, {"body": 37, "word": "CBDL+CDL", "fig": 2}, {"body": 52, "word": "fibrosis", "fig": 1}, {"body": 48, "word": "TIMP-1", "fig": 1}, {"body": 22, "word": "The", "fig": 2}, {"body": 19, "word": "TIMP-1\u2212/\u2212", "fig": 1}, {"body": 18, "word": "reduced", "fig": 1}, {"body": 16, "word": "BDL", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 5, "word": "Sirius", "fig": 2}, {"body": 5, "word": "red", "fig": 2}, {"body": 9, "word": "TIMP-1+/+", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 8, "word": "livers", "fig": 1}, {"body": 4, "word": "compared", "fig": 2}, {"body": 8, "word": "ligated", "fig": 1}, {"body": 6, "word": "positive", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 3, "word": "staining", "fig": 2}, {"body": 6, "word": "area", "fig": 1}, {"body": 6, "word": "received", "fig": 1}, {"body": 3, "word": "left", "fig": 2}, {"body": 5, "word": "PBDL", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 4, "word": "independent", "fig": 1}, {"body": 4, "word": "Student\u2019s", "fig": 1}, {"body": 4, "word": "2-tailed", "fig": 1}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "least", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 2, "word": "C", "fig": 2}, {"body": 4, "word": "P", "fig": 1}, {"body": 2, "word": "animals", "fig": 2}, {"body": 4, "word": "ALT", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 3, "word": "deficiency", "fig": 1}, {"body": 3, "word": "Serum", "fig": 1}, {"body": 3, "word": "Data", "fig": 1}, {"body": 2, "word": "Collagen", "fig": 1}, {"body": 1, "word": "assessed", "fig": 2}, {"body": 2, "word": "sacrificed", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "deposition", "fig": 1}]}], "4770269": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/figs1.jpg", "caption": "Metabolic phenotype of F0-male rats after 12 weeks on HFD. (A) Body weight curve (n = 19 (CD) and 20 (HFD)). (B) Energy Intake (n = 20/19). (C) Blood glucose levels during an intraperitoneal insulin tolerance test (ipITT) (n = 9/10). Blood (D) glucose and (E) insulin during the glucose tolerance test (ipGTT), n = 8). Results are represented as mean \u00b1 SEM. Student's t-test: *p \u2264 0.05, F0-HF vs F0-CD. N-numbers are indicated for CD and HF, respectively.", "co_occurrence": [{"body": 24, "word": "glucose", "fig": 3}, {"body": 35, "word": "HFD", "fig": 2}, {"body": 17, "word": "insulin", "fig": 2}, {"body": 23, "word": "rats", "fig": 1}, {"body": 9, "word": "tolerance", "fig": 2}, {"body": 18, "word": "F0-HF", "fig": 1}, {"body": 14, "word": "phenotype", "fig": 1}, {"body": 12, "word": "weight", "fig": 1}, {"body": 6, "word": "test", "fig": 2}, {"body": 12, "word": "levels", "fig": 1}, {"body": 5, "word": "Blood", "fig": 2}, {"body": 8, "word": "F0-CD", "fig": 1}, {"body": 8, "word": "weeks", "fig": 1}, {"body": 6, "word": "'s", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 1, "word": "n", "fig": 4}, {"body": 3, "word": "ipGTT", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "ipITT", "fig": 1}, {"body": 2, "word": "vs", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "Body", "fig": 1}, {"body": 1, "word": "intraperitoneal", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "Metabolic", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/figs2.jpg", "caption": "Glucose tolerance is impaired, while HFD-induced weight gain is not, in male F1 and F2 offspring. (A\u2013C) Metabolic phenotyping of F1 male offspring after 12 weeks of high fat feeding; blood (A) glucose and (B) insulin during an intraperitoneal glucose tolerance test (ipGTT) (n = 11\u201314 animals and litters) and (C) body weight curve (n = 18\u201322 animals from 15 to 16 litters; used more than 1 sibling per litter). (D\u2013F) Metabolic phenotyping of F2 male offspring after 12 weeks of high fat diet feeding. Blood (D) glucose and (E) insulin during an ipGTT (n = 10\u201311 litters; 1 sibling per litter) and (F) body weight curve (n = 18\u201324 animals from 10 to 13 litters; used more than 1 sibling per litter). Results are represented as mean \u00b1 SEM. Two-way ANOVA followed by Bonferroni post-hoc test: *p \u2264 0.05: PatCD-HF vs PatCD-CD or GpatCD-HF vs GpatCD-CD; \u00a4p \u2264 0.05: PatHF-CD vs PatCD-CD or GpatHF-CD vs GpatCD-CD; #p \u2264 0.05: PatHF-HF vs PatHF-CD or GpatHF-HF vs GpatHF-CD; +p \u2264 0.05: PatHF-HF vs PatCD-HF or GpatHF-HF vs GpatCD-HF; p < 0.07: GpatHF-HF vs GpatHF-CD or GpatCD-HF vs GpatCD-CD. PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD; GpatCD-CD: Grandpaternal-Chow on Chow; GpatHF-CD: Grandpaternal-HFD on Chow; GpatCD-HF: Grandpaternal-Chow on HFD; GpatHF-HF: Grandpaternal-HFD on HFD.", "co_occurrence": [{"body": 73, "word": "offspring", "fig": 3}, {"body": 35, "word": "HFD", "fig": 4}, {"body": 64, "word": "F1", "fig": 2}, {"body": 24, "word": "glucose", "fig": 3}, {"body": 32, "word": "F2", "fig": 2}, {"body": 14, "word": "male", "fig": 3}, {"body": 12, "word": "weight", "fig": 3}, {"body": 17, "word": "insulin", "fig": 2}, {"body": 29, "word": "diet", "fig": 1}, {"body": 12, "word": "used", "fig": 2}, {"body": 7, "word": "litter", "fig": 3}, {"body": 10, "word": "body", "fig": 2}, {"body": 2, "word": "vs", "fig": 10}, {"body": 6, "word": "per", "fig": 3}, {"body": 9, "word": "tolerance", "fig": 2}, {"body": 6, "word": "PatHF-CD", "fig": 3}, {"body": 8, "word": "weeks", "fig": 2}, {"body": 6, "word": "fat", "fig": 2}, {"body": 4, "word": "animals", "fig": 3}, {"body": 4, "word": "sibling", "fig": 3}, {"body": 6, "word": "test", "fig": 2}, {"body": 5, "word": "p", "fig": 2}, {"body": 3, "word": "PatHF-HF", "fig": 3}, {"body": 2, "word": "GpatHF-CD", "fig": 4}, {"body": 7, "word": "followed", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 3}, {"body": 3, "word": "ipGTT", "fig": 2}, {"body": 3, "word": "high", "fig": 2}, {"body": 6, "word": "blood", "fig": 1}, {"body": 5, "word": "HFD-induced", "fig": 1}, {"body": 5, "word": "Blood", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 2, "word": "feeding", "fig": 2}, {"body": 1, "word": "GpatHF-HF", "fig": 4}, {"body": 1, "word": "n", "fig": 4}, {"body": 1, "word": "GpatCD-CD", "fig": 4}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 3}, {"body": 3, "word": "F", "fig": 1}, {"body": 3, "word": "gain", "fig": 1}, {"body": 1, "word": "Metabolic", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "curve", "fig": 2}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "impaired", "fig": 1}, {"body": 1, "word": "intraperitoneal", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "Glucose", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/figs3.jpg", "caption": "Transcriptomic analysis and DNA methylation in metabolic tissues of offspring shows modest association to sperm DNA methylation. (A) Gene expression representation in Extensor Digitorum Longus (EDL) muscle, liver and white adipose tissue (WAT) of the F2-female offspring. Represented targets are the nearest genes of the 18 sperm DMRs common to F0 and F1 offspring. Data are represented as log2 of the fold change of GpatHF-CD vs GpatCD-CD F2-females. (B) Target-specific DNA methylation in WAT of F2 females. DNA methylation is represented as percentage of methylated DNA relative to input (total) DNA of each target measured by quantitative PCR after MBD-capture (n = 7\u20139). Student's t-test: *p < 0.05: GpatHF-CD vs GpatCD-CD. GpatCD-CD: Grandpaternal-Chow on Chow; GPatHF-CD: Grandpaternal-HFD on Chow. N.D.: Not Detected. FC: Fold Change.", "co_occurrence": [{"body": 73, "word": "offspring", "fig": 3}, {"body": 27, "word": "DNA", "fig": 6}, {"body": 25, "word": "methylation", "fig": 4}, {"body": 43, "word": "sperm", "fig": 2}, {"body": 65, "word": "expression", "fig": 1}, {"body": 64, "word": "F1", "fig": 1}, {"body": 34, "word": "F0", "fig": 1}, {"body": 32, "word": "metabolic", "fig": 1}, {"body": 16, "word": "WAT", "fig": 2}, {"body": 32, "word": "F2", "fig": 1}, {"body": 22, "word": "tissue", "fig": 1}, {"body": 22, "word": "analysis", "fig": 1}, {"body": 18, "word": "adipose", "fig": 1}, {"body": 17, "word": "genes", "fig": 1}, {"body": 14, "word": "females", "fig": 1}, {"body": 14, "word": "tissues", "fig": 1}, {"body": 13, "word": "targets", "fig": 1}, {"body": 9, "word": "target", "fig": 1}, {"body": 6, "word": "DMRs", "fig": 1}, {"body": 6, "word": "'s", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 5, "word": "PCR", "fig": 1}, {"body": 5, "word": "methylated", "fig": 1}, {"body": 5, "word": "white", "fig": 1}, {"body": 5, "word": "liver", "fig": 1}, {"body": 5, "word": "EDL", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "Gene", "fig": 1}, {"body": 2, "word": "GpatHF-CD", "fig": 2}, {"body": 2, "word": "vs", "fig": 2}, {"body": 4, "word": "muscle", "fig": 1}, {"body": 3, "word": "common", "fig": 1}, {"body": 3, "word": "Transcriptomic", "fig": 1}, {"body": 1, "word": "GpatCD-CD", "fig": 3}, {"body": 1, "word": "represented", "fig": 2}, {"body": 2, "word": "change", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "nearest", "fig": 1}, {"body": 2, "word": "F2-female", "fig": 1}, {"body": 1, "word": "input", "fig": 1}, {"body": 1, "word": "F2-females", "fig": 1}, {"body": 1, "word": "association", "fig": 1}, {"body": 1, "word": "Longus", "fig": 1}, {"body": 1, "word": "fold", "fig": 1}, {"body": 1, "word": "Extensor", "fig": 1}, {"body": 1, "word": "percentage", "fig": 1}, {"body": 1, "word": "n", "fig": 1}, {"body": 1, "word": "Digitorum", "fig": 1}, {"body": 1, "word": "modest", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/figs4.jpg", "caption": "SncRNA expression pattern in sperm from F0 and F1 rats. Distribution of different small non-coding RNAs (sncRNAs) categories in sperm of (A) F0 (n = 8\u201310) and (B) F1 (n = 7 per group) rats. (C\u2013E) Chromosomal distribution (sperm karyogram) of differentially expressed sncRNA: (C) F0-HF vs F0-CD; (D) F1 (PatHF-CD vs PatCD-CD) and (E) F1 (PatHF-HF vs PatCD-HF). F0-CD: F0 on chow diet; F0-HF: F0 on HFD; PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD. Student's t-test: *p \u2264 0.05 (F1 vs F0). F0-CD: F0 on chow diet; F0-HF: F0 on HFD; PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD.", "co_occurrence": [{"body": 64, "word": "F1", "fig": 5}, {"body": 34, "word": "F0", "fig": 7}, {"body": 35, "word": "HFD", "fig": 6}, {"body": 43, "word": "sperm", "fig": 3}, {"body": 65, "word": "expression", "fig": 1}, {"body": 29, "word": "diet", "fig": 2}, {"body": 18, "word": "F0-HF", "fig": 3}, {"body": 23, "word": "rats", "fig": 2}, {"body": 8, "word": "F0-CD", "fig": 3}, {"body": 10, "word": "chow", "fig": 2}, {"body": 6, "word": "PatHF-CD", "fig": 3}, {"body": 13, "word": "small", "fig": 1}, {"body": 12, "word": "sncRNA", "fig": 1}, {"body": 10, "word": "differentially", "fig": 1}, {"body": 9, "word": "expressed", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 3}, {"body": 2, "word": "vs", "fig": 4}, {"body": 6, "word": "'s", "fig": 1}, {"body": 6, "word": "per", "fig": 1}, {"body": 6, "word": "sncRNAs", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 3}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "non-coding", "fig": 1}, {"body": 4, "word": "RNAs", "fig": 1}, {"body": 4, "word": "group", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 3}, {"body": 3, "word": "D", "fig": 1}, {"body": 2, "word": "pattern", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "SncRNA", "fig": 1}, {"body": 1, "word": "distribution", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/figs5.jpg", "caption": "Gametic small non-coding RNA expression is altered by HFD and paternal diet. (A\u2013C) Number of differentially expressed sncRNAs (miRNAs, tRFs and piRNAs) in the sperm of (A) F0-HF vs F0-CD (n = 8\u201310), (B) F1 offspring of F0-HF (PatHF-CD) vs F1 of F0-CD (PatCD-CD) fed a chow diet or (C) a high fat diet (PatHF-HF vs PatCD-HF) (n = 7 per group; 1 sibling per litter). Sperm sncRNA expression pattern in percentage per group in (D) F0 and (E) F1. F0-CD: F0 on chow diet; F0-HF: F0 on HFD; PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD. DE: Differentially Expressed. rRNA (rRNA annotation from Ensemble) and rRNArep (rRNA annotation from repeatmask2).", "co_occurrence": [{"body": 64, "word": "F1", "fig": 3}, {"body": 35, "word": "HFD", "fig": 4}, {"body": 65, "word": "expression", "fig": 2}, {"body": 29, "word": "diet", "fig": 4}, {"body": 34, "word": "F0", "fig": 3}, {"body": 73, "word": "offspring", "fig": 1}, {"body": 18, "word": "F0-HF", "fig": 3}, {"body": 43, "word": "sperm", "fig": 1}, {"body": 8, "word": "F0-CD", "fig": 3}, {"body": 23, "word": "RNA", "fig": 1}, {"body": 10, "word": "chow", "fig": 2}, {"body": 19, "word": "fed", "fig": 1}, {"body": 6, "word": "per", "fig": 3}, {"body": 15, "word": "altered", "fig": 1}, {"body": 14, "word": "miRNAs", "fig": 1}, {"body": 13, "word": "small", "fig": 1}, {"body": 4, "word": "rRNA", "fig": 3}, {"body": 12, "word": "sncRNA", "fig": 1}, {"body": 12, "word": "paternal", "fig": 1}, {"body": 6, "word": "PatHF-CD", "fig": 2}, {"body": 10, "word": "differentially", "fig": 1}, {"body": 9, "word": "expressed", "fig": 1}, {"body": 9, "word": "tRFs", "fig": 1}, {"body": 4, "word": "group", "fig": 2}, {"body": 7, "word": "litter", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 2}, {"body": 2, "word": "vs", "fig": 3}, {"body": 6, "word": "sncRNAs", "fig": 1}, {"body": 6, "word": "piRNAs", "fig": 1}, {"body": 6, "word": "fat", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "non-coding", "fig": 1}, {"body": 4, "word": "sibling", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 2}, {"body": 3, "word": "high", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 2}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "pattern", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "Differentially", "fig": 1}, {"body": 1, "word": "percentage", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/figs6.jpg", "caption": "Expression of let-7c in WAT of male offspring and mRNA expression of predicted targets. Expression of let-7c in WAT of male offspring (A) F1 and (B) F2. The snoRNA was used as internal control. (C) Quantitative PCR validation of let-7c predicted target genes in WAT of F1 males (n = 6 per group; 1 sibling per litter). Geometric mean of the housekeeping genes RPLP0 and \u03b2-actin was used for normalization. Transcriptomic analysis in WAT of F2-female offspring (D) Known let-7 target genes in the insulin/Igf signaling pathway and (E) Insulin/Igf signaling predicted target genes of let-7c in rats (n = 6\u20137). Values are represented as mean \u00b1 SEM. *p \u2264 0.05: PatCD-HF vs PatCD-CD; \u00a4p \u2264 0.05: PatHF-CD vs PatCD-CD; +p \u2264 0.05: PatHF-HF vs PatCD-HF.", "co_occurrence": [{"body": 73, "word": "offspring", "fig": 3}, {"body": 45, "word": "let-7c", "fig": 4}, {"body": 64, "word": "F1", "fig": 2}, {"body": 17, "word": "genes", "fig": 4}, {"body": 65, "word": "expression", "fig": 1}, {"body": 16, "word": "WAT", "fig": 4}, {"body": 12, "word": "predicted", "fig": 3}, {"body": 32, "word": "F2", "fig": 1}, {"body": 14, "word": "male", "fig": 2}, {"body": 9, "word": "target", "fig": 3}, {"body": 12, "word": "used", "fig": 2}, {"body": 23, "word": "rats", "fig": 1}, {"body": 22, "word": "analysis", "fig": 1}, {"body": 18, "word": "control", "fig": 1}, {"body": 18, "word": "The", "fig": 1}, {"body": 13, "word": "let-7", "fig": 1}, {"body": 13, "word": "targets", "fig": 1}, {"body": 6, "word": "per", "fig": 2}, {"body": 5, "word": "signaling", "fig": 2}, {"body": 4, "word": "Expression", "fig": 2}, {"body": 7, "word": "litter", "fig": 1}, {"body": 2, "word": "vs", "fig": 3}, {"body": 6, "word": "PatHF-CD", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 5, "word": "PCR", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "sibling", "fig": 1}, {"body": 4, "word": "group", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 2}, {"body": 3, "word": "males", "fig": 1}, {"body": 3, "word": "Transcriptomic", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 1}, {"body": 2, "word": "F2-female", "fig": 1}, {"body": 2, "word": "pathway", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 1, "word": "PatCD-HF", "fig": 2}, {"body": 2, "word": "snoRNA", "fig": 1}, {"body": 1, "word": "insulin/Igf", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "normalization", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/figs7.jpg", "caption": "Validation of miRNA expression in sperm of F0 and F1 offspring. miRNA expression measured by quantitative PCR using TaqMan specific probes for (A) let-7c; (B) miR-293 and (C) miR-880. U6 was used as internal control. Values are represented as mean \u00b1 SEM. Student's t-test or two-way ANOVA followed by Bonferroni post-hoc test: *p \u2264 0.05: F0-HF vs F0-CD; +p \u2264 0.05: PatHF-HF vs PatCD-HF; #p \u2264 0.05: PatHF-HF vs PatHF-CD. F0 (n = 13\u201316); F1 (n = 7\u201312).", "co_occurrence": [{"body": 65, "word": "expression", "fig": 2}, {"body": 64, "word": "F1", "fig": 2}, {"body": 73, "word": "offspring", "fig": 1}, {"body": 34, "word": "F0", "fig": 2}, {"body": 45, "word": "let-7c", "fig": 1}, {"body": 43, "word": "sperm", "fig": 1}, {"body": 15, "word": "miRNA", "fig": 2}, {"body": 25, "word": "using", "fig": 1}, {"body": 18, "word": "control", "fig": 1}, {"body": 18, "word": "F0-HF", "fig": 1}, {"body": 12, "word": "used", "fig": 1}, {"body": 8, "word": "F0-CD", "fig": 1}, {"body": 7, "word": "followed", "fig": 1}, {"body": 7, "word": "specific", "fig": 1}, {"body": 2, "word": "vs", "fig": 3}, {"body": 6, "word": "test", "fig": 1}, {"body": 6, "word": "'s", "fig": 1}, {"body": 6, "word": "PatHF-CD", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 2}, {"body": 6, "word": "measured", "fig": 1}, {"body": 5, "word": "PCR", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "p", "fig": 1}, {"body": 3, "word": "TaqMan", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "probes", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/gr1.jpg", "caption": "Body weight and \u03b2-cell mass is altered in newborn offspring of HFD-fed founders. (A) Schematic diagram of study design: F0 male Sprague\u2013Dawley rats fed a chow (F0-CD) or high-fat diet (F0-HF) for 12 weeks were mated with control females fed a chow diet (CTL, CD) to generate the F1 offspring. Twelve week-old chow-fed F1 male rats from F0-CD or F0-HF were mated with females from an independent line (also maintained on chow diet) to generate the F2 offspring. At 10 weeks of age, a sub-group of F1 and F2 female and male offspring was subjected to chow or high fat diet (HFD) for 12 weeks. Metabolic status of the offspring was assessed. (B) Body weight of 3-day-old F1-offspring (n = 190 and 181 from 16 litters of PatCD-CD and 14 litters of PatHF-CD, respectively). (C) Body weight of 3-day-old F2-offspring (n = 52 and 71 from 5 litters of GpatCD-CD and 6 litters of GpatHF-CD, respectively). Decreased pancreatic \u03b2-cell mass in female F1-offspring from HFD-fed fathers: (D) Representative images of Optical Projection Tomography (OPT) analysis of insulin-secreting cells in whole pancreas from 5-day-old female rats (E) quantification of OPT measures (n = 4 and 5 from 4 litters of PatCD-CD and 2 litters of PatHF-CD, respectively). Results are represented as mean \u00b1 SEM. Student's t-test: *p \u2264 0.05: PatHF-CD vs PatCD-CD; **p \u2264 0.05, GpatHF-CD vs GpatCD-CD. PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; GpatCD-CD: Grandpaternal-Chow on Chow; GpatHF-CD: Grandpaternal-HFD on Chow.", "co_occurrence": [{"body": 73, "word": "offspring", "fig": 5}, {"body": 64, "word": "F1", "fig": 3}, {"body": 29, "word": "diet", "fig": 4}, {"body": 23, "word": "rats", "fig": 3}, {"body": 32, "word": "F2", "fig": 2}, {"body": 17, "word": "female", "fig": 3}, {"body": 14, "word": "male", "fig": 3}, {"body": 10, "word": "chow", "fig": 4}, {"body": 19, "word": "fed", "fig": 2}, {"body": 12, "word": "weight", "fig": 3}, {"body": 18, "word": "F0-HF", "fig": 2}, {"body": 35, "word": "HFD", "fig": 1}, {"body": 34, "word": "F0", "fig": 1}, {"body": 14, "word": "females", "fig": 2}, {"body": 8, "word": "weeks", "fig": 3}, {"body": 6, "word": "PatHF-CD", "fig": 4}, {"body": 22, "word": "analysis", "fig": 1}, {"body": 18, "word": "control", "fig": 1}, {"body": 8, "word": "F0-CD", "fig": 2}, {"body": 15, "word": "altered", "fig": 1}, {"body": 14, "word": "fathers", "fig": 1}, {"body": 6, "word": "mass", "fig": 2}, {"body": 11, "word": "founders", "fig": 1}, {"body": 11, "word": "cells", "fig": 1}, {"body": 5, "word": "HFD-fed", "fig": 2}, {"body": 3, "word": "respectively", "fig": 3}, {"body": 2, "word": "PatCD-CD", "fig": 4}, {"body": 8, "word": "high-fat", "fig": 1}, {"body": 6, "word": "fat", "fig": 1}, {"body": 2, "word": "GpatHF-CD", "fig": 3}, {"body": 6, "word": "'s", "fig": 1}, {"body": 5, "word": "subjected", "fig": 1}, {"body": 5, "word": "also", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "age", "fig": 1}, {"body": 2, "word": "F1-offspring", "fig": 2}, {"body": 2, "word": "mated", "fig": 2}, {"body": 2, "word": "vs", "fig": 2}, {"body": 4, "word": "At", "fig": 1}, {"body": 1, "word": "Body", "fig": 3}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "GpatCD-CD", "fig": 3}, {"body": 1, "word": "n", "fig": 3}, {"body": 3, "word": "high", "fig": 1}, {"body": 2, "word": "status", "fig": 1}, {"body": 2, "word": "design", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "week-old", "fig": 1}, {"body": 2, "word": "F2-offspring", "fig": 1}, {"body": 1, "word": "generate", "fig": 2}, {"body": 1, "word": "OPT", "fig": 2}, {"body": 2, "word": "pancreatic", "fig": 1}, {"body": 2, "word": "study", "fig": 1}, {"body": 2, "word": "chow-fed", "fig": 1}, {"body": 2, "word": "newborn", "fig": 1}, {"body": 2, "word": "maintained", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "line", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "5-day-old", "fig": 1}, {"body": 1, "word": "Metabolic", "fig": 1}, {"body": 1, "word": "Sprague\u2013Dawley", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "pancreas", "fig": 1}, {"body": 1, "word": "insulin-secreting", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/gr2.jpg", "caption": "Impaired glucose tolerance and reduced body weight gain in response to HFD persists into two generations. (A\u2013C) Metabolic profiling of F1 female offspring after 12 weeks of high fat feeding; blood (A) glucose and (B) insulin during an intraperitoneal glucose tolerance test (ipGTT) (n = 9\u201311 animals; 1 sibling per litter) and (C) body weight curve (n = 14\u201322 animals from 14 to 17 litters; used more than 1 sibling per litter). (D\u2013F) Metabolic profiling of F2 female offspring after 12 weeks of high fat feeding: Blood (D) glucose and (E) insulin during an ipGTT (n = 5\u20136 litters; 1 sibling per litter) and (F) body weight curve (n = 10\u201313 animals from 5 to 6 litters; used more than one sibling per litter). Results are represented as mean \u00b1 SEM. Two-way ANOVA followed by Bonferroni post-hoc test: *p \u2264 0.05: PatCD-HF vs PatCD-CD or GpatCD-HF vs GpatCD-CD; \u00a4p \u2264 0.05: PatHF-CD vs PatCD-CD or GpatHF-CD vs GpatCD-CD; #p \u2264 0.05: PatHF-HF vs PatHF-CD or GpatHF-HF vs GpatHF-CD; +p \u2264 0.05: PatHF-HF vs PatCD-HF or GpatHF-HF vs GpatCD-HF. PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD; GpatCD-CD: Grandpaternal-Chow on Chow; GpatHF-CD: Grandpaternal-HFD on Chow; GpatCD-HF: Grandpaternal-Chow on HFD; GpatHF-HF: Grandpaternal-HFD on HFD.", "co_occurrence": [{"body": 35, "word": "HFD", "fig": 5}, {"body": 73, "word": "offspring", "fig": 2}, {"body": 24, "word": "glucose", "fig": 4}, {"body": 64, "word": "F1", "fig": 1}, {"body": 12, "word": "weight", "fig": 3}, {"body": 17, "word": "insulin", "fig": 2}, {"body": 17, "word": "female", "fig": 2}, {"body": 32, "word": "F2", "fig": 1}, {"body": 10, "word": "body", "fig": 3}, {"body": 7, "word": "litter", "fig": 4}, {"body": 6, "word": "per", "fig": 4}, {"body": 12, "word": "used", "fig": 2}, {"body": 9, "word": "tolerance", "fig": 2}, {"body": 6, "word": "PatHF-CD", "fig": 3}, {"body": 8, "word": "weeks", "fig": 2}, {"body": 4, "word": "sibling", "fig": 4}, {"body": 2, "word": "vs", "fig": 8}, {"body": 6, "word": "fat", "fig": 2}, {"body": 12, "word": "one", "fig": 1}, {"body": 4, "word": "animals", "fig": 3}, {"body": 6, "word": "test", "fig": 2}, {"body": 3, "word": "PatHF-HF", "fig": 3}, {"body": 9, "word": "response", "fig": 1}, {"body": 8, "word": "generations", "fig": 1}, {"body": 8, "word": "two", "fig": 1}, {"body": 7, "word": "followed", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 3}, {"body": 6, "word": "reduced", "fig": 1}, {"body": 2, "word": "GpatHF-CD", "fig": 3}, {"body": 3, "word": "ipGTT", "fig": 2}, {"body": 3, "word": "high", "fig": 2}, {"body": 6, "word": "blood", "fig": 1}, {"body": 5, "word": "p", "fig": 1}, {"body": 5, "word": "Blood", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 2, "word": "feeding", "fig": 2}, {"body": 1, "word": "n", "fig": 4}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "GpatHF-HF", "fig": 3}, {"body": 3, "word": "F", "fig": 1}, {"body": 3, "word": "gain", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 3}, {"body": 1, "word": "GpatCD-CD", "fig": 3}, {"body": 1, "word": "Metabolic", "fig": 2}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "curve", "fig": 2}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "intraperitoneal", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/gr3.jpg", "caption": "High-fat diet alters the DNA methylation signature of spermatozoa. (A) Main biological functions obtained by DAVID ontology analysis of genes commonly differentially methylated in the sperm of F0 (HF vs CD) and F1 (PatHF-HF vs PatCD-HF). Bars represent the number of genes involved in each of the functional clusters that were differentially methylated and black dots indicate p-values. Total is the total number of genes near or overlapping with common differentially methylated regions. (B) Differentially methylated regions common in sperm of F0 and F1 indicates a direct gametic transgenerational reprogramming. Data are represented as log2 of the fold change in F0 (HF vs CD) or F1 (PatHF-CD vs PatCD-CD) founders. (C) Representative figure of genomic views of differentially methylated regions near transcription start sites (\u2212/+1000 bp relative to the TSS) in sperm from F0-HF and PatHF-CD as compared to their respective controls. Data is represented as \u2013log10(p value) of methylation signal and was generated using MACS2 bdgcmp with the \u2018-m ppois\u2019 parameter set (F0, n = 7 per group; F1-Chow, n = 8\u201311 litters; F1-HFD, 5\u20137 litters). F0-CD: F0 on chow diet; F0-HF: F0 on HFD; PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD.", "co_occurrence": [{"body": 34, "word": "F0", "fig": 6}, {"body": 64, "word": "F1", "fig": 3}, {"body": 43, "word": "sperm", "fig": 3}, {"body": 35, "word": "HFD", "fig": 3}, {"body": 29, "word": "diet", "fig": 2}, {"body": 17, "word": "genes", "fig": 3}, {"body": 25, "word": "methylation", "fig": 2}, {"body": 10, "word": "differentially", "fig": 4}, {"body": 18, "word": "F0-HF", "fig": 2}, {"body": 27, "word": "DNA", "fig": 1}, {"body": 25, "word": "using", "fig": 1}, {"body": 5, "word": "methylated", "fig": 5}, {"body": 22, "word": "compared", "fig": 1}, {"body": 22, "word": "analysis", "fig": 1}, {"body": 6, "word": "PatHF-CD", "fig": 3}, {"body": 15, "word": "transgenerational", "fig": 1}, {"body": 5, "word": "regions", "fig": 3}, {"body": 15, "word": "spermatozoa", "fig": 1}, {"body": 11, "word": "founders", "fig": 1}, {"body": 10, "word": "chow", "fig": 1}, {"body": 9, "word": "gametic", "fig": 1}, {"body": 8, "word": "controls", "fig": 1}, {"body": 8, "word": "F0-CD", "fig": 1}, {"body": 8, "word": "involved", "fig": 1}, {"body": 2, "word": "vs", "fig": 4}, {"body": 8, "word": "respective", "fig": 1}, {"body": 3, "word": "number", "fig": 2}, {"body": 3, "word": "common", "fig": 2}, {"body": 6, "word": "per", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 2}, {"body": 5, "word": "p", "fig": 1}, {"body": 5, "word": "reprogramming", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "group", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 2}, {"body": 4, "word": "obtained", "fig": 1}, {"body": 2, "word": "Data", "fig": 2}, {"body": 3, "word": "ontology", "fig": 1}, {"body": 3, "word": "signature", "fig": 1}, {"body": 3, "word": "Total", "fig": 1}, {"body": 2, "word": "biological", "fig": 1}, {"body": 2, "word": "set", "fig": 1}, {"body": 1, "word": "represented", "fig": 2}, {"body": 2, "word": "alters", "fig": 1}, {"body": 2, "word": "change", "fig": 1}, {"body": 2, "word": "commonly", "fig": 1}, {"body": 2, "word": "functional", "fig": 1}, {"body": 2, "word": "p-values", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 1, "word": "PatCD-HF", "fig": 2}, {"body": 2, "word": "transcription", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "MACS2", "fig": 1}, {"body": 1, "word": "direct", "fig": 1}, {"body": 1, "word": "fold", "fig": 1}, {"body": 1, "word": "genomic", "fig": 1}, {"body": 1, "word": "bp", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "High-fat", "fig": 1}, {"body": 1, "word": "start", "fig": 1}, {"body": 1, "word": "overlapping", "fig": 1}, {"body": 1, "word": "figure", "fig": 1}, {"body": 1, "word": "DAVID", "fig": 1}, {"body": 1, "word": "functions", "fig": 1}, {"body": 1, "word": "Differentially", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/gr4.jpg", "caption": "Small non-coding RNA expression in sperm of F0 and F1 rats shows transgenerational programming. (A) sncRNA molecules differentially expressed in sperm of high fat diet fed F0 founders (F0-HF vs F0-CD) and their F1 offspring (PatHF-CD vs PatCD-CD). Effect of HFD and/or paternal-HFD on the expression of (B) miRNAs in sperm of F0 and F1 rats and (C) tRNA fragments (tRF). F0: n = 8\u201310 and F1: n = 7\u201312. Y-axis represents normalized counts per total number of reads of each specific sncRNA category (counts per million). Values are represented as mean \u00b1 SEM. F0-CD: F0 on chow diet; F0-HF: F0 on HFD; PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD.", "co_occurrence": [{"body": 64, "word": "F1", "fig": 4}, {"body": 34, "word": "F0", "fig": 6}, {"body": 35, "word": "HFD", "fig": 4}, {"body": 65, "word": "expression", "fig": 2}, {"body": 43, "word": "sperm", "fig": 3}, {"body": 73, "word": "offspring", "fig": 1}, {"body": 29, "word": "diet", "fig": 2}, {"body": 23, "word": "rats", "fig": 2}, {"body": 18, "word": "F0-HF", "fig": 2}, {"body": 12, "word": "sncRNA", "fig": 2}, {"body": 23, "word": "RNA", "fig": 1}, {"body": 19, "word": "fed", "fig": 1}, {"body": 8, "word": "F0-CD", "fig": 2}, {"body": 15, "word": "transgenerational", "fig": 1}, {"body": 14, "word": "miRNAs", "fig": 1}, {"body": 6, "word": "per", "fig": 2}, {"body": 6, "word": "PatHF-CD", "fig": 2}, {"body": 11, "word": "founders", "fig": 1}, {"body": 10, "word": "chow", "fig": 1}, {"body": 10, "word": "differentially", "fig": 1}, {"body": 9, "word": "expressed", "fig": 1}, {"body": 7, "word": "specific", "fig": 1}, {"body": 6, "word": "fat", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "non-coding", "fig": 1}, {"body": 4, "word": "reads", "fig": 1}, {"body": 2, "word": "vs", "fig": 2}, {"body": 2, "word": "counts", "fig": 2}, {"body": 4, "word": "tRF", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 2}, {"body": 3, "word": "million", "fig": 1}, {"body": 3, "word": "high", "fig": 1}, {"body": 3, "word": "fragments", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 1}, {"body": 3, "word": "Small", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "tRNA", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "category", "fig": 1}, {"body": 1, "word": "molecules", "fig": 1}, {"body": 1, "word": "represents", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 1}, {"body": 1, "word": "programming", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/gr5.jpg", "caption": "Let-7c expression is altered in metabolic tissues of offspring. Let-7c expression in liver of (A) F1 (n = 11\u201312 from 11 to 12 litters), and (B) F2 (n = 6\u20137 litters; 1 sibling per litter); Extensor Digitorum Longus (EDL) muscle of (C) F1 (n = 5 litters; 1 sibling per litter) and (D) F2 (n = 5 litters; 1 sibling per litter); white adipose tissue (WAT) of (E) F1 (n = 8\u201310 from 6 to 7 litters; used more than 1 sibling per litter) or (G) F2 (n = 8\u201313 from 6 to 7 litters; used more than 1 sibling per litter). Expression of all let-7 family members in WAT of (F) F1 and (H) F2 female offspring. U6, U87 or snoRNA were used as internal controls depending on the tissue. Two-way ANOVA followed by Bonferroni post-hoc test: *p \u2264 0.05: PatCD-HF vs PatCD-CD or GpatCD-HF vs GpatCD-CD; \u00a4p \u2264 0.05: PatHF-CD vs PatCD-CD or GpatHF-CD vs GpatCD-CD; #p \u2264 0.05: PatHF-HF vs PatHF-CD or GpatHF-HF vs GpatHF-CD; +p \u2264 0.05: PatHF-HF vs PatCD-HF or GpatHF-HF vs GpatCD-HF. Results are represented as mean \u00b1 SEM. PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; PatCD-HF: Paternal-Chow on HFD; PatHF-HF: Paternal-HFD on HFD; GpatCD-CD: Grandpaternal-Chow on Chow; GpatHF-CD: Grandpaternal-HFD on Chow; GpatCD-HF: Grandpaternal-Chow on HFD; GpatHF-HF: Grandpaternal-HFD on HFD.", "co_occurrence": [{"body": 64, "word": "F1", "fig": 4}, {"body": 73, "word": "offspring", "fig": 2}, {"body": 35, "word": "HFD", "fig": 4}, {"body": 65, "word": "expression", "fig": 2}, {"body": 32, "word": "F2", "fig": 4}, {"body": 22, "word": "tissue", "fig": 2}, {"body": 12, "word": "used", "fig": 3}, {"body": 7, "word": "litter", "fig": 5}, {"body": 32, "word": "metabolic", "fig": 1}, {"body": 16, "word": "WAT", "fig": 2}, {"body": 6, "word": "per", "fig": 5}, {"body": 4, "word": "sibling", "fig": 5}, {"body": 6, "word": "PatHF-CD", "fig": 3}, {"body": 18, "word": "adipose", "fig": 1}, {"body": 17, "word": "female", "fig": 1}, {"body": 2, "word": "vs", "fig": 8}, {"body": 15, "word": "altered", "fig": 1}, {"body": 14, "word": "tissues", "fig": 1}, {"body": 13, "word": "let-7", "fig": 1}, {"body": 10, "word": "family", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 3}, {"body": 8, "word": "controls", "fig": 1}, {"body": 4, "word": "Let-7c", "fig": 2}, {"body": 7, "word": "followed", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 3}, {"body": 2, "word": "GpatHF-CD", "fig": 3}, {"body": 1, "word": "n", "fig": 6}, {"body": 6, "word": "test", "fig": 1}, {"body": 5, "word": "p", "fig": 1}, {"body": 5, "word": "white", "fig": 1}, {"body": 5, "word": "liver", "fig": 1}, {"body": 5, "word": "EDL", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 4, "word": "members", "fig": 1}, {"body": 4, "word": "muscle", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "GpatHF-HF", "fig": 3}, {"body": 3, "word": "F", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 3}, {"body": 1, "word": "GpatCD-CD", "fig": 3}, {"body": 2, "word": "snoRNA", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "Longus", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "Extensor", "fig": 1}, {"body": 1, "word": "Digitorum", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770269/bin/gr6.jpg", "caption": "Let-7c expression in WAT of female offspring shows inverse relationship with predicted target genes. (A) Inverse relationship between expression of let-7c and its predicted target genes in white adipose tissue (WAT) of F2 female offspring. Dotted black curve represents the permutation analysis of let-7c expression correlation to target genes. Red curve represents the correlation coefficients of let-7c to predicted target gene. Expression of let-7c predicted target genes was obtained by Affymetrix transcriptomic analysis. (B) Gene ontology analysis of let-7c predicted target genes with an inverse relationship to let-7c expression in WAT of F2-females (performed with DAVID Bioinformatics Resources). Bars represent the number of genes involved in each of the functional clusters and black dots indicate the p values. Total is the total number of genes found to have a significant inverse relationship to let-7c expression. (C) Quantitative PCR validation of let-7c predicted target genes inversely correlated to let-7c expression in WAT of F1 females (n = 10\u201312 per group; 1 sibling per litter). Geometric mean of the housekeeping genes RPLP0 and \u03b2-actin was used for normalization. Values are represented as mean \u00b1 SEM (D) Representation of let-7c predicted target genes inversely correlated to let-7c expression in transcriptomic analysis of F2 offspring WAT (n = 6\u20137 per group; 1 sibling per litter). (E) Representative blots of protein abundance of AKT2, IR-\u03b2, IRS2 and Caspase 9 (CASP9) in WAT of F1-female. (F) Protein abundance of AKT2, IR-\u03b2, IRS2 and CASP9. Ponceau staining of the membranes was used for data normalization. Results are represented as mean \u00b1 SEM. Two-way ANOVA followed by Bonferroni post-hoc test: *p \u2264 0.05: PatCD-HF vs PatCD-CD; \u00a4p \u2264 0.05: GpatCD-HF vs GpatCD-CD; +p \u2264 0.05: PatHF-HF vs PatCD-HF or GpatHF-HF vs GpatCD-HF. PatCD-CD: Paternal-Chow on Chow; PatHF-CD: Paternal-HFD on Chow; GpatCD-CD: Grandpaternal-Chow on Chow; GpatHF-CD: Grandpaternal-HFD on Chow; GpatCD-HF: Grandpaternal-Chow on HFD; GpatHF-HF: Grandpaternal-HFD on HFD. B\u2013H: Benjamini and Hochberg corrected p-values. AU: arbitrary units.", "co_occurrence": [{"body": 45, "word": "let-7c", "fig": 11}, {"body": 65, "word": "expression", "fig": 7}, {"body": 73, "word": "offspring", "fig": 3}, {"body": 17, "word": "genes", "fig": 10}, {"body": 16, "word": "WAT", "fig": 6}, {"body": 22, "word": "analysis", "fig": 4}, {"body": 12, "word": "predicted", "fig": 7}, {"body": 9, "word": "target", "fig": 8}, {"body": 35, "word": "HFD", "fig": 2}, {"body": 64, "word": "F1", "fig": 1}, {"body": 32, "word": "F2", "fig": 2}, {"body": 17, "word": "female", "fig": 2}, {"body": 6, "word": "per", "fig": 4}, {"body": 12, "word": "used", "fig": 2}, {"body": 22, "word": "tissue", "fig": 1}, {"body": 18, "word": "adipose", "fig": 1}, {"body": 17, "word": "found", "fig": 1}, {"body": 7, "word": "litter", "fig": 2}, {"body": 14, "word": "females", "fig": 1}, {"body": 12, "word": "data", "fig": 1}, {"body": 10, "word": "performed", "fig": 1}, {"body": 4, "word": "group", "fig": 2}, {"body": 2, "word": "vs", "fig": 4}, {"body": 8, "word": "protein", "fig": 1}, {"body": 8, "word": "involved", "fig": 1}, {"body": 4, "word": "sibling", "fig": 2}, {"body": 7, "word": "gene", "fig": 1}, {"body": 7, "word": "followed", "fig": 1}, {"body": 6, "word": "test", "fig": 1}, {"body": 3, "word": "transcriptomic", "fig": 2}, {"body": 6, "word": "PatHF-CD", "fig": 1}, {"body": 3, "word": "number", "fig": 2}, {"body": 5, "word": "p", "fig": 1}, {"body": 5, "word": "PCR", "fig": 1}, {"body": 5, "word": "white", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 2, "word": "AKT2", "fig": 2}, {"body": 4, "word": "Let-7c", "fig": 1}, {"body": 2, "word": "PatCD-CD", "fig": 2}, {"body": 4, "word": "obtained", "fig": 1}, {"body": 2, "word": "IR-\u03b2", "fig": 2}, {"body": 1, "word": "relationship", "fig": 4}, {"body": 4, "word": "Gene", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 2, "word": "abundance", "fig": 2}, {"body": 2, "word": "correlated", "fig": 2}, {"body": 2, "word": "correlation", "fig": 2}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "ontology", "fig": 1}, {"body": 3, "word": "PatHF-HF", "fig": 1}, {"body": 3, "word": "F", "fig": 1}, {"body": 3, "word": "Total", "fig": 1}, {"body": 2, "word": "functional", "fig": 1}, {"body": 1, "word": "represents", "fig": 2}, {"body": 2, "word": "Protein", "fig": 1}, {"body": 2, "word": "GpatHF-CD", "fig": 1}, {"body": 1, "word": "represented", "fig": 2}, {"body": 2, "word": "p-values", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 1, "word": "GpatHF-HF", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "corrected", "fig": 1}, {"body": 1, "word": "PatCD-HF", "fig": 2}, {"body": 1, "word": "IRS2", "fig": 2}, {"body": 1, "word": "n", "fig": 2}, {"body": 1, "word": "inversely", "fig": 2}, {"body": 1, "word": "GpatCD-CD", "fig": 2}, {"body": 2, "word": "Caspase", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "normalization", "fig": 2}, {"body": 1, "word": "curve", "fig": 2}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "F1-female", "fig": 1}, {"body": 1, "word": "Benjamini", "fig": 1}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "F2-females", "fig": 1}, {"body": 1, "word": "B\u2013H", "fig": 1}, {"body": 1, "word": "Hochberg", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "DAVID", "fig": 1}, {"body": 1, "word": "Ponceau", "fig": 1}, {"body": 1, "word": "Bioinformatics", "fig": 1}, {"body": 1, "word": "Affymetrix", "fig": 1}, {"body": 1, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "membranes", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}], "4186442": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186442/bin/prp20002-e00056-f1.jpg", "caption": "Effects of myocardial infarction (MI) induced by ligation of left anterior descending (LAD) artery in mice. (A) Left ventricular (LV) ejection fraction and (B) fractional shortening decreased significantly postinfarction. (C) MI increased the fibrotic area in the LV. (D) Number of DDR2+ and (E) FAP+ cells were significantly elevated at 3 and 5 days postinfarction. (F) MI resulted an increase in DDR2 mRNA levels at 4 weeks postinfarction. (G) Let-7c miRNA levels were significantly decreased in LV 5 days after MI. Results are mean \u00b1 SEM. (A\u2013C) n = 8\u201311, (D, E, G) n = 3\u20136, (F) n = 6\u20139. White column: sham-operated; black column: MI. Data were analyzed with Student\u2019s t-test. *P < 0.05, **P < 0.01, and ***P < 0.001 versus sham. DDR2, discoidin domain receptor 2; FAP, fibroblast activation protein; Let-7c, lethal-7c.", "co_occurrence": [{"body": 77, "word": "Let-7c", "fig": 2}, {"body": 35, "word": "LV", "fig": 3}, {"body": 19, "word": "MI", "fig": 5}, {"body": 16, "word": "postinfarction", "fig": 3}, {"body": 35, "word": "cells", "fig": 1}, {"body": 16, "word": "levels", "fig": 2}, {"body": 30, "word": "miRNA", "fig": 1}, {"body": 17, "word": "mice", "fig": 1}, {"body": 8, "word": "days", "fig": 2}, {"body": 5, "word": "significantly", "fig": 3}, {"body": 6, "word": "decreased", "fig": 2}, {"body": 6, "word": "DDR2", "fig": 2}, {"body": 8, "word": "increased", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 7, "word": "mRNA", "fig": 1}, {"body": 7, "word": "area", "fig": 1}, {"body": 7, "word": "fibroblast", "fig": 1}, {"body": 7, "word": "protein", "fig": 1}, {"body": 7, "word": "myocardial", "fig": 1}, {"body": 6, "word": "weeks", "fig": 1}, {"body": 6, "word": "DDR2+", "fig": 1}, {"body": 5, "word": "increase", "fig": 1}, {"body": 4, "word": "LAD", "fig": 1}, {"body": 4, "word": "infarction", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "fibrotic", "fig": 1}, {"body": 3, "word": "fraction", "fig": 1}, {"body": 3, "word": "resulted", "fig": 1}, {"body": 3, "word": "ejection", "fig": 1}, {"body": 3, "word": "FAP", "fig": 1}, {"body": 3, "word": "ligation", "fig": 1}, {"body": 2, "word": "activation", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "domain", "fig": 1}, {"body": 1, "word": "G", "fig": 2}, {"body": 2, "word": "FAP+", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 2, "word": "ventricular", "fig": 1}, {"body": 1, "word": "E", "fig": 2}, {"body": 2, "word": "Results", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "descending", "fig": 1}, {"body": 1, "word": "artery", "fig": 1}, {"body": 1, "word": "receptor", "fig": 1}, {"body": 1, "word": "sham-operated", "fig": 1}, {"body": 1, "word": "fractional", "fig": 1}, {"body": 1, "word": "induced", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "anterior", "fig": 1}, {"body": 1, "word": "shortening", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Left", "fig": 1}, {"body": 1, "word": "Number", "fig": 1}, {"body": 1, "word": "elevated", "fig": 1}, {"body": 1, "word": "discoidin", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186442/bin/prp20002-e00056-f2.jpg", "caption": "Efficacy of Let-7c inhibitor in vivo and in vitro. Let-7c inhibitor decreased significantly the levels of Let-7c miRNA in the infarcted myocardium compared to PBS-treated (A) or scramble-treated (B) mice 4 weeks after i.v. injection. (C) There was also a tendency for Let-7c miRNA to decrease in normal mice 2 weeks after administration of Let-7c inhibitor. (D) Let-7c inhibition reduced Let-7c miRNA levels in the kidney and liver in mice 4 weeks postinfarction. (E) Let-7c inhibitor decreased the expression of closely related members of Let-7 family. (F) Let-7c is expressed in cardiomyocytes and fibroblasts to the similar extent as analyzed from adult mouse heart immediately after ex vivo fractionation of cell types. Inhibition of Let-7c increased Sox2 (G) protein and (H) mRNA levels in isolated cardiac mouse fibroblasts in vitro. (I) Let-7c inhibitor resulted in elevation of LV Oct4 and Sox2 mRNA levels in normal mice 2 weeks after administration of Let-7c inhibitor. Results are mean \u00b1 SEM. (A, B, E) n = 7\u20138, (C, F, I) n = 4\u20135, (D) n = 4\u20136, (G) n = 3, (H) n = 8\u20139. White column: control; black column: Let-7c inhibitor. Data were analyzed with Student\u2019s t-test. *P < 0.05 and ***P < 0.001 versus control. Let-7c, lethal-7c; miRNA, microRNA; PBS, phosphate-buffered saline; LV, left ventricular; Oct4, octamer-binding transcription factor 4.", "co_occurrence": [{"body": 77, "word": "Let-7c", "fig": 14}, {"body": 31, "word": "inhibitor", "fig": 7}, {"body": 30, "word": "miRNA", "fig": 4}, {"body": 35, "word": "LV", "fig": 2}, {"body": 17, "word": "mice", "fig": 4}, {"body": 16, "word": "levels", "fig": 4}, {"body": 43, "word": "Let-7", "fig": 1}, {"body": 18, "word": "fibroblasts", "fig": 2}, {"body": 33, "word": "inhibition", "fig": 1}, {"body": 30, "word": "cardiac", "fig": 1}, {"body": 28, "word": "expression", "fig": 1}, {"body": 6, "word": "weeks", "fig": 4}, {"body": 23, "word": "cell", "fig": 1}, {"body": 9, "word": "Sox2", "fig": 2}, {"body": 18, "word": "heart", "fig": 1}, {"body": 9, "word": "Oct4", "fig": 2}, {"body": 17, "word": "family", "fig": 1}, {"body": 16, "word": "postinfarction", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 2}, {"body": 8, "word": "vivo", "fig": 2}, {"body": 7, "word": "mRNA", "fig": 2}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "decreased", "fig": 2}, {"body": 6, "word": "mouse", "fig": 2}, {"body": 11, "word": "members", "fig": 1}, {"body": 5, "word": "normal", "fig": 2}, {"body": 4, "word": "control", "fig": 2}, {"body": 4, "word": "vitro", "fig": 2}, {"body": 8, "word": "increased", "fig": 1}, {"body": 4, "word": "A", "fig": 2}, {"body": 7, "word": "decrease", "fig": 1}, {"body": 7, "word": "protein", "fig": 1}, {"body": 5, "word": "significantly", "fig": 1}, {"body": 5, "word": "PBS", "fig": 1}, {"body": 5, "word": "myocardium", "fig": 1}, {"body": 5, "word": "liver", "fig": 1}, {"body": 4, "word": "factor", "fig": 1}, {"body": 4, "word": "expressed", "fig": 1}, {"body": 4, "word": "kidney", "fig": 1}, {"body": 4, "word": "adult", "fig": 1}, {"body": 3, "word": "tendency", "fig": 1}, {"body": 3, "word": "closely", "fig": 1}, {"body": 3, "word": "reduced", "fig": 1}, {"body": 3, "word": "related", "fig": 1}, {"body": 3, "word": "resulted", "fig": 1}, {"body": 3, "word": "transcription", "fig": 1}, {"body": 3, "word": "isolated", "fig": 1}, {"body": 3, "word": "Inhibition", "fig": 1}, {"body": 2, "word": "infarcted", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "phosphate-buffered", "fig": 1}, {"body": 1, "word": "G", "fig": 2}, {"body": 2, "word": "cardiomyocytes", "fig": 1}, {"body": 2, "word": "ventricular", "fig": 1}, {"body": 2, "word": "There", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 2, "word": "saline", "fig": 1}, {"body": 2, "word": "compared", "fig": 1}, {"body": 1, "word": "administration", "fig": 2}, {"body": 1, "word": "E", "fig": 2}, {"body": 2, "word": "types", "fig": 1}, {"body": 2, "word": "Results", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "octamer-binding", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "similar", "fig": 1}, {"body": 1, "word": "Efficacy", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186442/bin/prp20002-e00056-f3.jpg", "caption": "Let-7c inhibition prevented the deterioration of systolic function after MI. (A) Representative images from echocardiography M-mode view. (B, C) Let-7c inhibitor maintained LV ejection fraction postinfarction. (D) There was a tendency for stroke volume to increase in response to Let-7c inhibitor. (E) Let-7c inhibitor enhanced cardiac output 4 weeks after MI. (F, G) Let-7c inhibitor had no effect on the LV posterior wall thickness in systole (LVPW;s) or diastole (LVPW;d). Results are mean \u00b1 SEM. (B\u2013G) n = 7\u20138. Data were analyzed with ANOVA. *P < 0.05 versus scramble. Let-7c, lethal-7c; MI, myocardial infarction; LV, left ventricular.", "co_occurrence": [{"body": 77, "word": "Let-7c", "fig": 6}, {"body": 31, "word": "inhibitor", "fig": 4}, {"body": 35, "word": "LV", "fig": 3}, {"body": 19, "word": "MI", "fig": 3}, {"body": 33, "word": "inhibition", "fig": 1}, {"body": 30, "word": "cardiac", "fig": 1}, {"body": 25, "word": "function", "fig": 1}, {"body": 16, "word": "postinfarction", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 7, "word": "myocardial", "fig": 1}, {"body": 7, "word": "response", "fig": 1}, {"body": 7, "word": "systolic", "fig": 1}, {"body": 6, "word": "weeks", "fig": 1}, {"body": 6, "word": "volume", "fig": 1}, {"body": 5, "word": "increase", "fig": 1}, {"body": 5, "word": "effect", "fig": 1}, {"body": 4, "word": "echocardiography", "fig": 1}, {"body": 4, "word": "maintained", "fig": 1}, {"body": 4, "word": "scramble", "fig": 1}, {"body": 4, "word": "infarction", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "tendency", "fig": 1}, {"body": 3, "word": "wall", "fig": 1}, {"body": 3, "word": "fraction", "fig": 1}, {"body": 3, "word": "ejection", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "ventricular", "fig": 1}, {"body": 2, "word": "There", "fig": 1}, {"body": 2, "word": "stroke", "fig": 1}, {"body": 2, "word": "Results", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "prevented", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "output", "fig": 1}, {"body": 1, "word": "thickness", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "view", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "posterior", "fig": 1}, {"body": 1, "word": "M-mode", "fig": 1}, {"body": 1, "word": "systole", "fig": 1}, {"body": 1, "word": "diastole", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186442/bin/prp20002-e00056-f4.jpg", "caption": "Let-7c inhibition reduced fibrosis in the LV. (A) Let-7c inhibitor significantly decreased the fibrotic area in the LV 4 weeks after MI and (B) also a nonsignificant reduction in the size of infarction scar was observed. (C) The number of DDR2+ cells decreased in response to Let-7c inhibition, and there was a trend for the number of Oct+ and Oct+DDR2+ cells to increase postinfarction. (D) A representative image of Oct+DDR2+ cells. Results are mean \u00b1 SEM. (A\u2013C) n = 5\u20138. White column: scramble; black column: Let-7c inhibitor. Scale bar, 50 \u03bcm (A), 1 mm (B), 10 \u03bcm (D). Data were analyzed with Mann\u2013Whitney U test. *P < 0.05 versus scramble. Let-7c, lethal-7c; LV, left ventricular; MI, myocardial infarction; DDR2, discoidin domain receptor 2; Oct4, octamer-binding transcription factor 4.", "co_occurrence": [{"body": 77, "word": "Let-7c", "fig": 5}, {"body": 35, "word": "cells", "fig": 3}, {"body": 35, "word": "LV", "fig": 3}, {"body": 33, "word": "inhibition", "fig": 2}, {"body": 31, "word": "inhibitor", "fig": 2}, {"body": 19, "word": "MI", "fig": 2}, {"body": 25, "word": "The", "fig": 1}, {"body": 11, "word": "number", "fig": 2}, {"body": 21, "word": "fibrosis", "fig": 1}, {"body": 16, "word": "postinfarction", "fig": 1}, {"body": 13, "word": "observed", "fig": 1}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "decreased", "fig": 2}, {"body": 4, "word": "A", "fig": 3}, {"body": 9, "word": "Oct4", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 4, "word": "scramble", "fig": 2}, {"body": 4, "word": "infarction", "fig": 2}, {"body": 7, "word": "area", "fig": 1}, {"body": 7, "word": "myocardial", "fig": 1}, {"body": 7, "word": "response", "fig": 1}, {"body": 6, "word": "weeks", "fig": 1}, {"body": 6, "word": "DDR2", "fig": 1}, {"body": 6, "word": "DDR2+", "fig": 1}, {"body": 5, "word": "significantly", "fig": 1}, {"body": 5, "word": "increase", "fig": 1}, {"body": 4, "word": "factor", "fig": 1}, {"body": 3, "word": "fibrotic", "fig": 1}, {"body": 3, "word": "reduced", "fig": 1}, {"body": 3, "word": "reduction", "fig": 1}, {"body": 3, "word": "scar", "fig": 1}, {"body": 3, "word": "transcription", "fig": 1}, {"body": 3, "word": "test", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "domain", "fig": 1}, {"body": 2, "word": "ventricular", "fig": 1}, {"body": 2, "word": "size", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 2, "word": "Mann\u2013Whitney", "fig": 1}, {"body": 2, "word": "representative", "fig": 1}, {"body": 2, "word": "U", "fig": 1}, {"body": 2, "word": "Results", "fig": 1}, {"body": 1, "word": "image", "fig": 1}, {"body": 1, "word": "octamer-binding", "fig": 1}, {"body": 1, "word": "receptor", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "discoidin", "fig": 1}, {"body": 1, "word": "Oct+", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186442/bin/prp20002-e00056-f5.jpg", "caption": "Effects of Let-7c inhibition on LV gene expression after MI. (A) There were no significant changes in pluripotency-associated genes with Let-7c inhibitor treatment when analyzed 4 weeks postinfarction. (B) The activation of genes involved in the regulation of fibrosis remained unaltered in response to Let-7c inhibition. Results are mean \u00b1 SEM (n = 7\u20138/group). White column: scramble; black column: Let-7c inhibitor. Data were analyzed with Student\u2019s t-test. Let-7c, lethal-7c; LV, left ventricular; MI, myocardial infarction.", "co_occurrence": [{"body": 77, "word": "Let-7c", "fig": 5}, {"body": 35, "word": "LV", "fig": 2}, {"body": 33, "word": "inhibition", "fig": 2}, {"body": 31, "word": "inhibitor", "fig": 2}, {"body": 19, "word": "MI", "fig": 2}, {"body": 28, "word": "expression", "fig": 1}, {"body": 25, "word": "The", "fig": 1}, {"body": 21, "word": "fibrosis", "fig": 1}, {"body": 16, "word": "postinfarction", "fig": 1}, {"body": 8, "word": "genes", "fig": 2}, {"body": 8, "word": "analyzed", "fig": 2}, {"body": 7, "word": "myocardial", "fig": 1}, {"body": 7, "word": "significant", "fig": 1}, {"body": 7, "word": "response", "fig": 1}, {"body": 6, "word": "weeks", "fig": 1}, {"body": 5, "word": "involved", "fig": 1}, {"body": 5, "word": "regulation", "fig": 1}, {"body": 5, "word": "treatment", "fig": 1}, {"body": 5, "word": "changes", "fig": 1}, {"body": 4, "word": "infarction", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "gene", "fig": 1}, {"body": 4, "word": "scramble", "fig": 1}, {"body": 3, "word": "remained", "fig": 1}, {"body": 2, "word": "There", "fig": 1}, {"body": 2, "word": "unaltered", "fig": 1}, {"body": 2, "word": "activation", "fig": 1}, {"body": 2, "word": "Results", "fig": 1}, {"body": 2, "word": "ventricular", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186442/bin/prp20002-e00056-f6.jpg", "caption": "Morphological changes in the LV analyzed by immunohistochemistry. (A) The number of TUNEL+ apoptotic cells decreased statistically significantly in response to Let-7c inhibition 4 weeks after MI. (B) Apoptotic cells were noncardiomyocytes and DDR2+ fibroblasts. (C) Let-7c inhibitor did not affect cardiomyocyte hypertrophy as assessed with cardiomyocyte cross-sectional area after Masson\u2019s trichrome stain and when observed with wheat germ agglutinin stain. The number of c-kit+ stem cells (D) and Ki-67+ proliferative cells (E) remained unaltered. (F) Let-7c inhibitor had no effect on angiogenesis. Results are mean \u00b1 SEM. (A\u2013F), n = 6\u20138/group. White column: scramble; black column: Let-7c inhibitor. Scale bar, 20 \u03bcm (A, C\u2013F) and 10 \u03bcm (B). Data were analyzed by Mann\u2013Whitney U test. *P < 0.05 versus scramble. LV, left ventricular; TUNEL, transferase-mediated dUTP nick end labeling; MI, myocardial infarction; DDR2, discoidin domain receptor 2; Let-7c, lethal-7c.", "co_occurrence": [{"body": 77, "word": "Let-7c", "fig": 5}, {"body": 35, "word": "cells", "fig": 4}, {"body": 31, "word": "inhibitor", "fig": 3}, {"body": 35, "word": "LV", "fig": 2}, {"body": 25, "word": "The", "fig": 2}, {"body": 19, "word": "MI", "fig": 2}, {"body": 33, "word": "inhibition", "fig": 1}, {"body": 11, "word": "number", "fig": 2}, {"body": 18, "word": "fibroblasts", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 2}, {"body": 13, "word": "observed", "fig": 1}, {"body": 8, "word": "stem", "fig": 1}, {"body": 4, "word": "scramble", "fig": 2}, {"body": 4, "word": "A", "fig": 2}, {"body": 7, "word": "area", "fig": 1}, {"body": 7, "word": "myocardial", "fig": 1}, {"body": 7, "word": "response", "fig": 1}, {"body": 3, "word": "cardiomyocyte", "fig": 2}, {"body": 6, "word": "decreased", "fig": 1}, {"body": 6, "word": "apoptotic", "fig": 1}, {"body": 6, "word": "weeks", "fig": 1}, {"body": 6, "word": "DDR2", "fig": 1}, {"body": 6, "word": "DDR2+", "fig": 1}, {"body": 5, "word": "significantly", "fig": 1}, {"body": 5, "word": "effect", "fig": 1}, {"body": 5, "word": "changes", "fig": 1}, {"body": 4, "word": "hypertrophy", "fig": 1}, {"body": 4, "word": "infarction", "fig": 1}, {"body": 3, "word": "affect", "fig": 1}, {"body": 3, "word": "statistically", "fig": 1}, {"body": 3, "word": "cross-sectional", "fig": 1}, {"body": 3, "word": "remained", "fig": 1}, {"body": 3, "word": "end", "fig": 1}, {"body": 3, "word": "test", "fig": 1}, {"body": 3, "word": "angiogenesis", "fig": 1}, {"body": 1, "word": "stain", "fig": 2}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 2, "word": "labeling", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "domain", "fig": 1}, {"body": 2, "word": "unaltered", "fig": 1}, {"body": 2, "word": "ventricular", "fig": 1}, {"body": 2, "word": "Mann\u2013Whitney", "fig": 1}, {"body": 2, "word": "c-kit+", "fig": 1}, {"body": 2, "word": "TUNEL+", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 2, "word": "U", "fig": 1}, {"body": 2, "word": "Results", "fig": 1}, {"body": 1, "word": "agglutinin", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "TUNEL", "fig": 1}, {"body": 1, "word": "receptor", "fig": 1}, {"body": 1, "word": "wheat", "fig": 1}, {"body": 1, "word": "Masson\u2019s", "fig": 1}, {"body": 1, "word": "trichrome", "fig": 1}, {"body": 1, "word": "dUTP", "fig": 1}, {"body": 1, "word": "transferase-mediated", "fig": 1}, {"body": 1, "word": "germ", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "Ki-67+", "fig": 1}, {"body": 1, "word": "nick", "fig": 1}, {"body": 1, "word": "discoidin", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}], "4749552": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig1.jpg", "caption": "Overall structure of the kinase domain of BRAF, zoom into the hydrophobic pocket of BRAF, and active- and inactive-like BRAF kinase domain 3D structures used for structure-energy calculation.(A) Structure of the BRAF kinase, with functional regions indicated. The BRAF kinase domain has two subdomains, a small N-terminal lobe and a large C-terminal lobe. The small lobe contains the nucleotide-binding pocket and the phosphate-binding loop, while the large lobe binds the proteins substrates and contains the catalytic loop. The two lobes are spatially connected through the activation segment (AS) of the large lobe. Sequentially, the N- and C-terminal lobes are connected by the hinge, and the AS is part of the C-lobe that interacts with the N-lobe. Movement of the two lobes relative to each other opens and closes the cleft. (B) The hydrophobic pocket around amino acid Val600 represented using the backbone and side chain view. Backbone residues are colored according to their location in the protein (see Figure 1A). Specifically, Leu597, Ala598, Val600, and Trp604 of the AS together with, Phe468, Leu525, Leu485, Val487, Phe498, and Ala497 of the N-terminal subdomain build the hydrophobic pocket. All BRAF structural representations were done with SwissPdbViewer, using PDB entry 4EHE (chain B of the crystallographic unit). (C) Superimposition of active-like BRAF kinase structures. The structural representations were made using SwissPdbViewer (PDB entries 4MNE, 3OG7 and 4MNF). (D) Superimposition of inactive-like BRAF kinase structures. Structural representations were made using SwissPdbViewer (PDB entries 4EHE and 3TV6). (E) Pairwise correlation of FoldX energies for mutations in the hydrophobic pocket derived from active and inactive structures. Similar correlation results were obtained from FoldX energies using a recently published 3D structure of inactive monomeric BRAF (Thevakumaran et al. (2015); PDB entry 4WO5, which is missing four residues in the AS/ data not shown).DOI: http://dx.doi.org/10.7554/eLife.12814.003", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 9}, {"body": 26, "word": "kinase", "fig": 6}, {"body": 26, "word": "The", "fig": 5}, {"body": 25, "word": "hydrophobic", "fig": 4}, {"body": 19, "word": "pocket", "fig": 5}, {"body": 31, "word": "AS", "fig": 3}, {"body": 14, "word": "using", "fig": 5}, {"body": 17, "word": "structures", "fig": 4}, {"body": 25, "word": "FoldX", "fig": 2}, {"body": 46, "word": "Figure", "fig": 1}, {"body": 42, "word": "mutations", "fig": 1}, {"body": 42, "word": "et", "fig": 1}, {"body": 12, "word": "two", "fig": 3}, {"body": 16, "word": "inactive", "fig": 2}, {"body": 15, "word": "energies", "fig": 2}, {"body": 14, "word": "loop", "fig": 2}, {"body": 9, "word": "domain", "fig": 3}, {"body": 5, "word": "lobe", "fig": 5}, {"body": 25, "word": "protein", "fig": 1}, {"body": 11, "word": "residues", "fig": 2}, {"body": 21, "word": "active", "fig": 1}, {"body": 8, "word": "Val600", "fig": 2}, {"body": 8, "word": "N-terminal", "fig": 2}, {"body": 6, "word": "structural", "fig": 2}, {"body": 6, "word": "correlation", "fig": 2}, {"body": 11, "word": "amino", "fig": 1}, {"body": 10, "word": "activation", "fig": 1}, {"body": 10, "word": "used", "fig": 1}, {"body": 4, "word": "small", "fig": 2}, {"body": 8, "word": "acid", "fig": 1}, {"body": 2, "word": "PDB", "fig": 4}, {"body": 4, "word": "structure", "fig": 2}, {"body": 2, "word": "large", "fig": 3}, {"body": 3, "word": "contains", "fig": 2}, {"body": 2, "word": "lobes", "fig": 3}, {"body": 3, "word": "C-terminal", "fig": 2}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 2, "word": "chain", "fig": 2}, {"body": 4, "word": "catalytic", "fig": 1}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "side", "fig": 1}, {"body": 4, "word": "phosphate-binding", "fig": 1}, {"body": 4, "word": "see", "fig": 1}, {"body": 4, "word": "data", "fig": 1}, {"body": 2, "word": "made", "fig": 2}, {"body": 2, "word": "inactive-like", "fig": 2}, {"body": 2, "word": "entry", "fig": 2}, {"body": 3, "word": "Leu597", "fig": 1}, {"body": 3, "word": "structure-energy", "fig": 1}, {"body": 3, "word": "regions", "fig": 1}, {"body": 2, "word": "relative", "fig": 1}, {"body": 1, "word": "3D", "fig": 2}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "spatially", "fig": 1}, {"body": 1, "word": "4EHE", "fig": 2}, {"body": 2, "word": "1A", "fig": 1}, {"body": 2, "word": "active-like", "fig": 1}, {"body": 2, "word": "4MNF", "fig": 1}, {"body": 2, "word": "4MNE", "fig": 1}, {"body": 2, "word": "Structural", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "backbone", "fig": 1}, {"body": 1, "word": "connected", "fig": 2}, {"body": 2, "word": "Leu525", "fig": 1}, {"body": 2, "word": "segment", "fig": 1}, {"body": 2, "word": "All", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "3OG7", "fig": 1}, {"body": 1, "word": "Similar", "fig": 1}, {"body": 1, "word": "Phe498", "fig": 1}, {"body": 1, "word": "3TV6", "fig": 1}, {"body": 1, "word": "Phe468", "fig": 1}, {"body": 1, "word": "nucleotide-binding", "fig": 1}, {"body": 1, "word": "Ala598", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "Ala497", "fig": 1}, {"body": 1, "word": "according", "fig": 1}, {"body": 1, "word": "published", "fig": 1}, {"body": 1, "word": "Pairwise", "fig": 1}, {"body": 1, "word": "substrates", "fig": 1}, {"body": 1, "word": "done", "fig": 1}, {"body": 1, "word": "opens", "fig": 1}, {"body": 1, "word": "N-", "fig": 1}, {"body": 1, "word": "Val487", "fig": 1}, {"body": 1, "word": "binds", "fig": 1}, {"body": 1, "word": "Trp604", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "al", "fig": 1}, {"body": 1, "word": "Thevakumaran", "fig": 1}, {"body": 1, "word": "cleft", "fig": 1}, {"body": 1, "word": "subdomain", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "derived", "fig": 1}, {"body": 1, "word": "Leu485", "fig": 1}, {"body": 1, "word": "subdomains", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig1-figsupp1.jpg", "caption": "BRAF activation cycle.The 14-3-3 dimer binds to Ser365 at the N-terminus and to Ser729 at the C-terminus, maintaining the kinase in a closed, inactive conformation. Dephosphorylation of the N-terminal phospho-Ser365 by phosphatase PPII sets free the Ras-binding domain to interact with Ras at the plasma membrane, which releases autoinhibition and enables either homodimerization or heterodimerization with CRAF, ARAF, or KSR1. Heterodimerization is favored by 14-3-3 dimer binding to the C-terminal, phosphorylated Ser729 of BRAF. The wild-type activation cycle is depicted with the N-terminal kinase lobe in grey and the C-terminal one in blue.DOI: http://dx.doi.org/10.7554/eLife.12814.004", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 2}, {"body": 26, "word": "kinase", "fig": 2}, {"body": 26, "word": "The", "fig": 1}, {"body": 10, "word": "activation", "fig": 2}, {"body": 16, "word": "inactive", "fig": 1}, {"body": 16, "word": "conformation", "fig": 1}, {"body": 8, "word": "N-terminal", "fig": 2}, {"body": 10, "word": "wild-type", "fig": 1}, {"body": 10, "word": "one", "fig": 1}, {"body": 9, "word": "domain", "fig": 1}, {"body": 3, "word": "C-terminal", "fig": 2}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "lobe", "fig": 1}, {"body": 4, "word": "free", "fig": 1}, {"body": 4, "word": "phosphorylated", "fig": 1}, {"body": 4, "word": "sets", "fig": 1}, {"body": 3, "word": "Ras-binding", "fig": 1}, {"body": 3, "word": "enables", "fig": 1}, {"body": 1, "word": "Ser729", "fig": 2}, {"body": 2, "word": "either", "fig": 1}, {"body": 2, "word": "Ser365", "fig": 1}, {"body": 2, "word": "Ras", "fig": 1}, {"body": 1, "word": "dimer", "fig": 2}, {"body": 1, "word": "binding", "fig": 1}, {"body": 1, "word": "ARAF", "fig": 1}, {"body": 1, "word": "interact", "fig": 1}, {"body": 1, "word": "homodimerization", "fig": 1}, {"body": 1, "word": "phosphatase", "fig": 1}, {"body": 1, "word": "closed", "fig": 1}, {"body": 1, "word": "membrane", "fig": 1}, {"body": 1, "word": "heterodimerization", "fig": 1}, {"body": 1, "word": "plasma", "fig": 1}, {"body": 1, "word": "releases", "fig": 1}, {"body": 1, "word": "autoinhibition", "fig": 1}, {"body": 1, "word": "binds", "fig": 1}, {"body": 1, "word": "CRAF", "fig": 1}, {"body": 1, "word": "PPII", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig1-figsupp2.jpg", "caption": "Cancer mutation frequencies in the hydrophobic pocket of BRAF.Each position in the hydrophobic pocket region is shown (rows) and mutation frequencies for the respective mutations (columns). The mutation frequencies are colored according to the absolute number (yellow: >0 to <10; orange: 10 to <100; red: 100 to <1000; pink: V600E, > 20.000).DOI: http://dx.doi.org/10.7554/eLife.12814.005", "co_occurrence": [{"body": 19, "word": "mutation", "fig": 3}, {"body": 25, "word": "hydrophobic", "fig": 2}, {"body": 42, "word": "mutations", "fig": 1}, {"body": 19, "word": "pocket", "fig": 2}, {"body": 9, "word": "frequencies", "fig": 3}, {"body": 26, "word": "The", "fig": 1}, {"body": 24, "word": "V600E", "fig": 1}, {"body": 8, "word": "position", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 6, "word": "region", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "respective", "fig": 1}, {"body": 1, "word": "according", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig1-figsupp3.jpg", "caption": "Basic principles of the FoldX force field, FoldX-based modeling, and the application of structure-energy calculations on mutations in BRAF\u2019s hydrophobic pocket.(A) Basic scheme of a folded and unfolded kinase and the associated folding energy (\u25b3G). (B) List of intramolecular forces contributing and opposing folding, which is integrated into the FoldX force field (see energy function in the 'Materials and methods' section). (C) Example of amino acid side chain mutations performed using FoldX. Different rotamers are shown for the mutation of Val600 to Phe, as well as for the movement of the neighboring residue, Trp604. (D) Example of change in folding energy when comparing WT to Mutant [\u25b3\u25b3G (BRAF Mutant-WT)]. (E) Pipeline of FoldX-based modeling of BRAF WT and mutants in the hydrophobic pocket. (F) Interpretation of FoldX energies and additional analysis.DOI: http://dx.doi.org/10.7554/eLife.12814.006", "co_occurrence": [{"body": 25, "word": "FoldX", "fig": 4}, {"body": 47, "word": "BRAF", "fig": 2}, {"body": 42, "word": "mutations", "fig": 2}, {"body": 26, "word": "energy", "fig": 3}, {"body": 25, "word": "hydrophobic", "fig": 2}, {"body": 19, "word": "pocket", "fig": 2}, {"body": 12, "word": "folding", "fig": 3}, {"body": 26, "word": "kinase", "fig": 1}, {"body": 19, "word": "mutation", "fig": 1}, {"body": 15, "word": "energies", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 11, "word": "amino", "fig": 1}, {"body": 10, "word": "change", "fig": 1}, {"body": 9, "word": "\u25b3\u25b3G", "fig": 1}, {"body": 9, "word": "performed", "fig": 1}, {"body": 4, "word": "WT", "fig": 2}, {"body": 8, "word": "acid", "fig": 1}, {"body": 8, "word": "Val600", "fig": 1}, {"body": 8, "word": "mutants", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "calculations", "fig": 1}, {"body": 4, "word": "side", "fig": 1}, {"body": 2, "word": "force", "fig": 2}, {"body": 4, "word": "see", "fig": 1}, {"body": 4, "word": "residue", "fig": 1}, {"body": 2, "word": "modeling", "fig": 2}, {"body": 2, "word": "field", "fig": 2}, {"body": 3, "word": "folded", "fig": 1}, {"body": 3, "word": "methods", "fig": 1}, {"body": 3, "word": "structure-energy", "fig": 1}, {"body": 2, "word": "chain", "fig": 1}, {"body": 1, "word": "FoldX-based", "fig": 2}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "contributing", "fig": 1}, {"body": 2, "word": "comparing", "fig": 1}, {"body": 2, "word": "function", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "well", "fig": 1}, {"body": 1, "word": "\u25b3G", "fig": 1}, {"body": 1, "word": "forces", "fig": 1}, {"body": 1, "word": "Mutant-WT", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "Mutant", "fig": 1}, {"body": 1, "word": "unfolded", "fig": 1}, {"body": 1, "word": "additional", "fig": 1}, {"body": 1, "word": "Trp604", "fig": 1}, {"body": 1, "word": "associated", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig2.jpg", "caption": "AS loop residues in 28 BRAF kinase structures and comparison with B-factors.(A) Percentage of the 28 BRAF X-ray structures that have a given AS residue solved. (B) Percentage of presence of AS loop amino acids in the X-ray structures, mapped onto a BRAF ribbon diagram (see legend for the color code). The structural representation was made using SwissPdbViewer (PDB entry 4EHE). (C) Normalized B-factor averages for loop residues from inactive structures (PDB entries 4EHE and 3TV6) plotted against the percentage of presence in the 28 BRAF X-ray structures.DOI: http://dx.doi.org/10.7554/eLife.12814.007", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 4}, {"body": 31, "word": "AS", "fig": 3}, {"body": 17, "word": "structures", "fig": 4}, {"body": 14, "word": "loop", "fig": 3}, {"body": 26, "word": "kinase", "fig": 1}, {"body": 26, "word": "The", "fig": 1}, {"body": 11, "word": "residues", "fig": 2}, {"body": 16, "word": "inactive", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 11, "word": "amino", "fig": 1}, {"body": 3, "word": "X-ray", "fig": 3}, {"body": 6, "word": "structural", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 4, "word": "see", "fig": 1}, {"body": 4, "word": "residue", "fig": 1}, {"body": 2, "word": "PDB", "fig": 2}, {"body": 4, "word": "solved", "fig": 1}, {"body": 3, "word": "acids", "fig": 1}, {"body": 1, "word": "presence", "fig": 2}, {"body": 2, "word": "given", "fig": 1}, {"body": 1, "word": "4EHE", "fig": 2}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "entry", "fig": 1}, {"body": 2, "word": "made", "fig": 1}, {"body": 1, "word": "B-factor", "fig": 1}, {"body": 1, "word": "3TV6", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "B-factors", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig3.jpg", "caption": "Structure-energy predictions and experimental analysis of mutations in the hydrophobic pocket of BRAF.(A) Comparison of the number of cancer mutations (>0) with destabilization of the hydrophobic pocket as predicted by FoldX (average energy values of 1EHE and 3TV6, \u2018FoldX \u25b3\u25b3G BRAF_inactive_loop\u2019). (B) Representative Western blot (upper panel) for selected Val600 mutations expressed 24 hr in normal medium and quantified using ImageJ (lower panel). Two out of at least six biological replicates are shown. Bar graph shows the results of six biological replicates for the abundance of MEK-P normalized to total BRAF. (C) Representative Western blot (upper panel) analysis for selected single and triple nucleotide substitution BRAF mutations expressed 24 hr in normal medium and quantified using ImageJ (lower panel). Two out of at four biological replicates are shown. Bar graphs show the results of two biological and two technical replicates for the abundance of MEK-P normalized to total BRAF. (D) Correlation of FoldX energies with MEK phosphorylation normalized by the total BRAF levels. FoldX energies were calculated from the inactive loop energy [BRAF_inactive_loop] minus the FoldX energies derided from active structures [BRAF_active] plus the hydrophobic solvation energy as a factor in the FoldX force field [BRAF hydr_solv_energy].DOI: http://dx.doi.org/10.7554/eLife.12814.008", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 6}, {"body": 42, "word": "mutations", "fig": 4}, {"body": 25, "word": "FoldX", "fig": 5}, {"body": 26, "word": "energy", "fig": 3}, {"body": 25, "word": "hydrophobic", "fig": 3}, {"body": 15, "word": "energies", "fig": 3}, {"body": 19, "word": "pocket", "fig": 2}, {"body": 14, "word": "using", "fig": 2}, {"body": 9, "word": "total", "fig": 3}, {"body": 12, "word": "two", "fig": 2}, {"body": 21, "word": "active", "fig": 1}, {"body": 21, "word": "cancer", "fig": 1}, {"body": 5, "word": "replicates", "fig": 4}, {"body": 17, "word": "structures", "fig": 1}, {"body": 16, "word": "inactive", "fig": 1}, {"body": 16, "word": "phosphorylation", "fig": 1}, {"body": 14, "word": "loop", "fig": 1}, {"body": 14, "word": "levels", "fig": 1}, {"body": 3, "word": "biological", "fig": 4}, {"body": 6, "word": "medium", "fig": 2}, {"body": 11, "word": "MEK", "fig": 1}, {"body": 5, "word": "results", "fig": 2}, {"body": 5, "word": "Western", "fig": 2}, {"body": 10, "word": "predicted", "fig": 1}, {"body": 9, "word": "\u25b3\u25b3G", "fig": 1}, {"body": 9, "word": "calculated", "fig": 1}, {"body": 8, "word": "Val600", "fig": 1}, {"body": 8, "word": "predictions", "fig": 1}, {"body": 8, "word": "destabilization", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 7, "word": "values", "fig": 1}, {"body": 7, "word": "nucleotide", "fig": 1}, {"body": 3, "word": "blot", "fig": 2}, {"body": 6, "word": "number", "fig": 1}, {"body": 2, "word": "normalized", "fig": 3}, {"body": 3, "word": "normal", "fig": 2}, {"body": 3, "word": "lower", "fig": 2}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "substitution", "fig": 1}, {"body": 4, "word": "show", "fig": 1}, {"body": 2, "word": "shown", "fig": 2}, {"body": 2, "word": "expressed", "fig": 2}, {"body": 2, "word": "Two", "fig": 2}, {"body": 2, "word": "hr", "fig": 2}, {"body": 1, "word": "quantified", "fig": 2}, {"body": 2, "word": "force", "fig": 1}, {"body": 1, "word": "selected", "fig": 2}, {"body": 1, "word": "ImageJ", "fig": 2}, {"body": 2, "word": "BRAF_inactive_loop", "fig": 1}, {"body": 2, "word": "single", "fig": 1}, {"body": 1, "word": "six", "fig": 2}, {"body": 2, "word": "field", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "solvation", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "factor", "fig": 1}, {"body": 1, "word": "3TV6", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "BRAF_active", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig3-figsupp1.jpg", "caption": "Mutations causing destabilization of the inactive loop and comparison with cancer frequencies.(A) Mutations having destabilization of the inactive loop above the threshold (\u2018loop energy\u2019), sorted by decreasing energy value. Colors indicate the number of cancer mutations. (B) Comparison of number of cancer mutations (>0) with destabilization of the hydrophobic pocket as predicted by FoldX (average energy values of 1EHE and 3TV6, normalized by its presence in the structure/B-factor).DOI: http://dx.doi.org/10.7554/eLife.12814.009", "co_occurrence": [{"body": 42, "word": "mutations", "fig": 2}, {"body": 21, "word": "cancer", "fig": 3}, {"body": 26, "word": "energy", "fig": 2}, {"body": 16, "word": "inactive", "fig": 2}, {"body": 14, "word": "loop", "fig": 2}, {"body": 25, "word": "FoldX", "fig": 1}, {"body": 25, "word": "hydrophobic", "fig": 1}, {"body": 8, "word": "destabilization", "fig": 3}, {"body": 19, "word": "pocket", "fig": 1}, {"body": 6, "word": "number", "fig": 2}, {"body": 10, "word": "predicted", "fig": 1}, {"body": 5, "word": "Mutations", "fig": 2}, {"body": 9, "word": "frequencies", "fig": 1}, {"body": 7, "word": "values", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "value", "fig": 1}, {"body": 2, "word": "causing", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 1, "word": "threshold", "fig": 1}, {"body": 1, "word": "presence", "fig": 1}, {"body": 1, "word": "3TV6", "fig": 1}, {"body": 1, "word": "decreasing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig3-figsupp2.jpg", "caption": "Mutations causing destabilization of the inactive structure above the threshold.Colors indicate the number of cancer mutations.DOI: http://dx.doi.org/10.7554/eLife.12814.010", "co_occurrence": [{"body": 21, "word": "cancer", "fig": 1}, {"body": 16, "word": "inactive", "fig": 1}, {"body": 8, "word": "destabilization", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "Mutations", "fig": 1}, {"body": 4, "word": "structure", "fig": 1}, {"body": 2, "word": "causing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig3-figsupp3.jpg", "caption": "Additional Western blots supporting Figure 3B.Western blots of biological replicates of BRAF WT, V600E, V600D, V600K, V600M, V600A, V600G, and V600W used for the quantifications shown in the bar diagram of Figure 3B.DOI: http://dx.doi.org/10.7554/eLife.12814.011", "co_occurrence": [{"body": 46, "word": "Figure", "fig": 2}, {"body": 47, "word": "BRAF", "fig": 1}, {"body": 24, "word": "V600E", "fig": 1}, {"body": 10, "word": "used", "fig": 1}, {"body": 5, "word": "replicates", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 4, "word": "V600K", "fig": 1}, {"body": 4, "word": "WT", "fig": 1}, {"body": 3, "word": "V600W", "fig": 1}, {"body": 3, "word": "biological", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "blots", "fig": 2}, {"body": 2, "word": "V600D", "fig": 1}, {"body": 2, "word": "V600G", "fig": 1}, {"body": 1, "word": "supporting", "fig": 1}, {"body": 1, "word": "V600M", "fig": 1}, {"body": 1, "word": "V600A", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig3-figsupp4.jpg", "caption": "Additional Western blots supporting Figure 3C.(A) Western blots of technical replicates of BRAF WT, V600E, V600H, and L597Y used for the quantifications shown in the bar diagram of Figure 3C. (B) Additional biological replicates for all BRAF mutants studied in this work.DOI: http://dx.doi.org/10.7554/eLife.12814.012", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 2}, {"body": 46, "word": "Figure", "fig": 2}, {"body": 24, "word": "V600E", "fig": 1}, {"body": 5, "word": "replicates", "fig": 2}, {"body": 5, "word": "Western", "fig": 2}, {"body": 10, "word": "used", "fig": 1}, {"body": 8, "word": "mutants", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 4, "word": "WT", "fig": 1}, {"body": 3, "word": "biological", "fig": 1}, {"body": 1, "word": "3C", "fig": 2}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "blots", "fig": 2}, {"body": 2, "word": "V600H", "fig": 1}, {"body": 1, "word": "supporting", "fig": 1}, {"body": 1, "word": "L597Y", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig4.jpg", "caption": "Structure-energy predictions and experimental analysis of mutations affecting the folding of BRAF and analysis of phosphorylation of Thr599 and Ser602 to keep the AS in a fixed active state.(A) Structural representations of the localization of Val487, Leu525, and Phe498 in BRAF (PDB entry 4EHE). (B) Destabilization of inactive and active states for V487E, L525E, and F498S BRAF (folding mutants) as predicted by FoldX. (C) Western blot analysis for BRAF mutations affecting folding. (D) Western blot analysis for BRAF F498S folding mutations. (E) Plot of BRAF soluble to insoluble ratios for the WT and mutations shown in the Western blots from pane (C) and (D), sorted in a similar order as in Figure 3B. Bar graphs show the results from two biological replicates. The soluble/insoluble value for BRAF F498S was estimated (see main text and represented with a star). (F) Illustration of the salt bridges that are proposed to stabilize the active conformation. The structural representation was done with the SwissPdbViewer, using PDB entry 4MNE. (G) Western blot analysis for the selected V600E and V600K mutations in combination with the T599A/S602A mutations expressed 24h in normal medium. (H) Quantifications of MEK phosphorylation levels normalized by total BRAF from (G) using ImageJ. Bars represent at least four biological replicates for the abundance of MEK-P normalized to total BRAF.DOI: http://dx.doi.org/10.7554/eLife.12814.013", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 8}, {"body": 42, "word": "mutations", "fig": 6}, {"body": 21, "word": "active", "fig": 3}, {"body": 26, "word": "The", "fig": 2}, {"body": 12, "word": "folding", "fig": 4}, {"body": 46, "word": "Figure", "fig": 1}, {"body": 16, "word": "phosphorylation", "fig": 2}, {"body": 31, "word": "AS", "fig": 1}, {"body": 14, "word": "using", "fig": 2}, {"body": 25, "word": "FoldX", "fig": 1}, {"body": 24, "word": "V600E", "fig": 1}, {"body": 5, "word": "Western", "fig": 4}, {"body": 4, "word": "analysis", "fig": 5}, {"body": 9, "word": "total", "fig": 2}, {"body": 16, "word": "conformation", "fig": 1}, {"body": 16, "word": "inactive", "fig": 1}, {"body": 5, "word": "F498S", "fig": 3}, {"body": 14, "word": "levels", "fig": 1}, {"body": 12, "word": "two", "fig": 1}, {"body": 11, "word": "MEK", "fig": 1}, {"body": 10, "word": "predicted", "fig": 1}, {"body": 5, "word": "replicates", "fig": 2}, {"body": 3, "word": "blot", "fig": 3}, {"body": 8, "word": "predictions", "fig": 1}, {"body": 8, "word": "mutants", "fig": 1}, {"body": 7, "word": "soluble", "fig": 1}, {"body": 7, "word": "similar", "fig": 1}, {"body": 6, "word": "structural", "fig": 1}, {"body": 3, "word": "biological", "fig": 2}, {"body": 6, "word": "insoluble", "fig": 1}, {"body": 6, "word": "state", "fig": 1}, {"body": 6, "word": "medium", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "value", "fig": 1}, {"body": 5, "word": "salt", "fig": 1}, {"body": 4, "word": "Ser602", "fig": 1}, {"body": 4, "word": "show", "fig": 1}, {"body": 4, "word": "Thr599", "fig": 1}, {"body": 4, "word": "L525E", "fig": 1}, {"body": 4, "word": "V600K", "fig": 1}, {"body": 4, "word": "WT", "fig": 1}, {"body": 4, "word": "see", "fig": 1}, {"body": 2, "word": "normalized", "fig": 2}, {"body": 2, "word": "PDB", "fig": 2}, {"body": 4, "word": "V487E", "fig": 1}, {"body": 2, "word": "entry", "fig": 2}, {"body": 3, "word": "3B", "fig": 1}, {"body": 3, "word": "normal", "fig": 1}, {"body": 3, "word": "order", "fig": 1}, {"body": 2, "word": "bridges", "fig": 1}, {"body": 2, "word": "combination", "fig": 1}, {"body": 2, "word": "stabilize", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "expressed", "fig": 1}, {"body": 1, "word": "C", "fig": 2}, {"body": 2, "word": "ratios", "fig": 1}, {"body": 2, "word": "4MNE", "fig": 1}, {"body": 2, "word": "Structural", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "Leu525", "fig": 1}, {"body": 1, "word": "proposed", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "soluble/insoluble", "fig": 1}, {"body": 1, "word": "main", "fig": 1}, {"body": 1, "word": "blots", "fig": 1}, {"body": 1, "word": "Phe498", "fig": 1}, {"body": 1, "word": "fixed", "fig": 1}, {"body": 1, "word": "ImageJ", "fig": 1}, {"body": 1, "word": "selected", "fig": 1}, {"body": 1, "word": "keep", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "4EHE", "fig": 1}, {"body": 1, "word": "done", "fig": 1}, {"body": 1, "word": "Val487", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig4-figsupp1.jpg", "caption": "Original western blots of spliced out lanes shown in Figure 4C and D.(A) Original Western blot and experimental procedure supporting Figure 4C. Supernatant (\u2018SUP\u2019) or pellet (\u2018PELLET\u2019) fractions of BRAF WT and mutants V600E, V487E, V600W, and L525E were each run on one SDS gel (five gels in total). Each gel was spliced into parts, one with the expected size of BRAF and one with the expected size of actin. All gel pieces for BRAF were placed on the iBlot (Invitrogen) Western blot membrane and transferred simultaneously. We proceeded similarly for the five actin gel pieces. As such, BRAF WT and mutants were treated similarly during gel transfer and Western blot antibody incubation, washing, and subsequent ECL development. (B) Original Western blot supporting Figure 4D. A 10-fold higher amount of lysate was loaded for BRAF mutant F498S compared to WT. WT, wild type.DOI: http://dx.doi.org/10.7554/eLife.12814.014", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 5}, {"body": 46, "word": "Figure", "fig": 3}, {"body": 10, "word": "one", "fig": 3}, {"body": 24, "word": "V600E", "fig": 1}, {"body": 5, "word": "Western", "fig": 4}, {"body": 4, "word": "WT", "fig": 4}, {"body": 8, "word": "mutants", "fig": 2}, {"body": 13, "word": "We", "fig": 1}, {"body": 3, "word": "blot", "fig": 4}, {"body": 9, "word": "total", "fig": 1}, {"body": 8, "word": "mutant", "fig": 1}, {"body": 5, "word": "F498S", "fig": 1}, {"body": 5, "word": "compared", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 2, "word": "five", "fig": 2}, {"body": 2, "word": "A", "fig": 2}, {"body": 4, "word": "L525E", "fig": 1}, {"body": 2, "word": "expected", "fig": 2}, {"body": 4, "word": "fractions", "fig": 1}, {"body": 4, "word": "V487E", "fig": 1}, {"body": 4, "word": "As", "fig": 1}, {"body": 3, "word": "V600W", "fig": 1}, {"body": 3, "word": "higher", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "supporting", "fig": 2}, {"body": 2, "word": "loaded", "fig": 1}, {"body": 2, "word": "4D", "fig": 1}, {"body": 1, "word": "4C", "fig": 2}, {"body": 2, "word": "All", "fig": 1}, {"body": 2, "word": "SDS", "fig": 1}, {"body": 1, "word": "blots", "fig": 1}, {"body": 1, "word": "run", "fig": 1}, {"body": 1, "word": "subsequent", "fig": 1}, {"body": 1, "word": "membrane", "fig": 1}, {"body": 1, "word": "Invitrogen", "fig": 1}, {"body": 1, "word": "antibody", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "pellet", "fig": 1}, {"body": 1, "word": "lysate", "fig": 1}, {"body": 1, "word": "parts", "fig": 1}, {"body": 1, "word": "10-fold", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig4-figsupp2.jpg", "caption": "Comparing experimental protein solubility with FoldX predicted folding energies.Comparing the ratios of BRAF expressed in the soluble and insoluble fractions with the FoldX folding energies. The correlation coefficient is 0.67.DOI: http://dx.doi.org/10.7554/eLife.12814.015", "co_occurrence": [{"body": 25, "word": "FoldX", "fig": 2}, {"body": 47, "word": "BRAF", "fig": 1}, {"body": 26, "word": "The", "fig": 1}, {"body": 25, "word": "protein", "fig": 1}, {"body": 12, "word": "folding", "fig": 2}, {"body": 15, "word": "energies", "fig": 1}, {"body": 10, "word": "predicted", "fig": 1}, {"body": 7, "word": "soluble", "fig": 1}, {"body": 6, "word": "insoluble", "fig": 1}, {"body": 6, "word": "correlation", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 4, "word": "fractions", "fig": 1}, {"body": 2, "word": "expressed", "fig": 1}, {"body": 2, "word": "ratios", "fig": 1}, {"body": 1, "word": "Comparing", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig4-figsupp3.jpg", "caption": "MEK phosphorylation of wild-type and V600E, V487E, and L525E mutant BRAF in the supernatant.(A) Western blot analysis of MEK-phosphorylation after expression for 24 hr in normal medium and ImageJ quantification (using two biological replicates). (B) MEK-phosphorylation levels normalized by the soluble fraction of BRAF (as shown in Figure 4C).DOI: http://dx.doi.org/10.7554/eLife.12814.016", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 2}, {"body": 46, "word": "Figure", "fig": 1}, {"body": 24, "word": "V600E", "fig": 1}, {"body": 16, "word": "phosphorylation", "fig": 1}, {"body": 14, "word": "levels", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 12, "word": "two", "fig": 1}, {"body": 11, "word": "MEK", "fig": 1}, {"body": 10, "word": "wild-type", "fig": 1}, {"body": 8, "word": "mutant", "fig": 1}, {"body": 7, "word": "soluble", "fig": 1}, {"body": 6, "word": "medium", "fig": 1}, {"body": 5, "word": "replicates", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 4, "word": "L525E", "fig": 1}, {"body": 4, "word": "V487E", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "normal", "fig": 1}, {"body": 3, "word": "biological", "fig": 1}, {"body": 3, "word": "expression", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "hr", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 1, "word": "ImageJ", "fig": 1}, {"body": 1, "word": "supernatant", "fig": 1}, {"body": 1, "word": "4C", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig4-figsupp4.jpg", "caption": "Conformations of Lys601 found in all structures having position 601 solved, and an overlay of ten active-like BRAF structures.(A) Close-up of the 4MNE structure indicating the salt bridge between Arg575 and Glu611 that is conserved in all Raf kinases. Lys601 points in the direction of this salt bridge. (B) Superimposition of all BRAF kinases that are solved at K601. For 4MNE, the ribbon representation is shown in grey, and the residues are as in panel (A). For the remaining structures, only the backbone and side chain of K601 is shown. The structural representations were made using SwissPdbViewer (PDB entries 4MNE, 1UWJ, 3TV4, 4E4X, 4EHE, 4G9R, 4PP7, 4JVG, 4MBJ, 4H58, 3Q4C, 4E26, and 4G9C). (C) Overlay of 10 active-like BRAF structures. Residues 597\u2013600 (red) are very similar between the different structures, while resides 601\u2013616 (blue) are more flexible. The structural representation was made using SwissPdbViewer (PDB entries 2FB8, 3D4Q, 3OG7, 3PPJ, 3PPK, 3PRI, 3PSB, 4H58, 4MNE, and 4MNF).DOI: http://dx.doi.org/10.7554/eLife.12814.017", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 3}, {"body": 17, "word": "structures", "fig": 5}, {"body": 26, "word": "The", "fig": 2}, {"body": 14, "word": "using", "fig": 2}, {"body": 19, "word": "found", "fig": 1}, {"body": 6, "word": "structural", "fig": 2}, {"body": 6, "word": "For", "fig": 2}, {"body": 11, "word": "residues", "fig": 1}, {"body": 5, "word": "kinases", "fig": 2}, {"body": 5, "word": "salt", "fig": 2}, {"body": 9, "word": "different", "fig": 1}, {"body": 2, "word": "4MNE", "fig": 4}, {"body": 4, "word": "bridge", "fig": 2}, {"body": 4, "word": "solved", "fig": 2}, {"body": 8, "word": "position", "fig": 1}, {"body": 7, "word": "similar", "fig": 1}, {"body": 5, "word": "Arg575", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 4, "word": "side", "fig": 1}, {"body": 2, "word": "shown", "fig": 2}, {"body": 2, "word": "active-like", "fig": 2}, {"body": 4, "word": "flexible", "fig": 1}, {"body": 2, "word": "PDB", "fig": 2}, {"body": 2, "word": "made", "fig": 2}, {"body": 2, "word": "A", "fig": 2}, {"body": 4, "word": "structure", "fig": 1}, {"body": 3, "word": "remaining", "fig": 1}, {"body": 2, "word": "chain", "fig": 1}, {"body": 1, "word": "Lys601", "fig": 2}, {"body": 2, "word": "Glu611", "fig": 1}, {"body": 2, "word": "4MNF", "fig": 1}, {"body": 2, "word": "conserved", "fig": 1}, {"body": 2, "word": "backbone", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "4EHE", "fig": 1}, {"body": 1, "word": "3OG7", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig4-figsupp5.jpg", "caption": "Biological replicates in minimal (serum-free) growth medium.DOI: http://dx.doi.org/10.7554/eLife.12814.018", "co_occurrence": [{"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "replicates", "fig": 1}, {"body": 3, "word": "growth", "fig": 1}, {"body": 1, "word": "serum-free", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig4-figsupp6.jpg", "caption": "Analysis of the interactions in the BRAF RD motif, and expression levels of BRAF wild-type and the single V600E, E611A, and double V600E/E6111A mutants.(A) Illustration of salt bridges that are proposed to stabilize the active conformation. The structural representation was done with the SwissPdbViewer, using PDB entry 4MNE. The bottom panel shows the salt bridge between Glu611 and Arg575 in the active conformation and the proposed participation of Lys601 when mutated to Glu. (B) Western blot analysis for wild-type and mutant BRAF expressed for 24 hr in normal medium. (C) Western blot analysis for wild-type and mutant BRAF expressed for 24 hr in minimal medium (no serum) with or without 5 min of EGF stimulation (at 50 ng/ml) before harvesting and lysis.DOI: http://dx.doi.org/10.7554/eLife.12814.019", "co_occurrence": [{"body": 47, "word": "BRAF", "fig": 4}, {"body": 26, "word": "The", "fig": 2}, {"body": 21, "word": "active", "fig": 2}, {"body": 16, "word": "conformation", "fig": 2}, {"body": 10, "word": "wild-type", "fig": 3}, {"body": 24, "word": "V600E", "fig": 1}, {"body": 8, "word": "mutant", "fig": 2}, {"body": 14, "word": "using", "fig": 1}, {"body": 14, "word": "levels", "fig": 1}, {"body": 6, "word": "medium", "fig": 2}, {"body": 5, "word": "Western", "fig": 2}, {"body": 10, "word": "Glu", "fig": 1}, {"body": 5, "word": "salt", "fig": 2}, {"body": 8, "word": "mutants", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 3, "word": "blot", "fig": 2}, {"body": 6, "word": "structural", "fig": 1}, {"body": 6, "word": "interactions", "fig": 1}, {"body": 6, "word": "mutated", "fig": 1}, {"body": 5, "word": "Arg575", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 2, "word": "expressed", "fig": 2}, {"body": 2, "word": "hr", "fig": 2}, {"body": 4, "word": "bridge", "fig": 1}, {"body": 3, "word": "expression", "fig": 1}, {"body": 3, "word": "normal", "fig": 1}, {"body": 1, "word": "proposed", "fig": 2}, {"body": 2, "word": "EGF", "fig": 1}, {"body": 2, "word": "bridges", "fig": 1}, {"body": 2, "word": "stabilize", "fig": 1}, {"body": 2, "word": "stimulation", "fig": 1}, {"body": 2, "word": "PDB", "fig": 1}, {"body": 2, "word": "Glu611", "fig": 1}, {"body": 2, "word": "4MNE", "fig": 1}, {"body": 2, "word": "motif", "fig": 1}, {"body": 2, "word": "single", "fig": 1}, {"body": 2, "word": "min", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "without", "fig": 1}, {"body": 2, "word": "entry", "fig": 1}, {"body": 1, "word": "Lys601", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "done", "fig": 1}, {"body": 1, "word": "serum", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig5.jpg", "caption": "Quantitative contribution of individual factors to the prediction of cancer frequencies.(A) Comparison of real and predicted cancer frequencies (labelled \u2018real value\u2019 and \u2018predicted value\u2019) for one exemplary random forest prediction (run 16). Black dots represent mutations that were in the training set, blue dots the ones in the test set, and red are the mutations that were tested experimentally in this work (some of them were included in the training set, some of them in the test set). (B) Plot of RMSD against correlation for all individual random forest runs with V600E in the training set. The correlation is the correlation between the predicted value by the random forest (\u2019predicted value\u2019) and the experimental value (\u2018real value\u2019), and the RMSD calculates the deviation of the predicted values from the real ones. (C) Results from random forest analyses with V600E in the training set. Abbreviation for parameters: 1) destabilization of inactive conformation and/or folding; 2) destabilization of active conformation (folding); 3) destabilization of inactive loop conformation; 4) nucleotide substitution frequency; 5) change in codon usage frequency; 6) salt bridge; and 7) change in hydrophobic solvation energy.DOI: http://dx.doi.org/10.7554/eLife.12814.020", "co_occurrence": [{"body": 42, "word": "mutations", "fig": 2}, {"body": 14, "word": "random", "fig": 4}, {"body": 24, "word": "V600E", "fig": 2}, {"body": 16, "word": "conformation", "fig": 3}, {"body": 12, "word": "forest", "fig": 4}, {"body": 7, "word": "set", "fig": 6}, {"body": 21, "word": "cancer", "fig": 2}, {"body": 16, "word": "inactive", "fig": 2}, {"body": 10, "word": "predicted", "fig": 3}, {"body": 26, "word": "The", "fig": 1}, {"body": 25, "word": "hydrophobic", "fig": 1}, {"body": 6, "word": "training", "fig": 4}, {"body": 12, "word": "folding", "fig": 2}, {"body": 8, "word": "destabilization", "fig": 3}, {"body": 21, "word": "active", "fig": 1}, {"body": 10, "word": "change", "fig": 2}, {"body": 9, "word": "frequencies", "fig": 2}, {"body": 6, "word": "correlation", "fig": 3}, {"body": 8, "word": "frequency", "fig": 2}, {"body": 14, "word": "loop", "fig": 1}, {"body": 6, "word": "prediction", "fig": 2}, {"body": 10, "word": "one", "fig": 1}, {"body": 5, "word": "value", "fig": 2}, {"body": 9, "word": "parameters", "fig": 1}, {"body": 7, "word": "contribution", "fig": 1}, {"body": 7, "word": "values", "fig": 1}, {"body": 7, "word": "nucleotide", "fig": 1}, {"body": 3, "word": "individual", "fig": 2}, {"body": 5, "word": "factors", "fig": 1}, {"body": 5, "word": "substitution", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "salt", "fig": 1}, {"body": 2, "word": "real", "fig": 2}, {"body": 4, "word": "and/or", "fig": 1}, {"body": 4, "word": "codon", "fig": 1}, {"body": 4, "word": "bridge", "fig": 1}, {"body": 2, "word": "RMSD", "fig": 2}, {"body": 4, "word": "included", "fig": 1}, {"body": 2, "word": "usage", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "solvation", "fig": 1}, {"body": 2, "word": "analyses", "fig": 1}, {"body": 2, "word": "tested", "fig": 1}, {"body": 2, "word": "deviation", "fig": 1}, {"body": 1, "word": "experimentally", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "run", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "work", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig5-figsupp1.jpg", "caption": "Random forest analyses without V600E in the training set.(A) Results from the random forest analyses without V600E in the training set. Abbreviation for parameters: 1, destabilization of inactive conformation/folding; 2, destabilization of active conformation (folding); 3, destabilization of inactive loop-conformation; 4, nucleotide substitution frequency; 5, change in codon usage frequency; 6, salt bridge; 7, change in hydrophobic solvation energy. (B) Plot of the RMSD against correlation for all random forest runs without V600E in the training set. The correlation is the correlation between the predicted value by the random forest (\u2019predicted value\u2019) and the experimental value (\u2018real value\u2019), and the RMSD calculates the deviation of the predicted values from the real ones.DOI: http://dx.doi.org/10.7554/eLife.12814.021", "co_occurrence": [{"body": 24, "word": "V600E", "fig": 3}, {"body": 12, "word": "forest", "fig": 4}, {"body": 14, "word": "random", "fig": 3}, {"body": 16, "word": "inactive", "fig": 2}, {"body": 26, "word": "energy", "fig": 1}, {"body": 26, "word": "The", "fig": 1}, {"body": 25, "word": "hydrophobic", "fig": 1}, {"body": 8, "word": "destabilization", "fig": 3}, {"body": 7, "word": "set", "fig": 3}, {"body": 21, "word": "active", "fig": 1}, {"body": 10, "word": "change", "fig": 2}, {"body": 10, "word": "predicted", "fig": 2}, {"body": 6, "word": "training", "fig": 3}, {"body": 6, "word": "correlation", "fig": 3}, {"body": 8, "word": "frequency", "fig": 2}, {"body": 16, "word": "conformation", "fig": 1}, {"body": 12, "word": "folding", "fig": 1}, {"body": 5, "word": "value", "fig": 2}, {"body": 9, "word": "parameters", "fig": 1}, {"body": 7, "word": "nucleotide", "fig": 1}, {"body": 7, "word": "values", "fig": 1}, {"body": 2, "word": "without", "fig": 3}, {"body": 5, "word": "http", "fig": 1}, {"body": 5, "word": "substitution", "fig": 1}, {"body": 5, "word": "salt", "fig": 1}, {"body": 4, "word": "bridge", "fig": 1}, {"body": 4, "word": "codon", "fig": 1}, {"body": 2, "word": "RMSD", "fig": 2}, {"body": 2, "word": "analyses", "fig": 2}, {"body": 3, "word": "Random", "fig": 1}, {"body": 2, "word": "deviation", "fig": 1}, {"body": 2, "word": "solvation", "fig": 1}, {"body": 2, "word": "usage", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "real", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749552/bin/elife-12814-fig6.jpg", "caption": "Schematic diagram depicting the relationship between structural flexibility, destabilization of the hydrophobic pocket, and cancer frequencies.The effect of a mutation on folding depends on the structural flexibility of the respective hydrophobic pocket where the mutated amino acid is located. In a region with higher structural flexibility destabilization in the hydrophobic pocket will cause activation of the kinase and still allows proper folding. Thus, the disease-causing propensity (cancer mutation frequency) will increase with increasing destabilization of the hydrophobic pocket. In contrast, mutations in structurally rigid areas of the hydrophobic pocket will only slightly increase the catalytic activity with increasing destabilization, and will then cause unfolding.DOI: http://dx.doi.org/10.7554/eLife.12814.022", "co_occurrence": [{"body": 25, "word": "hydrophobic", "fig": 5}, {"body": 19, "word": "pocket", "fig": 5}, {"body": 21, "word": "cancer", "fig": 2}, {"body": 42, "word": "mutations", "fig": 1}, {"body": 19, "word": "mutation", "fig": 2}, {"body": 8, "word": "destabilization", "fig": 4}, {"body": 26, "word": "kinase", "fig": 1}, {"body": 12, "word": "folding", "fig": 2}, {"body": 12, "word": "In", "fig": 2}, {"body": 6, "word": "structural", "fig": 3}, {"body": 11, "word": "amino", "fig": 1}, {"body": 5, "word": "cause", "fig": 2}, {"body": 10, "word": "activation", "fig": 1}, {"body": 3, "word": "flexibility", "fig": 3}, {"body": 8, "word": "frequency", "fig": 1}, {"body": 8, "word": "acid", "fig": 1}, {"body": 6, "word": "Thus", "fig": 1}, {"body": 6, "word": "mutated", "fig": 1}, {"body": 6, "word": "activity", "fig": 1}, {"body": 6, "word": "region", "fig": 1}, {"body": 5, "word": "http", "fig": 1}, {"body": 4, "word": "catalytic", "fig": 1}, {"body": 2, "word": "increase", "fig": 2}, {"body": 4, "word": "slightly", "fig": 1}, {"body": 3, "word": "still", "fig": 1}, {"body": 3, "word": "contrast", "fig": 1}, {"body": 3, "word": "higher", "fig": 1}, {"body": 3, "word": "effect", "fig": 1}, {"body": 2, "word": "depends", "fig": 1}, {"body": 2, "word": "disease-causing", "fig": 1}, {"body": 1, "word": "increasing", "fig": 2}, {"body": 2, "word": "structurally", "fig": 1}, {"body": 2, "word": "allows", "fig": 1}, {"body": 1, "word": "proper", "fig": 1}, {"body": 1, "word": "respective", "fig": 1}, {"body": 1, "word": "located", "fig": 1}, {"body": 1, "word": "rigid", "fig": 1}, {"body": 1, "word": "propensity", "fig": 1}, {"body": 1, "word": "areas", "fig": 1}]}], "4259308": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g001.jpg", "caption": "Prostate cancer cells expressed functional P2X7. (A) Relative mRNA expression of P2X7 was normalized by \u03b2-actin transcript in 1E8, 2B4, 22RV1 and BPH1 cells. (B) Protein levels of P2X7 in prostate cancer cells were detected by western blot analysis and data were normalized to \u03b2-actin. Protein expression of P2X7 in BPH1 cells was defined as 1. Values were presented as mean \u00b1 s.d. (vertical bars). (C) Representative intracellular calcium changes in response to ATP (1 mM) or BzATP (100 \u00b5M) in the presence or absence of KN62 (1 \u00b5M). (D) Representative ethidium uptake of prostate cancer cells in basal condition or upon stimulation with ATP (1 mM) or BzATP (100 \u00b5M) in the presence or absence of KN62. ATP/BzATP was added, as indicated by the arrow, to the HBSS containing 25 \u00b5M ethidium bromide. (E) Ethidium fluorescence intensity in basal condition or upon stimulation with ATP (1 mM) or BzATP (100 \u00b5M) in the presence or absence of KN62, was presented as a percentage relative to the value of digitonin-induced permeabilisation. At least three independent experiments were performed. *P<0.05.", "co_occurrence": [{"body": 104, "word": "cells", "fig": 5}, {"body": 86, "word": "P2X7", "fig": 4}, {"body": 81, "word": "cancer", "fig": 3}, {"body": 65, "word": "prostate", "fig": 2}, {"body": 36, "word": "ATP", "fig": 3}, {"body": 23, "word": "BzATP", "fig": 3}, {"body": 31, "word": "expression", "fig": 2}, {"body": 11, "word": "\u00b5M", "fig": 5}, {"body": 11, "word": "presented", "fig": 2}, {"body": 7, "word": "presence", "fig": 3}, {"body": 7, "word": "KN62", "fig": 3}, {"body": 9, "word": "normalized", "fig": 2}, {"body": 17, "word": "experiments", "fig": 1}, {"body": 17, "word": "1E8", "fig": 1}, {"body": 16, "word": "performed", "fig": 1}, {"body": 16, "word": "2B4", "fig": 1}, {"body": 13, "word": "data", "fig": 1}, {"body": 12, "word": "three", "fig": 1}, {"body": 4, "word": "absence", "fig": 3}, {"body": 11, "word": "expressed", "fig": 1}, {"body": 11, "word": "least", "fig": 1}, {"body": 10, "word": "22RV1", "fig": 1}, {"body": 9, "word": "mean", "fig": 1}, {"body": 9, "word": "changes", "fig": 1}, {"body": 3, "word": "mM", "fig": 3}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "independent", "fig": 1}, {"body": 9, "word": "At", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 8, "word": "blot", "fig": 1}, {"body": 8, "word": "s.d", "fig": 1}, {"body": 8, "word": "vertical", "fig": 1}, {"body": 8, "word": "bars", "fig": 1}, {"body": 4, "word": "ethidium", "fig": 2}, {"body": 8, "word": "levels", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 3, "word": "\u03b2-actin", "fig": 2}, {"body": 3, "word": "BPH1", "fig": 2}, {"body": 6, "word": "analysis", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 4, "word": "uptake", "fig": 1}, {"body": 2, "word": "Protein", "fig": 2}, {"body": 4, "word": "HBSS", "fig": 1}, {"body": 4, "word": "functional", "fig": 1}, {"body": 3, "word": "bromide", "fig": 1}, {"body": 3, "word": "calcium", "fig": 1}, {"body": 3, "word": "containing", "fig": 1}, {"body": 3, "word": "western", "fig": 1}, {"body": 2, "word": "detected", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "mRNA", "fig": 1}, {"body": 2, "word": "intracellular", "fig": 1}, {"body": 2, "word": "percentage", "fig": 1}, {"body": 2, "word": "Prostate", "fig": 1}, {"body": 2, "word": "added", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "upon", "fig": 2}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "Ethidium", "fig": 1}, {"body": 1, "word": "permeabilisation", "fig": 1}, {"body": 1, "word": "Values", "fig": 1}, {"body": 1, "word": "fluorescence", "fig": 1}, {"body": 1, "word": "Relative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g002.jpg", "caption": "Knockdown of P2X7 attenuated ATP-driven migration and invasion in prostate cancer cells. (A) 1E8 and 2B4 prostate cancer cells were treated with 1 mM ATP for 12 h and 24 h. Cell survival was estimated by MTT assay and data were normalized to those under control condition. (B) 1E8 and 2B4 cells were transfected with two different P2X7 siRNAs (siRNA1 and siRNA2) or a control siRNA (NC). Western blot experiments were performed to detect the knockdown efficiency. (C\u2013D) In vitro migration and invasion assays were carried out as described in methods section in the absence (Control) or presence of 1 mM ATP (ATP 12 h). Data of cell migration or invasion were calculated as a percentage of control cells. Results were demonstrated by histograms and values were presented as mean \u00b1 s.d. (vertical bars). At least three independent experiments were performed. *P<0.05.", "co_occurrence": [{"body": 104, "word": "cells", "fig": 4}, {"body": 86, "word": "P2X7", "fig": 2}, {"body": 81, "word": "cancer", "fig": 2}, {"body": 65, "word": "prostate", "fig": 2}, {"body": 36, "word": "ATP", "fig": 3}, {"body": 30, "word": "invasion", "fig": 3}, {"body": 29, "word": "migration", "fig": 3}, {"body": 21, "word": "control", "fig": 3}, {"body": 17, "word": "experiments", "fig": 2}, {"body": 17, "word": "1E8", "fig": 2}, {"body": 16, "word": "performed", "fig": 2}, {"body": 16, "word": "2B4", "fig": 2}, {"body": 20, "word": "cell", "fig": 1}, {"body": 13, "word": "data", "fig": 1}, {"body": 13, "word": "In", "fig": 1}, {"body": 12, "word": "three", "fig": 1}, {"body": 12, "word": "Cell", "fig": 1}, {"body": 11, "word": "presented", "fig": 1}, {"body": 11, "word": "demonstrated", "fig": 1}, {"body": 11, "word": "least", "fig": 1}, {"body": 10, "word": "assay", "fig": 1}, {"body": 10, "word": "knockdown", "fig": 1}, {"body": 10, "word": "Data", "fig": 1}, {"body": 10, "word": "siRNA", "fig": 1}, {"body": 9, "word": "mean", "fig": 1}, {"body": 9, "word": "normalized", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "independent", "fig": 1}, {"body": 9, "word": "At", "fig": 1}, {"body": 8, "word": "blot", "fig": 1}, {"body": 8, "word": "s.d", "fig": 1}, {"body": 8, "word": "vertical", "fig": 1}, {"body": 8, "word": "bars", "fig": 1}, {"body": 8, "word": "vitro", "fig": 1}, {"body": 8, "word": "two", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 6, "word": "Western", "fig": 1}, {"body": 3, "word": "h", "fig": 2}, {"body": 6, "word": "attenuated", "fig": 1}, {"body": 6, "word": "NC", "fig": 1}, {"body": 3, "word": "mM", "fig": 2}, {"body": 5, "word": "survival", "fig": 1}, {"body": 5, "word": "siRNA2", "fig": 1}, {"body": 5, "word": "siRNA1", "fig": 1}, {"body": 4, "word": "absence", "fig": 1}, {"body": 4, "word": "ATP-driven", "fig": 1}, {"body": 4, "word": "transfected", "fig": 1}, {"body": 3, "word": "estimated", "fig": 1}, {"body": 3, "word": "carried", "fig": 1}, {"body": 3, "word": "h.", "fig": 1}, {"body": 3, "word": "Knockdown", "fig": 1}, {"body": 3, "word": "calculated", "fig": 1}, {"body": 3, "word": "Results", "fig": 1}, {"body": 2, "word": "described", "fig": 1}, {"body": 2, "word": "percentage", "fig": 1}, {"body": 2, "word": "assays", "fig": 1}, {"body": 2, "word": "siRNAs", "fig": 1}, {"body": 2, "word": "different", "fig": 1}, {"body": 1, "word": "Control", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "detect", "fig": 1}, {"body": 1, "word": "section", "fig": 1}, {"body": 1, "word": "efficiency", "fig": 1}, {"body": 1, "word": "histograms", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "C\u2013D", "fig": 1}, {"body": 1, "word": "MTT", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g003.jpg", "caption": "Knockdown of P2X7 attenuated ATP-mediated expression changes of EMT/invasion-related genes in prostate cancer cells. P2X7 silenced cells (siRNA1 and siRNA2) and control siRNA cells (NC) were treated with or without 1 mM ATP for 12 hours. Protein levels of Snail (A), E-cadherin (B) and Claudin-1 (C) were examined by Western blot analysis. Protein levels of IL-8 (D) and MMP-3 (E) were evaluated by ELISA assay. Expressions of these proteins were normalized to their respective expression in control cells (without ATP). Data were presented as mean \u00b1 s.d. (vertical bars). At least three independent experiments were performed. *P<0.05.", "co_occurrence": [{"body": 104, "word": "cells", "fig": 4}, {"body": 86, "word": "P2X7", "fig": 2}, {"body": 81, "word": "cancer", "fig": 1}, {"body": 36, "word": "ATP", "fig": 2}, {"body": 65, "word": "prostate", "fig": 1}, {"body": 31, "word": "expression", "fig": 2}, {"body": 21, "word": "control", "fig": 2}, {"body": 11, "word": "without", "fig": 2}, {"body": 21, "word": "Snail", "fig": 1}, {"body": 20, "word": "E-cadherin", "fig": 1}, {"body": 17, "word": "experiments", "fig": 1}, {"body": 16, "word": "performed", "fig": 1}, {"body": 16, "word": "Claudin-1", "fig": 1}, {"body": 8, "word": "levels", "fig": 2}, {"body": 14, "word": "IL-8", "fig": 1}, {"body": 12, "word": "three", "fig": 1}, {"body": 12, "word": "EMT/invasion-related", "fig": 1}, {"body": 11, "word": "ATP-mediated", "fig": 1}, {"body": 11, "word": "least", "fig": 1}, {"body": 11, "word": "genes", "fig": 1}, {"body": 11, "word": "presented", "fig": 1}, {"body": 10, "word": "assay", "fig": 1}, {"body": 10, "word": "siRNA", "fig": 1}, {"body": 10, "word": "Data", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "independent", "fig": 1}, {"body": 9, "word": "normalized", "fig": 1}, {"body": 9, "word": "MMP-3", "fig": 1}, {"body": 9, "word": "At", "fig": 1}, {"body": 9, "word": "changes", "fig": 1}, {"body": 9, "word": "mean", "fig": 1}, {"body": 8, "word": "s.d", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 8, "word": "blot", "fig": 1}, {"body": 8, "word": "vertical", "fig": 1}, {"body": 8, "word": "bars", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "attenuated", "fig": 1}, {"body": 6, "word": "analysis", "fig": 1}, {"body": 6, "word": "respective", "fig": 1}, {"body": 6, "word": "NC", "fig": 1}, {"body": 6, "word": "Western", "fig": 1}, {"body": 6, "word": "Expressions", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "siRNA1", "fig": 1}, {"body": 5, "word": "ELISA", "fig": 1}, {"body": 5, "word": "siRNA2", "fig": 1}, {"body": 5, "word": "proteins", "fig": 1}, {"body": 2, "word": "Protein", "fig": 2}, {"body": 3, "word": "Knockdown", "fig": 1}, {"body": 3, "word": "mM", "fig": 1}, {"body": 2, "word": "examined", "fig": 1}, {"body": 2, "word": "evaluated", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "silenced", "fig": 1}, {"body": 2, "word": "hours", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g004.jpg", "caption": "Effects of PI3K/AKT and ERK1/2 signaling pathways on ATP-mediated migration and invasion. IE8 and 2B4 cells were treated with LY294002 (lanes denoted as LY294002) or U0126 (lanes denoted as U0126) or without treatment (served as a negative control, lanes denoted as NC). (A\u2013B) LY294002 and U0126 inhibited ATP-mediated PI3K/AKT and ERK1/2 activation respectively. (C\u2013D) Effects of LY294002 and U0126 on migration and invasion in 1E8 and 2B4 prostate cancer cells. Data of cell migration or invasion were calculated as a percentage of control cells. Results were demonstrated by histograms, and values were presented as mean \u00b1 s.d. (vertical bars). At least three independent experiments were performed. *P<0.05.", "co_occurrence": [{"body": 104, "word": "cells", "fig": 3}, {"body": 30, "word": "invasion", "fig": 3}, {"body": 29, "word": "migration", "fig": 3}, {"body": 81, "word": "cancer", "fig": 1}, {"body": 65, "word": "prostate", "fig": 1}, {"body": 26, "word": "ERK1/2", "fig": 2}, {"body": 21, "word": "control", "fig": 2}, {"body": 21, "word": "PI3K/AKT", "fig": 2}, {"body": 8, "word": "LY294002", "fig": 4}, {"body": 8, "word": "U0126", "fig": 4}, {"body": 16, "word": "2B4", "fig": 2}, {"body": 25, "word": "signaling", "fig": 1}, {"body": 8, "word": "denoted", "fig": 3}, {"body": 11, "word": "ATP-mediated", "fig": 2}, {"body": 20, "word": "cell", "fig": 1}, {"body": 19, "word": "pathways", "fig": 1}, {"body": 6, "word": "lanes", "fig": 3}, {"body": 17, "word": "experiments", "fig": 1}, {"body": 17, "word": "1E8", "fig": 1}, {"body": 16, "word": "performed", "fig": 1}, {"body": 16, "word": "activation", "fig": 1}, {"body": 12, "word": "three", "fig": 1}, {"body": 11, "word": "least", "fig": 1}, {"body": 11, "word": "demonstrated", "fig": 1}, {"body": 11, "word": "presented", "fig": 1}, {"body": 11, "word": "without", "fig": 1}, {"body": 10, "word": "Data", "fig": 1}, {"body": 9, "word": "independent", "fig": 1}, {"body": 9, "word": "At", "fig": 1}, {"body": 9, "word": "mean", "fig": 1}, {"body": 8, "word": "s.d", "fig": 1}, {"body": 8, "word": "bars", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 8, "word": "inhibited", "fig": 1}, {"body": 8, "word": "treatment", "fig": 1}, {"body": 8, "word": "vertical", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 6, "word": "NC", "fig": 1}, {"body": 3, "word": "Effects", "fig": 2}, {"body": 5, "word": "negative", "fig": 1}, {"body": 4, "word": "respectively", "fig": 1}, {"body": 3, "word": "calculated", "fig": 1}, {"body": 3, "word": "Results", "fig": 1}, {"body": 2, "word": "IE8", "fig": 1}, {"body": 2, "word": "percentage", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 1, "word": "histograms", "fig": 1}, {"body": 1, "word": "C\u2013D", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "A\u2013B", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g005.jpg", "caption": "Effects of PI3K/AKT and ERK1/2 signaling pathways on ATP-induced expression changes of EMT/invasion-related genes. IE8 and 2B4 cells were treated with LY294002 (lanes denoted as LY294002) or U0126 (lanes denoted as U0126) or without treatment (served as a negative control, lanes denoted as NC). Expressions of Snail (A), E-cadherin (B) and Claudin-1 (C) were detected by western blots. Expressions of IL-8 (D) and MMP-3 (E) were detected using ELISA. Expressions of these proteins were normalized to their respective expression in control cells (without ATP). Data were presented as mean \u00b1 s.d. (vertical bars). At least three independent experiments were performed. *P<0.05.", "co_occurrence": [{"body": 104, "word": "cells", "fig": 2}, {"body": 31, "word": "expression", "fig": 2}, {"body": 21, "word": "control", "fig": 2}, {"body": 36, "word": "ATP", "fig": 1}, {"body": 26, "word": "ERK1/2", "fig": 1}, {"body": 25, "word": "signaling", "fig": 1}, {"body": 8, "word": "denoted", "fig": 3}, {"body": 11, "word": "without", "fig": 2}, {"body": 21, "word": "Snail", "fig": 1}, {"body": 21, "word": "PI3K/AKT", "fig": 1}, {"body": 20, "word": "E-cadherin", "fig": 1}, {"body": 19, "word": "pathways", "fig": 1}, {"body": 6, "word": "lanes", "fig": 3}, {"body": 6, "word": "Expressions", "fig": 3}, {"body": 17, "word": "experiments", "fig": 1}, {"body": 17, "word": "using", "fig": 1}, {"body": 8, "word": "LY294002", "fig": 2}, {"body": 16, "word": "performed", "fig": 1}, {"body": 8, "word": "U0126", "fig": 2}, {"body": 16, "word": "Claudin-1", "fig": 1}, {"body": 16, "word": "2B4", "fig": 1}, {"body": 14, "word": "IL-8", "fig": 1}, {"body": 12, "word": "EMT/invasion-related", "fig": 1}, {"body": 12, "word": "three", "fig": 1}, {"body": 11, "word": "least", "fig": 1}, {"body": 11, "word": "genes", "fig": 1}, {"body": 11, "word": "presented", "fig": 1}, {"body": 10, "word": "Data", "fig": 1}, {"body": 9, "word": "At", "fig": 1}, {"body": 9, "word": "independent", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "normalized", "fig": 1}, {"body": 9, "word": "MMP-3", "fig": 1}, {"body": 9, "word": "mean", "fig": 1}, {"body": 9, "word": "changes", "fig": 1}, {"body": 8, "word": "s.d", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 8, "word": "bars", "fig": 1}, {"body": 8, "word": "vertical", "fig": 1}, {"body": 8, "word": "treatment", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 6, "word": "respective", "fig": 1}, {"body": 6, "word": "NC", "fig": 1}, {"body": 5, "word": "negative", "fig": 1}, {"body": 5, "word": "ELISA", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "proteins", "fig": 1}, {"body": 2, "word": "detected", "fig": 2}, {"body": 3, "word": "western", "fig": 1}, {"body": 3, "word": "ATP-induced", "fig": 1}, {"body": 3, "word": "Effects", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "IE8", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 1, "word": "blots", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g006.jpg", "caption": "Knockdown of P2X7 attenuated ATP-mediated activation of PI3K/AKT and ERK1/2 signaling pathways. P2X7 silenced cells (siRNA1 and siRNA2) and control siRNA cells (NC) were treated with or without 1 mM ATP for 15 min. Western blot experiments were performed to analyze phosphorylation level of AKT (A) and ERK1/2 (B). Expressions of p-AKT and p-ERK1/2 were normalized to their respective expression in control cells (without ATP). Data were presented as mean \u00b1 s.d. (vertical bars). At least three independent experiments were performed. *P<0.05.", "co_occurrence": [{"body": 104, "word": "cells", "fig": 3}, {"body": 86, "word": "P2X7", "fig": 2}, {"body": 36, "word": "ATP", "fig": 2}, {"body": 26, "word": "ERK1/2", "fig": 2}, {"body": 21, "word": "control", "fig": 2}, {"body": 17, "word": "experiments", "fig": 2}, {"body": 16, "word": "performed", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 25, "word": "signaling", "fig": 1}, {"body": 11, "word": "without", "fig": 2}, {"body": 21, "word": "PI3K/AKT", "fig": 1}, {"body": 19, "word": "pathways", "fig": 1}, {"body": 16, "word": "activation", "fig": 1}, {"body": 12, "word": "three", "fig": 1}, {"body": 11, "word": "ATP-mediated", "fig": 1}, {"body": 11, "word": "least", "fig": 1}, {"body": 11, "word": "presented", "fig": 1}, {"body": 10, "word": "siRNA", "fig": 1}, {"body": 10, "word": "Data", "fig": 1}, {"body": 9, "word": "At", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "independent", "fig": 1}, {"body": 9, "word": "normalized", "fig": 1}, {"body": 9, "word": "mean", "fig": 1}, {"body": 8, "word": "s.d", "fig": 1}, {"body": 8, "word": "bars", "fig": 1}, {"body": 8, "word": "blot", "fig": 1}, {"body": 8, "word": "vertical", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 6, "word": "attenuated", "fig": 1}, {"body": 6, "word": "respective", "fig": 1}, {"body": 6, "word": "min", "fig": 1}, {"body": 6, "word": "NC", "fig": 1}, {"body": 6, "word": "Western", "fig": 1}, {"body": 6, "word": "Expressions", "fig": 1}, {"body": 5, "word": "AKT", "fig": 1}, {"body": 5, "word": "siRNA1", "fig": 1}, {"body": 5, "word": "siRNA2", "fig": 1}, {"body": 3, "word": "p-AKT", "fig": 1}, {"body": 3, "word": "Knockdown", "fig": 1}, {"body": 3, "word": "p-ERK1/2", "fig": 1}, {"body": 3, "word": "mM", "fig": 1}, {"body": 3, "word": "phosphorylation", "fig": 1}, {"body": 2, "word": "silenced", "fig": 1}, {"body": 1, "word": "analyze", "fig": 1}, {"body": 1, "word": "level", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g007.jpg", "caption": "Knockdown of P2X7 suppressed invasiveness and metastases of prostate cancer cells in vivo. (A) 1E8 cells were stably transfected with P2X7 shRNA or a scramble shRNA (NC). Two stable P2X7 shRNA clones (shRNA1 and shRNA2) were shown to express low levels of P2X7 using western blot analysis. (B) Representative photograph of tumor sections and adjacent tissues (stained with haematoxylin and eosin (H&E)). Scale bars = 100 \u00b5m. (C) Representative photographs of kidney section and lymph node section (stained with H&E) from tumor-bearing mice. Scale bars = 50 \u00b5m. (D) The number of micrometastasis in kidney and lymph node per section from tumor-bearing mice. *P<0.05.", "co_occurrence": [{"body": 86, "word": "P2X7", "fig": 4}, {"body": 104, "word": "cells", "fig": 2}, {"body": 81, "word": "cancer", "fig": 1}, {"body": 65, "word": "prostate", "fig": 1}, {"body": 21, "word": "tumor", "fig": 1}, {"body": 10, "word": "mice", "fig": 2}, {"body": 18, "word": "The", "fig": 1}, {"body": 17, "word": "using", "fig": 1}, {"body": 17, "word": "1E8", "fig": 1}, {"body": 8, "word": "bars", "fig": 2}, {"body": 4, "word": "shRNA", "fig": 3}, {"body": 9, "word": "tissues", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 8, "word": "blot", "fig": 1}, {"body": 8, "word": "levels", "fig": 1}, {"body": 8, "word": "vivo", "fig": 1}, {"body": 7, "word": "invasiveness", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "NC", "fig": 1}, {"body": 6, "word": "analysis", "fig": 1}, {"body": 3, "word": "\u00b5m", "fig": 2}, {"body": 3, "word": "lymph", "fig": 2}, {"body": 6, "word": "metastases", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 2, "word": "node", "fig": 2}, {"body": 2, "word": "E", "fig": 2}, {"body": 4, "word": "transfected", "fig": 1}, {"body": 1, "word": "section", "fig": 3}, {"body": 3, "word": "Knockdown", "fig": 1}, {"body": 3, "word": "stable", "fig": 1}, {"body": 3, "word": "western", "fig": 1}, {"body": 1, "word": "kidney", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "sections", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "clones", "fig": 1}, {"body": 2, "word": "scramble", "fig": 1}, {"body": 1, "word": "stained", "fig": 2}, {"body": 1, "word": "shRNA1", "fig": 1}, {"body": 1, "word": "Two", "fig": 1}, {"body": 1, "word": "shRNA2", "fig": 1}, {"body": 1, "word": "suppressed", "fig": 1}, {"body": 1, "word": "eosin", "fig": 1}, {"body": 1, "word": "number", "fig": 1}, {"body": 1, "word": "micrometastasis", "fig": 1}, {"body": 1, "word": "haematoxylin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259308/bin/pone.0114371.g008.jpg", "caption": "Knockdown of P2X7 affected expression of EMT/invasion-related genes as well as activation of PI3K/AKT and ERK1/2 signaling pathways in vivo. (A) Immunofluorescence staining for Snail, E-cadherin, Claudin-1 (green) and DAPI (blue) were performed in tumor tissues of mice. Images were taken by confocal microscopy. Scale bars represent 75 \u00b5m or 25 \u00b5m as shown in the Figure. (B) Western blotting was performed to detect the protein levels of Snail, E-cadherin and Claudin-1 in tumor tissues. (C) ELISA was used to examine the expression of IL-8. (D) Western blotting was performed to analyze the phosphorylation level of AKT and ERK1/2 in tumor tissues. For each group, at least three distinct tumors from three different mice were used in the experiments. *P<0.05.", "co_occurrence": [{"body": 86, "word": "P2X7", "fig": 1}, {"body": 21, "word": "tumor", "fig": 3}, {"body": 31, "word": "expression", "fig": 2}, {"body": 26, "word": "ERK1/2", "fig": 2}, {"body": 16, "word": "performed", "fig": 3}, {"body": 21, "word": "Snail", "fig": 2}, {"body": 20, "word": "E-cadherin", "fig": 2}, {"body": 16, "word": "Claudin-1", "fig": 2}, {"body": 9, "word": "tissues", "fig": 3}, {"body": 25, "word": "signaling", "fig": 1}, {"body": 12, "word": "three", "fig": 2}, {"body": 21, "word": "PI3K/AKT", "fig": 1}, {"body": 10, "word": "mice", "fig": 2}, {"body": 19, "word": "pathways", "fig": 1}, {"body": 9, "word": "used", "fig": 2}, {"body": 18, "word": "Figure", "fig": 1}, {"body": 17, "word": "experiments", "fig": 1}, {"body": 16, "word": "activation", "fig": 1}, {"body": 14, "word": "IL-8", "fig": 1}, {"body": 6, "word": "Western", "fig": 2}, {"body": 12, "word": "EMT/invasion-related", "fig": 1}, {"body": 11, "word": "protein", "fig": 1}, {"body": 11, "word": "genes", "fig": 1}, {"body": 11, "word": "least", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "well", "fig": 1}, {"body": 8, "word": "bars", "fig": 1}, {"body": 8, "word": "*P", "fig": 1}, {"body": 8, "word": "vivo", "fig": 1}, {"body": 8, "word": "levels", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 3, "word": "\u00b5m", "fig": 2}, {"body": 6, "word": "tumors", "fig": 1}, {"body": 5, "word": "AKT", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "ELISA", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 3, "word": "phosphorylation", "fig": 1}, {"body": 3, "word": "Knockdown", "fig": 1}, {"body": 3, "word": "distinct", "fig": 1}, {"body": 3, "word": "Images", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "different", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "examine", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "microscopy", "fig": 1}, {"body": 1, "word": "detect", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "taken", "fig": 1}, {"body": 1, "word": "analyze", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "level", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}]}], "4307226": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307226/bin/12931_2014_162_Fig1_HTML.jpg", "caption": "Effect of TGF\u03b21 exposure on overall survival in maternally exposed doxycycline to NB TGF\u03b2TG, and TGF\u03b2TG X TGF\u03b2R2KO mice. NB TGF\u03b21TG, and TGF\u03b21TG X TGF\u03b2R2KO littermate mice were exposed to maternal dox at PN1 - PN7 and then overall survival was assessed. Where NB: newborn; PN: postnatal; TGF\u03b21TG: TGF\u03b21 transgenic mice; TGF\u03b21TG X TGF\u03b2R2KO: TGF\u03b21 transgene mice crossed with TGF\u03b2 receptor II knockout mice. N = 7 in each group; **p < 0.01 and ***p < 0.001 TGF\u03b21TG vs. TGF\u03b21TG X TGF\u03b2R2KO and TGF\u03b2R2KO vs. TGF\u03b21TG respectively.", "co_occurrence": [{"body": 60, "word": "mice", "fig": 5}, {"body": 41, "word": "TGF\u03b21TG", "fig": 7}, {"body": 24, "word": "TGF\u03b2R2KO", "fig": 5}, {"body": 34, "word": "TGF\u03b21", "fig": 3}, {"body": 16, "word": "X", "fig": 4}, {"body": 16, "word": "NB", "fig": 3}, {"body": 10, "word": "survival", "fig": 2}, {"body": 17, "word": "exposure", "fig": 1}, {"body": 12, "word": "TGF\u03b2", "fig": 1}, {"body": 5, "word": "exposed", "fig": 2}, {"body": 8, "word": "PN7", "fig": 1}, {"body": 8, "word": "receptor", "fig": 1}, {"body": 6, "word": "PN1", "fig": 1}, {"body": 5, "word": "Effect", "fig": 1}, {"body": 5, "word": "II", "fig": 1}, {"body": 5, "word": "dox", "fig": 1}, {"body": 2, "word": "TGF\u03b2TG", "fig": 2}, {"body": 3, "word": "assessed", "fig": 1}, {"body": 3, "word": "PN", "fig": 1}, {"body": 2, "word": "respectively", "fig": 1}, {"body": 1, "word": "knockout", "fig": 1}, {"body": 1, "word": "doxycycline", "fig": 1}, {"body": 1, "word": "postnatal", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "maternal", "fig": 1}, {"body": 1, "word": "littermate", "fig": 1}, {"body": 1, "word": "transgenic", "fig": 1}, {"body": 1, "word": "newborn", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307226/bin/12931_2014_162_Fig2_HTML.jpg", "caption": "TGF\u03b21-induced inflammation in TGF\u03b21TG and TGF\u03b21TG X TGF\u03b2R2KO mice. Multicolor flow cytometric analysis showed significantly greater staining of inflammatory macrophages and LY6C high monocytes in TGF\u03b21TG mice lungs as compared to WT controls. TGF\u03b21TG X TGF\u03b2R2KO developing lungs showed significantly decreased staining of inflammatory macrophages and LY6C high monocytes as compared to TGF\u03b21TG mice. (B) Ly6Clow monocytes were significantly decreased in the BALF of WT mice, as compared with TGF\u03b21TG mice. BALF: bronchoalveolar lavage fluid. N = 4 in each group; *p < 0.05, **p < 0.01 and ***p < 0.001.", "co_occurrence": [{"body": 60, "word": "mice", "fig": 5}, {"body": 41, "word": "TGF\u03b21TG", "fig": 6}, {"body": 32, "word": "lungs", "fig": 2}, {"body": 24, "word": "TGF\u03b2R2KO", "fig": 2}, {"body": 13, "word": "compared", "fig": 3}, {"body": 16, "word": "X", "fig": 2}, {"body": 9, "word": "significantly", "fig": 3}, {"body": 13, "word": "decreased", "fig": 2}, {"body": 11, "word": "macrophages", "fig": 2}, {"body": 6, "word": "monocytes", "fig": 3}, {"body": 7, "word": "inflammatory", "fig": 2}, {"body": 14, "word": "developing", "fig": 1}, {"body": 12, "word": "inflammation", "fig": 1}, {"body": 5, "word": "staining", "fig": 2}, {"body": 4, "word": "WT", "fig": 2}, {"body": 4, "word": "BALF", "fig": 2}, {"body": 3, "word": "showed", "fig": 2}, {"body": 6, "word": "analysis", "fig": 1}, {"body": 6, "word": "TGF\u03b21-induced", "fig": 1}, {"body": 4, "word": "flow", "fig": 1}, {"body": 3, "word": "Ly6Clow", "fig": 1}, {"body": 3, "word": "fluid", "fig": 1}, {"body": 3, "word": "lavage", "fig": 1}, {"body": 1, "word": "high", "fig": 2}, {"body": 2, "word": "bronchoalveolar", "fig": 1}, {"body": 2, "word": "controls", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "Multicolor", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307226/bin/12931_2014_162_Fig3_HTML.jpg", "caption": "Effect of TGF\u03b21 on lung apoptotic cell death. (A) TdT-mediated dUTP nick end labeling (TUNEL) was assessed in NB TGF\u03b21TG and TGF\u03b21TG X TGF\u03b2R2KO littermates where maternal dox exposure from PN7 \u2013 PN10 was carried out. Scale bar: 50 \u03bcm (B) Bar graph showing the percentage of TUNEL positive cells indicating the apoptosis quantification in TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO littermates. (C) Representative serial sectioning images of cleaved caspase 3 and surfactant protein C staining in the lung specimens of TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO littermates. Scale bar: 50 \u03bcm.", "co_occurrence": [{"body": 41, "word": "TGF\u03b21TG", "fig": 6}, {"body": 60, "word": "mice", "fig": 2}, {"body": 50, "word": "lung", "fig": 2}, {"body": 24, "word": "TGF\u03b2R2KO", "fig": 3}, {"body": 16, "word": "X", "fig": 3}, {"body": 34, "word": "TGF\u03b21", "fig": 1}, {"body": 23, "word": "cell", "fig": 1}, {"body": 17, "word": "exposure", "fig": 1}, {"body": 16, "word": "NB", "fig": 1}, {"body": 14, "word": "cells", "fig": 1}, {"body": 12, "word": "death", "fig": 1}, {"body": 6, "word": "TUNEL", "fig": 2}, {"body": 5, "word": "C", "fig": 2}, {"body": 8, "word": "PN7", "fig": 1}, {"body": 8, "word": "caspase", "fig": 1}, {"body": 7, "word": "apoptosis", "fig": 1}, {"body": 6, "word": "cleaved", "fig": 1}, {"body": 6, "word": "protein", "fig": 1}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "Effect", "fig": 1}, {"body": 5, "word": "apoptotic", "fig": 1}, {"body": 5, "word": "dox", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 4, "word": "PN10", "fig": 1}, {"body": 1, "word": "littermates", "fig": 3}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "assessed", "fig": 1}, {"body": 2, "word": "end", "fig": 1}, {"body": 1, "word": "serial", "fig": 1}, {"body": 1, "word": "nick", "fig": 1}, {"body": 1, "word": "TdT-mediated", "fig": 1}, {"body": 1, "word": "percentage", "fig": 1}, {"body": 1, "word": "maternal", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "surfactant", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}, {"body": 1, "word": "labeling", "fig": 1}, {"body": 1, "word": "dUTP", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307226/bin/12931_2014_162_Fig4_HTML.jpg", "caption": "Effect of TGF\u03b21 on lung morphometry. (A) Representative images of lung histology (H&E stain) of NB TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO mice. Scale bar: 100 \u03bcm (B) Bar graph showing the mean chord length in TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO mice. (C) Bar graph showing the septal thickness in TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO mice. (D) Bar graph showing the radial alveolar count in TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO mice. (E) Bar graph showing the secondary septal crest numbers in TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO mice. (F) Representative images of lung immunohistochemistry of vessel density (vWF staining) of NB TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO mice. Scale bar: 100 \u03bcm (G) Bar graph showing quantification of vessel density in TGF\u03b21TG mice and TGF\u03b21TG X TGF\u03b2R2KO mice. N = 4, in each group; *p < 0.05, **p < 0.01.", "co_occurrence": [{"body": 60, "word": "mice", "fig": 14}, {"body": 41, "word": "TGF\u03b21TG", "fig": 14}, {"body": 24, "word": "TGF\u03b2R2KO", "fig": 7}, {"body": 50, "word": "lung", "fig": 3}, {"body": 16, "word": "X", "fig": 7}, {"body": 34, "word": "TGF\u03b21", "fig": 1}, {"body": 16, "word": "NB", "fig": 2}, {"body": 9, "word": "septal", "fig": 2}, {"body": 7, "word": "alveolar", "fig": 1}, {"body": 7, "word": "thickness", "fig": 1}, {"body": 3, "word": "vessel", "fig": 2}, {"body": 3, "word": "images", "fig": 2}, {"body": 6, "word": "secondary", "fig": 1}, {"body": 3, "word": "density", "fig": 2}, {"body": 6, "word": "length", "fig": 1}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "chord", "fig": 1}, {"body": 5, "word": "Effect", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 1, "word": "showing", "fig": 5}, {"body": 2, "word": "E", "fig": 2}, {"body": 3, "word": "numbers", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 2, "word": "vWF", "fig": 1}, {"body": 2, "word": "crest", "fig": 1}, {"body": 2, "word": "morphometry", "fig": 1}, {"body": 1, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "count", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307226/bin/12931_2014_162_Fig5_HTML.jpg", "caption": "TGF\u03b21 signaling in NB TGF\u03b21TG, and TGF\u03b21TG X TGF\u03b2R2KO mice lungs. (A) Western blot analysis showed upregulation of phospho AKT, and down regulation of ANGPT2, and pro-apoptotic proteins (BAX; cleaved caspase 3) in NB TGF\u03b21TG X TGF\u03b2R2KO lungs as compared to TGF\u03b21TG mice. (B) Densitometric analysis showed increased ANGPT1 to ANGPT2 ratio in maternal dox exposed NB TGF\u03b21TG X TGF\u03b2R2KO lungs as compared to TGF\u03b2TG mice. N = 3, in each group; *p < 0.05.", "co_occurrence": [{"body": 41, "word": "TGF\u03b21TG", "fig": 5}, {"body": 60, "word": "mice", "fig": 3}, {"body": 32, "word": "lungs", "fig": 3}, {"body": 24, "word": "TGF\u03b2R2KO", "fig": 3}, {"body": 16, "word": "NB", "fig": 3}, {"body": 16, "word": "X", "fig": 3}, {"body": 34, "word": "TGF\u03b21", "fig": 1}, {"body": 29, "word": "signaling", "fig": 1}, {"body": 13, "word": "compared", "fig": 2}, {"body": 21, "word": "increased", "fig": 1}, {"body": 10, "word": "ANGPT2", "fig": 2}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 8, "word": "caspase", "fig": 1}, {"body": 6, "word": "cleaved", "fig": 1}, {"body": 3, "word": "showed", "fig": 2}, {"body": 5, "word": "exposed", "fig": 1}, {"body": 5, "word": "AKT", "fig": 1}, {"body": 5, "word": "ANGPT1", "fig": 1}, {"body": 5, "word": "dox", "fig": 1}, {"body": 4, "word": "BAX", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "ratio", "fig": 1}, {"body": 2, "word": "TGF\u03b2TG", "fig": 1}, {"body": 2, "word": "proteins", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "regulation", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "maternal", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "Densitometric", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307226/bin/12931_2014_162_Fig6_HTML.jpg", "caption": "TGF\u03b2R2KO mice have improved lung morphometry in hyperoxia settings. (A) Representative images of lung histology (H&E stain) of NB TGF\u03b2R2KO mice exposed to RA or 100% O2 from PN1 \u2013 PN7 with appropriate controls. Scale bar: 100 \u03bcm (B) Bar graph showing morphometric analysis of mean chord length in hyperoxia exposed PN7 TGF\u03b2R2KO mice as compared to room air controls. (C) Bar graph showing morphometric analysis of septal thickness in hyperoxia exposed PN7 TGF\u03b2R2KO mice as compared to room air controls. (D) Representative images of immunohistochemistry of myeloperoxidase (MPO) staining showing of inflammatory cells (neutrophils) in the lungs NB TGF\u03b2R2KO mice exposed to RA or 100% O2 from PN1 \u2013 PN7 with appropriate controls. Scale bar: 100 \u03bcm (E) Bar graph showing MPO levels (measured by ELISA) in hyperoxia exposed PN7 TGF\u03b2R2KO mice as compared to room air controls. N = 4 in each group; *p < 0.05, ***p < 0.001.", "co_occurrence": [{"body": 60, "word": "mice", "fig": 6}, {"body": 24, "word": "TGF\u03b2R2KO", "fig": 6}, {"body": 50, "word": "lung", "fig": 2}, {"body": 22, "word": "hyperoxia", "fig": 4}, {"body": 8, "word": "PN7", "fig": 5}, {"body": 13, "word": "compared", "fig": 3}, {"body": 11, "word": "room", "fig": 3}, {"body": 11, "word": "air", "fig": 3}, {"body": 16, "word": "NB", "fig": 2}, {"body": 32, "word": "lungs", "fig": 1}, {"body": 5, "word": "exposed", "fig": 5}, {"body": 14, "word": "cells", "fig": 1}, {"body": 6, "word": "PN1", "fig": 2}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 5, "word": "O2", "fig": 2}, {"body": 2, "word": "controls", "fig": 5}, {"body": 9, "word": "septal", "fig": 1}, {"body": 8, "word": "levels", "fig": 1}, {"body": 7, "word": "thickness", "fig": 1}, {"body": 7, "word": "inflammatory", "fig": 1}, {"body": 3, "word": "images", "fig": 2}, {"body": 6, "word": "length", "fig": 1}, {"body": 3, "word": "MPO", "fig": 2}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "chord", "fig": 1}, {"body": 2, "word": "E", "fig": 2}, {"body": 1, "word": "showing", "fig": 4}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "improved", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 2, "word": "ELISA", "fig": 1}, {"body": 1, "word": "RA", "fig": 2}, {"body": 2, "word": "morphometry", "fig": 1}, {"body": 1, "word": "morphometric", "fig": 2}, {"body": 1, "word": "appropriate", "fig": 2}, {"body": 1, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "settings", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "neutrophils", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307226/bin/12931_2014_162_Fig7_HTML.jpg", "caption": "Proposed schema of the mechanism of TGF\u03b21-induced TGF\u03b2R2-mediated effects in the developing lung. A proposed model illustrating the mechanism of TGF\u03b21-induced specific molecular mediators resulting in decreased inflammation, apoptosis and mortality in NB TGF\u03b21TG X TGF\u03b2R2KO, as compared to TGF\u03b21TG mice.", "co_occurrence": [{"body": 41, "word": "TGF\u03b21TG", "fig": 2}, {"body": 60, "word": "mice", "fig": 1}, {"body": 50, "word": "lung", "fig": 1}, {"body": 24, "word": "TGF\u03b2R2KO", "fig": 1}, {"body": 16, "word": "NB", "fig": 1}, {"body": 16, "word": "X", "fig": 1}, {"body": 14, "word": "developing", "fig": 1}, {"body": 13, "word": "compared", "fig": 1}, {"body": 13, "word": "decreased", "fig": 1}, {"body": 13, "word": "effects", "fig": 1}, {"body": 13, "word": "specific", "fig": 1}, {"body": 12, "word": "inflammation", "fig": 1}, {"body": 6, "word": "TGF\u03b21-induced", "fig": 2}, {"body": 7, "word": "mediators", "fig": 1}, {"body": 7, "word": "molecular", "fig": 1}, {"body": 7, "word": "apoptosis", "fig": 1}, {"body": 6, "word": "mortality", "fig": 1}, {"body": 5, "word": "model", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "mechanism", "fig": 2}, {"body": 1, "word": "proposed", "fig": 1}, {"body": 1, "word": "TGF\u03b2R2-mediated", "fig": 1}, {"body": 1, "word": "resulting", "fig": 1}]}], "3276580": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g001.jpg", "caption": "Comparison of ALK and LTK structure and sequence. (A) Schematic of ALK and LTK. ALK and LTK are RTKs, each containing an extracellular domain, a transmembrane domain (TMD, purple), and an intraceullar kinase domain (KD, green). ALK is a 1620 amino acid protein containing two MAM domains (blue) and an LDLa motif in its extracellular region. LTK is composed of 864 amino acids and has a much smaller extracellular domain that lacks these structures. The positions of the F1174L and R1275Q mutations of ALK and the corresponding mutations in LTK, F568L and R669Q, are indicated. (B) Alignment of ALK and LTK kinase domains. ALK and LTK proteins share 80% sequence identity in their kinase domains. Identical residues are indicated by an asterisk (*). Position of the F\u2192L and R\u2192Q residues of interest are shown in bold designated by arrows. Boundaries of the kinase domains were determined using the Simple Modular Architecture Research Tool, http://smart.embl-heidelberg.de/and the alignment was done using BLAST.", "co_occurrence": [{"body": 161, "word": "LTK", "fig": 7}, {"body": 58, "word": "ALK", "fig": 7}, {"body": 27, "word": "domain", "fig": 4}, {"body": 27, "word": "kinase", "fig": 4}, {"body": 36, "word": "mutations", "fig": 2}, {"body": 8, "word": "domains", "fig": 4}, {"body": 28, "word": "proteins", "fig": 1}, {"body": 27, "word": "protein", "fig": 1}, {"body": 10, "word": "residues", "fig": 2}, {"body": 20, "word": "The", "fig": 1}, {"body": 6, "word": "extracellular", "fig": 3}, {"body": 7, "word": "containing", "fig": 2}, {"body": 12, "word": "F568L", "fig": 1}, {"body": 12, "word": "R669Q", "fig": 1}, {"body": 11, "word": "two", "fig": 1}, {"body": 9, "word": "shown", "fig": 1}, {"body": 4, "word": "using", "fig": 2}, {"body": 4, "word": "sequence", "fig": 2}, {"body": 7, "word": "determined", "fig": 1}, {"body": 6, "word": "region", "fig": 1}, {"body": 5, "word": "R1275Q", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "motif", "fig": 1}, {"body": 2, "word": "amino", "fig": 2}, {"body": 4, "word": "RTKs", "fig": 1}, {"body": 4, "word": "corresponding", "fig": 1}, {"body": 4, "word": "transmembrane", "fig": 1}, {"body": 3, "word": "MAM", "fig": 1}, {"body": 3, "word": "acid", "fig": 1}, {"body": 3, "word": "blue", "fig": 1}, {"body": 3, "word": "much", "fig": 1}, {"body": 3, "word": "F1174L", "fig": 1}, {"body": 3, "word": "identity", "fig": 1}, {"body": 2, "word": "interest", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "LDLa", "fig": 1}, {"body": 1, "word": "composed", "fig": 1}, {"body": 1, "word": "structure", "fig": 1}, {"body": 1, "word": "share", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g002.jpg", "caption": "Expression of LTK constructs in 293T cells. (A) Relative protein expression of wildtype and mutant LTK constructs in 293T cells. Lysates of 293T cells transiently expressing either HA-tagged vector control (v, lane 1), wildtype LTK (wt, lane 2), LTK-R669Q (RQ, lane 3), or LTK-F568L (FL, lane 4) were immunoblotted with an anti-HA antibody as well as HSP90 as a loading control. (B) 293T cell lysates containing the LTK proteins were treated with PNGase F (lanes 3, 5, and 7) or left untreated (lanes 2, 4, and 6) and immunoblotted with HA antibodies and HSP90 as a loading control. (C) HA-tagged LTK proteins expressed in 293T cells were immunoprecipitated and immunoblotted with HA antibodies as well as anti-phosphotyrosine (pTyr) antibodies (top). Antibodies that recognize the indicated proteins (Shc, pShC-Y239/Y240, ERK, pERK-T202/Y204, JAK1, pJAK1-Y1022/Y1023, JAK2, pJAK2-Y1007/Y1008, AKT, and pAKT-S473) were used to immunoblot cell lysates of 293T cells expressing LTK proteins (bottom). The phosphorylated form of the protein is designated with a \u201cp\u201d preceding the protein name.", "co_occurrence": [{"body": 161, "word": "LTK", "fig": 6}, {"body": 147, "word": "cells", "fig": 5}, {"body": 28, "word": "proteins", "fig": 4}, {"body": 42, "word": "cell", "fig": 2}, {"body": 27, "word": "protein", "fig": 3}, {"body": 33, "word": "wildtype", "fig": 2}, {"body": 56, "word": "LTK-F568L", "fig": 1}, {"body": 9, "word": "293T", "fig": 6}, {"body": 26, "word": "expressing", "fig": 2}, {"body": 34, "word": "LTK-R669Q", "fig": 1}, {"body": 27, "word": "expression", "fig": 1}, {"body": 20, "word": "The", "fig": 1}, {"body": 10, "word": "well", "fig": 2}, {"body": 6, "word": "control", "fig": 3}, {"body": 17, "word": "mutant", "fig": 1}, {"body": 15, "word": "Shc", "fig": 1}, {"body": 14, "word": "AKT", "fig": 1}, {"body": 3, "word": "lane", "fig": 4}, {"body": 11, "word": "expressed", "fig": 1}, {"body": 11, "word": "ERK", "fig": 1}, {"body": 10, "word": "phosphorylated", "fig": 1}, {"body": 9, "word": "JAK1", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 3}, {"body": 8, "word": "either", "fig": 1}, {"body": 7, "word": "vector", "fig": 1}, {"body": 7, "word": "JAK2", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "containing", "fig": 1}, {"body": 3, "word": "HA-tagged", "fig": 2}, {"body": 5, "word": "form", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 4, "word": "used", "fig": 1}, {"body": 3, "word": "PNGase", "fig": 1}, {"body": 3, "word": "top", "fig": 1}, {"body": 3, "word": "F", "fig": 1}, {"body": 1, "word": "HA", "fig": 2}, {"body": 1, "word": "lysates", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "transiently", "fig": 1}, {"body": 1, "word": "immunoblot", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g003.jpg", "caption": "LTK-F568L transforms BaF3 cells to cytokine-independence. (A) BaF3 cells stably expressing LTK-F568L (red inverted triangles), LTK-R669Q (green triangles), or wildtype LTK (blue squares) and parental control cells (black circles) were cultured in the absence of IL-3 at Day 0. The total number of viable cells was determined at each timepoint by trypan blue exclusion. Similar results were obtained in three independent experiments. The dashed line indicates cell numbers going below the detection of the hemacytometer towards zero. (B) Lysates from cells stably expressing either HA-tagged vector control (v, lane 1), wildtype LTK (wt, lane 2), LTK-R669Q (RQ, lane 3), or LTK-F568L (FL, lane 4) were cultured in the absence of IL-3 for six hours and immunoprecipitated with HA antibodies, followed by immunoblotting with HA and pTyr antibodies (first two blots). The same lysates were immunoblotted with antibodies to the indicated cell signaling proteins (see Figure 2 legend plus pShc-Y317, STAT3, pSTAT3-Y705, STAT5 and pSTAT5-Y694). Cell lysate from IL-3-independent LTK-F568L-expressing BaF3 cells was also analyzed (lane 5).", "co_occurrence": [{"body": 147, "word": "cells", "fig": 6}, {"body": 161, "word": "LTK", "fig": 2}, {"body": 56, "word": "LTK-F568L", "fig": 3}, {"body": 42, "word": "cell", "fig": 2}, {"body": 34, "word": "LTK-R669Q", "fig": 2}, {"body": 33, "word": "wildtype", "fig": 2}, {"body": 20, "word": "The", "fig": 3}, {"body": 18, "word": "BaF3", "fig": 3}, {"body": 26, "word": "expressing", "fig": 2}, {"body": 52, "word": "Figure", "fig": 1}, {"body": 34, "word": "signaling", "fig": 1}, {"body": 14, "word": "IL-3", "fig": 2}, {"body": 28, "word": "proteins", "fig": 1}, {"body": 3, "word": "lane", "fig": 5}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "control", "fig": 2}, {"body": 11, "word": "two", "fig": 1}, {"body": 11, "word": "STAT5", "fig": 1}, {"body": 10, "word": "STAT3", "fig": 1}, {"body": 5, "word": "cultured", "fig": 2}, {"body": 3, "word": "antibodies", "fig": 3}, {"body": 4, "word": "stably", "fig": 2}, {"body": 4, "word": "absence", "fig": 2}, {"body": 8, "word": "either", "fig": 1}, {"body": 7, "word": "vector", "fig": 1}, {"body": 7, "word": "analyzed", "fig": 1}, {"body": 7, "word": "first", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 7, "word": "independent", "fig": 1}, {"body": 3, "word": "blue", "fig": 2}, {"body": 5, "word": "Day", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 4, "word": "six", "fig": 1}, {"body": 3, "word": "exclusion", "fig": 1}, {"body": 3, "word": "HA-tagged", "fig": 1}, {"body": 3, "word": "parental", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "trypan", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "Similar", "fig": 1}, {"body": 1, "word": "HA", "fig": 2}, {"body": 2, "word": "hours", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "IL-3-independent", "fig": 1}, {"body": 1, "word": "LTK-F568L-expressing", "fig": 1}, {"body": 1, "word": "transforms", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "see", "fig": 1}, {"body": 1, "word": "indicates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g004.jpg", "caption": "LTK-F568L transforms 32D cells to cytokine-independence. (A) 32D cells stably expressing LTK-F568L (red inverted triangles), LTK-R669Q (green triangles), or wildtype LTK (blue squares) and parental control cells (black circles) were cultured in the absence of IL-3 at Day 0. The total number of viable cells was determined at each timepoint by trypan blue exclusion. Similar results were obtained in three independent experiments. The dashed line indicates cell numbers going below the detection of the hemacytometer towards zero. (B) Lysates from cells stably expressing either HA-tagged vector control (v, lane 1), wildtype LTK (wt, lane 2), LTK-R669Q (RQ, lane 3), or LTK-F568L (FL, lane 4) were cultured in the absence of IL-3 for six hours and immunoprecipitated with HA antibodies, followed by immunoblotting with HA and pTyr antibodies (first two blots). The same lysates were immunoblotted with antibodies to the indicated cell signaling proteins (See Figure 3 legend). Cell lysate from IL-3-independent LTK-F568L-expressing 32D cells was also analyzed (lane 5).", "co_occurrence": [{"body": 147, "word": "cells", "fig": 6}, {"body": 161, "word": "LTK", "fig": 2}, {"body": 56, "word": "LTK-F568L", "fig": 3}, {"body": 42, "word": "cell", "fig": 2}, {"body": 34, "word": "LTK-R669Q", "fig": 2}, {"body": 33, "word": "wildtype", "fig": 2}, {"body": 20, "word": "The", "fig": 3}, {"body": 26, "word": "expressing", "fig": 2}, {"body": 52, "word": "Figure", "fig": 1}, {"body": 13, "word": "32D", "fig": 3}, {"body": 34, "word": "signaling", "fig": 1}, {"body": 14, "word": "IL-3", "fig": 2}, {"body": 28, "word": "proteins", "fig": 1}, {"body": 3, "word": "lane", "fig": 5}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "control", "fig": 2}, {"body": 11, "word": "two", "fig": 1}, {"body": 5, "word": "cultured", "fig": 2}, {"body": 3, "word": "antibodies", "fig": 3}, {"body": 4, "word": "stably", "fig": 2}, {"body": 4, "word": "absence", "fig": 2}, {"body": 8, "word": "either", "fig": 1}, {"body": 7, "word": "vector", "fig": 1}, {"body": 7, "word": "analyzed", "fig": 1}, {"body": 7, "word": "first", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 7, "word": "independent", "fig": 1}, {"body": 3, "word": "blue", "fig": 2}, {"body": 5, "word": "Day", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 4, "word": "six", "fig": 1}, {"body": 3, "word": "exclusion", "fig": 1}, {"body": 3, "word": "HA-tagged", "fig": 1}, {"body": 3, "word": "parental", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "trypan", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "Similar", "fig": 1}, {"body": 1, "word": "HA", "fig": 2}, {"body": 2, "word": "hours", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "IL-3-independent", "fig": 1}, {"body": 1, "word": "LTK-F568L-expressing", "fig": 1}, {"body": 1, "word": "transforms", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "indicates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g005.jpg", "caption": "Transformation of BaF3 cells by LTK-F568L requires JAK family kinase activity. (A) BaF3 cells transformed to cytokine independence by LTK-F568L were cultured in the presence of 0.5 \u00b5M (green squares) or 1 \u00b5M (blue triangles) JAK Inhibitor I (JI) or 0.1% DMSO (red circles) on Day 0. The total number of viable cells was determined by trypan blue exclusion. Dashed lines indicate viable cell counts going below the limit of detection of the hemacytometer towards zero. Similar results were obtained in two independent experiments. (B) IL-3-independent LTK-F568L BaF3 cells were treated with 1 \u00b5M (lane 2) JI or DMSO (lane 1) for three hours and immunoblotted for the indicated proteins (See Figure 3 legend). Phosphotyrosine (pTyr) on LTK-F568L was detected by immunoblotting following immunoprecipitating LTK-F568L with HA antibodies.", "co_occurrence": [{"body": 147, "word": "cells", "fig": 4}, {"body": 56, "word": "LTK-F568L", "fig": 5}, {"body": 18, "word": "BaF3", "fig": 3}, {"body": 52, "word": "Figure", "fig": 1}, {"body": 42, "word": "cell", "fig": 1}, {"body": 11, "word": "\u00b5M", "fig": 3}, {"body": 14, "word": "JAK", "fig": 2}, {"body": 28, "word": "proteins", "fig": 1}, {"body": 27, "word": "kinase", "fig": 1}, {"body": 20, "word": "The", "fig": 1}, {"body": 11, "word": "two", "fig": 1}, {"body": 10, "word": "transformed", "fig": 1}, {"body": 10, "word": "activity", "fig": 1}, {"body": 8, "word": "lines", "fig": 1}, {"body": 7, "word": "independence", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "independent", "fig": 1}, {"body": 7, "word": "cytokine", "fig": 1}, {"body": 3, "word": "blue", "fig": 2}, {"body": 3, "word": "lane", "fig": 2}, {"body": 5, "word": "Day", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "cultured", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "following", "fig": 1}, {"body": 4, "word": "I", "fig": 1}, {"body": 2, "word": "DMSO", "fig": 2}, {"body": 3, "word": "exclusion", "fig": 1}, {"body": 3, "word": "detected", "fig": 1}, {"body": 3, "word": "family", "fig": 1}, {"body": 3, "word": "presence", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 3, "word": "Inhibitor", "fig": 1}, {"body": 3, "word": "trypan", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "Similar", "fig": 1}, {"body": 2, "word": "hours", "fig": 1}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "IL-3-independent", "fig": 1}, {"body": 1, "word": "immunoprecipitating", "fig": 1}, {"body": 1, "word": "HA", "fig": 1}, {"body": 1, "word": "Transformation", "fig": 1}, {"body": 1, "word": "counts", "fig": 1}, {"body": 1, "word": "requires", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g006.jpg", "caption": "Transformed LTK-F568L BaF3 cells are sensitive to the ALK inhibitor PF-2341066. (A) BaF3 cells transformed to cytokine independence by LTK-F568L were left untreated (0.1% DMSO, black circles) or cultured in the presence of 0.5 \u00b5M (blue squares), 1 \u00b5M (green triangles), or 2 \u00b5M (red inverted triangles) of the cMET/ALK inhibitor PF2341066 (PF) on Day 0. The total number of viable cells for each treatment was determined daily by trypan blue exclusion. (B) IL-3-dependent (+IL-3) BaF3 cells harboring ALK-F1174L were cultured without (black circles) or with (blue squares) 0.5 \u00b5M PF2341066. BaF3 cells transformed to IL-3-independence by ALK-F1174L were cultured without (green triangles) or with (red inverted triangles) 0.5 \u00b5M PF2341066. The total number of viable cells for each treatment was determined daily by trypan blue exclusion. (C) Parental BaF3 cells were cultured without (black circles) or with (blue squares) 0.5 \u00b5M PF2341066. BaF3 cells expressing wildtype LTK were cultured without (green triangles) or with (red inverted triangles) 0.5 \u00b5M PF2341066. The total number of viable cells for each treatment was determined daily by trypan blue exclusion. (D) IL-3-dependent BaF3 cells expressing LTK-F568L were cultured without (black inverted triangles) or with (blue circles) 0.5 \u00b5M PF2341066. BaF3 cells transformed to IL-3 independence by LTK-F568L were cultured without (green squares) or with (red diamonds) 0.5 \u00b5M PF2341066. The total number of viable cells for each treatment was determined daily by trypan blue exclusion. In (A) thru (D), the dashed lines indicate viable cell counts going below the limit of detection of the hemacytometer towards zero. For each of the experiments in (A) thru (D), similar results were obtained in each independent (at least two) experiment performed. (E) IL-3-independent BaF3 LTK-F568L-expressing cells were treated with 1 \u00b5M PF-2341066 (lane 2) or DMSO (lane 1) for 2 hours. Cell lysates were collected and immunoprecipitated and/or immunoblotted, as indicated (see Figure 3 legend).", "co_occurrence": [{"body": 147, "word": "cells", "fig": 13}, {"body": 56, "word": "LTK-F568L", "fig": 4}, {"body": 18, "word": "BaF3", "fig": 9}, {"body": 161, "word": "LTK", "fig": 1}, {"body": 11, "word": "\u00b5M", "fig": 10}, {"body": 20, "word": "The", "fig": 4}, {"body": 58, "word": "ALK", "fig": 1}, {"body": 26, "word": "expressing", "fig": 2}, {"body": 52, "word": "Figure", "fig": 1}, {"body": 42, "word": "cell", "fig": 1}, {"body": 20, "word": "inhibitor", "fig": 2}, {"body": 5, "word": "cultured", "fig": 7}, {"body": 33, "word": "wildtype", "fig": 1}, {"body": 10, "word": "transformed", "fig": 3}, {"body": 7, "word": "determined", "fig": 4}, {"body": 25, "word": "In", "fig": 1}, {"body": 6, "word": "treatment", "fig": 4}, {"body": 3, "word": "blue", "fig": 8}, {"body": 12, "word": "PF-2341066", "fig": 2}, {"body": 5, "word": "A", "fig": 3}, {"body": 14, "word": "IL-3", "fig": 1}, {"body": 7, "word": "independence", "fig": 2}, {"body": 3, "word": "exclusion", "fig": 4}, {"body": 3, "word": "number", "fig": 4}, {"body": 3, "word": "trypan", "fig": 4}, {"body": 11, "word": "two", "fig": 1}, {"body": 8, "word": "similar", "fig": 1}, {"body": 4, "word": "ALK-F1174L", "fig": 2}, {"body": 8, "word": "lines", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "independent", "fig": 1}, {"body": 7, "word": "cytokine", "fig": 1}, {"body": 3, "word": "lane", "fig": 2}, {"body": 5, "word": "Day", "fig": 1}, {"body": 5, "word": "For", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 2, "word": "DMSO", "fig": 2}, {"body": 1, "word": "D", "fig": 3}, {"body": 3, "word": "IL-3-independence", "fig": 1}, {"body": 3, "word": "presence", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "harboring", "fig": 1}, {"body": 2, "word": "hours", "fig": 1}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "IL-3-independent", "fig": 1}, {"body": 2, "word": "cMET/ALK", "fig": 1}, {"body": 1, "word": "LTK-F568L-expressing", "fig": 1}, {"body": 1, "word": "and/or", "fig": 1}, {"body": 1, "word": "experiment", "fig": 1}, {"body": 1, "word": "sensitive", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "counts", "fig": 1}, {"body": 1, "word": "see", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g007.jpg", "caption": "LTK-F568L and LTK-R669Q transform epithelial cells. (A) Cell lysates from RIE cells stably expressing either empty vector (v, lane 1), wildtype LTK (wt, lane 2), LTK-R669Q (RQ, lane 3), or LTK-F568L (FL, lane 4) were analyzed by immunoprecipitation and immunoblotting, as indicated (see Figure 3 legend). (B) RIE cells stably expressing either wildtype LTK (wt), LTK-F568L (F568L), or LTK-R669Q (R669Q) were plated and reached confluency after six days. Cells were cultured further and growth was grossly assessed for the loss of contact inhibition. Cells expressing wildtype LTK did not grow beyond confluency, continuing to exhibit contact inhibition. However, cells expressing LTK-F568L continued to proliferate, forming swirling patterns of cells growing on top of the monolayer. Cells expressing LTK-R669Q formed distinct secondary morphological structures as these cells formed compact clusters of cells that grew on top of the monolayer of cells. Representative photographs of cells are shown: plates were stained with crystal violet (top row) after photographs were taken at 10\u00d7 with a digital camera (middle) and 50\u00d7 with a Zeiss Automated Fluorescent Microscope using AxioVision (bottom row). Results shown are representative of similar findings of three independent experiments.", "co_occurrence": [{"body": 147, "word": "cells", "fig": 9}, {"body": 161, "word": "LTK", "fig": 3}, {"body": 56, "word": "LTK-F568L", "fig": 4}, {"body": 34, "word": "LTK-R669Q", "fig": 4}, {"body": 26, "word": "expressing", "fig": 5}, {"body": 33, "word": "wildtype", "fig": 3}, {"body": 52, "word": "Figure", "fig": 1}, {"body": 29, "word": "growth", "fig": 1}, {"body": 9, "word": "RIE", "fig": 2}, {"body": 9, "word": "shown", "fig": 2}, {"body": 8, "word": "either", "fig": 2}, {"body": 6, "word": "inhibition", "fig": 2}, {"body": 12, "word": "F568L", "fig": 1}, {"body": 12, "word": "R669Q", "fig": 1}, {"body": 3, "word": "lane", "fig": 4}, {"body": 6, "word": "contact", "fig": 2}, {"body": 10, "word": "days", "fig": 1}, {"body": 10, "word": "plated", "fig": 1}, {"body": 3, "word": "top", "fig": 3}, {"body": 4, "word": "stably", "fig": 2}, {"body": 8, "word": "similar", "fig": 1}, {"body": 8, "word": "epithelial", "fig": 1}, {"body": 7, "word": "vector", "fig": 1}, {"body": 7, "word": "analyzed", "fig": 1}, {"body": 7, "word": "independent", "fig": 1}, {"body": 2, "word": "Cells", "fig": 3}, {"body": 6, "word": "However", "fig": 1}, {"body": 3, "word": "formed", "fig": 2}, {"body": 5, "word": "exhibit", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "transform", "fig": 1}, {"body": 5, "word": "cultured", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "using", "fig": 1}, {"body": 4, "word": "findings", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 4, "word": "six", "fig": 1}, {"body": 3, "word": "loss", "fig": 1}, {"body": 3, "word": "distinct", "fig": 1}, {"body": 3, "word": "empty", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 1, "word": "monolayer", "fig": 2}, {"body": 2, "word": "violet", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "forming", "fig": 1}, {"body": 2, "word": "crystal", "fig": 1}, {"body": 1, "word": "confluency", "fig": 2}, {"body": 1, "word": "compact", "fig": 1}, {"body": 1, "word": "clusters", "fig": 1}, {"body": 1, "word": "continued", "fig": 1}, {"body": 1, "word": "secondary", "fig": 1}, {"body": 1, "word": "swirling", "fig": 1}, {"body": 1, "word": "see", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}, {"body": 1, "word": "reached", "fig": 1}, {"body": 1, "word": "grew", "fig": 1}, {"body": 1, "word": "immunoprecipitation", "fig": 1}, {"body": 1, "word": "plates", "fig": 1}, {"body": 1, "word": "proliferate", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}, {"body": 1, "word": "grow", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g008.jpg", "caption": "LTK-F568L and LTK-R669Q induce anchorage independent growth, which is inhibited by PF-2341066. (A) RIE cells stably expressing either wildtype LTK, LTK-F568L, or LTK-R669Q were plated in soft agar and assessed for anchorage-independent growth. LTK-F568L-expressing cells formed large colonies in soft agar while LTK-R669Q-expressing cells formed fewer colonies which were also significantly smaller. Including PF2341066 (PF) in the medium inhibited anchorage independent growth in soft agar. Photographs show representative fields after two weeks of culture. Results shown for are representative of similar findings of three independent experiments. (B) Quantitation of anchorage independent growth of RIE cells expressing wildtype LTK, LTK-F568L, and LTK-R669Q fourteen days after plating in the absence (blue bars) and presence of 0.5 \u00b5M (green bars) or 1.0 \u00b5M (black bars) PF2341066 (PF). (C) Quantitation of anchorage independent growth of RIE cells expressing wildtype LTK, LTK-F568L, and LTK-R669Q fourteen days after plating in the absence (blue bars) and presence of 0.5 \u00b5M (yellow bars) or 1 \u00b5M JAK Inhibitor (red bars). Data represents average colonies per field view per plate. Error bars represent standard error of the mean from two or three independent experiments performed in duplicate.", "co_occurrence": [{"body": 147, "word": "cells", "fig": 5}, {"body": 161, "word": "LTK", "fig": 3}, {"body": 56, "word": "LTK-F568L", "fig": 4}, {"body": 29, "word": "growth", "fig": 5}, {"body": 34, "word": "LTK-R669Q", "fig": 4}, {"body": 33, "word": "wildtype", "fig": 3}, {"body": 26, "word": "expressing", "fig": 3}, {"body": 11, "word": "\u00b5M", "fig": 4}, {"body": 7, "word": "independent", "fig": 6}, {"body": 9, "word": "RIE", "fig": 3}, {"body": 9, "word": "agar", "fig": 3}, {"body": 6, "word": "anchorage", "fig": 4}, {"body": 8, "word": "colonies", "fig": 3}, {"body": 11, "word": "two", "fig": 2}, {"body": 7, "word": "soft", "fig": 3}, {"body": 10, "word": "days", "fig": 2}, {"body": 14, "word": "JAK", "fig": 1}, {"body": 13, "word": "also", "fig": 1}, {"body": 12, "word": "PF-2341066", "fig": 1}, {"body": 5, "word": "per", "fig": 2}, {"body": 5, "word": "three", "fig": 2}, {"body": 10, "word": "plated", "fig": 1}, {"body": 9, "word": "shown", "fig": 1}, {"body": 4, "word": "absence", "fig": 2}, {"body": 8, "word": "induce", "fig": 1}, {"body": 8, "word": "either", "fig": 1}, {"body": 8, "word": "similar", "fig": 1}, {"body": 4, "word": "inhibited", "fig": 2}, {"body": 3, "word": "blue", "fig": 2}, {"body": 3, "word": "presence", "fig": 2}, {"body": 3, "word": "formed", "fig": 2}, {"body": 3, "word": "plating", "fig": 2}, {"body": 5, "word": "medium", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 2, "word": "experiments", "fig": 2}, {"body": 4, "word": "stably", "fig": 1}, {"body": 4, "word": "plate", "fig": 1}, {"body": 4, "word": "findings", "fig": 1}, {"body": 4, "word": "LTK-R669Q-expressing", "fig": 1}, {"body": 3, "word": "significantly", "fig": 1}, {"body": 3, "word": "Inhibitor", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 2, "word": "field", "fig": 1}, {"body": 2, "word": "large", "fig": 1}, {"body": 2, "word": "view", "fig": 1}, {"body": 2, "word": "duplicate", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "LTK-F568L-expressing", "fig": 1}, {"body": 1, "word": "weeks", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276580/bin/pone.0031733.g009.jpg", "caption": "LTK-F568L and LTK-R669Q induce PC12 cell neurite outgrowth. (A) PC12 cells were co-transfected with GFP and either vector, wildtype LTK, LTK-R669Q, or LTK-F568L. Cells were observed for neurite outgrowth. PC12 cells treated with 1 uM NGF are shown as control for neurite extensions. Photographs of representative cells were taken four days after transfection. Arrows indicate neurite outgrowth. Two photographs for both LTK-F568L and LTK-R669Q are shown. (B) GFP-positive PC12 cells transiently expressing either vector control (v, red bars), wildtype LTK (wt, black bars), LTK-R669Q (RQ, blue bars), or LTK-F568L (FL, green bars) were counted daily for ten days and the percent exhibiting neurite outgrowth is shown. GFP was strongly expressed through Day 7, after which expression began to diminish and became undetectable after Day 10. Data shown is the average of two independent experiments done in duplicate with error bars representing standard error of mean. At least 500 GFP-positive cells were assessed per plate.", "co_occurrence": [{"body": 147, "word": "cells", "fig": 5}, {"body": 161, "word": "LTK", "fig": 2}, {"body": 56, "word": "LTK-F568L", "fig": 4}, {"body": 34, "word": "LTK-R669Q", "fig": 4}, {"body": 33, "word": "wildtype", "fig": 2}, {"body": 12, "word": "neurite", "fig": 5}, {"body": 13, "word": "PC12", "fig": 4}, {"body": 13, "word": "outgrowth", "fig": 4}, {"body": 42, "word": "cell", "fig": 1}, {"body": 9, "word": "shown", "fig": 4}, {"body": 27, "word": "expression", "fig": 1}, {"body": 26, "word": "expressing", "fig": 1}, {"body": 10, "word": "days", "fig": 2}, {"body": 9, "word": "GFP-positive", "fig": 2}, {"body": 8, "word": "either", "fig": 2}, {"body": 7, "word": "vector", "fig": 2}, {"body": 6, "word": "control", "fig": 2}, {"body": 11, "word": "expressed", "fig": 1}, {"body": 11, "word": "two", "fig": 1}, {"body": 5, "word": "Day", "fig": 2}, {"body": 9, "word": "observed", "fig": 1}, {"body": 8, "word": "induce", "fig": 1}, {"body": 4, "word": "GFP", "fig": 2}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "independent", "fig": 1}, {"body": 5, "word": "per", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "plate", "fig": 1}, {"body": 4, "word": "became", "fig": 1}, {"body": 3, "word": "blue", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 2, "word": "exhibiting", "fig": 1}, {"body": 2, "word": "ten", "fig": 1}, {"body": 2, "word": "Two", "fig": 1}, {"body": 2, "word": "duplicate", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "transiently", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "NGF", "fig": 1}, {"body": 1, "word": "began", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}, {"body": 1, "word": "counted", "fig": 1}]}], "3184399": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184399/bin/SCI2011-924782.001.jpg", "caption": "iPS cells as model to study metabolic liver diseases. Induced pluripotent stem cells (iPSCs) can be generated using retro- or lentiviral constructs expressing the canonical reprogramming factors Oct4, Klf4, and Sox2 with or without c-Myc. This technique allows the generation of pluripotent stem cells from diseased individuals. Subjection of these iPS cells to hepatic differentiation protocols results in an easily accessible source of disease-specific hepatic cells. Importantly, this technique might pave the way for in depth study of corresponding liver diseases.", "co_occurrence": [{"body": 97, "word": "cells", "fig": 5}, {"body": 48, "word": "hepatic", "fig": 2}, {"body": 19, "word": "liver", "fig": 2}, {"body": 26, "word": "differentiation", "fig": 1}, {"body": 13, "word": "stem", "fig": 2}, {"body": 20, "word": "iPSCs", "fig": 1}, {"body": 8, "word": "iPS", "fig": 2}, {"body": 8, "word": "pluripotent", "fig": 2}, {"body": 7, "word": "diseases", "fig": 2}, {"body": 13, "word": "using", "fig": 1}, {"body": 11, "word": "Oct4", "fig": 1}, {"body": 9, "word": "lentiviral", "fig": 1}, {"body": 9, "word": "model", "fig": 1}, {"body": 8, "word": "metabolic", "fig": 1}, {"body": 8, "word": "generated", "fig": 1}, {"body": 7, "word": "reprogramming", "fig": 1}, {"body": 7, "word": "disease-specific", "fig": 1}, {"body": 6, "word": "generation", "fig": 1}, {"body": 6, "word": "Sox2", "fig": 1}, {"body": 4, "word": "protocols", "fig": 1}, {"body": 3, "word": "This", "fig": 1}, {"body": 3, "word": "factors", "fig": 1}, {"body": 2, "word": "Klf4", "fig": 1}, {"body": 2, "word": "results", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "c-Myc", "fig": 1}, {"body": 1, "word": "individuals", "fig": 1}, {"body": 1, "word": "without", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184399/bin/SCI2011-924782.002.jpg", "caption": "Generation & characterization of toxic milk iPS cells. (a) iPSCs generated from fibroblasts isolated from toxic-milk mice using retroviral vectors expressing human OCT4, KLF4, SOX2 and c-MYC. (b) iPSCs were subcloned to obtain better colony morphology. (c)\u2013(f) Subcloned iPSCs stained positive for murine Oct4 and Nanog, whilst DAPI was used to stain the nuclei. (g) Staining for alkaline phosphatase expression of toxic-milk iPSC subclones. (h) Karyotype analysis of DAPI stained metaphase spreads. (i) qRT PCR analysis for endogenous Oct4, Nanog and Sox2 expression in toxic-milk iPSCs and OG2 ESCs compared to mouse embryonic stem cells. (j)\u2013(l) Teratoma sections depicting formation of neuroectoderm, mesoderm (connective tissue), and endoderm.", "co_occurrence": [{"body": 97, "word": "cells", "fig": 2}, {"body": 20, "word": "iPSCs", "fig": 4}, {"body": 14, "word": "toxic-milk", "fig": 3}, {"body": 18, "word": "expression", "fig": 2}, {"body": 26, "word": "mice", "fig": 1}, {"body": 11, "word": "Oct4", "fig": 2}, {"body": 17, "word": "murine", "fig": 1}, {"body": 8, "word": "Nanog", "fig": 2}, {"body": 15, "word": "human", "fig": 1}, {"body": 14, "word": "iPSC", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 13, "word": "embryonic", "fig": 1}, {"body": 13, "word": "stem", "fig": 1}, {"body": 5, "word": "stained", "fig": 2}, {"body": 10, "word": "fibroblasts", "fig": 1}, {"body": 9, "word": "mouse", "fig": 1}, {"body": 8, "word": "iPS", "fig": 1}, {"body": 8, "word": "generated", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 6, "word": "Sox2", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 2}, {"body": 6, "word": "vectors", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "formation", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 4, "word": "subcloned", "fig": 1}, {"body": 4, "word": "l", "fig": 1}, {"body": 4, "word": "PCR", "fig": 1}, {"body": 4, "word": "qRT", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "j", "fig": 1}, {"body": 3, "word": "endogenous", "fig": 1}, {"body": 3, "word": "g", "fig": 1}, {"body": 3, "word": "OCT4", "fig": 1}, {"body": 3, "word": "positive", "fig": 1}, {"body": 3, "word": "OG2", "fig": 1}, {"body": 2, "word": "morphology", "fig": 1}, {"body": 2, "word": "phosphatase", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "retroviral", "fig": 1}, {"body": 2, "word": "alkaline", "fig": 1}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "Karyotype", "fig": 1}, {"body": 2, "word": "SOX2", "fig": 1}, {"body": 2, "word": "compared", "fig": 1}, {"body": 2, "word": "KLF4", "fig": 1}, {"body": 2, "word": "toxic", "fig": 1}, {"body": 2, "word": "used", "fig": 1}, {"body": 2, "word": "nuclei", "fig": 1}, {"body": 1, "word": "milk", "fig": 1}, {"body": 1, "word": "Teratoma", "fig": 1}, {"body": 1, "word": "metaphase", "fig": 1}, {"body": 1, "word": "colony", "fig": 1}, {"body": 1, "word": "ESCs", "fig": 1}, {"body": 1, "word": "Staining", "fig": 1}, {"body": 1, "word": "tissue", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "depicting", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184399/bin/SCI2011-924782.003.jpg", "caption": "Hepatic differentiation of toxic milk iPS cells. (a, b) Toxic-milk iPS were subjected to hepatic differentiation using hanging drop method and transduced with lentiviral Alb-GFP expression vector. (c) qRT PCR analysis for hepatic marker genes Afp, Alb, Ck18, Abcc2, Ttr, and Hnf4\u03b1. Undifferentiated cells served as negative control, in which no hepatic gene expression was determined until cycle 45 (\u2193). (d) During the last seven days of differentiation, the cells were challenged with copper. The toxic-milk mice-derived cells could not export copper, and, therefore, no enrichment of Alb-positive cells was achieved. However, C3H-derived control cells were able to \u201cdetoxify\u201d copper after hepatic specifications and, therefore, Alb-eGFP-positive cells were enriched.", "co_occurrence": [{"body": 97, "word": "cells", "fig": 7}, {"body": 48, "word": "hepatic", "fig": 4}, {"body": 26, "word": "differentiation", "fig": 3}, {"body": 18, "word": "expression", "fig": 2}, {"body": 9, "word": "copper", "fig": 3}, {"body": 8, "word": "iPS", "fig": 2}, {"body": 16, "word": "The", "fig": 1}, {"body": 14, "word": "toxic-milk", "fig": 1}, {"body": 13, "word": "days", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 5, "word": "control", "fig": 2}, {"body": 10, "word": "transduced", "fig": 1}, {"body": 9, "word": "lentiviral", "fig": 1}, {"body": 8, "word": "gene", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 4, "word": "PCR", "fig": 1}, {"body": 4, "word": "Ttr", "fig": 1}, {"body": 4, "word": "Afp", "fig": 1}, {"body": 4, "word": "Ck18", "fig": 1}, {"body": 2, "word": "therefore", "fig": 2}, {"body": 4, "word": "qRT", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "d", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 4, "word": "could", "fig": 1}, {"body": 3, "word": "marker", "fig": 1}, {"body": 3, "word": "method", "fig": 1}, {"body": 3, "word": "Alb-GFP", "fig": 1}, {"body": 3, "word": "Alb", "fig": 1}, {"body": 2, "word": "Toxic-milk", "fig": 1}, {"body": 2, "word": "mice-derived", "fig": 1}, {"body": 2, "word": "hanging", "fig": 1}, {"body": 2, "word": "able", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "toxic", "fig": 1}, {"body": 2, "word": "However", "fig": 1}, {"body": 2, "word": "Hepatic", "fig": 1}, {"body": 2, "word": "last", "fig": 1}, {"body": 1, "word": "Hnf4\u03b1", "fig": 1}, {"body": 1, "word": "export", "fig": 1}, {"body": 1, "word": "milk", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "Abcc2", "fig": 1}, {"body": 1, "word": "genes", "fig": 1}, {"body": 1, "word": "drop", "fig": 1}, {"body": 1, "word": "vector", "fig": 1}, {"body": 1, "word": "served", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184399/bin/SCI2011-924782.004.jpg", "caption": "FAH\u2212/\u2212-iPS cells. (a)\u2013(c) iPS generated from fibroblasts isolated from FAH\u2212/\u2212-mice using retroviral vectors expressing human OCT4, KLF4, SOX2, and c-MYC were stained for murine Nanog and Oct4. (d) Karyotype analysis of DAPI stained metaphase spreads. (e) Expression of endogenous Oct4, Nanog, and Sox2 determined by qRT PCR compared to ES cells. (f)\u2013(h) FAH\u2212/\u2212-iPSCs were able to form tissues from all three germ layers when transplanted subcutaneously into NOD/SCID mice. (i) qRT PCR analysis for hepatic marker genes Afp, Alb, Ck18, Abcc2, Ttr, and Hnf4\u03b1. Undifferentiated cells served as negative control, in which no hepatic gene expression was determined until cycle 45 (\u2193). (j)-(k) FAH\u2212/\u2212-iPSCs differentiated using the hanging drop method and transduced with lentiviral Alb-eGFP expression vector. (l)-(m) FAH\u2212/\u2212-iPSCs differentiated with the same method but with NTBC treatment. The NTBC-treatment rescued the lethal phenotype of hepatic cells, and more Alb-eGFP positive cells were detectable.", "co_occurrence": [{"body": 97, "word": "cells", "fig": 5}, {"body": 48, "word": "hepatic", "fig": 3}, {"body": 18, "word": "expression", "fig": 2}, {"body": 13, "word": "using", "fig": 2}, {"body": 26, "word": "mice", "fig": 1}, {"body": 11, "word": "Oct4", "fig": 2}, {"body": 10, "word": "differentiated", "fig": 2}, {"body": 6, "word": "FAH\u2212/\u2212-iPSCs", "fig": 3}, {"body": 17, "word": "murine", "fig": 1}, {"body": 8, "word": "Nanog", "fig": 2}, {"body": 16, "word": "The", "fig": 1}, {"body": 15, "word": "human", "fig": 1}, {"body": 12, "word": "three", "fig": 1}, {"body": 11, "word": "phenotype", "fig": 1}, {"body": 5, "word": "stained", "fig": 2}, {"body": 10, "word": "fibroblasts", "fig": 1}, {"body": 10, "word": "transduced", "fig": 1}, {"body": 9, "word": "lentiviral", "fig": 1}, {"body": 4, "word": "PCR", "fig": 2}, {"body": 8, "word": "gene", "fig": 1}, {"body": 4, "word": "qRT", "fig": 2}, {"body": 8, "word": "iPS", "fig": 1}, {"body": 8, "word": "generated", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 6, "word": "Sox2", "fig": 1}, {"body": 3, "word": "method", "fig": 2}, {"body": 6, "word": "vectors", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 4, "word": "NTBC", "fig": 1}, {"body": 4, "word": "d", "fig": 1}, {"body": 4, "word": "l", "fig": 1}, {"body": 4, "word": "Afp", "fig": 1}, {"body": 4, "word": "ES", "fig": 1}, {"body": 4, "word": "j", "fig": 1}, {"body": 2, "word": "determined", "fig": 2}, {"body": 4, "word": "Ttr", "fig": 1}, {"body": 4, "word": "Ck18", "fig": 1}, {"body": 4, "word": "NOD/SCID", "fig": 1}, {"body": 3, "word": "FAH\u2212/\u2212-mice", "fig": 1}, {"body": 3, "word": "layers", "fig": 1}, {"body": 3, "word": "endogenous", "fig": 1}, {"body": 3, "word": "OCT4", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 1}, {"body": 3, "word": "marker", "fig": 1}, {"body": 3, "word": "positive", "fig": 1}, {"body": 3, "word": "germ", "fig": 1}, {"body": 3, "word": "form", "fig": 1}, {"body": 3, "word": "e", "fig": 1}, {"body": 3, "word": "Alb", "fig": 1}, {"body": 2, "word": "able", "fig": 1}, {"body": 2, "word": "hanging", "fig": 1}, {"body": 2, "word": "treatment", "fig": 1}, {"body": 2, "word": "subcutaneously", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "retroviral", "fig": 1}, {"body": 2, "word": "k", "fig": 1}, {"body": 2, "word": "f", "fig": 1}, {"body": 2, "word": "Karyotype", "fig": 1}, {"body": 2, "word": "m", "fig": 1}, {"body": 2, "word": "SOX2", "fig": 1}, {"body": 2, "word": "compared", "fig": 1}, {"body": 2, "word": "KLF4", "fig": 1}, {"body": 2, "word": "transplanted", "fig": 1}, {"body": 1, "word": "lethal", "fig": 1}, {"body": 1, "word": "drop", "fig": 1}, {"body": 1, "word": "vector", "fig": 1}, {"body": 1, "word": "served", "fig": 1}, {"body": 1, "word": "metaphase", "fig": 1}, {"body": 1, "word": "genes", "fig": 1}, {"body": 1, "word": "Hnf4\u03b1", "fig": 1}, {"body": 1, "word": "detectable", "fig": 1}, {"body": 1, "word": "Abcc2", "fig": 1}, {"body": 1, "word": "rescued", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184399/bin/SCI2011-924782.005.jpg", "caption": "PiZ iPS cells. (a) iPSCs generated from ear fibroblasts isolated from PiZ mice using lentiviral vectors expressing human OCT4, KLF4, and SOX2. (b) Staining for alkaline phosphatase expression of PiZ-iPSCs. (c) Karyotype analysis of DAPI stained metaphase spreads. (d) qRT PCR analysis for endogenous expression of pluripotency markers Oct4, Nanog and Sox2 in PiZ-iPS and OG2 ES. (e)\u2013(g) PiZ iPS were able to form tissues from all three germ layers when transplanted subcutaneously into NOD/SCID mice. (h) qRT PCR analysis for hepatic marker genes Afp, Alb, Ck18, Abcc2, Ttr, and Hnf4\u03b1. Undifferentiated cells served as negative control, in which no hepatic gene expression was determined until cycle 45 (\u2193). (i) Functional analysis of iPSC-derived hepatic cells: albumin secretion detected by ELISA, urea production, and CYP450 activity assay. (j)-(k) Day 5 + 9 + 14 hepatic differentiated PiZ-iPSCs transduced on day 5 + 9 + 3 with a lentiviral Alb-eGFP reporter construct (l) FACS-analysis on day 5 + 9 + 14 of hepatic differentiation for Alb-GFP positive cells. (m) qRT PCR analysis for expression of human SERPINA1 and Albumin on d 5 + 9 + 14 of cytokine-based differentiation, compared to undifferentiated PiZ-iPSCs (grey bars).", "co_occurrence": [{"body": 97, "word": "cells", "fig": 4}, {"body": 48, "word": "hepatic", "fig": 5}, {"body": 18, "word": "expression", "fig": 4}, {"body": 26, "word": "differentiation", "fig": 2}, {"body": 26, "word": "mice", "fig": 2}, {"body": 11, "word": "PiZ", "fig": 3}, {"body": 15, "word": "human", "fig": 2}, {"body": 15, "word": "day", "fig": 2}, {"body": 20, "word": "iPSCs", "fig": 1}, {"body": 4, "word": "analysis", "fig": 5}, {"body": 9, "word": "lentiviral", "fig": 2}, {"body": 8, "word": "iPS", "fig": 2}, {"body": 5, "word": "PiZ-iPSCs", "fig": 3}, {"body": 13, "word": "using", "fig": 1}, {"body": 4, "word": "PCR", "fig": 3}, {"body": 12, "word": "three", "fig": 1}, {"body": 4, "word": "qRT", "fig": 3}, {"body": 11, "word": "Oct4", "fig": 1}, {"body": 10, "word": "transduced", "fig": 1}, {"body": 10, "word": "differentiated", "fig": 1}, {"body": 10, "word": "fibroblasts", "fig": 1}, {"body": 10, "word": "markers", "fig": 1}, {"body": 4, "word": "d", "fig": 2}, {"body": 8, "word": "Nanog", "fig": 1}, {"body": 8, "word": "gene", "fig": 1}, {"body": 8, "word": "generated", "fig": 1}, {"body": 6, "word": "Sox2", "fig": 1}, {"body": 6, "word": "vectors", "fig": 1}, {"body": 5, "word": "pluripotency", "fig": 1}, {"body": 5, "word": "stained", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "albumin", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "ELISA", "fig": 1}, {"body": 4, "word": "Albumin", "fig": 1}, {"body": 4, "word": "ear", "fig": 1}, {"body": 4, "word": "l", "fig": 1}, {"body": 4, "word": "Afp", "fig": 1}, {"body": 4, "word": "reporter", "fig": 1}, {"body": 4, "word": "ES", "fig": 1}, {"body": 4, "word": "Ttr", "fig": 1}, {"body": 4, "word": "construct", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "j", "fig": 1}, {"body": 4, "word": "Ck18", "fig": 1}, {"body": 4, "word": "NOD/SCID", "fig": 1}, {"body": 3, "word": "layers", "fig": 1}, {"body": 3, "word": "production", "fig": 1}, {"body": 3, "word": "endogenous", "fig": 1}, {"body": 3, "word": "OCT4", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 1}, {"body": 3, "word": "Alb-GFP", "fig": 1}, {"body": 3, "word": "g", "fig": 1}, {"body": 3, "word": "marker", "fig": 1}, {"body": 3, "word": "positive", "fig": 1}, {"body": 3, "word": "germ", "fig": 1}, {"body": 3, "word": "iPSC-derived", "fig": 1}, {"body": 3, "word": "form", "fig": 1}, {"body": 3, "word": "OG2", "fig": 1}, {"body": 3, "word": "activity", "fig": 1}, {"body": 3, "word": "SERPINA1", "fig": 1}, {"body": 3, "word": "e", "fig": 1}, {"body": 3, "word": "Alb", "fig": 1}, {"body": 2, "word": "able", "fig": 1}, {"body": 2, "word": "detected", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 2, "word": "subcutaneously", "fig": 1}, {"body": 2, "word": "phosphatase", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "alkaline", "fig": 1}, {"body": 2, "word": "k", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "Karyotype", "fig": 1}, {"body": 2, "word": "m", "fig": 1}, {"body": 2, "word": "cytokine-based", "fig": 1}, {"body": 2, "word": "SOX2", "fig": 1}, {"body": 2, "word": "compared", "fig": 1}, {"body": 2, "word": "KLF4", "fig": 1}, {"body": 2, "word": "transplanted", "fig": 1}, {"body": 1, "word": "urea", "fig": 1}, {"body": 1, "word": "served", "fig": 1}, {"body": 1, "word": "undifferentiated", "fig": 1}, {"body": 1, "word": "metaphase", "fig": 1}, {"body": 1, "word": "genes", "fig": 1}, {"body": 1, "word": "Hnf4\u03b1", "fig": 1}, {"body": 1, "word": "secretion", "fig": 1}, {"body": 1, "word": "Abcc2", "fig": 1}, {"body": 1, "word": "CYP450", "fig": 1}, {"body": 1, "word": "Staining", "fig": 1}, {"body": 1, "word": "PiZ-iPS", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}]}], "4482781": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f1.jpg", "caption": "PICALM reductions in brain capillary endothelium in Alzheimer\u2019s disease a, PICALM and A\u03b2 immunostaining in the prefrontal cortex of an age\u2013matched control (Braak I, left) and AD case (Braak V\u2013VI, right). Bar=20 \u00b5m. b, Immunoblotting for PICALM, von Willebrand Factor (vWF), \u03b23\u2013tubulin, glial fibrillar acidic protein (GFAP), and GAPDH (loading control) in isolated microvessels and microvessel\u2013depleted brains from controls (Braak 0\u2013I) and AD cases (Braak V\u2013VI). c, Relative abundance of PICALM in microvessels and microvessel\u2013depleted brains from control and AD cases determined by densitometry analysis relative to GAPDH. Mean \u00b1 s.e.m., n=6/group; p<0.05 by ANOVA followed by Tukey\u2019s posthoc tests. d, PICALM (green), lectin\u2013positive endothelial capillary profiles (magenta) and microtubule\u2013associated protein 2 (MAP2)\u2013positive neurons (red) in the hippocampus (CA1) of an age\u2013matched control (Braak I) and AD cases (Braak III and V\u2013VI). Bar=20 \u00b5m. e, Quantification of PICALM\u2013positive area (percentage) occupying lectin\u2013positive endothelial capillary profiles in the prefrontal cortex and the CA1 hippocampal subfield. Mean \u00b1 s.d., n=9 controls (Braak 0\u2013I) and 7 AD cases (Braak V\u2013VI); p<0.01 by Student\u2019s t\u2013test. f\u2013i, Correlations between PICALM\u2013positive area occupying lectin\u2013positive endothelial capillary profiles (percentage) in the prefrontal cortex and A\u03b2 load (f), Braak stages (g), Clinical Dementia Rating (CDR) (h), and Mini\u2013Mental State Examination (MMSE) (i). Each point in f\u2013i is an individual value from 50 (f\u2013g), 28 (h) and 37 (i) controls and AD cases. CDR and MMSE were not available for all cases. Significance by Pearson and Spearman rank correlation analysis.", "co_occurrence": [{"body": 127, "word": "PICALM", "fig": 5}, {"body": 113, "word": "A\u03b2", "fig": 2}, {"body": 51, "word": "endothelial", "fig": 3}, {"body": 22, "word": "AD", "fig": 6}, {"body": 22, "word": "controls", "fig": 3}, {"body": 7, "word": "Braak", "fig": 9}, {"body": 48, "word": "brain", "fig": 1}, {"body": 12, "word": "control", "fig": 4}, {"body": 14, "word": "protein", "fig": 2}, {"body": 13, "word": "analysis", "fig": 2}, {"body": 3, "word": "cases", "fig": 6}, {"body": 4, "word": "capillary", "fig": 4}, {"body": 15, "word": "endothelium", "fig": 1}, {"body": 5, "word": "cortex", "fig": 3}, {"body": 7, "word": "microvessels", "fig": 2}, {"body": 13, "word": "hippocampus", "fig": 1}, {"body": 3, "word": "V\u2013VI", "fig": 4}, {"body": 12, "word": "neurons", "fig": 1}, {"body": 5, "word": "h", "fig": 2}, {"body": 5, "word": "area", "fig": 2}, {"body": 9, "word": "determined", "fig": 1}, {"body": 9, "word": "immunostaining", "fig": 1}, {"body": 2, "word": "lectin\u2013positive", "fig": 3}, {"body": 3, "word": "age\u2013matched", "fig": 2}, {"body": 6, "word": "followed", "fig": 1}, {"body": 2, "word": "profiles", "fig": 3}, {"body": 5, "word": "tests", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "load", "fig": 1}, {"body": 5, "word": "disease", "fig": 1}, {"body": 2, "word": "percentage", "fig": 2}, {"body": 2, "word": "brains", "fig": 2}, {"body": 4, "word": "isolated", "fig": 1}, {"body": 2, "word": "I", "fig": 2}, {"body": 3, "word": "reductions", "fig": 1}, {"body": 3, "word": "right", "fig": 1}, {"body": 1, "word": "prefrontal", "fig": 3}, {"body": 3, "word": "Alzheimer\u2019s", "fig": 1}, {"body": 3, "word": "hippocampal", "fig": 1}, {"body": 3, "word": "left", "fig": 1}, {"body": 1, "word": "0\u2013I", "fig": 2}, {"body": 1, "word": "p", "fig": 2}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 2, "word": "rank", "fig": 1}, {"body": 1, "word": "CDR", "fig": 2}, {"body": 2, "word": "stages", "fig": 1}, {"body": 1, "word": "MMSE", "fig": 2}, {"body": 2, "word": "correlation", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "vWF", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "microtubule\u2013associated", "fig": 1}, {"body": 1, "word": "Pearson", "fig": 1}, {"body": 1, "word": "III", "fig": 1}, {"body": 1, "word": "fibrillar", "fig": 1}, {"body": 1, "word": "value", "fig": 1}, {"body": 1, "word": "Factor", "fig": 1}, {"body": 1, "word": "acidic", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "available", "fig": 1}, {"body": 1, "word": "Spearman", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "point", "fig": 1}, {"body": 1, "word": "Willebrand", "fig": 1}, {"body": 1, "word": "Tukey\u2019s", "fig": 1}, {"body": 1, "word": "MAP2", "fig": 1}, {"body": 1, "word": "GFAP", "fig": 1}, {"body": 1, "word": "glial", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f2.jpg", "caption": "Diminished A\u03b2 clearance in Picalm+/\u2212 mice a, Immunostaining for PICALM (red) and endothelial\u2013specific lectin (blue) in brain microvessels from Picalm+/+ and Picalm+/\u2212 mice. b, Relative abundance of PICALM protein compared to \u03b2\u2013actin studied by immunoblotting and densitometry analysis in brain microvessels and microvessel\u2013depleted brain homogenates in Picalm+/+ and Picalm+/\u2212 mice. P<0.05 by Student\u2019s t\u2013test; NS, non\u2013significant. Means \u00b1 s.e.m. from 3\u20134 mice per group. c\u2013f, Brain retention of A\u03b240 (left), A\u03b242 (middle) and 14C\u2013inulin (right) (c), A\u03b240 and A\u03b242 clearance across the BBB (d) and by interstitial fluid (ISF) bulk flow (e) and plasma levels of A\u03b240 or A\u03b242 (f) after 30 min of intracerebral administration of human synthetic A\u03b240, A\u03b242 and 14C\u2013inulin into the caudate nucleus of 3 month old Picalm+/+ and Picalm+/\u2212 mice. A\u03b2 in brain and plasma was determined using human\u2013specific A\u03b240 or A\u03b242 ELISA. Means \u00b1 s.e.m., n=6 mice per group. Statistical significance by Student\u2019s t\u2013test. NS, non\u2013significant. p<0.05 by Student\u2019s t\u2013test. NS, non\u2013significant.", "co_occurrence": [{"body": 127, "word": "PICALM", "fig": 2}, {"body": 113, "word": "A\u03b2", "fig": 2}, {"body": 35, "word": "mice", "fig": 6}, {"body": 39, "word": "A\u03b240", "fig": 5}, {"body": 48, "word": "brain", "fig": 4}, {"body": 26, "word": "Picalm+/\u2212", "fig": 4}, {"body": 14, "word": "A\u03b242", "fig": 5}, {"body": 32, "word": "clearance", "fig": 2}, {"body": 35, "word": "using", "fig": 1}, {"body": 26, "word": "levels", "fig": 1}, {"body": 24, "word": "human", "fig": 1}, {"body": 22, "word": "compared", "fig": 1}, {"body": 19, "word": "across", "fig": 1}, {"body": 19, "word": "BBB", "fig": 1}, {"body": 17, "word": "min", "fig": 1}, {"body": 7, "word": "microvessels", "fig": 2}, {"body": 14, "word": "protein", "fig": 1}, {"body": 13, "word": "analysis", "fig": 1}, {"body": 4, "word": "Picalm+/+", "fig": 3}, {"body": 9, "word": "determined", "fig": 1}, {"body": 8, "word": "month", "fig": 1}, {"body": 8, "word": "old", "fig": 1}, {"body": 8, "word": "ISF", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "ELISA", "fig": 1}, {"body": 5, "word": "studied", "fig": 1}, {"body": 5, "word": "administration", "fig": 1}, {"body": 2, "word": "group", "fig": 2}, {"body": 4, "word": "lectin", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 3, "word": "right", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 3}, {"body": 3, "word": "endothelial\u2013specific", "fig": 1}, {"body": 3, "word": "left", "fig": 1}, {"body": 2, "word": "retention", "fig": 1}, {"body": 1, "word": "plasma", "fig": 2}, {"body": 2, "word": "fluid", "fig": 1}, {"body": 2, "word": "Statistical", "fig": 1}, {"body": 2, "word": "homogenates", "fig": 1}, {"body": 2, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "Brain", "fig": 1}, {"body": 1, "word": "synthetic", "fig": 1}, {"body": 1, "word": "intracerebral", "fig": 1}, {"body": 1, "word": "interstitial", "fig": 1}, {"body": 1, "word": "Diminished", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "bulk", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "flow", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f3.jpg", "caption": "Diminished A\u03b2 clearance and accelerated pathology in APPsw/0 Picalm+/\u2212 mice a\u2013b, ISF A\u03b240 and A\u03b242 levels monitored by in vivo hippocampal microdialysis of 3 month old APPsw/0; Picalm+/\u2212 and APPsw/0; Picalm+/+ mice. Baseline A\u03b2 levels were monitored for 3 hours. c, The elimination half\u2013life of ISF A\u03b240 and A\u03b242 determined after administration of compound E (\u03b3\u2013secretase inhibitor) 20 mg/kg intraperitoneally. d, Representative cortex and hippocampus sections stained with human A\u03b2 specific antibodies in 3 month old APPsw/0; Picalm+/+ and APPsw/0; Picalm+/\u2212 mice, showing no A\u03b2 deposition. Bar: 100 \u00b5m. e\u2013f, Representative hippocampus and cortex sections stained with human A\u03b2 specific antibodies in 9 month old APPsw/0; Picalm+/+ and APPsw/0; Picalm+/\u2212 mice, showing accelerated A\u03b2 deposition (e) and increased A\u03b2 load (f). In c and f, means \u00b1 s.e.m., n=5\u20136 mice per group. g\u2013i, Behavioral changes in 9 month old APPsw/0; Picalm+/+ and APPsw/0; Picalm+/\u2212 mice studied by nest construction (g), burrowing (h), novel object location (NOL) and novel object recognition (NOR) (i). Means \u00b1 s.e.m. n=12\u201314 mice per group. In g\u2013i, statistical significance by Student\u2019s t\u2013test. In i, boxplots represent the median (dark horizontal line), with the box representing the 25th and 75th percentiles, the whiskers the 5th and 95th percentile.", "co_occurrence": [{"body": 113, "word": "A\u03b2", "fig": 7}, {"body": 35, "word": "mice", "fig": 7}, {"body": 22, "word": "APPsw/0", "fig": 9}, {"body": 26, "word": "Picalm+/\u2212", "fig": 5}, {"body": 39, "word": "A\u03b240", "fig": 2}, {"body": 26, "word": "levels", "fig": 2}, {"body": 24, "word": "human", "fig": 2}, {"body": 15, "word": "In", "fig": 3}, {"body": 8, "word": "month", "fig": 4}, {"body": 8, "word": "old", "fig": 4}, {"body": 32, "word": "clearance", "fig": 1}, {"body": 14, "word": "A\u03b242", "fig": 2}, {"body": 13, "word": "hippocampus", "fig": 2}, {"body": 26, "word": "The", "fig": 1}, {"body": 8, "word": "ISF", "fig": 2}, {"body": 4, "word": "Picalm+/+", "fig": 4}, {"body": 5, "word": "showing", "fig": 2}, {"body": 5, "word": "specific", "fig": 2}, {"body": 5, "word": "antibodies", "fig": 2}, {"body": 5, "word": "cortex", "fig": 2}, {"body": 9, "word": "determined", "fig": 1}, {"body": 8, "word": "vivo", "fig": 1}, {"body": 3, "word": "object", "fig": 2}, {"body": 3, "word": "novel", "fig": 2}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "studied", "fig": 1}, {"body": 5, "word": "load", "fig": 1}, {"body": 5, "word": "administration", "fig": 1}, {"body": 2, "word": "group", "fig": 2}, {"body": 2, "word": "stained", "fig": 2}, {"body": 2, "word": "deposition", "fig": 2}, {"body": 4, "word": "pathology", "fig": 1}, {"body": 2, "word": "accelerated", "fig": 2}, {"body": 3, "word": "hours", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 3, "word": "hippocampal", "fig": 1}, {"body": 2, "word": "location", "fig": 1}, {"body": 2, "word": "increased", "fig": 1}, {"body": 2, "word": "recognition", "fig": 1}, {"body": 2, "word": "burrowing", "fig": 1}, {"body": 1, "word": "monitored", "fig": 2}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "changes", "fig": 1}, {"body": 2, "word": "microdialysis", "fig": 1}, {"body": 2, "word": "construction", "fig": 1}, {"body": 2, "word": "nest", "fig": 1}, {"body": 1, "word": "compound", "fig": 1}, {"body": 1, "word": "half\u2013life", "fig": 1}, {"body": 1, "word": "means", "fig": 1}, {"body": 1, "word": "Diminished", "fig": 1}, {"body": 1, "word": "Behavioral", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "mg/kg", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "\u03b3\u2013secretase", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "inhibitor", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f4.jpg", "caption": "Endothelial specific rescue of PICALM deficiency in the hippocampus of APPsw/0 Picalm+/\u2212 mice a, The scheme of endothelial specific rescue of PICALM in APPsw/0; Picalm+/\u2212; Tie2\u2013Cre mice using adeno\u2013associated virus (AAV) carrying a Cre recombinase dependent expression cassette of Flag\u2013Picalm transgene (see Methods for details). b, Expression of Flag\u2013PICALM in endothelium of 5 month old APPsw/0; Picalm+/\u2212; Tie2\u2013Cre mouse after AAV\u2013Flex\u2013Picalm administration in the hippocampus. Lectin, endothelial specific marker. Co\u2013injection of AAV\u2013Synapsin\u2013GFP shows insignificant expression of Flag\u2013PICALM in neurons (< 3%). c\u2013e, Endothelial\u2013specific expression of PICALM in the ipsilateral hippocampus of APPsw/0; Picalm+/\u2212; Tie2\u2013Cre mice injected with AAV\u2013Flex\u2013Picalm (see b) reduces A\u03b2 deposition (c\u2013d) and A\u03b240 and A\u03b242 accumulation (e) at 6 months of age compared to the contralateral hippocampus injected with AAV\u2013Flex control. Cortex that was not injected with AAV\u2013Flex\u2013Picalm shows no changes in A\u03b2 load (c, d). Red lines in d indicate average values. P<0.01 by paired Wilcoxon Signed Rank Test. f\u2013g, Bilateral hippocampal administration of AAV\u2013Flex\u2013Picalm compared to AAV\u2013Flex (control) improves behavior in 6 month old APPsw/0; Picalm+/\u2212; Tie2\u2013Cre mice. Means \u00b1 s.e.m., n=10 mice per group. p<0.05 by Student\u2019s t\u2013test.", "co_occurrence": [{"body": 127, "word": "PICALM", "fig": 3}, {"body": 113, "word": "A\u03b2", "fig": 2}, {"body": 35, "word": "mice", "fig": 5}, {"body": 26, "word": "Picalm+/\u2212", "fig": 5}, {"body": 22, "word": "APPsw/0", "fig": 5}, {"body": 51, "word": "endothelial", "fig": 2}, {"body": 18, "word": "expression", "fig": 3}, {"body": 13, "word": "hippocampus", "fig": 4}, {"body": 22, "word": "compared", "fig": 2}, {"body": 39, "word": "A\u03b240", "fig": 1}, {"body": 35, "word": "using", "fig": 1}, {"body": 26, "word": "The", "fig": 1}, {"body": 12, "word": "control", "fig": 2}, {"body": 5, "word": "Tie2\u2013Cre", "fig": 4}, {"body": 8, "word": "month", "fig": 2}, {"body": 8, "word": "old", "fig": 2}, {"body": 8, "word": "see", "fig": 2}, {"body": 4, "word": "AAV\u2013Flex\u2013Picalm", "fig": 4}, {"body": 5, "word": "specific", "fig": 3}, {"body": 15, "word": "endothelium", "fig": 1}, {"body": 14, "word": "A\u03b242", "fig": 1}, {"body": 12, "word": "neurons", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 5, "word": "administration", "fig": 2}, {"body": 3, "word": "injected", "fig": 3}, {"body": 4, "word": "rescue", "fig": 2}, {"body": 6, "word": "Methods", "fig": 1}, {"body": 6, "word": "carrying", "fig": 1}, {"body": 5, "word": "deficiency", "fig": 1}, {"body": 5, "word": "load", "fig": 1}, {"body": 5, "word": "mouse", "fig": 1}, {"body": 4, "word": "marker", "fig": 1}, {"body": 2, "word": "AAV\u2013Flex", "fig": 2}, {"body": 4, "word": "age", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 3, "word": "Endothelial", "fig": 1}, {"body": 3, "word": "months", "fig": 1}, {"body": 3, "word": "virus", "fig": 1}, {"body": 3, "word": "hippocampal", "fig": 1}, {"body": 3, "word": "lines", "fig": 1}, {"body": 2, "word": "group", "fig": 1}, {"body": 2, "word": "cassette", "fig": 1}, {"body": 2, "word": "accumulation", "fig": 1}, {"body": 2, "word": "AAV\u2013Synapsin\u2013GFP", "fig": 1}, {"body": 2, "word": "deposition", "fig": 1}, {"body": 2, "word": "transgene", "fig": 1}, {"body": 2, "word": "paired", "fig": 1}, {"body": 2, "word": "values", "fig": 1}, {"body": 2, "word": "behavior", "fig": 1}, {"body": 2, "word": "changes", "fig": 1}, {"body": 1, "word": "Flag\u2013PICALM", "fig": 2}, {"body": 1, "word": "ipsilateral", "fig": 1}, {"body": 1, "word": "reduces", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "contralateral", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "adeno\u2013associated", "fig": 1}, {"body": 1, "word": "indicate", "fig": 1}, {"body": 1, "word": "Co\u2013injection", "fig": 1}, {"body": 1, "word": "AAV", "fig": 1}, {"body": 1, "word": "details", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f5.jpg", "caption": "PICALM/clathrin\u2013dependent endocytosis of A\u03b2\u2013LRP1 complex by brain endothelial cells a\u2013b, Colocalization of LRP1\u2013A\u03b240 complex with PICALM (a) and clathrin heavy chain (CHC) (b) in human brain endothelial cells (BEC) within 30 s of FAM\u2013A\u03b240 (250 nM) treatment. c, Immunostaining for LRP1, PICALM and CHC without A\u03b2 (\u2013 A\u03b2). Dapi, nuclear staining (blue). Insets: higher magnification. Bar=10 \u00b5m. d, Quantification of LRP1 puncta colocalized with PICALM in a, c and with CHC in b, c, and FAM\u2013A\u03b240 puncta colocalized with LRP1 and PICALM in a, b. Means \u00b1 s.d. from 3 primary isolates in triplicate. p<0.05 by Student\u2019s t\u2013test. e, Coimmunoprecipitation of PICALM, CHC and clathrin adaptor protein \u03b1\u2013adaptin (AP\u20132) by LRP1\u2013specific antibody (IP: LRP1) in BEC 30 s or 5 min after stimulation with A\u03b240 (1 nM); IgG, non\u2013immune IgG. f, LRP1 internalization in control BEC (vehicle) and after transfection with si.Scramble RNA and/or si.RNAs targeting PICALM or CHC. A\u03b240 (1 nM) was applied for 15 min at 4\u00b0C followed by 1 min at 37\u00b0C to initiate LRP1 internalization. Values at 4\u00b0C were taken as 100%. Means \u00b1 s.d. from 3 primary isolates in triplicate. p<0.05 by ANOVA followed by Tukey\u2019s posthoc tests. g, In vitro binding of human recombinant PICALM to GST\u2013tagged LRP1 C\u2013terminus fusion protein (GST\u2013LRP1C). h, C\u2013terminal mutants of the human LRP1 minigene (LRP4T100). i, Coimmunoprecipitation of HA\u2013tagged C\u2013terminal LRP1 mutants (LRP4T100) by anti\u2013Flag antibody (IP: Flag) in HEK293T cells after transfection with Flag\u2013PICALM and HA\u2013LRP4T100 mutants. HA\u2013LRP4 and Flag\u2013PICALM were used as loading controls.", "co_occurrence": [{"body": 127, "word": "PICALM", "fig": 7}, {"body": 46, "word": "LRP1", "fig": 9}, {"body": 113, "word": "A\u03b2", "fig": 2}, {"body": 51, "word": "endothelial", "fig": 2}, {"body": 48, "word": "brain", "fig": 2}, {"body": 28, "word": "cells", "fig": 3}, {"body": 39, "word": "A\u03b240", "fig": 2}, {"body": 24, "word": "human", "fig": 3}, {"body": 17, "word": "min", "fig": 3}, {"body": 9, "word": "CHC", "fig": 5}, {"body": 13, "word": "BEC", "fig": 3}, {"body": 15, "word": "internalization", "fig": 2}, {"body": 14, "word": "protein", "fig": 2}, {"body": 12, "word": "antibody", "fig": 2}, {"body": 22, "word": "controls", "fig": 1}, {"body": 7, "word": "nM", "fig": 3}, {"body": 21, "word": "used", "fig": 1}, {"body": 19, "word": "binding", "fig": 1}, {"body": 8, "word": "complex", "fig": 2}, {"body": 15, "word": "In", "fig": 1}, {"body": 7, "word": "clathrin", "fig": 2}, {"body": 12, "word": "control", "fig": 1}, {"body": 6, "word": "followed", "fig": 2}, {"body": 12, "word": "within", "fig": 1}, {"body": 5, "word": "colocalized", "fig": 2}, {"body": 9, "word": "A\u03b2\u2013LRP1", "fig": 1}, {"body": 4, "word": "primary", "fig": 2}, {"body": 7, "word": "vitro", "fig": 1}, {"body": 3, "word": "4\u00b0C", "fig": 2}, {"body": 6, "word": "endocytosis", "fig": 1}, {"body": 2, "word": "mutants", "fig": 3}, {"body": 6, "word": "higher", "fig": 1}, {"body": 3, "word": "transfection", "fig": 2}, {"body": 5, "word": "tests", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "and/or", "fig": 1}, {"body": 4, "word": "staining", "fig": 1}, {"body": 4, "word": "fusion", "fig": 1}, {"body": 4, "word": "AP\u20132", "fig": 1}, {"body": 4, "word": "C\u2013terminus", "fig": 1}, {"body": 4, "word": "PICALM/clathrin\u2013dependent", "fig": 1}, {"body": 3, "word": "treatment", "fig": 1}, {"body": 3, "word": "recombinant", "fig": 1}, {"body": 1, "word": "c", "fig": 3}, {"body": 3, "word": "37\u00b0C", "fig": 1}, {"body": 2, "word": "chain", "fig": 1}, {"body": 1, "word": "p", "fig": 2}, {"body": 1, "word": "IgG", "fig": 2}, {"body": 2, "word": "RNA", "fig": 1}, {"body": 1, "word": "puncta", "fig": 2}, {"body": 2, "word": "taken", "fig": 1}, {"body": 1, "word": "FAM\u2013A\u03b240", "fig": 2}, {"body": 1, "word": "isolates", "fig": 2}, {"body": 1, "word": "Flag\u2013PICALM", "fig": 2}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "LRP1\u2013A\u03b240", "fig": 1}, {"body": 1, "word": "heavy", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "minigene", "fig": 1}, {"body": 1, "word": "LRP1\u2013specific", "fig": 1}, {"body": 1, "word": "\u03b1\u2013adaptin", "fig": 1}, {"body": 1, "word": "Tukey\u2019s", "fig": 1}, {"body": 1, "word": "adaptor", "fig": 1}, {"body": 1, "word": "without", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f6.jpg", "caption": "PICALM associates with LRP1 during A\u03b2 transcytosis across endothelial monolayer a, PICALM (red), ZO\u20131 (green) and F\u2013actin (magenta) in a monolayer. b, Colocalization of PICALM (red) with LRP1 (green) and FAM\u2013A\u03b240 (magenta) 1 min after LRP1\u2013A\u03b2 internalization at the basolateral membrane. c\u2013d, Proximity ligation assay (PLA) depicting PICALM\u2013LRP1 association (c, bar=10 \u00b5m) and kinetics of association between PICALM and LRP1 and clathrin and LRP1 in endothelium after A\u03b240 (1 nM) addition to the basolateral membrane studied by PLA (d). e, Internalization of A\u03b240 (1 nM) at the basolateral membrane of the monolayer transfected with si.LRP1, si.PICALM and si.CHC compared si.Scramble or untransfected control. f\u2013g, Basolateral\u2013to\u2013apical transcytosis of A\u03b240 (1 nM) across endothelial monolayer transfected with si.PICALM and si.CHC compared to si.Scramble (100%) over 60 min (f) and quantification of unidirectional trans\u2013endothelial A\u03b240 transport within 30 min (g). Mean \u00b1 s.e.m. from 3 primary isolates in triplicates. p<0.05 by ANOVA followed by Tukey\u2019s posthoc test.", "co_occurrence": [{"body": 127, "word": "PICALM", "fig": 4}, {"body": 46, "word": "LRP1", "fig": 4}, {"body": 39, "word": "A\u03b240", "fig": 4}, {"body": 113, "word": "A\u03b2", "fig": 1}, {"body": 51, "word": "endothelial", "fig": 2}, {"body": 20, "word": "monolayer", "fig": 4}, {"body": 17, "word": "min", "fig": 3}, {"body": 22, "word": "compared", "fig": 2}, {"body": 13, "word": "basolateral", "fig": 3}, {"body": 19, "word": "across", "fig": 2}, {"body": 18, "word": "transcytosis", "fig": 2}, {"body": 10, "word": "membrane", "fig": 3}, {"body": 7, "word": "nM", "fig": 3}, {"body": 15, "word": "internalization", "fig": 1}, {"body": 15, "word": "endothelium", "fig": 1}, {"body": 14, "word": "transport", "fig": 1}, {"body": 6, "word": "association", "fig": 2}, {"body": 12, "word": "control", "fig": 1}, {"body": 12, "word": "within", "fig": 1}, {"body": 8, "word": "assay", "fig": 1}, {"body": 4, "word": "PLA", "fig": 2}, {"body": 8, "word": "test", "fig": 1}, {"body": 7, "word": "clathrin", "fig": 1}, {"body": 6, "word": "followed", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "studied", "fig": 1}, {"body": 2, "word": "transfected", "fig": 2}, {"body": 4, "word": "primary", "fig": 1}, {"body": 3, "word": "addition", "fig": 1}, {"body": 3, "word": "associates", "fig": 1}, {"body": 3, "word": "unidirectional", "fig": 1}, {"body": 2, "word": "si.LRP1", "fig": 1}, {"body": 1, "word": "red", "fig": 2}, {"body": 2, "word": "trans\u2013endothelial", "fig": 1}, {"body": 1, "word": "si.CHC", "fig": 2}, {"body": 2, "word": "ligation", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "Tukey\u2019s", "fig": 1}, {"body": 1, "word": "Basolateral\u2013to\u2013apical", "fig": 1}, {"body": 1, "word": "FAM\u2013A\u03b240", "fig": 1}, {"body": 1, "word": "ZO\u20131", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}, {"body": 1, "word": "isolates", "fig": 1}, {"body": 1, "word": "F\u2013actin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f7.jpg", "caption": "PICALM interacts with Rab5 and Rab11 during A\u03b2 transcytosis across endothelial monolayer a, Colocalization between PICALM (red) and Rab5 (green) in primary human brain endothelial cells (BEC) cultured with FAM\u2013A\u03b240 (250 nM) for 2 min. b, Lack of association between PICALM (red) and Rab7 (green) in BEC cultured with FAM\u2013A\u03b240 for 5 min. c, Colocalization between PICALM (red) and Rab11 (green) in BEC cultured with FAM\u2013A\u03b240 for 5 min. Dapi, nuclear staining (blue). Insets: high magnification depicting colocalization. Bar=10 \u00b5m. d, Quantification of colocalization between PICALM and Rab5, Rab7, or Rab11 puncta in a\u2013c. e\u2013f, Colocalization of FAM\u2013A\u03b240 (green) with Rab5 (magenta, upper) or RAB11b (magenta, bottom) 2 and 4 min after A\u03b2 internalization at the basolateral side of endothelial monolayer, respectively. Arrows denote co\u2013localized white puncta. g\u2013h, PLA of PICALM\u2013Rab11 association (g, bar=10 \u00b5m) and kinetics of PICALM association with Rab5, Rab7 and Rab11 in endothelium after addition of A\u03b240 (1 nM) to the basolateral membrane (h). i, Coimmunoprecipitation of LRP1, Rab5, Rab7 and Rab11 by PICALM\u2013specific antibody (IP: PICALM) 0, 2 and 4 min after addition of A\u03b240 (1 nM) to the basloateral membrane. j\u2013k, Basolateral\u2013to\u2013apical transcytosis of A\u03b240 (1 nM) across monolayer expressing dominant negative Rab5\u2013S34N, Rab7\u2013T22N or Rab11b\u2013S25N mutants compared to control EGFP (100%) over 60 min (j) and quantification of unidirectional A\u03b240 transport within 30 min (k). Mean \u00b1 s.e.m. from 3 primary isolates in triplicates. p<0.05 by ANOVA followed by Tukey\u2019s posthoc test. l\u2013m, Inhibition of Rab5 (l) and Rab11 (m) GTPase activity by si.PICALM compared to si.Scramble control.", "co_occurrence": [{"body": 127, "word": "PICALM", "fig": 7}, {"body": 113, "word": "A\u03b2", "fig": 2}, {"body": 39, "word": "A\u03b240", "fig": 4}, {"body": 51, "word": "endothelial", "fig": 3}, {"body": 18, "word": "Rab5", "fig": 7}, {"body": 17, "word": "min", "fig": 7}, {"body": 19, "word": "Rab11", "fig": 6}, {"body": 20, "word": "monolayer", "fig": 3}, {"body": 48, "word": "brain", "fig": 1}, {"body": 46, "word": "LRP1", "fig": 1}, {"body": 22, "word": "compared", "fig": 2}, {"body": 13, "word": "BEC", "fig": 3}, {"body": 19, "word": "across", "fig": 2}, {"body": 18, "word": "transcytosis", "fig": 2}, {"body": 28, "word": "cells", "fig": 1}, {"body": 7, "word": "nM", "fig": 4}, {"body": 13, "word": "basolateral", "fig": 2}, {"body": 24, "word": "human", "fig": 1}, {"body": 12, "word": "control", "fig": 2}, {"body": 10, "word": "membrane", "fig": 2}, {"body": 5, "word": "Rab7", "fig": 4}, {"body": 6, "word": "association", "fig": 3}, {"body": 15, "word": "internalization", "fig": 1}, {"body": 15, "word": "endothelium", "fig": 1}, {"body": 5, "word": "cultured", "fig": 3}, {"body": 14, "word": "transport", "fig": 1}, {"body": 13, "word": "respectively", "fig": 1}, {"body": 12, "word": "antibody", "fig": 1}, {"body": 12, "word": "within", "fig": 1}, {"body": 4, "word": "primary", "fig": 2}, {"body": 8, "word": "test", "fig": 1}, {"body": 7, "word": "activity", "fig": 1}, {"body": 6, "word": "followed", "fig": 1}, {"body": 3, "word": "addition", "fig": 2}, {"body": 6, "word": "GTPase", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 4, "word": "staining", "fig": 1}, {"body": 4, "word": "PLA", "fig": 1}, {"body": 1, "word": "FAM\u2013A\u03b240", "fig": 4}, {"body": 3, "word": "upper", "fig": 1}, {"body": 1, "word": "red", "fig": 3}, {"body": 3, "word": "unidirectional", "fig": 1}, {"body": 3, "word": "negative", "fig": 1}, {"body": 3, "word": "high", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 1, "word": "puncta", "fig": 2}, {"body": 2, "word": "mutants", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "dominant", "fig": 1}, {"body": 1, "word": "PICALM\u2013Rab11", "fig": 1}, {"body": 1, "word": "side", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "RAB11b", "fig": 1}, {"body": 1, "word": "expressing", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "k", "fig": 1}, {"body": 1, "word": "Rab5\u2013S34N", "fig": 1}, {"body": 1, "word": "Tukey\u2019s", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}, {"body": 1, "word": "EGFP", "fig": 1}, {"body": 1, "word": "interacts", "fig": 1}, {"body": 1, "word": "isolates", "fig": 1}, {"body": 1, "word": "Rab7\u2013T22N", "fig": 1}, {"body": 1, "word": "Basolateral\u2013to\u2013apical", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482781/bin/nihms684788f8.jpg", "caption": "A\u03b2 transcytosis across AD\u2013derived endothelial monolayer and iPSC\u2013derived endothelium carrying the rs3851179 PICALM variants a, qRT\u2013PCR and western blot analysis of PICALM in control and AD endothelial monolayers. b, Diminished A\u03b240 (1 nM) transcytosis across AD\u2013derived endothelium and reversal by adenoviral\u2013mediated Ad.PICALM re\u2013expression. Ad.mLRP1, LRP1 minigene. Mean \u00b1 s.e.m., from 8 isolates in triplicate for control and AD monolayers. c, Diagram of CRISPR/Cas9\u2013based generation of isogenic iPSC lines homozygous for the protective (A) or non\u2013protective (G) allele of rs3851179. gRNA = guide RNA. d, SspI restriction digest of PCR products from iPSC genomic DNA at rs3851179 region. *denotes the CRISPR\u2013Cas9 modified iPSC line. e, Sanger sequencing of iPSCs at rs3851179 confirming independent isogenic lines homozygous for either the G or A variant. f, FACS dot plot showing 15.7% of iPSC\u2013derived endothelial cells via embryoid body (EB) formation are positive for endothelial markers CD31 and VE\u2013Cadherin. g, iPSC\u2013derived endothelial cells co\u2013cultured with pericyte conditioned media form monolayer in vitro with ZO\u20131 positive tight junctions (green). Bar=100 \u00b5m. h\u2013i, qRT\u2013PCR and western blot analysis of PICALM (h) and A\u03b240 (1 nM) transcytosis (i) in human iPSC\u2013derived endothelial monolayers carrying the protective rs3851179 (AA) variant and the non\u2013protective rs3851179 (GG) variant. In h\u2013i, means \u00b1 s.e.m., from 6 cultures for each rs3851179 variant in triplicates.", "co_occurrence": [{"body": 127, "word": "PICALM", "fig": 3}, {"body": 51, "word": "endothelial", "fig": 6}, {"body": 113, "word": "A\u03b2", "fig": 1}, {"body": 39, "word": "A\u03b240", "fig": 2}, {"body": 8, "word": "rs3851179", "fig": 7}, {"body": 28, "word": "cells", "fig": 2}, {"body": 18, "word": "transcytosis", "fig": 3}, {"body": 46, "word": "LRP1", "fig": 1}, {"body": 22, "word": "AD", "fig": 2}, {"body": 20, "word": "monolayer", "fig": 2}, {"body": 19, "word": "across", "fig": 2}, {"body": 15, "word": "endothelium", "fig": 2}, {"body": 10, "word": "monolayers", "fig": 3}, {"body": 13, "word": "analysis", "fig": 2}, {"body": 24, "word": "human", "fig": 1}, {"body": 12, "word": "control", "fig": 2}, {"body": 8, "word": "blot", "fig": 2}, {"body": 8, "word": "western", "fig": 2}, {"body": 15, "word": "In", "fig": 1}, {"body": 7, "word": "nM", "fig": 2}, {"body": 3, "word": "iPSC\u2013derived", "fig": 4}, {"body": 6, "word": "carrying", "fig": 2}, {"body": 6, "word": "A", "fig": 2}, {"body": 9, "word": "allele", "fig": 1}, {"body": 3, "word": "iPSC", "fig": 3}, {"body": 4, "word": "protective", "fig": 2}, {"body": 8, "word": "cultures", "fig": 1}, {"body": 2, "word": "variant", "fig": 4}, {"body": 7, "word": "vitro", "fig": 1}, {"body": 3, "word": "homozygous", "fig": 2}, {"body": 6, "word": "variants", "fig": 1}, {"body": 6, "word": "DNA", "fig": 1}, {"body": 3, "word": "AD\u2013derived", "fig": 2}, {"body": 6, "word": "iPSCs", "fig": 1}, {"body": 3, "word": "lines", "fig": 2}, {"body": 5, "word": "showing", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "gRNA", "fig": 1}, {"body": 5, "word": "PCR", "fig": 1}, {"body": 2, "word": "isogenic", "fig": 2}, {"body": 2, "word": "non\u2013protective", "fig": 2}, {"body": 4, "word": "markers", "fig": 1}, {"body": 2, "word": "positive", "fig": 2}, {"body": 4, "word": "pericyte", "fig": 1}, {"body": 4, "word": "conditioned", "fig": 1}, {"body": 3, "word": "media", "fig": 1}, {"body": 2, "word": "sequencing", "fig": 1}, {"body": 1, "word": "G", "fig": 2}, {"body": 2, "word": "formation", "fig": 1}, {"body": 2, "word": "re\u2013expression", "fig": 1}, {"body": 2, "word": "RNA", "fig": 1}, {"body": 2, "word": "products", "fig": 1}, {"body": 2, "word": "co\u2013cultured", "fig": 1}, {"body": 2, "word": "confirming", "fig": 1}, {"body": 2, "word": "tight", "fig": 1}, {"body": 2, "word": "region", "fig": 1}, {"body": 1, "word": "CD31", "fig": 1}, {"body": 1, "word": "Diminished", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "Sanger", "fig": 1}, {"body": 1, "word": "genomic", "fig": 1}, {"body": 1, "word": "minigene", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "adenoviral\u2013mediated", "fig": 1}, {"body": 1, "word": "via", "fig": 1}, {"body": 1, "word": "ZO\u20131", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "means", "fig": 1}, {"body": 1, "word": "isolates", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "Ad.mLRP1", "fig": 1}, {"body": 1, "word": "FACS", "fig": 1}, {"body": 1, "word": "embryoid", "fig": 1}]}], "4251486": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f1.jpg", "caption": "Embryonic origin of the bony skull in five vertebrate model organisms arrayed on a simplified vertebrate phylogeny. Neural crest-derived territories (blue) have been verified experimentally in each species, although the specific contributions from individual migratory streams are reported only for chicken, axolotl and Xenopus. Derivation of remaining components from mesoderm (magenta) has been verified experimentally in mouse and chicken and is presumed for the remaining species. Arrowheads point to the neural crest\u2013mesoderm interface in the skull roof, which is displaced caudally in Xenopus. Data for zebrafish are from refs 8, 9; diagram is based on ref. 8 (figure reproduced with permission from PLoS). Data for axolotl and Xenopus are from the present study; skulls are redrawn from refs 16, 42, respectively (figures reproduced with permission from John Wiley and Sons). Data for chicken are from ref. 43; diagram is based on ref. 44 (figure reproduced with permission from John Wiley and Sons). Data for mouse are from refs 7, 45; diagram is based on refs 4, 46 (figure reproduced with permission from John Wiley and Sons). F, frontal; Fp, frontoparietal; N, nasal; P, parietal; Px, premaxilla; Sq, squamosal.", "co_occurrence": [{"body": 36, "word": "skull", "fig": 2}, {"body": 22, "word": "Xenopus", "fig": 3}, {"body": 18, "word": "axolotl", "fig": 2}, {"body": 21, "word": "neural", "fig": 1}, {"body": 10, "word": "vertebrate", "fig": 2}, {"body": 15, "word": "bony", "fig": 1}, {"body": 6, "word": "species", "fig": 2}, {"body": 9, "word": "contributions", "fig": 1}, {"body": 3, "word": "ref", "fig": 3}, {"body": 7, "word": "individual", "fig": 1}, {"body": 7, "word": "streams", "fig": 1}, {"body": 2, "word": "chicken", "fig": 3}, {"body": 4, "word": "frontal", "fig": 1}, {"body": 4, "word": "parietal", "fig": 1}, {"body": 4, "word": "reported", "fig": 1}, {"body": 1, "word": "refs", "fig": 4}, {"body": 4, "word": "mesoderm", "fig": 1}, {"body": 3, "word": "migratory", "fig": 1}, {"body": 3, "word": "zebrafish", "fig": 1}, {"body": 3, "word": "caudally", "fig": 1}, {"body": 3, "word": "study", "fig": 1}, {"body": 3, "word": "Embryonic", "fig": 1}, {"body": 1, "word": "experimentally", "fig": 2}, {"body": 2, "word": "premaxilla", "fig": 1}, {"body": 2, "word": "origin", "fig": 1}, {"body": 2, "word": "Neural", "fig": 1}, {"body": 1, "word": "mouse", "fig": 2}, {"body": 2, "word": "nasal", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "squamosal", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "frontoparietal", "fig": 1}, {"body": 1, "word": "interface", "fig": 1}, {"body": 1, "word": "crest\u2013mesoderm", "fig": 1}, {"body": 1, "word": "territories", "fig": 1}, {"body": 1, "word": "presumed", "fig": 1}, {"body": 1, "word": "roof", "fig": 1}, {"body": 1, "word": "crest-derived", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f2.jpg", "caption": "Transverse sections through an axolotl skull showing GFP labelling of bone. GFP-labelled cells are rarely seen within the bony matrix, which is largely acellular (upper row), but they are abundant in the periosteum, a connective tissue layer that invests individual bones (lower row). (a\u2013d) A single GFP-labelled osteocyte (arrow) in the bony matrix of the premaxilla. (e\u2013h) Four labelled cells (arrows) in the periosteum of the parasphenoid. In each row, a single section is depicted four times at the same magnification, each with a different combination of fluorescent illumination. Labelling: DAPI-stained nuclei (blue); GFP-positive cells (green); and alizarin-stained bone matrix (red). Scale bar, 100 \u03bcm.", "co_occurrence": [{"body": 36, "word": "skull", "fig": 1}, {"body": 15, "word": "bony", "fig": 2}, {"body": 10, "word": "cells", "fig": 3}, {"body": 24, "word": "bones", "fig": 1}, {"body": 12, "word": "bone", "fig": 2}, {"body": 18, "word": "axolotl", "fig": 1}, {"body": 9, "word": "labelling", "fig": 1}, {"body": 7, "word": "individual", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 2, "word": "matrix", "fig": 3}, {"body": 6, "word": "sections", "fig": 1}, {"body": 6, "word": "GFP-positive", "fig": 1}, {"body": 6, "word": "largely", "fig": 1}, {"body": 6, "word": "In", "fig": 1}, {"body": 6, "word": "GFP", "fig": 1}, {"body": 5, "word": "seen", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "periosteum", "fig": 2}, {"body": 3, "word": "within", "fig": 1}, {"body": 3, "word": "times", "fig": 1}, {"body": 2, "word": "upper", "fig": 1}, {"body": 1, "word": "single", "fig": 2}, {"body": 2, "word": "premaxilla", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 2, "word": "lower", "fig": 1}, {"body": 2, "word": "fluorescent", "fig": 1}, {"body": 1, "word": "layer", "fig": 1}, {"body": 1, "word": "tissue", "fig": 1}, {"body": 1, "word": "parasphenoid", "fig": 1}, {"body": 1, "word": "rarely", "fig": 1}, {"body": 1, "word": "abundant", "fig": 1}, {"body": 1, "word": "section", "fig": 1}, {"body": 1, "word": "connective", "fig": 1}, {"body": 1, "word": "illumination", "fig": 1}, {"body": 1, "word": "combination", "fig": 1}, {"body": 1, "word": "labelled", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "acellular", "fig": 1}, {"body": 1, "word": "green", "fig": 1}, {"body": 1, "word": "invests", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f3.jpg", "caption": "Patterns of CNC derivation of the bony skull differ between Xenopus and axolotl. Coloured regions denote contributions from individual migratory streams of CNC. Red labels denote homologous bones that have a different embryonic origin between species. Data for axolotl and Xenopus, two amphibians, are from the present study; skulls are redrawn from refs 16, 42, respectively. Data for the domestic chicken, an amniote, are from ref. 43; diagram is based on ref. 44 (figure reproduced with permission from John Wiley and Sons).", "co_occurrence": [{"body": 31, "word": "CNC", "fig": 2}, {"body": 22, "word": "Xenopus", "fig": 2}, {"body": 18, "word": "axolotl", "fig": 2}, {"body": 36, "word": "skull", "fig": 1}, {"body": 24, "word": "bones", "fig": 1}, {"body": 24, "word": "derivation", "fig": 1}, {"body": 15, "word": "bony", "fig": 1}, {"body": 13, "word": "embryonic", "fig": 1}, {"body": 9, "word": "contributions", "fig": 1}, {"body": 8, "word": "two", "fig": 1}, {"body": 7, "word": "individual", "fig": 1}, {"body": 7, "word": "streams", "fig": 1}, {"body": 6, "word": "species", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 6, "word": "amphibians", "fig": 1}, {"body": 3, "word": "ref", "fig": 2}, {"body": 4, "word": "homologous", "fig": 1}, {"body": 3, "word": "migratory", "fig": 1}, {"body": 3, "word": "study", "fig": 1}, {"body": 2, "word": "origin", "fig": 1}, {"body": 2, "word": "chicken", "fig": 1}, {"body": 1, "word": "refs", "fig": 1}, {"body": 1, "word": "domestic", "fig": 1}, {"body": 1, "word": "regions", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "amniote", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f4.jpg", "caption": "CNC derivation of cartilages and bones in the skull of the adult axolotl. Most cartilages (a,c) and bones (b,d) are derived from the mandibular stream (yellow). Hyoid stream contributions (blue) are limited to (a) the stapes of the middle ear and (b) the retroarticular process of the lower jaw. There is no contribution to the skull proper from the branchial stream, which contributes extensively to the branchial or gill skeleton (not illustrated). The remainder of the skull (dark grey) is presumably derived from paraxial mesoderm, although this remains to be confirmed experimentally. Skulls are redrawn from ref. 42.", "co_occurrence": [{"body": 36, "word": "skull", "fig": 3}, {"body": 24, "word": "stream", "fig": 3}, {"body": 24, "word": "bones", "fig": 2}, {"body": 31, "word": "CNC", "fig": 1}, {"body": 24, "word": "derivation", "fig": 1}, {"body": 19, "word": "The", "fig": 1}, {"body": 18, "word": "axolotl", "fig": 1}, {"body": 9, "word": "derived", "fig": 2}, {"body": 17, "word": "adult", "fig": 1}, {"body": 13, "word": "contribution", "fig": 1}, {"body": 6, "word": "cartilages", "fig": 2}, {"body": 5, "word": "branchial", "fig": 2}, {"body": 10, "word": "mandibular", "fig": 1}, {"body": 9, "word": "contributions", "fig": 1}, {"body": 6, "word": "jaw", "fig": 1}, {"body": 4, "word": "mesoderm", "fig": 1}, {"body": 3, "word": "ref", "fig": 1}, {"body": 2, "word": "skeleton", "fig": 1}, {"body": 2, "word": "lower", "fig": 1}, {"body": 1, "word": "limited", "fig": 1}, {"body": 1, "word": "process", "fig": 1}, {"body": 1, "word": "There", "fig": 1}, {"body": 1, "word": "retroarticular", "fig": 1}, {"body": 1, "word": "dark", "fig": 1}, {"body": 1, "word": "experimentally", "fig": 1}, {"body": 1, "word": "stapes", "fig": 1}, {"body": 1, "word": "paraxial", "fig": 1}, {"body": 1, "word": "contributes", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f5.jpg", "caption": "Mandibular stream neural crest is the principal source of skull bones in the axolotl. Panels depict transverse sections from juvenile axolotls that received embryonic grafts of mandibular (a\u2013j) or hyoid (k,l) stream neural crest. Schematics of skulls show bone of interest (green); dashed red lines indicate plane of section. GFP-labelled cells are green; bony matrix is stained red; and cell nuclei are counterstained blue (except c). Arrows point to labelled osteocytes within bony matrix or labelled periosteal cells. Chondrocytes (arrowheads) and mesenchymal core of teeth (*) are also labelled. Br, brain; En, external naris; Fr, frontal; Mc, Meckel\u2019s cartilage; Na, nasal cartilage; Pa, parietal; Pt, pterygoid cartilage; Qu, quadrate; St, stapes. Scale bar, 100 \u03bcm.", "co_occurrence": [{"body": 24, "word": "stream", "fig": 2}, {"body": 21, "word": "neural", "fig": 2}, {"body": 36, "word": "skull", "fig": 1}, {"body": 16, "word": "crest", "fig": 2}, {"body": 15, "word": "bony", "fig": 2}, {"body": 24, "word": "bones", "fig": 1}, {"body": 10, "word": "cells", "fig": 2}, {"body": 18, "word": "axolotl", "fig": 1}, {"body": 13, "word": "embryonic", "fig": 1}, {"body": 13, "word": "hyoid", "fig": 1}, {"body": 12, "word": "bone", "fig": 1}, {"body": 10, "word": "mandibular", "fig": 1}, {"body": 6, "word": "sections", "fig": 1}, {"body": 4, "word": "frontal", "fig": 1}, {"body": 4, "word": "parietal", "fig": 1}, {"body": 2, "word": "matrix", "fig": 2}, {"body": 2, "word": "red", "fig": 2}, {"body": 3, "word": "source", "fig": 1}, {"body": 3, "word": "within", "fig": 1}, {"body": 3, "word": "also", "fig": 1}, {"body": 1, "word": "labelled", "fig": 3}, {"body": 2, "word": "show", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "osteocytes", "fig": 1}, {"body": 2, "word": "cell", "fig": 1}, {"body": 2, "word": "grafts", "fig": 1}, {"body": 2, "word": "nasal", "fig": 1}, {"body": 1, "word": "green", "fig": 2}, {"body": 1, "word": "brain", "fig": 1}, {"body": 1, "word": "principal", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "section", "fig": 1}, {"body": 1, "word": "pterygoid", "fig": 1}, {"body": 1, "word": "transverse", "fig": 1}, {"body": 1, "word": "external", "fig": 1}, {"body": 1, "word": "axolotls", "fig": 1}, {"body": 1, "word": "stapes", "fig": 1}, {"body": 1, "word": "lines", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f6.jpg", "caption": "All three CNC streams contribute to the osteocranium in X. laevis. Transverse sections are from postmetamorphic frogs that received GFP-positive embryonic grafts of the mandibular (a\u2013l), hyoid (m\u2013t) or branchial (u\u2013x) stream. Each pair of images depicts adjacent sections of the grafted (left) side. In most, the left section is stained histologically to reveal cartilage (blue) and bone (red); a,m are viewed with Nomarski (differential interference contrast) microscopy. The right section is immunostained for GFP (green); cell nuclei are counterstained blue. Note the composite origin of the premaxilla from both mandibular (a,b) and hyoid (m,n) streams. Scale bar, 50 \u03bcm.", "co_occurrence": [{"body": 31, "word": "CNC", "fig": 1}, {"body": 13, "word": "hyoid", "fig": 2}, {"body": 24, "word": "stream", "fig": 1}, {"body": 10, "word": "mandibular", "fig": 2}, {"body": 19, "word": "The", "fig": 1}, {"body": 7, "word": "streams", "fig": 2}, {"body": 13, "word": "embryonic", "fig": 1}, {"body": 6, "word": "sections", "fig": 2}, {"body": 12, "word": "bone", "fig": 1}, {"body": 9, "word": "osteocranium", "fig": 1}, {"body": 6, "word": "frogs", "fig": 1}, {"body": 6, "word": "GFP-positive", "fig": 1}, {"body": 6, "word": "GFP", "fig": 1}, {"body": 6, "word": "In", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "branchial", "fig": 1}, {"body": 4, "word": "laevis", "fig": 1}, {"body": 4, "word": "side", "fig": 1}, {"body": 4, "word": "reveal", "fig": 1}, {"body": 2, "word": "left", "fig": 2}, {"body": 3, "word": "X.", "fig": 1}, {"body": 2, "word": "origin", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 1, "word": "section", "fig": 2}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "cell", "fig": 1}, {"body": 2, "word": "adjacent", "fig": 1}, {"body": 2, "word": "grafts", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 2, "word": "premaxilla", "fig": 1}, {"body": 2, "word": "All", "fig": 1}, {"body": 1, "word": "contribute", "fig": 1}, {"body": 1, "word": "Each", "fig": 1}, {"body": 1, "word": "grafted", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "postmetamorphic", "fig": 1}, {"body": 1, "word": "viewed", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f7.jpg", "caption": "Hypothesis for the evolution of CNC derivation of the bony skull. Coloured regions depict contributions to the osteocranium from the three CNC migratory streams in four tetrapod model systems. Stream-level contributions are not known in the mouse, but they are presumed to resemble those in the chicken46. It is most parsimonious to posit that urodeles and amniotes share a common pattern of CNC derivation, which evolved no later than their common tetrapod ancestor (blue bar on the simplified phylogeny), and that the unique pattern in Xenopus evolved after the anuran clade diverged from urodeles (green bar).", "co_occurrence": [{"body": 31, "word": "CNC", "fig": 3}, {"body": 24, "word": "derivation", "fig": 2}, {"body": 23, "word": "pattern", "fig": 2}, {"body": 36, "word": "skull", "fig": 1}, {"body": 22, "word": "Xenopus", "fig": 1}, {"body": 9, "word": "contributions", "fig": 2}, {"body": 15, "word": "bony", "fig": 1}, {"body": 9, "word": "osteocranium", "fig": 1}, {"body": 4, "word": "evolved", "fig": 2}, {"body": 7, "word": "amniotes", "fig": 1}, {"body": 7, "word": "unique", "fig": 1}, {"body": 7, "word": "streams", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 2, "word": "common", "fig": 2}, {"body": 2, "word": "urodeles", "fig": 2}, {"body": 2, "word": "tetrapod", "fig": 2}, {"body": 3, "word": "migratory", "fig": 1}, {"body": 3, "word": "clade", "fig": 1}, {"body": 3, "word": "evolution", "fig": 1}, {"body": 3, "word": "diverged", "fig": 1}, {"body": 2, "word": "anuran", "fig": 1}, {"body": 2, "word": "It", "fig": 1}, {"body": 1, "word": "share", "fig": 1}, {"body": 1, "word": "mouse", "fig": 1}, {"body": 1, "word": "regions", "fig": 1}, {"body": 1, "word": "green", "fig": 1}, {"body": 1, "word": "ancestor", "fig": 1}, {"body": 1, "word": "presumed", "fig": 1}, {"body": 1, "word": "later", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251486/bin/ncomms6661-f8.jpg", "caption": "Grafting procedure. (a) Photograph of a living stage-16 axolotl embryo38, dorsal view, anterior at the top. Paired neural folds are about to meet in the midline and fuse postcranially, but they remain prominent and far apart in the head. (b) Drawing of stage-17 embryos depicting the seven regions within the left cranial neural fold39 that were grafted individually from GFP-positive donor embryos (green) into wild-type hosts. The approximate locations of premigratory mandibular, hyoid and branchial stream neural crest are depicted on the right side of the host embryo. (c) Stage-36 embryo in lateral view depicting migratory streams of mandibular, hyoid and branchial neural crest, which occupy the rostral region of the head and the oropharyngeal arches. (d\u2013f) Donor-derived CNC cells (green) migrating within the first, second and posterior oropharyngeal arches are visible in living chimeric embryos following grafts of premigratory mandibular, hyoid and branchial stream neural crest, respectively. Mandibular stream neural crest also populates the rostral region of the head in d. Lateral views, anterior is to the left. Scale bar, 1 mm.", "co_occurrence": [{"body": 21, "word": "neural", "fig": 6}, {"body": 24, "word": "stream", "fig": 3}, {"body": 16, "word": "crest", "fig": 4}, {"body": 13, "word": "hyoid", "fig": 3}, {"body": 31, "word": "CNC", "fig": 1}, {"body": 10, "word": "mandibular", "fig": 3}, {"body": 19, "word": "The", "fig": 1}, {"body": 18, "word": "axolotl", "fig": 1}, {"body": 5, "word": "branchial", "fig": 3}, {"body": 13, "word": "cranial", "fig": 1}, {"body": 4, "word": "embryos", "fig": 3}, {"body": 5, "word": "embryo", "fig": 2}, {"body": 10, "word": "cells", "fig": 1}, {"body": 7, "word": "streams", "fig": 1}, {"body": 6, "word": "GFP-positive", "fig": 1}, {"body": 3, "word": "region", "fig": 2}, {"body": 3, "word": "anterior", "fig": 2}, {"body": 3, "word": "within", "fig": 2}, {"body": 4, "word": "side", "fig": 1}, {"body": 2, "word": "living", "fig": 2}, {"body": 2, "word": "rostral", "fig": 2}, {"body": 2, "word": "oropharyngeal", "fig": 2}, {"body": 4, "word": "donor", "fig": 1}, {"body": 2, "word": "left", "fig": 2}, {"body": 3, "word": "migratory", "fig": 1}, {"body": 3, "word": "wild-type", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 3, "word": "also", "fig": 1}, {"body": 2, "word": "hosts", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "host", "fig": 1}, {"body": 2, "word": "visible", "fig": 1}, {"body": 2, "word": "grafts", "fig": 1}, {"body": 2, "word": "posterior", "fig": 1}, {"body": 1, "word": "green", "fig": 2}, {"body": 1, "word": "Grafting", "fig": 1}, {"body": 1, "word": "grafted", "fig": 1}, {"body": 1, "word": "far", "fig": 1}, {"body": 1, "word": "individually", "fig": 1}, {"body": 1, "word": "folds", "fig": 1}, {"body": 1, "word": "populates", "fig": 1}, {"body": 1, "word": "midline", "fig": 1}, {"body": 1, "word": "remain", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "first", "fig": 1}, {"body": 1, "word": "seven", "fig": 1}, {"body": 1, "word": "regions", "fig": 1}, {"body": 1, "word": "dorsal", "fig": 1}]}], "4816316": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816316/bin/pone.0152321.g001.jpg", "caption": "Localization of Nup98 fusion proteins. HeLa cells were transiently transfected with GFP constructs and visualized after 24 hours by direct fluorescence microscopy. All fusion proteins localize to the nucleus. (A) GFP-Nup98 is found at the nuclear rim and in the nucleoplasm, whereas Nup98 homeodomain fusions exhibit a punctate pattern: (B) GFP-Nup98-HOXA9, (C) GFP-Nup98-HOXA10, (D) GFP-Nup98-HHEX, and (E) GFP-Nup98-PMX1. Nup98 fusions with other chromatin-binding motifs show a different punctate distribution: (F) GFP-Nup98-JARID1A, and (G) GFP-Nup98-PHF23 (H) GFP-Nup98-NSD1, (I) GFP-Nup98-NSD3 and (K) GFP-Nup98-RARG. Nup98 fused to partners that lack chromatin-binding domains localize more dispersed to the nucleoplasm: (L) GFP-Nup98-LEDGF. Disruption of the FG, the HD or the PHD domain disrupts the localization of the Nup98 chimeras: (M) GFP-Nup98-PMX1 N51S, (N) GFP-Nup98-HOXA9 \u0394FG, (O) GFP-Nup98-HOXA9 N51S, (P) GFP-Nup98-HHEX \u0394FG, (Q) GFP-Nup98-HHEX \u0394HD, and (R) GFP-Nup98-JARID1A W1625A. (S) GFP-HOXA9 and (T) GFP-HHEX localize to the nucleoplasm. Shown are representative confocal images. Scale bars, 5 \u03bcm.", "co_occurrence": [{"body": 76, "word": "Nup98", "fig": 5}, {"body": 107, "word": "cells", "fig": 1}, {"body": 41, "word": "fusion", "fig": 2}, {"body": 41, "word": "proteins", "fig": 2}, {"body": 22, "word": "GFP-Nup98-HOXA9", "fig": 3}, {"body": 21, "word": "fusions", "fig": 2}, {"body": 13, "word": "nucleoplasm", "fig": 3}, {"body": 38, "word": "HeLa", "fig": 1}, {"body": 30, "word": "nuclear", "fig": 1}, {"body": 9, "word": "GFP-Nup98-HHEX", "fig": 3}, {"body": 10, "word": "\u0394FG", "fig": 2}, {"body": 20, "word": "chimeras", "fig": 1}, {"body": 10, "word": "GFP-Nup98-PMX1", "fig": 2}, {"body": 19, "word": "found", "fig": 1}, {"body": 19, "word": "localization", "fig": 1}, {"body": 9, "word": "N51S", "fig": 2}, {"body": 16, "word": "HD", "fig": 1}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 15, "word": "hours", "fig": 1}, {"body": 14, "word": "domain", "fig": 1}, {"body": 13, "word": "distribution", "fig": 1}, {"body": 4, "word": "localize", "fig": 3}, {"body": 12, "word": "GFP-Nup98", "fig": 1}, {"body": 6, "word": "GFP-Nup98-JARID1A", "fig": 2}, {"body": 12, "word": "A", "fig": 1}, {"body": 12, "word": "GFP", "fig": 1}, {"body": 10, "word": "microscopy", "fig": 1}, {"body": 10, "word": "transiently", "fig": 1}, {"body": 4, "word": "punctate", "fig": 2}, {"body": 8, "word": "pattern", "fig": 1}, {"body": 7, "word": "\u03bcm", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "constructs", "fig": 1}, {"body": 6, "word": "All", "fig": 1}, {"body": 5, "word": "show", "fig": 1}, {"body": 5, "word": "partners", "fig": 1}, {"body": 5, "word": "Scale", "fig": 1}, {"body": 5, "word": "domains", "fig": 1}, {"body": 5, "word": "bars", "fig": 1}, {"body": 5, "word": "FG", "fig": 1}, {"body": 5, "word": "homeodomain", "fig": 1}, {"body": 5, "word": "whereas", "fig": 1}, {"body": 4, "word": "PHD", "fig": 1}, {"body": 4, "word": "S", "fig": 1}, {"body": 4, "word": "GFP-HOXA9", "fig": 1}, {"body": 4, "word": "nucleus", "fig": 1}, {"body": 3, "word": "GFP-Nup98-NSD3", "fig": 1}, {"body": 3, "word": "GFP-Nup98-NSD1", "fig": 1}, {"body": 3, "word": "GFP-Nup98-RARG", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "fused", "fig": 1}, {"body": 3, "word": "different", "fig": 1}, {"body": 3, "word": "\u0394HD", "fig": 1}, {"body": 2, "word": "GFP-HHEX", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "GFP-Nup98-PHF23", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "W1625A", "fig": 1}, {"body": 2, "word": "confocal", "fig": 1}, {"body": 1, "word": "chromatin-binding", "fig": 2}, {"body": 2, "word": "GFP-Nup98-HOXA10", "fig": 1}, {"body": 2, "word": "GFP-Nup98-LEDGF", "fig": 1}, {"body": 1, "word": "lack", "fig": 1}, {"body": 1, "word": "visualized", "fig": 1}, {"body": 1, "word": "direct", "fig": 1}, {"body": 1, "word": "N", "fig": 1}, {"body": 1, "word": "R", "fig": 1}, {"body": 1, "word": "rim", "fig": 1}, {"body": 1, "word": "fluorescence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816316/bin/pone.0152321.g002.jpg", "caption": "Mitotic localization of Nup98 chimeras. HeLa cells were transiently transfected with GFP constructs and fixed and stained after 24 hours for immunofluorescence microscopy. (A) CREST serum, which in particular recognizes CENP-B [36, 55], was used to detect the inner kinetochore and DAPI to visualize DNA. Nup98-HD fusion proteins (Nup98-HOXA9, Nup98-HHEX, Nup98-PMX1; green) associate with chromatin (blue), but not with the inner kinetochore (red) during prometaphase. No association with chromatin was found for Nup98 or Nup98 fused to non-HD partners (i.e. Nup98-JARID1A and Nup98-RARG). Disruption of the HD domain of Nup98-HOXA9 (Nup98-HOXA9 N51S), but not of the FG domain (Nup98-HOXA9 \u0394FG) affects chromatin association of the fusion protein. Shown are single confocal sections. Scale bars, 5 \u03bcm. (B) Anti-Hec1 antibodies were used to detect the outer kinetochore (red), but no co-localization of Nup98-HOXA9, Nup98-HHEX, and Nup98-PMX1, respectively (green) was observed in prometaphase cells. The fusion proteins exclusively associated with chromatin (blue). Shown are single confocal sections. Scale bars, 5 \u03bcm.", "co_occurrence": [{"body": 76, "word": "Nup98", "fig": 3}, {"body": 107, "word": "cells", "fig": 2}, {"body": 28, "word": "Nup98-HOXA9", "fig": 5}, {"body": 41, "word": "fusion", "fig": 3}, {"body": 41, "word": "proteins", "fig": 2}, {"body": 15, "word": "chromatin", "fig": 4}, {"body": 38, "word": "HeLa", "fig": 1}, {"body": 15, "word": "Nup98-PMX1", "fig": 2}, {"body": 14, "word": "Nup98-HHEX", "fig": 2}, {"body": 14, "word": "domain", "fig": 2}, {"body": 26, "word": "The", "fig": 1}, {"body": 20, "word": "chimeras", "fig": 1}, {"body": 19, "word": "found", "fig": 1}, {"body": 19, "word": "localization", "fig": 1}, {"body": 16, "word": "HD", "fig": 1}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 15, "word": "hours", "fig": 1}, {"body": 14, "word": "non-HD", "fig": 1}, {"body": 7, "word": "\u03bcm", "fig": 2}, {"body": 7, "word": "used", "fig": 2}, {"body": 13, "word": "protein", "fig": 1}, {"body": 6, "word": "association", "fig": 2}, {"body": 12, "word": "Nup98-HD", "fig": 1}, {"body": 4, "word": "kinetochore", "fig": 3}, {"body": 12, "word": "A", "fig": 1}, {"body": 12, "word": "GFP", "fig": 1}, {"body": 11, "word": "respectively", "fig": 1}, {"body": 10, "word": "\u0394FG", "fig": 1}, {"body": 10, "word": "microscopy", "fig": 1}, {"body": 10, "word": "fixed", "fig": 1}, {"body": 5, "word": "Scale", "fig": 2}, {"body": 5, "word": "red", "fig": 2}, {"body": 5, "word": "bars", "fig": 2}, {"body": 5, "word": "inner", "fig": 2}, {"body": 10, "word": "transiently", "fig": 1}, {"body": 9, "word": "N51S", "fig": 1}, {"body": 8, "word": "observed", "fig": 1}, {"body": 8, "word": "antibodies", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "constructs", "fig": 1}, {"body": 6, "word": "outer", "fig": 1}, {"body": 6, "word": "DNA", "fig": 1}, {"body": 6, "word": "particular", "fig": 1}, {"body": 6, "word": "immunofluorescence", "fig": 1}, {"body": 5, "word": "partners", "fig": 1}, {"body": 5, "word": "stained", "fig": 1}, {"body": 5, "word": "FG", "fig": 1}, {"body": 5, "word": "CREST", "fig": 1}, {"body": 5, "word": "Nup98-JARID1A", "fig": 1}, {"body": 5, "word": "serum", "fig": 1}, {"body": 4, "word": "Nup98-RARG", "fig": 1}, {"body": 4, "word": "associate", "fig": 1}, {"body": 2, "word": "confocal", "fig": 2}, {"body": 3, "word": "DAPI", "fig": 1}, {"body": 3, "word": "fused", "fig": 1}, {"body": 2, "word": "co-localization", "fig": 1}, {"body": 2, "word": "i.e", "fig": 1}, {"body": 2, "word": "associated", "fig": 1}, {"body": 1, "word": "single", "fig": 2}, {"body": 1, "word": "detect", "fig": 2}, {"body": 1, "word": "recognizes", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816316/bin/pone.0152321.g003.jpg", "caption": "Nup98-HOXA9 affects lamin A/C and lamin B1 distribution. HeLa cells were transiently transfected with GFP constructs and fixed and stained after 24 hours for immunofluorescence microscopy. (A) Lamin A/C (LA/C, red) and lamin B1 (LB1, magenta) concentrate at the nuclear envelope (NE) in HeLa cells expressing Nup98 (green), but relocate to the nucleoplasm in cells expressing Nup98-HOXA9. White arrowheads point to some lobules decorating the NE. Disruption of the homeodomain of HOXA9 (Nup98-HOXA9 N51S) and the FG domain of Nup98 (Nup98-HOXA9 \u0394FG) prevent the relocation of the lamina proteins. Scale bars, 5 \u03bcm. (B) Fluorescence intensity of LA/C (left) and LB1 (right) staining was determined along the axis shown as line in the fluorescence images and plotted as a graph.", "co_occurrence": [{"body": 107, "word": "cells", "fig": 3}, {"body": 76, "word": "Nup98", "fig": 2}, {"body": 41, "word": "lamin", "fig": 3}, {"body": 28, "word": "Nup98-HOXA9", "fig": 4}, {"body": 39, "word": "expressing", "fig": 2}, {"body": 38, "word": "HeLa", "fig": 2}, {"body": 30, "word": "A/C", "fig": 2}, {"body": 21, "word": "NE", "fig": 2}, {"body": 41, "word": "proteins", "fig": 1}, {"body": 30, "word": "nuclear", "fig": 1}, {"body": 14, "word": "B1", "fig": 2}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 15, "word": "hours", "fig": 1}, {"body": 14, "word": "domain", "fig": 1}, {"body": 13, "word": "nucleoplasm", "fig": 1}, {"body": 13, "word": "distribution", "fig": 1}, {"body": 12, "word": "shown", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 12, "word": "GFP", "fig": 1}, {"body": 11, "word": "lamina", "fig": 1}, {"body": 10, "word": "\u0394FG", "fig": 1}, {"body": 10, "word": "microscopy", "fig": 1}, {"body": 10, "word": "fixed", "fig": 1}, {"body": 10, "word": "transiently", "fig": 1}, {"body": 9, "word": "N51S", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 4, "word": "LA/C", "fig": 2}, {"body": 7, "word": "\u03bcm", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "constructs", "fig": 1}, {"body": 6, "word": "immunofluorescence", "fig": 1}, {"body": 5, "word": "stained", "fig": 1}, {"body": 5, "word": "Scale", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "bars", "fig": 1}, {"body": 5, "word": "FG", "fig": 1}, {"body": 5, "word": "homeodomain", "fig": 1}, {"body": 2, "word": "LB1", "fig": 2}, {"body": 4, "word": "Lamin", "fig": 1}, {"body": 4, "word": "HOXA9", "fig": 1}, {"body": 3, "word": "intensity", "fig": 1}, {"body": 3, "word": "envelope", "fig": 1}, {"body": 2, "word": "lobules", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "along", "fig": 1}, {"body": 1, "word": "White", "fig": 1}, {"body": 1, "word": "arrowheads", "fig": 1}, {"body": 1, "word": "decorating", "fig": 1}, {"body": 1, "word": "relocate", "fig": 1}, {"body": 1, "word": "point", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "magenta", "fig": 1}, {"body": 1, "word": "axis", "fig": 1}, {"body": 1, "word": "fluorescence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816316/bin/pone.0152321.g004.jpg", "caption": "Electron micrographs of HeLa cells expressing Nup98 chimeras. (A) and (B) Nup98-HOXA9, (C) and (D) Nup98-HHEX, control cells expressing (E) GFP and (F) Nup98. HeLa TRex cells expressing (G) Nup98 and (H) Nup98-HOXA9. Scale bars, 2 \u03bcm (A, C, E, F, G, H); 1 \u03bcm (B and D).", "co_occurrence": [{"body": 107, "word": "cells", "fig": 3}, {"body": 76, "word": "Nup98", "fig": 3}, {"body": 39, "word": "expressing", "fig": 3}, {"body": 38, "word": "HeLa", "fig": 2}, {"body": 28, "word": "Nup98-HOXA9", "fig": 2}, {"body": 12, "word": "A", "fig": 2}, {"body": 20, "word": "chimeras", "fig": 1}, {"body": 7, "word": "B", "fig": 2}, {"body": 7, "word": "\u03bcm", "fig": 2}, {"body": 14, "word": "Nup98-HHEX", "fig": 1}, {"body": 12, "word": "GFP", "fig": 1}, {"body": 3, "word": "C", "fig": 2}, {"body": 5, "word": "Scale", "fig": 1}, {"body": 5, "word": "bars", "fig": 1}, {"body": 2, "word": "D", "fig": 2}, {"body": 3, "word": "control", "fig": 1}, {"body": 2, "word": "Electron", "fig": 1}, {"body": 1, "word": "TRex", "fig": 1}, {"body": 1, "word": "micrographs", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816316/bin/pone.0152321.g005.jpg", "caption": "Expression of Nup98 fusions perturbs the nuclear distribution of lamina-associated polypeptide 2\u03b1 (LAP2\u03b1). HeLa cells were transiently transfected with GFP constructs and fixed and stained after 24 hours for immunofluorescence microscopy. (A) Lamin A/C (LA/C, red) concentrates at the nuclear envelope in HeLa control cells and in Nup98 expressing cells (green), while LAP2\u03b1 (magenta) is found throughout the nucleoplasm. In HeLa cells expressing Nup98-HOXA9 (A) and Nup98-HHEX (B), LAP2\u03b1 diminished from the nucleoplasm and aggregates at the nuclear periphery. Disruption of the homeodomain in HOXA9 (A) and HHEX (B) and the FG domain of Nup98 (A and B) prevent the relocation of the lamina proteins. DAPI was used to visualize DNA (merge). (B) Fluorescence intensity of LAP2\u03b1 staining was determined along the axis shown as line in the fluorescence images and plotted as a graph. (D) Quantification of cells with altered LA/C and LAP2\u03b1 distribution. About 400 cells were analyzed for each sample. (E) Western blot analysis of the expression levels of LA/C, LAP2\u03b1, and LB1.", "co_occurrence": [{"body": 107, "word": "cells", "fig": 6}, {"body": 58, "word": "LAP2\u03b1", "fig": 6}, {"body": 76, "word": "Nup98", "fig": 3}, {"body": 38, "word": "HeLa", "fig": 3}, {"body": 30, "word": "nuclear", "fig": 3}, {"body": 39, "word": "expressing", "fig": 2}, {"body": 12, "word": "A", "fig": 4}, {"body": 41, "word": "proteins", "fig": 1}, {"body": 30, "word": "A/C", "fig": 1}, {"body": 28, "word": "Nup98-HOXA9", "fig": 1}, {"body": 7, "word": "B", "fig": 4}, {"body": 13, "word": "nucleoplasm", "fig": 2}, {"body": 13, "word": "distribution", "fig": 2}, {"body": 22, "word": "expression", "fig": 1}, {"body": 21, "word": "fusions", "fig": 1}, {"body": 19, "word": "found", "fig": 1}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 15, "word": "hours", "fig": 1}, {"body": 14, "word": "Nup98-HHEX", "fig": 1}, {"body": 14, "word": "domain", "fig": 1}, {"body": 4, "word": "LA/C", "fig": 3}, {"body": 12, "word": "shown", "fig": 1}, {"body": 12, "word": "GFP", "fig": 1}, {"body": 11, "word": "lamina", "fig": 1}, {"body": 10, "word": "microscopy", "fig": 1}, {"body": 10, "word": "fixed", "fig": 1}, {"body": 10, "word": "transiently", "fig": 1}, {"body": 10, "word": "In", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 7, "word": "constructs", "fig": 1}, {"body": 7, "word": "levels", "fig": 1}, {"body": 7, "word": "analysis", "fig": 1}, {"body": 6, "word": "Western", "fig": 1}, {"body": 6, "word": "DNA", "fig": 1}, {"body": 6, "word": "immunofluorescence", "fig": 1}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "stained", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "FG", "fig": 1}, {"body": 5, "word": "homeodomain", "fig": 1}, {"body": 4, "word": "Lamin", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 4, "word": "HOXA9", "fig": 1}, {"body": 4, "word": "altered", "fig": 1}, {"body": 3, "word": "intensity", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "lamina-associated", "fig": 1}, {"body": 3, "word": "control", "fig": 1}, {"body": 3, "word": "throughout", "fig": 1}, {"body": 3, "word": "envelope", "fig": 1}, {"body": 2, "word": "periphery", "fig": 1}, {"body": 2, "word": "LB1", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "along", "fig": 1}, {"body": 2, "word": "diminished", "fig": 1}, {"body": 2, "word": "polypeptide", "fig": 1}, {"body": 2, "word": "2\u03b1", "fig": 1}, {"body": 2, "word": "aggregates", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 1}, {"body": 1, "word": "concentrates", "fig": 1}, {"body": 1, "word": "HHEX", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "sample", "fig": 1}, {"body": 1, "word": "magenta", "fig": 1}, {"body": 1, "word": "axis", "fig": 1}, {"body": 1, "word": "fluorescence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816316/bin/pone.0152321.g006.jpg", "caption": "Lamina-associated polypeptide 2\u03b1 (LAP2\u03b1) is altered in Nup98 fusion expressing leukemic cells. (A) Mouse bone marrow cells were transduced with retroviral particles to express untagged Nup98-HOXA9 and Nup98-HHEX and stained for immunofluorescence microscopy. Expression of these fusion proteins induced lobulations in the NE as evident from the lamin B1 staining (LB1, green). Whereas lamin A/C is not expressed in mouse BM cells (LA/C, magenta), LAP2\u03b1 (red) is evenly distributed in nuclei from total bone marrow (TBM) cells and lineage minus precursor cells (Lin-), it is diminished from the nucleoplasm and aggregates at the nuclear periphery of mouse BM cells expressing Nup98-HHEX and Nup98-HOXA9, respectively. Electron micrographs of mouse bone marrow cells transduced with (B) Nup98-HHEX and (C) Nup98-HOXA9. Scale bars, 2 \u03bcm (C); 1 \u03bcm (B). (D) Lamin B1 staining of patient-derived bone marrow cells revealed irregular NE contour. Lamin A/C is not consistently expressed in patient cells and LAP2\u03b1 is diminished from the nucleoplasm and aggregates at the nuclear periphery. Patient 1 harbored a Nup98-RAP1GDS1, patient 2 a Nup98-NSD1, and patient 3 a Nup98-DDX10 fusion, respectively. Scale bars, 10 \u03bcm.", "co_occurrence": [{"body": 107, "word": "cells", "fig": 9}, {"body": 58, "word": "LAP2\u03b1", "fig": 3}, {"body": 41, "word": "fusion", "fig": 3}, {"body": 28, "word": "Nup98-HOXA9", "fig": 3}, {"body": 41, "word": "lamin", "fig": 2}, {"body": 39, "word": "expressing", "fig": 2}, {"body": 76, "word": "Nup98", "fig": 1}, {"body": 30, "word": "A/C", "fig": 2}, {"body": 15, "word": "bone", "fig": 4}, {"body": 30, "word": "nuclear", "fig": 2}, {"body": 15, "word": "marrow", "fig": 4}, {"body": 14, "word": "Nup98-HHEX", "fig": 3}, {"body": 21, "word": "NE", "fig": 2}, {"body": 41, "word": "proteins", "fig": 1}, {"body": 11, "word": "mouse", "fig": 3}, {"body": 14, "word": "B1", "fig": 2}, {"body": 13, "word": "nucleoplasm", "fig": 2}, {"body": 11, "word": "respectively", "fig": 2}, {"body": 7, "word": "\u03bcm", "fig": 3}, {"body": 8, "word": "staining", "fig": 2}, {"body": 5, "word": "patient", "fig": 3}, {"body": 7, "word": "B", "fig": 2}, {"body": 12, "word": "A", "fig": 1}, {"body": 5, "word": "BM", "fig": 2}, {"body": 10, "word": "microscopy", "fig": 1}, {"body": 5, "word": "bars", "fig": 2}, {"body": 5, "word": "Scale", "fig": 2}, {"body": 4, "word": "Lamin", "fig": 2}, {"body": 7, "word": "revealed", "fig": 1}, {"body": 3, "word": "C", "fig": 2}, {"body": 6, "word": "immunofluorescence", "fig": 1}, {"body": 5, "word": "stained", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "leukemic", "fig": 1}, {"body": 2, "word": "periphery", "fig": 2}, {"body": 4, "word": "LA/C", "fig": 1}, {"body": 2, "word": "expressed", "fig": 2}, {"body": 2, "word": "diminished", "fig": 2}, {"body": 4, "word": "Lin-", "fig": 1}, {"body": 4, "word": "Nup98-NSD1", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 4, "word": "altered", "fig": 1}, {"body": 2, "word": "aggregates", "fig": 2}, {"body": 4, "word": "nuclei", "fig": 1}, {"body": 3, "word": "consistently", "fig": 1}, {"body": 3, "word": "TBM", "fig": 1}, {"body": 3, "word": "lobulations", "fig": 1}, {"body": 2, "word": "LB1", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "patient-derived", "fig": 1}, {"body": 2, "word": "lineage", "fig": 1}, {"body": 2, "word": "retroviral", "fig": 1}, {"body": 2, "word": "polypeptide", "fig": 1}, {"body": 2, "word": "2\u03b1", "fig": 1}, {"body": 2, "word": "Electron", "fig": 1}, {"body": 1, "word": "distributed", "fig": 1}, {"body": 1, "word": "express", "fig": 1}, {"body": 1, "word": "Mouse", "fig": 1}, {"body": 1, "word": "Patient", "fig": 1}, {"body": 1, "word": "particles", "fig": 1}, {"body": 1, "word": "total", "fig": 1}, {"body": 1, "word": "untagged", "fig": 1}, {"body": 1, "word": "magenta", "fig": 1}, {"body": 1, "word": "micrographs", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816316/bin/pone.0152321.g007.jpg", "caption": "Expression of Nup98 fusion proteins deregulates cell cycle progression. HeLa cells were transiently transfected with GFP-Nup98-HOXA9 and GFP-Nup98-PMX1 and analyzed by live cell imaging and flow cytometry after release from a double-thymidine block. (A) Schematic presentation of the time course for live cell imaging and flow cytometric analysis. (B) GFP and differential interference contrast time-lapse images of HeLa cells after release from double-thymidine block are presented. Cells expressing Nup98-HOXA9 and Nup98-PMX1, respectively, show a delay in the re-entry into the cell cycle. Time is indicated in minutes. (C) Boxplot display of the quantitative analysis of the time between double-thymidine release and onset of mitosis. (D) Quantitative analysis of the relative time of mitosis onset. The differences between GFP, GFP-Nup98-HOXA9 and GFP-Nup98-PMX1 expressing cells were statistically highly relevant (**P>0.01; ***P>0.001). (E) DNA flow cytometry of control, GFP-Nup98-HOXA9 and GFP-Nup98-PMX1 expressing cells nine hours after release a double thymidine block. The differences between GFP, GFP-Nup98-HOXA9 and GFP-Nup98-PMX1 expressing cells were statistically highly relevant (**P>0.01; ***P>0.001; ****P>0.0001).", "co_occurrence": [{"body": 107, "word": "cells", "fig": 5}, {"body": 39, "word": "expressing", "fig": 4}, {"body": 22, "word": "GFP-Nup98-HOXA9", "fig": 4}, {"body": 21, "word": "cell", "fig": 4}, {"body": 38, "word": "HeLa", "fig": 2}, {"body": 76, "word": "Nup98", "fig": 1}, {"body": 26, "word": "The", "fig": 2}, {"body": 12, "word": "release", "fig": 4}, {"body": 41, "word": "fusion", "fig": 1}, {"body": 41, "word": "proteins", "fig": 1}, {"body": 10, "word": "GFP-Nup98-PMX1", "fig": 4}, {"body": 12, "word": "GFP", "fig": 3}, {"body": 16, "word": "mitosis", "fig": 2}, {"body": 28, "word": "Nup98-HOXA9", "fig": 1}, {"body": 12, "word": "cycle", "fig": 2}, {"body": 7, "word": "block", "fig": 3}, {"body": 7, "word": "analysis", "fig": 3}, {"body": 16, "word": "thymidine", "fig": 1}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 15, "word": "hours", "fig": 1}, {"body": 15, "word": "Nup98-PMX1", "fig": 1}, {"body": 12, "word": "contrast", "fig": 1}, {"body": 6, "word": "imaging", "fig": 2}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "Cells", "fig": 1}, {"body": 11, "word": "respectively", "fig": 1}, {"body": 10, "word": "transiently", "fig": 1}, {"body": 9, "word": "progression", "fig": 1}, {"body": 3, "word": "flow", "fig": 3}, {"body": 8, "word": "double", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "DNA", "fig": 1}, {"body": 2, "word": "time", "fig": 3}, {"body": 5, "word": "show", "fig": 1}, {"body": 5, "word": "minutes", "fig": 1}, {"body": 2, "word": "live", "fig": 2}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 2, "word": "cytometry", "fig": 2}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "control", "fig": 1}, {"body": 2, "word": "delay", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "cytometric", "fig": 1}, {"body": 2, "word": "relative", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 1, "word": "onset", "fig": 2}, {"body": 1, "word": "differential", "fig": 1}, {"body": 1, "word": "interference", "fig": 1}, {"body": 1, "word": "time-lapse", "fig": 1}, {"body": 1, "word": "re-entry", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}]}], "3266931": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g001.jpg", "caption": "IFI16 protein is a negative regulator of Herpesvirus replication. A) HELFs were electroporated with a mixture of four different small interfering RNAs (siRNA IFI16), scrambled control siRNA (siRNA ctrl), or left not electroporated (NE), and then infected with the indicated viruses at a multiplicity of 0.05 PFU/cell. Cell-free supernatants were harvested on the indicated hours post infection (hpi) and virus amounts determined by plaque assays. The data shown are the average of three experiments \u00b1 SD (*p<0.05, **p<0.01, ***p<0.001, one-way ANOVA followed by Bonferroni's post test). B) HELFs were transfected with siRNA IFI16 or siRNA ctrl or left not electroporated (NE) and IFI16 expression assayed by Western blotting on the indicated days (d) with anti-IFI16 polyclonal Abs. \u03b2-actin was included as a loading control. C) HELFs were treated with siRNA as described for panel A and then infected with HCMV at an MOI of 0.05 (left panel) or 1 (right panel) PFU/cell. Cell-free supernatants were harvested on the indicated hours post infection and the virus amounts determined by plaque assays. The data shown are the average of three experiments \u00b1 SD.", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 4}, {"body": 23, "word": "siRNA", "fig": 6}, {"body": 37, "word": "HELFs", "fig": 3}, {"body": 100, "word": "HCMV", "fig": 1}, {"body": 44, "word": "The", "fig": 2}, {"body": 38, "word": "infected", "fig": 2}, {"body": 33, "word": "control", "fig": 2}, {"body": 53, "word": "replication", "fig": 1}, {"body": 26, "word": "shown", "fig": 2}, {"body": 21, "word": "infection", "fig": 2}, {"body": 34, "word": "protein", "fig": 1}, {"body": 11, "word": "left", "fig": 3}, {"body": 16, "word": "experiments", "fig": 2}, {"body": 32, "word": "expression", "fig": 1}, {"body": 31, "word": "MOI", "fig": 1}, {"body": 10, "word": "electroporated", "fig": 3}, {"body": 15, "word": "virus", "fig": 2}, {"body": 14, "word": "ctrl", "fig": 2}, {"body": 13, "word": "data", "fig": 2}, {"body": 8, "word": "panel", "fig": 3}, {"body": 11, "word": "A", "fig": 2}, {"body": 5, "word": "indicated", "fig": 4}, {"body": 6, "word": "post", "fig": 3}, {"body": 7, "word": "three", "fig": 2}, {"body": 14, "word": "different", "fig": 1}, {"body": 14, "word": "hpi", "fig": 1}, {"body": 13, "word": "described", "fig": 1}, {"body": 6, "word": "PFU/cell", "fig": 2}, {"body": 11, "word": "'s", "fig": 1}, {"body": 5, "word": "hours", "fig": 2}, {"body": 4, "word": "SD", "fig": 2}, {"body": 4, "word": "NE", "fig": 2}, {"body": 4, "word": "plaque", "fig": 2}, {"body": 7, "word": "Western", "fig": 1}, {"body": 7, "word": "polyclonal", "fig": 1}, {"body": 7, "word": "negative", "fig": 1}, {"body": 6, "word": "transfected", "fig": 1}, {"body": 3, "word": "determined", "fig": 2}, {"body": 3, "word": "assays", "fig": 2}, {"body": 3, "word": "amounts", "fig": 2}, {"body": 3, "word": "average", "fig": 2}, {"body": 4, "word": "four", "fig": 1}, {"body": 4, "word": "anti-IFI16", "fig": 1}, {"body": 4, "word": "one-way", "fig": 1}, {"body": 4, "word": "Bonferroni", "fig": 1}, {"body": 4, "word": "followed", "fig": 1}, {"body": 2, "word": "harvested", "fig": 2}, {"body": 4, "word": "treated", "fig": 1}, {"body": 3, "word": "ANOVA", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "small", "fig": 1}, {"body": 3, "word": "interfering", "fig": 1}, {"body": 3, "word": "viruses", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "Herpesvirus", "fig": 1}, {"body": 3, "word": "test", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "**p", "fig": 1}, {"body": 2, "word": "mixture", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "Cell-free", "fig": 2}, {"body": 2, "word": "days", "fig": 1}, {"body": 2, "word": "***p", "fig": 1}, {"body": 1, "word": "supernatants", "fig": 2}, {"body": 2, "word": "Abs", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "RNAs", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "assayed", "fig": 1}, {"body": 1, "word": "scrambled", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g002.jpg", "caption": "Effect of dominant negative IFI16 (dnIFI16) overexpression on Herpesvirus growth. A) Western blot analysis was carried out to detect IFI16 and V5 expression in HELFs stably transduced with the recombinant Lentivirus carrying the full-length IFI16 (wtIFI16), mutated forms of IFI16 (dnIFI16), lacking the PYD domain (\u0394PYDIFI16, indicated as \u0394DIFI16), the HIN-B domain (\u0394HIN-BIFI16, indicated as \u0394BIFI16) or expressing the LacZ transgene as negative control (LacZ). \u03b2-actin immunodetection was used to control for equal loading. B) HELFs carrying wtIFI16, \u0394DIFI16, \u0394BIFI16 or the control LacZ gene were infected with HCMV at the indicated MOI. Viral supernatants were collected at 96 hours post infection (hpi) and analyzed by standard plaque assay. The data shown are the average of three experiments \u00b1 SD (*p<0.05, one-way ANOVA followed by Bonferroni's post test).", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 4}, {"body": 100, "word": "HCMV", "fig": 1}, {"body": 33, "word": "control", "fig": 3}, {"body": 37, "word": "HELFs", "fig": 2}, {"body": 19, "word": "LacZ", "fig": 3}, {"body": 44, "word": "The", "fig": 1}, {"body": 38, "word": "gene", "fig": 1}, {"body": 38, "word": "infected", "fig": 1}, {"body": 32, "word": "expression", "fig": 1}, {"body": 31, "word": "MOI", "fig": 1}, {"body": 14, "word": "domain", "fig": 2}, {"body": 14, "word": "\u0394DIFI16", "fig": 2}, {"body": 13, "word": "\u0394BIFI16", "fig": 2}, {"body": 26, "word": "shown", "fig": 1}, {"body": 21, "word": "infection", "fig": 1}, {"body": 16, "word": "experiments", "fig": 1}, {"body": 5, "word": "indicated", "fig": 3}, {"body": 15, "word": "overexpression", "fig": 1}, {"body": 15, "word": "analysis", "fig": 1}, {"body": 7, "word": "negative", "fig": 2}, {"body": 14, "word": "hpi", "fig": 1}, {"body": 13, "word": "data", "fig": 1}, {"body": 6, "word": "post", "fig": 2}, {"body": 11, "word": "'s", "fig": 1}, {"body": 11, "word": "A", "fig": 1}, {"body": 10, "word": "assay", "fig": 1}, {"body": 10, "word": "growth", "fig": 1}, {"body": 10, "word": "used", "fig": 1}, {"body": 4, "word": "wtIFI16", "fig": 2}, {"body": 8, "word": "HIN-B", "fig": 1}, {"body": 7, "word": "Western", "fig": 1}, {"body": 7, "word": "analyzed", "fig": 1}, {"body": 7, "word": "mutated", "fig": 1}, {"body": 7, "word": "transduced", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 6, "word": "lacking", "fig": 1}, {"body": 3, "word": "dnIFI16", "fig": 2}, {"body": 3, "word": "carrying", "fig": 2}, {"body": 5, "word": "PYD", "fig": 1}, {"body": 5, "word": "hours", "fig": 1}, {"body": 5, "word": "collected", "fig": 1}, {"body": 4, "word": "blot", "fig": 1}, {"body": 4, "word": "forms", "fig": 1}, {"body": 4, "word": "one-way", "fig": 1}, {"body": 4, "word": "expressing", "fig": 1}, {"body": 4, "word": "carried", "fig": 1}, {"body": 4, "word": "followed", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 4, "word": "Bonferroni", "fig": 1}, {"body": 4, "word": "plaque", "fig": 1}, {"body": 3, "word": "ANOVA", "fig": 1}, {"body": 3, "word": "recombinant", "fig": 1}, {"body": 3, "word": "standard", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "Herpesvirus", "fig": 1}, {"body": 3, "word": "dominant", "fig": 1}, {"body": 3, "word": "test", "fig": 1}, {"body": 3, "word": "average", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "\u0394HIN-BIFI16", "fig": 1}, {"body": 2, "word": "\u0394PYDIFI16", "fig": 1}, {"body": 2, "word": "Viral", "fig": 1}, {"body": 2, "word": "full-length", "fig": 1}, {"body": 2, "word": "V5", "fig": 1}, {"body": 1, "word": "stably", "fig": 1}, {"body": 1, "word": "detect", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "Effect", "fig": 1}, {"body": 1, "word": "supernatants", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "Lentivirus", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g003.jpg", "caption": "Overexpression of IFI16 reduces HCMV replication by inhibiting viral early and late gene expression. A) Kinetics of Adenovirus-mediated IFI16 overexpression. HELFs were infected with AdV IFI16, AdV LacZ (MOI of 200 PFU/cell), or mock-infected. At the indicated hours post infection (h), total cell extracts were prepared and subjected to Western blot analysis using anti-IFI16 polyclonal Ab. \u03b2-actin served as the internal control. B) HELFs were infected with AdV IFI16, AdV LacZ (MOI of 200 PFU/cell), or left untreated. After 24 hours, cells were infected with HCMV at an MOI of 0.1 (left panel) or 1 (right panel) PFU/cell. Cell-free supernatants were harvested on the indicated days post infection and the amounts of HCMV were determined by standard plaque assay. The data shown are the average of three experiments \u00b1 SD.", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 4}, {"body": 100, "word": "HCMV", "fig": 3}, {"body": 29, "word": "AdV", "fig": 4}, {"body": 38, "word": "infected", "fig": 3}, {"body": 31, "word": "MOI", "fig": 3}, {"body": 37, "word": "HELFs", "fig": 2}, {"body": 53, "word": "replication", "fig": 1}, {"body": 50, "word": "cells", "fig": 1}, {"body": 47, "word": "using", "fig": 1}, {"body": 44, "word": "The", "fig": 1}, {"body": 21, "word": "infection", "fig": 2}, {"body": 19, "word": "LacZ", "fig": 2}, {"body": 38, "word": "gene", "fig": 1}, {"body": 33, "word": "control", "fig": 1}, {"body": 32, "word": "viral", "fig": 1}, {"body": 32, "word": "expression", "fig": 1}, {"body": 26, "word": "shown", "fig": 1}, {"body": 25, "word": "cell", "fig": 1}, {"body": 11, "word": "left", "fig": 2}, {"body": 6, "word": "PFU/cell", "fig": 3}, {"body": 17, "word": "h", "fig": 1}, {"body": 16, "word": "experiments", "fig": 1}, {"body": 8, "word": "panel", "fig": 2}, {"body": 15, "word": "overexpression", "fig": 1}, {"body": 15, "word": "analysis", "fig": 1}, {"body": 14, "word": "extracts", "fig": 1}, {"body": 13, "word": "data", "fig": 1}, {"body": 6, "word": "post", "fig": 2}, {"body": 11, "word": "A", "fig": 1}, {"body": 10, "word": "assay", "fig": 1}, {"body": 5, "word": "hours", "fig": 2}, {"body": 5, "word": "indicated", "fig": 2}, {"body": 9, "word": "early", "fig": 1}, {"body": 7, "word": "Western", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 7, "word": "polyclonal", "fig": 1}, {"body": 6, "word": "At", "fig": 1}, {"body": 5, "word": "Ab", "fig": 1}, {"body": 4, "word": "blot", "fig": 1}, {"body": 4, "word": "anti-IFI16", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 4, "word": "inhibiting", "fig": 1}, {"body": 4, "word": "plaque", "fig": 1}, {"body": 3, "word": "subjected", "fig": 1}, {"body": 3, "word": "standard", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "determined", "fig": 1}, {"body": 3, "word": "average", "fig": 1}, {"body": 3, "word": "amounts", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "late", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "days", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "mock-infected", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "After", "fig": 1}, {"body": 1, "word": "reduces", "fig": 1}, {"body": 1, "word": "Cell-free", "fig": 1}, {"body": 1, "word": "supernatants", "fig": 1}, {"body": 1, "word": "prepared", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g004.jpg", "caption": "IFI16 impairs early and late, but not immediate early gene expression. A) HELFs were infected with AdV IFI16, AdV LacZ (MOI of 200 PFU/cell), or left untreated. After 24 hours, cells were infected with HCMV at an MOI of 1 PFU/cell. Total RNA was isolated at 24 hours post infection and assayed by quantitative real-time PCR to determine the relative levels of viral transcripts. Levels of viral mRNA are presented normalized to the levels of cellular \u03b2-actin. The data shown are the average of three experiments \u00b1 SD (*p<0.05, **p<0.01, one-way ANOVA followed by Bonferroni's post test). B) Cells were infected as described in the legend for panel A. Thirty \u00b5g of protein were analyzed by Western blotting for viral protein expression at 48 hours post infection and \u03b2-actin was used as internal control. C) Cells were infected as described in the legend for panel A. Viral DNA was isolated at the indicated hours post infection (hpi) and analyzed by quantitative real-time PCR, whereby primers amplified a segment of the E1 gene to determine the number of viral DNA genomes per nanogram of cellular reference DNA (18S rRNA gene). The data shown are the average of three experiments \u00b1 SD (*p<0.05, **p<0.01, ***p<0.001, one-way ANOVA followed by Bonferroni's post test).", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 2}, {"body": 38, "word": "infected", "fig": 4}, {"body": 32, "word": "viral", "fig": 4}, {"body": 40, "word": "DNA", "fig": 3}, {"body": 38, "word": "gene", "fig": 3}, {"body": 100, "word": "HCMV", "fig": 1}, {"body": 44, "word": "The", "fig": 2}, {"body": 34, "word": "protein", "fig": 2}, {"body": 32, "word": "expression", "fig": 2}, {"body": 21, "word": "infection", "fig": 3}, {"body": 31, "word": "MOI", "fig": 2}, {"body": 29, "word": "AdV", "fig": 2}, {"body": 26, "word": "shown", "fig": 2}, {"body": 50, "word": "cells", "fig": 1}, {"body": 37, "word": "HELFs", "fig": 1}, {"body": 33, "word": "control", "fig": 1}, {"body": 16, "word": "experiments", "fig": 2}, {"body": 15, "word": "PCR", "fig": 2}, {"body": 6, "word": "post", "fig": 5}, {"body": 13, "word": "described", "fig": 2}, {"body": 13, "word": "data", "fig": 2}, {"body": 11, "word": "cellular", "fig": 2}, {"body": 11, "word": "A", "fig": 2}, {"body": 11, "word": "'s", "fig": 2}, {"body": 5, "word": "hours", "fig": 4}, {"body": 19, "word": "LacZ", "fig": 1}, {"body": 9, "word": "early", "fig": 2}, {"body": 8, "word": "panel", "fig": 2}, {"body": 8, "word": "levels", "fig": 2}, {"body": 7, "word": "analyzed", "fig": 2}, {"body": 7, "word": "three", "fig": 2}, {"body": 7, "word": "real-time", "fig": 2}, {"body": 14, "word": "hpi", "fig": 1}, {"body": 12, "word": "relative", "fig": 1}, {"body": 6, "word": "PFU/cell", "fig": 2}, {"body": 6, "word": "quantitative", "fig": 2}, {"body": 11, "word": "left", "fig": 1}, {"body": 10, "word": "used", "fig": 1}, {"body": 4, "word": "one-way", "fig": 2}, {"body": 4, "word": "Bonferroni", "fig": 2}, {"body": 8, "word": "\u00b5g", "fig": 1}, {"body": 4, "word": "followed", "fig": 2}, {"body": 4, "word": "determine", "fig": 2}, {"body": 4, "word": "SD", "fig": 2}, {"body": 7, "word": "amplified", "fig": 1}, {"body": 7, "word": "Western", "fig": 1}, {"body": 3, "word": "ANOVA", "fig": 2}, {"body": 3, "word": "test", "fig": 2}, {"body": 3, "word": "average", "fig": 2}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 5, "word": "indicated", "fig": 1}, {"body": 5, "word": "primers", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 2}, {"body": 2, "word": "**p", "fig": 2}, {"body": 2, "word": "Cells", "fig": 2}, {"body": 4, "word": "number", "fig": 1}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 2, "word": "isolated", "fig": 2}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "presented", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "18S", "fig": 1}, {"body": 3, "word": "immediate", "fig": 1}, {"body": 3, "word": "Total", "fig": 1}, {"body": 2, "word": "late", "fig": 1}, {"body": 2, "word": "rRNA", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "***p", "fig": 1}, {"body": 2, "word": "transcripts", "fig": 1}, {"body": 2, "word": "Viral", "fig": 1}, {"body": 1, "word": "*p", "fig": 2}, {"body": 2, "word": "After", "fig": 1}, {"body": 1, "word": "genomes", "fig": 1}, {"body": 1, "word": "impairs", "fig": 1}, {"body": 1, "word": "reference", "fig": 1}, {"body": 1, "word": "nanogram", "fig": 1}, {"body": 1, "word": "segment", "fig": 1}, {"body": 1, "word": "Levels", "fig": 1}, {"body": 1, "word": "assayed", "fig": 1}, {"body": 1, "word": "whereby", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g005.jpg", "caption": "Effects of IFI16 overexpression on the activity of HCMV UL54, UL44, and MIEP promoters. A) Luciferase reporter plasmids containing HCMV UL54 promoter segments progressively deleted from the 5\u2032 end and mutated in the IR-1 or DR-ATF elements were transfected into HELFs that were subsequently infected with either AdV LacZ or AdV IFI16 at an MOI of 200. 24 hours later, cells were infected with HCMV (MOI of 0.5) and luciferase activity assessed after a further 24 hpi. B) Luciferase reporter plasmids containing the MIEP (major immediate-early promoter) segment were transfected into HELFs subsequently infected as described for panel A. C) Luciferase reporter plasmids containing HCMV UL44 promoter segments progressively deleted from the 5\u2032 end and the 3\u2032 end were transfected into HELFs subsequently infected as described for panel A. Sp1, putative binding sites for Sp1 transcription factor; oval circles indicates TATA boxes. Experiments were repeated at least three times and one representative result is shown (mean \u00b1 SD) (*p<0.05, **p<0.01, ***p<0.001, unpaired t test for comparison of AdV LacZ vs AdV IFI16).", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 3}, {"body": 100, "word": "HCMV", "fig": 4}, {"body": 59, "word": "promoter", "fig": 3}, {"body": 38, "word": "infected", "fig": 4}, {"body": 29, "word": "AdV", "fig": 4}, {"body": 37, "word": "HELFs", "fig": 3}, {"body": 47, "word": "activity", "fig": 2}, {"body": 46, "word": "UL54", "fig": 2}, {"body": 34, "word": "Sp1", "fig": 2}, {"body": 31, "word": "MOI", "fig": 2}, {"body": 50, "word": "cells", "fig": 1}, {"body": 20, "word": "UL44", "fig": 2}, {"body": 13, "word": "containing", "fig": 3}, {"body": 19, "word": "LacZ", "fig": 2}, {"body": 30, "word": "transcription", "fig": 1}, {"body": 26, "word": "shown", "fig": 1}, {"body": 13, "word": "described", "fig": 2}, {"body": 24, "word": "IR-1", "fig": 1}, {"body": 8, "word": "reporter", "fig": 3}, {"body": 11, "word": "A", "fig": 2}, {"body": 10, "word": "MIEP", "fig": 2}, {"body": 6, "word": "transfected", "fig": 3}, {"body": 6, "word": "subsequently", "fig": 3}, {"body": 8, "word": "panel", "fig": 2}, {"body": 15, "word": "overexpression", "fig": 1}, {"body": 14, "word": "hpi", "fig": 1}, {"body": 13, "word": "sites", "fig": 1}, {"body": 12, "word": "factor", "fig": 1}, {"body": 11, "word": "luciferase", "fig": 1}, {"body": 9, "word": "binding", "fig": 1}, {"body": 8, "word": "either", "fig": 1}, {"body": 7, "word": "DR-ATF", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 7, "word": "mutated", "fig": 1}, {"body": 7, "word": "later", "fig": 1}, {"body": 2, "word": "plasmids", "fig": 3}, {"body": 5, "word": "hours", "fig": 1}, {"body": 5, "word": "major", "fig": 1}, {"body": 5, "word": "assessed", "fig": 1}, {"body": 4, "word": "immediate-early", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 3}, {"body": 3, "word": "test", "fig": 1}, {"body": 3, "word": "elements", "fig": 1}, {"body": 3, "word": "promoters", "fig": 1}, {"body": 1, "word": "segments", "fig": 2}, {"body": 2, "word": "**p", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "deleted", "fig": 2}, {"body": 2, "word": "***p", "fig": 1}, {"body": 2, "word": "one", "fig": 1}, {"body": 2, "word": "TATA", "fig": 1}, {"body": 2, "word": "Experiments", "fig": 1}, {"body": 1, "word": "result", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "least", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "indicates", "fig": 1}, {"body": 1, "word": "vs", "fig": 1}, {"body": 1, "word": "segment", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g006.jpg", "caption": "IFI16 impairs IR-1 binding. A) Nuclear protein extracts from HELFs infected with AdV IFI16 or AdV LacZ at an MOI of 200 for 24 hours and then with HCMV at an MOI of 2 for 24 hours were incubated with a radiolabeled oligonucleotide containing the consensus IR-1 binding site. Competition experiments were performed with 100-fold excess of cold specific oligonucleotide in either the wild type or the mutated form. B) Super-shift experiments were performed by adding polyclonal antibodies against Sp1, control antobody (ctrl). Experiments were repeated at least three times and one representative result is shown.", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 2}, {"body": 100, "word": "HCMV", "fig": 1}, {"body": 31, "word": "MOI", "fig": 2}, {"body": 29, "word": "AdV", "fig": 2}, {"body": 24, "word": "IR-1", "fig": 2}, {"body": 38, "word": "infected", "fig": 1}, {"body": 37, "word": "HELFs", "fig": 1}, {"body": 34, "word": "protein", "fig": 1}, {"body": 34, "word": "Sp1", "fig": 1}, {"body": 33, "word": "control", "fig": 1}, {"body": 16, "word": "experiments", "fig": 2}, {"body": 26, "word": "shown", "fig": 1}, {"body": 23, "word": "antibodies", "fig": 1}, {"body": 11, "word": "performed", "fig": 2}, {"body": 19, "word": "LacZ", "fig": 1}, {"body": 9, "word": "binding", "fig": 2}, {"body": 14, "word": "ctrl", "fig": 1}, {"body": 14, "word": "extracts", "fig": 1}, {"body": 13, "word": "containing", "fig": 1}, {"body": 6, "word": "oligonucleotide", "fig": 2}, {"body": 11, "word": "specific", "fig": 1}, {"body": 11, "word": "A", "fig": 1}, {"body": 10, "word": "site", "fig": 1}, {"body": 5, "word": "hours", "fig": 2}, {"body": 8, "word": "type", "fig": 1}, {"body": 8, "word": "either", "fig": 1}, {"body": 7, "word": "mutated", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 7, "word": "polyclonal", "fig": 1}, {"body": 6, "word": "Nuclear", "fig": 1}, {"body": 6, "word": "form", "fig": 1}, {"body": 5, "word": "wild", "fig": 1}, {"body": 4, "word": "incubated", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 2, "word": "excess", "fig": 1}, {"body": 2, "word": "100-fold", "fig": 1}, {"body": 2, "word": "one", "fig": 1}, {"body": 2, "word": "Experiments", "fig": 1}, {"body": 1, "word": "result", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "least", "fig": 1}, {"body": 1, "word": "impairs", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g007.jpg", "caption": "Interplay between Sp1 and IFI16 down-regulates HCMV replication. A) Nuclear cell protein extracts from HELFs mock infected (lanes 1, 4, 7), infected with HCMV at an MOI of 2 for 24 hours (lanes 2, 5, 8), or infected with AdV IFI16 or AdV LacZ (data not shown) at an MOI of 200 for 24 hours and then with HCMV (lanes 3, 6, 9) were immunoprecipitated with polyclonal antibodies against IFI16 or control antibody (ctrl). Samples were then immunoblotted with polyclonal antibodies against Sp1 or IFI16. B) Infected cell lysates were immunoprecipitated with anti-IFI16 polyclonal antibodies in the absence (lane 2 or 4) or presence of benzonase (lanes 3 and 5) or with control antibody (ctrl). Proteins from the IP were analyzed by Western blotting using polyclonal antibody recognizing Sp1. C) Nuclear extracts from HELFs mock infected or infected with AdV IFI16 or AdV LacZ at an MOI of 200 for 24 hours and then with HCMV at an MOI of 2 for 24 hours were analyzed by ChIP assay using anti-Sp1 rabbit polyclonal antibody. Sp1-coprecipitating DNA was analyzed by quantitative real-time PCR with IR-1 sequence specific primers. An unrelated rabbit polyclonal anti-serum was used as control (data not shown). Non-immunoprecipitated whole cell extract (input) obtained from AdV LacZ- or AdV IFI16-infected cells was employed to normalize the IR-1 viral DNA subjected to immunoprecipitation. Experiments were repeated at least three times and one representative result is shown (mean \u00b1 SD) (***p<0.001, unpaired t test). D) Nuclear cell protein extracts from HELFs stably transduced with the recombinant Lentivirus carrying the full-length IFI16 protein (IFI16wt), or dnIFI16 ORFs (\u0394DIFI16 or \u0394BIFI16), were infected with HCMV at an MOI of 2 for 24 hours, immunoprecipitated with monoclonal antibodies against flag V5 or control antibodies (ctrl), and immunoblotted with polyclonal antibodies against Sp1 (top panel) or flag V5 (bottom panel).", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 6}, {"body": 100, "word": "HCMV", "fig": 5}, {"body": 38, "word": "infected", "fig": 6}, {"body": 29, "word": "AdV", "fig": 6}, {"body": 31, "word": "MOI", "fig": 5}, {"body": 23, "word": "antibodies", "fig": 6}, {"body": 34, "word": "Sp1", "fig": 4}, {"body": 33, "word": "control", "fig": 4}, {"body": 37, "word": "HELFs", "fig": 3}, {"body": 34, "word": "protein", "fig": 3}, {"body": 25, "word": "cell", "fig": 4}, {"body": 47, "word": "using", "fig": 2}, {"body": 40, "word": "DNA", "fig": 2}, {"body": 26, "word": "shown", "fig": 3}, {"body": 53, "word": "replication", "fig": 1}, {"body": 50, "word": "cells", "fig": 1}, {"body": 7, "word": "polyclonal", "fig": 7}, {"body": 24, "word": "IR-1", "fig": 2}, {"body": 14, "word": "extracts", "fig": 3}, {"body": 14, "word": "ctrl", "fig": 3}, {"body": 19, "word": "LacZ", "fig": 2}, {"body": 32, "word": "viral", "fig": 1}, {"body": 7, "word": "lanes", "fig": 4}, {"body": 7, "word": "antibody", "fig": 4}, {"body": 13, "word": "data", "fig": 2}, {"body": 5, "word": "hours", "fig": 5}, {"body": 7, "word": "analyzed", "fig": 3}, {"body": 6, "word": "immunoprecipitated", "fig": 3}, {"body": 6, "word": "Nuclear", "fig": 3}, {"body": 8, "word": "panel", "fig": 2}, {"body": 15, "word": "PCR", "fig": 1}, {"body": 15, "word": "lane", "fig": 1}, {"body": 14, "word": "\u0394DIFI16", "fig": 1}, {"body": 13, "word": "\u0394BIFI16", "fig": 1}, {"body": 11, "word": "specific", "fig": 1}, {"body": 11, "word": "A", "fig": 1}, {"body": 10, "word": "assay", "fig": 1}, {"body": 10, "word": "used", "fig": 1}, {"body": 9, "word": "absence", "fig": 1}, {"body": 9, "word": "presence", "fig": 1}, {"body": 8, "word": "lysates", "fig": 1}, {"body": 4, "word": "mock", "fig": 2}, {"body": 7, "word": "three", "fig": 1}, {"body": 7, "word": "Western", "fig": 1}, {"body": 7, "word": "real-time", "fig": 1}, {"body": 7, "word": "transduced", "fig": 1}, {"body": 7, "word": "IP", "fig": 1}, {"body": 6, "word": "benzonase", "fig": 1}, {"body": 6, "word": "sequence", "fig": 1}, {"body": 6, "word": "anti-Sp1", "fig": 1}, {"body": 6, "word": "obtained", "fig": 1}, {"body": 3, "word": "rabbit", "fig": 2}, {"body": 6, "word": "quantitative", "fig": 1}, {"body": 5, "word": "ChIP", "fig": 1}, {"body": 5, "word": "immunoprecipitation", "fig": 1}, {"body": 5, "word": "recognizing", "fig": 1}, {"body": 5, "word": "primers", "fig": 1}, {"body": 4, "word": "anti-IFI16", "fig": 1}, {"body": 4, "word": "SD", "fig": 1}, {"body": 2, "word": "V5", "fig": 2}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "subjected", "fig": 1}, {"body": 3, "word": "recombinant", "fig": 1}, {"body": 3, "word": "unrelated", "fig": 1}, {"body": 3, "word": "test", "fig": 1}, {"body": 3, "word": "dnIFI16", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "carrying", "fig": 1}, {"body": 3, "word": "input", "fig": 1}, {"body": 3, "word": "down-regulates", "fig": 1}, {"body": 2, "word": "IFI16-infected", "fig": 1}, {"body": 2, "word": "extract", "fig": 1}, {"body": 2, "word": "bottom", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "***p", "fig": 1}, {"body": 2, "word": "monoclonal", "fig": 1}, {"body": 2, "word": "one", "fig": 1}, {"body": 2, "word": "full-length", "fig": 1}, {"body": 2, "word": "Experiments", "fig": 1}, {"body": 1, "word": "stably", "fig": 1}, {"body": 1, "word": "employed", "fig": 1}, {"body": 1, "word": "Lentivirus", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "least", "fig": 1}, {"body": 1, "word": "LacZ-", "fig": 1}, {"body": 1, "word": "result", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266931/bin/ppat.1002498.g008.jpg", "caption": "Suppression of HCMV replication by IFI16 does not require IFN-\u03b2 antiviral activity. HELFs were electroporated with a mixture of four different small interfering RNA (siRNA IFN-\u03b2) or scrambled control siRNA (siRNA ctrl), or left not electroporated (NE), and then infected with AdV IFI16 or AdV LacZ (MOI of 200 PFU/cell) before subsequent infection with HCMV 24 hours later (MOI of 0.1 PFU/cell). A) Total RNA was isolated 24 hours post HCMV infection and IFN-\u03b2 mRNA expression was determined by quantitative real-time PCR. Levels of IFN-\u03b2 mRNA are presented normalized to the levels of cellular \u03b2-actin. Experiments were repeated at least three times and one representative result is shown (mean \u00b1 SD). B) Cell-free supernatants were harvested at the indicated hours post infection (hpi) and virus amounts determined by plaque assay. The data shown are the average of three experiments \u00b1 SD (*p<0.05, **p<0.01, one-way ANOVA followed by Bonferroni's post test).", "co_occurrence": [{"body": 168, "word": "IFI16", "fig": 2}, {"body": 100, "word": "HCMV", "fig": 3}, {"body": 20, "word": "IFN-\u03b2", "fig": 4}, {"body": 23, "word": "siRNA", "fig": 3}, {"body": 21, "word": "infection", "fig": 3}, {"body": 31, "word": "MOI", "fig": 2}, {"body": 29, "word": "AdV", "fig": 2}, {"body": 53, "word": "replication", "fig": 1}, {"body": 26, "word": "shown", "fig": 2}, {"body": 47, "word": "activity", "fig": 1}, {"body": 44, "word": "The", "fig": 1}, {"body": 38, "word": "infected", "fig": 1}, {"body": 37, "word": "HELFs", "fig": 1}, {"body": 33, "word": "control", "fig": 1}, {"body": 32, "word": "expression", "fig": 1}, {"body": 10, "word": "electroporated", "fig": 2}, {"body": 19, "word": "LacZ", "fig": 1}, {"body": 6, "word": "post", "fig": 3}, {"body": 16, "word": "experiments", "fig": 1}, {"body": 15, "word": "PCR", "fig": 1}, {"body": 5, "word": "hours", "fig": 3}, {"body": 15, "word": "virus", "fig": 1}, {"body": 7, "word": "three", "fig": 2}, {"body": 14, "word": "ctrl", "fig": 1}, {"body": 14, "word": "different", "fig": 1}, {"body": 14, "word": "hpi", "fig": 1}, {"body": 13, "word": "data", "fig": 1}, {"body": 6, "word": "PFU/cell", "fig": 2}, {"body": 11, "word": "left", "fig": 1}, {"body": 11, "word": "cellular", "fig": 1}, {"body": 11, "word": "'s", "fig": 1}, {"body": 11, "word": "A", "fig": 1}, {"body": 10, "word": "assay", "fig": 1}, {"body": 5, "word": "mRNA", "fig": 2}, {"body": 5, "word": "RNA", "fig": 2}, {"body": 10, "word": "antiviral", "fig": 1}, {"body": 4, "word": "SD", "fig": 2}, {"body": 8, "word": "levels", "fig": 1}, {"body": 7, "word": "real-time", "fig": 1}, {"body": 7, "word": "later", "fig": 1}, {"body": 3, "word": "determined", "fig": 2}, {"body": 6, "word": "quantitative", "fig": 1}, {"body": 5, "word": "indicated", "fig": 1}, {"body": 4, "word": "four", "fig": 1}, {"body": 4, "word": "one-way", "fig": 1}, {"body": 4, "word": "followed", "fig": 1}, {"body": 4, "word": "NE", "fig": 1}, {"body": 4, "word": "Bonferroni", "fig": 1}, {"body": 4, "word": "plaque", "fig": 1}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 3, "word": "ANOVA", "fig": 1}, {"body": 3, "word": "presented", "fig": 1}, {"body": 3, "word": "small", "fig": 1}, {"body": 3, "word": "interfering", "fig": 1}, {"body": 3, "word": "amounts", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "test", "fig": 1}, {"body": 3, "word": "average", "fig": 1}, {"body": 3, "word": "Total", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "**p", "fig": 1}, {"body": 2, "word": "mixture", "fig": 1}, {"body": 2, "word": "one", "fig": 1}, {"body": 2, "word": "require", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 2, "word": "Suppression", "fig": 1}, {"body": 2, "word": "Experiments", "fig": 1}, {"body": 1, "word": "Cell-free", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "least", "fig": 1}, {"body": 1, "word": "Levels", "fig": 1}, {"body": 1, "word": "supernatants", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "result", "fig": 1}, {"body": 1, "word": "scrambled", "fig": 1}]}], "4159784": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159784/bin/ijms-15-13135-g001.jpg", "caption": "Expression of Shox2 in the developing temporomandibular joint (TMJ) of Wnt1-Cre; pMes-stop Shox2 mice. (A,B) In situ hybridization shows Shox2 expression in the developing TMJ of E16.5 wild type (A) and Wnt1-Cre; pMes-stop Shox2 embryo (B). c, condyle; d, disc; and gf, glenoid fossa.", "co_occurrence": [{"body": 65, "word": "Shox2", "fig": 4}, {"body": 64, "word": "TMJ", "fig": 2}, {"body": 40, "word": "Wnt1-Cre", "fig": 2}, {"body": 40, "word": "pMes-stop", "fig": 2}, {"body": 37, "word": "mice", "fig": 1}, {"body": 24, "word": "condyle", "fig": 1}, {"body": 23, "word": "glenoid", "fig": 1}, {"body": 23, "word": "fossa", "fig": 1}, {"body": 15, "word": "type", "fig": 1}, {"body": 7, "word": "developing", "fig": 2}, {"body": 13, "word": "wild", "fig": 1}, {"body": 11, "word": "expression", "fig": 1}, {"body": 9, "word": "In", "fig": 1}, {"body": 6, "word": "E16.5", "fig": 1}, {"body": 6, "word": "situ", "fig": 1}, {"body": 3, "word": "B", "fig": 2}, {"body": 5, "word": "disc", "fig": 1}, {"body": 4, "word": "joint", "fig": 1}, {"body": 3, "word": "hybridization", "fig": 1}, {"body": 1, "word": "A", "fig": 2}, {"body": 1, "word": "temporomandibular", "fig": 1}, {"body": 1, "word": "Expression", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159784/bin/ijms-15-13135-g002.jpg", "caption": "Histological analyses of TMJ of Wnt1-Cre; pMes-stop Shox2 mice. (A\u2013E) Coronal sections of the TMJ in wild type mice and Wnt1-Cre; pMes-stop Shox2 mice at E16.5 (A,B), P0 (C,D), P7 (E,F), P14 (G,H), and P21 (I,J); (K,L) Comparison of condyle and glenoid fossa width of the TMJ in wild type and Wnt1-Cre; pMes-stop Shox2 mice. Bright blue and red line segments in (A) point to the measured location of condyle and glenoid fossa on sections, respectively; and (M) Comparison of body weight at different time points in wild type and Wnt1-Cre; pMes-stop Shox2 mice. Standard deviation is shown as error bars. * p < 0.05, ** p < 0.01. c, condyle; d, disc; and gf, glenoid fossa.", "co_occurrence": [{"body": 65, "word": "Shox2", "fig": 4}, {"body": 64, "word": "TMJ", "fig": 3}, {"body": 37, "word": "mice", "fig": 5}, {"body": 40, "word": "Wnt1-Cre", "fig": 4}, {"body": 40, "word": "pMes-stop", "fig": 4}, {"body": 24, "word": "condyle", "fig": 3}, {"body": 23, "word": "glenoid", "fig": 3}, {"body": 23, "word": "fossa", "fig": 3}, {"body": 15, "word": "type", "fig": 3}, {"body": 13, "word": "wild", "fig": 3}, {"body": 11, "word": "P0", "fig": 1}, {"body": 9, "word": "I", "fig": 1}, {"body": 8, "word": "P7", "fig": 1}, {"body": 6, "word": "E16.5", "fig": 1}, {"body": 3, "word": "sections", "fig": 2}, {"body": 5, "word": "body", "fig": 1}, {"body": 5, "word": "weight", "fig": 1}, {"body": 5, "word": "disc", "fig": 1}, {"body": 5, "word": "width", "fig": 1}, {"body": 5, "word": "time", "fig": 1}, {"body": 4, "word": "analyses", "fig": 1}, {"body": 4, "word": "P14", "fig": 1}, {"body": 3, "word": "Histological", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "P21", "fig": 1}, {"body": 2, "word": "point", "fig": 1}, {"body": 2, "word": "different", "fig": 1}, {"body": 1, "word": "A", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "J", "fig": 1}, {"body": 2, "word": "L", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "points", "fig": 1}, {"body": 1, "word": "M", "fig": 1}, {"body": 1, "word": "Standard", "fig": 1}, {"body": 1, "word": "blue", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159784/bin/ijms-15-13135-g003.jpg", "caption": "Expressions of Sox9, Runx2 and Ihh in the developing TMJ of Wnt1-Cre; pMes-stop Shox2 mice. (A\u2013D) Immunohistochemical staining shows Sox9 expression in the developing condyle of E14.5 (A,B) and E16.5 (C,D) wild type and Wnt1-Cre; pMes-stop Shox2 embryo; (E\u2013H) Immunohistochemical staining shows Runx2 expression in the developing TMJ of E14.5 (E,F) and E16.5 (G,H) wild type and Wnt1-Cre; pMes-stop Shox2 embryo; and (I,J) In situ hybridization shows Ihh expression in the developing condyle of E15.5 wild type and Wnt1-Cre; pMes-stop Shox2 embryo. c, condyle; and gf, glenoid fossa.", "co_occurrence": [{"body": 65, "word": "Shox2", "fig": 4}, {"body": 40, "word": "Wnt1-Cre", "fig": 4}, {"body": 40, "word": "pMes-stop", "fig": 4}, {"body": 64, "word": "TMJ", "fig": 2}, {"body": 24, "word": "condyle", "fig": 3}, {"body": 15, "word": "type", "fig": 3}, {"body": 13, "word": "wild", "fig": 3}, {"body": 37, "word": "mice", "fig": 1}, {"body": 11, "word": "expression", "fig": 3}, {"body": 16, "word": "Ihh", "fig": 2}, {"body": 7, "word": "developing", "fig": 4}, {"body": 23, "word": "glenoid", "fig": 1}, {"body": 23, "word": "fossa", "fig": 1}, {"body": 6, "word": "E16.5", "fig": 2}, {"body": 5, "word": "Runx2", "fig": 2}, {"body": 9, "word": "I", "fig": 1}, {"body": 9, "word": "In", "fig": 1}, {"body": 4, "word": "Sox9", "fig": 2}, {"body": 3, "word": "E14.5", "fig": 2}, {"body": 6, "word": "situ", "fig": 1}, {"body": 2, "word": "staining", "fig": 2}, {"body": 1, "word": "shows", "fig": 3}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "hybridization", "fig": 1}, {"body": 1, "word": "Immunohistochemical", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "J", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "E15.5", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "H", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159784/bin/ijms-15-13135-g004.jpg", "caption": "Expressions of extracellular matrix, Ihh and Gli2 in the postnatal TMJ of Wnt1-Cre; pMes-stop Shox2 mice. (A\u2013L) Expressions of Col I (A\u2013D), Col II (E\u2013H), and Aggrecan (I\u2013L) in the TMJ of P0 and P7 wild type (A,C,E,G,I,K) and Wnt1-Cre; pMes-stop Shox2 (B,D,F,H,J,L); (M\u2013P) Immunohistochemical staining on coronal sections of P0 wild type (M,O) and Wnt1-Cre; pMes-stop Shox2 (N,P) TMJ shows Ihh (M,N) and Gli2 (O,P) protein expression and distribution. Arrow heads point to the condyle and glenoid fossa where expression is altered.", "co_occurrence": [{"body": 65, "word": "Shox2", "fig": 3}, {"body": 64, "word": "TMJ", "fig": 3}, {"body": 40, "word": "Wnt1-Cre", "fig": 3}, {"body": 40, "word": "pMes-stop", "fig": 3}, {"body": 37, "word": "mice", "fig": 1}, {"body": 16, "word": "Ihh", "fig": 2}, {"body": 15, "word": "type", "fig": 2}, {"body": 14, "word": "Col", "fig": 2}, {"body": 13, "word": "wild", "fig": 2}, {"body": 24, "word": "condyle", "fig": 1}, {"body": 23, "word": "glenoid", "fig": 1}, {"body": 23, "word": "fossa", "fig": 1}, {"body": 11, "word": "P0", "fig": 2}, {"body": 11, "word": "expression", "fig": 2}, {"body": 9, "word": "I", "fig": 2}, {"body": 6, "word": "Gli2", "fig": 2}, {"body": 9, "word": "II", "fig": 1}, {"body": 8, "word": "P7", "fig": 1}, {"body": 7, "word": "heads", "fig": 1}, {"body": 6, "word": "Aggrecan", "fig": 1}, {"body": 4, "word": "postnatal", "fig": 1}, {"body": 3, "word": "sections", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 2, "word": "point", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "J", "fig": 1}, {"body": 1, "word": "M", "fig": 2}, {"body": 2, "word": "L", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "matrix", "fig": 1}, {"body": 1, "word": "Immunohistochemical", "fig": 1}, {"body": 1, "word": "extracellular", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "altered", "fig": 1}, {"body": 1, "word": "protein", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159784/bin/ijms-15-13135-g005.jpg", "caption": "Altered expressions of MMPs and apoptosis in the postnatal TMJ of Wnt1-Cre; pMes-stop Shox2 mice. (A,B) In situ zymography on coronal sections of wild type (A) and Wnt1-Cre; pMes-stop Shox2 (B) TMJ shows MMPs activity. The ectopic MMPs activity in the glenoid fossa (arrow heads) of the Wnt1-Cre; pMes-stop Shox2 TMJ; TUNEL assay on coronal sections of P0 wild type (C) and Wnt1-Cre; pMes-stop Shox2 (D) TMJ shows an increase of apoptotic cells in the glenoid fossa of the Wnt1-Cre; pMes-stop Shox2 TMJ. Arrow heads in (C,D) point to the apoptotic cells in the glenoid fossa; (E\u2013L) Immunohistochemical staining on coronal sections of wild type (E,G,I,K) and Wnt1-Cre; pMes-stop Shox2 (F,H,J,L) shows expressions of MMP9 (E\u2013H) and MMP13 (I\u2013L). Arrow heads in (E\u2013H,K,L) point to the protein levels of MMP9 and MMP13in the condyle and glenoid fossa where expression is altered; (M) Comparison of numbers of apoptotic cells in the glenoid fossa between wild type and Wnt1-Cre; pMes-stop Shox2 mice. Standard deviation is shown as error bars. * p < 0.05.", "co_occurrence": [{"body": 65, "word": "Shox2", "fig": 7}, {"body": 64, "word": "TMJ", "fig": 5}, {"body": 40, "word": "Wnt1-Cre", "fig": 7}, {"body": 40, "word": "pMes-stop", "fig": 7}, {"body": 23, "word": "glenoid", "fig": 5}, {"body": 23, "word": "fossa", "fig": 5}, {"body": 37, "word": "mice", "fig": 2}, {"body": 15, "word": "type", "fig": 4}, {"body": 13, "word": "wild", "fig": 4}, {"body": 13, "word": "MMPs", "fig": 3}, {"body": 24, "word": "condyle", "fig": 1}, {"body": 7, "word": "heads", "fig": 3}, {"body": 8, "word": "activity", "fig": 2}, {"body": 13, "word": "The", "fig": 1}, {"body": 11, "word": "P0", "fig": 1}, {"body": 11, "word": "expression", "fig": 1}, {"body": 3, "word": "sections", "fig": 3}, {"body": 9, "word": "I", "fig": 1}, {"body": 9, "word": "In", "fig": 1}, {"body": 4, "word": "expressions", "fig": 2}, {"body": 6, "word": "apoptosis", "fig": 1}, {"body": 3, "word": "B", "fig": 2}, {"body": 2, "word": "cells", "fig": 3}, {"body": 6, "word": "situ", "fig": 1}, {"body": 2, "word": "D", "fig": 2}, {"body": 2, "word": "L", "fig": 2}, {"body": 2, "word": "point", "fig": 2}, {"body": 4, "word": "postnatal", "fig": 1}, {"body": 2, "word": "MMP9", "fig": 2}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "TUNEL", "fig": 1}, {"body": 1, "word": "shows", "fig": 3}, {"body": 3, "word": "levels", "fig": 1}, {"body": 1, "word": "apoptotic", "fig": 3}, {"body": 2, "word": "staining", "fig": 1}, {"body": 1, "word": "A", "fig": 2}, {"body": 2, "word": "MMP13", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "increase", "fig": 1}, {"body": 2, "word": "J", "fig": 1}, {"body": 1, "word": "Standard", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "altered", "fig": 1}, {"body": 1, "word": "zymography", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "protein", "fig": 1}, {"body": 1, "word": "Immunohistochemical", "fig": 1}, {"body": 1, "word": "M", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159784/bin/ijms-15-13135-g006.jpg", "caption": "Changes of proliferation in the TMJ of Wnt1-Cre; pMes-stop Shox2 mice. (A\u2013D) BrdU labeling of cell proliferation in the condylar condensation of an E14.5 (A,B) and E16.5 (C,D) in wild type and Wnt1-Cre; pMes-stop Shox2 embryo; (E,F) Comparison of numbers of BrdUpositive cells in the fixed area (red frame) of the condylar primoridain between wild type (E) and Wnt1-Cre; pMes-stop Shox2 embryos (F). Standard deviation is shown as error bars.c, condyle; and m, Meckel\u2019s cartilage.", "co_occurrence": [{"body": 65, "word": "Shox2", "fig": 3}, {"body": 40, "word": "Wnt1-Cre", "fig": 3}, {"body": 40, "word": "pMes-stop", "fig": 3}, {"body": 64, "word": "TMJ", "fig": 1}, {"body": 37, "word": "mice", "fig": 1}, {"body": 15, "word": "type", "fig": 2}, {"body": 13, "word": "wild", "fig": 2}, {"body": 24, "word": "condyle", "fig": 1}, {"body": 7, "word": "cartilage", "fig": 1}, {"body": 6, "word": "E16.5", "fig": 1}, {"body": 3, "word": "proliferation", "fig": 2}, {"body": 5, "word": "cell", "fig": 1}, {"body": 4, "word": "fixed", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "E14.5", "fig": 1}, {"body": 3, "word": "labeling", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "condylar", "fig": 2}, {"body": 2, "word": "BrdU", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "F", "fig": 2}, {"body": 2, "word": "cells", "fig": 1}, {"body": 1, "word": "Standard", "fig": 1}, {"body": 1, "word": "A", "fig": 1}]}], "4467408": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467408/bin/oncotarget-06-5877-g001.jpg", "caption": "Decreased DACH1 expression in lung adenocarcinoma inversely correlated with tumor stage and related to survival (A) Representative images of DACH1 immunohistochemical stain of normal and lung cancer tissues. (B-D) Relative intensity of DACH1 protein in cancer tissues in relation to histological type, stage and grade. Quantitate mRNA expression of DACH1 in normal and cancer tissues (E), and DACH1 abundance in relation to tumor size (F) and lymph node status (G). Impact of DACH1 mRNA expression on relapse-free survival (H) and overall survival (I) revealed by Kaplan-Meier curves from dataset GSE31210.", "co_occurrence": [{"body": 93, "word": "DACH1", "fig": 6}, {"body": 50, "word": "expression", "fig": 3}, {"body": 41, "word": "tumor", "fig": 2}, {"body": 25, "word": "cancer", "fig": 3}, {"body": 19, "word": "survival", "fig": 3}, {"body": 25, "word": "lung", "fig": 2}, {"body": 15, "word": "tissues", "fig": 3}, {"body": 9, "word": "normal", "fig": 2}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 7, "word": "stage", "fig": 2}, {"body": 5, "word": "grade", "fig": 1}, {"body": 5, "word": "inversely", "fig": 1}, {"body": 5, "word": "adenocarcinoma", "fig": 1}, {"body": 5, "word": "overall", "fig": 1}, {"body": 4, "word": "dataset", "fig": 1}, {"body": 4, "word": "stain", "fig": 1}, {"body": 4, "word": "correlated", "fig": 1}, {"body": 3, "word": "protein", "fig": 1}, {"body": 3, "word": "type", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "related", "fig": 1}, {"body": 2, "word": "Kaplan-Meier", "fig": 1}, {"body": 2, "word": "revealed", "fig": 1}, {"body": 2, "word": "size", "fig": 1}, {"body": 2, "word": "histological", "fig": 1}, {"body": 2, "word": "relapse-free", "fig": 1}, {"body": 2, "word": "I", "fig": 1}, {"body": 2, "word": "GSE31210", "fig": 1}, {"body": 2, "word": "immunohistochemical", "fig": 1}, {"body": 2, "word": "abundance", "fig": 1}, {"body": 1, "word": "relation", "fig": 2}, {"body": 1, "word": "node", "fig": 1}, {"body": 1, "word": "intensity", "fig": 1}, {"body": 1, "word": "Decreased", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "lymph", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "curves", "fig": 1}, {"body": 1, "word": "status", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467408/bin/oncotarget-06-5877-g002.jpg", "caption": "Ectopic expression of DACH1 inhibited cellular proliferation and cell cycle progression Stable expression of HA-tagged DACH1 in lung cancer cell lines A549 (A-C) and A-427 by fluororescent staining (D-F). Proliferation was evaluated by MTT assay (B, E) and cell counting (C, F). Cell cycle distribution evaluated by FACS (G, H).", "co_occurrence": [{"body": 93, "word": "DACH1", "fig": 2}, {"body": 40, "word": "cell", "fig": 3}, {"body": 50, "word": "expression", "fig": 2}, {"body": 25, "word": "cancer", "fig": 1}, {"body": 25, "word": "lung", "fig": 1}, {"body": 15, "word": "A549", "fig": 1}, {"body": 11, "word": "proliferation", "fig": 1}, {"body": 10, "word": "lines", "fig": 1}, {"body": 9, "word": "A-427", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 4, "word": "cycle", "fig": 2}, {"body": 6, "word": "staining", "fig": 1}, {"body": 5, "word": "progression", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 3, "word": "cellular", "fig": 1}, {"body": 3, "word": "inhibited", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "MTT", "fig": 1}, {"body": 2, "word": "distribution", "fig": 1}, {"body": 1, "word": "counting", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "H", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467408/bin/oncotarget-06-5877-g003.jpg", "caption": "DACH1 inhibited clone formation and tumor growth in vivo (A) Representative images of contact-dependent clone formation and relative efficiency of 3 experiments for A549 and A-427. (B) Representative images of clone formation in soft agar and relative efficiency of 3 experiments for A549 and A-427. (C) Tumor growth curves of subcutaneously implanted A549 cells with or without DACH1 expression, representative images of dissected tumors and tumor weight.", "co_occurrence": [{"body": 93, "word": "DACH1", "fig": 2}, {"body": 41, "word": "tumor", "fig": 2}, {"body": 50, "word": "expression", "fig": 1}, {"body": 15, "word": "A549", "fig": 3}, {"body": 38, "word": "cells", "fig": 1}, {"body": 15, "word": "growth", "fig": 2}, {"body": 9, "word": "A-427", "fig": 2}, {"body": 6, "word": "formation", "fig": 3}, {"body": 4, "word": "agar", "fig": 1}, {"body": 4, "word": "soft", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "clone", "fig": 3}, {"body": 3, "word": "vivo", "fig": 1}, {"body": 3, "word": "inhibited", "fig": 1}, {"body": 2, "word": "weight", "fig": 1}, {"body": 2, "word": "tumors", "fig": 1}, {"body": 2, "word": "without", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "Tumor", "fig": 1}, {"body": 2, "word": "implanted", "fig": 1}, {"body": 2, "word": "subcutaneously", "fig": 1}, {"body": 2, "word": "contact-dependent", "fig": 1}, {"body": 1, "word": "curves", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467408/bin/oncotarget-06-5877-g004.jpg", "caption": "DACH1 inhibited lung cancer cell migration, invasion and CXCL5 secretion Representative images of wound-healing assay of A549 (A) and A-427 (B) cells, relative wound space was calculated on the right panel. (C) Representative images and quantitatively analysis of migrated A549 and A-427 cells expressing DACH1 or mutant \u0394DS versus vector control. (D) Representative images and quantitatively analysis of invaded A549 and A-427 cells expressing DACH1, mutant \u0394DS or vector control. (E) Migratory promoting effect of supernatant collected from A549 cells expressing DACH1 versus empty vector. Quantitative measurement of CXCL5 in the condition medium collected from A549 (F) or A-427 (G) by ELISA. (H) Representative immunohistochemical images of CXCL5 in implanted tumor from A549 expressing DACH1 versus control vector.", "co_occurrence": [{"body": 93, "word": "DACH1", "fig": 5}, {"body": 65, "word": "CXCL5", "fig": 3}, {"body": 38, "word": "cells", "fig": 4}, {"body": 15, "word": "A549", "fig": 6}, {"body": 16, "word": "expressing", "fig": 4}, {"body": 41, "word": "tumor", "fig": 1}, {"body": 40, "word": "cell", "fig": 1}, {"body": 10, "word": "vector", "fig": 4}, {"body": 9, "word": "A-427", "fig": 4}, {"body": 9, "word": "control", "fig": 3}, {"body": 25, "word": "cancer", "fig": 1}, {"body": 25, "word": "lung", "fig": 1}, {"body": 9, "word": "analysis", "fig": 2}, {"body": 8, "word": "\u0394DS", "fig": 2}, {"body": 14, "word": "invasion", "fig": 1}, {"body": 11, "word": "migration", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 7, "word": "medium", "fig": 1}, {"body": 7, "word": "effect", "fig": 1}, {"body": 2, "word": "versus", "fig": 3}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "inhibited", "fig": 1}, {"body": 1, "word": "mutant", "fig": 2}, {"body": 2, "word": "wound", "fig": 1}, {"body": 2, "word": "secretion", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "collected", "fig": 2}, {"body": 2, "word": "immunohistochemical", "fig": 1}, {"body": 2, "word": "implanted", "fig": 1}, {"body": 1, "word": "quantitatively", "fig": 2}, {"body": 2, "word": "calculated", "fig": 1}, {"body": 1, "word": "wound-healing", "fig": 1}, {"body": 1, "word": "migrated", "fig": 1}, {"body": 1, "word": "ELISA", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "supernatant", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467408/bin/oncotarget-06-5877-g005.jpg", "caption": "CXCL5 rescued invasion and antagonized tumor repression by DACH1 (A) The reciprocal mRNA expression between DACH1 and CXCL5 in normal lung epithelial cell line and 7 lung cancer cell lines from GSE7670. (B) The reciprocal mRNA expression between DACH1 and CXCL5 in NSCLC tissues from GSE7670. Addition of CXCL5 enhanced migration (C) and invasion (D) of A549 and A-427 cell expressing DACH1. Neutralized antibody to CXCL5 decreased migration (E) and invasion (F) of A549 and A-427 cells. Growth curve (G), weight (H) and representative images (I) of tumors from A549-DACH1 stable cells with ectopic CXCL5 expression versus vector control. (J) Representative immunohistochemical images of CXCL5 from A549-DACH1 cells with or without CXCL5 transduction.", "co_occurrence": [{"body": 65, "word": "CXCL5", "fig": 8}, {"body": 93, "word": "DACH1", "fig": 4}, {"body": 50, "word": "expression", "fig": 3}, {"body": 40, "word": "cell", "fig": 3}, {"body": 38, "word": "cells", "fig": 3}, {"body": 25, "word": "lung", "fig": 2}, {"body": 14, "word": "invasion", "fig": 3}, {"body": 41, "word": "tumor", "fig": 1}, {"body": 20, "word": "The", "fig": 2}, {"body": 15, "word": "A549", "fig": 2}, {"body": 25, "word": "cancer", "fig": 1}, {"body": 11, "word": "migration", "fig": 2}, {"body": 19, "word": "NSCLC", "fig": 1}, {"body": 9, "word": "A-427", "fig": 2}, {"body": 16, "word": "expressing", "fig": 1}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 15, "word": "tissues", "fig": 1}, {"body": 5, "word": "A549-DACH1", "fig": 2}, {"body": 10, "word": "vector", "fig": 1}, {"body": 10, "word": "decreased", "fig": 1}, {"body": 10, "word": "lines", "fig": 1}, {"body": 9, "word": "normal", "fig": 1}, {"body": 9, "word": "control", "fig": 1}, {"body": 5, "word": "repression", "fig": 1}, {"body": 4, "word": "epithelial", "fig": 1}, {"body": 4, "word": "line", "fig": 1}, {"body": 4, "word": "ectopic", "fig": 1}, {"body": 3, "word": "antibody", "fig": 1}, {"body": 3, "word": "transduction", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "versus", "fig": 1}, {"body": 2, "word": "curve", "fig": 1}, {"body": 2, "word": "tumors", "fig": 1}, {"body": 2, "word": "enhanced", "fig": 1}, {"body": 2, "word": "weight", "fig": 1}, {"body": 2, "word": "without", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "I", "fig": 1}, {"body": 2, "word": "stable", "fig": 1}, {"body": 2, "word": "immunohistochemical", "fig": 1}, {"body": 1, "word": "GSE7670", "fig": 2}, {"body": 1, "word": "Addition", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "rescued", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467408/bin/oncotarget-06-5877-g006.jpg", "caption": "CXCL5 expression correlated with tumor stage and influenced survival in NSCLC Association of CXCL5 mRNA abundance with tumor size (A) and differentiation (B). Kaplan-Meier curves for relapse-free survival (C) and overall survival (D) from dataset GSE31210. (E) Kaplan-Meiercurves for OS for lung adenocarcinoma patients with low, medium or high expressions of CXCL5 mRNA.", "co_occurrence": [{"body": 65, "word": "CXCL5", "fig": 3}, {"body": 41, "word": "tumor", "fig": 2}, {"body": 19, "word": "survival", "fig": 3}, {"body": 50, "word": "expression", "fig": 1}, {"body": 25, "word": "lung", "fig": 1}, {"body": 19, "word": "NSCLC", "fig": 1}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 9, "word": "high", "fig": 1}, {"body": 8, "word": "patients", "fig": 1}, {"body": 7, "word": "medium", "fig": 1}, {"body": 7, "word": "low", "fig": 1}, {"body": 7, "word": "stage", "fig": 1}, {"body": 5, "word": "adenocarcinoma", "fig": 1}, {"body": 5, "word": "OS", "fig": 1}, {"body": 5, "word": "overall", "fig": 1}, {"body": 4, "word": "dataset", "fig": 1}, {"body": 4, "word": "expressions", "fig": 1}, {"body": 4, "word": "correlated", "fig": 1}, {"body": 3, "word": "differentiation", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "GSE31210", "fig": 1}, {"body": 2, "word": "size", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "Kaplan-Meier", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "relapse-free", "fig": 1}, {"body": 2, "word": "abundance", "fig": 1}, {"body": 1, "word": "curves", "fig": 1}, {"body": 1, "word": "Association", "fig": 1}]}], "4329012": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329012/bin/cam40004-0293-f1.jpg", "caption": "\u03b2-actin staining. \u03b2-actin in the colorectal cancer tissues (A) or normal colorectal tissues (C) were visualized with anti-human \u03b2-actin mAb and biotin\u2013avidin\u2013peroxidase method. Hematoxylin staining of the colorectal cancer tissues (B) or normal colorectal tissues (D) as a control were also performed (\u00d7100).", "co_occurrence": [{"body": 25, "word": "colorectal", "fig": 4}, {"body": 32, "word": "cancer", "fig": 2}, {"body": 10, "word": "tissues", "fig": 4}, {"body": 20, "word": "staining", "fig": 2}, {"body": 14, "word": "normal", "fig": 2}, {"body": 7, "word": "\u03b2-actin", "fig": 3}, {"body": 4, "word": "performed", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "method", "fig": 1}, {"body": 1, "word": "biotin\u2013avidin\u2013peroxidase", "fig": 1}, {"body": 1, "word": "visualized", "fig": 1}, {"body": 1, "word": "also", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "control", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329012/bin/cam40004-0293-f2.jpg", "caption": "Recurrence-free survival analysis of stage I\u2013III colorectal cancer patients (n = 53) with Agaricus bisporus (ABA) and Hippeastrum hybrid (HHL) status. (A) Five-year recurrence-free survival were 82.0% and 24.7% for the patients with ABA <2.18, and ABA \u22652.18 (P = 0.001). (B) Five-year recurrence-free survival were 88.8% and 40.9% for the patients with HHL <4.00, and HHL \u22654.00 (P = 0.001).", "co_occurrence": [{"body": 24, "word": "ABA", "fig": 3}, {"body": 21, "word": "patients", "fig": 3}, {"body": 32, "word": "cancer", "fig": 1}, {"body": 9, "word": "survival", "fig": 3}, {"body": 25, "word": "colorectal", "fig": 1}, {"body": 8, "word": "HHL", "fig": 3}, {"body": 11, "word": "P", "fig": 2}, {"body": 7, "word": "recurrence-free", "fig": 2}, {"body": 13, "word": "analysis", "fig": 1}, {"body": 10, "word": "stage", "fig": 1}, {"body": 8, "word": "n", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "I\u2013III", "fig": 1}, {"body": 2, "word": "status", "fig": 1}, {"body": 1, "word": "bisporus", "fig": 1}, {"body": 1, "word": "Agaricus", "fig": 1}, {"body": 1, "word": "B", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329012/bin/cam40004-0293-f3.jpg", "caption": "Recurrence-free survival analysis of stage II colorectal cancer patients (n = 55) with Agaricus bisporus (ABA) status in the validation setting. Recurrence-free survival according to ABA status (P = 0.003).", "co_occurrence": [{"body": 24, "word": "ABA", "fig": 2}, {"body": 32, "word": "cancer", "fig": 1}, {"body": 25, "word": "colorectal", "fig": 1}, {"body": 21, "word": "patients", "fig": 1}, {"body": 9, "word": "survival", "fig": 2}, {"body": 13, "word": "analysis", "fig": 1}, {"body": 11, "word": "P", "fig": 1}, {"body": 10, "word": "stage", "fig": 1}, {"body": 8, "word": "n", "fig": 1}, {"body": 7, "word": "II", "fig": 1}, {"body": 2, "word": "status", "fig": 2}, {"body": 4, "word": "validation", "fig": 1}, {"body": 3, "word": "setting", "fig": 1}, {"body": 1, "word": "bisporus", "fig": 1}, {"body": 1, "word": "Agaricus", "fig": 1}, {"body": 1, "word": "according", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329012/bin/cam40004-0293-f4.jpg", "caption": "Agaricus bisporus (ABA) staining for colorectal cancer tissues. (A) Strong ABA staining was detected within the cytoplasm of cancer cells and the apical surface (\u00d7100, \u00d7400). (B) ABA staining was detected in the supranuclear region of the glandular epithelium of normal colorectal tissues (\u00d7100, \u00d7400).", "co_occurrence": [{"body": 24, "word": "ABA", "fig": 3}, {"body": 32, "word": "cancer", "fig": 2}, {"body": 20, "word": "staining", "fig": 3}, {"body": 25, "word": "colorectal", "fig": 2}, {"body": 10, "word": "tissues", "fig": 2}, {"body": 14, "word": "normal", "fig": 1}, {"body": 5, "word": "cells", "fig": 1}, {"body": 5, "word": "epithelium", "fig": 1}, {"body": 4, "word": "cytoplasm", "fig": 1}, {"body": 2, "word": "detected", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "surface", "fig": 1}, {"body": 2, "word": "glandular", "fig": 1}, {"body": 2, "word": "apical", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "bisporus", "fig": 1}, {"body": 1, "word": "Agaricus", "fig": 1}, {"body": 1, "word": "Strong", "fig": 1}, {"body": 1, "word": "supranuclear", "fig": 1}]}], "4364838": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/bin/acel0014-0265-f1.jpg", "caption": "Rapamycin differentially inhibits mTORC2 in various cell lines. PC3, HeLa, HEK 293T, H460, or C2C12 cells were treated with 100 nm rapamycin for 1 or 24 h. The phosphorylation of specific mTORC1 (P-S6K T389, P-S6 S240/244) (A) and mTORC2 (P-Akt S473, P-NDRG1 T346) substrates (B) was examined by Western blot analysis. The responsiveness of each cell line to mTORC2 inhibition by rapamycin is quantified (C). The phosphorylation of the mTORC1 substrate, Rictor, is inhibited by rapamycin in PC3, HeLa, HEK 293T, H460, and C2C12 cells to a similar extent (D).", "co_occurrence": [{"body": 90, "word": "mTORC2", "fig": 3}, {"body": 88, "word": "rapamycin", "fig": 3}, {"body": 52, "word": "cells", "fig": 2}, {"body": 94, "word": "inhibition", "fig": 1}, {"body": 42, "word": "mTORC1", "fig": 2}, {"body": 32, "word": "cell", "fig": 2}, {"body": 17, "word": "PC3", "fig": 2}, {"body": 15, "word": "HeLa", "fig": 2}, {"body": 12, "word": "293T", "fig": 2}, {"body": 12, "word": "HEK", "fig": 2}, {"body": 11, "word": "phosphorylation", "fig": 2}, {"body": 20, "word": "lines", "fig": 1}, {"body": 17, "word": "responsiveness", "fig": 1}, {"body": 5, "word": "The", "fig": 3}, {"body": 4, "word": "C2C12", "fig": 2}, {"body": 4, "word": "H460", "fig": 2}, {"body": 8, "word": "Rictor", "fig": 1}, {"body": 7, "word": "S473", "fig": 1}, {"body": 7, "word": "line", "fig": 1}, {"body": 5, "word": "S240/244", "fig": 1}, {"body": 5, "word": "extent", "fig": 1}, {"body": 5, "word": "inhibits", "fig": 1}, {"body": 5, "word": "T346", "fig": 1}, {"body": 5, "word": "P-NDRG1", "fig": 1}, {"body": 5, "word": "examined", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "treated", "fig": 1}, {"body": 4, "word": "similar", "fig": 1}, {"body": 3, "word": "P-Akt", "fig": 1}, {"body": 3, "word": "substrate", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "P-S6", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "T389", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "specific", "fig": 1}, {"body": 2, "word": "substrates", "fig": 1}, {"body": 1, "word": "Rapamycin", "fig": 1}, {"body": 1, "word": "various", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "P-S6K", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/bin/acel0014-0265-f2.jpg", "caption": "FKBP12/FKBP51 ratio determines cell's responsiveness to mTORC2 inhibition by rapamycin. Expression of FKBP12, 25, 51, and 52 was examined in PC3, HeLa, H460, HEK 293T, C2C12, and MEFs (A). The ratio of FKBP12 to FKBP51 was quantified from each cell line (B). The correlation between the responsiveness of each cell line to mTORC2 inhibition and FKBP12/51 ratio is plotted (C). The correlation between the responsiveness of each cell line to mTORC1 inhibition and FKBP12/51 ratio is plotted (D).", "co_occurrence": [{"body": 94, "word": "inhibition", "fig": 3}, {"body": 90, "word": "mTORC2", "fig": 2}, {"body": 32, "word": "cell", "fig": 4}, {"body": 62, "word": "FKBP12", "fig": 2}, {"body": 88, "word": "rapamycin", "fig": 1}, {"body": 17, "word": "responsiveness", "fig": 3}, {"body": 42, "word": "mTORC1", "fig": 1}, {"body": 26, "word": "FKBP51", "fig": 1}, {"body": 6, "word": "ratio", "fig": 4}, {"body": 7, "word": "line", "fig": 3}, {"body": 17, "word": "PC3", "fig": 1}, {"body": 15, "word": "HeLa", "fig": 1}, {"body": 5, "word": "The", "fig": 3}, {"body": 12, "word": "293T", "fig": 1}, {"body": 12, "word": "HEK", "fig": 1}, {"body": 6, "word": "'s", "fig": 1}, {"body": 5, "word": "examined", "fig": 1}, {"body": 5, "word": "MEFs", "fig": 1}, {"body": 4, "word": "C2C12", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "H460", "fig": 1}, {"body": 3, "word": "FKBP12/FKBP51", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "determines", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/bin/acel0014-0265-f3.jpg", "caption": "Knockdown of FKBP12 impairs mTORC2 inhibition by rapamycin. shRNA constructs directed toward FBKP12 were transfected into PC3, HeLa, or HEK 293T cells (A). PC3 cells expressing FKBP12 shRNA 1, 2, or 3 were treated with rapamycin for 24 h, and the effects of reducing FKBP12 levels on mTORC1 signaling (P-S6 S240/244) and mTORC2 signaling (P-Akt S473 and P-NDRG1 T346) were examined by Western blot analysis (B) and quantified (C). Immunoprecipitations for mTOR were performed in PC3 cells in the presence or absence of FKBP12 shRNA, and Western blot analysis was performed for mTOR, Rictor, and Raptor (D). HeLa (E) or HEK 293T cells (F) expressing FKBP12 shRNA 1, 2, or 3 were treated with rapamycin for 24 h, and the effects of reducing FKBP12 levels on mTORC1 signaling (P-S6K T389 and P-S6 S240/244) and mTORC2 signaling (P-Akt S473) were examined by Western blot analysis. Results are the average of three independent experiments \u00b1 SEM.", "co_occurrence": [{"body": 62, "word": "FKBP12", "fig": 6}, {"body": 90, "word": "mTORC2", "fig": 3}, {"body": 88, "word": "rapamycin", "fig": 3}, {"body": 52, "word": "cells", "fig": 4}, {"body": 94, "word": "inhibition", "fig": 1}, {"body": 42, "word": "mTORC1", "fig": 2}, {"body": 27, "word": "levels", "fig": 2}, {"body": 17, "word": "PC3", "fig": 3}, {"body": 20, "word": "effects", "fig": 2}, {"body": 15, "word": "HeLa", "fig": 2}, {"body": 15, "word": "mTOR", "fig": 2}, {"body": 7, "word": "shRNA", "fig": 4}, {"body": 12, "word": "293T", "fig": 2}, {"body": 12, "word": "HEK", "fig": 2}, {"body": 6, "word": "signaling", "fig": 4}, {"body": 7, "word": "S473", "fig": 2}, {"body": 6, "word": "h", "fig": 2}, {"body": 5, "word": "examined", "fig": 2}, {"body": 5, "word": "S240/244", "fig": 2}, {"body": 8, "word": "Rictor", "fig": 1}, {"body": 4, "word": "expressing", "fig": 2}, {"body": 4, "word": "treated", "fig": 2}, {"body": 2, "word": "blot", "fig": 3}, {"body": 2, "word": "Western", "fig": 3}, {"body": 3, "word": "P-Akt", "fig": 2}, {"body": 6, "word": "constructs", "fig": 1}, {"body": 2, "word": "analysis", "fig": 3}, {"body": 5, "word": "T346", "fig": 1}, {"body": 5, "word": "P-NDRG1", "fig": 1}, {"body": 2, "word": "P-S6", "fig": 2}, {"body": 4, "word": "FBKP12", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 3, "word": "presence", "fig": 1}, {"body": 3, "word": "Raptor", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 1, "word": "performed", "fig": 2}, {"body": 1, "word": "reducing", "fig": 2}, {"body": 2, "word": "T389", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "transfected", "fig": 1}, {"body": 1, "word": "P-S6K", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "impairs", "fig": 1}, {"body": 1, "word": "absence", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}, {"body": 1, "word": "toward", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/bin/acel0014-0265-f4.jpg", "caption": "Overexpressing FKBP12 sensitizes HEK 293T cells to mTORC2 inhibition by rapamycin. An FKBP12 lentiviral construct was introduced into FKBP12-shRNA expressing PC3 cells (A). PC3 cells expressing the shRNA construct in the presence or absence of the FKBP12 construct were treated with rapamycin for 24 h, and mTORC1 activity (P-S6 S240/244) and mTORC2 activity (P-Akt S473) were examined by Western blot analysis (B). The FKBP12 lentiviral construct was transfected into HEK 293T cells, and cells were treated with or without rapamycin for 24 h. Western blot analysis was performed to examine mTORC1 activity (P-S6 S240/244) and mTORC2 activity (P-Akt S473) (C) and quantified (D). FKBP12 expression was analyzed in HEK 293T cells +/\u2212 the FKBP12 construct (E). Results are the average of four independent experiments \u00b1 SEM. Statistical significance is indicated (*P < 0.001 compared to untreated control).", "co_occurrence": [{"body": 62, "word": "FKBP12", "fig": 6}, {"body": 52, "word": "cells", "fig": 6}, {"body": 90, "word": "mTORC2", "fig": 3}, {"body": 88, "word": "rapamycin", "fig": 3}, {"body": 94, "word": "inhibition", "fig": 1}, {"body": 42, "word": "mTORC1", "fig": 2}, {"body": 12, "word": "293T", "fig": 3}, {"body": 12, "word": "HEK", "fig": 3}, {"body": 17, "word": "PC3", "fig": 2}, {"body": 27, "word": "expression", "fig": 1}, {"body": 4, "word": "activity", "fig": 4}, {"body": 7, "word": "S473", "fig": 2}, {"body": 5, "word": "S240/244", "fig": 2}, {"body": 4, "word": "expressing", "fig": 2}, {"body": 4, "word": "treated", "fig": 2}, {"body": 7, "word": "shRNA", "fig": 1}, {"body": 6, "word": "h", "fig": 1}, {"body": 3, "word": "P-Akt", "fig": 2}, {"body": 5, "word": "examined", "fig": 1}, {"body": 5, "word": "The", "fig": 1}, {"body": 4, "word": "compared", "fig": 1}, {"body": 2, "word": "blot", "fig": 2}, {"body": 2, "word": "Western", "fig": 2}, {"body": 2, "word": "P-S6", "fig": 2}, {"body": 4, "word": "C", "fig": 1}, {"body": 2, "word": "analysis", "fig": 2}, {"body": 3, "word": "presence", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "sensitizes", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "control", "fig": 1}, {"body": 2, "word": "without", "fig": 1}, {"body": 2, "word": "transfected", "fig": 1}, {"body": 1, "word": "Overexpressing", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "examine", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "performed", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "absence", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/bin/acel0014-0265-f5.jpg", "caption": "Knockdown of FKBP51 renders cell lines more responsive to mTORC2 inhibition. shRNA constructs directed toward FBKP51 were transfected into PC3, HeLa, or HEK 293T cells (A). PC3 cells expressing shRNA 1, 2, or 3 were treated with rapamycin for 24 h, and the effects of knocking down FKBP51 on mTORC1 signaling (P-S6 S240/244) and mTORC2 signaling (P-Akt S473 and P-NDRG1 T346) were examined by Western blot analysis (B) and quantified (C). Wild-type,FKBP51\u2212/\u2212, or FKBP52\u2212/\u2212 MEFs were treated with rapamycin for 24 h, and their responsiveness to mTORC1 (P-S6 S240/244) and mTORC2 (P-Akt S473) was evaluated by Western blot analysis and quantified (D). Results are the average of five independent experiments \u00b1 SEM. Immunoprecipitations were performed using an anti-mTOR antibody on wild-type or FKBP51\u2212/\u2212 MEFs. Immunoprecipitated samples were then immunoblotted for mTOR, Rictor, or Raptor (E). Input samples were analyzed for mTOR, Raptor, Rictor, P-S6 (S240/244), or S6 (F). Results are the average of 3-5 independent experiments \u00b1 SEM. Statistical significance is indicated (*P < 0.001 compared to untreated control).", "co_occurrence": [{"body": 90, "word": "mTORC2", "fig": 3}, {"body": 88, "word": "rapamycin", "fig": 2}, {"body": 52, "word": "cells", "fig": 2}, {"body": 94, "word": "inhibition", "fig": 1}, {"body": 42, "word": "mTORC1", "fig": 2}, {"body": 26, "word": "FKBP51", "fig": 2}, {"body": 17, "word": "PC3", "fig": 2}, {"body": 32, "word": "cell", "fig": 1}, {"body": 15, "word": "mTOR", "fig": 2}, {"body": 20, "word": "effects", "fig": 1}, {"body": 20, "word": "lines", "fig": 1}, {"body": 17, "word": "responsive", "fig": 1}, {"body": 17, "word": "responsiveness", "fig": 1}, {"body": 8, "word": "Rictor", "fig": 2}, {"body": 15, "word": "HeLa", "fig": 1}, {"body": 5, "word": "S240/244", "fig": 3}, {"body": 7, "word": "S473", "fig": 2}, {"body": 7, "word": "shRNA", "fig": 2}, {"body": 6, "word": "FKBP51\u2212/\u2212", "fig": 2}, {"body": 6, "word": "h", "fig": 2}, {"body": 12, "word": "293T", "fig": 1}, {"body": 6, "word": "signaling", "fig": 2}, {"body": 12, "word": "HEK", "fig": 1}, {"body": 5, "word": "MEFs", "fig": 2}, {"body": 4, "word": "treated", "fig": 2}, {"body": 7, "word": "S6", "fig": 1}, {"body": 6, "word": "using", "fig": 1}, {"body": 3, "word": "P-Akt", "fig": 2}, {"body": 3, "word": "Raptor", "fig": 2}, {"body": 6, "word": "constructs", "fig": 1}, {"body": 2, "word": "P-S6", "fig": 3}, {"body": 5, "word": "P-NDRG1", "fig": 1}, {"body": 5, "word": "examined", "fig": 1}, {"body": 5, "word": "T346", "fig": 1}, {"body": 2, "word": "experiments", "fig": 2}, {"body": 2, "word": "blot", "fig": 2}, {"body": 2, "word": "Western", "fig": 2}, {"body": 4, "word": "five", "fig": 1}, {"body": 4, "word": "expressing", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "compared", "fig": 1}, {"body": 2, "word": "analysis", "fig": 2}, {"body": 1, "word": "samples", "fig": 2}, {"body": 2, "word": "transfected", "fig": 1}, {"body": 2, "word": "control", "fig": 1}, {"body": 2, "word": "wild-type", "fig": 1}, {"body": 2, "word": "anti-mTOR", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "FKBP52\u2212/\u2212", "fig": 1}, {"body": 1, "word": "Results", "fig": 2}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "antibody", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "toward", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "performed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/bin/acel0014-0265-f6.jpg", "caption": "FKBP expression in mouse tissues correlates with responsiveness to mTORC2 inhibition by rapamycin. Mice were IP injected with rapamycin (8 mg kg\u22121) every other day for 3 weeks. Mice were fasted overnight and injected for 15 min with insulin, and the responsiveness of each tissue to mTORC1 (P-S6 S240/244) or mTORC2 (P-Akt S473) inhibition by rapamycin was examined. Heart (A) and liver (B) are responsive to mTORC2 inhibition. Full characterization of other tissues is shown in Fig. S3 and quantified (C). Expression of FKBPs in mouse tissues was evaluated by Western blot analysis (D). Correlation between FKBP12/FKBP51 and mTORC2 inhibition in each tissue was evaluated under different tissue harvesting conditions: 6-h fast (E) or an overnight fast followed by 15-min insulin injection (F). Results are the average of 4 individual mice per cohort \u00b1 SEM.", "co_occurrence": [{"body": 94, "word": "inhibition", "fig": 4}, {"body": 90, "word": "mTORC2", "fig": 4}, {"body": 88, "word": "rapamycin", "fig": 3}, {"body": 15, "word": "tissues", "fig": 3}, {"body": 42, "word": "mTORC1", "fig": 1}, {"body": 17, "word": "responsiveness", "fig": 2}, {"body": 27, "word": "expression", "fig": 1}, {"body": 8, "word": "tissue", "fig": 3}, {"body": 17, "word": "responsive", "fig": 1}, {"body": 7, "word": "insulin", "fig": 2}, {"body": 12, "word": "FKBPs", "fig": 1}, {"body": 10, "word": "different", "fig": 1}, {"body": 9, "word": "mice", "fig": 1}, {"body": 4, "word": "overnight", "fig": 2}, {"body": 7, "word": "S473", "fig": 1}, {"body": 6, "word": "FKBP", "fig": 1}, {"body": 5, "word": "S240/244", "fig": 1}, {"body": 5, "word": "examined", "fig": 1}, {"body": 4, "word": "Fig", "fig": 1}, {"body": 4, "word": "harvesting", "fig": 1}, {"body": 2, "word": "Mice", "fig": 2}, {"body": 4, "word": "C", "fig": 1}, {"body": 2, "word": "fast", "fig": 2}, {"body": 2, "word": "injected", "fig": 2}, {"body": 4, "word": "min", "fig": 1}, {"body": 4, "word": "liver", "fig": 1}, {"body": 3, "word": "every", "fig": 1}, {"body": 3, "word": "day", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "P-Akt", "fig": 1}, {"body": 3, "word": "FKBP12/FKBP51", "fig": 1}, {"body": 3, "word": "mg", "fig": 1}, {"body": 3, "word": "fasted", "fig": 1}, {"body": 3, "word": "correlates", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "conditions", "fig": 1}, {"body": 2, "word": "S3", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "kg\u22121", "fig": 1}, {"body": 1, "word": "mouse", "fig": 2}, {"body": 2, "word": "P-S6", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "15-min", "fig": 1}, {"body": 1, "word": "weeks", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "Heart", "fig": 1}, {"body": 1, "word": "6-h", "fig": 1}, {"body": 1, "word": "individual", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "IP", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364838/bin/acel0014-0265-f7.jpg", "caption": "FKBP51 competes with FKBP12 for acute inhibition of mTORC1, while FKBP12 is required for prolonged inhibition of mTORC1 and mTORC2.", "co_occurrence": [{"body": 94, "word": "inhibition", "fig": 2}, {"body": 62, "word": "FKBP12", "fig": 2}, {"body": 90, "word": "mTORC2", "fig": 1}, {"body": 42, "word": "mTORC1", "fig": 2}, {"body": 26, "word": "FKBP51", "fig": 1}, {"body": 7, "word": "required", "fig": 1}, {"body": 3, "word": "prolonged", "fig": 1}, {"body": 1, "word": "acute", "fig": 1}]}], "3817409": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817409/bin/emss-54265-f0001.jpg", "caption": "Description of cerebral organoid culture system a, Schematic of the culture system described in detail in Methods. Example images of each stage are shown. b, Neuroepithelial tissues generated using this approach (left panel) exhibited large fluid-filled cavities and typical apical localization of the neural N-cadherin (arrow). These tissues were larger and more continuous than tissues grown in stationary suspension without Matrigel (right panel). c, Sectioning and immunohistochemistry revealed complex morphology with heterogeneous regions containing neural progenitors (Sox2, red) and neurons (Tuj1, green) (arrow). d, Low magnification bright field images revealing fluid-filled cavities reminiscent of ventricles (white arrow) and retina tissue, as indicated by retinal pigmented epithelium (black arrow). Scale bars: 200 \u03bcm.", "co_occurrence": [{"body": 55, "word": "tissues", "fig": 3}, {"body": 30, "word": "neural", "fig": 2}, {"body": 43, "word": "cerebral", "fig": 1}, {"body": 33, "word": "regions", "fig": 1}, {"body": 14, "word": "culture", "fig": 2}, {"body": 27, "word": "neurons", "fig": 1}, {"body": 26, "word": "morphology", "fig": 1}, {"body": 26, "word": "using", "fig": 1}, {"body": 21, "word": "tissue", "fig": 1}, {"body": 20, "word": "green", "fig": 1}, {"body": 19, "word": "revealing", "fig": 1}, {"body": 17, "word": "organoid", "fig": 1}, {"body": 17, "word": "reminiscent", "fig": 1}, {"body": 16, "word": "progenitors", "fig": 1}, {"body": 15, "word": "These", "fig": 1}, {"body": 14, "word": "apical", "fig": 1}, {"body": 14, "word": "revealed", "fig": 1}, {"body": 12, "word": "red", "fig": 1}, {"body": 6, "word": "panel", "fig": 2}, {"body": 11, "word": "typical", "fig": 1}, {"body": 5, "word": "system", "fig": 2}, {"body": 9, "word": "Sox2", "fig": 1}, {"body": 9, "word": "magnification", "fig": 1}, {"body": 2, "word": "arrow", "fig": 4}, {"body": 8, "word": "exhibited", "fig": 1}, {"body": 7, "word": "generated", "fig": 1}, {"body": 3, "word": "fluid-filled", "fig": 2}, {"body": 3, "word": "images", "fig": 2}, {"body": 6, "word": "shown", "fig": 1}, {"body": 3, "word": "cavities", "fig": 2}, {"body": 6, "word": "containing", "fig": 1}, {"body": 6, "word": "complex", "fig": 1}, {"body": 5, "word": "bars", "fig": 1}, {"body": 5, "word": "larger", "fig": 1}, {"body": 5, "word": "described", "fig": 1}, {"body": 5, "word": "stage", "fig": 1}, {"body": 5, "word": "left", "fig": 1}, {"body": 4, "word": "large", "fig": 1}, {"body": 4, "word": "Matrigel", "fig": 1}, {"body": 4, "word": "approach", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "without", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 1}, {"body": 3, "word": "Tuj1", "fig": 1}, {"body": 3, "word": "stationary", "fig": 1}, {"body": 3, "word": "right", "fig": 1}, {"body": 2, "word": "N-cadherin", "fig": 1}, {"body": 2, "word": "localization", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "Low", "fig": 1}, {"body": 2, "word": "retina", "fig": 1}, {"body": 2, "word": "retinal", "fig": 1}, {"body": 2, "word": "heterogeneous", "fig": 1}, {"body": 2, "word": "grown", "fig": 1}, {"body": 2, "word": "continuous", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "pigmented", "fig": 1}, {"body": 1, "word": "Schematic", "fig": 1}, {"body": 1, "word": "detail", "fig": 1}, {"body": 1, "word": "epithelium", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817409/bin/emss-54265-f0002.jpg", "caption": "Human cerebral organoids recapitulate various brain region identities a, RT-PCR for forebrain markers (BF1 and Six3) and hindbrain markers (Krox20 and Isl1) at 12, 16 and 20 days of differentiation. Human fetal brain cDNA was used as positive control. b, Immunohistochemistry in serial sections for the forebrain marker Pax6 (red, first panel) and the hindbrain markers Krox20 (green, first panel) and Pax2 (red, second panel) at 16 days of differentiation. Note the juxtaposition reminiscent of the mid-hindbrain boundary (arrows). DAPI marks nuclei (blue). c,-i, Staining for various brain region identities: forebrain, FoxG1 (c); dorsal cortex, Emx1 (d); prefrontal cortex (note the discrete boundary, arrow), Auts2 (e); hippocampus, Nrp2, Fzd9, Prox1 (f); ventral forebrain, Nkx2.1 (g) and choroid plexus, TTR (i). g, Staining for adjacent ventral (arrow) and dorsal (Pax6, arrowhead) forebrain and for calretinin (green) in a serial section revealing cortical interneurons in the ventral region (arrow). Calretinin interneurons within dorsal cortex (h) exhibit typical morphology of tangential migration (arrows). j, Hematoxylin-eosin staining of retinal tissue exhibiting stereotypical layering: retinal pigment epithelium (RPE), outer nuclear layer (ONL) and inner nuclear layer (INL). Scale bars: 100 \u03bcm.", "co_occurrence": [{"body": 35, "word": "brain", "fig": 3}, {"body": 12, "word": "forebrain", "fig": 5}, {"body": 57, "word": "organoids", "fig": 1}, {"body": 17, "word": "markers", "fig": 3}, {"body": 24, "word": "days", "fig": 2}, {"body": 15, "word": "dorsal", "fig": 3}, {"body": 43, "word": "cerebral", "fig": 1}, {"body": 20, "word": "green", "fig": 2}, {"body": 13, "word": "region", "fig": 3}, {"body": 35, "word": "cortical", "fig": 1}, {"body": 15, "word": "layer", "fig": 2}, {"body": 14, "word": "differentiation", "fig": 2}, {"body": 9, "word": "cortex", "fig": 3}, {"body": 13, "word": "arrows", "fig": 2}, {"body": 26, "word": "morphology", "fig": 1}, {"body": 12, "word": "red", "fig": 2}, {"body": 8, "word": "ventral", "fig": 3}, {"body": 22, "word": "marker", "fig": 1}, {"body": 21, "word": "control", "fig": 1}, {"body": 21, "word": "tissue", "fig": 1}, {"body": 20, "word": "staining", "fig": 1}, {"body": 19, "word": "revealing", "fig": 1}, {"body": 6, "word": "panel", "fig": 3}, {"body": 17, "word": "reminiscent", "fig": 1}, {"body": 8, "word": "Staining", "fig": 2}, {"body": 6, "word": "hindbrain", "fig": 2}, {"body": 6, "word": "Pax6", "fig": 2}, {"body": 6, "word": "identities", "fig": 2}, {"body": 12, "word": "used", "fig": 1}, {"body": 11, "word": "typical", "fig": 1}, {"body": 5, "word": "various", "fig": 2}, {"body": 10, "word": "within", "fig": 1}, {"body": 9, "word": "recapitulate", "fig": 1}, {"body": 9, "word": "adjacent", "fig": 1}, {"body": 4, "word": "Krox20", "fig": 2}, {"body": 4, "word": "Human", "fig": 2}, {"body": 4, "word": "interneurons", "fig": 2}, {"body": 2, "word": "arrow", "fig": 3}, {"body": 3, "word": "nuclear", "fig": 2}, {"body": 6, "word": "positive", "fig": 1}, {"body": 5, "word": "discrete", "fig": 1}, {"body": 5, "word": "plexus", "fig": 1}, {"body": 5, "word": "blue", "fig": 1}, {"body": 5, "word": "choroid", "fig": 1}, {"body": 5, "word": "bars", "fig": 1}, {"body": 5, "word": "migration", "fig": 1}, {"body": 5, "word": "nuclei", "fig": 1}, {"body": 4, "word": "outer", "fig": 1}, {"body": 4, "word": "RT-PCR", "fig": 1}, {"body": 2, "word": "boundary", "fig": 2}, {"body": 4, "word": "Nkx2.1", "fig": 1}, {"body": 2, "word": "c", "fig": 2}, {"body": 2, "word": "first", "fig": 2}, {"body": 2, "word": "retinal", "fig": 2}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "sections", "fig": 1}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 4, "word": "Calretinin", "fig": 1}, {"body": 3, "word": "marks", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 1}, {"body": 3, "word": "exhibiting", "fig": 1}, {"body": 3, "word": "stereotypical", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 1}, {"body": 3, "word": "exhibit", "fig": 1}, {"body": 2, "word": "Immunohistochemistry", "fig": 1}, {"body": 2, "word": "BF1", "fig": 1}, {"body": 2, "word": "Isl1", "fig": 1}, {"body": 2, "word": "Auts2", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "section", "fig": 1}, {"body": 2, "word": "Six3", "fig": 1}, {"body": 2, "word": "Note", "fig": 1}, {"body": 2, "word": "inner", "fig": 1}, {"body": 2, "word": "Pax2", "fig": 1}, {"body": 1, "word": "serial", "fig": 2}, {"body": 2, "word": "Emx1", "fig": 1}, {"body": 2, "word": "FoxG1", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 2, "word": "fetal", "fig": 1}, {"body": 1, "word": "layering", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "Fzd9", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "tangential", "fig": 1}, {"body": 1, "word": "prefrontal", "fig": 1}, {"body": 1, "word": "TTR", "fig": 1}, {"body": 1, "word": "hippocampus", "fig": 1}, {"body": 1, "word": "mid-hindbrain", "fig": 1}, {"body": 1, "word": "arrowhead", "fig": 1}, {"body": 1, "word": "Nrp2", "fig": 1}, {"body": 1, "word": "epithelium", "fig": 1}, {"body": 1, "word": "Prox1", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817409/bin/emss-54265-f0003.jpg", "caption": "Stereotypical organization and behavior of progenitors a, Immunohistochemistry for neurons (Tuj1, green) and RGs (Pax6, red) in a large dorsal cortical region. Note the additional Pax6+ RGs located outside the VZ (arrowheads), reminiscent of oRGs. b, Staining for the preplate marker Tbr1 (red) and neuronal marker MAP2 (green) revealing superficial preplate (upper bracket) and underlying neuronal IZ-like layer (lower bracket). c, Staining for the IP marker Tbr2 (red) revealing SVZ localization of IPs (arrows). d, Staining for phospho-histone H3 (PH3, green) to mark radial glia (Pax6+) in mitosis. Arrows mark apical surface divisions; arrowheads mark SVZ divisions. e, Phospho-Vimentin (green) staining for mitotic radial glia which primarily divide at the apical surface (arrows). f, Frames from live imaging of GFP electroporated radial glia showing cell body movement (arrow). Time shown in hrs:min. g, BrdU pulse-chase revealing progressive IKNM of BrdU labeled nuclei (green, arrowheads) from basal VZ (1hr) to more apical position (4-6hr). h, Quantification of radial glial division orientation displayed in bins of 0-30 (horizontal), 30-60 (oblique) and 60-90 degrees (vertical). n=27 anaphase cells from 5 cerebral cortical tissues. i. Lineage tracing in GFP electroporated and BrdU pulsed tissues to mark daughter cell pairs following 16-hr chase revealing symmetric (arrowheads) and asymmetric (arrows) fates indicated by Sox2 staining (blue). Quantification for 18 cell pairs from three cortical tissues. Numbers above bars are absolute cell numbers. Dashed line indicates apical surface (b, c, g, i). Scale bars: 100 \u03bcm (a-e,g), 10 \u03bcm (f, h), 20 \u03bcm (i).", "co_occurrence": [{"body": 55, "word": "tissues", "fig": 3}, {"body": 35, "word": "cortical", "fig": 3}, {"body": 20, "word": "green", "fig": 5}, {"body": 19, "word": "revealing", "fig": 4}, {"body": 22, "word": "marker", "fig": 3}, {"body": 14, "word": "cell", "fig": 4}, {"body": 14, "word": "apical", "fig": 4}, {"body": 27, "word": "GFP", "fig": 2}, {"body": 13, "word": "arrowheads", "fig": 4}, {"body": 13, "word": "radial", "fig": 4}, {"body": 47, "word": "cells", "fig": 1}, {"body": 43, "word": "cerebral", "fig": 1}, {"body": 20, "word": "staining", "fig": 2}, {"body": 13, "word": "arrows", "fig": 3}, {"body": 18, "word": "RGs", "fig": 2}, {"body": 12, "word": "red", "fig": 3}, {"body": 16, "word": "electroporated", "fig": 2}, {"body": 10, "word": "surface", "fig": 3}, {"body": 27, "word": "neurons", "fig": 1}, {"body": 8, "word": "glia", "fig": 3}, {"body": 8, "word": "Staining", "fig": 3}, {"body": 10, "word": "neuronal", "fig": 2}, {"body": 10, "word": "VZ", "fig": 2}, {"body": 19, "word": "organization", "fig": 1}, {"body": 17, "word": "reminiscent", "fig": 1}, {"body": 16, "word": "progenitors", "fig": 1}, {"body": 15, "word": "displayed", "fig": 1}, {"body": 15, "word": "layer", "fig": 1}, {"body": 5, "word": "BrdU", "fig": 3}, {"body": 15, "word": "dorsal", "fig": 1}, {"body": 14, "word": "imaging", "fig": 1}, {"body": 13, "word": "region", "fig": 1}, {"body": 11, "word": "basal", "fig": 1}, {"body": 5, "word": "bars", "fig": 2}, {"body": 5, "word": "divisions", "fig": 2}, {"body": 5, "word": "preplate", "fig": 2}, {"body": 9, "word": "Sox2", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 3}, {"body": 8, "word": "oRGs", "fig": 1}, {"body": 4, "word": "b", "fig": 2}, {"body": 7, "word": "orientation", "fig": 1}, {"body": 3, "word": "SVZ", "fig": 2}, {"body": 6, "word": "shown", "fig": 1}, {"body": 3, "word": "pairs", "fig": 2}, {"body": 6, "word": "Pax6", "fig": 1}, {"body": 5, "word": "division", "fig": 1}, {"body": 5, "word": "blue", "fig": 1}, {"body": 5, "word": "mitotic", "fig": 1}, {"body": 5, "word": "horizontal", "fig": 1}, {"body": 5, "word": "min", "fig": 1}, {"body": 5, "word": "nuclei", "fig": 1}, {"body": 5, "word": "lower", "fig": 1}, {"body": 5, "word": "glial", "fig": 1}, {"body": 4, "word": "Tbr1", "fig": 1}, {"body": 4, "word": "IPs", "fig": 1}, {"body": 4, "word": "large", "fig": 1}, {"body": 2, "word": "Quantification", "fig": 2}, {"body": 4, "word": "live", "fig": 1}, {"body": 2, "word": "c", "fig": 2}, {"body": 4, "word": "line", "fig": 1}, {"body": 4, "word": "located", "fig": 1}, {"body": 3, "word": "Tuj1", "fig": 1}, {"body": 3, "word": "upper", "fig": 1}, {"body": 3, "word": "daughter", "fig": 1}, {"body": 3, "word": "asymmetric", "fig": 1}, {"body": 3, "word": "behavior", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 3, "word": "symmetric", "fig": 1}, {"body": 2, "word": "oblique", "fig": 1}, {"body": 2, "word": "PH3", "fig": 1}, {"body": 2, "word": "Immunohistochemistry", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "Tbr2", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "pulse-chase", "fig": 1}, {"body": 2, "word": "movement", "fig": 1}, {"body": 2, "word": "arrow", "fig": 1}, {"body": 2, "word": "vertical", "fig": 1}, {"body": 2, "word": "localization", "fig": 1}, {"body": 2, "word": "superficial", "fig": 1}, {"body": 2, "word": "divide", "fig": 1}, {"body": 2, "word": "Note", "fig": 1}, {"body": 2, "word": "primarily", "fig": 1}, {"body": 1, "word": "f", "fig": 2}, {"body": 2, "word": "labeled", "fig": 1}, {"body": 2, "word": "IKNM", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 1, "word": "bracket", "fig": 2}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "outside", "fig": 1}, {"body": 1, "word": "anaphase", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "Phospho-Vimentin", "fig": 1}, {"body": 1, "word": "body", "fig": 1}, {"body": 1, "word": "phospho-histone", "fig": 1}, {"body": 1, "word": "H3", "fig": 1}, {"body": 1, "word": "MAP2", "fig": 1}, {"body": 1, "word": "chase", "fig": 1}, {"body": 1, "word": "IP", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817409/bin/emss-54265-f0004.jpg", "caption": "Organization and maturation of cerebral cortical neurons a, Immunohistochemical staining at day 30 showing preplate (Tbr1) with early signs of radial organization (MAP2, bracket i) and the presence of an IZ-like layer (bracket ii) adjacent to the VZ/SVZ (bracket iii). DAPI marks nuclei (blue). b, Reelin staining indicating Cajal-Retzius cells along the basal surface of dorsal cortical tissue. c, Staining for early born (Ctip2) and late born (Satb2) neurons at 75 days differentiation reveals separation and rudimentary inside-out organization. d. False color heat map frames from Fluo-4 calcium live imaging revealing spontaneous calcium surges (arrowheads). Time is displayed in min:sec. e. Single cell tracings of calcium surges with glutamate application (regions of interest, ROI, outlined in left panel) as measured by change in fluorescence (arbitrary units). Arrows mark the time of addition of glutamate. f. Single cell tracing (ROIs marked in image at left) of calcium surges before (left panels) and after the addition of TTX (right panels). Scale bars: 100 \u03bcm.", "co_occurrence": [{"body": 35, "word": "cortical", "fig": 2}, {"body": 27, "word": "neurons", "fig": 2}, {"body": 47, "word": "cells", "fig": 1}, {"body": 43, "word": "cerebral", "fig": 1}, {"body": 20, "word": "staining", "fig": 2}, {"body": 19, "word": "organization", "fig": 2}, {"body": 17, "word": "early", "fig": 2}, {"body": 33, "word": "regions", "fig": 1}, {"body": 8, "word": "calcium", "fig": 4}, {"body": 14, "word": "cell", "fig": 2}, {"body": 24, "word": "days", "fig": 1}, {"body": 21, "word": "tissue", "fig": 1}, {"body": 19, "word": "revealing", "fig": 1}, {"body": 15, "word": "displayed", "fig": 1}, {"body": 15, "word": "layer", "fig": 1}, {"body": 15, "word": "dorsal", "fig": 1}, {"body": 5, "word": "left", "fig": 3}, {"body": 14, "word": "differentiation", "fig": 1}, {"body": 14, "word": "imaging", "fig": 1}, {"body": 13, "word": "day", "fig": 1}, {"body": 13, "word": "radial", "fig": 1}, {"body": 13, "word": "arrowheads", "fig": 1}, {"body": 12, "word": "presence", "fig": 1}, {"body": 11, "word": "basal", "fig": 1}, {"body": 5, "word": "panels", "fig": 2}, {"body": 10, "word": "surface", "fig": 1}, {"body": 3, "word": "surges", "fig": 3}, {"body": 9, "word": "adjacent", "fig": 1}, {"body": 4, "word": "born", "fig": 2}, {"body": 8, "word": "Staining", "fig": 1}, {"body": 7, "word": "separation", "fig": 1}, {"body": 6, "word": "panel", "fig": 1}, {"body": 5, "word": "d.", "fig": 1}, {"body": 5, "word": "indicating", "fig": 1}, {"body": 5, "word": "bars", "fig": 1}, {"body": 5, "word": "sec", "fig": 1}, {"body": 5, "word": "blue", "fig": 1}, {"body": 5, "word": "image", "fig": 1}, {"body": 5, "word": "min", "fig": 1}, {"body": 5, "word": "preplate", "fig": 1}, {"body": 5, "word": "fluorescence", "fig": 1}, {"body": 5, "word": "nuclei", "fig": 1}, {"body": 4, "word": "Tbr1", "fig": 1}, {"body": 4, "word": "Ctip2", "fig": 1}, {"body": 4, "word": "e.", "fig": 1}, {"body": 4, "word": "along", "fig": 1}, {"body": 4, "word": "live", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "marks", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 1}, {"body": 3, "word": "reveals", "fig": 1}, {"body": 3, "word": "right", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 1}, {"body": 3, "word": "rudimentary", "fig": 1}, {"body": 3, "word": "frames", "fig": 1}, {"body": 3, "word": "application", "fig": 1}, {"body": 1, "word": "bracket", "fig": 3}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "inside-out", "fig": 1}, {"body": 2, "word": "TTX", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "marked", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 1, "word": "addition", "fig": 2}, {"body": 2, "word": "interest", "fig": 1}, {"body": 2, "word": "Reelin", "fig": 1}, {"body": 1, "word": "glutamate", "fig": 2}, {"body": 2, "word": "f.", "fig": 1}, {"body": 2, "word": "outlined", "fig": 1}, {"body": 2, "word": "measured", "fig": 1}, {"body": 1, "word": "Single", "fig": 2}, {"body": 1, "word": "ROIs", "fig": 1}, {"body": 1, "word": "Cajal-Retzius", "fig": 1}, {"body": 1, "word": "ROI", "fig": 1}, {"body": 1, "word": "Fluo-4", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "tracings", "fig": 1}, {"body": 1, "word": "arbitrary", "fig": 1}, {"body": 1, "word": "spontaneous", "fig": 1}, {"body": 1, "word": "MAP2", "fig": 1}, {"body": 1, "word": "Immunohistochemical", "fig": 1}, {"body": 1, "word": "units", "fig": 1}, {"body": 1, "word": "Satb2", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817409/bin/emss-54265-f0005.jpg", "caption": "Cerebral organoids produce oRGs with typical morphology and behavior a. Immunohistochemical staining for RGs (Sox2) and neuronal processes (Tuj1) reveals the presence of oRGs (arrowheads) organized similar to human cortical development (OSVZ-like layer, ** bracket) separated from the VZ by a layer of Tuj1+ fibers similar to IFL (* bracket). b. Staining for phospho-Vimentin revealing dividing oRGs (arrows) with typical morphology: possessing a basal process (arrowheads) but lacking an apical process. Right panel: a daughter cell pair showing unequal inheritance of the basal process. Apical-basal orientation indicated by \u201cA\u2192B\u201d. c. Staining for phospho-Vimentin (P-Vim) in a recently divided daughter cell pair with asymmetric fates: one oRG (arrow, Sox2+) while the other lacks Sox2 expression (arrowhead). d. Orientation of division of a mitotic oRG in anaphase revealing vertical (60-90 degrees) orientation relative to the apical surface (dashed line). Quantification of spindle orientation for 14 anaphase oRGs from 6 different cortical tissues. Scale bars: 50 \u03bcm (a), 20 \u03bcm (b-d).", "co_occurrence": [{"body": 35, "word": "cortical", "fig": 2}, {"body": 57, "word": "organoids", "fig": 1}, {"body": 55, "word": "tissues", "fig": 1}, {"body": 26, "word": "morphology", "fig": 2}, {"body": 48, "word": "human", "fig": 1}, {"body": 19, "word": "revealing", "fig": 2}, {"body": 8, "word": "oRGs", "fig": 4}, {"body": 15, "word": "layer", "fig": 2}, {"body": 14, "word": "cell", "fig": 2}, {"body": 14, "word": "apical", "fig": 2}, {"body": 13, "word": "arrowheads", "fig": 2}, {"body": 11, "word": "basal", "fig": 2}, {"body": 11, "word": "similar", "fig": 2}, {"body": 11, "word": "typical", "fig": 2}, {"body": 7, "word": "orientation", "fig": 3}, {"body": 21, "word": "development", "fig": 1}, {"body": 20, "word": "staining", "fig": 1}, {"body": 9, "word": "Sox2", "fig": 2}, {"body": 18, "word": "RGs", "fig": 1}, {"body": 8, "word": "Staining", "fig": 2}, {"body": 13, "word": "arrows", "fig": 1}, {"body": 12, "word": "presence", "fig": 1}, {"body": 5, "word": "oRG", "fig": 2}, {"body": 10, "word": "neuronal", "fig": 1}, {"body": 10, "word": "surface", "fig": 1}, {"body": 10, "word": "VZ", "fig": 1}, {"body": 9, "word": "expression", "fig": 1}, {"body": 8, "word": "processes", "fig": 1}, {"body": 7, "word": "c.", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 2}, {"body": 6, "word": "panel", "fig": 1}, {"body": 3, "word": "daughter", "fig": 2}, {"body": 5, "word": "d.", "fig": 1}, {"body": 5, "word": "spindle", "fig": 1}, {"body": 5, "word": "division", "fig": 1}, {"body": 5, "word": "bars", "fig": 1}, {"body": 5, "word": "mitotic", "fig": 1}, {"body": 5, "word": "one", "fig": 1}, {"body": 5, "word": "a.", "fig": 1}, {"body": 4, "word": "Cerebral", "fig": 1}, {"body": 4, "word": "Sox2+", "fig": 1}, {"body": 4, "word": "b.", "fig": 1}, {"body": 2, "word": "phospho-Vimentin", "fig": 2}, {"body": 4, "word": "line", "fig": 1}, {"body": 2, "word": "pair", "fig": 2}, {"body": 3, "word": "Tuj1", "fig": 1}, {"body": 3, "word": "reveals", "fig": 1}, {"body": 3, "word": "IFL", "fig": 1}, {"body": 1, "word": "process", "fig": 3}, {"body": 3, "word": "separated", "fig": 1}, {"body": 3, "word": "asymmetric", "fig": 1}, {"body": 3, "word": "behavior", "fig": 1}, {"body": 3, "word": "Tuj1+", "fig": 1}, {"body": 3, "word": "organized", "fig": 1}, {"body": 2, "word": "dividing", "fig": 1}, {"body": 2, "word": "lacking", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "arrow", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "recently", "fig": 1}, {"body": 2, "word": "vertical", "fig": 1}, {"body": 1, "word": "anaphase", "fig": 2}, {"body": 2, "word": "Quantification", "fig": 1}, {"body": 2, "word": "OSVZ-like", "fig": 1}, {"body": 1, "word": "bracket", "fig": 2}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "arrowhead", "fig": 1}, {"body": 1, "word": "fibers", "fig": 1}, {"body": 1, "word": "dashed", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}, {"body": 1, "word": "Immunohistochemical", "fig": 1}, {"body": 1, "word": "produce", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817409/bin/emss-54265-f0006.jpg", "caption": "Cerebral organoid modeling of microcephaly a. MRI scan from patient A3842 taken at birth (top) compared with age-matched control (bottom) showing brain and head size reduction and simplified cortical folding (arrows). Saggital T1 (left) and axial T2 (right) images. Scale bar 1cm. b. Sequencing chromatograms demonstrating compound heterozygous nonsense mutations inherited from each parent. c. CDK5RAP2 protein is undetectable on immunoblotting of patient cell lysate (A3842) compared with control skin fibroblasts. Vinculin (VCL), loading control. d. Representative bright-field images of control and patient-derived cerebral organoids (A3842 line 1M, all lines shown in Extended Data Figure 7d) at 6, 11, 15, and 22 days of differentiation. Control exhibits large fluid-filled cortical regions (arrows), while patient-derived exhibits increased outgrowth (arrowheads). e. Immunohistochemistry in control and patient-derived (10M) tissues at day 30 of differentiation revealing fewer neurons (Doublecortin, DCX, arrows) and smaller progenitor zones (Sox2, arrowheads). f. Staining at day 22 showing increased neurons (Tuj1, arrows) in patient-derived tissue (14B). g. BrdU pulse-chase in control and patient-derived organoids (14B) showing higher percentage of BrdU+ cells with neural identity and less in the VZ compared with control. Results quantified at right. Error bars are S.D. **P<0.01, Student\u2019s t-test. n=3 organoids for each condition (300 cells total for control, 204 cells for patient). h. P-Vimentin staining in control and patient-derived tissues (14B) showing RG mitotic divisions. Control RGs at anaphase divided exclusively horizontal (0-30 degree angle, arrow) whereas patient RGs displayed many oblique and vertical orientations (arrowhead). Results quantified at right (P<0.01, 2\u00d73 Fisher\u2019s exact test, n=11 cells for control, n=15 cells for patient-derived, from >5 cortical regions each). i. hESC organoids co-electroporated with GFP and scrambled or CDK5RAP2 shRNAs and examined after 5 days. Electroporated regions (demarcated by arrowheads) exhibit loss of Sox2+ progenitors and increased Doublecortin (DCX) neurons. Scale bars: 200 \u03bcm (d, e, i), 50 \u03bcm (f-h).", "co_occurrence": [{"body": 47, "word": "cells", "fig": 5}, {"body": 57, "word": "organoids", "fig": 4}, {"body": 21, "word": "control", "fig": 10}, {"body": 55, "word": "tissues", "fig": 2}, {"body": 35, "word": "cortical", "fig": 3}, {"body": 33, "word": "regions", "fig": 3}, {"body": 24, "word": "patient", "fig": 4}, {"body": 91, "word": "Figure", "fig": 1}, {"body": 27, "word": "neurons", "fig": 3}, {"body": 30, "word": "CDK5RAP2", "fig": 2}, {"body": 13, "word": "arrows", "fig": 4}, {"body": 7, "word": "patient-derived", "fig": 7}, {"body": 24, "word": "days", "fig": 2}, {"body": 45, "word": "Data", "fig": 1}, {"body": 44, "word": "Extended", "fig": 1}, {"body": 43, "word": "cerebral", "fig": 1}, {"body": 13, "word": "arrowheads", "fig": 3}, {"body": 12, "word": "compared", "fig": 3}, {"body": 18, "word": "RGs", "fig": 2}, {"body": 35, "word": "brain", "fig": 1}, {"body": 30, "word": "neural", "fig": 1}, {"body": 14, "word": "differentiation", "fig": 2}, {"body": 27, "word": "GFP", "fig": 1}, {"body": 13, "word": "day", "fig": 2}, {"body": 21, "word": "tissue", "fig": 1}, {"body": 20, "word": "staining", "fig": 1}, {"body": 19, "word": "revealing", "fig": 1}, {"body": 19, "word": "identity", "fig": 1}, {"body": 17, "word": "organoid", "fig": 1}, {"body": 16, "word": "progenitors", "fig": 1}, {"body": 15, "word": "displayed", "fig": 1}, {"body": 5, "word": "increased", "fig": 3}, {"body": 14, "word": "cell", "fig": 1}, {"body": 12, "word": "examined", "fig": 1}, {"body": 4, "word": "14B", "fig": 3}, {"body": 11, "word": "microcephaly", "fig": 1}, {"body": 11, "word": "progenitor", "fig": 1}, {"body": 5, "word": "bars", "fig": 2}, {"body": 10, "word": "size", "fig": 1}, {"body": 10, "word": "smaller", "fig": 1}, {"body": 10, "word": "VZ", "fig": 1}, {"body": 9, "word": "fibroblasts", "fig": 1}, {"body": 3, "word": "right", "fig": 3}, {"body": 3, "word": "A3842", "fig": 3}, {"body": 9, "word": "test", "fig": 1}, {"body": 9, "word": "Sox2", "fig": 1}, {"body": 4, "word": "DCX", "fig": 2}, {"body": 2, "word": "showing", "fig": 4}, {"body": 8, "word": "Staining", "fig": 1}, {"body": 7, "word": "loss", "fig": 1}, {"body": 7, "word": "c.", "fig": 1}, {"body": 7, "word": "lines", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 2}, {"body": 3, "word": "images", "fig": 2}, {"body": 6, "word": "shown", "fig": 1}, {"body": 5, "word": "d.", "fig": 1}, {"body": 5, "word": "mitotic", "fig": 1}, {"body": 5, "word": "horizontal", "fig": 1}, {"body": 5, "word": "divisions", "fig": 1}, {"body": 5, "word": "many", "fig": 1}, {"body": 5, "word": "BrdU", "fig": 1}, {"body": 5, "word": "a.", "fig": 1}, {"body": 5, "word": "whereas", "fig": 1}, {"body": 5, "word": "left", "fig": 1}, {"body": 4, "word": "Cerebral", "fig": 1}, {"body": 4, "word": "skin", "fig": 1}, {"body": 2, "word": "exhibits", "fig": 2}, {"body": 4, "word": "RG", "fig": 1}, {"body": 4, "word": "Sox2+", "fig": 1}, {"body": 4, "word": "b.", "fig": 1}, {"body": 4, "word": "zones", "fig": 1}, {"body": 4, "word": "large", "fig": 1}, {"body": 4, "word": "degree", "fig": 1}, {"body": 4, "word": "e.", "fig": 1}, {"body": 2, "word": "Scale", "fig": 2}, {"body": 4, "word": "line", "fig": 1}, {"body": 4, "word": "P-Vimentin", "fig": 1}, {"body": 4, "word": "protein", "fig": 1}, {"body": 4, "word": "shRNAs", "fig": 1}, {"body": 3, "word": "less", "fig": 1}, {"body": 3, "word": "Student\u2019s", "fig": 1}, {"body": 3, "word": "mutations", "fig": 1}, {"body": 3, "word": "Tuj1", "fig": 1}, {"body": 3, "word": "exhibit", "fig": 1}, {"body": 3, "word": "t-test", "fig": 1}, {"body": 3, "word": "1M", "fig": 1}, {"body": 3, "word": "orientations", "fig": 1}, {"body": 3, "word": "fluid-filled", "fig": 1}, {"body": 2, "word": "oblique", "fig": 1}, {"body": 2, "word": "Immunohistochemistry", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "birth", "fig": 1}, {"body": 2, "word": "g.", "fig": 1}, {"body": 2, "word": "arrow", "fig": 1}, {"body": 2, "word": "pulse-chase", "fig": 1}, {"body": 2, "word": "outgrowth", "fig": 1}, {"body": 1, "word": "Doublecortin", "fig": 2}, {"body": 2, "word": "reduction", "fig": 1}, {"body": 2, "word": "percentage", "fig": 1}, {"body": 2, "word": "head", "fig": 1}, {"body": 2, "word": "Error", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 2, "word": "f.", "fig": 1}, {"body": 2, "word": "vertical", "fig": 1}, {"body": 2, "word": "higher", "fig": 1}, {"body": 1, "word": "Results", "fig": 2}, {"body": 2, "word": "scrambled", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "heterozygous", "fig": 1}, {"body": 1, "word": "MRI", "fig": 1}, {"body": 1, "word": "compound", "fig": 1}, {"body": 1, "word": "bar", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "fewer", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "Representative", "fig": 1}, {"body": 1, "word": "simplified", "fig": 1}, {"body": 1, "word": "exclusively", "fig": 1}, {"body": 1, "word": "anaphase", "fig": 1}, {"body": 1, "word": "taken", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "7d", "fig": 1}, {"body": 1, "word": "demarcated", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}, {"body": 1, "word": "arrowhead", "fig": 1}, {"body": 1, "word": "immunoblotting", "fig": 1}]}], "2854093": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170001.jpg", "caption": "Arginylation regulates actin polymer level in vivo. (A) Staining of wild-type (WT) and Ate1 knockout (KO) cells with rhodamine-phalloidin. (B) Frequency histogram showing the distribution of the total fluorescence levels in individual (left) and averaged (right) WT and Ate1 KO cells (n = 54; error bars, SD between the readings shown on the left; p < 0.0001). (C) Fractionation of actin from the lysates of WT and KO cells by high-speed centrifugation (see Figure S1 for the other centrifugation steps and Supplemental Table 1 for the percentages plotted in the diagrams). Bars show percentages of actin present in the supernatant (G-actin, light gray) and pellet (F-actin, dark gray) for total actin and individual actin isoforms, estimated by Western blot quantification using antibodies specific to total, \u03b2- and \u03b3-actin, as labeled. Error bars, SD for two independent experiments. (D) Western blot analysis of WT and Ate1 KO cell lysates using antibody to total actin and \u03b2-tubulin as a loading control. Bars represent a quantification of total actin adjusted to the loading control, averaged from three independent experiments. (E) Percentage of total, \u03b2- and \u03b3-actin in the lower speed centrifugation steps (representing bundles and aggregates) calculated from the centrifugation steps shown in C and in Figure S1. Error bars, SD for two independent experiments. See also Supplemental Table 1 for the percentages used to obtain the bar diagrams shown in C and E.", "co_occurrence": [{"body": 194, "word": "actin", "fig": 7}, {"body": 88, "word": "KO", "fig": 4}, {"body": 49, "word": "WT", "fig": 4}, {"body": 45, "word": "cells", "fig": 3}, {"body": 36, "word": "Ate1", "fig": 3}, {"body": 52, "word": "Figure", "fig": 2}, {"body": 10, "word": "total", "fig": 6}, {"body": 12, "word": "centrifugation", "fig": 4}, {"body": 13, "word": "two", "fig": 2}, {"body": 23, "word": "polymer", "fig": 1}, {"body": 22, "word": "cell", "fig": 1}, {"body": 6, "word": "shown", "fig": 3}, {"body": 18, "word": "vivo", "fig": 1}, {"body": 8, "word": "Western", "fig": 2}, {"body": 8, "word": "using", "fig": 2}, {"body": 15, "word": "levels", "fig": 1}, {"body": 4, "word": "experiments", "fig": 3}, {"body": 6, "word": "\u03b2-", "fig": 2}, {"body": 6, "word": "\u03b3-actin", "fig": 2}, {"body": 11, "word": "level", "fig": 1}, {"body": 11, "word": "F-actin", "fig": 1}, {"body": 5, "word": "blot", "fig": 2}, {"body": 10, "word": "pellet", "fig": 1}, {"body": 5, "word": "lysates", "fig": 2}, {"body": 10, "word": "aggregates", "fig": 1}, {"body": 9, "word": "lower", "fig": 1}, {"body": 3, "word": "steps", "fig": 3}, {"body": 9, "word": "fluorescence", "fig": 1}, {"body": 8, "word": "regulates", "fig": 1}, {"body": 8, "word": "bundles", "fig": 1}, {"body": 8, "word": "also", "fig": 1}, {"body": 3, "word": "S1", "fig": 2}, {"body": 6, "word": "rhodamine-phalloidin", "fig": 1}, {"body": 2, "word": "independent", "fig": 3}, {"body": 6, "word": "used", "fig": 1}, {"body": 4, "word": "isoforms", "fig": 1}, {"body": 2, "word": "loading", "fig": 2}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 4, "word": "present", "fig": 1}, {"body": 2, "word": "averaged", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "supernatant", "fig": 1}, {"body": 3, "word": "speed", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "see", "fig": 1}, {"body": 3, "word": "estimated", "fig": 1}, {"body": 1, "word": "C", "fig": 3}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "high-speed", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 1, "word": "SD", "fig": 3}, {"body": 1, "word": "percentages", "fig": 3}, {"body": 2, "word": "show", "fig": 1}, {"body": 1, "word": "gray", "fig": 2}, {"body": 2, "word": "right", "fig": 1}, {"body": 1, "word": "Supplemental", "fig": 2}, {"body": 1, "word": "control", "fig": 2}, {"body": 2, "word": "G-actin", "fig": 1}, {"body": 2, "word": "distribution", "fig": 1}, {"body": 1, "word": "quantification", "fig": 2}, {"body": 2, "word": "light", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "Table", "fig": 2}, {"body": 1, "word": "left", "fig": 2}, {"body": 1, "word": "obtain", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "knockout", "fig": 1}, {"body": 1, "word": "antibody", "fig": 1}, {"body": 1, "word": "plotted", "fig": 1}, {"body": 1, "word": "Fractionation", "fig": 1}, {"body": 1, "word": "error", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170002.jpg", "caption": "Arginylation regulates polymerization properties of pure actin. (A) Coomassie blue\u2013stained SDS-PAGE of actin purified from WT and Ate1 KO fibroblasts. (B) Left, sedimentation-based actin polymerization assay using lower actin concentrations to determine the critical concentration for polymerization. To perform the assay, actin at each concentration was polymerized at room temperature for 4 h, followed by centrifugation at 100,000 \u00d7 g for 1 h at 17\u00b0C and quantification of actin in the pellets by SDS-PAGE and Coomassie blue staining. Inset, the Coomassie blue\u2013stained SDS-PAGE of the sedimented actin, which was quantified and plotted against the corresponding actin concentrations on the graph. Right, actin polymerization rates measured using a pyrene actin assay. The assembly rates derived as the slopes of the individual pyrene actin curves in the rapid growth phase were plotted against the corresponding concentrations of actin. The critical concentration values (denoted with an asterisk) were plotted on the graph as determined in sedimentation assays (left). Data were combined from two independent experiments. (C) Pyrene actin polymerization assay in the presence of seeds to determine the elongation rate. G-Actin concentration used to obtain the curve was 5 \u03bcm. See Figure S2 for the curves at other actin concentrations. (D) Left, rhodamine-phalloidin staining of filaments polymerized from arginylated (R) and nonarginylated (M) actin. Scale bar, 20 \u03bcm. Right, average lengths of filaments formed from M- and R-actin determined by measuring images shown on right. Error bars, SD for 100 measurements (p < 0.0001).", "co_occurrence": [{"body": 194, "word": "actin", "fig": 15}, {"body": 33, "word": "polymerization", "fig": 5}, {"body": 88, "word": "KO", "fig": 1}, {"body": 34, "word": "filaments", "fig": 2}, {"body": 52, "word": "Figure", "fig": 1}, {"body": 49, "word": "WT", "fig": 1}, {"body": 23, "word": "The", "fig": 2}, {"body": 36, "word": "Ate1", "fig": 1}, {"body": 9, "word": "concentration", "fig": 4}, {"body": 7, "word": "assay", "fig": 4}, {"body": 6, "word": "concentrations", "fig": 4}, {"body": 23, "word": "g", "fig": 1}, {"body": 11, "word": "polymerized", "fig": 2}, {"body": 8, "word": "staining", "fig": 2}, {"body": 8, "word": "using", "fig": 2}, {"body": 8, "word": "pyrene", "fig": 2}, {"body": 7, "word": "h", "fig": 2}, {"body": 13, "word": "two", "fig": 1}, {"body": 4, "word": "Coomassie", "fig": 3}, {"body": 12, "word": "centrifugation", "fig": 1}, {"body": 11, "word": "To", "fig": 1}, {"body": 9, "word": "arginylated", "fig": 1}, {"body": 3, "word": "SDS-PAGE", "fig": 3}, {"body": 9, "word": "lower", "fig": 1}, {"body": 8, "word": "regulates", "fig": 1}, {"body": 4, "word": "determine", "fig": 2}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "properties", "fig": 1}, {"body": 7, "word": "temperature", "fig": 1}, {"body": 7, "word": "room", "fig": 1}, {"body": 7, "word": "assays", "fig": 1}, {"body": 3, "word": "determined", "fig": 2}, {"body": 6, "word": "fibroblasts", "fig": 1}, {"body": 6, "word": "rate", "fig": 1}, {"body": 6, "word": "images", "fig": 1}, {"body": 6, "word": "sedimentation", "fig": 1}, {"body": 6, "word": "seeds", "fig": 1}, {"body": 3, "word": "rates", "fig": 2}, {"body": 3, "word": "corresponding", "fig": 2}, {"body": 6, "word": "rhodamine-phalloidin", "fig": 1}, {"body": 6, "word": "used", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "elongation", "fig": 1}, {"body": 5, "word": "purified", "fig": 1}, {"body": 5, "word": "nonarginylated", "fig": 1}, {"body": 5, "word": "phase", "fig": 1}, {"body": 5, "word": "pellets", "fig": 1}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "critical", "fig": 2}, {"body": 4, "word": "sedimented", "fig": 1}, {"body": 4, "word": "followed", "fig": 1}, {"body": 4, "word": "R-actin", "fig": 1}, {"body": 2, "word": "curves", "fig": 2}, {"body": 3, "word": "quantified", "fig": 1}, {"body": 3, "word": "M", "fig": 1}, {"body": 3, "word": "measurements", "fig": 1}, {"body": 1, "word": "plotted", "fig": 3}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 2, "word": "M-", "fig": 1}, {"body": 2, "word": "growth", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "assembly", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "combined", "fig": 1}, {"body": 2, "word": "formed", "fig": 1}, {"body": 2, "word": "values", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "derived", "fig": 1}, {"body": 2, "word": "average", "fig": 1}, {"body": 1, "word": "blue\u2013stained", "fig": 2}, {"body": 1, "word": "obtain", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "rapid", "fig": 1}, {"body": 1, "word": "S2", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}, {"body": 1, "word": "SD", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}, {"body": 1, "word": "17\u00b0C", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170003.jpg", "caption": "Purified arginylation-free actin forms bundles and aggregates that are structurally distinct from normal filaments. (A) Negative staining EM images of actin filaments polymerized from pure WT (left column) and KO (right column) actin. Scale bars, 100 nm. (B) Sucrose density gradient fractionation of actin filaments polymerized from actins purified from WT and KO cells. Top, gel of the gradient fractions and protein level profile across the gradient. Bottom, negative staining EM images of the gradient peak (fraction 10) and bottom (fraction 25). Error bars, SD for two experiments.", "co_occurrence": [{"body": 194, "word": "actin", "fig": 4}, {"body": 88, "word": "KO", "fig": 2}, {"body": 34, "word": "filaments", "fig": 3}, {"body": 49, "word": "WT", "fig": 2}, {"body": 45, "word": "cells", "fig": 1}, {"body": 10, "word": "gradient", "fig": 4}, {"body": 36, "word": "protein", "fig": 1}, {"body": 13, "word": "fraction", "fig": 2}, {"body": 11, "word": "polymerized", "fig": 2}, {"body": 8, "word": "staining", "fig": 2}, {"body": 13, "word": "two", "fig": 1}, {"body": 12, "word": "fractions", "fig": 1}, {"body": 6, "word": "images", "fig": 2}, {"body": 11, "word": "level", "fig": 1}, {"body": 5, "word": "EM", "fig": 2}, {"body": 10, "word": "aggregates", "fig": 1}, {"body": 8, "word": "bundles", "fig": 1}, {"body": 4, "word": "column", "fig": 2}, {"body": 7, "word": "normal", "fig": 1}, {"body": 7, "word": "bottom", "fig": 1}, {"body": 5, "word": "purified", "fig": 1}, {"body": 5, "word": "density", "fig": 1}, {"body": 4, "word": "forms", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 3, "word": "fractionation", "fig": 1}, {"body": 3, "word": "actins", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "negative", "fig": 1}, {"body": 2, "word": "distinct", "fig": 1}, {"body": 2, "word": "peak", "fig": 1}, {"body": 2, "word": "gel", "fig": 1}, {"body": 1, "word": "structurally", "fig": 1}, {"body": 1, "word": "SD", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170004.jpg", "caption": "Arginylation regulates ABPs and their interaction with F-actin. (A) Silver-stained 2D gels of actin filaments in complex with ABP obtained from WT and Ate1 KO fibroblasts by phalloidin-induced polymerization in clarified cell lysates followed by sedimentation. Gel pH range is 4.5\u201310, increasing left to right. Spots corresponding to those circled in the figure were excised from similarly run Coomassie-stained 2D gels and identified by mass spectrometry as (1) drebrin, (2) gelsolin, (3) PDI, (4) twinfilin, (5) capping protein \u03b1, and (6) capping protein \u03b2. (B) Table with identified proteins that are altered between the two gels. Fold-change p-values determined by Student's t test generated by gel comparison software based on the analysis of duplicate silver-stained gels were as follows: gelsolin spot A, 0.001; gelsolin spot B, 0.015; gelsolin spot C, 0.002; drebrin, 0.015; PDI, 0.028; twinfilin, 0.240; capping protein \u03b2, 0.041; and capping protein \u03b1, 1: 0.061. (C) Western blot analysis of WT and Ate1 KO total cell lysates.", "co_occurrence": [{"body": 194, "word": "actin", "fig": 1}, {"body": 88, "word": "KO", "fig": 2}, {"body": 36, "word": "protein", "fig": 4}, {"body": 49, "word": "WT", "fig": 2}, {"body": 21, "word": "capping", "fig": 4}, {"body": 36, "word": "Ate1", "fig": 2}, {"body": 17, "word": "gelsolin", "fig": 4}, {"body": 22, "word": "cell", "fig": 2}, {"body": 34, "word": "filaments", "fig": 1}, {"body": 33, "word": "polymerization", "fig": 1}, {"body": 20, "word": "proteins", "fig": 1}, {"body": 10, "word": "PDI", "fig": 2}, {"body": 8, "word": "drebrin", "fig": 2}, {"body": 13, "word": "two", "fig": 1}, {"body": 6, "word": "twinfilin", "fig": 2}, {"body": 3, "word": "gels", "fig": 4}, {"body": 11, "word": "test", "fig": 1}, {"body": 11, "word": "F-actin", "fig": 1}, {"body": 5, "word": "lysates", "fig": 2}, {"body": 10, "word": "pH", "fig": 1}, {"body": 10, "word": "total", "fig": 1}, {"body": 8, "word": "Western", "fig": 1}, {"body": 8, "word": "regulates", "fig": 1}, {"body": 4, "word": "A", "fig": 2}, {"body": 6, "word": "ABPs", "fig": 1}, {"body": 3, "word": "2D", "fig": 2}, {"body": 6, "word": "fibroblasts", "fig": 1}, {"body": 6, "word": "sedimentation", "fig": 1}, {"body": 6, "word": "interaction", "fig": 1}, {"body": 3, "word": "B", "fig": 2}, {"body": 5, "word": "blot", "fig": 1}, {"body": 2, "word": "identified", "fig": 2}, {"body": 4, "word": "clarified", "fig": 1}, {"body": 2, "word": "\u03b2", "fig": 2}, {"body": 4, "word": "followed", "fig": 1}, {"body": 2, "word": "analysis", "fig": 2}, {"body": 3, "word": "'s", "fig": 1}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 3, "word": "determined", "fig": 1}, {"body": 1, "word": "spot", "fig": 3}, {"body": 1, "word": "\u03b1", "fig": 2}, {"body": 2, "word": "gel", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 1, "word": "C", "fig": 2}, {"body": 2, "word": "run", "fig": 1}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 2, "word": "software", "fig": 1}, {"body": 2, "word": "silver-stained", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 2, "word": "altered", "fig": 1}, {"body": 1, "word": "based", "fig": 1}, {"body": 1, "word": "excised", "fig": 1}, {"body": 1, "word": "similarly", "fig": 1}, {"body": 1, "word": "duplicate", "fig": 1}, {"body": 1, "word": "Gel", "fig": 1}, {"body": 1, "word": "phalloidin-induced", "fig": 1}, {"body": 1, "word": "spectrometry", "fig": 1}, {"body": 1, "word": "figure", "fig": 1}, {"body": 1, "word": "generated", "fig": 1}, {"body": 1, "word": "mass", "fig": 1}, {"body": 1, "word": "Table", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170005.jpg", "caption": "Arginylation regulates gelsolin\u2013actin binding and gelsolin-induced severing of the actin filaments. (A) Cosedimentation assays in the presence of low Ca2+ at increasing gelsolin\u2013actin ratios confirm that gelsolin binding to WT actin is stronger than to KO actin. Error bars, SEM of three independent measurements. Two-tailed unpaired t test; p < 0.0001 for 50 nM gelsolin, 0.0019 for 100 nM gelsolin, and 0.0412 for 200 nM gelsolin. (B) Cosedimentation assays in the presence of high Ca2+ (evidenced by the severing-dependent reduction of pelleting of WT actin in the presence of gelsolin) show higher severing activity of gelsolin toward WT actin. Error bars, SEM of four independent measurements; p = 0.0458.", "co_occurrence": [{"body": 194, "word": "actin", "fig": 5}, {"body": 49, "word": "WT", "fig": 3}, {"body": 17, "word": "gelsolin", "fig": 6}, {"body": 88, "word": "KO", "fig": 1}, {"body": 34, "word": "filaments", "fig": 1}, {"body": 16, "word": "binding", "fig": 2}, {"body": 7, "word": "presence", "fig": 3}, {"body": 7, "word": "assays", "fig": 2}, {"body": 12, "word": "higher", "fig": 1}, {"body": 11, "word": "test", "fig": 1}, {"body": 5, "word": "Ca2+", "fig": 2}, {"body": 3, "word": "nM", "fig": 3}, {"body": 8, "word": "regulates", "fig": 1}, {"body": 3, "word": "measurements", "fig": 2}, {"body": 6, "word": "reduction", "fig": 1}, {"body": 6, "word": "activity", "fig": 1}, {"body": 3, "word": "severing", "fig": 2}, {"body": 5, "word": "high", "fig": 1}, {"body": 5, "word": "toward", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "independent", "fig": 2}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 2, "word": "confirm", "fig": 1}, {"body": 2, "word": "low", "fig": 1}, {"body": 1, "word": "SEM", "fig": 2}, {"body": 1, "word": "p", "fig": 2}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "gelsolin-induced", "fig": 1}, {"body": 1, "word": "pelleting", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170006.jpg", "caption": "Arginylation regulates actin network density and organization at the leading edge of the motile cells. Electron micrographs of the platinum replicas of the cytoskeleton in WT and Ate1 KO fibroblasts. (A and B) WT and Ate1 KO cell replicas at low magnification. (A1, A2, B1, and B2) Higher magnification images of the areas boxed in A and B, respectively, and represent the cell interior (A1 and B1) and leading edge (A2 and B2) from the WT and KO cells shown on the left. (C and D) Higher resolution images of lamellipodia from WT and Ate1 KO cells depicting the structural organization of actin network in these cells at the leading edge. Inset in B1, an enlarged image of a protein aggregate. Scale bars, (A and B) 10 \u03bcm and (A1, A2, B1, B2, C and D) 500 nm.", "co_occurrence": [{"body": 194, "word": "actin", "fig": 2}, {"body": 88, "word": "KO", "fig": 4}, {"body": 49, "word": "WT", "fig": 4}, {"body": 45, "word": "cells", "fig": 4}, {"body": 36, "word": "Ate1", "fig": 3}, {"body": 22, "word": "cell", "fig": 2}, {"body": 36, "word": "protein", "fig": 1}, {"body": 12, "word": "leading", "fig": 3}, {"body": 9, "word": "edge", "fig": 3}, {"body": 15, "word": "cytoskeleton", "fig": 1}, {"body": 7, "word": "network", "fig": 2}, {"body": 6, "word": "images", "fig": 2}, {"body": 4, "word": "A", "fig": 3}, {"body": 3, "word": "B", "fig": 3}, {"body": 8, "word": "regulates", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 3, "word": "magnification", "fig": 2}, {"body": 3, "word": "replicas", "fig": 2}, {"body": 3, "word": "D", "fig": 2}, {"body": 6, "word": "fibroblasts", "fig": 1}, {"body": 5, "word": "density", "fig": 1}, {"body": 1, "word": "B1", "fig": 4}, {"body": 3, "word": "areas", "fig": 1}, {"body": 2, "word": "platinum", "fig": 1}, {"body": 2, "word": "low", "fig": 1}, {"body": 1, "word": "C", "fig": 2}, {"body": 2, "word": "lamellipodia", "fig": 1}, {"body": 1, "word": "image", "fig": 1}, {"body": 1, "word": "structural", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "aggregate", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170007.jpg", "caption": "Absence of arginylation increases capping protein binding and the number of filament ends in the leading edge actin network. (A) Top, electron micrographs of platinum replicas of the lamellipodial actin network in a WT and a KO cell with filament ends marked as white dots. Middle, stereo electron micrographs of the magnified regions boxed in the top panels, showing individual actin filament ends. (Red-cyan glasses should be used to view these images, with red on the left eye). Bottom, electron micrographs of the same regions as in the middle panels without the stereo effect, with actin filament ends marked by red asterisks. Scale bars, 500 nm. (B) Bar diagram showing the average number of visible filament ends normalized to total cytoskeleton density and averaged from three different images (error bars, SD; p = 0.0136). (C) Top, areas of the leading edge in WT and KO cells stained with an antibody to the capping protein (left panels) and actin, presented as identically scaled images to show the difference in the actin intensity between WT and KO (middle panels), and the images of the same area adjusted to the optimal brightness for each condition (right panels). Bottom, quantification of the ratios of capping protein to actin in WT and KO cells (error bars, SD of measurements from 32 WT and 31 KO cells; p < 0.0001). (D) Western blot and quantification of the levels of purified capping protein bound to WT and KO F-actin in an in vitro sedimentation assay. Error bars, the average of three independent measurements; two-tailed unpaired t test; p = 0.0534.", "co_occurrence": [{"body": 194, "word": "actin", "fig": 7}, {"body": 88, "word": "KO", "fig": 6}, {"body": 49, "word": "WT", "fig": 6}, {"body": 36, "word": "protein", "fig": 4}, {"body": 45, "word": "cells", "fig": 3}, {"body": 21, "word": "capping", "fig": 4}, {"body": 12, "word": "filament", "fig": 5}, {"body": 8, "word": "ends", "fig": 5}, {"body": 35, "word": "arginylation", "fig": 1}, {"body": 6, "word": "images", "fig": 4}, {"body": 12, "word": "leading", "fig": 2}, {"body": 22, "word": "cell", "fig": 1}, {"body": 9, "word": "edge", "fig": 2}, {"body": 16, "word": "binding", "fig": 1}, {"body": 15, "word": "cytoskeleton", "fig": 1}, {"body": 15, "word": "levels", "fig": 1}, {"body": 7, "word": "network", "fig": 2}, {"body": 11, "word": "test", "fig": 1}, {"body": 11, "word": "F-actin", "fig": 1}, {"body": 5, "word": "number", "fig": 2}, {"body": 10, "word": "total", "fig": 1}, {"body": 8, "word": "Western", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 7, "word": "different", "fig": 1}, {"body": 7, "word": "effect", "fig": 1}, {"body": 3, "word": "measurements", "fig": 2}, {"body": 6, "word": "sedimentation", "fig": 1}, {"body": 3, "word": "three", "fig": 2}, {"body": 6, "word": "vitro", "fig": 1}, {"body": 6, "word": "used", "fig": 1}, {"body": 2, "word": "electron", "fig": 3}, {"body": 5, "word": "purified", "fig": 1}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "density", "fig": 1}, {"body": 1, "word": "panels", "fig": 5}, {"body": 4, "word": "difference", "fig": 1}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "stereo", "fig": 2}, {"body": 2, "word": "average", "fig": 2}, {"body": 3, "word": "stained", "fig": 1}, {"body": 3, "word": "areas", "fig": 1}, {"body": 1, "word": "p", "fig": 3}, {"body": 3, "word": "visible", "fig": 1}, {"body": 3, "word": "top", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "replicas", "fig": 1}, {"body": 3, "word": "lamellipodial", "fig": 1}, {"body": 1, "word": "showing", "fig": 2}, {"body": 2, "word": "increases", "fig": 1}, {"body": 1, "word": "red", "fig": 2}, {"body": 1, "word": "marked", "fig": 2}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "platinum", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 1, "word": "quantification", "fig": 2}, {"body": 2, "word": "averaged", "fig": 1}, {"body": 1, "word": "error", "fig": 2}, {"body": 1, "word": "SD", "fig": 2}, {"body": 1, "word": "middle", "fig": 2}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "left", "fig": 2}, {"body": 1, "word": "bound", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "intensity", "fig": 1}, {"body": 1, "word": "glasses", "fig": 1}, {"body": 1, "word": "antibody", "fig": 1}, {"body": 1, "word": "area", "fig": 1}, {"body": 1, "word": "without", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854093/bin/zmk0081094170008.jpg", "caption": "Arginylation is required for lamella formation, cell spreading, and locomotion. In a normal cell, arginylated actin facilitates the formation of a proper leading edge network and normal actin structures throughout the cell. Absence of arginylation results in actin forming abnormal aggregates, which are sequestered and disassembled back into the monomer pool, causing the overall reduction of the amount of the actin polymer. Increased binding of capping proteins further lowers the polymer levels, and decreased gelsolin-dependent actin turnover contributes to the cytoskeletal abnormalities, resulting in a scarce and disorganized actin network in the cell body and at the leading edge. These effects result in reduced cell spreading and lamella collapse, causing severe impairments in cell migration.", "co_occurrence": [{"body": 194, "word": "actin", "fig": 6}, {"body": 22, "word": "cell", "fig": 6}, {"body": 23, "word": "polymer", "fig": 2}, {"body": 35, "word": "arginylation", "fig": 1}, {"body": 14, "word": "formation", "fig": 2}, {"body": 12, "word": "leading", "fig": 2}, {"body": 21, "word": "capping", "fig": 1}, {"body": 20, "word": "proteins", "fig": 1}, {"body": 9, "word": "edge", "fig": 2}, {"body": 16, "word": "binding", "fig": 1}, {"body": 15, "word": "levels", "fig": 1}, {"body": 7, "word": "network", "fig": 2}, {"body": 7, "word": "normal", "fig": 2}, {"body": 12, "word": "results", "fig": 1}, {"body": 6, "word": "lamella", "fig": 2}, {"body": 11, "word": "amount", "fig": 1}, {"body": 10, "word": "aggregates", "fig": 1}, {"body": 10, "word": "resulting", "fig": 1}, {"body": 9, "word": "overall", "fig": 1}, {"body": 9, "word": "arginylated", "fig": 1}, {"body": 8, "word": "decreased", "fig": 1}, {"body": 7, "word": "result", "fig": 1}, {"body": 6, "word": "reduction", "fig": 1}, {"body": 6, "word": "reduced", "fig": 1}, {"body": 5, "word": "These", "fig": 1}, {"body": 5, "word": "effects", "fig": 1}, {"body": 5, "word": "In", "fig": 1}, {"body": 4, "word": "abnormal", "fig": 1}, {"body": 2, "word": "causing", "fig": 2}, {"body": 2, "word": "spreading", "fig": 2}, {"body": 4, "word": "severe", "fig": 1}, {"body": 3, "word": "proper", "fig": 1}, {"body": 3, "word": "scarce", "fig": 1}, {"body": 3, "word": "turnover", "fig": 1}, {"body": 2, "word": "cytoskeletal", "fig": 1}, {"body": 2, "word": "contributes", "fig": 1}, {"body": 2, "word": "collapse", "fig": 1}, {"body": 2, "word": "migration", "fig": 1}, {"body": 2, "word": "impairments", "fig": 1}, {"body": 2, "word": "disorganized", "fig": 1}, {"body": 1, "word": "throughout", "fig": 1}, {"body": 1, "word": "gelsolin-dependent", "fig": 1}, {"body": 1, "word": "monomer", "fig": 1}, {"body": 1, "word": "sequestered", "fig": 1}, {"body": 1, "word": "structures", "fig": 1}, {"body": 1, "word": "body", "fig": 1}, {"body": 1, "word": "forming", "fig": 1}, {"body": 1, "word": "lowers", "fig": 1}, {"body": 1, "word": "back", "fig": 1}, {"body": 1, "word": "abnormalities", "fig": 1}, {"body": 1, "word": "pool", "fig": 1}, {"body": 1, "word": "Increased", "fig": 1}, {"body": 1, "word": "required", "fig": 1}, {"body": 1, "word": "disassembled", "fig": 1}, {"body": 1, "word": "locomotion", "fig": 1}]}], "4511861": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153fig1g.jpg", "caption": "Galloway-Mowat syndrome (GMS) is a neurodevelopmental disorder characterized by microcephaly, cerebellar hypoplasia, nephrosis, and profound intellectual disability. Jinks et al. extend the GMS spectrum by identifying a novel nephrocerebellar syndrome with selective striatal cholinergic interneuron loss and complete lateral geniculate nucleus delamination, caused by a frameshift mutation in WDR73.", "co_occurrence": [{"body": 90, "word": "WDR73", "fig": 1}, {"body": 87, "word": "et", "fig": 1}, {"body": 14, "word": "syndrome", "fig": 2}, {"body": 12, "word": "cerebellar", "fig": 1}, {"body": 10, "word": "Galloway-Mowat", "fig": 1}, {"body": 8, "word": "mutation", "fig": 1}, {"body": 8, "word": "spectrum", "fig": 1}, {"body": 7, "word": "al", "fig": 1}, {"body": 6, "word": "loss", "fig": 1}, {"body": 5, "word": "frameshift", "fig": 1}, {"body": 5, "word": "lateral", "fig": 1}, {"body": 5, "word": "cholinergic", "fig": 1}, {"body": 5, "word": "geniculate", "fig": 1}, {"body": 5, "word": "novel", "fig": 1}, {"body": 4, "word": "nephrocerebellar", "fig": 1}, {"body": 4, "word": "characterized", "fig": 1}, {"body": 3, "word": "hypoplasia", "fig": 1}, {"body": 3, "word": "striatal", "fig": 1}, {"body": 3, "word": "microcephaly", "fig": 1}, {"body": 3, "word": "selective", "fig": 1}, {"body": 2, "word": "caused", "fig": 1}, {"body": 2, "word": "profound", "fig": 1}, {"body": 2, "word": "disorder", "fig": 1}, {"body": 1, "word": "delamination", "fig": 1}, {"body": 1, "word": "extend", "fig": 1}, {"body": 1, "word": "nucleus", "fig": 1}, {"body": 1, "word": "nephrosis", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153f1p.jpg", "caption": "Nephrocerebellar syndrome. (A) Postnatal brain growth is slow in children with NCS (grey-shaded area = normal head circumference for age, mean \u00b1 2 SD; red circles = NCS head circumference, mean \u00b1 SD). Inset: Children with NCS have no distinctive dysmorphic features, but the forehead characteristically recedes, reflecting relative hypoplasia of the cerebral cortex; post-mortem brain weights are only 50\u201360% of normal (photos used with parental permission). (B) MRI at 1.5 T (left to right: axial T2, coronal T2, sagittal T1) shows underdeveloped frontal lobes (asterisks), thin corpus callosum (yellow arrowheads), and severe atrophy of the cerebellar hemispheres (red arrows) and vermis (yellow arrows). Comparable images of the same NCS child, taken at 13 months (upper panel) and 32 months (lower panel), reveal progressive degeneration of cerebellar tissue (arrows). (C) Initial SNP genotyping of five children (inset) mapped recessive NCS to an 8.26 Mb autozygous block of DNA on chromosome 15 (blue arrow). After the initial mapping, we identified nine additional patients that allowed us to narrow the shared homozygous interval to 3.96 Mb. Yellow signal indicates the number of contiguous SNPs shared among NCS individuals. For each block of shared homozygous SNPs, purple signal shows the cumulative two-point LOD score (\u2018location score\u2019), a relative probability, based on population allele frequencies, that the disease gene resides in the homozygous block. Subsequent genotyping of all 27 NCS individuals refined the shared locus to 700 kb, which contained the novel WDR73 c.888delT mutation homozygous in all affected children.", "co_occurrence": [{"body": 51, "word": "NCS", "fig": 7}, {"body": 90, "word": "WDR73", "fig": 1}, {"body": 19, "word": "homozygous", "fig": 4}, {"body": 17, "word": "children", "fig": 3}, {"body": 13, "word": "normal", "fig": 2}, {"body": 12, "word": "cerebellar", "fig": 2}, {"body": 7, "word": "block", "fig": 3}, {"body": 5, "word": "shared", "fig": 4}, {"body": 19, "word": "affected", "fig": 1}, {"body": 9, "word": "brain", "fig": 2}, {"body": 8, "word": "individuals", "fig": 2}, {"body": 7, "word": "mean", "fig": 2}, {"body": 14, "word": "syndrome", "fig": 1}, {"body": 8, "word": "c.888delT", "fig": 1}, {"body": 8, "word": "identified", "fig": 1}, {"body": 4, "word": "Mb", "fig": 2}, {"body": 8, "word": "mutation", "fig": 1}, {"body": 8, "word": "additional", "fig": 1}, {"body": 8, "word": "patients", "fig": 1}, {"body": 8, "word": "age", "fig": 1}, {"body": 7, "word": "atrophy", "fig": 1}, {"body": 7, "word": "tissue", "fig": 1}, {"body": 3, "word": "relative", "fig": 2}, {"body": 6, "word": "child", "fig": 1}, {"body": 6, "word": "used", "fig": 1}, {"body": 5, "word": "progressive", "fig": 1}, {"body": 5, "word": "SNP", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "For", "fig": 1}, {"body": 5, "word": "cerebral", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "novel", "fig": 1}, {"body": 5, "word": "cortex", "fig": 1}, {"body": 4, "word": "slow", "fig": 1}, {"body": 4, "word": "five", "fig": 1}, {"body": 4, "word": "growth", "fig": 1}, {"body": 4, "word": "post-mortem", "fig": 1}, {"body": 4, "word": "DNA", "fig": 1}, {"body": 4, "word": "mapping", "fig": 1}, {"body": 4, "word": "autozygous", "fig": 1}, {"body": 3, "word": "features", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "degeneration", "fig": 1}, {"body": 3, "word": "hypoplasia", "fig": 1}, {"body": 3, "word": "disease", "fig": 1}, {"body": 3, "word": "severe", "fig": 1}, {"body": 1, "word": "signal", "fig": 2}, {"body": 2, "word": "dysmorphic", "fig": 1}, {"body": 1, "word": "red", "fig": 2}, {"body": 1, "word": "circumference", "fig": 2}, {"body": 1, "word": "SNPs", "fig": 2}, {"body": 2, "word": "contained", "fig": 1}, {"body": 2, "word": "corpus", "fig": 1}, {"body": 2, "word": "population", "fig": 1}, {"body": 2, "word": "nine", "fig": 1}, {"body": 2, "word": "thin", "fig": 1}, {"body": 1, "word": "SD", "fig": 2}, {"body": 2, "word": "LOD", "fig": 1}, {"body": 2, "word": "chromosome", "fig": 1}, {"body": 2, "word": "kb", "fig": 1}, {"body": 2, "word": "callosum", "fig": 1}, {"body": 1, "word": "cumulative", "fig": 1}, {"body": 1, "word": "vermis", "fig": 1}, {"body": 1, "word": "based", "fig": 1}, {"body": 1, "word": "allele", "fig": 1}, {"body": 1, "word": "hemispheres", "fig": 1}, {"body": 1, "word": "\u2018location", "fig": 1}, {"body": 1, "word": "axial", "fig": 1}, {"body": 1, "word": "score", "fig": 1}, {"body": 1, "word": "recessive", "fig": 1}, {"body": 1, "word": "among", "fig": 1}, {"body": 1, "word": "probability", "fig": 1}, {"body": 1, "word": "locus", "fig": 1}, {"body": 1, "word": "refined", "fig": 1}, {"body": 1, "word": "two-point", "fig": 1}, {"body": 1, "word": "indicates", "fig": 1}, {"body": 1, "word": "Children", "fig": 1}, {"body": 1, "word": "interval", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "frequencies", "fig": 1}, {"body": 1, "word": "score\u2019", "fig": 1}, {"body": 1, "word": "gene", "fig": 1}, {"body": 1, "word": "T", "fig": 1}, {"body": 1, "word": "weights", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153f2p.jpg", "caption": "Neuropathology of NCS. (A) A child with NCS died from complications of renal failure at 3.5 years of age. Total brain weight was 636 g (60% of expected) and the hindbrain weighed 7.9% of the total (expected 12%). (B) The cerebellum (yellow arrowhead in A) was small, firm and sclerotic. Luxol Fast Blue (C) and GFAP (D) stains show atrophy and gliosis within cross-sections of the optic nerve. (E) The normal hexalaminar structure of the lateral geniculate nucleus (LGN) is compared with the lateral geniculate nucleus of an NCS child (F), that is nearly devoid of magnocellular neurons, parvocellular neurons, and laminae. (G) Choline acetyltransferase staining of normal striatum reveals several large cholinergic interneurons (arrows), which are absent from a comparable histological section of NCS striatum (H). (I) Normal cerebellar cortex stained with haematoxylin-eosin is compared to that of NCS cerebellum (J), which has short, stubby folia with sparse nuclei in the granule cell layer. (K) Higher magnification shows severe depletion of granule cells with relative preservation of Purkinje neurons (arrow) and a thin, hypercellular molecular layer (ML). (L) Dentate nuclei (arrow) have normal structure and cellularity. (M) Deafferented Purkinje neurons (asterisk) stained for calbindin and neurofilament have \u2018weeping\u2019 dendrite configurations, profusion of dendritic elements into \u2018asteroid bodies\u2019 (N) and other complex branching patterns (O), and (P) bulbous (\u2018torpedo\u2019) swelling within proximal axons (arrow).", "co_occurrence": [{"body": 51, "word": "NCS", "fig": 5}, {"body": 11, "word": "neurons", "fig": 4}, {"body": 40, "word": "cells", "fig": 1}, {"body": 13, "word": "normal", "fig": 3}, {"body": 36, "word": "cell", "fig": 1}, {"body": 17, "word": "The", "fig": 2}, {"body": 11, "word": "within", "fig": 2}, {"body": 10, "word": "granule", "fig": 2}, {"body": 10, "word": "Purkinje", "fig": 2}, {"body": 10, "word": "layer", "fig": 2}, {"body": 8, "word": "nuclei", "fig": 2}, {"body": 5, "word": "A", "fig": 3}, {"body": 12, "word": "years", "fig": 1}, {"body": 12, "word": "cerebellar", "fig": 1}, {"body": 6, "word": "child", "fig": 2}, {"body": 6, "word": "cerebellum", "fig": 2}, {"body": 5, "word": "lateral", "fig": 2}, {"body": 5, "word": "geniculate", "fig": 2}, {"body": 9, "word": "brain", "fig": 1}, {"body": 9, "word": "renal", "fig": 1}, {"body": 8, "word": "age", "fig": 1}, {"body": 7, "word": "atrophy", "fig": 1}, {"body": 7, "word": "failure", "fig": 1}, {"body": 3, "word": "striatum", "fig": 2}, {"body": 5, "word": "depletion", "fig": 1}, {"body": 5, "word": "g", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "interneurons", "fig": 1}, {"body": 5, "word": "cholinergic", "fig": 1}, {"body": 5, "word": "cortex", "fig": 1}, {"body": 4, "word": "dendritic", "fig": 1}, {"body": 2, "word": "stained", "fig": 2}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "small", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "complex", "fig": 1}, {"body": 3, "word": "gliosis", "fig": 1}, {"body": 3, "word": "axons", "fig": 1}, {"body": 3, "word": "relative", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "died", "fig": 1}, {"body": 3, "word": "complications", "fig": 1}, {"body": 3, "word": "optic", "fig": 1}, {"body": 3, "word": "severe", "fig": 1}, {"body": 2, "word": "proximal", "fig": 1}, {"body": 2, "word": "short", "fig": 1}, {"body": 2, "word": "large", "fig": 1}, {"body": 2, "word": "magnocellular", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 1, "word": "expected", "fig": 2}, {"body": 2, "word": "Neuropathology", "fig": 1}, {"body": 2, "word": "\u2018torpedo\u2019", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "absent", "fig": 1}, {"body": 2, "word": "thin", "fig": 1}, {"body": 1, "word": "compared", "fig": 2}, {"body": 1, "word": "nucleus", "fig": 2}, {"body": 2, "word": "parvocellular", "fig": 1}, {"body": 1, "word": "Blue", "fig": 1}, {"body": 1, "word": "histological", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "nearly", "fig": 1}, {"body": 1, "word": "elements", "fig": 1}, {"body": 1, "word": "weight", "fig": 1}, {"body": 1, "word": "hindbrain", "fig": 1}, {"body": 1, "word": "bulbous", "fig": 1}, {"body": 1, "word": "section", "fig": 1}, {"body": 1, "word": "sclerotic", "fig": 1}, {"body": 1, "word": "acetyltransferase", "fig": 1}, {"body": 1, "word": "nerve", "fig": 1}, {"body": 1, "word": "hypercellular", "fig": 1}, {"body": 1, "word": "preservation", "fig": 1}, {"body": 1, "word": "\u2018asteroid", "fig": 1}, {"body": 1, "word": "molecular", "fig": 1}, {"body": 1, "word": "J", "fig": 1}, {"body": 1, "word": "neurofilament", "fig": 1}, {"body": 1, "word": "hexalaminar", "fig": 1}, {"body": 1, "word": "stubby", "fig": 1}, {"body": 1, "word": "weighed", "fig": 1}, {"body": 1, "word": "folia", "fig": 1}, {"body": 1, "word": "several", "fig": 1}, {"body": 1, "word": "M", "fig": 1}, {"body": 1, "word": "devoid", "fig": 1}, {"body": 1, "word": "patterns", "fig": 1}, {"body": 1, "word": "\u2018weeping\u2019", "fig": 1}, {"body": 1, "word": "bodies\u2019", "fig": 1}, {"body": 1, "word": "Dentate", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153f3p.jpg", "caption": "Kidney disease. (A) Variable onset of nephrosis is followed by progressive loss of glomerular function, shown as 1/serum creatinine (dl/mg), in three with NCS who died (red asterisks) from complications of renal failure at ages 3.5, 8, and 12 years. (B) Jones\u2019 stain reveals both global and segmental sclerosis of glomeruli. (C) \u2018Striped\u2019 fibrosis is seen throughout the kidney interstitium. (D) At higher magnification, linear tracks of fibrosis (arrow) correspond to adjacent tubular atrophy (asterisk). (E) Electron micrographs show a 3- to 4-fold thickening of the glomerular basement membrane (normal for age, 0.15 \u00b5m) accompanied by (F) effacement and microvillus transformation of podocyte foot processes (arrow).", "co_occurrence": [{"body": 51, "word": "NCS", "fig": 1}, {"body": 13, "word": "normal", "fig": 1}, {"body": 12, "word": "years", "fig": 1}, {"body": 9, "word": "renal", "fig": 1}, {"body": 8, "word": "three", "fig": 1}, {"body": 8, "word": "age", "fig": 1}, {"body": 7, "word": "atrophy", "fig": 1}, {"body": 7, "word": "failure", "fig": 1}, {"body": 6, "word": "loss", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "function", "fig": 1}, {"body": 3, "word": "glomerular", "fig": 2}, {"body": 5, "word": "progressive", "fig": 1}, {"body": 5, "word": "segmental", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "kidney", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 3, "word": "basement", "fig": 1}, {"body": 3, "word": "\u00b5m", "fig": 1}, {"body": 3, "word": "membrane", "fig": 1}, {"body": 3, "word": "followed", "fig": 1}, {"body": 3, "word": "complications", "fig": 1}, {"body": 3, "word": "ages", "fig": 1}, {"body": 3, "word": "disease", "fig": 1}, {"body": 3, "word": "podocyte", "fig": 1}, {"body": 3, "word": "died", "fig": 1}, {"body": 2, "word": "tubular", "fig": 1}, {"body": 2, "word": "microvillus", "fig": 1}, {"body": 2, "word": "glomeruli", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "creatinine", "fig": 1}, {"body": 1, "word": "fibrosis", "fig": 2}, {"body": 2, "word": "sclerosis", "fig": 1}, {"body": 1, "word": "foot", "fig": 1}, {"body": 1, "word": "4-fold", "fig": 1}, {"body": 1, "word": "stain", "fig": 1}, {"body": 1, "word": "transformation", "fig": 1}, {"body": 1, "word": "processes", "fig": 1}, {"body": 1, "word": "nephrosis", "fig": 1}, {"body": 1, "word": "accompanied", "fig": 1}, {"body": 1, "word": "effacement", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "seen", "fig": 1}, {"body": 1, "word": "onset", "fig": 1}, {"body": 1, "word": "Electron", "fig": 1}, {"body": 1, "word": "interstitium", "fig": 1}, {"body": 1, "word": "micrographs", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153f4p.jpg", "caption": "WDR73 expression in human brain and NCS cells. (A) Immunoblot of WDR73 expression in: lanes 1 and 2, normal post-mortem human cerebellum, cerebral cortex; lanes 3\u20135, cultured human cells as indicated. (B) Immunoblot of WDR73 from NHDFs and dermal fibroblasts from a heterozygous (WDR73 +/p.Phe296Leufs*26) parent of a child with NCS. Note the additional lower molecular mass band for the truncated WDR73 in the heterozygous parent\u2019s cell lysate. (C) NCS (p.Phe296Leufs*26) fibroblasts (fs/fs) grow poorly in primary culture. Left: Crystal violet cell proliferation assay demonstrating reduced proliferation of dermal fibroblasts from a child with NCS (WDR73 fs/fs) relative to the heterozygous parent\u2019s cells (WDR73 +/fs) and NHDF (WDR73 +/+) plated at the same density. Right: Quantification of cell proliferation by absorbance of extracted crystal violet at 590 nm (n = 4) (***P < 0.001). (D\u2013F) Phase contrast comparison of growth characteristics and morphologies of NHDF (WDR73 +/+), NCS (p.Phe296Leufs*26; WDR73 fs/fs), and heterozygous parent fibroblasts (p.Phe296Leufs*26; WDR73 +/fs) seeded at equal densities and grown under the same conditions on the same 6-well plate. (G\u2013I) Anti-\u03b2-actin immunofluorescence microscopy of NHDF (WDR73 +/+), NCS (p.Phe296Leufs*26; WDR73 fs/fs), and heterozygous parent fibroblasts (p.Phe296Leufs*26; WDR73 +/fs). Nuclei were counterstained with DAPI. Scale bars: D\u2013F = 140 \u00b5m; G\u2013I = 55 \u00b5m.", "co_occurrence": [{"body": 90, "word": "WDR73", "fig": 14}, {"body": 51, "word": "NCS", "fig": 6}, {"body": 26, "word": "fibroblasts", "fig": 5}, {"body": 40, "word": "cells", "fig": 3}, {"body": 36, "word": "cell", "fig": 3}, {"body": 14, "word": "p.Phe296Leufs*26", "fig": 5}, {"body": 12, "word": "heterozygous", "fig": 5}, {"body": 14, "word": "proliferation", "fig": 3}, {"body": 10, "word": "human", "fig": 3}, {"body": 19, "word": "n", "fig": 1}, {"body": 6, "word": "parent", "fig": 3}, {"body": 13, "word": "normal", "fig": 1}, {"body": 4, "word": "NHDF", "fig": 3}, {"body": 6, "word": "child", "fig": 2}, {"body": 9, "word": "brain", "fig": 1}, {"body": 9, "word": "NHDFs", "fig": 1}, {"body": 8, "word": "additional", "fig": 1}, {"body": 8, "word": "cultured", "fig": 1}, {"body": 7, "word": "microscopy", "fig": 1}, {"body": 7, "word": "reduced", "fig": 1}, {"body": 3, "word": "\u00b5m", "fig": 2}, {"body": 6, "word": "cerebellum", "fig": 1}, {"body": 5, "word": "cerebral", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "immunofluorescence", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "cortex", "fig": 1}, {"body": 2, "word": "expression", "fig": 2}, {"body": 4, "word": "primary", "fig": 1}, {"body": 4, "word": "post-mortem", "fig": 1}, {"body": 4, "word": "growth", "fig": 1}, {"body": 4, "word": "nm", "fig": 1}, {"body": 2, "word": "dermal", "fig": 2}, {"body": 3, "word": "density", "fig": 1}, {"body": 3, "word": "band", "fig": 1}, {"body": 3, "word": "truncated", "fig": 1}, {"body": 3, "word": "relative", "fig": 1}, {"body": 3, "word": "culture", "fig": 1}, {"body": 3, "word": "mass", "fig": 1}, {"body": 2, "word": "poorly", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 2, "word": "seeded", "fig": 1}, {"body": 1, "word": "violet", "fig": 2}, {"body": 2, "word": "contrast", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 2, "word": "equal", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "grown", "fig": 1}, {"body": 1, "word": "plate", "fig": 1}, {"body": 1, "word": "densities", "fig": 1}, {"body": 1, "word": "morphologies", "fig": 1}, {"body": 1, "word": "absorbance", "fig": 1}, {"body": 1, "word": "counterstained", "fig": 1}, {"body": 1, "word": "molecular", "fig": 1}, {"body": 1, "word": "crystal", "fig": 1}, {"body": 1, "word": "extracted", "fig": 1}, {"body": 1, "word": "grow", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153f5p.jpg", "caption": "WDR73 immunoreactivity in fibroblasts from a child with NCS and a heterozygous parent. (A\u2013D) Heterozygous (WDR73 +/p.Phe296Leufs*26) parent fibroblasts. (A) Anti-WDR73 (green) immunoreactivity is diffuse and cytosolic during interphase (anti-\u03b1-tubulin, red). (B) WDR73 immunoreactivity localizes to the spindle poles and spindle microtubules during metaphase. (C) WDR73 immunoreactivity at the mitotic spindle poles, kinetochore microtubules and central spindle microtubules during anaphase. (D) WDR73 immunoreactivity localizes to the midbody microtubules apposing the Flemming body (stem body) during telophase. (E\u2013H) WDR73 immunoreactivity is weak and cytosolic in NCS fibroblasts homozygous for WDR73 p.Phe296Leufs*26. (E and F) Twenty-two per cent of NCS fibroblasts observed were binucleate and an additional 20% displayed abnormal nuclear morphology (bi-/multi-lobed nuclei, budding micronuclei, or nucleoplasmic bridges). (G and H) Additional NCS fibroblasts displaying the range of microtubule network morphology observed. Note that the magnifications are reduced in E\u2013H. Scale bars: A\u2013D = 10 \u00b5m; E\u2013F = 50 \u00b5m; G\u2013H = 90 \u00b5m.", "co_occurrence": [{"body": 90, "word": "WDR73", "fig": 7}, {"body": 51, "word": "NCS", "fig": 4}, {"body": 26, "word": "fibroblasts", "fig": 5}, {"body": 16, "word": "microtubules", "fig": 4}, {"body": 14, "word": "spindle", "fig": 4}, {"body": 7, "word": "immunoreactivity", "fig": 6}, {"body": 15, "word": "observed", "fig": 2}, {"body": 19, "word": "homozygous", "fig": 1}, {"body": 14, "word": "p.Phe296Leufs*26", "fig": 1}, {"body": 6, "word": "poles", "fig": 2}, {"body": 6, "word": "parent", "fig": 2}, {"body": 12, "word": "heterozygous", "fig": 1}, {"body": 3, "word": "\u00b5m", "fig": 3}, {"body": 9, "word": "mitotic", "fig": 1}, {"body": 4, "word": "morphology", "fig": 2}, {"body": 8, "word": "additional", "fig": 1}, {"body": 8, "word": "nuclei", "fig": 1}, {"body": 7, "word": "reduced", "fig": 1}, {"body": 7, "word": "range", "fig": 1}, {"body": 6, "word": "child", "fig": 1}, {"body": 5, "word": "abnormal", "fig": 1}, {"body": 5, "word": "central", "fig": 1}, {"body": 5, "word": "interphase", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "per", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 3, "word": "binucleate", "fig": 1}, {"body": 3, "word": "metaphase", "fig": 1}, {"body": 3, "word": "nuclear", "fig": 1}, {"body": 2, "word": "network", "fig": 1}, {"body": 2, "word": "telophase", "fig": 1}, {"body": 1, "word": "body", "fig": 2}, {"body": 2, "word": "stem", "fig": 1}, {"body": 2, "word": "anaphase", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "anti-\u03b1-tubulin", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 1, "word": "displayed", "fig": 1}, {"body": 1, "word": "nucleoplasmic", "fig": 1}, {"body": 1, "word": "bridges", "fig": 1}, {"body": 1, "word": "microtubule", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "budding", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "weak", "fig": 1}, {"body": 1, "word": "midbody", "fig": 1}, {"body": 1, "word": "diffuse", "fig": 1}, {"body": 1, "word": "kinetochore", "fig": 1}, {"body": 1, "word": "apposing", "fig": 1}, {"body": 1, "word": "micronuclei", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153f6p.jpg", "caption": "Recombinant WDR73-V5 fusion protein rescues cell cycle defect in NCS patient fibroblasts. (A and B) Anti-V5 immunofluorescence (green) demonstrates that WDR73 C-terminal V5 fusion protein (WDR73\u2013V5) overexpressed in NCS patient fibroblasts localizes to the mitotic microtubules (anti-\u03b1-tubulin) during metaphase (A) and telophase (B), rescuing the cell cycle defect in these cells. (C\u2013E) Overexpression of WDR73 C-terminal V5 fusion protein (WDR73-V5) in HEK-293T cells. Anti-V5 immunofluorescence is in green; anti-\u03b1-tubulin in red. During pro-metaphase (C) and metaphase (D) recombinant WDR73-V5 colocalizes with \u03b1-tubulin at the mitotic spindle and aster microtubules. (E) WDR73-V5 localizes to the spindle poles, the kinetochore microtubules and the midzone microtubules during anaphase. Scale bars: A\u2013E = 10 \u00b5m. (F\u2013G) Western blots of recombinant N-terminal FLAG WDR73 fusion proteins (F) and WDR73 C-terminal V5 fusion proteins (G) overexpressed for 40\u201348 h in HEK-293T cells. Anti-COX IV was labelled as a protein loading control. The abundance of FLAG-WDR73 p.Phe296Leufs*26 (F296Lfs*26) was 2.6- to 5.6-fold lower and FLAG-WDR73 p.Arg256Profs*18 (R256Pfs*18) was 1.6- to 6.5-fold lower than that of FLAG-WDR73 wild-type (wt) across four replicates despite transfection of equivalent amounts of plasmid DNA, suggesting instability of the truncated proteins.", "co_occurrence": [{"body": 90, "word": "WDR73", "fig": 4}, {"body": 40, "word": "cells", "fig": 3}, {"body": 51, "word": "NCS", "fig": 2}, {"body": 36, "word": "cell", "fig": 2}, {"body": 16, "word": "microtubules", "fig": 4}, {"body": 16, "word": "protein", "fig": 4}, {"body": 26, "word": "fibroblasts", "fig": 2}, {"body": 9, "word": "fusion", "fig": 5}, {"body": 15, "word": "proteins", "fig": 3}, {"body": 10, "word": "FLAG-WDR73", "fig": 3}, {"body": 14, "word": "spindle", "fig": 2}, {"body": 14, "word": "cycle", "fig": 2}, {"body": 10, "word": "HEK-293T", "fig": 2}, {"body": 9, "word": "mitotic", "fig": 2}, {"body": 17, "word": "The", "fig": 1}, {"body": 5, "word": "C-terminal", "fig": 3}, {"body": 14, "word": "p.Phe296Leufs*26", "fig": 1}, {"body": 13, "word": "wild-type", "fig": 1}, {"body": 6, "word": "patient", "fig": 2}, {"body": 4, "word": "V5", "fig": 3}, {"body": 5, "word": "B", "fig": 2}, {"body": 5, "word": "A", "fig": 2}, {"body": 5, "word": "immunofluorescence", "fig": 2}, {"body": 4, "word": "recombinant", "fig": 2}, {"body": 7, "word": "p.Arg256Profs*18", "fig": 1}, {"body": 6, "word": "h", "fig": 1}, {"body": 3, "word": "metaphase", "fig": 2}, {"body": 6, "word": "poles", "fig": 1}, {"body": 5, "word": "abundance", "fig": 1}, {"body": 1, "word": "WDR73-V5", "fig": 4}, {"body": 2, "word": "overexpressed", "fig": 2}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "DNA", "fig": 1}, {"body": 2, "word": "anti-\u03b1-tubulin", "fig": 2}, {"body": 2, "word": "defect", "fig": 2}, {"body": 3, "word": "truncated", "fig": 1}, {"body": 3, "word": "replicates", "fig": 1}, {"body": 3, "word": "\u00b5m", "fig": 1}, {"body": 3, "word": "During", "fig": 1}, {"body": 3, "word": "N-terminal", "fig": 1}, {"body": 2, "word": "instability", "fig": 1}, {"body": 2, "word": "telophase", "fig": 1}, {"body": 2, "word": "\u03b1-tubulin", "fig": 1}, {"body": 2, "word": "across", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 2, "word": "FLAG", "fig": 1}, {"body": 2, "word": "anaphase", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "transfection", "fig": 1}, {"body": 1, "word": "green", "fig": 2}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "suggesting", "fig": 1}, {"body": 1, "word": "despite", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "control", "fig": 1}, {"body": 1, "word": "Recombinant", "fig": 1}, {"body": 1, "word": "kinetochore", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511861/bin/awv153f7p.jpg", "caption": "WDR73 interacts with \u03b1-, \u03b2-, and \u03b3-tubulin, CAD, HSP-70, HSP-90, and p70 S6 kinase. (A) FLAG-WDR73 F296Lfs*26 (38 kDa) overexpressed in HEK-293T cells co-immunoprecipitated (IP) substantially more endogenous \u03b1- and \u03b2-tubulin and HSP-70 than FLAG-WDR73 wild-type (45 kDa). (B) FLAG-WDR73 wild-type, F296Lfs*26, and R256Pfs*18 each co-immunoprecipitated \u03b3-tubulin at an abundance roughly proportional to abundance of the respective WDR73 construct. (C and D) Co-immunoprecipitation of (C) endogenous CAD, phospho-Ser1859 CAD, HSP-90, and (D) p70 S6 kinase from lysates of HEK-293T cells overexpressing the WDR73 constructs indicated. (E) Lentiviral transduction of shRNA plasmid constructs A and B targeting WDR73 in HEK-293FT cells successfully knocked down WDR73 and produced a concomitant decrease in ribosomal protein S6 phosphorylation. GAPDH was labelled as a protein loading control. This immunoblot was labelled with the same anti-WDR73 antibody (Novus) used for immunoblotting throughout the paper (validating the specificity of the antibody).", "co_occurrence": [{"body": 90, "word": "WDR73", "fig": 5}, {"body": 40, "word": "cells", "fig": 3}, {"body": 16, "word": "CAD", "fig": 3}, {"body": 16, "word": "protein", "fig": 2}, {"body": 10, "word": "FLAG-WDR73", "fig": 3}, {"body": 10, "word": "S6", "fig": 3}, {"body": 13, "word": "wild-type", "fig": 2}, {"body": 10, "word": "HEK-293T", "fig": 2}, {"body": 8, "word": "kinase", "fig": 2}, {"body": 6, "word": "kDa", "fig": 2}, {"body": 6, "word": "p70", "fig": 2}, {"body": 5, "word": "B", "fig": 2}, {"body": 5, "word": "abundance", "fig": 2}, {"body": 5, "word": "A", "fig": 2}, {"body": 5, "word": "\u03b1-", "fig": 2}, {"body": 4, "word": "endogenous", "fig": 2}, {"body": 4, "word": "D", "fig": 2}, {"body": 4, "word": "HSP-90", "fig": 2}, {"body": 4, "word": "co-immunoprecipitated", "fig": 2}, {"body": 3, "word": "HSP-70", "fig": 2}, {"body": 3, "word": "constructs", "fig": 2}, {"body": 6, "word": "used", "fig": 1}, {"body": 5, "word": "lysates", "fig": 1}, {"body": 5, "word": "\u03b2-tubulin", "fig": 1}, {"body": 5, "word": "interacts", "fig": 1}, {"body": 4, "word": "phosphorylation", "fig": 1}, {"body": 4, "word": "substantially", "fig": 1}, {"body": 2, "word": "antibody", "fig": 2}, {"body": 4, "word": "Novus", "fig": 1}, {"body": 4, "word": "immunoblotting", "fig": 1}, {"body": 3, "word": "Co-immunoprecipitation", "fig": 1}, {"body": 3, "word": "anti-WDR73", "fig": 1}, {"body": 2, "word": "ribosomal", "fig": 1}, {"body": 2, "word": "overexpressed", "fig": 1}, {"body": 1, "word": "\u03b3-tubulin", "fig": 2}, {"body": 2, "word": "This", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "\u03b2-", "fig": 1}, {"body": 1, "word": "HEK-293FT", "fig": 1}, {"body": 1, "word": "control", "fig": 1}, {"body": 1, "word": "decrease", "fig": 1}, {"body": 1, "word": "proportional", "fig": 1}, {"body": 1, "word": "knocked", "fig": 1}, {"body": 1, "word": "overexpressing", "fig": 1}, {"body": 1, "word": "transduction", "fig": 1}]}], "4186808": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186808/bin/pone.0108175.g001.jpg", "caption": "hnRNP A2/B1 is present in synaptic polyribosomal fractions and colocalizes with PSD95 in dendrites of hippocampal neurons. (A) Cultured hippocampal neurons immunostained for MAP2 (blue), hnRNP A2/B1 (red) and PSD95 (green) show that hnRNP A2/B1 is present in synaptic sites as indicated by the colocalization with the postsynaptic marker PSD95 (white arrows). Scale bars = 25 \u00b5m and 4 \u00b5m for low and high magnification images, respectively. The images are representative of six different experiments performed in independent preparations, with a total of 71 cells analysed. (A\u2032) The percentage of dendritic hnRNP A2/B1 signal that colocalizes with PSD95 was analysed using ImageJ software (mean \u00b1 SEM.). (B) Co-sedimentation of synaptoneurosomal proteins using a 10\u201350% linear sucrose gradient. The polyribosomes, monosomes and mRNPs (non-polysomal fractions) were detected by UV absorbance at 254 nm and the gradient was collected in 11 fractions. Equal volumes from each fraction were analysed by SDS-PAGE and Western blot using antibodies that recognize hnRNP A2/B1, Staufen1, eEF2 and ribosomal protein S6. The results are representative of two different experiments performed in independent synaptoneurosomal preparations.", "co_occurrence": [{"body": 76, "word": "hnRNP", "fig": 5}, {"body": 72, "word": "A2/B1", "fig": 5}, {"body": 38, "word": "synaptic", "fig": 2}, {"body": 18, "word": "The", "fig": 4}, {"body": 22, "word": "neurons", "fig": 2}, {"body": 14, "word": "using", "fig": 3}, {"body": 20, "word": "hippocampal", "fig": 2}, {"body": 25, "word": "dendrites", "fig": 1}, {"body": 22, "word": "protein", "fig": 1}, {"body": 7, "word": "fractions", "fig": 3}, {"body": 20, "word": "dendritic", "fig": 1}, {"body": 4, "word": "PSD95", "fig": 4}, {"body": 7, "word": "present", "fig": 2}, {"body": 5, "word": "performed", "fig": 2}, {"body": 3, "word": "analysed", "fig": 3}, {"body": 9, "word": "cells", "fig": 1}, {"body": 7, "word": "sites", "fig": 1}, {"body": 3, "word": "gradient", "fig": 2}, {"body": 5, "word": "Staufen1", "fig": 1}, {"body": 5, "word": "proteins", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 2, "word": "\u00b5m", "fig": 2}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 3, "word": "arrows", "fig": 1}, {"body": 3, "word": "software", "fig": 1}, {"body": 3, "word": "fraction", "fig": 1}, {"body": 3, "word": "percentage", "fig": 1}, {"body": 3, "word": "sucrose", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 1, "word": "experiments", "fig": 2}, {"body": 2, "word": "postsynaptic", "fig": 1}, {"body": 2, "word": "detected", "fig": 1}, {"body": 2, "word": "colocalization", "fig": 1}, {"body": 2, "word": "ImageJ", "fig": 1}, {"body": 2, "word": "linear", "fig": 1}, {"body": 2, "word": "marker", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 1, "word": "colocalizes", "fig": 2}, {"body": 1, "word": "signal", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "mRNPs", "fig": 1}, {"body": 1, "word": "polyribosomes", "fig": 1}, {"body": 1, "word": "two", "fig": 1}, {"body": 1, "word": "low", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "monosomes", "fig": 1}, {"body": 1, "word": "MAP2", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}, {"body": 1, "word": "volumes", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186808/bin/pone.0108175.g002.jpg", "caption": "Synaptic activity and the neurotrophin BDNF increase the abundance of hnRNP A2/B1 protein in the soma of hippocampal neurons, outside the nucleus. (A) Cultured hippocampal neurons were stimulated or not with bicuculline (50 \u00b5M), 4-AP (2.5 mM) and glycine (10 \u00b5M) for 30 min and then the cells immunostained for MAP2 (blue), hnRNP A2/B1 (red). Scale bar = 20 \u00b5m and 4 \u00b5m for low and high magnification images, respectively. (B) Cultured hippocampal neurons were stimulated or not with BDNF (100 \u00b5g/ml), for 30 min and then the cells immunostained for MAP2 (blue), hnRNP A2/B1 (red). Scale bar = 20 \u00b5m and 4 \u00b5m for low and high magnification images, respectively (C) The intensity of hnRNP A2/B1 protein in the cell body was analysed in similar regions of interest within the soma, away from the nucleus, using ImageJ software. Results are normalized to control and are averaged of 4\u20137 different experiments performed in independent preparations. The following number of cells was used in the analysis of the somatic-localized hnRNP A2/B1 Ctr (n = 71 cells), Bic (n = 40 cells), BDNF (n = 61 cells). Error bars, mean \u00b1 SEM. Statistical analysis was performed by one-way ANOVA, followed by Dunnet's test.* P<0.05; *** P<0.001.", "co_occurrence": [{"body": 76, "word": "hnRNP", "fig": 5}, {"body": 72, "word": "A2/B1", "fig": 5}, {"body": 44, "word": "BDNF", "fig": 3}, {"body": 22, "word": "neurons", "fig": 3}, {"body": 20, "word": "hippocampal", "fig": 3}, {"body": 9, "word": "cells", "fig": 6}, {"body": 22, "word": "protein", "fig": 2}, {"body": 18, "word": "The", "fig": 2}, {"body": 12, "word": "min", "fig": 2}, {"body": 11, "word": "analysis", "fig": 2}, {"body": 16, "word": "activity", "fig": 1}, {"body": 8, "word": "\u00b5M", "fig": 2}, {"body": 16, "word": "increase", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 12, "word": "mM", "fig": 1}, {"body": 6, "word": "stimulated", "fig": 2}, {"body": 5, "word": "soma", "fig": 2}, {"body": 5, "word": "performed", "fig": 2}, {"body": 9, "word": "cell", "fig": 1}, {"body": 8, "word": "intensity", "fig": 1}, {"body": 2, "word": "\u00b5m", "fig": 4}, {"body": 7, "word": "used", "fig": 1}, {"body": 6, "word": "neurotrophin", "fig": 1}, {"body": 5, "word": "bicuculline", "fig": 1}, {"body": 5, "word": "number", "fig": 1}, {"body": 5, "word": "\u00b5g/ml", "fig": 1}, {"body": 4, "word": "body", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 2, "word": "nucleus", "fig": 2}, {"body": 1, "word": "n", "fig": 3}, {"body": 3, "word": "analysed", "fig": 1}, {"body": 3, "word": "software", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 3, "word": "regions", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "'s", "fig": 1}, {"body": 2, "word": "glycine", "fig": 1}, {"body": 1, "word": "P", "fig": 2}, {"body": 2, "word": "ImageJ", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "respectively", "fig": 2}, {"body": 2, "word": "Statistical", "fig": 1}, {"body": 1, "word": "low", "fig": 2}, {"body": 1, "word": "MAP2", "fig": 2}, {"body": 2, "word": "similar", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "4-AP", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "outside", "fig": 1}, {"body": 1, "word": "Synaptic", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "interest", "fig": 1}, {"body": 1, "word": "abundance", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186808/bin/pone.0108175.g003.jpg", "caption": "Synaptic activity increases hnRNP A2/B1 in dendrites and induces the delivery of hnRNP A2/B1 to the synapse by a BDNF-dependent mechanism. Cultured hippocampal neurons were stimulated or not with bicuculline (50 \u00b5M), 4-AP (2.5 mM) and glycine (10 \u00b5M), for 30 min. Where indicated, neurons were treated with TrkB-Fc (1 \u00b5g/ml) for 30 min and then stimulated or not with bicuculline in the presence of the BDNF scavenger. The cells were immunostained for hnRNP A2/B1 (red), MAP2 (blue), and PSD95 (green) (A). White arrows indicate PSD95-positive clusters that also contain hnRNP A2/B1 (A). The integrated fluorescence intensity, area and number of hnRNP A2/B1 puncta in dendrites (B, C, and D) and at the synapse (as defined by the signal of hnRNP A2/B1 that overlaps with PSD95) (E, F, and G) was analysed using ImageJ software and represented per dendritic area. The percentage of dendritic hnRNP A2/B1 signal that colocalizes with PSD95 was also analysed (H). Results are normalized to control and are averaged of 3\u20137 different experiments performed in independent preparations. The following number of cells was used in the analysis of the dendritic-localized hnRNP A2/B1 puncta: Ctr (n = 87 cells), Bic (n = 64 cells), TrkB-Fc (n = 47 cells), TrkB-Fc+Bic (n = 48 cells). For the analysis of synaptic-localized hnRNP A2/B1 puncta the following number of cells was analysed: Ctr (n = 76 cells), Bic (n = 54 cells), TrkB-Fc (n = 35 cells), TrkB-Fc+Bic (n = 35 cells). Error bars, mean \u00b1 SEM. Statistical analysis was performed by one-way ANOVA, followed by Bonferroni's test. n.s. Not significant, * P<0.05; ** P<0.01; *** P<0.001. Scale bar = 4 \u00b5m.", "co_occurrence": [{"body": 76, "word": "hnRNP", "fig": 9}, {"body": 72, "word": "A2/B1", "fig": 9}, {"body": 9, "word": "cells", "fig": 11}, {"body": 18, "word": "The", "fig": 4}, {"body": 25, "word": "dendrites", "fig": 2}, {"body": 44, "word": "BDNF", "fig": 1}, {"body": 22, "word": "neurons", "fig": 2}, {"body": 20, "word": "dendritic", "fig": 2}, {"body": 11, "word": "analysis", "fig": 3}, {"body": 12, "word": "min", "fig": 2}, {"body": 11, "word": "synapse", "fig": 2}, {"body": 20, "word": "hippocampal", "fig": 1}, {"body": 6, "word": "TrkB-Fc", "fig": 3}, {"body": 6, "word": "puncta", "fig": 3}, {"body": 9, "word": "also", "fig": 2}, {"body": 8, "word": "\u00b5M", "fig": 2}, {"body": 16, "word": "activity", "fig": 1}, {"body": 8, "word": "area", "fig": 2}, {"body": 5, "word": "number", "fig": 3}, {"body": 14, "word": "using", "fig": 1}, {"body": 4, "word": "PSD95", "fig": 3}, {"body": 12, "word": "mM", "fig": 1}, {"body": 6, "word": "stimulated", "fig": 2}, {"body": 5, "word": "performed", "fig": 2}, {"body": 5, "word": "bicuculline", "fig": 2}, {"body": 10, "word": "delivery", "fig": 1}, {"body": 3, "word": "analysed", "fig": 3}, {"body": 8, "word": "intensity", "fig": 1}, {"body": 1, "word": "n", "fig": 8}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 3, "word": "following", "fig": 2}, {"body": 3, "word": "A", "fig": 2}, {"body": 5, "word": "For", "fig": 1}, {"body": 5, "word": "integrated", "fig": 1}, {"body": 5, "word": "\u00b5g/ml", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 4, "word": "dendritic-localized", "fig": 1}, {"body": 4, "word": "scavenger", "fig": 1}, {"body": 4, "word": "significant", "fig": 1}, {"body": 1, "word": "P", "fig": 3}, {"body": 3, "word": "arrows", "fig": 1}, {"body": 3, "word": "contain", "fig": 1}, {"body": 3, "word": "software", "fig": 1}, {"body": 3, "word": "percentage", "fig": 1}, {"body": 3, "word": "'s", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 2, "word": "glycine", "fig": 1}, {"body": 2, "word": "clusters", "fig": 1}, {"body": 2, "word": "increases", "fig": 1}, {"body": 1, "word": "signal", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "ImageJ", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "Statistical", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "4-AP", "fig": 1}, {"body": 2, "word": "fluorescence", "fig": 1}, {"body": 2, "word": "PSD95-positive", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "overlaps", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "Where", "fig": 1}, {"body": 1, "word": "Bonferroni", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "synaptic-localized", "fig": 1}, {"body": 1, "word": "Synaptic", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "colocalizes", "fig": 1}, {"body": 1, "word": "treated", "fig": 1}, {"body": 1, "word": "defined", "fig": 1}, {"body": 1, "word": "MAP2", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186808/bin/pone.0108175.g004.jpg", "caption": "BDNF induces the accumulation of hnRNP A2/B1 in dendrites and at the synapse in hippocampal neurons. Cultured hippocampal neurons were stimulated or not with 100 ng/ml BDNF for 30 min. The role of Trk receptor activity in BDNF-induced regulation of hnRNPA2/B1 distribution was tested using the inhibitor SHN722. Where indicated, neurons were treated 30 min with 1 \u00b5M SHN722 and then stimulated or not with 100 ng/ml BDNF in the presence of the inhibitor. The cells were immunostained for hnRNPA2/B1 (red), MAP2 (blue), and PSD95 (green) (A). White arrows indicate PSD95-positive clusters that also contain hnRNP A2/B1 (A). The integrated fluorescence intensity, area and number of hnRNP A2/B1 puncta in dendrites (B, C, and D) and at the synapse (as defined by the signal of hnRNP A2/B1 that overlaps with PSD95) (E, F, and G) was analysed using ImageJ software and represented per dendritic area. The percentage of dendritic hnRNP A2/B1 signal that colocalizes with PSD95 was also analysed (H). Results are normalized to control and are the average of 3\u20136 different experiments performed in independent preparations. The following number of cells was used in the analysis of the dendritic-localized hnRNP A2/B1 puncta: Ctr (n = 73 cells), Bic (n = 64 cells), TrkB-Fc (n = 47 cells), TrkB-Fc+Bic (n = 48 cells). For the analysis of synaptic-localized hnRNP A2/B1 puncta, the following number of cells was analysed: Ctr (n = 62 cells), Bic (n = 67 cells), TrkB-Fc (n = 37 cells), TrkB-Fc+Bic (n = 35 cells). Error bars, mean \u00b1 SEM. Statistical analysis was performed by one-way ANOVA, followed by Bonferroni's test. n.s. Not significant, * P<0.05; ** P<0.01; *** P<0.001. Scale bar = 4 \u00b5m.", "co_occurrence": [{"body": 76, "word": "hnRNP", "fig": 7}, {"body": 72, "word": "A2/B1", "fig": 7}, {"body": 44, "word": "BDNF", "fig": 3}, {"body": 9, "word": "cells", "fig": 11}, {"body": 18, "word": "The", "fig": 5}, {"body": 22, "word": "neurons", "fig": 3}, {"body": 25, "word": "dendrites", "fig": 2}, {"body": 20, "word": "dendritic", "fig": 2}, {"body": 20, "word": "hippocampal", "fig": 2}, {"body": 11, "word": "analysis", "fig": 3}, {"body": 14, "word": "using", "fig": 2}, {"body": 12, "word": "min", "fig": 2}, {"body": 11, "word": "synapse", "fig": 2}, {"body": 9, "word": "also", "fig": 2}, {"body": 6, "word": "puncta", "fig": 3}, {"body": 16, "word": "activity", "fig": 1}, {"body": 8, "word": "area", "fig": 2}, {"body": 5, "word": "number", "fig": 3}, {"body": 4, "word": "PSD95", "fig": 3}, {"body": 6, "word": "TrkB-Fc", "fig": 2}, {"body": 6, "word": "stimulated", "fig": 2}, {"body": 5, "word": "performed", "fig": 2}, {"body": 5, "word": "ng/ml", "fig": 2}, {"body": 5, "word": "inhibitor", "fig": 2}, {"body": 10, "word": "role", "fig": 1}, {"body": 9, "word": "accumulation", "fig": 1}, {"body": 3, "word": "analysed", "fig": 3}, {"body": 8, "word": "\u00b5M", "fig": 1}, {"body": 8, "word": "intensity", "fig": 1}, {"body": 1, "word": "n", "fig": 8}, {"body": 4, "word": "SHN722", "fig": 2}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 3, "word": "following", "fig": 2}, {"body": 6, "word": "BDNF-induced", "fig": 1}, {"body": 3, "word": "A", "fig": 2}, {"body": 5, "word": "Trk", "fig": 1}, {"body": 5, "word": "For", "fig": 1}, {"body": 5, "word": "integrated", "fig": 1}, {"body": 5, "word": "regulation", "fig": 1}, {"body": 5, "word": "distribution", "fig": 1}, {"body": 4, "word": "dendritic-localized", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 4, "word": "receptor", "fig": 1}, {"body": 4, "word": "significant", "fig": 1}, {"body": 1, "word": "P", "fig": 3}, {"body": 3, "word": "arrows", "fig": 1}, {"body": 3, "word": "contain", "fig": 1}, {"body": 3, "word": "software", "fig": 1}, {"body": 3, "word": "percentage", "fig": 1}, {"body": 3, "word": "'s", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 2, "word": "clusters", "fig": 1}, {"body": 1, "word": "signal", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "ImageJ", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "Statistical", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "fluorescence", "fig": 1}, {"body": 2, "word": "PSD95-positive", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "overlaps", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "Where", "fig": 1}, {"body": 1, "word": "Bonferroni", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "synaptic-localized", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "colocalizes", "fig": 1}, {"body": 1, "word": "treated", "fig": 1}, {"body": 1, "word": "defined", "fig": 1}, {"body": 1, "word": "MAP2", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186808/bin/pone.0108175.g005.jpg", "caption": "BDNF upregulates hnRNP A2/B1 mRNA in the cell body compartment of hippocampal neurons. Cultured hippocampal neurons were stimulated or not with 100 ng/ml BDNF, for 30 min or 2 h. The cell body mRNA was mechanically separated from the transcripts of neurites and 500\u20131000 ng of RNA from each compartment was used in the reverse transcription reaction. The analysis of hnRNP A2/B1 mRNA levels was performed by qRT-PCR using Ppia as internal control gene. The results are the average \u00b1 SEM of five (cell body compartment) or seven (neurite compartment) independent transcription reactions, performed in distinct preparations. Statistical analysis of logtransformed expression data was performed by one-way ANOVA, followed by Dunnet's test. * P<0.05.", "co_occurrence": [{"body": 76, "word": "hnRNP", "fig": 2}, {"body": 72, "word": "A2/B1", "fig": 2}, {"body": 44, "word": "BDNF", "fig": 2}, {"body": 18, "word": "The", "fig": 3}, {"body": 16, "word": "mRNA", "fig": 3}, {"body": 22, "word": "neurons", "fig": 2}, {"body": 20, "word": "hippocampal", "fig": 2}, {"body": 9, "word": "cell", "fig": 3}, {"body": 11, "word": "analysis", "fig": 2}, {"body": 4, "word": "compartment", "fig": 4}, {"body": 5, "word": "performed", "fig": 3}, {"body": 14, "word": "using", "fig": 1}, {"body": 12, "word": "min", "fig": 1}, {"body": 4, "word": "body", "fig": 3}, {"body": 12, "word": "RNA", "fig": 1}, {"body": 11, "word": "transcripts", "fig": 1}, {"body": 10, "word": "levels", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 6, "word": "stimulated", "fig": 1}, {"body": 5, "word": "ng/ml", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 4, "word": "expression", "fig": 1}, {"body": 3, "word": "'s", "fig": 1}, {"body": 3, "word": "reverse", "fig": 1}, {"body": 2, "word": "separated", "fig": 1}, {"body": 2, "word": "Ppia", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "neurite", "fig": 1}, {"body": 2, "word": "qRT-PCR", "fig": 1}, {"body": 2, "word": "Statistical", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "neurites", "fig": 1}, {"body": 1, "word": "ng", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "distinct", "fig": 1}, {"body": 1, "word": "gene", "fig": 1}]}], "3241690": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241690/bin/pone.0029160.g001.jpg", "caption": "Patterns of gene expression during odontoblast differentiation. MDPC-23 cells were cultured in differentiation medium for up to 3 weeks. (A) The expression of DSP was evaluated by western blot analysis. GAPDH was used as a loading control. (B) Mineralized nodules stained with alizarin red-S were photographed. (C) Four stages of differentiation were identified: confluent (preodontoblast; 0 days); early odontoblast differentiation (\u223c7 days); late odontoblast differentiation (7\u223c14 days); and mineralization (14\u223c21 days). Solid gray bars indicate the periods of elevated expression of genes indicated during culture. (D) The expression of NFI-C was evaluated by western blot analysis and the results were quantified using ImageJ. (E) TGF\u03b2-RI, TGF\u03b2-RII, p-Smad2/3, Runx2, Osx, and p21 were evaluated by western blot analysis.", "co_occurrence": [{"body": 32, "word": "differentiation", "fig": 5}, {"body": 149, "word": "NFI-C", "fig": 1}, {"body": 31, "word": "expression", "fig": 4}, {"body": 27, "word": "odontoblast", "fig": 3}, {"body": 68, "word": "cells", "fig": 1}, {"body": 22, "word": "blot", "fig": 3}, {"body": 32, "word": "The", "fig": 2}, {"body": 20, "word": "western", "fig": 3}, {"body": 11, "word": "days", "fig": 4}, {"body": 39, "word": "MDPC-23", "fig": 1}, {"body": 12, "word": "analysis", "fig": 3}, {"body": 15, "word": "p-Smad2/3", "fig": 1}, {"body": 15, "word": "using", "fig": 1}, {"body": 14, "word": "results", "fig": 1}, {"body": 11, "word": "control", "fig": 1}, {"body": 10, "word": "TGF\u03b2-RI", "fig": 1}, {"body": 8, "word": "p21", "fig": 1}, {"body": 8, "word": "gene", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 6, "word": "GAPDH", "fig": 1}, {"body": 6, "word": "genes", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 2, "word": "evaluated", "fig": 3}, {"body": 5, "word": "cultured", "fig": 1}, {"body": 5, "word": "early", "fig": 1}, {"body": 5, "word": "loading", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 4, "word": "late", "fig": 1}, {"body": 3, "word": "mineralization", "fig": 1}, {"body": 3, "word": "indicate", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "ImageJ", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "medium", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "nodules", "fig": 1}, {"body": 3, "word": "TGF\u03b2-RII", "fig": 1}, {"body": 2, "word": "confluent", "fig": 1}, {"body": 2, "word": "culture", "fig": 1}, {"body": 2, "word": "weeks", "fig": 1}, {"body": 2, "word": "quantified", "fig": 1}, {"body": 2, "word": "DSP", "fig": 1}, {"body": 2, "word": "red-S", "fig": 1}, {"body": 1, "word": "alizarin", "fig": 1}, {"body": 1, "word": "identified", "fig": 1}, {"body": 1, "word": "Runx2", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "Osx", "fig": 1}, {"body": 1, "word": "preodontoblast", "fig": 1}, {"body": 1, "word": "Patterns", "fig": 1}, {"body": 1, "word": "stages", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241690/bin/pone.0029160.g002.jpg", "caption": "NFI-C is degraded by TGF-\u03b21 in MDPC-23 cells. (A) The protein levels of NFI-C, p-Smad2/3, and p21 protein in TGF-\u03b21-treated MDPC-23 cells were analyzed by western blot (left panel), and the results were quantified using ImageJ (right panel). GAPDH used as a loading control. (B) MDPC-23 cells were incubated with TGF-\u03b21 (10 ng/ml) in the presence or absence of the proteasome inhibitor, MG132 (10 \u00b5M) for 1 hr. Cytoplasmic and nuclear fractions were isolated and subjected to western blot analysis. GAPDH and lamin B served as cell fractionation controls. (C) The subcellular localization of NFI-C was analyzed by immunostaining with NFI-C specific antibody. DAPI staining was used to detect nuclei.", "co_occurrence": [{"body": 149, "word": "NFI-C", "fig": 4}, {"body": 68, "word": "cells", "fig": 3}, {"body": 80, "word": "TGF-\u03b21", "fig": 2}, {"body": 39, "word": "MDPC-23", "fig": 3}, {"body": 45, "word": "protein", "fig": 2}, {"body": 32, "word": "The", "fig": 2}, {"body": 22, "word": "blot", "fig": 2}, {"body": 20, "word": "western", "fig": 2}, {"body": 16, "word": "analyzed", "fig": 2}, {"body": 31, "word": "hr", "fig": 1}, {"body": 31, "word": "levels", "fig": 1}, {"body": 17, "word": "ng/ml", "fig": 1}, {"body": 15, "word": "cell", "fig": 1}, {"body": 15, "word": "p-Smad2/3", "fig": 1}, {"body": 15, "word": "using", "fig": 1}, {"body": 15, "word": "incubated", "fig": 1}, {"body": 14, "word": "results", "fig": 1}, {"body": 7, "word": "used", "fig": 2}, {"body": 13, "word": "inhibitor", "fig": 1}, {"body": 13, "word": "antibody", "fig": 1}, {"body": 6, "word": "GAPDH", "fig": 2}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 11, "word": "control", "fig": 1}, {"body": 11, "word": "presence", "fig": 1}, {"body": 11, "word": "MG132", "fig": 1}, {"body": 5, "word": "B", "fig": 2}, {"body": 9, "word": "\u00b5M", "fig": 1}, {"body": 8, "word": "p21", "fig": 1}, {"body": 8, "word": "degraded", "fig": 1}, {"body": 4, "word": "panel", "fig": 2}, {"body": 7, "word": "proteasome", "fig": 1}, {"body": 6, "word": "absence", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "loading", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 4, "word": "specific", "fig": 1}, {"body": 3, "word": "ImageJ", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "nuclei", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "fractions", "fig": 1}, {"body": 2, "word": "quantified", "fig": 1}, {"body": 2, "word": "left", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241690/bin/pone.0029160.g003.jpg", "caption": "Degradation of NFI-C by TGF-\u03b21 induction requires Smad3 in MDPC-23 cells. (A) MDPC-23 cells were transfected with empty vector (pCMV empty vector, control), Smad2, or Smad3 expression vectors in the presence or absence of MG132. NFI-C protein levels were analyzed by western blot 48 hr post-transfection. GAPDH was used as a loading control. (B) HEK293T cells were co-transfected with HA-tagged NFI-C and FLAG-tagged Smad3 (F-Smad3) expression vectors for 48 hr and then lysed. The whole cell lysates (WCL) and NFI-C immunoprecipitates were analyzed by western blot with anti-FLAG antibody. (C) Co-localization of NFI-C (red) and FLAG-Smad3 (green). MDPC-23 cells were co-transfected with NFI-C and FLAG-tagged Smad3 expression vector for 48 hr. After 48 hr, transfected cells were stimulated with TGF-\u03b21 for 1 hr in the presence of MG132 (10 \u00b5M). Double immunostaining was performed with anti-NFI-C and anti-FLAG antibodies, followed by the secondary antibodies conjugated to goat anti-rabbit rhodamine (red, NFI-C) and goat anti-mouse FITC (green, FLAG-Smad3), respectively. The merged panel shows co-localization (yellow) of NFI-C and FLAG-Smad3 in the cytoplasm. DAPI staining was used to detect nuclei. (D) MDPC-23 cells were stimulated with TGF-\u03b21 (10 ng/ml) in the presence of the proteasome inhibitor, MG132 (10 \u00b5M) for 1 hr. Cytoplasmic and nuclear fractions were isolated and NFI-C immunoprecipitates were analyzed by western blot with the anti-NFI-C or anti-pSmad3 antibody. GAPDH and lamin B served as cell fractionation controls. (E) MDPC-23 cells were transfected with shRNA Smad3 expression vector or control empty vector. Knockdown of Smad3 was evaluated by RT-PCR (left panel). Cell lysates were analyzed by western blot with NFI-C antibody, and the results were quantified using ImageJ (right panel; *P<0.01).", "co_occurrence": [{"body": 149, "word": "NFI-C", "fig": 10}, {"body": 68, "word": "cells", "fig": 7}, {"body": 80, "word": "TGF-\u03b21", "fig": 3}, {"body": 38, "word": "Smad3", "fig": 6}, {"body": 39, "word": "MDPC-23", "fig": 5}, {"body": 31, "word": "hr", "fig": 6}, {"body": 31, "word": "expression", "fig": 4}, {"body": 22, "word": "blot", "fig": 4}, {"body": 20, "word": "western", "fig": 4}, {"body": 16, "word": "analyzed", "fig": 4}, {"body": 32, "word": "The", "fig": 2}, {"body": 10, "word": "vector", "fig": 5}, {"body": 45, "word": "protein", "fig": 1}, {"body": 13, "word": "antibody", "fig": 3}, {"body": 11, "word": "presence", "fig": 3}, {"body": 11, "word": "MG132", "fig": 3}, {"body": 11, "word": "control", "fig": 3}, {"body": 31, "word": "levels", "fig": 1}, {"body": 15, "word": "cell", "fig": 2}, {"body": 9, "word": "\u00b5M", "fig": 2}, {"body": 17, "word": "ng/ml", "fig": 1}, {"body": 8, "word": "lysates", "fig": 2}, {"body": 15, "word": "using", "fig": 1}, {"body": 5, "word": "transfected", "fig": 3}, {"body": 5, "word": "empty", "fig": 3}, {"body": 14, "word": "results", "fig": 1}, {"body": 7, "word": "used", "fig": 2}, {"body": 13, "word": "inhibitor", "fig": 1}, {"body": 6, "word": "GAPDH", "fig": 2}, {"body": 6, "word": "immunoprecipitates", "fig": 2}, {"body": 4, "word": "panel", "fig": 3}, {"body": 6, "word": "co-transfected", "fig": 2}, {"body": 6, "word": "antibodies", "fig": 2}, {"body": 12, "word": "HEK293T", "fig": 1}, {"body": 11, "word": "cytoplasm", "fig": 1}, {"body": 5, "word": "FLAG-tagged", "fig": 2}, {"body": 5, "word": "B", "fig": 2}, {"body": 5, "word": "anti-FLAG", "fig": 2}, {"body": 9, "word": "Smad2", "fig": 1}, {"body": 4, "word": "stimulated", "fig": 2}, {"body": 7, "word": "proteasome", "fig": 1}, {"body": 6, "word": "absence", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "HA-tagged", "fig": 1}, {"body": 5, "word": "loading", "fig": 1}, {"body": 5, "word": "performed", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 2, "word": "vectors", "fig": 2}, {"body": 2, "word": "anti-NFI-C", "fig": 2}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "nuclei", "fig": 1}, {"body": 3, "word": "ImageJ", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "Cell", "fig": 1}, {"body": 3, "word": "After", "fig": 1}, {"body": 3, "word": "WCL", "fig": 1}, {"body": 3, "word": "requires", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "RT-PCR", "fig": 1}, {"body": 2, "word": "whole", "fig": 1}, {"body": 2, "word": "quantified", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "fractions", "fig": 1}, {"body": 2, "word": "evaluated", "fig": 1}, {"body": 2, "word": "lysed", "fig": 1}, {"body": 2, "word": "post-transfection", "fig": 1}, {"body": 2, "word": "left", "fig": 1}, {"body": 1, "word": "pCMV", "fig": 1}, {"body": 1, "word": "secondary", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241690/bin/pone.0029160.g004.jpg", "caption": "Ubiquitination and degradation of NFI-C by TGF-\u03b21 is mediated by the ubiquitin ligase, Smurf1. (A) MDPC-23 cells were co-transfected with NFI-C, Smurf1, Smurf2, Nedd4, and Praja1 expression vectors for 48 hr. After 48 hr, transfected cells were incubated with or without TGF-\u03b21 (10 ng/ml) for 1 hr. NFI-C protein levels were analyzed by western blot. GAPDH was used as a loading control. (B) MDPC-23 cells were co-transfected with NFI-C and Smurf1 expression vector for 48 hr. After 48 hr, transfected cells were incubated with or without TGF-\u03b21 (10 ng/ml) in the presence or absence of MG132 for 1 hr. NFI-C protein levels were analyzed by western blot. (C) MDPC-23 cells were transfected with shRNA Smurf1 expression vector or control empty vector. Forty-eight hours post-transfection cells were stimulated with TGF-\u03b21 for 1 hr. Cell lysates were analyzed by western blot with NFI-C antibody (left panel), and the results were quantified using ImageJ. Knockdown of Smurf1 was evaluated by real time PCR (right panel). (D) HEK293T cells were co-transfected with HA-tagged NFI-C, FLAG-tagged ubiquitin (Ub), and Smurf1, and then treated with MG132 (5 \u00b5M) for 48 hr. Forty-eight hours post-transfection, cells were stimulated with TGF-\u03b21 for 1 hr. The NFI-C immunoprecipitates or whole cell lysates (WCL) were analyzed by western blot with anti-FLAG or anti-HA antibody.", "co_occurrence": [{"body": 149, "word": "NFI-C", "fig": 8}, {"body": 68, "word": "cells", "fig": 8}, {"body": 80, "word": "TGF-\u03b21", "fig": 5}, {"body": 31, "word": "hr", "fig": 9}, {"body": 35, "word": "Smurf1", "fig": 6}, {"body": 39, "word": "MDPC-23", "fig": 3}, {"body": 31, "word": "expression", "fig": 3}, {"body": 45, "word": "protein", "fig": 2}, {"body": 22, "word": "blot", "fig": 4}, {"body": 20, "word": "western", "fig": 4}, {"body": 16, "word": "analyzed", "fig": 4}, {"body": 31, "word": "levels", "fig": 2}, {"body": 37, "word": "Smurf2", "fig": 1}, {"body": 17, "word": "ng/ml", "fig": 2}, {"body": 32, "word": "degradation", "fig": 1}, {"body": 32, "word": "The", "fig": 1}, {"body": 10, "word": "vector", "fig": 3}, {"body": 15, "word": "incubated", "fig": 2}, {"body": 13, "word": "antibody", "fig": 2}, {"body": 11, "word": "control", "fig": 2}, {"body": 11, "word": "MG132", "fig": 2}, {"body": 6, "word": "co-transfected", "fig": 3}, {"body": 8, "word": "lysates", "fig": 2}, {"body": 15, "word": "using", "fig": 1}, {"body": 15, "word": "cell", "fig": 1}, {"body": 5, "word": "transfected", "fig": 3}, {"body": 14, "word": "results", "fig": 1}, {"body": 14, "word": "PCR", "fig": 1}, {"body": 12, "word": "HEK293T", "fig": 1}, {"body": 11, "word": "presence", "fig": 1}, {"body": 9, "word": "\u00b5M", "fig": 1}, {"body": 8, "word": "anti-HA", "fig": 1}, {"body": 8, "word": "Ub", "fig": 1}, {"body": 4, "word": "panel", "fig": 2}, {"body": 4, "word": "ubiquitin", "fig": 2}, {"body": 4, "word": "stimulated", "fig": 2}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 6, "word": "absence", "fig": 1}, {"body": 6, "word": "GAPDH", "fig": 1}, {"body": 6, "word": "immunoprecipitates", "fig": 1}, {"body": 3, "word": "After", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 3, "word": "without", "fig": 2}, {"body": 5, "word": "FLAG-tagged", "fig": 1}, {"body": 5, "word": "HA-tagged", "fig": 1}, {"body": 5, "word": "loading", "fig": 1}, {"body": 5, "word": "empty", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "anti-FLAG", "fig": 1}, {"body": 2, "word": "post-transfection", "fig": 2}, {"body": 3, "word": "mediated", "fig": 1}, {"body": 3, "word": "ImageJ", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "Cell", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "Ubiquitination", "fig": 1}, {"body": 3, "word": "WCL", "fig": 1}, {"body": 2, "word": "whole", "fig": 1}, {"body": 1, "word": "Forty-eight", "fig": 2}, {"body": 2, "word": "quantified", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "Praja1", "fig": 1}, {"body": 2, "word": "Nedd4", "fig": 1}, {"body": 1, "word": "hours", "fig": 2}, {"body": 2, "word": "vectors", "fig": 1}, {"body": 2, "word": "evaluated", "fig": 1}, {"body": 2, "word": "ligase", "fig": 1}, {"body": 2, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241690/bin/pone.0029160.g005.jpg", "caption": "NFI-C interaction with Smurf1 requires activation of the MAPK pathway by TGF-\u03b2 signaling. (A) MDPC-23 cells were treated with TGF-\u03b21 (10 ng/ml) for 1 hr and then lysed. The NFI-C immunoprecipitates or whole cell lysates (WCL) were subjected to western blot analysis with the anti-Smurf1 or anti-NFI-C antibody. GAPDH was used as a loading control. (B) HEK293T cells were co-transfected with HA-tagged NFI-C and FLAG-tagged Smurf1 expression vectors for 48 hr. WCL and NFI-C immunoprecipitates were analyzed by western blot with anti-FLAG or anti-HA antibody. (C) MDPC-23 cells were incubated with TGF-\u03b21 (1 hr, 10 ng/ml) in the presence or absence of the MEK inhibitor, U0126 (10 \u00b5M), added 1 hr prior to TGF-\u03b21 addition. Cells were lysed, and NFI-C, p-ERK, and GAPDH levels were analyzed by western blot. (D) MDPC-23 cells were stimulated with TGF-\u03b21 (10 ng/ml) for 1 hr in the presence or absence of the MEK inhibitor, U0126 (10 \u00b5M). WCL and NFI-C immunoprecipitates were analyzed by western blot. (E) WCL and anti-phospho-Ser/Thr-Pro immunoprecipitates were analyzed by western blot with anti-NFI-C antibody. (F) HA-tagged NFI-C protein was metabolically labeled with [\u03b3-32P]-ATP in HEK293T cells. Bound Smurf1 proteins were eluted from the beads and detected by western blot analysis with the indicated antibody. The incorporation of 32P was detected by autoradiography, and the amount of HA-NFI-C was detected by western blot analysis.", "co_occurrence": [{"body": 149, "word": "NFI-C", "fig": 7}, {"body": 68, "word": "cells", "fig": 5}, {"body": 80, "word": "TGF-\u03b21", "fig": 4}, {"body": 31, "word": "hr", "fig": 5}, {"body": 22, "word": "blot", "fig": 7}, {"body": 20, "word": "western", "fig": 7}, {"body": 39, "word": "MDPC-23", "fig": 3}, {"body": 35, "word": "Smurf1", "fig": 3}, {"body": 16, "word": "analyzed", "fig": 4}, {"body": 32, "word": "The", "fig": 2}, {"body": 13, "word": "antibody", "fig": 4}, {"body": 17, "word": "ng/ml", "fig": 3}, {"body": 45, "word": "protein", "fig": 1}, {"body": 12, "word": "analysis", "fig": 3}, {"body": 31, "word": "levels", "fig": 1}, {"body": 31, "word": "expression", "fig": 1}, {"body": 13, "word": "inhibitor", "fig": 2}, {"body": 6, "word": "immunoprecipitates", "fig": 4}, {"body": 12, "word": "HEK293T", "fig": 2}, {"body": 11, "word": "presence", "fig": 2}, {"body": 7, "word": "detected", "fig": 3}, {"body": 21, "word": "signaling", "fig": 1}, {"body": 19, "word": "interaction", "fig": 1}, {"body": 9, "word": "\u00b5M", "fig": 2}, {"body": 15, "word": "cell", "fig": 1}, {"body": 15, "word": "incubated", "fig": 1}, {"body": 6, "word": "absence", "fig": 2}, {"body": 12, "word": "proteins", "fig": 1}, {"body": 6, "word": "GAPDH", "fig": 2}, {"body": 6, "word": "U0126", "fig": 2}, {"body": 3, "word": "WCL", "fig": 4}, {"body": 11, "word": "control", "fig": 1}, {"body": 11, "word": "TGF-\u03b2", "fig": 1}, {"body": 5, "word": "HA-tagged", "fig": 2}, {"body": 8, "word": "anti-HA", "fig": 1}, {"body": 8, "word": "beads", "fig": 1}, {"body": 8, "word": "activation", "fig": 1}, {"body": 8, "word": "lysates", "fig": 1}, {"body": 8, "word": "pathway", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 6, "word": "co-transfected", "fig": 1}, {"body": 6, "word": "MAPK", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "FLAG-tagged", "fig": 1}, {"body": 5, "word": "HA-NFI-C", "fig": 1}, {"body": 5, "word": "loading", "fig": 1}, {"body": 5, "word": "amount", "fig": 1}, {"body": 5, "word": "addition", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "anti-FLAG", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 2, "word": "MEK", "fig": 2}, {"body": 2, "word": "lysed", "fig": 2}, {"body": 4, "word": "stimulated", "fig": 1}, {"body": 2, "word": "anti-NFI-C", "fig": 2}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "added", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "requires", "fig": 1}, {"body": 2, "word": "whole", "fig": 1}, {"body": 2, "word": "\u03b3-32P", "fig": 1}, {"body": 2, "word": "vectors", "fig": 1}, {"body": 2, "word": "prior", "fig": 1}, {"body": 2, "word": "anti-phospho-Ser/Thr-Pro", "fig": 1}, {"body": 2, "word": "autoradiography", "fig": 1}, {"body": 2, "word": "incorporation", "fig": 1}, {"body": 2, "word": "labeled", "fig": 1}, {"body": 2, "word": "32P", "fig": 1}, {"body": 1, "word": "metabolically", "fig": 1}, {"body": 1, "word": "-ATP", "fig": 1}, {"body": 1, "word": "eluted", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "Bound", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241690/bin/pone.0029160.g006.jpg", "caption": "Dephosphorylation of p-Smad2/3 by NFI-C in MDPC-23 cells. (A) MDPC-23 cells were transfected with NFI-C expression vector for 48 hr. The level of NFI-C, p-Smad2/3, p-Smad3, and total Smad2/3 (T-Smad2/3) protein were analyzed by western blot. GAPDH was used as a loading control. (B) MDPC-23 cells were transfected with HA-tagged NFI-C and FLAG-tagged ubiquitin (Ub) expression vector for 48 hr. The FLAG immunoprecipitates or whole cell lysates (WCL) were analyzed by western blot.", "co_occurrence": [{"body": 149, "word": "NFI-C", "fig": 4}, {"body": 68, "word": "cells", "fig": 3}, {"body": 39, "word": "MDPC-23", "fig": 3}, {"body": 32, "word": "The", "fig": 2}, {"body": 31, "word": "hr", "fig": 2}, {"body": 31, "word": "expression", "fig": 2}, {"body": 45, "word": "protein", "fig": 1}, {"body": 22, "word": "blot", "fig": 2}, {"body": 20, "word": "western", "fig": 2}, {"body": 16, "word": "analyzed", "fig": 2}, {"body": 15, "word": "p-Smad2/3", "fig": 2}, {"body": 10, "word": "vector", "fig": 2}, {"body": 15, "word": "cell", "fig": 1}, {"body": 11, "word": "control", "fig": 1}, {"body": 5, "word": "transfected", "fig": 2}, {"body": 8, "word": "lysates", "fig": 1}, {"body": 8, "word": "Ub", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 7, "word": "p-Smad3", "fig": 1}, {"body": 7, "word": "Smad2/3", "fig": 1}, {"body": 6, "word": "GAPDH", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "immunoprecipitates", "fig": 1}, {"body": 6, "word": "level", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "FLAG-tagged", "fig": 1}, {"body": 5, "word": "HA-tagged", "fig": 1}, {"body": 5, "word": "loading", "fig": 1}, {"body": 4, "word": "ubiquitin", "fig": 1}, {"body": 3, "word": "WCL", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "whole", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241690/bin/pone.0029160.g007.jpg", "caption": "A proposed model of the function of NFI-C and TGF-\u03b21 during odontoblast differentiation and homeostasis. During early odontoblast differentiation, p-Smad2/3 induced by TGF-\u03b21 signaling increased binding to NFI-C in the cytoplasm. On the other hand, MAPK activation by TGF-\u03b21 signaling increased the interaction of phosphorylated NFI-C and Smurf1/2. Collectively, TGF-\u03b21 and MAPK activation enhanced the interaction and formation of Smad2/3-NFI-C-Smurf1/2 complex and resulted in the degradation of NFI-C. In contrast, during late odontoblast differentiation and mineralization, NFI-C signaling resulted in the dephosphorylation of p-Smad2/3. Consequently, TGF-\u03b21 induces odontoblast differentiation through the Smad signaling pathway in early odontoblast differentiation, while NFI-C signaling modulates late odontoblast differentiation and mineralization.", "co_occurrence": [{"body": 149, "word": "NFI-C", "fig": 6}, {"body": 80, "word": "TGF-\u03b21", "fig": 5}, {"body": 32, "word": "differentiation", "fig": 6}, {"body": 27, "word": "odontoblast", "fig": 6}, {"body": 21, "word": "signaling", "fig": 5}, {"body": 20, "word": "increased", "fig": 2}, {"body": 19, "word": "interaction", "fig": 2}, {"body": 32, "word": "degradation", "fig": 1}, {"body": 15, "word": "p-Smad2/3", "fig": 2}, {"body": 8, "word": "activation", "fig": 2}, {"body": 15, "word": "In", "fig": 1}, {"body": 14, "word": "binding", "fig": 1}, {"body": 6, "word": "MAPK", "fig": 2}, {"body": 11, "word": "cytoplasm", "fig": 1}, {"body": 5, "word": "early", "fig": 2}, {"body": 9, "word": "induced", "fig": 1}, {"body": 4, "word": "late", "fig": 2}, {"body": 8, "word": "pathway", "fig": 1}, {"body": 8, "word": "formation", "fig": 1}, {"body": 3, "word": "mineralization", "fig": 2}, {"body": 6, "word": "induces", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "phosphorylated", "fig": 1}, {"body": 2, "word": "resulted", "fig": 2}, {"body": 4, "word": "dephosphorylation", "fig": 1}, {"body": 3, "word": "Smad", "fig": 1}, {"body": 3, "word": "complex", "fig": 1}, {"body": 2, "word": "enhanced", "fig": 1}, {"body": 1, "word": "homeostasis", "fig": 1}, {"body": 1, "word": "During", "fig": 1}, {"body": 1, "word": "contrast", "fig": 1}, {"body": 1, "word": "On", "fig": 1}, {"body": 1, "word": "hand", "fig": 1}, {"body": 1, "word": "Collectively", "fig": 1}]}], "2172346": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172346/bin/200402105f1.jpg", "caption": "An outline of the calcineurin signaling pathway. Calcineurin, a serine/threonine protein phosphatase, is activated by calcium and calmodulin after intracellular calcium levels are elevated for a sustained period of time. Activated calcineurin dephosphorylates several substrates, including the NFAT transcription factors, which then translocate from the cytoplasm to the nucleus and activate a tissue-specific set of genes. In muscle, this set of genes includes MCIP-1, the protein product of which inhibits calcineurin, resulting in a negative feedback loop. Nuclear GSK-3\u03b2 rephosphorylates nuclear NFATs, so that they are inactivated and exported from the nucleus.", "co_occurrence": [{"body": 88, "word": "calcineurin", "fig": 3}, {"body": 66, "word": "muscle", "fig": 1}, {"body": 22, "word": "signaling", "fig": 1}, {"body": 17, "word": "MCIP-1", "fig": 1}, {"body": 16, "word": "factors", "fig": 1}, {"body": 16, "word": "In", "fig": 1}, {"body": 13, "word": "pathway", "fig": 1}, {"body": 11, "word": "transcription", "fig": 1}, {"body": 11, "word": "GSK-3\u03b2", "fig": 1}, {"body": 4, "word": "protein", "fig": 2}, {"body": 4, "word": "genes", "fig": 2}, {"body": 7, "word": "levels", "fig": 1}, {"body": 7, "word": "NFAT", "fig": 1}, {"body": 7, "word": "NFATs", "fig": 1}, {"body": 4, "word": "activated", "fig": 1}, {"body": 2, "word": "set", "fig": 2}, {"body": 4, "word": "several", "fig": 1}, {"body": 2, "word": "nucleus", "fig": 2}, {"body": 2, "word": "calcium", "fig": 2}, {"body": 3, "word": "including", "fig": 1}, {"body": 3, "word": "Calcineurin", "fig": 1}, {"body": 3, "word": "resulting", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 3, "word": "inhibits", "fig": 1}, {"body": 2, "word": "negative", "fig": 1}, {"body": 2, "word": "nuclear", "fig": 1}, {"body": 1, "word": "activate", "fig": 1}, {"body": 1, "word": "feedback", "fig": 1}, {"body": 1, "word": "cytoplasm", "fig": 1}, {"body": 1, "word": "period", "fig": 1}, {"body": 1, "word": "intracellular", "fig": 1}, {"body": 1, "word": "phosphatase", "fig": 1}, {"body": 1, "word": "Nuclear", "fig": 1}, {"body": 1, "word": "product", "fig": 1}, {"body": 1, "word": "outline", "fig": 1}, {"body": 1, "word": "An", "fig": 1}, {"body": 1, "word": "substrates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172346/bin/200402105f2.jpg", "caption": "Virtual Northern blot demonstrates up-regulation of MCIP-1 expression in differentiating NCSC-derived SMCs as compared with undifferentiated NCSCs. First-strand cDNA from NCSC and SMC was amplified by limited PCR, run on an agarose gel, blotted, and hybridized to an MCIP-1\u2013specific probe. The filter was stripped and hybridized to a G3PDH probe, so that G3PDH serves as an internal control.", "co_occurrence": [{"body": 45, "word": "NCSCs", "fig": 1}, {"body": 30, "word": "SMC", "fig": 1}, {"body": 24, "word": "The", "fig": 1}, {"body": 17, "word": "MCIP-1", "fig": 1}, {"body": 17, "word": "expression", "fig": 1}, {"body": 16, "word": "SMCs", "fig": 1}, {"body": 12, "word": "cDNA", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 7, "word": "PCR", "fig": 1}, {"body": 7, "word": "NCSC", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "differentiating", "fig": 1}, {"body": 3, "word": "undifferentiated", "fig": 1}, {"body": 3, "word": "Northern", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 2, "word": "limited", "fig": 1}, {"body": 1, "word": "probe", "fig": 2}, {"body": 2, "word": "Virtual", "fig": 1}, {"body": 2, "word": "amplified", "fig": 1}, {"body": 2, "word": "demonstrates", "fig": 1}, {"body": 2, "word": "internal", "fig": 1}, {"body": 2, "word": "up-regulation", "fig": 1}, {"body": 1, "word": "hybridized", "fig": 2}, {"body": 1, "word": "stripped", "fig": 1}, {"body": 1, "word": "First-strand", "fig": 1}, {"body": 1, "word": "run", "fig": 1}, {"body": 1, "word": "agarose", "fig": 1}, {"body": 1, "word": "MCIP-1\u2013specific", "fig": 1}, {"body": 1, "word": "blotted", "fig": 1}, {"body": 1, "word": "gel", "fig": 1}, {"body": 1, "word": "serves", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172346/bin/200402105f3.jpg", "caption": "Calcineurin activation, like TGF-\u03b21 treatment, increases the proportion of smooth muscle in the neural crest cell population. (A) TGF-mediated smooth muscle differentiation as measured by flow cytometry. Approximately 18,000 NCSCs per well isolated from sciatic nerve were transduced with the pMIG retroviral vector, and 2 d later 20 pM TGF-\u03b21 was added to half of the wells. After four additional days, the cells were fixed and stained with a primary antibody directed against SMA and a PE-conjugated secondary antibody, and PE and GFP fluorescence were determined by flow cytometry. The horizontal and vertical lines on each plot denote the upper boundary of GFP-negative and SMA-negative NCSCs, respectively. Cells to the right of the vertical line are GFP-positive and thus successfully transduced, and cells above the horizontal line are SMA-positive and thus are SMCs. The percentage of cells in each quadrant is indicated. Increased SMC content is evident in wells treated with TGF. (B) Calcineurin expression increases the percentage of SMCs in NCSC cultures, and inhibitors of calcineurin activity decrease the percentage of SMCs in NCSC cultures. NCSCs were transduced the day after isolation, and then grown for 6 d. At that point, they were fixed and stained with a primary antibody directed against SMA and a PE-conjugated secondary antibody, and PE and GFP fluorescence were determined by flow cytometry. The horizontal and vertical lines on each plot denote the upper boundary of GFP-negative and SMA-negative NCSCs, respectively. Cells to the right of the vertical line are GFP-positive and thus successfully transduced, and cells above the horizontal line are SMA-positive and thus are SMCs. The percentage of transduced cells that has differentiated into smooth muscle is indicated in the top right of each plot. Note that the NCSCs in the calcineurin plot that express the highest GFP levels, and therefore presumably the highest calcineurin levels, are almost uniformly smooth muscle. Calcineurin/vector ratio of percentage of SMCs from three independent experiments was 2.4, with a SD of 0.06; for MCIP-1, the mean ratio was 0.6, with a SD of 0.26; and for GSK-3\u03b2, the ratio was 0.5, with a SD of 0.15. (C) Increased expression of GFP correlates with increased SMC differentiation. Three independent flow cytometric analyses of calcineurin-transduced cells were evaluated for a correlation between actin expression (i.e., SMC identity) and GFP expression. Because GFP and calcineurin are on a bicistronic message, we expect calcineurin expression to increase in tandem with GFP expression. The level of actin expression at each level of intensity of GFP fluorescence is expressed as fold above a pMIG retroviral vector control \u00b1 SD.", "co_occurrence": [{"body": 88, "word": "calcineurin", "fig": 5}, {"body": 60, "word": "cells", "fig": 6}, {"body": 66, "word": "muscle", "fig": 4}, {"body": 45, "word": "NCSCs", "fig": 5}, {"body": 56, "word": "smooth", "fig": 4}, {"body": 62, "word": "differentiation", "fig": 2}, {"body": 24, "word": "The", "fig": 5}, {"body": 17, "word": "expression", "fig": 7}, {"body": 30, "word": "SMC", "fig": 3}, {"body": 18, "word": "transduced", "fig": 5}, {"body": 16, "word": "SMCs", "fig": 5}, {"body": 10, "word": "GFP", "fig": 8}, {"body": 32, "word": "TGF-\u03b21", "fig": 2}, {"body": 9, "word": "flow", "fig": 4}, {"body": 8, "word": "antibody", "fig": 4}, {"body": 11, "word": "stained", "fig": 2}, {"body": 18, "word": "cell", "fig": 1}, {"body": 17, "word": "MCIP-1", "fig": 1}, {"body": 5, "word": "cytometry", "fig": 3}, {"body": 7, "word": "pMIG", "fig": 2}, {"body": 7, "word": "retroviral", "fig": 2}, {"body": 7, "word": "levels", "fig": 2}, {"body": 7, "word": "NCSC", "fig": 2}, {"body": 13, "word": "experiments", "fig": 1}, {"body": 6, "word": "SMA", "fig": 2}, {"body": 4, "word": "fluorescence", "fig": 3}, {"body": 11, "word": "GSK-3\u03b2", "fig": 1}, {"body": 4, "word": "fixed", "fig": 2}, {"body": 8, "word": "control", "fig": 1}, {"body": 2, "word": "line", "fig": 4}, {"body": 2, "word": "SD", "fig": 4}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "activation", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "isolated", "fig": 1}, {"body": 6, "word": "d", "fig": 1}, {"body": 3, "word": "vector", "fig": 2}, {"body": 3, "word": "Calcineurin", "fig": 2}, {"body": 3, "word": "Cells", "fig": 2}, {"body": 5, "word": "sciatic", "fig": 1}, {"body": 5, "word": "crest", "fig": 1}, {"body": 5, "word": "increased", "fig": 1}, {"body": 5, "word": "population", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 5, "word": "neural", "fig": 1}, {"body": 5, "word": "well", "fig": 1}, {"body": 2, "word": "GFP-positive", "fig": 2}, {"body": 2, "word": "increases", "fig": 2}, {"body": 2, "word": "secondary", "fig": 2}, {"body": 4, "word": "differentiated", "fig": 1}, {"body": 2, "word": "level", "fig": 2}, {"body": 2, "word": "PE", "fig": 2}, {"body": 4, "word": "activity", "fig": 1}, {"body": 4, "word": "nerve", "fig": 1}, {"body": 2, "word": "cultures", "fig": 2}, {"body": 2, "word": "determined", "fig": 2}, {"body": 1, "word": "thus", "fig": 4}, {"body": 4, "word": "later", "fig": 1}, {"body": 3, "word": "expressed", "fig": 1}, {"body": 3, "word": "day", "fig": 1}, {"body": 3, "word": "cytometric", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "like", "fig": 1}, {"body": 1, "word": "ratio", "fig": 3}, {"body": 3, "word": "decrease", "fig": 1}, {"body": 3, "word": "pM", "fig": 1}, {"body": 3, "word": "increase", "fig": 1}, {"body": 3, "word": "TGF", "fig": 1}, {"body": 2, "word": "four", "fig": 1}, {"body": 2, "word": "proportion", "fig": 1}, {"body": 2, "word": "treatment", "fig": 1}, {"body": 2, "word": "express", "fig": 1}, {"body": 1, "word": "primary", "fig": 2}, {"body": 1, "word": "PE-conjugated", "fig": 2}, {"body": 2, "word": "three", "fig": 1}, {"body": 1, "word": "directed", "fig": 2}, {"body": 2, "word": "evident", "fig": 1}, {"body": 2, "word": "isolation", "fig": 1}, {"body": 2, "word": "bicistronic", "fig": 1}, {"body": 2, "word": "grown", "fig": 1}, {"body": 2, "word": "After", "fig": 1}, {"body": 2, "word": "added", "fig": 1}, {"body": 1, "word": "wells", "fig": 2}, {"body": 1, "word": "GFP-negative", "fig": 2}, {"body": 1, "word": "content", "fig": 1}, {"body": 1, "word": "i.e.", "fig": 1}, {"body": 1, "word": "half", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "inhibitors", "fig": 1}, {"body": 1, "word": "days", "fig": 1}, {"body": 1, "word": "presumably", "fig": 1}, {"body": 1, "word": "point", "fig": 1}, {"body": 1, "word": "therefore", "fig": 1}, {"body": 1, "word": "almost", "fig": 1}, {"body": 1, "word": "calcineurin-transduced", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "analyses", "fig": 1}, {"body": 1, "word": "correlates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172346/bin/200402105f4.jpg", "caption": "Colonies of calcineurin-transduced NCSCs demonstrate a marked increase in SMC differentiation and assume a highly differentiated phenotype. NCSCs were transduced 24 h after isolation and replated at clonal density on the following day. They were allowed to grow for 10 d, and then stained with DAPI and the indicated antibodies. (A) Calcineurin- and pMIG-transduced colonies stained with anti-SMA antibody are shown. They were photographed sequentially, in the order that they were encountered on the plate. (B) Colony characterization of calcineurin- and pMIG-transduced colonies. Colonies were stained with cell type\u2013specific antibodies and characterized with respect to their content of undifferentiated (U), smooth muscle (M), or glial (G) content. Cn, calcineurin; Vec, pMIG. Means of three independent experiments plus SD are shown. (C) Calcineurin- or pMIG-transduced SMCs express the highly specific SMC markers calponin and smooth muscle myosin heavy chain, indicating a highly differentiated phenotype. Note that although the degree of magnification may appear to be higher in the photographs of calcineurin-transduced cells, magnification of parallel photomicrographs in A and C is in fact the same. The nuclei of SMCs are larger than those of undifferentiated NCSCs, giving the incorrect impression of different degrees of magnification.", "co_occurrence": [{"body": 45, "word": "NCSCs", "fig": 3}, {"body": 66, "word": "muscle", "fig": 2}, {"body": 56, "word": "smooth", "fig": 2}, {"body": 88, "word": "calcineurin", "fig": 1}, {"body": 62, "word": "differentiation", "fig": 1}, {"body": 60, "word": "cells", "fig": 1}, {"body": 30, "word": "SMC", "fig": 2}, {"body": 11, "word": "stained", "fig": 3}, {"body": 16, "word": "SMCs", "fig": 2}, {"body": 14, "word": "colonies", "fig": 2}, {"body": 24, "word": "The", "fig": 1}, {"body": 18, "word": "cell", "fig": 1}, {"body": 18, "word": "transduced", "fig": 1}, {"body": 8, "word": "A", "fig": 2}, {"body": 13, "word": "experiments", "fig": 1}, {"body": 6, "word": "antibodies", "fig": 2}, {"body": 5, "word": "shown", "fig": 2}, {"body": 9, "word": "h", "fig": 1}, {"body": 4, "word": "differentiated", "fig": 2}, {"body": 8, "word": "antibody", "fig": 1}, {"body": 7, "word": "pMIG", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "clonal", "fig": 1}, {"body": 6, "word": "d", "fig": 1}, {"body": 3, "word": "undifferentiated", "fig": 2}, {"body": 3, "word": "C", "fig": 2}, {"body": 3, "word": "phenotype", "fig": 2}, {"body": 5, "word": "replated", "fig": 1}, {"body": 5, "word": "anti-SMA", "fig": 1}, {"body": 5, "word": "different", "fig": 1}, {"body": 5, "word": "fact", "fig": 1}, {"body": 4, "word": "plate", "fig": 1}, {"body": 2, "word": "Colonies", "fig": 2}, {"body": 3, "word": "increase", "fig": 1}, {"body": 3, "word": "day", "fig": 1}, {"body": 1, "word": "highly", "fig": 3}, {"body": 3, "word": "may", "fig": 1}, {"body": 2, "word": "chain", "fig": 1}, {"body": 2, "word": "photographed", "fig": 1}, {"body": 2, "word": "specific", "fig": 1}, {"body": 2, "word": "characterized", "fig": 1}, {"body": 2, "word": "heavy", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 1, "word": "content", "fig": 2}, {"body": 2, "word": "myosin", "fig": 1}, {"body": 2, "word": "although", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 2, "word": "isolation", "fig": 1}, {"body": 2, "word": "SD", "fig": 1}, {"body": 1, "word": "calcineurin-transduced", "fig": 2}, {"body": 2, "word": "express", "fig": 1}, {"body": 1, "word": "indicating", "fig": 1}, {"body": 1, "word": "degree", "fig": 1}, {"body": 1, "word": "calponin", "fig": 1}, {"body": 1, "word": "density", "fig": 1}, {"body": 1, "word": "characterization", "fig": 1}, {"body": 1, "word": "marked", "fig": 1}, {"body": 1, "word": "respect", "fig": 1}, {"body": 1, "word": "following", "fig": 1}, {"body": 1, "word": "larger", "fig": 1}, {"body": 1, "word": "M", "fig": 1}, {"body": 1, "word": "U", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172346/bin/200402105f5.jpg", "caption": "Expression of NFATc1 in NCSCs causes smooth muscle differentiation. (top) Photomicrographs of NCSCs transduced with MSCV vector-derived or FLAG-NFATc1\u2013 expressing retrovirus and stained with FLAG antibody. (bottom) Representative example of flow cytometry of NCSCs transduced with MSCV virus (solid black peak) or NFATc1 virus (open peak with gray outline). Cells were fixed and stained for SMA expression 6 d after transduction. NFATc1/vector ratio of percentage of SMCs from three independent experiments was 2.0, with a SD of 0.1.", "co_occurrence": [{"body": 45, "word": "NCSCs", "fig": 3}, {"body": 66, "word": "muscle", "fig": 1}, {"body": 62, "word": "differentiation", "fig": 1}, {"body": 56, "word": "smooth", "fig": 1}, {"body": 18, "word": "NFATc1", "fig": 2}, {"body": 18, "word": "transduced", "fig": 2}, {"body": 11, "word": "stained", "fig": 2}, {"body": 17, "word": "expression", "fig": 1}, {"body": 16, "word": "SMCs", "fig": 1}, {"body": 13, "word": "experiments", "fig": 1}, {"body": 13, "word": "transduction", "fig": 1}, {"body": 9, "word": "flow", "fig": 1}, {"body": 4, "word": "virus", "fig": 2}, {"body": 8, "word": "antibody", "fig": 1}, {"body": 6, "word": "causes", "fig": 1}, {"body": 6, "word": "SMA", "fig": 1}, {"body": 6, "word": "d", "fig": 1}, {"body": 5, "word": "cytometry", "fig": 1}, {"body": 4, "word": "fixed", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "retrovirus", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 2, "word": "Expression", "fig": 1}, {"body": 2, "word": "example", "fig": 1}, {"body": 2, "word": "SD", "fig": 1}, {"body": 1, "word": "ratio", "fig": 1}, {"body": 1, "word": "expressing", "fig": 1}, {"body": 1, "word": "outline", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172346/bin/200402105f6.jpg", "caption": "NFATc1 transcript levels increase in TGF-treated NCSCs. NCSCs were treated with TGF-\u03b21 for 24\u201348 h, and then total RNA was isolated and quantitative real-time PCR was performed using NFATc1-specific primers. Both GAPDH and \u03b2-actin transcripts were also quantitated, and levels of NFATc1 transcript were normalized to either GAPDH or \u03b2-actin. The result was virtually identical using either GAPDH or \u03b2-actin to normalize (mean of 4.6, SD of 0.4 or mean of 4.5, SD of 0.5, respectively, three independent experiments).", "co_occurrence": [{"body": 45, "word": "NCSCs", "fig": 2}, {"body": 18, "word": "NFATc1", "fig": 2}, {"body": 32, "word": "TGF-\u03b21", "fig": 1}, {"body": 12, "word": "using", "fig": 2}, {"body": 24, "word": "The", "fig": 1}, {"body": 7, "word": "levels", "fig": 2}, {"body": 13, "word": "experiments", "fig": 1}, {"body": 6, "word": "either", "fig": 2}, {"body": 11, "word": "also", "fig": 1}, {"body": 9, "word": "h", "fig": 1}, {"body": 7, "word": "PCR", "fig": 1}, {"body": 7, "word": "isolated", "fig": 1}, {"body": 3, "word": "transcript", "fig": 2}, {"body": 5, "word": "treated", "fig": 1}, {"body": 4, "word": "real-time", "fig": 1}, {"body": 2, "word": "SD", "fig": 2}, {"body": 4, "word": "result", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 3}, {"body": 3, "word": "performed", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "increase", "fig": 1}, {"body": 3, "word": "quantitative", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 2, "word": "identical", "fig": 1}, {"body": 2, "word": "RNA", "fig": 1}, {"body": 2, "word": "transcripts", "fig": 1}, {"body": 1, "word": "quantitated", "fig": 1}, {"body": 1, "word": "primers", "fig": 1}]}], "4757796": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f1.jpg", "caption": "TRAF3 expression is upregulated in livers with hepatic steatosis. (a,b) The mRNA (a) and protein (b) levels of TRAF3 in liver biopsy samples from normal donors and patients with NAFLD. TRAF3 expression was normalized to that of GAPDH (n=4 for normal and 7 for NAFLD samples, *P<0.05 versus normal donors). (c,d) TRAF3 mRNA (c) and protein (d) expression in the liver of mice subjected to an HFD for 24 weeks and in NC controls (n=6 samples per experimental group, *P<0.05 compared with the NC group). (e) Immunofluorescence images of staining with antibodies against HNF4 (green) and TRAF3 (red). Nuclei were labelled with DAPI (blue; n=8 samples per experimental group). Scale bar, 50 \u03bcm. (f) Primary hepatocytes were isolated and stimulated with palmitate (0.25 mM) for 24 h, and TRAF3 expression was examined by immunoblotting. GAPDH served as a loading control (n=6 samples per experimental group, *P<0.05 versus control). The data represent as the mean\u00b1s.d. Statistical analysis was carried out by Student's two-tailed t-test.", "co_occurrence": [{"body": 143, "word": "TRAF3", "fig": 6}, {"body": 31, "word": "expression", "fig": 4}, {"body": 59, "word": "liver", "fig": 2}, {"body": 49, "word": "The", "fig": 2}, {"body": 76, "word": "mice", "fig": 1}, {"body": 14, "word": "samples", "fig": 5}, {"body": 65, "word": "hepatic", "fig": 1}, {"body": 51, "word": "steatosis", "fig": 1}, {"body": 22, "word": "protein", "fig": 2}, {"body": 37, "word": "HFD", "fig": 1}, {"body": 36, "word": "hepatocytes", "fig": 1}, {"body": 8, "word": "group", "fig": 4}, {"body": 29, "word": "levels", "fig": 1}, {"body": 18, "word": "palmitate", "fig": 1}, {"body": 16, "word": "mM", "fig": 1}, {"body": 15, "word": "'s", "fig": 1}, {"body": 14, "word": "controls", "fig": 1}, {"body": 13, "word": "weeks", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 2}, {"body": 6, "word": "control", "fig": 2}, {"body": 6, "word": "b", "fig": 2}, {"body": 4, "word": "normal", "fig": 3}, {"body": 5, "word": "d", "fig": 2}, {"body": 5, "word": "NC", "fig": 2}, {"body": 5, "word": "NAFLD", "fig": 2}, {"body": 10, "word": "livers", "fig": 1}, {"body": 10, "word": "examined", "fig": 1}, {"body": 9, "word": "h", "fig": 1}, {"body": 9, "word": "compared", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 7, "word": "antibodies", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 2}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "upregulated", "fig": 1}, {"body": 5, "word": "isolated", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "donors", "fig": 2}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 3, "word": "Primary", "fig": 1}, {"body": 3, "word": "Immunofluorescence", "fig": 1}, {"body": 3, "word": "patients", "fig": 1}, {"body": 3, "word": "data", "fig": 1}, {"body": 2, "word": "HNF4", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "biopsy", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "blue", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "immunoblotting", "fig": 1}, {"body": 1, "word": "mean\u00b1s.d", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f2.jpg", "caption": "Liver-specific TRAF3 deficiency inhibits HFD-induced obesity and insulin resistance. (a) Changes in the body weight of TRAF3-LKO and TRAF3-flox mice treated with an HFD or NC for 24 weeks (n=16\u201325 for each group per time point). (b) FBG, FINS and HOMA-IR in TRAF3-LKO or TRAF3-flox mice treated with an HFD or NC for 24 weeks. FBG levels were measured every 4 weeks. FINS was measured at the end point of this experiment. HOMA-IR was calculated as HOMA-IR=(FBG (mmol l\u22121) \u00d7 FINS (mIU l\u22121))/22.5 (n=8\u201312 for each group per time point). (c,d) Intraperitoneal glucose tolerance test (GTT) (1 g kg\u22121) (c) and intraperitoneal insulin tolerance test (ITT; 0.75 units per kg) (d) were performed on TRAF3-flox and TRAF3-LKO mice at the 22nd or 23rd week of food administered, respectively. The corresponding area under the curve (AUC) of blood glucose level was calculated (n=8\u201312 for each group). (e) Total and/or phosphorylated IRS1, AKT, GSK3\u03b2, FOXO1, PEPCK and G6Pase in liver samples of HFD-fed mice that were refed for 4 h after overnight fasting and NC mice under fasting state at the end of 24 weeks. GAPDH serves as the loading control (n=4 samples per experimental group). (f) Representative images of periodic acid\u2013Schiff (PAS) staining on the liver sections of TRAF3-flox and TRAF3-LKO mice after a 24-week HFD or NC treatment. n=3\u20134 per group. Scale bar, 50 \u03bcm. (g) The glycogen content levels measured in the liver samples of mice in TRAF3-flox/NC, TRAF3-LKO/NC, TRAF3-flox/HFD and TRAF3-LKO/HFD groups. n=8\u201312 for each group. (h) The mRNA levels of PEPCK and G6Pase in the liver from mice in the indicated groups. n=4 for each group. For a\u2013h, *P<0.05 compared with the corresponding TRAF3-flox/NC group; #P<0.05 compared with the corresponding TRAF3-flox/HFD group. All values are means\u00b1s.d. Significance determined by two-way analysis of variance with general linear model procedures using a univariate approach (a\u2013d,g) and Student's two-tailed t-test (e,h).", "co_occurrence": [{"body": 76, "word": "mice", "fig": 8}, {"body": 59, "word": "liver", "fig": 4}, {"body": 49, "word": "The", "fig": 3}, {"body": 143, "word": "TRAF3", "fig": 1}, {"body": 69, "word": "insulin", "fig": 2}, {"body": 37, "word": "HFD", "fig": 3}, {"body": 23, "word": "TRAF3-LKO", "fig": 4}, {"body": 29, "word": "levels", "fig": 3}, {"body": 8, "word": "group", "fig": 9}, {"body": 17, "word": "TRAF3-flox", "fig": 4}, {"body": 13, "word": "weeks", "fig": 4}, {"body": 14, "word": "samples", "fig": 3}, {"body": 17, "word": "glucose", "fig": 2}, {"body": 32, "word": "resistance", "fig": 1}, {"body": 9, "word": "h", "fig": 3}, {"body": 8, "word": "corresponding", "fig": 3}, {"body": 5, "word": "NC", "fig": 4}, {"body": 18, "word": "using", "fig": 1}, {"body": 9, "word": "compared", "fig": 2}, {"body": 18, "word": "treatment", "fig": 1}, {"body": 6, "word": "measured", "fig": 3}, {"body": 16, "word": "weight", "fig": 1}, {"body": 15, "word": "'s", "fig": 1}, {"body": 5, "word": "FBG", "fig": 3}, {"body": 7, "word": "tolerance", "fig": 2}, {"body": 4, "word": "FINS", "fig": 3}, {"body": 12, "word": "HFD-induced", "fig": 1}, {"body": 6, "word": "groups", "fig": 2}, {"body": 4, "word": "g", "fig": 3}, {"body": 12, "word": "indicated", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 10, "word": "obesity", "fig": 1}, {"body": 10, "word": "deficiency", "fig": 1}, {"body": 5, "word": "G6Pase", "fig": 2}, {"body": 5, "word": "PEPCK", "fig": 2}, {"body": 9, "word": "glycogen", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 8, "word": "body", "fig": 1}, {"body": 8, "word": "sections", "fig": 1}, {"body": 4, "word": "test", "fig": 2}, {"body": 4, "word": "fasting", "fig": 2}, {"body": 7, "word": "IRS1", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 6, "word": "level", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "AKT", "fig": 1}, {"body": 3, "word": "HOMA-IR", "fig": 2}, {"body": 6, "word": "b", "fig": 1}, {"body": 5, "word": "phosphorylated", "fig": 1}, {"body": 5, "word": "performed", "fig": 1}, {"body": 5, "word": "GSK3\u03b2", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "content", "fig": 1}, {"body": 2, "word": "l\u22121", "fig": 2}, {"body": 4, "word": "intraperitoneal", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "kg\u22121", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "periodic", "fig": 1}, {"body": 3, "word": "FOXO1", "fig": 1}, {"body": 3, "word": "administered", "fig": 1}, {"body": 3, "word": "overnight", "fig": 1}, {"body": 2, "word": "acid\u2013Schiff", "fig": 1}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "state", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "area", "fig": 1}, {"body": 2, "word": "approach", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 1, "word": "treated", "fig": 2}, {"body": 2, "word": "24-week", "fig": 1}, {"body": 1, "word": "calculated", "fig": 2}, {"body": 2, "word": "Total", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "units", "fig": 1}, {"body": 1, "word": "every", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "refed", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "mmol", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "mIU", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}, {"body": 1, "word": "blood", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f3.jpg", "caption": "Liver-specific TRAF3 overexpression exacerbates HFD-induced obesity and insulin resistance. (a) The body weights of TRAF3-LTG and NTG mice at 0, 4, 8, 12, 16, 20 and 24 weeks after HFD or NC feeding (n=17\u201325 in each group per time point). (b) FBG, FINS and HOMA-IR at indicated time points of TRAF3-LTG and NTG mice fed an HFD or NC diet (n=10\u201312 for each group). (c,d) The intraperitoneal glucose tolerance test (GTT) (c) and intraperitoneal insulin tolerance test (ITT) (d) assays were performed to evaluate the insulin sensitivity of mice in the indicated groups after HFD or NC treatment for 24 weeks. Area under the curve (AUC) was calculated (n=10\u201312 for each group). (e) The expression levels of the key factors in the insulin signalling measured in liver samples of HFD-fed mice that were refed for 4 h after overnight fasting and NC mice under fasting state. (f,g) The glycogen content levels examined by periodic acid\u2013Schiff (PAS) staining (f, n=3\u20134 per group; Scale bar, 50 \u03bcm) and Glycogen Assay Kit (g, n=8\u201312 per group) on the liver samples of TRAF3-flox and TRAF3-LKO mice after a 24-week HFD or NC treatment. (h) PEPCK and G6Pase expression levels in the liver from mice in the indicated groups measured by RT\u2013PCR analyses. n=4 for each group. For a\u2013h, *P<0.05 versus NTG/NC group; #P<0.05 versus NTG/HFD group. All values are means\u00b1s.d. Significance determined by two-way analysis of variance with general linear model procedures using a univariate approach (a\u2013d,g) and Student's two-tailed t-test (e,h).", "co_occurrence": [{"body": 76, "word": "mice", "fig": 7}, {"body": 69, "word": "insulin", "fig": 4}, {"body": 49, "word": "The", "fig": 4}, {"body": 59, "word": "liver", "fig": 3}, {"body": 37, "word": "HFD", "fig": 4}, {"body": 143, "word": "TRAF3", "fig": 1}, {"body": 29, "word": "levels", "fig": 3}, {"body": 8, "word": "group", "fig": 8}, {"body": 31, "word": "expression", "fig": 2}, {"body": 12, "word": "indicated", "fig": 3}, {"body": 18, "word": "treatment", "fig": 2}, {"body": 32, "word": "resistance", "fig": 1}, {"body": 15, "word": "TRAF3-LTG", "fig": 2}, {"body": 14, "word": "samples", "fig": 2}, {"body": 9, "word": "h", "fig": 3}, {"body": 27, "word": "signalling", "fig": 1}, {"body": 13, "word": "weeks", "fig": 2}, {"body": 5, "word": "NC", "fig": 5}, {"body": 23, "word": "TRAF3-LKO", "fig": 1}, {"body": 10, "word": "NTG", "fig": 2}, {"body": 18, "word": "using", "fig": 1}, {"body": 17, "word": "glucose", "fig": 1}, {"body": 17, "word": "TRAF3-flox", "fig": 1}, {"body": 15, "word": "'s", "fig": 1}, {"body": 7, "word": "tolerance", "fig": 2}, {"body": 12, "word": "HFD-induced", "fig": 1}, {"body": 4, "word": "g", "fig": 3}, {"body": 6, "word": "groups", "fig": 2}, {"body": 6, "word": "measured", "fig": 2}, {"body": 11, "word": "overexpression", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 10, "word": "obesity", "fig": 1}, {"body": 10, "word": "examined", "fig": 1}, {"body": 9, "word": "glycogen", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 4, "word": "intraperitoneal", "fig": 2}, {"body": 8, "word": "body", "fig": 1}, {"body": 8, "word": "analyses", "fig": 1}, {"body": 4, "word": "test", "fig": 2}, {"body": 4, "word": "fasting", "fig": 2}, {"body": 7, "word": "model", "fig": 1}, {"body": 7, "word": "assays", "fig": 1}, {"body": 6, "word": "b", "fig": 1}, {"body": 5, "word": "RT\u2013PCR", "fig": 1}, {"body": 5, "word": "evaluate", "fig": 1}, {"body": 5, "word": "FBG", "fig": 1}, {"body": 5, "word": "performed", "fig": 1}, {"body": 5, "word": "G6Pase", "fig": 1}, {"body": 5, "word": "Kit", "fig": 1}, {"body": 5, "word": "PEPCK", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "FINS", "fig": 1}, {"body": 4, "word": "content", "fig": 1}, {"body": 3, "word": "exacerbates", "fig": 1}, {"body": 3, "word": "factors", "fig": 1}, {"body": 3, "word": "periodic", "fig": 1}, {"body": 3, "word": "HOMA-IR", "fig": 1}, {"body": 3, "word": "sensitivity", "fig": 1}, {"body": 3, "word": "Assay", "fig": 1}, {"body": 3, "word": "diet", "fig": 1}, {"body": 3, "word": "overnight", "fig": 1}, {"body": 2, "word": "feeding", "fig": 1}, {"body": 2, "word": "acid\u2013Schiff", "fig": 1}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "state", "fig": 1}, {"body": 2, "word": "key", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "approach", "fig": 1}, {"body": 2, "word": "24-week", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 1, "word": "Glycogen", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "refed", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}, {"body": 1, "word": "weights", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f4.jpg", "caption": "Hepatocyte TRAF3 promotes hepatic steatosis induced by HFD treatment. (a,e) The liver weights and the ratio of liver weight to body weight (LW/BW) of liver-specific TRAF3-deficient mice and controls (a) or of TRAF3-LTG and NTG littermates (e) at 24 weeks post-HFD administration (n=17\u201325 samples per experimental group). (b,f) Haematoxylin and eosin (H&E; upper) and oil red O (bottom) staining of liver sections of TRAF3-LKO and floxed controls (b) or TRAF3-LTG and NTG groups (f) after HFD treatment (n=6\u20138 samples per experimental group). Scale bar, 100 \u03bcm. (c,g) Hepatic TG, TC and NEFA contents of mice in the indicated groups were measured by enzyme-linked immunosorbent assay (n=6\u20138 samples per experimental group). (d,h) Quantitative RT\u2013PCR was performed to determine mRNA expressions of genes related to cholesterol synthesis and efflux and fatty acid uptake, synthesis and \u03b2-oxidation in the liver samples of TRAF3-flox and TRAF3-LKO mice (d) or TRAF3-LTG and NTG mice (h) after HFD treatment for 24 weeks (n=6\u20138 samples per experimental group). #P<0.05 versus TRAF3-flox/HFD or NTG/HFD group, two-tailed, unpaired Student's t-test. (i,j) Lipid accumulations displayed by oil red O staining (i) and intracellular TG assay (j) in L-02 cell line infected with AdshTRAF3, AdTRAF3 or their corresponding controls, and subjected to palmitate or vehicle control administration for 24 h (n=10 samples per experimental group). Scale bar, 10 \u03bcm. *P<0.05 versus AdGFP/AdshRNA control group; #P<0.05 versus AdGFP/AdshRNA palmitate group; significance determined by two-way analysis of variance with general linear model procedures using a univariate approach.", "co_occurrence": [{"body": 76, "word": "mice", "fig": 4}, {"body": 59, "word": "liver", "fig": 4}, {"body": 143, "word": "TRAF3", "fig": 1}, {"body": 37, "word": "HFD", "fig": 3}, {"body": 14, "word": "samples", "fig": 6}, {"body": 65, "word": "hepatic", "fig": 1}, {"body": 8, "word": "group", "fig": 8}, {"body": 18, "word": "treatment", "fig": 3}, {"body": 51, "word": "steatosis", "fig": 1}, {"body": 49, "word": "The", "fig": 1}, {"body": 23, "word": "TRAF3-LKO", "fig": 2}, {"body": 15, "word": "TRAF3-LTG", "fig": 3}, {"body": 14, "word": "controls", "fig": 3}, {"body": 19, "word": "administration", "fig": 2}, {"body": 18, "word": "palmitate", "fig": 2}, {"body": 16, "word": "weight", "fig": 2}, {"body": 10, "word": "NTG", "fig": 3}, {"body": 9, "word": "h", "fig": 3}, {"body": 13, "word": "weeks", "fig": 2}, {"body": 25, "word": "fatty", "fig": 1}, {"body": 23, "word": "acid", "fig": 1}, {"body": 9, "word": "assay", "fig": 2}, {"body": 18, "word": "using", "fig": 1}, {"body": 9, "word": "synthesis", "fig": 2}, {"body": 17, "word": "cell", "fig": 1}, {"body": 17, "word": "TRAF3-flox", "fig": 1}, {"body": 8, "word": "staining", "fig": 2}, {"body": 15, "word": "'s", "fig": 1}, {"body": 7, "word": "TG", "fig": 2}, {"body": 12, "word": "induced", "fig": 1}, {"body": 6, "word": "groups", "fig": 2}, {"body": 6, "word": "control", "fig": 2}, {"body": 6, "word": "b", "fig": 2}, {"body": 12, "word": "indicated", "fig": 1}, {"body": 11, "word": "liver-specific", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 5, "word": "red", "fig": 2}, {"body": 5, "word": "O", "fig": 2}, {"body": 9, "word": "related", "fig": 1}, {"body": 8, "word": "body", "fig": 1}, {"body": 8, "word": "sections", "fig": 1}, {"body": 8, "word": "corresponding", "fig": 1}, {"body": 4, "word": "oil", "fig": 2}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 7, "word": "promotes", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 6, "word": "cholesterol", "fig": 1}, {"body": 5, "word": "line", "fig": 1}, {"body": 5, "word": "RT\u2013PCR", "fig": 1}, {"body": 5, "word": "genes", "fig": 1}, {"body": 5, "word": "performed", "fig": 1}, {"body": 5, "word": "AdTRAF3", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "g", "fig": 1}, {"body": 4, "word": "AdshTRAF3", "fig": 1}, {"body": 4, "word": "TC", "fig": 1}, {"body": 3, "word": "L-02", "fig": 1}, {"body": 2, "word": "displayed", "fig": 1}, {"body": 2, "word": "ratio", "fig": 1}, {"body": 2, "word": "uptake", "fig": 1}, {"body": 1, "word": "P", "fig": 2}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "eosin", "fig": 1}, {"body": 2, "word": "approach", "fig": 1}, {"body": 2, "word": "intracellular", "fig": 1}, {"body": 2, "word": "floxed", "fig": 1}, {"body": 2, "word": "Hepatic", "fig": 1}, {"body": 2, "word": "Quantitative", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "NEFA", "fig": 1}, {"body": 2, "word": "contents", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "\u03b2-oxidation", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "TRAF3-deficient", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "Hepatocyte", "fig": 1}, {"body": 1, "word": "littermates", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}, {"body": 1, "word": "efflux", "fig": 1}, {"body": 1, "word": "weights", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f5.jpg", "caption": "HFD-induced hepatic inflammatory response can be significantly aggravated by TRAF3 in hepatocytes. (a) mRNA expression levels of inflammatory cytokines and chemokines in the liver of indicated groups (n=6\u20138 samples per experimental group). (b) The expression levels of key proteins in NF-\u03baB signalling in the liver of TRAF3-LKO, TRAF3-LTG and their corresponding littermate controls after HFD or NC treatment for 24 weeks. Protein expression was normalized to that of GAPDH (n=4 samples per experimental group). For a and b, *P<0.05 versus TRAF3-flox/NC or NTG/NC group; #P<0.05 versus TRAF3-flox/HFD or NTG/HFD group. (c) Primary hepatocytes were isolated from TRAF3-LKO, TRAF3-LTG, TRAF3-flox and NTG groups followed by stimulation with palmitate (0.25 mM) or vehicle for 24 h. Total and phosphorylated p65 and I\u03baB\u03b1 were detected by western blot analysis. GAPDH served as a loading control (n=6 samples per experimental group). *P<0.05 versus TRAF3-flox/control or NTG/control group; #P<0.05 versus TRAF3-flox/palmitate or NTG/palmitate group. All values are means\u00b1s.d. Significance determined by Student's two-tailed t-test (a) and two-way analysis of variance with general linear model procedures using a univariate approach (b,c).", "co_occurrence": [{"body": 143, "word": "TRAF3", "fig": 1}, {"body": 59, "word": "liver", "fig": 2}, {"body": 31, "word": "expression", "fig": 3}, {"body": 36, "word": "hepatocytes", "fig": 2}, {"body": 65, "word": "hepatic", "fig": 1}, {"body": 29, "word": "levels", "fig": 2}, {"body": 8, "word": "group", "fig": 7}, {"body": 49, "word": "The", "fig": 1}, {"body": 23, "word": "TRAF3-LKO", "fig": 2}, {"body": 14, "word": "samples", "fig": 3}, {"body": 20, "word": "inflammatory", "fig": 2}, {"body": 37, "word": "HFD", "fig": 1}, {"body": 15, "word": "TRAF3-LTG", "fig": 2}, {"body": 27, "word": "signalling", "fig": 1}, {"body": 21, "word": "significantly", "fig": 1}, {"body": 19, "word": "response", "fig": 1}, {"body": 18, "word": "treatment", "fig": 1}, {"body": 18, "word": "using", "fig": 1}, {"body": 6, "word": "b", "fig": 3}, {"body": 18, "word": "palmitate", "fig": 1}, {"body": 17, "word": "TRAF3-flox", "fig": 1}, {"body": 16, "word": "mM", "fig": 1}, {"body": 15, "word": "'s", "fig": 1}, {"body": 14, "word": "controls", "fig": 1}, {"body": 13, "word": "weeks", "fig": 1}, {"body": 12, "word": "NF-\u03baB", "fig": 1}, {"body": 12, "word": "HFD-induced", "fig": 1}, {"body": 6, "word": "groups", "fig": 2}, {"body": 12, "word": "indicated", "fig": 1}, {"body": 10, "word": "NTG", "fig": 1}, {"body": 5, "word": "analysis", "fig": 2}, {"body": 8, "word": "corresponding", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 2}, {"body": 6, "word": "control", "fig": 1}, {"body": 5, "word": "followed", "fig": 1}, {"body": 5, "word": "NC", "fig": 1}, {"body": 5, "word": "phosphorylated", "fig": 1}, {"body": 5, "word": "isolated", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "Protein", "fig": 1}, {"body": 3, "word": "Primary", "fig": 1}, {"body": 3, "word": "stimulation", "fig": 1}, {"body": 2, "word": "cytokines", "fig": 1}, {"body": 1, "word": "P", "fig": 2}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 2, "word": "approach", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "key", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "Total", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "chemokines", "fig": 1}, {"body": 1, "word": "littermate", "fig": 1}, {"body": 1, "word": "aggravated", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "I\u03baB\u03b1", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f6.jpg", "caption": "TAK1\u2013JNK signalling is involved in TRAF3-regulated hepatic steatosis. (a) MKK\u2013JNK signalling activation was measured from the total and phosphorylated MKK7, JNK and C-JUN levels in the livers of TRAF3-LKO mice, TRAF3-LTG mice and their control littermates after HFD treatment for 24 weeks (n=6 samples per experimental group). (b) The expression of proteins in the MKK\u2013JNK\u2013C-JUN cascades in primary hepatocytes isolated from mice in the indicated groups and subjected to palmitate stimulation (0.25 mM) for 24 h (n=6 samples per experimental group). (c) TAK1 and p-TAK1 expression in the liver of TRAF3-flox, TRAF3-LKO, NTG and TRAF3-LTG mice at 24 weeks after HFD or NC administration (n=6 samples per experimental group). (d) TAK1 and p-TAK1 expression in primary hepatocytes in the indicated groups after palmitate (0.25 mM) or vehicle treatment for 24 h (n=6 samples per experimental group). Protein expressions were normalized to that of GAPDH. For a and c, *P<0.05 compared with TRAF3-flox/NC or NTG/NC group; #P<0.05 compared with TRAF3-flox/HFD or NTG/HFD group. For b and d, *P<0.05 versus TRAF3-flox/control or NTG/control group; #P<0.05 compared with TRAF3-flox/palmitate or NTG/palmitate group. (e\u2013g) Total and/or phosphorylated protein levels of key factors in the insulin signalling (e), gluconeogenesis-related axis (f) and JNK/IKK\u03b2 expression (g) in Adca-TAK1-infected primary TRAF3-flox or TRAF3-LKO hepatocytes challenged by palmitate, or in Addn-TAK1-treated hepatocytes isolated from NTG or TRAF3-LTG mice. Primary hepatocytes infected with AdGFP were served as controls. n=4 samples per experimental group. NS, no significant difference; *P<0.05 versus TRAF3-flox/AdGFP or NTG/AdGPF group. (h) Representative images of oil red O-stained L-02 cells co-infected with AdshTRAF3 and Adca-TAK1, or with AdTRAF3 and Addn-TAK1, and stimulated with palmitate for 24 h. AdGFP- or AdshRNA-infected cells were served as controls. Scale bar, 10 \u03bcm. All values are means\u00b1s.d. Significance determined by two-way analysis of variance with general linear model procedures using a univariate approach.", "co_occurrence": [{"body": 76, "word": "mice", "fig": 5}, {"body": 36, "word": "hepatocytes", "fig": 5}, {"body": 71, "word": "TAK1", "fig": 2}, {"body": 31, "word": "expression", "fig": 4}, {"body": 27, "word": "signalling", "fig": 3}, {"body": 8, "word": "group", "fig": 10}, {"body": 37, "word": "HFD", "fig": 2}, {"body": 18, "word": "palmitate", "fig": 4}, {"body": 14, "word": "samples", "fig": 5}, {"body": 23, "word": "TRAF3-LKO", "fig": 3}, {"body": 69, "word": "insulin", "fig": 1}, {"body": 65, "word": "hepatic", "fig": 1}, {"body": 59, "word": "liver", "fig": 1}, {"body": 29, "word": "levels", "fig": 2}, {"body": 51, "word": "steatosis", "fig": 1}, {"body": 49, "word": "The", "fig": 1}, {"body": 16, "word": "primary", "fig": 3}, {"body": 15, "word": "TRAF3-LTG", "fig": 3}, {"body": 18, "word": "treatment", "fig": 2}, {"body": 17, "word": "TRAF3-flox", "fig": 2}, {"body": 16, "word": "mM", "fig": 2}, {"body": 14, "word": "controls", "fig": 2}, {"body": 9, "word": "h", "fig": 3}, {"body": 9, "word": "compared", "fig": 3}, {"body": 13, "word": "weeks", "fig": 2}, {"body": 12, "word": "indicated", "fig": 2}, {"body": 22, "word": "activation", "fig": 1}, {"body": 22, "word": "protein", "fig": 1}, {"body": 10, "word": "cells", "fig": 2}, {"body": 10, "word": "NTG", "fig": 2}, {"body": 19, "word": "administration", "fig": 1}, {"body": 18, "word": "using", "fig": 1}, {"body": 6, "word": "groups", "fig": 2}, {"body": 6, "word": "b", "fig": 2}, {"body": 11, "word": "TRAF3-regulated", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 5, "word": "phosphorylated", "fig": 2}, {"body": 10, "word": "livers", "fig": 1}, {"body": 5, "word": "isolated", "fig": 2}, {"body": 8, "word": "JNK", "fig": 1}, {"body": 4, "word": "For", "fig": 2}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 6, "word": "AdGFP", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "cascades", "fig": 1}, {"body": 5, "word": "NC", "fig": 1}, {"body": 5, "word": "AdTRAF3", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "Adca-TAK1", "fig": 1}, {"body": 2, "word": "served", "fig": 2}, {"body": 4, "word": "Addn-TAK1", "fig": 1}, {"body": 4, "word": "g", "fig": 1}, {"body": 4, "word": "AdshTRAF3", "fig": 1}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 2, "word": "p-TAK1", "fig": 2}, {"body": 4, "word": "TAK1\u2013JNK", "fig": 1}, {"body": 4, "word": "oil", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "Protein", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "factors", "fig": 1}, {"body": 3, "word": "Primary", "fig": 1}, {"body": 3, "word": "MKK\u2013JNK", "fig": 1}, {"body": 3, "word": "stimulation", "fig": 1}, {"body": 3, "word": "axis", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "L-02", "fig": 1}, {"body": 2, "word": "involved", "fig": 1}, {"body": 1, "word": "P", "fig": 2}, {"body": 2, "word": "difference", "fig": 1}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "approach", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "key", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "Total", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "MKK7", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "littermates", "fig": 1}, {"body": 1, "word": "gluconeogenesis-related", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f7.jpg", "caption": "Hepatocyte TRAF3 regulates HFD-induced obesity, insulin resistance and hepatic steatosis in a TAK1-dependent manner. (a) Identification of the inhibitory effect of 5Z-7-ox on TAK1 activation by western blotting (n=6 samples per experimental group). 5Z-7-ox was administered intraperitoneally to NTG and TRAF3-LTG mice weekly at 5 mg kg\u22121 and continued for 24 weeks. (b) The body weights of NTG and TRAF3-LTG mice treated with or without 5Z-7-ox at 24 weeks after HFD administration (n=16\u201322). (c) FBG, FINS and HOMA-IR levels in mice with liver-specific TRAF3 overexpression and NTG littermates after 5Z-7-ox injection at 24 weeks post-HFD treatment (n=8\u201310). (d,e) Intraperitoneal glucose tolerance test (GTT) (d) and intraperitoneal insulin tolerance test (ITT) (e) were performed on the mice treated with a TAK1 inhibitor after continuous HFD feeding for 24 weeks, and the area under the curve (AUC) of glucose levels was measured (n=8\u201310). (f) The liver weight and the ratio of liver weight to body weight (LW/BW) of mice in the indicated groups after HFD administration for 24 weeks (n=16\u201322). (g) Representative haematoxylin and eosin (H&E; upper)- and oil red O (bottom)-staining images of liver sections from mice in the indicated group treated with HFD for 24 weeks (n=6\u20138). Scale bar, 100 \u03bcm. (h) TG, TC and NEFA levels in the liver samples of NTG and TRAF3-LTG mice injected with 5Z-7-ox at 24 week after HFD administration (n=6\u20138). (i) Relative mRNA expression of genes closely associated with fatty acid metabolism in the liver samples from mice in indicated groups after a 24-week HFD administration. (j) Total and phosphorylated IRS1, AKT and GSK3\u03b2 levels in the liver samples from indicated mice with or without 5Z-7-ox treatment 24 weeks after HFD feeding (n=6 samples per experimental group). (k) The expression of proteins in the NF-\u03baB and JNK signalling pathways in the liver samples of mice in the indicated groups after HFD administration for 24 weeks (n=6 samples per experimental group). GAPDH served as a loading control. *P<0.05 versus NTG/DMSO group; #P<0.05 versus TRAF3-LTG/DMSO group. All values are means\u00b1s.d. Significance determined by two-way analysis of variance with general linear model procedures using a univariate approach.", "co_occurrence": [{"body": 76, "word": "mice", "fig": 10}, {"body": 59, "word": "liver", "fig": 7}, {"body": 37, "word": "HFD", "fig": 8}, {"body": 143, "word": "TRAF3", "fig": 2}, {"body": 49, "word": "The", "fig": 3}, {"body": 71, "word": "TAK1", "fig": 2}, {"body": 69, "word": "insulin", "fig": 2}, {"body": 29, "word": "levels", "fig": 4}, {"body": 13, "word": "weeks", "fig": 8}, {"body": 14, "word": "samples", "fig": 7}, {"body": 19, "word": "administration", "fig": 5}, {"body": 65, "word": "hepatic", "fig": 1}, {"body": 31, "word": "expression", "fig": 2}, {"body": 12, "word": "indicated", "fig": 5}, {"body": 51, "word": "steatosis", "fig": 1}, {"body": 8, "word": "group", "fig": 6}, {"body": 16, "word": "weight", "fig": 3}, {"body": 15, "word": "TRAF3-LTG", "fig": 3}, {"body": 10, "word": "NTG", "fig": 4}, {"body": 18, "word": "treatment", "fig": 2}, {"body": 17, "word": "glucose", "fig": 2}, {"body": 32, "word": "resistance", "fig": 1}, {"body": 5, "word": "5Z-7-ox", "fig": 6}, {"body": 27, "word": "signalling", "fig": 1}, {"body": 25, "word": "fatty", "fig": 1}, {"body": 23, "word": "acid", "fig": 1}, {"body": 22, "word": "activation", "fig": 1}, {"body": 18, "word": "using", "fig": 1}, {"body": 6, "word": "groups", "fig": 3}, {"body": 8, "word": "body", "fig": 2}, {"body": 7, "word": "tolerance", "fig": 2}, {"body": 12, "word": "NF-\u03baB", "fig": 1}, {"body": 12, "word": "HFD-induced", "fig": 1}, {"body": 11, "word": "liver-specific", "fig": 1}, {"body": 11, "word": "overexpression", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 10, "word": "obesity", "fig": 1}, {"body": 9, "word": "h", "fig": 1}, {"body": 9, "word": "injected", "fig": 1}, {"body": 9, "word": "effect", "fig": 1}, {"body": 8, "word": "JNK", "fig": 1}, {"body": 8, "word": "sections", "fig": 1}, {"body": 4, "word": "test", "fig": 2}, {"body": 7, "word": "IRS1", "fig": 1}, {"body": 7, "word": "TG", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "AKT", "fig": 1}, {"body": 6, "word": "metabolism", "fig": 1}, {"body": 6, "word": "b", "fig": 1}, {"body": 6, "word": "inhibitor", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 3, "word": "without", "fig": 2}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "genes", "fig": 1}, {"body": 5, "word": "O", "fig": 1}, {"body": 5, "word": "injection", "fig": 1}, {"body": 5, "word": "phosphorylated", "fig": 1}, {"body": 5, "word": "FBG", "fig": 1}, {"body": 5, "word": "performed", "fig": 1}, {"body": 5, "word": "GSK3\u03b2", "fig": 1}, {"body": 5, "word": "pathways", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "feeding", "fig": 2}, {"body": 4, "word": "closely", "fig": 1}, {"body": 4, "word": "FINS", "fig": 1}, {"body": 4, "word": "oil", "fig": 1}, {"body": 4, "word": "intraperitoneal", "fig": 1}, {"body": 4, "word": "g", "fig": 1}, {"body": 4, "word": "kg\u22121", "fig": 1}, {"body": 4, "word": "associated", "fig": 1}, {"body": 4, "word": "TC", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "TAK1-dependent", "fig": 1}, {"body": 3, "word": "haematoxylin", "fig": 1}, {"body": 3, "word": "regulates", "fig": 1}, {"body": 3, "word": "HOMA-IR", "fig": 1}, {"body": 3, "word": "mg", "fig": 1}, {"body": 1, "word": "treated", "fig": 3}, {"body": 3, "word": "administered", "fig": 1}, {"body": 2, "word": "eosin", "fig": 1}, {"body": 2, "word": "intraperitoneally", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 2, "word": "ratio", "fig": 1}, {"body": 2, "word": "area", "fig": 1}, {"body": 2, "word": "approach", "fig": 1}, {"body": 2, "word": "continuous", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "NEFA", "fig": 1}, {"body": 2, "word": "24-week", "fig": 1}, {"body": 2, "word": "Total", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "inhibitory", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "Hepatocyte", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "littermates", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}, {"body": 1, "word": "weights", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f8.jpg", "caption": "The TRAF3\u2013TAK1 interaction is required for TRAF3-regulated hepatic steatosis and insulin resistance. (a,b) A co-immunoprecipitation assay was performed to examine the interaction of TRAF3 with TAK1. (c,d) The interaction domains of TRAF3 and TAK1 were explored using full-length and truncated TRAF3 (c) and TAK1 (d) expression constructs based on co-immunoprecipitation assays. Anti-Myc or anti-Flag antibodies were used to identify the binding sites of TRAF3 and TAK1, respectively. (e) WT mice were infected with an adenoviral vector carrying TRAF3 (AdTRAF3) or a TRAF3 mutant with 267\u2013376 aa domain mutation (AdTRAF3-M) at 20 weeks after HFD treatment, and TAK1 and p-TAK1 expression was measured by western blot after an additional 4 weeks. Mice injected with AdGFP served as controls. Protein expression levels were normalized to that of GAPDH (n=6 samples per experimental group). (f) The body weights of mice injected with AdGFP, AdTRAF3 or AdTRAF3-M after an additional 4 weeks' HFD treatment (n=17\u201325). (g) FBG and FINS levels were examined in indicated mice post-HFD administration for an additional 4 weeks, and HOMA-IR was calculated (n=6\u20138). (h,i) Intraperitoneal glucose tolerance test (GTT) (h) and intraperitoneal insulin tolerance test (ITT) (i) were performed on the mice in the indicated groups after 4 weeks' HFD treatment. The area under the curve (AUC) of glucose levels was measured (n=6\u20138). (j) The liver weight and ratio of liver weight to body weight (LW/BW) value of indicated mice after 4 weeks' HFD treatment (n=17\u201325). (k) Images of haematoxylin and eosin (H&E; upper) or oil red O (bottom) staining of liver sections of mice injected with indicated adenovirus (n=6\u20138). Scale bar, 100 \u03bcm. (l) Liver TG, TC and NEFA levels in indicated mice fed an HFD for an additional 4 weeks (n=6\u20138). (m,n) The expression levels of proteins in the IRS\u2013AKT\u2013GSK3\u03b2 insulin signalling (m) as well as NF-\u03baB and JNK signalling pathways (n) in the liver samples from indicated mice. Protein expression was examined by western blotting and normalized to the indicated total protein or GAPDH expression after 4 weeks' HFD treatment (n=6 samples per experimental group). For g\u2013n, *P<0.05 versus AdGFP group; NS, no significant difference. All values are means\u00b1s.d. Significance determined by two-way analysis of variance with general linear model procedures using a univariate approach.", "co_occurrence": [{"body": 143, "word": "TRAF3", "fig": 6}, {"body": 76, "word": "mice", "fig": 8}, {"body": 71, "word": "TAK1", "fig": 5}, {"body": 49, "word": "The", "fig": 6}, {"body": 59, "word": "liver", "fig": 4}, {"body": 37, "word": "HFD", "fig": 6}, {"body": 69, "word": "insulin", "fig": 3}, {"body": 31, "word": "expression", "fig": 6}, {"body": 29, "word": "levels", "fig": 5}, {"body": 13, "word": "weeks", "fig": 8}, {"body": 18, "word": "treatment", "fig": 5}, {"body": 12, "word": "indicated", "fig": 7}, {"body": 65, "word": "hepatic", "fig": 1}, {"body": 27, "word": "signalling", "fig": 2}, {"body": 51, "word": "steatosis", "fig": 1}, {"body": 16, "word": "weight", "fig": 3}, {"body": 14, "word": "samples", "fig": 3}, {"body": 18, "word": "using", "fig": 2}, {"body": 17, "word": "glucose", "fig": 2}, {"body": 32, "word": "resistance", "fig": 1}, {"body": 10, "word": "interaction", "fig": 3}, {"body": 9, "word": "injected", "fig": 3}, {"body": 8, "word": "group", "fig": 3}, {"body": 22, "word": "protein", "fig": 1}, {"body": 10, "word": "examined", "fig": 2}, {"body": 19, "word": "administration", "fig": 1}, {"body": 9, "word": "h", "fig": 2}, {"body": 6, "word": "AdGFP", "fig": 3}, {"body": 8, "word": "body", "fig": 2}, {"body": 15, "word": "used", "fig": 1}, {"body": 14, "word": "controls", "fig": 1}, {"body": 7, "word": "tolerance", "fig": 2}, {"body": 12, "word": "NF-\u03baB", "fig": 1}, {"body": 6, "word": "measured", "fig": 2}, {"body": 11, "word": "TRAF3-regulated", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 5, "word": "performed", "fig": 2}, {"body": 5, "word": "AdTRAF3", "fig": 2}, {"body": 5, "word": "AdTRAF3-M", "fig": 2}, {"body": 9, "word": "assay", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 8, "word": "JNK", "fig": 1}, {"body": 8, "word": "sections", "fig": 1}, {"body": 4, "word": "test", "fig": 2}, {"body": 4, "word": "normalized", "fig": 2}, {"body": 7, "word": "domain", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 7, "word": "assays", "fig": 1}, {"body": 7, "word": "TG", "fig": 1}, {"body": 7, "word": "antibodies", "fig": 1}, {"body": 3, "word": "Protein", "fig": 2}, {"body": 3, "word": "GAPDH", "fig": 2}, {"body": 6, "word": "groups", "fig": 1}, {"body": 6, "word": "b", "fig": 1}, {"body": 6, "word": "mutant", "fig": 1}, {"body": 5, "word": "WT", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "O", "fig": 1}, {"body": 5, "word": "pathways", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 5, "word": "FBG", "fig": 1}, {"body": 5, "word": "TRAF3\u2013TAK1", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "required", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "FINS", "fig": 1}, {"body": 4, "word": "intraperitoneal", "fig": 1}, {"body": 4, "word": "Mice", "fig": 1}, {"body": 4, "word": "g", "fig": 1}, {"body": 1, "word": "additional", "fig": 4}, {"body": 4, "word": "adenovirus", "fig": 1}, {"body": 4, "word": "oil", "fig": 1}, {"body": 2, "word": "western", "fig": 2}, {"body": 4, "word": "TC", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "sites", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "aa", "fig": 1}, {"body": 3, "word": "HOMA-IR", "fig": 1}, {"body": 3, "word": "Liver", "fig": 1}, {"body": 3, "word": "constructs", "fig": 1}, {"body": 3, "word": "haematoxylin", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "based", "fig": 1}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 1, "word": "n", "fig": 2}, {"body": 2, "word": "eosin", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 1, "word": "co-immunoprecipitation", "fig": 2}, {"body": 2, "word": "area", "fig": 1}, {"body": 2, "word": "approach", "fig": 1}, {"body": 2, "word": "p-TAK1", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "binding", "fig": 1}, {"body": 2, "word": "examine", "fig": 1}, {"body": 2, "word": "ratio", "fig": 1}, {"body": 2, "word": "difference", "fig": 1}, {"body": 2, "word": "NEFA", "fig": 1}, {"body": 1, "word": "identify", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "well", "fig": 1}, {"body": 1, "word": "vector", "fig": 1}, {"body": 1, "word": "truncated", "fig": 1}, {"body": 1, "word": "mutation", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "IRS\u2013AKT\u2013GSK3\u03b2", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "carrying", "fig": 1}, {"body": 1, "word": "full-length", "fig": 1}, {"body": 1, "word": "explored", "fig": 1}, {"body": 1, "word": "value", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}, {"body": 1, "word": "weights", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f9.jpg", "caption": "TRAF3 regulates lipid accumulation in hepatocytes dependent on TAK1 ubiquitination. (a) The ubiquitination of TAK1 in palmitate-stimulated primary WT hepatocytes was examined using immunoprecipitation with an anti-TAK1 antibody followed by western blotting with an anti-Ub antibody. (b) Immunoprecipitation assay measured the TAK1 ubiquitination in primary hepatocytes isolated from TRAF3+/+ and TRAF3\u2212/\u2212 mice, and stimulated with palmitate for 30 min. 293T cells were transfected with HA-TAK1 and His-Ub along with/without the infection of Flag-TRAF3 (c) or Flag-TRAF3 (C68A, H70A) (d), and subjected to immunoprecipitation and western blotting assays. (e) In vitro TAK1 ubiquitination was measured through incubating TAK1 protein with E1, E2 and biotinylated-Ub (Bt-Ub) combined with or without HA-TRAF3 protein and the subsequent immunoprecipitation and western blot analyses. (f) Expression levels of key proteins in the TAK1\u2013JNK/IKK\u03b2 cascades and insulin signalling were examined by western blotting in primary hepatocytes overexpressed TRAF3 (WT) or TRAF3 (C68A, H70A) and treated with palmitate for 24 h. Primary hepatocytes infected with GFP were as controls. GAPDH serves as loading controls (n=6 samples per experimental group). (g) Representative oil red O staining on the L-02 cells infected with AdGFP, AdTRAF3 (WT) or AdTRAF3 (C68A, H70A) after palmitate stimulation for 24 h. Scale bar, 10 \u03bcm. (h) The mRNA expression of genes related with lipid metabolisms in palmitate- or vehicle solution-treated L-02 cells overexpressed TRAF3 (WT), TRAF3 (C68A, H70A) or GFP. For f,h, NS, no significant difference; *P<0.05 versus GFP/palmitate group. All values are means\u00b1s.d. Significance determined by two-way analysis of variance with general linear model procedures using a univariate approach.", "co_occurrence": [{"body": 143, "word": "TRAF3", "fig": 5}, {"body": 71, "word": "TAK1", "fig": 5}, {"body": 36, "word": "hepatocytes", "fig": 5}, {"body": 49, "word": "The", "fig": 2}, {"body": 76, "word": "mice", "fig": 1}, {"body": 18, "word": "ubiquitination", "fig": 4}, {"body": 69, "word": "insulin", "fig": 1}, {"body": 27, "word": "lipid", "fig": 2}, {"body": 18, "word": "palmitate", "fig": 3}, {"body": 16, "word": "primary", "fig": 3}, {"body": 22, "word": "protein", "fig": 2}, {"body": 18, "word": "using", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 10, "word": "cells", "fig": 3}, {"body": 30, "word": "In", "fig": 1}, {"body": 29, "word": "levels", "fig": 1}, {"body": 14, "word": "controls", "fig": 2}, {"body": 27, "word": "signalling", "fig": 1}, {"body": 5, "word": "WT", "fig": 4}, {"body": 5, "word": "H70A", "fig": 4}, {"body": 5, "word": "C68A", "fig": 4}, {"body": 10, "word": "examined", "fig": 2}, {"body": 19, "word": "accumulation", "fig": 1}, {"body": 9, "word": "h", "fig": 2}, {"body": 8, "word": "group", "fig": 2}, {"body": 14, "word": "samples", "fig": 1}, {"body": 6, "word": "antibody", "fig": 2}, {"body": 4, "word": "immunoprecipitation", "fig": 3}, {"body": 6, "word": "measured", "fig": 2}, {"body": 5, "word": "AdTRAF3", "fig": 2}, {"body": 10, "word": "min", "fig": 1}, {"body": 3, "word": "blotting", "fig": 3}, {"body": 9, "word": "assay", "fig": 1}, {"body": 9, "word": "related", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 8, "word": "vitro", "fig": 1}, {"body": 8, "word": "analyses", "fig": 1}, {"body": 2, "word": "western", "fig": 4}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 7, "word": "assays", "fig": 1}, {"body": 6, "word": "AdGFP", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "b", "fig": 1}, {"body": 3, "word": "L-02", "fig": 2}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "genes", "fig": 1}, {"body": 5, "word": "O", "fig": 1}, {"body": 5, "word": "followed", "fig": 1}, {"body": 5, "word": "cascades", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 5, "word": "isolated", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "oil", "fig": 1}, {"body": 4, "word": "g", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "dependent", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "subsequent", "fig": 1}, {"body": 3, "word": "Primary", "fig": 1}, {"body": 3, "word": "regulates", "fig": 1}, {"body": 3, "word": "stimulation", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "without", "fig": 1}, {"body": 1, "word": "Flag-TRAF3", "fig": 2}, {"body": 2, "word": "procedures", "fig": 1}, {"body": 2, "word": "293T", "fig": 1}, {"body": 2, "word": "key", "fig": 1}, {"body": 2, "word": "transfected", "fig": 1}, {"body": 1, "word": "h.", "fig": 2}, {"body": 2, "word": "approach", "fig": 1}, {"body": 2, "word": "combined", "fig": 1}, {"body": 2, "word": "infection", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "difference", "fig": 1}, {"body": 1, "word": "univariate", "fig": 1}, {"body": 1, "word": "biotinylated-Ub", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "E1", "fig": 1}, {"body": 1, "word": "E2", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "HA-TAK1", "fig": 1}, {"body": 1, "word": "general", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}, {"body": 1, "word": "treated", "fig": 1}, {"body": 1, "word": "palmitate-stimulated", "fig": 1}, {"body": 1, "word": "HA-TRAF3", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757796/bin/ncomms10592-f10.jpg", "caption": "Schematic illustration of cellular and molecular events underlying hepatocyte TRAF3-regulated hepatic steatosis. In response to a continuous challenge with HFD, TRAF3 expression is increased in hepatocytes and directly interact with TAK1 to ubiquinate and phosphorylate TAK1, leading to the activation of downstream IKK\u03b2\u2013NF-\u03baB and MKK\u2013JNK signalling, thereby promoting inflammatory response. The activated JNK further aggravates insulin resistance through enhancing IRS phosphorylation at Ser307 and disrupts its downstream AKT\u2013GSK3\u03b2/FOXO1 phosphorylation, which contribute to glucose metabolic disorder. Inflammation and insulin resistance, together with glucose metabolic disorder, synergistically exacerbate fatty acid accumulation and the resultant hepatic steatosis.", "co_occurrence": [{"body": 143, "word": "TRAF3", "fig": 1}, {"body": 71, "word": "TAK1", "fig": 2}, {"body": 69, "word": "insulin", "fig": 2}, {"body": 65, "word": "hepatic", "fig": 2}, {"body": 51, "word": "steatosis", "fig": 2}, {"body": 32, "word": "resistance", "fig": 2}, {"body": 49, "word": "The", "fig": 1}, {"body": 19, "word": "response", "fig": 2}, {"body": 37, "word": "HFD", "fig": 1}, {"body": 36, "word": "hepatocytes", "fig": 1}, {"body": 17, "word": "glucose", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 30, "word": "In", "fig": 1}, {"body": 27, "word": "signalling", "fig": 1}, {"body": 25, "word": "fatty", "fig": 1}, {"body": 12, "word": "phosphorylation", "fig": 2}, {"body": 23, "word": "acid", "fig": 1}, {"body": 22, "word": "activation", "fig": 1}, {"body": 11, "word": "metabolic", "fig": 2}, {"body": 20, "word": "inflammatory", "fig": 1}, {"body": 20, "word": "increased", "fig": 1}, {"body": 19, "word": "accumulation", "fig": 1}, {"body": 14, "word": "hepatocyte", "fig": 1}, {"body": 6, "word": "disorder", "fig": 2}, {"body": 6, "word": "downstream", "fig": 2}, {"body": 11, "word": "TRAF3-regulated", "fig": 1}, {"body": 9, "word": "events", "fig": 1}, {"body": 8, "word": "molecular", "fig": 1}, {"body": 8, "word": "JNK", "fig": 1}, {"body": 6, "word": "cellular", "fig": 1}, {"body": 6, "word": "challenge", "fig": 1}, {"body": 5, "word": "activated", "fig": 1}, {"body": 4, "word": "directly", "fig": 1}, {"body": 3, "word": "thereby", "fig": 1}, {"body": 3, "word": "leading", "fig": 1}, {"body": 3, "word": "MKK\u2013JNK", "fig": 1}, {"body": 2, "word": "contribute", "fig": 1}, {"body": 2, "word": "underlying", "fig": 1}, {"body": 2, "word": "Ser307", "fig": 1}, {"body": 2, "word": "interact", "fig": 1}, {"body": 2, "word": "IRS", "fig": 1}, {"body": 2, "word": "IKK\u03b2\u2013NF-\u03baB", "fig": 1}, {"body": 2, "word": "continuous", "fig": 1}, {"body": 2, "word": "resultant", "fig": 1}, {"body": 1, "word": "promoting", "fig": 1}, {"body": 1, "word": "enhancing", "fig": 1}, {"body": 1, "word": "AKT\u2013GSK3\u03b2/FOXO1", "fig": 1}, {"body": 1, "word": "together", "fig": 1}, {"body": 1, "word": "synergistically", "fig": 1}]}], "3926834": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926834/bin/oncotarget-04-2383-g001.jpg", "caption": "EI24 regulates the cell motile phenotype (A) and (C) Immunoblot analysis of EI24 expression in B16F10 cells expressing either control vector (F10-Ctrl) or EI24 (F10-Ei24, A), and in ZR-75-1 cells stably expressing control (ZR-Ctrl) or EI24-specific shRNA (ZR-shEI24, C). (B) and (D) Cell migration assays with F10-Ei24 (B) and ZR-shEI24 cells (D). The cells were visualized by staining with crystal violet. Data are representative of at least two independent experiments. Scale bars represent 200 \u03bcm. (E) and (F) Actin cytoskeletal structures in B16F10 (E) and ZR-75-1 (F) variant cells were visualized by immunofluorescence (IF) staining using anti-Phalloidin and anti-Paxillin antibodies. Scale bars represent 50 \u03bcm. (G) and (H) Cell-cell adhesion in F10-Ei24 (G) and ZR-shEI24 (H) cells was evaluated using the hanging drop assay. Data are representative of five independent drops.", "co_occurrence": [{"body": 75, "word": "cells", "fig": 6}, {"body": 119, "word": "EI24", "fig": 3}, {"body": 23, "word": "using", "fig": 2}, {"body": 43, "word": "expression", "fig": 1}, {"body": 13, "word": "ZR-shEI24", "fig": 3}, {"body": 25, "word": "The", "fig": 1}, {"body": 19, "word": "cell", "fig": 1}, {"body": 9, "word": "control", "fig": 2}, {"body": 16, "word": "Cell", "fig": 1}, {"body": 5, "word": "F10-Ei24", "fig": 3}, {"body": 6, "word": "B16F10", "fig": 2}, {"body": 6, "word": "ZR-75-1", "fig": 2}, {"body": 7, "word": "assays", "fig": 1}, {"body": 6, "word": "assay", "fig": 1}, {"body": 6, "word": "migration", "fig": 1}, {"body": 6, "word": "adhesion", "fig": 1}, {"body": 3, "word": "A", "fig": 2}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "staining", "fig": 2}, {"body": 2, "word": "independent", "fig": 2}, {"body": 1, "word": "Data", "fig": 2}, {"body": 1, "word": "D", "fig": 2}, {"body": 2, "word": "variant", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 2, "word": "drop", "fig": 1}, {"body": 2, "word": "vector", "fig": 1}, {"body": 2, "word": "drops", "fig": 1}, {"body": 1, "word": "regulates", "fig": 1}, {"body": 1, "word": "violet", "fig": 1}, {"body": 1, "word": "evaluated", "fig": 1}, {"body": 1, "word": "immunofluorescence", "fig": 1}, {"body": 1, "word": "hanging", "fig": 1}, {"body": 1, "word": "least", "fig": 1}, {"body": 1, "word": "phenotype", "fig": 1}, {"body": 1, "word": "anti-Paxillin", "fig": 1}, {"body": 1, "word": "crystal", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "ZR-Ctrl", "fig": 1}, {"body": 1, "word": "five", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926834/bin/oncotarget-04-2383-g002.jpg", "caption": "Knockdown of EI24 induces EMT (A) Phase contrast microscopy of ZR-75-1 cells stably expressing control or EI24-specific shRNA. Scale bar represents 100 \u03bcm. (B) Immunoblot analysis of changes in the expression of epithelial and mesenchymal markers in control and ZR-shEI24 cells. (C) Confocal microscopic analysis of E-cadherin and Vimentin expression in ZR-Ctrl and ZR-shEI24 cells. Scale bar represents 50 \u03bcm. (D) and (E) Real-time quantitative PCR (qPCR) analysis of transcriptional regulation of the expression of epithelial and mesenchymal markers (D) and EMT-related transcription factors (E) in control and ZR-shEI24 cells. Data are means of measurements from two independent experiments performed in triplicate; P values were calculated by unpaired t-test using GraphPad Prism software. *p <0.05, **p <0.01, ***p <0.0001.", "co_occurrence": [{"body": 75, "word": "cells", "fig": 4}, {"body": 43, "word": "expression", "fig": 3}, {"body": 119, "word": "EI24", "fig": 1}, {"body": 13, "word": "ZR-shEI24", "fig": 3}, {"body": 9, "word": "control", "fig": 3}, {"body": 23, "word": "EMT", "fig": 1}, {"body": 23, "word": "using", "fig": 1}, {"body": 5, "word": "analysis", "fig": 3}, {"body": 6, "word": "mesenchymal", "fig": 2}, {"body": 6, "word": "epithelial", "fig": 2}, {"body": 9, "word": "transcriptional", "fig": 1}, {"body": 9, "word": "performed", "fig": 1}, {"body": 7, "word": "regulation", "fig": 1}, {"body": 6, "word": "ZR-75-1", "fig": 1}, {"body": 3, "word": "markers", "fig": 2}, {"body": 5, "word": "factors", "fig": 1}, {"body": 4, "word": "transcription", "fig": 1}, {"body": 4, "word": "changes", "fig": 1}, {"body": 3, "word": "EMT-related", "fig": 1}, {"body": 3, "word": "induces", "fig": 1}, {"body": 3, "word": "contrast", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "qPCR", "fig": 1}, {"body": 2, "word": "calculated", "fig": 1}, {"body": 2, "word": "software", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 1, "word": "PCR", "fig": 1}, {"body": 1, "word": "E-cadherin", "fig": 1}, {"body": 1, "word": "triplicate", "fig": 1}, {"body": 1, "word": "GraphPad", "fig": 1}, {"body": 1, "word": "Real-time", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "Prism", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "ZR-Ctrl", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "unpaired", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926834/bin/oncotarget-04-2383-g003.jpg", "caption": "Knockdown of EI24 promotes malignant characteristics that accompany EMT (A) The indicated cell lines were added to Matrigel-coated transwell inserts, and invading cells were visualized after 16 hours by crystal violet staining. Scale bar represents 200 \u03bcm. (B) Formation of invasive acini was evaluated using the 3D matrigel assay. The data are representative of at least two independent experiments. Scale bar represents 100 \u03bcm. (C) NMuMG Parental, NMu-Ctrl and NMu-shEi24 cells were maintained in suspension using ultra-low-attachment plates and cell viability was analyzed at the indicated time points. (D) and (E) F10-Ctrl or F10-EI24 cells were intravenously injected into C57BL/6NTac mice and specific metastatic ability was analyzed by counting nodules in the lungs; n \u22657; one-way analysis of variance, p <0.0001. (F) and (G) F1-Ctrl or F1-EI24 cells were intravenously injected into C57BL/6NTac mice and their specific metastatic ability was analyzed by counting nodules in the liver; n \u22653; one-way analysis of variance, p <0.01.", "co_occurrence": [{"body": 75, "word": "cells", "fig": 4}, {"body": 119, "word": "EI24", "fig": 1}, {"body": 25, "word": "The", "fig": 2}, {"body": 23, "word": "using", "fig": 2}, {"body": 19, "word": "cell", "fig": 2}, {"body": 23, "word": "EMT", "fig": 1}, {"body": 8, "word": "metastatic", "fig": 2}, {"body": 14, "word": "data", "fig": 1}, {"body": 6, "word": "mice", "fig": 2}, {"body": 5, "word": "nodules", "fig": 2}, {"body": 10, "word": "invasive", "fig": 1}, {"body": 5, "word": "analysis", "fig": 2}, {"body": 4, "word": "C57BL/6NTac", "fig": 2}, {"body": 6, "word": "malignant", "fig": 1}, {"body": 6, "word": "assay", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 3}, {"body": 3, "word": "injected", "fig": 2}, {"body": 6, "word": "characteristics", "fig": 1}, {"body": 6, "word": "lines", "fig": 1}, {"body": 2, "word": "specific", "fig": 2}, {"body": 2, "word": "p", "fig": 2}, {"body": 4, "word": "promotes", "fig": 1}, {"body": 3, "word": "3D", "fig": 1}, {"body": 3, "word": "hours", "fig": 1}, {"body": 3, "word": "NMuMG", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 1, "word": "intravenously", "fig": 2}, {"body": 2, "word": "maintained", "fig": 1}, {"body": 1, "word": "indicated", "fig": 2}, {"body": 1, "word": "counting", "fig": 2}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "liver", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "ultra-low-attachment", "fig": 1}, {"body": 1, "word": "acini", "fig": 1}, {"body": 1, "word": "violet", "fig": 1}, {"body": 1, "word": "viability", "fig": 1}, {"body": 1, "word": "least", "fig": 1}, {"body": 1, "word": "evaluated", "fig": 1}, {"body": 1, "word": "crystal", "fig": 1}, {"body": 1, "word": "plates", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926834/bin/oncotarget-04-2383-g004.jpg", "caption": "NF-\u03baB activation and upregulation of genes involved in inflammation-induced tumor progression by EI24 knockdown (A) The transcriptional activity of NF-\u03baB in control and EI24-overexpressing MDA-MB-231 cells was evaluated using a NF-\u03baB luciferase reporter assay. Data shown are mean \u00b1 S.D. n = 6, **p <0.0001. (B) Immunoblot analysis of p65 expression levels in nuclear extracts from control and EI24-overexpressing MDA-MB-231 cells. (C) and (D) GSEA for gene signatures in EI24 knockdown cells indicating genes that contain p65-binding sites in their promoter regions (p <0.001; C) and genes that are targets of NF-\u03baB and are associated with tumor invasiveness (p <0.001; D). NES, normalized enrichment score. (E) Relative mRNA expression levels of the indicated genes in control and ZR-shEI24 cells analyzed by real-time qPCR. Data shown are the mean \u00b1 S.D. of two independent experiments with each sample assayed in triplicate; P values were calculated by unpaired t-test using GraphPad Prism software. *p <0.005, **p <0.0001, ***p <0.0005. (F) Cell migratory potential was measured after treatment of ZR-shEI24 cells with an NF-\u03baB inhibitor. The red scale bar represents 200 \u03bcm.", "co_occurrence": [{"body": 75, "word": "cells", "fig": 5}, {"body": 119, "word": "EI24", "fig": 2}, {"body": 40, "word": "NF-\u03baB", "fig": 5}, {"body": 43, "word": "expression", "fig": 2}, {"body": 39, "word": "tumor", "fig": 2}, {"body": 25, "word": "The", "fig": 2}, {"body": 23, "word": "using", "fig": 2}, {"body": 21, "word": "knockdown", "fig": 2}, {"body": 7, "word": "genes", "fig": 4}, {"body": 9, "word": "control", "fig": 3}, {"body": 13, "word": "ZR-shEI24", "fig": 2}, {"body": 10, "word": "levels", "fig": 2}, {"body": 19, "word": "activity", "fig": 1}, {"body": 18, "word": "gene", "fig": 1}, {"body": 17, "word": "progression", "fig": 1}, {"body": 16, "word": "Cell", "fig": 1}, {"body": 10, "word": "activation", "fig": 1}, {"body": 5, "word": "MDA-MB-231", "fig": 2}, {"body": 9, "word": "transcriptional", "fig": 1}, {"body": 6, "word": "GSEA", "fig": 1}, {"body": 6, "word": "assay", "fig": 1}, {"body": 5, "word": "luciferase", "fig": 1}, {"body": 5, "word": "treatment", "fig": 1}, {"body": 5, "word": "reporter", "fig": 1}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 5, "word": "invasiveness", "fig": 1}, {"body": 5, "word": "p65", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "p", "fig": 2}, {"body": 4, "word": "measured", "fig": 1}, {"body": 3, "word": "signatures", "fig": 1}, {"body": 3, "word": "inhibitor", "fig": 1}, {"body": 3, "word": "upregulation", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 1, "word": "mean", "fig": 2}, {"body": 2, "word": "inflammation-induced", "fig": 1}, {"body": 2, "word": "targets", "fig": 1}, {"body": 1, "word": "shown", "fig": 2}, {"body": 2, "word": "nuclear", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "software", "fig": 1}, {"body": 1, "word": "EI24-overexpressing", "fig": 2}, {"body": 2, "word": "associated", "fig": 1}, {"body": 1, "word": "S.D", "fig": 2}, {"body": 1, "word": "Data", "fig": 2}, {"body": 2, "word": "involved", "fig": 1}, {"body": 2, "word": "qPCR", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "calculated", "fig": 1}, {"body": 1, "word": "evaluated", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "triplicate", "fig": 1}, {"body": 1, "word": "real-time", "fig": 1}, {"body": 1, "word": "sample", "fig": 1}, {"body": 1, "word": "promoter", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "unpaired", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "Prism", "fig": 1}, {"body": 1, "word": "GraphPad", "fig": 1}, {"body": 1, "word": "regions", "fig": 1}, {"body": 1, "word": "potential", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "Relative", "fig": 1}, {"body": 1, "word": "enrichment", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926834/bin/oncotarget-04-2383-g005.jpg", "caption": "EI24 binds to and promotes degradation of Complex I components, thus inhibiting downstream signaling (A) Immunoblot analysis of degradation of TRAF2, RIP1, and TRADD induced by EI24. (B) Interaction between EI24 and TRAF2/5 in 293T cells assessed using immunoprecipitation. (C) Colocalization of EI24 with TRAF2/5 in HeLa cells. Scale bar represents 10 \u03bcm. (D) Immunoprecipitation experiments showing that the RING domain of TRAF2 is required for its interaction with EI24. (E) siRNA-mediated knockdown of EI24 increases the binding of TRAF2 to TNFR1. Binding of TNFR1 with TRAF2, TRADD, and RIP1 was examined in control and EI24 knockdown 293T cells. WCL, whole cell lysate. (F) EI24 knockdown results in accumulation of K63-linked RIP1. RIP1-K63 ubiquitination was examined in the presence of TNF\u03b1 at the indicated time points. (G) Downstream molecules of Complex I-mediated signaling were evaluated upon EI24 overexpression. Levels of phospho (p)-IKK\u03b1/\u03b2, p-I\u03baB\u03b1, I\u03baB\u03b1, p-p65, and p65 in MDA-MB-231 cells were determined by immunoblotting.", "co_occurrence": [{"body": 119, "word": "EI24", "fig": 9}, {"body": 75, "word": "cells", "fig": 4}, {"body": 20, "word": "TRAF2", "fig": 4}, {"body": 21, "word": "knockdown", "fig": 3}, {"body": 19, "word": "signaling", "fig": 2}, {"body": 9, "word": "RIP1", "fig": 3}, {"body": 13, "word": "Complex", "fig": 2}, {"body": 23, "word": "using", "fig": 1}, {"body": 19, "word": "cell", "fig": 1}, {"body": 9, "word": "degradation", "fig": 2}, {"body": 7, "word": "examined", "fig": 2}, {"body": 14, "word": "I", "fig": 1}, {"body": 10, "word": "overexpression", "fig": 1}, {"body": 9, "word": "control", "fig": 1}, {"body": 4, "word": "TRADD", "fig": 2}, {"body": 4, "word": "TNFR1", "fig": 2}, {"body": 6, "word": "upon", "fig": 1}, {"body": 6, "word": "components", "fig": 1}, {"body": 5, "word": "MDA-MB-231", "fig": 1}, {"body": 5, "word": "binding", "fig": 1}, {"body": 5, "word": "p65", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 2, "word": "TRAF2/5", "fig": 2}, {"body": 4, "word": "induced", "fig": 1}, {"body": 4, "word": "promotes", "fig": 1}, {"body": 4, "word": "immunoprecipitation", "fig": 1}, {"body": 3, "word": "TNF\u03b1", "fig": 1}, {"body": 3, "word": "K63-linked", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "assessed", "fig": 1}, {"body": 3, "word": "required", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 2, "word": "HeLa", "fig": 1}, {"body": 2, "word": "downstream", "fig": 1}, {"body": 2, "word": "p", "fig": 1}, {"body": 1, "word": "293T", "fig": 2}, {"body": 2, "word": "interaction", "fig": 1}, {"body": 2, "word": "I\u03baB\u03b1", "fig": 1}, {"body": 1, "word": "molecules", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "increases", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "accumulation", "fig": 1}, {"body": 1, "word": "domain", "fig": 1}, {"body": 1, "word": "presence", "fig": 1}, {"body": 1, "word": "RING", "fig": 1}, {"body": 1, "word": "ubiquitination", "fig": 1}, {"body": 1, "word": "evaluated", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "lysate", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "thus", "fig": 1}, {"body": 1, "word": "immunoblotting", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926834/bin/oncotarget-04-2383-g006.jpg", "caption": "Decreased expression of EI24 correlates with increased tumor invasiveness and poor prognosis in human patients (A) Box plots showing EI24 gene expression in normal breast tissue and invasive breast carcinoma of breast cancer patients. (B) Box plots showing EI24 gene expression in high Elston-Ellis grade breast carcinomas. (C) and (D) Box plots showing EI24 gene copy numbers in DCIS and IDC (C), and in IDLC of various tumor grades (D). (E) EI24 gene expression in patients with breast cancer and its association with clinical outcomes at 3 and 5 years in patients with one or more metastatic events. (F) EI24 gene expression in melanoma patients and clinical outcomes at 3 years. (G) and (H) Kaplan-Meier plots of distant metastasis-free survival of human breast cancer patients. ER-positive patients (n = 417) were evaluated from 2011 version of database and categorized by median expression of EI24 (probe set 208289_s_t, G) or TRAF2 (probe set 204413_at, H). The p-values were calculated using the log-rank test. *Numbers in parentheses indicate number of samples included in the study.", "co_occurrence": [{"body": 119, "word": "EI24", "fig": 7}, {"body": 43, "word": "expression", "fig": 6}, {"body": 16, "word": "patients", "fig": 7}, {"body": 17, "word": "breast", "fig": 6}, {"body": 18, "word": "gene", "fig": 5}, {"body": 39, "word": "tumor", "fig": 2}, {"body": 20, "word": "cancer", "fig": 3}, {"body": 14, "word": "human", "fig": 2}, {"body": 25, "word": "The", "fig": 1}, {"body": 23, "word": "using", "fig": 1}, {"body": 20, "word": "TRAF2", "fig": 1}, {"body": 12, "word": "increased", "fig": 1}, {"body": 10, "word": "invasive", "fig": 1}, {"body": 9, "word": "study", "fig": 1}, {"body": 9, "word": "number", "fig": 1}, {"body": 4, "word": "years", "fig": 2}, {"body": 8, "word": "metastatic", "fig": 1}, {"body": 4, "word": "clinical", "fig": 2}, {"body": 7, "word": "copy", "fig": 1}, {"body": 5, "word": "invasiveness", "fig": 1}, {"body": 5, "word": "indicate", "fig": 1}, {"body": 4, "word": "samples", "fig": 1}, {"body": 4, "word": "poor", "fig": 1}, {"body": 2, "word": "set", "fig": 2}, {"body": 4, "word": "carcinomas", "fig": 1}, {"body": 4, "word": "survival", "fig": 1}, {"body": 4, "word": "melanoma", "fig": 1}, {"body": 1, "word": "showing", "fig": 3}, {"body": 3, "word": "various", "fig": 1}, {"body": 3, "word": "IDC", "fig": 1}, {"body": 3, "word": "high", "fig": 1}, {"body": 3, "word": "numbers", "fig": 1}, {"body": 3, "word": "prognosis", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "distant", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 1, "word": "outcomes", "fig": 2}, {"body": 2, "word": "normal", "fig": 1}, {"body": 2, "word": "carcinoma", "fig": 1}, {"body": 2, "word": "database", "fig": 1}, {"body": 2, "word": "calculated", "fig": 1}, {"body": 1, "word": "Elston-Ellis", "fig": 1}, {"body": 1, "word": "grade", "fig": 1}, {"body": 1, "word": "Decreased", "fig": 1}, {"body": 1, "word": "IDLC", "fig": 1}, {"body": 1, "word": "DCIS", "fig": 1}, {"body": 1, "word": "evaluated", "fig": 1}, {"body": 1, "word": "ER-positive", "fig": 1}, {"body": 1, "word": "events", "fig": 1}, {"body": 1, "word": "included", "fig": 1}, {"body": 1, "word": "correlates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926834/bin/oncotarget-04-2383-g007.jpg", "caption": "Proposed model of EI24-mediated suppression of tumor progression through the alleviation of NF-\u03baB signaling In the presence of EI24, TRAF2/5 in Complex I are bound with EI24 and subsequently degraded, functioning as a negative regulatory mechanism for the attenuation of downstream NF-\u03baB signaling. When the EI24 level is low, TRAF2 accumulates and promotes Complex I assembly, activation, and the nuclear translocation of NF-\u03baB, resulting in the induction of inflammation-related cytokine expression.", "co_occurrence": [{"body": 119, "word": "EI24", "fig": 3}, {"body": 40, "word": "NF-\u03baB", "fig": 3}, {"body": 43, "word": "expression", "fig": 1}, {"body": 39, "word": "tumor", "fig": 1}, {"body": 19, "word": "signaling", "fig": 2}, {"body": 14, "word": "I", "fig": 2}, {"body": 13, "word": "Complex", "fig": 2}, {"body": 20, "word": "TRAF2", "fig": 1}, {"body": 17, "word": "progression", "fig": 1}, {"body": 10, "word": "activation", "fig": 1}, {"body": 10, "word": "In", "fig": 1}, {"body": 8, "word": "induction", "fig": 1}, {"body": 7, "word": "level", "fig": 1}, {"body": 4, "word": "promotes", "fig": 1}, {"body": 3, "word": "mechanism", "fig": 1}, {"body": 3, "word": "suppression", "fig": 1}, {"body": 3, "word": "model", "fig": 1}, {"body": 3, "word": "EI24-mediated", "fig": 1}, {"body": 2, "word": "negative", "fig": 1}, {"body": 2, "word": "TRAF2/5", "fig": 1}, {"body": 2, "word": "nuclear", "fig": 1}, {"body": 2, "word": "low", "fig": 1}, {"body": 2, "word": "downstream", "fig": 1}, {"body": 2, "word": "resulting", "fig": 1}, {"body": 1, "word": "alleviation", "fig": 1}, {"body": 1, "word": "When", "fig": 1}, {"body": 1, "word": "bound", "fig": 1}, {"body": 1, "word": "presence", "fig": 1}, {"body": 1, "word": "translocation", "fig": 1}, {"body": 1, "word": "attenuation", "fig": 1}, {"body": 1, "word": "assembly", "fig": 1}, {"body": 1, "word": "inflammation-related", "fig": 1}]}], "4142619": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142619/bin/2485fig1.jpg", "caption": "PML negatively regulates Nrf2 protein abundance and its downstream target genes. (A) A heat map of significantly altered genes (greater than twofold, p < 0.01) involved in antioxidant pathways identified by microarray gene expression analysis in PML-knockdown HUVECs. siControl represents control siRNA, and siPML-1 and siPML-2 represent two independent PML siRNAs targeting different regions of PML mRNA. Asterisks mark known Nrf2 target genes. (B) The effects of PML knockdown on Nrf2 and NQO1 protein abundance in HUVECs. HUVECs were transfected with a nontargeting siRNA or two independent PML siRNAs for 72 h. Cell extracts were analyzed by immunoblotting with the indicated antibodies. \u03b2-Actin was used as a loading control. Relative intensities of the bands are normalized to both loading control and siControl. L.E., longer exposure; SE, shorter exposure. (C) Nrf2 and NQO1 protein expression in Pml+/+ and Pml\u2212/\u2212 MEFs. Relative intensities of the bands are normalized to both loading control and Pml+/+. (D) Nrf2 and NQO1 protein expression in Pml+/+ and Pml\u2212/\u2212 liver. Liver homogenates were prepared from 3 Pml+/+ and 3 Pml\u2212/\u2212 mice. Relative intensities of the bands are normalized to both loading control and Pml+/+ #1. (E) The effects of PML1 or PML4 overexpression on endogenous Nrf2 protein abundance in HeLa cells. HeLa cells were transfected with plasmids expressing HA-tagged PML1 or PML4. Relative intensities of the bands are normalized to both loading control and vector control. (F) The effects of PML1 and PML4 coexpression on endogenous Nrf2 protein abundance in HeLa cells. HeLa cells were transfected with plasmids expressing HA-tagged PML1, PML4, or PML1 combined with PML4. (G) The effects of PML1 or PML4 overexpression on cotransfected Nrf2 protein abundance in HeLa cells. HeLa cells were transfected with plasmids expressing FLAG-tagged Nrf2, GFP, and different amounts of HA-tagged PML4. GFP was cotransfected and used as a transfection and loading control. (H) The effects of PML4 overexpression on the half-life of cotransfected Nrf2 in HeLa cells. HeLa cells were transfected with plasmids expressing FLAG-tagged Nrf2 and GFP with or without HA-tagged PML4. After 24 h, cells were replated for CHX treatments. CHX was added to the medium at 20 \u03bcg/ml for 0, 15, 30, 60, 90, and 120 min. Relative intensities of the bands are normalized to both loading control and 0 min.", "co_occurrence": [{"body": 93, "word": "Nrf2", "fig": 11}, {"body": 132, "word": "PML", "fig": 5}, {"body": 52, "word": "cells", "fig": 9}, {"body": 26, "word": "protein", "fig": 7}, {"body": 16, "word": "control", "fig": 9}, {"body": 26, "word": "The", "fig": 5}, {"body": 11, "word": "HeLa", "fig": 8}, {"body": 22, "word": "HUVECs", "fig": 3}, {"body": 22, "word": "Pml\u2212/\u2212", "fig": 3}, {"body": 13, "word": "abundance", "fig": 5}, {"body": 13, "word": "Pml+/+", "fig": 5}, {"body": 12, "word": "transfected", "fig": 5}, {"body": 14, "word": "genes", "fig": 3}, {"body": 8, "word": "effects", "fig": 5}, {"body": 19, "word": "min", "fig": 2}, {"body": 10, "word": "expression", "fig": 3}, {"body": 15, "word": "siRNA", "fig": 2}, {"body": 3, "word": "PML4", "fig": 9}, {"body": 7, "word": "NQO1", "fig": 3}, {"body": 4, "word": "bands", "fig": 5}, {"body": 4, "word": "normalized", "fig": 5}, {"body": 10, "word": "target", "fig": 2}, {"body": 18, "word": "MEFs", "fig": 1}, {"body": 18, "word": "h", "fig": 1}, {"body": 9, "word": "used", "fig": 2}, {"body": 6, "word": "overexpression", "fig": 3}, {"body": 13, "word": "liver", "fig": 1}, {"body": 12, "word": "mice", "fig": 1}, {"body": 11, "word": "PML-knockdown", "fig": 1}, {"body": 2, "word": "plasmids", "fig": 4}, {"body": 8, "word": "gene", "fig": 1}, {"body": 8, "word": "knockdown", "fig": 1}, {"body": 7, "word": "significantly", "fig": 1}, {"body": 7, "word": "added", "fig": 1}, {"body": 7, "word": "antibodies", "fig": 1}, {"body": 1, "word": "PML1", "fig": 6}, {"body": 3, "word": "two", "fig": 2}, {"body": 3, "word": "siRNAs", "fig": 2}, {"body": 3, "word": "A", "fig": 2}, {"body": 3, "word": "independent", "fig": 2}, {"body": 2, "word": "cotransfected", "fig": 3}, {"body": 5, "word": "h.", "fig": 1}, {"body": 1, "word": "intensities", "fig": 5}, {"body": 5, "word": "indicated", "fig": 1}, {"body": 4, "word": "involved", "fig": 1}, {"body": 2, "word": "CHX", "fig": 2}, {"body": 1, "word": "HA-tagged", "fig": 4}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 4, "word": "antioxidant", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "without", "fig": 1}, {"body": 4, "word": "prepared", "fig": 1}, {"body": 4, "word": "pathways", "fig": 1}, {"body": 2, "word": "exposure", "fig": 2}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "After", "fig": 1}, {"body": 3, "word": "replated", "fig": 1}, {"body": 3, "word": "identified", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "medium", "fig": 1}, {"body": 3, "word": "regions", "fig": 1}, {"body": 3, "word": "microarray", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 1, "word": "GFP", "fig": 3}, {"body": 2, "word": "downstream", "fig": 1}, {"body": 2, "word": "vector", "fig": 1}, {"body": 2, "word": "mRNA", "fig": 1}, {"body": 2, "word": "regulates", "fig": 1}, {"body": 2, "word": "known", "fig": 1}, {"body": 1, "word": "endogenous", "fig": 2}, {"body": 1, "word": "different", "fig": 2}, {"body": 2, "word": "twofold", "fig": 1}, {"body": 2, "word": "altered", "fig": 1}, {"body": 2, "word": "treatments", "fig": 1}, {"body": 2, "word": "longer", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "greater", "fig": 1}, {"body": 1, "word": "map", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "homogenates", "fig": 1}, {"body": 1, "word": "targeting", "fig": 1}, {"body": 1, "word": "siPML-2", "fig": 1}, {"body": 1, "word": "siPML-1", "fig": 1}, {"body": 1, "word": "Liver", "fig": 1}, {"body": 1, "word": "heat", "fig": 1}, {"body": 1, "word": "nontargeting", "fig": 1}, {"body": 1, "word": "half-life", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142619/bin/2485fig2.jpg", "caption": "PML inhibits nuclear accumulation of Nrf2. (A) Subcellular fractionation and immunoblotting analysis of Pml+/+ and Pml\u2212/\u2212 MEFs. Nuclear and cytoplasmic fractions prepared from Pml+/+ and Pml\u2212/\u2212 MEFs were subjected to immunoblotting analysis with the indicated antibodies. Lamin B and \u03b1-tubulin were used as loading controls for nuclear and cytoplasmic fractions, respectively. Relative intensities of the bands are normalized to both loading control and Pml+/+. N, nucleus; C, cytoplasm. (B) Immunofluorescence analysis of MEFs. Cells were immunostained with anti-PML and anti-Nrf2 antibodies, and images were taken by a fluorescence microscope. DAPI-stained nuclei (a, d); PML (b, e); Nrf2 (c, f). Scale bar, 20 \u03bcm. (C) Subcellular fractionation and immunoblotting analysis of HeLa cells with PML overexpression. HeLa cells were transfected with plasmids expressing HA-tagged PML4. Nuclear and cytoplasmic fractions prepared from transfected HeLa cells were subjected to immunoblotting analysis with the indicated antibodies. Relative intensities of the bands are normalized to both loading control and vector control. N, nucleus; C, cytoplasm. (D) Immunofluorescence analysis of HeLa cells with PML1 or PML4 overexpression. HeLa cells were transfected with plasmids expressing HA-tagged PML1 or PML4. Cells were immunostained with anti-HA and anti-Nrf2 antibodies, and images were taken on a fluorescence microscope. DAPI-stained nuclei (a, d, g); HA-tagged PML (b, e, h); endogenous Nrf2 (c, f, i). The arrows mark cells expressing transfected PML. Scale bar, 20 \u03bcm. (E) Immunofluorescence analysis of HUVECs with PML1 or PML4 overexpression. The experiments were performed as described in D. (F) The effects of nuclear and cytoplasmic mutants of PML4 overexpression on endogenous Nrf2 protein abundance in HeLa cells. HeLa cells were transfected with plasmids expressing HA-tagged PML4 (wild type), PML4 (K487R), and NLS-PML4 (K487R). Dividing line marks edges of different parts of the same gel.", "co_occurrence": [{"body": 132, "word": "PML", "fig": 5}, {"body": 52, "word": "cells", "fig": 8}, {"body": 93, "word": "Nrf2", "fig": 4}, {"body": 44, "word": "nuclear", "fig": 3}, {"body": 20, "word": "cytoplasmic", "fig": 4}, {"body": 26, "word": "The", "fig": 3}, {"body": 11, "word": "HeLa", "fig": 7}, {"body": 12, "word": "transfected", "fig": 5}, {"body": 18, "word": "MEFs", "fig": 3}, {"body": 16, "word": "control", "fig": 3}, {"body": 22, "word": "Pml\u2212/\u2212", "fig": 2}, {"body": 13, "word": "Pml+/+", "fig": 3}, {"body": 38, "word": "accumulation", "fig": 1}, {"body": 7, "word": "antibodies", "fig": 4}, {"body": 4, "word": "analysis", "fig": 7}, {"body": 26, "word": "protein", "fig": 1}, {"body": 6, "word": "overexpression", "fig": 4}, {"body": 23, "word": "performed", "fig": 1}, {"body": 22, "word": "HUVECs", "fig": 1}, {"body": 3, "word": "PML4", "fig": 7}, {"body": 18, "word": "h", "fig": 1}, {"body": 13, "word": "abundance", "fig": 1}, {"body": 6, "word": "subjected", "fig": 2}, {"body": 4, "word": "C", "fig": 3}, {"body": 3, "word": "immunoblotting", "fig": 4}, {"body": 5, "word": "indicated", "fig": 2}, {"body": 5, "word": "Nuclear", "fig": 2}, {"body": 3, "word": "fractions", "fig": 3}, {"body": 9, "word": "used", "fig": 1}, {"body": 4, "word": "bands", "fig": 2}, {"body": 8, "word": "effects", "fig": 1}, {"body": 4, "word": "microscope", "fig": 2}, {"body": 4, "word": "taken", "fig": 2}, {"body": 4, "word": "normalized", "fig": 2}, {"body": 4, "word": "prepared", "fig": 2}, {"body": 4, "word": "nucleus", "fig": 2}, {"body": 3, "word": "Cells", "fig": 2}, {"body": 3, "word": "\u03bcm", "fig": 2}, {"body": 3, "word": "images", "fig": 2}, {"body": 2, "word": "plasmids", "fig": 3}, {"body": 3, "word": "K487R", "fig": 2}, {"body": 3, "word": "cytoplasm", "fig": 2}, {"body": 3, "word": "B", "fig": 2}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 2, "word": "fractionation", "fig": 2}, {"body": 1, "word": "HA-tagged", "fig": 4}, {"body": 2, "word": "fluorescence", "fig": 2}, {"body": 2, "word": "nuclei", "fig": 2}, {"body": 1, "word": "Immunofluorescence", "fig": 3}, {"body": 1, "word": "PML1", "fig": 3}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "anti-Nrf2", "fig": 2}, {"body": 2, "word": "controls", "fig": 1}, {"body": 1, "word": "d", "fig": 2}, {"body": 2, "word": "vector", "fig": 1}, {"body": 2, "word": "described", "fig": 1}, {"body": 1, "word": "endogenous", "fig": 2}, {"body": 1, "word": "intensities", "fig": 2}, {"body": 2, "word": "mutants", "fig": 1}, {"body": 1, "word": "anti-HA", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "wild", "fig": 1}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "parts", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142619/bin/2485fig3.jpg", "caption": "PML antagonizes transactivating activity of Nrf2. (A) qRT-PCR analysis of the mRNA levels of Nrf2 target genes and Pml in Pml+/+ and Pml\u2212/\u2212 MEFs. Total RNA was prepared from Pml+/+ and Pml\u2212/\u2212 MEFs and reverse transcribed into cDNA, which was used as a template for qRT-PCR analysis. Values normalized to the amount of each mRNA in Pml+/+ MEFs. Data presented as mean \u00b1 SD from triplicates. *p < 0.05; **p < 0.01; ***p < 0.001. (B) qRT-PCR analysis of mRNA levels of Nrf2 target genes and Pml in liver tissue isolated from Pml+/+ and Pml\u2212/\u2212 mice. Similar procedures were performed as in A. Data presented as mean \u00b1 SD from triplicates. *p < 0.05; **p < 0.01; ***p < 0.001. (C) Luciferase reporter assay and analysis of the effects of PML4 on an ARE-containing reporter. Different amounts of PML4 expression plasmid were transfected into CV-1 cells along with pNQO1-ARE reporter plasmid. At 24 h after transfection, the luciferase activity was measured in accordance with the instructions provided by the manufacturer. Data presented as mean \u00b1 SD from triplicates. *p < 0.05; ***p < 0.001. Cell extracts were analyzed by immunoblotting with the indicated antibodies. \u03b2-Actin was used as a loading control. (D) Effects of PML4 on the recruitment of Nrf2 to the NQO1 promoter. HeLa cells were transfected with plasmids expressing HA-tagged PML4 and harvested for ChIP assays using anti-Nrf2 antibodies or anti-HA antibodies as a control. Percentages of amplified DNA amounts from precipitates as normalized to 10% of input are shown. Data presented as mean \u00b1 SD from triplicates. ***p < 0.001. (E) The effects of PML4 on the recruitment of Nrf2 to the HO-1 promoter. Similar procedures were performed as in D. ***p < 0.001. (F) The effects of PML knockdown on the recruitment of Nrf2 to the NQO1 promoter. HUVECs were transfected with a nontargeting siRNA or a PML targeting siRNA for 72 h and harvested for ChIP assays using anti-Nrf2 antibodies or anti-HA antibodies as a control. Percentages of amplified DNA amounts from precipitates as normalized to 10% of input are shown. ***p < 0.001.", "co_occurrence": [{"body": 93, "word": "Nrf2", "fig": 6}, {"body": 132, "word": "PML", "fig": 3}, {"body": 52, "word": "cells", "fig": 2}, {"body": 22, "word": "Pml\u2212/\u2212", "fig": 3}, {"body": 18, "word": "MEFs", "fig": 3}, {"body": 13, "word": "Pml+/+", "fig": 4}, {"body": 26, "word": "The", "fig": 2}, {"body": 25, "word": "activity", "fig": 2}, {"body": 16, "word": "control", "fig": 3}, {"body": 23, "word": "performed", "fig": 2}, {"body": 21, "word": "using", "fig": 2}, {"body": 18, "word": "h", "fig": 2}, {"body": 9, "word": "presented", "fig": 4}, {"body": 12, "word": "transfected", "fig": 3}, {"body": 7, "word": "antibodies", "fig": 5}, {"body": 15, "word": "siRNA", "fig": 2}, {"body": 7, "word": "mean", "fig": 4}, {"body": 14, "word": "genes", "fig": 2}, {"body": 7, "word": "SD", "fig": 4}, {"body": 13, "word": "levels", "fig": 2}, {"body": 8, "word": "effects", "fig": 3}, {"body": 22, "word": "HUVECs", "fig": 1}, {"body": 10, "word": "target", "fig": 2}, {"body": 6, "word": "promoter", "fig": 3}, {"body": 9, "word": "used", "fig": 2}, {"body": 4, "word": "analysis", "fig": 4}, {"body": 3, "word": "PML4", "fig": 5}, {"body": 7, "word": "NQO1", "fig": 2}, {"body": 13, "word": "assay", "fig": 1}, {"body": 13, "word": "liver", "fig": 1}, {"body": 12, "word": "mice", "fig": 1}, {"body": 6, "word": "assays", "fig": 2}, {"body": 4, "word": "normalized", "fig": 3}, {"body": 11, "word": "HeLa", "fig": 1}, {"body": 10, "word": "expression", "fig": 1}, {"body": 5, "word": "harvested", "fig": 2}, {"body": 3, "word": "reporter", "fig": 3}, {"body": 3, "word": "qRT-PCR", "fig": 3}, {"body": 8, "word": "knockdown", "fig": 1}, {"body": 7, "word": "RNA", "fig": 1}, {"body": 7, "word": "tissue", "fig": 1}, {"body": 2, "word": "recruitment", "fig": 3}, {"body": 3, "word": "shown", "fig": 2}, {"body": 2, "word": "mRNA", "fig": 3}, {"body": 3, "word": "DNA", "fig": 2}, {"body": 3, "word": "plasmid", "fig": 2}, {"body": 3, "word": "A", "fig": 2}, {"body": 5, "word": "indicated", "fig": 1}, {"body": 5, "word": "measured", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 1, "word": "Data", "fig": 4}, {"body": 2, "word": "ChIP", "fig": 2}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 4, "word": "isolated", "fig": 1}, {"body": 4, "word": "prepared", "fig": 1}, {"body": 4, "word": "CV-1", "fig": 1}, {"body": 3, "word": "luciferase", "fig": 1}, {"body": 3, "word": "manufacturer", "fig": 1}, {"body": 3, "word": "reverse", "fig": 1}, {"body": 3, "word": "amount", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 3, "word": "ARE-containing", "fig": 1}, {"body": 1, "word": "anti-HA", "fig": 2}, {"body": 1, "word": "input", "fig": 2}, {"body": 2, "word": "provided", "fig": 1}, {"body": 2, "word": "plasmids", "fig": 1}, {"body": 1, "word": "anti-Nrf2", "fig": 2}, {"body": 1, "word": "Percentages", "fig": 2}, {"body": 1, "word": "HA-tagged", "fig": 1}, {"body": 1, "word": "HO-1", "fig": 1}, {"body": 1, "word": "targeting", "fig": 1}, {"body": 1, "word": "nontargeting", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 1}, {"body": 1, "word": "cDNA", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}, {"body": 1, "word": "At", "fig": 1}, {"body": 1, "word": "Total", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142619/bin/2485fig4.jpg", "caption": "ROS accumulation due to mitochondrial defects accounts for PML-mediated Nrf2 regulations. (A) ROS accumulation in Pml+/+ and Pml\u2212/\u2212 MEFs. Equal numbers of Pml+/+ and Pml\u2212/\u2212 MEFs were cultured in a 96-well plate. The ROS levels were measured according to manufacturer's instruction. Data presented as mean \u00b1 SD from triplicates. **p < 0.01. (B) ROS accumulation in PML-knockdown HUVECs. HUVECs were transfected with a nontargeting siRNA or a PML siRNA for 72 h, and ROS assays were carried out as in A. *p < 0.05. (C) ROS accumulation in HeLa cells overexpressing PML4. Different amounts of an expression plasmid for PML4 were transfected into HeLa cells, and ROS assays were carried out as in A. *p < 0.05; ***p < 0.001. (D) Effects of nuclear and cytoplasmic PML4 mutants on ROS accumulation in HeLa cells. Equal amounts of HA-tagged empty vector, wild-type PML, and cytoplasmic and nuclear PML mutants were transfected into HeLa cells, and ROS assays were carried out as in A. **p < 0.01; ***p < 0.001; n.s., not significant. (E) Complex II enzyme activity assay of Pml+/+ and Pml\u2212/\u2212 mouse liver. The rate of enzyme activity was determined according to the manufacturer's instruction. n = 3 per group. ***p < 0.001; n, number of mice. (F) qRT-PCR analysis of mRNA levels of genes encoding components of complex II in liver tissue isolated from Pml+/+ and Pml\u2212/\u2212 mice. Fold change on mRNA abundance was normalized to the amount of each mRNA in Pml+/+ tissue. n = 3 per group. *p < 0.05; **p < 0.01; n.s., not significant; n, number of mice. (G) Effects of NAC on Nrf2 protein accumulation in PML-knockdown HUVECs. HUVECs were transfected with a nontargeting siRNA or a PML siRNA for 48 h. Cells were then replated and treated with NAC for 24 h at 0 or 10 mM final concentration. Cell extracts were prepared and analyzed by immunoblotting with the indicated antibodies. \u03b2-Actin was used as a loading control. (H) The effects of C212/213A, C77/80A, and C88/91A mutations of PML on ROS accumulation and Nrf2 protein abundance. Equal amounts of HA-tagged empty vector, wild-type PML, and PML mutants were transfected into HeLa cells and split for ROS assays and immunoblotting. *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.", "co_occurrence": [{"body": 132, "word": "PML", "fig": 7}, {"body": 52, "word": "ROS", "fig": 11}, {"body": 93, "word": "Nrf2", "fig": 3}, {"body": 38, "word": "accumulation", "fig": 7}, {"body": 52, "word": "cells", "fig": 5}, {"body": 44, "word": "nuclear", "fig": 2}, {"body": 22, "word": "HUVECs", "fig": 4}, {"body": 22, "word": "Pml\u2212/\u2212", "fig": 4}, {"body": 26, "word": "The", "fig": 3}, {"body": 13, "word": "Pml+/+", "fig": 5}, {"body": 12, "word": "transfected", "fig": 5}, {"body": 15, "word": "siRNA", "fig": 4}, {"body": 11, "word": "HeLa", "fig": 5}, {"body": 26, "word": "protein", "fig": 2}, {"body": 25, "word": "activity", "fig": 2}, {"body": 20, "word": "cytoplasmic", "fig": 2}, {"body": 18, "word": "MEFs", "fig": 2}, {"body": 18, "word": "h", "fig": 2}, {"body": 12, "word": "mice", "fig": 3}, {"body": 17, "word": "II", "fig": 2}, {"body": 13, "word": "liver", "fig": 2}, {"body": 13, "word": "abundance", "fig": 2}, {"body": 13, "word": "levels", "fig": 2}, {"body": 6, "word": "assays", "fig": 4}, {"body": 11, "word": "PML-knockdown", "fig": 2}, {"body": 16, "word": "control", "fig": 1}, {"body": 16, "word": "complex", "fig": 1}, {"body": 14, "word": "genes", "fig": 1}, {"body": 7, "word": "number", "fig": 2}, {"body": 7, "word": "tissue", "fig": 2}, {"body": 13, "word": "assay", "fig": 1}, {"body": 4, "word": "carried", "fig": 3}, {"body": 6, "word": "according", "fig": 2}, {"body": 3, "word": "A", "fig": 4}, {"body": 5, "word": "enzyme", "fig": 2}, {"body": 10, "word": "expression", "fig": 1}, {"body": 10, "word": "plate", "fig": 1}, {"body": 5, "word": "'s", "fig": 2}, {"body": 3, "word": "PML4", "fig": 3}, {"body": 9, "word": "presented", "fig": 1}, {"body": 9, "word": "used", "fig": 1}, {"body": 4, "word": "NAC", "fig": 2}, {"body": 8, "word": "effects", "fig": 1}, {"body": 2, "word": "n", "fig": 4}, {"body": 7, "word": "mean", "fig": 1}, {"body": 7, "word": "SD", "fig": 1}, {"body": 7, "word": "antibodies", "fig": 1}, {"body": 2, "word": "mRNA", "fig": 3}, {"body": 3, "word": "manufacturer", "fig": 2}, {"body": 6, "word": "mitochondrial", "fig": 1}, {"body": 6, "word": "due", "fig": 1}, {"body": 6, "word": "treated", "fig": 1}, {"body": 2, "word": "mutants", "fig": 3}, {"body": 2, "word": "significant", "fig": 3}, {"body": 3, "word": "immunoblotting", "fig": 2}, {"body": 5, "word": "h.", "fig": 1}, {"body": 5, "word": "indicated", "fig": 1}, {"body": 5, "word": "measured", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 2, "word": "vector", "fig": 2}, {"body": 2, "word": "per", "fig": 2}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 4, "word": "PML-mediated", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 2, "word": "wild-type", "fig": 2}, {"body": 4, "word": "mM", "fig": 1}, {"body": 4, "word": "concentration", "fig": 1}, {"body": 4, "word": "isolated", "fig": 1}, {"body": 4, "word": "prepared", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 3, "word": "replated", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "plasmid", "fig": 1}, {"body": 3, "word": "qRT-PCR", "fig": 1}, {"body": 3, "word": "amount", "fig": 1}, {"body": 3, "word": "96-well", "fig": 1}, {"body": 3, "word": "final", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "components", "fig": 1}, {"body": 1, "word": "group", "fig": 2}, {"body": 1, "word": "HA-tagged", "fig": 2}, {"body": 2, "word": "rate", "fig": 1}, {"body": 2, "word": "encoding", "fig": 1}, {"body": 1, "word": "empty", "fig": 2}, {"body": 1, "word": "nontargeting", "fig": 2}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "mutations", "fig": 1}, {"body": 1, "word": "accounts", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "cultured", "fig": 1}, {"body": 1, "word": "C212/213A", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "Complex", "fig": 1}, {"body": 1, "word": "numbers", "fig": 1}, {"body": 1, "word": "overexpressing", "fig": 1}, {"body": 1, "word": "mouse", "fig": 1}, {"body": 1, "word": "C77/80A", "fig": 1}, {"body": 1, "word": "C88/91A", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142619/bin/2485fig5.jpg", "caption": "The effects of SFN on abundance and subcellular distribution of PML. (A) Immunoblotting analysis of HUVECs treated with different concentrations of SFN. HUVECs were treated with SFN for 1 h at 0, 10, 20, 40, or 80 \u03bcM final concentration. Cell extracts were analyzed by immunoblotting with the indicated antibodies. \u03b2-Actin was used as loading control. (B) Immunoblotting analysis of HUVECs treated with SFN. HUVECs were treated with vehicle control (DMSO) or SFN at 10 or 20 \u03bcM for 0.5, 1, 4, or 8 h. Relative intensities of the bands are normalized to both loading control and DMSO within each time point. (C) Subcellular fractionation and immunoblotting analysis of HUVECs treated with SFN. HUVECs were treated with vehicle control (DMSO) or SFN at 10 or 20 \u03bcM for 0.5, 1, 4, or 8 h. Nuclear and cytoplasmic fractions prepared were subjected to immunoblotting analysis with the indicated antibodies. Lamin B and \u03b1-tubulin were used as loading controls for nuclear and cytoplasmic fractions, respectively. Relative intensities of the bands are normalized to both loading control and DMSO within each time point. (D) Immunofluorescence analysis of HUVECs treated with SFN. HUVECs were treated with vehicle control (DMSO) or SFN at 10 \u03bcM for 1 h. Cells were immunostained with anti-PML antibodies, and images were taken on a fluorescence microscope. Nuclei were stained with DAPI, and PML NBs are shown in green. Statistical analysis of the PML NB number and nuclear fluorescence intensity. n > 150 per group. *p < 0.05; **p < 0.01; n, number of cells. Scale bar, 20 \u03bcm. (E) The effects of Keap1 knockdown on PML protein abundance in HUVECs. HUVECs were transfected with a nontargeting siRNA or two independent Keap1 siRNAs for 72 h. Cell extracts were analyzed by immunoblotting with the indicated antibodies. (F) The effects of Keap1 knockdown on subcellular distribution of PML in HUVECs. HUVECs were subjected to Keap1 knockdown as in E and followed by subcellular fractionation as in C. Asterisk, nonspecific band. (G) Immunoblotting analysis of Keap1-knockdown HUVECs treated with SFN. HUVECs were transfected with a nontargeting siRNA or Keap1 siRNA for 72 h and replated, treated with vehicle control (DMSO) or SFN at 10 \u03bcM for 1 h, and harvested for subcellular fractionation as in C.", "co_occurrence": [{"body": 132, "word": "PML", "fig": 5}, {"body": 47, "word": "SFN", "fig": 11}, {"body": 22, "word": "HUVECs", "fig": 14}, {"body": 16, "word": "control", "fig": 7}, {"body": 22, "word": "Keap1", "fig": 5}, {"body": 44, "word": "nuclear", "fig": 2}, {"body": 26, "word": "The", "fig": 3}, {"body": 6, "word": "treated", "fig": 10}, {"body": 18, "word": "h", "fig": 3}, {"body": 52, "word": "cells", "fig": 1}, {"body": 15, "word": "siRNA", "fig": 3}, {"body": 20, "word": "cytoplasmic", "fig": 2}, {"body": 8, "word": "subcellular", "fig": 4}, {"body": 7, "word": "antibodies", "fig": 4}, {"body": 4, "word": "analysis", "fig": 7}, {"body": 13, "word": "abundance", "fig": 2}, {"body": 26, "word": "protein", "fig": 1}, {"body": 8, "word": "effects", "fig": 3}, {"body": 8, "word": "knockdown", "fig": 3}, {"body": 12, "word": "transfected", "fig": 2}, {"body": 5, "word": "h.", "fig": 4}, {"body": 9, "word": "used", "fig": 2}, {"body": 3, "word": "\u03bcM", "fig": 5}, {"body": 5, "word": "indicated", "fig": 3}, {"body": 7, "word": "number", "fig": 2}, {"body": 6, "word": "subjected", "fig": 2}, {"body": 3, "word": "immunoblotting", "fig": 4}, {"body": 11, "word": "NBs", "fig": 1}, {"body": 4, "word": "bands", "fig": 2}, {"body": 4, "word": "C", "fig": 2}, {"body": 4, "word": "extracts", "fig": 2}, {"body": 4, "word": "Cell", "fig": 2}, {"body": 4, "word": "normalized", "fig": 2}, {"body": 4, "word": "distribution", "fig": 2}, {"body": 7, "word": "followed", "fig": 1}, {"body": 2, "word": "fractionation", "fig": 3}, {"body": 3, "word": "fractions", "fig": 2}, {"body": 3, "word": "B", "fig": 2}, {"body": 1, "word": "DMSO", "fig": 6}, {"body": 5, "word": "harvested", "fig": 1}, {"body": 5, "word": "Nuclear", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "microscope", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 4}, {"body": 4, "word": "taken", "fig": 1}, {"body": 2, "word": "n", "fig": 2}, {"body": 4, "word": "concentration", "fig": 1}, {"body": 4, "word": "prepared", "fig": 1}, {"body": 2, "word": "fluorescence", "fig": 2}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "two", "fig": 1}, {"body": 3, "word": "final", "fig": 1}, {"body": 3, "word": "replated", "fig": 1}, {"body": 3, "word": "siRNAs", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "independent", "fig": 1}, {"body": 2, "word": "controls", "fig": 1}, {"body": 2, "word": "intensity", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "Keap1-knockdown", "fig": 1}, {"body": 1, "word": "point", "fig": 2}, {"body": 1, "word": "within", "fig": 2}, {"body": 1, "word": "nontargeting", "fig": 2}, {"body": 1, "word": "intensities", "fig": 2}, {"body": 1, "word": "time", "fig": 2}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "concentrations", "fig": 1}, {"body": 1, "word": "different", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142619/bin/2485fig6.jpg", "caption": "SFN-mediated Nrf2 activation is PML dependent. (A) ROS accumulation in PML knockdown HUVECs. HUVECs were transfected with a nontargeting siRNA or a PML siRNA for 72 h. Equal number of HUVECs were replated in a 96-well plate and treated with vehicle control (DMSO) or SFN at 40 \u03bcM for 1 h. The ROS level was measured according to the manufacturer's instruction. Data presented as mean \u00b1 SD from triplicates. *p < 0.05; **p < 0.01; n.s., not significant. (B) Immunoblotting analysis of PML-knockdown HUVECs treated with SFN. HUVECs were transfected with a nontargeting siRNA or a PML targeting siRNA for 48 h. Cells were then replated and treated with vehicle control (DMSO) or SFN at 20 \u03bcM for 1 h. Cell extracts were analyzed by immunoblotting with the indicated antibodies. \u03b2-Actin was used as a loading control. Dividing line marks edges of different parts of the same gel. (C) qRT-PCR analysis of the mRNA levels of NQO1 in PML-knockdown HUVECs with SFN treatment. HUVECs were subjected to PML knockdown and SFN treatment as in B and harvested for qRT-PCR. Fold change of NQO1 mRNA was normalized to that in vehicle-treated cells within each group. Data presented as mean \u00b1 SD from triplicates. **p < 0.01; n.s., not significant. (D) The effects of PML on the recruitment of Nrf2 to the NQO1 promoter after SFN treatment. HUVECs were subjected to PML knockdown and SFN treatment as in B and harvested for ChIP assays using anti-Nrf2 antibodies or anti-HA antibodies as a control. Percentages of amplified DNA amounts from precipitates as normalized to 10% of input are shown. Data presented as mean \u00b1 SD from triplicates. ***p < 0.001.", "co_occurrence": [{"body": 132, "word": "PML", "fig": 7}, {"body": 47, "word": "SFN", "fig": 7}, {"body": 93, "word": "Nrf2", "fig": 2}, {"body": 22, "word": "HUVECs", "fig": 8}, {"body": 52, "word": "ROS", "fig": 2}, {"body": 16, "word": "control", "fig": 4}, {"body": 15, "word": "siRNA", "fig": 4}, {"body": 52, "word": "cells", "fig": 1}, {"body": 26, "word": "The", "fig": 2}, {"body": 10, "word": "treatment", "fig": 4}, {"body": 38, "word": "accumulation", "fig": 1}, {"body": 9, "word": "presented", "fig": 3}, {"body": 12, "word": "transfected", "fig": 2}, {"body": 8, "word": "knockdown", "fig": 3}, {"body": 11, "word": "PML-knockdown", "fig": 2}, {"body": 21, "word": "using", "fig": 1}, {"body": 7, "word": "NQO1", "fig": 3}, {"body": 7, "word": "mean", "fig": 3}, {"body": 7, "word": "SD", "fig": 3}, {"body": 7, "word": "antibodies", "fig": 3}, {"body": 5, "word": "h.", "fig": 4}, {"body": 6, "word": "treated", "fig": 3}, {"body": 13, "word": "levels", "fig": 1}, {"body": 6, "word": "subjected", "fig": 2}, {"body": 5, "word": "harvested", "fig": 2}, {"body": 10, "word": "plate", "fig": 1}, {"body": 3, "word": "B", "fig": 3}, {"body": 9, "word": "used", "fig": 1}, {"body": 8, "word": "effects", "fig": 1}, {"body": 4, "word": "normalized", "fig": 2}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 7, "word": "number", "fig": 1}, {"body": 3, "word": "replated", "fig": 2}, {"body": 6, "word": "level", "fig": 1}, {"body": 3, "word": "\u03bcM", "fig": 2}, {"body": 3, "word": "qRT-PCR", "fig": 2}, {"body": 6, "word": "according", "fig": 1}, {"body": 6, "word": "promoter", "fig": 1}, {"body": 6, "word": "assays", "fig": 1}, {"body": 6, "word": "SFN-mediated", "fig": 1}, {"body": 5, "word": "indicated", "fig": 1}, {"body": 5, "word": "'s", "fig": 1}, {"body": 5, "word": "measured", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "activation", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 2, "word": "mRNA", "fig": 2}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 2, "word": "significant", "fig": 2}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "manufacturer", "fig": 1}, {"body": 3, "word": "96-well", "fig": 1}, {"body": 1, "word": "Data", "fig": 3}, {"body": 3, "word": "DNA", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "recruitment", "fig": 1}, {"body": 2, "word": "ChIP", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 2}, {"body": 1, "word": "nontargeting", "fig": 2}, {"body": 1, "word": "DMSO", "fig": 2}, {"body": 1, "word": "anti-HA", "fig": 1}, {"body": 1, "word": "input", "fig": 1}, {"body": 1, "word": "dependent", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "targeting", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "within", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "anti-Nrf2", "fig": 1}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "parts", "fig": 1}, {"body": 1, "word": "Percentages", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142619/bin/2485fig7.jpg", "caption": "PML is required for SFN-mediated antiproliferation, antimigration, and antiangiogenesis activity. (A) The effects of PML knockdown on proliferation of SFN-treated HUVECs. HUVECs were transfected with a nontargeting siRNA or a PML siRNA for 48 h. Cells were then replated and treated with vehicle control (DMSO) or SFN at 10 \u03bcM for 3 h. A cell proliferation assay was performed in accordance with the instructions provided by the manufacturer. Cell numbers were determined at 0, 24, 48, and 72 h and normalized to the 0-h group. Data presented as mean \u00b1 SEM from triplicates. *p < 0.05; **p < 0.01; n.s., not significant. (B) The effects of PML knockdown on migration of SFN-treated HUVECs. HUVECs were transfected with a nontargeting siRNA or a PML siRNA for 48 h. Cells were then replated and treated with vehicle control (DMSO) or SFN at 10 \u03bcM for 4 h. Wounds were generated using a pipette tip, and images were taken at 0 and 12 h afterward. Wound widths were measured and are shown as percentages of migration. n = 6 per group. Data presented as mean \u00b1 SD from triplicates.***p < 0.001; n.s., not significant; n, number of fields. (C) The effects of PML knockdown on capillary tube formation of SFN-treated HUVECs. HUVECs were subjected to PML knockdown and SFN treatment as in B. In vitro capillary tube formation assays were performed according to manufacturer's instructions. Images were taken 21 h after HUVECs were seeded on Matrigel. Statistical analysis was performed by counting branch points per field. n = 5 per group. Data presented as mean \u00b1 SEM from triplicates. **p < 0.01; n.s., not significant; n, number of fields.", "co_occurrence": [{"body": 132, "word": "PML", "fig": 7}, {"body": 22, "word": "HUVECs", "fig": 7}, {"body": 47, "word": "SFN", "fig": 3}, {"body": 26, "word": "The", "fig": 3}, {"body": 23, "word": "performed", "fig": 3}, {"body": 15, "word": "siRNA", "fig": 4}, {"body": 18, "word": "h", "fig": 3}, {"body": 16, "word": "control", "fig": 2}, {"body": 8, "word": "knockdown", "fig": 4}, {"body": 9, "word": "presented", "fig": 3}, {"body": 25, "word": "activity", "fig": 1}, {"body": 8, "word": "effects", "fig": 3}, {"body": 12, "word": "transfected", "fig": 2}, {"body": 21, "word": "using", "fig": 1}, {"body": 7, "word": "mean", "fig": 3}, {"body": 5, "word": "h.", "fig": 4}, {"body": 18, "word": "In", "fig": 1}, {"body": 7, "word": "number", "fig": 2}, {"body": 13, "word": "assay", "fig": 1}, {"body": 12, "word": "cell", "fig": 1}, {"body": 6, "word": "proliferation", "fig": 2}, {"body": 6, "word": "treated", "fig": 2}, {"body": 10, "word": "treatment", "fig": 1}, {"body": 4, "word": "taken", "fig": 2}, {"body": 4, "word": "formation", "fig": 2}, {"body": 2, "word": "n", "fig": 4}, {"body": 7, "word": "SD", "fig": 1}, {"body": 2, "word": "per", "fig": 3}, {"body": 6, "word": "subjected", "fig": 1}, {"body": 3, "word": "replated", "fig": 2}, {"body": 3, "word": "Cells", "fig": 2}, {"body": 3, "word": "\u03bcM", "fig": 2}, {"body": 3, "word": "migration", "fig": 2}, {"body": 3, "word": "tube", "fig": 2}, {"body": 3, "word": "manufacturer", "fig": 2}, {"body": 6, "word": "according", "fig": 1}, {"body": 3, "word": "B", "fig": 2}, {"body": 6, "word": "assays", "fig": 1}, {"body": 6, "word": "SFN-mediated", "fig": 1}, {"body": 3, "word": "A", "fig": 2}, {"body": 6, "word": "generated", "fig": 1}, {"body": 2, "word": "significant", "fig": 3}, {"body": 5, "word": "'s", "fig": 1}, {"body": 5, "word": "measured", "fig": 1}, {"body": 5, "word": "points", "fig": 1}, {"body": 2, "word": "capillary", "fig": 2}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "antiproliferation", "fig": 1}, {"body": 4, "word": "Images", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 4, "word": "normalized", "fig": 1}, {"body": 4, "word": "antiangiogenesis", "fig": 1}, {"body": 4, "word": "branch", "fig": 1}, {"body": 4, "word": "required", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 1, "word": "group", "fig": 3}, {"body": 3, "word": "vitro", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "antimigration", "fig": 1}, {"body": 1, "word": "Data", "fig": 3}, {"body": 1, "word": "SFN-treated", "fig": 3}, {"body": 2, "word": "provided", "fig": 1}, {"body": 1, "word": "fields", "fig": 2}, {"body": 1, "word": "vehicle", "fig": 2}, {"body": 1, "word": "nontargeting", "fig": 2}, {"body": 2, "word": "seeded", "fig": 1}, {"body": 1, "word": "DMSO", "fig": 2}, {"body": 1, "word": "Wounds", "fig": 1}, {"body": 1, "word": "Matrigel", "fig": 1}, {"body": 1, "word": "Wound", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "numbers", "fig": 1}, {"body": 1, "word": "widths", "fig": 1}, {"body": 1, "word": "tip", "fig": 1}, {"body": 1, "word": "field", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "pipette", "fig": 1}]}], "4159791": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159791/bin/ijms-15-13236-g001.jpg", "caption": "The expression level of phosphoinositide-specific phospholipase \u03b31 (PLC\u03b31) in normal articular and OA chondrocytes. Normal samples were obtained from 3 patients with amputation from accident, and OA samples were obtained from 20 patients with advanced OA. (A) The protein expression levels of PLC\u03b31 and p-PLC\u03b31 in cultured normal and OA chondrocytes were detected with western blotting analysis using rat anti-PLC-\u03b31, p-PLC-\u03b31, and GAPDH antibodies according to Materials and Methods. The values represent the mean \u00b1S.E.M. of five independent experiments, each yielding similar results (* p < 0.05); (B) The protein expression level of PLC\u03b31 in normal articular and OA cartilage was detected with immunohistochemistry analysis according to Materials and Method (original magnification \u00d7100 or \u00d7400, * p < 0.05).", "co_occurrence": [{"body": 52, "word": "OA", "fig": 5}, {"body": 28, "word": "expression", "fig": 3}, {"body": 38, "word": "chondrocytes", "fig": 2}, {"body": 19, "word": "The", "fig": 4}, {"body": 15, "word": "PLC\u03b31", "fig": 3}, {"body": 8, "word": "normal", "fig": 3}, {"body": 10, "word": "p", "fig": 2}, {"body": 19, "word": "cartilage", "fig": 1}, {"body": 8, "word": "detected", "fig": 2}, {"body": 7, "word": "articular", "fig": 2}, {"body": 5, "word": "protein", "fig": 2}, {"body": 5, "word": "obtained", "fig": 2}, {"body": 5, "word": "level", "fig": 2}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 8, "word": "levels", "fig": 1}, {"body": 4, "word": "patients", "fig": 2}, {"body": 5, "word": "cultured", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 2, "word": "according", "fig": 2}, {"body": 4, "word": "western", "fig": 1}, {"body": 3, "word": "using", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "samples", "fig": 2}, {"body": 2, "word": "similar", "fig": 1}, {"body": 1, "word": "Materials", "fig": 2}, {"body": 2, "word": "advanced", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "rat", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "Normal", "fig": 1}, {"body": 1, "word": "phospholipase", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "accident", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "amputation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159791/bin/ijms-15-13236-g002.jpg", "caption": "The extracellular matrix (ECM) synthesis of OA chondrocytes partially depends on PLC-\u03b31 activation. OA chondrocytes were obtained from 16 patients with advanced OA. (A) Cultured cells were treated with or without U73122 (5 \u03bcM) for 3 h, and the protein expression levels of PLC-\u03b31, p-PLC-\u03b31, Sox-9, MMP-13, Col II, and AGG were detected by western blotting analysis using rat anti-PLC-\u03b31, p-PLC-\u03b31, Sox-9, MMP-13, Col II, AGG, and GAPDH antibodies; (B) Cultured cells were transfected with or without siRNA-PLC-\u03b31, and the protein expression levels of PLC-\u03b31, p-PLC-\u03b31, Sox-9, MMP-13, and TIMP1 were detected by western blotting using rat anti-PLC-\u03b31, p-PLC-\u03b31, Sox-9, MMP-13, TIMP1, and GAPDH antibodies. The values represent the mean \u00b1S.E.M. of three to five independent experiments, each yielding similar results (* p < 0.05, ** p < 0.01).", "co_occurrence": [{"body": 52, "word": "OA", "fig": 3}, {"body": 38, "word": "chondrocytes", "fig": 2}, {"body": 21, "word": "PLC-\u03b31", "fig": 3}, {"body": 28, "word": "expression", "fig": 2}, {"body": 24, "word": "II", "fig": 2}, {"body": 12, "word": "MMP-13", "fig": 4}, {"body": 10, "word": "Sox-9", "fig": 4}, {"body": 19, "word": "The", "fig": 2}, {"body": 14, "word": "Col", "fig": 2}, {"body": 26, "word": "ECM", "fig": 1}, {"body": 10, "word": "cells", "fig": 2}, {"body": 10, "word": "p", "fig": 2}, {"body": 8, "word": "AGG", "fig": 2}, {"body": 8, "word": "detected", "fig": 2}, {"body": 8, "word": "levels", "fig": 2}, {"body": 15, "word": "synthesis", "fig": 1}, {"body": 5, "word": "protein", "fig": 2}, {"body": 10, "word": "U73122", "fig": 1}, {"body": 8, "word": "activation", "fig": 1}, {"body": 4, "word": "western", "fig": 2}, {"body": 3, "word": "TIMP1", "fig": 2}, {"body": 3, "word": "blotting", "fig": 2}, {"body": 3, "word": "using", "fig": 2}, {"body": 5, "word": "obtained", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "patients", "fig": 1}, {"body": 3, "word": "matrix", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 2}, {"body": 2, "word": "depends", "fig": 1}, {"body": 2, "word": "h", "fig": 1}, {"body": 1, "word": "rat", "fig": 2}, {"body": 2, "word": "similar", "fig": 1}, {"body": 2, "word": "advanced", "fig": 1}, {"body": 2, "word": "partially", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "extracellular", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "treated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159791/bin/ijms-15-13236-g003.jpg", "caption": "PLC-\u03b31/IP3/Ca(2+)/CaMK II axis regulates the ECM synthesis of human OA chondrocytes. OA chondrocytes were obtained from 16 patients with advanced OA. (A) Cultured cells were treated with or without U73122 (5 \u03bcM), U73343 (5 \u03bcM), R59949 (10 \u03bcM), KN93 (20 \u03bcM), and BAPTA/AM (10 \u03bcM) for 3 h, respectively. The protein expression levels of MMP-13 and Col II were detected by western blotting analysis using rat anti-MMP-13, Col II, and GAPDH antibodies; (B) Cultured cells were treated with or without U73122 (5 \u03bcM), KN93 (20 \u03bcM), and BAPTA/AM (10 \u03bcM) for 3 h, respectively. The proteinexpression levels of mTOR, p-mTOR, p-p70S6K, p-S6, Sox-9, and NF-\u03baB p65 were detected by western blotting analysis using rat anti-mTOR, p-mTOR, p-p70S6K, p-S6, Sox-9, NF-\u03baB p65, and GAPDH antibodies. The values represent the mean \u00b1 S.E.M. of three to five independent experiments, each yielding similar results (* p < 0.05, ** p <0.01, *** p <0.001).", "co_occurrence": [{"body": 52, "word": "OA", "fig": 3}, {"body": 38, "word": "chondrocytes", "fig": 2}, {"body": 24, "word": "II", "fig": 3}, {"body": 19, "word": "The", "fig": 3}, {"body": 10, "word": "p", "fig": 3}, {"body": 28, "word": "expression", "fig": 1}, {"body": 14, "word": "Col", "fig": 2}, {"body": 26, "word": "ECM", "fig": 1}, {"body": 24, "word": "human", "fig": 1}, {"body": 10, "word": "U73122", "fig": 2}, {"body": 10, "word": "cells", "fig": 2}, {"body": 10, "word": "Sox-9", "fig": 2}, {"body": 8, "word": "detected", "fig": 2}, {"body": 8, "word": "levels", "fig": 2}, {"body": 15, "word": "synthesis", "fig": 1}, {"body": 12, "word": "MMP-13", "fig": 1}, {"body": 6, "word": "BAPTA/AM", "fig": 2}, {"body": 6, "word": "KN93", "fig": 2}, {"body": 9, "word": "mTOR", "fig": 1}, {"body": 8, "word": "axis", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 4, "word": "western", "fig": 2}, {"body": 3, "word": "blotting", "fig": 2}, {"body": 3, "word": "using", "fig": 2}, {"body": 5, "word": "/CaMK", "fig": 1}, {"body": 5, "word": "PLC-\u03b31/IP3/Ca", "fig": 1}, {"body": 5, "word": "obtained", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 2, "word": "h", "fig": 2}, {"body": 2, "word": "NF-\u03baB", "fig": 2}, {"body": 4, "word": "patients", "fig": 1}, {"body": 2, "word": "p65", "fig": 2}, {"body": 3, "word": "R59949", "fig": 1}, {"body": 2, "word": "advanced", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 2}, {"body": 1, "word": "p-S6", "fig": 2}, {"body": 1, "word": "respectively", "fig": 2}, {"body": 1, "word": "p-p70S6K", "fig": 2}, {"body": 1, "word": "treated", "fig": 2}, {"body": 2, "word": "similar", "fig": 1}, {"body": 1, "word": "rat", "fig": 2}, {"body": 1, "word": "p-mTOR", "fig": 2}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "U73343", "fig": 1}, {"body": 1, "word": "A", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159791/bin/ijms-15-13236-g004.jpg", "caption": "Schematic representation of regulatory mechanism of PLC-\u03b31 in the ECM synthesis of human OA chondrocytes.", "co_occurrence": [{"body": 52, "word": "OA", "fig": 1}, {"body": 38, "word": "chondrocytes", "fig": 1}, {"body": 26, "word": "ECM", "fig": 1}, {"body": 24, "word": "human", "fig": 1}, {"body": 21, "word": "PLC-\u03b31", "fig": 1}, {"body": 15, "word": "synthesis", "fig": 1}, {"body": 2, "word": "mechanism", "fig": 1}, {"body": 2, "word": "regulatory", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159791/bin/ijms-15-13236-g005.jpg", "caption": "The expression of MMP-13, Sox-9, and Col II in normal and OA chondrocytes. (A) The protein expression levels of MMP-13 and Sox-9 in cultured normal and OA chondrocytes were detected with western blotting using rat anti-MMP-13, Sox-9, and GAPDH antibodies according to Materials and Methods; (B) Cultured chondrocytes were fixed in 4% paraformaldehyde for 20 min, and the expression of Col II was detected with immunohistochemistry analysis according to Materials and Method (original magnification \u00d7100).", "co_occurrence": [{"body": 38, "word": "chondrocytes", "fig": 3}, {"body": 52, "word": "OA", "fig": 2}, {"body": 28, "word": "expression", "fig": 3}, {"body": 24, "word": "II", "fig": 2}, {"body": 19, "word": "The", "fig": 2}, {"body": 10, "word": "Sox-9", "fig": 3}, {"body": 14, "word": "Col", "fig": 2}, {"body": 12, "word": "MMP-13", "fig": 2}, {"body": 8, "word": "detected", "fig": 2}, {"body": 8, "word": "normal", "fig": 2}, {"body": 8, "word": "levels", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 5, "word": "cultured", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 2, "word": "according", "fig": 2}, {"body": 4, "word": "western", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "immunohistochemistry", "fig": 1}, {"body": 3, "word": "using", "fig": 1}, {"body": 2, "word": "paraformaldehyde", "fig": 1}, {"body": 1, "word": "Materials", "fig": 2}, {"body": 2, "word": "fixed", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "rat", "fig": 1}, {"body": 1, "word": "min", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}]}], "3762791": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g001.jpg", "caption": "Genomic organization of the mouse Lrig2 gene and the generation and molecular analyses of Lrig2-deficient mice. (A) Schematic drawing of the wild-type, conditional, and disrupted Lrig2 alleles. A PKG-neo selection cassette was inserted downstream of exon 12. Exon 12 and the PKG-neo cassette were flanked by loxP sites and were deleted together, in a single step, by mating with OzCre mice. Color coding is as in C. (B) Southern blot using tail DNA isolated from the offspring of an Lrig2E12+/- \u00d7 Lrig2E12+/- mating. The expected sizes are as follows: wild-type (Lrig2E12+) allele, 11.0 kb; and Lrig2 exon 12-ablated (Lrig2E12-) allele, 6.6 kb. Lane B13 is from Lrig2E12-/-, lanes B10-12 and B14-15 are from Lrig2E12+/-, and the remaining lanes are from Lrig2E12+/+ mice. (C) Genomic organization of the mouse Lrig2 gene. Gene structure of Mus musculus Lrig2 is shown. Gene organization was deduced from the sequence of the mouse genome and the Lrig2 mRNA (GenBank accession number NM_001025067). Exons are indicated with boxes and are drawn to scale. Exon numbers are indicated with numbers. The Lrig2 gene is approximately 58 kb, and it is located on mouse chromosome 3 F2. Color coding depicts the encoded protein domains, including a signal peptide (red), a leucine-rich repeats domain (yellow), three immunoglobulin-like domains (blue), a transmembrane domain (orange), and a cytosolic domain (green). (D) Western blot of MEF cell lines of different Lrig2 genotypes. Top, anti-Lrig2 polyclonal; Bottom, anti-actin. (E) Lrig mRNA levels in mice of different genotypes. The mRNA levels of Lrig1, exon 12-containing Lrig2 (Lrig2E12), exon 17-18 boundary-containing Lrig2 (Lrig2E17-18), and Lrig3 in brains of 3-week old mice were analyzed using quantitative real-time RT-PCR. The Lrig/Rn18s ratio was calculated and normalized to the corresponding ratio in reference RNA from Stratagene. Shown are the means of wild-type (n=6), Lrig2E12+/- (n=5), and Lrig2E12-/- (n=8) mice, with error bars indicating the standard deviations. Significant differences compared with the wild-type mice are indicated with asterisks (*p<0.01 and **p<0.001).", "co_occurrence": [{"body": 104, "word": "mice", "fig": 7}, {"body": 60, "word": "Lrig2", "fig": 10}, {"body": 74, "word": "The", "fig": 4}, {"body": 43, "word": "Lrig2E12-/-", "fig": 2}, {"body": 40, "word": "using", "fig": 2}, {"body": 18, "word": "Lrig2E12+/-", "fig": 4}, {"body": 33, "word": "levels", "fig": 2}, {"body": 9, "word": "mouse", "fig": 4}, {"body": 11, "word": "gene", "fig": 3}, {"body": 16, "word": "genotypes", "fig": 2}, {"body": 14, "word": "different", "fig": 2}, {"body": 23, "word": "Lrig2E12+/+", "fig": 1}, {"body": 21, "word": "analyzed", "fig": 1}, {"body": 13, "word": "shown", "fig": 1}, {"body": 13, "word": "cell", "fig": 1}, {"body": 13, "word": "protein", "fig": 1}, {"body": 3, "word": "exon", "fig": 4}, {"body": 3, "word": "wild-type", "fig": 4}, {"body": 4, "word": "indicated", "fig": 3}, {"body": 11, "word": "differences", "fig": 1}, {"body": 5, "word": "blot", "fig": 2}, {"body": 9, "word": "RNA", "fig": 1}, {"body": 8, "word": "Lrig2E12", "fig": 1}, {"body": 4, "word": "A", "fig": 2}, {"body": 7, "word": "Lrig1", "fig": 1}, {"body": 2, "word": "domain", "fig": 3}, {"body": 2, "word": "mRNA", "fig": 3}, {"body": 6, "word": "analyses", "fig": 1}, {"body": 3, "word": "domains", "fig": 2}, {"body": 6, "word": "Lrig", "fig": 1}, {"body": 6, "word": "three", "fig": 1}, {"body": 6, "word": "brains", "fig": 1}, {"body": 6, "word": "DNA", "fig": 1}, {"body": 5, "word": "tail", "fig": 1}, {"body": 5, "word": "Southern", "fig": 1}, {"body": 2, "word": "allele", "fig": 2}, {"body": 4, "word": "MEF", "fig": 1}, {"body": 4, "word": "Lrig2-deficient", "fig": 1}, {"body": 2, "word": "Exon", "fig": 2}, {"body": 2, "word": "ratio", "fig": 2}, {"body": 4, "word": "cytosolic", "fig": 1}, {"body": 3, "word": "transmembrane", "fig": 1}, {"body": 3, "word": "generation", "fig": 1}, {"body": 3, "word": "Lrig3", "fig": 1}, {"body": 3, "word": "standard", "fig": 1}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 3, "word": "immunoglobulin-like", "fig": 1}, {"body": 3, "word": "single", "fig": 1}, {"body": 3, "word": "compared", "fig": 1}, {"body": 3, "word": "isolated", "fig": 1}, {"body": 2, "word": "alleles", "fig": 1}, {"body": 2, "word": "including", "fig": 1}, {"body": 2, "word": "RT-PCR", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "remaining", "fig": 1}, {"body": 2, "word": "downstream", "fig": 1}, {"body": 1, "word": "Genomic", "fig": 2}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 1, "word": "Gene", "fig": 2}, {"body": 2, "word": "molecular", "fig": 1}, {"body": 2, "word": "lines", "fig": 1}, {"body": 1, "word": "peptide", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "disrupted", "fig": 1}, {"body": 1, "word": "Lrig2E17-18", "fig": 1}, {"body": 1, "word": "old", "fig": 1}, {"body": 1, "word": "scale", "fig": 1}, {"body": 1, "word": "deleted", "fig": 1}, {"body": 1, "word": "error", "fig": 1}, {"body": 1, "word": "step", "fig": 1}, {"body": 1, "word": "number", "fig": 1}, {"body": 1, "word": "approximately", "fig": 1}, {"body": 1, "word": "anti-actin", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "real-time", "fig": 1}, {"body": 1, "word": "Lrig2E12+", "fig": 1}, {"body": 1, "word": "offspring", "fig": 1}, {"body": 1, "word": "loxP", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}, {"body": 1, "word": "repeats", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}, {"body": 1, "word": "together", "fig": 1}, {"body": 1, "word": "polyclonal", "fig": 1}, {"body": 1, "word": "drawing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g002.jpg", "caption": "Lrig2-deficient mice have increased spontaneous mortality and show transiently reduced body weight compared with wild-type and heterozygous littermates. Kaplan-Meier curves for the survival of male (A) and female (B) C57BL/6 mice of the different Lrig2 genotypes based on 153 male and159 female mice. (C) There were no significant differences in embryonic weight at E13.5 or at birth, but by 5 days of age, the Lrig2E12-/- mice were significantly lighter than the Lrig2E12+/+ and Lrig2E12+/- mice (* p<0.05). Male (D) and female (E) Lrig2E12-/- mice had a lower body weight than the Lrig2E12+/+ and Lrig2E12+/- mice from 3 to 10 weeks of age. At 12 weeks of age, the male (F) (p = 0.019), but not the female (G) (p = 0.051), Lrig2E12-/- mice were significantly smaller than Lrig2E12+/+ and Lrig2E12+/- mice, and at 15 weeks or older, all genotypes had a similar body weight. At least eight mice were included per genotype and sex for all ages.", "co_occurrence": [{"body": 104, "word": "mice", "fig": 10}, {"body": 43, "word": "Lrig2E12-/-", "fig": 3}, {"body": 23, "word": "Lrig2E12+/+", "fig": 3}, {"body": 60, "word": "Lrig2", "fig": 1}, {"body": 18, "word": "Lrig2E12+/-", "fig": 3}, {"body": 16, "word": "age", "fig": 3}, {"body": 8, "word": "weight", "fig": 4}, {"body": 16, "word": "genotypes", "fig": 2}, {"body": 10, "word": "body", "fig": 3}, {"body": 9, "word": "weeks", "fig": 3}, {"body": 6, "word": "female", "fig": 4}, {"body": 7, "word": "p", "fig": 3}, {"body": 6, "word": "male", "fig": 3}, {"body": 14, "word": "different", "fig": 1}, {"body": 12, "word": "days", "fig": 1}, {"body": 11, "word": "differences", "fig": 1}, {"body": 11, "word": "significant", "fig": 1}, {"body": 4, "word": "significantly", "fig": 2}, {"body": 4, "word": "At", "fig": 2}, {"body": 7, "word": "C57BL/6", "fig": 1}, {"body": 7, "word": "survival", "fig": 1}, {"body": 7, "word": "genotype", "fig": 1}, {"body": 6, "word": "There", "fig": 1}, {"body": 6, "word": "lower", "fig": 1}, {"body": 5, "word": "mortality", "fig": 1}, {"body": 5, "word": "least", "fig": 1}, {"body": 4, "word": "show", "fig": 1}, {"body": 4, "word": "Lrig2-deficient", "fig": 1}, {"body": 4, "word": "reduced", "fig": 1}, {"body": 4, "word": "increased", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "E13.5", "fig": 1}, {"body": 3, "word": "wild-type", "fig": 1}, {"body": 3, "word": "spontaneous", "fig": 1}, {"body": 3, "word": "curves", "fig": 1}, {"body": 3, "word": "compared", "fig": 1}, {"body": 2, "word": "Kaplan-Meier", "fig": 1}, {"body": 2, "word": "similar", "fig": 1}, {"body": 2, "word": "smaller", "fig": 1}, {"body": 2, "word": "transiently", "fig": 1}, {"body": 2, "word": "eight", "fig": 1}, {"body": 2, "word": "included", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "birth", "fig": 1}, {"body": 1, "word": "embryonic", "fig": 1}, {"body": 1, "word": "sex", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "Male", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "littermates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g003.jpg", "caption": "Histological and in situ hybridization analyses of PDGFB-induced mouse brain tumors. Newborn mice were transduced intracranially with PDGFB-encoding RCAS retroviruses. At 12 weeks of age, the mice were sacrificed, and the histological sections were prepared. (A) A hematoxylin-eosin-stained section showing a tumor resembling human oligodendroglioma, WHO grade II/III (low grade). The tumor tissue showed moderate cellularity and was composed of monomorphic cells with uniform, round nuclei. Original magnification 200X. (B) A hematoxylin-eosin-stained section showing a tumor resembling human glioblastoma, WHO grade IV (high grade), with pseudopalisading necroses. Original magnification 100X. (C) A hematoxylin-eosin stained section showing a high grade glioma with pseudopalisading necroses (arrow) and frequent mitoses. Original magnification 200X. (D) Magnification of C, mitoses are shown with arrows. (E) In situ hybridization analysis of Lrig2 in high grade glioma. The in situ hybridization signals are shown as red dots. Original magnification 400X. (F) In situ hybridization analysis of the same tumor as in E, using a negative control probe, showing low non-specific background staining.", "co_occurrence": [{"body": 104, "word": "mice", "fig": 2}, {"body": 74, "word": "The", "fig": 2}, {"body": 15, "word": "grade", "fig": 6}, {"body": 60, "word": "Lrig2", "fig": 1}, {"body": 50, "word": "cells", "fig": 1}, {"body": 12, "word": "tumor", "fig": 4}, {"body": 24, "word": "In", "fig": 2}, {"body": 40, "word": "using", "fig": 1}, {"body": 13, "word": "shown", "fig": 2}, {"body": 11, "word": "analysis", "fig": 2}, {"body": 21, "word": "tumors", "fig": 1}, {"body": 8, "word": "glioma", "fig": 2}, {"body": 4, "word": "A", "fig": 4}, {"body": 16, "word": "age", "fig": 1}, {"body": 15, "word": "showed", "fig": 1}, {"body": 7, "word": "human", "fig": 2}, {"body": 4, "word": "high", "fig": 3}, {"body": 3, "word": "situ", "fig": 4}, {"body": 12, "word": "oligodendroglioma", "fig": 1}, {"body": 10, "word": "brain", "fig": 1}, {"body": 9, "word": "weeks", "fig": 1}, {"body": 9, "word": "mouse", "fig": 1}, {"body": 2, "word": "hybridization", "fig": 4}, {"body": 2, "word": "showing", "fig": 4}, {"body": 4, "word": "low", "fig": 2}, {"body": 6, "word": "analyses", "fig": 1}, {"body": 6, "word": "PDGFB-induced", "fig": 1}, {"body": 5, "word": "histological", "fig": 1}, {"body": 4, "word": "stained", "fig": 1}, {"body": 4, "word": "background", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 2, "word": "WHO", "fig": 2}, {"body": 4, "word": "tissue", "fig": 1}, {"body": 4, "word": "At", "fig": 1}, {"body": 3, "word": "probe", "fig": 1}, {"body": 3, "word": "RCAS", "fig": 1}, {"body": 3, "word": "hematoxylin-eosin", "fig": 1}, {"body": 3, "word": "PDGFB-encoding", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "intracranially", "fig": 1}, {"body": 2, "word": "transduced", "fig": 1}, {"body": 2, "word": "moderate", "fig": 1}, {"body": 1, "word": "necroses", "fig": 2}, {"body": 2, "word": "glioblastoma", "fig": 1}, {"body": 1, "word": "pseudopalisading", "fig": 2}, {"body": 1, "word": "resembling", "fig": 2}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "Histological", "fig": 1}, {"body": 1, "word": "retroviruses", "fig": 1}, {"body": 1, "word": "composed", "fig": 1}, {"body": 1, "word": "prepared", "fig": 1}, {"body": 1, "word": "non-specific", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "IV", "fig": 1}, {"body": 1, "word": "Newborn", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g004.jpg", "caption": "The transduction efficiency of RCAS-PDGFB-HA in Ntv-a cells of different Lrig2 genotypes. Neural cells from brains of newborn Ntv-a transgenic mice were transduced with RCAS-PDGFB-HA in vitro. After 5 days of infection, cells were stained with fluorescent anti-HA antibodies (green) and analyzed using fluorescence microscopy. Cell nuclei were counter-stained with DAPI (blue). (A) Wild-type (Lrig2E12+/+) cells. (B) Heterozygous (Lrig2E12+/-) cells. (C) Lrig2-defecient (Lrig2E12-/-) cells. (D) Quantifications of transduction efficiencies. Shown are the means from three independent experiments, including wild-type (n=7), heterozygous (n=12), and Lrig2-deficient (n=7) cell lines from three different litters, with standard deviations indicated by error bars. There were no apparent differences in the transduction efficiency between cells of different Lrig2 genotypes.", "co_occurrence": [{"body": 50, "word": "cells", "fig": 7}, {"body": 60, "word": "Lrig2", "fig": 2}, {"body": 104, "word": "mice", "fig": 1}, {"body": 74, "word": "The", "fig": 1}, {"body": 43, "word": "Lrig2E12-/-", "fig": 1}, {"body": 14, "word": "different", "fig": 3}, {"body": 40, "word": "using", "fig": 1}, {"body": 16, "word": "genotypes", "fig": 2}, {"body": 23, "word": "Lrig2E12+/+", "fig": 1}, {"body": 21, "word": "analyzed", "fig": 1}, {"body": 10, "word": "Ntv-a", "fig": 2}, {"body": 18, "word": "Lrig2E12+/-", "fig": 1}, {"body": 13, "word": "cell", "fig": 1}, {"body": 6, "word": "three", "fig": 2}, {"body": 12, "word": "days", "fig": 1}, {"body": 11, "word": "differences", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 3, "word": "transduction", "fig": 3}, {"body": 9, "word": "transgenic", "fig": 1}, {"body": 6, "word": "There", "fig": 1}, {"body": 3, "word": "RCAS-PDGFB-HA", "fig": 2}, {"body": 6, "word": "brains", "fig": 1}, {"body": 3, "word": "efficiency", "fig": 2}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 4, "word": "stained", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 4, "word": "apparent", "fig": 1}, {"body": 4, "word": "Lrig2-deficient", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "wild-type", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "After", "fig": 1}, {"body": 3, "word": "standard", "fig": 1}, {"body": 2, "word": "n=12", "fig": 1}, {"body": 2, "word": "vitro", "fig": 1}, {"body": 2, "word": "including", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "infection", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "transduced", "fig": 1}, {"body": 2, "word": "lines", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 1, "word": "newborn", "fig": 1}, {"body": 1, "word": "Heterozygous", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Neural", "fig": 1}, {"body": 1, "word": "litters", "fig": 1}, {"body": 1, "word": "error", "fig": 1}, {"body": 1, "word": "fluorescent", "fig": 1}, {"body": 1, "word": "fluorescence", "fig": 1}, {"body": 1, "word": "microscopy", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g005.jpg", "caption": "Pdgfr levels in serum-starved primary MEFs. Wild-type (Lrig2E12+/+), heterozygous (Lrig2E12+/-), or Lrig2-deficient (Lrig2E12-/-) MEF cell lines were serum-starved for the indicated times followed by analysis of Pdgfr levels using immunofluorescence microscopy (A\u2013H) or immunoblotting (I\u2013L). (A\u2013H) Cells were serum starved for 24 hours followed by analysis of Pdgfr\u03b1 (A\u2013D) or Pdgfr\u03b2 (E\u2013H) levels using immunofluorescence microscopy. Pdgfr immunoreactivity was visualized with Alexa-conjugated secondary antibodies (red), and the nuclei were counter-stained with DAPI (blue). (D, H) Quantifications of the Pdgfr\u03b1 and Pdgfr\u03b2 immunofluorescence levels, respectively. Shown are the means from three independent experiments, including wild-type (n=8), heterozygous (n=9), and Lrig2-deficient (n=6) cell lines from three different litters, with standard deviations indicated by error bars. There were no differences observed in Pdgfr\u03b1 or Pdgfr\u03b2 protein levels, as determined by quantitative immunofluorescence microscopy, between cells of different Lrig2 genotypes. (I\u2013L) Cells were serum starved for 0, 6, 12 or 24 hours followed by cell lysis and Western blot analyses with antibodies against Pdgfr\u03b1, Pdgfr\u03b2, or, as a loading control, actin. Representative immunoblots of Pdgfr\u03b1 (I) and Pdgfr\u03b2 (J) in wild-type (Lrig2E12+/+), heterozygous (Lrig2E12+/-), and Lrig2-deficient (Lrig2E12-/-) cells after 0 or 24 hours of serum starvation. (K\u2013L) Quantifications of Pdgfr\u03b1 (K) and Pdgfr\u03b2 (L) immunoblots in wild-type, heterozygotes and Lrig2-deficient cells after 0, 6, 12 and 24 h starvation. Shown are the means from three independent experiments including wild-type (n=8), heterozygous (n=9), and Lrig2-deficient (n=6) cell lines from three different litters, with standard deviations indicated by error bars. There were no differences observed in Pdgfr\u03b1 or Pdgfr\u03b2 protein levels as determined by immunoblotting, between cells of different Lrig2 genotypes.", "co_occurrence": [{"body": 50, "word": "cells", "fig": 4}, {"body": 33, "word": "levels", "fig": 6}, {"body": 60, "word": "Lrig2", "fig": 2}, {"body": 43, "word": "Lrig2E12-/-", "fig": 2}, {"body": 40, "word": "using", "fig": 2}, {"body": 14, "word": "different", "fig": 4}, {"body": 13, "word": "cell", "fig": 4}, {"body": 23, "word": "Lrig2E12+/+", "fig": 2}, {"body": 15, "word": "Pdgfr", "fig": 3}, {"body": 18, "word": "Lrig2E12+/-", "fig": 2}, {"body": 16, "word": "genotypes", "fig": 2}, {"body": 4, "word": "Pdgfr\u03b1", "fig": 7}, {"body": 13, "word": "protein", "fig": 2}, {"body": 6, "word": "three", "fig": 4}, {"body": 11, "word": "differences", "fig": 2}, {"body": 11, "word": "analysis", "fig": 2}, {"body": 7, "word": "followed", "fig": 3}, {"body": 3, "word": "Pdgfr\u03b2", "fig": 7}, {"body": 4, "word": "Lrig2-deficient", "fig": 5}, {"body": 10, "word": "antibodies", "fig": 2}, {"body": 6, "word": "observed", "fig": 2}, {"body": 6, "word": "There", "fig": 2}, {"body": 3, "word": "wild-type", "fig": 4}, {"body": 4, "word": "indicated", "fig": 3}, {"body": 11, "word": "MEFs", "fig": 1}, {"body": 10, "word": "primary", "fig": 1}, {"body": 3, "word": "hours", "fig": 3}, {"body": 4, "word": "determined", "fig": 2}, {"body": 2, "word": "immunofluorescence", "fig": 4}, {"body": 3, "word": "experiments", "fig": 2}, {"body": 3, "word": "standard", "fig": 2}, {"body": 6, "word": "analyses", "fig": 1}, {"body": 2, "word": "serum", "fig": 3}, {"body": 2, "word": "lines", "fig": 3}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "secondary", "fig": 1}, {"body": 5, "word": "times", "fig": 1}, {"body": 2, "word": "including", "fig": 2}, {"body": 2, "word": "Cells", "fig": 2}, {"body": 2, "word": "starvation", "fig": 2}, {"body": 2, "word": "independent", "fig": 2}, {"body": 2, "word": "serum-starved", "fig": 2}, {"body": 4, "word": "control", "fig": 1}, {"body": 4, "word": "MEF", "fig": 1}, {"body": 2, "word": "n=9", "fig": 2}, {"body": 1, "word": "microscopy", "fig": 3}, {"body": 2, "word": "visualized", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "lysis", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 1, "word": "litters", "fig": 2}, {"body": 2, "word": "respectively", "fig": 1}, {"body": 1, "word": "error", "fig": 2}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "heterozygotes", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g006.jpg", "caption": "Expression level analyses of co-transfected LRIG1, LRIG2, and PDGFR\u03b1. HEK-293T cells were co-transfected with expression vectors encoding myc-LRIG1 or FLAG-LRIG2 and PDGFR\u03b1. The numbers indicate amount of plasmid (\u03bcg) used in the respective transfection. Empty pcDNA 3.1 and p3XFLAG-CMV-13, respectively, were used to bring the total amount of plasmid DNA to the same amount (2 \u00b5g) in each transfection. Cell extracts were analyzed by Western blotting with antibodies against LRIG1, PDGFR\u03b1, FLAG (recognizing FLAG-LRIG2), or, as a loading control, actin. (A, C) Representative Western blots. Two specific PDGFR\u03b1 bands were observed, here called PDGFR\u03b1-upper and PDGFR\u03b1-lower, respectively. (B, D) Quantification of PDGFR\u03b1 immunoblots. Shown are the means of four independent co-transfection experiments, with error bars indicating the standard deviations. Significant differences compared with the empty vector control are indicated with asterisks (*p<0.05).", "co_occurrence": [{"body": 74, "word": "The", "fig": 1}, {"body": 50, "word": "cells", "fig": 1}, {"body": 21, "word": "analyzed", "fig": 1}, {"body": 4, "word": "PDGFR\u03b1", "fig": 5}, {"body": 19, "word": "expression", "fig": 1}, {"body": 17, "word": "LRIG2", "fig": 1}, {"body": 8, "word": "used", "fig": 2}, {"body": 7, "word": "LRIG1", "fig": 2}, {"body": 11, "word": "differences", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 4, "word": "control", "fig": 2}, {"body": 6, "word": "observed", "fig": 1}, {"body": 6, "word": "analyses", "fig": 1}, {"body": 6, "word": "DNA", "fig": 1}, {"body": 3, "word": "co-transfected", "fig": 2}, {"body": 5, "word": "level", "fig": 1}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 2, "word": "Western", "fig": 2}, {"body": 4, "word": "vector", "fig": 1}, {"body": 2, "word": "respectively", "fig": 2}, {"body": 4, "word": "encoding", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "transfection", "fig": 2}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "specific", "fig": 1}, {"body": 3, "word": "standard", "fig": 1}, {"body": 3, "word": "vectors", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "called", "fig": 1}, {"body": 3, "word": "respective", "fig": 1}, {"body": 3, "word": "compared", "fig": 1}, {"body": 2, "word": "blotting", "fig": 1}, {"body": 2, "word": "HEK-293T", "fig": 1}, {"body": 1, "word": "plasmid", "fig": 2}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "bands", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 1}, {"body": 1, "word": "indicate", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "error", "fig": 1}, {"body": 1, "word": "pcDNA", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g007.jpg", "caption": "The length of the primary cilia in growth-arrested primary MEFs. Wild-type, heterozygous, and Lrig2-deficient cells were serum starved for 24 hours followed by staining of primary cilia with antibodies against acetylated tubulin (red). The cell nuclei were counter-stained with DAPI (blue). Representative confocal immunofluorescence micrographs of: (A) wild-type (Lrig2E12+/+) cells, (B) heterozygous (Lrig2E12+/-) cells, and (C) Lrig2-defecient (Lrig2E12-/-) cells. (D) Quantification of primary cilia length. Shown are the means from three independent experiments including wild-type (n=8), heterozygous (n=9), and Lrig2-deficient (n=6) cell lines from three different litters, with standard deviation indicated by error bars. There were no differences observed in the abundance (data not shown) or the length of primary cilia in cells of different Lrig2 genotypes.", "co_occurrence": [{"body": 50, "word": "cells", "fig": 5}, {"body": 74, "word": "The", "fig": 2}, {"body": 60, "word": "Lrig2", "fig": 1}, {"body": 10, "word": "primary", "fig": 5}, {"body": 43, "word": "Lrig2E12-/-", "fig": 1}, {"body": 14, "word": "different", "fig": 2}, {"body": 13, "word": "cell", "fig": 2}, {"body": 23, "word": "Lrig2E12+/+", "fig": 1}, {"body": 18, "word": "Lrig2E12+/-", "fig": 1}, {"body": 4, "word": "cilia", "fig": 4}, {"body": 16, "word": "genotypes", "fig": 1}, {"body": 13, "word": "shown", "fig": 1}, {"body": 6, "word": "three", "fig": 2}, {"body": 11, "word": "differences", "fig": 1}, {"body": 11, "word": "MEFs", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 4, "word": "Lrig2-deficient", "fig": 2}, {"body": 7, "word": "followed", "fig": 1}, {"body": 6, "word": "There", "fig": 1}, {"body": 3, "word": "wild-type", "fig": 2}, {"body": 6, "word": "observed", "fig": 1}, {"body": 2, "word": "length", "fig": 3}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "standard", "fig": 1}, {"body": 3, "word": "hours", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "including", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "immunofluorescence", "fig": 1}, {"body": 2, "word": "serum", "fig": 1}, {"body": 2, "word": "n=9", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "lines", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "litters", "fig": 1}, {"body": 1, "word": "error", "fig": 1}, {"body": 1, "word": "abundance", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g008.jpg", "caption": "The effect of Lrig2 on the induction of immediate-early gene expression. Wild-type (Lrig2E12+/+), heterozygous (Lrig2E12+/-), or Lrig2-deficient (Lrig2E12-/-) MEFs were serum starved for 24 hours followed by stimulation with PDGF-BB for 0, 10, 20, 40, 60, or 120 minutes. Thereafter, total RNA was prepared, and gene expression was quantified using real-time RT-PCR. Samples were run in triplicate, and the specific mRNA levels were normalized to respective Rn18s levels. Shown are the specific mRNA/Rn18s ratios on arbitrary scales. (A) Kinetics of relative Fos expression in cells stimulated with 50 ng/ml PDGF-BB. Shown are the means from three independent experiments, including wild-type (n=8), heterozygous (n=9), and Lrig2-deficient (n=6) cell lines from three different litters, with standard error of the means indicated by error bars. (B) Kinetics of relative Egr2 expression levels in cells stimulated with 10 ng/ml PDGF-BB. Shown are the means from two independent experiments, including wild-type (n=6), heterozygous (n=6), and Lrig2-deficient (n=4) cell lines from two different litters, with standard error of the means indicated by error bars. Compared with wild-type cells, the Lrig2-deficient cells showed altered and faster kinetics of induction of both Fos and Egr2 expression in response to PDGF-BB stimulation. Significant differences compared with the wild-type cell lines are indicated with asterisks (*p<0.05 and **p<0.01).", "co_occurrence": [{"body": 50, "word": "cells", "fig": 4}, {"body": 33, "word": "levels", "fig": 3}, {"body": 19, "word": "expression", "fig": 5}, {"body": 74, "word": "The", "fig": 1}, {"body": 60, "word": "Lrig2", "fig": 1}, {"body": 11, "word": "PDGF-BB", "fig": 4}, {"body": 43, "word": "Lrig2E12-/-", "fig": 1}, {"body": 40, "word": "using", "fig": 1}, {"body": 13, "word": "cell", "fig": 3}, {"body": 14, "word": "different", "fig": 2}, {"body": 23, "word": "Lrig2E12+/+", "fig": 1}, {"body": 11, "word": "gene", "fig": 2}, {"body": 18, "word": "Lrig2E12+/-", "fig": 1}, {"body": 9, "word": "Fos", "fig": 2}, {"body": 4, "word": "Lrig2-deficient", "fig": 4}, {"body": 15, "word": "showed", "fig": 1}, {"body": 7, "word": "Egr2", "fig": 2}, {"body": 13, "word": "minutes", "fig": 1}, {"body": 6, "word": "induction", "fig": 2}, {"body": 3, "word": "wild-type", "fig": 4}, {"body": 6, "word": "three", "fig": 2}, {"body": 6, "word": "stimulation", "fig": 2}, {"body": 6, "word": "ng/ml", "fig": 2}, {"body": 4, "word": "indicated", "fig": 3}, {"body": 11, "word": "MEFs", "fig": 1}, {"body": 11, "word": "differences", "fig": 1}, {"body": 9, "word": "RNA", "fig": 1}, {"body": 4, "word": "two", "fig": 2}, {"body": 7, "word": "followed", "fig": 1}, {"body": 3, "word": "experiments", "fig": 2}, {"body": 3, "word": "specific", "fig": 2}, {"body": 3, "word": "standard", "fig": 2}, {"body": 3, "word": "stimulated", "fig": 2}, {"body": 2, "word": "lines", "fig": 3}, {"body": 5, "word": "immediate-early", "fig": 1}, {"body": 5, "word": "effect", "fig": 1}, {"body": 2, "word": "including", "fig": 2}, {"body": 2, "word": "relative", "fig": 2}, {"body": 1, "word": "error", "fig": 4}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "independent", "fig": 2}, {"body": 3, "word": "hours", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "respective", "fig": 1}, {"body": 3, "word": "compared", "fig": 1}, {"body": 3, "word": "altered", "fig": 1}, {"body": 2, "word": "mRNA/Rn18s", "fig": 1}, {"body": 1, "word": "litters", "fig": 2}, {"body": 2, "word": "mRNA", "fig": 1}, {"body": 2, "word": "RT-PCR", "fig": 1}, {"body": 2, "word": "Rn18s", "fig": 1}, {"body": 1, "word": "Kinetics", "fig": 2}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 2, "word": "serum", "fig": 1}, {"body": 2, "word": "n=9", "fig": 1}, {"body": 2, "word": "response", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "arbitrary", "fig": 1}, {"body": 1, "word": "Compared", "fig": 1}, {"body": 1, "word": "ratios", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "real-time", "fig": 1}, {"body": 1, "word": "kinetics", "fig": 1}, {"body": 1, "word": "n=4", "fig": 1}, {"body": 1, "word": "prepared", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762791/bin/pone.0073635.g009.jpg", "caption": "PDGF induced phosphorylation events in cells of different Lrig2 genotypes. Wild-type, heterozygous, or Lrig2-deficient MEFs were serum starved for 24 hours followed by stimulation with 50 ng/ml PDGF-BB for different times. (A\u2013N) Cells were untreated or stimulated with 50 ng/ml PDGF-BB for 10 minutes followed by cell fixation and analysis of the phosphorylation status of respective Pdgfr by in situ proximity ligation assay (PLA). Phosphorylated Pdgfr was visualized using fluorescence (red spots). Cell nuclei were counter-stained with DAPI (blue). (A\u2013F) Representative PLA images of phosphorylated Pdgfr\u03b1 (red spots) in un-stimulated (A\u2013C) or PDGF-BB stimulated (D\u2013F) cells of the indicated Lrig2 genotypes. (G\u2013L) Representative PLA images of phosphorylated Pdgfr\u03b2 (red spots) in non-stimulated (G\u2013I) or PDGF-BB-stimulated (J\u2013L) cells of the indicated Lrig2 genotypes. (M) Quantification of PLA spots for phosphorylated Pdgfr\u03b1. Shown are the means from three independent experiments, including wild-type (Lrig2E12+/+, n=8), heterozygous (Lrig2E12+/-, n=9), and Lrig2-deficient (Lrig2E12-/-, n=6) cell lines from three different litters, with standard deviations indicated by error bars. (N) Quantification of PLA spots for phosphorylated Pdgfr\u03b2. Shown are the means from three independent experiments, including wild-type (Lrig2E12+/+, n=8), heterozygous (Lrig2E12+/-, n=9), and Lrig2-deficient (Lrig2E12-/-, n=5) cell lines from three different litters, with standard deviations indicated by error bars. There were no differences observed in the levels of activated Pdgfr\u03b1 or Pdgfr\u03b2 between cells of different genotypes. (O\u2013Q) Cell lysates from cells that had been untreated or treated with 50 ng/ml PDGF-BB for 15 minutes were analyzed through Western blotting with antibodies against the indicated proteins. (O) A representative Western blot is shown of Akt, Erk1/2, phosphorylated Akt (pAkt), and phosphorylated Erk1/2 (pErk1/2) using cell lysates from cells of the indicated Lrig2 genotypes that had been untreated (-) or treated (+) with PDGF-BB. (P) Quantification of pAkt/Akt-ratios for non-stimulated and stimulated cells, respectively. Shown are the means from three independent experiments, including wild-type (n=8), heterozygous (n=9), and Lrig2-deficient (n=5) cell lines from three different litters, with standard deviations indicated by error bars. (Q) Quantification of pErk1/2/Erk1/2-ratios for non-stimulated and stimulated cells, respectively. Shown are the means and corresponding standard deviations as for P.", "co_occurrence": [{"body": 50, "word": "cells", "fig": 8}, {"body": 60, "word": "Lrig2", "fig": 4}, {"body": 43, "word": "Lrig2E12-/-", "fig": 2}, {"body": 14, "word": "different", "fig": 6}, {"body": 40, "word": "using", "fig": 2}, {"body": 16, "word": "genotypes", "fig": 5}, {"body": 13, "word": "cell", "fig": 5}, {"body": 11, "word": "PDGF-BB", "fig": 5}, {"body": 23, "word": "Lrig2E12+/+", "fig": 2}, {"body": 18, "word": "Lrig2E12+/-", "fig": 2}, {"body": 6, "word": "three", "fig": 6}, {"body": 33, "word": "levels", "fig": 1}, {"body": 15, "word": "Pdgfr", "fig": 2}, {"body": 4, "word": "indicated", "fig": 7}, {"body": 13, "word": "minutes", "fig": 2}, {"body": 21, "word": "analyzed", "fig": 1}, {"body": 6, "word": "ng/ml", "fig": 3}, {"body": 4, "word": "Lrig2-deficient", "fig": 4}, {"body": 7, "word": "phosphorylation", "fig": 2}, {"body": 7, "word": "followed", "fig": 2}, {"body": 13, "word": "shown", "fig": 1}, {"body": 4, "word": "Pdgfr\u03b1", "fig": 3}, {"body": 3, "word": "standard", "fig": 4}, {"body": 2, "word": "phosphorylated", "fig": 6}, {"body": 3, "word": "stimulated", "fig": 4}, {"body": 6, "word": "Akt", "fig": 2}, {"body": 11, "word": "MEFs", "fig": 1}, {"body": 11, "word": "PDGF", "fig": 1}, {"body": 11, "word": "differences", "fig": 1}, {"body": 11, "word": "analysis", "fig": 1}, {"body": 5, "word": "Cell", "fig": 2}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 2, "word": "PLA", "fig": 5}, {"body": 3, "word": "experiments", "fig": 3}, {"body": 3, "word": "wild-type", "fig": 3}, {"body": 3, "word": "Pdgfr\u03b2", "fig": 3}, {"body": 8, "word": "induced", "fig": 1}, {"body": 2, "word": "including", "fig": 3}, {"body": 6, "word": "proteins", "fig": 1}, {"body": 6, "word": "observed", "fig": 1}, {"body": 3, "word": "Erk1/2", "fig": 2}, {"body": 3, "word": "lysates", "fig": 2}, {"body": 6, "word": "There", "fig": 1}, {"body": 6, "word": "stimulation", "fig": 1}, {"body": 2, "word": "n=9", "fig": 3}, {"body": 2, "word": "independent", "fig": 3}, {"body": 2, "word": "lines", "fig": 3}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "times", "fig": 1}, {"body": 2, "word": "Western", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "images", "fig": 2}, {"body": 2, "word": "respectively", "fig": 2}, {"body": 1, "word": "Quantification", "fig": 4}, {"body": 1, "word": "litters", "fig": 3}, {"body": 1, "word": "error", "fig": 3}, {"body": 3, "word": "hours", "fig": 1}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 3, "word": "situ", "fig": 1}, {"body": 3, "word": "events", "fig": 1}, {"body": 3, "word": "respective", "fig": 1}, {"body": 2, "word": "visualized", "fig": 1}, {"body": 2, "word": "blotting", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 1, "word": "treated", "fig": 2}, {"body": 2, "word": "ligation", "fig": 1}, {"body": 2, "word": "serum", "fig": 1}, {"body": 1, "word": "activated", "fig": 1}, {"body": 1, "word": "M", "fig": 1}, {"body": 1, "word": "fluorescence", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}], "4001315": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001315/bin/cddis2014162f1.jpg", "caption": "Hepatic autophagy flux is impaired in NAS and NASH patients. Analysis of ER stress and autophagy markers in human liver samples from NL (n=34) individuals and NAS (n=26) and NASH (n=23) patients. (a) qPCR analysis from all samples. The fold induction value for triplicate wells was averaged and data are presented as mean\u00b1S.E.M. relative to NL. (b) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to all patients, data are presented as mean\u00b1S.E.M. relative to NL. (c) Representative anti-LC3 immunostaining in liver sections. (d) Representative images from H&E and Masson's trichrome staining. *P<0.05, **P<0.01 and ***P<0.005, NAS or NASH, respectively, versus NL; #P<0.05, ##P<0.01 and ###P<0.005, NASH versus NAS", "co_occurrence": [{"body": 33, "word": "NASH", "fig": 4}, {"body": 34, "word": "patients", "fig": 3}, {"body": 23, "word": "NAS", "fig": 4}, {"body": 38, "word": "liver", "fig": 2}, {"body": 27, "word": "autophagy", "fig": 2}, {"body": 13, "word": "NL", "fig": 4}, {"body": 30, "word": "flux", "fig": 1}, {"body": 27, "word": "ER", "fig": 1}, {"body": 13, "word": "samples", "fig": 2}, {"body": 24, "word": "stress", "fig": 1}, {"body": 18, "word": "human", "fig": 1}, {"body": 16, "word": "The", "fig": 1}, {"body": 8, "word": "analysis", "fig": 2}, {"body": 7, "word": "data", "fig": 2}, {"body": 3, "word": "P", "fig": 3}, {"body": 9, "word": "'s", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 7, "word": "sections", "fig": 1}, {"body": 7, "word": "individuals", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 5, "word": "markers", "fig": 1}, {"body": 4, "word": "E", "fig": 1}, {"body": 4, "word": "induction", "fig": 1}, {"body": 4, "word": "H", "fig": 1}, {"body": 2, "word": "presented", "fig": 2}, {"body": 4, "word": "Masson", "fig": 1}, {"body": 3, "word": "qPCR", "fig": 1}, {"body": 3, "word": "impaired", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 3, "word": "trichrome", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 1, "word": "versus", "fig": 2}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "anti-LC3", "fig": 1}, {"body": 2, "word": "Hepatic", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "triplicate", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "b", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001315/bin/cddis2014162f2.jpg", "caption": "Increased ER stress correlates with accumulation of p62 and LC3-II in livers of HFD-fed mice. Analysis of ER stress, autophagy and apoptosis in liver samples from C57BL6 mice fed with CHD or HFD for 30 weeks (n=8 animals per condition). (a) Representative images from H&E and Masson's trichrome staining. (b\u2013e) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to all samples, data are presented as mean\u00b1S.E.M. relative to CHD liver. (f) Representative anti-LC3 immunostaining (upper panel), EM images (middle panel) and TUNEL assay staining images (lower panel). *P<0.05 and **P<0.01, HFD versus CHD", "co_occurrence": [{"body": 38, "word": "liver", "fig": 2}, {"body": 27, "word": "ER", "fig": 2}, {"body": 24, "word": "stress", "fig": 2}, {"body": 22, "word": "mice", "fig": 2}, {"body": 27, "word": "autophagy", "fig": 1}, {"body": 13, "word": "samples", "fig": 2}, {"body": 25, "word": "p62", "fig": 1}, {"body": 24, "word": "accumulation", "fig": 1}, {"body": 20, "word": "LC3-II", "fig": 1}, {"body": 6, "word": "CHD", "fig": 3}, {"body": 8, "word": "staining", "fig": 2}, {"body": 7, "word": "HFD", "fig": 2}, {"body": 10, "word": "fed", "fig": 1}, {"body": 9, "word": "'s", "fig": 1}, {"body": 9, "word": "apoptosis", "fig": 1}, {"body": 8, "word": "EM", "fig": 1}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 7, "word": "data", "fig": 1}, {"body": 2, "word": "images", "fig": 3}, {"body": 6, "word": "HFD-fed", "fig": 1}, {"body": 5, "word": "livers", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 4, "word": "E", "fig": 1}, {"body": 4, "word": "H", "fig": 1}, {"body": 4, "word": "weeks", "fig": 1}, {"body": 4, "word": "TUNEL", "fig": 1}, {"body": 4, "word": "Masson", "fig": 1}, {"body": 3, "word": "lower", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 3, "word": "trichrome", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "anti-LC3", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 1, "word": "Increased", "fig": 1}, {"body": 1, "word": "versus", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "animals", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "correlates", "fig": 1}, {"body": 1, "word": "C57BL6", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001315/bin/cddis2014162f3.jpg", "caption": "Increased ER stress correlates with accumulation of p62 and LC3-II in livers of MCD diet-fed mice. Analysis of ER stress, autophagy and apoptosis in liver samples from C57BL6 mice fed with CHD or MCD for 4 weeks (n=10 animals per condition). (a) Representative images from H&E and Masson's trichrome staining. (b\u2013e) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to all samples, data are presented as mean\u00b1S.E.M. relative to CHD liver. (f) Representative anti-LC3 immunostaining (upper panel), EM images (middle panel) and TUNEL assay staining images (lower panel). #P<0.05 and ###P<0.005, MCD versus CHD", "co_occurrence": [{"body": 38, "word": "liver", "fig": 2}, {"body": 27, "word": "ER", "fig": 2}, {"body": 24, "word": "stress", "fig": 2}, {"body": 22, "word": "mice", "fig": 2}, {"body": 27, "word": "autophagy", "fig": 1}, {"body": 9, "word": "MCD", "fig": 3}, {"body": 13, "word": "samples", "fig": 2}, {"body": 25, "word": "p62", "fig": 1}, {"body": 24, "word": "accumulation", "fig": 1}, {"body": 20, "word": "LC3-II", "fig": 1}, {"body": 6, "word": "CHD", "fig": 3}, {"body": 8, "word": "staining", "fig": 2}, {"body": 10, "word": "fed", "fig": 1}, {"body": 9, "word": "'s", "fig": 1}, {"body": 9, "word": "apoptosis", "fig": 1}, {"body": 8, "word": "EM", "fig": 1}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 7, "word": "data", "fig": 1}, {"body": 2, "word": "images", "fig": 3}, {"body": 3, "word": "P", "fig": 2}, {"body": 5, "word": "livers", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 4, "word": "E", "fig": 1}, {"body": 4, "word": "H", "fig": 1}, {"body": 4, "word": "weeks", "fig": 1}, {"body": 4, "word": "TUNEL", "fig": 1}, {"body": 4, "word": "Masson", "fig": 1}, {"body": 3, "word": "lower", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 3, "word": "trichrome", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "anti-LC3", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 1, "word": "Increased", "fig": 1}, {"body": 1, "word": "versus", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "animals", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "correlates", "fig": 1}, {"body": 1, "word": "C57BL6", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001315/bin/cddis2014162f4.jpg", "caption": "Short-term treatment with PA induces autophagy in human Huh7 cells. Analysis of ER stress and autophagy markers in samples from Huh7 cells treated with PA (P, 800 \u03bcM) for 8 h with or without rapamycin (R, 25 ng/ml) or bafilomycin A1 (B, 10 nM). (a\u2013c and e). Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to four independent experiments performed in triplicate, data are presented as mean\u00b1S.E.M. (d) Representative anti-LC3 immunostaining and representative EM images. *P<0.05, **P<0.01 and ***P<0.005, P versus C or RP versus R; ##P<0.01, R versus C or RP versus P", "co_occurrence": [{"body": 46, "word": "cells", "fig": 2}, {"body": 40, "word": "PA", "fig": 2}, {"body": 27, "word": "autophagy", "fig": 2}, {"body": 24, "word": "Huh7", "fig": 2}, {"body": 27, "word": "ER", "fig": 1}, {"body": 24, "word": "stress", "fig": 1}, {"body": 18, "word": "human", "fig": 1}, {"body": 18, "word": "h", "fig": 1}, {"body": 16, "word": "treatment", "fig": 1}, {"body": 15, "word": "rapamycin", "fig": 1}, {"body": 13, "word": "samples", "fig": 1}, {"body": 3, "word": "P", "fig": 4}, {"body": 12, "word": "treated", "fig": 1}, {"body": 8, "word": "EM", "fig": 1}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "data", "fig": 1}, {"body": 6, "word": "A1", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 5, "word": "markers", "fig": 1}, {"body": 5, "word": "bafilomycin", "fig": 1}, {"body": 1, "word": "versus", "fig": 4}, {"body": 4, "word": "nM", "fig": 1}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 2, "word": "C", "fig": 2}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "anti-LC3", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}, {"body": 1, "word": "triplicate", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "ng/ml", "fig": 1}, {"body": 1, "word": "without", "fig": 1}, {"body": 1, "word": "Short-term", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001315/bin/cddis2014162f5.jpg", "caption": "Rapamycin recovers the autophagic flux after prolonged treatment with PA in human Huh7 cells and human primary hepatocytes. Analysis of autophagy-related proteins expression in samples from Huh7 cells treated with PA (P, 800 \u03bcM) for 24 h or bafilomycin A1 (B, 10 nM) or CQ (50 nM) (a and b) or treated with PA (P, 800 \u03bcM) for 24 h in the absence or presence of rapamycin (R, 25 ng/ml) (c and d). (a and c) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to four independent experiments performed in triplicate, data are presented as mean\u00b1S.E.M. (b and d). Representative anti-LC3 immunostaining and EM images. (e) Analysis of autophagy-related protein expression in human primary hepatocytes treated with PA (P, 600 \u03bcM) for 24 h and/or rapamycin (R, 25 ng/ml). Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to four independent experiments performed in triplicate, data are presented as mean\u00b1S.E.M. *P<0.05 and **P<0.01, P versus C or RP versus R; #P<0.05 and ##P<0.01, R versus C or RP versus P", "co_occurrence": [{"body": 40, "word": "PA", "fig": 4}, {"body": 46, "word": "cells", "fig": 2}, {"body": 18, "word": "human", "fig": 3}, {"body": 18, "word": "h", "fig": 3}, {"body": 24, "word": "Huh7", "fig": 2}, {"body": 12, "word": "treated", "fig": 3}, {"body": 33, "word": "autophagic", "fig": 1}, {"body": 15, "word": "rapamycin", "fig": 2}, {"body": 30, "word": "flux", "fig": 1}, {"body": 3, "word": "P", "fig": 7}, {"body": 9, "word": "hepatocytes", "fig": 2}, {"body": 18, "word": "protein", "fig": 1}, {"body": 16, "word": "treatment", "fig": 1}, {"body": 8, "word": "expression", "fig": 2}, {"body": 8, "word": "analysis", "fig": 2}, {"body": 7, "word": "performed", "fig": 2}, {"body": 7, "word": "data", "fig": 2}, {"body": 13, "word": "samples", "fig": 1}, {"body": 5, "word": "After", "fig": 2}, {"body": 4, "word": "experiments", "fig": 2}, {"body": 8, "word": "EM", "fig": 1}, {"body": 4, "word": "nM", "fig": 2}, {"body": 7, "word": "proteins", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 3}, {"body": 6, "word": "prolonged", "fig": 1}, {"body": 3, "word": "primary", "fig": 2}, {"body": 6, "word": "A1", "fig": 1}, {"body": 5, "word": "bafilomycin", "fig": 1}, {"body": 1, "word": "versus", "fig": 4}, {"body": 2, "word": "d", "fig": 2}, {"body": 2, "word": "presented", "fig": 2}, {"body": 2, "word": "C", "fig": 2}, {"body": 2, "word": "western", "fig": 2}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 2, "word": "antibodies", "fig": 2}, {"body": 3, "word": "absence", "fig": 1}, {"body": 3, "word": "CQ", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 1, "word": "four", "fig": 2}, {"body": 2, "word": "Rapamycin", "fig": 1}, {"body": 1, "word": "triplicate", "fig": 2}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "and/or", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 2}, {"body": 1, "word": "ng/ml", "fig": 2}, {"body": 1, "word": "b", "fig": 2}, {"body": 2, "word": "anti-LC3", "fig": 1}, {"body": 1, "word": "recovers", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001315/bin/cddis2014162f6.jpg", "caption": "Rapamycin decreases cell death after prolonged treatment with PA in human Huh7 cells. Analysis of ER stress markers and apoptosis in samples from Huh7 cells treated with PA (P, 800 \u03bcM) for 24 h and/or rapamycin (R, 25 ng/ml). (a and b) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to four independent experiments performed in triplicate, data are presented as mean\u00b1S.E.M. (c). Representative DAPI staining images. Quantification of fragmented nuclei after DAPI staining. Results correspond to four independent experiments performed in triplicate and are presented as mean\u00b1S.E.M. (d) Representative Nile Red staining images. Quantification of Nile Red staining of the intracellular lipid bodies measured by flow cytometry. Results correspond to two independent experiments performed in triplicate and are presented as mean\u00b1S.E.M. *P<0.05, **P<0.01 and ***P<0.005, P versus C or RP versus R; #P<0.05 and ###P<0.005, R versus C or RP versus P", "co_occurrence": [{"body": 46, "word": "cells", "fig": 2}, {"body": 40, "word": "PA", "fig": 2}, {"body": 24, "word": "Huh7", "fig": 2}, {"body": 8, "word": "staining", "fig": 4}, {"body": 27, "word": "ER", "fig": 1}, {"body": 24, "word": "stress", "fig": 1}, {"body": 22, "word": "cell", "fig": 1}, {"body": 7, "word": "performed", "fig": 3}, {"body": 18, "word": "human", "fig": 1}, {"body": 18, "word": "h", "fig": 1}, {"body": 16, "word": "treatment", "fig": 1}, {"body": 15, "word": "death", "fig": 1}, {"body": 3, "word": "P", "fig": 5}, {"body": 15, "word": "rapamycin", "fig": 1}, {"body": 13, "word": "samples", "fig": 1}, {"body": 4, "word": "experiments", "fig": 3}, {"body": 12, "word": "treated", "fig": 1}, {"body": 11, "word": "lipid", "fig": 1}, {"body": 9, "word": "apoptosis", "fig": 1}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 7, "word": "data", "fig": 1}, {"body": 2, "word": "presented", "fig": 3}, {"body": 6, "word": "prolonged", "fig": 1}, {"body": 3, "word": "Red", "fig": 2}, {"body": 3, "word": "DAPI", "fig": 2}, {"body": 3, "word": "Nile", "fig": 2}, {"body": 5, "word": "markers", "fig": 1}, {"body": 5, "word": "two", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 5, "word": "nuclei", "fig": 1}, {"body": 1, "word": "versus", "fig": 4}, {"body": 2, "word": "images", "fig": 2}, {"body": 2, "word": "C", "fig": 2}, {"body": 2, "word": "Results", "fig": 2}, {"body": 1, "word": "triplicate", "fig": 3}, {"body": 3, "word": "measured", "fig": 1}, {"body": 1, "word": "four", "fig": 2}, {"body": 2, "word": "decreases", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 2, "word": "and/or", "fig": 1}, {"body": 2, "word": "Rapamycin", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 1, "word": "intracellular", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "ng/ml", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "flow", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001315/bin/cddis2014162f7.jpg", "caption": "Efect of silencing of CHOP on the autophagic flux and cell death after prolonged treatment with PA in human Huh7 cells. Analysis of autophagy-related proteins expression and apoptosis in samples from Huh7 cells treated with control siRNA (siControl, 5 nM) or siCHOP (5 nM) for 36 h, followed by PA (P, 800 \u03bcM) for 24 h. (a) CHOP mRNA levels determined by real-time PCR. The fold induction value for triplicate wells was averaged and data are presented as mean\u00b1S.E.M. relative to siControl cells. (b) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to three independent experiments performed in triplicate, data are presented as mean\u00b1S.E.M. (c). Representative DAPI staining images. Quantification of fragmented nuclei after DAPI staining. Results correspond to three independent experiments performed in triplicate and are presented as mean\u00b1S.E.M. *P<0.05, **P<0.01 and ***P<0.005, P versus C or RP versus R; #P<0.05 siCHOP versus siControl", "co_occurrence": [{"body": 46, "word": "cells", "fig": 3}, {"body": 40, "word": "PA", "fig": 2}, {"body": 24, "word": "Huh7", "fig": 2}, {"body": 33, "word": "autophagic", "fig": 1}, {"body": 30, "word": "flux", "fig": 1}, {"body": 15, "word": "CHOP", "fig": 2}, {"body": 23, "word": "levels", "fig": 1}, {"body": 22, "word": "cell", "fig": 1}, {"body": 18, "word": "human", "fig": 1}, {"body": 18, "word": "h", "fig": 1}, {"body": 8, "word": "staining", "fig": 2}, {"body": 16, "word": "treatment", "fig": 1}, {"body": 16, "word": "The", "fig": 1}, {"body": 15, "word": "death", "fig": 1}, {"body": 7, "word": "performed", "fig": 2}, {"body": 7, "word": "data", "fig": 2}, {"body": 13, "word": "samples", "fig": 1}, {"body": 12, "word": "treated", "fig": 1}, {"body": 9, "word": "apoptosis", "fig": 1}, {"body": 3, "word": "P", "fig": 3}, {"body": 4, "word": "experiments", "fig": 2}, {"body": 8, "word": "expression", "fig": 1}, {"body": 4, "word": "nM", "fig": 2}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 7, "word": "proteins", "fig": 1}, {"body": 7, "word": "mRNA", "fig": 1}, {"body": 2, "word": "presented", "fig": 3}, {"body": 6, "word": "prolonged", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 2}, {"body": 6, "word": "control", "fig": 1}, {"body": 6, "word": "determined", "fig": 1}, {"body": 3, "word": "siCHOP", "fig": 2}, {"body": 5, "word": "After", "fig": 1}, {"body": 5, "word": "nuclei", "fig": 1}, {"body": 4, "word": "induction", "fig": 1}, {"body": 2, "word": "three", "fig": 2}, {"body": 4, "word": "siRNA", "fig": 1}, {"body": 1, "word": "versus", "fig": 3}, {"body": 1, "word": "triplicate", "fig": 3}, {"body": 1, "word": "siControl", "fig": 3}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 2, "word": "PCR", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "Results", "fig": 1}, {"body": 2, "word": "silencing", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "b", "fig": 1}]}], "3446386": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-1.jpg", "caption": "IGF-1 attenuates the cytotoxicity of hormonal treatments in ER+ breast cancer cells. (a) Cell number for the adherent versus detached cell population treated with hormones in the presence or absence of various concentrations of IGF-1. (b) Relative levels of active, dephosphorylated Rb110 protein, designated Rb, relative to levels of the inactive, phosphorylated Rb110, designated pRb (top panel), cleaved PARP (middle panel), and cleaved lamin A (bottom panel) in cells undergoing hormonal treatments in the presence and absence of IGF-1. Protein was isolated from cells undergoing the designated treatments at 48, 72, and 120 hours, and immunoblot analysis determined the levels of Rb, pRb, cleaved PARP, and cleaved lamin A; \u03b2-actin served as a loading control. (c) Relative levels of cleaved cytokeratin 18 after 72 hours of the hormonal treatments in the presence and absence of IGF-1. (d) The percentage of mitochondrial membrane depolarization in cells undergoing hormonal treatments in the presence or absence of IGF-1. Adherent and detached cells were combined, stained with JC-1 mitochondrial membrane dye, and examined by using flow cytometry. (a, c, d) Data are expressed as mean \u00b1 SD (n = 3). Comparisons were made between treatment groups, and a statistically significant difference was identified in cell number when compared with groups treated with aE2; bE2 + IGF-1; cE2 + 4-OHT + IGF-1; dE2 + MIF + IGF-1; eE2 + 4-OHT; and fE2 + MIF. *Significance at P < 0.001.", "co_occurrence": [{"body": 176, "word": "cells", "fig": 5}, {"body": 50, "word": "IGF-1", "fig": 8}, {"body": 62, "word": "levels", "fig": 4}, {"body": 75, "word": "cell", "fig": 2}, {"body": 59, "word": "MIF", "fig": 2}, {"body": 21, "word": "treatments", "fig": 5}, {"body": 50, "word": "4-OHT", "fig": 2}, {"body": 84, "word": "breast", "fig": 1}, {"body": 41, "word": "treated", "fig": 2}, {"body": 19, "word": "presence", "fig": 4}, {"body": 74, "word": "cancer", "fig": 1}, {"body": 70, "word": "treatment", "fig": 1}, {"body": 16, "word": "hormonal", "fig": 4}, {"body": 15, "word": "absence", "fig": 4}, {"body": 13, "word": "undergoing", "fig": 3}, {"body": 7, "word": "cleaved", "fig": 5}, {"body": 17, "word": "hours", "fig": 2}, {"body": 16, "word": "PARP", "fig": 2}, {"body": 29, "word": "ER+", "fig": 1}, {"body": 14, "word": "A", "fig": 2}, {"body": 13, "word": "mitochondrial", "fig": 2}, {"body": 12, "word": "membrane", "fig": 2}, {"body": 22, "word": "protein", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 10, "word": "lamin", "fig": 2}, {"body": 9, "word": "groups", "fig": 2}, {"body": 16, "word": "using", "fig": 1}, {"body": 6, "word": "number", "fig": 2}, {"body": 6, "word": "detached", "fig": 2}, {"body": 11, "word": "hormones", "fig": 1}, {"body": 11, "word": "significant", "fig": 1}, {"body": 5, "word": "c", "fig": 2}, {"body": 3, "word": "designated", "fig": 3}, {"body": 9, "word": "various", "fig": 1}, {"body": 3, "word": "panel", "fig": 3}, {"body": 9, "word": "cytotoxicity", "fig": 1}, {"body": 8, "word": "compared", "fig": 1}, {"body": 8, "word": "dephosphorylated", "fig": 1}, {"body": 8, "word": "combined", "fig": 1}, {"body": 8, "word": "depolarization", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 6, "word": "identified", "fig": 1}, {"body": 6, "word": "statistically", "fig": 1}, {"body": 6, "word": "Cell", "fig": 1}, {"body": 5, "word": "mean", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "SD", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "Rb", "fig": 2}, {"body": 4, "word": "versus", "fig": 1}, {"body": 4, "word": "adherent", "fig": 1}, {"body": 2, "word": "Rb110", "fig": 2}, {"body": 2, "word": "d", "fig": 2}, {"body": 3, "word": "percentage", "fig": 1}, {"body": 3, "word": "population", "fig": 1}, {"body": 3, "word": "relative", "fig": 1}, {"body": 3, "word": "phosphorylated", "fig": 1}, {"body": 3, "word": "cytokeratin", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "loading", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 2, "word": "active", "fig": 1}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 2, "word": "top", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 1, "word": "inactive", "fig": 1}, {"body": 1, "word": "made", "fig": 1}, {"body": 1, "word": "difference", "fig": 1}, {"body": 1, "word": "Protein", "fig": 1}, {"body": 1, "word": "Comparisons", "fig": 1}, {"body": 1, "word": "middle", "fig": 1}, {"body": 1, "word": "JC-1", "fig": 1}, {"body": 1, "word": "Adherent", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-2.jpg", "caption": "IGF-1 attenuates 4-OHT and/or MIF-induced cell death by reducing ROS levels. (a, b) ROS levels in cells undergoing hormonal treatments in the presence or absence of IGF-1 (a) or vitamin E (b). (c) The percentage of mitochondrial membrane permeabilization in cells undergoing hormonal treatments in the presence or absence of vitamin E. (d) The levels of cleaved PARP and lamin A in cells treated with 4-OHT and/or MIF in the presence and absence of vitamin E. fold diff., the levels of cleaved PARP or lamin A relative to levels in E2-treated cells, which were arbitrarily assigned a value of 1.0; \u03b2-actin served as a loading control. (a-d) MCF-7 cells treated with E2, E2 + 4-OHT, E2 + MIF, E2 + 4-OHT + MIF in the presence or absence of IGF-1 (20 ng/ml) or vitamin E (500 \u03bc;M) for the indicated times were harvested for determination of ROS levels, percentage mitochondrial membrane permeabilization, or levels of cleaved PARP and laminA, as described in Materials and Methods. Values are expressed as mean \u00b1 SD (n = 3). Statistically significant differences are identified between comparisons of the following treatment groups: (a) E2 versus E2 + vitamin E; (b) E2 + 4-OHT versus E2 + 4-OHT+ IGF-1 or E2 + 4-OHT + vitamin E; (c) E2 +MIF versus E2 + MIF+IGF-1 or E2 + MIF+ vitamin E; and (d) E2 + 4-OHT + MIF versus E2+ 4-OHT + MIF + IGF-1 or E2 + 4-OHT + MIF + vitamin E. *P < 0.001.", "co_occurrence": [{"body": 176, "word": "cells", "fig": 5}, {"body": 50, "word": "4-OHT", "fig": 9}, {"body": 62, "word": "levels", "fig": 7}, {"body": 59, "word": "MIF", "fig": 6}, {"body": 50, "word": "IGF-1", "fig": 5}, {"body": 36, "word": "ROS", "fig": 3}, {"body": 48, "word": "and/or", "fig": 2}, {"body": 11, "word": "vitamin", "fig": 8}, {"body": 41, "word": "treated", "fig": 2}, {"body": 19, "word": "presence", "fig": 4}, {"body": 75, "word": "cell", "fig": 1}, {"body": 70, "word": "treatment", "fig": 1}, {"body": 5, "word": "E2", "fig": 14}, {"body": 15, "word": "absence", "fig": 4}, {"body": 10, "word": "E", "fig": 5}, {"body": 16, "word": "PARP", "fig": 3}, {"body": 47, "word": "MCF-7", "fig": 1}, {"body": 22, "word": "The", "fig": 2}, {"body": 21, "word": "treatments", "fig": 2}, {"body": 33, "word": "death", "fig": 1}, {"body": 16, "word": "hormonal", "fig": 2}, {"body": 14, "word": "A", "fig": 2}, {"body": 13, "word": "mitochondrial", "fig": 2}, {"body": 13, "word": "undergoing", "fig": 2}, {"body": 12, "word": "membrane", "fig": 2}, {"body": 7, "word": "b", "fig": 3}, {"body": 7, "word": "cleaved", "fig": 3}, {"body": 10, "word": "lamin", "fig": 2}, {"body": 4, "word": "versus", "fig": 4}, {"body": 12, "word": "described", "fig": 1}, {"body": 11, "word": "significant", "fig": 1}, {"body": 5, "word": "c", "fig": 2}, {"body": 9, "word": "groups", "fig": 1}, {"body": 3, "word": "E.", "fig": 3}, {"body": 8, "word": "MIF-induced", "fig": 1}, {"body": 8, "word": "\u03bc", "fig": 1}, {"body": 7, "word": "times", "fig": 1}, {"body": 6, "word": "identified", "fig": 1}, {"body": 3, "word": "permeabilization", "fig": 2}, {"body": 3, "word": "percentage", "fig": 2}, {"body": 6, "word": "harvested", "fig": 1}, {"body": 5, "word": "mean", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "differences", "fig": 1}, {"body": 5, "word": "SD", "fig": 1}, {"body": 2, "word": "d", "fig": 2}, {"body": 4, "word": "E2-treated", "fig": 1}, {"body": 4, "word": "ng/ml", "fig": 1}, {"body": 3, "word": "relative", "fig": 1}, {"body": 3, "word": "reducing", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 3, "word": "M", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 2, "word": "loading", "fig": 1}, {"body": 2, "word": "determination", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "Values", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-3.jpg", "caption": "The IGF-1/MEK signaling axis blocks the cytotoxic action of 4-OHT and/or MIF-treatments of ER+ breast cancer cells. (a) Graphic representation of Western blot data showing pMAPK1/2 levels in cells treated with hormones in the absence and presence of IGF-1. The pMAPK1/2 level in E2-treated cells were arbitrarily set to a value of 100%; total MAPK levels served as the loading control. (b) Effective and selective blockade of MAPK1/2 phosphorylation by the MEK1 inhibitor PD 98059. Total MAPK1/2 and AKT levels served as loading controls. (c, d) PD 98059 blocked the proliferative effects of IGF-1 and restored the ability of 4-OHT and/or MIF therapy to induce cell detachment and cleavage of PARP (apoptosis) in the MCF-7 cell populations treated with 4-OHT and/or MIF. fold diff., levels of cleaved PARP after correction for differences in protein loading; \u03b2-actin levels served as loading controls. (a-d) Cells were treated for the indicated time periods with hormones, as indicated in the absence or presence of IGF-1 at 20 ng/ml and/or PD 98059 at 25 \u03bc;g/ml and harvested for immunoblotting or cell counts, as described in Materials and Methods. Values are expressed as mean \u00b1 SD (n = 3). Treatment effects on total cell number were determined to be significant when compared with (a) E2; (b) E2 + IGF-1; (c) E2 + 4-OHT + IGF-1; (d) E2 + MIF + IGF-1; (e) E2 + IGF-1 + PD 98059. *P < 0.001.", "co_occurrence": [{"body": 176, "word": "cells", "fig": 3}, {"body": 50, "word": "IGF-1", "fig": 7}, {"body": 62, "word": "levels", "fig": 5}, {"body": 75, "word": "cell", "fig": 4}, {"body": 50, "word": "4-OHT", "fig": 4}, {"body": 48, "word": "and/or", "fig": 4}, {"body": 59, "word": "MIF", "fig": 3}, {"body": 41, "word": "treated", "fig": 3}, {"body": 84, "word": "breast", "fig": 1}, {"body": 74, "word": "cancer", "fig": 1}, {"body": 66, "word": "MEK1", "fig": 1}, {"body": 47, "word": "MCF-7", "fig": 1}, {"body": 22, "word": "The", "fig": 2}, {"body": 19, "word": "presence", "fig": 2}, {"body": 9, "word": "PD", "fig": 4}, {"body": 16, "word": "PARP", "fig": 2}, {"body": 15, "word": "absence", "fig": 2}, {"body": 15, "word": "effects", "fig": 2}, {"body": 29, "word": "ER+", "fig": 1}, {"body": 28, "word": "data", "fig": 1}, {"body": 5, "word": "E2", "fig": 5}, {"body": 22, "word": "protein", "fig": 1}, {"body": 11, "word": "hormones", "fig": 2}, {"body": 21, "word": "action", "fig": 1}, {"body": 20, "word": "therapy", "fig": 1}, {"body": 19, "word": "blockade", "fig": 1}, {"body": 17, "word": "apoptosis", "fig": 1}, {"body": 16, "word": "signaling", "fig": 1}, {"body": 7, "word": "b", "fig": 2}, {"body": 13, "word": "cleavage", "fig": 1}, {"body": 6, "word": "MAPK1/2", "fig": 2}, {"body": 12, "word": "phosphorylation", "fig": 1}, {"body": 12, "word": "described", "fig": 1}, {"body": 12, "word": "cytotoxic", "fig": 1}, {"body": 11, "word": "level", "fig": 1}, {"body": 11, "word": "significant", "fig": 1}, {"body": 5, "word": "c", "fig": 2}, {"body": 5, "word": "pMAPK1/2", "fig": 2}, {"body": 2, "word": "loading", "fig": 4}, {"body": 8, "word": "\u03bc", "fig": 1}, {"body": 8, "word": "counts", "fig": 1}, {"body": 8, "word": "compared", "fig": 1}, {"body": 7, "word": "blocked", "fig": 1}, {"body": 7, "word": "ability", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 7, "word": "cleaved", "fig": 1}, {"body": 7, "word": "time", "fig": 1}, {"body": 6, "word": "induce", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 2, "word": "served", "fig": 3}, {"body": 6, "word": "populations", "fig": 1}, {"body": 6, "word": "harvested", "fig": 1}, {"body": 6, "word": "inhibitor", "fig": 1}, {"body": 5, "word": "mean", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "SD", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "AKT", "fig": 1}, {"body": 5, "word": "differences", "fig": 1}, {"body": 5, "word": "axis", "fig": 1}, {"body": 5, "word": "blocks", "fig": 1}, {"body": 4, "word": "detachment", "fig": 1}, {"body": 2, "word": "d", "fig": 2}, {"body": 4, "word": "E2-treated", "fig": 1}, {"body": 2, "word": "total", "fig": 2}, {"body": 4, "word": "proliferative", "fig": 1}, {"body": 4, "word": "ng/ml", "fig": 1}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 3, "word": "MAPK", "fig": 1}, {"body": 3, "word": "restored", "fig": 1}, {"body": 2, "word": "g/ml", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "controls", "fig": 2}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "selective", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "periods", "fig": 1}, {"body": 2, "word": "Values", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "Treatment", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-4.jpg", "caption": "SX13 cells expressing low-levels of IGF-1R are sensitive to the death-inducing effects of PD 98059. (a) Western blot showing low levels of IGF-1R, but comparable levels of ER\u03b1 and cleaved PARP in SX13 and NEO cells undergoing the indicated hormonal treatments for 120 hours. (b, c) Cell counts showing that IGF-1 does not enhance E2-stimulated SX13 cell proliferation, but that PD 98059 can restore the growth-inhibitory effects of 4-OHT treatment. Cells (2 \u00d7 105) were seeded and, after 24 hours, treated with either 1% or 5% FBS-DCC serum in the absence (E2 ablation) or presence of E2 and/or IGF-1 for 168 hours (b) or 144 hours (c). Cell counts were performed with a Coulter counter (c). (d) Trypan blue exclusion assay shows that IGF-1 attenuates the death-inducing effects of 4-OHT and/or MIF treatments in an MEK1-dependent manner. At 144 hours after treatments, adherent and detached cells were collected and counted by using a hemacytometer. (e) Representative images show that PD 98059 effectively reduces cell number in the E2-treated cell population (compare a with b), and induces cell shrinkage and detachment, indicative of apoptosis, in the 4-OHT plus MIF-treated cell population (compare c with d). Data in (b through d) are expressed as mean \u00b1 SD (n = 3). The following show significant differences in the induction of apoptosis (number of detached cells) and cell proliferation for the hormonal therapies compared with: (a) E2; (b) 4-OHT + MIF; (c) E2+IGF-1; (d) E2+IGF-1+PD 98059. *P < 0.05.", "co_occurrence": [{"body": 176, "word": "cells", "fig": 4}, {"body": 75, "word": "cell", "fig": 6}, {"body": 50, "word": "4-OHT", "fig": 4}, {"body": 50, "word": "IGF-1", "fig": 3}, {"body": 62, "word": "levels", "fig": 2}, {"body": 59, "word": "MIF", "fig": 2}, {"body": 48, "word": "and/or", "fig": 2}, {"body": 17, "word": "hours", "fig": 5}, {"body": 70, "word": "treatment", "fig": 1}, {"body": 21, "word": "treatments", "fig": 3}, {"body": 23, "word": "compare", "fig": 2}, {"body": 15, "word": "effects", "fig": 3}, {"body": 41, "word": "treated", "fig": 1}, {"body": 7, "word": "b", "fig": 5}, {"body": 17, "word": "apoptosis", "fig": 2}, {"body": 16, "word": "hormonal", "fig": 2}, {"body": 14, "word": "IGF-1R", "fig": 2}, {"body": 9, "word": "PD", "fig": 3}, {"body": 13, "word": "proliferation", "fig": 2}, {"body": 5, "word": "c", "fig": 5}, {"body": 11, "word": "show", "fig": 2}, {"body": 22, "word": "The", "fig": 1}, {"body": 7, "word": "SX13", "fig": 3}, {"body": 19, "word": "presence", "fig": 1}, {"body": 17, "word": "effectively", "fig": 1}, {"body": 16, "word": "PARP", "fig": 1}, {"body": 16, "word": "using", "fig": 1}, {"body": 8, "word": "counts", "fig": 2}, {"body": 15, "word": "absence", "fig": 1}, {"body": 5, "word": "E2", "fig": 3}, {"body": 15, "word": "plus", "fig": 1}, {"body": 13, "word": "undergoing", "fig": 1}, {"body": 6, "word": "number", "fig": 2}, {"body": 6, "word": "Cell", "fig": 2}, {"body": 6, "word": "detached", "fig": 2}, {"body": 11, "word": "significant", "fig": 1}, {"body": 9, "word": "either", "fig": 1}, {"body": 9, "word": "performed", "fig": 1}, {"body": 2, "word": "d", "fig": 4}, {"body": 8, "word": "compared", "fig": 1}, {"body": 7, "word": "seeded", "fig": 1}, {"body": 7, "word": "induces", "fig": 1}, {"body": 7, "word": "cleaved", "fig": 1}, {"body": 3, "word": "population", "fig": 2}, {"body": 5, "word": "mean", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "SD", "fig": 1}, {"body": 5, "word": "low", "fig": 1}, {"body": 5, "word": "differences", "fig": 1}, {"body": 4, "word": "adherent", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "detachment", "fig": 1}, {"body": 4, "word": "blue", "fig": 1}, {"body": 4, "word": "E2-treated", "fig": 1}, {"body": 4, "word": "NEO", "fig": 1}, {"body": 4, "word": "MIF-treated", "fig": 1}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "ER\u03b1", "fig": 1}, {"body": 3, "word": "shows", "fig": 1}, {"body": 3, "word": "therapies", "fig": 1}, {"body": 3, "word": "collected", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 3, "word": "MEK1-dependent", "fig": 1}, {"body": 3, "word": "counted", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "induction", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "serum", "fig": 1}, {"body": 2, "word": "At", "fig": 1}, {"body": 1, "word": "restore", "fig": 1}, {"body": 1, "word": "indicative", "fig": 1}, {"body": 1, "word": "reduces", "fig": 1}, {"body": 1, "word": "enhance", "fig": 1}, {"body": 1, "word": "manner", "fig": 1}, {"body": 1, "word": "growth-inhibitory", "fig": 1}, {"body": 1, "word": "Coulter", "fig": 1}, {"body": 1, "word": "E2-stimulated", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "hemacytometer", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-5.jpg", "caption": "MEK1 regulates oxidative stress and mitochondrial membrane function in ER+ breast cancer cells. (a through c) MEK1 downregulation blocked the prosurvival effects of IGF-1 and enhanced ROS and mitochondrial membrane depolarization in hormonally treated breast cancer cells. (a) Western blot shows effective RNAi targeting of MEK1, which was carried out for 48 hours before cells were treated with E2, E2 + 4-OHT, or E2 + 4-OHT + MIF for 24 hours. Protein was isolated from cells and analyzed for MEK1 expression with immunoblot analysis. (b, c) Cell populations with reduced MEK1 expression were analyzed at 6 and 72 hours for ROS and mitochondrial membrane depolarization, respectively. (d through f) MEK1 overexpression reduced ROS and mitochondrial membrane depolarization in hormonally treated breast cancer cells. Transient transfection of MEK1 cDNA (MEK1-GFP vector) increased MEK1 expression above levels seen in vector-only (pEGFP-1)-transfected control cells at 24 and 48 hours, as determined by immunoblot analysis (d), and reduced ROS levels and mitochondrial membrane depolarization at 24 and 72 hours, respectively (e, f). Values are expressed as mean \u00b1 SD (n = 3). Significant differences are designated as follows: (a) Scrambled versus SiMEK, E2 (\u00b1 IGF-1); (b) Scrambled versus SiMEK, E2 + 4-OHT (\u00b1 IGF-1); (c) Scrambled versus SiMEK, E2 + MIF (\u00b1 IGF-1); (d) Scrambled versus SiMEK, E2 + 4-OHT + MIF; (e) pEGFP-N1 versus MEK1-GFP, E2 + 4-OHT; (f) pEGFP-N1 versus MEK1-GFP, E2 + MIF; (g) pEGFP-N1, E2 + 4-OHT + MIF versus MEK1-GFP, E2 + 4-OHT + MIF. *P < 0.001.", "co_occurrence": [{"body": 176, "word": "cells", "fig": 6}, {"body": 66, "word": "MEK1", "fig": 8}, {"body": 59, "word": "MIF", "fig": 6}, {"body": 50, "word": "4-OHT", "fig": 7}, {"body": 84, "word": "breast", "fig": 3}, {"body": 74, "word": "cancer", "fig": 3}, {"body": 50, "word": "IGF-1", "fig": 4}, {"body": 36, "word": "ROS", "fig": 4}, {"body": 62, "word": "levels", "fig": 2}, {"body": 41, "word": "treated", "fig": 3}, {"body": 17, "word": "hours", "fig": 5}, {"body": 25, "word": "expression", "fig": 3}, {"body": 13, "word": "mitochondrial", "fig": 5}, {"body": 20, "word": "reduced", "fig": 3}, {"body": 12, "word": "membrane", "fig": 5}, {"body": 5, "word": "E2", "fig": 11}, {"body": 8, "word": "depolarization", "fig": 4}, {"body": 29, "word": "ER+", "fig": 1}, {"body": 4, "word": "versus", "fig": 7}, {"body": 8, "word": "hormonally", "fig": 2}, {"body": 8, "word": "analyzed", "fig": 2}, {"body": 16, "word": "prosurvival", "fig": 1}, {"body": 15, "word": "effects", "fig": 1}, {"body": 5, "word": "c", "fig": 3}, {"body": 7, "word": "respectively", "fig": 2}, {"body": 7, "word": "b", "fig": 2}, {"body": 13, "word": "targeting", "fig": 1}, {"body": 5, "word": "analysis", "fig": 2}, {"body": 9, "word": "increased", "fig": 1}, {"body": 8, "word": "seen", "fig": 1}, {"body": 7, "word": "blocked", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 2, "word": "d", "fig": 3}, {"body": 6, "word": "vector", "fig": 1}, {"body": 6, "word": "RNAi", "fig": 1}, {"body": 6, "word": "Cell", "fig": 1}, {"body": 6, "word": "function", "fig": 1}, {"body": 6, "word": "populations", "fig": 1}, {"body": 5, "word": "mean", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "effective", "fig": 1}, {"body": 5, "word": "differences", "fig": 1}, {"body": 5, "word": "SD", "fig": 1}, {"body": 5, "word": "downregulation", "fig": 1}, {"body": 5, "word": "overexpression", "fig": 1}, {"body": 1, "word": "MEK1-GFP", "fig": 4}, {"body": 3, "word": "designated", "fig": 1}, {"body": 3, "word": "shows", "fig": 1}, {"body": 1, "word": "pEGFP-N1", "fig": 3}, {"body": 3, "word": "cDNA", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "regulates", "fig": 1}, {"body": 2, "word": "oxidative", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 2, "word": "Values", "fig": 1}, {"body": 2, "word": "stress", "fig": 1}, {"body": 1, "word": "e", "fig": 2}, {"body": 1, "word": "Protein", "fig": 1}, {"body": 1, "word": "carried", "fig": 1}, {"body": 1, "word": "g", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-6.jpg", "caption": "Blockade of MEK1 increases the levels of dephosphorylated BimEL in MCF-7. (a through c) Western blot shows the expression level of the Bim isoforms (EL, extra long; L, long, and/or S, short) in cells treated with hormones plus and minus IGF-1 (a), with two apparent size variants of BimEL, a high-molecular-weight BimEL (top band, denoted by the dash) and a low-molecular-weight BimEL (bottom band, denoted by the arrow) (b, c). fold diff., fold difference in signal intensity of the lower-molecular-weight BimEL band divided by the signal intensity of the high-molecular-weight BimEL band by using the total MAPK signal intensity per lane as the loading control. (d, e) Western blot shows the accumulation of the upper Bim EL band when cells with active MEK1 are treated with the proteasome inhibitor MG132, and preferential loss of the upper BimEL band, concomitant with accumulation of the lower-molecular-weight Bim EL form after \u03bb protein phosphatase treatment of the protein lysates. The \u03bb protein phosphatase digestion (described in Materials and Methods) was carried out for 20 minutes (lanes 2 and 5) or 1 hour (lane 3) on protein lysates isolated from breast cancer cells undergoing E2 treatment for 24 hours. Immunoblotting determined the levels of BimEL and pMAPK1/2; total MAPK served as loading control. (f) Western blot shows that TAM- and/or U0126- treated cells show significantly higher levels of BimEL protein than do E2-treated cells, with the highest levels of dephosphorylated Bim EL, correlating directly to the cleavage of PARP detectable by 72 hours.", "co_occurrence": [{"body": 176, "word": "cells", "fig": 5}, {"body": 48, "word": "BimEL", "fig": 9}, {"body": 62, "word": "levels", "fig": 4}, {"body": 70, "word": "treatment", "fig": 2}, {"body": 66, "word": "MEK1", "fig": 2}, {"body": 41, "word": "treated", "fig": 3}, {"body": 28, "word": "Bim", "fig": 4}, {"body": 22, "word": "protein", "fig": 5}, {"body": 48, "word": "and/or", "fig": 2}, {"body": 84, "word": "breast", "fig": 1}, {"body": 13, "word": "band", "fig": 6}, {"body": 74, "word": "cancer", "fig": 1}, {"body": 50, "word": "IGF-1", "fig": 1}, {"body": 47, "word": "MCF-7", "fig": 1}, {"body": 18, "word": "lane", "fig": 2}, {"body": 17, "word": "hours", "fig": 2}, {"body": 33, "word": "lanes", "fig": 1}, {"body": 25, "word": "expression", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 5, "word": "EL", "fig": 4}, {"body": 16, "word": "PARP", "fig": 1}, {"body": 16, "word": "using", "fig": 1}, {"body": 8, "word": "dephosphorylated", "fig": 2}, {"body": 15, "word": "plus", "fig": 1}, {"body": 13, "word": "cleavage", "fig": 1}, {"body": 13, "word": "undergoing", "fig": 1}, {"body": 12, "word": "described", "fig": 1}, {"body": 12, "word": "higher", "fig": 1}, {"body": 11, "word": "show", "fig": 1}, {"body": 11, "word": "level", "fig": 1}, {"body": 11, "word": "hormones", "fig": 1}, {"body": 5, "word": "c", "fig": 2}, {"body": 5, "word": "lysates", "fig": 2}, {"body": 5, "word": "control", "fig": 2}, {"body": 3, "word": "signal", "fig": 3}, {"body": 9, "word": "significantly", "fig": 1}, {"body": 3, "word": "shows", "fig": 3}, {"body": 4, "word": "upper", "fig": 2}, {"body": 7, "word": "form", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 7, "word": "detectable", "fig": 1}, {"body": 2, "word": "Western", "fig": 3}, {"body": 3, "word": "phosphatase", "fig": 2}, {"body": 2, "word": "blot", "fig": 3}, {"body": 6, "word": "inhibitor", "fig": 1}, {"body": 6, "word": "minutes", "fig": 1}, {"body": 3, "word": "MAPK", "fig": 2}, {"body": 5, "word": "E2", "fig": 1}, {"body": 5, "word": "pMAPK1/2", "fig": 1}, {"body": 5, "word": "MG132", "fig": 1}, {"body": 4, "word": "E2-treated", "fig": 1}, {"body": 2, "word": "total", "fig": 2}, {"body": 2, "word": "loading", "fig": 2}, {"body": 3, "word": "proteasome", "fig": 1}, {"body": 3, "word": "increases", "fig": 1}, {"body": 1, "word": "intensity", "fig": 3}, {"body": 3, "word": "hour", "fig": 1}, {"body": 3, "word": "concomitant", "fig": 1}, {"body": 1, "word": "high-molecular-weight", "fig": 2}, {"body": 2, "word": "loss", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 1, "word": "accumulation", "fig": 2}, {"body": 2, "word": "Blockade", "fig": 1}, {"body": 2, "word": "active", "fig": 1}, {"body": 2, "word": "directly", "fig": 1}, {"body": 2, "word": "top", "fig": 1}, {"body": 2, "word": "two", "fig": 1}, {"body": 2, "word": "apparent", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 1, "word": "difference", "fig": 1}, {"body": 1, "word": "isoforms", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "carried", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "size", "fig": 1}, {"body": 1, "word": "Immunoblotting", "fig": 1}, {"body": 1, "word": "short", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-7.jpg", "caption": "RNAi targeting of BIM expression protects MCF-7 cells from apoptotic cell death induced by 4-OHT, MIF, and/or U0126 treatments. (a, c) BIM expression was reduced in all treatment groups by RNAi targeting. MCF-7 cells were seeded in DMEM/F12 medium containing 5% DCC FBS and, after 24 hours, transfected with scrambled or BIM-targeting RNAi. Forty-eight hours after transfection, the cells were treated with E2, E2 + 4-OHT, or E2 + 4-OHT + MIF in the absence (a) or presence of IGF-1 (20 ng/ml) (c, d) and/or U0126 (5 mM). Cells were harvested for protein at 48 hours (a, c) or 72 hours (d) after treatment and subjected to immunoblot analysis to determine levels of Bim, cleaved PARP, and cleaved lamin (a) \u03b2-actin levels served as a loading control. (b) BIM knockdown via siRNA targeting reduces the levels of ROS generated by 1 hour of treatment with 4-OHT and/or MIF. Values are expressed as mean \u00b1 SD. Statistical significance was identified between the following treatment groups: (a) scrambled E2 + 4-OHT versus siBimE2 +4-OHT; (b) scrambled E2 + MIF versus siBim E2 + MIF; (c) scrambled E2 + 4-OHT + MIF versus siBim E2 + 4-OHT + MIF; (d) scrambled E2 + 4-OHT + U0126 versus siBim E2 + 4-OHT + U0126; (e) scrambled E2 + MIF + U0126 versus siBim E2 + MIF + U0126; and (f) scrambled E2 + 4-OHT + MIF + U0126 versus siBim E2 + 4-OHT + MIF + U0126. *P < 0.001.", "co_occurrence": [{"body": 59, "word": "MIF", "fig": 11}, {"body": 50, "word": "4-OHT", "fig": 11}, {"body": 176, "word": "cells", "fig": 3}, {"body": 70, "word": "treatment", "fig": 4}, {"body": 62, "word": "levels", "fig": 3}, {"body": 48, "word": "and/or", "fig": 3}, {"body": 17, "word": "U0126", "fig": 8}, {"body": 47, "word": "MCF-7", "fig": 2}, {"body": 75, "word": "cell", "fig": 1}, {"body": 5, "word": "E2", "fig": 14}, {"body": 17, "word": "hours", "fig": 4}, {"body": 25, "word": "expression", "fig": 2}, {"body": 50, "word": "IGF-1", "fig": 1}, {"body": 41, "word": "treated", "fig": 1}, {"body": 13, "word": "targeting", "fig": 3}, {"body": 36, "word": "ROS", "fig": 1}, {"body": 33, "word": "death", "fig": 1}, {"body": 28, "word": "Bim", "fig": 1}, {"body": 4, "word": "versus", "fig": 6}, {"body": 22, "word": "protein", "fig": 1}, {"body": 21, "word": "medium", "fig": 1}, {"body": 21, "word": "treatments", "fig": 1}, {"body": 20, "word": "reduced", "fig": 1}, {"body": 5, "word": "c", "fig": 4}, {"body": 19, "word": "presence", "fig": 1}, {"body": 6, "word": "RNAi", "fig": 3}, {"body": 9, "word": "groups", "fig": 2}, {"body": 17, "word": "induced", "fig": 1}, {"body": 16, "word": "PARP", "fig": 1}, {"body": 15, "word": "absence", "fig": 1}, {"body": 7, "word": "b", "fig": 2}, {"body": 7, "word": "cleaved", "fig": 2}, {"body": 13, "word": "apoptotic", "fig": 1}, {"body": 10, "word": "lamin", "fig": 1}, {"body": 8, "word": "determine", "fig": 1}, {"body": 7, "word": "seeded", "fig": 1}, {"body": 1, "word": "scrambled", "fig": 7}, {"body": 2, "word": "d", "fig": 3}, {"body": 6, "word": "identified", "fig": 1}, {"body": 6, "word": "via", "fig": 1}, {"body": 6, "word": "harvested", "fig": 1}, {"body": 6, "word": "siRNA", "fig": 1}, {"body": 5, "word": "mean", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "SD", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "mM", "fig": 1}, {"body": 4, "word": "ng/ml", "fig": 1}, {"body": 4, "word": "FBS", "fig": 1}, {"body": 4, "word": "containing", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "DCC", "fig": 1}, {"body": 3, "word": "hour", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "subjected", "fig": 1}, {"body": 2, "word": "served", "fig": 1}, {"body": 2, "word": "loading", "fig": 1}, {"body": 2, "word": "generated", "fig": 1}, {"body": 2, "word": "Values", "fig": 1}, {"body": 1, "word": "reduces", "fig": 1}, {"body": 1, "word": "DMEM/F12", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "protects", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-8.jpg", "caption": "BimEL expression levels vary between ER+ breast cancer cell models and correlate to apoptotic outcome in response to hormonal treatments and MEK1 blockade. (a, b) Cell-number determinations showed that IGF-1 stimulated T-47D cell growth via a MEK1-dependent proliferation pathway. T-47D cells were treated with the indicated hormones in the presence or absence of IGF-1 (20 ng/ml) plus and minus PD 98059 for 216 hours (a) or U0126 for 144 hours (b). (c) Western blot showed BimEL levels relative to the levels of cleaved PARP in T-47D cells treated with hormones in the absence or presence of U0126 for 72 hours. The levels of ER and PR are provided for validation of the ER and PR status of T-47D and MCF-7 cells used in this study. (d) Western blot compared the levels of BimEL in MCF-7 versus T-47D cells treated with hormones plus or minus U0126 for 48 h. (e) ROS levels were determined for T-47D and MCF-7 cells treated with the indicated hormones in the presence or absence of IGF-1 plus or minus MEK1 blockade with U0126. (f) Western blot showed that treatment with MG132 caused an accumulation of phosphorylated Bim EL in MCF-7 cells, but not in T-47D cells. (a through f) As described in Materials and Methods, at the indicated times, cells were harvested and analyzed either for cell counts (a, b), protein expression by SDS/PAGE and immunoblotting for BimEL, pBimEL, pro-caspase-3, pMAPK, and total MAPK or \u03b2-actin, which were used as loading controls (c, d), or for ROS determination (e).", "co_occurrence": [{"body": 176, "word": "cells", "fig": 8}, {"body": 62, "word": "levels", "fig": 6}, {"body": 75, "word": "cell", "fig": 3}, {"body": 48, "word": "BimEL", "fig": 4}, {"body": 47, "word": "MCF-7", "fig": 4}, {"body": 41, "word": "treated", "fig": 4}, {"body": 22, "word": "T-47D", "fig": 7}, {"body": 50, "word": "IGF-1", "fig": 3}, {"body": 66, "word": "MEK1", "fig": 2}, {"body": 84, "word": "breast", "fig": 1}, {"body": 74, "word": "cancer", "fig": 1}, {"body": 36, "word": "ROS", "fig": 2}, {"body": 70, "word": "treatment", "fig": 1}, {"body": 17, "word": "U0126", "fig": 4}, {"body": 19, "word": "presence", "fig": 3}, {"body": 18, "word": "showed", "fig": 3}, {"body": 17, "word": "hours", "fig": 3}, {"body": 25, "word": "expression", "fig": 2}, {"body": 15, "word": "absence", "fig": 3}, {"body": 15, "word": "plus", "fig": 3}, {"body": 11, "word": "hormones", "fig": 4}, {"body": 21, "word": "used", "fig": 2}, {"body": 19, "word": "blockade", "fig": 2}, {"body": 29, "word": "ER+", "fig": 1}, {"body": 28, "word": "Bim", "fig": 1}, {"body": 13, "word": "PR", "fig": 2}, {"body": 22, "word": "protein", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 7, "word": "b", "fig": 3}, {"body": 21, "word": "treatments", "fig": 1}, {"body": 20, "word": "study", "fig": 1}, {"body": 18, "word": "growth", "fig": 1}, {"body": 9, "word": "ER", "fig": 2}, {"body": 16, "word": "PARP", "fig": 1}, {"body": 16, "word": "hormonal", "fig": 1}, {"body": 13, "word": "proliferation", "fig": 1}, {"body": 13, "word": "apoptotic", "fig": 1}, {"body": 13, "word": "response", "fig": 1}, {"body": 12, "word": "described", "fig": 1}, {"body": 5, "word": "c", "fig": 2}, {"body": 9, "word": "either", "fig": 1}, {"body": 9, "word": "PD", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 8, "word": "counts", "fig": 1}, {"body": 8, "word": "compared", "fig": 1}, {"body": 7, "word": "times", "fig": 1}, {"body": 7, "word": "determined", "fig": 1}, {"body": 7, "word": "cleaved", "fig": 1}, {"body": 2, "word": "blot", "fig": 3}, {"body": 2, "word": "Western", "fig": 3}, {"body": 6, "word": "via", "fig": 1}, {"body": 6, "word": "harvested", "fig": 1}, {"body": 2, "word": "indicated", "fig": 3}, {"body": 6, "word": "models", "fig": 1}, {"body": 5, "word": "EL", "fig": 1}, {"body": 5, "word": "MG132", "fig": 1}, {"body": 4, "word": "versus", "fig": 1}, {"body": 2, "word": "d", "fig": 2}, {"body": 4, "word": "ng/ml", "fig": 1}, {"body": 3, "word": "relative", "fig": 1}, {"body": 3, "word": "provided", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 3, "word": "phosphorylated", "fig": 1}, {"body": 3, "word": "outcome", "fig": 1}, {"body": 3, "word": "MAPK", "fig": 1}, {"body": 3, "word": "MEK1-dependent", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "determinations", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "pMAPK", "fig": 1}, {"body": 2, "word": "determination", "fig": 1}, {"body": 2, "word": "stimulated", "fig": 1}, {"body": 2, "word": "status", "fig": 1}, {"body": 2, "word": "loading", "fig": 1}, {"body": 1, "word": "e", "fig": 2}, {"body": 2, "word": "As", "fig": 1}, {"body": 1, "word": "vary", "fig": 1}, {"body": 1, "word": "controls", "fig": 1}, {"body": 1, "word": "accumulation", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "pathway", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446386/bin/bcr3153-9.jpg", "caption": "A schematic representation of the role of BimEL and induction of apoptosis in ER+ breast cancer cells. This model is a summary of data showing that MEK1 blockade, in addition to hormonal treatment (antiestrogen or antiprogestin treatment) will activate Bim via dephosphorylation and induce an ROS-dependent apoptotic cell death in some ER+ breast cancer cells, particularly if IGF-1-induced IGF-IR signaling is active.", "co_occurrence": [{"body": 176, "word": "cells", "fig": 2}, {"body": 84, "word": "breast", "fig": 2}, {"body": 74, "word": "cancer", "fig": 2}, {"body": 70, "word": "treatment", "fig": 2}, {"body": 75, "word": "cell", "fig": 1}, {"body": 66, "word": "MEK1", "fig": 1}, {"body": 29, "word": "ER+", "fig": 2}, {"body": 48, "word": "BimEL", "fig": 1}, {"body": 33, "word": "death", "fig": 1}, {"body": 28, "word": "Bim", "fig": 1}, {"body": 28, "word": "data", "fig": 1}, {"body": 26, "word": "antiestrogen", "fig": 1}, {"body": 19, "word": "blockade", "fig": 1}, {"body": 17, "word": "role", "fig": 1}, {"body": 17, "word": "apoptosis", "fig": 1}, {"body": 16, "word": "signaling", "fig": 1}, {"body": 16, "word": "hormonal", "fig": 1}, {"body": 14, "word": "A", "fig": 1}, {"body": 13, "word": "apoptotic", "fig": 1}, {"body": 13, "word": "antiprogestin", "fig": 1}, {"body": 7, "word": "This", "fig": 1}, {"body": 6, "word": "via", "fig": 1}, {"body": 6, "word": "induce", "fig": 1}, {"body": 3, "word": "addition", "fig": 1}, {"body": 3, "word": "ROS-dependent", "fig": 1}, {"body": 3, "word": "model", "fig": 1}, {"body": 2, "word": "particularly", "fig": 1}, {"body": 2, "word": "induction", "fig": 1}, {"body": 2, "word": "active", "fig": 1}, {"body": 1, "word": "activate", "fig": 1}]}], "4259421": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259421/bin/oncotarget-05-9577-g001.jpg", "caption": "A novel mTOR complex is distinct from mTORC1 and mTORC2 by size and sub-cellular localization (A) mTOR exists in a complex larger than mTORC1 and mTORC2. The Sephacryl S-500 gel-filtration profile of the total cell lysate prepared from MDA-MB-435 cells has been analyzed by immunoblotting with the indicated antibodies. mTOR is eluted in the fractions corresponding to a complex larger than mTORC1 and mTORC2 (Fractions 1-4). Molecular size was calculated by creating retention/molecular size curve. (B) Intact nuclei are purified by the isotonic buffer. Phase contrast images of MDA-MB435 cells before sub-cellular fractionation (a left panel) and nuclei after fractionation (a right panel). (C) mTOR is detected in the cytoplasmic and nuclear fractions but raptor, rictor, Sin1, and mLST8 are detected predominantly only in the cytoplasmic fraction. The cytoplasmic and nuclear sub-fractionation of MDA-MA-435 cells has been performed in isotonic buffer to preserve nuclei. Nuclei were fractionated by a sequential extraction with the salt containing buffers and indicated as the Salt Extractible Nuclear Fraction (SENF) containing 0.1 M LiCl and 0.2 M LiCl. Following the salt extraction, the Residual Nuclear Fraction (RNF) has been obtained by lysis in 8 M Urea buffer. The extracts were analyzed as described in (A). (D) mTOR co-elutes with a Nuclear Pore Complex (NPC) protein RanBP2 in the nuclear extract. The nuclear extract obtained by 0.1 M LiCl was fractionated using the S-500 Sephacryl gel column and analyzed as described in (A).", "co_occurrence": [{"body": 174, "word": "mTOR", "fig": 5}, {"body": 159, "word": "nuclear", "fig": 4}, {"body": 47, "word": "The", "fig": 4}, {"body": 61, "word": "cells", "fig": 3}, {"body": 31, "word": "mTORC1", "fig": 3}, {"body": 30, "word": "nuclei", "fig": 3}, {"body": 27, "word": "mTORC2", "fig": 3}, {"body": 69, "word": "RanBP2", "fig": 1}, {"body": 22, "word": "complex", "fig": 3}, {"body": 15, "word": "A", "fig": 4}, {"body": 15, "word": "M", "fig": 4}, {"body": 19, "word": "buffer", "fig": 3}, {"body": 26, "word": "detected", "fig": 2}, {"body": 52, "word": "protein", "fig": 1}, {"body": 13, "word": "LiCl", "fig": 3}, {"body": 10, "word": "cytoplasmic", "fig": 3}, {"body": 9, "word": "size", "fig": 3}, {"body": 12, "word": "obtained", "fig": 2}, {"body": 12, "word": "fractions", "fig": 2}, {"body": 12, "word": "containing", "fig": 2}, {"body": 23, "word": "fraction", "fig": 1}, {"body": 7, "word": "analyzed", "fig": 3}, {"body": 10, "word": "fractionation", "fig": 2}, {"body": 9, "word": "extraction", "fig": 2}, {"body": 18, "word": "B", "fig": 1}, {"body": 6, "word": "Nuclear", "fig": 3}, {"body": 9, "word": "salt", "fig": 2}, {"body": 8, "word": "sub-cellular", "fig": 2}, {"body": 16, "word": "localization", "fig": 1}, {"body": 15, "word": "cell", "fig": 1}, {"body": 7, "word": "described", "fig": 2}, {"body": 7, "word": "panel", "fig": 2}, {"body": 7, "word": "indicated", "fig": 2}, {"body": 13, "word": "rictor", "fig": 1}, {"body": 6, "word": "isotonic", "fig": 2}, {"body": 12, "word": "antibodies", "fig": 1}, {"body": 9, "word": "NPC", "fig": 1}, {"body": 9, "word": "raptor", "fig": 1}, {"body": 9, "word": "distinct", "fig": 1}, {"body": 4, "word": "S-500", "fig": 2}, {"body": 4, "word": "Sephacryl", "fig": 2}, {"body": 7, "word": "using", "fig": 1}, {"body": 7, "word": "lysis", "fig": 1}, {"body": 7, "word": "novel", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 6, "word": "purified", "fig": 1}, {"body": 6, "word": "SENF", "fig": 1}, {"body": 3, "word": "extract", "fig": 2}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "MDA-MB-435", "fig": 1}, {"body": 5, "word": "extracts", "fig": 1}, {"body": 5, "word": "total", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "gel", "fig": 1}, {"body": 2, "word": "Fraction", "fig": 2}, {"body": 4, "word": "images", "fig": 1}, {"body": 4, "word": "column", "fig": 1}, {"body": 4, "word": "Following", "fig": 1}, {"body": 3, "word": "eluted", "fig": 1}, {"body": 3, "word": "RNF", "fig": 1}, {"body": 3, "word": "mLST8", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "sub-fractionation", "fig": 1}, {"body": 2, "word": "exists", "fig": 1}, {"body": 2, "word": "buffers", "fig": 1}, {"body": 1, "word": "larger", "fig": 2}, {"body": 2, "word": "Residual", "fig": 1}, {"body": 2, "word": "Complex", "fig": 1}, {"body": 2, "word": "gel-filtration", "fig": 1}, {"body": 2, "word": "predominantly", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 1, "word": "Pore", "fig": 1}, {"body": 1, "word": "Nuclei", "fig": 1}, {"body": 1, "word": "Salt", "fig": 1}, {"body": 1, "word": "right", "fig": 1}, {"body": 1, "word": "sequential", "fig": 1}, {"body": 1, "word": "contrast", "fig": 1}, {"body": 1, "word": "preserve", "fig": 1}, {"body": 1, "word": "Fractions", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "lysate", "fig": 1}, {"body": 1, "word": "Urea", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}, {"body": 1, "word": "Intact", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259421/bin/oncotarget-05-9577-g002.jpg", "caption": "mTOR and RanBP2 proteins form a complex on the nuclear envelope (A-D) The co-localization of mTOR and RanBP2 on the nuclear envelope. Confocal images of mTOR and RanBP2 co-localization: (A) Immunostaining of mTOR in nuclei. (B) Immunostaining of RanBP2 in nuclei. (C) Nuclear staining by DAPI. (D) The merged images of mTOR and RanBP2. E-G, The immunoprecipitations of RanBP2 or mTOR from the salt extractable nuclear fraction (SENF) obtained from different human cancer cell lines have been analyzed by immunoblotting with the indicated antibodies. (E) mTOR is co-purified with RanBP2 and (F) RanBP2 is co-purified with mTOR from extracts of MDA-MB-435 cells. (G) Co-purification of RanBP2 with mTOR is specific: the shRNAs targeting luciferase (control) or mTOR were lentivirally transduced into MDA-MB-435 cells. The knock down of mTOR by expressing the specific shRNAs caused a substantial decrease in abundance of RanBP2 co-purified with mTOR antibody.", "co_occurrence": [{"body": 174, "word": "mTOR", "fig": 12}, {"body": 69, "word": "RanBP2", "fig": 10}, {"body": 159, "word": "nuclear", "fig": 3}, {"body": 47, "word": "The", "fig": 4}, {"body": 61, "word": "cells", "fig": 2}, {"body": 92, "word": "proteins", "fig": 1}, {"body": 30, "word": "nuclei", "fig": 2}, {"body": 23, "word": "fraction", "fig": 1}, {"body": 22, "word": "complex", "fig": 1}, {"body": 10, "word": "envelope", "fig": 2}, {"body": 18, "word": "B", "fig": 1}, {"body": 18, "word": "abundance", "fig": 1}, {"body": 15, "word": "cell", "fig": 1}, {"body": 15, "word": "A", "fig": 1}, {"body": 4, "word": "co-purified", "fig": 3}, {"body": 12, "word": "obtained", "fig": 1}, {"body": 12, "word": "antibodies", "fig": 1}, {"body": 5, "word": "MDA-MB-435", "fig": 2}, {"body": 9, "word": "caused", "fig": 1}, {"body": 9, "word": "salt", "fig": 1}, {"body": 4, "word": "images", "fig": 2}, {"body": 4, "word": "specific", "fig": 2}, {"body": 7, "word": "indicated", "fig": 1}, {"body": 7, "word": "analyzed", "fig": 1}, {"body": 6, "word": "Nuclear", "fig": 1}, {"body": 6, "word": "SENF", "fig": 1}, {"body": 6, "word": "substantial", "fig": 1}, {"body": 5, "word": "antibody", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "extracts", "fig": 1}, {"body": 2, "word": "Immunostaining", "fig": 2}, {"body": 4, "word": "decrease", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "immunoprecipitations", "fig": 1}, {"body": 2, "word": "co-localization", "fig": 2}, {"body": 4, "word": "different", "fig": 1}, {"body": 3, "word": "cancer", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 3, "word": "knock", "fig": 1}, {"body": 3, "word": "control", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "extractable", "fig": 1}, {"body": 2, "word": "human", "fig": 1}, {"body": 2, "word": "form", "fig": 1}, {"body": 1, "word": "shRNAs", "fig": 2}, {"body": 1, "word": "expressing", "fig": 1}, {"body": 1, "word": "targeting", "fig": 1}, {"body": 1, "word": "lines", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259421/bin/oncotarget-05-9577-g003.jpg", "caption": "The mTOR kinase activity regulates the nuclear accumulation of ribosomal proteins independent of rapamycin and rictor expression (A-B) The nuclear abundance of ribosomal proteins is dependent on the mTOR kinase activity. MDA-MB-435 cells were incubated with 500 nM pp242 (A) or 100 nM Torin 1 (B) for the indicated time points and then lysed with the following fractionation to cytoplasmic (Cyt) and nuclear fractions (SENF and RNF). The isolated fractions were analyzed by immunoblotting for the levels of indicated proteins. The mTOR-dependent phosphorylation of S6K1 on Thr-389 and Akt on Ser-473 sites has been examined in the cytosolic fraction by the phospho-specific antibodies. Detection of the Nup98 and S6K1 proteins is shown as the loading controls. (C) Immunostaining of a free ribosomal protein L7a (rpL7a) in MDA-MB-435 cells incubated with or without 500 nM pp242 for 1 hour. The rpL7a antibody (Cell Signaling Technology, #2415) shows an exclusive nucleolar localization of rpL7a where this protein is enriched prior its assembly to ribosomal subunit. (D) Acute inhibition of the mTOR kinase activity does not suppress translation of the ribosomal proteins rpL26 and rpS6. MDA-MB-435 cells were incubated with 500 nM pp242 and labeled with 35S-methione/cysteine for 1 hr and cells were lysed in RIPA buffer. The rpL26 and rpS6 immunoprecipitates were analyzed by autoradiography and immunoblotting for the levels of newly synthesized proteins and total rpL26 and rpS6. (E) The kinase activity of mTOR is required for association of RanBP2 and mTOR. The actively growing HEK 293T cells were treated by 500 nM pp242 for the indicated times and were lysed in a buffer optimized to extract nuclear pore components (the buffer E). RanBP2 immunoprecipitates were prepared from the total cellular lysates and analyzed by immunoblotting. Abundance of the analyzed proteins in the total cellular lysate is shown in a lower panel. (F) The nuclear abundance of ribosomal proteins is dependent on RanBP2 expression. Following expression of the control (luciferase) or two different RanBP2 shRNAs, the MDA-MB-435 cells were analyzed by a sub-cellular fractionation and were analyzed by immunoblotting for the levels of indicated proteins as in A. (G) Rapamycin does not regulate the nuclear accumulation of ribosomal proteins, but induces rpS6 and S6K1translocation to the nuclear (SENF) fraction. MDA-MB-435 cells were incubated with 50 nM rapamycin for the indicated times. The sub-cellular fractions were isolated and analyzed by immunoblotting for the levels of indicated proteins as in A. (H) The nuclear accumulation of ribosomal proteins is rictor independent. Rictor null and wild type mouse embryonic fibroblasts (MEFs) were analyzed by a sub-cellular fractionation to the cytoplasmic and nuclear fractions. The obtained fractions were analyzed by immunoblotting with the indicated antibodies as in A.", "co_occurrence": [{"body": 159, "word": "nuclear", "fig": 9}, {"body": 92, "word": "proteins", "fig": 12}, {"body": 174, "word": "mTOR", "fig": 5}, {"body": 88, "word": "ribosomal", "fig": 8}, {"body": 47, "word": "The", "fig": 12}, {"body": 61, "word": "cells", "fig": 7}, {"body": 69, "word": "RanBP2", "fig": 4}, {"body": 47, "word": "kinase", "fig": 4}, {"body": 34, "word": "activity", "fig": 4}, {"body": 52, "word": "protein", "fig": 2}, {"body": 22, "word": "pp242", "fig": 4}, {"body": 7, "word": "analyzed", "fig": 9}, {"body": 12, "word": "fractions", "fig": 5}, {"body": 15, "word": "A", "fig": 4}, {"body": 19, "word": "buffer", "fig": 3}, {"body": 7, "word": "indicated", "fig": 7}, {"body": 23, "word": "fraction", "fig": 2}, {"body": 15, "word": "accumulation", "fig": 3}, {"body": 37, "word": "inhibition", "fig": 1}, {"body": 12, "word": "expression", "fig": 3}, {"body": 18, "word": "abundance", "fig": 2}, {"body": 9, "word": "rpS6", "fig": 4}, {"body": 11, "word": "rpL7a", "fig": 3}, {"body": 10, "word": "fractionation", "fig": 3}, {"body": 5, "word": "nM", "fig": 6}, {"body": 14, "word": "cellular", "fig": 2}, {"body": 13, "word": "rictor", "fig": 2}, {"body": 5, "word": "MDA-MB-435", "fig": 5}, {"body": 8, "word": "sub-cellular", "fig": 3}, {"body": 6, "word": "incubated", "fig": 4}, {"body": 12, "word": "antibodies", "fig": 2}, {"body": 20, "word": "association", "fig": 1}, {"body": 10, "word": "cytoplasmic", "fig": 2}, {"body": 9, "word": "rapamycin", "fig": 2}, {"body": 9, "word": "shown", "fig": 2}, {"body": 18, "word": "B", "fig": 1}, {"body": 9, "word": "S6K1", "fig": 2}, {"body": 3, "word": "immunoblotting", "fig": 6}, {"body": 17, "word": "following", "fig": 1}, {"body": 16, "word": "localization", "fig": 1}, {"body": 5, "word": "total", "fig": 3}, {"body": 5, "word": "rpL26", "fig": 3}, {"body": 14, "word": "mTOR-dependent", "fig": 1}, {"body": 7, "word": "dependent", "fig": 2}, {"body": 14, "word": "regulates", "fig": 1}, {"body": 13, "word": "two", "fig": 1}, {"body": 6, "word": "SENF", "fig": 2}, {"body": 12, "word": "obtained", "fig": 1}, {"body": 12, "word": "hr", "fig": 1}, {"body": 4, "word": "lysed", "fig": 3}, {"body": 6, "word": "isolated", "fig": 2}, {"body": 11, "word": "without", "fig": 1}, {"body": 9, "word": "translation", "fig": 1}, {"body": 8, "word": "assembly", "fig": 1}, {"body": 8, "word": "lysates", "fig": 1}, {"body": 4, "word": "independent", "fig": 2}, {"body": 8, "word": "components", "fig": 1}, {"body": 7, "word": "controls", "fig": 1}, {"body": 7, "word": "phosphorylation", "fig": 1}, {"body": 7, "word": "panel", "fig": 1}, {"body": 6, "word": "nucleolar", "fig": 1}, {"body": 6, "word": "prior", "fig": 1}, {"body": 6, "word": "hour", "fig": 1}, {"body": 3, "word": "E", "fig": 2}, {"body": 6, "word": "time", "fig": 1}, {"body": 5, "word": "pore", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 5, "word": "antibody", "fig": 1}, {"body": 4, "word": "D", "fig": 1}, {"body": 4, "word": "Nup98", "fig": 1}, {"body": 4, "word": "Following", "fig": 1}, {"body": 4, "word": "examined", "fig": 1}, {"body": 4, "word": "different", "fig": 1}, {"body": 4, "word": "Akt", "fig": 1}, {"body": 4, "word": "optimized", "fig": 1}, {"body": 1, "word": "levels", "fig": 4}, {"body": 4, "word": "cytosolic", "fig": 1}, {"body": 3, "word": "extract", "fig": 1}, {"body": 3, "word": "293T", "fig": 1}, {"body": 3, "word": "RNF", "fig": 1}, {"body": 3, "word": "control", "fig": 1}, {"body": 3, "word": "suppress", "fig": 1}, {"body": 3, "word": "lower", "fig": 1}, {"body": 3, "word": "HEK", "fig": 1}, {"body": 3, "word": "actively", "fig": 1}, {"body": 2, "word": "shows", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "growing", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 1, "word": "times", "fig": 2}, {"body": 2, "word": "Immunostaining", "fig": 1}, {"body": 2, "word": "Detection", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "Rapamycin", "fig": 1}, {"body": 1, "word": "Cell", "fig": 1}, {"body": 1, "word": "sites", "fig": 1}, {"body": 1, "word": "Signaling", "fig": 1}, {"body": 1, "word": "enriched", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "labeled", "fig": 1}, {"body": 1, "word": "lysate", "fig": 1}, {"body": 1, "word": "Rictor", "fig": 1}, {"body": 1, "word": "RIPA", "fig": 1}, {"body": 1, "word": "null", "fig": 1}, {"body": 1, "word": "subunit", "fig": 1}, {"body": 1, "word": "shRNAs", "fig": 1}, {"body": 1, "word": "Technology", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259421/bin/oncotarget-05-9577-g004.jpg", "caption": "Nuclear import of the GFP-tagged ribosomal protein rpL7a is dependent on the mTOR kinase activity (A) The nuclear accumulation of ribosomal proteins by inhibition of the nuclear export is dependent on the mTOR kinase activity. To interfere with the nuclear export MDA-MB-435 cells were incubated with 200 nM leptomycin B for 2 hours. The leptomycin B treated cells were treated with or without pp242 at concentration 500 nM for 1 hour. The cytosolic and nuclear abundance of rpS3, rpS6, and rpL26 has been analyzed by immunoblotting of the nuclear fractions SENF and RNF. B-E, HeLa cells were transiently transfected with GFP-rpL7a, GFP-Lamin A, or GFP-tagged with the nuclear localization signal (GFP-NLS). Localization of the GFP-tagged proteins has been detected by fluorescent microscopy. The following images are presented: (B1-B2) after four hours of transfection, expression of GFP-L7a at the initial time point is not detectable, (C1) Control cells shows accumulation of GFP-RPL7a in nucleolus, (C2) Cells incubated with 1 \u03bcM of pp242 shows accumulation of GFP-L7a mostly in cytoplasm after 5 hours of treatment, (D1-D2 and E1-E2) The nuclear import of lamin A or GFP-NLS is not sensitive to the treatment of cells with 1 \u03bcM pp242. Both proteins show nuclear staining in cells with or without the drug treatement. (F) The nuclear import of GFP-rpL7a is dependent on the mTOR kinase activity. HeLa cells were transiently transfected with the expression plasmid encoding GFP-rpL7a protein and incubated with (the lower panel) or without (the upper panel) 1 \u03bcM of pp242. Following the photo-bleaching by a laser pulse, the recovery of rpL7a in nucleolus has been monitored by fluorescent microscopy. The images were taken within 6 min intervals.", "co_occurrence": [{"body": 159, "word": "nuclear", "fig": 9}, {"body": 174, "word": "mTOR", "fig": 3}, {"body": 61, "word": "cells", "fig": 7}, {"body": 47, "word": "The", "fig": 7}, {"body": 92, "word": "proteins", "fig": 3}, {"body": 88, "word": "ribosomal", "fig": 2}, {"body": 52, "word": "import", "fig": 3}, {"body": 47, "word": "kinase", "fig": 3}, {"body": 52, "word": "protein", "fig": 2}, {"body": 34, "word": "activity", "fig": 3}, {"body": 22, "word": "pp242", "fig": 4}, {"body": 15, "word": "accumulation", "fig": 3}, {"body": 15, "word": "A", "fig": 3}, {"body": 37, "word": "inhibition", "fig": 1}, {"body": 18, "word": "B", "fig": 2}, {"body": 11, "word": "without", "fig": 3}, {"body": 10, "word": "GFP-rpL7a", "fig": 3}, {"body": 26, "word": "detected", "fig": 1}, {"body": 8, "word": "hours", "fig": 3}, {"body": 12, "word": "expression", "fig": 2}, {"body": 8, "word": "GFP-tagged", "fig": 3}, {"body": 11, "word": "rpL7a", "fig": 2}, {"body": 11, "word": "treatment", "fig": 2}, {"body": 7, "word": "dependent", "fig": 3}, {"body": 20, "word": "min", "fig": 1}, {"body": 19, "word": "To", "fig": 1}, {"body": 6, "word": "incubated", "fig": 3}, {"body": 18, "word": "abundance", "fig": 1}, {"body": 17, "word": "following", "fig": 1}, {"body": 16, "word": "localization", "fig": 1}, {"body": 8, "word": "nucleolus", "fig": 2}, {"body": 15, "word": "within", "fig": 1}, {"body": 7, "word": "panel", "fig": 2}, {"body": 12, "word": "show", "fig": 1}, {"body": 12, "word": "fractions", "fig": 1}, {"body": 5, "word": "HeLa", "fig": 2}, {"body": 5, "word": "leptomycin", "fig": 2}, {"body": 5, "word": "export", "fig": 2}, {"body": 10, "word": "initial", "fig": 1}, {"body": 5, "word": "treated", "fig": 2}, {"body": 5, "word": "nM", "fig": 2}, {"body": 9, "word": "rpS6", "fig": 1}, {"body": 4, "word": "images", "fig": 2}, {"body": 8, "word": "transfection", "fig": 1}, {"body": 7, "word": "analyzed", "fig": 1}, {"body": 7, "word": "cytoplasm", "fig": 1}, {"body": 6, "word": "SENF", "fig": 1}, {"body": 6, "word": "photo-bleaching", "fig": 1}, {"body": 3, "word": "transfected", "fig": 2}, {"body": 6, "word": "hour", "fig": 1}, {"body": 6, "word": "Nuclear", "fig": 1}, {"body": 6, "word": "lamin", "fig": 1}, {"body": 6, "word": "time", "fig": 1}, {"body": 5, "word": "MDA-MB-435", "fig": 1}, {"body": 5, "word": "rpL26", "fig": 1}, {"body": 5, "word": "concentration", "fig": 1}, {"body": 5, "word": "recovery", "fig": 1}, {"body": 2, "word": "shows", "fig": 2}, {"body": 2, "word": "fluorescent", "fig": 2}, {"body": 4, "word": "drug", "fig": 1}, {"body": 4, "word": "sensitive", "fig": 1}, {"body": 2, "word": "GFP-L7a", "fig": 2}, {"body": 2, "word": "transiently", "fig": 2}, {"body": 4, "word": "Following", "fig": 1}, {"body": 4, "word": "laser", "fig": 1}, {"body": 4, "word": "cytosolic", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 1, "word": "\u03bcM", "fig": 3}, {"body": 3, "word": "upper", "fig": 1}, {"body": 3, "word": "interfere", "fig": 1}, {"body": 3, "word": "RNF", "fig": 1}, {"body": 3, "word": "plasmid", "fig": 1}, {"body": 3, "word": "rpS3", "fig": 1}, {"body": 3, "word": "lower", "fig": 1}, {"body": 3, "word": "immunoblotting", "fig": 1}, {"body": 2, "word": "monitored", "fig": 1}, {"body": 2, "word": "signal", "fig": 1}, {"body": 1, "word": "microscopy", "fig": 2}, {"body": 2, "word": "point", "fig": 1}, {"body": 2, "word": "mostly", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "intervals", "fig": 1}, {"body": 1, "word": "encoding", "fig": 1}, {"body": 1, "word": "Cells", "fig": 1}, {"body": 1, "word": "pulse", "fig": 1}, {"body": 1, "word": "GFP-Lamin", "fig": 1}, {"body": 1, "word": "taken", "fig": 1}, {"body": 1, "word": "detectable", "fig": 1}]}], "4661086": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0001.jpg", "caption": "Nerve injury reduces expression levels of Kcna4, Kcnd2, Kcnq2 and Kcnma1 and increases expression and activity of HDACs, G9a and EZH2 in the DRG (a) Time course of reduction in the mRNA level of Kcna4, Kcnd2, Kcnq2 and Kcnma1 in the DRG. The L5 and L6 DRGs were obtained from sham control and SNL rats before and at 5, 10, 21 and 28 days after surgery (n = 6 rats in each group). The mRNA of K+ channels was quantified using real-time PCR and normalized to a housekeeping gene (Gapdh). (b,c) Western blot gel images and mean data show protein levels of HDAC1, HDAC2, HDAC4, HDAC5, G9a and EZH2 in L5 and L6 DRG tissues obtained from sham control and SNL rats at 5 and 21 days after surgery (n = 9 in each group). (d,e) Original gel images and quantification data of the protein levels of acetyl-H3, H3K9me2, and H3K27me3 in the DRGs obtained from sham and SNL rats 21 days after surgery (n = 6 in each group). GAPDH was used as a loading control. Data are shown as mean \u00b1 s.e.m. Statistical analysis was performed using repeated-measures ANOVA or the Mann-Whitney test. * P < 0.05, ** P < 0.01, *** P < 0.001, compared with the respective baseline value. Supplementary Figure S8 contains the uncropped version of the gel images.", "co_occurrence": [{"body": 97, "word": "DRG", "fig": 3}, {"body": 95, "word": "G9a", "fig": 2}, {"body": 41, "word": "rats", "fig": 4}, {"body": 41, "word": "SNL", "fig": 3}, {"body": 41, "word": "levels", "fig": 3}, {"body": 57, "word": "expression", "fig": 2}, {"body": 55, "word": "The", "fig": 2}, {"body": 27, "word": "control", "fig": 3}, {"body": 34, "word": "using", "fig": 2}, {"body": 61, "word": "K+", "fig": 1}, {"body": 28, "word": "EZH2", "fig": 2}, {"body": 27, "word": "DRGs", "fig": 2}, {"body": 15, "word": "sham", "fig": 3}, {"body": 22, "word": "Kcna4", "fig": 2}, {"body": 21, "word": "Kcnd2", "fig": 2}, {"body": 21, "word": "Kcnq2", "fig": 2}, {"body": 42, "word": "injury", "fig": 1}, {"body": 20, "word": "Kcnma1", "fig": 2}, {"body": 13, "word": "obtained", "fig": 3}, {"body": 17, "word": "mRNA", "fig": 2}, {"body": 17, "word": "protein", "fig": 2}, {"body": 15, "word": "data", "fig": 2}, {"body": 29, "word": "gene", "fig": 1}, {"body": 24, "word": "level", "fig": 1}, {"body": 24, "word": "used", "fig": 1}, {"body": 23, "word": "HDACs", "fig": 1}, {"body": 22, "word": "H3K9me2", "fig": 1}, {"body": 19, "word": "channels", "fig": 1}, {"body": 19, "word": "Supplementary", "fig": 1}, {"body": 6, "word": "days", "fig": 3}, {"body": 5, "word": "surgery", "fig": 3}, {"body": 15, "word": "activity", "fig": 1}, {"body": 7, "word": "L5", "fig": 2}, {"body": 14, "word": "normalized", "fig": 1}, {"body": 14, "word": "performed", "fig": 1}, {"body": 7, "word": "L6", "fig": 2}, {"body": 14, "word": "analysis", "fig": 1}, {"body": 4, "word": "n", "fig": 3}, {"body": 4, "word": "P", "fig": 3}, {"body": 10, "word": "PCR", "fig": 1}, {"body": 3, "word": "group", "fig": 3}, {"body": 9, "word": "H3K27me3", "fig": 1}, {"body": 8, "word": "HDAC1", "fig": 1}, {"body": 8, "word": "HDAC2", "fig": 1}, {"body": 8, "word": "HDAC4", "fig": 1}, {"body": 7, "word": "Nerve", "fig": 1}, {"body": 7, "word": "HDAC5", "fig": 1}, {"body": 6, "word": "test", "fig": 1}, {"body": 6, "word": "tissues", "fig": 1}, {"body": 5, "word": "increases", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "Gapdh", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "reduction", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "baseline", "fig": 1}, {"body": 1, "word": "gel", "fig": 3}, {"body": 1, "word": "images", "fig": 3}, {"body": 3, "word": "compared", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "quantified", "fig": 1}, {"body": 2, "word": "reduces", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "acetyl-H3", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "course", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "housekeeping", "fig": 1}, {"body": 1, "word": "real-time", "fig": 1}, {"body": 1, "word": "value", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0002.jpg", "caption": "Cellular distribution of HDACs, G9a and EZH2 in control and injured DRGs (a-f) Double immunostaining and confocal images show co-localization of G9a (a), EZH2 (b), HDAC2 (d), HDAC4 (e) and HDAC5 (f), but not HDAC1 (c), with a neuronal marker (NeuN, red) in DRG sections from sham and SNL rats 21 days after surgery. N = 4 rats in each condition. Scale bar, 50 \u03bcm. In each panel, digitally merged images are shown at right.", "co_occurrence": [{"body": 95, "word": "G9a", "fig": 2}, {"body": 97, "word": "DRG", "fig": 1}, {"body": 41, "word": "rats", "fig": 2}, {"body": 28, "word": "EZH2", "fig": 2}, {"body": 41, "word": "SNL", "fig": 1}, {"body": 27, "word": "control", "fig": 1}, {"body": 27, "word": "DRGs", "fig": 1}, {"body": 23, "word": "injured", "fig": 1}, {"body": 23, "word": "HDACs", "fig": 1}, {"body": 15, "word": "sham", "fig": 1}, {"body": 12, "word": "In", "fig": 1}, {"body": 8, "word": "HDAC2", "fig": 1}, {"body": 8, "word": "HDAC4", "fig": 1}, {"body": 8, "word": "HDAC1", "fig": 1}, {"body": 7, "word": "HDAC5", "fig": 1}, {"body": 6, "word": "days", "fig": 1}, {"body": 6, "word": "neuronal", "fig": 1}, {"body": 6, "word": "distribution", "fig": 1}, {"body": 5, "word": "surgery", "fig": 1}, {"body": 5, "word": "sections", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 3, "word": "NeuN", "fig": 1}, {"body": 3, "word": "marker", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 1, "word": "images", "fig": 2}, {"body": 2, "word": "Double", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0003.jpg", "caption": "Nerve injury increases H3K9me2 levels at K+ channel promoters but does not change DNA methylation status at their promoter regions in the DRG (a-f) ChIP-PCR quantification data show the levels of two activating histone marks (H3K4me3 and H3K9ac) and two repressive histone marks (H3K9me2 and H3K27me3) around the TSS of Gapdh (a), Slc12a5 (b), Kcna4 (c), Kcnd2 (d), Kcnq2 (e) and Kcnma1 (f) in the DRG obtained from sham control and SNL rats 3 weeks after surgery (n = 7 independent experiments in each group). (g,h), ChIP-PCR quantification data show the enrichment levels of H3K9me2 at the two different promoter regions of Kcna4, Kcnd2, Kcnq2 and Kcnma1 in the DRG obtained from sham control and SNL rats 3 weeks after surgery (n = 7 independent experiments in each group). PCR-targeted promoter regions are indicated in the parenthesis in each panel. Data were normalized by input and total H3 values and are presented as mean \u00b1 SEM. * P < 0.05, ** P < 0.01, compared with sham control group (Mann-Whitney test). (i-l) Bisulfite sequencing PCR analysis of Kcna4 (i), Kcnd2 (j), Kcnq2 (k) and Kcnma1 (l) in L5 and L6 DRGs obtained from sham control and SNL rats 21 days after surgery (n = 3 independent experiments in each group). The DNA methylation pattern of CpG sites near the TSS was analyzed. Each row represents the methylation pattern of a single clone. Open circles represent unmethylated CpG sites, and closed circles represent methylated CpG sites at the TSS.", "co_occurrence": [{"body": 97, "word": "DRG", "fig": 3}, {"body": 41, "word": "SNL", "fig": 3}, {"body": 41, "word": "rats", "fig": 3}, {"body": 41, "word": "levels", "fig": 3}, {"body": 27, "word": "control", "fig": 4}, {"body": 22, "word": "Kcna4", "fig": 3}, {"body": 22, "word": "H3K9me2", "fig": 3}, {"body": 21, "word": "Kcnq2", "fig": 3}, {"body": 21, "word": "methylation", "fig": 3}, {"body": 21, "word": "Kcnd2", "fig": 3}, {"body": 61, "word": "K+", "fig": 1}, {"body": 20, "word": "Kcnma1", "fig": 3}, {"body": 15, "word": "sham", "fig": 4}, {"body": 55, "word": "The", "fig": 1}, {"body": 44, "word": "channel", "fig": 1}, {"body": 42, "word": "injury", "fig": 1}, {"body": 13, "word": "obtained", "fig": 3}, {"body": 18, "word": "histone", "fig": 2}, {"body": 11, "word": "promoter", "fig": 3}, {"body": 16, "word": "DNA", "fig": 2}, {"body": 10, "word": "two", "fig": 3}, {"body": 15, "word": "data", "fig": 2}, {"body": 9, "word": "experiments", "fig": 3}, {"body": 9, "word": "sites", "fig": 3}, {"body": 27, "word": "DRGs", "fig": 1}, {"body": 7, "word": "regions", "fig": 3}, {"body": 9, "word": "weeks", "fig": 2}, {"body": 5, "word": "surgery", "fig": 3}, {"body": 14, "word": "sequencing", "fig": 1}, {"body": 14, "word": "normalized", "fig": 1}, {"body": 14, "word": "analysis", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 3, "word": "group", "fig": 4}, {"body": 12, "word": "total", "fig": 1}, {"body": 4, "word": "n", "fig": 3}, {"body": 5, "word": "ChIP-PCR", "fig": 2}, {"body": 10, "word": "PCR", "fig": 1}, {"body": 9, "word": "H3K27me3", "fig": 1}, {"body": 3, "word": "CpG", "fig": 3}, {"body": 9, "word": "values", "fig": 1}, {"body": 4, "word": "P", "fig": 2}, {"body": 8, "word": "H3K9ac", "fig": 1}, {"body": 8, "word": "promoters", "fig": 1}, {"body": 8, "word": "enrichment", "fig": 1}, {"body": 7, "word": "L6", "fig": 1}, {"body": 7, "word": "H3", "fig": 1}, {"body": 7, "word": "Nerve", "fig": 1}, {"body": 7, "word": "L5", "fig": 1}, {"body": 3, "word": "marks", "fig": 2}, {"body": 2, "word": "TSS", "fig": 3}, {"body": 6, "word": "analyzed", "fig": 1}, {"body": 6, "word": "methylated", "fig": 1}, {"body": 6, "word": "days", "fig": 1}, {"body": 6, "word": "test", "fig": 1}, {"body": 5, "word": "increases", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "Gapdh", "fig": 1}, {"body": 2, "word": "show", "fig": 2}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "H3K4me3", "fig": 1}, {"body": 4, "word": "unmethylated", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "different", "fig": 1}, {"body": 4, "word": "repressive", "fig": 1}, {"body": 3, "word": "change", "fig": 1}, {"body": 3, "word": "g", "fig": 1}, {"body": 3, "word": "Slc12a5", "fig": 1}, {"body": 3, "word": "compared", "fig": 1}, {"body": 1, "word": "represent", "fig": 2}, {"body": 2, "word": "activating", "fig": 1}, {"body": 1, "word": "pattern", "fig": 2}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "Bisulfite", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "status", "fig": 1}, {"body": 1, "word": "input", "fig": 1}, {"body": 1, "word": "around", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "Each", "fig": 1}, {"body": 1, "word": "k", "fig": 1}, {"body": 1, "word": "closed", "fig": 1}, {"body": 1, "word": "near", "fig": 1}, {"body": 1, "word": "single", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0004.jpg", "caption": "Inhibition of G9a activity normalizes K+ channel gene expression in the DRG diminished by nerve injury (a-d) Effects of intrathecal treatments with vehicle (n = 10), SAHA (50 \u03bcg, n = 9), UNC0638 (10 \u03bcg, n = 8), GSK503 (5 \u03bcg, n = 10), SAHA plus GSK503 (n = 8), SAHA plus UNC0638 (n = 9) or UNC0638 plus GSK503 (n = 8) on the mRNA levels of Kcna4 (a), Kcnd2 (b), Kcnq2 (c), and Kcnma1 (d) in the DRG obtained from SNL rats 28 days after surgery. Data from sham control rats were plotted as the control (n = 6 rats). (e,f) Effects of nerve injury and UNC0638 on the protein levels of Kv1.4, Kv4.2, Kv7.2 and BK\u03b11 in the L5 and L6 DRG (n = 6 rats in each group). (g,h) Effect of G9a-specific siRNA on the G9a and H3K9me2 protein levels in the DRG obtained from SNL rats 24 h after the last injection (n = 5 in each group). (i,j) Effects of G9a-specific siRNA on the mRNA levels of G9a, Ezh2, Kcna4, Kcnd2, Kcnq2 and Kcnma1 in the DRG obtained from SNL (i) and sham control (j) rats 24 h after the last injection (n = 10 in each group). Data are presented as mean \u00b1 s.e.m. Statistical analysis was performed using two-way ANOVA followed by Bonferroni\u2019s post hoc tests (a-d), one-way ANOVA (f,h,i), or Mann-Whitney test (j). * P < 0.05, ** P < 0.01, *** P < 0.001, compared with the vehicle-treated group (a-f) or SNL + control-siRNA group (g-j). # P < 0.05, ## P < 0.01, ### P < 0.001, compared with the same color used for treatment with the single inhibitor (a-d). Supplementary Figure S9 contains the uncropped version of the gel images.", "co_occurrence": [{"body": 97, "word": "DRG", "fig": 5}, {"body": 95, "word": "G9a", "fig": 3}, {"body": 41, "word": "rats", "fig": 6}, {"body": 41, "word": "SNL", "fig": 4}, {"body": 41, "word": "levels", "fig": 4}, {"body": 53, "word": "nerve", "fig": 2}, {"body": 24, "word": "UNC0638", "fig": 4}, {"body": 42, "word": "injury", "fig": 2}, {"body": 27, "word": "control", "fig": 3}, {"body": 61, "word": "K+", "fig": 1}, {"body": 57, "word": "expression", "fig": 1}, {"body": 13, "word": "h", "fig": 4}, {"body": 24, "word": "siRNA", "fig": 2}, {"body": 22, "word": "Kcna4", "fig": 2}, {"body": 4, "word": "n", "fig": 11}, {"body": 44, "word": "channel", "fig": 1}, {"body": 21, "word": "Kcnd2", "fig": 2}, {"body": 21, "word": "Kcnq2", "fig": 2}, {"body": 20, "word": "Kcnma1", "fig": 2}, {"body": 13, "word": "obtained", "fig": 3}, {"body": 34, "word": "using", "fig": 1}, {"body": 17, "word": "mRNA", "fig": 2}, {"body": 17, "word": "protein", "fig": 2}, {"body": 15, "word": "sham", "fig": 2}, {"body": 29, "word": "gene", "fig": 1}, {"body": 24, "word": "used", "fig": 1}, {"body": 4, "word": "P", "fig": 6}, {"body": 22, "word": "H3K9me2", "fig": 1}, {"body": 7, "word": "SAHA", "fig": 3}, {"body": 7, "word": "\u03bcg", "fig": 3}, {"body": 7, "word": "GSK503", "fig": 3}, {"body": 19, "word": "Supplementary", "fig": 1}, {"body": 8, "word": "G9a-specific", "fig": 2}, {"body": 3, "word": "group", "fig": 5}, {"body": 15, "word": "activity", "fig": 1}, {"body": 14, "word": "performed", "fig": 1}, {"body": 14, "word": "analysis", "fig": 1}, {"body": 13, "word": "treatment", "fig": 1}, {"body": 12, "word": "inhibitor", "fig": 1}, {"body": 9, "word": "intrathecal", "fig": 1}, {"body": 3, "word": "plus", "fig": 3}, {"body": 4, "word": "f", "fig": 2}, {"body": 4, "word": "injection", "fig": 2}, {"body": 7, "word": "L5", "fig": 1}, {"body": 7, "word": "L6", "fig": 1}, {"body": 6, "word": "test", "fig": 1}, {"body": 6, "word": "days", "fig": 1}, {"body": 3, "word": "compared", "fig": 2}, {"body": 6, "word": "treatments", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 5, "word": "surgery", "fig": 1}, {"body": 5, "word": "followed", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 2}, {"body": 4, "word": "diminished", "fig": 1}, {"body": 2, "word": "Data", "fig": 2}, {"body": 4, "word": "b", "fig": 1}, {"body": 3, "word": "g", "fig": 1}, {"body": 2, "word": "vehicle-treated", "fig": 1}, {"body": 2, "word": "post", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 1, "word": "last", "fig": 2}, {"body": 2, "word": "vehicle", "fig": 1}, {"body": 2, "word": "Kv7.2", "fig": 1}, {"body": 2, "word": "Kv1.4", "fig": 1}, {"body": 2, "word": "hoc", "fig": 1}, {"body": 2, "word": "Kv4.2", "fig": 1}, {"body": 1, "word": "BK\u03b11", "fig": 1}, {"body": 1, "word": "gel", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "one-way", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "Ezh2", "fig": 1}, {"body": 1, "word": "normalizes", "fig": 1}, {"body": 1, "word": "Bonferroni\u2019s", "fig": 1}, {"body": 1, "word": "single", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0005.jpg", "caption": "Inhibition of G9a activity restores Kv channel currents in DRG neurons reduced by nerve injury (a) Original traces of total whole-cell Kv currents, A-type Kv currents, and non-A-type Kv currents in DRG neurons from sham control rats, SNL rats treated with vehicle, and SNL rats treated with UNC0638. Neurons were held at \u221280 mV and depolarized from \u221270 to 60 mV in 10-mV increments (inset). (b-d) Current densities of total whole-cell Kv currents (b, n = 21 neurons in each group, n = 5 rats in each group), A-type Kv currents (c, n = 16 neurons in each group, n = 5 rats in each group), and non-A-type Kv currents (d, n = 16 neurons in each group, n = 5 rats in each group) in DRG neurons dissociated from control rats, SNL rats treated with vehicle and SNL rats treated with UNC0638. (e-g) The conductance\u2013voltage (G\u2013V) curves of total and A-type Kv currents in DRG neurons from control and SNL rats treated with UNC0638 or vehicle. The V0.5 values of total Kv currents (control, 31.1 \u00b1 1.7 mV; SNL+vehicle, 33.0 \u00b1 1.0 mV; SNL+UNC0638, 32.5 \u00b1 1.2 mV), A-type Kv currents (control, 19.7 \u00b1 3.2 mV; SNL+vehicle, 16.0 \u00b1 5.3 mV; SNL+UNC0638, 16.8 \u00b1 4.3 mV) and non-A-type Kv currents (control, 46.4 \u00b1 1.3 mV; SNL+vehicle, 45.2 \u00b1 1.0 mV; SNL+UNC0638, 45.9 \u00b1 3.2 mV) were not significantly different between the three groups. There was no significant difference in the k value of total Kv currents (control, 24.6 \u00b1 1.1 mV; SNL+vehicle, 22.3 \u00b1 0.6 mV; SNL+UNC0638, 21.1 \u00b1 0.8 mV), A-type Kv currents (control, 19.6 \u00b1 1.9 mV; SNL+vehicle, 13.7 \u00b1 1.3 mV; SNL+UNC0638, 15.1 \u00b1 1.5 mV) and non-A-type Kv currents (control, 25.0 \u00b1 0.5 mV; SNL+vehicle, 24.3 \u00b1 0.4 mV; SNL+UNC0638, 24.7 \u00b1 1.3 mV) between the three groups. Data are presented as mean \u00b1 s.e.m. * P < 0.05, ** P < 0.01, *** P < 0.001, compared with the corresponding value in the control group (two-way ANOVA).", "co_occurrence": [{"body": 41, "word": "rats", "fig": 10}, {"body": 97, "word": "DRG", "fig": 4}, {"body": 44, "word": "neurons", "fig": 7}, {"body": 27, "word": "control", "fig": 10}, {"body": 41, "word": "SNL", "fig": 5}, {"body": 14, "word": "Kv", "fig": 14}, {"body": 14, "word": "currents", "fig": 14}, {"body": 55, "word": "The", "fig": 2}, {"body": 95, "word": "G9a", "fig": 1}, {"body": 24, "word": "UNC0638", "fig": 3}, {"body": 12, "word": "total", "fig": 5}, {"body": 53, "word": "nerve", "fig": 1}, {"body": 9, "word": "treated", "fig": 5}, {"body": 44, "word": "channel", "fig": 1}, {"body": 42, "word": "injury", "fig": 1}, {"body": 2, "word": "mV", "fig": 20}, {"body": 5, "word": "A-type", "fig": 5}, {"body": 4, "word": "n", "fig": 6}, {"body": 3, "word": "group", "fig": 7}, {"body": 15, "word": "activity", "fig": 1}, {"body": 15, "word": "sham", "fig": 1}, {"body": 4, "word": "P", "fig": 3}, {"body": 6, "word": "three", "fig": 2}, {"body": 11, "word": "significant", "fig": 1}, {"body": 5, "word": "groups", "fig": 2}, {"body": 9, "word": "reduced", "fig": 1}, {"body": 9, "word": "significantly", "fig": 1}, {"body": 9, "word": "values", "fig": 1}, {"body": 4, "word": "whole-cell", "fig": 2}, {"body": 2, "word": "non-A-type", "fig": 4}, {"body": 2, "word": "vehicle", "fig": 3}, {"body": 5, "word": "d", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "different", "fig": 1}, {"body": 3, "word": "curves", "fig": 1}, {"body": 3, "word": "compared", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "dissociated", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "V0.5", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "value", "fig": 2}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "increments", "fig": 1}, {"body": 1, "word": "k", "fig": 1}, {"body": 1, "word": "conductance\u2013voltage", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "Current", "fig": 1}, {"body": 1, "word": "G\u2013V", "fig": 1}, {"body": 1, "word": "10-mV", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0006.jpg", "caption": "Differential effects of inhibition of G9a, HDACs and EZH2 on pain hypersensitivity induced by nerve injury (a,b) Effects of intrathecal injections of vehicle (n = 12), UNC0638 (10 \u03bcg, n = 12), SAHA (50 \u03bcg, n = 12) or GSK503 (5 \u03bcg, n = 10) on the Randall-Selitto and von Frey withdrawal thresholds of SNL rats 3 weeks after surgery. (c,d) Effects of intrathecal treatments with UNC0638 plus SAHA (n = 9), UNC0638 plus GSK503 (n = 8) and SAHA plus GSK503 (n = 10) on the Randall-Selitto and von Frey thresholds of SNL rats. Drugs were injected intrathecally daily for 8 days starting 3 weeks after surgery, and each behavior test was performed 24 h after each treatment. (e,f) Effects of intrathecal treatment with control- and G9a-specific siRNA on the Randall-Selitto and von Frey thresholds of SNL rats of SNL rats (n = 12 rats in each group). Data are presented as mean \u00b1 s.e.m. Statistical analysis was performed using two-way ANOVA followed by Bonferroni\u2019s post hoc tests. * P < 0.05, ** P < 0.01, *** P < 0.001, compared with the baseline control (a,b,e,f). # P < 0.05, ## P < 0.01, ### P < 0.001, compared with the same color used for treatment with the single inhibitor (c,d).", "co_occurrence": [{"body": 41, "word": "rats", "fig": 5}, {"body": 41, "word": "SNL", "fig": 4}, {"body": 95, "word": "G9a", "fig": 1}, {"body": 24, "word": "UNC0638", "fig": 3}, {"body": 55, "word": "pain", "fig": 1}, {"body": 53, "word": "nerve", "fig": 1}, {"body": 42, "word": "injury", "fig": 1}, {"body": 13, "word": "treatment", "fig": 3}, {"body": 34, "word": "using", "fig": 1}, {"body": 4, "word": "n", "fig": 8}, {"body": 28, "word": "EZH2", "fig": 1}, {"body": 14, "word": "performed", "fig": 2}, {"body": 9, "word": "intrathecal", "fig": 3}, {"body": 27, "word": "control", "fig": 1}, {"body": 4, "word": "P", "fig": 6}, {"body": 24, "word": "siRNA", "fig": 1}, {"body": 24, "word": "used", "fig": 1}, {"body": 23, "word": "HDACs", "fig": 1}, {"body": 7, "word": "SAHA", "fig": 3}, {"body": 7, "word": "GSK503", "fig": 3}, {"body": 7, "word": "\u03bcg", "fig": 3}, {"body": 9, "word": "weeks", "fig": 2}, {"body": 18, "word": "inhibition", "fig": 1}, {"body": 14, "word": "analysis", "fig": 1}, {"body": 14, "word": "hypersensitivity", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 12, "word": "inhibitor", "fig": 1}, {"body": 11, "word": "effects", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 5, "word": "surgery", "fig": 2}, {"body": 3, "word": "thresholds", "fig": 3}, {"body": 3, "word": "plus", "fig": 3}, {"body": 4, "word": "b", "fig": 2}, {"body": 8, "word": "G9a-specific", "fig": 1}, {"body": 4, "word": "f", "fig": 2}, {"body": 6, "word": "test", "fig": 1}, {"body": 6, "word": "days", "fig": 1}, {"body": 3, "word": "compared", "fig": 2}, {"body": 6, "word": "treatments", "fig": 1}, {"body": 5, "word": "followed", "fig": 1}, {"body": 5, "word": "withdrawal", "fig": 1}, {"body": 4, "word": "injections", "fig": 1}, {"body": 2, "word": "c", "fig": 2}, {"body": 4, "word": "baseline", "fig": 1}, {"body": 3, "word": "intrathecally", "fig": 1}, {"body": 3, "word": "group", "fig": 1}, {"body": 1, "word": "Frey", "fig": 3}, {"body": 1, "word": "von", "fig": 3}, {"body": 1, "word": "Randall-Selitto", "fig": 3}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "induced", "fig": 1}, {"body": 2, "word": "post", "fig": 1}, {"body": 2, "word": "vehicle", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "hoc", "fig": 1}, {"body": 1, "word": "e", "fig": 2}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "Drugs", "fig": 1}, {"body": 1, "word": "injected", "fig": 1}, {"body": 1, "word": "Bonferroni\u2019s", "fig": 1}, {"body": 1, "word": "single", "fig": 1}, {"body": 1, "word": "daily", "fig": 1}, {"body": 1, "word": "starting", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0007.jpg", "caption": "Genetic deletion of G9a in DRG neurons prevents nerve injury-induced pain hypersensitivity and reduction in K+ channel gene expression in the DRG (a) Comparison of the von Frey (n = 6), Randall-Selitto (n = 6), heat (n = 5), and cold (n = 5) withdrawal thresholds between G9a condition KO and wild-type control mice. (b) Original gel images and mean data show the effects of G9a conditional deletion on the protein level of G9a in the lumbar DRGs and the dorsal spinal cord (n = 5 mice in each group). (c,d) Time course of changes in the Randall-Selitto and von Frey withdrawal thresholds of G9a conditional KO (cKO, n = 6) and littermate control (G9aflox/flox , n = 7) mice before and after speared nerve injury (SNI). (e,f) Quantitative PCR data show the mRNA levels of G9a, Kcna4, Kcnd2, Kcnq2 and Kcnma1 in the DRG obtained from wild-type controls (sham, n = 11; SNI, n = 11; e) and G9a cKO (sham, n = 6; SNI, n = 6; f) mice 21 days after surgery. Data are presented as mean \u00b1 s.e.m. Statistical analysis was performed using Mann-Whitney U test (a), one-way ANOVA followed by Bonferroni\u2019s post hoc tests (b), two-way ANOVA followed by Bonferroni\u2019s post hoc tests (c,d) or Mann-Whitney test (e,f). * P < 0.05, ** P < 0.01, *** P < 0.001, compared with the littermate control at the same time point (c,d) or the respective sham control (e,f). # P < 0.05, ## P < 0.01, ### P < 0.001, compared with the respective baseline control (3 day). Supplementary Figure S10 contains the uncropped version of the gel images.", "co_occurrence": [{"body": 95, "word": "G9a", "fig": 7}, {"body": 97, "word": "DRG", "fig": 3}, {"body": 27, "word": "control", "fig": 5}, {"body": 53, "word": "nerve", "fig": 2}, {"body": 19, "word": "mice", "fig": 4}, {"body": 61, "word": "K+", "fig": 1}, {"body": 57, "word": "expression", "fig": 1}, {"body": 55, "word": "pain", "fig": 1}, {"body": 15, "word": "sham", "fig": 3}, {"body": 4, "word": "n", "fig": 11}, {"body": 44, "word": "neurons", "fig": 1}, {"body": 44, "word": "channel", "fig": 1}, {"body": 42, "word": "injury", "fig": 1}, {"body": 41, "word": "levels", "fig": 1}, {"body": 34, "word": "using", "fig": 1}, {"body": 15, "word": "data", "fig": 2}, {"body": 29, "word": "gene", "fig": 1}, {"body": 27, "word": "DRGs", "fig": 1}, {"body": 4, "word": "P", "fig": 6}, {"body": 24, "word": "level", "fig": 1}, {"body": 22, "word": "Kcna4", "fig": 1}, {"body": 21, "word": "Kcnd2", "fig": 1}, {"body": 21, "word": "Kcnq2", "fig": 1}, {"body": 20, "word": "Kcnma1", "fig": 1}, {"body": 19, "word": "Supplementary", "fig": 1}, {"body": 17, "word": "mRNA", "fig": 1}, {"body": 17, "word": "protein", "fig": 1}, {"body": 4, "word": "f", "fig": 4}, {"body": 5, "word": "d", "fig": 3}, {"body": 14, "word": "performed", "fig": 1}, {"body": 14, "word": "hypersensitivity", "fig": 1}, {"body": 14, "word": "analysis", "fig": 1}, {"body": 13, "word": "obtained", "fig": 1}, {"body": 6, "word": "test", "fig": 2}, {"body": 11, "word": "effects", "fig": 1}, {"body": 10, "word": "PCR", "fig": 1}, {"body": 5, "word": "withdrawal", "fig": 2}, {"body": 5, "word": "followed", "fig": 2}, {"body": 4, "word": "conditional", "fig": 2}, {"body": 8, "word": "changes", "fig": 1}, {"body": 4, "word": "b", "fig": 2}, {"body": 4, "word": "KO", "fig": 2}, {"body": 7, "word": "spinal", "fig": 1}, {"body": 3, "word": "thresholds", "fig": 2}, {"body": 2, "word": "c", "fig": 3}, {"body": 6, "word": "days", "fig": 1}, {"body": 3, "word": "compared", "fig": 2}, {"body": 6, "word": "injury-induced", "fig": 1}, {"body": 5, "word": "G9aflox/flox", "fig": 1}, {"body": 5, "word": "surgery", "fig": 1}, {"body": 2, "word": "show", "fig": 2}, {"body": 2, "word": "ANOVA", "fig": 2}, {"body": 2, "word": "post", "fig": 2}, {"body": 4, "word": "baseline", "fig": 1}, {"body": 4, "word": "reduction", "fig": 1}, {"body": 2, "word": "hoc", "fig": 2}, {"body": 2, "word": "deletion", "fig": 2}, {"body": 4, "word": "dorsal", "fig": 1}, {"body": 1, "word": "e", "fig": 4}, {"body": 3, "word": "group", "fig": 1}, {"body": 3, "word": "controls", "fig": 1}, {"body": 1, "word": "SNI", "fig": 3}, {"body": 3, "word": "time", "fig": 1}, {"body": 2, "word": "day", "fig": 1}, {"body": 1, "word": "Frey", "fig": 2}, {"body": 1, "word": "gel", "fig": 2}, {"body": 1, "word": "images", "fig": 2}, {"body": 2, "word": "cord", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "heat", "fig": 1}, {"body": 2, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "Bonferroni\u2019s", "fig": 2}, {"body": 1, "word": "Randall-Selitto", "fig": 2}, {"body": 1, "word": "von", "fig": 2}, {"body": 1, "word": "course", "fig": 1}, {"body": 1, "word": "cold", "fig": 1}, {"body": 1, "word": "one-way", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "lumbar", "fig": 1}, {"body": 1, "word": "U", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661086/bin/nihms-730866-f0008.jpg", "caption": "G9a inhibition normalizes the expression level of K+ channel genes and a subset of other genes modified by nerve injury (a) Heat map generated with the expression values of 105 K+ channel-related genes found among the 16,876 mapped genes. The small dendrogram at top shows clustering of the samples regarding these expression values (4 rats in the sham group, 4 rats in the SNL group, and 3 SNL rats treated with UNC0638). (b) Scattered line plots (K-means clustering) show the effect of UNC0638 on individual K+ channel gene expression in the DRG, grouped according to their responses to nerve injury: down-regulated (n = 42), up-regulated (n = 4, not plotted), and no change (n = 26). (c) Heat map representing the expression values for the 638 genes that were modified at least two fold by nerve injury and normalized to the control level after treatment with UNC0638. (d) The 638 genes were separated into two clusters (K-means clustering) according to their changes in expression due to SNL and UNC0638 treatment. (e) Ingenuity Pathway Analysis showed the principal canonical pathways for the 638 genes shown in c and d.", "co_occurrence": [{"body": 49, "word": "genes", "fig": 7}, {"body": 57, "word": "expression", "fig": 6}, {"body": 61, "word": "K+", "fig": 3}, {"body": 53, "word": "nerve", "fig": 3}, {"body": 42, "word": "injury", "fig": 3}, {"body": 41, "word": "SNL", "fig": 3}, {"body": 41, "word": "rats", "fig": 3}, {"body": 55, "word": "The", "fig": 2}, {"body": 97, "word": "DRG", "fig": 1}, {"body": 24, "word": "UNC0638", "fig": 4}, {"body": 95, "word": "G9a", "fig": 1}, {"body": 44, "word": "channel", "fig": 2}, {"body": 24, "word": "level", "fig": 2}, {"body": 29, "word": "gene", "fig": 1}, {"body": 27, "word": "control", "fig": 1}, {"body": 9, "word": "values", "fig": 3}, {"body": 13, "word": "treatment", "fig": 2}, {"body": 10, "word": "two", "fig": 2}, {"body": 20, "word": "effect", "fig": 1}, {"body": 18, "word": "inhibition", "fig": 1}, {"body": 15, "word": "sham", "fig": 1}, {"body": 14, "word": "normalized", "fig": 1}, {"body": 4, "word": "n", "fig": 3}, {"body": 10, "word": "samples", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 9, "word": "treated", "fig": 1}, {"body": 8, "word": "changes", "fig": 1}, {"body": 7, "word": "found", "fig": 1}, {"body": 3, "word": "group", "fig": 2}, {"body": 3, "word": "according", "fig": 2}, {"body": 6, "word": "showed", "fig": 1}, {"body": 5, "word": "mapped", "fig": 1}, {"body": 5, "word": "up-regulated", "fig": 1}, {"body": 5, "word": "down-regulated", "fig": 1}, {"body": 4, "word": "b", "fig": 1}, {"body": 4, "word": "fold", "fig": 1}, {"body": 4, "word": "individual", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 2, "word": "c", "fig": 2}, {"body": 4, "word": "generated", "fig": 1}, {"body": 4, "word": "pathways", "fig": 1}, {"body": 3, "word": "Analysis", "fig": 1}, {"body": 3, "word": "change", "fig": 1}, {"body": 3, "word": "least", "fig": 1}, {"body": 3, "word": "line", "fig": 1}, {"body": 2, "word": "among", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 2, "word": "Pathway", "fig": 1}, {"body": 2, "word": "due", "fig": 1}, {"body": 2, "word": "separated", "fig": 1}, {"body": 2, "word": "Ingenuity", "fig": 1}, {"body": 1, "word": "map", "fig": 2}, {"body": 1, "word": "principal", "fig": 1}, {"body": 1, "word": "clusters", "fig": 1}, {"body": 1, "word": "canonical", "fig": 1}, {"body": 1, "word": "dendrogram", "fig": 1}, {"body": 1, "word": "responses", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "normalizes", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}], "3685218": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685218/bin/JME120251f01.jpg", "caption": "Mutational analysis of the Osx promoter. (A) Schematic representation of the relative positions of putative transcription factor binding sites in the \u22121269/+91 Osx promoter. (B) UMR106-01 cells transfected with the \u22121269/+91 Osx promoter reporter; promoter constructs with mutations in the regions indicated in brackets or empty vector (PGL3basic). Cells were assayed for luciferase and \u03b2-galactosidase activities 24 h after transfection. Corrected luciferase activities expressed relative to the wild-type promoter are shown. (C) PTH regulation of the indicated promoter luciferase constructs or empty vector was assessed using 10 nM rPTH(1\u201334) for 16 h before measuring luciferase activity. The values shown indicate luciferase activity in the presence of PTH relative to that in the basal state. (D) Luciferase activity of \u22121269/+91 Osx promoter reporter and the mutation of the first Sp site (\u221240/\u221244) reporter were tested for basal and PTH-regulated activity in primary mouse osteoblasts. Cells were treated with or without 10 nM rPTH(1\u201334) for 16 h before measuring luciferase activity. The values shown indicate luciferase activity in the presence of PTH relative to that in the basal state, cells transfected with empty vector were assessed without PTH stimulation. Statistical significance in B and C: *P<0.001 relative to \u22121269/+91; in D, statistical differences between bars are indicated by differences in letters P<0.05.", "co_occurrence": [{"body": 51, "word": "promoter", "fig": 7}, {"body": 61, "word": "Osx", "fig": 4}, {"body": 49, "word": "PTH", "fig": 4}, {"body": 23, "word": "activity", "fig": 6}, {"body": 9, "word": "luciferase", "fig": 7}, {"body": 25, "word": "cells", "fig": 2}, {"body": 13, "word": "shown", "fig": 3}, {"body": 11, "word": "The", "fig": 2}, {"body": 21, "word": "Sp", "fig": 1}, {"body": 19, "word": "sites", "fig": 1}, {"body": 5, "word": "h", "fig": 3}, {"body": 14, "word": "binding", "fig": 1}, {"body": 13, "word": "osteoblasts", "fig": 1}, {"body": 4, "word": "basal", "fig": 3}, {"body": 11, "word": "using", "fig": 1}, {"body": 5, "word": "transfected", "fig": 2}, {"body": 10, "word": "site", "fig": 1}, {"body": 10, "word": "transcription", "fig": 1}, {"body": 8, "word": "mouse", "fig": 1}, {"body": 4, "word": "assessed", "fig": 2}, {"body": 7, "word": "factor", "fig": 1}, {"body": 7, "word": "stimulation", "fig": 1}, {"body": 7, "word": "regulation", "fig": 1}, {"body": 3, "word": "C", "fig": 2}, {"body": 2, "word": "reporter", "fig": 3}, {"body": 3, "word": "constructs", "fig": 2}, {"body": 3, "word": "nM", "fig": 2}, {"body": 5, "word": "mutation", "fig": 1}, {"body": 5, "word": "wild-type", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 2, "word": "Cells", "fig": 2}, {"body": 4, "word": "UMR106-01", "fig": 1}, {"body": 4, "word": "expressed", "fig": 1}, {"body": 3, "word": "Statistical", "fig": 1}, {"body": 1, "word": "empty", "fig": 3}, {"body": 1, "word": "indicated", "fig": 3}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "activities", "fig": 2}, {"body": 2, "word": "primary", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "first", "fig": 1}, {"body": 1, "word": "rPTH", "fig": 2}, {"body": 1, "word": "differences", "fig": 2}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "without", "fig": 2}, {"body": 1, "word": "putative", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "PGL3basic", "fig": 1}, {"body": 1, "word": "tested", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}, {"body": 1, "word": "assayed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685218/bin/JME120251f02.jpg", "caption": "Mithramycin A (MA) inhibits Osx promoter activity and OSX expression. (A) UMR106-01 cells were transfected with \u22121269/+91 Osx promoter and incubated in the presence of increasing concentrations of MA or vehicle control for 8 h before assessment of luciferase activity corrected for \u03b2-galactosidase activity in the same cells. (B) UMR106-01 cells or neonatal mouse calvaria were incubated in the presence of 10 nM rPTH(1\u201334) (PTH), 2 \u03bcM MA (MA), or vehicle control (Con) for 16 h before extraction of RNA and assessment of Osx mRNA levels by real-time PCR relative to the levels of GAPDH in each sample. Bars indicate Osx mRNA levels relative to Con for each cell/tissue type. Statistical significance in A and B: *P<0.001 relative to control values. (C) The effect of incubation of UMR106-01 cells with 1 \u03bcM MA (+MA), 10 nM rPTH(1\u201334) (+PTH), 1 \u03bcM MA and 10 nM rPTH(1\u201334) (+MA+P) or vehicle control (Con) for 16 h on OSX and \u03b1-actin protein expression were assessed by SDS\u2013PAGE and immunoblot. Two isoforms of OSX were expressed and both were suppressed by MA or PTH by 50%. Duplicate samples were assessed in each experiment and each experiment was repeated twice with representative blots shown.", "co_occurrence": [{"body": 61, "word": "Osx", "fig": 4}, {"body": 38, "word": "OSX", "fig": 3}, {"body": 51, "word": "promoter", "fig": 2}, {"body": 25, "word": "cells", "fig": 4}, {"body": 49, "word": "PTH", "fig": 2}, {"body": 11, "word": "MA", "fig": 7}, {"body": 23, "word": "activity", "fig": 3}, {"body": 30, "word": "expression", "fig": 2}, {"body": 10, "word": "levels", "fig": 3}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 5, "word": "h", "fig": 3}, {"body": 14, "word": "protein", "fig": 1}, {"body": 13, "word": "shown", "fig": 1}, {"body": 4, "word": "UMR106-01", "fig": 3}, {"body": 11, "word": "The", "fig": 1}, {"body": 9, "word": "luciferase", "fig": 1}, {"body": 3, "word": "nM", "fig": 3}, {"body": 3, "word": "A", "fig": 3}, {"body": 9, "word": "effect", "fig": 1}, {"body": 8, "word": "mouse", "fig": 1}, {"body": 4, "word": "assessed", "fig": 2}, {"body": 6, "word": "calvaria", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 4, "word": "expressed", "fig": 1}, {"body": 4, "word": "isoforms", "fig": 1}, {"body": 1, "word": "control", "fig": 4}, {"body": 4, "word": "inhibits", "fig": 1}, {"body": 4, "word": "sample", "fig": 1}, {"body": 3, "word": "PCR", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "increasing", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "Statistical", "fig": 1}, {"body": 1, "word": "rPTH", "fig": 3}, {"body": 1, "word": "vehicle", "fig": 3}, {"body": 2, "word": "samples", "fig": 1}, {"body": 1, "word": "incubated", "fig": 2}, {"body": 2, "word": "neonatal", "fig": 1}, {"body": 2, "word": "incubation", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 1, "word": "blots", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "corrected", "fig": 1}, {"body": 1, "word": "\u03b1-actin", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "Mithramycin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685218/bin/JME120251f03.jpg", "caption": "Osterix but not other Sp factors bind to the Osx promoter. (A) Chromatin prepared from UMR106-01 cells was assessed for transcription factor binding to the Osx promoter proximal to the two Sp binding sites (\u221244/\u221234). Following immunoprecipitation with antibodies specific to the indicated transcription factors, the amount of Osx promoter binding to each factor was assessed by real-time PCR. Bars indicate the amount of Osx DNA in each sample relative to the total input amount in the assay. Nonspecific binding was assessed using IgG in the immunoprecipitation assay. *Statistical significance: P<0.0001 relative to IgG. (B) UMR106-01 cells were incubated with 10 nM rPTH(1\u201334) for the indicated times before cell extraction and chromatin preparation. PTH stimulation significantly decreased OSX binding to its own promoter within 2 h of stimulation and this continued to decrease over 24 h. Statistical significance: *P<0.05 relative to control values. (C) Immunoblots of 25 \u03bcg samples of UMR106-01 cell extracts showing expression of each of the transcription factors assessed in the ChIP assays. Incubation of the cells with 10 nM rPTH(1\u201334) for 8 h had no effect on the levels of any of these proteins. (D) Immunoblots of OSX expression in UMR106-01 cells treated with 10 nM rPTH(1\u201334) over the same time periods as used for ChIP assays show that OSX protein was decreased with treatments of 4 h or longer.", "co_occurrence": [{"body": 61, "word": "Osx", "fig": 4}, {"body": 51, "word": "promoter", "fig": 4}, {"body": 38, "word": "OSX", "fig": 3}, {"body": 25, "word": "cells", "fig": 4}, {"body": 14, "word": "binding", "fig": 5}, {"body": 30, "word": "expression", "fig": 2}, {"body": 49, "word": "PTH", "fig": 1}, {"body": 21, "word": "Sp", "fig": 2}, {"body": 10, "word": "transcription", "fig": 3}, {"body": 7, "word": "factors", "fig": 3}, {"body": 19, "word": "sites", "fig": 1}, {"body": 4, "word": "UMR106-01", "fig": 4}, {"body": 4, "word": "assessed", "fig": 4}, {"body": 5, "word": "h", "fig": 3}, {"body": 7, "word": "factor", "fig": 2}, {"body": 7, "word": "decreased", "fig": 2}, {"body": 7, "word": "stimulation", "fig": 2}, {"body": 7, "word": "assays", "fig": 2}, {"body": 14, "word": "protein", "fig": 1}, {"body": 11, "word": "using", "fig": 1}, {"body": 5, "word": "ChIP", "fig": 2}, {"body": 10, "word": "levels", "fig": 1}, {"body": 3, "word": "nM", "fig": 3}, {"body": 9, "word": "effect", "fig": 1}, {"body": 8, "word": "two", "fig": 1}, {"body": 8, "word": "DNA", "fig": 1}, {"body": 2, "word": "amount", "fig": 3}, {"body": 5, "word": "proximal", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 2, "word": "IgG", "fig": 2}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "significantly", "fig": 1}, {"body": 4, "word": "within", "fig": 1}, {"body": 4, "word": "sample", "fig": 1}, {"body": 4, "word": "used", "fig": 1}, {"body": 3, "word": "h.", "fig": 1}, {"body": 3, "word": "PCR", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "Statistical", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 1, "word": "rPTH", "fig": 3}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "samples", "fig": 1}, {"body": 2, "word": "chromatin", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "specific", "fig": 1}, {"body": 2, "word": "decrease", "fig": 1}, {"body": 1, "word": "cell", "fig": 2}, {"body": 2, "word": "treatments", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "Following", "fig": 1}, {"body": 1, "word": "indicated", "fig": 2}, {"body": 1, "word": "immunoprecipitation", "fig": 2}, {"body": 2, "word": "Osterix", "fig": 1}, {"body": 1, "word": "significance", "fig": 2}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 2, "word": "bind", "fig": 1}, {"body": 2, "word": "time", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "Chromatin", "fig": 1}, {"body": 1, "word": "input", "fig": 1}, {"body": 1, "word": "extracts", "fig": 1}, {"body": 1, "word": "control", "fig": 1}, {"body": 1, "word": "incubated", "fig": 1}, {"body": 1, "word": "antibodies", "fig": 1}, {"body": 1, "word": "longer", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685218/bin/JME120251f04.jpg", "caption": "Effect of PTH stimulation on the levels of MAPKs and the effect of MAPK inhibitors on Osx mRNA and Osx promoter luciferase activity. (A) UMR106-01 cells were incubated for the indicated times with 10 nM rPTH(1\u201334) before extraction of cellular proteins. 10 \u03bcg samples of cellular extracts were analyzed by SDS\u2013PAGE and immunoblots using specific antibodies to each of the indicated MAPKs and their activated (phosphorylated) forms as shown on the side of each blot. Levels of MKP-1, a phosphatase that can dephosphorylate MAPKs, are also shown in the bottom panel. (B) UMR106-01 cells were incubated with 10 \u03bcM concentrations of U0126, a specific inhibitor of ERK1/2; SP600125, a specific inhibitor of JNK (SP); SB203580, a specific inhibitor of p38 MAPK (SB), or vehicle control for 16 h before extraction of cellular RNA and assessment of Osx mRNA by real-time PCR. (C) UMR106-01 cells were transfected with \u22121269/+91 promoter luciferase construct and the cells were then incubated with either 10 \u03bcM SB203580 for the indicated times or 10 nM rPTH(1\u201334) for 24 h before assessment of luciferase activity. Statistical significance in B and C indicated by *P<0.05 relative to control values.", "co_occurrence": [{"body": 61, "word": "Osx", "fig": 3}, {"body": 51, "word": "promoter", "fig": 2}, {"body": 25, "word": "cells", "fig": 4}, {"body": 49, "word": "PTH", "fig": 1}, {"body": 23, "word": "activity", "fig": 2}, {"body": 19, "word": "MAPK", "fig": 2}, {"body": 9, "word": "luciferase", "fig": 3}, {"body": 13, "word": "shown", "fig": 2}, {"body": 20, "word": "p38", "fig": 1}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 5, "word": "inhibitor", "fig": 3}, {"body": 14, "word": "also", "fig": 1}, {"body": 4, "word": "UMR106-01", "fig": 3}, {"body": 4, "word": "MAPKs", "fig": 3}, {"body": 11, "word": "using", "fig": 1}, {"body": 5, "word": "h", "fig": 2}, {"body": 10, "word": "levels", "fig": 1}, {"body": 9, "word": "effect", "fig": 1}, {"body": 2, "word": "specific", "fig": 4}, {"body": 7, "word": "either", "fig": 1}, {"body": 7, "word": "stimulation", "fig": 1}, {"body": 3, "word": "C", "fig": 2}, {"body": 3, "word": "SB203580", "fig": 2}, {"body": 3, "word": "nM", "fig": 2}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "JNK", "fig": 1}, {"body": 4, "word": "construct", "fig": 1}, {"body": 1, "word": "indicated", "fig": 4}, {"body": 1, "word": "cellular", "fig": 3}, {"body": 3, "word": "PCR", "fig": 1}, {"body": 3, "word": "inhibitors", "fig": 1}, {"body": 3, "word": "MKP-1", "fig": 1}, {"body": 3, "word": "Statistical", "fig": 1}, {"body": 1, "word": "incubated", "fig": 3}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "samples", "fig": 1}, {"body": 2, "word": "SP600125", "fig": 1}, {"body": 2, "word": "U0126", "fig": 1}, {"body": 1, "word": "control", "fig": 2}, {"body": 1, "word": "rPTH", "fig": 2}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "phosphorylated", "fig": 1}, {"body": 1, "word": "activated", "fig": 1}, {"body": 1, "word": "immunoblots", "fig": 1}, {"body": 1, "word": "ERK1/2", "fig": 1}, {"body": 1, "word": "phosphatase", "fig": 1}, {"body": 1, "word": "extracts", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "antibodies", "fig": 1}, {"body": 1, "word": "dephosphorylate", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685218/bin/JME120251f05.jpg", "caption": "Effects of PTH on OSX and p38MAPK are also seen with forskolin stimulation of UMR cells. (A) UMR106-01 cells were transfected with the \u22121269/+91 Osx promoter reporter construct and treated with 10 nM rPTH(1\u201334), 10 \u03bcM forskolin, or vehicle control for 16 h before measuring luciferase activity. The values shown indicate luciferase activity relative to that in the basal state. (B) UMR106-01 cells were incubated in the presence of 10 nM rPTH(1\u201334) (PTH), 10 \u03bcM forskolin (FSK), or vehicle control (Con) for 16 h before extraction of RNA and assessment of Osx mRNA levels by real-time PCR relative to the levels of GAPDH in each sample. Bars indicate Osx mRNA levels relative to Con for each cell/tissue type. Statistical significance in A and B *P<0.001 relative to control values. (C) UMR106-01 cells were incubated in the presence of 10 nM rPTH(1\u201334) (PTH), 10 \u03bcM forskolin (FSK), or vehicle control (Con) for 16 h before extraction of protein and assessment of OSX protein levels by immunoblot relative to the levels of actin in each sample. (D) UMR106-01 cells were incubated for the 90 min with 10 nM rPTH(1\u201334) (PTH), 10 \u03bcM forskolin (FSK), or vehicle control (Con) before extraction of cellular proteins. Samples of cellular extracts were analyzed by SDS\u2013PAGE and immunoblots using specific antibodies to the indicated p38MAPK and its activated form (pp38) as shown on the side of each blot.", "co_occurrence": [{"body": 49, "word": "PTH", "fig": 4}, {"body": 61, "word": "Osx", "fig": 3}, {"body": 25, "word": "cells", "fig": 5}, {"body": 38, "word": "OSX", "fig": 2}, {"body": 51, "word": "promoter", "fig": 1}, {"body": 10, "word": "levels", "fig": 5}, {"body": 23, "word": "activity", "fig": 2}, {"body": 14, "word": "protein", "fig": 2}, {"body": 13, "word": "shown", "fig": 2}, {"body": 4, "word": "forskolin", "fig": 5}, {"body": 9, "word": "luciferase", "fig": 2}, {"body": 4, "word": "UMR106-01", "fig": 4}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 5, "word": "h", "fig": 3}, {"body": 14, "word": "also", "fig": 1}, {"body": 3, "word": "nM", "fig": 4}, {"body": 11, "word": "using", "fig": 1}, {"body": 11, "word": "The", "fig": 1}, {"body": 4, "word": "sample", "fig": 2}, {"body": 7, "word": "stimulation", "fig": 1}, {"body": 3, "word": "A", "fig": 2}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 1, "word": "control", "fig": 5}, {"body": 5, "word": "treated", "fig": 1}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "UMR", "fig": 1}, {"body": 1, "word": "rPTH", "fig": 4}, {"body": 4, "word": "construct", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 4}, {"body": 4, "word": "basal", "fig": 1}, {"body": 4, "word": "seen", "fig": 1}, {"body": 3, "word": "PCR", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "Statistical", "fig": 1}, {"body": 1, "word": "incubated", "fig": 3}, {"body": 2, "word": "actin", "fig": 1}, {"body": 1, "word": "cellular", "fig": 2}, {"body": 2, "word": "specific", "fig": 1}, {"body": 2, "word": "pp38", "fig": 1}, {"body": 2, "word": "reporter", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 1, "word": "p38MAPK", "fig": 2}, {"body": 1, "word": "activated", "fig": 1}, {"body": 1, "word": "immunoblots", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "extracts", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "antibodies", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685218/bin/JME120251f06.jpg", "caption": "Expression of constitutively active MKK6 but not JNK abrogates PTH inhibition of Osx mRNA, protein, and Osx promoter activity. (A) UMR106-01 cells were transfected with cDNAs encoding caMKK6, an upstream kinase that activated p38 MAPK or JNKK2-JNK1, a constitutively active JNK1. The following day, cells were incubated with or without 10 nM rPTH(1\u201334) for 8 h before RNA extraction and assessment of Osx mRNA by real-time PCR. *Values significantly different from basal levels, P<0.05; \u00b6values significantly different from control +PTH, P<0.05. (C and D) UMR106-01 cells were transfected with caMKK6, JNKK2-JNK1 (caJNK), or a control cDNA (control) in addition to \u22121269/+91 promoter luciferase construct. Cells were then incubated with 10 nM rPTH(1\u201334) for 8 or 16 h and compared with cells incubated without PTH (Basal). Luciferase activities relative to control basal are plotted. *Values significantly different from control basal levels, P<0.01. (B) UMR106-01 cells were transfected with caMKK6, JNKK2-JNK1 (caJNK), or a control cDNA (control) and then incubated with 10 nM rPTH(1\u201334) for 8 h before extraction of cellular proteins. 25 \u03bcg samples of protein extracts were run on SDS\u2013PAGE followed by immunoblot for OSX or actin. The numbers on top of the blots indicate the levels of OSX protein relative to control basal levels.", "co_occurrence": [{"body": 61, "word": "Osx", "fig": 3}, {"body": 25, "word": "cells", "fig": 5}, {"body": 51, "word": "promoter", "fig": 2}, {"body": 49, "word": "PTH", "fig": 2}, {"body": 38, "word": "OSX", "fig": 2}, {"body": 14, "word": "protein", "fig": 3}, {"body": 10, "word": "levels", "fig": 4}, {"body": 23, "word": "activity", "fig": 1}, {"body": 11, "word": "The", "fig": 2}, {"body": 20, "word": "p38", "fig": 1}, {"body": 19, "word": "MAPK", "fig": 1}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 4, "word": "basal", "fig": 4}, {"body": 5, "word": "h", "fig": 3}, {"body": 5, "word": "transfected", "fig": 3}, {"body": 5, "word": "caMKK6", "fig": 3}, {"body": 13, "word": "inhibition", "fig": 1}, {"body": 4, "word": "significantly", "fig": 3}, {"body": 4, "word": "UMR106-01", "fig": 3}, {"body": 9, "word": "luciferase", "fig": 1}, {"body": 3, "word": "nM", "fig": 3}, {"body": 4, "word": "active", "fig": 2}, {"body": 1, "word": "control", "fig": 8}, {"body": 4, "word": "constitutively", "fig": 2}, {"body": 2, "word": "P", "fig": 3}, {"body": 3, "word": "caJNK", "fig": 2}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 4, "word": "MKK6", "fig": 1}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "JNK", "fig": 1}, {"body": 1, "word": "incubated", "fig": 4}, {"body": 4, "word": "construct", "fig": 1}, {"body": 2, "word": "cDNA", "fig": 2}, {"body": 3, "word": "PCR", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 1, "word": "rPTH", "fig": 3}, {"body": 1, "word": "different", "fig": 3}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "JNKK2-JNK1", "fig": 3}, {"body": 2, "word": "actin", "fig": 1}, {"body": 2, "word": "samples", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 2, "word": "upstream", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "encoding", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "following", "fig": 1}, {"body": 1, "word": "without", "fig": 2}, {"body": 1, "word": "activated", "fig": 1}, {"body": 1, "word": "blots", "fig": 1}, {"body": 1, "word": "cellular", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 1, "word": "kinase", "fig": 1}, {"body": 1, "word": "addition", "fig": 1}, {"body": 1, "word": "extracts", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 1}, {"body": 1, "word": "activities", "fig": 1}, {"body": 1, "word": "compared", "fig": 1}]}], "4826236": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g001.jpg", "caption": "Nuclear morphology changes in different clinical and experimental settings Similar nuclear texture changes occur in: A. ovarian tumors after chemotherapy; B. breast tumors after neoadjuvant therapy; C. colorectal tumors after radiotherapy; D. ovarian tumor xenografts after carboplatin treatment; and E. the ovarian cancer cell line PEO1 after cisplatin treatment. A-D are formalin-fixed, paraffin embedded sections cut from tumor samples and stained with H&E. E shows PEO1 cell cytospins using the Feulgen nuclear stain.", "co_occurrence": [{"body": 50, "word": "treatment", "fig": 2}, {"body": 32, "word": "cell", "fig": 2}, {"body": 60, "word": "cisplatin", "fig": 1}, {"body": 28, "word": "changes", "fig": 2}, {"body": 26, "word": "PEO1", "fig": 2}, {"body": 16, "word": "ovarian", "fig": 3}, {"body": 22, "word": "nuclear", "fig": 2}, {"body": 24, "word": "cancer", "fig": 1}, {"body": 22, "word": "using", "fig": 1}, {"body": 5, "word": "tumors", "fig": 3}, {"body": 14, "word": "texture", "fig": 1}, {"body": 11, "word": "chemotherapy", "fig": 1}, {"body": 5, "word": "tumor", "fig": 2}, {"body": 8, "word": "carboplatin", "fig": 1}, {"body": 7, "word": "different", "fig": 1}, {"body": 6, "word": "line", "fig": 1}, {"body": 5, "word": "xenografts", "fig": 1}, {"body": 5, "word": "occur", "fig": 1}, {"body": 5, "word": "samples", "fig": 1}, {"body": 4, "word": "Nuclear", "fig": 1}, {"body": 4, "word": "stained", "fig": 1}, {"body": 3, "word": "radiotherapy", "fig": 1}, {"body": 3, "word": "clinical", "fig": 1}, {"body": 3, "word": "therapy", "fig": 1}, {"body": 3, "word": "breast", "fig": 1}, {"body": 3, "word": "sections", "fig": 1}, {"body": 2, "word": "colorectal", "fig": 1}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "morphology", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "paraffin", "fig": 1}, {"body": 1, "word": "embedded", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g002.jpg", "caption": "Alterations in nuclear texture in vitro and in vivo after treatment with platinum drugs or radiotherapy A. Changes in nuclear texture in PEO1 cells after irradiation or cisplatin treatment. PEO1 cells were grown on coverslips and treated with ionising radiation (6Gy) or cisplatin (6uM) for 24h, and nuclei were stained with DAPI for visualisation using a fluorescence microscope. At least 100 nuclei were included in each experiment. Nuclear texture was analysed by measuring five texture parameters (angular second moment, correlation, entropy, inverse different moment, and contrast) using Image J software. Data are presented as the average change (%) in the treated group for each parameter over the control group. B. Representative images from H&E-stained OV1002 ovarian tumor samples either untreated or after carboplatin (50 mg/kg) treatment in vivo. H&E stained images were acquired under 40x magnification. C. Nuclear texture parameter analysis in xenografts with and without carboplatin treatment on Day 2. Data for each spot represents the average value of each single sample with the number of nuclei analysed per sample ranging from 16 to 213 (average 103). Mann-Whitney U test (2-tailed); *P<0.05, **P<0.01 D. Changes in chromatin patterns in PEO1 cells after cisplatin (6uM) or radiation (6Gy) treatment for 24h, and in OV1002 xenografts in vivo after carboplatin treatment, measured by parameters describing nuclear texture using Image J. The (+) and (\u2212) represent positive and negative correlations with each type of chromatin pattern, respectively, and the arrows indicate the direction of change for each pattern.", "co_occurrence": [{"body": 50, "word": "treatment", "fig": 6}, {"body": 63, "word": "cells", "fig": 3}, {"body": 60, "word": "cisplatin", "fig": 3}, {"body": 14, "word": "texture", "fig": 6}, {"body": 26, "word": "PEO1", "fig": 3}, {"body": 22, "word": "using", "fig": 3}, {"body": 22, "word": "nuclear", "fig": 3}, {"body": 28, "word": "chromatin", "fig": 2}, {"body": 8, "word": "carboplatin", "fig": 3}, {"body": 7, "word": "vivo", "fig": 3}, {"body": 21, "word": "The", "fig": 1}, {"body": 7, "word": "nuclei", "fig": 3}, {"body": 8, "word": "24h", "fig": 2}, {"body": 16, "word": "ovarian", "fig": 1}, {"body": 8, "word": "treated", "fig": 2}, {"body": 7, "word": "moment", "fig": 2}, {"body": 12, "word": "contrast", "fig": 1}, {"body": 5, "word": "parameters", "fig": 2}, {"body": 5, "word": "xenografts", "fig": 2}, {"body": 5, "word": "images", "fig": 2}, {"body": 5, "word": "analysed", "fig": 2}, {"body": 5, "word": "radiation", "fig": 2}, {"body": 5, "word": "OV1002", "fig": 2}, {"body": 9, "word": "analysis", "fig": 1}, {"body": 4, "word": "stained", "fig": 2}, {"body": 4, "word": "pattern", "fig": 2}, {"body": 4, "word": "Nuclear", "fig": 2}, {"body": 7, "word": "number", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "vitro", "fig": 1}, {"body": 7, "word": "different", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 6, "word": "patterns", "fig": 1}, {"body": 5, "word": "entropy", "fig": 1}, {"body": 5, "word": "samples", "fig": 1}, {"body": 5, "word": "tumor", "fig": 1}, {"body": 5, "word": "software", "fig": 1}, {"body": 4, "word": "five", "fig": 1}, {"body": 4, "word": "second", "fig": 1}, {"body": 4, "word": "DAPI", "fig": 1}, {"body": 4, "word": "respectively", "fig": 1}, {"body": 2, "word": "change", "fig": 2}, {"body": 2, "word": "Image", "fig": 2}, {"body": 4, "word": "test", "fig": 1}, {"body": 4, "word": "correlation", "fig": 1}, {"body": 3, "word": "inverse", "fig": 1}, {"body": 3, "word": "angular", "fig": 1}, {"body": 3, "word": "negative", "fig": 1}, {"body": 3, "word": "indicate", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "radiotherapy", "fig": 1}, {"body": 3, "word": "grown", "fig": 1}, {"body": 2, "word": "ionising", "fig": 1}, {"body": 1, "word": "H", "fig": 2}, {"body": 2, "word": "correlations", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "type", "fig": 1}, {"body": 2, "word": "platinum", "fig": 1}, {"body": 2, "word": "least", "fig": 1}, {"body": 1, "word": "J", "fig": 2}, {"body": 1, "word": "sample", "fig": 2}, {"body": 1, "word": "Data", "fig": 2}, {"body": 2, "word": "single", "fig": 1}, {"body": 2, "word": "fluorescence", "fig": 1}, {"body": 1, "word": "visualisation", "fig": 1}, {"body": 1, "word": "coverslips", "fig": 1}, {"body": 1, "word": "untreated", "fig": 1}, {"body": 1, "word": "mg/kg", "fig": 1}, {"body": 1, "word": "microscope", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "Alterations", "fig": 1}, {"body": 1, "word": "Mann-Whitney", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "value", "fig": 1}, {"body": 1, "word": "At", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g003.jpg", "caption": "Expression of HDAC2 and heterochromatin proteins after cisplatin incubation A. Western blots for HDAC2, HP1\u03b1, HP1\u03b2, and HP1\u03b3 in PEO1 and PEO4 cells with or without cisplatin treatment (6 uM, 24h). Membranes were probed with the indicated antibodies, and tubulin was used as a loading control. B. HDAC2 and HP1 protein expression detected by immunofluorescence. Cells were seeded on cover slips and fixed as described in the Materials and Methods in PEO1 cells after cisplatin treatment for 6h and 24h. Alexa488 (green channel) and DAPI (blue channel) were used to stain target proteins and the nuclei, respectively. Images were taken using a confocal microscope. C. Expression of HDAC2, HP1\u03b1, HP1\u03b2, and HP1\u03b3 mRNA in PEO1 cells measured by RT-PCR as described in the Materials and Methods. Relative expression of the target gene was calculated as the average \u0394Ct and normalized to that of the housekeeping gene \u03b2-actin. Results are as presented as mean \u00b1SD from biological triplicates. *p<0.05, **p<0.01 (Student's t-test).", "co_occurrence": [{"body": 73, "word": "HDAC2", "fig": 4}, {"body": 63, "word": "cells", "fig": 3}, {"body": 60, "word": "cisplatin", "fig": 3}, {"body": 50, "word": "treatment", "fig": 2}, {"body": 46, "word": "expression", "fig": 2}, {"body": 26, "word": "PEO1", "fig": 3}, {"body": 16, "word": "proteins", "fig": 2}, {"body": 22, "word": "using", "fig": 1}, {"body": 11, "word": "used", "fig": 2}, {"body": 19, "word": "protein", "fig": 1}, {"body": 8, "word": "24h", "fig": 2}, {"body": 16, "word": "HP1", "fig": 1}, {"body": 7, "word": "described", "fig": 2}, {"body": 7, "word": "target", "fig": 2}, {"body": 13, "word": "heterochromatin", "fig": 1}, {"body": 6, "word": "gene", "fig": 2}, {"body": 5, "word": "HP1\u03b1", "fig": 2}, {"body": 10, "word": "PEO4", "fig": 1}, {"body": 9, "word": "antibodies", "fig": 1}, {"body": 4, "word": "Expression", "fig": 2}, {"body": 4, "word": "HP1\u03b3", "fig": 2}, {"body": 4, "word": "HP1\u03b2", "fig": 2}, {"body": 8, "word": "indicated", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 7, "word": "nuclei", "fig": 1}, {"body": 3, "word": "channel", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "measured", "fig": 1}, {"body": 5, "word": "incubation", "fig": 1}, {"body": 5, "word": "'s", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "DAPI", "fig": 1}, {"body": 4, "word": "respectively", "fig": 1}, {"body": 3, "word": "detected", "fig": 1}, {"body": 3, "word": "fixed", "fig": 1}, {"body": 3, "word": "mRNA", "fig": 1}, {"body": 3, "word": "immunofluorescence", "fig": 1}, {"body": 2, "word": "6h", "fig": 1}, {"body": 2, "word": "Membranes", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "RT-PCR", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "blots", "fig": 1}, {"body": 1, "word": "microscope", "fig": 1}, {"body": 1, "word": "seeded", "fig": 1}, {"body": 1, "word": "Images", "fig": 1}, {"body": 1, "word": "taken", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g004.jpg", "caption": "Expression of HDAC2, HP1\u03b1, HP1\u03b2 and HP1\u03b3 in the OV1002 and HOX424 ovarian xenograft tumor models on Day 7 after carboplatin treatment The sample TMA was probed with the indicated antibodies and expression levels were quantified by AQUA analysis. Boxplots depict AQUA scores representing the expression of proteins. Data was compared between control group (red bar) and carboplatin-treated group (blue bar) within the platinum sensitive model (OV1002) and resistant model (HOX424), respectively. Man-Whitney analysis was performed and P values are indicated.", "co_occurrence": [{"body": 46, "word": "expression", "fig": 2}, {"body": 73, "word": "HDAC2", "fig": 1}, {"body": 50, "word": "treatment", "fig": 1}, {"body": 21, "word": "The", "fig": 1}, {"body": 9, "word": "analysis", "fig": 2}, {"body": 8, "word": "indicated", "fig": 2}, {"body": 16, "word": "proteins", "fig": 1}, {"body": 16, "word": "ovarian", "fig": 1}, {"body": 7, "word": "model", "fig": 2}, {"body": 5, "word": "OV1002", "fig": 2}, {"body": 9, "word": "antibodies", "fig": 1}, {"body": 8, "word": "carboplatin", "fig": 1}, {"body": 4, "word": "HOX424", "fig": 2}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "xenograft", "fig": 1}, {"body": 6, "word": "performed", "fig": 1}, {"body": 6, "word": "sensitive", "fig": 1}, {"body": 3, "word": "AQUA", "fig": 2}, {"body": 5, "word": "HP1\u03b1", "fig": 1}, {"body": 5, "word": "compared", "fig": 1}, {"body": 5, "word": "levels", "fig": 1}, {"body": 5, "word": "tumor", "fig": 1}, {"body": 4, "word": "within", "fig": 1}, {"body": 4, "word": "HP1\u03b3", "fig": 1}, {"body": 4, "word": "HP1\u03b2", "fig": 1}, {"body": 4, "word": "models", "fig": 1}, {"body": 4, "word": "respectively", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 3, "word": "resistant", "fig": 1}, {"body": 2, "word": "platinum", "fig": 1}, {"body": 2, "word": "quantified", "fig": 1}, {"body": 1, "word": "sample", "fig": 1}, {"body": 1, "word": "TMA", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g005.jpg", "caption": "Time-dependent expression of DNA damage response proteins in PEO1 cells Cells were seeded and treated with or without cisplatin (6\u03bcM), and protein lysates were collected every 24h after treatment from 0h to 96h. Western blotting was performed to detect expression of pBRCA1, \u03b3H2AX, pATM, ATM, pATR, and ATR. Membranes were probed with the indicated antibodies, and tubulin was used as a loading control. Experiments were performed at least three times acquiring similar results. Blots from one representative experiment are shown.", "co_occurrence": [{"body": 46, "word": "expression", "fig": 2}, {"body": 63, "word": "cells", "fig": 1}, {"body": 60, "word": "cisplatin", "fig": 1}, {"body": 50, "word": "treatment", "fig": 1}, {"body": 34, "word": "DNA", "fig": 1}, {"body": 27, "word": "response", "fig": 1}, {"body": 26, "word": "PEO1", "fig": 1}, {"body": 23, "word": "\u03b3H2AX", "fig": 1}, {"body": 21, "word": "damage", "fig": 1}, {"body": 19, "word": "protein", "fig": 1}, {"body": 16, "word": "proteins", "fig": 1}, {"body": 6, "word": "performed", "fig": 2}, {"body": 11, "word": "used", "fig": 1}, {"body": 9, "word": "antibodies", "fig": 1}, {"body": 8, "word": "indicated", "fig": 1}, {"body": 8, "word": "pBRCA1", "fig": 1}, {"body": 8, "word": "24h", "fig": 1}, {"body": 8, "word": "pATM", "fig": 1}, {"body": 8, "word": "similar", "fig": 1}, {"body": 8, "word": "treated", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "pATR", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 5, "word": "ATM", "fig": 1}, {"body": 5, "word": "shown", "fig": 1}, {"body": 4, "word": "three", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "ATR", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "collected", "fig": 1}, {"body": 3, "word": "results", "fig": 1}, {"body": 2, "word": "least", "fig": 1}, {"body": 2, "word": "one", "fig": 1}, {"body": 2, "word": "Membranes", "fig": 1}, {"body": 2, "word": "times", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "seeded", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "Time-dependent", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}, {"body": 1, "word": "0h", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g006.jpg", "caption": "The effect of siHDAC2 knockdown on expression of other HDAC family members, HP1s, and DNA damage response proteins by western blotting in PEO1 cells alone (A) and in the presence / absence of cisplatin (B) Protein was lysed after HDAC2 was knocked down after 72 h using reverse transfection. Non-transfection (control), mock, and siRNA negative control were used as controls. Membranes were probed with the indicated antibodies, and tubulin was used as a loading control. Experiments were performed at least three times acquiring similar results. Blots from one representative experiment are shown. In (B), cells were treated with cisplatin (6\u03bcM) after 72h incubation with mock (lane 1), siRNA negative control (lane 2), or HDAC2 siRNA duplexes (10pmol in 6mL, lane 3). Protein lysates were collected at 6h, 24h, 48h, and 72h after cisplatin treatment and analysed by western blotting of DNA damage response proteins; tubulin was used as loading control. Experiments were performed at least three time acquiring similar results. Blots from one representative experiment are shown.", "co_occurrence": [{"body": 60, "word": "cisplatin", "fig": 3}, {"body": 73, "word": "HDAC2", "fig": 2}, {"body": 63, "word": "cells", "fig": 2}, {"body": 34, "word": "DNA", "fig": 2}, {"body": 27, "word": "response", "fig": 2}, {"body": 50, "word": "treatment", "fig": 1}, {"body": 46, "word": "expression", "fig": 1}, {"body": 21, "word": "damage", "fig": 2}, {"body": 7, "word": "control", "fig": 5}, {"body": 11, "word": "used", "fig": 3}, {"body": 16, "word": "proteins", "fig": 2}, {"body": 26, "word": "PEO1", "fig": 1}, {"body": 26, "word": "knockdown", "fig": 1}, {"body": 8, "word": "siRNA", "fig": 3}, {"body": 22, "word": "using", "fig": 1}, {"body": 21, "word": "h", "fig": 1}, {"body": 21, "word": "The", "fig": 1}, {"body": 18, "word": "HDAC", "fig": 1}, {"body": 8, "word": "similar", "fig": 2}, {"body": 6, "word": "performed", "fig": 2}, {"body": 12, "word": "In", "fig": 1}, {"body": 5, "word": "shown", "fig": 2}, {"body": 9, "word": "time", "fig": 1}, {"body": 9, "word": "antibodies", "fig": 1}, {"body": 8, "word": "24h", "fig": 1}, {"body": 8, "word": "treated", "fig": 1}, {"body": 4, "word": "three", "fig": 2}, {"body": 8, "word": "indicated", "fig": 1}, {"body": 7, "word": "effect", "fig": 1}, {"body": 3, "word": "results", "fig": 2}, {"body": 3, "word": "blotting", "fig": 2}, {"body": 3, "word": "negative", "fig": 2}, {"body": 3, "word": "B", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "analysed", "fig": 1}, {"body": 5, "word": "alone", "fig": 1}, {"body": 5, "word": "incubation", "fig": 1}, {"body": 2, "word": "Protein", "fig": 2}, {"body": 2, "word": "one", "fig": 2}, {"body": 2, "word": "least", "fig": 2}, {"body": 2, "word": "72h", "fig": 2}, {"body": 4, "word": "transfection", "fig": 1}, {"body": 2, "word": "western", "fig": 2}, {"body": 3, "word": "controls", "fig": 1}, {"body": 3, "word": "members", "fig": 1}, {"body": 3, "word": "collected", "fig": 1}, {"body": 1, "word": "loading", "fig": 2}, {"body": 2, "word": "times", "fig": 1}, {"body": 2, "word": "family", "fig": 1}, {"body": 2, "word": "6h", "fig": 1}, {"body": 1, "word": "representative", "fig": 2}, {"body": 2, "word": "Membranes", "fig": 1}, {"body": 1, "word": "mock", "fig": 2}, {"body": 1, "word": "reverse", "fig": 1}, {"body": 1, "word": "48h", "fig": 1}, {"body": 1, "word": "lysed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g007.jpg", "caption": "Immunofluorescence for \u03b3H2AX foci in PEO1 cells Cells were grown and treated as described before, and images were taken after 24 h treatment of cisplatin in cells with or without HDAC2 siRNA. Antibodies against H2AX phosphorylation at Ser 139 were used to probe cellular \u03b3H2AX foci (red channel), and DAPI was applied for nuclear staining (blue channel). A. Representative images from one experiment are shown. >100 cells in each group were included for one experiment, and three independent experiments were performed. B. Distribution of \u03b3H2AX foci / cell in PEO1 cells.", "co_occurrence": [{"body": 63, "word": "cells", "fig": 4}, {"body": 73, "word": "HDAC2", "fig": 1}, {"body": 23, "word": "\u03b3H2AX", "fig": 3}, {"body": 60, "word": "cisplatin", "fig": 1}, {"body": 26, "word": "PEO1", "fig": 2}, {"body": 50, "word": "treatment", "fig": 1}, {"body": 13, "word": "foci", "fig": 3}, {"body": 32, "word": "cell", "fig": 1}, {"body": 22, "word": "nuclear", "fig": 1}, {"body": 21, "word": "h", "fig": 1}, {"body": 11, "word": "used", "fig": 1}, {"body": 5, "word": "images", "fig": 2}, {"body": 9, "word": "cellular", "fig": 1}, {"body": 8, "word": "siRNA", "fig": 1}, {"body": 8, "word": "treated", "fig": 1}, {"body": 7, "word": "described", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "performed", "fig": 1}, {"body": 3, "word": "channel", "fig": 2}, {"body": 5, "word": "shown", "fig": 1}, {"body": 2, "word": "one", "fig": 2}, {"body": 4, "word": "three", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "DAPI", "fig": 1}, {"body": 3, "word": "grown", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 2, "word": "H2AX", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "phosphorylation", "fig": 1}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "taken", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g008.jpg", "caption": "The effect of HDAC2 knockdown on cell number (A), cell cycle distribution (B), and apoptosis (C) in PEO1 cells A SRB assay profile for growth inhibition of cisplatin on PEO1 cells with (green line) and without (blue line) HDAC2 knockdown. Cells were reverse transfected with HDAC2 siRNA, followed by treatment with cisplatin for 72h. Three controls were included as described before. B. Percentages of the populations selected in G0/1, S, G2/M phases of the cell cycle were detected by flow cytometry. Columns represent the mean percentage of triplicate independent samples. Error bars represent SD. The Brown-Forsythe test followed by Games-Howell post-hoc test were performed to compare groups for each phase. C. The effect of HDAC2 knockdown on apoptosis in PEO1 cells using the annexin V assay is shown. Cell number percentages of the population selected with positive annexin V staining were detected by flow cytometry after cisplatin treatment for 72h, and data are separated into early and late apoptosis based on propidium Iodide (PI) signal. Columns represent the mean percentage of triplicate independent samples. Error bars represent SD. One-way ANOVA analysis was performed to compare data among groups, and the Tukey HSD pot HOC test was used to compare groups.", "co_occurrence": [{"body": 73, "word": "HDAC2", "fig": 4}, {"body": 63, "word": "cells", "fig": 3}, {"body": 60, "word": "cisplatin", "fig": 3}, {"body": 50, "word": "treatment", "fig": 2}, {"body": 32, "word": "cell", "fig": 3}, {"body": 26, "word": "PEO1", "fig": 3}, {"body": 26, "word": "knockdown", "fig": 3}, {"body": 21, "word": "The", "fig": 3}, {"body": 9, "word": "apoptosis", "fig": 3}, {"body": 22, "word": "using", "fig": 1}, {"body": 6, "word": "groups", "fig": 3}, {"body": 7, "word": "number", "fig": 2}, {"body": 7, "word": "effect", "fig": 2}, {"body": 6, "word": "followed", "fig": 2}, {"body": 6, "word": "line", "fig": 2}, {"body": 6, "word": "performed", "fig": 2}, {"body": 4, "word": "test", "fig": 3}, {"body": 6, "word": "A", "fig": 2}, {"body": 11, "word": "used", "fig": 1}, {"body": 5, "word": "samples", "fig": 2}, {"body": 5, "word": "data", "fig": 2}, {"body": 3, "word": "compare", "fig": 3}, {"body": 9, "word": "analysis", "fig": 1}, {"body": 8, "word": "early", "fig": 1}, {"body": 8, "word": "siRNA", "fig": 1}, {"body": 4, "word": "cycle", "fig": 2}, {"body": 7, "word": "described", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 3, "word": "detected", "fig": 2}, {"body": 6, "word": "Cell", "fig": 1}, {"body": 3, "word": "B", "fig": 2}, {"body": 5, "word": "shown", "fig": 1}, {"body": 2, "word": "assay", "fig": 2}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "growth", "fig": 1}, {"body": 2, "word": "72h", "fig": 2}, {"body": 4, "word": "phase", "fig": 1}, {"body": 3, "word": "controls", "fig": 1}, {"body": 3, "word": "inhibition", "fig": 1}, {"body": 3, "word": "distribution", "fig": 1}, {"body": 2, "word": "based", "fig": 1}, {"body": 1, "word": "annexin", "fig": 2}, {"body": 1, "word": "selected", "fig": 2}, {"body": 1, "word": "V", "fig": 2}, {"body": 2, "word": "population", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 2}, {"body": 1, "word": "independent", "fig": 2}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "late", "fig": 1}, {"body": 1, "word": "signal", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "S", "fig": 1}, {"body": 1, "word": "propidium", "fig": 1}, {"body": 1, "word": "Tukey", "fig": 1}, {"body": 1, "word": "reverse", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "One-way", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826236/bin/oncotarget-07-4695-g009.jpg", "caption": "Changes in nuclear texture features in PEO1 cells treated with TSA (A) or transfected with HDAC2 siRNA before cisplatin treatment (B) A. PEO1 cells were grown on coverslips and treated with TSA (250 nM) for 24h, and nuclei were stained with DAPI for visualisation using a fluorescence microscope. At least 100 nuclei were included in one experiment. Nuclear texture was analysed by measuring five texture parameters (angular second moment, correlation, entropy, inverse different moment, and contrast) in Image J software. Data are presented as the average change (%) in TSA treated group for each parameter over control group. B. PEO1 cells were grown on coverslips, transfected with HDAC2 siRNA for 72h, and treated with cisplatin (6\u03bcM) for a further 24h. Nuclei were stained with DAPI for visualisation using fluorescence microscopy. At least 100 nuclei were included in each group in one experiment. Nuclear texture was analysed by measuring five texture parameters (angular second moment, correlation, entropy, inverse different moment, and contrast) using Image J.", "co_occurrence": [{"body": 63, "word": "cells", "fig": 3}, {"body": 73, "word": "HDAC2", "fig": 2}, {"body": 60, "word": "cisplatin", "fig": 2}, {"body": 26, "word": "PEO1", "fig": 3}, {"body": 14, "word": "texture", "fig": 5}, {"body": 22, "word": "using", "fig": 3}, {"body": 50, "word": "treatment", "fig": 1}, {"body": 8, "word": "treated", "fig": 4}, {"body": 7, "word": "moment", "fig": 4}, {"body": 12, "word": "contrast", "fig": 2}, {"body": 22, "word": "nuclear", "fig": 1}, {"body": 7, "word": "nuclei", "fig": 3}, {"body": 8, "word": "24h", "fig": 2}, {"body": 8, "word": "siRNA", "fig": 2}, {"body": 7, "word": "different", "fig": 2}, {"body": 5, "word": "analysed", "fig": 2}, {"body": 5, "word": "parameters", "fig": 2}, {"body": 5, "word": "entropy", "fig": 2}, {"body": 3, "word": "TSA", "fig": 3}, {"body": 4, "word": "correlation", "fig": 2}, {"body": 4, "word": "Nuclear", "fig": 2}, {"body": 4, "word": "second", "fig": 2}, {"body": 4, "word": "stained", "fig": 2}, {"body": 4, "word": "five", "fig": 2}, {"body": 4, "word": "DAPI", "fig": 2}, {"body": 7, "word": "control", "fig": 1}, {"body": 3, "word": "angular", "fig": 2}, {"body": 3, "word": "grown", "fig": 2}, {"body": 3, "word": "inverse", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "microscopy", "fig": 1}, {"body": 5, "word": "software", "fig": 1}, {"body": 2, "word": "least", "fig": 2}, {"body": 2, "word": "Image", "fig": 2}, {"body": 2, "word": "one", "fig": 2}, {"body": 2, "word": "fluorescence", "fig": 2}, {"body": 3, "word": "B", "fig": 1}, {"body": 1, "word": "visualisation", "fig": 2}, {"body": 2, "word": "features", "fig": 1}, {"body": 1, "word": "coverslips", "fig": 2}, {"body": 1, "word": "J", "fig": 2}, {"body": 2, "word": "change", "fig": 1}, {"body": 2, "word": "72h", "fig": 1}, {"body": 1, "word": "At", "fig": 2}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "microscope", "fig": 1}]}], "3898689": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/fx1.jpg", "caption": "", "co_occurrence": []}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/gr1.jpg", "caption": "Analysis of Light-Regulated Gene Expression in the SCN (A) Hierarchical clustering of the wild-type (Opn4+/+) SCN transcriptome. Sham = SCN from sham-pulsed mice; LP30, LP60, and LP120 = SCN from 30, 60, and 120 min after light pulse, respectively (n = 4). Two gene clusters are enlarged: The upper cluster shows acute upregulation and contains immediate early genes (Fos, Egr1, Nr4a1) and clock genes (Per1); the lower cluster shows downregulated transcripts including transcription factors (Sim1 and Nr2f2), signaling peptides (Tac1) and receptors (Glra1 and Glra2). Scale bar shows fold change; yellow = upregulation, blue = downregulation. Numbers beneath scale bar show levels of expression relative to Sham. (B) Functional annotation of the 536 genes changing in response to light using DAVID and visualized using the enrichment map plugin for Cytoscape. (C) Enrichment of the CREB-activated promoter CRE in the promoters of 108 genes showing >1.5-fold change in response to light in the Opn4+/+ SCN. Data are shown as observed/expected frequency of appearance of promoter elements (CRE_TATA: CRE within 300 bp of the TATA box, CRE_NoTATA: CRE site further upstream, others: absence of CRE sites) within the 108 genes. CRE_TATA shows significant enrichment (\u2217p = 0.02, Chi-square test), highlighting the role of CREB in high amplitude gene induction responses to light. See also Figures S1 and S2, and Tables S1, S2, S3, and S4.", "co_occurrence": [{"body": 60, "word": "SCN", "fig": 5}, {"body": 46, "word": "light", "fig": 4}, {"body": 26, "word": "genes", "fig": 5}, {"body": 36, "word": "using", "fig": 2}, {"body": 36, "word": "Per1", "fig": 1}, {"body": 28, "word": "clock", "fig": 1}, {"body": 14, "word": "response", "fig": 2}, {"body": 14, "word": "within", "fig": 2}, {"body": 28, "word": "min", "fig": 1}, {"body": 26, "word": "The", "fig": 1}, {"body": 24, "word": "mice", "fig": 1}, {"body": 21, "word": "CREB", "fig": 1}, {"body": 21, "word": "induction", "fig": 1}, {"body": 5, "word": "CRE", "fig": 4}, {"body": 10, "word": "gene", "fig": 2}, {"body": 20, "word": "expression", "fig": 1}, {"body": 18, "word": "transcription", "fig": 1}, {"body": 16, "word": "role", "fig": 1}, {"body": 14, "word": "including", "fig": 1}, {"body": 14, "word": "pulse", "fig": 1}, {"body": 3, "word": "shows", "fig": 4}, {"body": 6, "word": "Opn4+/+", "fig": 2}, {"body": 6, "word": "enrichment", "fig": 2}, {"body": 11, "word": "also", "fig": 1}, {"body": 10, "word": "transcripts", "fig": 1}, {"body": 9, "word": "show", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 4, "word": "S1", "fig": 2}, {"body": 8, "word": "responses", "fig": 1}, {"body": 8, "word": "n", "fig": 1}, {"body": 8, "word": "significant", "fig": 1}, {"body": 7, "word": "Fos", "fig": 1}, {"body": 6, "word": "Nr4a1", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "Egr1", "fig": 1}, {"body": 3, "word": "upregulation", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "promoters", "fig": 1}, {"body": 6, "word": "Figures", "fig": 1}, {"body": 5, "word": "Analysis", "fig": 1}, {"body": 5, "word": "Tables", "fig": 1}, {"body": 5, "word": "wild-type", "fig": 1}, {"body": 5, "word": "signaling", "fig": 1}, {"body": 5, "word": "Expression", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 4, "word": "relative", "fig": 1}, {"body": 4, "word": "downregulated", "fig": 1}, {"body": 2, "word": "cluster", "fig": 2}, {"body": 3, "word": "sites", "fig": 1}, {"body": 3, "word": "box", "fig": 1}, {"body": 3, "word": "DAVID", "fig": 1}, {"body": 2, "word": "receptors", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "transcriptome", "fig": 1}, {"body": 2, "word": "acute", "fig": 1}, {"body": 2, "word": "LP30", "fig": 1}, {"body": 2, "word": "LP60", "fig": 1}, {"body": 1, "word": "change", "fig": 2}, {"body": 1, "word": "S2", "fig": 2}, {"body": 2, "word": "Two", "fig": 1}, {"body": 2, "word": "S4", "fig": 1}, {"body": 2, "word": "LP120", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "site", "fig": 1}, {"body": 2, "word": "elements", "fig": 1}, {"body": 2, "word": "changing", "fig": 1}, {"body": 2, "word": "annotation", "fig": 1}, {"body": 2, "word": "early", "fig": 1}, {"body": 2, "word": "lower", "fig": 1}, {"body": 1, "word": "visualized", "fig": 1}, {"body": 1, "word": "Sim1", "fig": 1}, {"body": 1, "word": "absence", "fig": 1}, {"body": 1, "word": "clusters", "fig": 1}, {"body": 1, "word": "Tac1", "fig": 1}, {"body": 1, "word": "Functional", "fig": 1}, {"body": 1, "word": "TATA", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "bp", "fig": 1}, {"body": 1, "word": "plugin", "fig": 1}, {"body": 1, "word": "S3", "fig": 1}, {"body": 1, "word": "Cytoscape", "fig": 1}, {"body": 1, "word": "clustering", "fig": 1}, {"body": 1, "word": "contains", "fig": 1}, {"body": 1, "word": "Glra2", "fig": 1}, {"body": 1, "word": "Glra1", "fig": 1}, {"body": 1, "word": "immediate", "fig": 1}, {"body": 1, "word": "amplitude", "fig": 1}, {"body": 1, "word": "1.5-fold", "fig": 1}, {"body": 1, "word": "map", "fig": 1}, {"body": 1, "word": "factors", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/gr2.jpg", "caption": "The Role of Sik1 in Phase-Shifting Responses in NIH 3T3 Embryonic Fibroblasts (A) CRTC1 shows nuclear translocation after serum shock (before serum, top; after 10 min serum, bottom). (B and C) Bioinformatic analysis of the Sik1 promoter region showing conservation of the CRE across several mammalian species (B, top). Sik1 was induced after serum shock (B, bottom, n = 4), leading to (C) increased phosphorylation of CRTC. A CRTC peptide is phosphorylated by purified SIK1, measured by the incorporation of 32P from \u03b332P ATP (+SIK1). When incubated with cell lysates (lysate, 0 min), serum shock (lysate, 120 min) increased significantly phosphorylation of CRTC (p = 0.006, Student\u2019s t test, n = 8). Experiments containing no lysate are shown as a negative control (\u2212 lysate). Representative blots are shown (left). (D) Sik1 induction following serum shock was attenuated significantly following silencing of Sik1 or Crtc compared with nontargeting control siRNA (siNT: p = 1.5 \u00d7 10\u22126, siSik1: p = 4.1 \u00d7 10\u22121, siCrtc: p = 0.01, n = 4, area under curve [AUC] analysis shown in Figure S3). (E) Sik1 silencing enhanced Per1 induction following serum shock (siNT: p = 2.2 \u00d7 10\u22125, siSik1: p = 9.3 \u00d7 10\u22125). (F) Following Crtc silencing, no significant induction of Per1 expression was observed (siCrtc: p = 0.06). AUC analysis (normalized to NT control) for Per1 expression following silencing of Sik1 showed a significant increase (p = 0.00047 siSik1 versus siNT, Student\u2019s t test), not seen with Crtc silencing (p = 0.799 siCRTC versus siNT, Students\u2019 t test). (G) Normalised data for Per1 induction following Sik1 and Crtc knockdown as measured by Area Under Curve (AUC) from (E) and (F). (H and I) Egr1 (H) and (I) Nr4a1, both CRE-regulated transcripts, show enhanced expression with Sik1 silencing and attenuated or no induction with Crtc silencing. AUC analysis shown in Figure S3. All mRNA levels normalized to housekeeping controls and t = 0, change over time analyzed by one-way ANOVA, \u2217\u2217\u2217 = p < 0.001, \u2217 = p < 0.05, n.s. = p > 0.05. Error bars = SEM; n = 4. See also Figure S3 and Tables 1 and 2.", "co_occurrence": [{"body": 41, "word": "Sik1", "fig": 9}, {"body": 36, "word": "Per1", "fig": 4}, {"body": 18, "word": "serum", "fig": 7}, {"body": 10, "word": "p", "fig": 12}, {"body": 38, "word": "Figure", "fig": 3}, {"body": 21, "word": "induction", "fig": 5}, {"body": 28, "word": "min", "fig": 3}, {"body": 20, "word": "expression", "fig": 3}, {"body": 19, "word": "CRTC", "fig": 3}, {"body": 9, "word": "shock", "fig": 5}, {"body": 37, "word": "SIK1", "fig": 1}, {"body": 5, "word": "silencing", "fig": 7}, {"body": 8, "word": "n", "fig": 4}, {"body": 6, "word": "following", "fig": 5}, {"body": 13, "word": "phosphorylation", "fig": 2}, {"body": 26, "word": "The", "fig": 1}, {"body": 6, "word": "shown", "fig": 4}, {"body": 8, "word": "control", "fig": 3}, {"body": 4, "word": "Crtc", "fig": 5}, {"body": 9, "word": "attenuated", "fig": 2}, {"body": 4, "word": "siNT", "fig": 4}, {"body": 8, "word": "significant", "fig": 2}, {"body": 16, "word": "siRNA", "fig": 1}, {"body": 5, "word": "siSik1", "fig": 3}, {"body": 5, "word": "test", "fig": 3}, {"body": 15, "word": "time", "fig": 1}, {"body": 14, "word": "data", "fig": 1}, {"body": 12, "word": "CRTC1", "fig": 1}, {"body": 6, "word": "A", "fig": 2}, {"body": 3, "word": "analysis", "fig": 4}, {"body": 11, "word": "also", "fig": 1}, {"body": 5, "word": "significantly", "fig": 2}, {"body": 10, "word": "transcripts", "fig": 1}, {"body": 5, "word": "measured", "fig": 2}, {"body": 9, "word": "show", "fig": 1}, {"body": 9, "word": "cell", "fig": 1}, {"body": 9, "word": "showed", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 2, "word": "lysate", "fig": 4}, {"body": 7, "word": "NIH", "fig": 1}, {"body": 7, "word": "knockdown", "fig": 1}, {"body": 6, "word": "Egr1", "fig": 1}, {"body": 3, "word": "versus", "fig": 2}, {"body": 6, "word": "Nr4a1", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "3T3", "fig": 1}, {"body": 6, "word": "containing", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "species", "fig": 1}, {"body": 5, "word": "Tables", "fig": 1}, {"body": 5, "word": "CRE", "fig": 1}, {"body": 4, "word": "increase", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 2, "word": "increased", "fig": 2}, {"body": 2, "word": "enhanced", "fig": 2}, {"body": 4, "word": "Responses", "fig": 1}, {"body": 4, "word": "induced", "fig": 1}, {"body": 4, "word": "analyzed", "fig": 1}, {"body": 2, "word": "normalized", "fig": 2}, {"body": 2, "word": "siCrtc", "fig": 2}, {"body": 4, "word": "several", "fig": 1}, {"body": 4, "word": "translocation", "fig": 1}, {"body": 3, "word": "observed", "fig": 1}, {"body": 3, "word": "nuclear", "fig": 1}, {"body": 3, "word": "shows", "fig": 1}, {"body": 1, "word": "S3", "fig": 3}, {"body": 3, "word": "incubated", "fig": 1}, {"body": 3, "word": "Phase-Shifting", "fig": 1}, {"body": 3, "word": "negative", "fig": 1}, {"body": 3, "word": "nontargeting", "fig": 1}, {"body": 3, "word": "All", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "Under", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 2}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "one-way", "fig": 1}, {"body": 1, "word": "bottom", "fig": 2}, {"body": 2, "word": "across", "fig": 1}, {"body": 1, "word": "top", "fig": 2}, {"body": 1, "word": "F", "fig": 2}, {"body": 2, "word": "Following", "fig": 1}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "I", "fig": 2}, {"body": 2, "word": "curve", "fig": 1}, {"body": 1, "word": "peptide", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "housekeeping", "fig": 1}, {"body": 1, "word": "region", "fig": 1}, {"body": 1, "word": "area", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "ATP", "fig": 1}, {"body": 1, "word": "NT", "fig": 1}, {"body": 1, "word": "phosphorylated", "fig": 1}, {"body": 1, "word": "mammalian", "fig": 1}, {"body": 1, "word": "seen", "fig": 1}, {"body": 1, "word": "\u03b332P", "fig": 1}, {"body": 1, "word": "Experiments", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/gr3.jpg", "caption": "Pharmacological Inhibition of SIK1 by I3M Causes Enhanced Phase Shifting (A) Incorporation of 32P from 32P ATP into CRTC peptide by purified SIK1, SIK1 + 20 \u03bcM I3M (SIK1+I3M) and SIK1 + 100 nM Staurosporine (SIK1+Stau, staurosporine being a broad-spectrum kinase inhibitor); I3M directly inhibits SIK1. (B and C) Period1 and 2 induction following 30 min serum treatment in PER2::LUC MEFs treated with indirubin-3\u2032-monoxime (I3M) in DMSO or DMSO alone for the duration of the experiment. Relative gene expression of (B) per1 and (C) per2 normalized to GAPDH. (D) Representative baseline detrended bioluminescence recordings from PER2::LUC MEFS treated with a single (orange, first red arrow) or second serum shock 10 hr later (second red arrow) in the presence of I3M (red) or DMSO alone (green), with I3M creating a larger phase shift than the DMSO-treated controls. Timing of I3M or DMSO treatment is shown by the horizontal gray bar. The first serum pulse is given to synchronize the cells and the second allows for phase shift from synchronized conditions, allowing precise quantification of the phase shift. (E) Time of peak bioluminescence determined from data as shown in (C). Data are mean \u00b1 SEM first and second peaks after the second serum pulse. Cells treated with I3M peak significantly later than DMSO-treated controls (one-way ANOVA; p < 0.01, with post hoc t tests, \u2217p < 0.05). (F) Zeitgeber time of second peak of bioluminescence from SCN collected from light-pulsed per1::luc mice treated with I3M versus DMSO-treated (DMSO) controls (\u2217t test, p < 0.05). Error bars = SEM.", "co_occurrence": [{"body": 37, "word": "SIK1", "fig": 5}, {"body": 14, "word": "I3M", "fig": 9}, {"body": 18, "word": "serum", "fig": 4}, {"body": 21, "word": "phase", "fig": 3}, {"body": 60, "word": "SCN", "fig": 1}, {"body": 11, "word": "DMSO", "fig": 5}, {"body": 39, "word": "hr", "fig": 1}, {"body": 35, "word": "cells", "fig": 1}, {"body": 14, "word": "pulse", "fig": 2}, {"body": 28, "word": "min", "fig": 1}, {"body": 26, "word": "The", "fig": 1}, {"body": 12, "word": "treatment", "fig": 2}, {"body": 24, "word": "mice", "fig": 1}, {"body": 21, "word": "induction", "fig": 1}, {"body": 10, "word": "p", "fig": 2}, {"body": 20, "word": "expression", "fig": 1}, {"body": 5, "word": "treated", "fig": 4}, {"body": 19, "word": "CRTC", "fig": 1}, {"body": 3, "word": "second", "fig": 6}, {"body": 8, "word": "PER2", "fig": 2}, {"body": 8, "word": "later", "fig": 2}, {"body": 5, "word": "first", "fig": 3}, {"body": 15, "word": "time", "fig": 1}, {"body": 14, "word": "data", "fig": 1}, {"body": 4, "word": "controls", "fig": 3}, {"body": 6, "word": "shown", "fig": 2}, {"body": 4, "word": "shift", "fig": 3}, {"body": 10, "word": "kinase", "fig": 1}, {"body": 5, "word": ":LUC", "fig": 2}, {"body": 10, "word": "gene", "fig": 1}, {"body": 9, "word": "shock", "fig": 1}, {"body": 3, "word": "peak", "fig": 3}, {"body": 4, "word": "alone", "fig": 2}, {"body": 6, "word": "Cells", "fig": 1}, {"body": 6, "word": "\u03bcM", "fig": 1}, {"body": 6, "word": "following", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 5, "word": "significantly", "fig": 1}, {"body": 5, "word": "collected", "fig": 1}, {"body": 5, "word": "determined", "fig": 1}, {"body": 5, "word": "synchronized", "fig": 1}, {"body": 5, "word": "Phase", "fig": 1}, {"body": 2, "word": "per1", "fig": 2}, {"body": 4, "word": "nM", "fig": 1}, {"body": 3, "word": "versus", "fig": 1}, {"body": 3, "word": "MEFs", "fig": 1}, {"body": 3, "word": "directly", "fig": 1}, {"body": 3, "word": "experiment", "fig": 1}, {"body": 1, "word": "red", "fig": 3}, {"body": 1, "word": "DMSO-treated", "fig": 3}, {"body": 3, "word": "inhibitor", "fig": 1}, {"body": 3, "word": "duration", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "synchronize", "fig": 1}, {"body": 2, "word": "one-way", "fig": 1}, {"body": 2, "word": "presence", "fig": 1}, {"body": 2, "word": "inhibits", "fig": 1}, {"body": 2, "word": "given", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 2, "word": "quantification", "fig": 1}, {"body": 2, "word": "per2", "fig": 1}, {"body": 1, "word": "precise", "fig": 1}, {"body": 1, "word": "tests", "fig": 1}, {"body": 1, "word": "peptide", "fig": 1}, {"body": 1, "word": "conditions", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "Staurosporine", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "post", "fig": 1}, {"body": 1, "word": "recordings", "fig": 1}, {"body": 1, "word": "Enhanced", "fig": 1}, {"body": 1, "word": "ATP", "fig": 1}, {"body": 1, "word": "Shifting", "fig": 1}, {"body": 1, "word": "Zeitgeber", "fig": 1}, {"body": 1, "word": "indirubin-3\u2032-monoxime", "fig": 1}, {"body": 1, "word": "baseline", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "Pharmacological", "fig": 1}, {"body": 1, "word": "Inhibition", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "peaks", "fig": 1}, {"body": 1, "word": "hoc", "fig": 1}, {"body": 1, "word": "Relative", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/gr4.jpg", "caption": "Induction of the CRTC1-SIK1 Pathway in the SCN in Response to Phase-Shifting Stimuli (A) Expression data from exon arrays indicating relative levels of Crtc isoforms in the SCN, showing Crtc1 is the most abundant isoform. (B) CRTC1 (green) translocates from the cytoplasm (upper left, 0 min) to the nucleus (upper right, 10 min) 10 min after the application of 50% horse serum to dissociated SCN cell cultures. Merged figures with DAPI staining (blue, nuclei) and phalloidin (white, cytoskeleton) are indicated in the respective lower panels. (C) SIK1 protein is increased in the SCN 120 min after a CT16 light pulse, representative blots shown. \u03b2-actin levels shown for comparison. (D) Sik1 was upregulated by light in the SCN of animals after a CT16 phase-delaying and CT22 phase-advancing light pulse, as measured by qPCR (CT16: p = 0.0002 \u2217\u2217\u2217, n = 5, CT22: p = 0.009 \u2217\u2217, n = 3). Egr1 and Nr4a1 levels are shown for comparison, where in contrast, their induction is lower at CT22 than at CT16. Sham = SCN from sham-pulsed mice; LP30, LP60, and LP120 = SCN from 30, 60, and 120 min after light pulse, respectively. Error bars = SEM.", "co_occurrence": [{"body": 60, "word": "SCN", "fig": 7}, {"body": 46, "word": "light", "fig": 4}, {"body": 28, "word": "min", "fig": 5}, {"body": 14, "word": "pulse", "fig": 3}, {"body": 41, "word": "Sik1", "fig": 1}, {"body": 37, "word": "SIK1", "fig": 1}, {"body": 9, "word": "levels", "fig": 3}, {"body": 24, "word": "mice", "fig": 1}, {"body": 21, "word": "induction", "fig": 1}, {"body": 10, "word": "p", "fig": 2}, {"body": 6, "word": "shown", "fig": 3}, {"body": 18, "word": "serum", "fig": 1}, {"body": 8, "word": "n", "fig": 2}, {"body": 14, "word": "data", "fig": 1}, {"body": 12, "word": "CRTC1", "fig": 1}, {"body": 3, "word": "CT16", "fig": 4}, {"body": 9, "word": "cell", "fig": 1}, {"body": 3, "word": "CT22", "fig": 3}, {"body": 7, "word": "qPCR", "fig": 1}, {"body": 6, "word": "Nr4a1", "fig": 1}, {"body": 6, "word": "protein", "fig": 1}, {"body": 6, "word": "Egr1", "fig": 1}, {"body": 6, "word": "upregulated", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "isoforms", "fig": 1}, {"body": 5, "word": "horse", "fig": 1}, {"body": 5, "word": "measured", "fig": 1}, {"body": 5, "word": "Expression", "fig": 1}, {"body": 5, "word": "animals", "fig": 1}, {"body": 4, "word": "Crtc", "fig": 1}, {"body": 4, "word": "relative", "fig": 1}, {"body": 4, "word": "white", "fig": 1}, {"body": 4, "word": "nucleus", "fig": 1}, {"body": 2, "word": "lower", "fig": 2}, {"body": 3, "word": "Phase-Shifting", "fig": 1}, {"body": 3, "word": "arrays", "fig": 1}, {"body": 3, "word": "Crtc1", "fig": 1}, {"body": 2, "word": "increased", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "exon", "fig": 1}, {"body": 2, "word": "LP30", "fig": 1}, {"body": 2, "word": "dissociated", "fig": 1}, {"body": 2, "word": "phase-delaying", "fig": 1}, {"body": 2, "word": "LP60", "fig": 1}, {"body": 2, "word": "LP120", "fig": 1}, {"body": 2, "word": "cultures", "fig": 1}, {"body": 2, "word": "application", "fig": 1}, {"body": 1, "word": "CRTC1-SIK1", "fig": 1}, {"body": 1, "word": "translocates", "fig": 1}, {"body": 1, "word": "indicating", "fig": 1}, {"body": 1, "word": "Pathway", "fig": 1}, {"body": 1, "word": "phase-advancing", "fig": 1}, {"body": 1, "word": "contrast", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "cytoplasm", "fig": 1}, {"body": 1, "word": "Induction", "fig": 1}, {"body": 1, "word": "Stimuli", "fig": 1}, {"body": 1, "word": "green", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/gr5.jpg", "caption": "In Vivo Knockdown of Sik1 Results in Enhanced Phase Shifting and Rapid Re-Entrainment in a Jet-Lag Protocol (A) C57Bl/6 mice were housed under a 12:12 hr LD cycle before siRNA ICV injection into the 3V (indicated by red asterisk on actograms). Ninety-six hours postinjection, the mice were given a 30 min light pulse (red arrow) at CT14.5, then placed in DD to enable phase-shift magnitude to be determined. Representative actograms from light-pulsed animals receiving siNT (siNT Light, top) or siSik1 (siSik1 Light, bottom) shown. Actograms are enlarged around the day of the light pulse for clarity (right). (B) Phase-shifting responses to light are significantly larger following knockdown of Sik1 in the SCN (siSik1) when compared to nontargeting siRNA (siNT) controls (98 min versus 59 min, p = 0.036, Student\u2019s t test, n = 5). Error bars = SEM. See also Figure S4. (C) C57Bl/6 mice were housed under a 12:12 hr LD cycle before siRNA ICV injection into the 3V (indicated by red asterisk). Fourty-eight hours postinjection, the LD cycle was advanced by 6 hr and 10 days after the first shift, the LD cycle was advanced 6 hr again. Faster re-entrainment was observed with the Sik1 knockdown (siSik1) mice. Three actograms are displayed for each treatment (siNT or siSik1), showing that regardless of activity levels, Sik1 knockdown accelerates re-entrainment. (D) Phase relative to new LD cycle (second shift) plotted against days after the shift in cycle. Day before shift indicated as 0 (before the dotted line). \u2217\u2217 = p < 0.01, \u2217 = p < 0.05 Student\u2019s t test, phase of siSik1 versus siNT-treated animals on each day, n = 6 for siNT, n = 11 for siSik1. Representative actograms enlarged around the area plotted in the graph are indicated. Error bars = SEM. See also Figures S4 and S5.", "co_occurrence": [{"body": 41, "word": "Sik1", "fig": 4}, {"body": 39, "word": "hr", "fig": 4}, {"body": 46, "word": "light", "fig": 3}, {"body": 24, "word": "mice", "fig": 4}, {"body": 28, "word": "min", "fig": 3}, {"body": 13, "word": "cycle", "fig": 6}, {"body": 60, "word": "SCN", "fig": 1}, {"body": 12, "word": "LD", "fig": 5}, {"body": 16, "word": "siRNA", "fig": 3}, {"body": 38, "word": "Figure", "fig": 1}, {"body": 5, "word": "siSik1", "fig": 7}, {"body": 10, "word": "p", "fig": 3}, {"body": 14, "word": "pulse", "fig": 2}, {"body": 8, "word": "n", "fig": 3}, {"body": 23, "word": "In", "fig": 1}, {"body": 11, "word": "also", "fig": 2}, {"body": 11, "word": "days", "fig": 2}, {"body": 7, "word": "knockdown", "fig": 3}, {"body": 21, "word": "phase", "fig": 1}, {"body": 4, "word": "siNT", "fig": 5}, {"body": 4, "word": "shift", "fig": 4}, {"body": 12, "word": "treatment", "fig": 1}, {"body": 5, "word": "test", "fig": 2}, {"body": 5, "word": "day", "fig": 2}, {"body": 5, "word": "advanced", "fig": 2}, {"body": 5, "word": "re-entrainment", "fig": 2}, {"body": 10, "word": "activity", "fig": 1}, {"body": 5, "word": "animals", "fig": 2}, {"body": 5, "word": "Phase", "fig": 2}, {"body": 9, "word": "levels", "fig": 1}, {"body": 8, "word": "responses", "fig": 1}, {"body": 3, "word": "versus", "fig": 2}, {"body": 3, "word": "C57Bl/6", "fig": 2}, {"body": 6, "word": "shown", "fig": 1}, {"body": 3, "word": "Light", "fig": 2}, {"body": 3, "word": "injection", "fig": 2}, {"body": 6, "word": "following", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "Figures", "fig": 1}, {"body": 5, "word": "magnitude", "fig": 1}, {"body": 5, "word": "significantly", "fig": 1}, {"body": 5, "word": "first", "fig": 1}, {"body": 5, "word": "placed", "fig": 1}, {"body": 5, "word": "determined", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 2, "word": "3V", "fig": 2}, {"body": 2, "word": "S4", "fig": 2}, {"body": 4, "word": "relative", "fig": 1}, {"body": 3, "word": "observed", "fig": 1}, {"body": 3, "word": "second", "fig": 1}, {"body": 1, "word": "red", "fig": 3}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "nontargeting", "fig": 1}, {"body": 3, "word": "DD", "fig": 1}, {"body": 3, "word": "Results", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 2}, {"body": 2, "word": "showing", "fig": 1}, {"body": 1, "word": "housed", "fig": 2}, {"body": 2, "word": "Vivo", "fig": 1}, {"body": 1, "word": "hours", "fig": 2}, {"body": 2, "word": "S5", "fig": 1}, {"body": 2, "word": "given", "fig": 1}, {"body": 2, "word": "Knockdown", "fig": 1}, {"body": 2, "word": "CT14.5", "fig": 1}, {"body": 1, "word": "area", "fig": 1}, {"body": 1, "word": "bottom", "fig": 1}, {"body": 1, "word": "Enhanced", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "Shifting", "fig": 1}, {"body": 1, "word": "siNT-treated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/figs1.jpg", "caption": "SCN Sample Collection, Gene Expression Arrays, and Analysis, Related to Figure 1 and Experimental Procedures (A) Schematic of SCN sample collection: Mice housed under 12:12 hr LD were released into one day of darkness and subjected to a 30 min light pulse (400 lux) at CT16. Animals were sacrificed at the time points as indicated under dim red light; LP30, LP60, and LP120 = SCN from 30, 60, and 120 min, respectively following the start of a 30 min light pulse at CT16. Time matched sham-pulsed controls were collected at each time point and pooled. Brains were collected, sections were taken by inserting blades as indicated and SCN punches were cored and stored frozen until use. (B) Real time PCR conducted on SCN or control (SCN CT) for (B) Six6 and Per1 normalized to three housekeeping genes. (C) RNA quality for SCN samples used for microarrays, Affymetrix sample data provided for reference. (D) Schematic of data analysis from Affymetrix Exon arrays; 48% of core probe sets were detected as reliably present above background in the SCN (DABG p < 0.05, 110,026 probe sets out of a total of 228,090). Of these, 4.1% were found to significantly change in expression in response to light (4,489 probe sets corresponding to 3,187 genes p < 0.05, one-way ANOVA). Of these probe sets, 1,470 were found to be significantly enriched, that is, significantly more probe sets per gene than would be expected by chance alone. These probe sets correspond to 536 genes. Error bars = SEM.", "co_occurrence": [{"body": 60, "word": "SCN", "fig": 8}, {"body": 46, "word": "light", "fig": 4}, {"body": 16, "word": "probe", "fig": 6}, {"body": 28, "word": "min", "fig": 3}, {"body": 26, "word": "genes", "fig": 3}, {"body": 12, "word": "sets", "fig": 6}, {"body": 15, "word": "time", "fig": 3}, {"body": 39, "word": "hr", "fig": 1}, {"body": 38, "word": "Figure", "fig": 1}, {"body": 36, "word": "Per1", "fig": 1}, {"body": 14, "word": "pulse", "fig": 2}, {"body": 14, "word": "data", "fig": 2}, {"body": 10, "word": "p", "fig": 2}, {"body": 20, "word": "expression", "fig": 1}, {"body": 5, "word": "significantly", "fig": 3}, {"body": 14, "word": "response", "fig": 1}, {"body": 12, "word": "LD", "fig": 1}, {"body": 12, "word": "used", "fig": 1}, {"body": 11, "word": "RNA", "fig": 1}, {"body": 5, "word": "found", "fig": 2}, {"body": 10, "word": "gene", "fig": 1}, {"body": 5, "word": "Affymetrix", "fig": 2}, {"body": 5, "word": "collected", "fig": 2}, {"body": 9, "word": "These", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 7, "word": "would", "fig": 1}, {"body": 3, "word": "CT16", "fig": 2}, {"body": 6, "word": "Animals", "fig": 1}, {"body": 6, "word": "following", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "day", "fig": 1}, {"body": 5, "word": "Analysis", "fig": 1}, {"body": 5, "word": "lux", "fig": 1}, {"body": 5, "word": "conducted", "fig": 1}, {"body": 5, "word": "Expression", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 2, "word": "Of", "fig": 2}, {"body": 4, "word": "background", "fig": 1}, {"body": 4, "word": "Mice", "fig": 1}, {"body": 4, "word": "Experimental", "fig": 1}, {"body": 4, "word": "sacrificed", "fig": 1}, {"body": 4, "word": "alone", "fig": 1}, {"body": 4, "word": "three", "fig": 1}, {"body": 2, "word": "sample", "fig": 2}, {"body": 4, "word": "Procedures", "fig": 1}, {"body": 3, "word": "arrays", "fig": 1}, {"body": 3, "word": "per", "fig": 1}, {"body": 3, "word": "Exon", "fig": 1}, {"body": 3, "word": "core", "fig": 1}, {"body": 3, "word": "point", "fig": 1}, {"body": 3, "word": "one", "fig": 1}, {"body": 3, "word": "analysis", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "detected", "fig": 1}, {"body": 2, "word": "enriched", "fig": 1}, {"body": 2, "word": "samples", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "DABG", "fig": 1}, {"body": 2, "word": "LP30", "fig": 1}, {"body": 2, "word": "PCR", "fig": 1}, {"body": 2, "word": "one-way", "fig": 1}, {"body": 2, "word": "LP60", "fig": 1}, {"body": 2, "word": "quality", "fig": 1}, {"body": 2, "word": "use", "fig": 1}, {"body": 2, "word": "LP120", "fig": 1}, {"body": 2, "word": "taken", "fig": 1}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 2, "word": "punches", "fig": 1}, {"body": 2, "word": "Arrays", "fig": 1}, {"body": 2, "word": "collection", "fig": 1}, {"body": 2, "word": "corresponding", "fig": 1}, {"body": 1, "word": "stored", "fig": 1}, {"body": 1, "word": "dim", "fig": 1}, {"body": 1, "word": "provided", "fig": 1}, {"body": 1, "word": "darkness", "fig": 1}, {"body": 1, "word": "Brains", "fig": 1}, {"body": 1, "word": "Six6", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "housed", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "housekeeping", "fig": 1}, {"body": 1, "word": "Collection", "fig": 1}, {"body": 1, "word": "start", "fig": 1}, {"body": 1, "word": "CT", "fig": 1}, {"body": 1, "word": "frozen", "fig": 1}, {"body": 1, "word": "Sample", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/figs2.jpg", "caption": "Light-Regulated Gene Expression in the Opn4\u2212/\u2212 SCN, Related to Figure 1 (A) Scatter plot comparing fold change in the light-regulated SCN transcriptome in Opn4+/+ and Opn4\u2212/\u2212 mice showing attenuated regulation in the melanopsin deficient animals. Upregulation in response to light = yellow; downregulation = blue. Fos, Egr1, Nr4a1, Per1, Sim1, and Tac1 highlighted. (B) Heat map comparison of a section of the light-regulated SCN transcriptome of Opn4+/+ (+/+) and Opn4\u2212/\u2212 (\u2212/\u2212) mice. Scale shows downregulation in blue (up to 0-fold) and upregulation in yellow (2-fold). (C) Temporal expression profiles of Fos, Per1 and Egr1 from SCN of Opn4+/+ (black) and Opn4\u2212/\u2212 (red) mice from array (upper plots) and qPCR (lower plots). Error bars = SEM.", "co_occurrence": [{"body": 60, "word": "SCN", "fig": 4}, {"body": 36, "word": "Per1", "fig": 2}, {"body": 24, "word": "mice", "fig": 3}, {"body": 46, "word": "light", "fig": 1}, {"body": 11, "word": "Opn4\u2212/\u2212", "fig": 4}, {"body": 38, "word": "Figure", "fig": 1}, {"body": 20, "word": "expression", "fig": 1}, {"body": 6, "word": "Opn4+/+", "fig": 3}, {"body": 7, "word": "Fos", "fig": 2}, {"body": 14, "word": "response", "fig": 1}, {"body": 6, "word": "Egr1", "fig": 2}, {"body": 5, "word": "light-regulated", "fig": 2}, {"body": 9, "word": "attenuated", "fig": 1}, {"body": 7, "word": "qPCR", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "Nr4a1", "fig": 1}, {"body": 5, "word": "regulation", "fig": 1}, {"body": 5, "word": "Expression", "fig": 1}, {"body": 5, "word": "animals", "fig": 1}, {"body": 5, "word": "melanopsin", "fig": 1}, {"body": 4, "word": "array", "fig": 1}, {"body": 2, "word": "transcriptome", "fig": 2}, {"body": 3, "word": "upregulation", "fig": 1}, {"body": 3, "word": "shows", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "lower", "fig": 1}, {"body": 1, "word": "Sim1", "fig": 1}, {"body": 1, "word": "comparing", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "map", "fig": 1}, {"body": 1, "word": "highlighted", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "Tac1", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/figs3.jpg", "caption": "RNAi to Validate the Role of SIK1 in Regulating Phase Shifting of the Clock in NIH 3T3 Fibroblasts, Related to Figure 2 (A) Relative expression in NIH 3T3 fibroblasts of Sik1 after transfection siSik1-1 (red) or a nontargeting control siRNA (siNT; white). siSik1-1 is modified (siStable formulation) for in vivo use, resulting in marginally lower efficiency compared with unmodified siRNA. (B) Relative expression of Crtc1 (light green), Crtc2 (green) and Crtc3 (dark green) mRNA in NIH 3T3 fibroblasts. (C) Relative expression levels to measure silencing of Crtc1 (light green) and Crtc3 (dark green) after transfection of siRNA against Crtc1 (siCrtc1) and Crtc3 (siCrtc3) respectively. (D) Relative expression levels of Sik1 (red) Crtc1 (green) and Crtc3 (blue) after transfection with nontargeting control (siNT); Sik1 siRNA (siSik1) or Crtc1 and Crtc3 siRNAs (siCrtc). (E) Level of CRTC1 phosphorylation, indicated by incorporation of 32P from 32P ATP by NIH 3T3 cell lysates. Cells treated with nontargeting siRNA (siNT) show significant increase in CRTC1 phosphorylation after serum shock (siNT 120 min) when compared with before (siNT 0 min). Cells treated with Sik1 siRNA show no increase in CRTC1 phosphorylation after serum shock (siSik1 120 min) when compared with before (siSik1 0 min). (F\u2013I) Areas under the curve from traces in Figure 2H (Egr1 - F), 2I (Nr4a1- G) and 2D (Sik1- H) showing increased expression of Egr1 (siSik1 versus siNT: p = 0.0006) and Nr4a1 (siSik1 versus siNT: p = 0.046) and decreased expression of Sik1 (siSik1 versus siNT: 0.008) with Sik1 siRNA (siSik1). Crtc siRNA (siCrtc) induced reduced or unchanged expression of all three transcripts as indicated by the area under the curve (siCrtc versus siNT: p = 0.38 for Egr1, p = 0.07 for Nr4a1, p = 7.7 \u00d7 10\u22127 for Sik1) All p values derived from Students\u2019 t test, error bars = SEM and n = 4. See Table 1 and Table 2 for results of individual comparisons and statistical tests in Figures 2D\u20132I and S3F\u2013S3H. In order to ensure the increases of Per1, Egr1 and Nr4a1 induction seen after Sik1 silencing are not due to off-target effects, we confirmed the expression patterns with two separate siRNA sequences against Sik1 (siSik1-2 and siSik1-3) (I). (J\u2013L) Per1 (J) Nr4a1 (K) and Egr1 (L) in NIH 3T3 fibroblasts treated with either nontargeting control siRNA (siNT; blue); siRNA sequence 2 against Sik1 (siSik1-2; red) or siRNA sequence 3 against Sik1 (siSik1-3; orange) all show increased induction following a serum shock after silencing of Sik1. Error bars = SEM, n = 4.", "co_occurrence": [{"body": 41, "word": "Sik1", "fig": 12}, {"body": 16, "word": "siRNA", "fig": 12}, {"body": 20, "word": "expression", "fig": 8}, {"body": 28, "word": "min", "fig": 4}, {"body": 46, "word": "light", "fig": 2}, {"body": 38, "word": "Figure", "fig": 2}, {"body": 36, "word": "Per1", "fig": 2}, {"body": 10, "word": "p", "fig": 6}, {"body": 18, "word": "serum", "fig": 3}, {"body": 21, "word": "induction", "fig": 2}, {"body": 4, "word": "siNT", "fig": 10}, {"body": 13, "word": "phosphorylation", "fig": 3}, {"body": 37, "word": "SIK1", "fig": 1}, {"body": 12, "word": "CRTC1", "fig": 3}, {"body": 7, "word": "NIH", "fig": 5}, {"body": 5, "word": "siSik1", "fig": 7}, {"body": 6, "word": "3T3", "fig": 5}, {"body": 6, "word": "Egr1", "fig": 5}, {"body": 9, "word": "show", "fig": 3}, {"body": 9, "word": "shock", "fig": 3}, {"body": 6, "word": "Nr4a1", "fig": 4}, {"body": 8, "word": "control", "fig": 3}, {"body": 23, "word": "In", "fig": 1}, {"body": 6, "word": "compared", "fig": 3}, {"body": 9, "word": "levels", "fig": 2}, {"body": 8, "word": "n", "fig": 2}, {"body": 3, "word": "Crtc1", "fig": 5}, {"body": 3, "word": "Crtc3", "fig": 5}, {"body": 5, "word": "treated", "fig": 3}, {"body": 5, "word": "silencing", "fig": 3}, {"body": 3, "word": "versus", "fig": 4}, {"body": 6, "word": "Cells", "fig": 2}, {"body": 3, "word": "nontargeting", "fig": 4}, {"body": 6, "word": "Table", "fig": 2}, {"body": 10, "word": "vivo", "fig": 1}, {"body": 10, "word": "transcripts", "fig": 1}, {"body": 3, "word": "fibroblasts", "fig": 3}, {"body": 9, "word": "RNAi", "fig": 1}, {"body": 9, "word": "cell", "fig": 1}, {"body": 8, "word": "results", "fig": 1}, {"body": 4, "word": "increase", "fig": 2}, {"body": 8, "word": "effects", "fig": 1}, {"body": 8, "word": "significant", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "sequences", "fig": 1}, {"body": 6, "word": "following", "fig": 1}, {"body": 2, "word": "siCrtc", "fig": 3}, {"body": 6, "word": "A", "fig": 1}, {"body": 2, "word": "transfection", "fig": 3}, {"body": 6, "word": "Figures", "fig": 1}, {"body": 6, "word": "order", "fig": 1}, {"body": 1, "word": "green", "fig": 6}, {"body": 5, "word": "test", "fig": 1}, {"body": 5, "word": "either", "fig": 1}, {"body": 5, "word": "Phase", "fig": 1}, {"body": 4, "word": "measure", "fig": 1}, {"body": 4, "word": "induced", "fig": 1}, {"body": 2, "word": "sequence", "fig": 2}, {"body": 4, "word": "three", "fig": 1}, {"body": 4, "word": "white", "fig": 1}, {"body": 4, "word": "Crtc", "fig": 1}, {"body": 2, "word": "increased", "fig": 2}, {"body": 4, "word": "two", "fig": 1}, {"body": 2, "word": "curve", "fig": 2}, {"body": 1, "word": "Relative", "fig": 4}, {"body": 3, "word": "All", "fig": 1}, {"body": 1, "word": "red", "fig": 3}, {"body": 3, "word": "resulting", "fig": 1}, {"body": 3, "word": "siRNAs", "fig": 1}, {"body": 2, "word": "individual", "fig": 1}, {"body": 2, "word": "use", "fig": 1}, {"body": 2, "word": "confirmed", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "lower", "fig": 1}, {"body": 2, "word": "2D", "fig": 1}, {"body": 1, "word": "area", "fig": 1}, {"body": 1, "word": "tests", "fig": 1}, {"body": 1, "word": "increases", "fig": 1}, {"body": 1, "word": "2H", "fig": 1}, {"body": 1, "word": "2I", "fig": 1}, {"body": 1, "word": "off-target", "fig": 1}, {"body": 1, "word": "Clock", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "ATP", "fig": 1}, {"body": 1, "word": "Shifting", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "seen", "fig": 1}, {"body": 1, "word": "ensure", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "I", "fig": 1}, {"body": 1, "word": "derived", "fig": 1}, {"body": 1, "word": "patterns", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/figs4.jpg", "caption": "In Vivo Knockdown of Sik1, Related to Figure 5 (A) Cy3-labeled siRNA (red) was delivered via intracerebellar ventricular injection (ICV) into the third ventricle (3V) above the SCN (left panel). siRNA was subsequently localized in SCN neurons (right panel). DAPI staining for nuclei is shown in blue. (B) Sik1 mRNA (left panel) and protein levels (right panel) were attenuated in the SCN after ICV injection of Sik1 siRNA (siSik1) when compared to nontargeting siRNA (siNT) (54% knockdown of mRNA, p = 0.03 and 49% protein, p = 0.02, Student\u2019s t test, n = 4). Representative blots are shown with beta-ACTIN levels for comparison. (C) Oas1 (induction indicates interferon response) levels in WT SCN from either mice injected in the 3V with Sik1 siRNA (siSik1) or NT siRNA (siNT), (siRNA-injected SCN) versus noninjected controls (noninjected SCN), n = 5. Error bars = SEM.", "co_occurrence": [{"body": 60, "word": "SCN", "fig": 6}, {"body": 41, "word": "Sik1", "fig": 4}, {"body": 16, "word": "siRNA", "fig": 6}, {"body": 38, "word": "Figure", "fig": 1}, {"body": 9, "word": "levels", "fig": 3}, {"body": 24, "word": "mice", "fig": 1}, {"body": 23, "word": "In", "fig": 1}, {"body": 21, "word": "induction", "fig": 1}, {"body": 10, "word": "p", "fig": 2}, {"body": 8, "word": "n", "fig": 2}, {"body": 14, "word": "response", "fig": 1}, {"body": 6, "word": "shown", "fig": 2}, {"body": 6, "word": "mRNA", "fig": 2}, {"body": 6, "word": "protein", "fig": 2}, {"body": 5, "word": "siSik1", "fig": 2}, {"body": 9, "word": "attenuated", "fig": 1}, {"body": 4, "word": "siNT", "fig": 2}, {"body": 7, "word": "via", "fig": 1}, {"body": 7, "word": "knockdown", "fig": 1}, {"body": 3, "word": "injection", "fig": 2}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "either", "fig": 1}, {"body": 5, "word": "injected", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 2, "word": "3V", "fig": 2}, {"body": 3, "word": "subsequently", "fig": 1}, {"body": 3, "word": "versus", "fig": 1}, {"body": 3, "word": "nontargeting", "fig": 1}, {"body": 2, "word": "Knockdown", "fig": 1}, {"body": 2, "word": "Cy3-labeled", "fig": 1}, {"body": 2, "word": "delivered", "fig": 1}, {"body": 2, "word": "Vivo", "fig": 1}, {"body": 2, "word": "interferon", "fig": 1}, {"body": 1, "word": "noninjected", "fig": 2}, {"body": 1, "word": "WT", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "Oas1", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "ventricle", "fig": 1}, {"body": 1, "word": "NT", "fig": 1}, {"body": 1, "word": "neurons", "fig": 1}, {"body": 1, "word": "siRNA-injected", "fig": 1}, {"body": 1, "word": "third", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898689/bin/figs5.jpg", "caption": "Effect of Sik1 Knockdown on Period Length, Related to Figure 5 (A) Representative traces from Per2::Luc U2OS cells transfected with siSik1, siNT or siCry1. siSik1 (inducing > 90% knockdown of Sik1) induces period lengthening while siCry1 (>90% knockdown of Cry1) induces period shortening. Data summated in (B) \u2217\u2217\u2217 = p < 0.001, Student\u2019s t test, n = 8. (C) Representative actograms from C57Bl/6 mice injected with either Sik1 siRNA (siSik1, 50% knockdown of Sik1) or nontargeting siRNA (siNT). 4 days after injection of siRNA into the 3V the animals were maintained in constant dark in order for their free-running period to be determined. (D) Mice treated with siSik1 show greater period length than control mice injected with siNT (p = 0.016, Student\u2019s t test, n = 11, error bars = SEM).", "co_occurrence": [{"body": 41, "word": "Sik1", "fig": 4}, {"body": 24, "word": "mice", "fig": 2}, {"body": 12, "word": "period", "fig": 4}, {"body": 16, "word": "siRNA", "fig": 3}, {"body": 38, "word": "Figure", "fig": 1}, {"body": 35, "word": "cells", "fig": 1}, {"body": 7, "word": "knockdown", "fig": 3}, {"body": 10, "word": "p", "fig": 2}, {"body": 5, "word": "siSik1", "fig": 4}, {"body": 8, "word": "n", "fig": 2}, {"body": 13, "word": "maintained", "fig": 1}, {"body": 4, "word": "siNT", "fig": 3}, {"body": 11, "word": "days", "fig": 1}, {"body": 5, "word": "test", "fig": 2}, {"body": 5, "word": "injected", "fig": 2}, {"body": 9, "word": "show", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 7, "word": "Per2", "fig": 1}, {"body": 7, "word": "length", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "order", "fig": 1}, {"body": 5, "word": "either", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 5, "word": "animals", "fig": 1}, {"body": 5, "word": "determined", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 4, "word": ":Luc", "fig": 1}, {"body": 4, "word": "Mice", "fig": 1}, {"body": 4, "word": "U2OS", "fig": 1}, {"body": 3, "word": "C57Bl/6", "fig": 1}, {"body": 3, "word": "injection", "fig": 1}, {"body": 3, "word": "nontargeting", "fig": 1}, {"body": 3, "word": "lengthening", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 2}, {"body": 2, "word": "Knockdown", "fig": 1}, {"body": 2, "word": "3V", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "greater", "fig": 1}, {"body": 2, "word": "Cry1", "fig": 1}, {"body": 1, "word": "inducing", "fig": 1}, {"body": 1, "word": "Effect", "fig": 1}, {"body": 1, "word": "Period", "fig": 1}, {"body": 1, "word": "constant", "fig": 1}]}], "3726710": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726710/bin/jcav04p0481g01.jpg", "caption": "Expression of CBP in CRC cell lines. The indicated CRC cell lines were left untreated or treated overnight (17.5 hr) with 5 mM butyrate, total protein was isolated, and analyzed with western blot, with anti-CBP antibody. Actin was used as a loading control. Mock treated (M), butyrate treated (B). Representative data are shown.", "co_occurrence": [{"body": 63, "word": "butyrate", "fig": 2}, {"body": 52, "word": "cell", "fig": 2}, {"body": 49, "word": "CRC", "fig": 2}, {"body": 11, "word": "treated", "fig": 3}, {"body": 15, "word": "lines", "fig": 2}, {"body": 20, "word": "CBP", "fig": 1}, {"body": 18, "word": "The", "fig": 1}, {"body": 11, "word": "mM", "fig": 1}, {"body": 8, "word": "data", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "hr", "fig": 1}, {"body": 3, "word": "control", "fig": 1}, {"body": 3, "word": "used", "fig": 1}, {"body": 2, "word": "antibody", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "overnight", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Actin", "fig": 1}, {"body": 1, "word": "total", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726710/bin/jcav04p0481g02.jpg", "caption": "Coimmunoprecipitation analysis of HCT-116 and SW620 cells treated with ICG-001. (A) Coimmunoprecipitation of HCT-116 CRC cells, performed as described in Materials and Methods, using 75 \u03bcM ICG-001. Anti-CBP or anti-p300 antibody was used for the immunoprecipitation and beta-catenin was detected with an anti-beta-catenin antibody after SDS-PAGE. (B) Coimmunoprecipitation assay, similar to that described in (A), showing activity of 100 \u03bcM ICG-001 against CBP-beta-catenin association in SW620 CRC cells. Representative coimmunoprecipitation data are shown.", "co_occurrence": [{"body": 89, "word": "cells", "fig": 3}, {"body": 80, "word": "ICG-001", "fig": 3}, {"body": 49, "word": "CRC", "fig": 2}, {"body": 37, "word": "SW620", "fig": 2}, {"body": 37, "word": "HCT-116", "fig": 2}, {"body": 55, "word": "activity", "fig": 1}, {"body": 10, "word": "\u03bcM", "fig": 2}, {"body": 7, "word": "described", "fig": 2}, {"body": 14, "word": "association", "fig": 1}, {"body": 11, "word": "treated", "fig": 1}, {"body": 9, "word": "beta-catenin", "fig": 1}, {"body": 8, "word": "performed", "fig": 1}, {"body": 8, "word": "data", "fig": 1}, {"body": 5, "word": "using", "fig": 1}, {"body": 2, "word": "antibody", "fig": 2}, {"body": 4, "word": "shown", "fig": 1}, {"body": 1, "word": "Coimmunoprecipitation", "fig": 3}, {"body": 3, "word": "used", "fig": 1}, {"body": 2, "word": "coimmunoprecipitation", "fig": 1}, {"body": 1, "word": "A", "fig": 2}, {"body": 2, "word": "similar", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "detected", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726710/bin/jcav04p0481g03.jpg", "caption": "Effects of ICG-001 on butyrate-mediated WNT signaling and apoptosis in CRC cells. (A) ICG-001 inhibits butyrate-induced WNT activity in HCT-116 cells. HCT-116 cells were transfected with TOP/FOPFlash reporter vectors and with pRLTK for normalization of transfection efficiency. After 5 hours cells were mock treated (M) or treated with 75 \u03bcM ICG-001 (I), 5 mM sodium butyrate (B) or both agents (IB) 17.5 hr. WNT signaling measured by the ratio of luciferase expression from TOPFlash (T) to FOPFlash (F) is shown (B) ICG-001 inhibits butyrate-induced WNT activity in SW620 cells. Experiment was performed as in (A). (C) Butyrate potentiates apoptosis mediated by ICG-001 in HCT-116 cells. The fold induction of caspase activity compared to mock treated control is shown for butyrate-treated (B), ICG-001 treated (I) and cells cotreated with both reagents (IB). (D) ICG-001 interferes with butyrate-induced apoptosis in SW620 cells. Experiment was performed as in (C). For (A)-(D), data are for three separate experiments; Bars, SDs; * = statistical significance.", "co_occurrence": [{"body": 89, "word": "cells", "fig": 8}, {"body": 80, "word": "ICG-001", "fig": 7}, {"body": 55, "word": "activity", "fig": 3}, {"body": 37, "word": "HCT-116", "fig": 3}, {"body": 36, "word": "apoptosis", "fig": 3}, {"body": 21, "word": "WNT", "fig": 4}, {"body": 37, "word": "SW620", "fig": 2}, {"body": 63, "word": "butyrate", "fig": 1}, {"body": 25, "word": "signaling", "fig": 2}, {"body": 49, "word": "CRC", "fig": 1}, {"body": 11, "word": "treated", "fig": 4}, {"body": 11, "word": "butyrate-induced", "fig": 3}, {"body": 18, "word": "The", "fig": 1}, {"body": 17, "word": "expression", "fig": 1}, {"body": 8, "word": "performed", "fig": 2}, {"body": 15, "word": "caspase", "fig": 1}, {"body": 14, "word": "agents", "fig": 1}, {"body": 12, "word": "compared", "fig": 1}, {"body": 6, "word": "mock", "fig": 2}, {"body": 11, "word": "mM", "fig": 1}, {"body": 10, "word": "\u03bcM", "fig": 1}, {"body": 8, "word": "data", "fig": 1}, {"body": 4, "word": "shown", "fig": 2}, {"body": 6, "word": "induction", "fig": 1}, {"body": 5, "word": "reporter", "fig": 1}, {"body": 5, "word": "measured", "fig": 1}, {"body": 4, "word": "hr", "fig": 1}, {"body": 2, "word": "inhibits", "fig": 2}, {"body": 4, "word": "butyrate-treated", "fig": 1}, {"body": 3, "word": "Butyrate", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "control", "fig": 1}, {"body": 1, "word": "B", "fig": 3}, {"body": 3, "word": "interferes", "fig": 1}, {"body": 1, "word": "A", "fig": 3}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "luciferase", "fig": 1}, {"body": 2, "word": "sodium", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 2, "word": "significance", "fig": 1}, {"body": 2, "word": "For", "fig": 1}, {"body": 2, "word": "vectors", "fig": 1}, {"body": 2, "word": "FOPFlash", "fig": 1}, {"body": 2, "word": "TOPFlash", "fig": 1}, {"body": 1, "word": "statistical", "fig": 1}, {"body": 1, "word": "Effects", "fig": 1}, {"body": 1, "word": "mediated", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "pRLTK", "fig": 1}, {"body": 1, "word": "butyrate-mediated", "fig": 1}, {"body": 1, "word": "cotreated", "fig": 1}, {"body": 1, "word": "normalization", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726710/bin/jcav04p0481g04.jpg", "caption": "Possible relationship between CRC cell proliferation and apoptosis. (A) HCT-116 CRC cells were mock treated (M) or treated with 5 mM butyrate (B), 75 \u03bcM ICG-001 (I) or both agents (BI) for 24 hr. Samples were assayed with the QuickCell Proliferation kit (Biovision) according to manufacturer's instructions. (B) SW620 cells were assayed for proliferation as in (A), except that the ICG-001 concentration was 100 \u03bcM. (C) Western blot data showing expression of p21 and survivin in HCT-116 (H) and SW620 (S) CRC cells mock treated (M) or treated with 5 mM butyrate (B) , 75 (HCT-116) or 100 mM (SW620) ICG-001 (I), or both agents (BI) for 17.5 hr. For (A)-(B), data are from three separate experiments; Bars, SDs. * = statistical significance.", "co_occurrence": [{"body": 89, "word": "cells", "fig": 3}, {"body": 80, "word": "ICG-001", "fig": 3}, {"body": 49, "word": "CRC", "fig": 3}, {"body": 63, "word": "butyrate", "fig": 2}, {"body": 37, "word": "SW620", "fig": 3}, {"body": 37, "word": "HCT-116", "fig": 3}, {"body": 52, "word": "cell", "fig": 1}, {"body": 11, "word": "treated", "fig": 4}, {"body": 36, "word": "apoptosis", "fig": 1}, {"body": 11, "word": "mM", "fig": 3}, {"body": 14, "word": "agents", "fig": 2}, {"body": 13, "word": "proliferation", "fig": 2}, {"body": 10, "word": "\u03bcM", "fig": 2}, {"body": 17, "word": "expression", "fig": 1}, {"body": 8, "word": "data", "fig": 2}, {"body": 6, "word": "mock", "fig": 2}, {"body": 9, "word": "survivin", "fig": 1}, {"body": 4, "word": "hr", "fig": 2}, {"body": 7, "word": "p21", "fig": 1}, {"body": 1, "word": "B", "fig": 4}, {"body": 4, "word": "'s", "fig": 1}, {"body": 3, "word": "Proliferation", "fig": 1}, {"body": 3, "word": "Western", "fig": 1}, {"body": 1, "word": "A", "fig": 3}, {"body": 3, "word": "kit", "fig": 1}, {"body": 2, "word": "For", "fig": 1}, {"body": 2, "word": "concentration", "fig": 1}, {"body": 2, "word": "according", "fig": 1}, {"body": 2, "word": "instructions", "fig": 1}, {"body": 1, "word": "assayed", "fig": 2}, {"body": 2, "word": "manufacturer", "fig": 1}, {"body": 2, "word": "significance", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 1, "word": "statistical", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "QuickCell", "fig": 1}, {"body": 1, "word": "Biovision", "fig": 1}, {"body": 1, "word": "three", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726710/bin/jcav04p0481g05.jpg", "caption": "ICG-001 represses the high-WNT signaling fraction of CRC cells induced by butyrate. HCT-116 cells stably transfected with TOP-EGFP and FOP-EGFP 1, were mock treated (M) or treated with 5 mM butyrate (B), 75 \u03bcM ICG-001 (I) or both agents (IB) 17hr. Data are from three separate experiments; Bars, SDs. * = statistical significance.", "co_occurrence": [{"body": 89, "word": "cells", "fig": 2}, {"body": 80, "word": "ICG-001", "fig": 2}, {"body": 63, "word": "butyrate", "fig": 2}, {"body": 49, "word": "CRC", "fig": 1}, {"body": 37, "word": "HCT-116", "fig": 1}, {"body": 25, "word": "signaling", "fig": 1}, {"body": 11, "word": "treated", "fig": 2}, {"body": 14, "word": "agents", "fig": 1}, {"body": 11, "word": "mM", "fig": 1}, {"body": 10, "word": "\u03bcM", "fig": 1}, {"body": 6, "word": "mock", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "stably", "fig": 1}, {"body": 2, "word": "significance", "fig": 1}, {"body": 2, "word": "high-WNT", "fig": 1}, {"body": 2, "word": "induced", "fig": 1}, {"body": 2, "word": "FOP-EGFP", "fig": 1}, {"body": 2, "word": "TOP-EGFP", "fig": 1}, {"body": 1, "word": "statistical", "fig": 1}, {"body": 1, "word": "fraction", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "represses", "fig": 1}, {"body": 1, "word": "three", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726710/bin/jcav04p0481g06.jpg", "caption": "Central role of CBP/beta-catenin in the effects of butyrate on CRC cells. (Center). The association between CBP and beta-catenin, which is blocked by ICG-001, contributes to basal WNT/catenin activity and is required for butyrate-induced WNT hyperactivation. The hyperactivation of WNT/catenin activity mediated by butyrate enhances apoptosis. (Left) Butyrate-mediated WNT hyperactivation increases the proportion of cells exhibiting high levels of WNT/catenin activity, which may influence tumorigenesis. ICG-001 represses WNT hyperactivation and decreases the proportion of high-WNT activity cells. (Right Top). Both ICG-001 and butyrate repress CRC cell proliferation. (Right Bottom). Treatment of SW620 CRC cells with ICG-001 induces a strong cell cycle arrest, which may interfere with butyrate-mediated apoptosis. This negative interaction between ICG-001 and butyrate may involve altered expression of factors such as p21. In HCT-116 cells, butyrate downregulates expression of the anti-apoptotic factor survivin, and in this cell line, ICG-001 does not interfere with butyrate-induced apoptosis. Arrows indicate positive interactions (activation); blocked lines indicate negative interactions (repression).", "co_occurrence": [{"body": 80, "word": "ICG-001", "fig": 6}, {"body": 89, "word": "cells", "fig": 5}, {"body": 63, "word": "butyrate", "fig": 5}, {"body": 55, "word": "activity", "fig": 4}, {"body": 52, "word": "cell", "fig": 3}, {"body": 49, "word": "CRC", "fig": 3}, {"body": 46, "word": "WNT/catenin", "fig": 3}, {"body": 36, "word": "apoptosis", "fig": 3}, {"body": 21, "word": "WNT", "fig": 3}, {"body": 37, "word": "HCT-116", "fig": 1}, {"body": 37, "word": "SW620", "fig": 1}, {"body": 9, "word": "hyperactivation", "fig": 4}, {"body": 18, "word": "The", "fig": 2}, {"body": 17, "word": "expression", "fig": 2}, {"body": 10, "word": "may", "fig": 3}, {"body": 11, "word": "butyrate-induced", "fig": 2}, {"body": 20, "word": "CBP", "fig": 1}, {"body": 20, "word": "levels", "fig": 1}, {"body": 17, "word": "effects", "fig": 1}, {"body": 15, "word": "lines", "fig": 1}, {"body": 14, "word": "association", "fig": 1}, {"body": 13, "word": "proliferation", "fig": 1}, {"body": 12, "word": "In", "fig": 1}, {"body": 10, "word": "arrest", "fig": 1}, {"body": 9, "word": "survivin", "fig": 1}, {"body": 9, "word": "beta-catenin", "fig": 1}, {"body": 9, "word": "high", "fig": 1}, {"body": 9, "word": "cycle", "fig": 1}, {"body": 8, "word": "CBP/beta-catenin", "fig": 1}, {"body": 7, "word": "p21", "fig": 1}, {"body": 3, "word": "interactions", "fig": 2}, {"body": 3, "word": "interfere", "fig": 2}, {"body": 5, "word": "Treatment", "fig": 1}, {"body": 5, "word": "downregulates", "fig": 1}, {"body": 2, "word": "indicate", "fig": 2}, {"body": 3, "word": "factor", "fig": 1}, {"body": 3, "word": "induces", "fig": 1}, {"body": 3, "word": "anti-apoptotic", "fig": 1}, {"body": 1, "word": "blocked", "fig": 2}, {"body": 1, "word": "proportion", "fig": 2}, {"body": 2, "word": "high-WNT", "fig": 1}, {"body": 2, "word": "This", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 1, "word": "negative", "fig": 2}, {"body": 2, "word": "influence", "fig": 1}, {"body": 2, "word": "role", "fig": 1}, {"body": 2, "word": "required", "fig": 1}, {"body": 1, "word": "repression", "fig": 1}, {"body": 1, "word": "Both", "fig": 1}, {"body": 1, "word": "activation", "fig": 1}, {"body": 1, "word": "represses", "fig": 1}, {"body": 1, "word": "factors", "fig": 1}, {"body": 1, "word": "mediated", "fig": 1}, {"body": 1, "word": "interaction", "fig": 1}, {"body": 1, "word": "basal", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "Butyrate-mediated", "fig": 1}, {"body": 1, "word": "butyrate-mediated", "fig": 1}, {"body": 1, "word": "tumorigenesis", "fig": 1}, {"body": 1, "word": "altered", "fig": 1}]}], "3853869": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853869/bin/fnana-07-00041-g0001.jpg", "caption": "Distribution of TH and DBH immunoreactivity in the PAG. (A) Schematic representation of the PAG and adjacent nuclei. (B) Micrograph of a coronal section showing TH-labeled fibers and terminals in the PAG and deep layers of the SC. The dlPAG is outlined in red; the subdivisions of the PAG are depicted in yellow. (C) Micrograph of a coronal section showing DBH-labeled fibers and terminals in the PAG and deep layers of the SC. The dlPAG is outlined in red. Comparison between Figures 1B,C suggests that dopamine is more abundant than noradrenaline in the dlPAG. Scale bar is 200 \u03bcm. For abbreviations, see list.", "co_occurrence": [{"body": 78, "word": "dlPAG", "fig": 3}, {"body": 57, "word": "The", "fig": 2}, {"body": 17, "word": "PAG", "fig": 5}, {"body": 18, "word": "fibers", "fig": 2}, {"body": 29, "word": "TH", "fig": 1}, {"body": 21, "word": "dopamine", "fig": 1}, {"body": 10, "word": "SC", "fig": 2}, {"body": 9, "word": "DBH", "fig": 1}, {"body": 4, "word": "deep", "fig": 2}, {"body": 4, "word": "layers", "fig": 2}, {"body": 7, "word": "For", "fig": 1}, {"body": 3, "word": "section", "fig": 2}, {"body": 4, "word": "abundant", "fig": 1}, {"body": 4, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "red", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "immunoreactivity", "fig": 1}, {"body": 3, "word": "noradrenaline", "fig": 1}, {"body": 2, "word": "1B", "fig": 1}, {"body": 1, "word": "outlined", "fig": 2}, {"body": 1, "word": "C", "fig": 2}, {"body": 1, "word": "showing", "fig": 2}, {"body": 1, "word": "coronal", "fig": 2}, {"body": 2, "word": "Figures", "fig": 1}, {"body": 2, "word": "suggests", "fig": 1}, {"body": 1, "word": "see", "fig": 1}, {"body": 1, "word": "Distribution", "fig": 1}, {"body": 1, "word": "representation", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853869/bin/fnana-07-00041-g0002.jpg", "caption": "Injection sites of retrograde tracer experiments. (A) Schematic drawings representing CTb deposits by pressure injections along the rostro-caudal extent of the dlPAG and the SC. The four cases are represented by different colors (R22 in red, R23 in brown, R25 in green and R26 in blue). (B) Schematic representation of CTb iontophoresis deposits in the dlPAG. R30 is in purple and R29 in dark brown. The injection made in case R29 was placed in the deep layers of the SC and did not include the dlPAG. This case was used as a control injection. For abbreviations, see list.", "co_occurrence": [{"body": 78, "word": "dlPAG", "fig": 3}, {"body": 57, "word": "The", "fig": 2}, {"body": 39, "word": "injection", "fig": 2}, {"body": 27, "word": "CTb", "fig": 2}, {"body": 24, "word": "case", "fig": 2}, {"body": 32, "word": "tracer", "fig": 1}, {"body": 28, "word": "cases", "fig": 1}, {"body": 20, "word": "different", "fig": 1}, {"body": 10, "word": "SC", "fig": 2}, {"body": 13, "word": "sites", "fig": 1}, {"body": 12, "word": "pressure", "fig": 1}, {"body": 12, "word": "R30", "fig": 1}, {"body": 6, "word": "R29", "fig": 2}, {"body": 11, "word": "This", "fig": 1}, {"body": 11, "word": "R22", "fig": 1}, {"body": 11, "word": "R26", "fig": 1}, {"body": 11, "word": "R23", "fig": 1}, {"body": 9, "word": "retrograde", "fig": 1}, {"body": 4, "word": "deposits", "fig": 2}, {"body": 7, "word": "injections", "fig": 1}, {"body": 7, "word": "For", "fig": 1}, {"body": 7, "word": "R25", "fig": 1}, {"body": 7, "word": "extent", "fig": 1}, {"body": 6, "word": "used", "fig": 1}, {"body": 5, "word": "rostro-caudal", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "along", "fig": 1}, {"body": 4, "word": "layers", "fig": 1}, {"body": 4, "word": "deep", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "Injection", "fig": 1}, {"body": 3, "word": "iontophoresis", "fig": 1}, {"body": 3, "word": "made", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "placed", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 2, "word": "dark", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "drawings", "fig": 1}, {"body": 1, "word": "see", "fig": 1}, {"body": 1, "word": "representation", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "representing", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853869/bin/fnana-07-00041-g0003.jpg", "caption": "Double-labeled neurons in the A13 dopaminergic cell group projecting to the dlPAG. (A) Diagrammatic representation of the distribution of CTb/TH-positive cells in the A13 cell group, cases R22 (black dots) and R30 (red dots). Figures modified from Paxinos and Watson (1998). (B) Fluorescence micrographs showing TH-labeled (green) and CTb-labeled neurons (red) in the A13 group in case R22. Double-labeled neurons appear yellow in the merged image (white arrows). Scale bar is 60 \u03bcm.", "co_occurrence": [{"body": 62, "word": "neurons", "fig": 3}, {"body": 52, "word": "group", "fig": 3}, {"body": 63, "word": "cell", "fig": 2}, {"body": 34, "word": "A13", "fig": 3}, {"body": 78, "word": "dlPAG", "fig": 1}, {"body": 62, "word": "dopaminergic", "fig": 1}, {"body": 28, "word": "cases", "fig": 1}, {"body": 24, "word": "case", "fig": 1}, {"body": 11, "word": "R22", "fig": 2}, {"body": 18, "word": "cells", "fig": 1}, {"body": 12, "word": "R30", "fig": 1}, {"body": 10, "word": "CTb/TH-positive", "fig": 1}, {"body": 4, "word": "Double-labeled", "fig": 2}, {"body": 6, "word": "projecting", "fig": 1}, {"body": 5, "word": "distribution", "fig": 1}, {"body": 2, "word": "red", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "Watson", "fig": 1}, {"body": 2, "word": "Figures", "fig": 1}, {"body": 2, "word": "Paxinos", "fig": 1}, {"body": 1, "word": "CTb-labeled", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "green", "fig": 1}, {"body": 1, "word": "merged", "fig": 1}, {"body": 1, "word": "representation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853869/bin/fnana-07-00041-g0004.jpg", "caption": "Double-labeled neurons in the A11 dopaminergic cell group projecting to the dlPAG. (A) Distribution of CTb/TH-positive cells in the A11 cell group, cases R22 (black dots) and R30 (red dots). Figures modified from Paxinos and Watson (1998). (B) Fluorescence micrographs showing TH-labeled (green) and CTb-labeled neurons (red) in the A11 group in case R22. Double-labeled neurons appear yellow in the merged image (white arrows). Scale bar is 50 \u03bcm.", "co_occurrence": [{"body": 62, "word": "neurons", "fig": 3}, {"body": 52, "word": "group", "fig": 3}, {"body": 63, "word": "cell", "fig": 2}, {"body": 78, "word": "dlPAG", "fig": 1}, {"body": 62, "word": "dopaminergic", "fig": 1}, {"body": 12, "word": "A11", "fig": 3}, {"body": 28, "word": "cases", "fig": 1}, {"body": 24, "word": "case", "fig": 1}, {"body": 11, "word": "R22", "fig": 2}, {"body": 18, "word": "cells", "fig": 1}, {"body": 12, "word": "R30", "fig": 1}, {"body": 10, "word": "CTb/TH-positive", "fig": 1}, {"body": 4, "word": "Double-labeled", "fig": 2}, {"body": 6, "word": "projecting", "fig": 1}, {"body": 2, "word": "red", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "Watson", "fig": 1}, {"body": 2, "word": "Figures", "fig": 1}, {"body": 2, "word": "Paxinos", "fig": 1}, {"body": 1, "word": "CTb-labeled", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "Distribution", "fig": 1}, {"body": 1, "word": "green", "fig": 1}, {"body": 1, "word": "merged", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853869/bin/fnana-07-00041-g0005.jpg", "caption": "Double-labeled neurons in the A10 dopaminergic cell group projecting to the dlPAG. (A) Distribution of CTb/TH-positive cells in the posterior hypothalamic area (PHA), case R22 (black dots) and R30 (red dots). Figures modified from Paxinos and Watson (1998). (B) Distribution of double-labeled neurons in the rostral linear nucleus of the raphe and the ventral PAG. Figures modified from Paxinos and Watson (1998). (C) Fluorescence micrographs showing TH-labeled (green) and CTb-labeled neurons (red) in the rostral linear nucleus in case R22. Double-labeled neurons appear yellow in the merged image (white arrows). Scale bar is 100 \u03bcm.", "co_occurrence": [{"body": 62, "word": "neurons", "fig": 4}, {"body": 78, "word": "dlPAG", "fig": 1}, {"body": 63, "word": "cell", "fig": 1}, {"body": 62, "word": "dopaminergic", "fig": 1}, {"body": 52, "word": "group", "fig": 1}, {"body": 24, "word": "case", "fig": 2}, {"body": 29, "word": "double-labeled", "fig": 1}, {"body": 11, "word": "R22", "fig": 2}, {"body": 18, "word": "cells", "fig": 1}, {"body": 17, "word": "PAG", "fig": 1}, {"body": 14, "word": "area", "fig": 1}, {"body": 7, "word": "rostral", "fig": 2}, {"body": 13, "word": "A10", "fig": 1}, {"body": 12, "word": "R30", "fig": 1}, {"body": 10, "word": "CTb/TH-positive", "fig": 1}, {"body": 9, "word": "PHA", "fig": 1}, {"body": 4, "word": "Double-labeled", "fig": 2}, {"body": 7, "word": "hypothalamic", "fig": 1}, {"body": 6, "word": "ventral", "fig": 1}, {"body": 6, "word": "projecting", "fig": 1}, {"body": 3, "word": "nucleus", "fig": 2}, {"body": 2, "word": "Watson", "fig": 2}, {"body": 2, "word": "red", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 2, "word": "linear", "fig": 2}, {"body": 4, "word": "posterior", "fig": 1}, {"body": 2, "word": "Figures", "fig": 2}, {"body": 4, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "Paxinos", "fig": 2}, {"body": 1, "word": "Distribution", "fig": 2}, {"body": 2, "word": "raphe", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "CTb-labeled", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "green", "fig": 1}, {"body": 1, "word": "merged", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853869/bin/fnana-07-00041-g0006.jpg", "caption": "BDA injection site in the area of the mZI, including the A13 cell group. Images from fluorescent microscopy show neurons containing the anterograde tracer (in red) and TH in (green). Double-labeled cells are indicated by arrows and appear in yellow. Scale bar is 30 \u03bcm.", "co_occurrence": [{"body": 63, "word": "cell", "fig": 1}, {"body": 62, "word": "neurons", "fig": 1}, {"body": 52, "word": "group", "fig": 1}, {"body": 39, "word": "injection", "fig": 1}, {"body": 34, "word": "A13", "fig": 1}, {"body": 32, "word": "tracer", "fig": 1}, {"body": 29, "word": "TH", "fig": 1}, {"body": 18, "word": "cells", "fig": 1}, {"body": 14, "word": "area", "fig": 1}, {"body": 13, "word": "BDA", "fig": 1}, {"body": 9, "word": "site", "fig": 1}, {"body": 9, "word": "mZI", "fig": 1}, {"body": 7, "word": "anterograde", "fig": 1}, {"body": 4, "word": "containing", "fig": 1}, {"body": 4, "word": "\u03bcm", "fig": 1}, {"body": 4, "word": "Double-labeled", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853869/bin/fnana-07-00041-g0007.jpg", "caption": "BDA-labeled terminals and terminal boutons in the dlPAG originating from the A13 dopaminergic cell group. Upper panel: images from confocal microscopy showing BDA- (in green) and TH-labeled fibers (in red) in the dlPAG. Arrowheads indicate double-labeled processes. Middle and lower panels: high magnification images of double-labeled processes. Arrowheads indicate double labeling. Scale bar is 10 \u03bcm.", "co_occurrence": [{"body": 78, "word": "dlPAG", "fig": 2}, {"body": 63, "word": "cell", "fig": 1}, {"body": 62, "word": "dopaminergic", "fig": 1}, {"body": 29, "word": "double-labeled", "fig": 2}, {"body": 52, "word": "group", "fig": 1}, {"body": 34, "word": "A13", "fig": 1}, {"body": 18, "word": "fibers", "fig": 1}, {"body": 9, "word": "double", "fig": 1}, {"body": 7, "word": "labeling", "fig": 1}, {"body": 4, "word": "high", "fig": 1}, {"body": 2, "word": "images", "fig": 2}, {"body": 4, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "originating", "fig": 1}, {"body": 1, "word": "indicate", "fig": 2}, {"body": 2, "word": "red", "fig": 1}, {"body": 1, "word": "processes", "fig": 2}, {"body": 1, "word": "magnification", "fig": 1}, {"body": 1, "word": "boutons", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "lower", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}], "3688685": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g001.jpg", "caption": "Morphological characteristics of the malignant mesothelioma cell lines. Characteristic micrographs presenting the different cell lines with increasing length/width ratios from A to F. A: Epitheliod STAV-AB cells. B: Biphasic M-14-K cells. C: Biphasic STAV-FCS cells. D: Biphasic ZL-34 cells. E: Biphasic JL-1 cells. F: Sarcomatoid DM-3 cells. Scale bar = 100 \u00b5m.", "co_occurrence": [{"body": 116, "word": "cells", "fig": 6}, {"body": 77, "word": "cell", "fig": 2}, {"body": 49, "word": "lines", "fig": 2}, {"body": 25, "word": "STAV-AB", "fig": 1}, {"body": 18, "word": "M-14-K", "fig": 1}, {"body": 18, "word": "ZL-34", "fig": 1}, {"body": 16, "word": "different", "fig": 1}, {"body": 16, "word": "mesothelioma", "fig": 1}, {"body": 4, "word": "Biphasic", "fig": 4}, {"body": 15, "word": "JL-1", "fig": 1}, {"body": 15, "word": "length/width", "fig": 1}, {"body": 15, "word": "DM-3", "fig": 1}, {"body": 10, "word": "STAV-FCS", "fig": 1}, {"body": 4, "word": "A", "fig": 2}, {"body": 8, "word": "ratios", "fig": 1}, {"body": 7, "word": "malignant", "fig": 1}, {"body": 2, "word": "micrographs", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 1, "word": "Morphological", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "Sarcomatoid", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g002.jpg", "caption": "Sensitivity of mesothelioma cell lines to different cytotoxic drugs. Treated cells were normalized to untreated cells and cell viability was measured using the WST-1 assay after 24 (red) and 48 hours (blue). Results are mean values of at least three independent experiments with four replicates in each. Error bars denote the 95% confidence intervals. Cell lines are presented with increasing length/width ratios from left to right and divided into three sub-groups according to their phenotype, epithelioid cell line on the left and sarcomatoid to the right on grey background, biphasic in the middle.", "co_occurrence": [{"body": 116, "word": "cells", "fig": 2}, {"body": 77, "word": "cell", "fig": 3}, {"body": 49, "word": "lines", "fig": 2}, {"body": 33, "word": "drugs", "fig": 1}, {"body": 31, "word": "hours", "fig": 1}, {"body": 11, "word": "three", "fig": 2}, {"body": 16, "word": "different", "fig": 1}, {"body": 16, "word": "mesothelioma", "fig": 1}, {"body": 15, "word": "length/width", "fig": 1}, {"body": 14, "word": "phenotype", "fig": 1}, {"body": 12, "word": "using", "fig": 1}, {"body": 12, "word": "sarcomatoid", "fig": 1}, {"body": 10, "word": "viability", "fig": 1}, {"body": 8, "word": "epithelioid", "fig": 1}, {"body": 8, "word": "ratios", "fig": 1}, {"body": 8, "word": "line", "fig": 1}, {"body": 8, "word": "cytotoxic", "fig": 1}, {"body": 7, "word": "experiments", "fig": 1}, {"body": 7, "word": "biphasic", "fig": 1}, {"body": 7, "word": "untreated", "fig": 1}, {"body": 6, "word": "four", "fig": 1}, {"body": 6, "word": "WST-1", "fig": 1}, {"body": 5, "word": "least", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "normalized", "fig": 1}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 4, "word": "Results", "fig": 1}, {"body": 4, "word": "values", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 2, "word": "according", "fig": 1}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "denote", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "sub-groups", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g003.jpg", "caption": "Cell cycle distribution after 48 hours of pemetrexed treatment. All cells were stained with PI. Cells were normalized according to FlowJo algorithms (% of max), considering the different amount of live cells in controls and treated cells. Mesothelioma cell lines arranged with increasing length/width ratios from A to F. One representative experiment is shown for each cell line with control cells marked in grey and 48 hours pemetrexed treated cells in black. STAV-AB (A), M-14-K (B), STAV-FCS (C) and Jurkat cells (G, used as positive control) show an S-phase arrest.", "co_occurrence": [{"body": 116, "word": "cells", "fig": 6}, {"body": 77, "word": "cell", "fig": 2}, {"body": 31, "word": "hours", "fig": 2}, {"body": 25, "word": "pemetrexed", "fig": 2}, {"body": 49, "word": "lines", "fig": 1}, {"body": 33, "word": "treatment", "fig": 1}, {"body": 14, "word": "treated", "fig": 2}, {"body": 25, "word": "STAV-AB", "fig": 1}, {"body": 10, "word": "control", "fig": 2}, {"body": 18, "word": "M-14-K", "fig": 1}, {"body": 17, "word": "used", "fig": 1}, {"body": 16, "word": "different", "fig": 1}, {"body": 15, "word": "length/width", "fig": 1}, {"body": 11, "word": "shown", "fig": 1}, {"body": 10, "word": "STAV-FCS", "fig": 1}, {"body": 9, "word": "cycle", "fig": 1}, {"body": 8, "word": "ratios", "fig": 1}, {"body": 4, "word": "A", "fig": 2}, {"body": 8, "word": "line", "fig": 1}, {"body": 7, "word": "Jurkat", "fig": 1}, {"body": 6, "word": "controls", "fig": 1}, {"body": 6, "word": "live", "fig": 1}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 5, "word": "Mesothelioma", "fig": 1}, {"body": 5, "word": "normalized", "fig": 1}, {"body": 5, "word": "amount", "fig": 1}, {"body": 4, "word": "S-phase", "fig": 1}, {"body": 4, "word": "arrest", "fig": 1}, {"body": 4, "word": "PI", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "distribution", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 2, "word": "experiment", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "FlowJo", "fig": 1}, {"body": 2, "word": "All", "fig": 1}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 2, "word": "according", "fig": 1}, {"body": 1, "word": "considering", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "max", "fig": 1}, {"body": 1, "word": "arranged", "fig": 1}, {"body": 1, "word": "algorithms", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g004.jpg", "caption": "Effects of conventional drug combinations on mesothelioma cells. Cells were treated with combinations of the conventional drugs, normalized to untreated cells and viability was measured with the WST-1 assay after 24 (red) and 48 hours (blue). Mean values of at least three independent experiments with four replicates in each are presented. Error bars denote the 95% confidence intervals. Cell lines are divided into three sub-groups with increasing length/width ratios from left to right and according to their phenotype; biphasic in the middle, epithelioid cell line on the left and sarcomatoid to the right on grey background.", "co_occurrence": [{"body": 116, "word": "cells", "fig": 2}, {"body": 77, "word": "cell", "fig": 1}, {"body": 49, "word": "lines", "fig": 1}, {"body": 38, "word": "drug", "fig": 1}, {"body": 33, "word": "drugs", "fig": 1}, {"body": 31, "word": "hours", "fig": 1}, {"body": 14, "word": "combinations", "fig": 2}, {"body": 11, "word": "three", "fig": 2}, {"body": 8, "word": "conventional", "fig": 2}, {"body": 16, "word": "mesothelioma", "fig": 1}, {"body": 15, "word": "length/width", "fig": 1}, {"body": 14, "word": "phenotype", "fig": 1}, {"body": 14, "word": "treated", "fig": 1}, {"body": 12, "word": "sarcomatoid", "fig": 1}, {"body": 10, "word": "viability", "fig": 1}, {"body": 8, "word": "epithelioid", "fig": 1}, {"body": 8, "word": "ratios", "fig": 1}, {"body": 8, "word": "line", "fig": 1}, {"body": 7, "word": "experiments", "fig": 1}, {"body": 7, "word": "biphasic", "fig": 1}, {"body": 7, "word": "untreated", "fig": 1}, {"body": 6, "word": "four", "fig": 1}, {"body": 6, "word": "WST-1", "fig": 1}, {"body": 5, "word": "least", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "normalized", "fig": 1}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "values", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 2, "word": "Effects", "fig": 1}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 2, "word": "according", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "sub-groups", "fig": 1}, {"body": 1, "word": "denote", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g005.jpg", "caption": "Drug combinations with selenite, cytotoxic effects on mesothelioma cells. Cells exposed to selenite in combination with the remaining five drugs, normalized to untreated cells. Viability was measured with the WST-1 assay after 24 (red) and 48 hours (blue). The six different cell lines are shown with increasing length/width ratios and in three phenotypic sub-groups; biphasic cell lines in the middle, epithelioid on the left and sarcomatoid to the right on grey background. Results are mean values of at least three independent experiments with four replicates in each. Error bars denote the 95% confidence intervals.", "co_occurrence": [{"body": 116, "word": "cells", "fig": 2}, {"body": 77, "word": "cell", "fig": 2}, {"body": 49, "word": "lines", "fig": 2}, {"body": 27, "word": "selenite", "fig": 2}, {"body": 37, "word": "The", "fig": 1}, {"body": 35, "word": "effects", "fig": 1}, {"body": 33, "word": "drugs", "fig": 1}, {"body": 31, "word": "hours", "fig": 1}, {"body": 23, "word": "combination", "fig": 1}, {"body": 11, "word": "three", "fig": 2}, {"body": 16, "word": "different", "fig": 1}, {"body": 16, "word": "mesothelioma", "fig": 1}, {"body": 15, "word": "length/width", "fig": 1}, {"body": 14, "word": "combinations", "fig": 1}, {"body": 12, "word": "sarcomatoid", "fig": 1}, {"body": 11, "word": "shown", "fig": 1}, {"body": 9, "word": "Drug", "fig": 1}, {"body": 8, "word": "epithelioid", "fig": 1}, {"body": 8, "word": "ratios", "fig": 1}, {"body": 8, "word": "cytotoxic", "fig": 1}, {"body": 7, "word": "experiments", "fig": 1}, {"body": 7, "word": "untreated", "fig": 1}, {"body": 7, "word": "biphasic", "fig": 1}, {"body": 6, "word": "four", "fig": 1}, {"body": 6, "word": "six", "fig": 1}, {"body": 6, "word": "WST-1", "fig": 1}, {"body": 5, "word": "least", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "normalized", "fig": 1}, {"body": 4, "word": "Results", "fig": 1}, {"body": 4, "word": "remaining", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "values", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "phenotypic", "fig": 1}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "Viability", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "sub-groups", "fig": 1}, {"body": 1, "word": "denote", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g006.jpg", "caption": "Effects of drug combinations with bortezomib on mesothelioma. Viability of cells measured using the WST-1 assay after 24 (red) and 48 hours (blue) of treatment with bortezomib in combination with the four conventional drugs and normalized to untreated cells. Results are shown as mean values of at least three independent experiments with four replicates in each experiment. Error bars denote the 95% confidence intervals. Cell lines are presented with increasing length/width ratios from left to right and divided into three sub-groups according to their phenotype, epithelioid cell line on the left and sarcomatoid to the right on grey background, biphasic in the middle.", "co_occurrence": [{"body": 116, "word": "cells", "fig": 2}, {"body": 77, "word": "cell", "fig": 1}, {"body": 28, "word": "bortezomib", "fig": 2}, {"body": 49, "word": "lines", "fig": 1}, {"body": 38, "word": "drug", "fig": 1}, {"body": 33, "word": "drugs", "fig": 1}, {"body": 33, "word": "treatment", "fig": 1}, {"body": 31, "word": "hours", "fig": 1}, {"body": 23, "word": "combination", "fig": 1}, {"body": 11, "word": "three", "fig": 2}, {"body": 16, "word": "mesothelioma", "fig": 1}, {"body": 15, "word": "length/width", "fig": 1}, {"body": 14, "word": "phenotype", "fig": 1}, {"body": 14, "word": "combinations", "fig": 1}, {"body": 6, "word": "four", "fig": 2}, {"body": 12, "word": "using", "fig": 1}, {"body": 12, "word": "sarcomatoid", "fig": 1}, {"body": 11, "word": "shown", "fig": 1}, {"body": 8, "word": "conventional", "fig": 1}, {"body": 8, "word": "epithelioid", "fig": 1}, {"body": 8, "word": "ratios", "fig": 1}, {"body": 8, "word": "line", "fig": 1}, {"body": 7, "word": "experiments", "fig": 1}, {"body": 7, "word": "biphasic", "fig": 1}, {"body": 7, "word": "untreated", "fig": 1}, {"body": 6, "word": "WST-1", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 5, "word": "least", "fig": 1}, {"body": 5, "word": "normalized", "fig": 1}, {"body": 4, "word": "Results", "fig": 1}, {"body": 4, "word": "values", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 2, "word": "experiment", "fig": 1}, {"body": 2, "word": "Effects", "fig": 1}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 2, "word": "according", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "Viability", "fig": 1}, {"body": 1, "word": "denote", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "sub-groups", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g007.jpg", "caption": "Synergistic and antagonistic effects of drug combinations. Comparison between mean effects of drug combinations and the theoretical effects, defined as the product of the mean effects of the two single drugs in the combination. Each data point represents a comparison and error bars in red denote the 95% confidence intervals. Statistical significance was accepted as p<0.05. A: Synergistic and antagonistic effects with respect to the different drugs. Doxorubicin was significantly different from zero (Wilcoxon signed-rank test). B: Synergistic and antagonistic effects with respect to the different cell lines. Cell lines are arranged with increasing length/width ratios from left to right and divided into three sub-groups according to their phenotype, epithelioid cell line on the left and sarcomatoid to the right on gray background, biphasic in the middle. Subpopulations within the cell lines can be distinguished in JL-1, STAV-AB and ZL-34 cells. Wilcoxon signed-rank test showed that JL-1 were significantly different from zero.", "co_occurrence": [{"body": 77, "word": "cell", "fig": 3}, {"body": 35, "word": "effects", "fig": 6}, {"body": 49, "word": "lines", "fig": 3}, {"body": 116, "word": "cells", "fig": 1}, {"body": 38, "word": "drug", "fig": 2}, {"body": 33, "word": "drugs", "fig": 2}, {"body": 16, "word": "different", "fig": 4}, {"body": 15, "word": "JL-1", "fig": 2}, {"body": 14, "word": "combinations", "fig": 2}, {"body": 25, "word": "STAV-AB", "fig": 1}, {"body": 23, "word": "combination", "fig": 1}, {"body": 18, "word": "ZL-34", "fig": 1}, {"body": 15, "word": "length/width", "fig": 1}, {"body": 15, "word": "showed", "fig": 1}, {"body": 14, "word": "phenotype", "fig": 1}, {"body": 13, "word": "two", "fig": 1}, {"body": 6, "word": "significantly", "fig": 2}, {"body": 4, "word": "antagonistic", "fig": 3}, {"body": 12, "word": "sarcomatoid", "fig": 1}, {"body": 11, "word": "three", "fig": 1}, {"body": 10, "word": "p", "fig": 1}, {"body": 8, "word": "epithelioid", "fig": 1}, {"body": 8, "word": "ratios", "fig": 1}, {"body": 8, "word": "line", "fig": 1}, {"body": 7, "word": "biphasic", "fig": 1}, {"body": 7, "word": "data", "fig": 1}, {"body": 3, "word": "mean", "fig": 2}, {"body": 2, "word": "Synergistic", "fig": 3}, {"body": 6, "word": "Doxorubicin", "fig": 1}, {"body": 6, "word": "single", "fig": 1}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "within", "fig": 1}, {"body": 3, "word": "theoretical", "fig": 1}, {"body": 3, "word": "product", "fig": 1}, {"body": 2, "word": "accepted", "fig": 1}, {"body": 1, "word": "zero", "fig": 2}, {"body": 1, "word": "signed-rank", "fig": 2}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 2, "word": "according", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "defined", "fig": 1}, {"body": 2, "word": "significance", "fig": 1}, {"body": 1, "word": "test", "fig": 2}, {"body": 1, "word": "Wilcoxon", "fig": 2}, {"body": 1, "word": "represents", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "point", "fig": 1}, {"body": 1, "word": "arranged", "fig": 1}, {"body": 1, "word": "denote", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}, {"body": 1, "word": "sub-groups", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688685/bin/pone.0065903.g008.jpg", "caption": "Correlation between immunoreactivity of predictive markers and drug sensitivity. The sensitivity of mesothelioma cell lines to different drugs plotted against the immunoreactivity of different predictive markers, presented together with results from the linear regression analyses. Statistical significance was accepted at p<0.05 and was seen for MRP-1 immunoreactivity and sensitivity of cell lines to carboplatin treatment (A) and for xCT and pemetrexed effect (B). Abbreviations: Pgp = P-glycoprotein, MRP-1 = Multidrug resistance-associated protein 1, ERCC1 = Excision repair cross-complementing rodent repair deficiency, complementation group 1, RRM1 = Ribonucleotide reductase M1, TS = Thymidylate synthase, xCT = xc- cystine transporter and 20S P = 20S proteasome.", "co_occurrence": [{"body": 77, "word": "cell", "fig": 2}, {"body": 49, "word": "lines", "fig": 2}, {"body": 27, "word": "sensitivity", "fig": 3}, {"body": 42, "word": "effect", "fig": 1}, {"body": 13, "word": "immunoreactivity", "fig": 3}, {"body": 38, "word": "drug", "fig": 1}, {"body": 37, "word": "The", "fig": 1}, {"body": 17, "word": "markers", "fig": 2}, {"body": 33, "word": "treatment", "fig": 1}, {"body": 33, "word": "drugs", "fig": 1}, {"body": 16, "word": "different", "fig": 2}, {"body": 15, "word": "MRP-1", "fig": 2}, {"body": 13, "word": "predictive", "fig": 2}, {"body": 26, "word": "carboplatin", "fig": 1}, {"body": 25, "word": "pemetrexed", "fig": 1}, {"body": 12, "word": "xCT", "fig": 2}, {"body": 10, "word": "20S", "fig": 2}, {"body": 16, "word": "mesothelioma", "fig": 1}, {"body": 15, "word": "ERCC1", "fig": 1}, {"body": 10, "word": "p", "fig": 1}, {"body": 10, "word": "proteasome", "fig": 1}, {"body": 9, "word": "RRM1", "fig": 1}, {"body": 9, "word": "results", "fig": 1}, {"body": 9, "word": "regression", "fig": 1}, {"body": 7, "word": "Pgp", "fig": 1}, {"body": 7, "word": "P", "fig": 1}, {"body": 3, "word": "repair", "fig": 2}, {"body": 6, "word": "TS", "fig": 1}, {"body": 6, "word": "Correlation", "fig": 1}, {"body": 5, "word": "seen", "fig": 1}, {"body": 4, "word": "protein", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "cystine", "fig": 1}, {"body": 3, "word": "plotted", "fig": 1}, {"body": 2, "word": "analyses", "fig": 1}, {"body": 2, "word": "group", "fig": 1}, {"body": 2, "word": "rodent", "fig": 1}, {"body": 2, "word": "Excision", "fig": 1}, {"body": 2, "word": "transporter", "fig": 1}, {"body": 2, "word": "reductase", "fig": 1}, {"body": 2, "word": "Multidrug", "fig": 1}, {"body": 2, "word": "resistance-associated", "fig": 1}, {"body": 2, "word": "P-glycoprotein", "fig": 1}, {"body": 2, "word": "Thymidylate", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "Ribonucleotide", "fig": 1}, {"body": 2, "word": "significance", "fig": 1}, {"body": 2, "word": "xc-", "fig": 1}, {"body": 2, "word": "cross-complementing", "fig": 1}, {"body": 2, "word": "accepted", "fig": 1}, {"body": 2, "word": "complementation", "fig": 1}, {"body": 2, "word": "synthase", "fig": 1}, {"body": 2, "word": "M1", "fig": 1}, {"body": 1, "word": "deficiency", "fig": 1}, {"body": 1, "word": "together", "fig": 1}, {"body": 1, "word": "linear", "fig": 1}, {"body": 1, "word": "Abbreviations", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}]}], "4600982": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f1.jpg", "caption": "Knockdown of Homeobox containing 1 (HMBOX1) induced human umbilical vascular endothelial cell (HUVEC) apoptosis. (A) Subcellular distribution of HMBOX1 in normal HUVECs. Scale bar: 16 \u03bcm. (B) Western blot analysis of siRNA knockdown of HMBOX1 (20, 40 or 60 nM) or scramble siRNA (60 nM; Ctr) for 24 h in HUVECs. HMBOX1 levels are relative to that of GAPDH. Nor, HUVECs cultured in normal M199 medium. (cropped, full-length blots are in Supplementary Fig. S1) (C) Morphological changes of HUVECs treated with 60 nM siRNA of HMBOX1 for 24 or 48 h (20\u00d7). RNAi, HUVECs transfected with HMBOX1 siRNA (60 nM). (D) Acridine orange (AO), Hoechst 33258 and TUNEL staining of apoptotic HUVECs. Arrows indicate apoptotic cells and typical nuclear fragmentation. Scale bar: 16 \u03bcm. The proportion of apoptosis was quantified by TUNEL staining at 24 h. (E) Western blot analysis of cleaved forms of PARP in HUVECs transfected with HMBOX1 siRNA for 24 or 48 h. The level of cleaved PARP was relative to that of \u03b2-actin. (cropped, full-length blots are in Supplementary Fig. S1). (Data are mean \u00b1 SEM, *p < 0.05, **p < 0.01, n = 3). (F) AnnexinV-FITC/PI staining and flow cytometry assay to determine the proportion of apoptosis after HMBOX1 knockdown for 24 h. Images showed the typical morphologies of cells in the different regions.", "co_occurrence": [{"body": 100, "word": "HMBOX1", "fig": 8}, {"body": 39, "word": "HUVECs", "fig": 7}, {"body": 42, "word": "apoptosis", "fig": 3}, {"body": 19, "word": "siRNA", "fig": 5}, {"body": 41, "word": "cells", "fig": 2}, {"body": 39, "word": "Fig", "fig": 2}, {"body": 43, "word": "level", "fig": 1}, {"body": 17, "word": "The", "fig": 2}, {"body": 16, "word": "h", "fig": 2}, {"body": 16, "word": "knockdown", "fig": 2}, {"body": 18, "word": "HUVEC", "fig": 1}, {"body": 17, "word": "cell", "fig": 1}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 8, "word": "apoptotic", "fig": 2}, {"body": 8, "word": "cleaved", "fig": 2}, {"body": 7, "word": "blot", "fig": 2}, {"body": 14, "word": "assay", "fig": 1}, {"body": 7, "word": "normal", "fig": 2}, {"body": 4, "word": "staining", "fig": 3}, {"body": 6, "word": "proportion", "fig": 2}, {"body": 12, "word": "induced", "fig": 1}, {"body": 3, "word": "nM", "fig": 4}, {"body": 4, "word": "PARP", "fig": 2}, {"body": 4, "word": "Western", "fig": 2}, {"body": 4, "word": "Supplementary", "fig": 2}, {"body": 8, "word": "flow", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 7, "word": "showed", "fig": 1}, {"body": 6, "word": "endothelial", "fig": 1}, {"body": 6, "word": "containing", "fig": 1}, {"body": 5, "word": "human", "fig": 1}, {"body": 5, "word": "fragmentation", "fig": 1}, {"body": 2, "word": "TUNEL", "fig": 2}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 4, "word": "M199", "fig": 1}, {"body": 2, "word": "full-length", "fig": 2}, {"body": 4, "word": "medium", "fig": 1}, {"body": 4, "word": "cytometry", "fig": 1}, {"body": 3, "word": "orange", "fig": 1}, {"body": 3, "word": "vascular", "fig": 1}, {"body": 3, "word": "AnnexinV-FITC/PI", "fig": 1}, {"body": 1, "word": "h.", "fig": 3}, {"body": 3, "word": "distribution", "fig": 1}, {"body": 3, "word": "treated", "fig": 1}, {"body": 3, "word": "AO", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "relative", "fig": 2}, {"body": 2, "word": "RNAi", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "S1", "fig": 2}, {"body": 2, "word": "cultured", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "scramble", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "levels", "fig": 1}, {"body": 2, "word": "Hoechst", "fig": 1}, {"body": 1, "word": "regions", "fig": 1}, {"body": 1, "word": "forms", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "Acridine", "fig": 1}, {"body": 1, "word": "Homeobox", "fig": 1}, {"body": 1, "word": "Images", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "determine", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f2.jpg", "caption": "The level of HMBOX1 decreased in HUVECs deprived of fibroblast growth factor 2 (FGF-2). (A) Quantitative PCR (qPCR) analysis of the mRNA level of HMBOX1 and (B) western blot analysis of the protein level of HMBOX1 in HUVECs cultured in basal M199 medium with FGF-2 deprivation for 6, 12 and 24 h. Protein levels are relative to that of GAPDH. (cropped, full-length blots are in Supplementary Fig. S3). (Data are mean \u00b1 SEM, *p < 0.05, ** p < 0.01, n = 3). (C) Immunofluorescence images of HMBOX1 in normal cells and cells deprived of FGF-2 for 6 h under confocal microscopy. Images are representative of three independent experiments. DAPI staining of nuclei was in blue. Scale bar: 16 \u03bcm. (D) Western blot analysis of the transfection efficiency of HMBOX1. Ctr, HUVECs transfected with pRC-CMV for 24 h; HMBOX1+, HUVECs transfected with pCMV-HMBOX1 (0.1, 0.5, 1, 2 or 4 \u03bcg) for 12 or 24 h. Relative level of HMBOX1 to that of GAPDH. (*p < 0.05, **p < 0.01, n = 3). HUVECs were transfected with pRC-CMV or pCMV-HMBOX1 for 24 h, then cultured in the basal M199 medium without FGF-2 for 6 or 12 h. (cropped, full-length blots are in Supplementary Fig. S3) (E) Microscopy images of the morphological changes of HUVECs. (20\u00d7). (F) Acridine orange (AO) staining of the nuclear condensation and fragmentation of HUVECs. Arrows indicate apoptotic cells and typical nuclear fragmentation. Scale bars: 20 \u03bcm. Images are representative of at least 3 independent experiments.", "co_occurrence": [{"body": 100, "word": "HMBOX1", "fig": 6}, {"body": 39, "word": "HUVECs", "fig": 7}, {"body": 43, "word": "level", "fig": 4}, {"body": 41, "word": "cells", "fig": 3}, {"body": 39, "word": "Fig", "fig": 2}, {"body": 16, "word": "h", "fig": 3}, {"body": 20, "word": "pCMV-HMBOX1", "fig": 2}, {"body": 10, "word": "FGF-2", "fig": 4}, {"body": 8, "word": "transfected", "fig": 3}, {"body": 9, "word": "pRC-CMV", "fig": 2}, {"body": 17, "word": "The", "fig": 1}, {"body": 7, "word": "blot", "fig": 2}, {"body": 4, "word": "analysis", "fig": 3}, {"body": 10, "word": "decreased", "fig": 1}, {"body": 5, "word": "fragmentation", "fig": 2}, {"body": 10, "word": "protein", "fig": 1}, {"body": 4, "word": "staining", "fig": 2}, {"body": 4, "word": "nuclear", "fig": 2}, {"body": 4, "word": "M199", "fig": 2}, {"body": 4, "word": "medium", "fig": 2}, {"body": 8, "word": "apoptotic", "fig": 1}, {"body": 4, "word": "Supplementary", "fig": 2}, {"body": 7, "word": "normal", "fig": 1}, {"body": 3, "word": "experiments", "fig": 2}, {"body": 6, "word": "deprivation", "fig": 1}, {"body": 3, "word": "basal", "fig": 2}, {"body": 3, "word": "independent", "fig": 2}, {"body": 6, "word": "transfection", "fig": 1}, {"body": 5, "word": "western", "fig": 1}, {"body": 4, "word": "Western", "fig": 1}, {"body": 4, "word": "factor", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 2}, {"body": 4, "word": "efficiency", "fig": 1}, {"body": 2, "word": "cultured", "fig": 2}, {"body": 2, "word": "deprived", "fig": 2}, {"body": 2, "word": "full-length", "fig": 2}, {"body": 4, "word": "without", "fig": 1}, {"body": 3, "word": "orange", "fig": 1}, {"body": 1, "word": "h.", "fig": 3}, {"body": 3, "word": "least", "fig": 1}, {"body": 3, "word": "AO", "fig": 1}, {"body": 3, "word": "condensation", "fig": 1}, {"body": 2, "word": "Immunofluorescence", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "confocal", "fig": 1}, {"body": 1, "word": "Images", "fig": 2}, {"body": 1, "word": "representative", "fig": 2}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "levels", "fig": 1}, {"body": 2, "word": "nuclei", "fig": 1}, {"body": 1, "word": "Protein", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "growth", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "mRNA", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "fibroblast", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Acridine", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f3.jpg", "caption": "HMBOX1 inhibited HUVEC apoptosis induced by FGF-2 deprivation. (A) Nuclear fragmentation of cells by TUNEL staining. Cells were transfected with pRC-CMV or pCMV-HMBOX1 for 24 h, then cultured in basal medium deprived of FGF-2 for 6 or 12 h. Scale bar: 16 \u03bcm. (B) Proportion of apoptosis quantified by TUNEL staining. (#p > 0.05, **P < 0.01, n = 3) (C) Western blot analysis of cleaved PARP level in HUVECs. The level of cleaved PARP is relative to that of GAPDH. Cells were transfected with pRC-CMV or pCMV-HMBOX1 for 24 h, then cultured in basal medium deprived of FGF-2 for 6 or 12 h. (cropped, full-length blots are in Supplementary Fig. S4). (Data are mean \u00b1 SEM, **p < 0.01, n = 3). (D) AnnexinV-FITC/PI staining and flow cytometry assay to determine the proportion of apoptosis after HMBOX1 overexpression with FGF-2 or without FGF-2 for 12 h.", "co_occurrence": [{"body": 100, "word": "HMBOX1", "fig": 2}, {"body": 42, "word": "apoptosis", "fig": 3}, {"body": 43, "word": "level", "fig": 2}, {"body": 10, "word": "FGF-2", "fig": 5}, {"body": 16, "word": "h", "fig": 3}, {"body": 41, "word": "cells", "fig": 1}, {"body": 20, "word": "pCMV-HMBOX1", "fig": 2}, {"body": 39, "word": "Fig", "fig": 1}, {"body": 39, "word": "HUVECs", "fig": 1}, {"body": 9, "word": "pRC-CMV", "fig": 2}, {"body": 18, "word": "HUVEC", "fig": 1}, {"body": 17, "word": "The", "fig": 1}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 8, "word": "cleaved", "fig": 2}, {"body": 16, "word": "overexpression", "fig": 1}, {"body": 14, "word": "assay", "fig": 1}, {"body": 13, "word": "inhibited", "fig": 1}, {"body": 4, "word": "staining", "fig": 3}, {"body": 6, "word": "Cells", "fig": 2}, {"body": 12, "word": "induced", "fig": 1}, {"body": 4, "word": "PARP", "fig": 2}, {"body": 4, "word": "medium", "fig": 2}, {"body": 8, "word": "flow", "fig": 1}, {"body": 7, "word": "blot", "fig": 1}, {"body": 6, "word": "proportion", "fig": 1}, {"body": 6, "word": "deprivation", "fig": 1}, {"body": 3, "word": "basal", "fig": 2}, {"body": 5, "word": "fragmentation", "fig": 1}, {"body": 4, "word": "Western", "fig": 1}, {"body": 2, "word": "TUNEL", "fig": 2}, {"body": 2, "word": "deprived", "fig": 2}, {"body": 2, "word": "cultured", "fig": 2}, {"body": 4, "word": "Supplementary", "fig": 1}, {"body": 4, "word": "cytometry", "fig": 1}, {"body": 4, "word": "without", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "AnnexinV-FITC/PI", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "h.", "fig": 2}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "full-length", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "determine", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Nuclear", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f4.jpg", "caption": "HMBOX1 promotion of autophagy in HUVECs. (A) Western blot analysis of protein levels of LC3-I and LC3-II in HUVECs treated with scramble siRNA (Ctr) or HMBOX1 siRNA (HMBOX1-) for 24 or 48 h. Levels of LC3-I and LC3-II are relative to that of \u03b2-actin, (cropped, full-length blots are in Supplementary Fig. S5). (B) Western blot analysis of protein levels of LC3-I and LC3-II in HUVECs transfected with pRC-CMV (Ctr) or pCMV-HMBOX1 (HMBOX1+) for 24 or 48 h. Levels of LC3-II are relative to that of \u03b2-actin. (cropped, full-length blots are in Supplementary Fig. S5). Western blot analysis of protein levels of LC3-I and LC3-II in HUVECs transfected with pRC-CMV or pCMV-HMBOX1 for 24 h (C) or 48 h (D) with or without 50 nM Bafilomycin A1 (Baf A1). Levels of LC3-II are relative to that of \u03b2-actin, (cropped, full-length blots are in Supplementary Fig. S5). (E) Immunostaining of LC3B in HUVECs. a, HUVECs transfected with scramble siRNA; b, HMBOX1 siRNA; c, pRC-CMV; d, pCMV-HMBOX1. Scale bar: 16 \u03bcm. (F) Proportion of cells containing LC3B puncta (>5) in (E). (Data are mean \u00b1 SEM, *p < 0.05, **p < 0.01, n = 3).", "co_occurrence": [{"body": 100, "word": "HMBOX1", "fig": 3}, {"body": 39, "word": "HUVECs", "fig": 6}, {"body": 39, "word": "Fig", "fig": 3}, {"body": 19, "word": "siRNA", "fig": 4}, {"body": 20, "word": "pCMV-HMBOX1", "fig": 3}, {"body": 41, "word": "cells", "fig": 1}, {"body": 16, "word": "h", "fig": 2}, {"body": 31, "word": "autophagy", "fig": 1}, {"body": 10, "word": "protein", "fig": 3}, {"body": 9, "word": "pRC-CMV", "fig": 3}, {"body": 4, "word": "LC3-II", "fig": 6}, {"body": 8, "word": "transfected", "fig": 3}, {"body": 7, "word": "blot", "fig": 3}, {"body": 4, "word": "Western", "fig": 3}, {"body": 4, "word": "Supplementary", "fig": 3}, {"body": 4, "word": "analysis", "fig": 3}, {"body": 2, "word": "\u03b2-actin", "fig": 3}, {"body": 3, "word": "LC3B", "fig": 2}, {"body": 2, "word": "full-length", "fig": 3}, {"body": 6, "word": "containing", "fig": 1}, {"body": 3, "word": "A1", "fig": 2}, {"body": 2, "word": "levels", "fig": 3}, {"body": 2, "word": "scramble", "fig": 2}, {"body": 2, "word": "E", "fig": 2}, {"body": 4, "word": "without", "fig": 1}, {"body": 1, "word": "relative", "fig": 3}, {"body": 3, "word": "treated", "fig": 1}, {"body": 3, "word": "nM", "fig": 1}, {"body": 3, "word": "Bafilomycin", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "promotion", "fig": 1}, {"body": 1, "word": "h.", "fig": 2}, {"body": 2, "word": "puncta", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "F", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f5.jpg", "caption": "The autophagy induced by HMBOX1 depended on mammalian target of rapamycin (mTOR) and HMBOX1 interacted with metallothionein 2A (MT2A). Western blot analysis of (A) protein levels of 4EBP1 and phosphorylated 4EBP1 (p-4EBP1, Thr37/46) and (B) protein levels of p70S6K and phosphorylated p70S6K (p-p70S6K, Thr389) in HUVECs transfected with scramble siRNA (Ctr) or HMBOX1 siRNA (HMBOX1-) for 24 or 48 h. Western blot analysis of (C) protein levels of 4EBP1 and phosphorylated 4EBP1 (p-4EBP1, Thr37/46) (D) protein levels of p70S6K and phosphorylated p70S6K (p-p70S6K, Thr389) in HUVECs transfected with pRC-CMV (Ctr) or pCMV-HMBOX1 (HMBOX1+) for 24 or 48 h. Level of p-4EBP1 is relative to that of 4EBP1,level of p-p70S6K is relative to that of p70S6K. (cropped, full-length blots are in Supplementary Fig. S6). (Data are mean \u00b1 SEM, *p < 0.05, **p < 0.01, n = 3) (E) Co-immunoprecipitation (Co-IP) of HMBOX1 with GFP-tagged MT2A proteins from HEK293 cells. HEK293 cells were transfected with pEGFP or pEGFP-MT2A for 48 h. (cropped, full-length blots are in Supplementary Fig. S7). (F) Double immunocytochemical staining of HMBOX1 (green) and MT2A (red) showing agglomeration and co-localization in HUVECs. Overlay of the HMBOX1 and MT2A with yellow indicates co-localization. Scale bar: 16 \u03bcm. Images are representative of at least 3 independent experiments.", "co_occurrence": [{"body": 100, "word": "HMBOX1", "fig": 6}, {"body": 40, "word": "MT2A", "fig": 4}, {"body": 39, "word": "HUVECs", "fig": 3}, {"body": 41, "word": "cells", "fig": 2}, {"body": 39, "word": "Fig", "fig": 2}, {"body": 43, "word": "level", "fig": 1}, {"body": 10, "word": "protein", "fig": 4}, {"body": 19, "word": "siRNA", "fig": 2}, {"body": 31, "word": "autophagy", "fig": 1}, {"body": 8, "word": "transfected", "fig": 3}, {"body": 4, "word": "4EBP1", "fig": 5}, {"body": 4, "word": "p70S6K", "fig": 5}, {"body": 20, "word": "pCMV-HMBOX1", "fig": 1}, {"body": 17, "word": "The", "fig": 1}, {"body": 7, "word": "blot", "fig": 2}, {"body": 13, "word": "proteins", "fig": 1}, {"body": 12, "word": "induced", "fig": 1}, {"body": 9, "word": "pRC-CMV", "fig": 1}, {"body": 4, "word": "Western", "fig": 2}, {"body": 4, "word": "Supplementary", "fig": 2}, {"body": 2, "word": "levels", "fig": 4}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 6, "word": "mTOR", "fig": 1}, {"body": 3, "word": "HEK293", "fig": 2}, {"body": 4, "word": "staining", "fig": 1}, {"body": 4, "word": "interacted", "fig": 1}, {"body": 2, "word": "full-length", "fig": 2}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 1, "word": "p-p70S6K", "fig": 3}, {"body": 1, "word": "p-4EBP1", "fig": 3}, {"body": 1, "word": "h.", "fig": 3}, {"body": 3, "word": "least", "fig": 1}, {"body": 3, "word": "independent", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "relative", "fig": 2}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "scramble", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "co-localization", "fig": 2}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "pEGFP-MT2A", "fig": 1}, {"body": 1, "word": "pEGFP", "fig": 1}, {"body": 1, "word": "depended", "fig": 1}, {"body": 1, "word": "rapamycin", "fig": 1}, {"body": 1, "word": "agglomeration", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "mammalian", "fig": 1}, {"body": 1, "word": "Images", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}, {"body": 1, "word": "target", "fig": 1}, {"body": 1, "word": "2A", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f6.jpg", "caption": "HMBOX1 regulated the intracellular free zinc level by interacting with MT2A. (A) Immunofluorescence assay of level of intracellular free zinc regulated by HMBOX1. Images represent fluorescence intensity of FluoZin-3\u2013Zn2+ by fluorescence microscopy. HUVECs were transfected with a, scramble control siRNA; b, specific HMBOX1 siRNA; c, pRC-CMV; d, pCMV-HMBOX1; or e, pCMV-HMBOX1, then with N,N,N = ,N = -tetrakis (2-pyridylmethyl) ethylenediamine (TPEN). Scale bar: 16 \u03bcm. (B) Flow cytometry of the intracellular level of zinc. pRC-CMV, HUVECs transfected with pRC-CMV; pCMV-HMBOX1, HUVECs transfected with pCMV-HMBOX1. Images are representative of at least 3 independent experiments. (C) Quantification of relative fluorescence intensity per cell in A. (*p < 0.05, **p < 0.01, n = 3). (D) Fluorescence microscopy of FluoZin-3\u2013Zn2+. HUVECs were transfected with scramble control siRNA for 24 h, then a, pRC-CMV or b, pCMV-HMBOX1. HUVECs were transfected with specific MT2A siRNA for 24 h, then c, pRC-CMV or d, pCMV-HMBOX1. (E) Immunofluorescence images of MT2A in HUVECs. Ctr, HUVECs were transfected with scramble siRNA; 20, 60, 80 nM: HUVECs were transfected with specific MT2A siRNA at 20 nM, 60 nM or 80 nM. Quantification of relative fluorescence intensity per cell. (**P < 0.01, n = 3). Scale bar: 16 \u03bcm. (F) Quantification of relative fluorescence intensity per cell in D. (#p > 0.05, *p < 0.05, **p < 0.01, n = 3).", "co_occurrence": [{"body": 39, "word": "HUVECs", "fig": 8}, {"body": 100, "word": "HMBOX1", "fig": 3}, {"body": 40, "word": "MT2A", "fig": 4}, {"body": 53, "word": "zinc", "fig": 3}, {"body": 43, "word": "level", "fig": 3}, {"body": 20, "word": "pCMV-HMBOX1", "fig": 6}, {"body": 19, "word": "siRNA", "fig": 6}, {"body": 25, "word": "intracellular", "fig": 3}, {"body": 8, "word": "transfected", "fig": 7}, {"body": 17, "word": "cell", "fig": 3}, {"body": 25, "word": "free", "fig": 2}, {"body": 9, "word": "pRC-CMV", "fig": 5}, {"body": 16, "word": "h", "fig": 2}, {"body": 6, "word": "fluorescence", "fig": 5}, {"body": 5, "word": "specific", "fig": 3}, {"body": 14, "word": "assay", "fig": 1}, {"body": 7, "word": "regulated", "fig": 2}, {"body": 7, "word": "control", "fig": 2}, {"body": 3, "word": "nM", "fig": 4}, {"body": 11, "word": "TPEN", "fig": 1}, {"body": 7, "word": "interacting", "fig": 1}, {"body": 2, "word": "scramble", "fig": 3}, {"body": 2, "word": "Immunofluorescence", "fig": 2}, {"body": 2, "word": "d", "fig": 2}, {"body": 2, "word": "microscopy", "fig": 2}, {"body": 1, "word": "intensity", "fig": 4}, {"body": 4, "word": "cytometry", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 1, "word": "relative", "fig": 3}, {"body": 3, "word": "least", "fig": 1}, {"body": 3, "word": "independent", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "Images", "fig": 2}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f7.jpg", "caption": "HMBOX1 regulated HUVEC apoptosis and autophagy by increasing the level of intracellular free zinc. Western blot analysis of (A) caspase-3 and (B) cleaved PARP protein levels with \u03b2-actin as a loading control, and quantification. HUVECs were transfected with pRC-CMV or pCMV-HMBOX1 for 24 h, then cultured in basal M199 medium without FGF-2 for 12 h with or without 2.5 \u03bcM TPEN. (cropped, full-length blots are in Supplementary Fig. S8) (Data are mean \u00b1 SEM, #p > 0.05, *p < 0.05, **p < 0.01, n = 3) (C) Western blot analysis of protein levels of LC3-I and LC3-II and quantification. HUVECs were transfected with pRC-CMV or pCMV-HMBOX1 for 12 h, then with 2.5 \u03bcM TPEN for 12 h. (D) Immunostaining of LC3B in HUVECs. HUVECs were transfected with a, pRC-CMV or b, pCMV-HMBOX1 for 24 h; c, HUVECs were transfected with pCMV-HMBOX1 for 12 h, then with 2.5 \u03bcM TPEN for 12 h; d, HUVECs were treated with 2.5 \u03bcM TPEN for 12 h. Scale bar: 16 \u03bcm. (E)The proportion of cells containing LC3B puncta (>5) in D. (**P < 0.01, n = 3). Western blot analysis of the protein levels of 4EBP1 or p-4EBP1 (Thr37/46) (F) and p70S6K or p-p70S6K (Thr389) (G), HUVECs were transfected with pRC-CMV or pCMV-HMBOX1 for 12 h, then treated with 2.5 \u03bcM TPEN for 12 h. (cropped, full-length blots are in Supplementary Fig. S9). (Data are mean \u00b1 SEM, #p > 0.05, *p < 0.05, **p < 0.01, n = 3).", "co_occurrence": [{"body": 39, "word": "HUVECs", "fig": 7}, {"body": 16, "word": "h", "fig": 7}, {"body": 20, "word": "pCMV-HMBOX1", "fig": 5}, {"body": 100, "word": "HMBOX1", "fig": 1}, {"body": 39, "word": "Fig", "fig": 2}, {"body": 11, "word": "TPEN", "fig": 5}, {"body": 53, "word": "zinc", "fig": 1}, {"body": 43, "word": "level", "fig": 1}, {"body": 42, "word": "apoptosis", "fig": 1}, {"body": 41, "word": "cells", "fig": 1}, {"body": 8, "word": "transfected", "fig": 5}, {"body": 9, "word": "pRC-CMV", "fig": 4}, {"body": 31, "word": "autophagy", "fig": 1}, {"body": 10, "word": "protein", "fig": 3}, {"body": 25, "word": "free", "fig": 1}, {"body": 25, "word": "intracellular", "fig": 1}, {"body": 7, "word": "blot", "fig": 3}, {"body": 18, "word": "HUVEC", "fig": 1}, {"body": 17, "word": "The", "fig": 1}, {"body": 3, "word": "\u03bcM", "fig": 5}, {"body": 4, "word": "Western", "fig": 3}, {"body": 4, "word": "analysis", "fig": 3}, {"body": 10, "word": "FGF-2", "fig": 1}, {"body": 4, "word": "Supplementary", "fig": 2}, {"body": 8, "word": "cleaved", "fig": 1}, {"body": 4, "word": "without", "fig": 2}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "regulated", "fig": 1}, {"body": 7, "word": "caspase-3", "fig": 1}, {"body": 6, "word": "proportion", "fig": 1}, {"body": 3, "word": "LC3B", "fig": 2}, {"body": 3, "word": "treated", "fig": 2}, {"body": 6, "word": "containing", "fig": 1}, {"body": 2, "word": "levels", "fig": 3}, {"body": 4, "word": "PARP", "fig": 1}, {"body": 4, "word": "4EBP1", "fig": 1}, {"body": 4, "word": "LC3-II", "fig": 1}, {"body": 4, "word": "M199", "fig": 1}, {"body": 4, "word": "p70S6K", "fig": 1}, {"body": 2, "word": "Data", "fig": 2}, {"body": 4, "word": "medium", "fig": 1}, {"body": 2, "word": "full-length", "fig": 2}, {"body": 1, "word": "h.", "fig": 3}, {"body": 3, "word": "basal", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "loading", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "mean", "fig": 2}, {"body": 2, "word": "puncta", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "cultured", "fig": 1}, {"body": 1, "word": "SEM", "fig": 2}, {"body": 2, "word": "F", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 1, "word": "increasing", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "p-4EBP1", "fig": 1}, {"body": 1, "word": "p-p70S6K", "fig": 1}, {"body": 1, "word": "B", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600982/bin/srep15121-f8.jpg", "caption": "Working model of HMBOX1 effect in HUVECs. HMBOX1 interacted with MT2A to increase the intracellular level of free zinc in HUVECs, which promoted HUVEC autophagy by inactivating mTOR and inhibited HUVEC apoptosis by reducing the activity of caspase-3. TPEN reversed the pro-autophagy and anti-apoptotic effects of HMBOX1.", "co_occurrence": [{"body": 100, "word": "HMBOX1", "fig": 3}, {"body": 39, "word": "HUVECs", "fig": 2}, {"body": 53, "word": "zinc", "fig": 1}, {"body": 43, "word": "level", "fig": 1}, {"body": 42, "word": "apoptosis", "fig": 1}, {"body": 40, "word": "MT2A", "fig": 1}, {"body": 18, "word": "HUVEC", "fig": 2}, {"body": 31, "word": "autophagy", "fig": 1}, {"body": 25, "word": "intracellular", "fig": 1}, {"body": 25, "word": "free", "fig": 1}, {"body": 13, "word": "inhibited", "fig": 1}, {"body": 11, "word": "TPEN", "fig": 1}, {"body": 7, "word": "caspase-3", "fig": 1}, {"body": 7, "word": "effect", "fig": 1}, {"body": 6, "word": "mTOR", "fig": 1}, {"body": 4, "word": "interacted", "fig": 1}, {"body": 4, "word": "activity", "fig": 1}, {"body": 3, "word": "promoted", "fig": 1}, {"body": 2, "word": "reversed", "fig": 1}, {"body": 2, "word": "model", "fig": 1}, {"body": 1, "word": "increase", "fig": 1}]}], "4008708": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f1.jpg", "caption": "Atg16 associates with Cx43 in an early step of autophagosome biogenesis (a) Immunoblot for the indicated Cx of homogenates and autophagic vacuoles (AV) isolated from fed or 6h starved (Stv) mice. Quantification of enrichment is shown in Supplementary Fig. 1a. (b) Immunofluorescence for LC3 and Atg16 in NRK cells expressing GFP-Cx43 maintained in the presence or absence of serum for 4h. Single channels are shown in reverse black and white and magnification of single and merged images are shown in color. Arrows: colocalization of Atg16/Cx43 (yellow) or Atg16/Cx43/LC3 (white). Quantification is shown in Supplementary Fig. 1c. (c) Immunofluorescence for the indicated endogenous proteins in NRK cells maintained in serum-supplemented media without additions (None) or treated with chloroquine (CQ) for 4h. Full fields are shown in Supplementary Fig. 1d. (d) Maximum projection confocal microscopy 3D reconstruction (left) followed by a single plane time-lapse acquisition of the region outlined by the white square in HeLa cells expressing EBFP2-Cx43 (pseudocolored in red) and sfGFP-ATG16. (e) Immunofluorescence for LC3 and Atg16 in NRK cells expressing GFP-Cx43 but knocked down for Eps15. Single channels are shown in reverse black and white and merged images in color. Inset shows higher magnification. Bottom: Quantification of colocalization between Atg16 and Cx43 (n=3 wells, 4 independent experiments, >20 cells per experiment). Values are mean+s.e.m. (*) p <0.05. (f, g) Immunoblot for the indicated proteins of immunoprecipitates (IP) of endogenous Cx43 and Atg16 from mouse embryonic fibroblasts (MEF) wild type cells maintained in the presence (f, g) or absence of serum (4h) (g). I: input; FT: flow through. (h) Immunoblot for the indicated proteins of immunoprecipitates (IP) of endogenous Cx43 from MEFs wild type untreated (Wt), upon incubation with 3-methyladenine (3MA) or in MEFs from Atg5 null mice (Atg5\u2212/\u2212). (i) Immunoblot for flag and Cx43 of immunoprecipitates (IP) of endogenous Cx43 in Wt MEFs transfected with the indicated flag-tagged constructs of truncated Atg16. GAPDH, LC3 and Atg5 are show as negative controls for IP. All values are mean+s.e.m. Nuclei are highlighted with DAPI. Bars: 5 \u03bcm. Uncropped images of blots are shown in Supplementary Fig. 9.", "co_occurrence": [{"body": 123, "word": "Fig", "fig": 4}, {"body": 79, "word": "Cx43", "fig": 6}, {"body": 40, "word": "cells", "fig": 6}, {"body": 53, "word": "Supplementary", "fig": 4}, {"body": 34, "word": "Atg16", "fig": 6}, {"body": 7, "word": "shown", "fig": 7}, {"body": 16, "word": "proteins", "fig": 3}, {"body": 14, "word": "LC3", "fig": 3}, {"body": 42, "word": "Cx", "fig": 1}, {"body": 9, "word": "endogenous", "fig": 4}, {"body": 7, "word": "indicated", "fig": 5}, {"body": 29, "word": "autophagosome", "fig": 1}, {"body": 8, "word": "images", "fig": 3}, {"body": 12, "word": "serum", "fig": 2}, {"body": 9, "word": "presence", "fig": 2}, {"body": 15, "word": "upon", "fig": 1}, {"body": 15, "word": "autophagic", "fig": 1}, {"body": 6, "word": "mice", "fig": 2}, {"body": 4, "word": "MEFs", "fig": 3}, {"body": 3, "word": "Immunoblot", "fig": 4}, {"body": 6, "word": "Atg5", "fig": 2}, {"body": 11, "word": "All", "fig": 1}, {"body": 5, "word": "reverse", "fig": 2}, {"body": 9, "word": "biogenesis", "fig": 1}, {"body": 3, "word": "g", "fig": 3}, {"body": 9, "word": "higher", "fig": 1}, {"body": 4, "word": "absence", "fig": 2}, {"body": 4, "word": "GFP-Cx43", "fig": 2}, {"body": 4, "word": "single", "fig": 2}, {"body": 7, "word": "negative", "fig": 1}, {"body": 3, "word": "colocalization", "fig": 2}, {"body": 6, "word": "microscopy", "fig": 1}, {"body": 6, "word": "mouse", "fig": 1}, {"body": 6, "word": "1a", "fig": 1}, {"body": 3, "word": "f", "fig": 2}, {"body": 6, "word": "isolated", "fig": 1}, {"body": 5, "word": "experiments", "fig": 1}, {"body": 5, "word": "Eps15", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 2, "word": "Wt", "fig": 2}, {"body": 4, "word": "reconstruction", "fig": 1}, {"body": 4, "word": "vacuoles", "fig": 1}, {"body": 4, "word": "3D", "fig": 1}, {"body": 4, "word": "1c", "fig": 1}, {"body": 4, "word": "1d", "fig": 1}, {"body": 4, "word": "e", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 3}, {"body": 1, "word": "expressing", "fig": 3}, {"body": 1, "word": "immunoprecipitates", "fig": 3}, {"body": 1, "word": "Quantification", "fig": 3}, {"body": 3, "word": "6h", "fig": 1}, {"body": 3, "word": "constructs", "fig": 1}, {"body": 1, "word": "NRK", "fig": 3}, {"body": 1, "word": "merged", "fig": 2}, {"body": 2, "word": "early", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "fibroblasts", "fig": 1}, {"body": 2, "word": "embryonic", "fig": 1}, {"body": 2, "word": "Atg5\u2212/\u2212", "fig": 1}, {"body": 2, "word": "truncated", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 1, "word": "wild", "fig": 2}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "3-methyladenine", "fig": 1}, {"body": 1, "word": "type", "fig": 2}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "media", "fig": 1}, {"body": 2, "word": "flag", "fig": 1}, {"body": 2, "word": "without", "fig": 1}, {"body": 2, "word": "enrichment", "fig": 1}, {"body": 1, "word": "yellow", "fig": 1}, {"body": 1, "word": "HeLa", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "h", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "None", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "fed", "fig": 1}, {"body": 1, "word": "chloroquine", "fig": 1}, {"body": 1, "word": "knocked", "fig": 1}, {"body": 1, "word": "sfGFP-ATG16", "fig": 1}, {"body": 1, "word": "associates", "fig": 1}, {"body": 1, "word": "null", "fig": 1}, {"body": 1, "word": "starved", "fig": 1}, {"body": 1, "word": "serum-supplemented", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f2.jpg", "caption": "Autophagy is highly upregulated in cells from Cx43 knock-out mice (a) Immunostaining for LC3 and GABARAP in mouse osteoblasts (MOB) from wild type (Wt) or Cx43 null mice (Cx43\u2212/\u2212) grown in serum-supplemented media. Reverse black and white channels (top) and color images (bottom). Right: Average number of LC3 and GABARAP puncta per cell (n=3 wells, 3 independent experiments, >50 cells per experiment). (b) Electron micrographs of Wt and Cx43\u2212/\u2212 MOB grown in serum-supplemented media. Yellow arrows: autophagic vacuoles. Insets: autophagic vacuoles (AV) at higher magnification. Right: Percentage of cytoplasm area occupied by AV (top) and number of AV per area (bottom) (n=3 mice, >10 micrographs per mice). (c) Immunoblot for LC3 of the same cells grown in serum-supplemented media untreated or treated with lysosomal protease inhibitors (PI) for 2 or 4h. Top: representative immunoblot. GAPDH is shown as loading control. Bottom: LC3 flux (left) and increase in LC3-II during lysosomal inhibition (right) (n= 3 independent experiments). (d) Representative images of the same cells transfected with the mCherry-GFP-LC3 tandem reporter and grown in serum-supplemented media. Single channel images (inverted black and white) and merged images (color). Bottom: Number of vesicles positive for GFP and mCherry (autophagosomes; APG) and only for mCherry (autophagolysosomes; APL) (n=4 wells, 4 independent experiments, >30 cells per experiment). (e) Electron micrographs of livers from Wt and Cx43+/\u2212 mice. Arrows indicate AV. Right: Percentage of cytosolic area occupied by AVs (n=3 mice, >10 micrographs per mice). (f) Immunofluorescence for LC3 in Cx43\u2212/\u2212 MOBs expressing GFP-tagged full-length Cx43. Single channels (inverted black and white) and merged channels (color). Asterisks: transfected (green) and untransfected (red) cells. (g) LC3-positive puncta per cell in the indicated cells (n=3 wells, 3 independent experiments, >50 cells per experiment). All values are mean+s.e.m. and differences with Wt were significant for (*) p<0.01. Nuclei are highlighted with DAPI. Bars: 5 \u03bcm in fluorescence images; 1 \u03bcm and 0.1 \u03bcm in top panels and inserts of b and e. Uncropped images of blots are shown in Supplementary Fig. 9", "co_occurrence": [{"body": 40, "word": "cells", "fig": 8}, {"body": 79, "word": "Cx43", "fig": 3}, {"body": 123, "word": "Fig", "fig": 1}, {"body": 14, "word": "LC3", "fig": 5}, {"body": 53, "word": "Supplementary", "fig": 1}, {"body": 8, "word": "images", "fig": 6}, {"body": 6, "word": "mice", "fig": 7}, {"body": 13, "word": "Cx43\u2212/\u2212", "fig": 3}, {"body": 17, "word": "number", "fig": 2}, {"body": 15, "word": "autophagic", "fig": 2}, {"body": 5, "word": "experiments", "fig": 4}, {"body": 5, "word": "independent", "fig": 4}, {"body": 8, "word": "lysosomal", "fig": 2}, {"body": 8, "word": "puncta", "fig": 2}, {"body": 7, "word": "shown", "fig": 2}, {"body": 14, "word": "autophagosomes", "fig": 1}, {"body": 13, "word": "LC3-II", "fig": 1}, {"body": 11, "word": "vesicles", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 5, "word": "cell", "fig": 2}, {"body": 9, "word": "increase", "fig": 1}, {"body": 9, "word": "inhibition", "fig": 1}, {"body": 9, "word": "flux", "fig": 1}, {"body": 9, "word": "higher", "fig": 1}, {"body": 2, "word": "Wt", "fig": 4}, {"body": 4, "word": "vacuoles", "fig": 2}, {"body": 1, "word": "per", "fig": 8}, {"body": 2, "word": "micrographs", "fig": 4}, {"body": 2, "word": "media", "fig": 4}, {"body": 7, "word": "autophagolysosomes", "fig": 1}, {"body": 7, "word": "indicated", "fig": 1}, {"body": 6, "word": "positive", "fig": 1}, {"body": 6, "word": "mouse", "fig": 1}, {"body": 5, "word": "immunoblot", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 4, "word": "mCherry-GFP-LC3", "fig": 1}, {"body": 2, "word": "GABARAP", "fig": 2}, {"body": 2, "word": "MOB", "fig": 2}, {"body": 4, "word": "representative", "fig": 1}, {"body": 2, "word": "b", "fig": 2}, {"body": 1, "word": "grown", "fig": 4}, {"body": 2, "word": "Electron", "fig": 2}, {"body": 1, "word": "serum-supplemented", "fig": 4}, {"body": 4, "word": "e", "fig": 1}, {"body": 3, "word": "Immunoblot", "fig": 1}, {"body": 3, "word": "g", "fig": 1}, {"body": 3, "word": "fluorescence", "fig": 1}, {"body": 3, "word": "f", "fig": 1}, {"body": 3, "word": "LC3-positive", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "cytosolic", "fig": 1}, {"body": 1, "word": "merged", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "Percentage", "fig": 2}, {"body": 2, "word": "inhibitors", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 2, "word": "reporter", "fig": 1}, {"body": 1, "word": "transfected", "fig": 2}, {"body": 2, "word": "Cx43+/\u2212", "fig": 1}, {"body": 2, "word": "livers", "fig": 1}, {"body": 2, "word": "osteoblasts", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "GFP-tagged", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "expressing", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "protease", "fig": 1}, {"body": 1, "word": "Immunostaining", "fig": 1}, {"body": 1, "word": "highly", "fig": 1}, {"body": 1, "word": "MOBs", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "differences", "fig": 1}, {"body": 1, "word": "Autophagy", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "wild", "fig": 1}, {"body": 1, "word": "null", "fig": 1}, {"body": 1, "word": "GFP", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f3.jpg", "caption": "Cx43 domains responsible for the inhibitory effect over macroautophagy (a) Immunoblot for LC3 in MOB from wild type (Wt) or Cx43 null mice (Cx43\u2212/\u2212) treated with vehicle or with 18\u03b1 glycyrrhetinic acid (18\u03b1 GA). Glyceraldehyde-3-dehydrogenae (GPD) is shown as loading control. Levels of LC3-II (left) and LC3-II flux (right) (n= 3 independent experiments). (b) Immunofluorescence for LC3 in MOB cells treated with vehicle or 18\u03b1 GA. Where indicated, chloroquine (CQ) was added to block lysosomal degradation. Bottom: Quantification of the average number of LC3-positive puncta per cell (n=3 wells, 3 independent experiments, >30 cells per experiment). (c) Immunofluorescence for LC3 in Wt or Cx43\u2212/\u2212 MOBs cells treated with the indicated kinase inhibitors for 2 hours. Insets: Higher magnification images in inverted black and white. (d) Endogenous LC3 puncta in the same cells shown in c (n=3 wells, 3 independent experiments, >50 cells per experiment). *, differences with Wt and \u00a7, differences with untreated. (e) LC3 puncta in Cx43\u2212/\u2212 MOBs transfected with constructs coding for different forms of Cx43 (full length, CT, \u0394CT258 or \u0394CT245) tagged as indicated in the scheme. Left: Representative images. Merged fields (left) and LC3 channel in reverse black and white (right) are shown (images of GFP-Cx43 are shown in Fig. 2f). Right: Quantification of the average number of LC3 puncta per cell (n=3 wells, 3 independent experiments, >50 cells per experiment). (f, g) Immunoblot for the indicated proteins of the immunoprecipitates (IP) of Atg16 from MEFs transfected with GFP-tagged full length (FL-) Cx43 or flag tagged C-terminus (CT-) Cx43 (f) or \u0394CT258-Cx43 (g) I: input; FT: flow through. GAPDH and GFP alone were used as negative controls for IP and Atg5 as positive control. All values are mean+s.e.m. Differences with control were significant for (*, \u00a7) p<0.01. Bars: 5 \u03bcm. Uncropped images of blots are shown in Supplementary Fig. 9.", "co_occurrence": [{"body": 79, "word": "Cx43", "fig": 5}, {"body": 123, "word": "Fig", "fig": 2}, {"body": 40, "word": "cells", "fig": 6}, {"body": 14, "word": "LC3", "fig": 7}, {"body": 53, "word": "Supplementary", "fig": 1}, {"body": 13, "word": "Cx43\u2212/\u2212", "fig": 3}, {"body": 7, "word": "shown", "fig": 5}, {"body": 17, "word": "number", "fig": 2}, {"body": 34, "word": "Atg16", "fig": 1}, {"body": 8, "word": "images", "fig": 4}, {"body": 8, "word": "puncta", "fig": 4}, {"body": 7, "word": "indicated", "fig": 4}, {"body": 13, "word": "LC3-II", "fig": 2}, {"body": 5, "word": "experiments", "fig": 4}, {"body": 5, "word": "independent", "fig": 4}, {"body": 18, "word": "effect", "fig": 1}, {"body": 16, "word": "proteins", "fig": 1}, {"body": 5, "word": "control", "fig": 3}, {"body": 14, "word": "inhibitory", "fig": 1}, {"body": 13, "word": "different", "fig": 1}, {"body": 11, "word": "degradation", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 5, "word": "cell", "fig": 2}, {"body": 9, "word": "flux", "fig": 1}, {"body": 9, "word": "used", "fig": 1}, {"body": 9, "word": "C-terminus", "fig": 1}, {"body": 4, "word": "tagged", "fig": 2}, {"body": 8, "word": "lysosomal", "fig": 1}, {"body": 4, "word": "average", "fig": 2}, {"body": 7, "word": "negative", "fig": 1}, {"body": 6, "word": "mice", "fig": 1}, {"body": 6, "word": "kinase", "fig": 1}, {"body": 2, "word": "Wt", "fig": 3}, {"body": 3, "word": "g", "fig": 2}, {"body": 6, "word": "positive", "fig": 1}, {"body": 3, "word": "f", "fig": 2}, {"body": 2, "word": "18\u03b1", "fig": 3}, {"body": 3, "word": "Immunoblot", "fig": 2}, {"body": 6, "word": "Atg5", "fig": 1}, {"body": 1, "word": "per", "fig": 5}, {"body": 5, "word": "reverse", "fig": 1}, {"body": 4, "word": "MEFs", "fig": 1}, {"body": 2, "word": "full", "fig": 2}, {"body": 2, "word": "length", "fig": 2}, {"body": 2, "word": "MOB", "fig": 2}, {"body": 4, "word": "GFP-Cx43", "fig": 1}, {"body": 4, "word": "e", "fig": 1}, {"body": 3, "word": "acid", "fig": 1}, {"body": 3, "word": "constructs", "fig": 1}, {"body": 3, "word": "LC3-positive", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 2}, {"body": 2, "word": "glycyrrhetinic", "fig": 1}, {"body": 2, "word": "\u0394CT245", "fig": 1}, {"body": 2, "word": "Where", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "inhibitors", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 1, "word": "Quantification", "fig": 2}, {"body": 1, "word": "transfected", "fig": 2}, {"body": 1, "word": "MOBs", "fig": 2}, {"body": 1, "word": "differences", "fig": 2}, {"body": 2, "word": "flag", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "responsible", "fig": 1}, {"body": 1, "word": "Higher", "fig": 1}, {"body": 1, "word": "forms", "fig": 1}, {"body": 1, "word": "GA", "fig": 1}, {"body": 1, "word": "2f", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "\u0394CT258", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "alone", "fig": 1}, {"body": 1, "word": "immunoprecipitates", "fig": 1}, {"body": 1, "word": "domains", "fig": 1}, {"body": 1, "word": "Differences", "fig": 1}, {"body": 1, "word": "coding", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "chloroquine", "fig": 1}, {"body": 1, "word": "macroautophagy", "fig": 1}, {"body": 1, "word": "wild", "fig": 1}, {"body": 1, "word": "GFP", "fig": 1}, {"body": 1, "word": "null", "fig": 1}, {"body": 1, "word": "GFP-tagged", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f4.jpg", "caption": "Cx43 internalization triggers mobilization of pre-autophagosomal structures from the plasma membrane and autophagosome biogenesis (a) Immunoblots for the indicated proteins in mouse embryonic fibroblasts (MEFs) treated with tamoxifen (Tx) or lindane (Lnd) in the absence or presence of lysosomal protease inhibitors (PI). Right: Changes in LC3-II levels relative to those detected in untreated cells (n=4 independent experiments). (b) Immunofluorescence for Cx43 and LC3 in NRK cells treated as in a in the presence or absence of chloroquine (CQ) for 3h. Right: Quantification of the average number of LC3-positive puncta per cell (n= 3 wells, 3 independent experiments, >30 cells per experiment). (c) Time course of changes in the average LC3-positive puncta per cell after addition of Lnd to control NRK cells. (d) Fluorescence images of Wt or Cx43\u2212/\u2212 MOBs transfected with mCherry-GFP-LC3 and incubated or not with Tx or Lnd. Bottom: Quantification of autophagolysosomes (n= 3 wells, 3 independent experiments, >50 cells per experiment). (e) Immunostaining for Atg16 and Cx43 in MEFs treated with the indicated compounds. Representative images as merged channels are shown. Right: quantification of the average of cytosolic Atg16-positive puncta per cell (n= 3 wells, 3 independent experiments, >30 cells per experiment). (f) Immunofluorescence for LC3 and Atg16 in NRK cells expressing GFP-Cx43 treated with Lnd and untreated. Single channel images in inverse black and white and merged color images are shown. Boxed areas are shown at higher magnification. Arrows: double (yellow) and triple (white) colocalization. (g, h) Immunostaining for Atg16 in Cx43 knocked down (\u2212) (g) or knocked out (\u2212/\u2212) (h) cells. Right: quantification of the average of cytosolic Atg16 positive puncta per cell (n= 3 wells, 3 independent experiments, >50 cells per experiment). (i) Immunoblot for Atg16 and Atg14 in immunoprecipitates (IP) of endogenous Cx43 from MEFs wild type cells maintained in the absence of serum (4h) or incubated in presence of Tx or Lind. I: input; FT: flow through. All values are mean+s.e.m and differences with untreated cells are significant for (*) p<0.01. Bars: 5 \u03bcm. Uncropped images of blots are shown in Supplementary Fig. 9.", "co_occurrence": [{"body": 40, "word": "cells", "fig": 11}, {"body": 79, "word": "Cx43", "fig": 5}, {"body": 34, "word": "Atg16", "fig": 5}, {"body": 123, "word": "Fig", "fig": 1}, {"body": 53, "word": "Supplementary", "fig": 1}, {"body": 8, "word": "images", "fig": 5}, {"body": 8, "word": "puncta", "fig": 4}, {"body": 29, "word": "autophagosome", "fig": 1}, {"body": 14, "word": "LC3", "fig": 2}, {"body": 7, "word": "shown", "fig": 4}, {"body": 9, "word": "presence", "fig": 3}, {"body": 26, "word": "internalization", "fig": 1}, {"body": 5, "word": "experiments", "fig": 5}, {"body": 5, "word": "independent", "fig": 5}, {"body": 22, "word": "Atg14", "fig": 1}, {"body": 5, "word": "cell", "fig": 4}, {"body": 17, "word": "membrane", "fig": 1}, {"body": 17, "word": "number", "fig": 1}, {"body": 16, "word": "proteins", "fig": 1}, {"body": 4, "word": "average", "fig": 4}, {"body": 7, "word": "indicated", "fig": 2}, {"body": 13, "word": "Cx43\u2212/\u2212", "fig": 1}, {"body": 13, "word": "LC3-II", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 4, "word": "MEFs", "fig": 3}, {"body": 4, "word": "absence", "fig": 3}, {"body": 6, "word": "quantification", "fig": 2}, {"body": 12, "word": "serum", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 9, "word": "biogenesis", "fig": 1}, {"body": 9, "word": "structures", "fig": 1}, {"body": 9, "word": "endogenous", "fig": 1}, {"body": 9, "word": "higher", "fig": 1}, {"body": 8, "word": "lysosomal", "fig": 1}, {"body": 1, "word": "per", "fig": 8}, {"body": 8, "word": "changes", "fig": 1}, {"body": 7, "word": "autophagolysosomes", "fig": 1}, {"body": 6, "word": "pre-autophagosomal", "fig": 1}, {"body": 3, "word": "g", "fig": 2}, {"body": 6, "word": "positive", "fig": 1}, {"body": 3, "word": "LC3-positive", "fig": 2}, {"body": 6, "word": "mouse", "fig": 1}, {"body": 3, "word": "cytosolic", "fig": 2}, {"body": 5, "word": "detected", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 4, "word": "addition", "fig": 1}, {"body": 4, "word": "GFP-Cx43", "fig": 1}, {"body": 4, "word": "mCherry-GFP-LC3", "fig": 1}, {"body": 4, "word": "e", "fig": 1}, {"body": 4, "word": "lindane", "fig": 1}, {"body": 3, "word": "plasma", "fig": 1}, {"body": 3, "word": "colocalization", "fig": 1}, {"body": 1, "word": "Tx", "fig": 3}, {"body": 3, "word": "Atg16-positive", "fig": 1}, {"body": 3, "word": "f", "fig": 1}, {"body": 3, "word": "Immunoblot", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 1, "word": "NRK", "fig": 3}, {"body": 2, "word": "tamoxifen", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 2}, {"body": 1, "word": "merged", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "h", "fig": 2}, {"body": 2, "word": "fibroblasts", "fig": 1}, {"body": 2, "word": "embryonic", "fig": 1}, {"body": 2, "word": "inhibitors", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 2}, {"body": 1, "word": "Immunostaining", "fig": 2}, {"body": 1, "word": "incubated", "fig": 2}, {"body": 2, "word": "Wt", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "double", "fig": 1}, {"body": 1, "word": "knocked", "fig": 2}, {"body": 1, "word": "yellow", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "expressing", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "wild", "fig": 1}, {"body": 1, "word": "immunoprecipitates", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "protease", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "MOBs", "fig": 1}, {"body": 1, "word": "mobilization", "fig": 1}, {"body": 1, "word": "chloroquine", "fig": 1}, {"body": 1, "word": "differences", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f5.jpg", "caption": "Internalized Cx43 is targeted to recycling endosomes during serum deprivation (a\u2013c) Immunofluorescence for the indicated endosomal markers in NRK cells expressing GFP-Cx43 maintained in presence of serum (a), absence of serum (b) or treated with lindane (c). Single black and white inverted channels, merged channels and higher magnification insets are shown. (d) Immunoblots for indicated proteins in isolated fractions from starved mouse liver HOM: homogenate; LE: late endosomes; CYT: cytosol; APG: autophagosomes; APL: autophagolysosomes. (e) Immunoblots for different connexins in homogenates and late endosomes isolated from fed and 6h starved mice. (f\u2013h) Fluorescence images of NRK cells expressing GFP-Cx43 maintained in presence of serum (f), absence of serum (g) or treated with lindane (h) and incubated with Alexa594-transferrin for 15 minutes before fixation. Top: single and merged channels and boxed area at higher magnification. Bottom: 3D reconstructions and higher magnification details of the boxed areas. Nuclei are highlighted with DAPI. Bars: 5 \u03bcm. Uncropped images of blots are shown in Supplementary Fig. 9.", "co_occurrence": [{"body": 123, "word": "Fig", "fig": 1}, {"body": 40, "word": "cells", "fig": 2}, {"body": 79, "word": "Cx43", "fig": 1}, {"body": 12, "word": "serum", "fig": 5}, {"body": 53, "word": "Supplementary", "fig": 1}, {"body": 9, "word": "endosomes", "fig": 3}, {"body": 9, "word": "higher", "fig": 3}, {"body": 9, "word": "presence", "fig": 2}, {"body": 16, "word": "proteins", "fig": 1}, {"body": 8, "word": "images", "fig": 2}, {"body": 7, "word": "shown", "fig": 2}, {"body": 14, "word": "autophagosomes", "fig": 1}, {"body": 7, "word": "indicated", "fig": 2}, {"body": 13, "word": "different", "fig": 1}, {"body": 6, "word": "isolated", "fig": 2}, {"body": 4, "word": "late", "fig": 2}, {"body": 4, "word": "absence", "fig": 2}, {"body": 4, "word": "GFP-Cx43", "fig": 2}, {"body": 4, "word": "lindane", "fig": 2}, {"body": 7, "word": "recycling", "fig": 1}, {"body": 7, "word": "autophagolysosomes", "fig": 1}, {"body": 6, "word": "mice", "fig": 1}, {"body": 6, "word": "mouse", "fig": 1}, {"body": 4, "word": "3D", "fig": 1}, {"body": 4, "word": "fractions", "fig": 1}, {"body": 4, "word": "single", "fig": 1}, {"body": 4, "word": "e", "fig": 1}, {"body": 3, "word": "markers", "fig": 1}, {"body": 3, "word": "g", "fig": 1}, {"body": 3, "word": "6h", "fig": 1}, {"body": 3, "word": "liver", "fig": 1}, {"body": 3, "word": "f", "fig": 1}, {"body": 2, "word": "cytosol", "fig": 1}, {"body": 1, "word": "merged", "fig": 2}, {"body": 2, "word": "Internalized", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 1, "word": "expressing", "fig": 2}, {"body": 2, "word": "deprivation", "fig": 1}, {"body": 1, "word": "NRK", "fig": 2}, {"body": 2, "word": "endosomal", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 1, "word": "starved", "fig": 2}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "h", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "targeted", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "incubated", "fig": 1}, {"body": 1, "word": "fed", "fig": 1}, {"body": 1, "word": "connexins", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f6.jpg", "caption": "Atg14 is recruited to Cx43-enriched plasma membrane regions during nutritional deprivation (a) Immunoblot for the indicated proteins in homogenates and purified plasma membrane from fed (F) and 24 h starved mice (Stv). Starvation-induced changes in the PM content relative to fed levels were as follows: Vps15 (1.2+0.2), Beclin-1 (0.7+0.5), Vps34 (0.9+0.1), Atg16 (1.1+0.3), Atg14 (2.5+0.2) and only Atg14 were significant for p<0.01. (b) Immunoblot of Cx43 immunoprecipitates (IP) in mouse embryonic fibroblasts (MEFs) maintained in the presence or absence of serum. I: input; FT: flow through. GAPDH is shown as negative control for IP. (c) Immunoblot of Cx43 IP in MEFs from Wt or Atg5\u2212/\u2212 mice grown in serum-supplemented media. (d) Immunoblot of Cx43 IP in Wt or Atg16 knockdowns (KD) MEFs maintained in the presence/ absence of serum for 4h. (e) Co-staining for Atg14 and Cx43 in NRK cells maintained in presence/absence of serum. Merged channels are shown and single channels and broad field images are shown in Supplementary Fig. 5d. Insets: higher magnification. (f) Maximum intensity confocal microscopy 3D reconstruction in HeLa cells expressing EBFP2-Cx43 (pseudocolored in red) and EGFP-ATG14 followed by a single-plane time-lapse acquisition of the boxed area; cells were incubated in serum-deprived medium for 1h before imaging. (g) Immunoblot of Atg14 IP in Wt or Atg5\u2212/\u2212 MEFs maintained in the presence of serum. (h) Immunoblot in total homogenates and plasma membrane (PM) purified from Wt or Cx43\u2212/\u2212 mice. (i) Immunofluorescence for e-cadherin and Vps34 in NRK cells wild-type (Wt) or knocked down (\u2212) for Cx43. Single channel and merge (left) and Z-stack surface reconstruction and higher magnification of the boxed region (right). (j) Immunostaining for Cx43 and e-cadherin in NRK cells expressing a tandem FYVE domain (2xFYVE) tagged to GFP and maintained in serum-free media for 4h. Single channels (inverted black and white) and the merged image of the boxed area (color). Inset: higher magnification image. Bars: 5 \u03bcm. Uncropped images of blots are shown in Supplementary Fig. 9.", "co_occurrence": [{"body": 79, "word": "Cx43", "fig": 6}, {"body": 123, "word": "Fig", "fig": 2}, {"body": 40, "word": "cells", "fig": 5}, {"body": 22, "word": "Atg14", "fig": 5}, {"body": 53, "word": "Supplementary", "fig": 2}, {"body": 41, "word": "PM", "fig": 2}, {"body": 34, "word": "Atg16", "fig": 2}, {"body": 17, "word": "membrane", "fig": 3}, {"body": 12, "word": "serum", "fig": 4}, {"body": 7, "word": "shown", "fig": 4}, {"body": 9, "word": "higher", "fig": 3}, {"body": 9, "word": "presence", "fig": 2}, {"body": 6, "word": "mice", "fig": 3}, {"body": 3, "word": "Immunoblot", "fig": 6}, {"body": 4, "word": "MEFs", "fig": 4}, {"body": 16, "word": "proteins", "fig": 1}, {"body": 8, "word": "images", "fig": 2}, {"body": 13, "word": "Cx43\u2212/\u2212", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 2, "word": "Wt", "fig": 5}, {"body": 3, "word": "plasma", "fig": 3}, {"body": 9, "word": "regions", "fig": 1}, {"body": 4, "word": "reconstruction", "fig": 2}, {"body": 8, "word": "changes", "fig": 1}, {"body": 4, "word": "absence", "fig": 2}, {"body": 4, "word": "Vps34", "fig": 2}, {"body": 7, "word": "negative", "fig": 1}, {"body": 7, "word": "indicated", "fig": 1}, {"body": 6, "word": "microscopy", "fig": 1}, {"body": 3, "word": "image", "fig": 2}, {"body": 6, "word": "mouse", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 4, "word": "tagged", "fig": 1}, {"body": 2, "word": "Atg5\u2212/\u2212", "fig": 2}, {"body": 4, "word": "3D", "fig": 1}, {"body": 4, "word": "5d", "fig": 1}, {"body": 4, "word": "single", "fig": 1}, {"body": 4, "word": "Cx43-enriched", "fig": 1}, {"body": 4, "word": "e", "fig": 1}, {"body": 2, "word": "media", "fig": 2}, {"body": 3, "word": "f", "fig": 1}, {"body": 3, "word": "content", "fig": 1}, {"body": 3, "word": "g", "fig": 1}, {"body": 1, "word": "NRK", "fig": 3}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 1, "word": "purified", "fig": 2}, {"body": 1, "word": "expressing", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "Vps15", "fig": 1}, {"body": 2, "word": "fibroblasts", "fig": 1}, {"body": 1, "word": "h", "fig": 2}, {"body": 2, "word": "embryonic", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 2, "word": "deprivation", "fig": 1}, {"body": 2, "word": "nutritional", "fig": 1}, {"body": 1, "word": "fed", "fig": 2}, {"body": 2, "word": "1h", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "Beclin-1", "fig": 1}, {"body": 1, "word": "e-cadherin", "fig": 2}, {"body": 1, "word": "merged", "fig": 1}, {"body": 1, "word": "follows", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "HeLa", "fig": 1}, {"body": 1, "word": "domain", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "FYVE", "fig": 1}, {"body": 1, "word": "immunoprecipitates", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "serum-free", "fig": 1}, {"body": 1, "word": "Immunostaining", "fig": 1}, {"body": 1, "word": "incubated", "fig": 1}, {"body": 1, "word": "wild-type", "fig": 1}, {"body": 1, "word": "total", "fig": 1}, {"body": 1, "word": "medium", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "knocked", "fig": 1}, {"body": 1, "word": "surface", "fig": 1}, {"body": 1, "word": "grown", "fig": 1}, {"body": 1, "word": "Co-staining", "fig": 1}, {"body": 1, "word": "serum-supplemented", "fig": 1}, {"body": 1, "word": "GFP", "fig": 1}, {"body": 1, "word": "starved", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f7.jpg", "caption": "Cx43 modulates formation of pre-autophagosomal structures through direct interaction with autophagy-related proteins (a) Co-immunostaining for Cx43 and the indicated Atgs in NRK cells maintained in the presence or absence of serum (top). Single and merged channels of the 3D reconstruction of the boxed regions are shown (bottom). Nuclei are highlighted with DAPI. (b, c) Immunoblot for the indicated proteins of immunoprecipitates (IP) of Cx43 in NRK cells maintained in the presence or absence of serum (b) or treated or not with 3-methyladenine (c) Atg5 is shown as negative control for IP. (d) Co-staining for Atg9 and e-cadherin in NRK cells control and knocked down for Cx43. Single and merged channels at higher magnification areas are shown. (e) Immunofluorescence for endogenous Atg9 and Cx43 in NRK cells control or knocked down for Eps15. (f, g) Immunofluorescence for endogenous Cx43 (green) in NRK cells control or knocked down for Atg14 (f) or Atg9 (g) maintained in the presence or absence of serum. (h) Immunofluorescence of endogenous Cx43 in NRK cells control or knocked down for Atg14 treated (or not) with Tx or Lnd (left). e-cadherin staining (red) is shown to highlight plasma membrane in g and h. Full fields are shown in Supplementary Fig. 6h. Quantification of intracytoplasmic Cx43-positives vesicles (right) (n= 3 wells, 3 independent experiments, >30 cells per experiment). Values are mean+s.e.m and significant for (*) p<0.01 using ANOVA+Bonferroni test. Bars: 5 \u03bcm. Uncropped images of blots are shown in Supplementary Fig. 9.", "co_occurrence": [{"body": 79, "word": "Cx43", "fig": 7}, {"body": 40, "word": "cells", "fig": 7}, {"body": 123, "word": "Fig", "fig": 2}, {"body": 53, "word": "Supplementary", "fig": 2}, {"body": 23, "word": "Atg9", "fig": 3}, {"body": 22, "word": "Atg14", "fig": 2}, {"body": 7, "word": "shown", "fig": 6}, {"body": 12, "word": "serum", "fig": 3}, {"body": 16, "word": "proteins", "fig": 2}, {"body": 9, "word": "presence", "fig": 3}, {"body": 9, "word": "endogenous", "fig": 3}, {"body": 26, "word": "using", "fig": 1}, {"body": 5, "word": "control", "fig": 5}, {"body": 17, "word": "membrane", "fig": 1}, {"body": 7, "word": "indicated", "fig": 2}, {"body": 4, "word": "absence", "fig": 3}, {"body": 11, "word": "formation", "fig": 1}, {"body": 11, "word": "vesicles", "fig": 1}, {"body": 9, "word": "regions", "fig": 1}, {"body": 3, "word": "g", "fig": 3}, {"body": 9, "word": "structures", "fig": 1}, {"body": 9, "word": "higher", "fig": 1}, {"body": 8, "word": "images", "fig": 1}, {"body": 7, "word": "interaction", "fig": 1}, {"body": 7, "word": "negative", "fig": 1}, {"body": 6, "word": "pre-autophagosomal", "fig": 1}, {"body": 3, "word": "f", "fig": 2}, {"body": 1, "word": "NRK", "fig": 6}, {"body": 6, "word": "Atg5", "fig": 1}, {"body": 5, "word": "experiments", "fig": 1}, {"body": 5, "word": "Eps15", "fig": 1}, {"body": 5, "word": "Atgs", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 4, "word": "3D", "fig": 1}, {"body": 4, "word": "reconstruction", "fig": 1}, {"body": 2, "word": "b", "fig": 2}, {"body": 1, "word": "knocked", "fig": 4}, {"body": 4, "word": "e", "fig": 1}, {"body": 3, "word": "plasma", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 3}, {"body": 3, "word": "6h", "fig": 1}, {"body": 3, "word": "Immunoblot", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 1, "word": "merged", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "3-methyladenine", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 1, "word": "e-cadherin", "fig": 2}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "intracytoplasmic", "fig": 1}, {"body": 1, "word": "h", "fig": 1}, {"body": 1, "word": "Co-staining", "fig": 1}, {"body": 1, "word": "autophagy-related", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "immunoprecipitates", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 1}, {"body": 1, "word": "modulates", "fig": 1}, {"body": 1, "word": "Tx", "fig": 1}, {"body": 1, "word": "highlight", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008708/bin/nihms566966f8.jpg", "caption": "Depletion of connexins induces autophagosome formation (a) Immunoblot for the indicated proteins in mouse embryonic fibroblasts (MEFs) control or knocked down (\u2212) for the three different connexins. (b) Immunofluorescence of LC3 in MEFs control (Ctr) or knocked down (\u2212) for three different Cx maintained in the presence or absence of serum. Left: representative fields and higher magnification insets. Nuclei are highlighted with DAPI. Right: Quantification of the average number of LC3-positive puncta per cell (n= 3 wells, 3 independent experiments, >50 cells per experiment). (c) Immunoblot for LC3 in the same cells maintained in the presence of serum untreated (\u2212) or treated with inhibitors of lysosomal proteases (PI) for the indicated times. GAPDH is shown as loading control. (d) Representative images of MEFs control or knocked-down (\u2212) for the indicated proteins transfected with the mCherry-GFP-LC3 tandem reporter. Right: quantification of the average number per cell of puncta positive for GFP and mCherry (autophagosomes; APG) and those positive only for mCherry (autophagolysosomes; APL) (n= 3 wells, 3 independent experiments, >50 cells per experiment). (e) Electron micrographs of MEFs control or knock-down for the indicated Cx. Insets show autophagic vesicles. Bottom: Quantification of the average number of AV (left) and percentage of cytosolic area (right) occupied by AVs (n= 4 wells, 4 independent experiments, >10 micrographs per well). (f) Immunoblot for indicated proteins in immunoprecipitates (IP) for Cx26 or Cx32 (left) or Atg16 (right) from liver homogenates. Inp: input, FT: flow through. BIP is shown as negative control for IP. All values are mean+s.e.m and significant for (*) p<0.01 (ANOVA+Bonferroni test was used in b). Bars: 5 \u03bcm in fluorescence images; 1 \u03bcm and 0.1 \u03bcm in top panels and inserts of e. Uncropped images of blots are shown in Supplementary Fig. 9.", "co_occurrence": [{"body": 123, "word": "Fig", "fig": 1}, {"body": 40, "word": "cells", "fig": 3}, {"body": 42, "word": "Cx", "fig": 2}, {"body": 53, "word": "Supplementary", "fig": 1}, {"body": 17, "word": "number", "fig": 3}, {"body": 16, "word": "proteins", "fig": 3}, {"body": 7, "word": "indicated", "fig": 5}, {"body": 34, "word": "Atg16", "fig": 1}, {"body": 5, "word": "control", "fig": 6}, {"body": 29, "word": "autophagosome", "fig": 1}, {"body": 14, "word": "LC3", "fig": 2}, {"body": 13, "word": "different", "fig": 2}, {"body": 8, "word": "images", "fig": 3}, {"body": 12, "word": "serum", "fig": 2}, {"body": 7, "word": "shown", "fig": 3}, {"body": 9, "word": "presence", "fig": 2}, {"body": 4, "word": "MEFs", "fig": 4}, {"body": 8, "word": "puncta", "fig": 2}, {"body": 5, "word": "experiments", "fig": 3}, {"body": 15, "word": "autophagic", "fig": 1}, {"body": 5, "word": "independent", "fig": 3}, {"body": 14, "word": "autophagosomes", "fig": 1}, {"body": 6, "word": "positive", "fig": 2}, {"body": 4, "word": "average", "fig": 3}, {"body": 11, "word": "formation", "fig": 1}, {"body": 11, "word": "vesicles", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 5, "word": "cell", "fig": 2}, {"body": 3, "word": "Immunoblot", "fig": 3}, {"body": 9, "word": "higher", "fig": 1}, {"body": 9, "word": "used", "fig": 1}, {"body": 8, "word": "lysosomal", "fig": 1}, {"body": 7, "word": "negative", "fig": 1}, {"body": 7, "word": "autophagolysosomes", "fig": 1}, {"body": 6, "word": "quantification", "fig": 1}, {"body": 6, "word": "mouse", "fig": 1}, {"body": 1, "word": "per", "fig": 5}, {"body": 5, "word": "Cx32", "fig": 1}, {"body": 4, "word": "Cx26", "fig": 1}, {"body": 4, "word": "mCherry-GFP-LC3", "fig": 1}, {"body": 4, "word": "absence", "fig": 1}, {"body": 4, "word": "knock-down", "fig": 1}, {"body": 4, "word": "times", "fig": 1}, {"body": 2, "word": "three", "fig": 2}, {"body": 4, "word": "representative", "fig": 1}, {"body": 2, "word": "b", "fig": 2}, {"body": 4, "word": "e", "fig": 1}, {"body": 2, "word": "micrographs", "fig": 2}, {"body": 3, "word": "f", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "fluorescence", "fig": 1}, {"body": 3, "word": "LC3-positive", "fig": 1}, {"body": 3, "word": "liver", "fig": 1}, {"body": 3, "word": "cytosolic", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "fibroblasts", "fig": 1}, {"body": 2, "word": "embryonic", "fig": 1}, {"body": 2, "word": "inhibitors", "fig": 1}, {"body": 2, "word": "reporter", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 2}, {"body": 1, "word": "connexins", "fig": 2}, {"body": 1, "word": "knocked", "fig": 2}, {"body": 2, "word": "Electron", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "p", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "immunoprecipitates", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "percentage", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "GFP", "fig": 1}, {"body": 1, "word": "well", "fig": 1}]}], "4076706": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0001.jpg", "caption": "Cyclin D1-CDK4 modulates PGC-1\u03b1 acetylation through GCN5. a) Scatter plot of chemicals plotted with first test z scores on the X-axis and repeated test scores on the Y-axis. b) Fascaplysin reduces PGC-1\u03b1 acetylation and Rb phoshorylation. c) Fascaplysin and PD 0332991 treatments decrease PGC-1\u03b1 acetylation. d) CDK4 knockdown causes PGC-1\u03b1 deacetylation. e) GCN5 knockdown blunts fascaplysin-mediated PGC-1\u03b1 deacetylation. f) GCN5 acetyltransferase activity is reduced upon fascaplysin treatment (n=2, mean\u00b1S.E.M). g) Endogenous GCN5 and CDK4 interact. h) Cyclin D1-CDK4 kinase phosphorylates GCN5 in vitro. i) GCN5 T272A/S372A (AA) phosphorylation by cyclin D1-CDK4 kinase is diminished compared to GCN5 wild-type (WT). j) GCN5 T272A/S372A displays decreased acetyltransferase capacity. k) GCN5 T272A/S372A has decreased acetyltransferase activity and insensitivity to fascaplysin treatment. Kinetic constants were calculated by Michaelis-Menten equation (n=4, AU/min=arbitrary unit/min, mean\u00b1S.E.M). U-2OS cells were used for these experiments.", "co_occurrence": [{"body": 31, "word": "GCN5", "fig": 9}, {"body": 36, "word": "PGC-1\u03b1", "fig": 5}, {"body": 27, "word": "D1-CDK4", "fig": 3}, {"body": 33, "word": "CDK4", "fig": 2}, {"body": 20, "word": "acetylation", "fig": 3}, {"body": 55, "word": "cyclin", "fig": 1}, {"body": 20, "word": "activity", "fig": 2}, {"body": 27, "word": "cells", "fig": 1}, {"body": 13, "word": "kinase", "fig": 2}, {"body": 9, "word": "test", "fig": 2}, {"body": 17, "word": "used", "fig": 1}, {"body": 15, "word": "phosphorylation", "fig": 1}, {"body": 6, "word": "fascaplysin", "fig": 2}, {"body": 4, "word": "acetyltransferase", "fig": 3}, {"body": 6, "word": "Cyclin", "fig": 2}, {"body": 10, "word": "experiments", "fig": 1}, {"body": 9, "word": "upon", "fig": 1}, {"body": 4, "word": "deacetylation", "fig": 2}, {"body": 8, "word": "wild-type", "fig": 1}, {"body": 4, "word": "knockdown", "fig": 2}, {"body": 7, "word": "Rb", "fig": 1}, {"body": 3, "word": "treatment", "fig": 2}, {"body": 6, "word": "compared", "fig": 1}, {"body": 5, "word": "reduced", "fig": 1}, {"body": 5, "word": "U-2OS", "fig": 1}, {"body": 5, "word": "vitro", "fig": 1}, {"body": 4, "word": "PD", "fig": 1}, {"body": 3, "word": "AA", "fig": 1}, {"body": 3, "word": "calculated", "fig": 1}, {"body": 1, "word": "decreased", "fig": 2}, {"body": 2, "word": "modulates", "fig": 1}, {"body": 2, "word": "repeated", "fig": 1}, {"body": 1, "word": "Michaelis-Menten", "fig": 1}, {"body": 1, "word": "capacity", "fig": 1}, {"body": 1, "word": "z", "fig": 1}, {"body": 1, "word": "decrease", "fig": 1}, {"body": 1, "word": "treatments", "fig": 1}, {"body": 1, "word": "constants", "fig": 1}, {"body": 1, "word": "Kinetic", "fig": 1}, {"body": 1, "word": "equation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0002.jpg", "caption": "Cyclin D1-CDK4 regulates gluconeogenesis in primary hepatocytes and whole animals. a-b) PD 0332991 increases gluconeogenic gene expression and glucose production (a: one-way ANOVA with Tukey post test, n=3, b: two-tailed unpaired t-test, n=8). c) PGC-1\u03b1 acetylation is decreased by PD 0332991 treatment. d-e) CDK4 knockdown increases gluconeogenic gene expression and glucose production (d: oneway ANOVA with Tukey post test, n=6, e: two-tailed unpaired t-test, n=6). f) PGC-1\u03b1 acetylation is decreased upon CDK4 deletion. g-h) Cyclin D1 wild-type decreases gluconeogenic gene expression, and cyclin D1 wild-type and cyclin D1 T286A, but not cyclin D1 K112E, repress glucose production (g: one-way ANOVA with Tukey post test, n=3/GFP, PGC-1\u03b1, n=6/Cyclin D1 WT and KE, h: one-way ANOVA with Dunnett post test, n=8). i) Overexpression of cyclin D1 wild-type (WT) and T286A (TA), but not cyclin D1 K112E (KE), induces PGC-1\u03b1 acetylation. j) GCN5 knockdown blunts the increase of glucose production by CDK4 knockdown (two-tailed unpaired t-test, n=8). k) PD 0332991 increases glucose production with GCN5 wild-type (WT), but not with GCN5 T272A/S372A (AA) (one-way ANOVA with Newman-Keuls post test, n=8). l-m) PD 0332991 administration increases Pck1 gene expression and glycemia in mice (two-tailed unpaired t-test, n=18/vehicle, n=17/PD 0332991). n-o) Gluconeogenic gene expression and glycemia are reduced by cyclin D1 T286A overexpression in liver (two-tailed unpaired t-test, n=10/GFP, n=9/D1 T286A). p) Cyclin D1 T286A overexpression in liver decreases hepatic glucose production capacity assessed by pyruvate tolerance test (two-tailed unpaired t-test, n=20/GFP, n=24/D1 T286A AUC=area under curve). Statistical significance is represented by asterisk corresponding to *P<0.05, **P<0.01, ***P<0.001. Data are shown as mean\u00b1S.E.M.", "co_occurrence": [{"body": 46, "word": "D1", "fig": 9}, {"body": 55, "word": "cyclin", "fig": 6}, {"body": 32, "word": "glucose", "fig": 6}, {"body": 36, "word": "PGC-1\u03b1", "fig": 4}, {"body": 33, "word": "CDK4", "fig": 3}, {"body": 31, "word": "GCN5", "fig": 3}, {"body": 20, "word": "acetylation", "fig": 3}, {"body": 11, "word": "expression", "fig": 5}, {"body": 9, "word": "T286A", "fig": 6}, {"body": 9, "word": "production", "fig": 6}, {"body": 9, "word": "test", "fig": 6}, {"body": 15, "word": "gluconeogenic", "fig": 3}, {"body": 44, "word": "mice", "fig": 1}, {"body": 41, "word": "Data", "fig": 1}, {"body": 17, "word": "liver", "fig": 2}, {"body": 8, "word": "wild-type", "fig": 4}, {"body": 27, "word": "D1-CDK4", "fig": 1}, {"body": 4, "word": "gene", "fig": 5}, {"body": 6, "word": "Cyclin", "fig": 3}, {"body": 4, "word": "PD", "fig": 4}, {"body": 7, "word": "glycemia", "fig": 2}, {"body": 12, "word": "hepatocytes", "fig": 1}, {"body": 4, "word": "knockdown", "fig": 3}, {"body": 11, "word": "hepatic", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 5}, {"body": 9, "word": "gluconeogenesis", "fig": 1}, {"body": 9, "word": "upon", "fig": 1}, {"body": 8, "word": "pyruvate", "fig": 1}, {"body": 2, "word": "increases", "fig": 4}, {"body": 4, "word": "K112E", "fig": 2}, {"body": 4, "word": "overexpression", "fig": 2}, {"body": 7, "word": "primary", "fig": 1}, {"body": 6, "word": "tolerance", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 6}, {"body": 1, "word": "t-test", "fig": 6}, {"body": 1, "word": "unpaired", "fig": 6}, {"body": 5, "word": "reduced", "fig": 1}, {"body": 5, "word": "increase", "fig": 1}, {"body": 1, "word": "post", "fig": 5}, {"body": 5, "word": "regulates", "fig": 1}, {"body": 1, "word": "one-way", "fig": 4}, {"body": 3, "word": "treatment", "fig": 1}, {"body": 1, "word": "Tukey", "fig": 3}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 3, "word": "administration", "fig": 1}, {"body": 3, "word": "AA", "fig": 1}, {"body": 3, "word": "whole", "fig": 1}, {"body": 1, "word": "decreased", "fig": 2}, {"body": 2, "word": "animals", "fig": 1}, {"body": 1, "word": "Dunnett", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "deletion", "fig": 1}, {"body": 1, "word": "Newman-Keuls", "fig": 1}, {"body": 1, "word": "Pck1", "fig": 1}, {"body": 1, "word": "capacity", "fig": 1}, {"body": 1, "word": "repress", "fig": 1}, {"body": 1, "word": "asterisk", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0003.jpg", "caption": "Cyclin D1-CDK4 is regulated by insulin/GSK3\u03b2 and hepatic cyclin D1 deletion causes increased gluconeogenesis and glycemia upon refeeding. a) Cyclin D1 gene expression is increased during refeeding (one-way ANOVA with Tukey post test, n=3/fast and10hr refed, n=4/4hr refed). b) Cyclin D1 protein and Rb phosphorylation are induced upon refeeding (N=nuclear and C=cytoplasmic liver extracts). c) Phosphorylation of GCN5 is increased upon refeeding. GCN5 was immunoprecipitated using anti-phosphoS*P (pS*P) antibody from livers infected with GFP or GCN5 adenovirus. d) Hepatocytes ploidy does not change upon fasting and refeeding (n=5). e) Ki-67 staining in liver shows no differences upon fasting and refeeding. Small intestine was used as a positive control. f) Nuclear cyclin D1 protein level is increased upon insulin and GSK3\u03b2 inhibitors treatment in primary hepatocytes. All cells were infected with cyclin D1 wild-type adenovirus. g) Insulin and GSK3\u03b2 inhibitors suppress gluconeogenic gene expression. All cells were infected with PGC-1\u03b1 adenovirus (oneway ANOVA with Tukey post test, n=6). h) Phosphorylation of GCN5 is induced by insulin and blunted by PD 0332991 treatment. GCN5 was overexpressed whereas GFP was used as a negative control. i) Cyclin D1 is transcriptionally induced by dietary intake of amino acids. Mice were fasted overnight or refed 4hr with chow diet, empty calorie, glucose or glucose and amino acids diet (one-way ANOVA with Tukey post test, n=5). j-k) Liver-specific cyclin D1 KO (D1 LKO) mice exhibit no differences on gluconeogenic gene expression and glycemia during fasting. l-m) D1 LKO mice display increased gluconeogenic gene expression and glycemia upon 4hr refeeding (one-way ANOVA with Tukey post test, combined 4 cohorts of n=3/fasting, n=5/refeeding). n) D1 LKO mice show mild glucose intolerance (two-way ANOVA, multiple comparison, n=11/WT1, n=7/WT2, n=10/D1 LKO). o) D1 LKO mice exhibit mild insulin intolerance (two-way ANOVA, significant interaction, multiple comparison, n=10/WT1, n=7/WT2, n=9/D1 LKO). Statistical significance is represented by asterisk corresponding to *P<0.05, **P<0.01, ***P<0.001. Data are shown as mean\u00b1S.E.M.", "co_occurrence": [{"body": 46, "word": "D1", "fig": 11}, {"body": 55, "word": "cyclin", "fig": 4}, {"body": 44, "word": "mice", "fig": 4}, {"body": 31, "word": "GCN5", "fig": 5}, {"body": 32, "word": "glucose", "fig": 3}, {"body": 13, "word": "refeeding", "fig": 7}, {"body": 25, "word": "insulin", "fig": 3}, {"body": 9, "word": "upon", "fig": 7}, {"body": 27, "word": "cells", "fig": 2}, {"body": 15, "word": "gluconeogenic", "fig": 3}, {"body": 11, "word": "expression", "fig": 4}, {"body": 7, "word": "LKO", "fig": 6}, {"body": 41, "word": "Data", "fig": 1}, {"body": 8, "word": "increased", "fig": 5}, {"body": 36, "word": "PGC-1\u03b1", "fig": 1}, {"body": 9, "word": "test", "fig": 4}, {"body": 17, "word": "liver", "fig": 2}, {"body": 17, "word": "used", "fig": 2}, {"body": 27, "word": "D1-CDK4", "fig": 1}, {"body": 12, "word": "amino", "fig": 2}, {"body": 6, "word": "Cyclin", "fig": 4}, {"body": 8, "word": "fasting", "fig": 3}, {"body": 12, "word": "acids", "fig": 2}, {"body": 7, "word": "glycemia", "fig": 3}, {"body": 10, "word": "All", "fig": 2}, {"body": 9, "word": "control", "fig": 2}, {"body": 4, "word": "gene", "fig": 4}, {"body": 16, "word": "antibody", "fig": 1}, {"body": 8, "word": "protein", "fig": 2}, {"body": 15, "word": "phosphorylation", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 6}, {"body": 12, "word": "hepatocytes", "fig": 1}, {"body": 4, "word": "refed", "fig": 3}, {"body": 4, "word": "adenovirus", "fig": 3}, {"body": 6, "word": "diet", "fig": 2}, {"body": 11, "word": "hepatic", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 5, "word": "inhibitors", "fig": 2}, {"body": 5, "word": "GSK3\u03b2", "fig": 2}, {"body": 3, "word": "infected", "fig": 3}, {"body": 9, "word": "gluconeogenesis", "fig": 1}, {"body": 4, "word": "4hr", "fig": 2}, {"body": 8, "word": "immunoprecipitated", "fig": 1}, {"body": 8, "word": "wild-type", "fig": 1}, {"body": 7, "word": "Rb", "fig": 1}, {"body": 7, "word": "primary", "fig": 1}, {"body": 7, "word": "overnight", "fig": 1}, {"body": 3, "word": "treatment", "fig": 2}, {"body": 5, "word": "negative", "fig": 1}, {"body": 5, "word": "significant", "fig": 1}, {"body": 5, "word": "fasted", "fig": 1}, {"body": 4, "word": "level", "fig": 1}, {"body": 4, "word": "PD", "fig": 1}, {"body": 4, "word": "Insulin", "fig": 1}, {"body": 1, "word": "post", "fig": 4}, {"body": 2, "word": "comparison", "fig": 2}, {"body": 1, "word": "Tukey", "fig": 4}, {"body": 4, "word": "livers", "fig": 1}, {"body": 4, "word": "Ki-67", "fig": 1}, {"body": 2, "word": "GFP", "fig": 2}, {"body": 3, "word": "overexpressed", "fig": 1}, {"body": 1, "word": "one-way", "fig": 3}, {"body": 1, "word": "induced", "fig": 3}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 2, "word": "ploidy", "fig": 1}, {"body": 2, "word": "interaction", "fig": 1}, {"body": 1, "word": "two-way", "fig": 2}, {"body": 2, "word": "blunted", "fig": 1}, {"body": 2, "word": "dietary", "fig": 1}, {"body": 2, "word": "regulated", "fig": 1}, {"body": 2, "word": "Hepatocytes", "fig": 1}, {"body": 1, "word": "intolerance", "fig": 2}, {"body": 2, "word": "intestine", "fig": 1}, {"body": 2, "word": "KO", "fig": 1}, {"body": 2, "word": "whereas", "fig": 1}, {"body": 2, "word": "suppress", "fig": 1}, {"body": 1, "word": "multiple", "fig": 2}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "asterisk", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "Mice", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "Liver-specific", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "calorie", "fig": 1}, {"body": 1, "word": "combined", "fig": 1}, {"body": 1, "word": "empty", "fig": 1}, {"body": 1, "word": "intake", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "deletion", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0004.jpg", "caption": "In diabetic hyperinsulinemic mice, cyclin D1-CDK4 is dysregulated and hyperactivation of cyclin D1-CDK4 attenuates the diabetic phenotype. a) Cyclin D1 is chronically elevated in livers of db/db mice (N=nuclear and C=cytoplasmic liver extracts). b-c) Cyclin D1 T286A, but not cyclin D1 K112E, overexpression in liver represses gluconeogenic genes and glycemia in db/db mice (one-way ANOVA, Tukey post test, n=6/GFP, D1 K112E, n=5/D1 T286A). d-h) In db/db mice, cyclin D1 T286A overexpression in liver suppresses hepatic glucose production tested by hyperinsulinemic-euglycemic clamp. d) Plasma glycemia and glucose infusion rate (twoway ANOVA, significant interaction, n=7). e) Body weights. f) Clamped glucose infusion rate. g) Whole-body glucose uptake. h) Hepatic glucose output (average of last 40min values for f-g, two-tailed unpaired t-test for d-h, n=7). Statistical significance is represented by asterisk corresponding to *P<0.05, **P<0.01, ***P<0.001. Data are shown as mean\u00b1S.E.M.", "co_occurrence": [{"body": 46, "word": "D1", "fig": 5}, {"body": 55, "word": "cyclin", "fig": 4}, {"body": 44, "word": "mice", "fig": 4}, {"body": 32, "word": "glucose", "fig": 5}, {"body": 27, "word": "D1-CDK4", "fig": 2}, {"body": 17, "word": "liver", "fig": 3}, {"body": 41, "word": "Data", "fig": 1}, {"body": 15, "word": "In", "fig": 2}, {"body": 9, "word": "T286A", "fig": 3}, {"body": 7, "word": "db/db", "fig": 3}, {"body": 15, "word": "gluconeogenic", "fig": 1}, {"body": 7, "word": "glycemia", "fig": 2}, {"body": 6, "word": "Cyclin", "fig": 2}, {"body": 11, "word": "hepatic", "fig": 1}, {"body": 11, "word": "genes", "fig": 1}, {"body": 5, "word": "diabetic", "fig": 2}, {"body": 9, "word": "production", "fig": 1}, {"body": 9, "word": "test", "fig": 1}, {"body": 4, "word": "K112E", "fig": 2}, {"body": 4, "word": "overexpression", "fig": 2}, {"body": 3, "word": "infusion", "fig": 2}, {"body": 6, "word": "elevated", "fig": 1}, {"body": 5, "word": "significant", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 2}, {"body": 4, "word": "clamp", "fig": 1}, {"body": 2, "word": "rate", "fig": 2}, {"body": 4, "word": "tested", "fig": 1}, {"body": 4, "word": "livers", "fig": 1}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 2, "word": "uptake", "fig": 1}, {"body": 2, "word": "Whole-body", "fig": 1}, {"body": 2, "word": "suppresses", "fig": 1}, {"body": 2, "word": "interaction", "fig": 1}, {"body": 2, "word": "hyperinsulinemic-euglycemic", "fig": 1}, {"body": 1, "word": "chronically", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "one-way", "fig": 1}, {"body": 1, "word": "dysregulated", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "post", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "Tukey", "fig": 1}, {"body": 1, "word": "Hepatic", "fig": 1}, {"body": 1, "word": "unpaired", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "asterisk", "fig": 1}, {"body": 1, "word": "hyperactivation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0005.jpg", "caption": "A cell-based high throughput screen reveals compounds regulating PGC-1\u03b1 acetylation. a) Scheme of high throughput chemical assay. b) Compounds with significant z scores either >3.0 or <-3.0 are listed. Inhibitors indicate the compounds that increased PGC-1\u03b1 acetylation while activators indicate the ones that decreased PGC-1\u03b1 acetylation.", "co_occurrence": [{"body": 36, "word": "PGC-1\u03b1", "fig": 3}, {"body": 20, "word": "acetylation", "fig": 3}, {"body": 12, "word": "A", "fig": 1}, {"body": 5, "word": "high", "fig": 2}, {"body": 4, "word": "indicate", "fig": 2}, {"body": 8, "word": "increased", "fig": 1}, {"body": 3, "word": "compounds", "fig": 2}, {"body": 5, "word": "significant", "fig": 1}, {"body": 4, "word": "chemical", "fig": 1}, {"body": 4, "word": "assay", "fig": 1}, {"body": 1, "word": "throughput", "fig": 2}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "z", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0006.jpg", "caption": "Cyclin D1-CDK4 modulates PGC-1\u03b1 acetylation through GCN5. a) Fascaplysin decreases PGC-1\u03b1 acetylation in dose-dependent manner. Dose-dependent response of PGC-1\u03b1 acetylation treated with fascaplysin concentrations ranging from 31.25nM to 8\u03bcM. IC50 value was calculated using three independent measurements from the assay described in Extended Data Fig. 1 a. b) Chemical structures of fascaplysin and PD 0332991. c) CDK4 is knockdown by various CDK4 shRNAs used in Fig. 1d. d) Fascaplysin decreases PGC-1\u03b1 acetylation upon EX527 or trichostatin A treatments. Cells were treated for 8hr in case of 1\u03bcM fascaplysin and 4hr in case of 1\u03bcM EX527 or trichostatin A prior to harvest. DMSO (-) was used as a control treatment. e) Fascpalysin has blunted effect on PCAF-mediated PGC-1\u03b1 acetylation. f) Ectopically expressed CDK4 and GCN5 interact. As a comparison, PGC-1\u03b1, Sirt1 and Sirt6 were used while GFP was overexpressed as a negative control. g) Phosphorylation of GCN5 by cyclin D1-CDK4 complex is reduced by fascaplysin. DMSO or 1\u03bcM fascaplysin was added to the kinase reaction. h) In vitro phosphorylation of GST-GCN5 recombinant proteins (1-224aa, 1-386aa, 1-553aa, 1-837aa) by cyclin D1-CDK4 and the protein level of those fragments. i) GCN5 wild-type (WT), treated with fascaplysin and GCN5 T272A/S372A (AA) mutant immunoprecipitated by anti-phospho-S*P (pS*P) antibody. j) Acetylation of PGC-1\u03b1 closely follows the amount of PAF65\u03b2 bound to GCN5. Nuclear extracts of U-2OS overexpressing various amounts of GCN5 were used for western-blot analysis to detect GCN5 and PAF65\u03b2. Empty vector was transfected as a negative control. k) Interaction between GCN5 T272A/S372A (AA) and PAF65\u03b2 is reduced compared to GCN5 wild-type (WT). U-2OS cells were used for western-blot analysis experiments.", "co_occurrence": [{"body": 31, "word": "GCN5", "fig": 10}, {"body": 36, "word": "PGC-1\u03b1", "fig": 7}, {"body": 72, "word": "Fig", "fig": 2}, {"body": 55, "word": "cyclin", "fig": 2}, {"body": 20, "word": "acetylation", "fig": 5}, {"body": 33, "word": "CDK4", "fig": 3}, {"body": 17, "word": "used", "fig": 5}, {"body": 27, "word": "D1-CDK4", "fig": 3}, {"body": 41, "word": "Data", "fig": 1}, {"body": 41, "word": "Extended", "fig": 1}, {"body": 6, "word": "fascaplysin", "fig": 6}, {"body": 27, "word": "cells", "fig": 1}, {"body": 9, "word": "control", "fig": 3}, {"body": 8, "word": "1\u03bcM", "fig": 3}, {"body": 12, "word": "A", "fig": 2}, {"body": 16, "word": "antibody", "fig": 1}, {"body": 8, "word": "wild-type", "fig": 2}, {"body": 15, "word": "phosphorylation", "fig": 1}, {"body": 15, "word": "In", "fig": 1}, {"body": 13, "word": "kinase", "fig": 1}, {"body": 11, "word": "added", "fig": 1}, {"body": 11, "word": "complex", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 5, "word": "reduced", "fig": 2}, {"body": 10, "word": "experiments", "fig": 1}, {"body": 5, "word": "U-2OS", "fig": 2}, {"body": 5, "word": "negative", "fig": 2}, {"body": 3, "word": "treated", "fig": 3}, {"body": 9, "word": "upon", "fig": 1}, {"body": 8, "word": "immunoprecipitated", "fig": 1}, {"body": 8, "word": "prior", "fig": 1}, {"body": 8, "word": "protein", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 7, "word": "harvest", "fig": 1}, {"body": 3, "word": "AA", "fig": 2}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "Cyclin", "fig": 1}, {"body": 5, "word": "vitro", "fig": 1}, {"body": 4, "word": "assay", "fig": 1}, {"body": 4, "word": "level", "fig": 1}, {"body": 4, "word": "4hr", "fig": 1}, {"body": 4, "word": "PD", "fig": 1}, {"body": 4, "word": "knockdown", "fig": 1}, {"body": 2, "word": "case", "fig": 2}, {"body": 2, "word": "trichostatin", "fig": 2}, {"body": 2, "word": "DMSO", "fig": 2}, {"body": 3, "word": "overexpressed", "fig": 1}, {"body": 3, "word": "treatment", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 1, "word": "PAF65\u03b2", "fig": 3}, {"body": 3, "word": "vector", "fig": 1}, {"body": 3, "word": "described", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "mutant", "fig": 1}, {"body": 3, "word": "shRNAs", "fig": 1}, {"body": 3, "word": "calculated", "fig": 1}, {"body": 2, "word": "IC50", "fig": 1}, {"body": 2, "word": "anti-phospho-S*P", "fig": 1}, {"body": 1, "word": "various", "fig": 2}, {"body": 2, "word": "blunted", "fig": 1}, {"body": 2, "word": "effect", "fig": 1}, {"body": 1, "word": "western-blot", "fig": 2}, {"body": 2, "word": "amount", "fig": 1}, {"body": 2, "word": "modulates", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 2, "word": "GFP", "fig": 1}, {"body": 2, "word": "manner", "fig": 1}, {"body": 2, "word": "reaction", "fig": 1}, {"body": 1, "word": "Chemical", "fig": 1}, {"body": 1, "word": "recombinant", "fig": 1}, {"body": 1, "word": "detect", "fig": 1}, {"body": 1, "word": "expressed", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "PCAF-mediated", "fig": 1}, {"body": 1, "word": "GST-GCN5", "fig": 1}, {"body": 1, "word": "8hr", "fig": 1}, {"body": 1, "word": "1d", "fig": 1}, {"body": 1, "word": "1-224aa", "fig": 1}, {"body": 1, "word": "1-386aa", "fig": 1}, {"body": 1, "word": "1-553aa", "fig": 1}, {"body": 1, "word": "treatments", "fig": 1}, {"body": 1, "word": "response", "fig": 1}, {"body": 1, "word": "1-837aa", "fig": 1}, {"body": 1, "word": "As", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0007.jpg", "caption": "Cyclin D1-CDK4 regulates gluconeogenesis in primary hepatocytes and in whole animals. a) Western-blot analysis of endogenous, forskolin-induced (Fsk) or adenovirally overexpressed (O/E) PGC-1\u03b1. Nuclear extracts of primary hepatocytes were used to immunoprecipitate PGC-1\u03b1. Cells were infected with GFP or PGC-1\u03b1 48hr prior to harvest. 10\u03bcM forskolin was added for 2hr before harvest. b) PD 0332991 increases forskolin-induced gluconeogenic gene expression. Primary hepatocytes were treated with 10\u03bcM forskolin for 1.5hr following 3hr of starvation medium incubation while 1\u03bcM PD 0332991 was added overnight (one-way ANOVA with Tukey post test, n=3). c) CDK4 knockdown increases forskolin-induced gluconeogenic gene expression (one-way ANOVA with Tukey post test, n=3). d) Cyclin D1 wild-type, but not cyclin D1 K112E mutant, suppresses forskolin-induced gluconeogenic gene expression (one-way ANOVA with Tukey post test, n=3). e) Phosphorylation of GCN5, FoxO1 N-terminus, FoxO1 C-terminus, FoxO3A and PGC-1\u03b1 SR domain by cyclin D1-CDK4. f) PGC-1\u03b1 knockdown blocks the increase of forskolin-induced gluconeogenic genes by fascaplysin in HepG2 cells. PGC-1\u03b1 knockdown or a negative control HepG2 cells were treated with 30\u03bcM forskolin and 1\u03bcM fascaplysin overnight (one-way ANOVA with Tukey post test, n=3). g) GCN5 knockdown blunts the increase of gluconeogenic gene expression caused by CDK4 knockdown. qRT-PCR analysis of Pck1 and Gcn5 and western-blot of CDK4 and GCN5 knockdown are shown. All cells were infected with PGC-1\u03b1 adenoviruses (one-way ANOVA with Tukey post test, n=15). h) PD 0332991 increases gluconeogenic genes when combined with GCN5 wild-type (WT) overexpression, but not with GCN5 T272A/S372A (AA) mutant. GFP infected cells shown as a comparison to GCN5 overexpressing cells. All cells were infected with PGC-1\u03b1 adenoviruses (two-tailed unpaired t-test, n=6). I-j) Insulin levels measured from serum and western-blot analysis of Rb and AKT using nuclear (N) and cytoplasmic (C) liver extracts from mice treated with vehicle or 150mg/kg PD 0332991, shown in Fig. 2lm (i: two-tailed unpaired t-test, n=18/GFP, n=17/PD 0332991). k) Levels of cyclin D1 and Rb phosphorylation in GFP or Cyclin D1 T286A tail-vein injected mice, shown in Fig. 2n-o. Statistical significance is represented by asterisk corresponding to *P<0.05, **P<0.01, ***P<0.001. Data are shown as mean\u00b1S.E.M.", "co_occurrence": [{"body": 36, "word": "PGC-1\u03b1", "fig": 8}, {"body": 31, "word": "GCN5", "fig": 6}, {"body": 46, "word": "D1", "fig": 4}, {"body": 55, "word": "cyclin", "fig": 3}, {"body": 27, "word": "cells", "fig": 6}, {"body": 72, "word": "Fig", "fig": 2}, {"body": 33, "word": "CDK4", "fig": 3}, {"body": 15, "word": "gluconeogenic", "fig": 6}, {"body": 44, "word": "mice", "fig": 2}, {"body": 27, "word": "D1-CDK4", "fig": 2}, {"body": 9, "word": "test", "fig": 5}, {"body": 11, "word": "expression", "fig": 4}, {"body": 41, "word": "Data", "fig": 1}, {"body": 12, "word": "hepatocytes", "fig": 3}, {"body": 4, "word": "knockdown", "fig": 6}, {"body": 11, "word": "added", "fig": 2}, {"body": 11, "word": "genes", "fig": 2}, {"body": 10, "word": "All", "fig": 2}, {"body": 6, "word": "Cyclin", "fig": 3}, {"body": 17, "word": "liver", "fig": 1}, {"body": 17, "word": "used", "fig": 1}, {"body": 4, "word": "PD", "fig": 4}, {"body": 8, "word": "1\u03bcM", "fig": 2}, {"body": 4, "word": "gene", "fig": 4}, {"body": 8, "word": "wild-type", "fig": 2}, {"body": 15, "word": "phosphorylation", "fig": 1}, {"body": 7, "word": "Rb", "fig": 2}, {"body": 7, "word": "primary", "fig": 2}, {"body": 7, "word": "harvest", "fig": 2}, {"body": 7, "word": "overnight", "fig": 2}, {"body": 6, "word": "fascaplysin", "fig": 2}, {"body": 3, "word": "infected", "fig": 4}, {"body": 12, "word": "medium", "fig": 1}, {"body": 4, "word": "analysis", "fig": 3}, {"body": 2, "word": "ANOVA", "fig": 5}, {"body": 10, "word": "using", "fig": 1}, {"body": 5, "word": "increase", "fig": 2}, {"body": 5, "word": "adenoviruses", "fig": 2}, {"body": 9, "word": "T286A", "fig": 1}, {"body": 9, "word": "control", "fig": 1}, {"body": 3, "word": "treated", "fig": 3}, {"body": 9, "word": "gluconeogenesis", "fig": 1}, {"body": 8, "word": "prior", "fig": 1}, {"body": 8, "word": "levels", "fig": 1}, {"body": 7, "word": "endogenous", "fig": 1}, {"body": 2, "word": "increases", "fig": 3}, {"body": 2, "word": "forskolin", "fig": 3}, {"body": 3, "word": "mutant", "fig": 2}, {"body": 2, "word": "GFP", "fig": 3}, {"body": 5, "word": "caused", "fig": 1}, {"body": 5, "word": "3hr", "fig": 1}, {"body": 1, "word": "one-way", "fig": 5}, {"body": 5, "word": "nuclear", "fig": 1}, {"body": 1, "word": "post", "fig": 5}, {"body": 1, "word": "Tukey", "fig": 5}, {"body": 5, "word": "regulates", "fig": 1}, {"body": 5, "word": "negative", "fig": 1}, {"body": 5, "word": "following", "fig": 1}, {"body": 2, "word": "HepG2", "fig": 2}, {"body": 4, "word": "K112E", "fig": 1}, {"body": 4, "word": "Insulin", "fig": 1}, {"body": 4, "word": "Primary", "fig": 1}, {"body": 4, "word": "measured", "fig": 1}, {"body": 4, "word": "incubation", "fig": 1}, {"body": 4, "word": "overexpression", "fig": 1}, {"body": 3, "word": "overexpressed", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "AKT", "fig": 1}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 3, "word": "injected", "fig": 1}, {"body": 3, "word": "AA", "fig": 1}, {"body": 3, "word": "whole", "fig": 1}, {"body": 2, "word": "starvation", "fig": 1}, {"body": 2, "word": "domain", "fig": 1}, {"body": 2, "word": "2hr", "fig": 1}, {"body": 2, "word": "suppresses", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 2}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 1, "word": "western-blot", "fig": 2}, {"body": 2, "word": "tail-vein", "fig": 1}, {"body": 2, "word": "animals", "fig": 1}, {"body": 1, "word": "10\u03bcM", "fig": 2}, {"body": 1, "word": "unpaired", "fig": 2}, {"body": 2, "word": "serum", "fig": 1}, {"body": 2, "word": "1.5hr", "fig": 1}, {"body": 2, "word": "immunoprecipitate", "fig": 1}, {"body": 1, "word": "FoxO1", "fig": 2}, {"body": 1, "word": "t-test", "fig": 2}, {"body": 2, "word": "48hr", "fig": 1}, {"body": 1, "word": "150mg/kg", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "Pck1", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "FoxO3A", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "combined", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "SR", "fig": 1}, {"body": 1, "word": "cytoplasmic", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "asterisk", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0008.jpg", "caption": "PD 0332991 administration or cyclin D1 T286A adenoviral overexpression does not cause toxicity compared to its respective control treatment. a) Basal physiological indexes of mice challenged with either vehicle or PD 0332991 administration (n=5). b) Basal physiological indexes of mice injected with either GFP or cyclin D1 T286A adenoviruses (n=5). (ALT=alanine transaminase, AST=aspartate transaminase, LDH=lactate dehydrogenase, mean\u00b1S.E.M)", "co_occurrence": [{"body": 55, "word": "cyclin", "fig": 2}, {"body": 46, "word": "D1", "fig": 2}, {"body": 44, "word": "mice", "fig": 2}, {"body": 9, "word": "T286A", "fig": 2}, {"body": 9, "word": "control", "fig": 1}, {"body": 4, "word": "PD", "fig": 2}, {"body": 6, "word": "compared", "fig": 1}, {"body": 3, "word": "administration", "fig": 2}, {"body": 5, "word": "adenoviruses", "fig": 1}, {"body": 2, "word": "transaminase", "fig": 2}, {"body": 4, "word": "overexpression", "fig": 1}, {"body": 3, "word": "injected", "fig": 1}, {"body": 3, "word": "treatment", "fig": 1}, {"body": 3, "word": "adenoviral", "fig": 1}, {"body": 2, "word": "GFP", "fig": 1}, {"body": 1, "word": "physiological", "fig": 2}, {"body": 1, "word": "dehydrogenase", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "toxicity", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0009.jpg", "caption": "Cyclin D1-CDK4 is regulated by insulin/GSK3\u03b2 and hepatic specific cyclin D1 deletion causes increased gluconeogenesis and glycemia upon refeeding. a) Cyclin D1 transcripts are increased upon refeeding. qRT-PCR analysis of Ccnd1, Ccnd2 and Ccne1 gene expression upon overnight fasting, 4hr and 10hr refeeding in BALB/c mice livers (one-way ANOVA with Tukey post test, n=3). b) Cyclin D1 protein is increased upon refeeding. Western-blot analysis of cyclin D1 protein levels and associated signaling pathway upon fasting and refeeding measured from nuclear (N) and cytoplasmic (C) liver extracts from BALB/c mice. c) Cyclin D1-CDK4 kinase activity is increased upon 4hr refeding. In vitro 32P incorporation into recombinant Rb by immunoprecipitated cyclin D1-CDK4 kinase from whole-cell extracts of overnight fast and 4hr refed livers. d) Western-blot analysis of cyclin D1 protein level and associated signaling pathway upon fasting and refeeding and qRT-PCR analysis of Ccnd1 and Pgc1\u03b1 mRNA level in various tissues (L=liver, M=skeletal muscle, B=brown adipose tissue, W=epididymal white adipose tissue, and P=pancreas, two-tailed unpaired t-test, n=12/L, n=4/M, B, W, P). e) qRT-PCR analysis of PGC-1\u03b1 target genes in liver and epididymal white adipose tissues (eWAT) upon vehicle or PD 0332991 treatment (two-tailed unpaired t-test, n=10). f) Ccnb1 and Pcna gene expressions in liver do not change upon fasting and refeeding (n=3/fast and 10hr refed, n=4/4hr refed). g) BrdU incorporation in liver does not change upon fasting and refeeding. Small intestine was used as a positive control. h) Ki-67 staining in liver does not change upon fasting and refeeding following vehicle or PD 0332991 administration. Small intestine used as a positive control. i) Ki-67 staining in liver does not change upon fasting and refeeding following GFP or cyclin D1 T286A tail-vein injection. Small intestine used as a positive control. j) Hepatic ploidy profiles of livers of GFP or cyclin D1 T286A adenovirus tail-vein injected mice do not show significant difference. Ploidy analysis of primary hepatocytes isolated from livers measured by propidium iodide staining and flow cytometry (n=6/fast and 4hr refed, n=4/10hr refed). k) Western-blot analysis of endogenous nuclear (N) and cytoplasmic (C) cyclin D1 protein level upon insulin or GSK3\u03b2 inhibitors treatments in primary hepatocytes. l) PGC-1\u03b1 acetylation is increased upon insulin or GSK3\u03b2 inhibitors treatment in primary hepatocytes. m) No effect of insulin or GSK3\u03b2 inhibitors on cyclin D1 mRNA level (n=3). n) Minimum essential medium (MEM) amino acids addition increases cyclin D1 mRNA in primary hepatocytes (one-way ANOVA with Tukey post test, n=3). o) Insulin does not change Ccnd1 mRNA in primary hepatocytes (oneway ANOVA with Tukey post test, n=3). p-q) Body, liver weights and Ccnd1 and Ccnd2 gene expression of wild-type and liver-specific cyclin D1 KO (D1 LKO) mice (combined 4 cohorts of n=3/fasting, n=5/refeeding). r) Western-blot analysis of cyclin D1 protein levels and associated signaling pathway by using nuclear and cytoplasmic liver extracts from wild-type and D1 LKO mice upon fasting (F) and 4hr refeeding (R). s) Endogenous acetylation of PGC-1\u03b1 is decreased in livers of D1 LKO mice compared to wild-type mice. Western-blot analysis of acetylation of PGC-1\u03b1 immunoprecipitated from liver nuclear extracts. All mice were sacrificed upon 4hr refeeding. t-u) PD 0332991 increases glycemia with similar tendency for gluconeogenic gene expression only in wild-type mice, but not in D1 LKO mice (two-tailed unpaired t-test, n=8, except n=6 for vehicle treated wild-type mice). v-w) Gluconeogenic gene expression and hepatic glucose production are increased in primary hepatocytes isolated from D1 LKO mice (v: one-way ANOVA Tukey post test, n=3, w: two-tailed unpaired test, n=6). Statistical significance is represented by asterisk corresponding to *P<0.05, **P<0.01, ***P<0.001. Data are shown as mean\u00b1S.E.M.", "co_occurrence": [{"body": 46, "word": "D1", "fig": 17}, {"body": 55, "word": "cyclin", "fig": 11}, {"body": 44, "word": "mice", "fig": 12}, {"body": 13, "word": "refeeding", "fig": 12}, {"body": 17, "word": "liver", "fig": 9}, {"body": 36, "word": "PGC-1\u03b1", "fig": 4}, {"body": 9, "word": "upon", "fig": 16}, {"body": 27, "word": "D1-CDK4", "fig": 3}, {"body": 25, "word": "insulin", "fig": 3}, {"body": 12, "word": "hepatocytes", "fig": 6}, {"body": 8, "word": "fasting", "fig": 8}, {"body": 20, "word": "acetylation", "fig": 3}, {"body": 17, "word": "used", "fig": 3}, {"body": 8, "word": "increased", "fig": 6}, {"body": 9, "word": "test", "fig": 5}, {"body": 11, "word": "expression", "fig": 4}, {"body": 7, "word": "primary", "fig": 6}, {"body": 41, "word": "Data", "fig": 1}, {"body": 8, "word": "wild-type", "fig": 5}, {"body": 8, "word": "protein", "fig": 5}, {"body": 4, "word": "analysis", "fig": 9}, {"body": 7, "word": "LKO", "fig": 5}, {"body": 32, "word": "glucose", "fig": 1}, {"body": 9, "word": "control", "fig": 3}, {"body": 13, "word": "kinase", "fig": 2}, {"body": 4, "word": "4hr", "fig": 6}, {"body": 6, "word": "Cyclin", "fig": 4}, {"body": 8, "word": "signaling", "fig": 3}, {"body": 11, "word": "hepatic", "fig": 2}, {"body": 20, "word": "activity", "fig": 1}, {"body": 4, "word": "refed", "fig": 5}, {"body": 4, "word": "gene", "fig": 5}, {"body": 4, "word": "livers", "fig": 5}, {"body": 5, "word": "nuclear", "fig": 4}, {"body": 9, "word": "T286A", "fig": 2}, {"body": 4, "word": "level", "fig": 4}, {"body": 8, "word": "immunoprecipitated", "fig": 2}, {"body": 4, "word": "mRNA", "fig": 4}, {"body": 8, "word": "levels", "fig": 2}, {"body": 15, "word": "gluconeogenic", "fig": 1}, {"body": 15, "word": "In", "fig": 1}, {"body": 5, "word": "inhibitors", "fig": 3}, {"body": 5, "word": "GSK3\u03b2", "fig": 3}, {"body": 7, "word": "glycemia", "fig": 2}, {"body": 7, "word": "overnight", "fig": 2}, {"body": 4, "word": "PD", "fig": 3}, {"body": 12, "word": "medium", "fig": 1}, {"body": 12, "word": "amino", "fig": 1}, {"body": 12, "word": "acids", "fig": 1}, {"body": 11, "word": "genes", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 5, "word": "following", "fig": 2}, {"body": 10, "word": "All", "fig": 1}, {"body": 9, "word": "production", "fig": 1}, {"body": 9, "word": "gluconeogenesis", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 4}, {"body": 4, "word": "Ki-67", "fig": 2}, {"body": 4, "word": "isolated", "fig": 2}, {"body": 4, "word": "measured", "fig": 2}, {"body": 7, "word": "Rb", "fig": 1}, {"body": 7, "word": "injection", "fig": 1}, {"body": 7, "word": "endogenous", "fig": 1}, {"body": 7, "word": "similar", "fig": 1}, {"body": 3, "word": "treatment", "fig": 2}, {"body": 2, "word": "intestine", "fig": 3}, {"body": 3, "word": "tissues", "fig": 2}, {"body": 6, "word": "compared", "fig": 1}, {"body": 1, "word": "change", "fig": 5}, {"body": 5, "word": "vitro", "fig": 1}, {"body": 5, "word": "significant", "fig": 1}, {"body": 2, "word": "increases", "fig": 2}, {"body": 4, "word": "Insulin", "fig": 1}, {"body": 1, "word": "post", "fig": 4}, {"body": 1, "word": "two-tailed", "fig": 4}, {"body": 1, "word": "Tukey", "fig": 4}, {"body": 4, "word": "adenovirus", "fig": 1}, {"body": 2, "word": "tail-vein", "fig": 2}, {"body": 2, "word": "incorporation", "fig": 2}, {"body": 1, "word": "unpaired", "fig": 4}, {"body": 2, "word": "GFP", "fig": 2}, {"body": 2, "word": "BALB/c", "fig": 2}, {"body": 1, "word": "t-test", "fig": 3}, {"body": 3, "word": "injected", "fig": 1}, {"body": 1, "word": "staining", "fig": 3}, {"body": 1, "word": "one-way", "fig": 3}, {"body": 1, "word": "cytoplasmic", "fig": 3}, {"body": 1, "word": "adipose", "fig": 3}, {"body": 3, "word": "addition", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 3}, {"body": 3, "word": "treated", "fig": 1}, {"body": 3, "word": "target", "fig": 1}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 3, "word": "administration", "fig": 1}, {"body": 3, "word": "BrdU", "fig": 1}, {"body": 2, "word": "ploidy", "fig": 1}, {"body": 2, "word": "difference", "fig": 1}, {"body": 2, "word": "specific", "fig": 1}, {"body": 2, "word": "except", "fig": 1}, {"body": 2, "word": "effect", "fig": 1}, {"body": 2, "word": "regulated", "fig": 1}, {"body": 1, "word": "white", "fig": 2}, {"body": 2, "word": "KO", "fig": 1}, {"body": 1, "word": "tissue", "fig": 2}, {"body": 2, "word": "sacrificed", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "asterisk", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "iodide", "fig": 1}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "recombinant", "fig": 1}, {"body": 1, "word": "MEM", "fig": 1}, {"body": 1, "word": "Ploidy", "fig": 1}, {"body": 1, "word": "Pgc1\u03b1", "fig": 1}, {"body": 1, "word": "various", "fig": 1}, {"body": 1, "word": "tendency", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "essential", "fig": 1}, {"body": 1, "word": "No", "fig": 1}, {"body": 1, "word": "combined", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Hepatic", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "deletion", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "treatments", "fig": 1}, {"body": 1, "word": "liver-specific", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076706/bin/nihms-578216-f0010.jpg", "caption": "In diabetic hyperinsulinemic mice, cyclin D1-CDK4 is dysregulated and hyperactivation of cyclin D1-CDK4 attenuates the diabetic phenotype. a) qRT-PCR analysis of gluconeogenic and Ccnd1 gene expression changes upon fasting and refeeding in Leprdb/+ (db/+) and Leprdb/db (db/db) mice livers (two-tailed unpaired t-test, n=3). b) Cyclin D1 protein is chronically elevated upon fasting and refeeding in livers of high fat diet fed mice compared to control diet fed mice. Nuclear (N) and cytoplasmic (C) liver extracts were used. c-d) Phosphorylation of GCN5 is elevated upon fasting in db/db or high fat diet fed (HFD) mice liver compared its respective control mice and it remains insensitive to fast-refed transitions. Western-blot analysis of GCN5 immnunoprecipiated by anti-phosphoS*P (pS*P) antibody using liver extracts from mice that were tail-vein injected with adenoviruses expressing GFP or GCN5 (F=16hr fast, R=4hr refed). e) Cyclin D1 and Rb phosphorylation levels in livers from db/db mice tail-vein injected with GFP, cyclin D1 T286A, or cyclin D1 K112E adenoviruses, shown in Fig. 4b-c. Nuclear and cytoplasmic liver extracts were used. f-g) Cyclin D1 T286A overexpression reduces gluconeogenic genes and glycemia in high fat diet fed mice (two-tailed unpaired t-test, n=6/GFP, n=7/D1 T286A). h) Cyclin D1 and Rb phosphorylation levels in livers of high fat diet fed mice that were tail-vein injected with adenoviruses expressing GFP or cyclin D1 T286A, shown in Extended Data Fig. 4f-g. i) Overall Model. Statistical significance is represented by asterisk corresponding to *P<0.05, **P<0.01, ***P<0.001. Data are shown as mean\u00b1S.E.M.", "co_occurrence": [{"body": 44, "word": "mice", "fig": 10}, {"body": 46, "word": "D1", "fig": 7}, {"body": 55, "word": "cyclin", "fig": 5}, {"body": 72, "word": "Fig", "fig": 2}, {"body": 31, "word": "GCN5", "fig": 3}, {"body": 41, "word": "Data", "fig": 2}, {"body": 17, "word": "liver", "fig": 4}, {"body": 27, "word": "D1-CDK4", "fig": 2}, {"body": 41, "word": "Extended", "fig": 1}, {"body": 9, "word": "T286A", "fig": 4}, {"body": 17, "word": "used", "fig": 2}, {"body": 15, "word": "gluconeogenic", "fig": 2}, {"body": 15, "word": "phosphorylation", "fig": 2}, {"body": 6, "word": "diet", "fig": 5}, {"body": 9, "word": "upon", "fig": 3}, {"body": 13, "word": "refeeding", "fig": 2}, {"body": 5, "word": "fed", "fig": 5}, {"body": 6, "word": "Cyclin", "fig": 4}, {"body": 8, "word": "fasting", "fig": 3}, {"body": 7, "word": "db/db", "fig": 3}, {"body": 5, "word": "high", "fig": 4}, {"body": 9, "word": "control", "fig": 2}, {"body": 16, "word": "antibody", "fig": 1}, {"body": 4, "word": "livers", "fig": 4}, {"body": 8, "word": "levels", "fig": 2}, {"body": 5, "word": "adenoviruses", "fig": 3}, {"body": 15, "word": "In", "fig": 1}, {"body": 7, "word": "Rb", "fig": 2}, {"body": 6, "word": "compared", "fig": 2}, {"body": 6, "word": "elevated", "fig": 2}, {"body": 3, "word": "fat", "fig": 4}, {"body": 11, "word": "genes", "fig": 1}, {"body": 11, "word": "expression", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 5, "word": "expressing", "fig": 2}, {"body": 5, "word": "diabetic", "fig": 2}, {"body": 3, "word": "injected", "fig": 3}, {"body": 8, "word": "protein", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 7, "word": "glycemia", "fig": 1}, {"body": 2, "word": "tail-vein", "fig": 3}, {"body": 6, "word": "changes", "fig": 1}, {"body": 2, "word": "GFP", "fig": 3}, {"body": 4, "word": "refed", "fig": 1}, {"body": 4, "word": "K112E", "fig": 1}, {"body": 4, "word": "gene", "fig": 1}, {"body": 4, "word": "overexpression", "fig": 1}, {"body": 3, "word": "db/+", "fig": 1}, {"body": 3, "word": "corresponding", "fig": 1}, {"body": 1, "word": "cytoplasmic", "fig": 2}, {"body": 2, "word": "transitions", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 2}, {"body": 1, "word": "t-test", "fig": 2}, {"body": 1, "word": "unpaired", "fig": 2}, {"body": 1, "word": "chronically", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "insensitive", "fig": 1}, {"body": 1, "word": "dysregulated", "fig": 1}, {"body": 1, "word": "asterisk", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "hyperactivation", "fig": 1}, {"body": 1, "word": "represented", "fig": 1}, {"body": 1, "word": "Leprdb/db", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}]}], "4780821": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g001.jpg", "caption": "Survey of Plk3 expression in the developing mouse retina. (A) A heatmap showing the expression of Plk family members in Math5-positive cells. The four E12 cells at the left are Math5-negative, but were previously identified as G2/M progenitor cells [2]. These cells are shown as a comparison. In the heatmap, the genes (in rows) expressed in isolated single retinal progenitor cells (in columns) at various stages of development from embryonic day (E)12.5 to E16.5 are shown. Higher levels of microarray signal of a given gene correspond to higher expression levels in a particular single cell and are indicated by the different shades of red (see the scale below [B]), while the absence of expression is indicated with a black square. (B) A heatmap showing G2/M cell cycle marker expression in Math5 and Plk3 expressing single cells. As in (A) the log transformed signal intensities have been scaled according to the intensity of red color, with black indicating the absence of expression signal. The eleven single cells shown on the left are included for comparison and are Plk3-negative cells that were previously identified as in the G2/M phase of the cell cycle [2]. (C) In situ hybridization of Plk3 expression in the embryonic mouse retina. (D) In situ hybridization showing the expression of Tcfap2b, Tcfap2d, and Nhlh2, markers of developing amacrine interneurons, at E14.5. (E) Double fluorescent in situ hybridization of Math5 (green) and Plk3 (red) at E14.5. The results are quantified in (F). All scale bars represent 100 \u03bcm.", "co_occurrence": [{"body": 94, "word": "cells", "fig": 8}, {"body": 77, "word": "expression", "fig": 8}, {"body": 95, "word": "Plk3", "fig": 4}, {"body": 48, "word": "cell", "fig": 3}, {"body": 24, "word": "The", "fig": 3}, {"body": 27, "word": "retina", "fig": 2}, {"body": 54, "word": "retinal", "fig": 1}, {"body": 12, "word": "A", "fig": 4}, {"body": 43, "word": "genes", "fig": 1}, {"body": 14, "word": "In", "fig": 3}, {"body": 20, "word": "Math5", "fig": 2}, {"body": 13, "word": "shown", "fig": 3}, {"body": 9, "word": "single", "fig": 4}, {"body": 11, "word": "hybridization", "fig": 3}, {"body": 11, "word": "situ", "fig": 3}, {"body": 15, "word": "progenitor", "fig": 2}, {"body": 15, "word": "mouse", "fig": 2}, {"body": 28, "word": "amacrine", "fig": 1}, {"body": 25, "word": "development", "fig": 1}, {"body": 11, "word": "cycle", "fig": 2}, {"body": 10, "word": "embryonic", "fig": 2}, {"body": 10, "word": "developing", "fig": 2}, {"body": 18, "word": "expressed", "fig": 1}, {"body": 18, "word": "gene", "fig": 1}, {"body": 5, "word": "G2/M", "fig": 3}, {"body": 14, "word": "family", "fig": 1}, {"body": 7, "word": "E14.5", "fig": 2}, {"body": 14, "word": "different", "fig": 1}, {"body": 12, "word": "markers", "fig": 1}, {"body": 12, "word": "members", "fig": 1}, {"body": 11, "word": "E16.5", "fig": 1}, {"body": 5, "word": "previously", "fig": 2}, {"body": 10, "word": "log", "fig": 1}, {"body": 10, "word": "transformed", "fig": 1}, {"body": 5, "word": "E", "fig": 2}, {"body": 5, "word": "levels", "fig": 2}, {"body": 9, "word": "isolated", "fig": 1}, {"body": 9, "word": "F", "fig": 1}, {"body": 4, "word": "absence", "fig": 2}, {"body": 4, "word": "identified", "fig": 2}, {"body": 8, "word": "stages", "fig": 1}, {"body": 7, "word": "according", "fig": 1}, {"body": 3, "word": "scale", "fig": 2}, {"body": 6, "word": "Plk", "fig": 1}, {"body": 5, "word": "phase", "fig": 1}, {"body": 5, "word": "These", "fig": 1}, {"body": 5, "word": "microarray", "fig": 1}, {"body": 4, "word": "four", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 2, "word": "B", "fig": 2}, {"body": 4, "word": "interneurons", "fig": 1}, {"body": 3, "word": "results", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "showing", "fig": 3}, {"body": 1, "word": "signal", "fig": 3}, {"body": 3, "word": "bars", "fig": 1}, {"body": 3, "word": "Nhlh2", "fig": 1}, {"body": 3, "word": "included", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "day", "fig": 1}, {"body": 2, "word": "Tcfap2b", "fig": 1}, {"body": 2, "word": "Tcfap2d", "fig": 1}, {"body": 2, "word": "various", "fig": 1}, {"body": 2, "word": "marker", "fig": 1}, {"body": 2, "word": "particular", "fig": 1}, {"body": 1, "word": "indicated", "fig": 2}, {"body": 2, "word": "All", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "color", "fig": 1}, {"body": 1, "word": "expressing", "fig": 1}, {"body": 1, "word": "fluorescent", "fig": 1}, {"body": 1, "word": "indicating", "fig": 1}, {"body": 1, "word": "As", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g002.jpg", "caption": "Morphological characterization of adult Plk3-KO retinas. Populations of adult (>P35) retinal cells were identified using antibodies to neuron-specific markers. DAPI, in blue, marks nuclei. Rod photoreceptors (anti-Rhodopsin [Rho4d2], A,A\u2019), bipolar interneurons (anti-Chx10, B,B\u2019; anti-PKC-\u03b1, C,C\u2019), M\u00fcller glia (anti-Glutamine synthetase [GS] D,D\u2019), amacrine interneurons (anti-Pax6, E,E\u2019; anti-Chat, F,F\u2019), retinal ganglion cells (anti-Brn3b, G,G\u2019), and horizontal, amacrine and ganglion cells (anti-Calretinin [Calr], anti-Calbindin28k [Calb28k], H,H\u2019) are shown. Scale bars represent 100 \u03bcm.", "co_occurrence": [{"body": 94, "word": "cells", "fig": 3}, {"body": 54, "word": "retinal", "fig": 2}, {"body": 57, "word": "retinas", "fig": 1}, {"body": 28, "word": "amacrine", "fig": 2}, {"body": 46, "word": "Plk3-KO", "fig": 1}, {"body": 18, "word": "ganglion", "fig": 2}, {"body": 23, "word": "using", "fig": 1}, {"body": 11, "word": "adult", "fig": 2}, {"body": 13, "word": "shown", "fig": 1}, {"body": 13, "word": "photoreceptors", "fig": 1}, {"body": 12, "word": "markers", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "horizontal", "fig": 1}, {"body": 9, "word": "bipolar", "fig": 1}, {"body": 9, "word": "F", "fig": 1}, {"body": 4, "word": "interneurons", "fig": 2}, {"body": 7, "word": "anti-Calretinin", "fig": 1}, {"body": 7, "word": "antibodies", "fig": 1}, {"body": 6, "word": "anti-Calbindin28k", "fig": 1}, {"body": 5, "word": "anti-Chx10", "fig": 1}, {"body": 5, "word": "anti-Brn3b", "fig": 1}, {"body": 5, "word": "glia", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 5, "word": "M\u00fcller", "fig": 1}, {"body": 5, "word": "anti-Pax6", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "identified", "fig": 1}, {"body": 3, "word": "bars", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "D\u2019", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "C\u2019", "fig": 1}, {"body": 2, "word": "E\u2019", "fig": 1}, {"body": 2, "word": "A\u2019", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "B\u2019", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "characterization", "fig": 1}, {"body": 1, "word": "anti-PKC-\u03b1", "fig": 1}, {"body": 1, "word": "Calr", "fig": 1}, {"body": 1, "word": "synthetase", "fig": 1}, {"body": 1, "word": "anti-Glutamine", "fig": 1}, {"body": 1, "word": "anti-Chat", "fig": 1}, {"body": 1, "word": "F\u2019", "fig": 1}, {"body": 1, "word": "Rho4d2", "fig": 1}, {"body": 1, "word": "Calb28k", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "anti-Rhodopsin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g003.jpg", "caption": "Assessment of cell numbers by flat mount antibody staining. To more quantitatively assess any gains/losses in cell number in the Plk3-KO retina, immunohistochemistry was performed on flat mounted retinas from adult (>P35) wildtype and Plk3-KO littermates. Confocal scans were performed on four different quadrants from each retina and representative quadrant-matched images are shown. DAPI, in blue, marks nuclei. Horizontal cells (anti-Hnf6, A,A\u2019; anti-Calbindin28k [Calb28k], B,B\u2019), amacrine interneurons (anti-Ap2a, C,C\u2019), a combination of amacrine and ganglion cells (anti-Calretinin [Calr], D,D\u2019) and retinal ganglion cells (anti-Brn3a, E,E\u2019; anti-Opn4, F,F\u2019) are shown. Scale bars represent 100 \u03bcm.", "co_occurrence": [{"body": 94, "word": "cells", "fig": 3}, {"body": 48, "word": "cell", "fig": 2}, {"body": 46, "word": "Plk3-KO", "fig": 2}, {"body": 57, "word": "retinas", "fig": 1}, {"body": 28, "word": "amacrine", "fig": 2}, {"body": 27, "word": "retina", "fig": 2}, {"body": 54, "word": "retinal", "fig": 1}, {"body": 20, "word": "performed", "fig": 2}, {"body": 18, "word": "ganglion", "fig": 2}, {"body": 13, "word": "shown", "fig": 2}, {"body": 26, "word": "To", "fig": 1}, {"body": 18, "word": "wildtype", "fig": 1}, {"body": 15, "word": "antibody", "fig": 1}, {"body": 14, "word": "littermates", "fig": 1}, {"body": 14, "word": "different", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "adult", "fig": 1}, {"body": 9, "word": "F", "fig": 1}, {"body": 8, "word": "number", "fig": 1}, {"body": 7, "word": "anti-Calretinin", "fig": 1}, {"body": 6, "word": "anti-Calbindin28k", "fig": 1}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "assess", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 4, "word": "four", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "numbers", "fig": 1}, {"body": 4, "word": "interneurons", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "combination", "fig": 1}, {"body": 3, "word": "bars", "fig": 1}, {"body": 3, "word": "anti-Brn3a", "fig": 1}, {"body": 3, "word": "D\u2019", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "B\u2019", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "E\u2019", "fig": 1}, {"body": 2, "word": "immunohistochemistry", "fig": 1}, {"body": 2, "word": "anti-Ap2a", "fig": 1}, {"body": 2, "word": "C\u2019", "fig": 1}, {"body": 2, "word": "anti-Opn4", "fig": 1}, {"body": 1, "word": "flat", "fig": 2}, {"body": 2, "word": "anti-Hnf6", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "A\u2019", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "F\u2019", "fig": 1}, {"body": 1, "word": "mounted", "fig": 1}, {"body": 1, "word": "mount", "fig": 1}, {"body": 1, "word": "Calb28k", "fig": 1}, {"body": 1, "word": "quantitatively", "fig": 1}, {"body": 1, "word": "Calr", "fig": 1}, {"body": 1, "word": "quadrants", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g004.jpg", "caption": "Morphological characterization of postnatal developing Plk3-KO retinas. Populations of retinal cells in postnatal day (P)7 Plk3-KO retinas were compared to WT littermates using cell type-specific markers. Specifically, populations of rod photoreceptors (anti-Rhodopsin [Rho4d2], A,A\u2019), bipolar cells (anti-Chx10, B,B\u2019), retinal ganglion cells (anti-Brn3b, C,C\u2019), bipolar cells, amacrine cells and ganglion cells (anti-Isl1, D, D\u2019), amacrine, horizontal and ganglion cells (anti-Pax6, E,E\u2019; anti-Calretinin [Calr], anti-Calbindin28k [Calb28k], F,F\u2019) were examined. Scale bars indicate 100 \u03bcm.", "co_occurrence": [{"body": 94, "word": "cells", "fig": 7}, {"body": 57, "word": "retinas", "fig": 2}, {"body": 54, "word": "retinal", "fig": 2}, {"body": 46, "word": "Plk3-KO", "fig": 2}, {"body": 28, "word": "amacrine", "fig": 2}, {"body": 18, "word": "ganglion", "fig": 3}, {"body": 48, "word": "cell", "fig": 1}, {"body": 25, "word": "WT", "fig": 1}, {"body": 23, "word": "using", "fig": 1}, {"body": 9, "word": "bipolar", "fig": 2}, {"body": 14, "word": "littermates", "fig": 1}, {"body": 7, "word": "postnatal", "fig": 2}, {"body": 13, "word": "indicate", "fig": 1}, {"body": 13, "word": "photoreceptors", "fig": 1}, {"body": 12, "word": "markers", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "horizontal", "fig": 1}, {"body": 10, "word": "developing", "fig": 1}, {"body": 9, "word": "F", "fig": 1}, {"body": 8, "word": "rod", "fig": 1}, {"body": 8, "word": "populations", "fig": 1}, {"body": 7, "word": "examined", "fig": 1}, {"body": 7, "word": "anti-Calretinin", "fig": 1}, {"body": 6, "word": "anti-Calbindin28k", "fig": 1}, {"body": 5, "word": "anti-Chx10", "fig": 1}, {"body": 5, "word": "anti-Brn3b", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 5, "word": "anti-Pax6", "fig": 1}, {"body": 4, "word": "compared", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 3, "word": "bars", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "anti-Isl1", "fig": 1}, {"body": 3, "word": "D\u2019", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "C\u2019", "fig": 1}, {"body": 2, "word": "E\u2019", "fig": 1}, {"body": 2, "word": "A\u2019", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "day", "fig": 1}, {"body": 2, "word": "B\u2019", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "characterization", "fig": 1}, {"body": 1, "word": "Calr", "fig": 1}, {"body": 1, "word": "F\u2019", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "Rho4d2", "fig": 1}, {"body": 1, "word": "Calb28k", "fig": 1}, {"body": 1, "word": "anti-Rhodopsin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g005.jpg", "caption": "Survey of retinal cell types in P4 Plk3-KO retinas. Populations of retinal cells in P4 Plk3-KO retinas were compared to WT littermates using cell type-specific markers for photoreceptors (anti-Recoverin, A,A\u2019), bipolar cells (anti-Chx10, B,B\u2019), retinal ganglion cells (anti-Brn3b, C,C\u2019), ganglion and amacrine cells (anti-Isl1, D,D\u2019; anti-Pax6, E,E\u2019) and amacrine, horizontal and ganglion cells (anti-Calretinin [Calr], anti-Calbindin28k [Calb28k], F,F\u2019). Scale bars indicate 100 \u03bcm.", "co_occurrence": [{"body": 94, "word": "cells", "fig": 5}, {"body": 54, "word": "retinal", "fig": 3}, {"body": 57, "word": "retinas", "fig": 2}, {"body": 48, "word": "cell", "fig": 2}, {"body": 46, "word": "Plk3-KO", "fig": 2}, {"body": 28, "word": "amacrine", "fig": 2}, {"body": 18, "word": "ganglion", "fig": 3}, {"body": 25, "word": "WT", "fig": 1}, {"body": 23, "word": "using", "fig": 1}, {"body": 14, "word": "littermates", "fig": 1}, {"body": 13, "word": "indicate", "fig": 1}, {"body": 13, "word": "photoreceptors", "fig": 1}, {"body": 12, "word": "markers", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "horizontal", "fig": 1}, {"body": 9, "word": "bipolar", "fig": 1}, {"body": 9, "word": "F", "fig": 1}, {"body": 7, "word": "anti-Calretinin", "fig": 1}, {"body": 7, "word": "types", "fig": 1}, {"body": 6, "word": "anti-Calbindin28k", "fig": 1}, {"body": 5, "word": "anti-Chx10", "fig": 1}, {"body": 5, "word": "anti-Brn3b", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 5, "word": "anti-Pax6", "fig": 1}, {"body": 4, "word": "compared", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 2, "word": "P4", "fig": 2}, {"body": 3, "word": "bars", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "anti-Isl1", "fig": 1}, {"body": 3, "word": "D\u2019", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "C\u2019", "fig": 1}, {"body": 2, "word": "E\u2019", "fig": 1}, {"body": 2, "word": "A\u2019", "fig": 1}, {"body": 2, "word": "anti-Recoverin", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "B\u2019", "fig": 1}, {"body": 1, "word": "Calr", "fig": 1}, {"body": 1, "word": "F\u2019", "fig": 1}, {"body": 1, "word": "Calb28k", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g006.jpg", "caption": "Survey of retinal cell types in P14 Plk3-KO retinas. Populations of retinal cells in P14 Plk3-KO retinas were compared to WT littermates using cell type-specific markers for rod photoreceptors (anti-Rhodopsin [Rho4d2], A,A\u2019), bipolar cells (anti-Chx10, B,B\u2019), retinal ganglion cells (anti-Brn3b, C,C\u2019), ganglion and amacrine cells (anti-Isl1, D,D\u2019; anti-Pax6, E,E\u2019) and amacrine, horizontal and ganglion cells (anti-Calretinin [Calr], anti-Calbindin28k [Calb28k], F,F\u2019). Scale bars indicate 100 \u03bcm.", "co_occurrence": [{"body": 94, "word": "cells", "fig": 5}, {"body": 54, "word": "retinal", "fig": 3}, {"body": 57, "word": "retinas", "fig": 2}, {"body": 48, "word": "cell", "fig": 2}, {"body": 46, "word": "Plk3-KO", "fig": 2}, {"body": 28, "word": "amacrine", "fig": 2}, {"body": 18, "word": "ganglion", "fig": 3}, {"body": 25, "word": "WT", "fig": 1}, {"body": 23, "word": "using", "fig": 1}, {"body": 14, "word": "littermates", "fig": 1}, {"body": 13, "word": "photoreceptors", "fig": 1}, {"body": 13, "word": "indicate", "fig": 1}, {"body": 12, "word": "markers", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "horizontal", "fig": 1}, {"body": 9, "word": "bipolar", "fig": 1}, {"body": 9, "word": "F", "fig": 1}, {"body": 8, "word": "rod", "fig": 1}, {"body": 7, "word": "anti-Calretinin", "fig": 1}, {"body": 7, "word": "types", "fig": 1}, {"body": 6, "word": "anti-Calbindin28k", "fig": 1}, {"body": 5, "word": "anti-Chx10", "fig": 1}, {"body": 5, "word": "anti-Brn3b", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 5, "word": "anti-Pax6", "fig": 1}, {"body": 4, "word": "compared", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 3, "word": "bars", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "anti-Isl1", "fig": 1}, {"body": 3, "word": "D\u2019", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "C\u2019", "fig": 1}, {"body": 2, "word": "E\u2019", "fig": 1}, {"body": 2, "word": "A\u2019", "fig": 1}, {"body": 1, "word": "P14", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "B\u2019", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "Calr", "fig": 1}, {"body": 1, "word": "F\u2019", "fig": 1}, {"body": 1, "word": "Rho4d2", "fig": 1}, {"body": 1, "word": "Calb28k", "fig": 1}, {"body": 1, "word": "anti-Rhodopsin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g007.jpg", "caption": "qPCR based examination of gene expression in Plk3-KO retinas. Retinas of Plk3-KO and WT littermates were isolated and hybridized to Affymetrix microarrays at various timepoints (n = 3 for each of four timepoints). Genes with significant differential expression at multiple timepoints were confirmed using qPCR at adult timepoints. (A) An examination of Plk3 expression in the Plk3 deficient mouse. An amplicon at the 3\u2019 end of the gene showed upregulation (p<0.001), while one at the 5\u2019 end of Plk3 was significantly downregulated (p<0.05). (B) Tac1 showed decreased expression (p<0.05), whereas retinitis pigmentosa 1 (Rp1) displayed increased expression (p<0.05).", "co_occurrence": [{"body": 77, "word": "expression", "fig": 5}, {"body": 95, "word": "Plk3", "fig": 3}, {"body": 46, "word": "Plk3-KO", "fig": 2}, {"body": 57, "word": "retinas", "fig": 1}, {"body": 9, "word": "p", "fig": 4}, {"body": 18, "word": "gene", "fig": 2}, {"body": 25, "word": "WT", "fig": 1}, {"body": 23, "word": "using", "fig": 1}, {"body": 10, "word": "qPCR", "fig": 2}, {"body": 20, "word": "n", "fig": 1}, {"body": 16, "word": "significant", "fig": 1}, {"body": 15, "word": "mouse", "fig": 1}, {"body": 14, "word": "littermates", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 6, "word": "showed", "fig": 2}, {"body": 12, "word": "differential", "fig": 1}, {"body": 3, "word": "timepoints", "fig": 4}, {"body": 11, "word": "adult", "fig": 1}, {"body": 11, "word": "deficient", "fig": 1}, {"body": 9, "word": "isolated", "fig": 1}, {"body": 8, "word": "significantly", "fig": 1}, {"body": 7, "word": "confirmed", "fig": 1}, {"body": 7, "word": "multiple", "fig": 1}, {"body": 6, "word": "Affymetrix", "fig": 1}, {"body": 4, "word": "downregulated", "fig": 1}, {"body": 4, "word": "four", "fig": 1}, {"body": 2, "word": "end", "fig": 2}, {"body": 4, "word": "Retinas", "fig": 1}, {"body": 4, "word": "one", "fig": 1}, {"body": 4, "word": "Tac1", "fig": 1}, {"body": 3, "word": "whereas", "fig": 1}, {"body": 3, "word": "Rp1", "fig": 1}, {"body": 2, "word": "microarrays", "fig": 1}, {"body": 1, "word": "An", "fig": 2}, {"body": 2, "word": "upregulation", "fig": 1}, {"body": 1, "word": "examination", "fig": 2}, {"body": 2, "word": "pigmentosa", "fig": 1}, {"body": 2, "word": "various", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "decreased", "fig": 1}, {"body": 2, "word": "retinitis", "fig": 1}, {"body": 1, "word": "Genes", "fig": 1}, {"body": 1, "word": "increased", "fig": 1}, {"body": 1, "word": "displayed", "fig": 1}, {"body": 1, "word": "hybridized", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780821/bin/pone.0150878.g008.jpg", "caption": "Examination of Plk family member expression patterns and cell cycle at E14.5. The expression patterns of Plk3 (A, A\u2019), Plk1 (B,B\u2019), Plk2 (C,C\u2019), and Plk4 (D,D\u2019) in WT and Plk3-KO retinas were determined using in situ hybridization at E14.5. E14.5 developing WT and Plk3-KO retinas were also stained using anti-phospho-histone H3 (PH3) to mark mitotic cells (E,E\u2019).", "co_occurrence": [{"body": 77, "word": "expression", "fig": 2}, {"body": 57, "word": "retinas", "fig": 2}, {"body": 95, "word": "Plk3", "fig": 1}, {"body": 94, "word": "cells", "fig": 1}, {"body": 46, "word": "Plk3-KO", "fig": 2}, {"body": 25, "word": "WT", "fig": 2}, {"body": 48, "word": "cell", "fig": 1}, {"body": 23, "word": "using", "fig": 2}, {"body": 24, "word": "The", "fig": 1}, {"body": 7, "word": "E14.5", "fig": 3}, {"body": 8, "word": "patterns", "fig": 2}, {"body": 14, "word": "family", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "situ", "fig": 1}, {"body": 11, "word": "also", "fig": 1}, {"body": 11, "word": "hybridization", "fig": 1}, {"body": 11, "word": "cycle", "fig": 1}, {"body": 10, "word": "developing", "fig": 1}, {"body": 6, "word": "Plk", "fig": 1}, {"body": 5, "word": "E", "fig": 1}, {"body": 5, "word": "Plk2", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "Plk1", "fig": 1}, {"body": 3, "word": "D\u2019", "fig": 1}, {"body": 2, "word": "C\u2019", "fig": 1}, {"body": 2, "word": "A\u2019", "fig": 1}, {"body": 2, "word": "member", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "B\u2019", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "E\u2019", "fig": 1}, {"body": 1, "word": "anti-phospho-histone", "fig": 1}, {"body": 1, "word": "H3", "fig": 1}, {"body": 1, "word": "mitotic", "fig": 1}, {"body": 1, "word": "Examination", "fig": 1}, {"body": 1, "word": "Plk4", "fig": 1}]}], "4490096": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f1.jpg", "caption": "Bioinformatic analysis of the ER N-end rule pathway, and the generation of antibodies to the arginylated form of the ER chaperone BiP. (a) A summary of this study that describes a dual role for the Nt-Arg residue as a degron for both the UPS and autophagy. The Nt-Arg residue generated through the N-end rule pathway is known to act as a degron for selective proteolysis by the UPS. In the Ub-dependent N-end rule pathway, specific recognition components, called N-recognins, recognize and bind the primary degron Nt-Arg and mediate ubiquitination for targeting to the proteasome. The results of this study show that N-terminal arginylation of ER-residing chaperons generates a cis-acting delivery determinant and degron for lysosomal degradation along with associated cargoes. In this autophagic proteolysis, Nt-Arg of BiP and other ER proteins is recognized by a recognin, the autophagic adaptor p62. The binding of Nt-Arg to p62 activates p62, leading to the delivery of p62, R-BiP, and its cargoes to autophagosomes. In definition, Nt-Arg also acts as a trans-acting degron for its cargoes. (b) A sequence alignment of the N-terminal regions of human BiP and its sequelogs. The red box indicates the N-terminal residues (P1\u2032 sites) of mature BiP proteins from various species. Shown above are secondary structures (solid line, \u03b1helices; arrows, \u03b2strands). (c) Generation of anti-R-BiP DH1 antibody. Shown is a peptide binding/competition assay. An 11-mer R-BiP peptide (R-BiP-peptide) corresponding to the N-terminal region of R-BiP was immobilized on a 96-well plate, followed by incubation with serially diluted anti-R-BiP antibody and, subsequently, anti-goat secondary antibody conjugated with horseradish peroxide. The amounts of R-BiP antibody that bound to immobilized R-BiP peptide were determined based on O.D. value at 450 nm of secondary antibody. As a control, BiP-peptide, a 10-mer peptide corresponding to the N-terminal region of unarginylated BiP, was used. (d) A dot blotting analysis of R-BiP antibody using the peptides corresponding to the N-terminal region of unarginylated (left) or arginylated (right) BiP.", "co_occurrence": [{"body": 60, "word": "R-BiP", "fig": 6}, {"body": 75, "word": "p62", "fig": 4}, {"body": 38, "word": "BiP", "fig": 6}, {"body": 35, "word": "N-terminal", "fig": 6}, {"body": 37, "word": "The", "fig": 5}, {"body": 30, "word": "Nt-Arg", "fig": 6}, {"body": 44, "word": "proteins", "fig": 2}, {"body": 17, "word": "peptide", "fig": 4}, {"body": 22, "word": "ER", "fig": 3}, {"body": 8, "word": "antibody", "fig": 6}, {"body": 23, "word": "autophagic", "fig": 2}, {"body": 14, "word": "In", "fig": 3}, {"body": 18, "word": "arginylated", "fig": 2}, {"body": 33, "word": "using", "fig": 1}, {"body": 11, "word": "N-end", "fig": 3}, {"body": 11, "word": "rule", "fig": 3}, {"body": 16, "word": "analysis", "fig": 2}, {"body": 31, "word": "arginylation", "fig": 1}, {"body": 6, "word": "degron", "fig": 5}, {"body": 8, "word": "cargoes", "fig": 3}, {"body": 8, "word": "A", "fig": 3}, {"body": 11, "word": "delivery", "fig": 2}, {"body": 21, "word": "binding", "fig": 1}, {"body": 6, "word": "pathway", "fig": 3}, {"body": 14, "word": "autophagy", "fig": 1}, {"body": 7, "word": "residue", "fig": 2}, {"body": 13, "word": "followed", "fig": 1}, {"body": 12, "word": "autophagosomes", "fig": 1}, {"body": 6, "word": "immobilized", "fig": 2}, {"body": 11, "word": "antibodies", "fig": 1}, {"body": 10, "word": "degradation", "fig": 1}, {"body": 5, "word": "study", "fig": 2}, {"body": 3, "word": "secondary", "fig": 3}, {"body": 9, "word": "various", "fig": 1}, {"body": 9, "word": "role", "fig": 1}, {"body": 9, "word": "residues", "fig": 1}, {"body": 8, "word": "results", "fig": 1}, {"body": 4, "word": "proteolysis", "fig": 2}, {"body": 8, "word": "peptides", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "incubation", "fig": 1}, {"body": 7, "word": "determinant", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 7, "word": "generated", "fig": 1}, {"body": 6, "word": "show", "fig": 1}, {"body": 6, "word": "human", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 2, "word": "corresponding", "fig": 3}, {"body": 6, "word": "known", "fig": 1}, {"body": 6, "word": "determined", "fig": 1}, {"body": 6, "word": "also", "fig": 1}, {"body": 6, "word": "DH1", "fig": 1}, {"body": 2, "word": "region", "fig": 3}, {"body": 5, "word": "ER-residing", "fig": 1}, {"body": 5, "word": "bound", "fig": 1}, {"body": 5, "word": "targeting", "fig": 1}, {"body": 5, "word": "associated", "fig": 1}, {"body": 5, "word": "nm", "fig": 1}, {"body": 4, "word": "lysosomal", "fig": 1}, {"body": 4, "word": "species", "fig": 1}, {"body": 3, "word": "plate", "fig": 1}, {"body": 3, "word": "selective", "fig": 1}, {"body": 3, "word": "primary", "fig": 1}, {"body": 3, "word": "leading", "fig": 1}, {"body": 3, "word": "ubiquitination", "fig": 1}, {"body": 3, "word": "subsequently", "fig": 1}, {"body": 2, "word": "conjugated", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "peroxide", "fig": 1}, {"body": 1, "word": "UPS", "fig": 2}, {"body": 2, "word": "diluted", "fig": 1}, {"body": 2, "word": "recognized", "fig": 1}, {"body": 1, "word": "anti-R-BiP", "fig": 2}, {"body": 1, "word": "unarginylated", "fig": 2}, {"body": 2, "word": "adaptor", "fig": 1}, {"body": 2, "word": "mature", "fig": 1}, {"body": 2, "word": "called", "fig": 1}, {"body": 2, "word": "bind", "fig": 1}, {"body": 2, "word": "As", "fig": 1}, {"body": 2, "word": "components", "fig": 1}, {"body": 1, "word": "blotting", "fig": 1}, {"body": 1, "word": "based", "fig": 1}, {"body": 1, "word": "trans-acting", "fig": 1}, {"body": 1, "word": "proteasome", "fig": 1}, {"body": 1, "word": "summary", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "11-mer", "fig": 1}, {"body": 1, "word": "O.D", "fig": 1}, {"body": 1, "word": "96-well", "fig": 1}, {"body": 1, "word": "recognition", "fig": 1}, {"body": 1, "word": "horseradish", "fig": 1}, {"body": 1, "word": "P1\u2032", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "binding/competition", "fig": 1}, {"body": 1, "word": "mediate", "fig": 1}, {"body": 1, "word": "structures", "fig": 1}, {"body": 1, "word": "form", "fig": 1}, {"body": 1, "word": "value", "fig": 1}, {"body": 1, "word": "N-recognins", "fig": 1}, {"body": 1, "word": "cis-acting", "fig": 1}, {"body": 1, "word": "Bioinformatic", "fig": 1}, {"body": 1, "word": "10-mer", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}, {"body": 1, "word": "dot", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f2.jpg", "caption": "ATE1-dependent N-terminal arginylation of multiple ER-residing proteins is induced by cytosolic foreign dsDNA. (a) BiP is N-terminally arginylated at Nt-Glu19. HeLa cells were transfected with a plasmid expressing X-BiP-flag wherein the flag epitope was inserted between BiP protein body and the C-terminal KDEL sequence. (b) Schematic diagrams of full length BiP in comparison with Ub-X-BiP-myc/his in which Ub is C-terminally conjugated with N-terminal X residue (X= Glu, Arg-Glu, Val) of BiP-myc/his. In the Ub fusion technique, Ub-X-BiP-myc/his is cotranslationally cleaved by Ub hydrolases at the Ub-BiP junction, producing Ub and X-BiP-myc/his. (c) ATE11A7A promotes N-terminal arginylation of Glu19-BiP-myc/his in HEK293 cells cotranslationally generated from Ub-X-BiP-myc/his (X= Arg-Glu19, Glu19, or Val19). (d) N-terminal arginylation of X-BiP-myc/his (X= Arg-Glu19 or Glu19) was measured in ATE1\u2212/\u2212 MEFs transiently expressing an ATE1 isoform (ATE11B7A, ATE11B7B, or ATE11A7A) which contains either of alternatively spliced exons (1A, 1B, 7A, and 7B). (e) N-terminal arginylation of endogenous BiP was measured in HeLa cells expressing an ATE1 isoform. (f) ATE1-knockdown inhibits the N-terminal arginylation of BiP in HeLa cells expressing ATE11A7A. (g) N-terminal arginylation of endogenous BiP is not induced by thapsigargin (200 nM) but by overexpressing ATE11A7A in HeLa cells. (h) Cell fractionation assay shows that R-BiP localizes to the cytosol. To, total extracts; Cyt, cytosolic fraction; Mic, microsomal fraction. (i) Lumenal BiP is short-lived, and endogenous R-BiP generated by ATE11A7A exhibits a longer half-life. HeLa cells expressing ATE11A7A were treated with 10 \u03bcg/ml cycloheximide, followed by time-course immunoblotting. (j\u2013k) N-terminal arginylation of BiP and CRT is induced by the transfection of dsDNAs. Cells were incubated with various types of nucleic acids in the presence or absence of Lipofectamine LTX. Salmo. sp. DNA, Salmon sperm DNA. (l) DNA-induced R-BiP is cytosolic and down-regulated by ATE1-knockdown. HeLa cells were co-transfected with ATE1 siRNA #204 and a plasmid expressing NHK-GFP, followed by fractionation of cytosolic proteins. (m) N-terminal arginylation of BiP and CRT is induced by poly(dA:dT) dsDNA but not by 5\u2032ppp-dsRNA. (n\u2013q) N-terminal arginylation of ER proteins is triggered by poly(dA:dT) (n), coinduced with autophagy in poly(dA:dT)-treated HeLa cells (o), facilitated by overexpressing ATE11A7A (p), and induced by the transfection of various dsDNAs (q). mNHK-GFP, GFP-fused mouse \u03b11-antitrypsin null Hong-Kong.", "co_occurrence": [{"body": 35, "word": "N-terminal", "fig": 10}, {"body": 38, "word": "BiP", "fig": 9}, {"body": 31, "word": "arginylation", "fig": 9}, {"body": 33, "word": "cells", "fig": 8}, {"body": 60, "word": "R-BiP", "fig": 3}, {"body": 44, "word": "proteins", "fig": 3}, {"body": 26, "word": "cytosolic", "fig": 4}, {"body": 6, "word": "HeLa", "fig": 7}, {"body": 6, "word": "expressing", "fig": 6}, {"body": 7, "word": "induced", "fig": 5}, {"body": 13, "word": "followed", "fig": 2}, {"body": 8, "word": "dT", "fig": 3}, {"body": 8, "word": "dA", "fig": 3}, {"body": 12, "word": "CRT", "fig": 2}, {"body": 8, "word": "ATE1", "fig": 3}, {"body": 22, "word": "ER", "fig": 1}, {"body": 3, "word": "ATE11A7A", "fig": 7}, {"body": 7, "word": "poly", "fig": 3}, {"body": 20, "word": "To", "fig": 1}, {"body": 9, "word": "various", "fig": 2}, {"body": 9, "word": "DNA", "fig": 2}, {"body": 18, "word": "arginylated", "fig": 1}, {"body": 4, "word": "Ub", "fig": 4}, {"body": 14, "word": "protein", "fig": 1}, {"body": 7, "word": "generated", "fig": 2}, {"body": 14, "word": "In", "fig": 1}, {"body": 14, "word": "autophagy", "fig": 1}, {"body": 4, "word": "endogenous", "fig": 3}, {"body": 6, "word": "dsDNA", "fig": 2}, {"body": 6, "word": "plasmid", "fig": 2}, {"body": 11, "word": "MEFs", "fig": 1}, {"body": 10, "word": "mouse", "fig": 1}, {"body": 5, "word": "transfection", "fig": 2}, {"body": 9, "word": "extracts", "fig": 1}, {"body": 3, "word": "X=", "fig": 3}, {"body": 9, "word": "incubated", "fig": 1}, {"body": 8, "word": "Cell", "fig": 1}, {"body": 7, "word": "X", "fig": 1}, {"body": 7, "word": "residue", "fig": 1}, {"body": 7, "word": "g", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "HEK293", "fig": 1}, {"body": 7, "word": "immunoblotting", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 3, "word": "cotranslationally", "fig": 2}, {"body": 6, "word": "Glu", "fig": 1}, {"body": 5, "word": "Val", "fig": 1}, {"body": 5, "word": "cytosol", "fig": 1}, {"body": 5, "word": "ER-residing", "fig": 1}, {"body": 5, "word": "thapsigargin", "fig": 1}, {"body": 4, "word": "ATE1\u2212/\u2212", "fig": 1}, {"body": 4, "word": "\u03bcg/ml", "fig": 1}, {"body": 4, "word": "absence", "fig": 1}, {"body": 4, "word": "Lipofectamine", "fig": 1}, {"body": 4, "word": "DNA-induced", "fig": 1}, {"body": 4, "word": "transfected", "fig": 1}, {"body": 2, "word": "ATE1-knockdown", "fig": 2}, {"body": 2, "word": "measured", "fig": 2}, {"body": 4, "word": "N-terminally", "fig": 1}, {"body": 1, "word": "Ub-X-BiP-myc/his", "fig": 3}, {"body": 3, "word": "foreign", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "wherein", "fig": 1}, {"body": 3, "word": "multiple", "fig": 1}, {"body": 3, "word": "cycloheximide", "fig": 1}, {"body": 3, "word": "C-terminal", "fig": 1}, {"body": 1, "word": "dsDNAs", "fig": 2}, {"body": 2, "word": "n", "fig": 1}, {"body": 2, "word": "conjugated", "fig": 1}, {"body": 2, "word": "Arg-Glu", "fig": 1}, {"body": 2, "word": "Nt-Glu19", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "either", "fig": 1}, {"body": 2, "word": "h", "fig": 1}, {"body": 1, "word": "fractionation", "fig": 2}, {"body": 2, "word": "short-lived", "fig": 1}, {"body": 2, "word": "coinduced", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 1, "word": "isoform", "fig": 2}, {"body": 1, "word": "fraction", "fig": 2}, {"body": 2, "word": "triggered", "fig": 1}, {"body": 2, "word": "transiently", "fig": 1}, {"body": 2, "word": "half-life", "fig": 1}, {"body": 2, "word": "nM", "fig": 1}, {"body": 1, "word": "overexpressing", "fig": 2}, {"body": 2, "word": "KDEL", "fig": 1}, {"body": 2, "word": "cleaved", "fig": 1}, {"body": 2, "word": "inserted", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 2, "word": "longer", "fig": 1}, {"body": 1, "word": "sperm", "fig": 1}, {"body": 1, "word": "C-terminally", "fig": 1}, {"body": 1, "word": "Cells", "fig": 1}, {"body": 1, "word": "fusion", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "full", "fig": 1}, {"body": 1, "word": "NHK-GFP", "fig": 1}, {"body": 1, "word": "o", "fig": 1}, {"body": 1, "word": "length", "fig": 1}, {"body": 1, "word": "1A", "fig": 1}, {"body": 1, "word": "hydrolases", "fig": 1}, {"body": 1, "word": "contains", "fig": 1}, {"body": 1, "word": "LTX", "fig": 1}, {"body": 1, "word": "ATE11B7B", "fig": 1}, {"body": 1, "word": "BiP-myc/his", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "promotes", "fig": 1}, {"body": 1, "word": "siRNA", "fig": 1}, {"body": 1, "word": "7A", "fig": 1}, {"body": 1, "word": "m", "fig": 1}, {"body": 1, "word": "q", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f3.jpg", "caption": "R-BiP is targeted to the autophagosome via p62 bodies. Scale bars, 10 \u03bcm. (a) Colocalization of cytoplasmic R-BiP puncta with p62 puncta in poly(dA:dT)-treated HeLa cells. (b) Colocalization of R-BiP puncta with LC3 puncta in HeLa cells stably expressing RFP-GFP-LC3 as determined by immunostaining of R-BiP in comparison with RFP signal (red) which represents LC3-positive autophagic vacuoles. (c) Three color colocalization analysis between R-BiP (blue), p62 (red), and LC3 (green) in poly(dA:dT)-treated HeLa cells. (d) HeLa cells expressing RFP-GFP-LC3 were subjected to three color colocalization analysis between R-BiP (blue), acid-resistant RFP (red), and acid-sensitive GFP (green). Most R-BiP puncta show a strong colocalization with LC3 puncta which are positive for both RFP and GFP, indicating the delivery of R-BiP to autophagosomes. (e) Immunohistochemistry of total BiP and LC3 on sections of mouse embryonic hearts at embryonic day 13.5, which reveals BiP puncta that colocalize with LC3 puncta. (f) RNA interference assay of ATE1, BiP, and p62 in poly(dA:dT)-treated HeLa cells, followed by colocalization analysis between R-BiP and p62. Note that knockdown of any of ATE1, BiP, and p62 disrupts the targeting of both R-BiP and p62 to autophagic vacuoles. (g) RNA interference assay of ATE1 and BiP in poly(dA:dT)-treated HeLa cells expressing RFP-GFP-LC3, followed by colocalization analysis between R-BiP and LC3. (h) RNA interference assay of LC3 in poly(dA:dT)-treated HeLa cells, followed by colocalization analysis between R-BiP, p62, and LC3. LC3-knockdown apparently did not affect significantly the delivery of R-BiP to p62 puncta.", "co_occurrence": [{"body": 60, "word": "R-BiP", "fig": 13}, {"body": 75, "word": "p62", "fig": 9}, {"body": 33, "word": "cells", "fig": 7}, {"body": 38, "word": "BiP", "fig": 5}, {"body": 19, "word": "puncta", "fig": 9}, {"body": 17, "word": "LC3", "fig": 8}, {"body": 16, "word": "analysis", "fig": 5}, {"body": 23, "word": "autophagic", "fig": 2}, {"body": 6, "word": "HeLa", "fig": 7}, {"body": 8, "word": "dA", "fig": 5}, {"body": 8, "word": "dT", "fig": 5}, {"body": 13, "word": "followed", "fig": 3}, {"body": 7, "word": "poly", "fig": 5}, {"body": 5, "word": "colocalization", "fig": 6}, {"body": 8, "word": "ATE1", "fig": 3}, {"body": 11, "word": "delivery", "fig": 2}, {"body": 7, "word": "assay", "fig": 3}, {"body": 6, "word": "expressing", "fig": 3}, {"body": 12, "word": "autophagosomes", "fig": 1}, {"body": 5, "word": "vacuoles", "fig": 2}, {"body": 10, "word": "mouse", "fig": 1}, {"body": 3, "word": "interference", "fig": 3}, {"body": 3, "word": "RNA", "fig": 3}, {"body": 7, "word": "indicating", "fig": 1}, {"body": 7, "word": "signal", "fig": 1}, {"body": 7, "word": "g", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 7, "word": "bodies", "fig": 1}, {"body": 6, "word": "show", "fig": 1}, {"body": 6, "word": "determined", "fig": 1}, {"body": 5, "word": "targeting", "fig": 1}, {"body": 2, "word": "embryonic", "fig": 2}, {"body": 4, "word": "targeted", "fig": 1}, {"body": 2, "word": "color", "fig": 2}, {"body": 2, "word": "Colocalization", "fig": 2}, {"body": 1, "word": "RFP-GFP-LC3", "fig": 3}, {"body": 3, "word": "total", "fig": 1}, {"body": 1, "word": "red", "fig": 3}, {"body": 1, "word": "RFP", "fig": 3}, {"body": 3, "word": "colocalize", "fig": 1}, {"body": 3, "word": "via", "fig": 1}, {"body": 3, "word": "LC3-positive", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 2, "word": "subjected", "fig": 1}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "h", "fig": 1}, {"body": 1, "word": "blue", "fig": 2}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 1, "word": "GFP", "fig": 2}, {"body": 1, "word": "green", "fig": 2}, {"body": 1, "word": "stably", "fig": 1}, {"body": 1, "word": "affect", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "represents", "fig": 1}, {"body": 1, "word": "significantly", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "knockdown", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "LC3-knockdown", "fig": 1}, {"body": 1, "word": "hearts", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f4.jpg", "caption": "The Nt-Arg residue of R-Bip is a delivery determinant to the autophagosome. (a) A schematic diagram showing that the Ub fusion protein Ub-X-BiP-GFP is cotranslationally cleaved into Ub and X-BiP-GFP by Ub hydrolases. Also shown is how Ub-X-BiP19\u2013124-GFP (Ub-X-BiP\u0394-GFP) is cotranslationally cleaved into Ub and X-BiP\u0394-GFP. (b) Colocalization analysis between X-BiP-GFP (X= Arg (an arginylated form of Glu-BiP, Arg-Glu-BiP) or Val (a Glu-to-Val mutant, Val-BiP-GFP)) and p62 in HeLa cells. X-BiP-GFP is produced in vivo from a precursor protein, Ub-X-BiP-GFP, which is elaborated in a. Scale bar, 10 \u03bcm. (c) An analogous colocalization assay with X-BiP-RFP and LC3. Scale bar, 10 \u03bcm. (d) Puncta colocalization analysis of X-BiP19\u2013124-GFP (X-BiP\u0394-GFP; X= Arg, Glu, and Val) and p62 in +/+ and p62\u2212/\u2212 MEFs. Note that the ability of X-BiP\u0394-GFP to form cytosolic puncta not only follows the N-end rule but also requires p62. Scale bar, 10 \u03bcm. (e) Puncta colocalization analysis of X-BiP\u0394-GFP and LC3 in +/+ and p62\u2212/\u2212 MEFs, which shows that the colocalization of R-BiP puncta with LC3 depends on both the N-end rule and p62. Scale bar, 10 \u03bcm. (f) Quantitation of d and e indicating that the ability of R-BiP to form cytosolic puncta depends on p62. The graph shows the percentage of BiP\u0394-GFP-positive cells that form BiP\u0394-GFP punta. Mean +/\u2212 s.d. of n=3 independent experiments in which 200 cells were analysed per experimental point. Statistical significance was calculated using a one-way ANOVA test (N.S. p > 0.05; **** p < 0.0001).", "co_occurrence": [{"body": 75, "word": "p62", "fig": 5}, {"body": 60, "word": "R-BiP", "fig": 2}, {"body": 33, "word": "cells", "fig": 3}, {"body": 37, "word": "The", "fig": 2}, {"body": 19, "word": "puncta", "fig": 3}, {"body": 26, "word": "cytosolic", "fig": 2}, {"body": 17, "word": "LC3", "fig": 3}, {"body": 16, "word": "analysis", "fig": 3}, {"body": 33, "word": "using", "fig": 1}, {"body": 30, "word": "Nt-Arg", "fig": 1}, {"body": 14, "word": "protein", "fig": 2}, {"body": 11, "word": "MEFs", "fig": 2}, {"body": 11, "word": "N-end", "fig": 2}, {"body": 11, "word": "rule", "fig": 2}, {"body": 5, "word": "colocalization", "fig": 4}, {"body": 18, "word": "arginylated", "fig": 1}, {"body": 4, "word": "Ub", "fig": 4}, {"body": 6, "word": "Arg", "fig": 2}, {"body": 11, "word": "delivery", "fig": 1}, {"body": 5, "word": "Val", "fig": 2}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "indicating", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 7, "word": "residue", "fig": 1}, {"body": 7, "word": "determinant", "fig": 1}, {"body": 6, "word": "HeLa", "fig": 1}, {"body": 6, "word": "also", "fig": 1}, {"body": 3, "word": "cotranslationally", "fig": 2}, {"body": 3, "word": "p62\u2212/\u2212", "fig": 2}, {"body": 3, "word": "X=", "fig": 2}, {"body": 6, "word": "Glu", "fig": 1}, {"body": 5, "word": "mutant", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 4}, {"body": 2, "word": "d", "fig": 2}, {"body": 4, "word": "shown", "fig": 1}, {"body": 1, "word": "form", "fig": 4}, {"body": 2, "word": "e", "fig": 2}, {"body": 2, "word": "cleaved", "fig": 2}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 1, "word": "X-BiP-GFP", "fig": 3}, {"body": 3, "word": "independent", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "point", "fig": 1}, {"body": 2, "word": "follows", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 1, "word": "Ub-X-BiP-GFP", "fig": 2}, {"body": 1, "word": "ability", "fig": 2}, {"body": 2, "word": "Ub-X-BiP19\u2013124-GFP", "fig": 1}, {"body": 2, "word": "vivo", "fig": 1}, {"body": 2, "word": "Colocalization", "fig": 1}, {"body": 2, "word": "requires", "fig": 1}, {"body": 1, "word": "produced", "fig": 1}, {"body": 1, "word": "fusion", "fig": 1}, {"body": 1, "word": "s.d", "fig": 1}, {"body": 1, "word": "one-way", "fig": 1}, {"body": 1, "word": "precursor", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "hydrolases", "fig": 1}, {"body": 1, "word": "percentage", "fig": 1}, {"body": 1, "word": "R-Bip", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "Glu-to-Val", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f5.jpg", "caption": "The Nt-Arg residue of R-BiP binds to the ZZ domain of p62. (a) The sequences of X-BiP peptides used to pulldown p62. (b) The Nt-Arg residue of R-Bip binds to p62. X-BiP peptides crosslinked to beads were used to pulldown p62 from HEK293 cell extracts transiently expressing p62. (c) Similar to b except that X-nsP4 peptides (X= Arg, Phe, and Val) were used. (d) A diagram showing C-terminally (D1-D4) and N-terminally (D5-D7) deleted p62 mutant proteins. (e) R-BiP peptide pulldown assay with serially deleted p62 mutants. (f) R-nsP4 peptide pulldown assay with serially deleted p62 mutants. (g) A diagram showing wild-type p62 and a ZZ-deletion mutant (p62ZZ\u0394). (h) R-nsP4 pulldown assay with wild-type p62 and p62ZZ\u0394. (i) A diagram showing a ZZ-only fragment (p62ZZ(WT), #83\u2013175) and its mutant (p62ZZ(D129A)) in which the conserved Asp129 was mutated to Ala. (j) R-nsP4 peptide pulldown assay using p62ZZ(WT) and p62ZZ(D129A). (k) A GST-pulldown assay combined with X-BiP pulldown assay. A p62-GST fusion, p62ZZ-GST or p62ZZ(D129A)-GST, immobilized on gluthathione beads was incubated with HEK293 extracts expressing Ub-X-BiP-myc/his (X= Arg or Val), followed by centrifugation and immunoblotting analysis of X-BiP-myc/his that bound to p62 ZZ fragments. Note that R-BiP-myc/his binds to wild-type ZZ-only fragment but not to D129A-ZZ fragment. No binding was detected with V-BiP-myc/his. (l) Colocalization assay of X-BiP\u0394-GFP (X= Arg or Val) and p62ZZ-RFP coexpressed in p62\u2212/\u2212 MEFs. X-BiP\u0394-GFP was cotranslationally generated from Ub-X-BiP\u0394-GFP using the Ub fusion technique. Note that R-BiP\u0394-GFP, but not V-BiP\u0394-GFP, forms cytosolic puncta colocalizing with p62ZZ-RFP.", "co_occurrence": [{"body": 75, "word": "p62", "fig": 11}, {"body": 60, "word": "R-BiP", "fig": 2}, {"body": 37, "word": "The", "fig": 3}, {"body": 33, "word": "using", "fig": 2}, {"body": 30, "word": "Nt-Arg", "fig": 2}, {"body": 17, "word": "peptide", "fig": 3}, {"body": 7, "word": "assay", "fig": 7}, {"body": 44, "word": "proteins", "fig": 1}, {"body": 8, "word": "A", "fig": 5}, {"body": 4, "word": "pulldown", "fig": 7}, {"body": 26, "word": "cytosolic", "fig": 1}, {"body": 8, "word": "fragment", "fig": 3}, {"body": 8, "word": "used", "fig": 3}, {"body": 8, "word": "peptides", "fig": 3}, {"body": 7, "word": "binds", "fig": 3}, {"body": 21, "word": "binding", "fig": 1}, {"body": 10, "word": "ZZ", "fig": 2}, {"body": 19, "word": "puncta", "fig": 1}, {"body": 9, "word": "beads", "fig": 2}, {"body": 6, "word": "Arg", "fig": 3}, {"body": 9, "word": "extracts", "fig": 2}, {"body": 16, "word": "analysis", "fig": 1}, {"body": 5, "word": "Val", "fig": 3}, {"body": 5, "word": "mutant", "fig": 3}, {"body": 7, "word": "residue", "fig": 2}, {"body": 7, "word": "HEK293", "fig": 2}, {"body": 13, "word": "cell", "fig": 1}, {"body": 13, "word": "followed", "fig": 1}, {"body": 12, "word": "domain", "fig": 1}, {"body": 6, "word": "expressing", "fig": 2}, {"body": 11, "word": "MEFs", "fig": 1}, {"body": 11, "word": "centrifugation", "fig": 1}, {"body": 9, "word": "incubated", "fig": 1}, {"body": 3, "word": "R-nsP4", "fig": 3}, {"body": 3, "word": "X=", "fig": 3}, {"body": 7, "word": "immunoblotting", "fig": 1}, {"body": 7, "word": "g", "fig": 1}, {"body": 7, "word": "generated", "fig": 1}, {"body": 6, "word": "immobilized", "fig": 1}, {"body": 5, "word": "bound", "fig": 1}, {"body": 1, "word": "p62ZZ", "fig": 5}, {"body": 4, "word": "detected", "fig": 1}, {"body": 4, "word": "Ub", "fig": 1}, {"body": 4, "word": "N-terminally", "fig": 1}, {"body": 2, "word": "ZZ-only", "fig": 2}, {"body": 4, "word": "conserved", "fig": 1}, {"body": 4, "word": "Phe", "fig": 1}, {"body": 2, "word": "mutants", "fig": 2}, {"body": 3, "word": "p62ZZ-GST", "fig": 1}, {"body": 3, "word": "cotranslationally", "fig": 1}, {"body": 1, "word": "X-BiP", "fig": 3}, {"body": 1, "word": "D129A", "fig": 3}, {"body": 1, "word": "deleted", "fig": 3}, {"body": 3, "word": "sequences", "fig": 1}, {"body": 3, "word": "forms", "fig": 1}, {"body": 3, "word": "R-BiP\u0394-GFP", "fig": 1}, {"body": 3, "word": "p62\u2212/\u2212", "fig": 1}, {"body": 1, "word": "fusion", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "h", "fig": 1}, {"body": 2, "word": "fragments", "fig": 1}, {"body": 2, "word": "transiently", "fig": 1}, {"body": 1, "word": "p62ZZ-RFP", "fig": 2}, {"body": 2, "word": "Colocalization", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 1, "word": "GST-pulldown", "fig": 1}, {"body": 1, "word": "C-terminally", "fig": 1}, {"body": 1, "word": "Ub-X-BiP-myc/his", "fig": 1}, {"body": 1, "word": "No", "fig": 1}, {"body": 1, "word": "V-BiP\u0394-GFP", "fig": 1}, {"body": 1, "word": "colocalizing", "fig": 1}, {"body": 1, "word": "D1-D4", "fig": 1}, {"body": 1, "word": "D5-D7", "fig": 1}, {"body": 1, "word": "combined", "fig": 1}, {"body": 1, "word": "R-BiP-myc/his", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "k", "fig": 1}, {"body": 1, "word": "R-Bip", "fig": 1}, {"body": 1, "word": "X-nsP4", "fig": 1}, {"body": 1, "word": "Asp129", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f6.jpg", "caption": "The Nt-Arg residue induces oligomerization and aggregation of p62 in vitro. (a) In vitro oligomerization/aggregation assays of HEK293 cell lysates expressing p62-myc/his. The dipeptide Arg-Ala (type-1) at a final concentration of 20 mM was added to the extracts (1 \u03bcg) in comparison with other dipeptides. (b, c) Similar to a. Arg-Ala was compared with Ala-Arg in a time-dependent (b) and dose-dependent (c) manner. (d) The p62-LC3 interaction assay shows that Nt-Arg of Arg-Ala promotes the interaction of p62 with LC3-GST. LC3-GST (3 \u03bcg) was immobilized to gluthathione (GSH)-coated wells and incubated with HEK293 cell extracts (20 \u03bcg) expressing p62. Following incubation with dipeptides for 2 hrs, bound p62 was detected using anti-p62 antibody. Quantification is of n = 3 independent experiments; bars represent mean \u00b1 s.d. Statistical significance was calculated using a one-way ANOVA test (N.S. P > 0.05; ** P < 0.01; **** P < 0.0001. (e) Quantitation of f. Quantification is of n = 3 independent experiments; bars represent mean \u00b1 SEM. Statistical significance was calculated using a one-way ANOVA test (* P < 0.05; ** P < 0.01). (f) R-BiP\u0394-GST, but not V-BiP\u0394-GST, is metabolically stabilized by p62 knockout or pharmaceutical inhibition of autophagy. Shown is immunoblotting of X-BiP\u0394-GST (X= Arg or Val) in +/+ and p62\u2212/\u2212 MEFs with or without the treatment of 25 \u03bcM hydroxychloroquine for 16 hrs. Note that the level of R-BiP\u0394-GST (as determined by GST immunoblotting) is lower as compared with V-BiP\u0394-GST because of its degradation (lanes 2 vs. 3) and increased in p62-deficient cells (lanes 2 vs. 5) or by the treatment of hydroxychloroquine. (g) R-BiP\u0394-GST, but not V-BiP\u0394-GST, is metabolically stabilized in ATG5\u2212/\u2212 MEFs. Shown is immunoblotting of X-BiP19\u2013124-GST (X-BiP\u0394-GST, X= Arg or Val) in +/+ and ATG5\u2212/\u2212 MEFs. Note that the level of R-BiP\u0394-GST, as determined by GST immunoblotting, is lower than V-BiP19\u2013124-GST (lanes 2 vs. 3) and increased in ATG5-deficient cells (lanes 2 vs. 5). (h) Cycloheximide degradation assay of R-BiP-myc/his generated from Ub-R-BiP-myc/his in +/+ and ATG5\u2212/\u2212 MEFs in the absence or presence of 5 \u03bcM MG132. Cells were treated with 50 \u03bcg/ml cycloheximide, followed by time-course immunoblotting of R-BiP. (i) Quantitation of h. Shown is a representative of two independent experiments.", "co_occurrence": [{"body": 75, "word": "p62", "fig": 5}, {"body": 37, "word": "The", "fig": 3}, {"body": 33, "word": "using", "fig": 3}, {"body": 33, "word": "cells", "fig": 2}, {"body": 16, "word": "vs.", "fig": 4}, {"body": 15, "word": "lanes", "fig": 4}, {"body": 60, "word": "R-BiP", "fig": 1}, {"body": 30, "word": "Nt-Arg", "fig": 2}, {"body": 11, "word": "MEFs", "fig": 4}, {"body": 7, "word": "immunoblotting", "fig": 5}, {"body": 16, "word": "interaction", "fig": 2}, {"body": 13, "word": "cell", "fig": 2}, {"body": 26, "word": "mM", "fig": 1}, {"body": 12, "word": "hrs", "fig": 2}, {"body": 10, "word": "degradation", "fig": 2}, {"body": 9, "word": "extracts", "fig": 2}, {"body": 16, "word": "assays", "fig": 1}, {"body": 5, "word": "\u03bcg", "fig": 3}, {"body": 7, "word": "assay", "fig": 2}, {"body": 14, "word": "autophagy", "fig": 1}, {"body": 7, "word": "HEK293", "fig": 2}, {"body": 14, "word": "In", "fig": 1}, {"body": 13, "word": "followed", "fig": 1}, {"body": 6, "word": "Arg", "fig": 2}, {"body": 6, "word": "\u03bcM", "fig": 2}, {"body": 6, "word": "expressing", "fig": 2}, {"body": 3, "word": "R-BiP\u0394-GST", "fig": 4}, {"body": 6, "word": "dipeptides", "fig": 2}, {"body": 6, "word": "determined", "fig": 2}, {"body": 5, "word": "Val", "fig": 2}, {"body": 3, "word": "experiments", "fig": 3}, {"body": 9, "word": "incubated", "fig": 1}, {"body": 3, "word": "Arg-Ala", "fig": 3}, {"body": 3, "word": "independent", "fig": 3}, {"body": 9, "word": "inhibition", "fig": 1}, {"body": 8, "word": "antibody", "fig": 1}, {"body": 4, "word": "vitro", "fig": 2}, {"body": 4, "word": "compared", "fig": 2}, {"body": 7, "word": "aggregation", "fig": 1}, {"body": 7, "word": "residue", "fig": 1}, {"body": 7, "word": "g", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "incubation", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "generated", "fig": 1}, {"body": 3, "word": "GST", "fig": 2}, {"body": 6, "word": "induces", "fig": 1}, {"body": 3, "word": "X=", "fig": 2}, {"body": 6, "word": "immobilized", "fig": 1}, {"body": 5, "word": "bound", "fig": 1}, {"body": 5, "word": "Following", "fig": 1}, {"body": 1, "word": "P", "fig": 5}, {"body": 2, "word": "ANOVA", "fig": 2}, {"body": 4, "word": "detected", "fig": 1}, {"body": 2, "word": "increased", "fig": 2}, {"body": 2, "word": "metabolically", "fig": 2}, {"body": 4, "word": "\u03bcg/ml", "fig": 1}, {"body": 4, "word": "lysates", "fig": 1}, {"body": 4, "word": "absence", "fig": 1}, {"body": 2, "word": "n", "fig": 2}, {"body": 4, "word": "MG132", "fig": 1}, {"body": 4, "word": "type-1", "fig": 1}, {"body": 3, "word": "p62\u2212/\u2212", "fig": 1}, {"body": 1, "word": "V-BiP\u0394-GST", "fig": 3}, {"body": 3, "word": "cycloheximide", "fig": 1}, {"body": 3, "word": "oligomerization", "fig": 1}, {"body": 3, "word": "anti-p62", "fig": 1}, {"body": 1, "word": "ATG5\u2212/\u2212", "fig": 3}, {"body": 3, "word": "added", "fig": 1}, {"body": 1, "word": "represent", "fig": 2}, {"body": 1, "word": "stabilized", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "h", "fig": 1}, {"body": 1, "word": "mean", "fig": 2}, {"body": 1, "word": "one-way", "fig": 2}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 1, "word": "LC3-GST", "fig": 2}, {"body": 1, "word": "Quantification", "fig": 2}, {"body": 1, "word": "Statistical", "fig": 2}, {"body": 2, "word": "dipeptide", "fig": 1}, {"body": 1, "word": "X-BiP\u0394-GST", "fig": 2}, {"body": 2, "word": "two", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 1, "word": "GSH", "fig": 1}, {"body": 1, "word": "Cells", "fig": 1}, {"body": 1, "word": "promotes", "fig": 1}, {"body": 1, "word": "-coated", "fig": 1}, {"body": 1, "word": "p62-myc/his", "fig": 1}, {"body": 1, "word": "Ub-R-BiP-myc/his", "fig": 1}, {"body": 1, "word": "s.d", "fig": 1}, {"body": 1, "word": "pharmaceutical", "fig": 1}, {"body": 1, "word": "p62-LC3", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "manner", "fig": 1}, {"body": 1, "word": "concentration", "fig": 1}, {"body": 1, "word": "wells", "fig": 1}, {"body": 1, "word": "R-BiP-myc/his", "fig": 1}, {"body": 1, "word": "Ala-Arg", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f7.jpg", "caption": "R-BiP is induced by and associated with cytosolic misfolded proteins, and ATE1-deficient cells are hypersensitive to misregulation of protein quality control. (a) Immunoblotting analysis of R-BiP and Ub conjugates in HeLa cells treated with 0.4 \u03bcg/ml poly(dA:dT) for 16 hrs. (b) Colocalization assay with antibodies specific to Ub conjugates (FK2 antibody), p62, and R-BiP in HeLa cells treated with 1 \u03bcg/ml poly(dA:dT) for 21 hrs. Scale bar, 10 \u03bcm. (c) HeLa cells were treated with various stressors for 24 hrs as described in Methods and subjected to immunoblotting analysis of R-BiP and Ub conjugates using FK1 antibody. (d) HeLa cells were treated with 10 \u03bcM MG132 in combination with 200 nM thapsigargin or 200 nM bafilomycin A1 for 16 hrs. The cells were treated with 10 \u03bcg/ml cycloheximide, followed by immunoblotting assay. (e) Arginylation of ER proteins is synergistically induced by proteasomal inhibition and ER stress. HeLa cells were treated with 10 \u03bcM MG132 and 100 nM thapsigargin for 18 hrs. (f) The treatment of geldanamycin, an inhibitor of the HSP90, for 17 hrs results in co-induction of autophagy with arginylation of ER-residing chaperons. (g) Measurement of the interaction between R-BiP and CL1-YFP, a model substrate that undergoes spontaneous misfolding. See Methods for experimental details. (h) Colocalization assay of YFP-CL1 with R-BiP and p62. MEFs ectopically expressing YFP-CL1 was treated with 1 \u03bcg/ml poly(dA:dT) alone for 18 hrs or 10 \u03bcM MG132 and 200 nM bafilomycin A1 for 6 hrs, followed by immunostaining of endogenous R-BiP and p62 in comparison with YFP-CL1 fluorescence. Scale bar, 5 \u03bcm. (i) Ub-R-BiP was coexpressed with YFP-CL1 or GFP in HeLa cells, followed by fluorescence analysis. (j) Puncta formation assay of p62 in +/+ and ATE1\u2212/\u2212 MEFs treated with 10 \u03bcM MG132 and/or 0.2 \u03bcM bafilomycin A1 for 6 hrs. (k) Control and ATE1-knockdown cells were treated with 10 \u03bcM MG132 and/or 0.2 \u03bcM bafilomycin A1 for 18 hrs, followed by immunoblotting analysis. (l) MTT assay of control and ATE1-knockdown cells treated with various stressors, including 10 \u03bcM MG132. Mean +/\u2212 s.d. of n=3 independent experiments in which 10,000 cells in a 24-well plate were analysed per experimental point. Statistical significance was calculated using a two-way ANOVA test (* p < 0.05; ** p < 0.01).", "co_occurrence": [{"body": 60, "word": "R-BiP", "fig": 7}, {"body": 33, "word": "cells", "fig": 11}, {"body": 75, "word": "p62", "fig": 4}, {"body": 12, "word": "hrs", "fig": 10}, {"body": 44, "word": "proteins", "fig": 2}, {"body": 37, "word": "The", "fig": 2}, {"body": 7, "word": "treated", "fig": 10}, {"body": 33, "word": "using", "fig": 2}, {"body": 16, "word": "analysis", "fig": 4}, {"body": 13, "word": "followed", "fig": 4}, {"body": 6, "word": "\u03bcM", "fig": 8}, {"body": 22, "word": "ER", "fig": 2}, {"body": 6, "word": "HeLa", "fig": 6}, {"body": 7, "word": "assay", "fig": 5}, {"body": 31, "word": "arginylation", "fig": 1}, {"body": 26, "word": "cytosolic", "fig": 1}, {"body": 6, "word": "YFP-CL1", "fig": 4}, {"body": 8, "word": "dA", "fig": 3}, {"body": 8, "word": "dT", "fig": 3}, {"body": 4, "word": "MG132", "fig": 6}, {"body": 11, "word": "MEFs", "fig": 2}, {"body": 7, "word": "poly", "fig": 3}, {"body": 7, "word": "immunoblotting", "fig": 3}, {"body": 9, "word": "various", "fig": 2}, {"body": 4, "word": "\u03bcg/ml", "fig": 4}, {"body": 16, "word": "interaction", "fig": 1}, {"body": 8, "word": "antibody", "fig": 2}, {"body": 14, "word": "autophagy", "fig": 1}, {"body": 7, "word": "induced", "fig": 2}, {"body": 14, "word": "protein", "fig": 1}, {"body": 6, "word": "control", "fig": 2}, {"body": 4, "word": "Ub", "fig": 3}, {"body": 3, "word": "A1", "fig": 4}, {"body": 3, "word": "bafilomycin", "fig": 4}, {"body": 11, "word": "antibodies", "fig": 1}, {"body": 10, "word": "misfolded", "fig": 1}, {"body": 5, "word": "thapsigargin", "fig": 2}, {"body": 9, "word": "inhibition", "fig": 1}, {"body": 9, "word": "proteasomal", "fig": 1}, {"body": 8, "word": "results", "fig": 1}, {"body": 8, "word": "inhibitor", "fig": 1}, {"body": 2, "word": "nM", "fig": 4}, {"body": 7, "word": "g", "fig": 1}, {"body": 6, "word": "expressing", "fig": 1}, {"body": 3, "word": "stressors", "fig": 2}, {"body": 5, "word": "ER-residing", "fig": 1}, {"body": 5, "word": "substrate", "fig": 1}, {"body": 5, "word": "formation", "fig": 1}, {"body": 5, "word": "stress", "fig": 1}, {"body": 5, "word": "associated", "fig": 1}, {"body": 4, "word": "ATE1\u2212/\u2212", "fig": 1}, {"body": 4, "word": "endogenous", "fig": 1}, {"body": 4, "word": "including", "fig": 1}, {"body": 2, "word": "ATE1-knockdown", "fig": 2}, {"body": 2, "word": "Colocalization", "fig": 2}, {"body": 4, "word": "model", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 1, "word": "conjugates", "fig": 3}, {"body": 3, "word": "plate", "fig": 1}, {"body": 3, "word": "independent", "fig": 1}, {"body": 3, "word": "quality", "fig": 1}, {"body": 3, "word": "Immunoblotting", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 3, "word": "cycloheximide", "fig": 1}, {"body": 2, "word": "ANOVA", "fig": 1}, {"body": 2, "word": "spontaneous", "fig": 1}, {"body": 2, "word": "subjected", "fig": 1}, {"body": 2, "word": "hypersensitive", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 1, "word": "Methods", "fig": 2}, {"body": 2, "word": "d", "fig": 1}, {"body": 2, "word": "h", "fig": 1}, {"body": 2, "word": "misfolding", "fig": 1}, {"body": 1, "word": "and/or", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "comparison", "fig": 1}, {"body": 1, "word": "experimental", "fig": 2}, {"body": 2, "word": "point", "fig": 1}, {"body": 2, "word": "e", "fig": 1}, {"body": 2, "word": "geldanamycin", "fig": 1}, {"body": 2, "word": "misregulation", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "Measurement", "fig": 1}, {"body": 1, "word": "s.d", "fig": 1}, {"body": 1, "word": "ectopically", "fig": 1}, {"body": 1, "word": "alone", "fig": 1}, {"body": 1, "word": "k", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "described", "fig": 1}, {"body": 1, "word": "synergistically", "fig": 1}, {"body": 1, "word": "Ub-R-BiP", "fig": 1}, {"body": 1, "word": "FK2", "fig": 1}, {"body": 1, "word": "GFP", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490096/bin/nihms683748f8.jpg", "caption": "A model illustrating the role of the N-end rule pathway in N-terminal arginylation of ER-residing proteins and the ligand-mediated regulation of autophagy in stressed cells. In this model, ER residents and clients acquire cotranslationally and cotranslocationally the degrons of the N-end rule pathway, which normally remain separated from cytosolic N-end rule machinery. N-terminal arginylation of ER-residing proteins, especially BiP, is induced by various stress signals such as cytosolic misfolded proteins that are initially tagged with Ub but cannot be readily processed by the proteasome (Step 1). One physiological stress signal that induces N-terminal arginylation of ER proteins is the presence of cytosolic foreign dsDNA which triggers innate immune responses. N-terminal arginylation is thought to occur when the N-terminal residue of the substrates is exposed to the cytosolic surface of the ER membrane (Step 2), which may facilitate the cytosolic relocalization of arginylated ER proteins. We do not exclude the possibility that N-terminal arginylation occurs after the substrates complete their cytosolic relocalization. Arginylated ER proteins relocated to non-ER compartments appear to have both shared and distinct functions and metabolic fates. At least a subpopulation of cytosolic R-BiP appears to be associated with its cargoes such as cytosolic misfolded proteins (Step 3). R-BiP, alone or loaded with its cargo, binds to the ZZ domain of p62 through the N-end rule interaction of its Nt-Arg (Step 4). This induces an allosteric conformational change of p62, exposing PB1 and LIR domains. PB1 domain promotes self-oligomerization and aggregation of p62 (Step 5), together with cargoes such as cytosolic misfolded proteins (Step 6). LIR domain mediates the interaction of p62 with LC3 on the autophagic membranes (Step 7). In this model, the Nt-Arg residue acts as an autophagic delivery determinant to autophagosomes for BiP and its cargoes, an activating ligand to p62, and an autophagic degron for BiP and the cargoes of R-BiP and p62.", "co_occurrence": [{"body": 75, "word": "p62", "fig": 6}, {"body": 44, "word": "proteins", "fig": 8}, {"body": 26, "word": "cytosolic", "fig": 9}, {"body": 35, "word": "N-terminal", "fig": 6}, {"body": 60, "word": "R-BiP", "fig": 3}, {"body": 31, "word": "arginylation", "fig": 5}, {"body": 38, "word": "BiP", "fig": 3}, {"body": 22, "word": "ER", "fig": 5}, {"body": 23, "word": "autophagic", "fig": 3}, {"body": 30, "word": "Nt-Arg", "fig": 2}, {"body": 11, "word": "N-end", "fig": 4}, {"body": 11, "word": "rule", "fig": 4}, {"body": 12, "word": "domain", "fig": 3}, {"body": 33, "word": "cells", "fig": 1}, {"body": 16, "word": "interaction", "fig": 2}, {"body": 8, "word": "cargoes", "fig": 4}, {"body": 10, "word": "misfolded", "fig": 3}, {"body": 14, "word": "In", "fig": 2}, {"body": 18, "word": "arginylated", "fig": 1}, {"body": 17, "word": "LC3", "fig": 1}, {"body": 14, "word": "autophagy", "fig": 1}, {"body": 7, "word": "residue", "fig": 2}, {"body": 6, "word": "induces", "fig": 2}, {"body": 12, "word": "autophagosomes", "fig": 1}, {"body": 6, "word": "pathway", "fig": 2}, {"body": 4, "word": "model", "fig": 3}, {"body": 11, "word": "delivery", "fig": 1}, {"body": 5, "word": "ER-residing", "fig": 2}, {"body": 10, "word": "ZZ", "fig": 1}, {"body": 10, "word": "functions", "fig": 1}, {"body": 5, "word": "stress", "fig": 2}, {"body": 9, "word": "various", "fig": 1}, {"body": 9, "word": "role", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "We", "fig": 1}, {"body": 7, "word": "aggregation", "fig": 1}, {"body": 7, "word": "signal", "fig": 1}, {"body": 7, "word": "induced", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "determinant", "fig": 1}, {"body": 7, "word": "binds", "fig": 1}, {"body": 3, "word": "LIR", "fig": 2}, {"body": 6, "word": "dsDNA", "fig": 1}, {"body": 6, "word": "degron", "fig": 1}, {"body": 6, "word": "ligand", "fig": 1}, {"body": 6, "word": "self-oligomerization", "fig": 1}, {"body": 3, "word": "PB1", "fig": 2}, {"body": 6, "word": "responses", "fig": 1}, {"body": 3, "word": "substrates", "fig": 2}, {"body": 6, "word": "degrons", "fig": 1}, {"body": 5, "word": "domains", "fig": 1}, {"body": 5, "word": "associated", "fig": 1}, {"body": 5, "word": "membranes", "fig": 1}, {"body": 5, "word": "non-ER", "fig": 1}, {"body": 4, "word": "mediates", "fig": 1}, {"body": 4, "word": "Ub", "fig": 1}, {"body": 4, "word": "readily", "fig": 1}, {"body": 4, "word": "innate", "fig": 1}, {"body": 4, "word": "separated", "fig": 1}, {"body": 4, "word": "immune", "fig": 1}, {"body": 4, "word": "may", "fig": 1}, {"body": 3, "word": "cotranslationally", "fig": 1}, {"body": 3, "word": "foreign", "fig": 1}, {"body": 3, "word": "least", "fig": 1}, {"body": 3, "word": "acquire", "fig": 1}, {"body": 3, "word": "One", "fig": 1}, {"body": 2, "word": "tagged", "fig": 1}, {"body": 2, "word": "activating", "fig": 1}, {"body": 2, "word": "cotranslocationally", "fig": 1}, {"body": 2, "word": "physiological", "fig": 1}, {"body": 2, "word": "signals", "fig": 1}, {"body": 1, "word": "relocalization", "fig": 2}, {"body": 2, "word": "This", "fig": 1}, {"body": 2, "word": "change", "fig": 1}, {"body": 2, "word": "exposing", "fig": 1}, {"body": 2, "word": "residents", "fig": 1}, {"body": 2, "word": "allosteric", "fig": 1}, {"body": 2, "word": "conformational", "fig": 1}, {"body": 2, "word": "together", "fig": 1}, {"body": 1, "word": "proteasome", "fig": 1}, {"body": 1, "word": "exposed", "fig": 1}, {"body": 1, "word": "shared", "fig": 1}, {"body": 1, "word": "alone", "fig": 1}, {"body": 1, "word": "metabolic", "fig": 1}, {"body": 1, "word": "fates", "fig": 1}, {"body": 1, "word": "regulation", "fig": 1}, {"body": 1, "word": "Arginylated", "fig": 1}, {"body": 1, "word": "clients", "fig": 1}, {"body": 1, "word": "promotes", "fig": 1}, {"body": 1, "word": "remain", "fig": 1}, {"body": 1, "word": "surface", "fig": 1}, {"body": 1, "word": "compartments", "fig": 1}, {"body": 1, "word": "At", "fig": 1}, {"body": 1, "word": "machinery", "fig": 1}]}], "4488719": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488719/bin/viruses-07-02752-g001.jpg", "caption": "Activation of the DDR during lytic replication of KSHV in TRE-BCBL-1-RTA cells. (A) Expression of immediate-early lytic proteins RTA and ORF57 and late lytic glycoprotein K8.1A in TRE-BCBL-1-RTA cells following addition of 0.5 \u03bcg/mL doxycycline; (B) Phosphorylation of DDR proteins in TRE-BCBL-1-RTA cells following addition of 0.5 \u03bcg/mL doxycycline. TRE-BCBL-1-RTA cells treated with ionising radiation (IR) and ultraviolet light (UV) represent positive controls for DDR activation.", "co_occurrence": [{"body": 105, "word": "cells", "fig": 4}, {"body": 59, "word": "lytic", "fig": 3}, {"body": 58, "word": "DDR", "fig": 3}, {"body": 35, "word": "TRE-BCBL-1-RTA", "fig": 4}, {"body": 31, "word": "following", "fig": 2}, {"body": 60, "word": "replication", "fig": 1}, {"body": 29, "word": "doxycycline", "fig": 2}, {"body": 25, "word": "proteins", "fig": 2}, {"body": 22, "word": "addition", "fig": 2}, {"body": 39, "word": "KSHV", "fig": 1}, {"body": 31, "word": "activation", "fig": 1}, {"body": 13, "word": "\u03bcg/mL", "fig": 2}, {"body": 24, "word": "treated", "fig": 1}, {"body": 11, "word": "RTA", "fig": 1}, {"body": 9, "word": "B", "fig": 1}, {"body": 8, "word": "late", "fig": 1}, {"body": 7, "word": "positive", "fig": 1}, {"body": 7, "word": "ORF57", "fig": 1}, {"body": 7, "word": "UV", "fig": 1}, {"body": 6, "word": "K8.1A", "fig": 1}, {"body": 6, "word": "Expression", "fig": 1}, {"body": 5, "word": "controls", "fig": 1}, {"body": 5, "word": "immediate-early", "fig": 1}, {"body": 3, "word": "glycoprotein", "fig": 1}, {"body": 3, "word": "Activation", "fig": 1}, {"body": 3, "word": "IR", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "radiation", "fig": 1}, {"body": 1, "word": "ultraviolet", "fig": 1}, {"body": 1, "word": "ionising", "fig": 1}, {"body": 1, "word": "light", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488719/bin/viruses-07-02752-g002.jpg", "caption": "DDR activation following inhibition of viral DNA synthesis and late viral gene expression. (A) Immunofluorescence microscopy analysis of LANA expression in EA.hy926 cells following infection with supernatants obtained from TRE-BCBL-1-RTA cells collected 48 h after treatment with 100 \u03bcM ganciclovir alone, 0.5 \u03bcg/mL doxycycline alone or both compounds in combination; (B) Phosphorylation of RPA32 and H2AX in TRE-BCBL-1-RTA cells treated with 100 \u03bcM ganciclovir alone, 0.5 \u03bcg/mL doxycycline alone or both compounds in combination.", "co_occurrence": [{"body": 105, "word": "cells", "fig": 3}, {"body": 45, "word": "viral", "fig": 2}, {"body": 35, "word": "TRE-BCBL-1-RTA", "fig": 2}, {"body": 34, "word": "expression", "fig": 2}, {"body": 31, "word": "following", "fig": 2}, {"body": 29, "word": "doxycycline", "fig": 2}, {"body": 58, "word": "DDR", "fig": 1}, {"body": 40, "word": "DNA", "fig": 1}, {"body": 35, "word": "h", "fig": 1}, {"body": 8, "word": "alone", "fig": 4}, {"body": 31, "word": "activation", "fig": 1}, {"body": 15, "word": "ganciclovir", "fig": 2}, {"body": 13, "word": "\u03bcg/mL", "fig": 2}, {"body": 24, "word": "treated", "fig": 1}, {"body": 16, "word": "EA.hy926", "fig": 1}, {"body": 15, "word": "RPA32", "fig": 1}, {"body": 7, "word": "\u03bcM", "fig": 2}, {"body": 12, "word": "H2AX", "fig": 1}, {"body": 11, "word": "inhibition", "fig": 1}, {"body": 10, "word": "supernatants", "fig": 1}, {"body": 10, "word": "LANA", "fig": 1}, {"body": 10, "word": "infection", "fig": 1}, {"body": 9, "word": "treatment", "fig": 1}, {"body": 9, "word": "B", "fig": 1}, {"body": 9, "word": "gene", "fig": 1}, {"body": 8, "word": "late", "fig": 1}, {"body": 6, "word": "synthesis", "fig": 1}, {"body": 6, "word": "microscopy", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 4, "word": "collected", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488719/bin/viruses-07-02752-g003.jpg", "caption": "Effect of DDR inhibition on production of infectious virus. (A) Expression of late lytic glycoprotein K8.1A in TRE-BCBL-1-RTA cells 24 and 48 h following treatment with DDR kinase inhibitors and doxycycline; (B) Expression of LANA in EA.hy926 cells following infection with supernatants collected from TRE-BCBL-1-RTA cells 24 and 48 h after treatment with DDR kinase inhibitors and doxycycline; (C) Immunofluorescence microscopy analysis of the percentage of EA.hy926 cells expressing LANA following infection with supernatants collected from TRE-BCBL-1-RTA cells 24 and 48 h after treatment with DDR kinase inhibitors and doxycycline. Each column represents the mean of three independent experiments while the error bars represent the standard error of the mean (SEM). A minimum of 500 cells were analysed for each repetition. * p < 0.05; ** p < 0.01; *** p < 0.001 (statistical analyses were performed using a two-tailed and unpaired Student\u2019s t-test); (D) Percentage of TRE-BCBL-1-RTA cells expressing early lytic protein ORF59 24 h following treatment with DDR kinase inhibitors and doxycycline. Each column represents the mean of three independent experiments while the error bars represent the standard error of the mean (SEM). A minimum of 500 cells were analysed for each repetition; (E) Levels of phosphorylated DDR proteins in TRE-BCBL-1-RTA cells 24 h following treatment with DDR kinase inhibitors and doxycycline.", "co_occurrence": [{"body": 105, "word": "cells", "fig": 9}, {"body": 58, "word": "DDR", "fig": 7}, {"body": 35, "word": "h", "fig": 5}, {"body": 35, "word": "TRE-BCBL-1-RTA", "fig": 5}, {"body": 31, "word": "following", "fig": 5}, {"body": 29, "word": "doxycycline", "fig": 5}, {"body": 59, "word": "lytic", "fig": 2}, {"body": 10, "word": "inhibitors", "fig": 5}, {"body": 9, "word": "treatment", "fig": 5}, {"body": 7, "word": "kinase", "fig": 5}, {"body": 16, "word": "EA.hy926", "fig": 2}, {"body": 28, "word": "virus", "fig": 1}, {"body": 25, "word": "proteins", "fig": 1}, {"body": 10, "word": "LANA", "fig": 2}, {"body": 10, "word": "infection", "fig": 2}, {"body": 10, "word": "supernatants", "fig": 2}, {"body": 13, "word": "protein", "fig": 1}, {"body": 6, "word": "Expression", "fig": 2}, {"body": 12, "word": "production", "fig": 1}, {"body": 11, "word": "inhibition", "fig": 1}, {"body": 11, "word": "infectious", "fig": 1}, {"body": 9, "word": "using", "fig": 1}, {"body": 9, "word": "B", "fig": 1}, {"body": 8, "word": "late", "fig": 1}, {"body": 4, "word": "expressing", "fig": 2}, {"body": 4, "word": "collected", "fig": 2}, {"body": 6, "word": "microscopy", "fig": 1}, {"body": 3, "word": "three", "fig": 2}, {"body": 6, "word": "phosphorylated", "fig": 1}, {"body": 6, "word": "K8.1A", "fig": 1}, {"body": 2, "word": "A", "fig": 3}, {"body": 4, "word": "early", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "glycoprotein", "fig": 1}, {"body": 1, "word": "analysed", "fig": 2}, {"body": 2, "word": "ORF59", "fig": 1}, {"body": 2, "word": "percentage", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "Levels", "fig": 1}, {"body": 1, "word": "performed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488719/bin/viruses-07-02752-g004.jpg", "caption": "Inhibition of CHK1 signalling at late times during KSHV lytic replication. Levels of phosphorylated CHK1 (S317 and S345) following UV treatment of TRE-BCBL-1-RTA cells treated with doxycycline for varying lengths of time. At each time point following the addition of doxycycline, cells were treated with 20 Jm\u22122 UV and levels of phosphorylated CHK1 were assessed by western blot.", "co_occurrence": [{"body": 105, "word": "cells", "fig": 2}, {"body": 31, "word": "following", "fig": 2}, {"body": 60, "word": "replication", "fig": 1}, {"body": 59, "word": "lytic", "fig": 1}, {"body": 29, "word": "doxycycline", "fig": 2}, {"body": 24, "word": "treated", "fig": 2}, {"body": 39, "word": "KSHV", "fig": 1}, {"body": 12, "word": "CHK1", "fig": 3}, {"body": 35, "word": "TRE-BCBL-1-RTA", "fig": 1}, {"body": 22, "word": "addition", "fig": 1}, {"body": 7, "word": "UV", "fig": 2}, {"body": 6, "word": "phosphorylated", "fig": 2}, {"body": 5, "word": "time", "fig": 2}, {"body": 9, "word": "treatment", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 8, "word": "late", "fig": 1}, {"body": 7, "word": "assessed", "fig": 1}, {"body": 6, "word": "Inhibition", "fig": 1}, {"body": 6, "word": "times", "fig": 1}, {"body": 6, "word": "signalling", "fig": 1}, {"body": 5, "word": "western", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "At", "fig": 1}, {"body": 2, "word": "Jm\u22122", "fig": 1}, {"body": 2, "word": "S345", "fig": 1}, {"body": 2, "word": "S317", "fig": 1}, {"body": 1, "word": "point", "fig": 1}, {"body": 1, "word": "Levels", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488719/bin/viruses-07-02752-g005.jpg", "caption": "Cell cycle changes during lytic replication of KSHV. (A) Representative cell cycle profiles following PI staining of TRE-BCBL-1-RTA cells after addition of doxycycline in the presence and absence of DDR kinase inhibitors; (B) Percentage of TRE-BCBL-1-RTA cells in different phases of the cell cycle at 4 different time points following addition of doxycycline in the presence and absence of DDR kinase inhibitors. Each data point represents the mean of three independent experiments while the error bars represent the standard error of the mean (SEM).", "co_occurrence": [{"body": 105, "word": "cells", "fig": 2}, {"body": 58, "word": "DDR", "fig": 2}, {"body": 25, "word": "cycle", "fig": 3}, {"body": 35, "word": "TRE-BCBL-1-RTA", "fig": 2}, {"body": 31, "word": "following", "fig": 2}, {"body": 60, "word": "replication", "fig": 1}, {"body": 59, "word": "lytic", "fig": 1}, {"body": 29, "word": "doxycycline", "fig": 2}, {"body": 26, "word": "cell", "fig": 2}, {"body": 22, "word": "addition", "fig": 2}, {"body": 39, "word": "KSHV", "fig": 1}, {"body": 12, "word": "presence", "fig": 2}, {"body": 10, "word": "inhibitors", "fig": 2}, {"body": 7, "word": "kinase", "fig": 2}, {"body": 11, "word": "Cell", "fig": 1}, {"body": 9, "word": "B", "fig": 1}, {"body": 9, "word": "changes", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 5, "word": "time", "fig": 1}, {"body": 4, "word": "PI", "fig": 1}, {"body": 4, "word": "data", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "points", "fig": 1}, {"body": 1, "word": "different", "fig": 2}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "phases", "fig": 1}, {"body": 1, "word": "point", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488719/bin/viruses-07-02752-g006.jpg", "caption": "Localisation of DDR proteins during lytic replication of KSHV. (A) Localisation of \u03b3H2AX, RPA32, MRE11 and 53BP1 in TRE-BCBL-1-RTA cells 24 h following addition of doxycycline and in cells without doxycycline treatment. KSHV lytic proteins K8\u03b1 and ORF6 were used as markers of lytic reactivation. In the bottom panels, BrdU was used to confirm that ORF6 localises to sites of viral replication; (B) Localisation of \u03b3H2AX, RPA32, MRE11 and 53BP1 in KSHV-infected EA.hy926-RTA cells 24 h following addition of doxycycline and in cells without doxycycline treatment. KSHV lytic proteins K8\u03b1 and ORF6 were used as markers of lytic reactivation. In the bottom panels, RPA32 was used as a surrogate marker for sites of viral replication. DAPI staining is only shown in the left hand set of panels in each case for clarity.", "co_occurrence": [{"body": 105, "word": "cells", "fig": 4}, {"body": 59, "word": "lytic", "fig": 5}, {"body": 60, "word": "replication", "fig": 3}, {"body": 39, "word": "KSHV", "fig": 3}, {"body": 29, "word": "doxycycline", "fig": 4}, {"body": 45, "word": "viral", "fig": 2}, {"body": 25, "word": "proteins", "fig": 3}, {"body": 35, "word": "h", "fig": 2}, {"body": 17, "word": "used", "fig": 4}, {"body": 31, "word": "following", "fig": 2}, {"body": 58, "word": "DDR", "fig": 1}, {"body": 15, "word": "RPA32", "fig": 3}, {"body": 22, "word": "addition", "fig": 2}, {"body": 35, "word": "TRE-BCBL-1-RTA", "fig": 1}, {"body": 16, "word": "In", "fig": 2}, {"body": 11, "word": "53BP1", "fig": 2}, {"body": 7, "word": "ORF6", "fig": 3}, {"body": 9, "word": "treatment", "fig": 2}, {"body": 7, "word": "\u03b3H2AX", "fig": 2}, {"body": 12, "word": "shown", "fig": 1}, {"body": 6, "word": "sites", "fig": 2}, {"body": 5, "word": "reactivation", "fig": 2}, {"body": 10, "word": "EA.hy926-RTA", "fig": 1}, {"body": 5, "word": "K8\u03b1", "fig": 2}, {"body": 9, "word": "B", "fig": 1}, {"body": 8, "word": "staining", "fig": 1}, {"body": 4, "word": "MRE11", "fig": 2}, {"body": 3, "word": "without", "fig": 2}, {"body": 5, "word": "marker", "fig": 1}, {"body": 5, "word": "confirm", "fig": 1}, {"body": 2, "word": "markers", "fig": 2}, {"body": 4, "word": "BrdU", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "case", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}, {"body": 1, "word": "localises", "fig": 1}, {"body": 1, "word": "surrogate", "fig": 1}, {"body": 1, "word": "KSHV-infected", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488719/bin/viruses-07-02752-g007.jpg", "caption": "Activation of the DNA damage response during lytic replication of KSHV in EA.hy926 cells and following RTA expression alone. Levels of phosphorylated H2AX and RPA32 following addition of doxycyline to control EA.hy926 cells, EA.hy926 cells containing an ORF50 expression construct (EA.hy926-RTA) and KSHV-infected EA.hy926 cells containing an ORF50 expression construct (rKSHV-EA.hy926-RTA). Expression of LANA and ORF57 confirm presence of KSHV and lytic reactivation of the virus respectively.", "co_occurrence": [{"body": 105, "word": "cells", "fig": 4}, {"body": 59, "word": "lytic", "fig": 2}, {"body": 34, "word": "expression", "fig": 3}, {"body": 39, "word": "KSHV", "fig": 2}, {"body": 16, "word": "EA.hy926", "fig": 4}, {"body": 31, "word": "following", "fig": 2}, {"body": 60, "word": "replication", "fig": 1}, {"body": 40, "word": "DNA", "fig": 1}, {"body": 28, "word": "virus", "fig": 1}, {"body": 11, "word": "containing", "fig": 2}, {"body": 22, "word": "addition", "fig": 1}, {"body": 15, "word": "RPA32", "fig": 1}, {"body": 12, "word": "presence", "fig": 1}, {"body": 12, "word": "H2AX", "fig": 1}, {"body": 11, "word": "RTA", "fig": 1}, {"body": 10, "word": "EA.hy926-RTA", "fig": 1}, {"body": 10, "word": "LANA", "fig": 1}, {"body": 10, "word": "damage", "fig": 1}, {"body": 9, "word": "control", "fig": 1}, {"body": 4, "word": "construct", "fig": 2}, {"body": 8, "word": "alone", "fig": 1}, {"body": 7, "word": "ORF57", "fig": 1}, {"body": 6, "word": "Expression", "fig": 1}, {"body": 6, "word": "phosphorylated", "fig": 1}, {"body": 5, "word": "confirm", "fig": 1}, {"body": 5, "word": "reactivation", "fig": 1}, {"body": 5, "word": "rKSHV-EA.hy926-RTA", "fig": 1}, {"body": 3, "word": "Activation", "fig": 1}, {"body": 3, "word": "response", "fig": 1}, {"body": 1, "word": "ORF50", "fig": 2}, {"body": 1, "word": "KSHV-infected", "fig": 1}, {"body": 1, "word": "Levels", "fig": 1}]}], "3162406": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162406/bin/zbc0401177000001.jpg", "caption": "JMJD2A is ubiquitinated and degraded by the 26S proteasome. A, the proteasomal inhibitor MG132 prevents the decrease in JMJD2A levels during cell cycle. Asynchronous HEK293T cells (Asyn), cells arrested in G1/S after 1 mm HU for 24 h, cells released from HU for 2.5 h into S phase, or cells arrested in G2/M with nocodazole were treated or not treated with 20 \u03bcm MG132 for 2.5 h before lysis and immunoblotting. B, JMJD2A immunoprecipitated under denaturing conditions contains ubiquitin. Asynchronous HEK293T cells were treated with 20 \u03bcm MG132 for 2.5 h before lysis and then immunoprecipitated (IP) in the presence of 100 \u03bcg/ml of EtBr for JMJD2A, washed in denaturing buffer, and immunoblotted for ubiquitin. C, JMJD2A is degraded by the 26S proteasome. HEK293T cells were treated for the indicated times with 400 \u03bcm cycloheximide (CHX) in the presence of 20 \u03bcm MG132 or vehicle for 4 h and then lysed and immunoblotted. D, graphical representation of C. The y axis represents the ratio of JMJD2A relative to time 0, which was normalized to \u03b2-actin. The average of three independent experiments is shown. The errors bars represent the mean \u00b1 S.E. WCE, whole cell extract.", "co_occurrence": [{"body": 126, "word": "JMJD2A", "fig": 6}, {"body": 50, "word": "cells", "fig": 6}, {"body": 37, "word": "The", "fig": 3}, {"body": 13, "word": "h", "fig": 5}, {"body": 29, "word": "ubiquitin", "fig": 2}, {"body": 28, "word": "cell", "fig": 2}, {"body": 32, "word": "levels", "fig": 1}, {"body": 25, "word": "S", "fig": 1}, {"body": 6, "word": "MG132", "fig": 4}, {"body": 23, "word": "phase", "fig": 1}, {"body": 5, "word": "\u03bcm", "fig": 4}, {"body": 20, "word": "cycle", "fig": 1}, {"body": 4, "word": "treated", "fig": 4}, {"body": 5, "word": "HEK293T", "fig": 3}, {"body": 10, "word": "G2/M", "fig": 1}, {"body": 5, "word": "presence", "fig": 2}, {"body": 4, "word": "arrested", "fig": 2}, {"body": 8, "word": "nocodazole", "fig": 1}, {"body": 8, "word": "mm", "fig": 1}, {"body": 3, "word": "proteasome", "fig": 2}, {"body": 6, "word": "ubiquitinated", "fig": 1}, {"body": 5, "word": "proteasomal", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 2, "word": "degraded", "fig": 2}, {"body": 2, "word": "immunoblotted", "fig": 2}, {"body": 2, "word": "26S", "fig": 2}, {"body": 4, "word": "bars", "fig": 1}, {"body": 2, "word": "HU", "fig": 2}, {"body": 4, "word": "G1/S", "fig": 1}, {"body": 4, "word": "buffer", "fig": 1}, {"body": 2, "word": "denaturing", "fig": 2}, {"body": 3, "word": "washed", "fig": 1}, {"body": 3, "word": "conditions", "fig": 1}, {"body": 3, "word": "decrease", "fig": 1}, {"body": 3, "word": "average", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "immunoprecipitated", "fig": 2}, {"body": 2, "word": "three", "fig": 1}, {"body": 2, "word": "inhibitor", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "\u03bcg/ml", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "contains", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "prevents", "fig": 1}, {"body": 1, "word": "S.E", "fig": 1}, {"body": 1, "word": "lysed", "fig": 1}, {"body": 1, "word": "cycloheximide", "fig": 1}, {"body": 1, "word": "released", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162406/bin/zbc0401177000002.jpg", "caption": "The SCF complex regulates the degradation of JMJD2A. A, dominant negative cullin 1 prevents the degradation of JMJD2A. HEK293T cells overexpressing control N-GFP or N-GFP-JMJD2A were transfected with the dominant negative version of cullin 1 (DN-1) or cullin 4a (DN-4a) and arrested in G2/M with nocodazole. Cells were then lysed and immunoblotted. Asyn, asynchronous. B and C, JMJD2A interacts with cullin 1. B, HEK293T cells overexpressing control N-GFP or N-GFP-JMJD2A were transfected with Myc-cullin 1 and then lysed, immunoprecipitated (IP) with either JMJD2A or Myc in the presence of 100 \u03bcg/ml of EtBr, and immunoblotted. WCE, whole cell extract. C, HEK293T cells were treated with 20 \u03bcm MG132 2.5 h before lysis and then immunoprecipitated in presence of 100 \u03bcg/ml of EtBr and immunoblotted. D, dominant negative cullin 1 decreased the ubiquitination of JMJD2A. HEK293T cells overexpressing HA-ubiquitin and DN-Cul1 or a control vector were arrested in S phase in the presence of 20 \u03bcm MG132 and 25 mm N-ethylmaleimide, lysed, immunoprecipitated, and immunoblotted. E, dominant negative cullin 1 prevents the proteasomal degradation of JMJD2A. HEK293T cells overexpressing DN-Cul1 or a control vector were treated for the indicated times with 400 \u03bcm of cycloheximide (CHX) and then lysed and immunoblotted. The y axis represents the ratio of JMJD2A relative to time 0, which was normalized to \u03b2-actin. The average of two independent experiments is shown. The errors bars represent the mean \u00b1 S.E.", "co_occurrence": [{"body": 126, "word": "JMJD2A", "fig": 7}, {"body": 50, "word": "cells", "fig": 5}, {"body": 26, "word": "cullin", "fig": 6}, {"body": 37, "word": "The", "fig": 4}, {"body": 15, "word": "overexpressing", "fig": 4}, {"body": 12, "word": "control", "fig": 4}, {"body": 11, "word": "dominant", "fig": 4}, {"body": 11, "word": "negative", "fig": 4}, {"body": 28, "word": "cell", "fig": 1}, {"body": 9, "word": "degradation", "fig": 3}, {"body": 25, "word": "S", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 5}, {"body": 23, "word": "phase", "fig": 1}, {"body": 5, "word": "\u03bcm", "fig": 3}, {"body": 5, "word": "presence", "fig": 3}, {"body": 13, "word": "h", "fig": 1}, {"body": 13, "word": "ubiquitination", "fig": 1}, {"body": 6, "word": "MG132", "fig": 2}, {"body": 2, "word": "immunoblotted", "fig": 5}, {"body": 10, "word": "G2/M", "fig": 1}, {"body": 4, "word": "arrested", "fig": 2}, {"body": 4, "word": "transfected", "fig": 2}, {"body": 8, "word": "nocodazole", "fig": 1}, {"body": 4, "word": "DN-Cul1", "fig": 2}, {"body": 8, "word": "mm", "fig": 1}, {"body": 4, "word": "treated", "fig": 2}, {"body": 6, "word": "complex", "fig": 1}, {"body": 5, "word": "SCF", "fig": 1}, {"body": 5, "word": "proteasomal", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "decreased", "fig": 1}, {"body": 4, "word": "DN-1", "fig": 1}, {"body": 4, "word": "bars", "fig": 1}, {"body": 4, "word": "two", "fig": 1}, {"body": 4, "word": "asynchronous", "fig": 1}, {"body": 1, "word": "lysed", "fig": 4}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "either", "fig": 1}, {"body": 1, "word": "immunoprecipitated", "fig": 3}, {"body": 3, "word": "regulates", "fig": 1}, {"body": 3, "word": "average", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 1, "word": "\u03bcg/ml", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "Myc", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "C", "fig": 2}, {"body": 1, "word": "B", "fig": 2}, {"body": 1, "word": "prevents", "fig": 2}, {"body": 2, "word": "interacts", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "DN-4a", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "S.E", "fig": 1}, {"body": 1, "word": "cycloheximide", "fig": 1}, {"body": 1, "word": "4a", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162406/bin/zbc0401177000003.jpg", "caption": "The F-box protein FbxL4 interacts with JMJD2A and contributes to JMJD2A degradation. A, screen of F-box proteins involved in the degradation of JMJD2A. HeLa cells were transfected with siRNAs targeting F-box proteins. For each siRNA, lysates from both asynchronous cells and cells arrested in G2/M by nocodazole and a shake off were immunoblotted for JMJD2A or \u03b2-actin. The asynchronous lysates are the first lanes followed by G2/M lysates for each siRNA treatment. The stars denote siRNA treatments that exhibited increased JMJD2A protein levels after nocodazole treatment when compared to si-Ctrl. B, depletion of FbxL4 and FbxW2 prevent the proteasomal degradation of JMJD2A in HeLa cells. HeLa cells transfected with an siRNA targeting FbxL4, FbxW2, FbxL19, or a control siRNA were treated for the indicated times with 89 \u03bcm of cycloheximide and then lysed and immunoblotted. C, depletion of FbxW2 prevents the proteasomal degradation of JMJD2A in HEK293T cells. HEK293T cells transfected with an siRNA targeting FbxW2 or a control siRNA were treated for the indicated times with 400 \u03bcm of cycloheximide and then lysed and immunoblotted. D, depletion of FbxL4 prevents the proteasomal degradation of JMJD2A in HEK293T cells. HEK293T cells transfected with an siRNA targeting FbxL4 or a control siRNA were treated for the indicated times with 400 \u03bcm of cycloheximide and then lysed and immunoblotted. E and F, JMJD2A interacts with FbxL4. E, HEK293T cells were treated with 20 \u03bcm MG132 2.5 h before lysis and then immunoprecipitated (IP) in the presence of 100 \u03bcg/ml of EtBr and immunoblotted. F, HA-immobilized FLAG-HA-JMJD2A was incubated with HEK293T lysates overexpressing FLAG-FbxL4 in the presence of 100 \u03bcg/ml of EtBr and immunoblotted. WCE, whole cell extract.", "co_occurrence": [{"body": 126, "word": "JMJD2A", "fig": 9}, {"body": 50, "word": "cells", "fig": 10}, {"body": 37, "word": "The", "fig": 3}, {"body": 16, "word": "FbxL4", "fig": 6}, {"body": 8, "word": "siRNA", "fig": 9}, {"body": 35, "word": "protein", "fig": 2}, {"body": 9, "word": "degradation", "fig": 5}, {"body": 10, "word": "FbxW2", "fig": 4}, {"body": 13, "word": "F-box", "fig": 3}, {"body": 12, "word": "control", "fig": 3}, {"body": 32, "word": "levels", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 6}, {"body": 28, "word": "cell", "fig": 1}, {"body": 13, "word": "proteins", "fig": 2}, {"body": 5, "word": "\u03bcm", "fig": 4}, {"body": 10, "word": "G2/M", "fig": 2}, {"body": 20, "word": "increased", "fig": 1}, {"body": 4, "word": "transfected", "fig": 4}, {"body": 8, "word": "nocodazole", "fig": 2}, {"body": 4, "word": "treated", "fig": 4}, {"body": 5, "word": "HeLa", "fig": 3}, {"body": 5, "word": "proteasomal", "fig": 3}, {"body": 15, "word": "overexpressing", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 2, "word": "immunoblotted", "fig": 6}, {"body": 5, "word": "presence", "fig": 2}, {"body": 3, "word": "depletion", "fig": 3}, {"body": 4, "word": "treatment", "fig": 2}, {"body": 2, "word": "targeting", "fig": 4}, {"body": 4, "word": "asynchronous", "fig": 2}, {"body": 7, "word": "For", "fig": 1}, {"body": 6, "word": "MG132", "fig": 1}, {"body": 5, "word": "incubated", "fig": 1}, {"body": 5, "word": "compared", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "arrested", "fig": 1}, {"body": 2, "word": "interacts", "fig": 2}, {"body": 1, "word": "times", "fig": 3}, {"body": 3, "word": "lanes", "fig": 1}, {"body": 3, "word": "siRNAs", "fig": 1}, {"body": 1, "word": "lysed", "fig": 3}, {"body": 1, "word": "cycloheximide", "fig": 3}, {"body": 2, "word": "FbxL19", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 1, "word": "prevents", "fig": 2}, {"body": 1, "word": "\u03bcg/ml", "fig": 2}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "FLAG-FbxL4", "fig": 1}, {"body": 1, "word": "contributes", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "immunoprecipitated", "fig": 1}, {"body": 1, "word": "screen", "fig": 1}, {"body": 1, "word": "first", "fig": 1}, {"body": 1, "word": "stars", "fig": 1}, {"body": 1, "word": "B", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162406/bin/zbc0401177000004.jpg", "caption": "Cullin 1-dependent ubiquitination regulates the JMJD2A-dependent faster S phase progression. A and B, the overexpression of ubiquitin (Ub) leads to a faster degradation of exogenous JMJD2A (A) while not altering endogenous JMJD2A turnover (B). Dominant negative cullin 1 (DN-1) prevented the turnover of both endogenous and exogenous JMJD2A. HEK293T cells overexpressing control N-GFP or N-GFP-JMJD2A were transfected with HA-ubiquitin and DN-1 or control vector. Cells were then treated for the indicated times with 400 \u03bcm of cycloheximide (CHX), lysed, and immunoblotted. The y axis represents the ratio of JMJD2A relative to time 0, which was normalized to \u03b2-actin. The average of two independent experiments is shown. The errors bars represent the mean \u00b1 S.E. C and D, overexpression of ubiquitin prevents the faster S phase because of JMJD2A overexpression, which was blocked by dominant negative cullin 1. HEK293T cells overexpressing control N-GFP or N-GFP-JMJD2A were transfected with HA-ubiquitin and DN-1 or a control vector, arrested in G2/M with nocodazole, and released for the indicated times prior to collection for FACS analysis. A graphical representation of the average of three independent experiments is shown.", "co_occurrence": [{"body": 126, "word": "JMJD2A", "fig": 5}, {"body": 37, "word": "The", "fig": 3}, {"body": 50, "word": "cells", "fig": 2}, {"body": 29, "word": "ubiquitin", "fig": 2}, {"body": 28, "word": "turnover", "fig": 2}, {"body": 26, "word": "cullin", "fig": 2}, {"body": 17, "word": "overexpression", "fig": 3}, {"body": 25, "word": "S", "fig": 2}, {"body": 12, "word": "control", "fig": 4}, {"body": 23, "word": "phase", "fig": 2}, {"body": 15, "word": "overexpressing", "fig": 2}, {"body": 8, "word": "faster", "fig": 3}, {"body": 11, "word": "negative", "fig": 2}, {"body": 8, "word": "endogenous", "fig": 2}, {"body": 16, "word": "progression", "fig": 1}, {"body": 8, "word": "exogenous", "fig": 2}, {"body": 5, "word": "A", "fig": 3}, {"body": 13, "word": "ubiquitination", "fig": 1}, {"body": 4, "word": "DN-1", "fig": 3}, {"body": 11, "word": "dominant", "fig": 1}, {"body": 10, "word": "G2/M", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 2}, {"body": 9, "word": "degradation", "fig": 1}, {"body": 4, "word": "transfected", "fig": 2}, {"body": 8, "word": "nocodazole", "fig": 1}, {"body": 3, "word": "average", "fig": 2}, {"body": 5, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "experiments", "fig": 2}, {"body": 4, "word": "blocked", "fig": 1}, {"body": 4, "word": "arrested", "fig": 1}, {"body": 4, "word": "bars", "fig": 1}, {"body": 2, "word": "shown", "fig": 2}, {"body": 4, "word": "JMJD2A-dependent", "fig": 1}, {"body": 4, "word": "two", "fig": 1}, {"body": 4, "word": "Cullin", "fig": 1}, {"body": 4, "word": "treated", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "regulates", "fig": 1}, {"body": 2, "word": "immunoblotted", "fig": 1}, {"body": 1, "word": "times", "fig": 2}, {"body": 2, "word": "prior", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "released", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "prevents", "fig": 1}, {"body": 1, "word": "S.E", "fig": 1}, {"body": 1, "word": "lysed", "fig": 1}, {"body": 1, "word": "1-dependent", "fig": 1}, {"body": 1, "word": "cycloheximide", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162406/bin/zbc0401177000005.jpg", "caption": "JMJD2A occupancy and BrdU incorporation are regulated by ubiquitin. A, ubiquitin (Ub) overexpression prevents the increase of ssDNA (indicative of replication forks) in JMJD2A-overexpressing cells (25, 35). HEK293T cells overexpressing control N-GFP or N-GFP-JMJD2A were transfected with HA-ubiquitin or a control vector and then treated with BrdU for 24 h prior to arrest in G2/M with nocodazole. Cells were released for the indicated times prior to DNA collection. Samples were purified and slot-blotted, and then immunoblotted for BrdU. The y axis represents the ratio of native/denaturated BrdU signal normalized to the level in control cells at each time point. The average of two independent experiments is shown. The errors bars represent the mean \u00b1 S.E. Stars, p < 0.05. B, ubiquitin overexpression decreases the enrichment of JMJD2A at Chr1 sat2 (25). HEK293T cells overexpressing control N-GFP or N-GFP-JMJD2A were transfected with HA-ubiquitin or a control vector and released 1 h after HU treatment before performing the ChIP experiment. JMJD2A cells were statistically different from control cells (p = 0.02), whereas JMJD2A cells overexpressing ubiquitin were not (p = 0.1). C, ubiquitin overexpression prevents the increased EdU incorporation at Chr1 sat2 in JMJD2A-overexpressing cells (25). HEK293T cells overexpressing control N-GFP or N-GFP-JMJD2A were transfected with HA-ubiquitin or a control vector and then treated with EdU for 1 h prior to DNA collection. The DNA was then biotinylated and replicated DNA was enriched with streptavidin beads prior to analysis by quantitative PCR. Stars, p < 0.05 relative to control cells treated with control vector; #, p < 0.05 relative to JMJD2A cells + control vector. D, JMJD2A overexpression leads to increased BrdU incorporation at JMJD2A binding sites, which was ameliorated upon overexpression of ubiquitin. JMJD2A binding sites in JMJD2A-overexpressing cells were identified by ChIP-chip and analysis with MA2C software (28). BrdU ChIP-chip data were then analyzed by meta-analysis at these JMJD2A-bound genomic locations in control and JMJD2A-overexpressing cells with and without exogenous ubiquitin. The graph depicts the average BrdU ChIP profile around JMJD2A binding sites (solid curves) compared with random regions (dashed curves). Data are centered on the JMJD2A binding sites (0 on x axis). The average BrdU intensities were smoothed using a moving average with a 50-kb window in 1-kb increment step sizes.", "co_occurrence": [{"body": 126, "word": "JMJD2A", "fig": 10}, {"body": 50, "word": "cells", "fig": 13}, {"body": 37, "word": "The", "fig": 6}, {"body": 29, "word": "ubiquitin", "fig": 7}, {"body": 22, "word": "BrdU", "fig": 8}, {"body": 12, "word": "control", "fig": 12}, {"body": 17, "word": "overexpression", "fig": 5}, {"body": 17, "word": "DNA", "fig": 4}, {"body": 15, "word": "overexpressing", "fig": 4}, {"body": 20, "word": "increased", "fig": 2}, {"body": 8, "word": "p", "fig": 5}, {"body": 13, "word": "h", "fig": 3}, {"body": 7, "word": "sites", "fig": 4}, {"body": 7, "word": "binding", "fig": 4}, {"body": 9, "word": "incorporation", "fig": 3}, {"body": 4, "word": "JMJD2A-overexpressing", "fig": 4}, {"body": 5, "word": "HEK293T", "fig": 3}, {"body": 13, "word": "regulated", "fig": 1}, {"body": 4, "word": "transfected", "fig": 3}, {"body": 4, "word": "treated", "fig": 3}, {"body": 3, "word": "average", "fig": 4}, {"body": 11, "word": "data", "fig": 1}, {"body": 10, "word": "G2/M", "fig": 1}, {"body": 5, "word": "EdU", "fig": 2}, {"body": 9, "word": "using", "fig": 1}, {"body": 4, "word": "Chr1", "fig": 2}, {"body": 8, "word": "replication", "fig": 1}, {"body": 8, "word": "increase", "fig": 1}, {"body": 2, "word": "prior", "fig": 4}, {"body": 8, "word": "nocodazole", "fig": 1}, {"body": 8, "word": "exogenous", "fig": 1}, {"body": 6, "word": "occupancy", "fig": 1}, {"body": 6, "word": "regions", "fig": 1}, {"body": 3, "word": "sat2", "fig": 2}, {"body": 5, "word": "beads", "fig": 1}, {"body": 5, "word": "ssDNA", "fig": 1}, {"body": 5, "word": "compared", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "treatment", "fig": 1}, {"body": 2, "word": "ChIP-chip", "fig": 2}, {"body": 4, "word": "bars", "fig": 1}, {"body": 2, "word": "ChIP", "fig": 2}, {"body": 4, "word": "two", "fig": 1}, {"body": 4, "word": "different", "fig": 1}, {"body": 2, "word": "analysis", "fig": 2}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "identified", "fig": 1}, {"body": 3, "word": "genomic", "fig": 1}, {"body": 3, "word": "forks", "fig": 1}, {"body": 3, "word": "solid", "fig": 1}, {"body": 3, "word": "whereas", "fig": 1}, {"body": 3, "word": "upon", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "immunoblotted", "fig": 1}, {"body": 2, "word": "arrest", "fig": 1}, {"body": 2, "word": "profile", "fig": 1}, {"body": 2, "word": "HU", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "experiment", "fig": 1}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 2, "word": "centered", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "released", "fig": 2}, {"body": 1, "word": "prevents", "fig": 2}, {"body": 2, "word": "intensities", "fig": 1}, {"body": 2, "word": "locations", "fig": 1}, {"body": 2, "word": "dashed", "fig": 1}, {"body": 2, "word": "MA2C", "fig": 1}, {"body": 2, "word": "biotinylated", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "random", "fig": 1}, {"body": 1, "word": "graph", "fig": 1}, {"body": 1, "word": "ameliorated", "fig": 1}, {"body": 1, "word": "purified", "fig": 1}, {"body": 1, "word": "window", "fig": 1}, {"body": 1, "word": "depicts", "fig": 1}, {"body": 1, "word": "level", "fig": 1}, {"body": 1, "word": "performing", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "PCR", "fig": 1}, {"body": 1, "word": "around", "fig": 1}, {"body": 1, "word": "replicated", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "meta-analysis", "fig": 1}, {"body": 1, "word": "step", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "software", "fig": 1}, {"body": 1, "word": "streptavidin", "fig": 1}, {"body": 1, "word": "50-kb", "fig": 1}, {"body": 1, "word": "smoothed", "fig": 1}, {"body": 1, "word": "S.E", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "1-kb", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "increment", "fig": 1}, {"body": 1, "word": "sizes", "fig": 1}, {"body": 1, "word": "moving", "fig": 1}, {"body": 1, "word": "JMJD2A-bound", "fig": 1}, {"body": 1, "word": "without", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}, {"body": 1, "word": "enrichment", "fig": 1}]}], "3684578": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684578/bin/pone.0066604.g001.jpg", "caption": "Liver damage in TAM\u2212/\u2212 mice. (A) Representative images of H&E stained paraffin-embedded liver sections of 12-month-old WT and TAM\u2212/\u2212 female mice. Scale bar = 10 \u00b5m. (B) Serum ALT and AST levels in 12-month-old mice. Each circle represents unit of ALT or AST in sera of an individual mouse. (C) Serum ALT and AST levels in mice at the indicated ages. Note that the livers were progressively damaged as TAM\u2212/\u2212 mice aged. (D) Serum ALT and AST levels in 12-month-old mice mutant singly, doubly, and triply for TAM RTKs. T, A, and M represent Tyro3, Axl and Mer, respectively. Data are mean \u00b1 SEM, n\u226510. *P<0.05, **P<0.01.", "co_occurrence": [{"body": 71, "word": "mice", "fig": 6}, {"body": 45, "word": "TAM\u2212/\u2212", "fig": 3}, {"body": 93, "word": "liver", "fig": 1}, {"body": 11, "word": "AST", "fig": 4}, {"body": 10, "word": "ALT", "fig": 4}, {"body": 31, "word": "TAM", "fig": 1}, {"body": 25, "word": "damage", "fig": 1}, {"body": 23, "word": "RTKs", "fig": 1}, {"body": 7, "word": "levels", "fig": 3}, {"body": 15, "word": "WT", "fig": 1}, {"body": 8, "word": "sera", "fig": 1}, {"body": 7, "word": "mutant", "fig": 1}, {"body": 5, "word": "mouse", "fig": 1}, {"body": 5, "word": "sections", "fig": 1}, {"body": 5, "word": "Axl", "fig": 1}, {"body": 5, "word": "T", "fig": 1}, {"body": 4, "word": "aged", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 3, "word": "Mer", "fig": 1}, {"body": 3, "word": "progressively", "fig": 1}, {"body": 1, "word": "Serum", "fig": 3}, {"body": 3, "word": "Tyro3", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "female", "fig": 1}, {"body": 2, "word": "livers", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "individual", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684578/bin/pone.0066604.g002.jpg", "caption": "Histologic analysis of cellular infiltrations in the liver of TAM\u2212/\u2212 mice. (A) H&E staining of paraffin-embedded liver sections of TAM\u2212/\u2212 mice at the indicated ages. M1, M6 and M12 represent the liver sections of 1, 6 and 12 month-old mice respectively. Note a progression of cellular infiltrations in the liver as TAM\u2212/\u2212 mice aged. Arrows indicate focal infiltrates. (B) Characterization of infiltrated lymphocytes. Immunofluorescence was performed using FITC-conjugated antibodies against lymphocyte markers. Note that the infiltrated lymphocytes predominantly consist of CD4+ and CD8+ T cells. (C) Quantitatively analysis of lymphocytes. The cells were labeled with FITC-conjugated antibodies against CD4, CD8 and B220, and subsequently subject to flow cytometry. (D) Identification of macrophages. Immunohistochemistry was used for the identification of total macrophages (F4/80+), circulating macrophages (ED1+) and resident macrophages (ED2+). Note that the macrophages consist of resident and infiltrated cells in the liver of TAM\u2212/\u2212 mice, whereas only resident macrophages were observed in WT controls. Frozen liver sections of 10-month-old mice were used for the immune staining. Images are representatives of at least 5 mice. Scale bar = 20 \u00b5m.", "co_occurrence": [{"body": 93, "word": "liver", "fig": 6}, {"body": 71, "word": "mice", "fig": 7}, {"body": 45, "word": "TAM\u2212/\u2212", "fig": 4}, {"body": 60, "word": "cells", "fig": 3}, {"body": 9, "word": "macrophages", "fig": 6}, {"body": 35, "word": "The", "fig": 1}, {"body": 8, "word": "lymphocytes", "fig": 3}, {"body": 11, "word": "infiltrations", "fig": 2}, {"body": 11, "word": "antibodies", "fig": 2}, {"body": 7, "word": "infiltrated", "fig": 3}, {"body": 18, "word": "immune", "fig": 1}, {"body": 15, "word": "WT", "fig": 1}, {"body": 5, "word": "sections", "fig": 3}, {"body": 7, "word": "staining", "fig": 2}, {"body": 14, "word": "using", "fig": 1}, {"body": 7, "word": "analysis", "fig": 2}, {"body": 6, "word": "cellular", "fig": 2}, {"body": 12, "word": "observed", "fig": 1}, {"body": 4, "word": "resident", "fig": 3}, {"body": 4, "word": "used", "fig": 2}, {"body": 3, "word": "FITC-conjugated", "fig": 2}, {"body": 6, "word": "performed", "fig": 1}, {"body": 5, "word": "controls", "fig": 1}, {"body": 5, "word": "T", "fig": 1}, {"body": 5, "word": "circulating", "fig": 1}, {"body": 4, "word": "aged", "fig": 1}, {"body": 3, "word": "CD8+", "fig": 1}, {"body": 3, "word": "CD4+", "fig": 1}, {"body": 2, "word": "Immunohistochemistry", "fig": 1}, {"body": 2, "word": "Immunofluorescence", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "CD4", "fig": 1}, {"body": 2, "word": "progression", "fig": 1}, {"body": 2, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "B220", "fig": 1}, {"body": 2, "word": "ED2+", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "CD8", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "flow", "fig": 1}, {"body": 2, "word": "subsequently", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "M6", "fig": 1}, {"body": 1, "word": "F4/80+", "fig": 1}, {"body": 1, "word": "M12", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "ED1+", "fig": 1}, {"body": 1, "word": "indicate", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "labeled", "fig": 1}, {"body": 1, "word": "whereas", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 1}, {"body": 1, "word": "predominantly", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684578/bin/pone.0066604.g003.jpg", "caption": "Autoantibodies diagnostic of AIH in sera from TAM\u2212/\u2212 mice. (A) Immunofluorescence on Hepa1-6 cells for detection of ANAs. The images are representative staining patterns using \u00d7200 diluted sera of 12-month-old WT and TAM\u2212/\u2212 mice (n = 5 mice each genotype). Scale bar = 40 \u00b5m. (B) The sera were diluted in series. Each circle indicates the maximum dilution of sera from individual mice, in which ANAs can be detectable. (C) Measurement of anti-actin autoantibody component of SMA using ELISA. Each circle indicates unit of anti-actin autoantibodies in sera of individual mice. (D) Titer of SMA. The microscope slides (Rat stomach) were stained using sera at the indicated dilutions. (E) Plasma IgG. The plasma were collected from 12-month-old mice. IgG levels were measured using ELISA.", "co_occurrence": [{"body": 71, "word": "mice", "fig": 6}, {"body": 35, "word": "The", "fig": 4}, {"body": 45, "word": "TAM\u2212/\u2212", "fig": 2}, {"body": 60, "word": "cells", "fig": 1}, {"body": 14, "word": "using", "fig": 4}, {"body": 8, "word": "sera", "fig": 6}, {"body": 16, "word": "AIH", "fig": 1}, {"body": 15, "word": "WT", "fig": 1}, {"body": 7, "word": "IgG", "fig": 2}, {"body": 6, "word": "SMA", "fig": 2}, {"body": 8, "word": "autoantibodies", "fig": 1}, {"body": 7, "word": "staining", "fig": 1}, {"body": 7, "word": "levels", "fig": 1}, {"body": 3, "word": "ELISA", "fig": 2}, {"body": 3, "word": "Hepa1-6", "fig": 1}, {"body": 3, "word": "plasma", "fig": 1}, {"body": 1, "word": "anti-actin", "fig": 2}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "series", "fig": 1}, {"body": 2, "word": "detection", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 1, "word": "diluted", "fig": 2}, {"body": 2, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "collected", "fig": 1}, {"body": 2, "word": "Immunofluorescence", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "slides", "fig": 1}, {"body": 2, "word": "measured", "fig": 1}, {"body": 2, "word": "dilution", "fig": 1}, {"body": 2, "word": "patterns", "fig": 1}, {"body": 2, "word": "microscope", "fig": 1}, {"body": 1, "word": "individual", "fig": 2}, {"body": 2, "word": "autoantibody", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "Plasma", "fig": 1}, {"body": 1, "word": "genotype", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Rat", "fig": 1}, {"body": 1, "word": "component", "fig": 1}, {"body": 1, "word": "n", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684578/bin/pone.0066604.g004.jpg", "caption": "Expression of TAM RTKs, Gas6 and Protein S. (A) Western blot analyses of the liver lysates for the examination of TAM RTKs, Gas6 and Protein S. (B) Expression of TAM RTKs, Gas6 and Protein S in isolated liver cells: parenchymal cells (PCs), Kupffer cells(KCs) and sinusoidal endothelial cells (SECs). The primary cells were subjected to Western blotting. (C) Immunohistochemistry for the detection of TAM RTKs, Gas6 and Protein S. Arrowheads indicate PCs, and arrows indicate spindle-shaped sinusoidal cells corresponding to KCs and SECs. In negative controls (islets), sections were incubated with primary antibodies pre-incubated with an excess of blocking peptide. The livers of 15-week-old WT mice were used for the protein analyses. The images are representatives of at least three experiments. Scale bar = 20 \u00b5m.", "co_occurrence": [{"body": 60, "word": "cells", "fig": 6}, {"body": 93, "word": "liver", "fig": 2}, {"body": 31, "word": "TAM", "fig": 4}, {"body": 35, "word": "The", "fig": 3}, {"body": 23, "word": "RTKs", "fig": 4}, {"body": 71, "word": "mice", "fig": 1}, {"body": 5, "word": "Gas6", "fig": 4}, {"body": 15, "word": "WT", "fig": 1}, {"body": 3, "word": "Protein", "fig": 4}, {"body": 11, "word": "antibodies", "fig": 1}, {"body": 8, "word": "parenchymal", "fig": 1}, {"body": 4, "word": "KCs", "fig": 2}, {"body": 4, "word": "PCs", "fig": 2}, {"body": 7, "word": "In", "fig": 1}, {"body": 3, "word": "SECs", "fig": 2}, {"body": 3, "word": "sinusoidal", "fig": 2}, {"body": 5, "word": "incubated", "fig": 1}, {"body": 5, "word": "controls", "fig": 1}, {"body": 5, "word": "sections", "fig": 1}, {"body": 2, "word": "primary", "fig": 2}, {"body": 4, "word": "used", "fig": 1}, {"body": 4, "word": "isolated", "fig": 1}, {"body": 4, "word": "three", "fig": 1}, {"body": 2, "word": "Western", "fig": 2}, {"body": 4, "word": "S", "fig": 1}, {"body": 3, "word": "Kupffer", "fig": 1}, {"body": 3, "word": "negative", "fig": 1}, {"body": 2, "word": "endothelial", "fig": 1}, {"body": 2, "word": "livers", "fig": 1}, {"body": 2, "word": "detection", "fig": 1}, {"body": 2, "word": "blotting", "fig": 1}, {"body": 2, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "Immunohistochemistry", "fig": 1}, {"body": 1, "word": "indicate", "fig": 2}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "analyses", "fig": 2}, {"body": 1, "word": "Expression", "fig": 2}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "spindle-shaped", "fig": 1}, {"body": 1, "word": "blocking", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684578/bin/pone.0066604.g005.jpg", "caption": "Activation of TLR signaling in the liver of TAM\u2212/\u2212 mice. (A) Expression of inflammatory cytokines. The mRNAs were analyzed by real-time RT-PCR (left panel) and the protein levels were determined by ELISA assay (right panel). Total RNAs were extracted from the liver and analyzed for the cytokine expression using RT-PCR, and cytokine levels in liver lysates were measured using ELISA. Data are mean \u00b1 SEM of three independent experiments. **P<0.01. (B) Analysis on the phosphorylation of NF-\u03baB and IRF3. The liver lysates were used for immunoblots probed for phosphor-P65 (p-P65) and phosphor-IRF3 (p-IRF3).", "co_occurrence": [{"body": 93, "word": "liver", "fig": 4}, {"body": 71, "word": "mice", "fig": 1}, {"body": 35, "word": "The", "fig": 2}, {"body": 45, "word": "TAM\u2212/\u2212", "fig": 1}, {"body": 14, "word": "using", "fig": 2}, {"body": 27, "word": "inflammatory", "fig": 1}, {"body": 7, "word": "levels", "fig": 2}, {"body": 12, "word": "cytokines", "fig": 1}, {"body": 5, "word": "cytokine", "fig": 2}, {"body": 3, "word": "ELISA", "fig": 2}, {"body": 3, "word": "analyzed", "fig": 2}, {"body": 6, "word": "expression", "fig": 1}, {"body": 5, "word": "IRF3", "fig": 1}, {"body": 4, "word": "NF-\u03baB", "fig": 1}, {"body": 4, "word": "three", "fig": 1}, {"body": 4, "word": "TLR", "fig": 1}, {"body": 4, "word": "signaling", "fig": 1}, {"body": 4, "word": "used", "fig": 1}, {"body": 1, "word": "RT-PCR", "fig": 2}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "measured", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 1, "word": "Activation", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "Expression", "fig": 1}, {"body": 1, "word": "Total", "fig": 1}, {"body": 1, "word": "phosphorylation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684578/bin/pone.0066604.g006.jpg", "caption": "Bone marrow transplantation. Lethally irradiated 6-month-old mice were injected with bone marrow from 2-month-old donor mice through a tail vein. The engrafted mice were analyzed at 6 months after bone marrow transplantation. (A) Expression of inflammatory cytokines in the liver of WT\u2192TAM\u2212/\u2212 mice. (B) Activities of serum ALT and AST in WT\u2192TAM\u2212/\u2212 mice. (C) Cytokine expression in the liver of TAM\u2212/\u2212\u2192WT mice. (D) Serum AST and ALT activities in the TAM\u2212/\u2212\u2192WT mice. Total RNA was extracted from the liver, and the mRNAs of cytokines were determined by real-time RT-PCR. Serum AST and ALT activities were measured by enzymatic assay kits. (E) The expression of Axl in the circulating leukocytes in engrafted mice. Data are mean \u00b1 SEM (n = 10). **P<0.01.", "co_occurrence": [{"body": 71, "word": "mice", "fig": 8}, {"body": 93, "word": "liver", "fig": 3}, {"body": 35, "word": "The", "fig": 2}, {"body": 11, "word": "AST", "fig": 3}, {"body": 10, "word": "ALT", "fig": 3}, {"body": 27, "word": "inflammatory", "fig": 1}, {"body": 12, "word": "cytokines", "fig": 2}, {"body": 5, "word": "marrow", "fig": 3}, {"body": 14, "word": "months", "fig": 1}, {"body": 6, "word": "activities", "fig": 2}, {"body": 6, "word": "transplantation", "fig": 2}, {"body": 6, "word": "expression", "fig": 2}, {"body": 6, "word": "bone", "fig": 2}, {"body": 4, "word": "engrafted", "fig": 2}, {"body": 8, "word": "serum", "fig": 1}, {"body": 3, "word": "TAM\u2212/\u2212\u2192WT", "fig": 2}, {"body": 3, "word": "WT\u2192TAM\u2212/\u2212", "fig": 2}, {"body": 5, "word": "circulating", "fig": 1}, {"body": 5, "word": "Axl", "fig": 1}, {"body": 3, "word": "Bone", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 2, "word": "kits", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "irradiated", "fig": 1}, {"body": 2, "word": "tail", "fig": 1}, {"body": 2, "word": "donor", "fig": 1}, {"body": 2, "word": "leukocytes", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "assay", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "vein", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "RNA", "fig": 1}, {"body": 2, "word": "measured", "fig": 1}, {"body": 1, "word": "Serum", "fig": 2}, {"body": 1, "word": "2-month-old", "fig": 1}, {"body": 1, "word": "injected", "fig": 1}, {"body": 1, "word": "Expression", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "Activities", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "Cytokine", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "RT-PCR", "fig": 1}, {"body": 1, "word": "enzymatic", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "n", "fig": 1}, {"body": 1, "word": "Total", "fig": 1}]}], "4914296": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g001.jpg", "caption": "Lung tumor cells expressing GOF p53 show higher EGFR levels RT-QPCR of EGFR levels in lung tumors. cDNA was prepared from human lung tumor RNAs using the Superscript III cDNA synthesis kit (Invitrogen) and QPCR performed using primers specific for EGFR. The degree of expression was quantitated using a relative standard curve, normalized to GAPDH corresponding to the cDNA batch, and presented as a box plot to show the distribution of EGFR expression in WT and GOF p53 containing lung tumors. We used 15 NSCLC lung tumor samples for each set of either WT or mutant p53. Mutations within the samples were found mostly within the DNA binding domain (DBD) with a few located within the oligomerization domain. Experiments were performed in technical triplicates as described in the text. Error bars showing standard deviations are indicated and the p-value has been included.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 3}, {"body": 130, "word": "EGFR", "fig": 4}, {"body": 146, "word": "GOF", "fig": 2}, {"body": 26, "word": "lung", "fig": 4}, {"body": 31, "word": "expression", "fig": 2}, {"body": 19, "word": "using", "fig": 3}, {"body": 56, "word": "cells", "fig": 1}, {"body": 25, "word": "performed", "fig": 2}, {"body": 19, "word": "show", "fig": 2}, {"body": 14, "word": "levels", "fig": 2}, {"body": 26, "word": "We", "fig": 1}, {"body": 25, "word": "binding", "fig": 1}, {"body": 8, "word": "tumor", "fig": 3}, {"body": 19, "word": "The", "fig": 1}, {"body": 18, "word": "expressing", "fig": 1}, {"body": 18, "word": "described", "fig": 1}, {"body": 18, "word": "used", "fig": 1}, {"body": 16, "word": "mutant", "fig": 1}, {"body": 7, "word": "WT", "fig": 2}, {"body": 6, "word": "tumors", "fig": 2}, {"body": 5, "word": "samples", "fig": 2}, {"body": 3, "word": "cDNA", "fig": 3}, {"body": 7, "word": "found", "fig": 1}, {"body": 7, "word": "QPCR", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 7, "word": "primers", "fig": 1}, {"body": 6, "word": "specific", "fig": 1}, {"body": 6, "word": "set", "fig": 1}, {"body": 6, "word": "indicated", "fig": 1}, {"body": 6, "word": "higher", "fig": 1}, {"body": 6, "word": "prepared", "fig": 1}, {"body": 5, "word": "human", "fig": 1}, {"body": 5, "word": "presented", "fig": 1}, {"body": 2, "word": "domain", "fig": 2}, {"body": 3, "word": "showing", "fig": 1}, {"body": 3, "word": "either", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "within", "fig": 3}, {"body": 3, "word": "RT-QPCR", "fig": 1}, {"body": 2, "word": "p-value", "fig": 1}, {"body": 2, "word": "degree", "fig": 1}, {"body": 1, "word": "standard", "fig": 2}, {"body": 2, "word": "kit", "fig": 1}, {"body": 2, "word": "Invitrogen", "fig": 1}, {"body": 2, "word": "Lung", "fig": 1}, {"body": 2, "word": "corresponding", "fig": 1}, {"body": 1, "word": "RNAs", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "Superscript", "fig": 1}, {"body": 1, "word": "synthesis", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "batch", "fig": 1}, {"body": 1, "word": "containing", "fig": 1}, {"body": 1, "word": "III", "fig": 1}, {"body": 1, "word": "included", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g002.jpg", "caption": "Gain-of-function p53 upregulates expression of EGFR in H1299 lung cancer cells H1299 cells have been stably transfected to express p53 mutants -R175H and -R273H (or vector alone). A. RT-QPCR was used to assay for EGFR levels in different cell clones. The data presented show that GOF p53 upregulates EGFR mRNA expression. Data represent QPCR values normalized to GAPDH levels (that are not affected by GOF p53). Different cell clones are indicated by clone numbers. Experiments were performed in technical triplicates. Error bars showing standard deviations are indicated. Asterisks indicate a p-value of less than 0.05. B. Representative Western analysis showing EGFR and GOF p53 levels in different cell clones.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 5}, {"body": 130, "word": "EGFR", "fig": 4}, {"body": 146, "word": "GOF", "fig": 3}, {"body": 56, "word": "cells", "fig": 2}, {"body": 23, "word": "cell", "fig": 3}, {"body": 31, "word": "expression", "fig": 2}, {"body": 14, "word": "levels", "fig": 3}, {"body": 18, "word": "H1299", "fig": 2}, {"body": 10, "word": "clones", "fig": 3}, {"body": 26, "word": "lung", "fig": 1}, {"body": 25, "word": "performed", "fig": 1}, {"body": 12, "word": "different", "fig": 2}, {"body": 23, "word": "data", "fig": 1}, {"body": 19, "word": "cancer", "fig": 1}, {"body": 19, "word": "The", "fig": 1}, {"body": 19, "word": "show", "fig": 1}, {"body": 18, "word": "used", "fig": 1}, {"body": 6, "word": "indicated", "fig": 2}, {"body": 12, "word": "mutants", "fig": 1}, {"body": 12, "word": "assay", "fig": 1}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 9, "word": "vector", "fig": 1}, {"body": 4, "word": "upregulates", "fig": 2}, {"body": 8, "word": "Western", "fig": 1}, {"body": 7, "word": "QPCR", "fig": 1}, {"body": 7, "word": "transfected", "fig": 1}, {"body": 3, "word": "showing", "fig": 2}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 5, "word": "presented", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "stably", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "indicate", "fig": 1}, {"body": 3, "word": "RT-QPCR", "fig": 1}, {"body": 2, "word": "-R273H", "fig": 1}, {"body": 2, "word": "p-value", "fig": 1}, {"body": 2, "word": "clone", "fig": 1}, {"body": 2, "word": "alone", "fig": 1}, {"body": 1, "word": "affected", "fig": 1}, {"body": 1, "word": "standard", "fig": 1}, {"body": 1, "word": "less", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g003.jpg", "caption": "p53 knock-down in H1975 and KNS-62 cells reduces EGFR levels A. Western blot showing EGFR, phospho-EGFR, p53, and Erk2 levels in H1299 cells stably expressing either an empty vector or the p53 mutants R175H, R273H, and D281G as well as different cell clones generated by recombinant lentiviruses expressing p53 shRNA or control GFP shRNA in H1975 and KNS-62 cells. B. RT-QPCR data for EGFR in different cell lines under study. cDNA was prepared from cell line RNAs using the Superscript III cDNA synthesis kit (Invitrogen) and QPCR performed using primers specific for EGFR cDNA. The degree of expression was quantitated using a relative standard curve and normalized to GAPDH corresponding to the cDNA batch. Different cell clones are indicated by clone numbers. Experiments were performed in technical triplicates. Error bars showing standard deviations are indicated and p-values have been included.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 4}, {"body": 130, "word": "EGFR", "fig": 4}, {"body": 56, "word": "cells", "fig": 3}, {"body": 23, "word": "cell", "fig": 4}, {"body": 19, "word": "using", "fig": 3}, {"body": 25, "word": "performed", "fig": 2}, {"body": 18, "word": "expressing", "fig": 2}, {"body": 16, "word": "H1975", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 14, "word": "levels", "fig": 2}, {"body": 12, "word": "different", "fig": 2}, {"body": 23, "word": "data", "fig": 1}, {"body": 11, "word": "KNS-62", "fig": 2}, {"body": 10, "word": "clones", "fig": 2}, {"body": 19, "word": "The", "fig": 1}, {"body": 18, "word": "H1299", "fig": 1}, {"body": 13, "word": "knock-down", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 6, "word": "indicated", "fig": 2}, {"body": 3, "word": "cDNA", "fig": 4}, {"body": 12, "word": "mutants", "fig": 1}, {"body": 9, "word": "vector", "fig": 1}, {"body": 8, "word": "Western", "fig": 1}, {"body": 8, "word": "well", "fig": 1}, {"body": 7, "word": "QPCR", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "primers", "fig": 1}, {"body": 7, "word": "lines", "fig": 1}, {"body": 3, "word": "showing", "fig": 2}, {"body": 6, "word": "specific", "fig": 1}, {"body": 6, "word": "prepared", "fig": 1}, {"body": 5, "word": "blot", "fig": 1}, {"body": 4, "word": "stably", "fig": 1}, {"body": 2, "word": "shRNA", "fig": 2}, {"body": 3, "word": "either", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "RT-QPCR", "fig": 1}, {"body": 2, "word": "R273H", "fig": 1}, {"body": 2, "word": "degree", "fig": 1}, {"body": 1, "word": "standard", "fig": 2}, {"body": 2, "word": "kit", "fig": 1}, {"body": 2, "word": "Invitrogen", "fig": 1}, {"body": 2, "word": "corresponding", "fig": 1}, {"body": 2, "word": "phospho-EGFR", "fig": 1}, {"body": 2, "word": "clone", "fig": 1}, {"body": 2, "word": "generated", "fig": 1}, {"body": 2, "word": "GFP", "fig": 1}, {"body": 1, "word": "Erk2", "fig": 1}, {"body": 1, "word": "RNAs", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "Superscript", "fig": 1}, {"body": 1, "word": "synthesis", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "batch", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}, {"body": 1, "word": "III", "fig": 1}, {"body": 1, "word": "included", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g004a.jpg", "caption": "Reduction of GOF p53 and EGFR in lung cancer cells retards tumorigenicity, growth rate and cell motility A. H1975 and KNS-62 cell clones stably expressing shRNA against p53 were injected into nude (H1975) or Scid (KNS-62) mice. Western blot analysis was performed on extracts derived from tumors after removal from the mice. B. H1975 lung cancer cells were transfected with siRNA targeting EGFR and subsequently injected into nude mice. Western blot analysis was performed on extracts derived from tumors after removal from the mice and used to show knoc-kdown of the EGFR protein in 4B, 4Cii, and 4E. C. (i) Growth assay of H1975 cells knocked-down for p53 (and control) generated by recombinant lentivirus expressing p53 shRNA. Western blot analysis was performed to show knock-down of the EGFR protein in 4Ci and 4F. (ii) Growth rate of H1975 cells depends on the EGFR level. H1975 cells were transfected with control or EGFR-specific siRNA, plated in equal numbers, and harvested every 48 hours for five time points to determine the rate of doubling. Asterisks indicate a p-value of less than 0.05. D. H1975 p53 knock-down cells were transfected with an EGFR expression plasmid to compensate for the EGFR expression loss, and a growth assay was performed. The assay has been described in the text. A representative immunoblot showing the level of EGFR is shown in 4G. Asterisks indicate a p-value of less than 0.05. E. Migration of H1975 after transient transfection of RNAi against EGFR shows a reduced migration rate. Asterisk indicates a p-value of less than 0.05. F. H1975 cells show a reduction in migration when the endogenous GOF p53 is stably knocked-down. Asterisk indicates a p-value of less than 0.05. G. H1975 p53 knock-down cells were transfected with an EGFR expression plasmid to compensate for the EGFR expression loss, and tumorigenicity (in nude mice) assays were performed. Nude mice were injected with following cell systems: I. H1975 shGFP, (ii) H1975 shp53, (iii) H1975 shp53 + vector and (iv) H1975 shp53 + EGFR. EGFR expression recovers GOF activity loss observed on knock-down of GOF p53 of H1975 cells. Western blot showing EGFR and p53 levels in tumors that were resected from nude mice is shown. Experiments were performed in triplicate. Error bars showing standard deviations are indicated. The p-value has been indicated.", "co_occurrence": [{"body": 130, "word": "EGFR", "fig": 14}, {"body": 184, "word": "p53", "fig": 9}, {"body": 146, "word": "GOF", "fig": 4}, {"body": 56, "word": "cells", "fig": 9}, {"body": 16, "word": "H1975", "fig": 15}, {"body": 31, "word": "expression", "fig": 5}, {"body": 25, "word": "performed", "fig": 6}, {"body": 23, "word": "cell", "fig": 3}, {"body": 19, "word": "show", "fig": 3}, {"body": 13, "word": "knock-down", "fig": 4}, {"body": 26, "word": "lung", "fig": 2}, {"body": 6, "word": "mice", "fig": 7}, {"body": 19, "word": "cancer", "fig": 2}, {"body": 19, "word": "The", "fig": 2}, {"body": 12, "word": "assay", "fig": 3}, {"body": 18, "word": "expressing", "fig": 2}, {"body": 12, "word": "analysis", "fig": 3}, {"body": 8, "word": "Western", "fig": 4}, {"body": 8, "word": "rate", "fig": 4}, {"body": 14, "word": "level", "fig": 2}, {"body": 7, "word": "transfected", "fig": 4}, {"body": 13, "word": "growth", "fig": 2}, {"body": 13, "word": "control", "fig": 2}, {"body": 13, "word": "protein", "fig": 2}, {"body": 23, "word": "assays", "fig": 1}, {"body": 11, "word": "KNS-62", "fig": 2}, {"body": 11, "word": "tumorigenicity", "fig": 2}, {"body": 11, "word": "shown", "fig": 2}, {"body": 5, "word": "blot", "fig": 4}, {"body": 6, "word": "tumors", "fig": 3}, {"body": 18, "word": "shows", "fig": 1}, {"body": 18, "word": "used", "fig": 1}, {"body": 18, "word": "described", "fig": 1}, {"body": 15, "word": "reduction", "fig": 1}, {"body": 14, "word": "determine", "fig": 1}, {"body": 7, "word": "siRNA", "fig": 2}, {"body": 14, "word": "levels", "fig": 1}, {"body": 3, "word": "nude", "fig": 4}, {"body": 6, "word": "plasmid", "fig": 2}, {"body": 6, "word": "indicated", "fig": 2}, {"body": 2, "word": "p-value", "fig": 5}, {"body": 5, "word": "extracts", "fig": 2}, {"body": 10, "word": "clones", "fig": 1}, {"body": 3, "word": "showing", "fig": 3}, {"body": 9, "word": "vector", "fig": 1}, {"body": 9, "word": "transfection", "fig": 1}, {"body": 4, "word": "stably", "fig": 2}, {"body": 8, "word": "endogenous", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 3, "word": "knocked-down", "fig": 2}, {"body": 6, "word": "reduced", "fig": 1}, {"body": 3, "word": "indicate", "fig": 2}, {"body": 6, "word": "motility", "fig": 1}, {"body": 6, "word": "following", "fig": 1}, {"body": 2, "word": "migration", "fig": 2}, {"body": 4, "word": "RNAi", "fig": 1}, {"body": 2, "word": "shRNA", "fig": 2}, {"body": 4, "word": "harvested", "fig": 1}, {"body": 2, "word": "indicates", "fig": 2}, {"body": 1, "word": "less", "fig": 4}, {"body": 2, "word": "Growth", "fig": 2}, {"body": 4, "word": "time", "fig": 1}, {"body": 1, "word": "injected", "fig": 3}, {"body": 1, "word": "shp53", "fig": 3}, {"body": 3, "word": "activity", "fig": 1}, {"body": 3, "word": "triplicate", "fig": 1}, {"body": 3, "word": "transient", "fig": 1}, {"body": 3, "word": "plated", "fig": 1}, {"body": 2, "word": "Reduction", "fig": 1}, {"body": 2, "word": "Scid", "fig": 1}, {"body": 1, "word": "compensate", "fig": 2}, {"body": 2, "word": "immunoblot", "fig": 1}, {"body": 2, "word": "equal", "fig": 1}, {"body": 2, "word": "points", "fig": 1}, {"body": 2, "word": "generated", "fig": 1}, {"body": 2, "word": "4G", "fig": 1}, {"body": 1, "word": "Migration", "fig": 1}, {"body": 1, "word": "observed", "fig": 1}, {"body": 1, "word": "Nude", "fig": 1}, {"body": 1, "word": "standard", "fig": 1}, {"body": 1, "word": "retards", "fig": 1}, {"body": 1, "word": "targeting", "fig": 1}, {"body": 1, "word": "4F", "fig": 1}, {"body": 1, "word": "4E", "fig": 1}, {"body": 1, "word": "4B", "fig": 1}, {"body": 1, "word": "five", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g005a.jpg", "caption": "p53 ChIP sequence peaks on EGFR gene upstream sequences and QPCR verification of ChIP on the EGFR promoter Details of ChIP seq analysis and their verifications have been described previously [36]. A. The peaks representing areas under which maximal p53-R273H binding occurs as apparent by next generation sequence analysis. B. Sequence of the major peak (shown above in red brackets in A where GOF p53 binding occurs along with some of the prominent TF binding sites. C. and D. ChIP assay results showing p53-R273H and AcH3 binding to the EGFR promoter. E. ChIP assay result showing GOF p53 binding to the EGFR promoter in cells stably expressing the R175H and D281G p53 mutants as well as two lung cancer cell lines (H1975 and KNS-62) that endogenously express different p53 mutants (\u2212R273H and -R249S respectively). F. ChIP assay result showing AcH3 binding to the EGFR promoter in cells stably expressing the R175H and D281G p53 mutants as well as two lung cancer cell lines (H1975 and KNS-62). G. Transient EGFR promoter assay in H1299 cells transfected with p53 expression plasmids for p53-WT, -R175H, -R273H, and -D281G. Two regions of the EGFR promoter were cloned into a minimal promoter vector (pGL4-luc): one that did not contain a p53 binding site (BS), and one that did. Sequences to the right show the EGFR promoter with and without the p53 binding site. The sequence in red indicates the p53 binding site, sequences underlined indicate Ets-1 transcription factor sites, and sequences in italics indicate Sp1 transcription factor sites. H. QPCR analysis of a negative control region on the GAPDH promoter shows that neither mutant p53 or AcH3 binds in H1299 cells stably expressing different p53 mutants or in H1975 or KNS-62. I. Confocal microscope images of primary lung cells derived from mice expressing p53 \u2212/\u2212 and R172H/R172H after transfection with our mCherry-EGFR.luc expression plasmid (where the EGFR minimal promoter with and without the p53 binding site was cloned), and mounted on slides after fixation [24, 25]. Cells were viewed under a Zeiss LSM 700 confocal microscope using the 20X objective. Area within red box is enlarged to the right. J. Luciferase assay in cells derived from p53 \u2212/\u2212, p53 +/+, and p53-R172H/R172H transfected with the mCherry-EGFR.luc (minimal EGFR promoter containing a p53 binding site and the promoter without the binding site). Sequences cloned for the EGFR promoter response element are indicated in G; the p53 binding site is in red and bold. ChIP assays were carried out as described in Materials and Methods with H1299 cells expressing p53-R273H, -R175H, and -D281G and vector control as well as H1975 and KNS-62 using antibodies against p53 and AcH3. Data represent QPCR values normalized to a fragment on the GAPDH promoter not affected by GOF p53. Experiments were performed in technical triplicates. Error bars indicate standard deviations. Experiments were performed multiple times with similar results. Asterisks indicate a p-value of less than 0.05.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 20}, {"body": 130, "word": "EGFR", "fig": 11}, {"body": 70, "word": "promoter", "fig": 14}, {"body": 146, "word": "GOF", "fig": 3}, {"body": 56, "word": "cells", "fig": 7}, {"body": 25, "word": "binding", "fig": 13}, {"body": 26, "word": "ChIP", "fig": 7}, {"body": 18, "word": "expressing", "fig": 5}, {"body": 26, "word": "lung", "fig": 3}, {"body": 16, "word": "H1975", "fig": 4}, {"body": 31, "word": "expression", "fig": 2}, {"body": 12, "word": "assay", "fig": 5}, {"body": 18, "word": "H1299", "fig": 3}, {"body": 25, "word": "performed", "fig": 2}, {"body": 7, "word": "site", "fig": 7}, {"body": 12, "word": "AcH3", "fig": 4}, {"body": 12, "word": "mutants", "fig": 4}, {"body": 23, "word": "cell", "fig": 2}, {"body": 15, "word": "p53-R273H", "fig": 3}, {"body": 11, "word": "KNS-62", "fig": 4}, {"body": 19, "word": "using", "fig": 2}, {"body": 19, "word": "cancer", "fig": 2}, {"body": 19, "word": "The", "fig": 2}, {"body": 18, "word": "described", "fig": 2}, {"body": 12, "word": "analysis", "fig": 3}, {"body": 17, "word": "transcription", "fig": 2}, {"body": 29, "word": "Sp1", "fig": 1}, {"body": 9, "word": "sequences", "fig": 3}, {"body": 13, "word": "control", "fig": 2}, {"body": 8, "word": "well", "fig": 3}, {"body": 12, "word": "different", "fig": 2}, {"body": 23, "word": "assays", "fig": 1}, {"body": 7, "word": "QPCR", "fig": 3}, {"body": 10, "word": "one", "fig": 2}, {"body": 19, "word": "show", "fig": 1}, {"body": 9, "word": "vector", "fig": 2}, {"body": 6, "word": "sequence", "fig": 3}, {"body": 18, "word": "shows", "fig": 1}, {"body": 16, "word": "mutant", "fig": 1}, {"body": 5, "word": "cloned", "fig": 3}, {"body": 7, "word": "transfected", "fig": 2}, {"body": 7, "word": "A", "fig": 2}, {"body": 7, "word": "lines", "fig": 2}, {"body": 13, "word": "gene", "fig": 1}, {"body": 6, "word": "results", "fig": 2}, {"body": 4, "word": "stably", "fig": 3}, {"body": 4, "word": "sites", "fig": 3}, {"body": 6, "word": "factor", "fig": 2}, {"body": 3, "word": "indicate", "fig": 4}, {"body": 11, "word": "shown", "fig": 1}, {"body": 10, "word": "region", "fig": 1}, {"body": 3, "word": "showing", "fig": 3}, {"body": 3, "word": "minimal", "fig": 3}, {"body": 9, "word": "TF", "fig": 1}, {"body": 9, "word": "transfection", "fig": 1}, {"body": 4, "word": "result", "fig": 2}, {"body": 8, "word": "carried", "fig": 1}, {"body": 4, "word": "two", "fig": 2}, {"body": 7, "word": "Ets-1", "fig": 1}, {"body": 7, "word": "multiple", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 2}, {"body": 6, "word": "plasmid", "fig": 1}, {"body": 6, "word": "mice", "fig": 1}, {"body": 6, "word": "indicated", "fig": 1}, {"body": 5, "word": "Methods", "fig": 1}, {"body": 5, "word": "previously", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 5, "word": "binds", "fig": 1}, {"body": 1, "word": "red", "fig": 4}, {"body": 4, "word": "Materials", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "response", "fig": 1}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 2, "word": "Sequences", "fig": 2}, {"body": 3, "word": "upstream", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "fragment", "fig": 1}, {"body": 3, "word": "regions", "fig": 1}, {"body": 3, "word": "element", "fig": 1}, {"body": 1, "word": "without", "fig": 3}, {"body": 2, "word": "Zeiss", "fig": 1}, {"body": 2, "word": "p-value", "fig": 1}, {"body": 1, "word": "microscope", "fig": 2}, {"body": 2, "word": "primary", "fig": 1}, {"body": 1, "word": "occurs", "fig": 2}, {"body": 2, "word": "major", "fig": 1}, {"body": 2, "word": "similar", "fig": 1}, {"body": 1, "word": "-D281G", "fig": 2}, {"body": 2, "word": "-R273H", "fig": 1}, {"body": 2, "word": "indicates", "fig": 1}, {"body": 2, "word": "times", "fig": 1}, {"body": 1, "word": "mCherry-EGFR.luc", "fig": 2}, {"body": 1, "word": "peaks", "fig": 2}, {"body": 1, "word": "20X", "fig": 1}, {"body": 1, "word": "maximal", "fig": 1}, {"body": 1, "word": "fixation", "fig": 1}, {"body": 1, "word": "objective", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "contain", "fig": 1}, {"body": 1, "word": "generation", "fig": 1}, {"body": 1, "word": "brackets", "fig": 1}, {"body": 1, "word": "LSM", "fig": 1}, {"body": 1, "word": "neither", "fig": 1}, {"body": 1, "word": "standard", "fig": 1}, {"body": 1, "word": "along", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "R172H/R172H", "fig": 1}, {"body": 1, "word": "within", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 1}, {"body": 1, "word": "next", "fig": 1}, {"body": 1, "word": "Transient", "fig": 1}, {"body": 1, "word": "slides", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "mounted", "fig": 1}, {"body": 1, "word": "affected", "fig": 1}, {"body": 1, "word": "viewed", "fig": 1}, {"body": 1, "word": "less", "fig": 1}, {"body": 1, "word": "containing", "fig": 1}, {"body": 1, "word": "peak", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g006a.jpg", "caption": "TFs are involved in inducing binding of acetylated histone H3 and p53 on the EGFR promoter H1299 cells stably expressing p53-R273H (or vector alone) were transfected with RNAi against TFs suspected of binding to the EGFR promoter (or scrambled siRNA). A. ChIP analysis was performed using an antibody against AcH3 as described in Materials and Methods. QPCR was performed using gene specific primers. Data represent QPCR values normalized to a region on the GAPDH promoter which is not affected by GOF p53. Normalized values for each siRNA treatment were divided by the normalized IgG value to calculate fold binding over IgG. The vector was then set to 1 in each set to be able to compare AcH3 binding between the different transcription factor knock-downs. The data show that multiple TFs influence AcH3 binding to the EGFR promoter. Experiments were performed in triplicate. Error bars showing standard deviations are indicated. Asterisks indicate a p-value of less than 0.05. B. Western blot shows extent of knock-down of different TF levels. C. ChIP assays to determine the extent of TF-mediated p53 binding on the EGFR promoter. H1299 cells expressing p53-R273H (or vector alone) were transfected with RNAi against Sp1, CBP and Ets1 (or scrambled siRNA), and ChIP analysis was performed using p53 antibodies as described in Materials and Methods. Data represent QPCR values normalized to a region on the GAPDH promoter which is not affected by GOF p53. Normalized values for each siRNA treatment were divided by the normalized IgG value to calculate fold binding over IgG. The vector was then set to 1 in each set to be able to compare p53 binding between the different transcription factor knock-downs. Error bars showing standard deviations are indicated. Asterisks indicate a p-value of less than 0.05. D. Western analysis of p53 and EGFR expression in siRNA treated cells used for ChIP in A and C. E. EGFR mRNA expression in siRNA treated cells used for ChIP in A and C. Asterisks indicate a p-value of less than 0.005. F. Western analysis of Sp1 and Ets-1 expression in H1975 and KNS-62 cell lines stably expressing shRNA against the endogenous p53 mutant (or GFP) in the cells.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 8}, {"body": 130, "word": "EGFR", "fig": 6}, {"body": 70, "word": "promoter", "fig": 6}, {"body": 146, "word": "GOF", "fig": 2}, {"body": 56, "word": "cells", "fig": 5}, {"body": 25, "word": "binding", "fig": 8}, {"body": 26, "word": "ChIP", "fig": 5}, {"body": 25, "word": "performed", "fig": 4}, {"body": 31, "word": "expression", "fig": 3}, {"body": 21, "word": "TFs", "fig": 3}, {"body": 29, "word": "Sp1", "fig": 2}, {"body": 19, "word": "using", "fig": 3}, {"body": 19, "word": "The", "fig": 3}, {"body": 18, "word": "expressing", "fig": 3}, {"body": 12, "word": "analysis", "fig": 4}, {"body": 7, "word": "siRNA", "fig": 6}, {"body": 18, "word": "H1299", "fig": 2}, {"body": 9, "word": "vector", "fig": 4}, {"body": 18, "word": "described", "fig": 2}, {"body": 12, "word": "AcH3", "fig": 3}, {"body": 12, "word": "different", "fig": 3}, {"body": 18, "word": "used", "fig": 2}, {"body": 17, "word": "transcription", "fig": 2}, {"body": 15, "word": "p53-R273H", "fig": 2}, {"body": 6, "word": "set", "fig": 4}, {"body": 8, "word": "Western", "fig": 3}, {"body": 23, "word": "cell", "fig": 1}, {"body": 23, "word": "assays", "fig": 1}, {"body": 23, "word": "data", "fig": 1}, {"body": 7, "word": "QPCR", "fig": 3}, {"body": 7, "word": "A", "fig": 3}, {"body": 10, "word": "region", "fig": 2}, {"body": 20, "word": "CBP", "fig": 1}, {"body": 19, "word": "show", "fig": 1}, {"body": 18, "word": "histone", "fig": 1}, {"body": 18, "word": "shows", "fig": 1}, {"body": 16, "word": "H1975", "fig": 1}, {"body": 16, "word": "mutant", "fig": 1}, {"body": 14, "word": "determine", "fig": 1}, {"body": 7, "word": "transfected", "fig": 2}, {"body": 14, "word": "levels", "fig": 1}, {"body": 13, "word": "knock-down", "fig": 1}, {"body": 13, "word": "gene", "fig": 1}, {"body": 13, "word": "Ets1", "fig": 1}, {"body": 6, "word": "factor", "fig": 2}, {"body": 12, "word": "H3", "fig": 1}, {"body": 3, "word": "IgG", "fig": 4}, {"body": 6, "word": "indicated", "fig": 2}, {"body": 11, "word": "KNS-62", "fig": 1}, {"body": 5, "word": "Methods", "fig": 2}, {"body": 5, "word": "Data", "fig": 2}, {"body": 3, "word": "indicate", "fig": 3}, {"body": 9, "word": "TF", "fig": 1}, {"body": 4, "word": "stably", "fig": 2}, {"body": 8, "word": "endogenous", "fig": 1}, {"body": 4, "word": "RNAi", "fig": 2}, {"body": 4, "word": "Materials", "fig": 2}, {"body": 7, "word": "Ets-1", "fig": 1}, {"body": 7, "word": "multiple", "fig": 1}, {"body": 7, "word": "primers", "fig": 1}, {"body": 7, "word": "lines", "fig": 1}, {"body": 6, "word": "involved", "fig": 1}, {"body": 2, "word": "p-value", "fig": 3}, {"body": 3, "word": "showing", "fig": 2}, {"body": 6, "word": "specific", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 2}, {"body": 6, "word": "acetylated", "fig": 1}, {"body": 5, "word": "antibody", "fig": 1}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 5, "word": "blot", "fig": 1}, {"body": 2, "word": "extent", "fig": 2}, {"body": 2, "word": "alone", "fig": 2}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 1, "word": "normalized", "fig": 4}, {"body": 2, "word": "able", "fig": 2}, {"body": 3, "word": "triplicate", "fig": 1}, {"body": 3, "word": "inducing", "fig": 1}, {"body": 1, "word": "less", "fig": 3}, {"body": 1, "word": "treatment", "fig": 2}, {"body": 1, "word": "affected", "fig": 2}, {"body": 1, "word": "standard", "fig": 2}, {"body": 2, "word": "shRNA", "fig": 1}, {"body": 1, "word": "divided", "fig": 2}, {"body": 2, "word": "GFP", "fig": 1}, {"body": 1, "word": "scrambled", "fig": 2}, {"body": 1, "word": "influence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g007.jpg", "caption": "GOF p53 facilitates interaction of TFs on the EGFR promoter A. ChIP assays were carried out for individual TFs using specific antibodies in H1299 cells stably expressing p53-R273H (and vector control). QPCR was performed using gene specific primers. Data represent QPCR values normalized to a region on the GAPDH promoter which is not affected by GOF p53. Normalized values for each transcription factor were divided by the normalized IgG value to calculate fold binding over IgG. The vector was then set to 1 in each set to be able to compare binding between the different transcription factors. Experiments were performed in triplicate. Error bars showing standard deviations are indicated. Asterisks indicate a p-value of less than 0.05. ChIP of individual TFs on the EGFR promoter in the presence and absence of GOF p53 shows enhanced interaction of different TFs on the promoter. B. In vivo interactions between different TFs were carried out in H1299 cells stably expressing p53-R273H (or vector alone) without transfection of TFs by immunoprecipitation (IP) analysis. One set of immunoprecipitations was performed using an antibody against p53 and western blots were probed for Sp1, Ets1, and CBP; another set of immunoprecipitations was performed using antibodies against Sp1, Ets1, and CBP and then the western blots were probed for p53. Immunoprecipitation of p53-R273H from GOF p53 expressing cells shows binding of GOF p53 with CBP, Ets1, and Sp1. Erk2 is shown as a loading control for the IP inputs. C. ChIP-re-ChIP assay showing an increased interaction between GOF p53 and CBP as well as GOF p53 and Sp1. ChIP-re-ChIP procedures were carried out as described in Materials and Methods. Antibodies used for the first immunoprecipitation are indicated in the body of the figure, and antibodies used for the second immunoprecipitation are shown on the X-axis. Asterisks indicate a p-value of less than 0.05 for CBP and less than 0.005 for Sp1. D. Chromatin opening was tested by digestion of ChIP samples with restriction enzymes that are either present or absent in the EGFR promoter (and is described in Materials and Methods). ChIP was performed on H1299 cells stably expressing p53 mutant R273H (or vector control) using antibodies against p53 or IgG control and are indicated in the legend of the graph. The enzyme used for digestion is indicated on the X-axis. Primers used for PCR were located upstream and downstream of where restriction sites were located. Successful PCR indicated uncut chromatin while less or no PCR product indicated chromatin that was open for digestion. Digestion with HinfI and to some extent StuI prevented a PCR product from being formed. HindIII, which does not have a site within the promoter, was used as a digestion negative control. A schematic of the loop-digestion principle is shown. Experiments have been performed multiple times and similar results have been obtained. Asterisks indicate a p-value of less than 0.05.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 11}, {"body": 146, "word": "GOF", "fig": 7}, {"body": 70, "word": "promoter", "fig": 6}, {"body": 130, "word": "EGFR", "fig": 3}, {"body": 56, "word": "cells", "fig": 4}, {"body": 25, "word": "performed", "fig": 6}, {"body": 29, "word": "Sp1", "fig": 5}, {"body": 21, "word": "TFs", "fig": 6}, {"body": 26, "word": "ChIP", "fig": 4}, {"body": 20, "word": "CBP", "fig": 5}, {"body": 19, "word": "using", "fig": 5}, {"body": 18, "word": "used", "fig": 5}, {"body": 25, "word": "binding", "fig": 3}, {"body": 18, "word": "expressing", "fig": 4}, {"body": 13, "word": "control", "fig": 5}, {"body": 18, "word": "H1299", "fig": 3}, {"body": 15, "word": "p53-R273H", "fig": 3}, {"body": 13, "word": "Ets1", "fig": 3}, {"body": 19, "word": "The", "fig": 2}, {"body": 9, "word": "vector", "fig": 4}, {"body": 18, "word": "shows", "fig": 2}, {"body": 18, "word": "described", "fig": 2}, {"body": 12, "word": "interaction", "fig": 3}, {"body": 6, "word": "indicated", "fig": 6}, {"body": 12, "word": "different", "fig": 3}, {"body": 17, "word": "transcription", "fig": 2}, {"body": 11, "word": "shown", "fig": 3}, {"body": 16, "word": "chromatin", "fig": 2}, {"body": 6, "word": "set", "fig": 4}, {"body": 6, "word": "PCR", "fig": 4}, {"body": 8, "word": "carried", "fig": 3}, {"body": 23, "word": "assays", "fig": 1}, {"body": 16, "word": "interactions", "fig": 1}, {"body": 4, "word": "digestion", "fig": 4}, {"body": 4, "word": "antibodies", "fig": 4}, {"body": 16, "word": "mutant", "fig": 1}, {"body": 7, "word": "QPCR", "fig": 2}, {"body": 7, "word": "A", "fig": 2}, {"body": 13, "word": "gene", "fig": 1}, {"body": 4, "word": "stably", "fig": 3}, {"body": 6, "word": "restriction", "fig": 2}, {"body": 6, "word": "specific", "fig": 2}, {"body": 4, "word": "immunoprecipitation", "fig": 3}, {"body": 12, "word": "assay", "fig": 1}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 11, "word": "In", "fig": 1}, {"body": 5, "word": "Methods", "fig": 2}, {"body": 10, "word": "region", "fig": 1}, {"body": 9, "word": "increased", "fig": 1}, {"body": 3, "word": "IgG", "fig": 3}, {"body": 9, "word": "presence", "fig": 1}, {"body": 3, "word": "indicate", "fig": 3}, {"body": 9, "word": "transfection", "fig": 1}, {"body": 4, "word": "individual", "fig": 2}, {"body": 4, "word": "Materials", "fig": 2}, {"body": 4, "word": "ChIP-re-ChIP", "fig": 2}, {"body": 8, "word": "well", "fig": 1}, {"body": 7, "word": "enhanced", "fig": 1}, {"body": 7, "word": "factors", "fig": 1}, {"body": 7, "word": "opening", "fig": 1}, {"body": 7, "word": "tested", "fig": 1}, {"body": 7, "word": "site", "fig": 1}, {"body": 7, "word": "multiple", "fig": 1}, {"body": 7, "word": "primers", "fig": 1}, {"body": 6, "word": "results", "fig": 1}, {"body": 2, "word": "p-value", "fig": 3}, {"body": 6, "word": "factor", "fig": 1}, {"body": 3, "word": "showing", "fig": 2}, {"body": 1, "word": "less", "fig": 5}, {"body": 5, "word": "samples", "fig": 1}, {"body": 5, "word": "antibody", "fig": 1}, {"body": 5, "word": "open", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 2, "word": "product", "fig": 2}, {"body": 4, "word": "sites", "fig": 1}, {"body": 2, "word": "IP", "fig": 2}, {"body": 3, "word": "upstream", "fig": 1}, {"body": 3, "word": "either", "fig": 1}, {"body": 3, "word": "triplicate", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "Chromatin", "fig": 1}, {"body": 3, "word": "enzyme", "fig": 1}, {"body": 3, "word": "present", "fig": 1}, {"body": 2, "word": "StuI", "fig": 1}, {"body": 1, "word": "blots", "fig": 2}, {"body": 2, "word": "R273H", "fig": 1}, {"body": 2, "word": "HinfI", "fig": 1}, {"body": 2, "word": "loading", "fig": 1}, {"body": 2, "word": "extent", "fig": 1}, {"body": 2, "word": "alone", "fig": 1}, {"body": 2, "word": "times", "fig": 1}, {"body": 1, "word": "normalized", "fig": 2}, {"body": 2, "word": "similar", "fig": 1}, {"body": 2, "word": "One", "fig": 1}, {"body": 2, "word": "able", "fig": 1}, {"body": 1, "word": "facilitates", "fig": 1}, {"body": 1, "word": "Erk2", "fig": 1}, {"body": 1, "word": "absence", "fig": 1}, {"body": 1, "word": "affected", "fig": 1}, {"body": 1, "word": "downstream", "fig": 1}, {"body": 1, "word": "prevented", "fig": 1}, {"body": 1, "word": "schematic", "fig": 1}, {"body": 1, "word": "procedures", "fig": 1}, {"body": 1, "word": "second", "fig": 1}, {"body": 1, "word": "standard", "fig": 1}, {"body": 1, "word": "obtained", "fig": 1}, {"body": 1, "word": "first", "fig": 1}, {"body": 1, "word": "within", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "Antibodies", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}, {"body": 1, "word": "HindIII", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}, {"body": 1, "word": "vivo", "fig": 1}, {"body": 1, "word": "enzymes", "fig": 1}, {"body": 1, "word": "without", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g008.jpg", "caption": "EGFR transactivation by GOF p53 can withstand mutations in the transactivation domain of GOF p53 H1299 cells were stably transfected with expression plasmids containing either the p53 mutant R273H, the p53 TAD mutant R273H (L22Q/W23S), or vector alone and cell clones were isloted. A. Western blots show expression levels of EGFR and mutant p53. B. RT-QPCR analysis showing levels of EGFR in different cell lines. QPCR was performed using gene specific primers. Normalized values represent QPCR values relative to GAPDH (not affected by GOF p53). Experiments were performed in triplicate. Error bars showing standard deviations are indicated. Asterisks indicate a p-value of less than 0.005. C. Luciferase assay showing transactivation of the EGFR promoter by both p53-R273H as well as p53-R273H L22Q/W23S. Asterisks indicate a p-value of less than 0.05.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 6}, {"body": 130, "word": "EGFR", "fig": 4}, {"body": 146, "word": "GOF", "fig": 3}, {"body": 70, "word": "promoter", "fig": 1}, {"body": 31, "word": "expression", "fig": 2}, {"body": 56, "word": "cells", "fig": 1}, {"body": 17, "word": "transactivation", "fig": 3}, {"body": 25, "word": "performed", "fig": 2}, {"body": 16, "word": "mutant", "fig": 3}, {"body": 23, "word": "cell", "fig": 2}, {"body": 15, "word": "p53-R273H", "fig": 2}, {"body": 14, "word": "levels", "fig": 2}, {"body": 21, "word": "TAD", "fig": 1}, {"body": 19, "word": "show", "fig": 1}, {"body": 19, "word": "using", "fig": 1}, {"body": 18, "word": "H1299", "fig": 1}, {"body": 7, "word": "QPCR", "fig": 2}, {"body": 13, "word": "gene", "fig": 1}, {"body": 12, "word": "assay", "fig": 1}, {"body": 12, "word": "different", "fig": 1}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 10, "word": "mutations", "fig": 1}, {"body": 10, "word": "clones", "fig": 1}, {"body": 3, "word": "showing", "fig": 3}, {"body": 9, "word": "vector", "fig": 1}, {"body": 8, "word": "Western", "fig": 1}, {"body": 8, "word": "well", "fig": 1}, {"body": 7, "word": "transfected", "fig": 1}, {"body": 7, "word": "lines", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "primers", "fig": 1}, {"body": 6, "word": "specific", "fig": 1}, {"body": 3, "word": "indicate", "fig": 2}, {"body": 6, "word": "indicated", "fig": 1}, {"body": 2, "word": "p-value", "fig": 2}, {"body": 4, "word": "stably", "fig": 1}, {"body": 2, "word": "L22Q/W23S", "fig": 2}, {"body": 2, "word": "R273H", "fig": 2}, {"body": 3, "word": "either", "fig": 1}, {"body": 3, "word": "triplicate", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 1}, {"body": 3, "word": "RT-QPCR", "fig": 1}, {"body": 2, "word": "domain", "fig": 1}, {"body": 2, "word": "alone", "fig": 1}, {"body": 1, "word": "less", "fig": 2}, {"body": 1, "word": "blots", "fig": 1}, {"body": 1, "word": "affected", "fig": 1}, {"body": 1, "word": "withstand", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "standard", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 1}, {"body": 1, "word": "containing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g009a.jpg", "caption": "TAD mutations differentially affect GOF p53 interactions and binding of acetylated histones with the EGFR promoter A. ChIP assays showing mutations in TAD alter a majority of interactions of GOF p53 and enhanced binding of acetylated histone H3 to the EGFR promoter. Experiments were carried out as described in Materials and Methods. Data represent QPCR values normalized to a region on the GAPDH promoter which is not affected by GOF p53. Normalized values were divided by the normalized IgG. Error bars showing standard deviations are indicated. Asterisks indicate a p-value of less than 0.05. B. ChIP assays showing mutations in TAD alter binding of different transcription factors to the EGFR promoter. Experiments were carried out as described in Materials and Methods. Data represent QPCR values normalized to a region on the GAPDH promoter which is not affected by GOF p53. Error bars showing standard deviations are indicated. Asterisks indicate a p-value of less than 0.05. C. ChIP samples in Figure 9B were assayed using a different set of primers on the EGFR promoter about 1.5kb upstream of set 1 to show GOF p53 and its TAD mutant have a similar binding pattern at a distant location (as shown in the diagram). Data represent QPCR values normalized to a region on the GAPDH promoter which is not affected by GOF p53. Error bars showing standard deviations are indicated. N.S. indicates no significant difference. D. ChIP samples in Figure 9A were assayed using three different sets of primers on the EGFR promoter about 500bp-1.5kb upstream of set 1 to show GOF p53 and its TAD mutant have a similar binding pattern at a distant locations. Positions of the primer sets are shown in the figure. Data represent QPCR values normalized to a region on the GAPDH promoter which is not affected by GOF p53. Error bars showing standard deviations are indicated. N.S. indicates no significant difference.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 8}, {"body": 146, "word": "GOF", "fig": 8}, {"body": 130, "word": "EGFR", "fig": 5}, {"body": 70, "word": "promoter", "fig": 9}, {"body": 64, "word": "Figure", "fig": 2}, {"body": 25, "word": "binding", "fig": 5}, {"body": 21, "word": "TAD", "fig": 5}, {"body": 26, "word": "ChIP", "fig": 4}, {"body": 23, "word": "assays", "fig": 2}, {"body": 10, "word": "region", "fig": 4}, {"body": 19, "word": "using", "fig": 2}, {"body": 19, "word": "show", "fig": 2}, {"body": 18, "word": "described", "fig": 2}, {"body": 12, "word": "different", "fig": 3}, {"body": 16, "word": "interactions", "fig": 2}, {"body": 16, "word": "mutant", "fig": 2}, {"body": 10, "word": "mutations", "fig": 3}, {"body": 7, "word": "QPCR", "fig": 4}, {"body": 6, "word": "indicated", "fig": 4}, {"body": 11, "word": "shown", "fig": 2}, {"body": 5, "word": "Data", "fig": 4}, {"body": 18, "word": "histone", "fig": 1}, {"body": 3, "word": "showing", "fig": 6}, {"body": 6, "word": "set", "fig": 3}, {"body": 17, "word": "transcription", "fig": 1}, {"body": 8, "word": "carried", "fig": 2}, {"body": 7, "word": "primers", "fig": 2}, {"body": 12, "word": "H3", "fig": 1}, {"body": 3, "word": "GAPDH", "fig": 4}, {"body": 6, "word": "acetylated", "fig": 2}, {"body": 5, "word": "samples", "fig": 2}, {"body": 5, "word": "Methods", "fig": 2}, {"body": 5, "word": "significant", "fig": 2}, {"body": 4, "word": "Materials", "fig": 2}, {"body": 7, "word": "enhanced", "fig": 1}, {"body": 7, "word": "factors", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 3, "word": "upstream", "fig": 2}, {"body": 3, "word": "indicate", "fig": 2}, {"body": 3, "word": "assayed", "fig": 2}, {"body": 5, "word": "affect", "fig": 1}, {"body": 1, "word": "normalized", "fig": 5}, {"body": 2, "word": "p-value", "fig": 2}, {"body": 1, "word": "affected", "fig": 4}, {"body": 1, "word": "standard", "fig": 4}, {"body": 2, "word": "similar", "fig": 2}, {"body": 2, "word": "indicates", "fig": 2}, {"body": 3, "word": "IgG", "fig": 1}, {"body": 1, "word": "less", "fig": 2}, {"body": 1, "word": "difference", "fig": 2}, {"body": 2, "word": "histones", "fig": 1}, {"body": 2, "word": "9A", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 1, "word": "primer", "fig": 1}, {"body": 1, "word": "differentially", "fig": 1}, {"body": 1, "word": "9B", "fig": 1}, {"body": 1, "word": "locations", "fig": 1}, {"body": 1, "word": "divided", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914296/bin/oncotarget-07-12426-g010.jpg", "caption": "Proposed model for GOF p53 nucleating on the EGFR promoter Arrow towards the right hand side depicts transcription direction. The model proposes a single tetramer of GOF p53 to interact with multiple TFs resulting in nucleation of HAT. Two GOF p53 interaction sites are shown, one is sensitive to TAD-I mutations, the other is not. Empirically, Site I has been shown with one set of transcription factors and Site II with with a different set. TF1/2 and TF3/4 could be similar or different, but presumably TF1/2 is different from TF3/4. For simplicity, TAF and other factors are not shown. TF = transcription factor.", "co_occurrence": [{"body": 184, "word": "p53", "fig": 3}, {"body": 146, "word": "GOF", "fig": 3}, {"body": 130, "word": "EGFR", "fig": 1}, {"body": 70, "word": "promoter", "fig": 1}, {"body": 17, "word": "transcription", "fig": 3}, {"body": 12, "word": "different", "fig": 3}, {"body": 11, "word": "shown", "fig": 3}, {"body": 21, "word": "TFs", "fig": 1}, {"body": 10, "word": "one", "fig": 2}, {"body": 19, "word": "The", "fig": 1}, {"body": 7, "word": "factors", "fig": 2}, {"body": 6, "word": "set", "fig": 2}, {"body": 12, "word": "interaction", "fig": 1}, {"body": 10, "word": "mutations", "fig": 1}, {"body": 9, "word": "TF", "fig": 1}, {"body": 7, "word": "multiple", "fig": 1}, {"body": 6, "word": "TAD-I", "fig": 1}, {"body": 6, "word": "factor", "fig": 1}, {"body": 5, "word": "nucleation", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "sites", "fig": 1}, {"body": 2, "word": "model", "fig": 2}, {"body": 3, "word": "interact", "fig": 1}, {"body": 3, "word": "could", "fig": 1}, {"body": 2, "word": "similar", "fig": 1}, {"body": 2, "word": "depicts", "fig": 1}, {"body": 1, "word": "single", "fig": 1}, {"body": 1, "word": "nucleating", "fig": 1}, {"body": 1, "word": "HAT", "fig": 1}, {"body": 1, "word": "sensitive", "fig": 1}, {"body": 1, "word": "side", "fig": 1}]}], "4552866": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g001.jpg", "caption": "HL-1 cell death is induced after 48 hours exposure to 2% ethanol. (A and B) Direct exposure to ethanol induces nuclear chromatin condensation and plasma membrane injury in HL-1 cells. The cells were incubated in medium containing 0, 0.5, 1, or 2% ethanol for 48 hours, stained with Hoechst and PI fluorescence dyes, and observed under light as well as fluorescence microscopy (A). BF, bright field image. Percentages of cells showing nuclear chromatin condensation (apoptotic cells) and cells positive to PI staining (PI-positive cells) (B). (C) Ethanol decreases cell viability. Cellular viabilities were determined by MTT assay. Mean cell viability of untreated cells (0% ethanol) was set to 100%, and relative cell viabilities of ethanol-treated cells are shown. (D) Ethanol activates caspase-3. The cleaved form of caspase-3 (15 kDa, activated caspase-3) was identified by western blot analysis. Actin was also identified as a loading control. Relative levels of cleaved caspase-3 to actin were densitometrically determined. Each graph shows mean\u00b1S.E. (n = 3). **, p<0.01 versus 0%.", "co_occurrence": [{"body": 77, "word": "cells", "fig": 8}, {"body": 54, "word": "ethanol", "fig": 4}, {"body": 27, "word": "exposure", "fig": 2}, {"body": 26, "word": "HL-1", "fig": 2}, {"body": 19, "word": "The", "fig": 2}, {"body": 9, "word": "cell", "fig": 4}, {"body": 7, "word": "caspase-3", "fig": 4}, {"body": 13, "word": "hours", "fig": 2}, {"body": 17, "word": "observed", "fig": 1}, {"body": 15, "word": "levels", "fig": 1}, {"body": 7, "word": "nuclear", "fig": 2}, {"body": 13, "word": "also", "fig": 1}, {"body": 13, "word": "shown", "fig": 1}, {"body": 5, "word": "fluorescence", "fig": 2}, {"body": 9, "word": "well", "fig": 1}, {"body": 8, "word": "membrane", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 7, "word": "ethanol-treated", "fig": 1}, {"body": 7, "word": "plasma", "fig": 1}, {"body": 6, "word": "incubated", "fig": 1}, {"body": 6, "word": "analysis", "fig": 1}, {"body": 5, "word": "apoptotic", "fig": 1}, {"body": 4, "word": "actin", "fig": 1}, {"body": 4, "word": "untreated", "fig": 1}, {"body": 2, "word": "viability", "fig": 2}, {"body": 4, "word": "medium", "fig": 1}, {"body": 2, "word": "Ethanol", "fig": 2}, {"body": 3, "word": "activated", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "death", "fig": 1}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "containing", "fig": 1}, {"body": 3, "word": "PI-positive", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 1, "word": "PI", "fig": 2}, {"body": 1, "word": "viabilities", "fig": 2}, {"body": 1, "word": "B", "fig": 2}, {"body": 1, "word": "cleaved", "fig": 2}, {"body": 1, "word": "activates", "fig": 1}, {"body": 1, "word": "decreases", "fig": 1}, {"body": 1, "word": "microscopy", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "induced", "fig": 1}, {"body": 1, "word": "image", "fig": 1}, {"body": 1, "word": "form", "fig": 1}, {"body": 1, "word": "MTT", "fig": 1}, {"body": 1, "word": "light", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g002.jpg", "caption": "Time-dependent activation of caspases in ethanol-exposed HL-1 cells. (A) Activation of caspases in HL-1 cells occurs after 24\u201348 hours of exposure to 2% ethanol. Cells were incubated in medium containing 2% ethanol for the indicated time periods, and the levels of the cleaved (activated) forms of caspase-9 and -3 were determined by western blot analysis. Hsc70 served as a loading control. Quantitative analysis of cleaved caspase-9 (B) and -3 (C) is shown. Relative levels to ethanol (48 h)-treated group were shown. Each graph shows mean\u00b1S.E. of 6 samples. **, p<0.01.", "co_occurrence": [{"body": 54, "word": "ethanol", "fig": 3}, {"body": 77, "word": "cells", "fig": 2}, {"body": 26, "word": "HL-1", "fig": 2}, {"body": 15, "word": "levels", "fig": 2}, {"body": 27, "word": "exposure", "fig": 1}, {"body": 13, "word": "shown", "fig": 2}, {"body": 13, "word": "activation", "fig": 1}, {"body": 13, "word": "hours", "fig": 1}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 11, "word": "ethanol-exposed", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 6, "word": "incubated", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 2, "word": "caspases", "fig": 2}, {"body": 4, "word": "medium", "fig": 1}, {"body": 3, "word": "activated", "fig": 1}, {"body": 3, "word": "containing", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 3, "word": "samples", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 1, "word": "cleaved", "fig": 2}, {"body": 1, "word": "caspase-9", "fig": 2}, {"body": 2, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "periods", "fig": 1}, {"body": 1, "word": "Activation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g003.jpg", "caption": "Time-dependent and rapid decrease in Cx43 protein levels in ethanol-treated HL-1 cells. (A-D) Cells were incubated in medium containing 2% ethanol for the indicated time periods, and the protein levels of Cx43, Cx40 and Cx45 were determined by western blot analysis (A). Hsc70 served as a loading control. Quantitative analysis of Cx43 (B), Cx40 (C) and Cx45 (D) is shown. Each graph shows mean\u00b1S.E. (n = 4\u20136). **, p<0.01 versus 0 h. Relative levels to control (0 h) group were shown for Cx43 (B). (E) The levels of Cx43 mRNA were determined by qPCR. GAPDH served as an internal control. The graph shows mean\u00b1S.E. (n = 3). **, p<0.01, *, p<0.05 versus 0 h. (F) Ethanol disrupts cell-cell coupling. Cells were incubated in the medium containing 2% ethanol for 48 hours, and scrape-loading dye transfer assay was performed as described in the Materials and methods. Areas of dye spread (fluorescent areas) were quantified using ImageJ software. The graph shows mean\u00b1S.E. (n = 5). **, p<0.01 versus control.", "co_occurrence": [{"body": 52, "word": "Cx43", "fig": 5}, {"body": 54, "word": "ethanol", "fig": 2}, {"body": 77, "word": "cells", "fig": 1}, {"body": 15, "word": "levels", "fig": 4}, {"body": 19, "word": "The", "fig": 3}, {"body": 23, "word": "protein", "fig": 2}, {"body": 8, "word": "control", "fig": 4}, {"body": 13, "word": "shown", "fig": 2}, {"body": 26, "word": "HL-1", "fig": 1}, {"body": 14, "word": "cell-cell", "fig": 1}, {"body": 13, "word": "hours", "fig": 1}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 6, "word": "incubated", "fig": 2}, {"body": 4, "word": "medium", "fig": 2}, {"body": 7, "word": "ethanol-treated", "fig": 1}, {"body": 6, "word": "using", "fig": 1}, {"body": 3, "word": "Cells", "fig": 2}, {"body": 3, "word": "dye", "fig": 2}, {"body": 3, "word": "containing", "fig": 2}, {"body": 5, "word": "performed", "fig": 1}, {"body": 4, "word": "decrease", "fig": 1}, {"body": 4, "word": "transfer", "fig": 1}, {"body": 2, "word": "Cx40", "fig": 2}, {"body": 2, "word": "Cx45", "fig": 2}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 4, "word": "coupling", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "fluorescent", "fig": 1}, {"body": 2, "word": "mRNA", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 2, "word": "Quantitative", "fig": 1}, {"body": 2, "word": "qPCR", "fig": 1}, {"body": 2, "word": "Ethanol", "fig": 1}, {"body": 1, "word": "scrape-loading", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "areas", "fig": 1}, {"body": 1, "word": "ImageJ", "fig": 1}, {"body": 1, "word": "rapid", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "software", "fig": 1}, {"body": 1, "word": "described", "fig": 1}, {"body": 1, "word": "periods", "fig": 1}, {"body": 1, "word": "internal", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g004.jpg", "caption": "Lysosomal localization of Cx43 in ethanol-treated HL-1 cells. (A and B) Change of Cx43 localization from the plasma membrane to lysosomes in HL-1 cells in response to ethanol exposure. Cells were transfected with combinations of vectors (Cx43-mApple and LAMP1-mGFP for (A) and Cx43-mApple and LMP2-GFP for (B)) and incubated in medium containing 2% ethanol for 24 hours. The cells were then observed under a fluorescence microscope. Arrows indicate gap-junctional cell-cell contact. (C) Proteasome inhibitors do not affect Cx43 protein levels. HL-1 cells were treated with 2% ethanol for 24 hours and Cx43 levels were determined. In some samples, MG132 (500 nM) or bortezomib (5 nM) was included in the medium during the last 6 hours of ethanol exposure. GAPDH served as a loading control. The graph shows mean\u00b1S.E. (n = 3). (D) A lysosome inhibitor affects Cx43 protein levels. HL-1 cells were treated with 2% ethanol with or without bafilomycinA1 (50 nM) for 48 hours, and Cx43 levels were determined. The graph shows mean\u00b1S.E. (n = 3).", "co_occurrence": [{"body": 77, "word": "cells", "fig": 5}, {"body": 52, "word": "Cx43", "fig": 6}, {"body": 54, "word": "ethanol", "fig": 5}, {"body": 26, "word": "HL-1", "fig": 4}, {"body": 15, "word": "levels", "fig": 4}, {"body": 19, "word": "The", "fig": 3}, {"body": 27, "word": "exposure", "fig": 2}, {"body": 13, "word": "hours", "fig": 4}, {"body": 23, "word": "protein", "fig": 2}, {"body": 17, "word": "observed", "fig": 1}, {"body": 7, "word": "localization", "fig": 2}, {"body": 14, "word": "cell-cell", "fig": 1}, {"body": 14, "word": "In", "fig": 1}, {"body": 6, "word": "treated", "fig": 2}, {"body": 8, "word": "membrane", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 4, "word": "medium", "fig": 2}, {"body": 7, "word": "plasma", "fig": 1}, {"body": 7, "word": "ethanol-treated", "fig": 1}, {"body": 7, "word": "inhibitor", "fig": 1}, {"body": 3, "word": "Cx43-mApple", "fig": 2}, {"body": 6, "word": "incubated", "fig": 1}, {"body": 5, "word": "fluorescence", "fig": 1}, {"body": 4, "word": "microscope", "fig": 1}, {"body": 4, "word": "contact", "fig": 1}, {"body": 3, "word": "samples", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "vectors", "fig": 1}, {"body": 1, "word": "nM", "fig": 3}, {"body": 3, "word": "lysosomes", "fig": 1}, {"body": 3, "word": "containing", "fig": 1}, {"body": 2, "word": "bortezomib", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "LAMP1-mGFP", "fig": 1}, {"body": 2, "word": "MG132", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 1, "word": "lysosome", "fig": 1}, {"body": 1, "word": "Lysosomal", "fig": 1}, {"body": 1, "word": "affects", "fig": 1}, {"body": 1, "word": "inhibitors", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "LMP2-GFP", "fig": 1}, {"body": 1, "word": "bafilomycinA1", "fig": 1}, {"body": 1, "word": "without", "fig": 1}, {"body": 1, "word": "response", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g005.jpg", "caption": "Autophagy is not involved in the degradation of Cx43. (A) LC3-II levels do not increase in HL-1 cells during ethanol exposure. Cells were exposed to 2% ethanol for the indicated time periods, and LC3-II levels were examined by western blot analysis. Hsc70 levels were also examined as a loading control. The graph shows mean\u00b1S.E. (n = 3). (B) The inhibition of autophagy by 3MA did not affect Cx43 levels. HL-1 cells were treated with 2% ethanol with or without 5 mM 3MA for 24 hours. Cx43 levels were determined by western blot analysis. The graph shows mean\u00b1S.E. (n = 3). (C) Ethanol induces lysosomal localization of a mutant form of Cx43. An expression vector expressing an endocytosis-resistant mutant of Cx43 (Cx43Y286A) fused with GFP was transfected into HL-1 cells together with LAMP1-RFP expression vector, after which the cells were exposed to 2% ethanol for 24 hours and observed under a fluorescence microscope. Arrows indicate gap-junctional cell-cell contact.", "co_occurrence": [{"body": 77, "word": "cells", "fig": 4}, {"body": 52, "word": "Cx43", "fig": 5}, {"body": 54, "word": "ethanol", "fig": 4}, {"body": 26, "word": "HL-1", "fig": 3}, {"body": 15, "word": "levels", "fig": 5}, {"body": 19, "word": "The", "fig": 3}, {"body": 27, "word": "exposure", "fig": 1}, {"body": 13, "word": "hours", "fig": 2}, {"body": 10, "word": "examined", "fig": 2}, {"body": 17, "word": "degradation", "fig": 1}, {"body": 17, "word": "observed", "fig": 1}, {"body": 14, "word": "cell-cell", "fig": 1}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "expression", "fig": 2}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 4, "word": "exposed", "fig": 2}, {"body": 8, "word": "control", "fig": 1}, {"body": 8, "word": "mM", "fig": 1}, {"body": 7, "word": "localization", "fig": 1}, {"body": 3, "word": "blot", "fig": 2}, {"body": 6, "word": "autophagy", "fig": 1}, {"body": 6, "word": "treated", "fig": 1}, {"body": 5, "word": "lysosomal", "fig": 1}, {"body": 5, "word": "fluorescence", "fig": 1}, {"body": 4, "word": "microscope", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 4, "word": "contact", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "expressing", "fig": 1}, {"body": 3, "word": "involved", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 1, "word": "vector", "fig": 2}, {"body": 2, "word": "increase", "fig": 1}, {"body": 1, "word": "LC3-II", "fig": 2}, {"body": 1, "word": "3MA", "fig": 2}, {"body": 2, "word": "together", "fig": 1}, {"body": 1, "word": "mutant", "fig": 2}, {"body": 2, "word": "Ethanol", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "form", "fig": 1}, {"body": 1, "word": "LAMP1-RFP", "fig": 1}, {"body": 1, "word": "periods", "fig": 1}, {"body": 1, "word": "Cx43Y286A", "fig": 1}, {"body": 1, "word": "endocytosis-resistant", "fig": 1}, {"body": 1, "word": "without", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g006.jpg", "caption": "Down-regulation of N-cadherin and desmoglein1/2, as well as rupture of the cytoskeleton in ethanol-exposed HL-1 cells. (A-C) Decreases in the levels of N-cadherin and desmoglein1/2 in HL-1 cells during ethanol exposure. Cells were incubated in medium containing 2% ethanol for the indicated time periods, and the N-cadherin and desmoglein1/2 protein levels were determined by western blot analysis. Hsc70 served as a loading control (A). Quantitative analysis of N-cadherin (B) and desmoglein1/2 (C) is shown. Each graph shows mean\u00b1S.E. (n = 3). **, p<0.01, *, p<0.05 versus 0 h. (D) Rupture of the organization of myofibrils and intermediate filaments in ethanol-exposed HL-1 cells. Cells were incubated in medium containing 2% ethanol for 24 hours, stained with phalloidin-rhodamine to visualize filamentous actin, and observed under a confocal fluorescence microscope (upper panel). Cells were also transfected with the vimentin-PSmOrange expression vector, exposed to 2% ethanol for 24 hours, and observed under a fluorescence microscope (lower panel).", "co_occurrence": [{"body": 77, "word": "cells", "fig": 3}, {"body": 54, "word": "ethanol", "fig": 4}, {"body": 26, "word": "HL-1", "fig": 3}, {"body": 17, "word": "observed", "fig": 2}, {"body": 15, "word": "levels", "fig": 2}, {"body": 27, "word": "exposure", "fig": 1}, {"body": 13, "word": "hours", "fig": 2}, {"body": 23, "word": "protein", "fig": 1}, {"body": 11, "word": "ethanol-exposed", "fig": 2}, {"body": 4, "word": "N-cadherin", "fig": 4}, {"body": 13, "word": "shown", "fig": 1}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "incubated", "fig": 2}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 5, "word": "fluorescence", "fig": 2}, {"body": 3, "word": "Cells", "fig": 3}, {"body": 9, "word": "well", "fig": 1}, {"body": 4, "word": "microscope", "fig": 2}, {"body": 8, "word": "control", "fig": 1}, {"body": 4, "word": "medium", "fig": 2}, {"body": 6, "word": "expression", "fig": 1}, {"body": 3, "word": "containing", "fig": 2}, {"body": 4, "word": "actin", "fig": 1}, {"body": 4, "word": "exposed", "fig": 1}, {"body": 4, "word": "intermediate", "fig": 1}, {"body": 1, "word": "desmoglein1/2", "fig": 4}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "filaments", "fig": 1}, {"body": 3, "word": "filamentous", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 3, "word": "organization", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "vimentin-PSmOrange", "fig": 1}, {"body": 2, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "vector", "fig": 1}, {"body": 1, "word": "visualize", "fig": 1}, {"body": 1, "word": "myofibrils", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "phalloidin-rhodamine", "fig": 1}, {"body": 1, "word": "rupture", "fig": 1}, {"body": 1, "word": "periods", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g007.jpg", "caption": "Decreased activation of the hippo pathway and YAP phosphorylation by ethanol in HL-1 cells. (A) Phosphorylation of Mst1/2 and LATS1 and their suppression in HL-1 cells exposed to ethanol. Cells were treated with or without 2% ethanol for the indicated time periods. Levels of phosphorylated Mst1/2 (p-Mst1/2) and phosphorylated LATS1 (p-LATS1) were determined by western blot analysis. Hsc70 served as a loading control. (B) Phosphorylation of YAP and its suppression in HL-1 cells exposed to ethanol. Cells were treated with or without 2% ethanol for the indicated time periods. Levels of phosphorylated YAP (p-YAP) were determined by western blot analysis and normalized to Hsc70 levels. The graph shows mean\u00b1S.E. (n = 3). *, p<0.05 versus control. (C) Sub-cellular localization of YAP in cells treated with or without ethanol. Cells were treated with or without 2% ethanol for 24 hours, and the sub-cellular localization of YAP was examined by immunocytochemical analysis under fluorescence microscopy. The white arrow indicates a high-cell-density region where YAP is localized to the nucleus as well as cytoplasm. The yellow arrow indicates a low-cell-density region where YAP is localized to the nucleus.", "co_occurrence": [{"body": 54, "word": "ethanol", "fig": 7}, {"body": 77, "word": "cells", "fig": 4}, {"body": 17, "word": "YAP", "fig": 7}, {"body": 26, "word": "HL-1", "fig": 3}, {"body": 19, "word": "The", "fig": 3}, {"body": 29, "word": "hippo", "fig": 1}, {"body": 26, "word": "pathway", "fig": 1}, {"body": 6, "word": "treated", "fig": 4}, {"body": 6, "word": "analysis", "fig": 3}, {"body": 8, "word": "control", "fig": 2}, {"body": 15, "word": "levels", "fig": 1}, {"body": 7, "word": "localization", "fig": 2}, {"body": 13, "word": "activation", "fig": 1}, {"body": 13, "word": "hours", "fig": 1}, {"body": 10, "word": "examined", "fig": 1}, {"body": 3, "word": "Cells", "fig": 3}, {"body": 9, "word": "well", "fig": 1}, {"body": 4, "word": "exposed", "fig": 2}, {"body": 4, "word": "indicated", "fig": 2}, {"body": 3, "word": "blot", "fig": 2}, {"body": 3, "word": "LATS1", "fig": 2}, {"body": 3, "word": "time", "fig": 2}, {"body": 5, "word": "phosphorylation", "fig": 1}, {"body": 5, "word": "fluorescence", "fig": 1}, {"body": 2, "word": "localized", "fig": 2}, {"body": 2, "word": "Mst1/2", "fig": 2}, {"body": 4, "word": "cytoplasm", "fig": 1}, {"body": 2, "word": "nucleus", "fig": 2}, {"body": 1, "word": "without", "fig": 4}, {"body": 1, "word": "phosphorylated", "fig": 3}, {"body": 2, "word": "low-cell-density", "fig": 1}, {"body": 1, "word": "periods", "fig": 2}, {"body": 1, "word": "suppression", "fig": 2}, {"body": 1, "word": "sub-cellular", "fig": 1}, {"body": 1, "word": "high-cell-density", "fig": 1}, {"body": 1, "word": "microscopy", "fig": 1}, {"body": 1, "word": "Decreased", "fig": 1}, {"body": 1, "word": "B", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552866/bin/pone.0136952.g008.jpg", "caption": "Effects of okadaic acid and carbenoxolone on ethanol-induced apoptosis in HL-1 cells. (A) Okadaic acid (OA) mitigates ethanol-induced apoptosis in HL-1 cells. Cells were treated with OA (10 nM), ethanol (2%), or both for 48 hours, and caspase-3 activation was assessed by western blot analysis. The graph shows mean\u00b1S.E. (n = 6). *, p<0.05. (B) Carbenoxolone (CBX) suppresses ethanol-induced apoptosis in HL-1 cells. Cells were treated with CBX (100 \u03bcM), ethanol (2%), or both for 48 hours, and caspase-3 activation was assessed by western blot analysis. The graph shows mean\u00b1S.E. (n = 5). *, p<0.05.", "co_occurrence": [{"body": 77, "word": "cells", "fig": 3}, {"body": 54, "word": "ethanol", "fig": 2}, {"body": 26, "word": "HL-1", "fig": 3}, {"body": 19, "word": "The", "fig": 2}, {"body": 11, "word": "apoptosis", "fig": 3}, {"body": 13, "word": "activation", "fig": 2}, {"body": 13, "word": "hours", "fig": 2}, {"body": 5, "word": "ethanol-induced", "fig": 3}, {"body": 7, "word": "caspase-3", "fig": 2}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 6, "word": "treated", "fig": 2}, {"body": 5, "word": "OA", "fig": 2}, {"body": 3, "word": "assessed", "fig": 2}, {"body": 3, "word": "Cells", "fig": 2}, {"body": 3, "word": "blot", "fig": 2}, {"body": 2, "word": "CBX", "fig": 2}, {"body": 1, "word": "acid", "fig": 2}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 1, "word": "nM", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "okadaic", "fig": 1}, {"body": 1, "word": "carbenoxolone", "fig": 1}]}], "4440640": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440640/bin/pgen.1005263.g001.jpg", "caption": "LKB1 and its downstream kinase SIK3 are required for lipid homeostasis. (A) qPCR analysis of LKB1 and its cofactors required for the catalytic activity, STRAD and MO25, in Drosophila larvae under feeding condition. (B) TAG amounts of wild-type and LKB1 mutant larvae (n = 10 per genotype). (C) qPCR analysis for lipogenic genes (SREBP, FAS and ACC) and lipolytic genes (bmm and HSL) in wild-type and LKB1 mutant larvae at mid-to-late L2 (60 hr AEL) stage under feeding conditions. (D) qPCR analysis of LKB1, SIKs (SIK2 and SIK3), and AMPK complex (AMPK\u03b1, AMPK\u03b2, and AMPK\u03b3) in larvae. (E) TAG amounts in LKB1 mutants following fat body-specific expression of wild-type, kinase-dead (K201I) LKB1, constitutively active (T196E) SIK3 or constitutively active (T184D) AMPK. Genotypes are as follows: FB> (FB-Gal4/+), LKB1X5,FB> (FB-Gal4/+;LKB1 X5 /LKB1 X5), LKB1X5,FB>LKB1WT (FB-Gal4/UAS-LKB1;LKB1 X5 /LKB1 X5), LKB1X5,FB>LKB1KI (FB-Gal4/UAS-LKB1 K201I;LKB1 X5 /LKB1 X5), LKB1X5,FB>SIK3TE (FB-Gal4/UAS-SIK3 T196E;LKB1 X5 /LKB1 X5), and LKB1X5,FB>AMPKTD (FB-Gal4/UAS-AMPK T184D;LKB1 X5 /LKB1 X5) (n = 10 per genotype). (F) qPCR analysis of bmm gene expression in LKB1 mutants following fat body-specific expression of wild-type LKB1 or constitutively active (T196E) SIK3 at mid-to-late L2 stage under feeding condition. Genotypes are as follows: FB> (FB-Gal4/+), LKB1X5,FB> (FB-Gal4/+;LKB1 X5 /LKB1 X5), LKB1X5,FB>LKB1WT (FB-Gal4/UAS-LKB1;LKB1 X5 /LKB1 X5), and LKB1X5,FB>SIK3TE (FB-Gal4/UAS-SIK3 T196E;LKB1 X5 /LKB1 X5). (G) Immunoblot analyses showing the effect of LKB1 on Thr196 phosphorylation of SIK3 protein in larvae. Wild-type and kinase-dead (K70M) SIK3 were highly phosphorylated at Thr196 by LKB1 (second panel). SIK3T196A was used as a control. FB-Gal4 was used to drive transgene expression in the fat body. (H) Immunoblot analyses showing relative amounts of SIK3 Thr196 phosphorylation in wild-type and LKB1 X5 mutant larvae. The phosphorylation was absolutely dependent on LKB1 (first panel). FB-Gal4 was used to drive transgene expression. (G-H) Anti-LKB1, -phospho-Thr196 SIK3, -Myc (SIK3 protein), and -\u03b2-tubulin (TUB) antibodies were used. Data are presented as mean \u00b1 SEM (*P < 0.05).", "co_occurrence": [{"body": 97, "word": "LKB1", "fig": 21}, {"body": 118, "word": "SIK3", "fig": 9}, {"body": 21, "word": "X5", "fig": 17}, {"body": 43, "word": "expression", "fig": 5}, {"body": 14, "word": "LKB1X5", "fig": 8}, {"body": 35, "word": "mutant", "fig": 3}, {"body": 34, "word": "fat", "fig": 3}, {"body": 15, "word": "wild-type", "fig": 5}, {"body": 7, "word": "FB", "fig": 10}, {"body": 35, "word": "mutants", "fig": 2}, {"body": 10, "word": "larvae", "fig": 6}, {"body": 18, "word": "phosphorylation", "fig": 3}, {"body": 26, "word": "bmm", "fig": 2}, {"body": 12, "word": "analysis", "fig": 4}, {"body": 5, "word": "/LKB1", "fig": 8}, {"body": 40, "word": "lipid", "fig": 1}, {"body": 10, "word": "used", "fig": 4}, {"body": 35, "word": "Drosophila", "fig": 1}, {"body": 10, "word": "active", "fig": 3}, {"body": 7, "word": "qPCR", "fig": 4}, {"body": 27, "word": "body", "fig": 1}, {"body": 9, "word": "constitutively", "fig": 3}, {"body": 9, "word": "amounts", "fig": 3}, {"body": 6, "word": "T196E", "fig": 4}, {"body": 11, "word": "TAG", "fig": 2}, {"body": 22, "word": "activity", "fig": 1}, {"body": 7, "word": "feeding", "fig": 3}, {"body": 21, "word": "The", "fig": 1}, {"body": 5, "word": "FB-Gal4/+", "fig": 4}, {"body": 9, "word": "follows", "fig": 2}, {"body": 9, "word": "Genotypes", "fig": 2}, {"body": 16, "word": "gene", "fig": 1}, {"body": 5, "word": "Thr196", "fig": 3}, {"body": 13, "word": "hr", "fig": 1}, {"body": 13, "word": "A", "fig": 1}, {"body": 12, "word": "conditions", "fig": 1}, {"body": 12, "word": "control", "fig": 1}, {"body": 6, "word": "body-specific", "fig": 2}, {"body": 6, "word": "protein", "fig": 2}, {"body": 11, "word": "homeostasis", "fig": 1}, {"body": 5, "word": "stage", "fig": 2}, {"body": 5, "word": "AMPK", "fig": 2}, {"body": 10, "word": "B", "fig": 1}, {"body": 4, "word": "condition", "fig": 2}, {"body": 4, "word": "kinase-dead", "fig": 2}, {"body": 8, "word": "kinase", "fig": 1}, {"body": 4, "word": "following", "fig": 2}, {"body": 4, "word": "required", "fig": 2}, {"body": 7, "word": "presented", "fig": 1}, {"body": 6, "word": "mean", "fig": 1}, {"body": 3, "word": "per", "fig": 2}, {"body": 6, "word": "highly", "fig": 1}, {"body": 6, "word": "SEM", "fig": 1}, {"body": 5, "word": "downstream", "fig": 1}, {"body": 5, "word": "lipolytic", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 5, "word": "complex", "fig": 1}, {"body": 2, "word": "SIK3TE", "fig": 2}, {"body": 2, "word": "FB-Gal4", "fig": 2}, {"body": 2, "word": "FB-Gal4/UAS-SIK3", "fig": 2}, {"body": 4, "word": "*P", "fig": 1}, {"body": 2, "word": "L2", "fig": 2}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 3, "word": "SIKs", "fig": 1}, {"body": 3, "word": "first", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "genes", "fig": 2}, {"body": 1, "word": "LKB1WT", "fig": 2}, {"body": 2, "word": "K70M", "fig": 1}, {"body": 1, "word": "genotype", "fig": 2}, {"body": 1, "word": "K201I", "fig": 2}, {"body": 1, "word": "T184D", "fig": 2}, {"body": 1, "word": "Immunoblot", "fig": 2}, {"body": 2, "word": "AEL", "fig": 1}, {"body": 1, "word": "MO25", "fig": 1}, {"body": 1, "word": "STRAD", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "second", "fig": 1}, {"body": 1, "word": "ACC", "fig": 1}, {"body": 1, "word": "SREBP", "fig": 1}, {"body": 1, "word": "lipogenic", "fig": 1}, {"body": 1, "word": "FAS", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440640/bin/pgen.1005263.g002.jpg", "caption": "SIK3 null mutant is defective in lipid homeostasis and storage. (A) Amino acid sequence identities (similarities) of Drosophila SIK3 with human SIK3. (B) Genomic map of Drosophila SIK3 locus. The exons of SIK3 are indicated by boxes, and the coding regions are colored black. The deleted regions for SIK3 null mutants (SIK3 \u03945\u201331) are also presented. (C) Genomic PCR analyses in wild-type (WT), heterozygous SIK3 mutants (SIK3 \u03945\u201331/+) and SIK3 \u03945\u201331 using the A primer set in (B). (D) qPCR analysis for SIK3, using the B primer set in (B), and CG15071 in wild-type and SIK3 null mutant. (E) Restored viability of SIK3 mutants by fat body-specific expression of wild-type SIK3, but not by kinase-dead (K70M) SIK3. (F) Relative survival rates in SIK3 mutants with fat body-specific expression of wild-type and kinase-dead (K70M) SIK3 during development: embryo (E), first, second and third instar larva, pupa (P) and adult (A). Experimental and control survival rates are compared using the log-rank test (***P < 0.001). (E-F) Genotypes are as follows: FB> (FB-Gal4/+), SIK3\u03945\u201331,FB> (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331), SIK3\u03945\u201331,FB>SIK3WT (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331 ;UAS-SIK3/+), and SIK3\u03945\u201331,FB>SIK3KM (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331 ;UAS-SIK3 K70M/+). (G) Wild-type and SIK3 null mutant in the L3 larval stage. (H) EGFP expression in the fat body of wild-type and SIK3 null mutant larvae. Genotypes are as follows: FB>EGFP (FB-Gal4/UAS-2xEGFP) and SIK3\u03945\u201331,FB>EGFP (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331,UAS-2xEGFP). (I) TAG amounts of wild-type and SIK3 null mutant larvae (n = 10 per genotype). (J) qPCR analysis of bmm in wild-type and SIK3 null mutant larvae at mid-L2 stage under feeding condition. (K) TAG amounts in SIK3 mutants with fat body-specific expression of wild-type, constitutively active (T196E), non-phosphorylable by LKB1 (T196A) or kinase-dead (K70M) SIK3. (n = 10 per genotype). (L) qPCR analysis of bmm in SIK3 mutants following fat body-specific expression of wild-type, constitutively active (T196E) SIK3 or two kinase-dead SIK3 (T196A and K70M) at mid-L2 stage under feeding condition. (K-L) Genotypes are as follows: FB> (FB-Gal4/+), SIK3\u03945\u201331,FB> (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331), SIK3\u03945\u201331,FB>SIK3WT (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331 ;UAS-SIK3/+), SIK3\u03945\u201331,FB>SIK3TE (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331 ;UAS-SIK3 T196E/+), SIK3\u03945\u201331,FB>SIK3TA (FB-Gal4,SIK3 \u0394531 /SIK3 \u03945\u201331 ;UAS-SIK3 T196A/+), and SIK3\u03945\u201331,FB>SIK3KM (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331 ;UAS-SIK3 K70M/+). Data are presented as mean \u00b1 SEM (*P < 0.05; ***P < 0.001).", "co_occurrence": [{"body": 118, "word": "SIK3", "fig": 35}, {"body": 27, "word": "\u03945\u201331", "fig": 19}, {"body": 43, "word": "expression", "fig": 5}, {"body": 35, "word": "mutant", "fig": 6}, {"body": 35, "word": "mutants", "fig": 6}, {"body": 34, "word": "fat", "fig": 5}, {"body": 15, "word": "wild-type", "fig": 9}, {"body": 19, "word": "null", "fig": 7}, {"body": 97, "word": "LKB1", "fig": 1}, {"body": 10, "word": "SIK3\u03945\u201331", "fig": 9}, {"body": 7, "word": "FB", "fig": 12}, {"body": 8, "word": "/SIK3", "fig": 9}, {"body": 35, "word": "Drosophila", "fig": 2}, {"body": 26, "word": "bmm", "fig": 2}, {"body": 15, "word": "using", "fig": 3}, {"body": 21, "word": "The", "fig": 2}, {"body": 40, "word": "lipid", "fig": 1}, {"body": 10, "word": "B", "fig": 4}, {"body": 13, "word": "A", "fig": 3}, {"body": 12, "word": "analysis", "fig": 3}, {"body": 10, "word": "larvae", "fig": 3}, {"body": 9, "word": "follows", "fig": 3}, {"body": 9, "word": "Genotypes", "fig": 3}, {"body": 27, "word": "body", "fig": 1}, {"body": 6, "word": "body-specific", "fig": 4}, {"body": 11, "word": "TAG", "fig": 2}, {"body": 7, "word": "qPCR", "fig": 3}, {"body": 10, "word": "active", "fig": 2}, {"body": 2, "word": "FB-Gal4", "fig": 9}, {"body": 9, "word": "constitutively", "fig": 2}, {"body": 9, "word": "amounts", "fig": 2}, {"body": 4, "word": "kinase-dead", "fig": 4}, {"body": 5, "word": "stage", "fig": 3}, {"body": 7, "word": "T196A", "fig": 2}, {"body": 7, "word": "survival", "fig": 2}, {"body": 7, "word": "presented", "fig": 2}, {"body": 7, "word": "feeding", "fig": 2}, {"body": 14, "word": "storage", "fig": 1}, {"body": 12, "word": "control", "fig": 1}, {"body": 6, "word": "T196E", "fig": 2}, {"body": 11, "word": "homeostasis", "fig": 1}, {"body": 5, "word": "FB-Gal4/+", "fig": 2}, {"body": 10, "word": "also", "fig": 1}, {"body": 8, "word": "WT", "fig": 1}, {"body": 2, "word": "K70M", "fig": 4}, {"body": 4, "word": "rates", "fig": 2}, {"body": 4, "word": "condition", "fig": 2}, {"body": 7, "word": "compared", "fig": 1}, {"body": 3, "word": "per", "fig": 2}, {"body": 6, "word": "mean", "fig": 1}, {"body": 6, "word": "SEM", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "*P", "fig": 1}, {"body": 1, "word": "UAS-SIK3", "fig": 4}, {"body": 2, "word": "***P", "fig": 2}, {"body": 4, "word": "following", "fig": 1}, {"body": 3, "word": "human", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 3, "word": "first", "fig": 1}, {"body": 3, "word": "larval", "fig": 1}, {"body": 3, "word": "two", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 1, "word": "EGFP", "fig": 3}, {"body": 3, "word": "development", "fig": 1}, {"body": 1, "word": "SIK3WT", "fig": 2}, {"body": 1, "word": "primer", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "log-rank", "fig": 1}, {"body": 2, "word": "Experimental", "fig": 1}, {"body": 1, "word": "Genomic", "fig": 2}, {"body": 1, "word": "genotype", "fig": 2}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "SIK3TA", "fig": 1}, {"body": 2, "word": "instar", "fig": 1}, {"body": 2, "word": "coding", "fig": 1}, {"body": 1, "word": "UAS-SIK3/+", "fig": 2}, {"body": 2, "word": "adult", "fig": 1}, {"body": 2, "word": "SIK3TE", "fig": 1}, {"body": 1, "word": "regions", "fig": 2}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "black", "fig": 1}, {"body": 1, "word": "pupa", "fig": 1}, {"body": 1, "word": "larva", "fig": 1}, {"body": 1, "word": "boxes", "fig": 1}, {"body": 1, "word": "CG15071", "fig": 1}, {"body": 1, "word": "sequence", "fig": 1}, {"body": 1, "word": "PCR", "fig": 1}, {"body": 1, "word": "second", "fig": 1}, {"body": 1, "word": "acid", "fig": 1}, {"body": 1, "word": "viability", "fig": 1}, {"body": 1, "word": "non-phosphorylable", "fig": 1}, {"body": 1, "word": "colored", "fig": 1}, {"body": 1, "word": "embryo", "fig": 1}, {"body": 1, "word": "locus", "fig": 1}, {"body": 1, "word": "UAS-2xEGFP", "fig": 1}, {"body": 1, "word": "third", "fig": 1}, {"body": 1, "word": "Relative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440640/bin/pgen.1005263.g003.jpg", "caption": "HDAC4 is the responsible target of LKB1-SIK3 signaling for controlling lipid homeostasis. (A-B) Effects of the fat body-specific knockdown of HDAC4 (HDAC4 RNAi) on TAG amounts (A) and bmm gene expression (B) in LKB1 and SIK3 null mutants. Genotypes are as follows: FB> (FB-Gal4/+), LKB1X5,FB> (FB-Gal4/+;LKB1 X5 /LKB1 X5), SIK3\u03945\u201331,FB> (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331), FB>HDAC4 RNAi (FB-Gal4/+;UAS-HDAC4 RNAi/+), LKB1X5,FB>HDAC4 RNAi (FB-Gal4/+;LKB1 X5 /LKB1 X5,UAS-HDAC4 RNAi), and SIK3\u03945\u201331,FB>HDAC4 RNAi (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331 ;UAS-HDAC4 RNAi). (C) Drosophila HDAC4 protein structure showing three SIK3 phosphorylation sites and an HDAC class IIa domain (top panel). Immunoblot analyses showing the effect of wild-type and constitutively active (T196E) SIK3 on HDAC4 Ser239 phosphorylation in larvae (middle four panels). Densitometric analyses of phospho-HDAC4 bands (bottom panel). FB-Gal4 was used to drive transgene expression. Anti-phospho-Ser239 HDAC4, -FLAG (HDAC protein), -Myc (SIK3 protein), and -\u03b2-tubulin (TUB) antibodies were used. (D) Immunohistochemical analyses of HDAC4 (anti-FLAG antibody, green) in the fat body cells of wild type (first, second, and third rows), LKB1 mutant (LKB1 X5) (fourth row) and SIK3 mutant (SIK3 \u03945\u201331) (fifth row) L3 larvae in feeding or 4 hr fasting condition as denoted in figures. Similar experiments were also conducted for phosphorylation-defective and constitutively active HDAC4 (HDAC3A) in wild type L3 larvae in feeding (sixth row) or 4 hr fasting condition (bottom row). Cell nuclei were stained by Hoechst 33258 (blue). The graphs on the right of each image showed the intensity plot profile for each antibody staining along the red lines. Genotypes are as follows: Control (FB-Gal4/+), FLAG-HDAC4 (FB-Gal4/UAS-HDAC4), FLAG-HDAC43A (FB-Gal4/UAS-HDAC4 3A), FLAG-HDAC4,LKB1X5 (FB-Gal4/UAS-HDAC4;LKB1 X5/LKB1 X5), and FLAG-HDAC4,SIK3\u03945\u201331 (FB-Gal4,SIK3 \u03945\u201331/UAS-HDAC4,SIK3 \u03945\u201331). Scale bars, 20 \u03bcm. (E) Effect of fat body-specific expression of constitutively active SIK3 (SIK3 T196E) on bmm gene expression in larvae expressing wild-type HDAC4 in the fat body. Genotypes are as follows: FB> (FB-Gal4/+), FB>HDAC4WT (FB-Gal4/UAS-HDAC4), FB>SIK3TE (FB-Gal4/+;UAS-SIK3 T196E/+), and FB>HDAC4 WT,SIK3TE (FB-Gal4/UAS-HDAC4;UAS-SIK3 T196E/+). (F-G) Effects of the fat body-specific knockdown of bmm (bmm RNAi) on TAG amounts (F) and bmm gene expression (G) in LKB1 and SIK3 null mutants. Genotypes are as follows: FB> (FB-Gal4/+), LKB1X5,FB> (FB-Gal4/+;LKB1 X5 /LKB1 X5), SIK3\u03945\u201331,FB> (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331), FB>bmm RNAi (FB-Gal4/;UAS-bmm RNAi/+), LKB1X5,FB>bmm RNAi (FB-Gal4/+;LKB1 X5 /LKB1 X5,UAS-bmm RNAi) and SIK3\u03945\u201331,FB>bmm RNAi (FB-Gal4,SIK3 \u03945\u201331 /SIK3 \u03945\u201331 ;UAS-bmm RNAi). Data are presented as mean \u00b1 SEM (*P < 0.05; **P < 0.01; ***P < 0.001).", "co_occurrence": [{"body": 118, "word": "SIK3", "fig": 15}, {"body": 97, "word": "LKB1", "fig": 9}, {"body": 48, "word": "HDAC4", "fig": 13}, {"body": 27, "word": "\u03945\u201331", "fig": 10}, {"body": 43, "word": "expression", "fig": 5}, {"body": 21, "word": "X5", "fig": 10}, {"body": 26, "word": "bmm", "fig": 8}, {"body": 34, "word": "fat", "fig": 5}, {"body": 7, "word": "FB", "fig": 16}, {"body": 14, "word": "LKB1X5", "fig": 5}, {"body": 35, "word": "mutant", "fig": 2}, {"body": 35, "word": "mutants", "fig": 2}, {"body": 27, "word": "body", "fig": 2}, {"body": 5, "word": "FB-Gal4/+", "fig": 10}, {"body": 10, "word": "SIK3\u03945\u201331", "fig": 5}, {"body": 16, "word": "gene", "fig": 3}, {"body": 23, "word": "fasting", "fig": 2}, {"body": 40, "word": "lipid", "fig": 1}, {"body": 10, "word": "larvae", "fig": 4}, {"body": 19, "word": "null", "fig": 2}, {"body": 9, "word": "follows", "fig": 4}, {"body": 18, "word": "phosphorylation", "fig": 2}, {"body": 3, "word": "RNAi", "fig": 12}, {"body": 9, "word": "Genotypes", "fig": 4}, {"body": 35, "word": "Drosophila", "fig": 1}, {"body": 8, "word": "/SIK3", "fig": 4}, {"body": 10, "word": "active", "fig": 3}, {"body": 15, "word": "wild-type", "fig": 2}, {"body": 9, "word": "constitutively", "fig": 3}, {"body": 13, "word": "hr", "fig": 2}, {"body": 11, "word": "TAG", "fig": 2}, {"body": 21, "word": "The", "fig": 1}, {"body": 5, "word": "/LKB1", "fig": 4}, {"body": 10, "word": "used", "fig": 2}, {"body": 19, "word": "signaling", "fig": 1}, {"body": 6, "word": "body-specific", "fig": 3}, {"body": 6, "word": "protein", "fig": 3}, {"body": 9, "word": "amounts", "fig": 2}, {"body": 7, "word": "feeding", "fig": 2}, {"body": 13, "word": "A", "fig": 1}, {"body": 2, "word": "FB-Gal4", "fig": 6}, {"body": 6, "word": "T196E", "fig": 2}, {"body": 11, "word": "homeostasis", "fig": 1}, {"body": 11, "word": "showed", "fig": 1}, {"body": 10, "word": "LKB1-SIK3", "fig": 1}, {"body": 10, "word": "B", "fig": 1}, {"body": 10, "word": "also", "fig": 1}, {"body": 5, "word": "antibody", "fig": 2}, {"body": 4, "word": "condition", "fig": 2}, {"body": 8, "word": "WT", "fig": 1}, {"body": 7, "word": "presented", "fig": 1}, {"body": 7, "word": "cells", "fig": 1}, {"body": 6, "word": "mean", "fig": 1}, {"body": 6, "word": "SEM", "fig": 1}, {"body": 3, "word": "knockdown", "fig": 2}, {"body": 6, "word": "X5/LKB1", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 5, "word": "3A", "fig": 1}, {"body": 5, "word": "A-B", "fig": 1}, {"body": 4, "word": "**P", "fig": 1}, {"body": 2, "word": "Effects", "fig": 2}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 2, "word": "SIK3TE", "fig": 2}, {"body": 4, "word": "nuclei", "fig": 1}, {"body": 4, "word": "target", "fig": 1}, {"body": 2, "word": "type", "fig": 2}, {"body": 4, "word": "*P", "fig": 1}, {"body": 1, "word": "UAS-bmm", "fig": 3}, {"body": 1, "word": "UAS-HDAC4", "fig": 3}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 3, "word": "first", "fig": 1}, {"body": 3, "word": "controlling", "fig": 1}, {"body": 3, "word": "IIa", "fig": 1}, {"body": 3, "word": "blue", "fig": 1}, {"body": 3, "word": "class", "fig": 1}, {"body": 3, "word": "Hoechst", "fig": 1}, {"body": 3, "word": "green", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "UAS-SIK3", "fig": 2}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "***P", "fig": 1}, {"body": 2, "word": "bars", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "phosphorylation-defective", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 1, "word": "wild", "fig": 2}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "domain", "fig": 1}, {"body": 1, "word": "second", "fig": 1}, {"body": 1, "word": "expressing", "fig": 1}, {"body": 1, "word": "Effect", "fig": 1}, {"body": 1, "word": "Immunoblot", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "third", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440640/bin/pgen.1005263.g004.jpg", "caption": "The AKH pathway regulates LKB1-SIK3-HDAC4 signaling to control lipid homeostasis. (A-B) Effects of AKHR gene disruption on TAG amounts (A) and bmm gene expression (B) in LKB1 and SIK3 null mutants. Genotypes are as follows: WT (w 1118), LKB1X5 (LKB1 X5/LKB1 X5), SIK3\u03945\u201331 (SIK3 \u03945\u201331 /SIK3 \u03945\u201331), AKHR1 (AKHR 1 /AKHR 1), LKB1X5,AKHR1 (AKHR 1 /AKHR 1;LKB1 X5/LKB1 X5), and SIK3\u03945\u201331,AKHR1 (SIK3 \u03945\u201331,AKHR 1 /SIK3 \u03945\u201331,AKHR 1). (C) Immunoblot analyses showing the effect of 4 hr fasting and AKH on Thr196 phosphorylation of SIK3 protein in larvae (top four panels). Densitometric analyses of phospho-SIK3 bands (bottom panel). FB-Gal4 was used to drive transgene expression in the fat body. Anti-phospho-Thr196 SIK3, -Myc (SIK3 protein), -AKH and -\u03b2-tubulin (TUB) antibodies were used. (D) Immunohistochemical analyses of HDAC4 (anti-FLAG antibody, green) in AKHR mutant (AKHR 1) L3 larvae in feeding or 4 hr fasting condition as denoted in figures. Cell nuclei were stained by Hoechst 33258 (blue). Genotypes are as follows: Control (FB-Gal4,AKHR 1/AKHR 1) and FLAG-HDAC4,AKHR1 (FB-Gal4,AKHR 1/UAS-HDAC4,AKHR 1). The graphs showed the staining intensity profile for each antibody along the red lines. Scale bars, 20 \u03bcm. (E-F) Effect of the fat body-specific expression of constitutively active HDAC4 (HDAC3A) on TAG amounts (E) and bmm gene expression (F) in AKHR mutant. Genotypes: FB> (FB-Gal4/+), AKHR1,FB> (FB-Gal4,AKHR 1/AKHR 1), FB>HDAC43A (FB-Gal4/UAS-HDAC4 3A), and AKHR1,FB>HDAC43A (FB-Gal4,AKHR 1/UAS-HDAC4 3A,AKHR 1). Data are presented as mean \u00b1 SEM (*P < 0.05; **P < 0.01; ***P < 0.001; NS, non-significant).", "co_occurrence": [{"body": 118, "word": "SIK3", "fig": 6}, {"body": 97, "word": "LKB1", "fig": 3}, {"body": 17, "word": "AKHR", "fig": 14}, {"body": 43, "word": "expression", "fig": 4}, {"body": 27, "word": "\u03945\u201331", "fig": 4}, {"body": 48, "word": "HDAC4", "fig": 2}, {"body": 35, "word": "mutant", "fig": 2}, {"body": 34, "word": "fat", "fig": 2}, {"body": 26, "word": "bmm", "fig": 2}, {"body": 16, "word": "gene", "fig": 3}, {"body": 23, "word": "fasting", "fig": 2}, {"body": 21, "word": "X5", "fig": 2}, {"body": 21, "word": "The", "fig": 2}, {"body": 40, "word": "lipid", "fig": 1}, {"body": 35, "word": "mutants", "fig": 1}, {"body": 14, "word": "LKB1X5", "fig": 2}, {"body": 7, "word": "FB", "fig": 4}, {"body": 9, "word": "Genotypes", "fig": 3}, {"body": 27, "word": "body", "fig": 1}, {"body": 13, "word": "AKH", "fig": 2}, {"body": 13, "word": "hr", "fig": 2}, {"body": 11, "word": "TAG", "fig": 2}, {"body": 22, "word": "pathway", "fig": 1}, {"body": 10, "word": "SIK3\u03945\u201331", "fig": 2}, {"body": 10, "word": "larvae", "fig": 2}, {"body": 10, "word": "used", "fig": 2}, {"body": 19, "word": "signaling", "fig": 1}, {"body": 19, "word": "null", "fig": 1}, {"body": 9, "word": "follows", "fig": 2}, {"body": 18, "word": "phosphorylation", "fig": 1}, {"body": 9, "word": "amounts", "fig": 2}, {"body": 8, "word": "/SIK3", "fig": 2}, {"body": 13, "word": "A", "fig": 1}, {"body": 12, "word": "control", "fig": 1}, {"body": 6, "word": "protein", "fig": 2}, {"body": 6, "word": "X5/LKB1", "fig": 2}, {"body": 11, "word": "homeostasis", "fig": 1}, {"body": 11, "word": "showed", "fig": 1}, {"body": 2, "word": "FB-Gal4", "fig": 5}, {"body": 5, "word": "3A", "fig": 2}, {"body": 10, "word": "active", "fig": 1}, {"body": 10, "word": "B", "fig": 1}, {"body": 5, "word": "antibody", "fig": 2}, {"body": 9, "word": "constitutively", "fig": 1}, {"body": 8, "word": "WT", "fig": 1}, {"body": 8, "word": "LKB1-SIK3-HDAC4", "fig": 1}, {"body": 7, "word": "feeding", "fig": 1}, {"body": 7, "word": "presented", "fig": 1}, {"body": 6, "word": "body-specific", "fig": 1}, {"body": 6, "word": "mean", "fig": 1}, {"body": 6, "word": "w", "fig": 1}, {"body": 6, "word": "SEM", "fig": 1}, {"body": 5, "word": "Thr196", "fig": 1}, {"body": 5, "word": "FB-Gal4/+", "fig": 1}, {"body": 5, "word": "A-B", "fig": 1}, {"body": 5, "word": "regulates", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "**P", "fig": 1}, {"body": 4, "word": "condition", "fig": 1}, {"body": 4, "word": "non-significant", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 4, "word": "NS", "fig": 1}, {"body": 4, "word": "*P", "fig": 1}, {"body": 4, "word": "nuclei", "fig": 1}, {"body": 3, "word": "disruption", "fig": 1}, {"body": 3, "word": "blue", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 3, "word": "Hoechst", "fig": 1}, {"body": 3, "word": "green", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "Effects", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "bars", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "***P", "fig": 1}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "Effect", "fig": 1}, {"body": 1, "word": "Immunoblot", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440640/bin/pgen.1005263.g005.jpg", "caption": "HDAC4 accumulated in the nuclei of the fat body cells in AKHR mutants under prolonged fasting. (A) Immunohistochemical analyses of HDAC4 (anti-FLAG antibody, green) in AKHR mutant (AKHR 1) L3 larvae in 10 hr fasting condition as denoted in figures. Cell nuclei were stained by Hoechst 33258 (blue). Genotypes are as follows: Control (FB-Gal4,AKHR 1/AKHR 1) and FLAG-HDAC4,AKHR1 (FB-Gal4,AKHR 1/UAS-HDAC4,AKHR 1). The graphs showed the staining intensity profile for each antibody along the red lines. Scale bars, 20 \u03bcm. (B) Effects of the fat body-specific knockdown of HDAC4 (HDAC4 RNAi) on bmm gene expression in AKHR mutant adult flies (AKHR 1) in 10 hr fasting condition. Genotypes are as follows: Control (FB-Gal4/+), HDAC4 RNAi (FB-Gal4/+;UAS-HDAC4 RNAi/+), AKHR1 (FB-Gal4,AKHR 1/AKHR 1), and AKHR1,HDAC4 RNAi (FB-Gal4,AKHR 1/AKHR 1 ;UAS-HDAC4 RNAi/+). (C) Immunohistochemical analyses of HDAC4 (anti-FLAG antibody, green) in the fat body cells following expression of constitutively active (T196E) SIK3 in 10 hr fasting condition as denoted in figures. Genotypes are as follows: Control (FB-Gal4/+), FLAG-HDAC4 (FB-Gal4/UAS-HDAC4), and FLAG-HDAC4,SIK3TE (FB-Gal4/UAS-HDAC4;UAS-SIK3 T196E/+). The graphs showed the staining intensity profile for each antibody along the red lines. Scale bars, 20 \u03bcm. Data are presented as mean \u00b1 SEM (**P < 0.01; ***P < 0.001).", "co_occurrence": [{"body": 48, "word": "HDAC4", "fig": 7}, {"body": 17, "word": "AKHR", "fig": 10}, {"body": 118, "word": "SIK3", "fig": 1}, {"body": 34, "word": "fat", "fig": 3}, {"body": 23, "word": "fasting", "fig": 4}, {"body": 43, "word": "expression", "fig": 2}, {"body": 35, "word": "mutant", "fig": 2}, {"body": 27, "word": "body", "fig": 2}, {"body": 21, "word": "The", "fig": 2}, {"body": 13, "word": "hr", "fig": 3}, {"body": 35, "word": "mutants", "fig": 1}, {"body": 9, "word": "follows", "fig": 3}, {"body": 9, "word": "Genotypes", "fig": 3}, {"body": 26, "word": "bmm", "fig": 1}, {"body": 11, "word": "showed", "fig": 2}, {"body": 5, "word": "antibody", "fig": 4}, {"body": 17, "word": "flies", "fig": 1}, {"body": 16, "word": "gene", "fig": 1}, {"body": 5, "word": "FB-Gal4/+", "fig": 3}, {"body": 7, "word": "cells", "fig": 2}, {"body": 13, "word": "A", "fig": 1}, {"body": 4, "word": "condition", "fig": 3}, {"body": 10, "word": "active", "fig": 1}, {"body": 10, "word": "larvae", "fig": 1}, {"body": 10, "word": "B", "fig": 1}, {"body": 9, "word": "prolonged", "fig": 1}, {"body": 3, "word": "RNAi", "fig": 3}, {"body": 9, "word": "constitutively", "fig": 1}, {"body": 2, "word": "FB-Gal4", "fig": 4}, {"body": 4, "word": "nuclei", "fig": 2}, {"body": 7, "word": "presented", "fig": 1}, {"body": 6, "word": "mean", "fig": 1}, {"body": 6, "word": "T196E", "fig": 1}, {"body": 6, "word": "body-specific", "fig": 1}, {"body": 6, "word": "SEM", "fig": 1}, {"body": 3, "word": "green", "fig": 2}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "**P", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 2, "word": "bars", "fig": 2}, {"body": 2, "word": "Scale", "fig": 2}, {"body": 4, "word": "following", "fig": 1}, {"body": 3, "word": "blue", "fig": 1}, {"body": 3, "word": "knockdown", "fig": 1}, {"body": 3, "word": "Hoechst", "fig": 1}, {"body": 1, "word": "staining", "fig": 2}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "Effects", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "UAS-HDAC4", "fig": 2}, {"body": 2, "word": "***P", "fig": 1}, {"body": 2, "word": "SIK3TE", "fig": 1}, {"body": 2, "word": "accumulated", "fig": 1}, {"body": 2, "word": "adult", "fig": 1}, {"body": 1, "word": "UAS-SIK3", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440640/bin/pgen.1005263.g006.jpg", "caption": "Activation of insulin receptor increases phosphorylation of SIK3 by Akt. (A) Immunoblot analyses showing the effect of 4 hr fasting and constitutively active insulin receptor (InRCA) on Thr196 phosphorylation of SIK3 protein in larvae (top three panels). Anti-phospho-Thr196 SIK3, -Myc (SIK3 protein), and -\u03b2-tubulin (TUB) antibodies were used. Densitometry of phospho-Thr196 SIK3 bands (bottom panel). FB-Gal4 was used to drive transgene expression in the fat body. (B) Immunoblot analyses showing the effect of constitutively active insulin receptor (InRCA) on Akt-dependent phosphorylation of SIK3 protein in larvae (top four panels). The lysates were immunoprecipitated with an anti-Myc (SIK3 protein) antibody, and then immunoblotted with an anti-phospho-Akt substrate antibody. Densitometry of phospho-SIK3 bands (bottom panel). (C) A schematic model for LKB1 and SIK3 function to regulate lipid homeostasis in Drosophila fat body. LKB1 regulates the nucleocytoplasmic localization of HDAC4 via SIK3-dependent phosphorylation. Under feeding condition, DILPs-induced Akt activation leads to SIK3 activation, thereby inhibiting HDAC4 activity by phosphorylation. Under short-term fasting conditions, the AKH pathway inhibits the kinase activity of LKB1 in phosphorylating SIK3 Thr196 residue and controls SIK3 activity via PKA-dependent phosphorylation. Unphosphorylated and nuclear localized HDAC4 deacetylates and activates FOXO to increase bmm expression [19], thereby reducing lipid storage. AKH-independent signaling modulates the LKB1-SIK3-HDAC4 pathway to induce bmm expression when fasting is prolonged. Data are presented as mean \u00b1 SEM (*P < 0.05; **P < 0.01; NS, non-significant).", "co_occurrence": [{"body": 118, "word": "SIK3", "fig": 11}, {"body": 97, "word": "LKB1", "fig": 3}, {"body": 48, "word": "HDAC4", "fig": 3}, {"body": 43, "word": "expression", "fig": 3}, {"body": 18, "word": "phosphorylation", "fig": 6}, {"body": 40, "word": "lipid", "fig": 2}, {"body": 23, "word": "fasting", "fig": 3}, {"body": 34, "word": "fat", "fig": 2}, {"body": 22, "word": "activity", "fig": 3}, {"body": 27, "word": "body", "fig": 2}, {"body": 26, "word": "bmm", "fig": 2}, {"body": 22, "word": "pathway", "fig": 2}, {"body": 35, "word": "Drosophila", "fig": 1}, {"body": 13, "word": "A", "fig": 2}, {"body": 6, "word": "protein", "fig": 4}, {"body": 21, "word": "The", "fig": 1}, {"body": 10, "word": "active", "fig": 2}, {"body": 10, "word": "larvae", "fig": 2}, {"body": 10, "word": "used", "fig": 2}, {"body": 19, "word": "signaling", "fig": 1}, {"body": 9, "word": "constitutively", "fig": 2}, {"body": 14, "word": "storage", "fig": 1}, {"body": 13, "word": "AKH", "fig": 1}, {"body": 13, "word": "hr", "fig": 1}, {"body": 6, "word": "via", "fig": 2}, {"body": 12, "word": "conditions", "fig": 1}, {"body": 11, "word": "homeostasis", "fig": 1}, {"body": 5, "word": "Thr196", "fig": 2}, {"body": 5, "word": "antibody", "fig": 2}, {"body": 10, "word": "B", "fig": 1}, {"body": 9, "word": "prolonged", "fig": 1}, {"body": 8, "word": "localization", "fig": 1}, {"body": 8, "word": "LKB1-SIK3-HDAC4", "fig": 1}, {"body": 8, "word": "kinase", "fig": 1}, {"body": 7, "word": "feeding", "fig": 1}, {"body": 7, "word": "presented", "fig": 1}, {"body": 6, "word": "mean", "fig": 1}, {"body": 6, "word": "SEM", "fig": 1}, {"body": 5, "word": "regulates", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 5, "word": "regulate", "fig": 1}, {"body": 2, "word": "Under", "fig": 2}, {"body": 4, "word": "**P", "fig": 1}, {"body": 4, "word": "condition", "fig": 1}, {"body": 4, "word": "non-significant", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 4, "word": "*P", "fig": 1}, {"body": 4, "word": "NS", "fig": 1}, {"body": 2, "word": "activation", "fig": 2}, {"body": 3, "word": "activates", "fig": 1}, {"body": 3, "word": "inhibits", "fig": 1}, {"body": 3, "word": "localized", "fig": 1}, {"body": 1, "word": "insulin", "fig": 3}, {"body": 1, "word": "receptor", "fig": 3}, {"body": 3, "word": "controls", "fig": 1}, {"body": 3, "word": "phosphorylating", "fig": 1}, {"body": 3, "word": "short-term", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "modulates", "fig": 1}, {"body": 2, "word": "FB-Gal4", "fig": 1}, {"body": 2, "word": "substrate", "fig": 1}, {"body": 2, "word": "FOXO", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 2, "word": "nucleocytoplasmic", "fig": 1}, {"body": 1, "word": "Immunoblot", "fig": 2}, {"body": 2, "word": "AKH-independent", "fig": 1}, {"body": 2, "word": "anti-Myc", "fig": 1}, {"body": 2, "word": "model", "fig": 1}, {"body": 1, "word": "increases", "fig": 1}, {"body": 1, "word": "leads", "fig": 1}, {"body": 1, "word": "Akt-dependent", "fig": 1}, {"body": 1, "word": "PKA-dependent", "fig": 1}, {"body": 1, "word": "residue", "fig": 1}, {"body": 1, "word": "anti-phospho-Akt", "fig": 1}, {"body": 1, "word": "induce", "fig": 1}, {"body": 1, "word": "increase", "fig": 1}, {"body": 1, "word": "function", "fig": 1}, {"body": 1, "word": "inhibiting", "fig": 1}]}], "4203941": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341_Fig1.jpg", "caption": "Mosaic-Tsc1KO mice develop multisystem lesions showing similarities with human TSC. (a) Genomic DNA was prepared from control (ctrl) and mosaic-Tsc1KO mice 1.5 mo after tamoxifen injection, and the floxed/mutant alleles were detected by PCR in the indicated organs. (b) Expression of phospho-rpS6 in cerebral cortex sections from ctrl and mosaic-Tsc1KO mice was analyzed by immunohistochemical staining. (c) Skin samples of ctrl and mosaic-Tsc1KO mice were stained for ICAM-1 expression and using Trichrome. Arrows indicate ICAM-1+ vessels. (d) Plasma urea concentrations were determined in ctrl and mosaic-Tsc1KO kidneys (Mean \u00b1 SEM; n = 4 mice/group; *, P < 0.05). Bars, 100 \u00b5m. Three independent pregnant females were injected with tamoxifen. For immunohistochemistry analysis, similar stainings were found in four different ctrl/mosaic-Tsc1KO mice (6 wk of age, two sections per mouse).", "co_occurrence": [{"body": 34, "word": "mice", "fig": 5}, {"body": 25, "word": "mosaic-Tsc1KO", "fig": 4}, {"body": 28, "word": "TSC", "fig": 1}, {"body": 28, "word": "lesions", "fig": 1}, {"body": 25, "word": "mouse", "fig": 1}, {"body": 20, "word": "kidneys", "fig": 1}, {"body": 18, "word": "human", "fig": 1}, {"body": 15, "word": "control", "fig": 1}, {"body": 13, "word": "c", "fig": 1}, {"body": 11, "word": "samples", "fig": 1}, {"body": 11, "word": "b", "fig": 1}, {"body": 10, "word": "d", "fig": 1}, {"body": 10, "word": "expression", "fig": 1}, {"body": 8, "word": "using", "fig": 1}, {"body": 8, "word": "indicated", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 1}, {"body": 5, "word": "injected", "fig": 1}, {"body": 5, "word": "detected", "fig": 1}, {"body": 5, "word": "For", "fig": 1}, {"body": 5, "word": "different", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "found", "fig": 1}, {"body": 4, "word": "two", "fig": 1}, {"body": 1, "word": "ctrl", "fig": 4}, {"body": 4, "word": "develop", "fig": 1}, {"body": 3, "word": "wk", "fig": 1}, {"body": 3, "word": "multisystem", "fig": 1}, {"body": 3, "word": "prepared", "fig": 1}, {"body": 3, "word": "cortex", "fig": 1}, {"body": 1, "word": "tamoxifen", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "similarities", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "urea", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "pregnant", "fig": 1}, {"body": 2, "word": "vessels", "fig": 1}, {"body": 2, "word": "DNA", "fig": 1}, {"body": 1, "word": "sections", "fig": 2}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "organs", "fig": 1}, {"body": 1, "word": "alleles", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "PCR", "fig": 1}, {"body": 1, "word": "Plasma", "fig": 1}, {"body": 1, "word": "cerebral", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "Trichrome", "fig": 1}, {"body": 1, "word": "indicate", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "ICAM-1", "fig": 1}, {"body": 1, "word": "similar", "fig": 1}, {"body": 1, "word": "females", "fig": 1}, {"body": 1, "word": "Mosaic-Tsc1KO", "fig": 1}, {"body": 1, "word": "age", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341R_Fig2.jpg", "caption": "Mosaic-Tsc1KO mice develop renal mesenchymal lesions recapitulating PEComas associated with human TSC. Kidneys from ctrl (n = 3) and mosaic-Tsc1KO (n = 3) mice were analyzed at 6 wk of age. (a) Macroscopic photos and representative H&E staining. Arrows indicate hemorrhages. (b\u2013d) Expression of vimentin (b and c), phospho-rpS6, and Ki67 (c) and Hmb45/Pmel (d) was assessed by immunohistochemistry. H&E staining was shown on left in c. Arrows in b indicate vimentin+ microhamartomas in mosaic-Tsc1KO kidneys. For immunohistochemistry analysis, similar stainings were found in three different ctrl/mosaic-Tsc1KO mice (three sections per mouse). (e) Expression of Mart1, Cathepsin K, Pmel, and Tyrp1 mRNA was assessed by qRT-PCR. Mean \u00b1 SEM; n = 3 mice/group; *, P < 0.05. (f) Expression of \u03b1-SMA, Mart1, p-rpS6, and total rpS6 protein was assessed by Immunoblot. (g) Expression of the indicated proteins in three distinct human angiomyolipoma (AML) samples was assessed by immunohistochemistry. Arrows indicate the microhamartoma. Bar, 100 \u00b5m unless otherwise indicated. Insets show higher magnification of the lesions indicated with squares.", "co_occurrence": [{"body": 34, "word": "mice", "fig": 3}, {"body": 28, "word": "lesions", "fig": 2}, {"body": 25, "word": "mosaic-Tsc1KO", "fig": 2}, {"body": 18, "word": "human", "fig": 2}, {"body": 28, "word": "TSC", "fig": 1}, {"body": 13, "word": "c", "fig": 2}, {"body": 25, "word": "mouse", "fig": 1}, {"body": 8, "word": "indicated", "fig": 3}, {"body": 11, "word": "b", "fig": 2}, {"body": 22, "word": "protein", "fig": 1}, {"body": 20, "word": "kidneys", "fig": 1}, {"body": 5, "word": "assessed", "fig": 4}, {"body": 17, "word": "mesenchymal", "fig": 1}, {"body": 12, "word": "PEComas", "fig": 1}, {"body": 11, "word": "samples", "fig": 1}, {"body": 10, "word": "d", "fig": 1}, {"body": 10, "word": "renal", "fig": 1}, {"body": 8, "word": "e", "fig": 1}, {"body": 3, "word": "Mart1", "fig": 2}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 1}, {"body": 6, "word": "g", "fig": 1}, {"body": 6, "word": "rpS6", "fig": 1}, {"body": 5, "word": "For", "fig": 1}, {"body": 5, "word": "different", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "staining", "fig": 2}, {"body": 4, "word": "found", "fig": 1}, {"body": 4, "word": "K", "fig": 1}, {"body": 4, "word": "angiomyolipoma", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "develop", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "Pmel", "fig": 1}, {"body": 3, "word": "wk", "fig": 1}, {"body": 1, "word": "three", "fig": 3}, {"body": 1, "word": "indicate", "fig": 3}, {"body": 2, "word": "microhamartomas", "fig": 1}, {"body": 2, "word": "unless", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "otherwise", "fig": 1}, {"body": 2, "word": "Ki67", "fig": 1}, {"body": 2, "word": "Cathepsin", "fig": 1}, {"body": 2, "word": "Tyrp1", "fig": 1}, {"body": 1, "word": "\u03b1-SMA", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "higher", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "distinct", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "similar", "fig": 1}, {"body": 1, "word": "associated", "fig": 1}, {"body": 1, "word": "ctrl", "fig": 1}, {"body": 1, "word": "recapitulating", "fig": 1}, {"body": 1, "word": "hemorrhages", "fig": 1}, {"body": 1, "word": "Mosaic-Tsc1KO", "fig": 1}, {"body": 1, "word": "age", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341R_Fig3.jpg", "caption": "Mosaic-Tsc1KO mice develop renal H-caldesmon+ mesenchymal lesions containing CD31+ endothelial cells and PDGFR\u03b2+/\u03b1SMA+ pericytes. (a and b) Kidney tissues were isolated from ctrl and mosaic-Tsc1KO mice at 6 wk of age and analyzed by immunofluorescence for H-caldesmon and CD31 (a) or PDGFR\u03b2 and \u03b1SMA (b). Arrows in b indicate PDGFR\u03b2\u2013 and \u03b1SMA\u2013double-positive pericytes. (c) Expression of \u03b2-gal and vimentin on kidney sections from Ctrl;R26-floxstop-LacZ and mosaic-Tsc1KO;R26-floxstop-LacZ mice was assessed by immunofluorescence. Arrows indicate \u03b2-gal+ cells and arrowheads show \u03b2-gal negative cells. Insets show higher magnification of tissue indicated with squares. Similar stainings were found in three different mice/genotype (three sections per each mouse). Bars: (A\u2013C) 100 \u00b5m.", "co_occurrence": [{"body": 54, "word": "cells", "fig": 3}, {"body": 34, "word": "mice", "fig": 3}, {"body": 25, "word": "mosaic-Tsc1KO", "fig": 2}, {"body": 11, "word": "b", "fig": 3}, {"body": 28, "word": "lesions", "fig": 1}, {"body": 25, "word": "mouse", "fig": 1}, {"body": 18, "word": "kidney", "fig": 1}, {"body": 17, "word": "mesenchymal", "fig": 1}, {"body": 13, "word": "c", "fig": 1}, {"body": 10, "word": "renal", "fig": 1}, {"body": 8, "word": "indicated", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 1}, {"body": 5, "word": "assessed", "fig": 1}, {"body": 5, "word": "tissue", "fig": 1}, {"body": 5, "word": "different", "fig": 1}, {"body": 4, "word": "tissues", "fig": 1}, {"body": 2, "word": "immunofluorescence", "fig": 2}, {"body": 4, "word": "develop", "fig": 1}, {"body": 4, "word": "found", "fig": 1}, {"body": 3, "word": "wk", "fig": 1}, {"body": 1, "word": "R26-floxstop-LacZ", "fig": 2}, {"body": 1, "word": "pericytes", "fig": 2}, {"body": 1, "word": "indicate", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 1, "word": "sections", "fig": 2}, {"body": 2, "word": "\u03b1SMA", "fig": 1}, {"body": 1, "word": "three", "fig": 2}, {"body": 1, "word": "endothelial", "fig": 1}, {"body": 1, "word": "ctrl", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "CD31+", "fig": 1}, {"body": 1, "word": "Mosaic-Tsc1KO", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "Similar", "fig": 1}, {"body": 1, "word": "higher", "fig": 1}, {"body": 1, "word": "age", "fig": 1}, {"body": 1, "word": "Kidney", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341R_Fig4.jpg", "caption": "YAP is up-regulated by mTOR in renal lesions of mosaic-Tsc1KO mice and human angiomyolipoma. (a and b) Expression of indicated genes was determined by qRT-PCR (a) and immunoblot analysis (b) in kidney samples from Ctrl mice treated with placebo, mosaic-Tsc1KO mice treated with placebo, or temsirolimus. Mice were injected i.p. with vehicle or temsirolimus (5 mg/kg) every other day for 2 wk before sacrifice. Mice were sacrificed at 6 wk of age. Mean \u00b1 SEM; n = 3 mice/group; *, P < 0.05, **, P < 0.01. (c) Expression of indicated proteins was analyzed by immunoblot in nuclear and cytoplasmic protein extractions from ctrl and mosaic-Tsc1KO mouse kidney samples. Similar results were found in three different mice/genotype. (d) YAP expression was assessed on kidney sections from ctrl and mosaic-Tsc1KO mice by immunohistochemistry. Arrows indicate cells with YAP nuclear localization. Bars, 100 \u00b5m. Similar stainings were found in three different mice/genotype (three sections per each mouse). (e) Expression of indicated proteins was analyzed by immunoblot in control human kidney and angiomyolipoma samples. (f and g) YAP expression was analyzed by immunohistochemistry on human angiomyolipoma samples (N, normal kidney; T, Tumor). Arrows indicate cells with YAP nuclear localization. Bars, 100 \u00b5m. Insets show higher magnification of the lesions indicated with squares. Similar results were found in 7/7 different human angiomyolipoma samples.", "co_occurrence": [{"body": 81, "word": "YAP", "fig": 5}, {"body": 34, "word": "mice", "fig": 4}, {"body": 54, "word": "cells", "fig": 2}, {"body": 25, "word": "mosaic-Tsc1KO", "fig": 4}, {"body": 18, "word": "kidney", "fig": 5}, {"body": 18, "word": "human", "fig": 4}, {"body": 28, "word": "lesions", "fig": 2}, {"body": 11, "word": "samples", "fig": 5}, {"body": 25, "word": "mouse", "fig": 2}, {"body": 8, "word": "indicated", "fig": 4}, {"body": 11, "word": "b", "fig": 2}, {"body": 22, "word": "protein", "fig": 1}, {"body": 10, "word": "expression", "fig": 2}, {"body": 6, "word": "analyzed", "fig": 3}, {"body": 17, "word": "mTOR", "fig": 1}, {"body": 4, "word": "angiomyolipoma", "fig": 4}, {"body": 15, "word": "control", "fig": 1}, {"body": 5, "word": "different", "fig": 3}, {"body": 13, "word": "c", "fig": 1}, {"body": 4, "word": "found", "fig": 3}, {"body": 10, "word": "d", "fig": 1}, {"body": 10, "word": "renal", "fig": 1}, {"body": 8, "word": "day", "fig": 1}, {"body": 4, "word": "Mice", "fig": 2}, {"body": 8, "word": "mg/kg", "fig": 1}, {"body": 8, "word": "e", "fig": 1}, {"body": 6, "word": "every", "fig": 1}, {"body": 3, "word": "proteins", "fig": 2}, {"body": 6, "word": "i.p", "fig": 1}, {"body": 3, "word": "wk", "fig": 2}, {"body": 6, "word": "g", "fig": 1}, {"body": 5, "word": "injected", "fig": 1}, {"body": 5, "word": "assessed", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 2, "word": "treated", "fig": 2}, {"body": 2, "word": "temsirolimus", "fig": 2}, {"body": 1, "word": "immunoblot", "fig": 3}, {"body": 1, "word": "Similar", "fig": 3}, {"body": 1, "word": "nuclear", "fig": 3}, {"body": 3, "word": "up-regulated", "fig": 1}, {"body": 1, "word": "three", "fig": 3}, {"body": 1, "word": "results", "fig": 2}, {"body": 1, "word": "P", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 1, "word": "localization", "fig": 2}, {"body": 2, "word": "genes", "fig": 1}, {"body": 1, "word": "indicate", "fig": 2}, {"body": 2, "word": "vehicle", "fig": 1}, {"body": 1, "word": "sections", "fig": 2}, {"body": 2, "word": "determined", "fig": 1}, {"body": 1, "word": "ctrl", "fig": 2}, {"body": 2, "word": "normal", "fig": 1}, {"body": 1, "word": "extractions", "fig": 1}, {"body": 1, "word": "cytoplasmic", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "higher", "fig": 1}, {"body": 1, "word": "sacrifice", "fig": 1}, {"body": 1, "word": "age", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341_Fig5.jpg", "caption": "YAP is required for the abnormal proliferation and survival of TSC1/2-null cells in vitro. (a and b) Expression of indicated proteins was analyzed by immunoblot in Tsc2+/+ and Tsc2\u2212/\u2212 MEFs (these MEFs were generated in p53\u2212/\u2212 background) cultured with or without serum for 24 h. Similar results were observed in three independent experiments. (c\u2013e) Tsc2+/+ and Tsc2\u2212/\u2212 MEFs transfected with siCtrl or siYAP were cultured in serum starvation conditions for a 72-h period. (c) Cell number was counted in different groups. Three independent experiments were performed and analyzed (Mean \u00b1 SEM; **, P < 0.01). (d) Expression of YAP protein was analyzed by immunoblot at the 24-h time point. Similar results were observed in three independent experiments. (e) Apoptotic cells were identified by TUNEL assay at the 48-h time point. The percentage of TUNEL+ cells was determined by counting TUNEL+ nuclei among at least 500 cells in distinct fields of each experiment. Three independent experiments were performed and analyzed. Mean \u00b1 SEM; *, P < 0.05, **, P < 0.01. (f and g) Tsc2+/+ and Tsc2\u2212/\u2212 MEFs were cultured under serum starvation conditions and treated with DMSO or Verteporfin for a 72-h period. (f) Cell number was counted. Three independent experiments were performed and analyzed. Mean \u00b1 SEM; *, P < 0.05, **, P < 0.01. (g) Expression of Ctgf mRNA was assessed by qRT-PCR in different treatments. Three independent experiments were performed and analyzed. Mean \u00b1 SEM; *, P < 0.05, **, P < 0.01, ***, P < 0.001. (h) Expression of indicated proteins was analyzed by immunoblot in HEK293 cells transfected with siRNAs against TSC1, TSC2, or siCtrl. YAP protein level was normalized with \u03b2-actin. Four independent experiments were performed and analyzed. Mean \u00b1 SEM; *, P < 0.05. (i) Percentage of BrdU+ HEK293 cells with indicated treatments under serum deprivation conditions for 24 h was assessed by 3-h BrdU pulse-labeling before harvest. Three independent experiments were performed and analyzed. Mean \u00b1 SEM; **, P < 0.01, ***, P < 0.001.", "co_occurrence": [{"body": 54, "word": "cells", "fig": 6}, {"body": 81, "word": "YAP", "fig": 3}, {"body": 6, "word": "analyzed", "fig": 9}, {"body": 11, "word": "MEFs", "fig": 4}, {"body": 22, "word": "protein", "fig": 2}, {"body": 14, "word": "Tsc2\u2212/\u2212", "fig": 3}, {"body": 6, "word": "performed", "fig": 6}, {"body": 8, "word": "conditions", "fig": 3}, {"body": 8, "word": "indicated", "fig": 3}, {"body": 24, "word": "The", "fig": 1}, {"body": 7, "word": "cultured", "fig": 3}, {"body": 10, "word": "observed", "fig": 2}, {"body": 5, "word": "serum", "fig": 4}, {"body": 8, "word": "h", "fig": 2}, {"body": 13, "word": "c", "fig": 1}, {"body": 6, "word": "starvation", "fig": 2}, {"body": 12, "word": "proliferation", "fig": 1}, {"body": 6, "word": "g", "fig": 2}, {"body": 6, "word": "Cell", "fig": 2}, {"body": 1, "word": "P", "fig": 11}, {"body": 11, "word": "b", "fig": 1}, {"body": 10, "word": "d", "fig": 1}, {"body": 5, "word": "different", "fig": 2}, {"body": 5, "word": "assessed", "fig": 2}, {"body": 3, "word": "Tsc2+/+", "fig": 3}, {"body": 1, "word": "experiments", "fig": 8}, {"body": 4, "word": "HEK293", "fig": 2}, {"body": 4, "word": "f", "fig": 2}, {"body": 8, "word": "e", "fig": 1}, {"body": 3, "word": "number", "fig": 2}, {"body": 3, "word": "proteins", "fig": 2}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 1, "word": "SEM", "fig": 6}, {"body": 5, "word": "abnormal", "fig": 1}, {"body": 4, "word": "vitro", "fig": 1}, {"body": 4, "word": "TSC2", "fig": 1}, {"body": 4, "word": "TSC1", "fig": 1}, {"body": 4, "word": "TSC1/2-null", "fig": 1}, {"body": 4, "word": "BrdU", "fig": 1}, {"body": 2, "word": "transfected", "fig": 2}, {"body": 4, "word": "required", "fig": 1}, {"body": 1, "word": "immunoblot", "fig": 3}, {"body": 3, "word": "survival", "fig": 1}, {"body": 3, "word": "background", "fig": 1}, {"body": 3, "word": "identified", "fig": 1}, {"body": 3, "word": "p53\u2212/\u2212", "fig": 1}, {"body": 3, "word": "nuclei", "fig": 1}, {"body": 2, "word": "least", "fig": 1}, {"body": 1, "word": "results", "fig": 2}, {"body": 2, "word": "TUNEL", "fig": 1}, {"body": 1, "word": "72-h", "fig": 2}, {"body": 1, "word": "Similar", "fig": 2}, {"body": 1, "word": "period", "fig": 2}, {"body": 2, "word": "siRNAs", "fig": 1}, {"body": 2, "word": "among", "fig": 1}, {"body": 1, "word": "point", "fig": 2}, {"body": 1, "word": "siCtrl", "fig": 2}, {"body": 1, "word": "three", "fig": 2}, {"body": 2, "word": "percentage", "fig": 1}, {"body": 1, "word": "TUNEL+", "fig": 2}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 2, "word": "counting", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "treatments", "fig": 2}, {"body": 2, "word": "generated", "fig": 1}, {"body": 1, "word": "time", "fig": 2}, {"body": 2, "word": "DMSO", "fig": 1}, {"body": 1, "word": "siYAP", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "BrdU+", "fig": 1}, {"body": 1, "word": "level", "fig": 1}, {"body": 1, "word": "fields", "fig": 1}, {"body": 1, "word": "Ctgf", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "distinct", "fig": 1}, {"body": 1, "word": "Verteporfin", "fig": 1}, {"body": 1, "word": "harvest", "fig": 1}, {"body": 1, "word": "without", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341_Fig6.jpg", "caption": "Verteporfin treatment inhibits proliferation and induces apoptosis of Tsc1-null cells in vivo. Mice were administered i.p. with vehicle or verteporfin at a dose of 100 mg/kg every other day for 10 d before sacrifice. Mice were sacrificed at 6 wk of age. Three independent experiments were performed and mice in different treatments were pooled for analysis. (a) Kidney/body weight ratio of Ctrl and mosaic-Tsc1KO mice treated with placebo or Verteporfin. n = 3 mice/group. Mean \u00b1 SEM; *, P < 0.05, ***, P < 0.001. (b) Representative pictures of hematoxylin and eosin staining of kidney sections from Ctrl and mosaic-Tsc1KO mice treated with placebo or Verteporfin. Bar, 1 mm. (c) Expression of indicated mRNAs was analyzed by qRT-PCR in kidney samples from Ctrl and mosaic-Tsc1KO mice treated with placebo or Verteporfin. n = 3 mice/group. Mean \u00b1 SEM; *, P < 0.05, **, P < 0.01. (d) Percentage of Ki67 and \u03b1SMA double-positive cells in \u03b1-SMA+ mesenchymal lesions in the indicated kidneys. Immunofluorescence staining and counting were performed on three sagittal sections from different kidney regions for each mouse. Representative images are shown. Mean \u00b1 SEM; n = 3 mice/group; **, P < 0.01; Bar, 100 \u00b5m. Insets show the lesions indicated with arrows. (e) In situ apoptotic cells were assessed by TUNEL assay on the kidney sections from Ctrl and mosaic-Tsc1KO mice treated with placebo or verteporfin. The number of TUNEL+ cells were counted in ten distinct fields of each section. Three sections were analyzed per each mouse. Representative images are shown. Arrows indicate TUNEL+ epithelial cells and arrowheads show TUNEL+ mesenchymal cells. Insets show the lesions indicated with arrows. Mean \u00b1 SEM; n = 3 mice/group; *, P < 0.05; Bar 100 \u00b5m.", "co_occurrence": [{"body": 54, "word": "cells", "fig": 6}, {"body": 34, "word": "mice", "fig": 5}, {"body": 25, "word": "mosaic-Tsc1KO", "fig": 4}, {"body": 28, "word": "lesions", "fig": 3}, {"body": 18, "word": "kidney", "fig": 4}, {"body": 25, "word": "mouse", "fig": 2}, {"body": 17, "word": "mesenchymal", "fig": 2}, {"body": 8, "word": "indicated", "fig": 4}, {"body": 24, "word": "The", "fig": 1}, {"body": 10, "word": "d", "fig": 2}, {"body": 20, "word": "kidneys", "fig": 1}, {"body": 7, "word": "verteporfin", "fig": 2}, {"body": 13, "word": "c", "fig": 1}, {"body": 13, "word": "In", "fig": 1}, {"body": 12, "word": "treatment", "fig": 1}, {"body": 6, "word": "shown", "fig": 2}, {"body": 12, "word": "proliferation", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 2}, {"body": 6, "word": "performed", "fig": 2}, {"body": 11, "word": "samples", "fig": 1}, {"body": 11, "word": "b", "fig": 1}, {"body": 5, "word": "different", "fig": 2}, {"body": 8, "word": "day", "fig": 1}, {"body": 8, "word": "mg/kg", "fig": 1}, {"body": 8, "word": "epithelial", "fig": 1}, {"body": 4, "word": "Mice", "fig": 2}, {"body": 2, "word": "treated", "fig": 4}, {"body": 8, "word": "e", "fig": 1}, {"body": 1, "word": "P", "fig": 6}, {"body": 6, "word": "every", "fig": 1}, {"body": 6, "word": "i.p", "fig": 1}, {"body": 5, "word": "dose", "fig": 1}, {"body": 5, "word": "assessed", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "staining", "fig": 2}, {"body": 1, "word": "SEM", "fig": 4}, {"body": 1, "word": "sections", "fig": 4}, {"body": 1, "word": "Verteporfin", "fig": 4}, {"body": 4, "word": "vivo", "fig": 1}, {"body": 3, "word": "apoptosis", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "wk", "fig": 1}, {"body": 1, "word": "TUNEL+", "fig": 3}, {"body": 2, "word": "ratio", "fig": 1}, {"body": 2, "word": "TUNEL", "fig": 1}, {"body": 2, "word": "weight", "fig": 1}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 2, "word": "vehicle", "fig": 1}, {"body": 2, "word": "\u03b1SMA", "fig": 1}, {"body": 2, "word": "Ki67", "fig": 1}, {"body": 2, "word": "counting", "fig": 1}, {"body": 2, "word": "administered", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "regions", "fig": 1}, {"body": 1, "word": "fields", "fig": 1}, {"body": 1, "word": "mRNAs", "fig": 1}, {"body": 1, "word": "\u03b1-SMA+", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "indicate", "fig": 1}, {"body": 1, "word": "distinct", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "apoptotic", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "Tsc1-null", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}, {"body": 1, "word": "sacrifice", "fig": 1}, {"body": 1, "word": "treatments", "fig": 1}, {"body": 1, "word": "age", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341R_Fig7.jpg", "caption": "Heterozygous deletion of Yap compromises the proliferation of renal mesenchymal lesions in mosaic-Tsc1KO mice. Three independent tamoxifen injection experiments were performed and female mice of indicated genotypes were pooled for analysis. (a) Kidney/body weight ratio of the indicated mice sacrificed at 6 wk of age (Ctrl, n = 4; mosaic-Tsc1KO, n = 5; mosaic-Tsc1KO;Yap+/\u2212, n = 3). (b) Representative pictures of hematoxylin and eosin staining of kidney sections from the indicated mice. (c) Expression of indicated proteins was analyzed by immunoblot in mouse kidney samples from the indicated genotypes. (d) Percentage of Ki67 and \u03b1-SMA double-positive cells in \u03b1-SMA+ kidney lesions from mice of the indicated genotypes. Immunofluorescence staining and counting were performed on three sagittal sections from different kidney regions for each mouse (Ctrl, n = 4, mosaic-Tsc1KO, n = 5; mosaic-Tsc1KO;Yap+/\u2212, n = 3). Insets show the lesions indicated with arrows. Bars, 100 \u00b5m. Mean \u00b1 SEM, **, P < 0.01. (e) Percentage of BrdU and Vimentin double-positive cells in Vimentin+ mesenchymal lesions in the indicated kidneys. BrdU (50 mg/kg) was injected i.p. 24 h before sacrifice. Immunofluorescence staining and counting were performed on three sagittal sections from different kidney regions for each mouse. Representative images are shown (Ctrl, n = 4; mosaic-Tsc1KO, n = 5; mosaic-Tsc1KO;Yap+/\u2212, n = 3; mean \u00b1 SEM; **, P < 0.01; Bar, 100 \u00b5m). Insets show the lesions indicated with arrows. (f) Kidney/body weight ratio of Yap+/+ (n = 3) and Yap+/\u2212 (n = 3) mice. (g) Hematoxylin and eosin staining of kidney sections from Yap+/+ and Yap+/\u2212 mice. Bar, 1 mm. (h) Percentage of Ki67+ cells per mm2 in kidney sections from Yap+/+ and Yap+/\u2212 mice (n = 3). The number of Ki67+ cells were counted in 10 distinct fields per each section. Two sections were analyzed per each mouse.", "co_occurrence": [{"body": 34, "word": "mice", "fig": 8}, {"body": 54, "word": "cells", "fig": 4}, {"body": 25, "word": "mosaic-Tsc1KO", "fig": 7}, {"body": 28, "word": "lesions", "fig": 5}, {"body": 18, "word": "kidney", "fig": 7}, {"body": 25, "word": "mouse", "fig": 4}, {"body": 8, "word": "indicated", "fig": 9}, {"body": 17, "word": "mesenchymal", "fig": 2}, {"body": 5, "word": "Yap+/\u2212", "fig": 6}, {"body": 24, "word": "The", "fig": 1}, {"body": 20, "word": "kidneys", "fig": 1}, {"body": 6, "word": "performed", "fig": 3}, {"body": 8, "word": "h", "fig": 2}, {"body": 13, "word": "c", "fig": 1}, {"body": 12, "word": "proliferation", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 2}, {"body": 11, "word": "samples", "fig": 1}, {"body": 11, "word": "b", "fig": 1}, {"body": 10, "word": "d", "fig": 1}, {"body": 5, "word": "different", "fig": 2}, {"body": 10, "word": "renal", "fig": 1}, {"body": 9, "word": "deletion", "fig": 1}, {"body": 2, "word": "staining", "fig": 4}, {"body": 8, "word": "mg/kg", "fig": 1}, {"body": 4, "word": "BrdU", "fig": 2}, {"body": 8, "word": "e", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 2, "word": "per", "fig": 3}, {"body": 6, "word": "i.p", "fig": 1}, {"body": 6, "word": "g", "fig": 1}, {"body": 1, "word": "sections", "fig": 6}, {"body": 5, "word": "injected", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 2, "word": "ratio", "fig": 2}, {"body": 2, "word": "weight", "fig": 2}, {"body": 4, "word": "Yap", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 2, "word": "counting", "fig": 2}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 1, "word": "genotypes", "fig": 3}, {"body": 3, "word": "wk", "fig": 1}, {"body": 1, "word": "Yap+/+", "fig": 3}, {"body": 3, "word": "number", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 2}, {"body": 1, "word": "P", "fig": 2}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 1, "word": "three", "fig": 2}, {"body": 1, "word": "SEM", "fig": 2}, {"body": 2, "word": "Ki67", "fig": 1}, {"body": 1, "word": "regions", "fig": 2}, {"body": 1, "word": "tamoxifen", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "Vimentin", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "\u03b1-SMA", "fig": 1}, {"body": 1, "word": "immunoblot", "fig": 1}, {"body": 1, "word": "\u03b1-SMA+", "fig": 1}, {"body": 1, "word": "fields", "fig": 1}, {"body": 1, "word": "distinct", "fig": 1}, {"body": 1, "word": "sacrifice", "fig": 1}, {"body": 1, "word": "age", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203941/bin/JEM_20140341R_Fig8.jpg", "caption": "YAP is accumulated in TSC deficient cells due to blockage of autophagy. (a) Expression of indicated proteins was analyzed by immunoblot in Tsc2+/+ and Tsc2\u2212/\u2212 MEFs treated with or without chloroquine (CQ) for 8 h. Similar results were observed in three independent experiments. (b, c) Localization of YAP and Lamp2 was analyzed by immunofluorescence in Tsc2+/+ and Tsc2\u2212/\u2212 MEFs treated with or without CQ (20 \u00b5M) for 24 h. Insets show part of the cells indicated with squares. 50 cells were counted for yellow punctas in each group. Three independent experiments were performed and analyzed (mean \u00b1 SEM; *, P < 0.05, **, P < 0.01; Bar 10 \u00b5m). (d and e) Expression of indicated proteins was analyzed by immunoblot in Tsc2+/+, Tsc2\u2212/\u2212 and Atg7+/+, Atg7\u2212/\u2212 MEFs culturing with or without Torin1 for 24 h. Similar results were observed in three independent experiments. (f) Immunoblot analysis of YAP and LC3 in HeLa cells with indicated treatments. YAP levels were normalized with \u03b2-actin. Similar results were observed in three independent experiments. (g) Immunoprecipitation analysis of interacting proteins of flag-tagged YAP in the indicated culturing conditions for 0.5 h. Similar results were observed in three independent experiments. (h) Expression of indicated proteins was analyzed by immunoblot in ctrl (n = 3) and proximal tubule\u2013specific Atg7 knockout mouse kidney samples (n = 3).", "co_occurrence": [{"body": 81, "word": "YAP", "fig": 5}, {"body": 54, "word": "cells", "fig": 4}, {"body": 8, "word": "indicated", "fig": 6}, {"body": 14, "word": "Tsc2\u2212/\u2212", "fig": 3}, {"body": 10, "word": "observed", "fig": 4}, {"body": 11, "word": "MEFs", "fig": 3}, {"body": 6, "word": "analyzed", "fig": 5}, {"body": 28, "word": "TSC", "fig": 1}, {"body": 25, "word": "mouse", "fig": 1}, {"body": 21, "word": "levels", "fig": 1}, {"body": 18, "word": "kidney", "fig": 1}, {"body": 13, "word": "c", "fig": 1}, {"body": 3, "word": "proteins", "fig": 4}, {"body": 11, "word": "samples", "fig": 1}, {"body": 11, "word": "autophagy", "fig": 1}, {"body": 11, "word": "b", "fig": 1}, {"body": 10, "word": "d", "fig": 1}, {"body": 5, "word": "analysis", "fig": 2}, {"body": 3, "word": "Tsc2+/+", "fig": 3}, {"body": 8, "word": "h", "fig": 1}, {"body": 8, "word": "conditions", "fig": 1}, {"body": 8, "word": "e", "fig": 1}, {"body": 6, "word": "g", "fig": 1}, {"body": 6, "word": "performed", "fig": 1}, {"body": 1, "word": "experiments", "fig": 5}, {"body": 1, "word": "results", "fig": 4}, {"body": 4, "word": "Torin1", "fig": 1}, {"body": 1, "word": "Similar", "fig": 4}, {"body": 1, "word": "three", "fig": 4}, {"body": 1, "word": "h.", "fig": 4}, {"body": 4, "word": "chloroquine", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 2, "word": "treated", "fig": 2}, {"body": 1, "word": "immunoblot", "fig": 3}, {"body": 3, "word": "due", "fig": 1}, {"body": 1, "word": "without", "fig": 3}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "P", "fig": 2}, {"body": 2, "word": "deficient", "fig": 1}, {"body": 1, "word": "CQ", "fig": 2}, {"body": 2, "word": "immunofluorescence", "fig": 1}, {"body": 2, "word": "Atg7\u2212/\u2212", "fig": 1}, {"body": 2, "word": "Atg7", "fig": 1}, {"body": 1, "word": "proximal", "fig": 1}, {"body": 1, "word": "LC3", "fig": 1}, {"body": 1, "word": "knockout", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "Lamp2", "fig": 1}, {"body": 1, "word": "\u00b5M", "fig": 1}, {"body": 1, "word": "accumulated", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "blockage", "fig": 1}, {"body": 1, "word": "Atg7+/+", "fig": 1}, {"body": 1, "word": "ctrl", "fig": 1}, {"body": 1, "word": "treatments", "fig": 1}]}], "2766270": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766270/bin/fnana-03-017-g001.jpg", "caption": "Rare doublecortin-immunoreactive (DBX+) cells in the hippocampal dentate gyrus (DG) of rhesus monkeys aged around 20 years old (mid-age group). Shown are low magnification views of the DG and CA3 sector in a 19-year-old (A,B) and a 22-year-old (D\u2013I) animals, with enlarged areas depicting examples of apparently dysmorphic DCX+ cells at the border between the granular cell layer (GCL) and the hilus. DCX+ cells are small, mostly bipolar, and often arranged with their long somal diameter parallel to the GCL. Some cells (arrows in G\u2013I) have a few dendritic processes extending across the GCL into the molecular layer (ML). Scale bar = 1 mm in (A) applying to (E,F), equivalent to 2 mm for (D), 100 \u03bcm for (B) and 50 \u03bcm for (G\u2013I), and 25 \u03bcm for (C).", "co_occurrence": [{"body": 84, "word": "cells", "fig": 4}, {"body": 63, "word": "DCX+", "fig": 2}, {"body": 28, "word": "aged", "fig": 1}, {"body": 19, "word": "monkeys", "fig": 1}, {"body": 19, "word": "mid-age", "fig": 1}, {"body": 6, "word": "GCL", "fig": 3}, {"body": 14, "word": "areas", "fig": 1}, {"body": 7, "word": "layer", "fig": 2}, {"body": 11, "word": "cell", "fig": 1}, {"body": 11, "word": "group", "fig": 1}, {"body": 9, "word": "around", "fig": 1}, {"body": 9, "word": "animals", "fig": 1}, {"body": 9, "word": "gyrus", "fig": 1}, {"body": 8, "word": "years", "fig": 1}, {"body": 8, "word": "small", "fig": 1}, {"body": 8, "word": "dentate", "fig": 1}, {"body": 4, "word": "DG", "fig": 2}, {"body": 7, "word": "hippocampal", "fig": 1}, {"body": 6, "word": "across", "fig": 1}, {"body": 6, "word": "long", "fig": 1}, {"body": 6, "word": "F", "fig": 1}, {"body": 3, "word": "mm", "fig": 2}, {"body": 5, "word": "border", "fig": 1}, {"body": 4, "word": "rhesus", "fig": 1}, {"body": 4, "word": "somal", "fig": 1}, {"body": 4, "word": "low", "fig": 1}, {"body": 2, "word": "B", "fig": 2}, {"body": 4, "word": "mostly", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 3, "word": "processes", "fig": 1}, {"body": 3, "word": "old", "fig": 1}, {"body": 3, "word": "parallel", "fig": 1}, {"body": 2, "word": "granular", "fig": 1}, {"body": 2, "word": "bipolar", "fig": 1}, {"body": 2, "word": "diameter", "fig": 1}, {"body": 2, "word": "arranged", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "Some", "fig": 1}, {"body": 1, "word": "dendritic", "fig": 1}, {"body": 1, "word": "apparently", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766270/bin/fnana-03-017-g002.jpg", "caption": "Distribution of DCX+ cells in the temporal lobe cortical areas surrounding the amygdala (A\u2013K), in the insular (Ins) and secondary somatosensory (S2) cortex (L), and in the ventral prefrontal cortex including the medial and lateral orbital gyri (MOG, LOG) (M\u2013O) in a 22-year-old rhesus monkey. Framed areas in lower magnification panels are enlarged sequentially as indicated. DCX+ cells in the amygdala (Amyg) are located near the white matter deep to the entorhinal cortex (Ent) as a cellular band, which continues into the adjoining Ent and further dorsally into the inferior temporal gyrus (ITG) around the border of layers I and II (A\u2013C). Labeled cells are mostly small and bipolar, often arrange as clusters and chains with cells seemingly migrate outside-in intracortically (C,F). However, in the ITG a large number of cells are associated with tangentially arranged migratory chains that can extend very long (D,G\u2013K). Some of these chains appear to extend from layer I and then enter the cortical plate, with cells dispatching or being dispersed around the end of the chains (D,J,K, green arrows). Note that labeled cells are also fairly common in the MOG and LOG (M,N), but fewer in the Ins cortex and S2 (L). A few relatively large cells with reduced DCX reactivity are present in layers II/III (indicated with black arrows in K,N,O). rf, rhinal fissure; LF, lateral fissure. Arab numbers indicate cortical layers. Scale bar = 3 mm in (A) applying to (E,F), equivalent to 1 mm for (B,C), 500 \u03bcm for (D), 100 \u03bcm for (G,H,L\u2013N) and 50 \u03bcm for (E,F,I\u2013K,O).", "co_occurrence": [{"body": 84, "word": "cells", "fig": 8}, {"body": 63, "word": "DCX+", "fig": 2}, {"body": 25, "word": "cortex", "fig": 4}, {"body": 32, "word": "cortical", "fig": 3}, {"body": 13, "word": "layers", "fig": 3}, {"body": 8, "word": "chains", "fig": 4}, {"body": 15, "word": "amygdala", "fig": 2}, {"body": 14, "word": "areas", "fig": 2}, {"body": 10, "word": "temporal", "fig": 2}, {"body": 9, "word": "around", "fig": 2}, {"body": 6, "word": "F", "fig": 3}, {"body": 8, "word": "Ent", "fig": 2}, {"body": 13, "word": "DCX", "fig": 1}, {"body": 12, "word": "labeled", "fig": 1}, {"body": 6, "word": "ITG", "fig": 2}, {"body": 6, "word": "I", "fig": 2}, {"body": 10, "word": "monkey", "fig": 1}, {"body": 9, "word": "migratory", "fig": 1}, {"body": 9, "word": "gyrus", "fig": 1}, {"body": 8, "word": "small", "fig": 1}, {"body": 7, "word": "present", "fig": 1}, {"body": 7, "word": "band", "fig": 1}, {"body": 7, "word": "cellular", "fig": 1}, {"body": 7, "word": "layer", "fig": 1}, {"body": 7, "word": "II", "fig": 1}, {"body": 3, "word": "large", "fig": 2}, {"body": 3, "word": "mm", "fig": 2}, {"body": 6, "word": "reduced", "fig": 1}, {"body": 3, "word": "MOG", "fig": 2}, {"body": 6, "word": "long", "fig": 1}, {"body": 2, "word": "D", "fig": 3}, {"body": 5, "word": "clusters", "fig": 1}, {"body": 5, "word": "prefrontal", "fig": 1}, {"body": 5, "word": "appear", "fig": 1}, {"body": 5, "word": "lobe", "fig": 1}, {"body": 5, "word": "border", "fig": 1}, {"body": 4, "word": "including", "fig": 1}, {"body": 4, "word": "also", "fig": 1}, {"body": 4, "word": "rhesus", "fig": 1}, {"body": 4, "word": "common", "fig": 1}, {"body": 4, "word": "mostly", "fig": 1}, {"body": 4, "word": "II/III", "fig": 1}, {"body": 2, "word": "Ins", "fig": 2}, {"body": 4, "word": "associated", "fig": 1}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 4, "word": "migrate", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "matter", "fig": 1}, {"body": 3, "word": "end", "fig": 1}, {"body": 2, "word": "seemingly", "fig": 1}, {"body": 2, "word": "tangentially", "fig": 1}, {"body": 2, "word": "medial", "fig": 1}, {"body": 2, "word": "fairly", "fig": 1}, {"body": 2, "word": "However", "fig": 1}, {"body": 2, "word": "bipolar", "fig": 1}, {"body": 1, "word": "extend", "fig": 2}, {"body": 1, "word": "K", "fig": 2}, {"body": 1, "word": "O", "fig": 2}, {"body": 2, "word": "ventral", "fig": 1}, {"body": 1, "word": "lateral", "fig": 2}, {"body": 2, "word": "white", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "arranged", "fig": 1}, {"body": 2, "word": "plate", "fig": 1}, {"body": 2, "word": "relatively", "fig": 1}, {"body": 1, "word": "E", "fig": 2}, {"body": 2, "word": "Some", "fig": 1}, {"body": 1, "word": "arrange", "fig": 1}, {"body": 1, "word": "inferior", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "entorhinal", "fig": 1}, {"body": 1, "word": "insular", "fig": 1}, {"body": 1, "word": "J", "fig": 1}, {"body": 1, "word": "deep", "fig": 1}, {"body": 1, "word": "numbers", "fig": 1}, {"body": 1, "word": "orbital", "fig": 1}, {"body": 1, "word": "located", "fig": 1}, {"body": 1, "word": "reactivity", "fig": 1}, {"body": 1, "word": "M", "fig": 1}, {"body": 1, "word": "gyri", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766270/bin/fnana-03-017-g003.jpg", "caption": "Presence of DCX+ cells (A\u2013H) in the amygdala (A,B) and the cortex (C\u2013H) of a 34-year-old monkey with cerebral amyloid plaques (I,J), as indicated. A decreased amount of DCX labeling is noticeable as compared to Figure 2 in corresponding cerebral areas. Labeled profiles in layers I\u2013III, especially their clusters, appear disorganized (C\u2013F). An expanded bizarre-looking migratory cell cluster is illustrated in (D). Long tangential and oblique migratory chains occur around layers I and II (E,F). The distribution of amyloid plaques around the hippocampal formation and temporal lobe structures is shown with 6E10 immunolabeling with Nissl counterstain (I,J). Some plaques occur in layers II and III wherein DCX+ cells exist (J). Sub, subiculum; PHG, parahippocampal gyrus, FuG, fusiform gyrus; opts, occipitotemporal sulcus. Other abbreviations are the same as in Figure 2. Scale bar = 250 \u03bcm in (A), equivalent to 500 \u03bcm for (I), 150 \u03bcm for (C,G), 100 \u03bcm for (J) and 50 \u03bcm for (B,D\u2013F,H).", "co_occurrence": [{"body": 84, "word": "cells", "fig": 2}, {"body": 63, "word": "DCX+", "fig": 2}, {"body": 13, "word": "layers", "fig": 3}, {"body": 13, "word": "cerebral", "fig": 2}, {"body": 25, "word": "cortex", "fig": 1}, {"body": 6, "word": "I", "fig": 4}, {"body": 9, "word": "migratory", "fig": 2}, {"body": 9, "word": "around", "fig": 2}, {"body": 9, "word": "gyrus", "fig": 2}, {"body": 9, "word": "Figure", "fig": 2}, {"body": 15, "word": "amygdala", "fig": 1}, {"body": 14, "word": "areas", "fig": 1}, {"body": 7, "word": "amyloid", "fig": 2}, {"body": 7, "word": "II", "fig": 2}, {"body": 13, "word": "DCX", "fig": 1}, {"body": 4, "word": "plaques", "fig": 3}, {"body": 11, "word": "cell", "fig": 1}, {"body": 11, "word": "The", "fig": 1}, {"body": 10, "word": "temporal", "fig": 1}, {"body": 10, "word": "monkey", "fig": 1}, {"body": 8, "word": "chains", "fig": 1}, {"body": 7, "word": "hippocampal", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "F", "fig": 1}, {"body": 2, "word": "A", "fig": 3}, {"body": 5, "word": "lobe", "fig": 1}, {"body": 5, "word": "appear", "fig": 1}, {"body": 5, "word": "clusters", "fig": 1}, {"body": 4, "word": "6E10", "fig": 1}, {"body": 4, "word": "structures", "fig": 1}, {"body": 2, "word": "B", "fig": 2}, {"body": 1, "word": "J", "fig": 4}, {"body": 4, "word": "distribution", "fig": 1}, {"body": 3, "word": "tangential", "fig": 1}, {"body": 2, "word": "labeling", "fig": 1}, {"body": 2, "word": "formation", "fig": 1}, {"body": 2, "word": "expanded", "fig": 1}, {"body": 2, "word": "profiles", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 1, "word": "occur", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "compared", "fig": 1}, {"body": 2, "word": "Some", "fig": 1}, {"body": 1, "word": "oblique", "fig": 1}, {"body": 1, "word": "illustrated", "fig": 1}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "immunolabeling", "fig": 1}, {"body": 1, "word": "noticeable", "fig": 1}, {"body": 1, "word": "amount", "fig": 1}, {"body": 1, "word": "bizarre-looking", "fig": 1}, {"body": 1, "word": "34-year-old", "fig": 1}, {"body": 1, "word": "Other", "fig": 1}, {"body": 1, "word": "III", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "especially", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766270/bin/fnana-03-017-g004.jpg", "caption": "Schematic drawings illustrating an overview of age-related change in DCX+ cell distribution in the temporoparietal cortical areas at four representative anterioposterior frontal levels as indicated in the top-left map. In the young adult group (A\u2013D), DCX+ cortical cells occur in layers II/III as a continuous cellular band (blue line) extending ventrally from the entorhinal cortex (Ent) to laterally all of the temporal neocortical areas. There follows a parallel decline in the abundance of labeled cells along this band with age (E\u2013L). Thus, the cellular band \u201cretracts\u201d dorsoventrally to become impressive only in the ventral temporal areas, especially around the joining portion between the Ent and inferior temporal gyrus, in the aged group (I\u2013L). A small number of labeled cells exists in the insular and parietal cortical areas in young and mid-age animals (broken line), and they disappears in the aged animals. A cellular band at the border of the amygdala and the cortical white matter is seen in all groups (red line): sts, superior temporal sulcus; amts, anteriomedial temporal sulcus; ots, occipitotemporal sulcus; Pul, putamen; ips, interparietal sulcus; ot, optic tract; rs, rhinal sulcus. Scale bar = 1 cm.", "co_occurrence": [{"body": 84, "word": "cells", "fig": 3}, {"body": 32, "word": "cortical", "fig": 4}, {"body": 63, "word": "DCX+", "fig": 2}, {"body": 14, "word": "areas", "fig": 4}, {"body": 28, "word": "aged", "fig": 2}, {"body": 10, "word": "temporal", "fig": 5}, {"body": 16, "word": "young", "fig": 2}, {"body": 7, "word": "band", "fig": 4}, {"body": 25, "word": "cortex", "fig": 1}, {"body": 12, "word": "labeled", "fig": 2}, {"body": 11, "word": "group", "fig": 2}, {"body": 7, "word": "cellular", "fig": 3}, {"body": 19, "word": "adult", "fig": 1}, {"body": 19, "word": "mid-age", "fig": 1}, {"body": 9, "word": "animals", "fig": 2}, {"body": 8, "word": "Ent", "fig": 2}, {"body": 16, "word": "In", "fig": 1}, {"body": 15, "word": "amygdala", "fig": 1}, {"body": 13, "word": "layers", "fig": 1}, {"body": 13, "word": "groups", "fig": 1}, {"body": 11, "word": "cell", "fig": 1}, {"body": 9, "word": "around", "fig": 1}, {"body": 9, "word": "gyrus", "fig": 1}, {"body": 9, "word": "Thus", "fig": 1}, {"body": 8, "word": "small", "fig": 1}, {"body": 8, "word": "age", "fig": 1}, {"body": 5, "word": "border", "fig": 1}, {"body": 4, "word": "distribution", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 4, "word": "levels", "fig": 1}, {"body": 4, "word": "II/III", "fig": 1}, {"body": 3, "word": "frontal", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "decline", "fig": 1}, {"body": 1, "word": "line", "fig": 3}, {"body": 3, "word": "matter", "fig": 1}, {"body": 3, "word": "parallel", "fig": 1}, {"body": 2, "word": "along", "fig": 1}, {"body": 2, "word": "age-related", "fig": 1}, {"body": 2, "word": "There", "fig": 1}, {"body": 2, "word": "white", "fig": 1}, {"body": 2, "word": "abundance", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "seen", "fig": 1}, {"body": 2, "word": "ventral", "fig": 1}, {"body": 1, "word": "inferior", "fig": 1}, {"body": 1, "word": "become", "fig": 1}, {"body": 1, "word": "exists", "fig": 1}, {"body": 1, "word": "entorhinal", "fig": 1}, {"body": 1, "word": "insular", "fig": 1}, {"body": 1, "word": "temporoparietal", "fig": 1}, {"body": 1, "word": "occur", "fig": 1}, {"body": 1, "word": "especially", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766270/bin/fnana-03-017-g005.jpg", "caption": "Age-related decline of DCX+ cells in the monkey forebrain based on densitometry over representative areas including the amygdala (Amyg), entorhinal cortex (Ent), inferior temporal gyrus (ITG), medial orbital gyrus (MOG) and dentate gyrus (DG). (A) shows an example of cell map reproduced from montaged 10\u00d7 microscopic images over a mid-amygdala section from the 22-year-old animal. Red lines mark the borders between the white matter and gray matter of the cortex or between the amygdala and cortical white matter, and green line defines the pial surface. Blue bars indicate the locations used to divide the cortical areas, and to define the length of corresponding cellular bands in the amygdala (along the white matter border) and cortex (along the pial surface). Bar graph (B) shows cell densities (mean \u00b1 SD) in different areas in the three age groups. Bar graph (C) represents averaged densities normalized to the mean densities of corresponding regions in the young adult group (i.e., defined as 100%). Statistic analyses indicate a significant (*) reduction of DCX+ cells with age in all analyzed areas (B), and a significantly greater decline of cells in the DG relative to the amygdala and cortical areas (C).", "co_occurrence": [{"body": 84, "word": "cells", "fig": 3}, {"body": 63, "word": "DCX+", "fig": 2}, {"body": 32, "word": "cortical", "fig": 3}, {"body": 25, "word": "cortex", "fig": 3}, {"body": 14, "word": "areas", "fig": 5}, {"body": 15, "word": "amygdala", "fig": 4}, {"body": 9, "word": "gyrus", "fig": 3}, {"body": 11, "word": "cell", "fig": 2}, {"body": 19, "word": "adult", "fig": 1}, {"body": 8, "word": "mean", "fig": 2}, {"body": 16, "word": "young", "fig": 1}, {"body": 8, "word": "age", "fig": 2}, {"body": 13, "word": "groups", "fig": 1}, {"body": 4, "word": "densities", "fig": 3}, {"body": 12, "word": "relative", "fig": 1}, {"body": 3, "word": "matter", "fig": 4}, {"body": 11, "word": "group", "fig": 1}, {"body": 10, "word": "temporal", "fig": 1}, {"body": 10, "word": "monkey", "fig": 1}, {"body": 8, "word": "Ent", "fig": 1}, {"body": 8, "word": "dentate", "fig": 1}, {"body": 4, "word": "DG", "fig": 2}, {"body": 7, "word": "cellular", "fig": 1}, {"body": 3, "word": "decline", "fig": 2}, {"body": 2, "word": "white", "fig": 3}, {"body": 6, "word": "ITG", "fig": 1}, {"body": 6, "word": "regions", "fig": 1}, {"body": 6, "word": "used", "fig": 1}, {"body": 5, "word": "forebrain", "fig": 1}, {"body": 5, "word": "analyzed", "fig": 1}, {"body": 5, "word": "border", "fig": 1}, {"body": 4, "word": "including", "fig": 1}, {"body": 2, "word": "along", "fig": 2}, {"body": 2, "word": "B", "fig": 2}, {"body": 2, "word": "pial", "fig": 2}, {"body": 2, "word": "surface", "fig": 2}, {"body": 3, "word": "MOG", "fig": 1}, {"body": 2, "word": "medial", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "animal", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 1, "word": "based", "fig": 1}, {"body": 1, "word": "inferior", "fig": 1}, {"body": 1, "word": "bands", "fig": 1}, {"body": 1, "word": "significantly", "fig": 1}, {"body": 1, "word": "entorhinal", "fig": 1}, {"body": 1, "word": "densitometry", "fig": 1}, {"body": 1, "word": "reduction", "fig": 1}, {"body": 1, "word": "line", "fig": 1}, {"body": 1, "word": "averaged", "fig": 1}, {"body": 1, "word": "example", "fig": 1}, {"body": 1, "word": "SD", "fig": 1}, {"body": 1, "word": "orbital", "fig": 1}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "significant", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766270/bin/fnana-03-017-g006.jpg", "caption": "Immunofluorescent images from the 22-year-old monkey illustrating colocalization of polysialylated neural cell adhesion molecule (PSA-NCAM) and neuron-specific nuclear protein (NeuN) in DCX+ cells (including bisbenzimide nuclear stain in D and H) in the prefrontal (MOG, A\u2013C) and temporal lobe cortex (D\u2013K). PSA-NCAM and DCX are colocalized in individual cells as well as cells arranged in chains perpendicular (A\u2013C) or tangential (D) to the cortical surface. NeuN is detectable in a small number of DCX+ cells with relatively larger size and lighter DCX reactivity (arrows in I\u2013J, and enlarged circles in G) than those lack colocalization (arrowheads in I\u2013K). Note DCX+ tracts and migratory chains in layers I (E\u2013G) and II (H). Abbreviations are the same as in Figure 2. Scale bar = 100 \u03bcm in (A\u2013C), equivalent to 200 \u03bcm for (E\u2013G), 50 \u03bcm for (D,I\u2013K).", "co_occurrence": [{"body": 84, "word": "cells", "fig": 4}, {"body": 63, "word": "DCX+", "fig": 3}, {"body": 32, "word": "cortical", "fig": 1}, {"body": 13, "word": "DCX", "fig": 2}, {"body": 25, "word": "cortex", "fig": 1}, {"body": 8, "word": "chains", "fig": 2}, {"body": 13, "word": "layers", "fig": 1}, {"body": 6, "word": "PSA-NCAM", "fig": 2}, {"body": 11, "word": "cell", "fig": 1}, {"body": 10, "word": "temporal", "fig": 1}, {"body": 10, "word": "monkey", "fig": 1}, {"body": 9, "word": "migratory", "fig": 1}, {"body": 9, "word": "Figure", "fig": 1}, {"body": 4, "word": "colocalization", "fig": 2}, {"body": 8, "word": "small", "fig": 1}, {"body": 4, "word": "NeuN", "fig": 2}, {"body": 7, "word": "II", "fig": 1}, {"body": 2, "word": "D", "fig": 3}, {"body": 6, "word": "I", "fig": 1}, {"body": 5, "word": "lobe", "fig": 1}, {"body": 5, "word": "prefrontal", "fig": 1}, {"body": 4, "word": "including", "fig": 1}, {"body": 2, "word": "nuclear", "fig": 2}, {"body": 4, "word": "well", "fig": 1}, {"body": 3, "word": "tangential", "fig": 1}, {"body": 3, "word": "MOG", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 3, "word": "size", "fig": 1}, {"body": 3, "word": "neuron-specific", "fig": 1}, {"body": 1, "word": "H", "fig": 2}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "bisbenzimide", "fig": 1}, {"body": 2, "word": "arranged", "fig": 1}, {"body": 2, "word": "surface", "fig": 1}, {"body": 2, "word": "relatively", "fig": 1}, {"body": 2, "word": "neural", "fig": 1}, {"body": 1, "word": "stain", "fig": 1}, {"body": 1, "word": "adhesion", "fig": 1}, {"body": 1, "word": "perpendicular", "fig": 1}, {"body": 1, "word": "Immunofluorescent", "fig": 1}, {"body": 1, "word": "larger", "fig": 1}, {"body": 1, "word": "detectable", "fig": 1}, {"body": 1, "word": "polysialylated", "fig": 1}, {"body": 1, "word": "protein", "fig": 1}, {"body": 1, "word": "reactivity", "fig": 1}, {"body": 1, "word": "molecule", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766270/bin/fnana-03-017-g007.jpg", "caption": "Representative immunofluorescent images from the 19-year-old (A\u2013K) and the 34-year-old (L\u2013O) monkeys depicting double labeling of DCX with \u03b3-aminobutyric acid (GABA), tyrosine hydroxylase (TH) and \u03b2-amyloid peptide (A\u03b2, 6E10 staining) in the cortical areas as indicated. GABA immunoreactivity is detectable in a small subset of relatively large DCX+ cells (arrows, A\u2013F). TH immunoreactive axonal plexuses (arrows) occur around DCX+ cells and chains in layer II (G\u2013K). DCX+ cells do not appear to preferentially occur around amyloid plaques, nor do they apparently disappear from areas with plaques (L\u2013N). Scale bar = 50 \u03bcm in (A\u2013C) applying to (J,K), equivalent to 100 \u03bcm for (G\u2013I,L\u2013N), and 25 \u03bcm for (D\u2013F,O).", "co_occurrence": [{"body": 84, "word": "cells", "fig": 3}, {"body": 63, "word": "DCX+", "fig": 3}, {"body": 32, "word": "cortical", "fig": 1}, {"body": 14, "word": "areas", "fig": 2}, {"body": 19, "word": "monkeys", "fig": 1}, {"body": 9, "word": "around", "fig": 2}, {"body": 13, "word": "DCX", "fig": 1}, {"body": 8, "word": "small", "fig": 1}, {"body": 8, "word": "chains", "fig": 1}, {"body": 4, "word": "plaques", "fig": 2}, {"body": 7, "word": "amyloid", "fig": 1}, {"body": 7, "word": "layer", "fig": 1}, {"body": 7, "word": "II", "fig": 1}, {"body": 3, "word": "GABA", "fig": 2}, {"body": 5, "word": "appear", "fig": 1}, {"body": 4, "word": "6E10", "fig": 1}, {"body": 3, "word": "large", "fig": 1}, {"body": 3, "word": "double", "fig": 1}, {"body": 2, "word": "labeling", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "acid", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 1, "word": "occur", "fig": 2}, {"body": 2, "word": "relatively", "fig": 1}, {"body": 1, "word": "TH", "fig": 2}, {"body": 1, "word": "axonal", "fig": 1}, {"body": 1, "word": "peptide", "fig": 1}, {"body": 1, "word": "K", "fig": 1}, {"body": 1, "word": "O", "fig": 1}, {"body": 1, "word": "preferentially", "fig": 1}, {"body": 1, "word": "\u03b3-aminobutyric", "fig": 1}, {"body": 1, "word": "detectable", "fig": 1}, {"body": 1, "word": "tyrosine", "fig": 1}, {"body": 1, "word": "34-year-old", "fig": 1}, {"body": 1, "word": "J", "fig": 1}, {"body": 1, "word": "plexuses", "fig": 1}, {"body": 1, "word": "apparently", "fig": 1}, {"body": 1, "word": "hydroxylase", "fig": 1}]}], "3667825": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667825/bin/pone.0063829.g001.jpg", "caption": "The survival estimates, and cardiac structure and function of HF and SHAM mice. (A) The survival estimates surveyed during the experimental procedures were shown. (B) Representative M mode echocardiograms of HF and SHAM mice were shown. (C) Representative hematoxylin and eosin (HE) staining of heart slices from control and HF mice three months after surgery was shown. Scale bar: 1 mm.", "co_occurrence": [{"body": 105, "word": "mice", "fig": 3}, {"body": 42, "word": "SHAM", "fig": 2}, {"body": 40, "word": "The", "fig": 2}, {"body": 37, "word": "heart", "fig": 1}, {"body": 34, "word": "surgery", "fig": 1}, {"body": 11, "word": "HF", "fig": 3}, {"body": 26, "word": "months", "fig": 1}, {"body": 19, "word": "three", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 3, "word": "shown", "fig": 3}, {"body": 8, "word": "slices", "fig": 1}, {"body": 4, "word": "survival", "fig": 2}, {"body": 8, "word": "cardiac", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "mm", "fig": 1}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "function", "fig": 1}, {"body": 2, "word": "Representative", "fig": 2}, {"body": 4, "word": "control", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 1, "word": "estimates", "fig": 2}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "structure", "fig": 1}, {"body": 2, "word": "bar", "fig": 1}, {"body": 1, "word": "surveyed", "fig": 1}, {"body": 1, "word": "eosin", "fig": 1}, {"body": 1, "word": "procedures", "fig": 1}, {"body": 1, "word": "hematoxylin", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667825/bin/pone.0063829.g002.jpg", "caption": "MicroPET/CT imaging and the integrity of blood brain barrier (BBB) in CHF and SHAM mice. (A) Three months after surgery, male CHF and SHAM mice were subjected to MicroPET/CT analysis. Representative MicroPET/CT images showing the glucose uptake and metabolism in the heart and brain were displayed. (B) The permeability of blood brain barrier (BBB) was indicated by extravasations of Evans blue dye. Evans blue concentrations (\u00b5g/g) in the brains of CHF and SHAM mice were assessed three months after surgery. Data are expressed as mean \u00b1 SE, n = 3\u20135 for SHAM and n = 4 for CHF group.", "co_occurrence": [{"body": 105, "word": "mice", "fig": 3}, {"body": 77, "word": "CHF", "fig": 4}, {"body": 42, "word": "SHAM", "fig": 4}, {"body": 27, "word": "brain", "fig": 3}, {"body": 34, "word": "surgery", "fig": 2}, {"body": 26, "word": "months", "fig": 2}, {"body": 40, "word": "The", "fig": 1}, {"body": 37, "word": "heart", "fig": 1}, {"body": 17, "word": "n", "fig": 2}, {"body": 28, "word": "male", "fig": 1}, {"body": 19, "word": "three", "fig": 1}, {"body": 15, "word": "group", "fig": 1}, {"body": 5, "word": "MicroPET/CT", "fig": 3}, {"body": 14, "word": "glucose", "fig": 1}, {"body": 13, "word": "metabolism", "fig": 1}, {"body": 10, "word": "mean", "fig": 1}, {"body": 5, "word": "blood", "fig": 2}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "uptake", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "brains", "fig": 1}, {"body": 7, "word": "analysis", "fig": 1}, {"body": 6, "word": "SE", "fig": 1}, {"body": 5, "word": "imaging", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 4, "word": "expressed", "fig": 1}, {"body": 2, "word": "BBB", "fig": 2}, {"body": 2, "word": "Evans", "fig": 2}, {"body": 3, "word": "Three", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 2, "word": "displayed", "fig": 1}, {"body": 1, "word": "blue", "fig": 2}, {"body": 1, "word": "barrier", "fig": 2}, {"body": 2, "word": "Representative", "fig": 1}, {"body": 2, "word": "dye", "fig": 1}, {"body": 1, "word": "assessed", "fig": 1}, {"body": 1, "word": "integrity", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667825/bin/pone.0063829.g003.jpg", "caption": "The results from open field test (A, B, C) and elevated plus-maze test (D, E, F, G). The bar diagrams show: (A) Total distance traveled (cm); (B) The ratio of distance traveled in center to total distance (%) and (C) The sum time spent in the center in the open field test. (D) The entrance times to the open arms; (E) The number of total entrances; (F) The number of explorations into the open arms and (G) Total explorations into the four arms in the elevated plus-maze test. Mice were tested at different time after surgery. Data are expressed as mean \u00b1 SE, *P<0.05, **P<0.01, n = 8\u201310 for SHAM and n = 10\u201312 for HF group in the open field test and the elevated plus-maze test.", "co_occurrence": [{"body": 40, "word": "The", "fig": 7}, {"body": 18, "word": "test", "fig": 6}, {"body": 42, "word": "SHAM", "fig": 1}, {"body": 34, "word": "surgery", "fig": 1}, {"body": 17, "word": "n", "fig": 2}, {"body": 4, "word": "open", "fig": 5}, {"body": 10, "word": "time", "fig": 2}, {"body": 9, "word": "A", "fig": 2}, {"body": 8, "word": "total", "fig": 2}, {"body": 15, "word": "group", "fig": 1}, {"body": 5, "word": "distance", "fig": 3}, {"body": 7, "word": "B", "fig": 2}, {"body": 4, "word": "field", "fig": 3}, {"body": 11, "word": "HF", "fig": 1}, {"body": 10, "word": "mean", "fig": 1}, {"body": 9, "word": "Mice", "fig": 1}, {"body": 8, "word": "times", "fig": 1}, {"body": 2, "word": "elevated", "fig": 3}, {"body": 2, "word": "plus-maze", "fig": 3}, {"body": 2, "word": "arms", "fig": 3}, {"body": 3, "word": "center", "fig": 2}, {"body": 6, "word": "SE", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "show", "fig": 1}, {"body": 2, "word": "traveled", "fig": 2}, {"body": 4, "word": "*P", "fig": 1}, {"body": 4, "word": "expressed", "fig": 1}, {"body": 2, "word": "C", "fig": 2}, {"body": 2, "word": "G", "fig": 2}, {"body": 3, "word": "different", "fig": 1}, {"body": 3, "word": "tested", "fig": 1}, {"body": 2, "word": "cm", "fig": 1}, {"body": 2, "word": "**P", "fig": 1}, {"body": 2, "word": "four", "fig": 1}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "D", "fig": 2}, {"body": 2, "word": "ratio", "fig": 1}, {"body": 2, "word": "bar", "fig": 1}, {"body": 1, "word": "results", "fig": 1}, {"body": 1, "word": "sum", "fig": 1}, {"body": 1, "word": "spent", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667825/bin/pone.0063829.g004.jpg", "caption": "The effects of chronic heart failure on spatial learning and memory in mice. Cognitive behavioral tests were performed by the hidden-platform Morris water maze test. (A) There were no significant changes in the mean swimming speed for each group (P>0.05); (B) The average (4 trails per day) escape latency in water maze training was measured for 6 days. (C) Crossing times over the former platform location were shown. Twenty-four hours after the acquisition phase, mice were subjected to a probe test in which the platform was removed. Mice were tested three months after surgery. Data are expressed as mean \u00b1 SE, *P<0.05, **P<0.01, n = 5\u20137 for SHAM and n = 5\u201311 for CHF group.", "co_occurrence": [{"body": 105, "word": "mice", "fig": 2}, {"body": 40, "word": "The", "fig": 2}, {"body": 77, "word": "CHF", "fig": 1}, {"body": 42, "word": "SHAM", "fig": 1}, {"body": 37, "word": "heart", "fig": 1}, {"body": 18, "word": "test", "fig": 2}, {"body": 34, "word": "surgery", "fig": 1}, {"body": 17, "word": "n", "fig": 2}, {"body": 15, "word": "group", "fig": 2}, {"body": 26, "word": "months", "fig": 1}, {"body": 21, "word": "failure", "fig": 1}, {"body": 10, "word": "mean", "fig": 2}, {"body": 19, "word": "three", "fig": 1}, {"body": 13, "word": "performed", "fig": 1}, {"body": 6, "word": "water", "fig": 2}, {"body": 5, "word": "platform", "fig": 2}, {"body": 5, "word": "maze", "fig": 2}, {"body": 9, "word": "Mice", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "times", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "SE", "fig": 1}, {"body": 5, "word": "changes", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 4, "word": "expressed", "fig": 1}, {"body": 4, "word": "learning", "fig": 1}, {"body": 4, "word": "*P", "fig": 1}, {"body": 4, "word": "measured", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 3, "word": "day", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "hours", "fig": 1}, {"body": 3, "word": "memory", "fig": 1}, {"body": 3, "word": "tested", "fig": 1}, {"body": 3, "word": "spatial", "fig": 1}, {"body": 3, "word": "Morris", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "probe", "fig": 1}, {"body": 2, "word": "**P", "fig": 1}, {"body": 2, "word": "effects", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "chronic", "fig": 1}, {"body": 2, "word": "average", "fig": 1}, {"body": 2, "word": "behavioral", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "speed", "fig": 1}, {"body": 1, "word": "phase", "fig": 1}, {"body": 1, "word": "escape", "fig": 1}, {"body": 1, "word": "swimming", "fig": 1}, {"body": 1, "word": "There", "fig": 1}, {"body": 1, "word": "removed", "fig": 1}, {"body": 1, "word": "days", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667825/bin/pone.0063829.g005.jpg", "caption": "Transcriptional alterations of selected genes detected by real-time PCR in the brains of CHF mice three months after surgery. Transcriptional levels of selected genes in the male cortex (A) and hippocampus (B), female cortex (C) and hippocampus (D) were shown. All mRNA expression levels were normalized to \u03b2-actin. Data are presented as mean \u00b1 SE, *P<0.05, **P<0.01, n = 4\u20136 for SHAM and CHF group.", "co_occurrence": [{"body": 77, "word": "CHF", "fig": 2}, {"body": 105, "word": "mice", "fig": 1}, {"body": 42, "word": "SHAM", "fig": 1}, {"body": 19, "word": "hippocampus", "fig": 2}, {"body": 34, "word": "surgery", "fig": 1}, {"body": 17, "word": "cortex", "fig": 2}, {"body": 29, "word": "female", "fig": 1}, {"body": 28, "word": "male", "fig": 1}, {"body": 26, "word": "months", "fig": 1}, {"body": 19, "word": "three", "fig": 1}, {"body": 19, "word": "expression", "fig": 1}, {"body": 9, "word": "levels", "fig": 2}, {"body": 17, "word": "n", "fig": 1}, {"body": 15, "word": "group", "fig": 1}, {"body": 10, "word": "detected", "fig": 1}, {"body": 5, "word": "genes", "fig": 2}, {"body": 10, "word": "mean", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "alterations", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "brains", "fig": 1}, {"body": 6, "word": "SE", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 4, "word": "PCR", "fig": 1}, {"body": 2, "word": "selected", "fig": 2}, {"body": 4, "word": "*P", "fig": 1}, {"body": 4, "word": "presented", "fig": 1}, {"body": 3, "word": "\u03b2-actin", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 2, "word": "**P", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "mRNA", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 1, "word": "Transcriptional", "fig": 2}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667825/bin/pone.0063829.g006.jpg", "caption": "Expression levels of APP, BACE1, APP CTFs, Bcl-2, Bax, t-Tau, p-Tau proteins in the brain lysates of SHAM and CHF mice three months after surgery. Representative immunoblots and densitometric analysis of protein levels in the male cortex (A) and hippocampus (B), female cortex (C) and hippocampus (D) were depicted. \u03b2-actin served as the internal control. Data are presented as mean \u00b1 SE, *P<0.05, **P<0.01, n = 3\u20135 for SHAM and n = 4\u20136 for CHF group.", "co_occurrence": [{"body": 77, "word": "CHF", "fig": 2}, {"body": 105, "word": "mice", "fig": 1}, {"body": 42, "word": "SHAM", "fig": 2}, {"body": 19, "word": "hippocampus", "fig": 2}, {"body": 34, "word": "surgery", "fig": 1}, {"body": 17, "word": "n", "fig": 2}, {"body": 17, "word": "cortex", "fig": 2}, {"body": 16, "word": "APP", "fig": 2}, {"body": 29, "word": "female", "fig": 1}, {"body": 28, "word": "male", "fig": 1}, {"body": 27, "word": "brain", "fig": 1}, {"body": 26, "word": "months", "fig": 1}, {"body": 19, "word": "three", "fig": 1}, {"body": 9, "word": "levels", "fig": 2}, {"body": 15, "word": "group", "fig": 1}, {"body": 10, "word": "BACE1", "fig": 1}, {"body": 10, "word": "mean", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "Bax", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "Bcl-2", "fig": 1}, {"body": 7, "word": "analysis", "fig": 1}, {"body": 7, "word": "protein", "fig": 1}, {"body": 6, "word": "SE", "fig": 1}, {"body": 6, "word": "proteins", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "*P", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 4, "word": "presented", "fig": 1}, {"body": 3, "word": "\u03b2-actin", "fig": 1}, {"body": 3, "word": "CTFs", "fig": 1}, {"body": 2, "word": "t-Tau", "fig": 1}, {"body": 2, "word": "Representative", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "Expression", "fig": 1}, {"body": 2, "word": "**P", "fig": 1}, {"body": 2, "word": "p-Tau", "fig": 1}, {"body": 1, "word": "immunoblots", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "densitometric", "fig": 1}, {"body": 1, "word": "served", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667825/bin/pone.0063829.g007.jpg", "caption": "No amyloidogenesis, neuronal degeneration and activation of astrocytes and microglial cells on the brain slices of CHF mice. (A) Brain slices were stained with Thioflavin-S. Three months after surgery, Thioflavin S-stained amyloid plaques were not detected in the brain of male (a) SHAM and (b) CHF mice, female (c) SHAM and (d) CHF mice and (e) normal control mice, while the image in (f) depicts severe Thioflavin S-stained amyloid plaques (indicated by arrows) in the cortex and hippocampal area of APP/PS1 transgenic mice (12 months old). Scale bar: 500 \u00b5m. (B) Brain slices were stained with Fluoro-Jade B. Three months after surgery, no typical Fluoro-Jade B stained degenerating neurons were detected in the brain of male (a) SHAM and (b) CHF mice, female (c) SHAM and (d) CHF mice and (e) normal control mice, (f) APP/PS1 transgenic mice (12 months old). Arrows indicate typical spots of degenerating neurons. Scale bar: 500 \u00b5m. (C) Immunofluorescence staining of astrocytes and microglial cells in the brain slices of SHAM and CHF mice at six months post-surgery. Scale bar: 100 \u00b5m.", "co_occurrence": [{"body": 105, "word": "mice", "fig": 10}, {"body": 77, "word": "CHF", "fig": 6}, {"body": 42, "word": "SHAM", "fig": 5}, {"body": 26, "word": "months", "fig": 5}, {"body": 27, "word": "brain", "fig": 4}, {"body": 34, "word": "surgery", "fig": 2}, {"body": 29, "word": "female", "fig": 2}, {"body": 28, "word": "male", "fig": 2}, {"body": 8, "word": "slices", "fig": 4}, {"body": 12, "word": "amyloid", "fig": 2}, {"body": 7, "word": "B", "fig": 3}, {"body": 10, "word": "detected", "fig": 2}, {"body": 9, "word": "Brain", "fig": 2}, {"body": 17, "word": "cortex", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 4, "word": "Thioflavin", "fig": 2}, {"body": 4, "word": "plaques", "fig": 2}, {"body": 4, "word": "control", "fig": 2}, {"body": 2, "word": "stained", "fig": 3}, {"body": 3, "word": "astrocytes", "fig": 2}, {"body": 2, "word": "Scale", "fig": 3}, {"body": 2, "word": "\u00b5m", "fig": 3}, {"body": 3, "word": "normal", "fig": 2}, {"body": 3, "word": "Three", "fig": 2}, {"body": 2, "word": "bar", "fig": 3}, {"body": 3, "word": "d", "fig": 2}, {"body": 6, "word": "neuronal", "fig": 1}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "six", "fig": 1}, {"body": 5, "word": "severe", "fig": 1}, {"body": 2, "word": "old", "fig": 2}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 2, "word": "neurons", "fig": 2}, {"body": 4, "word": "degeneration", "fig": 1}, {"body": 2, "word": "S-stained", "fig": 2}, {"body": 4, "word": "hippocampal", "fig": 1}, {"body": 2, "word": "c", "fig": 2}, {"body": 2, "word": "b", "fig": 2}, {"body": 2, "word": "APP/PS1", "fig": 2}, {"body": 3, "word": "post-surgery", "fig": 1}, {"body": 2, "word": "No", "fig": 1}, {"body": 1, "word": "Fluoro-Jade", "fig": 2}, {"body": 2, "word": "area", "fig": 1}, {"body": 1, "word": "degenerating", "fig": 2}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "activation", "fig": 1}, {"body": 2, "word": "amyloidogenesis", "fig": 1}, {"body": 1, "word": "cells", "fig": 2}, {"body": 1, "word": "microglial", "fig": 2}, {"body": 1, "word": "transgenic", "fig": 2}, {"body": 1, "word": "image", "fig": 1}, {"body": 1, "word": "indicate", "fig": 1}, {"body": 1, "word": "Thioflavin-S.", "fig": 1}, {"body": 1, "word": "depicts", "fig": 1}, {"body": 1, "word": "arrows", "fig": 1}, {"body": 1, "word": "Immunofluorescence", "fig": 1}]}], "3082196": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig1.jpg", "caption": "Podocalyxin is excluded from the CMD before emergence of a cilium. (A) MDCK cells expressing GFP-PODXL were grown on filters for 8 d and were fixed and stained with antiacetylated tubulin to visualize primary cilia and phalloidin to visualize F-actin. Bar, 20 \u00b5m. (B) Cells expressing GFP-PODXL and RFP-NHERF1 were fixed and stained with antiacetylated tubulin 4 or 8 d after seeding on filters. GFP-PODXL and RFP-NHERF1 patterns are similar between days 4 and 8, but few cilia are present on day 4. Bar, 20 \u00b5m. (C) Live cells expressing GFP-PODXL were imaged and individually scored for the appearance of a GFP-PODXL exclusion zone in the center of the apical membrane. Three fields of cells were counted for each of two experiments, and the percentage of cells with apparent exclusion zones appears on each image. On day 1, only 16/150 cells appeared to have a GFP-PODXL exclusion zone. The fraction rose on day 2 (46/214) and dramatically increased on day 3 (166/257) before reaching a plateau on day 4 (182/250). Images were collected with identical microscope settings. Bar, 10 \u00b5m. (D) 24 h after seeding on a filter, cells were fixed and stained with anti\u2013\u03b3-tubulin to visualize centrioles and anti-gp135 to visualize endogenous podocalyxin. Centrioles are aligned below the center of the apical membrane before podocalyxin is excluded from the CMD. Small podocalyxin exclusion zones are only seen in fixed samples. Images represent a single confocal plane. Bar, 20 \u00b5m. (E) SEM imaging of cells 4 d after seeding surprisingly shows microvilli in the CMD. After 8 d, an area at the base of primary cilia (arrowheads) is free of microvilli. Images in A\u2013C are projected z stacks. Bars: (left) 5 \u00b5m; (right) 2 \u00b5m.", "co_occurrence": [{"body": 60, "word": "cells", "fig": 7}, {"body": 70, "word": "CMD", "fig": 3}, {"body": 30, "word": "GFP-PODXL", "fig": 6}, {"body": 82, "word": "membrane", "fig": 2}, {"body": 28, "word": "exclusion", "fig": 4}, {"body": 34, "word": "podocalyxin", "fig": 3}, {"body": 45, "word": "apical", "fig": 2}, {"body": 67, "word": "cilium", "fig": 1}, {"body": 29, "word": "primary", "fig": 2}, {"body": 14, "word": "cilia", "fig": 3}, {"body": 12, "word": "expressing", "fig": 3}, {"body": 17, "word": "excluded", "fig": 2}, {"body": 8, "word": "fixed", "fig": 4}, {"body": 7, "word": "d", "fig": 4}, {"body": 22, "word": "A", "fig": 1}, {"body": 4, "word": "day", "fig": 5}, {"body": 19, "word": "The", "fig": 1}, {"body": 6, "word": "seeding", "fig": 3}, {"body": 8, "word": "filters", "fig": 2}, {"body": 4, "word": "visualize", "fig": 4}, {"body": 14, "word": "B", "fig": 1}, {"body": 14, "word": "MDCK", "fig": 1}, {"body": 12, "word": "Cells", "fig": 1}, {"body": 6, "word": "microvilli", "fig": 2}, {"body": 11, "word": "C", "fig": 1}, {"body": 11, "word": "endogenous", "fig": 1}, {"body": 5, "word": "RFP-NHERF1", "fig": 2}, {"body": 10, "word": "similar", "fig": 1}, {"body": 10, "word": "D", "fig": 1}, {"body": 8, "word": "E", "fig": 1}, {"body": 8, "word": "base", "fig": 1}, {"body": 8, "word": "h", "fig": 1}, {"body": 7, "word": "F-actin", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 2, "word": "stained", "fig": 3}, {"body": 1, "word": "\u00b5m", "fig": 6}, {"body": 3, "word": "tubulin", "fig": 2}, {"body": 6, "word": "appearance", "fig": 1}, {"body": 5, "word": "Podocalyxin", "fig": 1}, {"body": 5, "word": "fraction", "fig": 1}, {"body": 4, "word": "Live", "fig": 1}, {"body": 2, "word": "antiacetylated", "fig": 2}, {"body": 4, "word": "two", "fig": 1}, {"body": 2, "word": "center", "fig": 2}, {"body": 3, "word": "represent", "fig": 1}, {"body": 3, "word": "centrioles", "fig": 1}, {"body": 3, "word": "scored", "fig": 1}, {"body": 3, "word": "appears", "fig": 1}, {"body": 3, "word": "filter", "fig": 1}, {"body": 1, "word": "Images", "fig": 3}, {"body": 3, "word": "appeared", "fig": 1}, {"body": 3, "word": "SEM", "fig": 1}, {"body": 3, "word": "After", "fig": 1}, {"body": 1, "word": "zone", "fig": 2}, {"body": 2, "word": "fields", "fig": 1}, {"body": 2, "word": "microscope", "fig": 1}, {"body": 2, "word": "imaged", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "imaging", "fig": 1}, {"body": 2, "word": "days", "fig": 1}, {"body": 2, "word": "confocal", "fig": 1}, {"body": 2, "word": "image", "fig": 1}, {"body": 2, "word": "present", "fig": 1}, {"body": 2, "word": "seen", "fig": 1}, {"body": 2, "word": "grown", "fig": 1}, {"body": 1, "word": "phalloidin", "fig": 1}, {"body": 1, "word": "identical", "fig": 1}, {"body": 1, "word": "increased", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "area", "fig": 1}, {"body": 1, "word": "collected", "fig": 1}, {"body": 1, "word": "samples", "fig": 1}, {"body": 1, "word": "apparent", "fig": 1}, {"body": 1, "word": "z", "fig": 1}, {"body": 1, "word": "surprisingly", "fig": 1}, {"body": 1, "word": "anti\u2013\u03b3-tubulin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig2.jpg", "caption": "GFP-PODXL\u03944 and GFP-GPI are found in the CMD and cilia of live MDCK cells, but fixation can create the appearance of CMD exclusion. (A) Live cells expressing GFP-PODXL\u03944 or GFP-GPI were imaged 4 d after seeding and, in contrast to GFP-PODXL, failed to show exclusion from the CMD. Images were collected with microscope settings identical to Fig. 1 C. GFP-PODXL day 4 image from Fig. 1 C is shown for comparison. (B) Paraformaldehyde-fixed cells expressing GFP-PODXL (top row) or GFP-PODXL\u03944 (bottom row) were stained with phalloidin 4 d after seeding. GFP-PODXL\u03944 appeared to be excluded from the CMD in many cells. (C) Cells expressing GFP-PODXL, GFP-PODXL\u03944, or GFP-GPI were imaged and individually scored for the appearance of an exclusion zone. In live cells, GFP-PODXL was excluded from the CMD in 182/250 cells scored, in contrast to GFP-PODXL\u03944 (5/276) and GFP-GPI (11/269). In fixed cells, GFP-PODXL was still excluded from the CMD in most cells (209/243), but the fraction of cells that also excluded GFP-PODXL\u03944 increased from <5 to 40% (82/204). (D) Images of live cells 12 d after seeding on filters show that GFP-PODXL\u03944 and GFP-GPI are present in both the CMD and ciliary membrane. (top row) Z stacks of the apical membrane of live cells expressing GFP-PODXL, GFP-PODXL\u03944, or GFP-GPI were projected into a single image. Images were collected with identical microscope settings to Fig. 1 C, but at lower digital zoom. (bottom row) Single confocal sections above the apical membrane were taken from the z stacks in the top row, and image brightness was increased. Visible cilia are labeled with arrowheads. (E) Cells expressing GFP-PODXL, GFP-PODXL\u03944, or GFP-GPI (green) were fixed and stained with antiacetylated tubulin (white) to image primary cilia 12 d after seeding on filters. (F) Cilia longer than 2 \u00b5m extending from GFP-positive cells were counted in five fields in each of two experiments. In fixed cells, cilia were identified by antiacetylated tubulin (ciliated); in live cells, cilia were identified as GFP-positive projections from the center of the apical membrane (GFP + cilium). Scoring GFP-PODXL\u2013expressing cells, 54/188 fixed cells were ciliated, but only 4/144 live cells had a GFP-positive cilium. In contrast, GFP-PODXL\u03944\u2013expressing cells had similar numbers of cilia that could be detected using the two methods (24/77 fixed and 34/126 live), as did GFP-GPI\u2013expressing cells (77/219 fixed and 64/194 live). Images in A, B, and E are projections of z stacks. Error bars represent standard deviation between experiments. Bars, 10 \u00b5m.", "co_occurrence": [{"body": 60, "word": "cells", "fig": 19}, {"body": 70, "word": "CMD", "fig": 7}, {"body": 82, "word": "membrane", "fig": 4}, {"body": 30, "word": "GFP-PODXL", "fig": 8}, {"body": 46, "word": "Fig", "fig": 3}, {"body": 45, "word": "apical", "fig": 3}, {"body": 67, "word": "cilium", "fig": 2}, {"body": 9, "word": "GFP-PODXL\u03944", "fig": 10}, {"body": 28, "word": "exclusion", "fig": 3}, {"body": 14, "word": "cilia", "fig": 6}, {"body": 10, "word": "GFP-GPI", "fig": 7}, {"body": 17, "word": "excluded", "fig": 4}, {"body": 12, "word": "expressing", "fig": 5}, {"body": 8, "word": "fixed", "fig": 6}, {"body": 6, "word": "live", "fig": 8}, {"body": 22, "word": "A", "fig": 2}, {"body": 11, "word": "C", "fig": 3}, {"body": 32, "word": "ciliary", "fig": 1}, {"body": 8, "word": "In", "fig": 4}, {"body": 29, "word": "primary", "fig": 1}, {"body": 7, "word": "d", "fig": 4}, {"body": 14, "word": "B", "fig": 2}, {"body": 12, "word": "Cells", "fig": 2}, {"body": 6, "word": "seeding", "fig": 4}, {"body": 8, "word": "filters", "fig": 2}, {"body": 16, "word": "also", "fig": 1}, {"body": 8, "word": "E", "fig": 2}, {"body": 15, "word": "found", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 14, "word": "MDCK", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 4, "word": "GFP-positive", "fig": 3}, {"body": 4, "word": "contrast", "fig": 3}, {"body": 6, "word": "appearance", "fig": 2}, {"body": 11, "word": "GFP", "fig": 1}, {"body": 5, "word": "show", "fig": 2}, {"body": 10, "word": "similar", "fig": 1}, {"body": 10, "word": "D", "fig": 1}, {"body": 9, "word": "shown", "fig": 1}, {"body": 9, "word": "create", "fig": 1}, {"body": 2, "word": "image", "fig": 4}, {"body": 4, "word": "two", "fig": 2}, {"body": 7, "word": "could", "fig": 1}, {"body": 3, "word": "scored", "fig": 2}, {"body": 3, "word": "identified", "fig": 2}, {"body": 3, "word": "tubulin", "fig": 2}, {"body": 5, "word": "fraction", "fig": 1}, {"body": 2, "word": "stained", "fig": 2}, {"body": 4, "word": "fixation", "fig": 1}, {"body": 4, "word": "day", "fig": 1}, {"body": 2, "word": "microscope", "fig": 2}, {"body": 2, "word": "antiacetylated", "fig": 2}, {"body": 2, "word": "imaged", "fig": 2}, {"body": 4, "word": "Live", "fig": 1}, {"body": 2, "word": "bottom", "fig": 2}, {"body": 1, "word": "Images", "fig": 4}, {"body": 4, "word": "F", "fig": 1}, {"body": 3, "word": "represent", "fig": 1}, {"body": 3, "word": "zoom", "fig": 1}, {"body": 3, "word": "appeared", "fig": 1}, {"body": 1, "word": "top", "fig": 3}, {"body": 3, "word": "digital", "fig": 1}, {"body": 1, "word": "identical", "fig": 2}, {"body": 1, "word": "increased", "fig": 2}, {"body": 2, "word": "fields", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 1, "word": "ciliated", "fig": 2}, {"body": 2, "word": "standard", "fig": 1}, {"body": 2, "word": "extending", "fig": 1}, {"body": 2, "word": "confocal", "fig": 1}, {"body": 1, "word": "collected", "fig": 2}, {"body": 2, "word": "present", "fig": 1}, {"body": 2, "word": "center", "fig": 1}, {"body": 1, "word": "z", "fig": 2}, {"body": 1, "word": "projections", "fig": 2}, {"body": 2, "word": "lower", "fig": 1}, {"body": 2, "word": "five", "fig": 1}, {"body": 1, "word": "numbers", "fig": 1}, {"body": 1, "word": "zone", "fig": 1}, {"body": 1, "word": "phalloidin", "fig": 1}, {"body": 1, "word": "brightness", "fig": 1}, {"body": 1, "word": "detected", "fig": 1}, {"body": 1, "word": "methods", "fig": 1}, {"body": 1, "word": "many", "fig": 1}, {"body": 1, "word": "Cilia", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig3.jpg", "caption": "CMD exclusion of GFP-PODXL is dependent on NHERF1. (A) NHERF1 was knocked down in GFP-PODXL cells (NHERF1 shRNA) using a retroviral shRNA system. Control cells expressing GFP-PODXL (vector) were retrovirally transduced with a puromycin resistance plasmid without an shRNA sequence. Cell lysates were blotted with anti-NHERF1 and antiezrin antibodies. Molecular mass is indicated in kilodaltons. (B) Live imaging of cells 4 d after seeding revealed that control cells (vector) exclude GFP-PODXL from the CMD but NHERF1 shRNA cells do not. Exclusion was quantified as in Fig. 1 C, and the percentage of cells excluding GFP-PODXL from the CMD appears on each image. 148/230 control cells (vector) excluded GFP-PODXL from the CMD, whereas very few cells expressing NHERF1 shRNA (8/186) excluded GFP-PODXL. Images were collected with identical microscope settings to Fig. 1 C. (C) Knocking down NHERF1 allowed GFP-PODXL to enter primary cilia. Cells were imaged live 12 d after seeding on filters. (top row) Z stacks of the apical membrane of control (vector) or NHERF1 shRNA live cells expressing GFP-PODXL were projected into a single image. Images were collected with identical microscope settings to Fig. 1 C, but at lower digital zoom. (bottom row) Single confocal sections above the apical membrane were taken from the z stacks in the top row, and image brightness was increased. Visible cilia are labeled with arrowheads. (D) 12 d after seeding, NHERF1 shRNA and control cells (vector) were fixed and stained with phalloidin and antiacetylated tubulin. GFP-PODXL is found in the CMD of NHERF1 shRNA cells, but actin is still excluded from the CMD, and primary cilia appear to grow normally. (E) 100/214 control cells (vector) had a cilium detected by antiacetylated tubulin after fixation, whereas only 15/208 live cells had a GFP-PODXL\u2013positive cilium. After NHERF1 knockdown, similar numbers of cilia could be detected using each method (74/194 fixed and 57/145 live). Images in B and D are projections of z stacks. Error bars represent standard deviation between experiments. Bars, 10 \u00b5m.", "co_occurrence": [{"body": 60, "word": "cells", "fig": 13}, {"body": 70, "word": "CMD", "fig": 6}, {"body": 39, "word": "NHERF1", "fig": 10}, {"body": 30, "word": "GFP-PODXL", "fig": 10}, {"body": 82, "word": "membrane", "fig": 2}, {"body": 46, "word": "Fig", "fig": 3}, {"body": 67, "word": "cilium", "fig": 2}, {"body": 45, "word": "apical", "fig": 2}, {"body": 29, "word": "primary", "fig": 2}, {"body": 14, "word": "cilia", "fig": 4}, {"body": 17, "word": "excluded", "fig": 3}, {"body": 12, "word": "expressing", "fig": 3}, {"body": 11, "word": "C", "fig": 3}, {"body": 4, "word": "shRNA", "fig": 8}, {"body": 28, "word": "exclusion", "fig": 1}, {"body": 14, "word": "using", "fig": 2}, {"body": 14, "word": "B", "fig": 2}, {"body": 4, "word": "vector", "fig": 6}, {"body": 6, "word": "live", "fig": 4}, {"body": 22, "word": "A", "fig": 1}, {"body": 7, "word": "d", "fig": 3}, {"body": 10, "word": "D", "fig": 2}, {"body": 4, "word": "control", "fig": 5}, {"body": 6, "word": "seeding", "fig": 3}, {"body": 8, "word": "fixed", "fig": 2}, {"body": 15, "word": "found", "fig": 1}, {"body": 12, "word": "Cells", "fig": 1}, {"body": 10, "word": "actin", "fig": 1}, {"body": 10, "word": "similar", "fig": 1}, {"body": 8, "word": "filters", "fig": 1}, {"body": 8, "word": "sequence", "fig": 1}, {"body": 8, "word": "E", "fig": 1}, {"body": 8, "word": "knockdown", "fig": 1}, {"body": 7, "word": "could", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 2, "word": "image", "fig": 3}, {"body": 3, "word": "tubulin", "fig": 2}, {"body": 3, "word": "whereas", "fig": 2}, {"body": 5, "word": "dependent", "fig": 1}, {"body": 2, "word": "microscope", "fig": 2}, {"body": 2, "word": "antiacetylated", "fig": 2}, {"body": 4, "word": "fixation", "fig": 1}, {"body": 4, "word": "appear", "fig": 1}, {"body": 4, "word": "Live", "fig": 1}, {"body": 4, "word": "enter", "fig": 1}, {"body": 3, "word": "represent", "fig": 1}, {"body": 3, "word": "zoom", "fig": 1}, {"body": 3, "word": "appears", "fig": 1}, {"body": 1, "word": "Images", "fig": 3}, {"body": 3, "word": "Cell", "fig": 1}, {"body": 3, "word": "After", "fig": 1}, {"body": 3, "word": "digital", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 1, "word": "identical", "fig": 2}, {"body": 2, "word": "imaged", "fig": 1}, {"body": 2, "word": "bottom", "fig": 1}, {"body": 2, "word": "standard", "fig": 1}, {"body": 2, "word": "imaging", "fig": 1}, {"body": 2, "word": "confocal", "fig": 1}, {"body": 1, "word": "top", "fig": 2}, {"body": 2, "word": "system", "fig": 1}, {"body": 1, "word": "collected", "fig": 2}, {"body": 2, "word": "lower", "fig": 1}, {"body": 1, "word": "z", "fig": 2}, {"body": 1, "word": "detected", "fig": 2}, {"body": 2, "word": "revealed", "fig": 1}, {"body": 1, "word": "puromycin", "fig": 1}, {"body": 1, "word": "phalloidin", "fig": 1}, {"body": 1, "word": "brightness", "fig": 1}, {"body": 1, "word": "projections", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "retroviral", "fig": 1}, {"body": 1, "word": "transduced", "fig": 1}, {"body": 1, "word": "plasmid", "fig": 1}, {"body": 1, "word": "knocked", "fig": 1}, {"body": 1, "word": "antiezrin", "fig": 1}, {"body": 1, "word": "numbers", "fig": 1}, {"body": 1, "word": "allowed", "fig": 1}, {"body": 1, "word": "exclude", "fig": 1}, {"body": 1, "word": "increased", "fig": 1}, {"body": 1, "word": "anti-NHERF1", "fig": 1}, {"body": 1, "word": "normally", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig4.jpg", "caption": "GFP-PODXL mobility is increased by PDZ-binding motif deletion or NHERF1 knockdown. (A) FRAP measurements on cells 4 d after seeding show that the lateral mobility of GFP-PODXL was increased either by deletion of the last four amino acids of its cytoplasmic tail (GFP-PODXL\u03944) or by knockdown of NHERF1 (NHERF1 shRNA). GFP-GPI is thought to freely diffuse in the membrane and recovers faster than the GFP-PODXL constructs. (B) FRAP measurements taken 120 s after photobleaching show a significant difference in FRAP between GFP-PODXL and GFP-PODXL\u03944 (P < 0.005). A similar difference was found between FRAP of GFP-PODXL after shRNA knockdown of NHERF1 and vector controls (P < 0.005). Values are means of FRAP measurements from 10 cells for GFP-GPI, GFP-PODXL, GFP-PODXL\u03944, and GFP-GPI and 8 cells for vector and NHERF1 shRNA. Error bars represent standard deviation between measurements.", "co_occurrence": [{"body": 39, "word": "NHERF1", "fig": 5}, {"body": 30, "word": "GFP-PODXL", "fig": 6}, {"body": 60, "word": "cells", "fig": 3}, {"body": 82, "word": "membrane", "fig": 1}, {"body": 11, "word": "FRAP", "fig": 5}, {"body": 22, "word": "A", "fig": 2}, {"body": 10, "word": "GFP-GPI", "fig": 3}, {"body": 9, "word": "GFP-PODXL\u03944", "fig": 3}, {"body": 8, "word": "knockdown", "fig": 3}, {"body": 10, "word": "mobility", "fig": 2}, {"body": 18, "word": "tail", "fig": 1}, {"body": 15, "word": "cytoplasmic", "fig": 1}, {"body": 15, "word": "found", "fig": 1}, {"body": 14, "word": "B", "fig": 1}, {"body": 14, "word": "constructs", "fig": 1}, {"body": 3, "word": "measurements", "fig": 4}, {"body": 4, "word": "shRNA", "fig": 3}, {"body": 10, "word": "motif", "fig": 1}, {"body": 5, "word": "show", "fig": 2}, {"body": 10, "word": "PDZ-binding", "fig": 1}, {"body": 10, "word": "similar", "fig": 1}, {"body": 4, "word": "vector", "fig": 2}, {"body": 7, "word": "amino", "fig": 1}, {"body": 7, "word": "d", "fig": 1}, {"body": 7, "word": "either", "fig": 1}, {"body": 6, "word": "seeding", "fig": 1}, {"body": 6, "word": "last", "fig": 1}, {"body": 6, "word": "acids", "fig": 1}, {"body": 5, "word": "four", "fig": 1}, {"body": 5, "word": "lateral", "fig": 1}, {"body": 2, "word": "deletion", "fig": 2}, {"body": 4, "word": "freely", "fig": 1}, {"body": 3, "word": "represent", "fig": 1}, {"body": 1, "word": "increased", "fig": 2}, {"body": 2, "word": "standard", "fig": 1}, {"body": 2, "word": "thought", "fig": 1}, {"body": 1, "word": "means", "fig": 1}, {"body": 1, "word": "Values", "fig": 1}, {"body": 1, "word": "diffuse", "fig": 1}, {"body": 1, "word": "photobleaching", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig5.jpg", "caption": "CEACAM1 can be excluded from the CMD by adding tails from NHERF1-binding proteins. (A) GFP-CEACAM1\u2013based constructs differ in their exclusion from the CMD 4 d after seeding. Images were collected with identical microscope settings to Fig. 1 C. (B) Cells were scored for GFP exclusion from the CMD as in Fig. 1 C. Only 5/169 cells appeared to exclude GFP-CEACAM1 from the CMD, and GFP-CEACAM1-DTHL (13/135), GFP-CEACAM1-PODXL\u03944 (10/237), and GFP-CEACAM1-CFTR\u03944 (12/148) were similar, whereas GFP-CEACAM1-PODXL (146/253) and GFP-CEACAM1-CFTR (94/111) were excluded from the CMD in most cells. (C) FRAP measurements indicated that GFP-CEACAM1 constructs that were excluded from the CMD were also less mobile in the apical membrane. (D) There was no significant difference between FRAP measurements of GFP-CEACAM1 and GFP-CEACAM1-DTHL after 120 s; however, there were significant differences between GFP-CEACAM1-PODXL and GFP-CEACAM1-PODXL\u03944, GFP-CEACAM1-CFTR and GFP-CEACAM1-CFTR\u03944, and GFP-CEACAM1-CBP and GFP-CEACAM1-CBP\u03944 (P < 0.005). (C and D) Each FRAP value is a mean of measurements from eight cells. Error bars represent standard deviation between measurements. (E) Cells expressing GFP constructs were grown on tissue culture plates and lysed when confluent. GFP constructs were immunoprecipitated from cell lysates, eluted, and Western blotted. Membranes were probed with anti-NHERF1 and either anti-GFP or anti-gp135 antibodies. The arrow to the left of the podocalyxin blot points to the GFP-PODXL band; the large band below is endogenous podocalyxin. GFP-PODXL and GFP-PODXL\u03944 lysate lanes represent 2% of the lysate used in the IP, and CEACAM1 lysate blots represent 1% of the lysate used in the IP. Molecular mass is indicated in kilodaltons. (F) Cells expressing high levels of GFP-CEACAM1-PODXL or GFP-CEACAM1-PODXL\u03944 were grown on filters for 4 d, methanol fixed, and stained for endogenous podocalyxin with anti-gp135 antibody. Podocalyxin did not appear to be excluded from the CMD in cells expressing GFP-CEACAM1-PODXL, whereas podocalyxin distribution was unaffected by expression of GFP-CEACAM1-PODXL\u03944. (G) CMD exclusion of endogenous podocalyxin was scored in cells expressing high levels of GFP-CEACAM1-PODXL or GFP-CEACAM1-PODXL\u03944 and in neighboring cells not expressing a GFP construct. Only 34/197 cells expressing GFP-CEACAM1-PODXL appeared to be excluding endogenous podocalyxin from the CMD, whereas 131/143 neighboring cells were excluding podocalyxin. The fraction of cells excluding podocalyxin was similar between those expressing GFP-CEACAM1-PODXL\u03944 (119/143) and neighbors (128/149). Images are projections of z stacks. Error bars represent standard deviation between experiments, except in D. Bars, 10 \u00b5m.", "co_occurrence": [{"body": 70, "word": "CMD", "fig": 9}, {"body": 60, "word": "cells", "fig": 9}, {"body": 34, "word": "podocalyxin", "fig": 8}, {"body": 46, "word": "Fig", "fig": 2}, {"body": 28, "word": "exclusion", "fig": 3}, {"body": 12, "word": "expressing", "fig": 7}, {"body": 82, "word": "membrane", "fig": 1}, {"body": 12, "word": "GFP-CEACAM1-PODXL", "fig": 6}, {"body": 17, "word": "excluded", "fig": 4}, {"body": 30, "word": "GFP-PODXL", "fig": 2}, {"body": 19, "word": "GFP-CEACAM1", "fig": 3}, {"body": 14, "word": "constructs", "fig": 4}, {"body": 45, "word": "apical", "fig": 1}, {"body": 11, "word": "endogenous", "fig": 4}, {"body": 11, "word": "GFP", "fig": 4}, {"body": 19, "word": "The", "fig": 2}, {"body": 12, "word": "Cells", "fig": 3}, {"body": 11, "word": "FRAP", "fig": 3}, {"body": 33, "word": "proteins", "fig": 1}, {"body": 5, "word": "GFP-CEACAM1-PODXL\u03944", "fig": 6}, {"body": 15, "word": "used", "fig": 2}, {"body": 11, "word": "C", "fig": 2}, {"body": 22, "word": "A", "fig": 1}, {"body": 10, "word": "D", "fig": 2}, {"body": 10, "word": "similar", "fig": 2}, {"body": 10, "word": "levels", "fig": 2}, {"body": 18, "word": "cell", "fig": 1}, {"body": 16, "word": "also", "fig": 1}, {"body": 7, "word": "d", "fig": 2}, {"body": 14, "word": "B", "fig": 1}, {"body": 7, "word": "high", "fig": 2}, {"body": 3, "word": "represent", "fig": 4}, {"body": 3, "word": "measurements", "fig": 4}, {"body": 11, "word": "distribution", "fig": 1}, {"body": 5, "word": "CEACAM1", "fig": 2}, {"body": 10, "word": "construct", "fig": 1}, {"body": 9, "word": "GFP-PODXL\u03944", "fig": 1}, {"body": 3, "word": "whereas", "fig": 3}, {"body": 8, "word": "filters", "fig": 1}, {"body": 8, "word": "fixed", "fig": 1}, {"body": 8, "word": "E", "fig": 1}, {"body": 4, "word": "IP", "fig": 2}, {"body": 8, "word": "expression", "fig": 1}, {"body": 7, "word": "either", "fig": 1}, {"body": 7, "word": "anti-GFP", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 3, "word": "GFP-CEACAM1-CFTR", "fig": 2}, {"body": 3, "word": "scored", "fig": 2}, {"body": 6, "word": "culture", "fig": 1}, {"body": 6, "word": "antibody", "fig": 1}, {"body": 3, "word": "appeared", "fig": 2}, {"body": 3, "word": "GFP-CEACAM1-DTHL", "fig": 2}, {"body": 6, "word": "seeding", "fig": 1}, {"body": 3, "word": "GFP-CEACAM1-CFTR\u03944", "fig": 2}, {"body": 6, "word": "mobile", "fig": 1}, {"body": 5, "word": "Podocalyxin", "fig": 1}, {"body": 5, "word": "fraction", "fig": 1}, {"body": 4, "word": "appear", "fig": 1}, {"body": 4, "word": "however", "fig": 1}, {"body": 2, "word": "standard", "fig": 2}, {"body": 1, "word": "lysate", "fig": 4}, {"body": 2, "word": "grown", "fig": 2}, {"body": 4, "word": "F", "fig": 1}, {"body": 2, "word": "band", "fig": 2}, {"body": 3, "word": "less", "fig": 1}, {"body": 3, "word": "adding", "fig": 1}, {"body": 3, "word": "GFP-CEACAM1-CBP", "fig": 1}, {"body": 3, "word": "Western", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "microscope", "fig": 1}, {"body": 1, "word": "Only", "fig": 2}, {"body": 2, "word": "G", "fig": 1}, {"body": 2, "word": "confluent", "fig": 1}, {"body": 1, "word": "Images", "fig": 2}, {"body": 2, "word": "NHERF1-binding", "fig": 1}, {"body": 1, "word": "neighboring", "fig": 2}, {"body": 2, "word": "Membranes", "fig": 1}, {"body": 2, "word": "GFP-CEACAM1-CBP\u03944", "fig": 1}, {"body": 1, "word": "neighbors", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "identical", "fig": 1}, {"body": 1, "word": "large", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "immunoprecipitated", "fig": 1}, {"body": 1, "word": "anti-NHERF1", "fig": 1}, {"body": 1, "word": "collected", "fig": 1}, {"body": 1, "word": "z", "fig": 1}, {"body": 1, "word": "eluted", "fig": 1}, {"body": 1, "word": "projections", "fig": 1}, {"body": 1, "word": "tissue", "fig": 1}, {"body": 1, "word": "exclude", "fig": 1}, {"body": 1, "word": "methanol", "fig": 1}, {"body": 1, "word": "plates", "fig": 1}, {"body": 1, "word": "eight", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig6.jpg", "caption": "CEACAM1 can be excluded from the CMD independently of NHERF1 by adding domains that bind more directly to the cytoskeleton. (A) Addition of NHERF1\u2019s ERM-binding domain or ezrin\u2019s actin-binding domain is sufficient to exclude GFP-CEACAM1 from the CMD 4 d after seeding. NHERF1 was knocked down in GFP-CEACAM1-NHERF1 cells (GFP-CEACAM1-NHERF1 shRNA), and exclusion was similar to control cells (GFP-CEACAM1-NHERF1 vector). Images were collected with identical microscope settings to Fig. 1 C. (B) GFP-CEACAM1-NHERF1 shRNA and GFP-CEACAM1-NHERF1 vector cell lysates were blotted with anti-NHERF1 and antiezrin antibodies. Molecular mass is indicated in kilodaltons. (C) Cells were scored for GFP exclusion from the CMD as in Fig. 1 C. 113/199 cells expressing GFP-CEACAM1-NHERF1 appeared to exclude the construct from the CMD, and similar results were seen for GFP-CEACAM1-ezrin (105/185). After shRNA knockdown of NHERF1, GFP-CEACAM1-NHERF1 was excluded from the CMD in 193/393 cells, a similar ratio to cells only treated with vector (125/232). Error bars represent standard deviation between experiments. (D) FRAP measurements indicated that GFP-CEACAM1 was less mobile in the apical membrane after addition of an ERM- or actin-binding domain, and this was independent of NHERF1 knockdown. (E) There are significant differences in the FRAP measurements between GFP-CEACAM1 and both GFP-CEACAM1-NHERF1 (**, P < 0.005) and GFP-CEACAM1-ezrin (*, P < 0.05) after 120 s. No significant difference was seen in the FRAP of GFP-CEACAM1-NHERF1 after shRNA knockdown of NHERF1. GFP-CEACAM1 data are from Fig. 5 and are included as a reference. (D and E) Each FRAP value is a mean of measurements from eight cells. Error bars represent standard deviation between measurements. Images are projections of z stacks. Bars, 10 \u00b5m.", "co_occurrence": [{"body": 60, "word": "cells", "fig": 6}, {"body": 70, "word": "CMD", "fig": 5}, {"body": 39, "word": "NHERF1", "fig": 5}, {"body": 46, "word": "Fig", "fig": 3}, {"body": 82, "word": "membrane", "fig": 1}, {"body": 19, "word": "GFP-CEACAM1", "fig": 4}, {"body": 20, "word": "domain", "fig": 3}, {"body": 28, "word": "exclusion", "fig": 2}, {"body": 6, "word": "GFP-CEACAM1-NHERF1", "fig": 9}, {"body": 45, "word": "apical", "fig": 1}, {"body": 11, "word": "FRAP", "fig": 4}, {"body": 17, "word": "excluded", "fig": 2}, {"body": 10, "word": "similar", "fig": 3}, {"body": 8, "word": "knockdown", "fig": 3}, {"body": 22, "word": "A", "fig": 1}, {"body": 10, "word": "D", "fig": 2}, {"body": 18, "word": "cell", "fig": 1}, {"body": 4, "word": "shRNA", "fig": 4}, {"body": 8, "word": "E", "fig": 2}, {"body": 14, "word": "B", "fig": 1}, {"body": 12, "word": "Cells", "fig": 1}, {"body": 4, "word": "vector", "fig": 3}, {"body": 3, "word": "measurements", "fig": 4}, {"body": 12, "word": "expressing", "fig": 1}, {"body": 11, "word": "C", "fig": 1}, {"body": 11, "word": "GFP", "fig": 1}, {"body": 10, "word": "construct", "fig": 1}, {"body": 9, "word": "addition", "fig": 1}, {"body": 4, "word": "actin-binding", "fig": 2}, {"body": 7, "word": "d", "fig": 1}, {"body": 3, "word": "represent", "fig": 2}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 6, "word": "seeding", "fig": 1}, {"body": 6, "word": "sufficient", "fig": 1}, {"body": 6, "word": "ERM-binding", "fig": 1}, {"body": 6, "word": "mobile", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "domains", "fig": 1}, {"body": 5, "word": "CEACAM1", "fig": 1}, {"body": 5, "word": "bind", "fig": 1}, {"body": 2, "word": "standard", "fig": 2}, {"body": 4, "word": "control", "fig": 1}, {"body": 2, "word": "seen", "fig": 2}, {"body": 2, "word": "GFP-CEACAM1-ezrin", "fig": 2}, {"body": 3, "word": "adding", "fig": 1}, {"body": 3, "word": "less", "fig": 1}, {"body": 3, "word": "scored", "fig": 1}, {"body": 3, "word": "appeared", "fig": 1}, {"body": 3, "word": "NHERF1\u2019s", "fig": 1}, {"body": 3, "word": "cytoskeleton", "fig": 1}, {"body": 3, "word": "After", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "microscope", "fig": 1}, {"body": 1, "word": "Images", "fig": 2}, {"body": 2, "word": "directly", "fig": 1}, {"body": 2, "word": "ERM-", "fig": 1}, {"body": 1, "word": "exclude", "fig": 2}, {"body": 2, "word": "data", "fig": 1}, {"body": 1, "word": "identical", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 1}, {"body": 1, "word": "collected", "fig": 1}, {"body": 1, "word": "knocked", "fig": 1}, {"body": 1, "word": "z", "fig": 1}, {"body": 1, "word": "antiezrin", "fig": 1}, {"body": 1, "word": "projections", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "eight", "fig": 1}, {"body": 1, "word": "anti-NHERF1", "fig": 1}, {"body": 1, "word": "included", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig7.jpg", "caption": "Smo can be retained outside the CMD by association with the retention matrix. Live cells expressing GFP-Smo-NHERF1-FR or GFP-Smo-NHERF1 were labeled with Alexa Fluor 647 anti-GFP on the apical side (surface label). (A) XY projections of cells expressing the ERM binding\u2013deficient GFP-Smo-NHERF1-FR exhibit bright spots corresponding to cilia. Pairs of spots are concentrations of GFP at the base and tip of a single cilium. In contrast, Smo fused to a NHERF1 domain capable of binding ERMs (GFP-Smo-NHERF1) was localized over the entire apical plasma membrane outside the CMD. Bar, 10 \u00b5m. (B) XZ sections of cells expressing GFP-Smo-NHERF1-FR reveal cilia with an uneven distribution of GFP. Surface labeling shows GFP-Smo-NHERF1 across the apical membrane. Image brightness was increased in B. Bar, 5 \u00b5m.", "co_occurrence": [{"body": 60, "word": "cells", "fig": 3}, {"body": 82, "word": "membrane", "fig": 2}, {"body": 70, "word": "CMD", "fig": 2}, {"body": 45, "word": "apical", "fig": 3}, {"body": 67, "word": "cilium", "fig": 1}, {"body": 32, "word": "Smo", "fig": 2}, {"body": 39, "word": "NHERF1", "fig": 1}, {"body": 12, "word": "expressing", "fig": 3}, {"body": 14, "word": "cilia", "fig": 2}, {"body": 14, "word": "B", "fig": 2}, {"body": 24, "word": "retention", "fig": 1}, {"body": 11, "word": "outside", "fig": 2}, {"body": 22, "word": "A", "fig": 1}, {"body": 11, "word": "GFP", "fig": 2}, {"body": 20, "word": "domain", "fig": 1}, {"body": 19, "word": "plasma", "fig": 1}, {"body": 4, "word": "GFP-Smo-NHERF1", "fig": 3}, {"body": 11, "word": "distribution", "fig": 1}, {"body": 3, "word": "GFP-Smo-NHERF1-FR", "fig": 3}, {"body": 8, "word": "base", "fig": 1}, {"body": 8, "word": "retained", "fig": 1}, {"body": 8, "word": "surface", "fig": 1}, {"body": 8, "word": "In", "fig": 1}, {"body": 7, "word": "anti-GFP", "fig": 1}, {"body": 7, "word": "matrix", "fig": 1}, {"body": 5, "word": "corresponding", "fig": 1}, {"body": 5, "word": "binding", "fig": 1}, {"body": 4, "word": "association", "fig": 1}, {"body": 4, "word": "Live", "fig": 1}, {"body": 4, "word": "contrast", "fig": 1}, {"body": 4, "word": "Alexa", "fig": 1}, {"body": 4, "word": "Fluor", "fig": 1}, {"body": 3, "word": "across", "fig": 1}, {"body": 3, "word": "ERMs", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 2, "word": "ERM", "fig": 1}, {"body": 1, "word": "bright", "fig": 1}, {"body": 1, "word": "localized", "fig": 1}, {"body": 1, "word": "increased", "fig": 1}, {"body": 1, "word": "reveal", "fig": 1}, {"body": 1, "word": "brightness", "fig": 1}, {"body": 1, "word": "side", "fig": 1}, {"body": 1, "word": "projections", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "fused", "fig": 1}, {"body": 1, "word": "Image", "fig": 1}, {"body": 1, "word": "tip", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082196/bin/JCB_201009001_RGB_Fig8.jpg", "caption": "GFP-CEACAM1 is concentrated in the primary cilium after addition of a microtubule-binding domain. (A) Live cells expressing GFP-CEACAM1-tau were imaged 4 d after seeding. The image is a projection of a z stack and was collected with identical microscope settings to Fig. 1 C. Bar, 10 \u00b5m. (B) FRAP measurements of GFP-CEACAM1-tau 4 d after seeding show mobility similar to GFP-CEACAM1. GFP-CEACAM1 data are from Fig. 5 and are included as a reference. Each FRAP value is a mean of measurements from eight cells. Error bars represent standard deviation between measurements. (C) XZ sections of cells 12 d after seeding show GFP-CEACAM1-tau enriched in the cilium relative to the apical membrane, whereas GFP-CEACAM1 is evenly distributed. Bar, 3 \u00b5m.", "co_occurrence": [{"body": 60, "word": "cells", "fig": 3}, {"body": 67, "word": "cilium", "fig": 2}, {"body": 46, "word": "Fig", "fig": 2}, {"body": 82, "word": "membrane", "fig": 1}, {"body": 19, "word": "GFP-CEACAM1", "fig": 4}, {"body": 45, "word": "apical", "fig": 1}, {"body": 29, "word": "primary", "fig": 1}, {"body": 22, "word": "A", "fig": 1}, {"body": 11, "word": "FRAP", "fig": 2}, {"body": 7, "word": "GFP-CEACAM1-tau", "fig": 3}, {"body": 7, "word": "d", "fig": 3}, {"body": 20, "word": "domain", "fig": 1}, {"body": 19, "word": "The", "fig": 1}, {"body": 6, "word": "seeding", "fig": 3}, {"body": 14, "word": "B", "fig": 1}, {"body": 12, "word": "expressing", "fig": 1}, {"body": 11, "word": "C", "fig": 1}, {"body": 5, "word": "show", "fig": 2}, {"body": 10, "word": "mobility", "fig": 1}, {"body": 10, "word": "similar", "fig": 1}, {"body": 9, "word": "addition", "fig": 1}, {"body": 3, "word": "measurements", "fig": 3}, {"body": 4, "word": "Live", "fig": 1}, {"body": 4, "word": "enriched", "fig": 1}, {"body": 4, "word": "relative", "fig": 1}, {"body": 3, "word": "whereas", "fig": 1}, {"body": 3, "word": "distributed", "fig": 1}, {"body": 3, "word": "represent", "fig": 1}, {"body": 2, "word": "imaged", "fig": 1}, {"body": 2, "word": "data", "fig": 1}, {"body": 1, "word": "\u00b5m", "fig": 2}, {"body": 2, "word": "evenly", "fig": 1}, {"body": 2, "word": "image", "fig": 1}, {"body": 2, "word": "standard", "fig": 1}, {"body": 2, "word": "concentrated", "fig": 1}, {"body": 2, "word": "microscope", "fig": 1}, {"body": 2, "word": "microtubule-binding", "fig": 1}, {"body": 1, "word": "identical", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "stack", "fig": 1}, {"body": 1, "word": "collected", "fig": 1}, {"body": 1, "word": "eight", "fig": 1}, {"body": 1, "word": "included", "fig": 1}, {"body": 1, "word": "z", "fig": 1}]}], "3459986": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g001.jpg", "caption": "Utx mutant alleles. (A) Schematics of mouse mutations in Utx. Included are annotations and locations of where the protein would be mutated. Two Utx mutant alleles included a gene trap in intron 3 (XUtxGT1) and a gene trap/floxed exon 3 (XUtxGT2fl). A UTX protein annotation is illustrated at the top to indicate to positions of Utx alleles. A germline Cre recombinase deleted exon 3 in the XUtxGT2fl background to create XUtxGT2\u0394. Additionally, the gene trap of XUtxGT2fl was excised with Flp recombinase to create a standard floxed exon 3 (XUtxfl) and Cre recombination created XUtx\u0394. (B) Western blotting of E18.5 liver demonstrates a complete loss of UTX in XUtxGT1 YUty+ lysates. RbBP5 was used as a loading control. (C) Western blotting of E10.5 whole embryo demonstrates a complete loss of UTX in XUtx\u0394 YUty+ and XUtx\u0394 XUtx\u0394 lysates. RbBP5 was used as a loading control. (D) Western blotting of E12.5 primary MEFs demonstrates a reduction of UTX in XUtxGT2fl YUty+ and XUtxGT2fl XUtxGT2fl lysates. RbBP5 was used as a loading control.", "co_occurrence": [{"body": 97, "word": "UTX", "fig": 4}, {"body": 83, "word": "Utx", "fig": 4}, {"body": 22, "word": "XUtxGT2fl", "fig": 6}, {"body": 31, "word": "gene", "fig": 3}, {"body": 24, "word": "YUty+", "fig": 3}, {"body": 29, "word": "XUtxGT1", "fig": 2}, {"body": 26, "word": "mutant", "fig": 2}, {"body": 40, "word": "mouse", "fig": 1}, {"body": 13, "word": "control", "fig": 3}, {"body": 12, "word": "A", "fig": 3}, {"body": 11, "word": "alleles", "fig": 3}, {"body": 13, "word": "trap", "fig": 2}, {"body": 13, "word": "protein", "fig": 2}, {"body": 8, "word": "blotting", "fig": 3}, {"body": 8, "word": "exon", "fig": 3}, {"body": 12, "word": "loss", "fig": 2}, {"body": 22, "word": "XUtxGT2\u0394", "fig": 1}, {"body": 19, "word": "MEFs", "fig": 1}, {"body": 17, "word": "E10.5", "fig": 1}, {"body": 4, "word": "Western", "fig": 3}, {"body": 11, "word": "mutations", "fig": 1}, {"body": 11, "word": "E18.5", "fig": 1}, {"body": 10, "word": "reduction", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "intron", "fig": 1}, {"body": 2, "word": "demonstrates", "fig": 3}, {"body": 2, "word": "lysates", "fig": 3}, {"body": 6, "word": "E12.5", "fig": 1}, {"body": 5, "word": "XUtxfl", "fig": 1}, {"body": 4, "word": "Additionally", "fig": 1}, {"body": 4, "word": "background", "fig": 1}, {"body": 1, "word": "XUtx\u0394", "fig": 4}, {"body": 2, "word": "Cre", "fig": 2}, {"body": 3, "word": "embryo", "fig": 1}, {"body": 1, "word": "loading", "fig": 3}, {"body": 3, "word": "primary", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "deleted", "fig": 1}, {"body": 1, "word": "used", "fig": 3}, {"body": 2, "word": "Two", "fig": 1}, {"body": 1, "word": "recombinase", "fig": 2}, {"body": 1, "word": "create", "fig": 2}, {"body": 1, "word": "complete", "fig": 2}, {"body": 2, "word": "germline", "fig": 1}, {"body": 1, "word": "illustrated", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "created", "fig": 1}, {"body": 1, "word": "whole", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "would", "fig": 1}, {"body": 1, "word": "indicate", "fig": 1}, {"body": 1, "word": "mutated", "fig": 1}, {"body": 1, "word": "floxed", "fig": 1}, {"body": 1, "word": "recombination", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g002.jpg", "caption": "Hemizygous male Utx mutant mice are runted. (A) Hemizygous male Utx mutant mice are runted in size. Wild type male XUtx + Y+ mice are displayed next to hemizygous XUtxGT1 Y+ mice. (B) The hemizygous mice exhibit a smaller size throughout adulthood.", "co_occurrence": [{"body": 83, "word": "Utx", "fig": 2}, {"body": 14, "word": "mice", "fig": 5}, {"body": 27, "word": "hemizygous", "fig": 2}, {"body": 26, "word": "mutant", "fig": 2}, {"body": 15, "word": "male", "fig": 3}, {"body": 37, "word": "The", "fig": 1}, {"body": 29, "word": "XUtxGT1", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 5, "word": "Hemizygous", "fig": 2}, {"body": 5, "word": "Y+", "fig": 2}, {"body": 7, "word": "throughout", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 5, "word": "smaller", "fig": 1}, {"body": 5, "word": "type", "fig": 1}, {"body": 2, "word": "size", "fig": 2}, {"body": 2, "word": "runted", "fig": 2}, {"body": 3, "word": "adulthood", "fig": 1}, {"body": 1, "word": "exhibit", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g003.jpg", "caption": "Homozygous female Utx mutant embryos have mid-gestational developmental delay. (A) Compared to controls (A-i and A-v), homozygous female E10.5 XUtxGT1 XUtxGT1 (A-ii) and XUtxGT2\u0394 XUtxGT2\u0394 (A-vi) embryos have some developmental delay including smaller size, underdeveloped hearts (white arrows), and open neural tube in the head (arrowheads). More severe embryos resemble the size and features of E9.5 embryos with cardiac abnormalities and peri-cardial edema (A-iii, vii, red arrows). Hemizygous male XUtxGT1 YUty+ embryos appear phenotypically normal at this stage (A-iv). The XUtxGT1 and XUtxGT2\u0394 alleles fail to complement as female XUtxGT1 XUtxGT2\u0394 embryos have identical phenotypes to homozygotes (A-viii). (B) At E10.5, homozygous XUtxGT1 XUtxGT1 female embryos exhibit either normal yolk sac vasculature with a reduction in red blood cells (B-ii) or have a completely pale yolk sac with unremodeled vascular plexus (B-iii).", "co_occurrence": [{"body": 29, "word": "embryos", "fig": 7}, {"body": 29, "word": "XUtxGT1", "fig": 7}, {"body": 22, "word": "XUtxGT2\u0394", "fig": 4}, {"body": 83, "word": "Utx", "fig": 1}, {"body": 20, "word": "homozygous", "fig": 2}, {"body": 37, "word": "The", "fig": 1}, {"body": 17, "word": "E10.5", "fig": 2}, {"body": 26, "word": "mutant", "fig": 1}, {"body": 24, "word": "YUty+", "fig": 1}, {"body": 12, "word": "developmental", "fig": 2}, {"body": 6, "word": "female", "fig": 4}, {"body": 23, "word": "cells", "fig": 1}, {"body": 15, "word": "male", "fig": 1}, {"body": 6, "word": "yolk", "fig": 2}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "alleles", "fig": 1}, {"body": 11, "word": "phenotypes", "fig": 1}, {"body": 10, "word": "homozygotes", "fig": 1}, {"body": 10, "word": "reduction", "fig": 1}, {"body": 5, "word": "sac", "fig": 2}, {"body": 5, "word": "delay", "fig": 2}, {"body": 5, "word": "normal", "fig": 2}, {"body": 8, "word": "hearts", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "cardiac", "fig": 1}, {"body": 3, "word": "red", "fig": 2}, {"body": 6, "word": "neural", "fig": 1}, {"body": 6, "word": "At", "fig": 1}, {"body": 5, "word": "identical", "fig": 1}, {"body": 5, "word": "smaller", "fig": 1}, {"body": 5, "word": "Hemizygous", "fig": 1}, {"body": 5, "word": "severe", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 4, "word": "phenotypically", "fig": 1}, {"body": 4, "word": "tube", "fig": 1}, {"body": 4, "word": "vii", "fig": 1}, {"body": 2, "word": "size", "fig": 2}, {"body": 4, "word": "mid-gestational", "fig": 1}, {"body": 3, "word": "either", "fig": 1}, {"body": 3, "word": "Homozygous", "fig": 1}, {"body": 3, "word": "completely", "fig": 1}, {"body": 1, "word": "arrows", "fig": 2}, {"body": 2, "word": "pale", "fig": 1}, {"body": 2, "word": "appear", "fig": 1}, {"body": 2, "word": "vascular", "fig": 1}, {"body": 2, "word": "features", "fig": 1}, {"body": 2, "word": "open", "fig": 1}, {"body": 1, "word": "edema", "fig": 1}, {"body": 1, "word": "including", "fig": 1}, {"body": 1, "word": "B-iii", "fig": 1}, {"body": 1, "word": "plexus", "fig": 1}, {"body": 1, "word": "underdeveloped", "fig": 1}, {"body": 1, "word": "vasculature", "fig": 1}, {"body": 1, "word": "complement", "fig": 1}, {"body": 1, "word": "exhibit", "fig": 1}, {"body": 1, "word": "A-ii", "fig": 1}, {"body": 1, "word": "A-iv", "fig": 1}, {"body": 1, "word": "white", "fig": 1}, {"body": 1, "word": "head", "fig": 1}, {"body": 1, "word": "abnormalities", "fig": 1}, {"body": 1, "word": "B-ii", "fig": 1}, {"body": 1, "word": "A-iii", "fig": 1}, {"body": 1, "word": "E9.5", "fig": 1}, {"body": 1, "word": "peri-cardial", "fig": 1}, {"body": 1, "word": "blood", "fig": 1}, {"body": 1, "word": "unremodeled", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g004.jpg", "caption": "UTX and UTY have essential, redundant functions in embryonic development. (A) Schematic of mouse mutation in Uty. The Uty gene trap YUtyGT is located in intron 4. Protein annotation is illustrated at the top to denote the location of the gene trap within the Uty coding sequence. (B) Quantitative RT-PCR downstream of the gene trap (exon 15) from tail RNA of X+ YUtyGT mice demonstrates essentially no mutant RNA. (C) XUtxGT2\u0394 YUtyGT males (C-iii, iv) have identical phenotypes to XUtxGT2\u0394 XUtxGT2\u0394 females (Figure 3A-vi, vii). Arrowheads denote open neural tube in the head, while white and red arrows denote moderate and more severe cardiac phenotypes.", "co_occurrence": [{"body": 102, "word": "UTY", "fig": 1}, {"body": 97, "word": "UTX", "fig": 1}, {"body": 31, "word": "gene", "fig": 3}, {"body": 26, "word": "Uty", "fig": 3}, {"body": 73, "word": "Figure", "fig": 1}, {"body": 22, "word": "XUtxGT2\u0394", "fig": 3}, {"body": 15, "word": "YUtyGT", "fig": 3}, {"body": 40, "word": "mouse", "fig": 1}, {"body": 13, "word": "trap", "fig": 3}, {"body": 37, "word": "The", "fig": 1}, {"body": 31, "word": "embryonic", "fig": 1}, {"body": 26, "word": "mutant", "fig": 1}, {"body": 25, "word": "males", "fig": 1}, {"body": 22, "word": "development", "fig": 1}, {"body": 11, "word": "phenotypes", "fig": 2}, {"body": 15, "word": "females", "fig": 1}, {"body": 14, "word": "mice", "fig": 1}, {"body": 7, "word": "RNA", "fig": 2}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "essential", "fig": 1}, {"body": 10, "word": "RT-PCR", "fig": 1}, {"body": 8, "word": "exon", "fig": 1}, {"body": 7, "word": "sequence", "fig": 1}, {"body": 7, "word": "cardiac", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "iv", "fig": 1}, {"body": 6, "word": "intron", "fig": 1}, {"body": 6, "word": "neural", "fig": 1}, {"body": 5, "word": "downstream", "fig": 1}, {"body": 5, "word": "severe", "fig": 1}, {"body": 5, "word": "redundant", "fig": 1}, {"body": 5, "word": "identical", "fig": 1}, {"body": 4, "word": "tail", "fig": 1}, {"body": 4, "word": "vii", "fig": 1}, {"body": 4, "word": "Quantitative", "fig": 1}, {"body": 4, "word": "tube", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "mutation", "fig": 1}, {"body": 3, "word": "red", "fig": 1}, {"body": 3, "word": "within", "fig": 1}, {"body": 2, "word": "functions", "fig": 1}, {"body": 2, "word": "open", "fig": 1}, {"body": 2, "word": "location", "fig": 1}, {"body": 2, "word": "demonstrates", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "coding", "fig": 1}, {"body": 1, "word": "illustrated", "fig": 1}, {"body": 1, "word": "Schematic", "fig": 1}, {"body": 1, "word": "X+", "fig": 1}, {"body": 1, "word": "white", "fig": 1}, {"body": 1, "word": "moderate", "fig": 1}, {"body": 1, "word": "arrows", "fig": 1}, {"body": 1, "word": "head", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g005.jpg", "caption": "UTX and UTY redundancy is essential for progression of cardiac development. (A) Similar sized Utx heterozygous (i), Utx homozygous (ii), Utx hemizygous (iii), or Utx/Uty compound hemizygous (iv) embryos were analyzed in more detail for cardiac developmental abnormalities. Frontal views of the respective hearts of these embryos revealed that Utx homozygotes and Utx/Uty compound hemizygotes (A-vi, viii) have smaller hearts that have not completed looping relative to Utx heterozygotes (A-v) or hemizygotes (A-vii). A white dashed line was drawn at an identical angle in all panels to illustrate the failure of hearts to loop around in alignment with this appropriate plane. Only control and Utx hemizygous embryos (A-v, vii) have initiated the formation of the interventricular groove (white arrows), indicative of early interventricular septum development. (B) Transverse sections of E10.5 XUtxGT2\u0394 XUtxGT2\u0394 (B-ii) and XUtxGT2\u0394 YUtyGT (B-iv) embryos reveal smaller heart size with defects in ventricular myocardial trabeculation and organization. The control and Utx hemizygous hearts initiated the formation of the interventricular septum (B-i, iii, IVS, black arrow), while other mutant combinations (B-ii, iv) have not (red asterisk). RA and LA = Right and Left Atrium, and RV and LV = Right and Left Ventricle. (C) More magnified images further illustrate the narrowing of the ventricular wall (red scale) and the lack of myocardial cells and structure in Utx homozygotes and Utx/Uty compound hemizygotes (Epi = epicardium, MC = myocardium, Endo = Endocardium).", "co_occurrence": [{"body": 83, "word": "Utx", "fig": 8}, {"body": 29, "word": "embryos", "fig": 4}, {"body": 27, "word": "hemizygous", "fig": 4}, {"body": 102, "word": "UTY", "fig": 1}, {"body": 97, "word": "UTX", "fig": 1}, {"body": 22, "word": "XUtxGT2\u0394", "fig": 3}, {"body": 22, "word": "development", "fig": 2}, {"body": 37, "word": "The", "fig": 1}, {"body": 11, "word": "hemizygotes", "fig": 3}, {"body": 8, "word": "hearts", "fig": 4}, {"body": 13, "word": "control", "fig": 2}, {"body": 26, "word": "mutant", "fig": 1}, {"body": 12, "word": "A", "fig": 2}, {"body": 23, "word": "cells", "fig": 1}, {"body": 7, "word": "compound", "fig": 3}, {"body": 20, "word": "homozygous", "fig": 1}, {"body": 10, "word": "homozygotes", "fig": 2}, {"body": 17, "word": "E10.5", "fig": 1}, {"body": 15, "word": "YUtyGT", "fig": 1}, {"body": 5, "word": "Utx/Uty", "fig": 3}, {"body": 7, "word": "iv", "fig": 2}, {"body": 7, "word": "cardiac", "fig": 2}, {"body": 12, "word": "developmental", "fig": 1}, {"body": 12, "word": "heart", "fig": 1}, {"body": 6, "word": "iii", "fig": 2}, {"body": 11, "word": "essential", "fig": 1}, {"body": 5, "word": "smaller", "fig": 2}, {"body": 8, "word": "redundancy", "fig": 1}, {"body": 7, "word": "lack", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "early", "fig": 1}, {"body": 6, "word": "relative", "fig": 1}, {"body": 3, "word": "red", "fig": 2}, {"body": 5, "word": "line", "fig": 1}, {"body": 5, "word": "identical", "fig": 1}, {"body": 5, "word": "defects", "fig": 1}, {"body": 2, "word": "ventricular", "fig": 2}, {"body": 4, "word": "vii", "fig": 1}, {"body": 4, "word": "heterozygous", "fig": 1}, {"body": 2, "word": "myocardial", "fig": 2}, {"body": 4, "word": "structure", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 1, "word": "interventricular", "fig": 3}, {"body": 3, "word": "respective", "fig": 1}, {"body": 3, "word": "revealed", "fig": 1}, {"body": 2, "word": "sized", "fig": 1}, {"body": 2, "word": "size", "fig": 1}, {"body": 1, "word": "formation", "fig": 2}, {"body": 1, "word": "septum", "fig": 2}, {"body": 1, "word": "white", "fig": 2}, {"body": 1, "word": "B-ii", "fig": 2}, {"body": 2, "word": "panels", "fig": 1}, {"body": 1, "word": "looping", "fig": 1}, {"body": 1, "word": "alignment", "fig": 1}, {"body": 1, "word": "progression", "fig": 1}, {"body": 1, "word": "B-i", "fig": 1}, {"body": 1, "word": "arrows", "fig": 1}, {"body": 1, "word": "viii", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "wall", "fig": 1}, {"body": 1, "word": "black", "fig": 1}, {"body": 1, "word": "abnormalities", "fig": 1}, {"body": 1, "word": "failure", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "ii", "fig": 1}, {"body": 1, "word": "heterozygotes", "fig": 1}, {"body": 1, "word": "trabeculation", "fig": 1}, {"body": 1, "word": "combinations", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g006.jpg", "caption": "Human and mouse UTY have no H3K27 demethylase activity. (A) HEK293T cells were transfected with Flag-tagged C-terminal human (H) and mouse (M) UTX and UTY constructs. The C-terminal fragments span AA 880\u20131401 in human UTX (Figure S6) and include the corresponding regions in mouse UTX. Transfected cells (white arrows) over-expressing H-UTX and M-UTX (Flag immunofluorescence, green pseudo-color) exhibited global loss of H3K27me3 immunofluorescence (red pseudo-color). Cells transfected with H-UTY and M-UTY C-terminal constructs did not demethylate H3K27me3. (B) H3K27me3 demethylase assay of UTX and UTY mutant constructs. H-UTX H1146A contains a point mutation in a residue that was previously reported as defective in H3K27 demethylation. Cells expressing H-UTX H1146A had no loss of H3K27me3. Mouse UTY has a Y to C amino acid change that corresponds to position 1135 in human UTX. This UTX residue is predicted to regulate H3K27me3 binding and demethylation. Expression of H-UTX Y1135C failed to demethylate H3K27me3. Mouse UTY also has a T to I amino acid change that corresponds to position 1143 in human UTX that is predicted to regulate binding of ketoglutarate in the demethylase reaction. Expression of H-UTX T1143I failed to demethylate H3K27me3. Correction of these two altered residues in mouse Uty (M-UTY-C947Y, I955T) failed to recover H3K27me3 demethylase activity. (C) Alignment of the JmjC domains of human/mouse UTX human UTY, mouse UTY, and human/mouse JMJD3. UTY non-conservative substitutions are indicated by white boxes and residues of interest are labeled with red asterisks. The UTX mutations that were analyzed are listed above the alignment, while JMJD3 mutations are listed below the alignment. (D) HEK293T cells were transfected with C-terminal UTX and UTY constructs or full-length mouse JMJD3 constructs carrying various AA substitutions. Medium-high expressing cells (N\u2265100 cells scored for each experiment) were scored for any visible reduction in H3K27me3 levels relative to nearby untransfected cells. 100% of WT H-UTX, M-UTX and M-JMJD3 expressing cells had observable H3K27me3 demethylation. The negative controls of H-UTX H1146A, M-JMJD3 H1388A, and M-JMJD3 with deletion of the JmjC domain had no visible H3K27me3 demethylation (0% of cells). Wild type H-UTY and M-UTY had 0% of cells with detectable demethylation. Of the point mutations in UTY predicted to affect H3K27me3, only mutation of H-UTX Y1135C and T1143I with corresponding M-JMJD3 Y1377C and T1385I had no cells with any detectable H3K27 demethylation (0%). (E) Stereo view of the active site of human UTX (PDB ID: 3AVR). The corresponding residues in mouse UTY are also indicated in parentheses. The figure was prepared with the program Pymol (Schrodinger LLC).", "co_occurrence": [{"body": 102, "word": "UTY", "fig": 11}, {"body": 97, "word": "UTX", "fig": 11}, {"body": 26, "word": "H3K27me3", "fig": 12}, {"body": 40, "word": "mouse", "fig": 7}, {"body": 23, "word": "cells", "fig": 10}, {"body": 32, "word": "demethylation", "fig": 6}, {"body": 37, "word": "The", "fig": 5}, {"body": 55, "word": "H3K27", "fig": 3}, {"body": 38, "word": "demethylase", "fig": 4}, {"body": 19, "word": "human", "fig": 6}, {"body": 10, "word": "H-UTX", "fig": 8}, {"body": 73, "word": "Figure", "fig": 1}, {"body": 33, "word": "activity", "fig": 2}, {"body": 17, "word": "JMJD3", "fig": 3}, {"body": 8, "word": "constructs", "fig": 5}, {"body": 11, "word": "mutations", "fig": 3}, {"body": 26, "word": "Uty", "fig": 1}, {"body": 26, "word": "mutant", "fig": 1}, {"body": 13, "word": "also", "fig": 2}, {"body": 12, "word": "loss", "fig": 2}, {"body": 7, "word": "residues", "fig": 3}, {"body": 6, "word": "corresponding", "fig": 3}, {"body": 9, "word": "immunofluorescence", "fig": 2}, {"body": 8, "word": "JmjC", "fig": 2}, {"body": 4, "word": "C-terminal", "fig": 4}, {"body": 15, "word": "domain", "fig": 1}, {"body": 5, "word": "transfected", "fig": 3}, {"body": 5, "word": "demethylate", "fig": 3}, {"body": 7, "word": "binding", "fig": 2}, {"body": 12, "word": "A", "fig": 1}, {"body": 4, "word": "failed", "fig": 3}, {"body": 6, "word": "HEK293T", "fig": 2}, {"body": 11, "word": "WT", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 5, "word": "Mouse", "fig": 2}, {"body": 10, "word": "Flag", "fig": 1}, {"body": 10, "word": "reduction", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 4, "word": "amino", "fig": 2}, {"body": 4, "word": "indicated", "fig": 2}, {"body": 8, "word": "Y", "fig": 1}, {"body": 7, "word": "This", "fig": 1}, {"body": 7, "word": "exhibited", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "relative", "fig": 1}, {"body": 3, "word": "acid", "fig": 2}, {"body": 3, "word": "mutation", "fig": 2}, {"body": 2, "word": "expressing", "fig": 3}, {"body": 3, "word": "red", "fig": 2}, {"body": 3, "word": "C", "fig": 2}, {"body": 3, "word": "Y1135C", "fig": 2}, {"body": 5, "word": "negative", "fig": 1}, {"body": 5, "word": "type", "fig": 1}, {"body": 5, "word": "site", "fig": 1}, {"body": 2, "word": "Expression", "fig": 2}, {"body": 4, "word": "controls", "fig": 1}, {"body": 2, "word": "Cells", "fig": 2}, {"body": 4, "word": "E", "fig": 1}, {"body": 4, "word": "active", "fig": 1}, {"body": 4, "word": "Alignment", "fig": 1}, {"body": 2, "word": "point", "fig": 2}, {"body": 2, "word": "listed", "fig": 2}, {"body": 2, "word": "M-UTX", "fig": 2}, {"body": 2, "word": "M-UTY", "fig": 2}, {"body": 4, "word": "untransfected", "fig": 1}, {"body": 2, "word": "regulate", "fig": 2}, {"body": 2, "word": "H-UTY", "fig": 2}, {"body": 3, "word": "global", "fig": 1}, {"body": 1, "word": "predicted", "fig": 3}, {"body": 3, "word": "reported", "fig": 1}, {"body": 3, "word": "reaction", "fig": 1}, {"body": 1, "word": "H1146A", "fig": 3}, {"body": 3, "word": "Human", "fig": 1}, {"body": 1, "word": "alignment", "fig": 2}, {"body": 2, "word": "affect", "fig": 1}, {"body": 1, "word": "residue", "fig": 2}, {"body": 2, "word": "over-expressing", "fig": 1}, {"body": 1, "word": "change", "fig": 2}, {"body": 2, "word": "previously", "fig": 1}, {"body": 2, "word": "S6", "fig": 1}, {"body": 1, "word": "substitutions", "fig": 2}, {"body": 2, "word": "two", "fig": 1}, {"body": 1, "word": "white", "fig": 2}, {"body": 2, "word": "ketoglutarate", "fig": 1}, {"body": 2, "word": "Flag-tagged", "fig": 1}, {"body": 2, "word": "deletion", "fig": 1}, {"body": 2, "word": "Of", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 2, "word": "green", "fig": 1}, {"body": 1, "word": "position", "fig": 2}, {"body": 1, "word": "T1143I", "fig": 2}, {"body": 1, "word": "T1385I", "fig": 1}, {"body": 1, "word": "program", "fig": 1}, {"body": 1, "word": "include", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "arrows", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "I955T", "fig": 1}, {"body": 1, "word": "domains", "fig": 1}, {"body": 1, "word": "nearby", "fig": 1}, {"body": 1, "word": "Y1377C", "fig": 1}, {"body": 1, "word": "carrying", "fig": 1}, {"body": 1, "word": "full-length", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "recover", "fig": 1}, {"body": 1, "word": "defective", "fig": 1}, {"body": 1, "word": "regions", "fig": 1}, {"body": 1, "word": "M", "fig": 1}, {"body": 1, "word": "Transfected", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g007.jpg", "caption": "UTX and UTY associate in common protein complexes and are capable of H3K27 demethylase independent gene regulation. (A) Co-transfection of HA-UTX with Flag-UTX or Flag-UTY demonstrates that HA-UTX can immunoprecipitate with both Flag-UTX and Flag-UTY. (B) Immunoprecipitation of Flag-UTX and Flag-UTY reveal interaction with RBBP5, a component of the H3K4 methyl-transferase complex. Flag vector transfection was used as a negative control for immunoprecipitation. (C) Fnbp1, a gene targeted directly by UTX, has intermediate downregulation in XUtx\u2212 YUty+ MEFs (68% of WT, t-test p-value = 0.002), but was further compromised in XUtx\u2212 XUtx\u2212 (42% of WT, t-test p-value relative to XUtx\u2212 YUty+ = 0.001) and XUtx\u2212 YUty\u2212 (48% of WT, t-test p-value relative to XUtx\u2212 YUty+ = 0.02, N>4 independent MEF lines per genotype) MEFs. MEFs were generated from the XUtxGT2\u0394 and YUtyGT alleles. (D) Fnbp1 is similarly mis-expressed in XUtxGT2fl allelic combinations of E12.5 MEFs. XUtx\u2212 XUtx\u2212 and XUtx\u2212 YUty\u2212 MEFs significantly differ from XUtx\u2212 YUty+ MEFs (t-test p-value = 0.05 and 0.02 respectively, N>4 independent MEF lines per genotype). (E) H3K27me3 ChIP was performed on E12.5 XUtx+ YUty+ control (green) and XUtx\u2212 XUtx\u2212 (red) MEFs. An IgG antibody control is indicated in grey. Quantitative PCR for the ChIP was performed over a negative control region (an intergenic region) as well as a positive control (HoxB1). Fnbp1 failed to accumulate H3K27me3 in XUtx\u2212 XUtx\u2212 MEFs (t-test p-value = 0.5, N = 4 independent MEF lines per genotype). (F) H3K4me3 ChIP was performed on E12.5 XUtx+ YUty+ control (green) and XUtx\u2212 XUtx\u2212 (red) MEFs. An IgG antibody control is indicated in grey. Quantitative PCR for the ChIP was performed over a negative control region (intergenic region) as well as a positive control (Npm1). The WT Fnbp1 promoter exhibited significant H3K4me3 accumulation, which was reduced in XUtx\u2212 XUtx\u2212 MEFs (t-test p-value = 0.005, N = 3 independent MEF lines per genotype).", "co_occurrence": [{"body": 34, "word": "XUtx\u2212", "fig": 18}, {"body": 97, "word": "UTX", "fig": 2}, {"body": 19, "word": "MEFs", "fig": 10}, {"body": 24, "word": "YUty+", "fig": 6}, {"body": 13, "word": "control", "fig": 9}, {"body": 102, "word": "UTY", "fig": 1}, {"body": 13, "word": "p-value", "fig": 6}, {"body": 14, "word": "independent", "fig": 5}, {"body": 16, "word": "performed", "fig": 4}, {"body": 31, "word": "gene", "fig": 2}, {"body": 55, "word": "H3K27", "fig": 1}, {"body": 26, "word": "H3K27me3", "fig": 2}, {"body": 11, "word": "WT", "fig": 4}, {"body": 11, "word": "Fnbp1", "fig": 4}, {"body": 38, "word": "demethylase", "fig": 1}, {"body": 37, "word": "The", "fig": 1}, {"body": 8, "word": "ChIP", "fig": 4}, {"body": 8, "word": "genotype", "fig": 4}, {"body": 6, "word": "lines", "fig": 4}, {"body": 22, "word": "XUtxGT2\u0394", "fig": 1}, {"body": 22, "word": "XUtxGT2fl", "fig": 1}, {"body": 11, "word": "XUtx+", "fig": 2}, {"body": 5, "word": "region", "fig": 4}, {"body": 6, "word": "E12.5", "fig": 3}, {"body": 4, "word": "MEF", "fig": 4}, {"body": 15, "word": "YUtyGT", "fig": 1}, {"body": 5, "word": "negative", "fig": 3}, {"body": 7, "word": "YUty\u2212", "fig": 2}, {"body": 7, "word": "PCR", "fig": 2}, {"body": 13, "word": "protein", "fig": 1}, {"body": 6, "word": "relative", "fig": 2}, {"body": 12, "word": "associate", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 11, "word": "alleles", "fig": 1}, {"body": 11, "word": "regulation", "fig": 1}, {"body": 10, "word": "Flag", "fig": 1}, {"body": 10, "word": "promoter", "fig": 1}, {"body": 10, "word": "complex", "fig": 1}, {"body": 9, "word": "H3K4", "fig": 1}, {"body": 2, "word": "per", "fig": 4}, {"body": 8, "word": "capable", "fig": 1}, {"body": 2, "word": "N", "fig": 4}, {"body": 4, "word": "Quantitative", "fig": 2}, {"body": 4, "word": "indicated", "fig": 2}, {"body": 4, "word": "well", "fig": 2}, {"body": 7, "word": "exhibited", "fig": 1}, {"body": 7, "word": "significantly", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "complexes", "fig": 1}, {"body": 7, "word": "generated", "fig": 1}, {"body": 6, "word": "common", "fig": 1}, {"body": 3, "word": "red", "fig": 2}, {"body": 1, "word": "t-test", "fig": 6}, {"body": 3, "word": "antibody", "fig": 2}, {"body": 6, "word": "methyl-transferase", "fig": 1}, {"body": 3, "word": "intergenic", "fig": 2}, {"body": 4, "word": "failed", "fig": 1}, {"body": 4, "word": "RBBP5", "fig": 1}, {"body": 2, "word": "H3K4me3", "fig": 2}, {"body": 2, "word": "IgG", "fig": 2}, {"body": 2, "word": "positive", "fig": 2}, {"body": 4, "word": "E", "fig": 1}, {"body": 2, "word": "green", "fig": 2}, {"body": 3, "word": "vector", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "Co-transfection", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "interaction", "fig": 1}, {"body": 1, "word": "grey", "fig": 2}, {"body": 2, "word": "demonstrates", "fig": 1}, {"body": 1, "word": "HA-UTX", "fig": 2}, {"body": 2, "word": "reduced", "fig": 1}, {"body": 2, "word": "directly", "fig": 1}, {"body": 2, "word": "immunoprecipitation", "fig": 1}, {"body": 2, "word": "transfection", "fig": 1}, {"body": 2, "word": "significant", "fig": 1}, {"body": 1, "word": "HoxB1", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "combinations", "fig": 1}, {"body": 1, "word": "accumulation", "fig": 1}, {"body": 1, "word": "targeted", "fig": 1}, {"body": 1, "word": "component", "fig": 1}, {"body": 1, "word": "similarly", "fig": 1}, {"body": 1, "word": "compromised", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "used", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459986/bin/pgen.1002964.g008.jpg", "caption": "UTY associates with BRG1 and heart transcription factors, and regulates downstream ANF gene expression. (A) Myc-UTY was co-transfected with a Flag vector control or Flag BRG1 and immunoprecipitated with Flag-Agarose beads. Myc-UTY specifically immunoprecipitates with Flag-BRG1. (B) Myc-UTY was co-transfected with the Flag vector control or Flag-NKX2\u20135. Myc-UTY was co-immunoprecipitated by Flag-NKX2\u20135. (C) ANF:Luciferase reporter assay. HEK293T were transfected with the reporter ANF:Luciferase construct alone (-), with NKX2\u20135, with NKX2\u20135 and UTY, or with NKX2\u20135 and UTX. Reporter activity was significantly enhanced with the addition of UTY (t-test p-value = 0.01). Right panel illustrates the comparison of UTY versus UTX enhancement of NKX2\u20135 driven ANF expression. N = 3 independent transfections per group. (D) Anf expression was analyzed from E10.5 heart RT-PCR of various XUtxGT2\u0394 and YUtyGT allelic combinations. A moderate, but not significant downregulation of ANF was observed in XUtx\u2212 YUty+ hearts (76% of WT, t-test p-value = 0.06), but was significantly compromised in XUtx\u2212 XUtx\u2212 (52% of WT, t-test p-value relative to XUtx+ YUty+ = 0.005) and XUtx\u2212 YUty\u2212 (57% of WT, t-test p-value relative to XUtx+ YUty+ = 0.02, N>4 per genotype) hearts.", "co_occurrence": [{"body": 102, "word": "UTY", "fig": 4}, {"body": 97, "word": "UTX", "fig": 2}, {"body": 34, "word": "XUtx\u2212", "fig": 4}, {"body": 16, "word": "ANF", "fig": 5}, {"body": 26, "word": "expression", "fig": 3}, {"body": 24, "word": "YUty+", "fig": 3}, {"body": 13, "word": "p-value", "fig": 4}, {"body": 11, "word": "WT", "fig": 3}, {"body": 33, "word": "activity", "fig": 1}, {"body": 31, "word": "gene", "fig": 1}, {"body": 10, "word": "Flag", "fig": 3}, {"body": 13, "word": "control", "fig": 2}, {"body": 12, "word": "heart", "fig": 2}, {"body": 6, "word": "Myc-UTY", "fig": 4}, {"body": 12, "word": "A", "fig": 2}, {"body": 22, "word": "XUtxGT2\u0394", "fig": 1}, {"body": 11, "word": "reporter", "fig": 2}, {"body": 11, "word": "XUtx+", "fig": 2}, {"body": 5, "word": "NKX2\u20135", "fig": 4}, {"body": 17, "word": "E10.5", "fig": 1}, {"body": 8, "word": "BRG1", "fig": 2}, {"body": 8, "word": "hearts", "fig": 2}, {"body": 15, "word": "YUtyGT", "fig": 1}, {"body": 7, "word": "significantly", "fig": 2}, {"body": 14, "word": "independent", "fig": 1}, {"body": 6, "word": "relative", "fig": 2}, {"body": 6, "word": "Luciferase", "fig": 2}, {"body": 10, "word": "RT-PCR", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 9, "word": "observed", "fig": 1}, {"body": 9, "word": "factors", "fig": 1}, {"body": 8, "word": "genotype", "fig": 1}, {"body": 4, "word": "co-transfected", "fig": 2}, {"body": 8, "word": "transcription", "fig": 1}, {"body": 7, "word": "YUty\u2212", "fig": 1}, {"body": 7, "word": "construct", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 3, "word": "vector", "fig": 2}, {"body": 6, "word": "HEK293T", "fig": 1}, {"body": 5, "word": "downstream", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 2, "word": "per", "fig": 2}, {"body": 1, "word": "t-test", "fig": 4}, {"body": 2, "word": "N", "fig": 2}, {"body": 3, "word": "versus", "fig": 1}, {"body": 3, "word": "enhanced", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "comparison", "fig": 1}, {"body": 3, "word": "associates", "fig": 1}, {"body": 2, "word": "beads", "fig": 1}, {"body": 1, "word": "Flag-NKX2\u20135", "fig": 2}, {"body": 2, "word": "Reporter", "fig": 1}, {"body": 2, "word": "driven", "fig": 1}, {"body": 2, "word": "co-immunoprecipitated", "fig": 1}, {"body": 2, "word": "significant", "fig": 1}, {"body": 1, "word": "illustrates", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "combinations", "fig": 1}, {"body": 1, "word": "transfections", "fig": 1}, {"body": 1, "word": "enhancement", "fig": 1}, {"body": 1, "word": "moderate", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "alone", "fig": 1}, {"body": 1, "word": "specifically", "fig": 1}, {"body": 1, "word": "addition", "fig": 1}, {"body": 1, "word": "compromised", "fig": 1}, {"body": 1, "word": "Flag-BRG1", "fig": 1}]}], "4951198": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig1.jpg", "caption": "Compound deletion of BRAF and RAF1 in the epidermis leads to severe skin inflammation in adult mice.(A) BRAF and RAF1 are efficiently deleted in epidermal cells as shown by PCR analysis of tail tissue and immunoblotting of epidermal lysates isolated from 3 weeks old F/F2 and \u0394/\u0394ep2 (n = 4). ACTB is shown as a loading control. (B) Macroscopic appearance of newborn and adult F/F2 and \u0394/\u0394ep2 mice. Arrowhead highlights the open eye phenotype of \u0394/\u0394ep2 pups. (C) Hematoxylin/eosin (H and E) staining shows epidermal thickening and dermal inflammatory infiltrates in \u0394/\u0394ep2 mice. BrdU incorporation confirms hyperproliferation in the basal layer of \u0394/\u0394ep2 epidermis. The numbers in the inset represent BrdU+ cells/mm2 of epidermis (n = 5\u20137, mean \u00b1 SEM). Infiltrating cells: activated mast cells (\u03b21 Tryptase+), granulocytes (esterase+), dendritic cells (CD11c+). (D) Quantification of the infiltrating cells: T cells (CD4+ and CD8+), macrophages (F4/80+), total mast cells (MC, toluidine blue+), granulocytes (GR, esterase+). (E) Increased expression of K6, ICAM1, and MHC II in \u0394/\u0394ep2 keratinocytes/epidermis. Representative images (C, E) and quantification (D) of 5\u20137 individual couples. Scale bars, 50 \u00b5m. (F) Inflammatory chemokines and cytokines in epidermal lysates (n = 3\u20134). TSLP levels were determined by immunoblotting and quantified by Image J. ACTB served as a loading control. The results were normalized by arbitrarily setting one of the F/F2 samples as 1 and plotted as mean \u00b1 SEM. Data represent mean \u00b1 SEM. p = 0.011, p1 = 0.001, p2 = 0.007, p3 = 0.001, p4 = 3.06E-6, p5 = 1.37E-4, p6 = 0.002, p7 = 0.049, p8 = 0.042, p9 = 0.046 and p10 = 0.001.DOI: http://dx.doi.org/10.7554/eLife.14012.003", "co_occurrence": [{"body": 63, "word": "\u0394/\u0394ep2", "fig": 6}, {"body": 50, "word": "cells", "fig": 7}, {"body": 31, "word": "mice", "fig": 3}, {"body": 27, "word": "epidermis", "fig": 3}, {"body": 20, "word": "epidermal", "fig": 4}, {"body": 22, "word": "The", "fig": 2}, {"body": 19, "word": "lysates", "fig": 2}, {"body": 19, "word": "RAF1", "fig": 2}, {"body": 19, "word": "BRAF", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 9, "word": "F/F2", "fig": 3}, {"body": 26, "word": "skin", "fig": 1}, {"body": 11, "word": "mast", "fig": 2}, {"body": 16, "word": "inflammatory", "fig": 1}, {"body": 16, "word": "TSLP", "fig": 1}, {"body": 14, "word": "inflammation", "fig": 1}, {"body": 7, "word": "control", "fig": 2}, {"body": 14, "word": "ICAM1", "fig": 1}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 6, "word": "D", "fig": 2}, {"body": 11, "word": "chemokines", "fig": 1}, {"body": 10, "word": "activated", "fig": 1}, {"body": 8, "word": "weeks", "fig": 1}, {"body": 4, "word": "adult", "fig": 2}, {"body": 4, "word": "granulocytes", "fig": 2}, {"body": 8, "word": "dendritic", "fig": 1}, {"body": 8, "word": "phenotype", "fig": 1}, {"body": 7, "word": "T", "fig": 1}, {"body": 7, "word": "old", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 3, "word": "ACTB", "fig": 2}, {"body": 2, "word": "mean", "fig": 3}, {"body": 3, "word": "shown", "fig": 2}, {"body": 6, "word": "K6", "fig": 1}, {"body": 6, "word": "numbers", "fig": 1}, {"body": 5, "word": "II", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "dermal", "fig": 1}, {"body": 4, "word": "thickening", "fig": 1}, {"body": 4, "word": "MHC", "fig": 1}, {"body": 4, "word": "basal", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "tissue", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "results", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "samples", "fig": 1}, {"body": 3, "word": "deletion", "fig": 1}, {"body": 1, "word": "E", "fig": 3}, {"body": 3, "word": "severe", "fig": 1}, {"body": 2, "word": "p", "fig": 1}, {"body": 2, "word": "infiltrates", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "\u03b21", "fig": 1}, {"body": 2, "word": "Increased", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "hyperproliferation", "fig": 1}, {"body": 2, "word": "efficiently", "fig": 1}, {"body": 1, "word": "tail", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "Inflammatory", "fig": 1}, {"body": 1, "word": "toluidine", "fig": 1}, {"body": 1, "word": "served", "fig": 1}, {"body": 1, "word": "PCR", "fig": 1}, {"body": 1, "word": "open", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "macrophages", "fig": 1}, {"body": 1, "word": "deleted", "fig": 1}, {"body": 1, "word": "one", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "incorporation", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "BrdU", "fig": 1}, {"body": 1, "word": "Tryptase+", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig1-figsupp1.jpg", "caption": "Local inflammation in adult mice lacking BRAF and RAF1 in the epidermis.(A) Immunohistochemical analysis of epidermal differentiation (K5, K10 and FLG (filaggrin)) and apoptosis (TUNEL+). (B) Skin sections of adult F/F2 and \u25b3/\u25b3ep2 mice showing dermal infiltration: total mast cells (toluidine blue, TB+), macrophages (F4/80+) and T cells (CD4+ and CD8+). Arrows indicate positive cells. Quantification is shown in Figure 1D (n = 5\u20137). Scale bars, 50 \u00b5m.DOI: http://dx.doi.org/10.7554/eLife.14012.004", "co_occurrence": [{"body": 50, "word": "cells", "fig": 3}, {"body": 76, "word": "Figure", "fig": 1}, {"body": 31, "word": "mice", "fig": 2}, {"body": 27, "word": "epidermis", "fig": 1}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 19, "word": "RAF1", "fig": 1}, {"body": 19, "word": "BRAF", "fig": 1}, {"body": 14, "word": "inflammation", "fig": 1}, {"body": 11, "word": "mast", "fig": 1}, {"body": 9, "word": "F/F2", "fig": 1}, {"body": 4, "word": "adult", "fig": 2}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "T", "fig": 1}, {"body": 5, "word": "dermal", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "lacking", "fig": 1}, {"body": 2, "word": "1D", "fig": 1}, {"body": 2, "word": "differentiation", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "Skin", "fig": 1}, {"body": 1, "word": "K10", "fig": 1}, {"body": 1, "word": "infiltration", "fig": 1}, {"body": 1, "word": "K5", "fig": 1}, {"body": 1, "word": "FLG", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "macrophages", "fig": 1}, {"body": 1, "word": "apoptosis", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "toluidine", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig2.jpg", "caption": "Inflammatory response in adult \u0394/\u0394ep2 animals.(A) The body weight of \u0394/\u0394ep2 mice is significantly reduced compared to their littermates (n = 5). The data was analyzed by two-way analysis of variance (ANOVA) test. (B) Increased spleen/body weight ratio and increased numbers of splenic Mac1+Gr1+ cells in adult \u0394/\u0394ep2 animals (n = 4\u20135). (C) Enlarged lymph nodes and and activated T, B, and dendritic cells in adult \u0394/\u0394ep2 (n = 4\u20138). T cells (CD4+ or CD8+) and B cells (B220+) activation was determined by costaining with CD69; activated dendritic cells were identified as CD11c+ and MHC IIhi or CD80+. (D) Circulating blood cells and plasma levels of chemokines and IgE antibodies in adult mice (n = 6\u20138). Data represent mean \u00b1 SEM. p1 = 0.0002, p2 = 0.023, p3 = 0.002, p4 = 0.002, p5 = 9.83E-8, p6 = 6.31E-7, p7 = 2.91E-7, p8 = 0.004, p9 = 0.001, p10 = 0.008, p11 = 0.011, p12 = 0.046, p13 = 0.050, p14 = 3.65E-4 and p15 = 0.001.DOI: http://dx.doi.org/10.7554/eLife.14012.005", "co_occurrence": [{"body": 50, "word": "cells", "fig": 6}, {"body": 63, "word": "\u0394/\u0394ep2", "fig": 4}, {"body": 31, "word": "mice", "fig": 2}, {"body": 26, "word": "animals", "fig": 2}, {"body": 22, "word": "The", "fig": 2}, {"body": 42, "word": "activation", "fig": 1}, {"body": 29, "word": "increased", "fig": 1}, {"body": 22, "word": "reduced", "fig": 1}, {"body": 7, "word": "B", "fig": 3}, {"body": 10, "word": "activated", "fig": 2}, {"body": 4, "word": "adult", "fig": 4}, {"body": 8, "word": "dendritic", "fig": 2}, {"body": 7, "word": "T", "fig": 2}, {"body": 13, "word": "levels", "fig": 1}, {"body": 11, "word": "chemokines", "fig": 1}, {"body": 9, "word": "lymph", "fig": 1}, {"body": 8, "word": "nodes", "fig": 1}, {"body": 8, "word": "significantly", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 7, "word": "IgE", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 3, "word": "weight", "fig": 2}, {"body": 6, "word": "numbers", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "blood", "fig": 1}, {"body": 5, "word": "data", "fig": 1}, {"body": 4, "word": "MHC", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "body", "fig": 1}, {"body": 3, "word": "Mac1+Gr1+", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "Increased", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "littermates", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "ratio", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "Inflammatory", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "CD69", "fig": 1}, {"body": 1, "word": "response", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig3.jpg", "caption": "Local and systemic inflammatory phenotype in young \u0394/\u0394ep2 animals.(A) Local inflammation in 3 weeks old \u0394/\u0394ep2 animals. Total mast cells (toluidine blue staining, TB; quantified in the plot, n = 4\u20135) and ICAM1 staining. Scale bars, 25 \u00b5m. (B) Inflammatory chemokines and cytokines in epidermal lysates (n = 4\u20135). TSLP levels were determined by immunoblotting and quantified and analyzed as in Figure 1F. TUBA served as a loading control. (C, D) Systemic inflammatory parameters in 3 weeks old mice. (C) Lymph node size and composition (n = 4). (D) Circulating blood cells (n = 8) and plasma concentration of IgE (n = 8) and chemokines (n = 9). (E, F) Systemic inflammatory parameters in 10 days old mice. (E) Lymph node size and composition (n = 4\u201310). (F) Hemogram showing elevated amounts of granulocytes (upper panel, n = 4\u20137) and plasma chemokine levels showing increased GCSF (n = 4). Data represent mean \u00b1 SEM. p1 = 0.016, p2 = 0.041, p3 = 0.013, p4 = 0.040, p5 = 0.013, p6 = 0.032, p7 = 0.026, p8 = 0.007, p9 = 0.029, p10 = 0.048, p11 = 0.015, p12 = 0.018, p13 = 0.033, p14 = 0.036, p15 = 3.00E-04, p16 = 3.88E-05, p17 = 0.026, p18 = 0.021, p19 = 0.048, p20 = 0.034, p21 = 0.042, p22 = 0.008, p23 = 0.001, p24 = 0.018, p25 = 0.005, p26 = 0.001, p27 = 0.001, p28 = 0.011 and p29 = 0.014.DOI: http://dx.doi.org/10.7554/eLife.14012.006", "co_occurrence": [{"body": 63, "word": "\u0394/\u0394ep2", "fig": 2}, {"body": 50, "word": "cells", "fig": 2}, {"body": 76, "word": "Figure", "fig": 1}, {"body": 31, "word": "mice", "fig": 2}, {"body": 26, "word": "animals", "fig": 2}, {"body": 16, "word": "inflammatory", "fig": 3}, {"body": 29, "word": "increased", "fig": 1}, {"body": 13, "word": "levels", "fig": 2}, {"body": 11, "word": "chemokines", "fig": 2}, {"body": 7, "word": "old", "fig": 3}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 8, "word": "weeks", "fig": 2}, {"body": 16, "word": "TSLP", "fig": 1}, {"body": 14, "word": "inflammation", "fig": 1}, {"body": 14, "word": "ICAM1", "fig": 1}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 6, "word": "D", "fig": 2}, {"body": 11, "word": "mast", "fig": 1}, {"body": 8, "word": "systemic", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 8, "word": "phenotype", "fig": 1}, {"body": 7, "word": "IgE", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "elevated", "fig": 1}, {"body": 7, "word": "amounts", "fig": 1}, {"body": 3, "word": "staining", "fig": 2}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "blood", "fig": 1}, {"body": 4, "word": "days", "fig": 1}, {"body": 4, "word": "GCSF", "fig": 1}, {"body": 4, "word": "granulocytes", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 1, "word": "showing", "fig": 2}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "node", "fig": 2}, {"body": 2, "word": "blue", "fig": 1}, {"body": 1, "word": "size", "fig": 2}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "F", "fig": 2}, {"body": 1, "word": "composition", "fig": 2}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "Inflammatory", "fig": 1}, {"body": 1, "word": "served", "fig": 1}, {"body": 1, "word": "TUBA", "fig": 1}, {"body": 1, "word": "1F", "fig": 1}, {"body": 1, "word": "toluidine", "fig": 1}, {"body": 1, "word": "chemokine", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig3-figsupp1.jpg", "caption": "Local and systemic response in 3 weeks old \u25b3/\u25b3ep2 animals.(A) Eyelid inflammation in 3 weeks old \u25b3/\u25b3ep2 animals. Skin architecture (H&E), proliferation rate (percentage of BrdU+ cells in the epidermis), mast cells activation (\u03b21 Tryptase+), granulocytes (esterase+) and dendritic cell (CD11c+) numbers are indistinguishable in 3 weeks old F/F2 and \u25b3/\u25b3ep2 littermates. Quantifications of the proliferating cells and granulocytes are shown in the insets (n = 3). (B) Three weeks old \u25b3/\u25b3ep2 epidermis does not express the activation markers K6 and MHC II. Scale bars, 25 \u00b5m. (C) Inflammatory chemokines and cytokines in 3 weeks old epidermal lysates (n = 5). (D) Normal spleen size and composition in 3 weeks old \u25b3/\u25b3ep2 mice (n = 4\u20136). Data represent mean \u00b1 SEM.DOI: http://dx.doi.org/10.7554/eLife.14012.007", "co_occurrence": [{"body": 50, "word": "cells", "fig": 3}, {"body": 42, "word": "activation", "fig": 2}, {"body": 27, "word": "epidermis", "fig": 2}, {"body": 26, "word": "animals", "fig": 2}, {"body": 8, "word": "weeks", "fig": 6}, {"body": 7, "word": "old", "fig": 6}, {"body": 31, "word": "mice", "fig": 1}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 16, "word": "cell", "fig": 1}, {"body": 14, "word": "inflammation", "fig": 1}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 11, "word": "chemokines", "fig": 1}, {"body": 11, "word": "mast", "fig": 1}, {"body": 9, "word": "F/F2", "fig": 1}, {"body": 8, "word": "systemic", "fig": 1}, {"body": 8, "word": "dendritic", "fig": 1}, {"body": 4, "word": "granulocytes", "fig": 2}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "proliferation", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 6, "word": "K6", "fig": 1}, {"body": 6, "word": "numbers", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "II", "fig": 1}, {"body": 4, "word": "indistinguishable", "fig": 1}, {"body": 4, "word": "MHC", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "spleen", "fig": 1}, {"body": 3, "word": "architecture", "fig": 1}, {"body": 2, "word": "littermates", "fig": 1}, {"body": 2, "word": "\u03b21", "fig": 1}, {"body": 2, "word": "Skin", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "size", "fig": 1}, {"body": 1, "word": "Tryptase+", "fig": 1}, {"body": 1, "word": "composition", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "response", "fig": 1}, {"body": 1, "word": "Inflammatory", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig4.jpg", "caption": "Transient inside-outside barrier defects in \u0394/\u0394ep2 animals.(A) Intact outside-in barrier function (determined by toluidine blue penetration of the stratum corneum) in E19.5-day-old \u0394/\u0394ep2 embryos compared to controls (n = 6). Representative pictures; two independent experiments were performed with identical results. (B) Increased water loss in the \u0394/\u0394ep2 E18.5 embryos as demonstrated by weight analysis. Results are displayed as percentage of initial weight (n = 41 for F/F2 and n = 11 for \u0394/\u0394ep2). The data was analyzed by two-way analysis of variance (ANOVA) test. (C, D) Immunoblot analysis of CDH1, CLDN1 and OCLN expression in epidermal lysates of 3 days old (C, n = 3; quantification shown in the plot, performed as in Figure 1F) or 3 weeks old \u0394/\u0394ep2 animals. TUBA and GAPDH are shown as loading controls. Data represent mean \u00b1 SEM. p1 = 0.0001, p2 = 0.028, p3 = 0.020.DOI: http://dx.doi.org/10.7554/eLife.14012.008", "co_occurrence": [{"body": 63, "word": "\u0394/\u0394ep2", "fig": 5}, {"body": 76, "word": "Figure", "fig": 1}, {"body": 26, "word": "animals", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 12, "word": "barrier", "fig": 2}, {"body": 22, "word": "The", "fig": 1}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 7, "word": "old", "fig": 2}, {"body": 6, "word": "controls", "fig": 2}, {"body": 4, "word": "analysis", "fig": 3}, {"body": 5, "word": "embryos", "fig": 2}, {"body": 9, "word": "F/F2", "fig": 1}, {"body": 8, "word": "weeks", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 4, "word": "performed", "fig": 2}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 3, "word": "weight", "fig": 2}, {"body": 3, "word": "shown", "fig": 2}, {"body": 6, "word": "function", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "data", "fig": 1}, {"body": 4, "word": "corneum", "fig": 1}, {"body": 4, "word": "stratum", "fig": 1}, {"body": 4, "word": "loss", "fig": 1}, {"body": 4, "word": "days", "fig": 1}, {"body": 4, "word": "defects", "fig": 1}, {"body": 4, "word": "two", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 3, "word": "results", "fig": 1}, {"body": 3, "word": "CLDN1", "fig": 1}, {"body": 3, "word": "independent", "fig": 1}, {"body": 2, "word": "CDH1", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "water", "fig": 1}, {"body": 2, "word": "Increased", "fig": 1}, {"body": 2, "word": "E18.5", "fig": 1}, {"body": 2, "word": "OCLN", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "penetration", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "demonstrated", "fig": 1}, {"body": 1, "word": "TUBA", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "1F", "fig": 1}, {"body": 1, "word": "initial", "fig": 1}, {"body": 1, "word": "outside-in", "fig": 1}, {"body": 1, "word": "toluidine", "fig": 1}, {"body": 1, "word": "inside-outside", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig4-figsupp1.jpg", "caption": "Skin architecture and inflammatory factors in 3 days old F/F2 and \u25b3/\u25b3ep2 animals.(A) Similar skin architecture in F/F2 and \u25b3/\u25b3ep2 pups based on H and E staining and on the analysis of differentiation markers (K5, K10 and involucrin). Scale bars, 50 \u00b5m. (B) Inflammatory chemokines and cytokines in epidermal lysates (n = 3). (C) Transepidermal water loss as determined by body weight analysis in E18.5 embryos lacking either BRAF (BRAF\u0394/\u0394ep) or RAF1 (RAF1\u0394/\u0394ep) in the epidermis (n = 10 for F/F2, n = 4 for \u0394/\u0394ep2, n = 3 for BRAF\u0394/\u0394ep and n = 6 for RAF1\u0394/\u0394ep). The data was analyzed by two-way analysis of variance (ANOVA) test. (D) Expression levels of tight junction proteins in the epidermis of P3 BRAF\u0394/\u0394ep or RAF1\u0394/\u0394ep pups quantified and plotted as in Figure 1F (n = 3). TUBA is used as a loading control. Data represent mean \u00b1 SEM. p1 = 0.0442.DOI: http://dx.doi.org/10.7554/eLife.14012.009", "co_occurrence": [{"body": 76, "word": "Figure", "fig": 1}, {"body": 63, "word": "\u0394/\u0394ep2", "fig": 1}, {"body": 27, "word": "epidermis", "fig": 2}, {"body": 9, "word": "F/F2", "fig": 3}, {"body": 26, "word": "skin", "fig": 1}, {"body": 26, "word": "animals", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 19, "word": "RAF1", "fig": 1}, {"body": 19, "word": "BRAF", "fig": 1}, {"body": 16, "word": "inflammatory", "fig": 1}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 4, "word": "analysis", "fig": 3}, {"body": 11, "word": "chemokines", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "old", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 3, "word": "architecture", "fig": 2}, {"body": 5, "word": "embryos", "fig": 1}, {"body": 5, "word": "tight", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "data", "fig": 1}, {"body": 4, "word": "junction", "fig": 1}, {"body": 4, "word": "loss", "fig": 1}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "P3", "fig": 1}, {"body": 4, "word": "days", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "lacking", "fig": 1}, {"body": 3, "word": "weight", "fig": 1}, {"body": 3, "word": "body", "fig": 1}, {"body": 1, "word": "RAF1\u0394/\u0394ep", "fig": 3}, {"body": 1, "word": "BRAF\u0394/\u0394ep", "fig": 3}, {"body": 2, "word": "differentiation", "fig": 1}, {"body": 2, "word": "Skin", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "factors", "fig": 1}, {"body": 2, "word": "water", "fig": 1}, {"body": 2, "word": "E18.5", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "K10", "fig": 1}, {"body": 1, "word": "based", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "two-way", "fig": 1}, {"body": 1, "word": "Inflammatory", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "TUBA", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "K5", "fig": 1}, {"body": 1, "word": "1F", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig5.jpg", "caption": "Local and systemic inflammation in \u0394/\u0394ep2TX mice.(A) PCR analysis of tail tissue (left) and immunoblot analysis of epidermal lysates obtained from \u0394/\u0394ep2TX animals. (B) Macroscopic appearance of \u0394/\u0394ep2TX mice and histological analysis of H&E sections. Scale bars, 25 \u00b5m. Infiltrating cells: mast cells (MC; TB+), activated mast cells (\u03b21 Tryptase+; modest), granulocytes (GR; esterase+). The plot shows a quantification of the histological analysis. (C) Mild splenomegaly with increased numbers of Mac1+Gr1+ cells in \u0394/\u0394ep2TX animals. (D) Activated T cells, B cells and dendritic cells in the lymph nodes of \u0394/\u0394ep2TX animals. (E) Mild lymphocytosis and significantly elevated granulocyte numbers in \u0394/\u0394ep2TX mice. The right panel shows comparable IgE plasma levels in control and \u0394/\u0394ep2TX animals. Data are plotted as mean \u00b1 SEM (n = 5; p1 = 0.034, p2 = 0.014, p3 = 0.005, p4 = 2.63E-4, p5 = 0.001, p6 = 0.001, p7 = 0.019 and p8 = 0.042).DOI: http://dx.doi.org/10.7554/eLife.14012.010", "co_occurrence": [{"body": 50, "word": "cells", "fig": 7}, {"body": 26, "word": "animals", "fig": 4}, {"body": 31, "word": "mice", "fig": 3}, {"body": 22, "word": "The", "fig": 2}, {"body": 29, "word": "increased", "fig": 1}, {"body": 11, "word": "mast", "fig": 2}, {"body": 3, "word": "\u0394/\u0394ep2TX", "fig": 7}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 4, "word": "analysis", "fig": 4}, {"body": 14, "word": "inflammation", "fig": 1}, {"body": 7, "word": "B", "fig": 2}, {"body": 13, "word": "levels", "fig": 1}, {"body": 6, "word": "numbers", "fig": 2}, {"body": 10, "word": "activated", "fig": 1}, {"body": 9, "word": "lymph", "fig": 1}, {"body": 8, "word": "systemic", "fig": 1}, {"body": 8, "word": "nodes", "fig": 1}, {"body": 8, "word": "significantly", "fig": 1}, {"body": 8, "word": "dendritic", "fig": 1}, {"body": 7, "word": "T", "fig": 1}, {"body": 7, "word": "IgE", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "elevated", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "granulocytes", "fig": 1}, {"body": 4, "word": "tissue", "fig": 1}, {"body": 3, "word": "Mac1+Gr1+", "fig": 1}, {"body": 3, "word": "splenomegaly", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "\u03b21", "fig": 1}, {"body": 1, "word": "shows", "fig": 2}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 1, "word": "E", "fig": 2}, {"body": 1, "word": "tail", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "PCR", "fig": 1}, {"body": 1, "word": "comparable", "fig": 1}, {"body": 1, "word": "Tryptase+", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "modest", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig5-figsupp1.jpg", "caption": "Representative FACS analysis of lymph node and spleen cells isolated from adult F/F2TX \u0394/\u0394ep2TX animals.The percentage of activated lymphocytes in lymph nodes was assessed by combining lineage specific markers (CD4 and CD8 for T lymphocytes; B220 for B lymphocytes) with the activation marker CD69. Activated dendriditic cells were identified by staining with CD11c and MHC II antibodies. Myeloid cells in the spleen were analyzed by staining with Mac1 and Gr1 antibodies. The percentage of single and double positive cells is indicated.DOI: http://dx.doi.org/10.7554/eLife.14012.011", "co_occurrence": [{"body": 50, "word": "cells", "fig": 4}, {"body": 42, "word": "activation", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 9, "word": "lymph", "fig": 2}, {"body": 10, "word": "activated", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 8, "word": "nodes", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "T", "fig": 1}, {"body": 3, "word": "staining", "fig": 2}, {"body": 2, "word": "lymphocytes", "fig": 3}, {"body": 3, "word": "antibodies", "fig": 2}, {"body": 3, "word": "spleen", "fig": 2}, {"body": 6, "word": "specific", "fig": 1}, {"body": 5, "word": "II", "fig": 1}, {"body": 4, "word": "MHC", "fig": 1}, {"body": 4, "word": "adult", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "\u0394/\u0394ep2TX", "fig": 1}, {"body": 3, "word": "assessed", "fig": 1}, {"body": 2, "word": "CD4", "fig": 1}, {"body": 2, "word": "marker", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "CD8", "fig": 1}, {"body": 2, "word": "CD11c", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "node", "fig": 1}, {"body": 1, "word": "Gr1", "fig": 1}, {"body": 1, "word": "CD69", "fig": 1}, {"body": 1, "word": "lineage", "fig": 1}, {"body": 1, "word": "double", "fig": 1}, {"body": 1, "word": "Mac1", "fig": 1}, {"body": 1, "word": "FACS", "fig": 1}, {"body": 1, "word": "B220", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig6.jpg", "caption": "Molecular consequences of BRAF/RAF1 deletion in primary keratinocytes and epidermis.(A, B) Immunohistochemical analysis of pERK and pJNK, their downstream targets pRSK and pJUN, and the p38 downstream target pMAPKAPK2 in adult F/F2 and \u0394/\u0394ep2 (A), and F/F2TX \u0394/\u0394ep2TX epidermis (B). Scale bars, 50 \u00b5m. The plots on the right show the percentage of positive cells in the epidermis (n = 4\u20135). (C) Immunoblot analysis of MAPK signaling in 3 weeks old epidermal lysates (n = 4), quantified as in Figure 1F. ACTB is shown as a loading control. Phosphorylation is expressed as the ratio between the signals obtained obtained with the phosphospecific antibody and with the protein-specific antibody. In both cases, the data are normalized to one of the F/F2 samples, which was arbitrarily set as 1. Data are plotted as mean \u00b1 SEM. p1 = 2.73E-4, p2 = 4.15E-5, p3 = 0.042, p4 = 0.031, p5 = 0.001, p6 = 0.023, p7 = 0.038, p8 = 0.049, p9 = 0.010, p10 = 0.030, p11 = 0.033, p12 = 0.023 and p13 = 0.018.DOI: http://dx.doi.org/10.7554/eLife.14012.012", "co_occurrence": [{"body": 27, "word": "epidermis", "fig": 3}, {"body": 76, "word": "Figure", "fig": 1}, {"body": 63, "word": "\u0394/\u0394ep2", "fig": 1}, {"body": 50, "word": "cells", "fig": 1}, {"body": 24, "word": "keratinocytes", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 20, "word": "In", "fig": 1}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 9, "word": "F/F2", "fig": 2}, {"body": 7, "word": "B", "fig": 2}, {"body": 14, "word": "signaling", "fig": 1}, {"body": 5, "word": "A", "fig": 2}, {"body": 8, "word": "weeks", "fig": 1}, {"body": 8, "word": "BRAF/RAF1", "fig": 1}, {"body": 4, "word": "analysis", "fig": 2}, {"body": 7, "word": "old", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "primary", "fig": 1}, {"body": 7, "word": "MAPK", "fig": 1}, {"body": 6, "word": "p38", "fig": 1}, {"body": 5, "word": "data", "fig": 1}, {"body": 4, "word": "set", "fig": 1}, {"body": 4, "word": "expressed", "fig": 1}, {"body": 2, "word": "obtained", "fig": 2}, {"body": 4, "word": "adult", "fig": 1}, {"body": 3, "word": "\u0394/\u0394ep2TX", "fig": 1}, {"body": 3, "word": "samples", "fig": 1}, {"body": 3, "word": "ACTB", "fig": 1}, {"body": 3, "word": "targets", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "pJNK", "fig": 1}, {"body": 3, "word": "pRSK", "fig": 1}, {"body": 3, "word": "deletion", "fig": 1}, {"body": 3, "word": "pJUN", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 1, "word": "downstream", "fig": 2}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 1, "word": "ratio", "fig": 1}, {"body": 1, "word": "one", "fig": 1}, {"body": 1, "word": "1F", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "target", "fig": 1}, {"body": 1, "word": "pERK", "fig": 1}, {"body": 1, "word": "pMAPKAPK2", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig7.jpg", "caption": "MEK/ERK inhibition in RAF1\u0394ep animals phenocopies the \u0394/\u0394ep2 phenotype.RAF1\u0394ep animals were treated with a MEK inhibitor (MEKi; trametinib, daily by gavage for 32 days). (A) Immunoblot of epidermal lysates showing the effect of MEKi on the phosphorylation and expression of the indicated proteins. GAPDH is shown as a loading control. (B) Macroscopic appearance (top panels) and histological analysis of vehicle versus MEKi-treated animals. Mast cells (TB+) and activated mast cells (\u03b21 Tryptase+) are quantified in the plots on the left. Scale bars 25 \u03bcm. (C) Inflammatory chemokines and cytokines in epidermal lysates of MEKi treated-mice. TSLP levels were determined by immunoblotting and quantified and analyzed as in Figure 1F. ACTB served as a loading control. (D) Increased numbers of splenic Mac1+ Gr1+ cells and of activated T cells, B cells and dendritic cells in the lymph nodes of MEKi-treated RAF1\u0394ep animals. (E) Mild monocytosis and granulocytosis in MEKi-treated RAF1\u0394ep animals and elevated amount of plasma IgE. Data represent mean \u00b1 SEM (n = 3; p1 = 0.002, p2 = 0.017, p3 = 0.003, p4 = 0.025, p5 = 0.041, p6 = 0.022, p7 = 0.023, p8 = 0.029, p9 = 0.010, p10 = 0.032, p11 = 0.044, p12 = 0.053, p13 = 0.015, p14 = 0.001, p15 = 0.031, p16 = 0.049, p17 = 0.026, p18 = 0.038, p19 = 0.015, p20 = 0.001, p21 = 0.005, p22 = 0.002, p23 = 0.033, p24 = 0.006, p25 = 0.039, p26 = 0.025, p27 = 0.004, p28 = 0.020, p29 = 0.027 and p30 = 0.028).DOI: http://dx.doi.org/10.7554/eLife.14012.013", "co_occurrence": [{"body": 50, "word": "cells", "fig": 6}, {"body": 26, "word": "animals", "fig": 5}, {"body": 76, "word": "Figure", "fig": 1}, {"body": 63, "word": "\u0394/\u0394ep2", "fig": 1}, {"body": 20, "word": "epidermal", "fig": 2}, {"body": 13, "word": "RAF1\u0394ep", "fig": 3}, {"body": 19, "word": "lysates", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 10, "word": "activated", "fig": 2}, {"body": 16, "word": "TSLP", "fig": 1}, {"body": 15, "word": "phosphorylation", "fig": 1}, {"body": 7, "word": "control", "fig": 2}, {"body": 7, "word": "B", "fig": 2}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 12, "word": "inhibitor", "fig": 1}, {"body": 4, "word": "MEKi", "fig": 3}, {"body": 11, "word": "chemokines", "fig": 1}, {"body": 11, "word": "mast", "fig": 1}, {"body": 9, "word": "lymph", "fig": 1}, {"body": 8, "word": "dendritic", "fig": 1}, {"body": 8, "word": "nodes", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 8, "word": "MEK", "fig": 1}, {"body": 7, "word": "trametinib", "fig": 1}, {"body": 7, "word": "T", "fig": 1}, {"body": 7, "word": "IgE", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "elevated", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 6, "word": "numbers", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "inhibition", "fig": 1}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "days", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "ACTB", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "MEK/ERK", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "\u03b21", "fig": 1}, {"body": 2, "word": "gavage", "fig": 1}, {"body": 2, "word": "effect", "fig": 1}, {"body": 2, "word": "Increased", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "granulocytosis", "fig": 1}, {"body": 2, "word": "daily", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "Inflammatory", "fig": 1}, {"body": 1, "word": "served", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "1F", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "Tryptase+", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig7-figsupp1.jpg", "caption": "Epidermal chemokine and cytokine levels in MEKi treated mice.Inflammatory chemokines and cytokines in epidermal lysates of vehicle or MEKi treated mice. Data represents mean \u00b1 SEM (n = 3; p1 = 0.043, p2 = 0.054 and p3 = 0.029).DOI: http://dx.doi.org/10.7554/eLife.14012.014", "co_occurrence": [{"body": 31, "word": "mice", "fig": 1}, {"body": 20, "word": "epidermal", "fig": 1}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 7, "word": "treated", "fig": 2}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 11, "word": "chemokines", "fig": 1}, {"body": 4, "word": "MEKi", "fig": 2}, {"body": 7, "word": "cytokine", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "Epidermal", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "represents", "fig": 1}, {"body": 1, "word": "chemokine", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig8.jpg", "caption": "D-JNKI1 treatment rescues inflammation in \u0394/\u0394ep2 mice.Mice were treated with D-JNKI1 or TAT peptide (22 mg/kg i.p. at 10 days of age) and analyzed after 12 days (A) D-JNKI1 treatment prevents disease onset in \u0394/\u0394ep2 mice. Immunoblot of epidermal lysates showing the effect of D-JNKI1 on the phosphorylation and expression of the indicated proteins, quantified as in Figure 1F. ACTB is shown as a loading control. (B\u2013D) Decreased eyelid inflammation, mast cells infiltration (B; TB+; quantified in the plot on the right), epidermal chemokine/cytokine levels (C) and activated T cells, B cells and dendritic cells in lymph nodes (D) in D-JNKI1-treated \u0394/\u0394ep2 mice. Scale bars, 25 \u00b5m. Data represent mean \u00b1 SEM (n = 3\u20135; p1 = 0.026, p2 = 0.042, p3 = 0.022, p4 = 0.048, p5 = 0.044, p6 = 0.020, p7 = 0.025, p8 = 0.018, p9 = 0.016, p10 = 0.014, p11 = 0.023, p12 = 0.011, p13 = 0.039, p14 = 0.049, p15 = 0.015, p16 = 0.003, p17 = 1.70E-4, p18 = 0.008, p19 = 0.008, p20 = 0.004, p21 = 0.003, p22 = 0.017, p23 = 0.026, p24 = 0.027, p25 = 0.005, p26 = 2.13E-6, p27 = 4.50E-8, p28 = 1.39E-5, p29 = 0.001, p30 = 0.001, p31 = 0.001, p32 = 0.023, p33 = 2.35E-4, p34 = 0.050, p35 = 0.002, p36 = 0.050 and p37 = 0.012).DOI: http://dx.doi.org/10.7554/eLife.14012.015", "co_occurrence": [{"body": 50, "word": "cells", "fig": 4}, {"body": 63, "word": "\u0394/\u0394ep2", "fig": 3}, {"body": 76, "word": "Figure", "fig": 1}, {"body": 31, "word": "mice", "fig": 2}, {"body": 12, "word": "D-JNKI1", "fig": 4}, {"body": 20, "word": "epidermal", "fig": 2}, {"body": 31, "word": "expression", "fig": 1}, {"body": 31, "word": "disease", "fig": 1}, {"body": 14, "word": "inflammation", "fig": 2}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 15, "word": "phosphorylation", "fig": 1}, {"body": 7, "word": "B", "fig": 2}, {"body": 13, "word": "levels", "fig": 1}, {"body": 6, "word": "treatment", "fig": 2}, {"body": 11, "word": "mast", "fig": 1}, {"body": 10, "word": "activated", "fig": 1}, {"body": 9, "word": "lymph", "fig": 1}, {"body": 8, "word": "nodes", "fig": 1}, {"body": 8, "word": "analyzed", "fig": 1}, {"body": 4, "word": "days", "fig": 2}, {"body": 8, "word": "dendritic", "fig": 1}, {"body": 7, "word": "T", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 6, "word": "peptide", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 4, "word": "proteins", "fig": 1}, {"body": 4, "word": "age", "fig": 1}, {"body": 3, "word": "ACTB", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "onset", "fig": 1}, {"body": 2, "word": "TAT", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "eyelid", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "prevents", "fig": 1}, {"body": 2, "word": "effect", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "chemokine/cytokine", "fig": 1}, {"body": 1, "word": "mg/kg", "fig": 1}, {"body": 1, "word": "infiltration", "fig": 1}, {"body": 1, "word": "i.p", "fig": 1}, {"body": 1, "word": "1F", "fig": 1}, {"body": 1, "word": "Decreased", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig8-figsupp1.jpg", "caption": "K6 expression and epidermal chemokine and cytokine levels in D-JNKI1-treated mice.(A) K6 expression is indistinguishable in TAT or D-JNKI1 treated F/F2 and \u25b3/\u25b3ep2 littermates. Scale bars, 25 \u00b5m. (B) Inflammatory chemokines and cytokines in epidermal lysates of TAT or D-JNKI1-treated mice. Data represent mean \u00b1 SEM (n = 3\u20135; p1 = 0.005, p2 = 0.001, p3 = 0.043, p4 = 0.026, p5 = 0.032, p6 = 0.016 and p7 = 0.051).DOI: http://dx.doi.org/10.7554/eLife.14012.016", "co_occurrence": [{"body": 31, "word": "mice", "fig": 2}, {"body": 31, "word": "expression", "fig": 2}, {"body": 20, "word": "epidermal", "fig": 2}, {"body": 19, "word": "lysates", "fig": 1}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 6, "word": "K6", "fig": 2}, {"body": 12, "word": "D-JNKI1", "fig": 1}, {"body": 11, "word": "chemokines", "fig": 1}, {"body": 9, "word": "F/F2", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "cytokine", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 2, "word": "TAT", "fig": 2}, {"body": 4, "word": "indistinguishable", "fig": 1}, {"body": 2, "word": "littermates", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "Inflammatory", "fig": 1}, {"body": 1, "word": "chemokine", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig8-figsupp2.jpg", "caption": "The inflammatory phenotype of \u0394/\u0394ep2 mice is not rescued by MyD88, caspase 1/11, or TNF knockout.Macroscopic appearance, spleen and lymph node size and circulating blood cell analysis are shown for the indicated genotypes (A\u2013C). (A) Representative pictures of 4 month old \u0394/\u0394ep2, \u0394/\u0394ep2 MyD88-/- and control animals. Plots on the right represent the ratio between total splenocytes or lymph node cell numbers and body weight (n = 3\u20134). (B) Representative pictures and hemogram of 4 month old \u0394/\u0394ep2, \u0394/\u0394ep2 caspase 1/11-/- and control animals (n = 5\u20136). (C) Representative pictures and hemogram of 4 month old \u0394/\u0394ep2, \u0394/\u0394ep2 TNF-/- and control animals (n = 4\u20135). The macroscopic appearance of at least ten mice per genotype was monitored. Data represent mean \u00b1 SEM. p1 = 0.041, p2 = 0.052, p3 = 0.024, p4 = 0.023, p5 = 0.026, p6 = 0.034, p7 = 0.023, p8 = 0.007, p9 = 0.031, p10 = 0.011, and p11 = 0.034.DOI: http://dx.doi.org/10.7554/eLife.14012.017", "co_occurrence": [{"body": 63, "word": "\u0394/\u0394ep2", "fig": 7}, {"body": 26, "word": "animals", "fig": 3}, {"body": 31, "word": "mice", "fig": 2}, {"body": 22, "word": "The", "fig": 2}, {"body": 16, "word": "cell", "fig": 2}, {"body": 7, "word": "old", "fig": 3}, {"body": 7, "word": "control", "fig": 3}, {"body": 9, "word": "lymph", "fig": 2}, {"body": 16, "word": "inflammatory", "fig": 1}, {"body": 5, "word": "caspase", "fig": 2}, {"body": 8, "word": "phenotype", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 6, "word": "numbers", "fig": 1}, {"body": 5, "word": "MyD88", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 5, "word": "blood", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 1, "word": "month", "fig": 3}, {"body": 3, "word": "weight", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "body", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "TNF", "fig": 1}, {"body": 3, "word": "spleen", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "node", "fig": 2}, {"body": 2, "word": "circulating", "fig": 1}, {"body": 2, "word": "genotype", "fig": 1}, {"body": 2, "word": "least", "fig": 1}, {"body": 1, "word": "ratio", "fig": 1}, {"body": 1, "word": "per", "fig": 1}, {"body": 1, "word": "genotypes", "fig": 1}, {"body": 1, "word": "monitored", "fig": 1}, {"body": 1, "word": "size", "fig": 1}, {"body": 1, "word": "splenocytes", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig9.jpg", "caption": "Increased stress kinase signaling and JNK pathway-dependent cytokine and chemokine production by primary keratinocytes lacking BRAF and RAF1.(A) Reduced ERK phosphorylation and increased JNK/p38 activation in primary \u0394/\u0394ep2 keratinocytes stimulated with EGF and/or TNF\u03b1 and IL1\u03b2 for 15 min. (B) Increased cytokine and chemokine production in primary \u0394/\u0394ep2 keratinocytes treated with EGF, TNF\u03b1 and IL1\u03b2 for 24 hr. Cytokine and chemokine production was determined by multiplex analysis, except for TSLP which was quantified by ELISA. Data represent mean \u00b1 SEM of 3\u20135 biological replicates. (C\u2013D) Cells were pretreated with D-JNKI1 inhibitors prior to stimulation with EGF, TNF\u03b1 and IL1\u03b2 for 15 min (C) or 24 hr (D). Data represent the mean \u00b1 SEM of technical replicates (n = 3). (E\u2013F) Effect of shRNA-mediated Mlk3 silencing on ERK and JNK phosphorylation and ICAM1 expression (E; stimulation with EGF, TNF\u03b1 and IL1\u03b2 for 15 min) and on the expression of Ccl2 and Tslp mRNA (F; stimulation with EGF, TNF\u03b1 and IL1\u03b2 for 24 hr) by F/F2 and \u0394/\u0394ep2 keratinocytes. shRen, shRNA targeting Renilla, used as a control; sh1 and sh2, targeting Mlk3, binding sites nucleotide 2266\u20132285 and 2383\u20132402, respectively. The shRNAs were encoded by lentiviral vectors coexpressing GFP. GFP immunoblots are shown to confirm similar levels of infection in all samples. Data represent mean \u00b1 SEM of 4 biological replicates. Each keratinocyte culture represents a pool of three mice. Immunoblots are representative of three independent experiments. p1 = 0.041, p2 = 0.040, p3 = 1.89E-4, p4 = 0.018, p5 = 0.046, p6 = 0.020, p7 = 0.008, p8 = 0.016, p9 = 0.001, p10 = 0.018, p11 = 3.23E-4, p12 = 1.47E-4, p13 = 0.007, p14 = 0.03, p15 = 0.035, p16 = 0.023 and p17 = 0.046.DOI: http://dx.doi.org/10.7554/eLife.14012.018", "co_occurrence": [{"body": 63, "word": "\u0394/\u0394ep2", "fig": 3}, {"body": 24, "word": "keratinocytes", "fig": 4}, {"body": 31, "word": "expression", "fig": 2}, {"body": 30, "word": "ERK", "fig": 2}, {"body": 25, "word": "JNK", "fig": 2}, {"body": 42, "word": "activation", "fig": 1}, {"body": 31, "word": "mice", "fig": 1}, {"body": 15, "word": "phosphorylation", "fig": 2}, {"body": 29, "word": "increased", "fig": 1}, {"body": 5, "word": "EGF", "fig": 5}, {"body": 22, "word": "The", "fig": 1}, {"body": 7, "word": "production", "fig": 3}, {"body": 7, "word": "primary", "fig": 3}, {"body": 19, "word": "RAF1", "fig": 1}, {"body": 19, "word": "BRAF", "fig": 1}, {"body": 16, "word": "TSLP", "fig": 1}, {"body": 3, "word": "TNF\u03b1", "fig": 5}, {"body": 5, "word": "hr", "fig": 3}, {"body": 14, "word": "ICAM1", "fig": 1}, {"body": 14, "word": "signaling", "fig": 1}, {"body": 7, "word": "cytokine", "fig": 2}, {"body": 13, "word": "levels", "fig": 1}, {"body": 12, "word": "D-JNKI1", "fig": 1}, {"body": 10, "word": "inhibitors", "fig": 1}, {"body": 2, "word": "IL1\u03b2", "fig": 5}, {"body": 9, "word": "F/F2", "fig": 1}, {"body": 8, "word": "kinase", "fig": 1}, {"body": 8, "word": "keratinocyte", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 7, "word": "stress", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 2, "word": "mean", "fig": 3}, {"body": 2, "word": "replicates", "fig": 3}, {"body": 2, "word": "stimulation", "fig": 3}, {"body": 6, "word": "D", "fig": 1}, {"body": 2, "word": "Data", "fig": 3}, {"body": 3, "word": "three", "fig": 2}, {"body": 5, "word": "similar", "fig": 1}, {"body": 5, "word": "A", "fig": 1}, {"body": 2, "word": "targeting", "fig": 2}, {"body": 2, "word": "Increased", "fig": 2}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "samples", "fig": 1}, {"body": 3, "word": "lacking", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "mRNA", "fig": 1}, {"body": 1, "word": "min", "fig": 3}, {"body": 3, "word": "independent", "fig": 1}, {"body": 1, "word": "chemokine", "fig": 3}, {"body": 2, "word": "Tslp", "fig": 1}, {"body": 1, "word": "biological", "fig": 2}, {"body": 2, "word": "and/or", "fig": 1}, {"body": 2, "word": "Ccl2", "fig": 1}, {"body": 2, "word": "vectors", "fig": 1}, {"body": 2, "word": "prior", "fig": 1}, {"body": 2, "word": "ELISA", "fig": 1}, {"body": 2, "word": "culture", "fig": 1}, {"body": 2, "word": "binding", "fig": 1}, {"body": 2, "word": "shRNAs", "fig": 1}, {"body": 1, "word": "multiplex", "fig": 1}, {"body": 1, "word": "represents", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "sites", "fig": 1}, {"body": 1, "word": "pretreated", "fig": 1}, {"body": 1, "word": "except", "fig": 1}, {"body": 1, "word": "Each", "fig": 1}, {"body": 1, "word": "lentiviral", "fig": 1}, {"body": 1, "word": "technical", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "shRNA", "fig": 1}, {"body": 1, "word": "stimulated", "fig": 1}, {"body": 1, "word": "Cells", "fig": 1}, {"body": 1, "word": "infection", "fig": 1}, {"body": 1, "word": "Renilla", "fig": 1}, {"body": 1, "word": "pool", "fig": 1}, {"body": 1, "word": "silencing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig9-figsupp1.jpg", "caption": "Compound knockdown (KD2) of BRAF and RAF1 induce the expression of inflammation markers by HaCat cells in a MLK3/JNK-dependent manner.(A) Reduced ERK and increased JNK/p38 activation in BRAF and RAF1 knockdown (KD2) HaCat cells stimulated with EGF, TNF\u03b1 and IL1\u03b2 for 15 min. (B) D-JNKI1 reduces ICAM1 and CCL2 (n = 4) expression in KD2 cells treated with TNF\u03b1. (C) MEKi induces ICAM1 and CCL2 (n = 3) expression in RAF1KD cells treated with TNF\u03b1. In (B\u2013C), ICAM1 expression was measured after a 3 hr, CCL2 expression after a 24 hr treatment with TNF\u03b1. (D) Effect of MLK3 silencing on ERK and JNK phosphorylation in WT and KD2 cells stimulated as in (A). MLK3 was silenced using a pool of oligonucleotides targeting the following regions: 686\u2013704; 1489\u20131507; 2122\u20132138; and 2348\u20132366. MLK3 KD cells stimulated as in (B\u2013C) show a decrease in JNK activation, ICAM1 and CCL2 (n = 7) expression. Immunoblots are representative of three independent experiments. qPCR data represent mean \u00b1 SEM of three independent experiments run in duplicates (p1 = 4.62E-4, p2 = 0.013, p3 = 0.050, p4 = 8.60E-8, p5 = 0.050, p6 = 0.001, p7 = 0.001 and p8 = 0.012).DOI: http://dx.doi.org/10.7554/eLife.14012.019", "co_occurrence": [{"body": 50, "word": "cells", "fig": 6}, {"body": 31, "word": "expression", "fig": 6}, {"body": 42, "word": "activation", "fig": 2}, {"body": 15, "word": "CCL2", "fig": 4}, {"body": 30, "word": "ERK", "fig": 2}, {"body": 14, "word": "ICAM1", "fig": 4}, {"body": 25, "word": "JNK", "fig": 2}, {"body": 15, "word": "MLK3", "fig": 3}, {"body": 19, "word": "RAF1", "fig": 2}, {"body": 19, "word": "BRAF", "fig": 2}, {"body": 29, "word": "increased", "fig": 1}, {"body": 6, "word": "KD2", "fig": 4}, {"body": 20, "word": "In", "fig": 1}, {"body": 15, "word": "phosphorylation", "fig": 1}, {"body": 14, "word": "inflammation", "fig": 1}, {"body": 7, "word": "HaCat", "fig": 2}, {"body": 7, "word": "treated", "fig": 2}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 3, "word": "TNF\u03b1", "fig": 4}, {"body": 12, "word": "D-JNKI1", "fig": 1}, {"body": 11, "word": "using", "fig": 1}, {"body": 5, "word": "hr", "fig": 2}, {"body": 5, "word": "knockdown", "fig": 2}, {"body": 5, "word": "A", "fig": 2}, {"body": 7, "word": "B", "fig": 1}, {"body": 3, "word": "three", "fig": 2}, {"body": 6, "word": "treatment", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 3, "word": "independent", "fig": 2}, {"body": 5, "word": "EGF", "fig": 1}, {"body": 5, "word": "data", "fig": 1}, {"body": 4, "word": "MEKi", "fig": 1}, {"body": 3, "word": "induces", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 1, "word": "stimulated", "fig": 3}, {"body": 2, "word": "show", "fig": 1}, {"body": 2, "word": "WT", "fig": 1}, {"body": 2, "word": "IL1\u03b2", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "decrease", "fig": 1}, {"body": 2, "word": "targeting", "fig": 1}, {"body": 2, "word": "qPCR", "fig": 1}, {"body": 2, "word": "RAF1KD", "fig": 1}, {"body": 1, "word": "induce", "fig": 1}, {"body": 1, "word": "reduces", "fig": 1}, {"body": 1, "word": "silenced", "fig": 1}, {"body": 1, "word": "manner", "fig": 1}, {"body": 1, "word": "min", "fig": 1}, {"body": 1, "word": "pool", "fig": 1}, {"body": 1, "word": "silencing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951198/bin/elife-14012-fig10.jpg", "caption": "Molecular and physiological defects in mice lacking BRAF and RAF1 in the epidermis.Compound BRAF/RAF1 ablation in keratinocytes induces an imbalance in MAPK signaling, resulting in low ERK, high JNK activation. This causes early inside-outside barrier defects accompanied by reduced CDN1 expression (yellow arrows), followed by a breakdown of the immunological barrier and local as well as systemic allergic inflammation akin to atopic dermatitis, characterized by the presence of Th2 cytokines in the epidermis. The phenotype can be prevented by inhibiting the JNK pathway in \u0394/\u0394ep2 animals and cells, and phenocopied by inhibiting the ERK pathway in Raf1\u0394/\u0394ep animals. Systemic effects (lymph node involvement, circulating IgEs) are separated from local effect by a dashed line. B (B cells), T (T cells), Mc (Mast cells), D (dendritic cells).DOI: http://dx.doi.org/10.7554/eLife.14012.020", "co_occurrence": [{"body": 50, "word": "cells", "fig": 5}, {"body": 63, "word": "\u0394/\u0394ep2", "fig": 1}, {"body": 30, "word": "ERK", "fig": 2}, {"body": 26, "word": "animals", "fig": 2}, {"body": 25, "word": "JNK", "fig": 2}, {"body": 42, "word": "activation", "fig": 1}, {"body": 31, "word": "mice", "fig": 1}, {"body": 31, "word": "expression", "fig": 1}, {"body": 27, "word": "epidermis", "fig": 1}, {"body": 12, "word": "barrier", "fig": 2}, {"body": 24, "word": "keratinocytes", "fig": 1}, {"body": 22, "word": "reduced", "fig": 1}, {"body": 22, "word": "The", "fig": 1}, {"body": 21, "word": "dermatitis", "fig": 1}, {"body": 20, "word": "atopic", "fig": 1}, {"body": 19, "word": "RAF1", "fig": 1}, {"body": 19, "word": "BRAF", "fig": 1}, {"body": 14, "word": "inflammation", "fig": 1}, {"body": 7, "word": "B", "fig": 2}, {"body": 14, "word": "signaling", "fig": 1}, {"body": 7, "word": "pathway", "fig": 2}, {"body": 7, "word": "T", "fig": 2}, {"body": 13, "word": "cytokines", "fig": 1}, {"body": 13, "word": "ablation", "fig": 1}, {"body": 12, "word": "well", "fig": 1}, {"body": 9, "word": "allergic", "fig": 1}, {"body": 9, "word": "lymph", "fig": 1}, {"body": 8, "word": "systemic", "fig": 1}, {"body": 4, "word": "defects", "fig": 2}, {"body": 8, "word": "dendritic", "fig": 1}, {"body": 8, "word": "phenotype", "fig": 1}, {"body": 8, "word": "BRAF/RAF1", "fig": 1}, {"body": 7, "word": "effects", "fig": 1}, {"body": 7, "word": "MAPK", "fig": 1}, {"body": 6, "word": "IgEs", "fig": 1}, {"body": 6, "word": "D", "fig": 1}, {"body": 6, "word": "characterized", "fig": 1}, {"body": 5, "word": "imbalance", "fig": 1}, {"body": 5, "word": "This", "fig": 1}, {"body": 2, "word": "local", "fig": 2}, {"body": 4, "word": "causes", "fig": 1}, {"body": 4, "word": "line", "fig": 1}, {"body": 3, "word": "lacking", "fig": 1}, {"body": 3, "word": "induces", "fig": 1}, {"body": 3, "word": "low", "fig": 1}, {"body": 3, "word": "Th2", "fig": 1}, {"body": 2, "word": "circulating", "fig": 1}, {"body": 2, "word": "prevented", "fig": 1}, {"body": 2, "word": "resulting", "fig": 1}, {"body": 2, "word": "presence", "fig": 1}, {"body": 1, "word": "inhibiting", "fig": 2}, {"body": 2, "word": "effect", "fig": 1}, {"body": 2, "word": "immunological", "fig": 1}, {"body": 1, "word": "inside-outside", "fig": 1}, {"body": 1, "word": "early", "fig": 1}, {"body": 1, "word": "accompanied", "fig": 1}, {"body": 1, "word": "involvement", "fig": 1}, {"body": 1, "word": "high", "fig": 1}, {"body": 1, "word": "node", "fig": 1}]}], "4047890": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047890/bin/cddis2014174f1.jpg", "caption": "Plasma and hepatic OPN expression is increased in response to liver I\u2013R and the OPN deficiency increased hepatic I\u2013R injury. Wt (n=8\u201310) and Opn\u2212/\u2212 (Opn\u2212/\u2212) (n=5) mice underwent ischemia for 45 min followed by 4 h of reperfusion. SHAM controls (n=4\u20136) underwent the same procedure but without vascular occlusion. (a) The plasma level of OPN was evaluated before and after I\u2013R in Wt mice. (b) Hepatic expression of OPN was evaluated in I\u2013R lobes from Wt mice (Wt I\u2013R) versus SHAM mice. (c) The plasma level of ALT and AST was evaluated before and after I\u2013R in Wt, Opn\u2212/\u2212 and in SHAM mice. Results were expressed as means\u00b1S.E.M. Data were statistically analyzed using the Mann\u2013Whitney test. *versus before I\u2013R (a) or SHAM (b and c); $versus Wt I\u2013R (c). P<0.05. (d) H&E staining of liver samples from Wt, Opn\u2212/\u2212 after I\u2013R and SHAM mice. Typical pictures are shown. Dotted lines and arrows limit areas of necrosis; PT indicates portal triad; CLV indicates centrolobular vein. (e) The TUNEL assay was performed on liver sections as described in the Materials and Methods section. The liver sections were then counterstained with hematoxylin. Typical pictures are shown. (f) The level of caspase 3 activity was evaluated from a total lysate of control and I\u2013R lobes from Wt (Wt Ctr; Wt I\u2013R) (n=7), Opn\u2212/\u2212 (Opn\u2212/\u2212 Ctr; Opn\u2212/\u2212 I\u2013R) (n=5) and SHAM mice (n=5). Results were expressed as means\u00b1S.E.M. Data were statistically analyzed using the Mann\u2013Whitney test. \u2260versus SHAM, #versus Wt Ctr and *versus Opn\u2212/\u2212 Ctr. P<0.05", "co_occurrence": [{"body": 59, "word": "I\u2013R", "fig": 12}, {"body": 137, "word": "OPN", "fig": 4}, {"body": 48, "word": "The", "fig": 5}, {"body": 33, "word": "mice", "fig": 7}, {"body": 49, "word": "liver", "fig": 4}, {"body": 17, "word": "Wt", "fig": 11}, {"body": 17, "word": "Opn\u2212/\u2212", "fig": 8}, {"body": 44, "word": "expression", "fig": 2}, {"body": 21, "word": "evaluated", "fig": 4}, {"body": 19, "word": "Ctr", "fig": 4}, {"body": 30, "word": "hepatic", "fig": 2}, {"body": 19, "word": "level", "fig": 3}, {"body": 8, "word": "SHAM", "fig": 7}, {"body": 40, "word": "injury", "fig": 1}, {"body": 18, "word": "increased", "fig": 2}, {"body": 31, "word": "response", "fig": 1}, {"body": 14, "word": "using", "fig": 2}, {"body": 8, "word": "versus", "fig": 3}, {"body": 24, "word": "deficiency", "fig": 1}, {"body": 11, "word": "shown", "fig": 2}, {"body": 5, "word": "c", "fig": 3}, {"body": 13, "word": "h", "fig": 1}, {"body": 6, "word": "plasma", "fig": 2}, {"body": 6, "word": "expressed", "fig": 2}, {"body": 6, "word": "lobes", "fig": 2}, {"body": 11, "word": "necrosis", "fig": 1}, {"body": 10, "word": "min", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 9, "word": "reperfusion", "fig": 1}, {"body": 9, "word": "activity", "fig": 1}, {"body": 9, "word": "ischemia", "fig": 1}, {"body": 8, "word": "caspase", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 7, "word": "ALT", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 2}, {"body": 3, "word": "test", "fig": 2}, {"body": 5, "word": "followed", "fig": 1}, {"body": 5, "word": "performed", "fig": 1}, {"body": 2, "word": "P", "fig": 2}, {"body": 2, "word": "underwent", "fig": 2}, {"body": 2, "word": "statistically", "fig": 2}, {"body": 2, "word": "Mann\u2013Whitney", "fig": 2}, {"body": 4, "word": "Hepatic", "fig": 1}, {"body": 2, "word": "b", "fig": 2}, {"body": 2, "word": "Results", "fig": 2}, {"body": 3, "word": "TUNEL", "fig": 1}, {"body": 3, "word": "areas", "fig": 1}, {"body": 3, "word": "AST", "fig": 1}, {"body": 3, "word": "procedure", "fig": 1}, {"body": 2, "word": "vascular", "fig": 1}, {"body": 1, "word": "sections", "fig": 2}, {"body": 2, "word": "described", "fig": 1}, {"body": 1, "word": "Data", "fig": 2}, {"body": 2, "word": "hematoxylin", "fig": 1}, {"body": 1, "word": "staining", "fig": 1}, {"body": 1, "word": "controls", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "H", "fig": 1}, {"body": 1, "word": "occlusion", "fig": 1}, {"body": 1, "word": "arrows", "fig": 1}, {"body": 1, "word": "Plasma", "fig": 1}, {"body": 1, "word": "total", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "counterstained", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "portal", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "lines", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047890/bin/cddis2014174f2.jpg", "caption": "OPN deficiency aggravated the liver inflammation induced by I\u2013R. The gene expression of iNOS (a), TNF\u03b1 (b), IL6 (c) and IFN\u03b3 (d) was evaluated for control and ischemic-reperfused lobes (ischemia for 45 min and then 4 h of reperfusion) from Wt (Wt Ctr; Wt I\u2013R) (n=8\u201310), Opn\u2212/\u2212 (Opn\u2212/\u2212 Ctr; Opn\u2212/\u2212 I\u2013R) (n=5) and SHAM mice (n=4\u20136). The mRNA levels were normalized to RPLP0 mRNA levels and expressed as fold stimulation\u00b1S.E.M. versus SHAM or Wt Ctr. Data were statistically analyzed using the Mann\u2013Whitney test. \u00a4versus SHAM, *versus Wt Ctr, $versus Wt I\u2013R and #versus Opn\u2212/\u2212 Ctr. P<0.05", "co_occurrence": [{"body": 59, "word": "I\u2013R", "fig": 4}, {"body": 137, "word": "OPN", "fig": 1}, {"body": 17, "word": "Wt", "fig": 6}, {"body": 48, "word": "The", "fig": 2}, {"body": 19, "word": "Ctr", "fig": 5}, {"body": 17, "word": "Opn\u2212/\u2212", "fig": 4}, {"body": 49, "word": "liver", "fig": 1}, {"body": 44, "word": "expression", "fig": 1}, {"body": 33, "word": "mice", "fig": 1}, {"body": 28, "word": "TNF\u03b1", "fig": 1}, {"body": 25, "word": "iNOS", "fig": 1}, {"body": 24, "word": "deficiency", "fig": 1}, {"body": 8, "word": "versus", "fig": 3}, {"body": 8, "word": "SHAM", "fig": 3}, {"body": 22, "word": "induced", "fig": 1}, {"body": 11, "word": "levels", "fig": 2}, {"body": 21, "word": "evaluated", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 10, "word": "min", "fig": 1}, {"body": 9, "word": "ischemia", "fig": 1}, {"body": 9, "word": "reperfusion", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 8, "word": "IL6", "fig": 1}, {"body": 7, "word": "inflammation", "fig": 1}, {"body": 6, "word": "expressed", "fig": 1}, {"body": 6, "word": "IFN\u03b3", "fig": 1}, {"body": 6, "word": "lobes", "fig": 1}, {"body": 6, "word": "gene", "fig": 1}, {"body": 5, "word": "aggravated", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 3, "word": "test", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 2, "word": "RPLP0", "fig": 1}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 2, "word": "Mann\u2013Whitney", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 1, "word": "mRNA", "fig": 2}, {"body": 2, "word": "b", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047890/bin/cddis2014174f3.jpg", "caption": "OPN deficiency decreased primary and AML12 hepatocyte viability and caused decreased Bcl2 expression. (a) The viability of hepatocytes freshly isolated from Opn+/+ (n=10) and Wt livers (n=4) was evaluated by trypan blue exclusion. (b\u2013e) After silencing of OPN with siRNA in AML12 cells, the cell viability (MTT assay) (b) and LDH release (c) were evaluated after 16 h in DMEM, 4.5 g/l glucose supplemented with 0.5% BSA (n=6). Expression of Bcl2 was also evaluated at the mRNA ((d), n=3) and protein levels ((e), n=2). (f\u2013g) Hepatic expression of Bcl2 was evaluated in I\u2013R lobes from Opn\u2212/\u2212 and Wt mice (Wt I\u2013R) versus SHAM mice by immunoblotting ((f), three mice per group). Results from (f) were analyzed by densitometry (g). (a\u2013d and g) Results were expressed as means\u00b1S.E.M. Data were statistically analyzed using the Mann\u2013Whitney or Student's t-test. *P<0.05", "co_occurrence": [{"body": 137, "word": "OPN", "fig": 2}, {"body": 59, "word": "I\u2013R", "fig": 2}, {"body": 33, "word": "mice", "fig": 3}, {"body": 44, "word": "expression", "fig": 2}, {"body": 21, "word": "evaluated", "fig": 4}, {"body": 17, "word": "Wt", "fig": 3}, {"body": 16, "word": "Bcl2", "fig": 3}, {"body": 48, "word": "The", "fig": 1}, {"body": 12, "word": "viability", "fig": 3}, {"body": 36, "word": "cells", "fig": 1}, {"body": 33, "word": "hepatocytes", "fig": 1}, {"body": 16, "word": "AML12", "fig": 2}, {"body": 32, "word": "also", "fig": 1}, {"body": 29, "word": "cell", "fig": 1}, {"body": 24, "word": "deficiency", "fig": 1}, {"body": 22, "word": "silencing", "fig": 1}, {"body": 17, "word": "Opn\u2212/\u2212", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 11, "word": "release", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 5, "word": "decreased", "fig": 2}, {"body": 10, "word": "hepatocyte", "fig": 1}, {"body": 9, "word": "supplemented", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 9, "word": "LDH", "fig": 1}, {"body": 8, "word": "versus", "fig": 1}, {"body": 8, "word": "SHAM", "fig": 1}, {"body": 8, "word": "'s", "fig": 1}, {"body": 7, "word": "protein", "fig": 1}, {"body": 6, "word": "caused", "fig": 1}, {"body": 6, "word": "expressed", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 2}, {"body": 3, "word": "g", "fig": 2}, {"body": 6, "word": "lobes", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "primary", "fig": 1}, {"body": 5, "word": "siRNA", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 4, "word": "per", "fig": 1}, {"body": 4, "word": "glucose", "fig": 1}, {"body": 4, "word": "Hepatic", "fig": 1}, {"body": 4, "word": "MTT", "fig": 1}, {"body": 4, "word": "g/l", "fig": 1}, {"body": 2, "word": "Results", "fig": 2}, {"body": 3, "word": "DMEM", "fig": 1}, {"body": 3, "word": "isolated", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 1, "word": "f", "fig": 2}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "Mann\u2013Whitney", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "livers", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "exclusion", "fig": 1}, {"body": 1, "word": "blue", "fig": 1}, {"body": 1, "word": "mRNA", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "n=3", "fig": 1}, {"body": 1, "word": "trypan", "fig": 1}, {"body": 1, "word": "freshly", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047890/bin/cddis2014174f4.jpg", "caption": "OPN silencing sensitized AML12 hepatocytes to cell death induced by OGD and caused increased NQO1 expression and decreased ATP levels. After silencing of OPN with siRNA in AML12 cells, cell viability (MTT assay) (a) (n=6), LDH release (b) (n=6), cell apoptosis (c) (n=4), cleaved caspase 3 level (d) (n=2), the ATP level (e) (n=4) and gene expression of NQO1 (f) (n=3) were evaluated in the basal state and in response to KCN (2.5, 5 or 10 mM as indicated) after 1 h in DMEM without glucose, followed by a 16- (a, b and f) or 2-h (c, d and e) restoration period in DMEM, 4.5 g/l glucose supplemented with 0.5% BSA. Results relative to either its own control (si Ctr or si OPN) (a and b) or si Ctr (c, d and f) were expressed as means\u00b1S.E.M. Data were statistically analyzed using Student's t-test. *P<0.05", "co_occurrence": [{"body": 137, "word": "OPN", "fig": 3}, {"body": 44, "word": "expression", "fig": 2}, {"body": 29, "word": "cell", "fig": 3}, {"body": 22, "word": "silencing", "fig": 2}, {"body": 14, "word": "si", "fig": 3}, {"body": 19, "word": "level", "fig": 2}, {"body": 19, "word": "Ctr", "fig": 2}, {"body": 36, "word": "cells", "fig": 1}, {"body": 33, "word": "hepatocytes", "fig": 1}, {"body": 16, "word": "AML12", "fig": 2}, {"body": 31, "word": "response", "fig": 1}, {"body": 12, "word": "ATP", "fig": 2}, {"body": 22, "word": "induced", "fig": 1}, {"body": 21, "word": "evaluated", "fig": 1}, {"body": 18, "word": "increased", "fig": 1}, {"body": 15, "word": "death", "fig": 1}, {"body": 5, "word": "c", "fig": 3}, {"body": 15, "word": "mM", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 13, "word": "apoptosis", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 12, "word": "viability", "fig": 1}, {"body": 11, "word": "release", "fig": 1}, {"body": 11, "word": "basal", "fig": 1}, {"body": 11, "word": "indicated", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 11, "word": "OGD", "fig": 1}, {"body": 9, "word": "supplemented", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 9, "word": "LDH", "fig": 1}, {"body": 4, "word": "NQO1", "fig": 2}, {"body": 8, "word": "caspase", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 4, "word": "glucose", "fig": 2}, {"body": 8, "word": "'s", "fig": 1}, {"body": 7, "word": "state", "fig": 1}, {"body": 7, "word": "without", "fig": 1}, {"body": 6, "word": "caused", "fig": 1}, {"body": 6, "word": "expressed", "fig": 1}, {"body": 6, "word": "KCN", "fig": 1}, {"body": 6, "word": "gene", "fig": 1}, {"body": 3, "word": "DMEM", "fig": 2}, {"body": 2, "word": "b", "fig": 3}, {"body": 5, "word": "decreased", "fig": 1}, {"body": 5, "word": "sensitized", "fig": 1}, {"body": 5, "word": "followed", "fig": 1}, {"body": 5, "word": "period", "fig": 1}, {"body": 5, "word": "siRNA", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 4, "word": "MTT", "fig": 1}, {"body": 4, "word": "g/l", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "restoration", "fig": 1}, {"body": 1, "word": "f", "fig": 3}, {"body": 2, "word": "relative", "fig": 1}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "e", "fig": 2}, {"body": 2, "word": "Results", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "2-h", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "n=3", "fig": 1}, {"body": 1, "word": "cleaved", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047890/bin/cddis2014174f5.jpg", "caption": "OPN silencing sensitized AML12 hepatocytes to cell death induced by TNF\u03b1. After silencing of OPN with siRNA in AML12 cells, the cell viability (MTT assay) (a) and LDH release (b) were evaluated in response to TNF\u03b1 (20 ng/ml) for 16 h in DMEM, 4.5 g/l glucose supplemented with 0.5% BSA (n=3). As OPN silencing affected the basal cell viability, the results were expressed as a function of the corresponding basal state (si Ctr or si OPN, respectively) and as means\u00b1S.E.M. Data were statistically analyzed using Student's t-test. *P<0.05", "co_occurrence": [{"body": 137, "word": "OPN", "fig": 4}, {"body": 29, "word": "cell", "fig": 3}, {"body": 22, "word": "silencing", "fig": 3}, {"body": 28, "word": "TNF\u03b1", "fig": 2}, {"body": 36, "word": "cells", "fig": 1}, {"body": 33, "word": "hepatocytes", "fig": 1}, {"body": 16, "word": "AML12", "fig": 2}, {"body": 31, "word": "response", "fig": 1}, {"body": 14, "word": "si", "fig": 2}, {"body": 12, "word": "viability", "fig": 2}, {"body": 22, "word": "induced", "fig": 1}, {"body": 11, "word": "basal", "fig": 2}, {"body": 21, "word": "evaluated", "fig": 1}, {"body": 19, "word": "Ctr", "fig": 1}, {"body": 15, "word": "death", "fig": 1}, {"body": 14, "word": "using", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 11, "word": "As", "fig": 1}, {"body": 11, "word": "release", "fig": 1}, {"body": 9, "word": "LDH", "fig": 1}, {"body": 9, "word": "supplemented", "fig": 1}, {"body": 9, "word": "assay", "fig": 1}, {"body": 8, "word": "'s", "fig": 1}, {"body": 7, "word": "state", "fig": 1}, {"body": 6, "word": "results", "fig": 1}, {"body": 6, "word": "expressed", "fig": 1}, {"body": 5, "word": "siRNA", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 5, "word": "sensitized", "fig": 1}, {"body": 4, "word": "glucose", "fig": 1}, {"body": 4, "word": "MTT", "fig": 1}, {"body": 4, "word": "g/l", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "DMEM", "fig": 1}, {"body": 2, "word": "ng/ml", "fig": 1}, {"body": 2, "word": "affected", "fig": 1}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 2, "word": "function", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "n=3", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047890/bin/cddis2014174f6.jpg", "caption": "OPN deficiency increased iNOS expression in the basal state and sensitized macrophages to inflammatory signals. After silencing of OPN with siRNA in RAW macrophages, the gene expression of OPN, its receptors (CD44, integrins \u03b21, \u03b1V and \u03b23) (a) and inflammation (iNOS and the cytokines IL1\u03b2, TNF\u03b1 and IL6) (b) were evaluated in the basal state (n=3). (c) After silencing of OPN with siRNA, RAW macrophages were incubated or not with LPS (100 ng/ml) for 6 h. The gene expression of iNOS, IL1\u03b2, TNF\u03b1 and IL6 was then evaluated (n=3). The mRNA levels were normalized to RPLP0 mRNA levels and expressed as fold stimulation\u00b1S.E.M. versus si Ctr or si Ctr plus LPS. Data were statistically analyzed using the Mann\u2013Whitney or Student's t-test. *versus si Ctr and $versus si Ctr plus LPS. P<0.05", "co_occurrence": [{"body": 137, "word": "OPN", "fig": 4}, {"body": 44, "word": "expression", "fig": 3}, {"body": 48, "word": "The", "fig": 2}, {"body": 19, "word": "Ctr", "fig": 4}, {"body": 25, "word": "iNOS", "fig": 3}, {"body": 19, "word": "macrophages", "fig": 3}, {"body": 28, "word": "TNF\u03b1", "fig": 2}, {"body": 14, "word": "si", "fig": 4}, {"body": 22, "word": "silencing", "fig": 2}, {"body": 21, "word": "evaluated", "fig": 2}, {"body": 24, "word": "deficiency", "fig": 1}, {"body": 11, "word": "basal", "fig": 2}, {"body": 11, "word": "levels", "fig": 2}, {"body": 18, "word": "increased", "fig": 1}, {"body": 6, "word": "LPS", "fig": 3}, {"body": 8, "word": "versus", "fig": 2}, {"body": 8, "word": "RAW", "fig": 2}, {"body": 8, "word": "IL6", "fig": 2}, {"body": 7, "word": "state", "fig": 2}, {"body": 14, "word": "using", "fig": 1}, {"body": 13, "word": "inflammatory", "fig": 1}, {"body": 6, "word": "gene", "fig": 2}, {"body": 5, "word": "siRNA", "fig": 2}, {"body": 5, "word": "After", "fig": 2}, {"body": 8, "word": "'s", "fig": 1}, {"body": 7, "word": "inflammation", "fig": 1}, {"body": 6, "word": "expressed", "fig": 1}, {"body": 3, "word": "IL1\u03b2", "fig": 2}, {"body": 5, "word": "sensitized", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 4, "word": "signals", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "CD44", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "mRNA", "fig": 2}, {"body": 2, "word": "Student", "fig": 1}, {"body": 2, "word": "RPLP0", "fig": 1}, {"body": 2, "word": "incubated", "fig": 1}, {"body": 1, "word": "n=3", "fig": 2}, {"body": 2, "word": "\u03b21", "fig": 1}, {"body": 2, "word": "Mann\u2013Whitney", "fig": 1}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "ng/ml", "fig": 1}, {"body": 2, "word": "b", "fig": 1}, {"body": 2, "word": "\u03b23", "fig": 1}, {"body": 1, "word": "\u03b1V", "fig": 1}, {"body": 1, "word": "receptors", "fig": 1}, {"body": 1, "word": "integrins", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047890/bin/cddis2014174f7.jpg", "caption": "Schematic representation showing the potential roles of OPN in hepatic I\u2013R injury. The hepatic I\u2013R with 45 min of ischemia followed by 4 h of reperfusion induced upregulation of OPN and revealed its protective role in I\u2013R injury. Endogenous OPN in hepatocytes conferred partial resistance to cell death induced by OGD and TNF\u03b1. This could be mediated by the regulation of the Bcl2 and ATP levels by OPN. Endogenous OPN in macrophages also mediated negative feedback on iNOS-derived NO production and partially limited liver macrophage activation and TNF\u03b1 production in response to an inflammatory signal. The decreased rate of death of hepatocytes could consequently decrease the activation of liver macrophages and thus macrophage-mediated NO and TNF\u03b1 release. Finally, lowering TNF\u03b1 and NO levels could prevent additional hepatocyte injury induced by inflammation", "co_occurrence": [{"body": 137, "word": "OPN", "fig": 5}, {"body": 59, "word": "I\u2013R", "fig": 3}, {"body": 40, "word": "injury", "fig": 3}, {"body": 28, "word": "TNF\u03b1", "fig": 4}, {"body": 49, "word": "liver", "fig": 2}, {"body": 48, "word": "The", "fig": 2}, {"body": 33, "word": "hepatocytes", "fig": 2}, {"body": 22, "word": "induced", "fig": 3}, {"body": 30, "word": "hepatic", "fig": 2}, {"body": 20, "word": "could", "fig": 3}, {"body": 17, "word": "NO", "fig": 3}, {"body": 19, "word": "macrophages", "fig": 2}, {"body": 32, "word": "also", "fig": 1}, {"body": 31, "word": "response", "fig": 1}, {"body": 15, "word": "death", "fig": 2}, {"body": 29, "word": "cell", "fig": 1}, {"body": 11, "word": "levels", "fig": 2}, {"body": 16, "word": "role", "fig": 1}, {"body": 16, "word": "Bcl2", "fig": 1}, {"body": 7, "word": "activation", "fig": 2}, {"body": 7, "word": "mediated", "fig": 2}, {"body": 13, "word": "inflammatory", "fig": 1}, {"body": 13, "word": "h", "fig": 1}, {"body": 12, "word": "ATP", "fig": 1}, {"body": 11, "word": "OGD", "fig": 1}, {"body": 11, "word": "protective", "fig": 1}, {"body": 11, "word": "release", "fig": 1}, {"body": 10, "word": "upregulation", "fig": 1}, {"body": 10, "word": "min", "fig": 1}, {"body": 10, "word": "hepatocyte", "fig": 1}, {"body": 5, "word": "production", "fig": 2}, {"body": 9, "word": "ischemia", "fig": 1}, {"body": 9, "word": "This", "fig": 1}, {"body": 9, "word": "reperfusion", "fig": 1}, {"body": 7, "word": "decrease", "fig": 1}, {"body": 7, "word": "inflammation", "fig": 1}, {"body": 7, "word": "iNOS-derived", "fig": 1}, {"body": 6, "word": "thus", "fig": 1}, {"body": 5, "word": "followed", "fig": 1}, {"body": 5, "word": "resistance", "fig": 1}, {"body": 5, "word": "decreased", "fig": 1}, {"body": 4, "word": "negative", "fig": 1}, {"body": 4, "word": "regulation", "fig": 1}, {"body": 2, "word": "Endogenous", "fig": 2}, {"body": 3, "word": "partial", "fig": 1}, {"body": 3, "word": "additional", "fig": 1}, {"body": 3, "word": "macrophage", "fig": 1}, {"body": 3, "word": "signal", "fig": 1}, {"body": 2, "word": "limited", "fig": 1}, {"body": 2, "word": "feedback", "fig": 1}, {"body": 2, "word": "potential", "fig": 1}, {"body": 2, "word": "conferred", "fig": 1}, {"body": 2, "word": "consequently", "fig": 1}, {"body": 1, "word": "lowering", "fig": 1}, {"body": 1, "word": "macrophage-mediated", "fig": 1}, {"body": 1, "word": "rate", "fig": 1}, {"body": 1, "word": "revealed", "fig": 1}, {"body": 1, "word": "partially", "fig": 1}, {"body": 1, "word": "roles", "fig": 1}, {"body": 1, "word": "prevent", "fig": 1}, {"body": 1, "word": "Finally", "fig": 1}]}], "3843111": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f001.jpg", "caption": "Identification of Tip60-p400-interacting proteins in ESCs.(A) Silver stained gel of purified Tip60 complex from Tip60-H3F ESCs and MEFs, along with untagged control cells. (B) Validation of Hdac6 interaction. Western blots for Hdac6, p400, and Dmap1 following immunoprecipitation with anti-FLAG antibody from nuclear extracts derived from the indicated ESC lines. (C) Tip60 complexes purified from Tip60-H3F ESC and MEF nuclear extracts were subjected to Western blotting for Hdac6, Dmap1, and FLAG. (D) Tip60-H3F was immunoprecipitated from MEF whole cell extracts as above and blotted for the indicated proteins.DOI: http://dx.doi.org/10.7554/eLife.01557.003", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 3}, {"body": 79, "word": "ESCs", "fig": 2}, {"body": 72, "word": "Tip60", "fig": 2}, {"body": 53, "word": "cells", "fig": 1}, {"body": 47, "word": "complex", "fig": 1}, {"body": 15, "word": "Tip60-H3F", "fig": 3}, {"body": 21, "word": "nuclear", "fig": 2}, {"body": 33, "word": "cell", "fig": 1}, {"body": 15, "word": "ESC", "fig": 2}, {"body": 11, "word": "purified", "fig": 2}, {"body": 22, "word": "interaction", "fig": 1}, {"body": 15, "word": "proteins", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 4, "word": "extracts", "fig": 3}, {"body": 5, "word": "Western", "fig": 2}, {"body": 10, "word": "MEFs", "fig": 1}, {"body": 10, "word": "p400", "fig": 1}, {"body": 9, "word": "lines", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "immunoprecipitation", "fig": 1}, {"body": 3, "word": "indicated", "fig": 2}, {"body": 5, "word": "blotting", "fig": 1}, {"body": 5, "word": "complexes", "fig": 1}, {"body": 2, "word": "Dmap1", "fig": 2}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 4, "word": "immunoprecipitated", "fig": 1}, {"body": 2, "word": "MEF", "fig": 2}, {"body": 4, "word": "untagged", "fig": 1}, {"body": 3, "word": "whole", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "antibody", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "Tip60-p400-interacting", "fig": 1}, {"body": 2, "word": "along", "fig": 1}, {"body": 2, "word": "gel", "fig": 1}, {"body": 1, "word": "derived", "fig": 1}, {"body": 1, "word": "following", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs001.jpg", "caption": "Targeting of H3F tag to C-terminus of endogenous Tip60 gene.Shown are the 3' end of the Tip60 gene plus downstream sequence (below) and the targeting construct for introducing the C-terminal tandem 6-His-3-FLAG (H3F) tag (above). The counter-selection cassette within the targeting construct is omitted for brevity. See \u2018Materials and methods\u2019 for details of ESC targeting.DOI: http://dx.doi.org/10.7554/eLife.01557.004", "co_occurrence": [{"body": 72, "word": "Tip60", "fig": 2}, {"body": 31, "word": "gene", "fig": 1}, {"body": 30, "word": "The", "fig": 1}, {"body": 18, "word": "within", "fig": 1}, {"body": 15, "word": "ESC", "fig": 1}, {"body": 9, "word": "downstream", "fig": 1}, {"body": 2, "word": "tag", "fig": 2}, {"body": 2, "word": "H3F", "fig": 2}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "endogenous", "fig": 1}, {"body": 2, "word": "C-terminus", "fig": 1}, {"body": 2, "word": "end", "fig": 1}, {"body": 1, "word": "targeting", "fig": 2}, {"body": 2, "word": "plus", "fig": 1}, {"body": 1, "word": "sequence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs002.jpg", "caption": "Reciprocal co-immunoprecipitation of Tip60 and Hdac6.(Above) Immunoprecipitations from untagged or Hdac6-H3F ESCs with or without stable expression of Tip60-GFP (as indicated) were subjected to Western blotting for Tip60-GFP or Hdac6. (Below) Mild overexpression of Tip60 in Tip60-GFP cells. RT-qPCR of Tip60 or Hdac6 in untagged and Hdac6-H3F cells stably expressing Tip60-GFP.DOI: http://dx.doi.org/10.7554/eLife.01557.005", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 3}, {"body": 72, "word": "Tip60", "fig": 3}, {"body": 53, "word": "cells", "fig": 2}, {"body": 79, "word": "ESCs", "fig": 1}, {"body": 28, "word": "expression", "fig": 1}, {"body": 4, "word": "untagged", "fig": 2}, {"body": 5, "word": "blotting", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "without", "fig": 1}, {"body": 1, "word": "Hdac6-H3F", "fig": 2}, {"body": 2, "word": "RT-qPCR", "fig": 1}, {"body": 2, "word": "stable", "fig": 1}, {"body": 1, "word": "co-immunoprecipitation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs003.jpg", "caption": "Hdac6 does not interact with RNA Polymerase II in ESCs.Western blot of purified Tip60 complex from ESCs for RNA polymerase II (RNA Pol II) and Dmap1. (Tip60-p400 subunit Dmap1 is shown to confirm the presence of subunits of Tip60-p400 complex after purification.)DOI: http://dx.doi.org/10.7554/eLife.01557.006", "co_occurrence": [{"body": 110, "word": "Tip60-p400", "fig": 2}, {"body": 195, "word": "Hdac6", "fig": 1}, {"body": 47, "word": "complex", "fig": 2}, {"body": 79, "word": "ESCs", "fig": 1}, {"body": 72, "word": "Tip60", "fig": 1}, {"body": 10, "word": "II", "fig": 3}, {"body": 16, "word": "subunits", "fig": 1}, {"body": 5, "word": "RNA", "fig": 3}, {"body": 11, "word": "purified", "fig": 1}, {"body": 9, "word": "subunit", "fig": 1}, {"body": 8, "word": "purification", "fig": 1}, {"body": 5, "word": "Pol", "fig": 1}, {"body": 2, "word": "Dmap1", "fig": 2}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 2, "word": "interact", "fig": 1}, {"body": 2, "word": "confirm", "fig": 1}, {"body": 1, "word": "presence", "fig": 1}, {"body": 1, "word": "Polymerase", "fig": 1}, {"body": 1, "word": "polymerase", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs004.jpg", "caption": "Hdac6 interaction with Tip60-p400 is independent of DNA.DNase I (left) or ethidium bromide (right) was added into nuclear extracts during immunoprecipitation, and the Tip60-interacting proteins were analyzed by Western blotting with the indicated antibodies.DOI: http://dx.doi.org/10.7554/eLife.01557.007", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 1}, {"body": 110, "word": "Tip60-p400", "fig": 1}, {"body": 22, "word": "interaction", "fig": 1}, {"body": 21, "word": "nuclear", "fig": 1}, {"body": 15, "word": "proteins", "fig": 1}, {"body": 7, "word": "immunoprecipitation", "fig": 1}, {"body": 5, "word": "blotting", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "added", "fig": 1}, {"body": 1, "word": "I", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs005.jpg", "caption": "Hdac6 interaction with Tip60-p400 is resistant to high salt concentrations.Tip60-H3F was purified from ESCs as above and subjected to washes with buffer containing the salt concentrations indicated.DOI: http://dx.doi.org/10.7554/eLife.01557.008", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 1}, {"body": 110, "word": "Tip60-p400", "fig": 1}, {"body": 79, "word": "ESCs", "fig": 1}, {"body": 22, "word": "interaction", "fig": 1}, {"body": 11, "word": "purified", "fig": 1}, {"body": 11, "word": "buffer", "fig": 1}, {"body": 5, "word": "washes", "fig": 1}, {"body": 4, "word": "high", "fig": 1}, {"body": 4, "word": "containing", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 1, "word": "salt", "fig": 2}, {"body": 1, "word": "resistant", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f002.jpg", "caption": "Hdac6 is partially nuclear in multiple types of undifferentiated cells and interacts with Tip60-p400 in NSCs and cancer cell lines.(A) ESCs (top) or MEFs (bottom) were subjected to immunofluorescence using an antibody recognizing Hdac6. DAPI staining is shown to identify nuclei. (B) High levels of nuclear Hdac6 in stem cells but not differentiated cells. Western blots of Hdac6 and known Tip60-p400 subunit Dmap1 in cytoplasmic (C) and nuclear (N) fractions of indicated cells are shown, with \u03b2-actin serving as a loading control. (C) Hdac6 relocalizes to the cytoplasm during ESC differentiation. Cytoplasmic (C) and nuclear (N) fractions from ESCs differentiated for the indicated number of days were Western blotted for the indicated proteins. (D) Hdac6 relocalizes to the cytoplasm during NSC differentiation. Cytoplasmic (C) and nuclear (N) fractions from undifferentiated NSCs (day 0) or NSCs differentiated for 7 days were Western blotted for the indicated proteins. (E) Hdac6 interacts with Tip60-p400 in NSCs. Shown are Western blots for the proteins indicated of input or Tip60-p400 complex immunoprecipitated from NSCs. (F) Hdac6 is nuclear localized in cancer cell lines. Cells were fractionated and Western blotted as in (B). (G) Hdac6 interacts with Tip60-p400 in a cancer cell line. 293.T cells were transfected with the indicated constructs. Nuclear extracts were prepared, subjected to immunoprecipitation with an anti-HA antibody, and Western blotted as indicated. (H) Re-localization of Hdac6 to the nucleus is an early event during transformation. MEFs were infected with pBABE-puro retrovirus expressing SV40 large T antigen or empty vector, harvested after 5 days (including 3 days of selection), and fractionated as in (B). Western blots are shown for the proteins indicated.DOI: http://dx.doi.org/10.7554/eLife.01557.010", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 10}, {"body": 110, "word": "Tip60-p400", "fig": 5}, {"body": 53, "word": "cells", "fig": 5}, {"body": 79, "word": "ESCs", "fig": 2}, {"body": 21, "word": "nuclear", "fig": 6}, {"body": 33, "word": "cell", "fig": 3}, {"body": 30, "word": "differentiation", "fig": 2}, {"body": 15, "word": "proteins", "fig": 4}, {"body": 16, "word": "cancer", "fig": 3}, {"body": 47, "word": "complex", "fig": 1}, {"body": 8, "word": "NSCs", "fig": 5}, {"body": 5, "word": "Western", "fig": 7}, {"body": 8, "word": "days", "fig": 4}, {"body": 9, "word": "differentiated", "fig": 3}, {"body": 21, "word": "using", "fig": 1}, {"body": 3, "word": "indicated", "fig": 7}, {"body": 7, "word": "interacts", "fig": 3}, {"body": 10, "word": "MEFs", "fig": 2}, {"body": 9, "word": "lines", "fig": 2}, {"body": 16, "word": "types", "fig": 1}, {"body": 15, "word": "stem", "fig": 1}, {"body": 15, "word": "ESC", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 6, "word": "cytoplasm", "fig": 2}, {"body": 11, "word": "cytoplasmic", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 3, "word": "shown", "fig": 3}, {"body": 9, "word": "subunit", "fig": 1}, {"body": 4, "word": "subjected", "fig": 2}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "including", "fig": 1}, {"body": 7, "word": "known", "fig": 1}, {"body": 7, "word": "immunoprecipitation", "fig": 1}, {"body": 3, "word": "antibody", "fig": 2}, {"body": 2, "word": "fractions", "fig": 3}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 5, "word": "nucleus", "fig": 1}, {"body": 5, "word": "number", "fig": 1}, {"body": 2, "word": "undifferentiated", "fig": 2}, {"body": 4, "word": "immunoprecipitated", "fig": 1}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 4, "word": "infected", "fig": 1}, {"body": 3, "word": "transformation", "fig": 1}, {"body": 3, "word": "large", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "line", "fig": 1}, {"body": 2, "word": "identify", "fig": 1}, {"body": 2, "word": "Dmap1", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 2, "word": "early", "fig": 1}, {"body": 2, "word": "event", "fig": 1}, {"body": 2, "word": "G", "fig": 1}, {"body": 2, "word": "293.T", "fig": 1}, {"body": 2, "word": "partially", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "localized", "fig": 1}, {"body": 1, "word": "selection", "fig": 1}, {"body": 1, "word": "Re-localization", "fig": 1}, {"body": 1, "word": "T", "fig": 1}, {"body": 1, "word": "antigen", "fig": 1}, {"body": 1, "word": "vector", "fig": 1}, {"body": 1, "word": "SV40", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "constructs", "fig": 1}, {"body": 1, "word": "harvested", "fig": 1}, {"body": 1, "word": "NSC", "fig": 1}, {"body": 1, "word": "recognizing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f003.jpg", "caption": "Overlapping effects of Hdac6 KD and Tip60 KD on gene expression in ESCs.(A) Scatter plot of gene expression (Log2 (fold change) relative to control KD ESCs) upon Tip60 KD relative to Hdac6 KD. Genes misregulated upon Tip60 KD (adjusted p<0.1) are shown in red. (B) Western blot showing the levels of p400, Dmap1, Hdac6 and Tip60 (FLAG) upon Tip60 or Hdac6 KD. \u03b2-actin is shown as a loading control. (C) Unsupervised hierarchical clustering of genes misregulated (adjusted p<0.1) upon Tip60 KD. Up-regulated genes are indicated in yellow and downregulated genes are indicated in blue. The first cluster (#1) includes 200 genes that were upregulated upon Tip60 KD but not Hdac6 KD, the second cluster (#2) includes 867 genes upregulated in both Tip60 KD and Hdac6 KD ESCs, the third cluster (#3) includes 277 genes that were downregulated only in Tip60 KD cells and the forth cluster (#4) includes 424 genes that were downregulated in both Tip60 KD and Hdac6 KD ESCs. (D) Hdac6-dependent target genes are biased toward genes repressed by Tip60. Genes repressed or activated by Tip60 were split based on their Hdac6-dependence, and each group was plotted as the Log2 (ratio) of genes observed in each group relative to the expected number of genes if Hdac6-dependence was randomly distributed. Asterisk indicates statistically significant enrichment (p<10\u201320). (E) Validation of microarray datasets. The expression levels of genes from each cluster were measured by RT-qPCR in the indicated KDs and expressed as Log2 (fold change) values relative to control (GFP) KD ESCs after normalization. Data shown are mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.011", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 7}, {"body": 67, "word": "KD", "fig": 16}, {"body": 72, "word": "Tip60", "fig": 12}, {"body": 62, "word": "genes", "fig": 12}, {"body": 79, "word": "ESCs", "fig": 5}, {"body": 17, "word": "upon", "fig": 5}, {"body": 28, "word": "expression", "fig": 3}, {"body": 31, "word": "gene", "fig": 2}, {"body": 30, "word": "The", "fig": 2}, {"body": 53, "word": "cells", "fig": 1}, {"body": 9, "word": "cluster", "fig": 5}, {"body": 13, "word": "control", "fig": 3}, {"body": 26, "word": "target", "fig": 1}, {"body": 11, "word": "levels", "fig": 2}, {"body": 17, "word": "observed", "fig": 1}, {"body": 15, "word": "two", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 10, "word": "p400", "fig": 1}, {"body": 3, "word": "shown", "fig": 3}, {"body": 3, "word": "downregulated", "fig": 3}, {"body": 3, "word": "indicated", "fig": 3}, {"body": 2, "word": "relative", "fig": 4}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "expressed", "fig": 1}, {"body": 7, "word": "significant", "fig": 1}, {"body": 7, "word": "enrichment", "fig": 1}, {"body": 3, "word": "misregulated", "fig": 2}, {"body": 3, "word": "upregulated", "fig": 2}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "effects", "fig": 1}, {"body": 5, "word": "number", "fig": 1}, {"body": 5, "word": "Hdac6-dependent", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "first", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 2, "word": "Dmap1", "fig": 1}, {"body": 1, "word": "repressed", "fig": 2}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 2, "word": "KDs", "fig": 1}, {"body": 1, "word": "Genes", "fig": 2}, {"body": 2, "word": "microarray", "fig": 1}, {"body": 2, "word": "RT-qPCR", "fig": 1}, {"body": 2, "word": "GFP", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}, {"body": 1, "word": "clustering", "fig": 1}, {"body": 1, "word": "expected", "fig": 1}, {"body": 1, "word": "hierarchical", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "toward", "fig": 1}, {"body": 1, "word": "randomly", "fig": 1}, {"body": 1, "word": "ratio", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs006.jpg", "caption": "Hdac6 mutant ESCs.Diagram of Hdac6 mutant ESC line Hdac6tm1a(EUCOMM)Wtsi before (Hdac6reduced) and after (Hdac6null) CRE expression. Since, prior to CRE expression, this line produces a low level of Hdac6 protein, we infer that some transcripts fail to include the gene trap allele and therefore produce full-length, wild-type transcript. SA: splice acceptor; pA: cleavage and polyadenylation sequence.DOI: http://dx.doi.org/10.7554/eLife.01557.012", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 3}, {"body": 28, "word": "expression", "fig": 2}, {"body": 32, "word": "protein", "fig": 1}, {"body": 31, "word": "gene", "fig": 1}, {"body": 15, "word": "ESC", "fig": 1}, {"body": 4, "word": "CRE", "fig": 2}, {"body": 3, "word": "line", "fig": 2}, {"body": 2, "word": "mutant", "fig": 2}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "Hdac6null", "fig": 1}, {"body": 2, "word": "wild-type", "fig": 1}, {"body": 2, "word": "Hdac6reduced", "fig": 1}, {"body": 2, "word": "allele", "fig": 1}, {"body": 2, "word": "therefore", "fig": 1}, {"body": 2, "word": "EUCOMM", "fig": 1}, {"body": 1, "word": "produces", "fig": 1}, {"body": 1, "word": "Since", "fig": 1}, {"body": 1, "word": "Wtsi", "fig": 1}, {"body": 1, "word": "low", "fig": 1}, {"body": 1, "word": "Hdac6tm1a", "fig": 1}, {"body": 1, "word": "prior", "fig": 1}, {"body": 1, "word": "trap", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs007.jpg", "caption": "Hypomorphic and null Hdac6 mutant ESCs.Whole cell extracts from normal (WT) ESCs or Hdac6 mutant ESCs as diagrammed in Figure 3\u2014figure supplement 1 were prepared, followed by Western blotting for the proteins indicated. Note higher levels of acetylated tubulin upon CRE expression.DOI: http://dx.doi.org/10.7554/eLife.01557.013", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 2}, {"body": 79, "word": "ESCs", "fig": 2}, {"body": 62, "word": "Figure", "fig": 1}, {"body": 33, "word": "cell", "fig": 1}, {"body": 23, "word": "supplement", "fig": 1}, {"body": 17, "word": "upon", "fig": 1}, {"body": 15, "word": "proteins", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 7, "word": "normal", "fig": 1}, {"body": 6, "word": "3\u2014figure", "fig": 1}, {"body": 5, "word": "blotting", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "acetylated", "fig": 1}, {"body": 2, "word": "mutant", "fig": 2}, {"body": 4, "word": "followed", "fig": 1}, {"body": 4, "word": "CRE", "fig": 1}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 2, "word": "tubulin", "fig": 1}, {"body": 1, "word": "higher", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs008.jpg", "caption": "Hdac6 mutant ESCs exhibit alterations in Tip60-target gene expression consistent with KD phenotypes.Cells described in Figure 3\u2014figure supplement 1 were harvested for RNA and subjected to RT-qPCR for the genes indicated from Tip60/Hdac6 target gene cluster 2 (cluster 4 gene shown as a control). Data shown are mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.014", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 1}, {"body": 31, "word": "gene", "fig": 3}, {"body": 79, "word": "ESCs", "fig": 1}, {"body": 67, "word": "KD", "fig": 1}, {"body": 62, "word": "genes", "fig": 1}, {"body": 62, "word": "Figure", "fig": 1}, {"body": 28, "word": "expression", "fig": 1}, {"body": 26, "word": "target", "fig": 1}, {"body": 23, "word": "supplement", "fig": 1}, {"body": 9, "word": "cluster", "fig": 2}, {"body": 15, "word": "two", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 10, "word": "consistent", "fig": 1}, {"body": 7, "word": "described", "fig": 1}, {"body": 3, "word": "shown", "fig": 2}, {"body": 6, "word": "3\u2014figure", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 4, "word": "Tip60-target", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 2, "word": "mutant", "fig": 1}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 2, "word": "RT-qPCR", "fig": 1}, {"body": 1, "word": "exhibit", "fig": 1}, {"body": 1, "word": "Tip60/Hdac6", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "harvested", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs009.jpg", "caption": "GO-term enrichment of gene clusters.The significance of enrichment [\u2212Log10 (p-value)] of Gene Ontology (GO) terms over-represented in each cluster of genes in Figure 3C. GO terms that were partially redundant with those listed were eliminated for brevity.DOI: http://dx.doi.org/10.7554/eLife.01557.015", "co_occurrence": [{"body": 62, "word": "genes", "fig": 1}, {"body": 62, "word": "Figure", "fig": 1}, {"body": 31, "word": "gene", "fig": 1}, {"body": 7, "word": "enrichment", "fig": 2}, {"body": 9, "word": "cluster", "fig": 1}, {"body": 3, "word": "3C", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 1, "word": "terms", "fig": 2}, {"body": 2, "word": "partially", "fig": 1}, {"body": 1, "word": "listed", "fig": 1}, {"body": 1, "word": "Ontology", "fig": 1}, {"body": 1, "word": "Gene", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f004.jpg", "caption": "Tip60 and Hdac6 co-localize on chromatin.(A) Heat map representation of ChIP-seq data for H3F-tagged Tip60 and Hdac6 comprising the 2 kb surrounding the transcriptional start sites (TSS) of 10,507 genes for which published p400 ChIP-chip data (Fazzio et al., 2008a) (p400 enrichment) were available. ChIP-seq data from E14 (Untagged) cells is shown as a control. All panels are sorted by decreasing p400 binding for the 1 kb surrounding the TSS, ranging from high levels of p400 binding (red) to genes unbound by p400 (white). (B) Tip60 and Hdac6 binding correlate with p400 binding. Genes in the p400 ChIP-chip dataset were grouped by the intensity of p400 enrichment: The groups of genes exhibiting the top 10% of p400 enrichment (top 10%), the 11th\u201330th percentile (next 20%), the 31st\u201360th percentile (middle 30%) and the rest of genes in dataset (last 40%). Upper panel: averaged Tip60 enrichment for groups of genes at each level of p400 binding are shown relative to the TSS. Lower panel: averaged Hdac6 binding data for genes in the same groups. (C) Correlation of Tip60 and Hdac6 binding. Shown is a Venn diagram delineating the overlap between the gene sets bound by Tip60 and Hdac6. The p-value was calculated by summing the hypergeometric probabilities of Tip60/Hdac6 overlap below the number observed and subtracting from one. (D) Hdac6 and Tip60 are enriched at genes regulated by these factors. Upper panel: Tip60 binding segregated by genes that are upregulated, downregulated, or unchanged by Tip60 KD. Bottom panel: Hdac6 binding at genes segregated as in upper panel. (E) Tip60 and Hdac6 are enriched at genes within clusters 2, 3, and 4. Tip60 (upper panel) and Hdac6 (bottom panel) binding data are shown for genes segregated by cluster, as in Figure 2C. Asterisks mark clusters exhibiting statistically significantly higher promoter-proximal (\u2212500 to +500) binding of indicated factor than does the set of genes not regulated by Tip60 and Hdac6: *(p<0.05); **(p<0.01); ***(p<10-5).DOI: http://dx.doi.org/10.7554/eLife.01557.016", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 11}, {"body": 72, "word": "Tip60", "fig": 12}, {"body": 62, "word": "genes", "fig": 12}, {"body": 21, "word": "binding", "fig": 11}, {"body": 10, "word": "p400", "fig": 10}, {"body": 86, "word": "al.", "fig": 1}, {"body": 86, "word": "et", "fig": 1}, {"body": 17, "word": "data", "fig": 5}, {"body": 67, "word": "KD", "fig": 1}, {"body": 62, "word": "Figure", "fig": 1}, {"body": 30, "word": "The", "fig": 2}, {"body": 53, "word": "cells", "fig": 1}, {"body": 31, "word": "gene", "fig": 1}, {"body": 7, "word": "enrichment", "fig": 4}, {"body": 8, "word": "TSS", "fig": 3}, {"body": 18, "word": "within", "fig": 1}, {"body": 17, "word": "observed", "fig": 1}, {"body": 17, "word": "chromatin", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 6, "word": "enriched", "fig": 2}, {"body": 11, "word": "levels", "fig": 1}, {"body": 5, "word": "regulated", "fig": 2}, {"body": 3, "word": "shown", "fig": 3}, {"body": 9, "word": "cluster", "fig": 1}, {"body": 8, "word": "Fazzio", "fig": 1}, {"body": 8, "word": "factors", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "factor", "fig": 1}, {"body": 7, "word": "2008a", "fig": 1}, {"body": 3, "word": "clusters", "fig": 2}, {"body": 6, "word": "set", "fig": 1}, {"body": 3, "word": "overlap", "fig": 2}, {"body": 5, "word": "number", "fig": 1}, {"body": 4, "word": "significantly", "fig": 1}, {"body": 2, "word": "ChIP-seq", "fig": 2}, {"body": 4, "word": "bound", "fig": 1}, {"body": 4, "word": "high", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "downregulated", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "upregulated", "fig": 1}, {"body": 2, "word": "relative", "fig": 1}, {"body": 1, "word": "surrounding", "fig": 2}, {"body": 2, "word": "sites", "fig": 1}, {"body": 2, "word": "next", "fig": 1}, {"body": 2, "word": "start", "fig": 1}, {"body": 2, "word": "sets", "fig": 1}, {"body": 1, "word": "intensity", "fig": 1}, {"body": 1, "word": "unbound", "fig": 1}, {"body": 1, "word": "E14", "fig": 1}, {"body": 1, "word": "transcriptional", "fig": 1}, {"body": 1, "word": "Tip60/Hdac6", "fig": 1}, {"body": 1, "word": "Genes", "fig": 1}, {"body": 1, "word": "higher", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs010.jpg", "caption": "Targeting of the H3F tag to the C-terminus of the endogenous Hdac6 gene.Shown are the 3' end of the Hdac6 gene plus downstream sequence (below) and the targeting construct for introducing the C-terminal tandem 6-His-3-FLAG tag (above). The counter-selection cassette within the targeting construct is omitted for brevity. See \u2018Materials and methods\u2019 for details of ESC targeting.DOI: http://dx.doi.org/10.7554/eLife.01557.017", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 2}, {"body": 31, "word": "gene", "fig": 1}, {"body": 30, "word": "The", "fig": 1}, {"body": 18, "word": "within", "fig": 1}, {"body": 15, "word": "ESC", "fig": 1}, {"body": 9, "word": "downstream", "fig": 1}, {"body": 2, "word": "tag", "fig": 2}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "endogenous", "fig": 1}, {"body": 2, "word": "C-terminus", "fig": 1}, {"body": 2, "word": "end", "fig": 1}, {"body": 2, "word": "H3F", "fig": 1}, {"body": 1, "word": "targeting", "fig": 2}, {"body": 2, "word": "plus", "fig": 1}, {"body": 1, "word": "sequence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs011.jpg", "caption": "Hdac6 is enriched at genes marked by H3K4me3.Heatmaps showing the enrichment of various histone modifications or variants within promoter-proximal regions (TSS \u00b1 2 kb) of all genes, sorted by Hdac6 enrichment. H3K4me3 is strongly enriched at genes with high levels of Hdac6 binding, including bivalent genes marked by both H3K4me3 and H3K27me3, similar to previous findings for the p400 subunit of Tip60-p400. Histone modification data are from the following sources: H3K4me1/me2/me3, H3K27me3, H3K36me3 (Mikkelsen et al., 2007); H2AZ (Hu et al., 2013); and H3K9me3 (Teif et al., 2012)DOI: http://dx.doi.org/10.7554/eLife.01557.018", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 3}, {"body": 86, "word": "et", "fig": 3}, {"body": 86, "word": "al.", "fig": 3}, {"body": 62, "word": "genes", "fig": 4}, {"body": 110, "word": "Tip60-p400", "fig": 1}, {"body": 21, "word": "binding", "fig": 1}, {"body": 18, "word": "within", "fig": 1}, {"body": 17, "word": "data", "fig": 1}, {"body": 7, "word": "enrichment", "fig": 2}, {"body": 13, "word": "histone", "fig": 1}, {"body": 6, "word": "enriched", "fig": 2}, {"body": 11, "word": "levels", "fig": 1}, {"body": 10, "word": "p400", "fig": 1}, {"body": 9, "word": "subunit", "fig": 1}, {"body": 9, "word": "similar", "fig": 1}, {"body": 8, "word": "TSS", "fig": 1}, {"body": 7, "word": "including", "fig": 1}, {"body": 5, "word": "strongly", "fig": 1}, {"body": 4, "word": "findings", "fig": 1}, {"body": 2, "word": "marked", "fig": 2}, {"body": 4, "word": "high", "fig": 1}, {"body": 3, "word": "previous", "fig": 1}, {"body": 3, "word": "modifications", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 2, "word": "Hu", "fig": 1}, {"body": 1, "word": "H3K4me3", "fig": 2}, {"body": 2, "word": "regions", "fig": 1}, {"body": 1, "word": "H3K27me3", "fig": 2}, {"body": 1, "word": "various", "fig": 1}, {"body": 1, "word": "bivalent", "fig": 1}, {"body": 1, "word": "following", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs012.jpg", "caption": "Hdac6-dependent Tip60 targets in ESCs are not bound by Tip60 in MEFs.Tip60 enrichment near the promoters of the genes indicated was determined by ChIP-qPCR in ESCs and MEFs. We examined binding to Cdkn1a, a known Tip60 target in MEFs, as a positive control for ChIP in MEFs. Data shown are the mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.019", "co_occurrence": [{"body": 72, "word": "Tip60", "fig": 3}, {"body": 79, "word": "ESCs", "fig": 2}, {"body": 62, "word": "genes", "fig": 1}, {"body": 10, "word": "MEFs", "fig": 3}, {"body": 26, "word": "target", "fig": 1}, {"body": 21, "word": "binding", "fig": 1}, {"body": 19, "word": "We", "fig": 1}, {"body": 18, "word": "targets", "fig": 1}, {"body": 15, "word": "two", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 8, "word": "promoters", "fig": 1}, {"body": 7, "word": "known", "fig": 1}, {"body": 7, "word": "enrichment", "fig": 1}, {"body": 6, "word": "examined", "fig": 1}, {"body": 5, "word": "ChIP", "fig": 1}, {"body": 5, "word": "Hdac6-dependent", "fig": 1}, {"body": 4, "word": "bound", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "near", "fig": 1}, {"body": 3, "word": "determined", "fig": 1}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f005.jpg", "caption": "The Hdac6 deacetylase domains are necessary for Tip60-p400 binding but do not reverse histone acetylation catalyzed by Tip60.(A) Treatment of ESCs with Hdac6 catalytic domain inhibitor Tubastatin A causes de-repression of Tip60-p400 target genes. RT-qPCRs for indicated genes are shown for GFP KD or Tip60 KD ESCs treated with either Tubastatin A (TubA) or DMSO vehicle. Data are expressed as Log2 (fold change) values relative to DMSO treated GFP KD ESCs after normalization. Shown are the mean \u00b1 SD values of three technical replicates from one representative experiment of two biological replicates performed. (B) H4 acetylation levels for several common Tip60/Hdac6 target genes in Tip60 KD and Hdac6 KD ESCs were measured by ChIP-qPCR, using an antibody specific for tetra-acetylated histone H4. H4 acetylation levels in cells knocked down as indicated are expressed as a fraction of the input. Shown are the mean \u00b1 SD values of three technical replicates from one representative experiment of two biological replicates performed. (C) ESCs were treated overnight with the indicated amounts of TubA in their growth medium, Tip60-H3F was immunoprecipitated as above, and co-immunoprecipitating proteins were examined by Western blotting. (D) Tip60-H3F was immunoprecipitated from ESCs grown under normal conditions, and the beads were washed in buffer with or without TubA. The Hdac6 eluted in the TubA wash or remaining bound to beads is shown by Western blotting, along with canonical Tip60 subunit Dmap1. (E) HA-tagged wild type, deacetylase domain 1 (HD1) mutant, or double deacetylase domain mutant (HD1 + HD2) Hdac6 was stably expressed in Tip60-H3F ESCs, Tip60-H3F was immunoprecipitated from nuclear extracts, and co-precipitating proteins were examined by Western blotting. Co-IP of canonical Tip60 complex subunit Dmap1 is shown as a control.DOI: http://dx.doi.org/10.7554/eLife.01557.020", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 5}, {"body": 79, "word": "ESCs", "fig": 7}, {"body": 72, "word": "Tip60", "fig": 5}, {"body": 67, "word": "KD", "fig": 5}, {"body": 110, "word": "Tip60-p400", "fig": 2}, {"body": 62, "word": "genes", "fig": 3}, {"body": 16, "word": "TubA", "fig": 4}, {"body": 15, "word": "Tip60-H3F", "fig": 4}, {"body": 30, "word": "The", "fig": 2}, {"body": 53, "word": "cells", "fig": 1}, {"body": 26, "word": "target", "fig": 2}, {"body": 47, "word": "complex", "fig": 1}, {"body": 14, "word": "deacetylase", "fig": 3}, {"body": 12, "word": "acetylation", "fig": 3}, {"body": 15, "word": "proteins", "fig": 2}, {"body": 15, "word": "two", "fig": 2}, {"body": 13, "word": "histone", "fig": 2}, {"body": 13, "word": "one", "fig": 2}, {"body": 12, "word": "performed", "fig": 2}, {"body": 8, "word": "A", "fig": 3}, {"body": 11, "word": "levels", "fig": 2}, {"body": 21, "word": "using", "fig": 1}, {"body": 21, "word": "nuclear", "fig": 1}, {"body": 7, "word": "expressed", "fig": 3}, {"body": 21, "word": "binding", "fig": 1}, {"body": 10, "word": "beads", "fig": 2}, {"body": 9, "word": "subunit", "fig": 2}, {"body": 6, "word": "H4", "fig": 3}, {"body": 16, "word": "necessary", "fig": 1}, {"body": 5, "word": "blotting", "fig": 3}, {"body": 5, "word": "Western", "fig": 3}, {"body": 14, "word": "several", "fig": 1}, {"body": 4, "word": "immunoprecipitated", "fig": 3}, {"body": 12, "word": "domains", "fig": 1}, {"body": 6, "word": "examined", "fig": 2}, {"body": 11, "word": "buffer", "fig": 1}, {"body": 3, "word": "shown", "fig": 3}, {"body": 3, "word": "indicated", "fig": 3}, {"body": 8, "word": "common", "fig": 1}, {"body": 7, "word": "normal", "fig": 1}, {"body": 6, "word": "specific", "fig": 1}, {"body": 2, "word": "domain", "fig": 3}, {"body": 6, "word": "either", "fig": 1}, {"body": 3, "word": "three", "fig": 2}, {"body": 2, "word": "treated", "fig": 3}, {"body": 5, "word": "catalytic", "fig": 1}, {"body": 5, "word": "growth", "fig": 1}, {"body": 5, "word": "type", "fig": 1}, {"body": 5, "word": "overnight", "fig": 1}, {"body": 2, "word": "Dmap1", "fig": 2}, {"body": 4, "word": "bound", "fig": 1}, {"body": 1, "word": "replicates", "fig": 4}, {"body": 4, "word": "washed", "fig": 1}, {"body": 4, "word": "extracts", "fig": 1}, {"body": 2, "word": "mutant", "fig": 2}, {"body": 2, "word": "GFP", "fig": 2}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "conditions", "fig": 1}, {"body": 3, "word": "de-repression", "fig": 1}, {"body": 3, "word": "antibody", "fig": 1}, {"body": 3, "word": "without", "fig": 1}, {"body": 2, "word": "remaining", "fig": 1}, {"body": 2, "word": "double", "fig": 1}, {"body": 1, "word": "biological", "fig": 2}, {"body": 2, "word": "relative", "fig": 1}, {"body": 2, "word": "eluted", "fig": 1}, {"body": 2, "word": "along", "fig": 1}, {"body": 1, "word": "HD1", "fig": 2}, {"body": 2, "word": "medium", "fig": 1}, {"body": 2, "word": "fraction", "fig": 1}, {"body": 2, "word": "knocked", "fig": 1}, {"body": 2, "word": "grown", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "HD2", "fig": 1}, {"body": 1, "word": "inhibitor", "fig": 1}, {"body": 1, "word": "Tip60/Hdac6", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs013.jpg", "caption": "Hdac6 KD does not cause general disruption of Tip60-p400 complex.(Left) Silver stain of Tip60-p400 complex purified from control or Hdac6 KD Tip60-H3F ESCs or untagged ESCs, as indicated. (Right) Tip60-p400 complex purified from control or Hdac6 KD ESCs Western blotted for indicated proteins.DOI: http://dx.doi.org/10.7554/eLife.01557.021", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 3}, {"body": 110, "word": "Tip60-p400", "fig": 3}, {"body": 79, "word": "ESCs", "fig": 3}, {"body": 67, "word": "KD", "fig": 3}, {"body": 47, "word": "complex", "fig": 3}, {"body": 13, "word": "control", "fig": 2}, {"body": 11, "word": "purified", "fig": 2}, {"body": 15, "word": "Tip60-H3F", "fig": 1}, {"body": 3, "word": "indicated", "fig": 2}, {"body": 5, "word": "Western", "fig": 1}, {"body": 4, "word": "untagged", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 2, "word": "cause", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs014.jpg", "caption": "Tubastatin A has no effect on Hdac6 expression or localization.ESCs were treated as shown, and nuclear and cytoplasmic fractions were Western blotted for the proteins indicated.DOI: http://dx.doi.org/10.7554/eLife.01557.022", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 1}, {"body": 28, "word": "expression", "fig": 1}, {"body": 21, "word": "nuclear", "fig": 1}, {"body": 15, "word": "proteins", "fig": 1}, {"body": 11, "word": "cytoplasmic", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "effect", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 2, "word": "fractions", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs015.jpg", "caption": "Hdac6 KD reduces H2AK5 acetylation at Tip60-target genes.H2AK5 acetylation levels for several common Tip60/Hdac6 target genes in Tip60 and Hdac6 KD ESCs was measured by ChIP-qPCR, expressed as Log2 ratios relative to control (GFP) KD. Data shown are mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.023", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 2}, {"body": 67, "word": "KD", "fig": 3}, {"body": 79, "word": "ESCs", "fig": 1}, {"body": 72, "word": "Tip60", "fig": 1}, {"body": 62, "word": "genes", "fig": 1}, {"body": 26, "word": "target", "fig": 1}, {"body": 12, "word": "acetylation", "fig": 2}, {"body": 15, "word": "two", "fig": 1}, {"body": 14, "word": "several", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 8, "word": "common", "fig": 1}, {"body": 7, "word": "expressed", "fig": 1}, {"body": 4, "word": "Tip60-target", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 2, "word": "relative", "fig": 1}, {"body": 2, "word": "GFP", "fig": 1}, {"body": 1, "word": "Tip60/Hdac6", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs016.jpg", "caption": "Hdac6 KD has no effect on bulk H4 acetylation levels, but strongly increases tubulin acetylation.ESCs knocked down as indicated were Western blotted with antibodies to tetra-acetylated histone H4 or H3 (left), or acetylated tubulin (right).DOI: http://dx.doi.org/10.7554/eLife.01557.024", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 1}, {"body": 67, "word": "KD", "fig": 1}, {"body": 13, "word": "histone", "fig": 1}, {"body": 12, "word": "acetylation", "fig": 1}, {"body": 6, "word": "H4", "fig": 2}, {"body": 11, "word": "levels", "fig": 1}, {"body": 5, "word": "strongly", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "acetylated", "fig": 1}, {"body": 5, "word": "effect", "fig": 1}, {"body": 2, "word": "tubulin", "fig": 2}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "knocked", "fig": 1}, {"body": 1, "word": "bulk", "fig": 1}, {"body": 1, "word": "increases", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs017.jpg", "caption": "Hdac6 KD does not induce Tip60-p400 acetylation or ubiquitination.Tip60-p400 complex purified from control or Hdac6 KD Tip60-H3F ESCs or untagged ESCs Western blotted with antibodies recognizing acetylated lysine (left) or ubiquitin (right). Note that the background band in the ubiquitin western blot is also found in the untagged control, and is therefore non-specific.DOI: http://dx.doi.org/10.7554/eLife.01557.025", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 2}, {"body": 79, "word": "ESCs", "fig": 2}, {"body": 67, "word": "KD", "fig": 2}, {"body": 110, "word": "Tip60-p400", "fig": 1}, {"body": 47, "word": "complex", "fig": 1}, {"body": 13, "word": "control", "fig": 2}, {"body": 21, "word": "found", "fig": 1}, {"body": 15, "word": "Tip60-H3F", "fig": 1}, {"body": 12, "word": "acetylation", "fig": 1}, {"body": 11, "word": "purified", "fig": 1}, {"body": 10, "word": "also", "fig": 1}, {"body": 4, "word": "untagged", "fig": 2}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "acetylated", "fig": 1}, {"body": 2, "word": "ubiquitin", "fig": 2}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "therefore", "fig": 1}, {"body": 1, "word": "recognizing", "fig": 1}, {"body": 1, "word": "induce", "fig": 1}, {"body": 1, "word": "background", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f006.jpg", "caption": "Hdac6 is necessary for normal Tip60 binding to its targets on chromatin.(A) Heat map representations of Tip60 binding as measured by ChIP-seq in Tip60-H3F ESCs upon GFP KD or Hdac6 KD. Data are sorted by p400 binding as in Figure 3A. (B) Averaged Tip60 binding upon GFP KD or Hdac6 KD are shown relative to the TSS. (C) Hdac6 KD mainly reduces Tip60 enrichment at genes that are misregulated upon Tip60 KD. Average Tip60 binding profiles upon GFP KD or Hdac6 KD are shown for genes misregulated upon Tip60 KD (adjusted p<0.1) and genes that are unaffected. (D) Heat map representations of p400 binding as measured by ChIP-seq using an antibody against endogenous p400 in control and Hdac6 KD ESCs. Genes are sorted exactly as in (A). (E) Average p400 binding profiles upon GFP KD or Hdac6 KD are shown relative to the TSS. (F) Tip60 KD does not affect Hdac6 binding. Average Hdac6 binding profiles upon GFP KD or Hdac6 KD are plotted as in (B and E).DOI: http://dx.doi.org/10.7554/eLife.01557.026", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 10}, {"body": 67, "word": "KD", "fig": 15}, {"body": 72, "word": "Tip60", "fig": 8}, {"body": 21, "word": "binding", "fig": 9}, {"body": 62, "word": "genes", "fig": 3}, {"body": 79, "word": "ESCs", "fig": 2}, {"body": 17, "word": "upon", "fig": 7}, {"body": 62, "word": "Figure", "fig": 1}, {"body": 10, "word": "p400", "fig": 4}, {"body": 21, "word": "using", "fig": 1}, {"body": 18, "word": "targets", "fig": 1}, {"body": 17, "word": "chromatin", "fig": 1}, {"body": 16, "word": "necessary", "fig": 1}, {"body": 8, "word": "A", "fig": 2}, {"body": 8, "word": "TSS", "fig": 2}, {"body": 15, "word": "Tip60-H3F", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 4, "word": "profiles", "fig": 3}, {"body": 2, "word": "GFP", "fig": 5}, {"body": 3, "word": "shown", "fig": 3}, {"body": 7, "word": "normal", "fig": 1}, {"body": 7, "word": "enrichment", "fig": 1}, {"body": 3, "word": "misregulated", "fig": 2}, {"body": 2, "word": "relative", "fig": 2}, {"body": 4, "word": "unaffected", "fig": 1}, {"body": 2, "word": "ChIP-seq", "fig": 2}, {"body": 4, "word": "mainly", "fig": 1}, {"body": 3, "word": "endogenous", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "antibody", "fig": 1}, {"body": 1, "word": "Genes", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "affect", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs018.jpg", "caption": "Reduced levels of Tip60 binding to differentiation genes upon Hdac6 KD.(Left) Example genomic loci showing Tip60 binding as measured by ChIP-seq upon GFP KD or Hdac6 KD. The first two panels show that Tip60 binding to the promoter regions of highly expressed genes (Rps9, Rpl27a) is relatively unaffected by Hdac6 KD. The second two panels show that Tip60 binding to the promoter regions of differentiation genes (Nodal, Nefl) is strongly reduced downstream of the TSS upon Hdac6 KD. (Right) Anti-FLAG ChIP-qPCR data are shown for the indicated ESCs at the promoter-proximal regions of the target genes shown. Note that Speer2 is a negative control locus to which Tip60-p400 does not bind. Data shown are mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.027", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 4}, {"body": 67, "word": "KD", "fig": 5}, {"body": 72, "word": "Tip60", "fig": 4}, {"body": 62, "word": "genes", "fig": 4}, {"body": 110, "word": "Tip60-p400", "fig": 1}, {"body": 21, "word": "binding", "fig": 4}, {"body": 79, "word": "ESCs", "fig": 1}, {"body": 30, "word": "differentiation", "fig": 2}, {"body": 30, "word": "The", "fig": 2}, {"body": 17, "word": "upon", "fig": 3}, {"body": 15, "word": "two", "fig": 3}, {"body": 26, "word": "target", "fig": 1}, {"body": 17, "word": "data", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 13, "word": "control", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 5, "word": "show", "fig": 2}, {"body": 9, "word": "downstream", "fig": 1}, {"body": 3, "word": "shown", "fig": 3}, {"body": 8, "word": "TSS", "fig": 1}, {"body": 7, "word": "expressed", "fig": 1}, {"body": 2, "word": "regions", "fig": 3}, {"body": 5, "word": "reduced", "fig": 1}, {"body": 5, "word": "strongly", "fig": 1}, {"body": 2, "word": "promoter", "fig": 2}, {"body": 4, "word": "unaffected", "fig": 1}, {"body": 3, "word": "genomic", "fig": 1}, {"body": 3, "word": "first", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 2, "word": "locus", "fig": 1}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 2, "word": "ChIP-seq", "fig": 1}, {"body": 2, "word": "highly", "fig": 1}, {"body": 2, "word": "GFP", "fig": 1}, {"body": 2, "word": "bind", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs019.jpg", "caption": "Reduced levels of p400 binding to differentiation genes upon Hdac6 KD.Effects of Tip60 or Hdac6 KD (left) or mutation (right) on p400 binding to target genes. Anti-p400 ChIP-qPCR data are shown for the indicated KDs/mutations at the promoter-proximal regions of target genes. Data are normalized to IgG background ChIPs. Data shown are mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.028", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 2}, {"body": 62, "word": "genes", "fig": 3}, {"body": 72, "word": "Tip60", "fig": 1}, {"body": 67, "word": "KD", "fig": 1}, {"body": 26, "word": "target", "fig": 2}, {"body": 21, "word": "binding", "fig": 2}, {"body": 30, "word": "differentiation", "fig": 1}, {"body": 10, "word": "p400", "fig": 2}, {"body": 17, "word": "upon", "fig": 1}, {"body": 17, "word": "data", "fig": 1}, {"body": 15, "word": "two", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 3, "word": "shown", "fig": 2}, {"body": 6, "word": "mutation", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 2, "word": "regions", "fig": 1}, {"body": 1, "word": "Data", "fig": 2}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557fs020.jpg", "caption": "Hdac6 binding is unaffected by Tip60 KD.Anti-FLAG ChIP-qPCR data are shown for the indicated ESCs at the promoter-proximal regions of target genes. Data shown are mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.029", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 1}, {"body": 79, "word": "ESCs", "fig": 1}, {"body": 72, "word": "Tip60", "fig": 1}, {"body": 62, "word": "genes", "fig": 1}, {"body": 26, "word": "target", "fig": 1}, {"body": 21, "word": "binding", "fig": 1}, {"body": 17, "word": "data", "fig": 1}, {"body": 15, "word": "two", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 3, "word": "shown", "fig": 2}, {"body": 4, "word": "unaffected", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 2, "word": "regions", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f007.jpg", "caption": "Hdac6 is necessary for ESC colony and EB formation.(A) Colony formation assays. Indicated KD ESCs were plated at clonal density and grown for seven days, at which time they were stained with crystal violet for visualization. (B) Growth curve. ESCs were infected with shRNA expressing viruses as shown and cultured in normal ESC medium. Cells were counted at the times indicated. (C) EB formation assay. Left and upper right: Brightfield images of EBs formed by hanging-drop cultures of ESCs knocked down as indicated, then cultured in differentiation medium, as described in \u2018Materials and methods\u2019. Scale bars equal 400 \u03bcm. Lower right: box plot quantification of the range of EB sizes by diameter. The upper and lower limits of the box correspond to the 75th and 25th percentiles of each KD, respectively, and the dark line corresponds to the median of each box. At least 88 EBs were measured for each KD.DOI: http://dx.doi.org/10.7554/eLife.01557.030", "co_occurrence": [{"body": 79, "word": "ESCs", "fig": 3}, {"body": 195, "word": "Hdac6", "fig": 1}, {"body": 67, "word": "KD", "fig": 2}, {"body": 13, "word": "formation", "fig": 3}, {"body": 30, "word": "differentiation", "fig": 1}, {"body": 15, "word": "ESC", "fig": 2}, {"body": 30, "word": "The", "fig": 1}, {"body": 16, "word": "necessary", "fig": 1}, {"body": 5, "word": "EBs", "fig": 2}, {"body": 3, "word": "EB", "fig": 3}, {"body": 8, "word": "days", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "described", "fig": 1}, {"body": 7, "word": "normal", "fig": 1}, {"body": 3, "word": "indicated", "fig": 2}, {"body": 5, "word": "colony", "fig": 1}, {"body": 4, "word": "infected", "fig": 1}, {"body": 2, "word": "medium", "fig": 2}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "plated", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 1, "word": "cultured", "fig": 2}, {"body": 2, "word": "shRNA", "fig": 1}, {"body": 2, "word": "knocked", "fig": 1}, {"body": 2, "word": "grown", "fig": 1}, {"body": 1, "word": "visualization", "fig": 1}, {"body": 1, "word": "assay", "fig": 1}, {"body": 1, "word": "dark", "fig": 1}, {"body": 1, "word": "Colony", "fig": 1}, {"body": 1, "word": "violet", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "hanging-drop", "fig": 1}, {"body": 1, "word": "cultures", "fig": 1}, {"body": 1, "word": "formed", "fig": 1}, {"body": 1, "word": "crystal", "fig": 1}, {"body": 1, "word": "At", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f008.jpg", "caption": "Impaired differentiation of Hdac6 KD ESCs.Indicated KDs were differentiated for 0, 2, 4, or 6 days. At the indicated time points, RNA was isolated and RT-qPCR quantification of several differentiation markers of each primary germ layer was performed. Data shown are mean \u00b1 SD of three technical replicates from one representative experiment of two biological replicates performed.DOI: http://dx.doi.org/10.7554/eLife.01557.031", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 1}, {"body": 67, "word": "KD", "fig": 1}, {"body": 30, "word": "differentiation", "fig": 2}, {"body": 15, "word": "two", "fig": 1}, {"body": 14, "word": "several", "fig": 1}, {"body": 13, "word": "one", "fig": 1}, {"body": 12, "word": "performed", "fig": 1}, {"body": 9, "word": "differentiated", "fig": 1}, {"body": 8, "word": "days", "fig": 1}, {"body": 5, "word": "isolated", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "markers", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 1, "word": "replicates", "fig": 2}, {"body": 2, "word": "KDs", "fig": 1}, {"body": 2, "word": "RT-qPCR", "fig": 1}, {"body": 1, "word": "germ", "fig": 1}, {"body": 1, "word": "points", "fig": 1}, {"body": 1, "word": "At", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843111/bin/elife01557f009.jpg", "caption": "Model for Hdac6- and Tip60-p400-dependent repression of differentiation genes in ESCs.In the presence of Hdac6, Tip60-p400 binds both upstream and downstream of TSSs and differentiation genes are silenced. In the absence of Hdac6, Tip60-p400 binding is reduced causing de-repression of differentiation genes. Tip60-p400 binding downstream of target TSSs appears to be more strongly affected by Hdac6 KD. Note that Hdac6 also appears to affect the activation of some genes (not depicted), also by recruitment of Tip60-p400 complex.DOI: http://dx.doi.org/10.7554/eLife.01557.032", "co_occurrence": [{"body": 195, "word": "Hdac6", "fig": 4}, {"body": 110, "word": "Tip60-p400", "fig": 4}, {"body": 62, "word": "genes", "fig": 4}, {"body": 30, "word": "differentiation", "fig": 3}, {"body": 67, "word": "KD", "fig": 1}, {"body": 21, "word": "binding", "fig": 2}, {"body": 26, "word": "target", "fig": 1}, {"body": 10, "word": "also", "fig": 2}, {"body": 9, "word": "downstream", "fig": 2}, {"body": 14, "word": "In", "fig": 1}, {"body": 5, "word": "strongly", "fig": 1}, {"body": 5, "word": "recruitment", "fig": 1}, {"body": 5, "word": "repression", "fig": 1}, {"body": 5, "word": "reduced", "fig": 1}, {"body": 2, "word": "TSSs", "fig": 2}, {"body": 4, "word": "upstream", "fig": 1}, {"body": 2, "word": "appears", "fig": 2}, {"body": 4, "word": "binds", "fig": 1}, {"body": 3, "word": "http", "fig": 1}, {"body": 3, "word": "de-repression", "fig": 1}, {"body": 2, "word": "activation", "fig": 1}, {"body": 1, "word": "presence", "fig": 1}, {"body": 1, "word": "absence", "fig": 1}, {"body": 1, "word": "affect", "fig": 1}, {"body": 1, "word": "Tip60-p400-dependent", "fig": 1}]}], "3343020": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343020/bin/pone.0036565.g001.jpg", "caption": "Overexpression of LRP6 in HCC cell lines and human HCCs. (A) Quantitative real-time PCR and Western blotting. Both transcripts and protein of LRP6 were expressed in all seven HCC cell lines. (B) In human HCCs, the transcript level of LRP6 was frequently (45%) up-regulated as compared with their corresponding non-tumorous livers (P = 0.003). (C) Western blot analysis. LRP6 protein level was determined in 28 HCC pairs and was found to be overexpressed in 9 (32%) cases. The 9 cases with LRP6 protein overexpression in the tumors are shown. (D) Immunohistochemical analysis. LRP6 protein was found to be overexpressed in the HCC as compared with the corresponding non-tumorous liver. High power magnification of the tumor showed strong positive staining of LRP6 protein in the cytoplasm (white arrows) and also the membranes (black short arrows) of the tumor cells.", "co_occurrence": [{"body": 116, "word": "LRP6", "fig": 7}, {"body": 33, "word": "HCC", "fig": 4}, {"body": 18, "word": "protein", "fig": 5}, {"body": 40, "word": "cell", "fig": 2}, {"body": 54, "word": "cells", "fig": 1}, {"body": 24, "word": "human", "fig": 2}, {"body": 15, "word": "HCCs", "fig": 2}, {"body": 15, "word": "tumor", "fig": 2}, {"body": 26, "word": "The", "fig": 1}, {"body": 13, "word": "level", "fig": 2}, {"body": 13, "word": "found", "fig": 2}, {"body": 25, "word": "overexpression", "fig": 1}, {"body": 22, "word": "In", "fig": 1}, {"body": 9, "word": "cases", "fig": 2}, {"body": 18, "word": "showed", "fig": 1}, {"body": 7, "word": "overexpressed", "fig": 2}, {"body": 7, "word": "compared", "fig": 2}, {"body": 7, "word": "lines", "fig": 2}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "analysis", "fig": 2}, {"body": 12, "word": "P", "fig": 1}, {"body": 5, "word": "non-tumorous", "fig": 2}, {"body": 9, "word": "transcript", "fig": 1}, {"body": 3, "word": "Western", "fig": 2}, {"body": 3, "word": "corresponding", "fig": 2}, {"body": 5, "word": "staining", "fig": 1}, {"body": 5, "word": "Overexpression", "fig": 1}, {"body": 5, "word": "liver", "fig": 1}, {"body": 5, "word": "tumors", "fig": 1}, {"body": 4, "word": "cytoplasm", "fig": 1}, {"body": 4, "word": "up-regulated", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "pairs", "fig": 1}, {"body": 2, "word": "arrows", "fig": 2}, {"body": 3, "word": "PCR", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 2, "word": "livers", "fig": 1}, {"body": 2, "word": "expressed", "fig": 1}, {"body": 2, "word": "Immunohistochemical", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "seven", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "black", "fig": 1}, {"body": 1, "word": "white", "fig": 1}, {"body": 1, "word": "Both", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "real-time", "fig": 1}, {"body": 1, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "strong", "fig": 1}, {"body": 1, "word": "frequently", "fig": 1}, {"body": 1, "word": "short", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "transcripts", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343020/bin/pone.0036565.g002.jpg", "caption": "Ectopic expression of LRP6 activated the Wnt/\u03b2-catenin pathway. (A) Schematic diagram showing the structural domains of Myc-tagged full length form of LRP6 (myc-FL LRP6) and the constitutively active form (myc-CA LRP6). (B) Western blotting. Myc-FL LRP6 and myc-CA LRP6 were transiently overexpressed in BEL-7402 HCC cell line and human embryonic kidney cell HEK293T cells. The protein level of \u03b2-catenin was increased in both BEL-7402 HCC cell line and HEK293T cells. (C) TOP/FOP luciferase reporter assay. Expression of myc-FL LRP6 led to an activation of TCF/\u03b2-catenin reporter up to \u223c40-fold (without Wnt3a treatment) and \u223c120-fold (with Wnt3a treatment), respectively, as compared with the vector control. The fold of induction in myc-CA LRP6 cells reached \u223c150-fold even without Wnt3a treatment. (D) Similar results were also observed in HEK293T cells.", "co_occurrence": [{"body": 116, "word": "LRP6", "fig": 8}, {"body": 54, "word": "cells", "fig": 4}, {"body": 40, "word": "cell", "fig": 3}, {"body": 24, "word": "myc-CA", "fig": 3}, {"body": 33, "word": "HCC", "fig": 2}, {"body": 26, "word": "The", "fig": 2}, {"body": 22, "word": "BEL-7402", "fig": 2}, {"body": 34, "word": "\u03b2-catenin", "fig": 1}, {"body": 15, "word": "form", "fig": 2}, {"body": 27, "word": "Wnt/\u03b2-catenin", "fig": 1}, {"body": 24, "word": "human", "fig": 1}, {"body": 24, "word": "expression", "fig": 1}, {"body": 21, "word": "pathway", "fig": 1}, {"body": 18, "word": "protein", "fig": 1}, {"body": 6, "word": "HEK293T", "fig": 3}, {"body": 17, "word": "vector", "fig": 1}, {"body": 8, "word": "reporter", "fig": 2}, {"body": 16, "word": "control", "fig": 1}, {"body": 15, "word": "assay", "fig": 1}, {"body": 13, "word": "also", "fig": 1}, {"body": 13, "word": "level", "fig": 1}, {"body": 12, "word": "activation", "fig": 1}, {"body": 6, "word": "myc-FL", "fig": 2}, {"body": 10, "word": "active", "fig": 1}, {"body": 9, "word": "constitutively", "fig": 1}, {"body": 8, "word": "respectively", "fig": 1}, {"body": 7, "word": "activated", "fig": 1}, {"body": 7, "word": "overexpressed", "fig": 1}, {"body": 7, "word": "compared", "fig": 1}, {"body": 6, "word": "luciferase", "fig": 1}, {"body": 2, "word": "treatment", "fig": 3}, {"body": 2, "word": "Wnt3a", "fig": 3}, {"body": 5, "word": "TCF/\u03b2-catenin", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "increased", "fig": 1}, {"body": 2, "word": "line", "fig": 2}, {"body": 2, "word": "without", "fig": 2}, {"body": 3, "word": "observed", "fig": 1}, {"body": 3, "word": "blotting", "fig": 1}, {"body": 3, "word": "Western", "fig": 1}, {"body": 3, "word": "Similar", "fig": 1}, {"body": 2, "word": "TOP/FOP", "fig": 1}, {"body": 2, "word": "results", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "Myc-tagged", "fig": 1}, {"body": 1, "word": "Ectopic", "fig": 1}, {"body": 1, "word": "led", "fig": 1}, {"body": 1, "word": "kidney", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "full", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "reached", "fig": 1}, {"body": 1, "word": "transiently", "fig": 1}, {"body": 1, "word": "Expression", "fig": 1}, {"body": 1, "word": "induction", "fig": 1}, {"body": 1, "word": "length", "fig": 1}, {"body": 1, "word": "embryonic", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343020/bin/pone.0036565.g003.jpg", "caption": "Constitutively active LRP6 enhanced cell proliferation in vitro. (A) LRP6 expressing BEL-7402 stable cells were established using myc-CA LRP6 construct. The protein level of \u03b2-catenin was upregulated as compared with the parental BEL-7402 cells. (B) Cell proliferation assay. The numbers of cells of CA LRP6 Clones #1, #3, #8 and #11 on Day 7 were significantly higher than the vector control BEL-7402 cells (P = 0.032, <0.001, = 0.002 and 0.005, respectively).", "co_occurrence": [{"body": 116, "word": "LRP6", "fig": 4}, {"body": 54, "word": "cells", "fig": 4}, {"body": 22, "word": "BEL-7402", "fig": 3}, {"body": 26, "word": "The", "fig": 2}, {"body": 40, "word": "cell", "fig": 1}, {"body": 34, "word": "\u03b2-catenin", "fig": 1}, {"body": 24, "word": "myc-CA", "fig": 1}, {"body": 12, "word": "proliferation", "fig": 2}, {"body": 18, "word": "protein", "fig": 1}, {"body": 17, "word": "vector", "fig": 1}, {"body": 16, "word": "control", "fig": 1}, {"body": 15, "word": "assay", "fig": 1}, {"body": 13, "word": "level", "fig": 1}, {"body": 12, "word": "higher", "fig": 1}, {"body": 12, "word": "P", "fig": 1}, {"body": 12, "word": "using", "fig": 1}, {"body": 11, "word": "significantly", "fig": 1}, {"body": 11, "word": "enhanced", "fig": 1}, {"body": 10, "word": "Clones", "fig": 1}, {"body": 10, "word": "active", "fig": 1}, {"body": 9, "word": "Cell", "fig": 1}, {"body": 9, "word": "expressing", "fig": 1}, {"body": 9, "word": "stable", "fig": 1}, {"body": 8, "word": "vitro", "fig": 1}, {"body": 8, "word": "respectively", "fig": 1}, {"body": 8, "word": "CA", "fig": 1}, {"body": 7, "word": "compared", "fig": 1}, {"body": 5, "word": "construct", "fig": 1}, {"body": 5, "word": "numbers", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "established", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "Constitutively", "fig": 1}, {"body": 1, "word": "upregulated", "fig": 1}, {"body": 1, "word": "Day", "fig": 1}, {"body": 1, "word": "parental", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343020/bin/pone.0036565.g004.jpg", "caption": "Constitutively active LRP6 promoted both cell migration and invasion. Cell migration and invasion assays were performed using LRP6-stably expressing BEL-7402 cells. (A) Overexpression of myc-CA LRP6 enhanced cell migration in BEL-7402 cells. The numbers of migrated cells in CA LRP6 Clones #3 and #8 were significantly higher than the vector control (P<0.001 for both). (B) Overexpression of myc-CA LRP6 promoted cell invasion in BEL-7402 cells. The numbers of invaded cells in CA LRP6 Clones #3 and #8 were significantly higher than the vector control cells (P<0.001 and = 0.009, respectively).", "co_occurrence": [{"body": 116, "word": "LRP6", "fig": 5}, {"body": 54, "word": "cells", "fig": 6}, {"body": 40, "word": "cell", "fig": 3}, {"body": 22, "word": "BEL-7402", "fig": 3}, {"body": 26, "word": "The", "fig": 2}, {"body": 24, "word": "myc-CA", "fig": 2}, {"body": 14, "word": "invasion", "fig": 3}, {"body": 13, "word": "migration", "fig": 3}, {"body": 17, "word": "vector", "fig": 2}, {"body": 16, "word": "control", "fig": 2}, {"body": 12, "word": "higher", "fig": 2}, {"body": 12, "word": "P", "fig": 2}, {"body": 11, "word": "significantly", "fig": 2}, {"body": 10, "word": "Clones", "fig": 2}, {"body": 8, "word": "CA", "fig": 2}, {"body": 12, "word": "using", "fig": 1}, {"body": 11, "word": "enhanced", "fig": 1}, {"body": 5, "word": "numbers", "fig": 2}, {"body": 5, "word": "Overexpression", "fig": 2}, {"body": 10, "word": "active", "fig": 1}, {"body": 5, "word": "promoted", "fig": 2}, {"body": 9, "word": "Cell", "fig": 1}, {"body": 9, "word": "expressing", "fig": 1}, {"body": 9, "word": "performed", "fig": 1}, {"body": 8, "word": "respectively", "fig": 1}, {"body": 5, "word": "assays", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "invaded", "fig": 1}, {"body": 2, "word": "migrated", "fig": 1}, {"body": 2, "word": "Constitutively", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "LRP6-stably", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343020/bin/pone.0036565.g005.jpg", "caption": "Constitutively active LRP6 enhanced tumor cell growth in vivo. (A) In vivo nude mice injection assay was performed by injecting myc-CA LRP6 stably expressing and vector control BEL-7402 cells subcutaneously into the flank of the nude mice. (B) The tumor sizes of two myc-CA LRP6 stably expressing tumors were significantly higher as compared with the tumor of vector control (P<0.001). (C) The tumor weight of Clone #3 was higher in myc-CA LRP6 than the control vector (P = 0.002). Another clone (Clone #8) showed a trend of higher tumor weight but the difference did not reach statistical significance (P = 0.165). Error bar = SEM.", "co_occurrence": [{"body": 116, "word": "LRP6", "fig": 4}, {"body": 15, "word": "tumor", "fig": 5}, {"body": 24, "word": "myc-CA", "fig": 3}, {"body": 54, "word": "cells", "fig": 1}, {"body": 26, "word": "The", "fig": 2}, {"body": 17, "word": "vector", "fig": 3}, {"body": 16, "word": "control", "fig": 3}, {"body": 40, "word": "cell", "fig": 1}, {"body": 12, "word": "higher", "fig": 3}, {"body": 12, "word": "P", "fig": 3}, {"body": 22, "word": "In", "fig": 1}, {"body": 22, "word": "BEL-7402", "fig": 1}, {"body": 9, "word": "expressing", "fig": 2}, {"body": 18, "word": "showed", "fig": 1}, {"body": 15, "word": "assay", "fig": 1}, {"body": 7, "word": "mice", "fig": 2}, {"body": 7, "word": "vivo", "fig": 2}, {"body": 6, "word": "nude", "fig": 2}, {"body": 11, "word": "significantly", "fig": 1}, {"body": 11, "word": "enhanced", "fig": 1}, {"body": 10, "word": "active", "fig": 1}, {"body": 9, "word": "performed", "fig": 1}, {"body": 4, "word": "stably", "fig": 2}, {"body": 7, "word": "compared", "fig": 1}, {"body": 3, "word": "weight", "fig": 2}, {"body": 6, "word": "growth", "fig": 1}, {"body": 5, "word": "tumors", "fig": 1}, {"body": 5, "word": "two", "fig": 1}, {"body": 2, "word": "Clone", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "clone", "fig": 1}, {"body": 3, "word": "flank", "fig": 1}, {"body": 3, "word": "subcutaneously", "fig": 1}, {"body": 2, "word": "trend", "fig": 1}, {"body": 2, "word": "significance", "fig": 1}, {"body": 2, "word": "Constitutively", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "reach", "fig": 1}, {"body": 2, "word": "statistical", "fig": 1}, {"body": 2, "word": "difference", "fig": 1}, {"body": 2, "word": "Another", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "injecting", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "bar", "fig": 1}, {"body": 1, "word": "sizes", "fig": 1}]}], "4560833": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560833/bin/ncomms9100-f1.jpg", "caption": "PAQR3 modulates SREBP activation and cholesterol biosynthesis. (a) Serum levels of total cholesterol (TC) and LDL-C measured in wild-type (wt, n=15) or PAQR3 deletion (Paqr3\u2212/\u2212, n=13) mice fed with high fat diet for 16 weeks.(b) Cellular TC and TG contents measured in primary hepatocyte infected with control-shRNA or PAQR3-shRNA adenoviruses. (c) Gene expression levels measured by reverse transcription\u2013PCR (RT\u2013PCR) in primary hepatocytes infected with control-shRNA or PAQR3-shRNA adenoviruses in normal medium. (d) Gene expression levels measured by RT\u2013PCR in HepG2 cells transfected with control or PAQR3-overexpression plasmids in normal medium. (e,f) Huh7 cells were transiently transfected with the plasmids as indicated together with \u03b2-galactosidase and SRE-containing luciferase reporter. Luciferase activities were determined under lipid-loaded medium (control), lipid depletion medium (LD) with or without 25-HC/cholesterol replenishment after normalization to \u03b2-galactosidase activities. (g,h) Western blot analysis of CHO-7 cells transfected with the plasmids as indicated. Cells were cultured in normal medium (g) or LD medium (h). (j) Western blot analysis of CHO-7 cells transfected with the plasmids as indicated. Cells were cultured in LD medium for 16 h and then with or without 25-HC replenishment for 6 h. (i) Western blot analysis of primary hepatocyte from wt or Paqr3\u2212/\u2212 mice in normal medium or LD medium for different times as indicated. All bars show mean\u00b1s.d., *P<0.05, **P<0.01, ***P<0.001 by Student's t-test; NS, not significant. All experiments were repeated at least twice with similar results and representative data are shown.", "co_occurrence": [{"body": 174, "word": "PAQR3", "fig": 2}, {"body": 30, "word": "medium", "fig": 9}, {"body": 52, "word": "cells", "fig": 4}, {"body": 82, "word": "cholesterol", "fig": 2}, {"body": 19, "word": "LD", "fig": 4}, {"body": 66, "word": "SREBP", "fig": 1}, {"body": 21, "word": "levels", "fig": 3}, {"body": 26, "word": "expression", "fig": 2}, {"body": 13, "word": "normal", "fig": 4}, {"body": 15, "word": "h", "fig": 3}, {"body": 20, "word": "control", "fig": 2}, {"body": 17, "word": "mice", "fig": 2}, {"body": 31, "word": "activation", "fig": 1}, {"body": 7, "word": "indicated", "fig": 4}, {"body": 9, "word": "primary", "fig": 3}, {"body": 11, "word": "CHO-7", "fig": 2}, {"body": 22, "word": "TG", "fig": 1}, {"body": 11, "word": "All", "fig": 2}, {"body": 10, "word": "TC", "fig": 2}, {"body": 16, "word": "biosynthesis", "fig": 1}, {"body": 4, "word": "transfected", "fig": 4}, {"body": 16, "word": "'s", "fig": 1}, {"body": 15, "word": "lipid", "fig": 1}, {"body": 5, "word": "analysis", "fig": 3}, {"body": 6, "word": "activities", "fig": 2}, {"body": 3, "word": "plasmids", "fig": 4}, {"body": 6, "word": "cultured", "fig": 2}, {"body": 12, "word": "diet", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 4, "word": "PAQR3-shRNA", "fig": 2}, {"body": 2, "word": "measured", "fig": 4}, {"body": 7, "word": "hepatocytes", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 6, "word": "h.", "fig": 1}, {"body": 6, "word": "high", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 5, "word": "deletion", "fig": 1}, {"body": 5, "word": "times", "fig": 1}, {"body": 5, "word": "modulates", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 2, "word": "\u03b2-galactosidase", "fig": 2}, {"body": 4, "word": "fed", "fig": 1}, {"body": 2, "word": "Cells", "fig": 2}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "together", "fig": 1}, {"body": 2, "word": "without", "fig": 2}, {"body": 3, "word": "HepG2", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 1, "word": "Western", "fig": 3}, {"body": 3, "word": "depletion", "fig": 1}, {"body": 3, "word": "reverse", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 3, "word": "Huh7", "fig": 1}, {"body": 3, "word": "25-HC", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 2, "word": "fat", "fig": 1}, {"body": 2, "word": "reporter", "fig": 1}, {"body": 1, "word": "adenoviruses", "fig": 2}, {"body": 1, "word": "control-shRNA", "fig": 2}, {"body": 1, "word": "g", "fig": 2}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "hepatocyte", "fig": 2}, {"body": 1, "word": "replenishment", "fig": 2}, {"body": 2, "word": "j", "fig": 1}, {"body": 2, "word": "contents", "fig": 1}, {"body": 2, "word": "LDL-C", "fig": 1}, {"body": 1, "word": "luciferase", "fig": 1}, {"body": 1, "word": "weeks", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "twice", "fig": 1}, {"body": 1, "word": "shown", "fig": 1}, {"body": 1, "word": "wild-type", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "lipid-loaded", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560833/bin/ncomms9100-f2.jpg", "caption": "PAQR3 tethers Scap to the Golgi apparatus. (a) Analysis of Scap and PAQR3 subcellular localization by fractionation. Myc-tagged Scap (for all three groups) and GFP-fused PAQR3 (for the last group) were transfected into sterol-sensitive and Scap-deficient SRD-13A cells. At 36 h after the transfection, the cells were switched to normal medium or lipid depletion medium for 90 min, and then subjected to homogenization and cell fractionation by gradient centrifugation. The relative distribution of each protein in different fractions is shown in the lower panels after densitometry analysis of the blots. (b) PAQR3 overexpression promotes Golgi localization of Scap. SRD-13A cells were transiently transfected with the plasmids as in a and used in immunofluorescence staining and confocal analysis. The arrows indicate apparent localization of Scap in the Golgi. (c) Knockdown of PAQR3 reduces lipid depletion-induced Golgi localization of Scap. SRD-13A cells were transfected either with control siRNA or PAQR3 siRNA. At 24 h after transfection, the cells were transfected with Myc-tagged Scap and cultured for 24 h. Then the cells were subjected to normal culture medium or lipid depletion medium before immunofluorescence staining and confocal analysis. The arrow indicates LD-induced localization of Scap in the Golgi. Scale bar,10 \u03bcm. All experiments were repeated at least twice with similar results and representative data are shown.", "co_occurrence": [{"body": 174, "word": "PAQR3", "fig": 6}, {"body": 76, "word": "Scap", "fig": 8}, {"body": 52, "word": "cells", "fig": 6}, {"body": 30, "word": "medium", "fig": 4}, {"body": 38, "word": "The", "fig": 3}, {"body": 21, "word": "Golgi", "fig": 5}, {"body": 17, "word": "localization", "fig": 5}, {"body": 15, "word": "lipid", "fig": 3}, {"body": 11, "word": "SRD-13A", "fig": 3}, {"body": 15, "word": "h", "fig": 2}, {"body": 28, "word": "protein", "fig": 1}, {"body": 13, "word": "normal", "fig": 2}, {"body": 20, "word": "control", "fig": 1}, {"body": 9, "word": "transfection", "fig": 2}, {"body": 4, "word": "transfected", "fig": 4}, {"body": 8, "word": "At", "fig": 2}, {"body": 15, "word": "used", "fig": 1}, {"body": 15, "word": "overexpression", "fig": 1}, {"body": 5, "word": "analysis", "fig": 3}, {"body": 7, "word": "subjected", "fig": 2}, {"body": 13, "word": "min", "fig": 1}, {"body": 12, "word": "cell", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 8, "word": "three", "fig": 1}, {"body": 3, "word": "fractionation", "fig": 2}, {"body": 6, "word": "centrifugation", "fig": 1}, {"body": 3, "word": "depletion", "fig": 2}, {"body": 6, "word": "h.", "fig": 1}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 6, "word": "fractions", "fig": 1}, {"body": 6, "word": "promotes", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 5, "word": "group", "fig": 1}, {"body": 5, "word": "LD-induced", "fig": 1}, {"body": 5, "word": "subcellular", "fig": 1}, {"body": 5, "word": "lower", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 2, "word": "staining", "fig": 2}, {"body": 4, "word": "either", "fig": 1}, {"body": 2, "word": "siRNA", "fig": 2}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "reduces", "fig": 1}, {"body": 3, "word": "culture", "fig": 1}, {"body": 3, "word": "plasmids", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 1, "word": "Myc-tagged", "fig": 2}, {"body": 2, "word": "relative", "fig": 1}, {"body": 2, "word": "tethers", "fig": 1}, {"body": 2, "word": "groups", "fig": 1}, {"body": 1, "word": "confocal", "fig": 2}, {"body": 2, "word": "homogenization", "fig": 1}, {"body": 2, "word": "Then", "fig": 1}, {"body": 1, "word": "shown", "fig": 2}, {"body": 2, "word": "apparatus", "fig": 1}, {"body": 1, "word": "sterol-sensitive", "fig": 1}, {"body": 1, "word": "Knockdown", "fig": 1}, {"body": 1, "word": "Analysis", "fig": 1}, {"body": 1, "word": "twice", "fig": 1}, {"body": 1, "word": "gradient", "fig": 1}, {"body": 1, "word": "Scap-deficient", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "indicates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560833/bin/ncomms9100-f3.jpg", "caption": "PAQR3 interacts with SREBP-2 and Scap via distinct structural motifs. (a,b) Interaction of PAQR3 with Scap and SREBP-2. HEK293T cells were transiently transfected with the plasmids as indicated. The cell lysate was used in immunoblotting (IB) and immunoprecipitation (IP) with the antibodies as indicated. (c,d) Interaction of endogenous PAQR3 with endogenous Scap and SREBP-2 in HEK293T cells. The cell lysate was used in IB and IP using the antibodies as indicated. (e) A two-step co-immunoprecipitation assay to determine the ternary complex containing PAQR3, Scap and SREBP-2. The procedures of the two-step co-immunoprecipitation are outlined in the left. HEK293T cells were transfected with the plasmids as indicated and used in the immunoprecipitation. (f,g) Determination of PAQR3 domains required for its interaction with Scap and SREBP-2. Different PAQR3 deletion constructs were co-transfected with Myc-tagged Scap (f) or Flag-tagged SREBP-2 (g) into HEK293T cells. The cells were then subjected to lysis and IP, followed by IB with different antibodies as indicated. (h) A schematic diagram depicts critical domains of PAQR3 involved in the interaction with Scap and SREBP-2, respectively. (i) PAQR3 promotes Scap and SREBP-2 interaction. HEK293T cells were transiently transfected with the plasmids as indicated and the cell lysate was used in IB and IP with the antibodies as indicated. All experiments were repeated three times with similar results and representative data are shown.", "co_occurrence": [{"body": 174, "word": "PAQR3", "fig": 8}, {"body": 76, "word": "Scap", "fig": 8}, {"body": 44, "word": "SREBP-2", "fig": 8}, {"body": 52, "word": "cells", "fig": 6}, {"body": 38, "word": "The", "fig": 4}, {"body": 29, "word": "interaction", "fig": 3}, {"body": 15, "word": "used", "fig": 4}, {"body": 7, "word": "indicated", "fig": 7}, {"body": 10, "word": "antibodies", "fig": 4}, {"body": 12, "word": "cell", "fig": 3}, {"body": 26, "word": "complex", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 5}, {"body": 9, "word": "co-immunoprecipitation", "fig": 2}, {"body": 15, "word": "h", "fig": 1}, {"body": 14, "word": "containing", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 4, "word": "transfected", "fig": 3}, {"body": 6, "word": "immunoprecipitation", "fig": 2}, {"body": 11, "word": "involved", "fig": 1}, {"body": 11, "word": "via", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 10, "word": "immunoblotting", "fig": 1}, {"body": 3, "word": "plasmids", "fig": 3}, {"body": 9, "word": "data", "fig": 1}, {"body": 4, "word": "endogenous", "fig": 2}, {"body": 8, "word": "three", "fig": 1}, {"body": 4, "word": "A", "fig": 2}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 6, "word": "lysis", "fig": 1}, {"body": 6, "word": "promotes", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 3, "word": "two-step", "fig": 2}, {"body": 5, "word": "structural", "fig": 1}, {"body": 5, "word": "times", "fig": 1}, {"body": 5, "word": "deletion", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "procedures", "fig": 1}, {"body": 4, "word": "critical", "fig": 1}, {"body": 4, "word": "motifs", "fig": 1}, {"body": 4, "word": "followed", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 1, "word": "lysate", "fig": 3}, {"body": 3, "word": "similar", "fig": 1}, {"body": 3, "word": "interacts", "fig": 1}, {"body": 3, "word": "required", "fig": 1}, {"body": 2, "word": "respectively", "fig": 1}, {"body": 1, "word": "g", "fig": 2}, {"body": 2, "word": "distinct", "fig": 1}, {"body": 1, "word": "f", "fig": 2}, {"body": 2, "word": "Flag-tagged", "fig": 1}, {"body": 2, "word": "ternary", "fig": 1}, {"body": 1, "word": "Myc-tagged", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "shown", "fig": 1}, {"body": 1, "word": "determine", "fig": 1}, {"body": 1, "word": "constructs", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560833/bin/ncomms9100-f4.jpg", "caption": "Mutually exclusive interaction of Scap with PAQR3 or Insig-1 in the control of cholesterol homeostasis. (a) Mutually exclusive interaction of Scap with PAQR3 or Insig-1. HEK293T cells were transfected with the plasmids as indicated and the cell lysate was used in immunoblotting (IB) and immunoprecipitation (IP) with the antibodies as indicated. (b,c) Mutually exclusive competition between PAQR3 and Insig-1 for Scap binding. HEK293T cells were transfected with plasmids as indicated, followed by IB and IP. (d) The relative levels of PAQR3 and Insig-1 determine SREBP-2 activation. CHO-7 cells were transfected with the plasmids as indicated and the cell lysate was used in IB. The relative ratios of N-SREBP-2 versus P-SREBP-2 were obtained by densitometric analysis (shown in the lower penal, **P<0.01, ***P<0.001 by Student's t-test). (e) The interaction of Scap with PAQR3 or Insig-1 is regulated by cholesterol. HEK293T cells were transfected with the plasmids as indicated and subjected to normal medium, LD medium with or without 25-HC replenishment for different time as indicated, followed by IB and IP assays. All experiments were repeated three times with similar results and representative data are shown.(f) A model depicts the functional role of PAQR3 in regulating cholesterol biosynthesis. When cellular cholesterol level is high, Scap/SREBP complex is retained in the ER by Insig, resulting in inactivation of SREBP. When cholesterol level is low, Insig is separated from Scap/SREBP complex which is then transported to the GA via COPII vesicles. PAQR3 facilitates anchoring of Scap/SREBP complex in the GA and promotes SREBP activation. What is not illustrated in the model is that this process is regulated by cholesterol. Low cholesterol induces degradation of Insig-1 while elevates PAQR3 expression, favouring retention of Scap/SREBP complex in the GA.", "co_occurrence": [{"body": 174, "word": "PAQR3", "fig": 8}, {"body": 82, "word": "cholesterol", "fig": 7}, {"body": 76, "word": "Scap", "fig": 4}, {"body": 52, "word": "cells", "fig": 4}, {"body": 36, "word": "Scap/SREBP", "fig": 4}, {"body": 66, "word": "SREBP", "fig": 2}, {"body": 21, "word": "Insig-1", "fig": 6}, {"body": 38, "word": "The", "fig": 3}, {"body": 26, "word": "complex", "fig": 4}, {"body": 31, "word": "GA", "fig": 3}, {"body": 29, "word": "interaction", "fig": 3}, {"body": 31, "word": "activation", "fig": 2}, {"body": 30, "word": "medium", "fig": 2}, {"body": 44, "word": "SREBP-2", "fig": 1}, {"body": 7, "word": "indicated", "fig": 6}, {"body": 18, "word": "level", "fig": 2}, {"body": 18, "word": "Insig", "fig": 2}, {"body": 15, "word": "used", "fig": 2}, {"body": 26, "word": "ER", "fig": 1}, {"body": 26, "word": "expression", "fig": 1}, {"body": 12, "word": "cell", "fig": 2}, {"body": 21, "word": "levels", "fig": 1}, {"body": 20, "word": "control", "fig": 1}, {"body": 19, "word": "LD", "fig": 1}, {"body": 16, "word": "biosynthesis", "fig": 1}, {"body": 4, "word": "transfected", "fig": 4}, {"body": 16, "word": "'s", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 3}, {"body": 7, "word": "regulated", "fig": 2}, {"body": 13, "word": "cellular", "fig": 1}, {"body": 13, "word": "normal", "fig": 1}, {"body": 3, "word": "plasmids", "fig": 4}, {"body": 11, "word": "via", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 11, "word": "CHO-7", "fig": 1}, {"body": 10, "word": "homeostasis", "fig": 1}, {"body": 10, "word": "immunoblotting", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 8, "word": "retention", "fig": 1}, {"body": 4, "word": "followed", "fig": 2}, {"body": 8, "word": "three", "fig": 1}, {"body": 8, "word": "low", "fig": 1}, {"body": 4, "word": "model", "fig": 2}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 2, "word": "exclusive", "fig": 3}, {"body": 6, "word": "degradation", "fig": 1}, {"body": 6, "word": "promotes", "fig": 1}, {"body": 6, "word": "binding", "fig": 1}, {"body": 6, "word": "high", "fig": 1}, {"body": 6, "word": "immunoprecipitation", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 5, "word": "anchoring", "fig": 1}, {"body": 5, "word": "times", "fig": 1}, {"body": 5, "word": "lower", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 2, "word": "relative", "fig": 2}, {"body": 4, "word": "inactivation", "fig": 1}, {"body": 2, "word": "When", "fig": 2}, {"body": 4, "word": "assays", "fig": 1}, {"body": 4, "word": "role", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "facilitates", "fig": 1}, {"body": 3, "word": "versus", "fig": 1}, {"body": 3, "word": "functional", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 3, "word": "25-HC", "fig": 1}, {"body": 3, "word": "resulting", "fig": 1}, {"body": 1, "word": "shown", "fig": 2}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "COPII", "fig": 1}, {"body": 1, "word": "lysate", "fig": 2}, {"body": 2, "word": "process", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 2, "word": "transported", "fig": 1}, {"body": 2, "word": "without", "fig": 1}, {"body": 2, "word": "regulating", "fig": 1}, {"body": 1, "word": "What", "fig": 1}, {"body": 1, "word": "elevates", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "N-SREBP-2", "fig": 1}, {"body": 1, "word": "obtained", "fig": 1}, {"body": 1, "word": "retained", "fig": 1}, {"body": 1, "word": "determine", "fig": 1}, {"body": 1, "word": "separated", "fig": 1}, {"body": 1, "word": "replenishment", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560833/bin/ncomms9100-f5.jpg", "caption": "PAQR3 modulates SREBP activity and lipid synthesis of the liver on refeeding. Eight-week-old male C57BL/6J mice were injected with control or PAQR3 knockdown adenovirus i.v. Seven days after injection, the mice (n=6 per group) were subjected to fasting and refeeding. The non-fasted group (NF) was fed a chow diet ad libitum, the fasted group (F) was fasted for 24 h, and the refed group (R) was fasted for 24 h and then refed a high-carbohydrate/low-fat diet for 12 h. (a) Western blot analysis of the mouse livers. (b) Total cholesterol (TC) and triglyceride (TG) contents in the livers. (c) Gene expression profiles in the mouse liver measured by RT\u2013PCR. The same experiment was repeated twice with similar results. All data show mean\u00b1s.d., *P<0.05, **P<0.01, ***P<0.001 by Student's t-test.", "co_occurrence": [{"body": 174, "word": "PAQR3", "fig": 2}, {"body": 82, "word": "cholesterol", "fig": 1}, {"body": 38, "word": "The", "fig": 2}, {"body": 66, "word": "SREBP", "fig": 1}, {"body": 23, "word": "liver", "fig": 2}, {"body": 17, "word": "mice", "fig": 2}, {"body": 15, "word": "h", "fig": 2}, {"body": 26, "word": "expression", "fig": 1}, {"body": 13, "word": "mouse", "fig": 2}, {"body": 12, "word": "diet", "fig": 2}, {"body": 23, "word": "knockdown", "fig": 1}, {"body": 22, "word": "TG", "fig": 1}, {"body": 5, "word": "group", "fig": 4}, {"body": 20, "word": "control", "fig": 1}, {"body": 17, "word": "synthesis", "fig": 1}, {"body": 16, "word": "'s", "fig": 1}, {"body": 8, "word": "refeeding", "fig": 2}, {"body": 15, "word": "lipid", "fig": 1}, {"body": 12, "word": "activity", "fig": 1}, {"body": 11, "word": "All", "fig": 1}, {"body": 10, "word": "TC", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 6, "word": "h.", "fig": 1}, {"body": 6, "word": "fasting", "fig": 1}, {"body": 5, "word": "experiment", "fig": 1}, {"body": 5, "word": "chow", "fig": 1}, {"body": 5, "word": "modulates", "fig": 1}, {"body": 5, "word": "injection", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "per", "fig": 1}, {"body": 4, "word": "days", "fig": 1}, {"body": 4, "word": "fed", "fig": 1}, {"body": 3, "word": "injected", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 3, "word": "C57BL/6J", "fig": 1}, {"body": 1, "word": "fasted", "fig": 3}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "livers", "fig": 2}, {"body": 2, "word": "adenovirus", "fig": 1}, {"body": 2, "word": "contents", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 2, "word": "measured", "fig": 1}, {"body": 1, "word": "refed", "fig": 2}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "libitum", "fig": 1}, {"body": 1, "word": "twice", "fig": 1}, {"body": 1, "word": "high-carbohydrate/low-fat", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "male", "fig": 1}, {"body": 1, "word": "ad", "fig": 1}, {"body": 1, "word": "triglyceride", "fig": 1}, {"body": 1, "word": "Total", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560833/bin/ncomms9100-f6.jpg", "caption": "PAQR3 modulates SREBP activity and lipid biosynthesis mainly at low dietary cholesterol levels. Seven-week-old male C57BL/6J mice were injected with control or PAQR3-shRNA adenovirus i.v. Seven days after injection, the mice (n=7 per group) were subjected to diets containing different cholesterol levels ad libitum for 3 days, and then killed for analysis. (a\u2013c) Western blotting analysis, gene expression levels as measured by RT\u2013PCR and lipid measurement in the livers of mice fed with a diet containing 0% cholesterol. (d\u2013f) Western blotting analysis, mRNA and lipid levels in the livers of mice fed with diets of varying cholesterol concentrations. All data show mean\u00b1s.d., *P<0.05, **P<0.01, ***P<0.001 by Student's t-test, NS, not significant. All experiments were repeated at least twice with similar results and representative data are shown.", "co_occurrence": [{"body": 82, "word": "cholesterol", "fig": 4}, {"body": 174, "word": "PAQR3", "fig": 1}, {"body": 21, "word": "levels", "fig": 4}, {"body": 17, "word": "mice", "fig": 4}, {"body": 66, "word": "SREBP", "fig": 1}, {"body": 15, "word": "lipid", "fig": 3}, {"body": 14, "word": "containing", "fig": 2}, {"body": 26, "word": "expression", "fig": 1}, {"body": 11, "word": "All", "fig": 2}, {"body": 20, "word": "control", "fig": 1}, {"body": 9, "word": "data", "fig": 2}, {"body": 16, "word": "biosynthesis", "fig": 1}, {"body": 16, "word": "'s", "fig": 1}, {"body": 5, "word": "analysis", "fig": 3}, {"body": 12, "word": "activity", "fig": 1}, {"body": 12, "word": "diet", "fig": 1}, {"body": 8, "word": "mainly", "fig": 1}, {"body": 4, "word": "days", "fig": 2}, {"body": 4, "word": "fed", "fig": 2}, {"body": 8, "word": "low", "fig": 1}, {"body": 4, "word": "diets", "fig": 2}, {"body": 7, "word": "subjected", "fig": 1}, {"body": 7, "word": "concentrations", "fig": 1}, {"body": 3, "word": "blotting", "fig": 2}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 5, "word": "group", "fig": 1}, {"body": 5, "word": "modulates", "fig": 1}, {"body": 5, "word": "injection", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "per", "fig": 1}, {"body": 4, "word": "PAQR3-shRNA", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "measurement", "fig": 1}, {"body": 3, "word": "injected", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 3, "word": "gene", "fig": 1}, {"body": 3, "word": "C57BL/6J", "fig": 1}, {"body": 1, "word": "Western", "fig": 2}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "livers", "fig": 2}, {"body": 2, "word": "measured", "fig": 1}, {"body": 2, "word": "adenovirus", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 1, "word": "libitum", "fig": 1}, {"body": 1, "word": "killed", "fig": 1}, {"body": 1, "word": "twice", "fig": 1}, {"body": 1, "word": "shown", "fig": 1}, {"body": 1, "word": "male", "fig": 1}, {"body": 1, "word": "ad", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560833/bin/ncomms9100-f7.jpg", "caption": "Disruption of PAQR3 interaction with Scap/SREBP by a synthetic peptide effectively blunts SREBP activity and lipid biosynthesis in the liver. (a,b) A synthetic peptide P6\u201355 blocks the interaction of PAQR3 with Scap and SREBP-2. HEK293T cells were transfected with the plasmids as indicated. At 24 h after transfection, the cells were treated with P6\u201355 (1, 4 or 20 ng \u03bcl\u22121) for 12 h and the cell lysate was used for immunoblotting (IB) and immunoprecipitation (IP) using the indicated antibodies. (c) P6\u201355 reduces SREBP activation. CHO-7 cell was transfected with Flag-tagged SREBP-2. At 6 h after transfection, the cells were treated with P6\u201355 (4 or 20 ng \u03bcl\u22121) in normal medium or LD medium for 16 h, and the cell lysate was used in western blotting with the indicated antibodies. (d) P6\u201355 decreases lipid-synthesizing gene expression in cells. CHO-7 cells were treated with control peptide or P6\u201355 (20 ng \u03bcl\u22121) for 96 h and then used in RT\u2013PCR. (e,f) P6\u201355 alleviates PAQR3-mediated Golgi localization of Scap. HeLa cells were transiently transfected with PAQR3 and Scap. After culturing in normal medium for 48 h, the cells were treated with 20 ng \u03bcl\u22121 of control peptide or P6\u201355 for 12 h before immunofluorescence staining and confocal analysis. The nuclei were stained with Hoechst 33342 (only shown in the merged images). The arrows denote co-localization of PAQR3 with Scap in the GA. The arrowheads indicate apparent loss of co-localization of PAQR3 with Scap in the GA. Quantitation of the co-localization of the proteins in the GA is shown in f. (g\u2013i) P6\u201355 shuts down SREBP activation and cholesterol synthesis in the liver. Western blotting analysis, gene expression analysis and lipid levels in the livers of mice (n=7 per group) treated with a control peptide or P6\u201355 (500 \u03bcg kg\u22121 per day) for 14 days. All bars show mean\u00b1s.d., *P<0.05, **P<0.01, ***P<0.001 by Student's t-test; NS, not significant. Scale bar, 10 \u03bcm. All experiments were repeated at least twice with similar results and representative data are shown.", "co_occurrence": [{"body": 174, "word": "PAQR3", "fig": 5}, {"body": 76, "word": "Scap", "fig": 5}, {"body": 52, "word": "cells", "fig": 7}, {"body": 66, "word": "SREBP", "fig": 3}, {"body": 18, "word": "P6\u201355", "fig": 10}, {"body": 38, "word": "The", "fig": 3}, {"body": 15, "word": "h", "fig": 7}, {"body": 30, "word": "medium", "fig": 3}, {"body": 44, "word": "SREBP-2", "fig": 2}, {"body": 82, "word": "cholesterol", "fig": 1}, {"body": 15, "word": "peptide", "fig": 5}, {"body": 31, "word": "activation", "fig": 2}, {"body": 31, "word": "GA", "fig": 2}, {"body": 20, "word": "control", "fig": 3}, {"body": 29, "word": "interaction", "fig": 2}, {"body": 26, "word": "expression", "fig": 2}, {"body": 23, "word": "liver", "fig": 2}, {"body": 15, "word": "used", "fig": 3}, {"body": 36, "word": "Scap/SREBP", "fig": 1}, {"body": 12, "word": "cell", "fig": 3}, {"body": 15, "word": "lipid", "fig": 2}, {"body": 13, "word": "normal", "fig": 2}, {"body": 11, "word": "All", "fig": 2}, {"body": 11, "word": "CHO-7", "fig": 2}, {"body": 21, "word": "Golgi", "fig": 1}, {"body": 7, "word": "indicated", "fig": 3}, {"body": 21, "word": "levels", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 2}, {"body": 19, "word": "LD", "fig": 1}, {"body": 9, "word": "transfection", "fig": 2}, {"body": 17, "word": "localization", "fig": 1}, {"body": 17, "word": "synthesis", "fig": 1}, {"body": 17, "word": "mice", "fig": 1}, {"body": 16, "word": "biosynthesis", "fig": 1}, {"body": 16, "word": "'s", "fig": 1}, {"body": 8, "word": "At", "fig": 2}, {"body": 5, "word": "analysis", "fig": 3}, {"body": 13, "word": "using", "fig": 1}, {"body": 12, "word": "activity", "fig": 1}, {"body": 12, "word": "proteins", "fig": 1}, {"body": 4, "word": "transfected", "fig": 3}, {"body": 10, "word": "\u03bcg", "fig": 1}, {"body": 10, "word": "immunoblotting", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 4, "word": "per", "fig": 2}, {"body": 7, "word": "After", "fig": 1}, {"body": 3, "word": "blotting", "fig": 2}, {"body": 3, "word": "synthetic", "fig": 2}, {"body": 6, "word": "immunoprecipitation", "fig": 1}, {"body": 3, "word": "gene", "fig": 2}, {"body": 5, "word": "group", "fig": 1}, {"body": 5, "word": "GA.", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "days", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "experiments", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 3, "word": "reduces", "fig": 1}, {"body": 1, "word": "shown", "fig": 3}, {"body": 3, "word": "plasmids", "fig": 1}, {"body": 3, "word": "western", "fig": 1}, {"body": 1, "word": "co-localization", "fig": 3}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "decreases", "fig": 1}, {"body": 2, "word": "kg\u22121", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "lysate", "fig": 2}, {"body": 2, "word": "Flag-tagged", "fig": 1}, {"body": 2, "word": "Student", "fig": 1}, {"body": 1, "word": "HeLa", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "merged", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "day", "fig": 1}, {"body": 1, "word": "loss", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "twice", "fig": 1}, {"body": 1, "word": "nuclei", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "blunts", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "livers", "fig": 1}, {"body": 1, "word": "effectively", "fig": 1}, {"body": 1, "word": "blocks", "fig": 1}, {"body": 1, "word": "Hoechst", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}], "4415602": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f1.jpg", "caption": "POLQ is highly expressed in epithelial ovarian cancers (EOCs) and POLQ expression correlates with expression of HR genes Gene set enrichment analysis (GSEA) for expression of TransLesion Synthesis (TLS) (a) and polymerase (b) genes between primary cancers and control samples in 28 independent datasets from 19 different cancers types. Enrichment values (represented as a single dot for each gene in a defined dataset) were determined using the rank metric score to compare expression values between cancers and control samples. Dots above the dashed line reflect enrichment in cancer samples, whereas dots below the dashed line show gene expression enriched in control samples. Datasets were ranked based on the amplitude of the rank metric score and plotted as shown. c, POLQ gene expression in 40 independent datasets from 19 different cancer types. For each dataset, POLQ values were expressed as fold-change differences relative to the mean expression in control samples, which was arbitrarily set to 1. d, POLQ expression correlates with tumor grade and MKi67 gene expression in the ovarian TCGA (n=494 patients with ovarian carcinoma (grade 1, n=5; grade 2, n=61; grade 3, n=428) and control samples, n=8). e, POLQ expression correlates with tumor grade MKi67 gene expression in the ovarian dataset GSE9891 (n=251 patients with ovarian serous and endometrious carcinoma for which grade status was available (grade 1, n=20; grade 2, n=88; grade 3, n=143)). Statistical correlation was assessed using the Pearson test (for d: r=0.65, P < 10-3; for e: r=0.77, P < 10-3). f, Top-ranked biological pathways differentially expressed between samples expressing high levels of POLQ (high POLQ, 1st 33%, n=95) relative to samples with low POLQ expression (low POLQ, 67%, n=190) on the ovarian dataset GSE9891 (n=285 patients with ovarian carcinoma). Significance values were determined by the hypergeometrical test using the 200 most differentially expressed probesets between the 2 groups (high POLQ and low POLQ). g, GSEA for expression of DNA repair genes between primary cancers and control samples in 5 independent ovarian cancer datasets. A representative heat map showing differential gene expression between ovarian cancers and controls is shown from GSE14407. For each dataset, DNA repair genes were ranked based on the metric score reflecting their enrichment in cancer samples. The top 20 DNA repair genes primarily expressed in cancer samples compared to control samples is shown on the right. h, GSEA for the top 20 DNA repair genes defined in (g) between primary cancers and control samples in 40 independent cancer datasets. The nominal P-value was used as a measure of the expression enrichment in cancer samples and represented as a waterfall plot. When the gene set expression was enriched in control samples, the P-value was arbitrarily set to 1. i, POLQ expression correlates with RAD51 and FANCD2 gene expression in 285 samples from the ovarian dataset GSE9891. Statistical correlation was assessed using the Pearson test (r=0.71, P < 10-3). j, Top 10 genes that most closely correlated with POLQ expression (gene neighbors analysis) for 1046 cell lines from the CCLE collection. DNA repair activity for these genes is indicated in the table. Increased HR gene expression is known to positively correlate with improved response to platinum based chemotherapy (a surrogate of HR deficiency) and thus can be predictive of decreased HR activity31,38. Conceptually, a state of HR deficiency may lead to compensatory increased expression of other HR genes. k, Top-ranked Gene Ontology (GO) terms for the molecular functions encoded by the top 20 DNA repair genes defined in Extended Data Figure 1g. l, Schematic representation of POLQ domain structure with the helicases (BLM, RECQL4, RAD54B and RAD54L) that co-expressed with POLQ (from Extended Data Figure 1g). Conserved amino-acid sequences of ATP binding and hydrolysis motifs (namely Walker A and B) are indicated. Cox plots in c that show twenty-fifth to seventy-fifth percentiles, with lines indicating the median, and whiskers indicating the smallest and largest values. For d and e (top panels), each dot represents the expression value from one patient, brackets show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 16}, {"body": 28, "word": "expression", "fig": 22}, {"body": 37, "word": "HR", "fig": 6}, {"body": 31, "word": "DNA", "fig": 6}, {"body": 13, "word": "gene", "fig": 10}, {"body": 29, "word": "using", "fig": 4}, {"body": 46, "word": "Data", "fig": 2}, {"body": 15, "word": "repair", "fig": 6}, {"body": 45, "word": "Extended", "fig": 2}, {"body": 8, "word": "ovarian", "fig": 10}, {"body": 8, "word": "control", "fig": 9}, {"body": 7, "word": "genes", "fig": 10}, {"body": 23, "word": "For", "fig": 3}, {"body": 4, "word": "samples", "fig": 16}, {"body": 25, "word": "The", "fig": 2}, {"body": 7, "word": "cancers", "fig": 7}, {"body": 8, "word": "expressed", "fig": 5}, {"body": 35, "word": "RAD51", "fig": 1}, {"body": 7, "word": "values", "fig": 5}, {"body": 4, "word": "cancer", "fig": 7}, {"body": 6, "word": "datasets", "fig": 4}, {"body": 12, "word": "analysis", "fig": 2}, {"body": 11, "word": "indicated", "fig": 2}, {"body": 10, "word": "relative", "fig": 2}, {"body": 9, "word": "A", "fig": 2}, {"body": 2, "word": "grade", "fig": 9}, {"body": 6, "word": "e", "fig": 3}, {"body": 4, "word": "set", "fig": 4}, {"body": 8, "word": "tumor", "fig": 2}, {"body": 5, "word": "GSEA", "fig": 3}, {"body": 5, "word": "P", "fig": 3}, {"body": 5, "word": "test", "fig": 3}, {"body": 5, "word": "carcinoma", "fig": 3}, {"body": 13, "word": "binding", "fig": 1}, {"body": 2, "word": "dataset", "fig": 6}, {"body": 12, "word": "used", "fig": 1}, {"body": 4, "word": "shown", "fig": 3}, {"body": 4, "word": "low", "fig": 3}, {"body": 4, "word": "high", "fig": 3}, {"body": 6, "word": "assessed", "fig": 2}, {"body": 5, "word": "Figure", "fig": 2}, {"body": 10, "word": "activity", "fig": 1}, {"body": 5, "word": "deficiency", "fig": 2}, {"body": 3, "word": "GSE9891", "fig": 3}, {"body": 3, "word": "d", "fig": 3}, {"body": 3, "word": "defined", "fig": 3}, {"body": 8, "word": "cell", "fig": 1}, {"body": 2, "word": "top", "fig": 4}, {"body": 4, "word": "line", "fig": 2}, {"body": 4, "word": "determined", "fig": 2}, {"body": 2, "word": "independent", "fig": 4}, {"body": 7, "word": "EOCs", "fig": 1}, {"body": 7, "word": "TCGA", "fig": 1}, {"body": 7, "word": "polymerase", "fig": 1}, {"body": 6, "word": "expressing", "fig": 1}, {"body": 3, "word": "mean", "fig": 2}, {"body": 6, "word": "domain", "fig": 1}, {"body": 3, "word": "1g", "fig": 2}, {"body": 3, "word": "Gene", "fig": 2}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "levels", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 4, "word": "median", "fig": 1}, {"body": 4, "word": "response", "fig": 1}, {"body": 2, "word": "g", "fig": 2}, {"body": 2, "word": "Statistical", "fig": 2}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "ATP", "fig": 1}, {"body": 4, "word": "pathways", "fig": 1}, {"body": 2, "word": "lines", "fig": 2}, {"body": 1, "word": "correlates", "fig": 4}, {"body": 2, "word": "correlation", "fig": 2}, {"body": 1, "word": "enrichment", "fig": 4}, {"body": 1, "word": "show", "fig": 3}, {"body": 3, "word": "one", "fig": 1}, {"body": 3, "word": "motifs", "fig": 1}, {"body": 3, "word": "decreased", "fig": 1}, {"body": 3, "word": "FANCD2", "fig": 1}, {"body": 3, "word": "groups", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 3, "word": "plotted", "fig": 1}, {"body": 1, "word": "primary", "fig": 3}, {"body": 3, "word": "table", "fig": 1}, {"body": 3, "word": "differences", "fig": 1}, {"body": 3, "word": "increased", "fig": 1}, {"body": 3, "word": "serous", "fig": 1}, {"body": 1, "word": "patients", "fig": 3}, {"body": 1, "word": "enriched", "fig": 2}, {"body": 1, "word": "indicating", "fig": 2}, {"body": 2, "word": "represents", "fig": 1}, {"body": 2, "word": "fold-change", "fig": 1}, {"body": 1, "word": "differentially", "fig": 2}, {"body": 2, "word": "available", "fig": 1}, {"body": 2, "word": "BLM", "fig": 1}, {"body": 1, "word": "represented", "fig": 2}, {"body": 1, "word": "c", "fig": 2}, {"body": 1, "word": "arbitrarily", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "different", "fig": 2}, {"body": 2, "word": "may", "fig": 1}, {"body": 2, "word": "functions", "fig": 1}, {"body": 1, "word": "n=143", "fig": 1}, {"body": 1, "word": "Synthesis", "fig": 1}, {"body": 1, "word": "nominal", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "Enrichment", "fig": 1}, {"body": 1, "word": "differential", "fig": 1}, {"body": 1, "word": "l", "fig": 1}, {"body": 1, "word": "biological", "fig": 1}, {"body": 1, "word": "sequences", "fig": 1}, {"body": 1, "word": "n=20", "fig": 1}, {"body": 1, "word": "waterfall", "fig": 1}, {"body": 1, "word": "When", "fig": 1}, {"body": 1, "word": "platinum", "fig": 1}, {"body": 1, "word": "plot", "fig": 1}, {"body": 1, "word": "chemotherapy", "fig": 1}, {"body": 1, "word": "TLS", "fig": 1}, {"body": 1, "word": "reflecting", "fig": 1}, {"body": 1, "word": "known", "fig": 1}, {"body": 1, "word": "positively", "fig": 1}, {"body": 1, "word": "compensatory", "fig": 1}, {"body": 1, "word": "molecular", "fig": 1}, {"body": 1, "word": "epithelial", "fig": 1}, {"body": 1, "word": "status", "fig": 1}, {"body": 1, "word": "hypergeometrical", "fig": 1}, {"body": 1, "word": "correlated", "fig": 1}, {"body": 1, "word": "surrogate", "fig": 1}, {"body": 1, "word": "TransLesion", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f2.jpg", "caption": "POLQ is a RAD51-interacting protein required for maintenance of genomic stability a, siRNA sequences (siPOLQ1 and siPOLQ2) efficiently down-regulate exogenously transfected POLQ protein. POLQ levels were detected by immunoblotting with Flag or POLQ antibody (left) and by RT-qPCR using 2 different sets of POLQ primers (right). The asterisk on the immunoblot indicates a non-specific band. Expression was normalized using GAPDH as a reference gene. POLQ gene expression values are displayed as fold-change differences relative to the mean expression in control cells, which was arbitrarily set to 1. b, Quantification of baseline and HU-induced RAD51 foci in U2OS cells transfected with indicated siRNA. c, Quantification of baseline and HU-induced \u03b3H2AX foci in U2OS cells transfected with indicated siRNA. d, Quantification of IR-induced RAD51 foci in BrdU-positive U2OS cells transfected with indicated siRNA. e, POLQ inhibition by siRNA induced a decrease in the cellular survival of 293T cells treated with MMC in a 3-day survival assay. f, Quantification of chromosomal aberrations in 293T cells transfected with indicated siRNA. g, Schematic representation of POLQ truncation proteins used for RAD51 interaction studies. h, Endogenous RAD51 co-precipitates with Flag-tagged POLQ-\u0394Pol1 (POLQ-1-1416) but not POLQ-1633-Cter, each stably expressed in HeLa cells. i, Sequence alignment between the RAD51-interacting motifs of C. elegans RFS-1 and human POLQ. j, Schematic of POLQ domain structure with its homologs HELQ and POLN. All data show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 10}, {"body": 69, "word": "cells", "fig": 7}, {"body": 35, "word": "RAD51", "fig": 4}, {"body": 29, "word": "using", "fig": 2}, {"body": 28, "word": "expression", "fig": 2}, {"body": 11, "word": "indicated", "fig": 4}, {"body": 7, "word": "siRNA", "fig": 6}, {"body": 8, "word": "transfected", "fig": 5}, {"body": 10, "word": "foci", "fig": 3}, {"body": 14, "word": "survival", "fig": 2}, {"body": 13, "word": "gene", "fig": 2}, {"body": 25, "word": "The", "fig": 1}, {"body": 8, "word": "protein", "fig": 2}, {"body": 12, "word": "used", "fig": 1}, {"body": 11, "word": "treated", "fig": 1}, {"body": 11, "word": "data", "fig": 1}, {"body": 10, "word": "relative", "fig": 1}, {"body": 10, "word": "MMC", "fig": 1}, {"body": 8, "word": "human", "fig": 1}, {"body": 4, "word": "293T", "fig": 2}, {"body": 8, "word": "expressed", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 7, "word": "inhibition", "fig": 1}, {"body": 7, "word": "cellular", "fig": 1}, {"body": 7, "word": "values", "fig": 1}, {"body": 6, "word": "assay", "fig": 1}, {"body": 3, "word": "mean", "fig": 2}, {"body": 6, "word": "domain", "fig": 1}, {"body": 6, "word": "genomic", "fig": 1}, {"body": 6, "word": "levels", "fig": 1}, {"body": 6, "word": "studies", "fig": 1}, {"body": 6, "word": "primers", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "antibody", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "Expression", "fig": 1}, {"body": 4, "word": "interaction", "fig": 1}, {"body": 4, "word": "set", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "All", "fig": 1}, {"body": 3, "word": "stability", "fig": 1}, {"body": 3, "word": "\u03b3H2AX", "fig": 1}, {"body": 3, "word": "stably", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "motifs", "fig": 1}, {"body": 3, "word": "differences", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 1, "word": "U2OS", "fig": 3}, {"body": 3, "word": "required", "fig": 1}, {"body": 3, "word": "sets", "fig": 1}, {"body": 2, "word": "siPOLQ1", "fig": 1}, {"body": 2, "word": "fold-change", "fig": 1}, {"body": 2, "word": "IR-induced", "fig": 1}, {"body": 2, "word": "induced", "fig": 1}, {"body": 2, "word": "chromosomal", "fig": 1}, {"body": 2, "word": "g", "fig": 1}, {"body": 2, "word": "RT-qPCR", "fig": 1}, {"body": 1, "word": "RAD51-interacting", "fig": 2}, {"body": 2, "word": "aberrations", "fig": 1}, {"body": 2, "word": "Flag-tagged", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "siPOLQ2", "fig": 1}, {"body": 1, "word": "detected", "fig": 1}, {"body": 1, "word": "immunoblot", "fig": 1}, {"body": 1, "word": "proteins", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "elegans", "fig": 1}, {"body": 1, "word": "Flag", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "arbitrarily", "fig": 1}, {"body": 1, "word": "decrease", "fig": 1}, {"body": 1, "word": "sequences", "fig": 1}, {"body": 1, "word": "C.", "fig": 1}, {"body": 1, "word": "maintenance", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "immunoblotting", "fig": 1}, {"body": 1, "word": "truncation", "fig": 1}, {"body": 1, "word": "indicates", "fig": 1}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "Sequence", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f3.jpg", "caption": "Characterization of RAD51-interacting motifs in POLQ a, Substitution peptide array probed with recombinant RAD51 and analyzed by immunoblotting. A 20-mer peptide spanning each of the RAD51 binding sites (shown in Fig. 1g) were created in which each amino acid of the original peptide was mutated to each of the 20 amino acids and RAD51 binding activity was tested. The amino acid change for each of the amino acids of the RAD51 interacting domain of POLQ is shown on the right. Ponceau staining was used to visualize position of the peptides within the array. b, GST-RAD51 pull-down with in vitro-translated POLQ proteins missing indicated amino acids. c, Schematic of POLQ mutants used in complementation studies. d, Quantification of IR-induced RAD51 foci in U2OS cells stably integrated with empty vector (EV) or POLQ- \u0394Pol1 cDNA, that is refractory to siPOLQ1. Cells were transfected with indicated siRNA and subsequently treated with IR. The number of cells with more than 10 RAD51 foci was calculated relative to control cells (si Scr). e, DR-GFP assay in U2OS cells stably integrated with empty vector (EV) or indicated POLQ cDNA constructs refractory to siPOLQ1 and transfected with indicated siRNA. All data show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 5}, {"body": 69, "word": "cells", "fig": 4}, {"body": 35, "word": "RAD51", "fig": 6}, {"body": 69, "word": "Fig", "fig": 1}, {"body": 25, "word": "The", "fig": 2}, {"body": 11, "word": "indicated", "fig": 4}, {"body": 13, "word": "binding", "fig": 2}, {"body": 12, "word": "used", "fig": 2}, {"body": 10, "word": "foci", "fig": 2}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 7, "word": "siRNA", "fig": 2}, {"body": 12, "word": "analyzed", "fig": 1}, {"body": 6, "word": "cDNA", "fig": 2}, {"body": 11, "word": "treated", "fig": 1}, {"body": 11, "word": "data", "fig": 1}, {"body": 10, "word": "activity", "fig": 1}, {"body": 10, "word": "relative", "fig": 1}, {"body": 2, "word": "amino", "fig": 5}, {"body": 3, "word": "peptide", "fig": 3}, {"body": 9, "word": "A", "fig": 1}, {"body": 4, "word": "shown", "fig": 2}, {"body": 8, "word": "control", "fig": 1}, {"body": 8, "word": "si", "fig": 1}, {"body": 7, "word": "Cells", "fig": 1}, {"body": 7, "word": "Scr", "fig": 1}, {"body": 7, "word": "calculated", "fig": 1}, {"body": 3, "word": "stably", "fig": 2}, {"body": 6, "word": "domain", "fig": 1}, {"body": 3, "word": "acid", "fig": 2}, {"body": 6, "word": "IR", "fig": 1}, {"body": 6, "word": "studies", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 6, "word": "constructs", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 6, "word": "assay", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "staining", "fig": 1}, {"body": 2, "word": "siPOLQ1", "fig": 2}, {"body": 4, "word": "recombinant", "fig": 1}, {"body": 2, "word": "vector", "fig": 2}, {"body": 4, "word": "\u0394Pol1", "fig": 1}, {"body": 4, "word": "GST-RAD51", "fig": 1}, {"body": 4, "word": "All", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "motifs", "fig": 1}, {"body": 3, "word": "complementation", "fig": 1}, {"body": 3, "word": "1g", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 1, "word": "acids", "fig": 3}, {"body": 2, "word": "Substitution", "fig": 1}, {"body": 2, "word": "DR-GFP", "fig": 1}, {"body": 2, "word": "IR-induced", "fig": 1}, {"body": 1, "word": "U2OS", "fig": 2}, {"body": 2, "word": "subsequently", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "pull-down", "fig": 1}, {"body": 1, "word": "proteins", "fig": 1}, {"body": 1, "word": "visualize", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "RAD51-interacting", "fig": 1}, {"body": 1, "word": "mutated", "fig": 1}, {"body": 1, "word": "spanning", "fig": 1}, {"body": 1, "word": "mutants", "fig": 1}, {"body": 1, "word": "immunoblotting", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f4.jpg", "caption": "POLQ is an ATPase that suppresses RAD51-ssDNA nucleofilament assembly and formation of RAD51-dependent D-loop structures a, Representative \u0394Pol2 WT radiometric ATPase assay. b, Gel mobility shift assays with \u0394Pol2 WT and ssDNA. c, Coomassie-stained gel showing the purified \u0394Pol2-A-dead fragment. d, Representative \u0394Pol2-A-dead radiometric ATPase assay. e, Quantification of \u0394Pol2-A-dead ATPase activity. (ssDNA: single-stranded DNA; dsDNA: double-stranded DNA). f, Assembly/disruption of RAD51-ssDNA filaments in the presence of increasing amounts of \u0394Pol2 WT. The order in which each component was added to the reaction is noted above. g, Schematics of the formation of RAD51-dependent D-loop structures. h Formation of RAD51-containing D-loop structures following the addition of increasing amounts of \u0394Pol2 WT. i, Fraction of D-loop formed following the addition of increasing amounts of \u0394Pol2 WT. j, Effect of POLQ expression levels and HR status on tumor sensitivity to cisplatin or PARPi. Data in i shows mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 2}, {"body": 31, "word": "DNA", "fig": 2}, {"body": 46, "word": "Data", "fig": 1}, {"body": 37, "word": "HR", "fig": 1}, {"body": 9, "word": "ATPase", "fig": 4}, {"body": 28, "word": "expression", "fig": 1}, {"body": 25, "word": "The", "fig": 1}, {"body": 11, "word": "ssDNA", "fig": 2}, {"body": 4, "word": "\u0394Pol2", "fig": 5}, {"body": 4, "word": "D-loop", "fig": 4}, {"body": 14, "word": "PARPi", "fig": 1}, {"body": 6, "word": "assay", "fig": 2}, {"body": 6, "word": "following", "fig": 2}, {"body": 5, "word": "RAD51-ssDNA", "fig": 2}, {"body": 10, "word": "activity", "fig": 1}, {"body": 10, "word": "assays", "fig": 1}, {"body": 9, "word": "added", "fig": 1}, {"body": 8, "word": "purified", "fig": 1}, {"body": 4, "word": "formation", "fig": 2}, {"body": 8, "word": "tumor", "fig": 1}, {"body": 6, "word": "gel", "fig": 1}, {"body": 2, "word": "increasing", "fig": 3}, {"body": 3, "word": "addition", "fig": 2}, {"body": 6, "word": "reaction", "fig": 1}, {"body": 6, "word": "levels", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 2, "word": "amounts", "fig": 3}, {"body": 1, "word": "WT", "fig": 5}, {"body": 5, "word": "dsDNA", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "assembly", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "nucleofilament", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "formed", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 1, "word": "structures", "fig": 3}, {"body": 2, "word": "fragment", "fig": 1}, {"body": 2, "word": "shows", "fig": 1}, {"body": 2, "word": "g", "fig": 1}, {"body": 2, "word": "single-stranded", "fig": 1}, {"body": 2, "word": "Gel", "fig": 1}, {"body": 1, "word": "cisplatin", "fig": 1}, {"body": 1, "word": "presence", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "sensitivity", "fig": 1}, {"body": 1, "word": "double-stranded", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "mobility", "fig": 1}, {"body": 1, "word": "shift", "fig": 1}, {"body": 1, "word": "status", "fig": 1}, {"body": 1, "word": "order", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f5.jpg", "caption": "POLQ functions under replicative stress and is induced by HR deficiency a, POLQ recruitment to the chromatin is enhanced by UV treatment. HeLa cells stably integrated with either Flag-tagged \u0394Pol1 or POLQ-1633-Cter (Extended Data Fig. 2g) were subjected to UV treatment. Cells were collected at indicated time points after UV treatment and IPs were performed on nuclear and chromatin fractions. b, HeLa cells stably integrated with \u0394Pol1 were treated with UV and harvested at indicated time points following UV exposure. POLQ and RAD51 co-precipitation is enhanced by UV treatment. c, Quantification of DNA fiber lengths isolated from WT or Polq-/- MEFs. d, Quantification of DNA fiber lengths isolated from WT or Polq-/- MEFs transfected with either EV, or POLQ cDNA constructs. e, POLQ gene expression was analyzed by RT-qPCR in HR-deficient ovarian cancer cell lines (PEO-1 and UWB1-289) compared with other ovarian cancer cell lines, HeLa (cervical cancer) cells and 293T (transformed human embryonic kidney) cells. Expression was normalized using GAPDH gene as a reference. POLQ expression values are displayed as fold-change relative to the mean expression in HR-proficient control cells, which was arbitrarily set to 1. f, POLQ gene expression analysis (RT-qPCR) in 293T cells transfected with siRNA targeting FANCD2, BRCA1 or BRCA2 (left panel) and in corrected PD20 cells (PD20 + FANCD2) relative to FANCD2-deficient cells (PD20) (right panel). Expression was normalized using GAPDH gene as a reference. POLQ expression values are presented as fold-change relative to the mean expression in control cells, which was arbitrarily set to 1. g, POLQ gene expression in 5 datasets of serous epithelial ovarian carcinoma (frequently associated with an HR deficiency) and 1 dataset of clear cell ovarian carcinoma (subgroup not associated with HR alterations). For each dataset, POLQ expression values are displayed as fold-change differences relative to the mean expression in control samples, which was arbitrarily set to 1. h, Progression-free survival (PFS) after first line platinum chemotherapy for patients with ovarian carcinoma (ovarian carcinoma TCGA). Statistical significance was assessed by the Log-Rank test (P < 10-2). i, Effect of siPOLQ and the different POLQ cDNA constructs on HR read-out. NA: not applicable. Box plots in c, d, and g show twenty-fifth to seventy-fifth percentiles, with lines indicating the median, and whiskers indicating the smallest and largest values. Data in e and f show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 11}, {"body": 69, "word": "cells", "fig": 9}, {"body": 28, "word": "expression", "fig": 9}, {"body": 37, "word": "HR", "fig": 4}, {"body": 23, "word": "treatment", "fig": 4}, {"body": 46, "word": "Data", "fig": 2}, {"body": 69, "word": "Fig", "fig": 1}, {"body": 13, "word": "gene", "fig": 5}, {"body": 31, "word": "DNA", "fig": 2}, {"body": 29, "word": "using", "fig": 2}, {"body": 8, "word": "ovarian", "fig": 6}, {"body": 45, "word": "Extended", "fig": 1}, {"body": 10, "word": "relative", "fig": 4}, {"body": 6, "word": "UV", "fig": 6}, {"body": 35, "word": "RAD51", "fig": 1}, {"body": 7, "word": "values", "fig": 4}, {"body": 8, "word": "cell", "fig": 3}, {"body": 8, "word": "control", "fig": 3}, {"body": 23, "word": "For", "fig": 1}, {"body": 11, "word": "indicated", "fig": 2}, {"body": 5, "word": "carcinoma", "fig": 4}, {"body": 19, "word": "performed", "fig": 1}, {"body": 17, "word": "HR-deficient", "fig": 1}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 14, "word": "survival", "fig": 1}, {"body": 4, "word": "cancer", "fig": 3}, {"body": 3, "word": "mean", "fig": 4}, {"body": 4, "word": "set", "fig": 3}, {"body": 12, "word": "analyzed", "fig": 1}, {"body": 6, "word": "constructs", "fig": 2}, {"body": 6, "word": "cDNA", "fig": 2}, {"body": 6, "word": "e", "fig": 2}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 11, "word": "treated", "fig": 1}, {"body": 5, "word": "deficiency", "fig": 2}, {"body": 4, "word": "Expression", "fig": 2}, {"body": 4, "word": "f", "fig": 2}, {"body": 4, "word": "either", "fig": 2}, {"body": 8, "word": "human", "fig": 1}, {"body": 4, "word": "293T", "fig": 2}, {"body": 4, "word": "\u0394Pol1", "fig": 2}, {"body": 7, "word": "Cells", "fig": 1}, {"body": 7, "word": "TCGA", "fig": 1}, {"body": 7, "word": "siRNA", "fig": 1}, {"body": 3, "word": "stably", "fig": 2}, {"body": 2, "word": "fold-change", "fig": 3}, {"body": 6, "word": "datasets", "fig": 1}, {"body": 3, "word": "MEFs", "fig": 2}, {"body": 3, "word": "d", "fig": 2}, {"body": 3, "word": "FANCD2", "fig": 2}, {"body": 6, "word": "assessed", "fig": 1}, {"body": 6, "word": "following", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 2, "word": "lines", "fig": 3}, {"body": 3, "word": "time", "fig": 2}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 5, "word": "test", "fig": 1}, {"body": 5, "word": "P", "fig": 1}, {"body": 4, "word": "samples", "fig": 1}, {"body": 2, "word": "chromatin", "fig": 2}, {"body": 4, "word": "median", "fig": 1}, {"body": 2, "word": "g", "fig": 2}, {"body": 2, "word": "dataset", "fig": 2}, {"body": 4, "word": "line", "fig": 1}, {"body": 2, "word": "RT-qPCR", "fig": 2}, {"body": 3, "word": "serous", "fig": 1}, {"body": 3, "word": "BRCA1", "fig": 1}, {"body": 3, "word": "replicative", "fig": 1}, {"body": 3, "word": "BRCA2", "fig": 1}, {"body": 3, "word": "embryonic", "fig": 1}, {"body": 3, "word": "targeting", "fig": 1}, {"body": 1, "word": "arbitrarily", "fig": 3}, {"body": 3, "word": "differences", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 3, "word": "harvested", "fig": 1}, {"body": 3, "word": "fractions", "fig": 1}, {"body": 3, "word": "exposure", "fig": 1}, {"body": 3, "word": "stress", "fig": 1}, {"body": 1, "word": "show", "fig": 2}, {"body": 1, "word": "WT", "fig": 2}, {"body": 1, "word": "indicating", "fig": 2}, {"body": 2, "word": "2g", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 2}, {"body": 1, "word": "enhanced", "fig": 2}, {"body": 2, "word": "induced", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "Statistical", "fig": 1}, {"body": 2, "word": "first", "fig": 1}, {"body": 2, "word": "collected", "fig": 1}, {"body": 1, "word": "Polq-/-", "fig": 2}, {"body": 2, "word": "alterations", "fig": 1}, {"body": 1, "word": "normalized", "fig": 2}, {"body": 1, "word": "associated", "fig": 2}, {"body": 2, "word": "Flag-tagged", "fig": 1}, {"body": 2, "word": "functions", "fig": 1}, {"body": 1, "word": "isolated", "fig": 2}, {"body": 2, "word": "significance", "fig": 1}, {"body": 1, "word": "points", "fig": 2}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "transformed", "fig": 1}, {"body": 1, "word": "epithelial", "fig": 1}, {"body": 1, "word": "Log-Rank", "fig": 1}, {"body": 1, "word": "HR-proficient", "fig": 1}, {"body": 1, "word": "platinum", "fig": 1}, {"body": 1, "word": "Progression-free", "fig": 1}, {"body": 1, "word": "chemotherapy", "fig": 1}, {"body": 1, "word": "FANCD2-deficient", "fig": 1}, {"body": 1, "word": "patients", "fig": 1}, {"body": 1, "word": "different", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f6.jpg", "caption": "POLQ inhibition sensitizes HR-deficient tumors to cytotoxic drug exposure Clonogenic formation of A2780 cells expressing Scrambled (Scr) shRNA or shRNAs against FANCD2 or BRCA2 with increasing amounts of MMC (a), UV (b) or IR (c). Clonogenic formation of A2780 cells expressing Scrambled (Scr) or FANCD2 shRNA, together with shRNA targeting POLQ, in increasing concentrations of CDDP (d), MMC (e) or PARPi (f). g, Inhibition of POLQ reduces the survival of A2780 cells after 3 days of continuous exposure to the ATM inhibitor Ku55933. h, Immunoblot analyses in A2780 cells expressing FANCD2 shRNA together with siRNA targeting POLQ or Scr at 24 hours after indicated MMC pulse treatment. i, FANCA-deficient fibroblasts (GM6418) were infected with a whole-genome shRNA library and treated with MMC for 7 days. The fold-change enrichment of each shRNA after MMC treatment was determined by sequencing relative to the infected cells before treatment. TP53 depletion is known to improve survival of FANCA-/- cells33. WRN depletion has recently been shown to be synthetically lethal with HR deficiency39. Each column represents the mean of at least 2 independent shRNAs. All data show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 4}, {"body": 69, "word": "cells", "fig": 5}, {"body": 23, "word": "treatment", "fig": 3}, {"body": 10, "word": "shRNA", "fig": 6}, {"body": 10, "word": "MMC", "fig": 5}, {"body": 37, "word": "HR", "fig": 1}, {"body": 29, "word": "hours", "fig": 1}, {"body": 14, "word": "survival", "fig": 2}, {"body": 25, "word": "The", "fig": 1}, {"body": 22, "word": "tumors", "fig": 1}, {"body": 7, "word": "Scr", "fig": 3}, {"body": 5, "word": "A2780", "fig": 4}, {"body": 6, "word": "expressing", "fig": 3}, {"body": 17, "word": "HR-deficient", "fig": 1}, {"body": 14, "word": "PARPi", "fig": 1}, {"body": 7, "word": "depletion", "fig": 2}, {"body": 11, "word": "treated", "fig": 1}, {"body": 11, "word": "indicated", "fig": 1}, {"body": 11, "word": "data", "fig": 1}, {"body": 10, "word": "relative", "fig": 1}, {"body": 5, "word": "days", "fig": 2}, {"body": 3, "word": "FANCD2", "fig": 3}, {"body": 4, "word": "formation", "fig": 2}, {"body": 7, "word": "inhibition", "fig": 1}, {"body": 7, "word": "siRNA", "fig": 1}, {"body": 3, "word": "mean", "fig": 2}, {"body": 6, "word": "CDDP", "fig": 1}, {"body": 6, "word": "UV", "fig": 1}, {"body": 6, "word": "least", "fig": 1}, {"body": 3, "word": "targeting", "fig": 2}, {"body": 6, "word": "drug", "fig": 1}, {"body": 3, "word": "shRNAs", "fig": 2}, {"body": 6, "word": "IR", "fig": 1}, {"body": 3, "word": "exposure", "fig": 2}, {"body": 6, "word": "e", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 2, "word": "increasing", "fig": 2}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "inhibitor", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "All", "fig": 1}, {"body": 3, "word": "BRCA2", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 2, "word": "fold-change", "fig": 1}, {"body": 2, "word": "sequencing", "fig": 1}, {"body": 2, "word": "represents", "fig": 1}, {"body": 2, "word": "fibroblasts", "fig": 1}, {"body": 2, "word": "Each", "fig": 1}, {"body": 2, "word": "analyses", "fig": 1}, {"body": 2, "word": "g", "fig": 1}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 1, "word": "infected", "fig": 2}, {"body": 2, "word": "cytotoxic", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "together", "fig": 2}, {"body": 2, "word": "amounts", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "lethal", "fig": 1}, {"body": 1, "word": "FANCA-/-", "fig": 1}, {"body": 1, "word": "pulse", "fig": 1}, {"body": 1, "word": "whole-genome", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "column", "fig": 1}, {"body": 1, "word": "ATM", "fig": 1}, {"body": 1, "word": "known", "fig": 1}, {"body": 1, "word": "Immunoblot", "fig": 1}, {"body": 1, "word": "enrichment", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f7.jpg", "caption": "HR and POLQ repair pathways are synthetical lethal in vivo a, Genotypes frequencies of offspring from interbred Fancd2+/\u2212Polq+/\u2212 mice. \u03a8: four Fancd2-/-Polq-/- offsprings were observed with several congenital malformations and premature death within 48 hours of birth. b, Description of Fancd2\u2212/\u2212Polq\u2212/\u2212 offspring generated in the study. The offspring presented congenital malformations (i.e., eye defects) together with reduced size and body weight. The arrow shows absence of the right eye. c, Genotypes frequencies of E13.5 to E15 embryos (13.5 to 15 days post coitum) from interbred Fancd2+/\u2212Polq+/\u2212 mice. d, Description of congenital malformations and their measured frequencies observed in E13.5 to E15 Fancd2\u2212/\u2212Polq\u2212/\u2212 embryos generated in the study. e, Clonogenic formation of WT, Fancd2-/-, Polq-/- and Fancd2\u2212/\u2212Polq\u2212/\u2212 MEFs with increasing concentrations of PARPi. f, A2780 cells were transduced with indicated shRNAs and xenotransplanted into both flanks of athymic nude mice. The tumor volumes for individual mice were measured biweekly for 8 weeks. Each group represents n \u2265 5 tumors from n \u2265 5 mice. g, Ki67 and \u03b3H2AX quantification in tumors treated with either vehicle or PARPi. h, Representative Ki67 and \u03b3H2AX staining of A2780-shFANCD2 xenografts expressing sh Scr or sh POLQ in athymic nude mice, treated with either vehicle or PARPi. Scale bars, 100 \u03bcM. i, In vivo competition assay design. j, Tumor chimerism post xenotransplantation for indicated conditions. k, Representative flow cytometry analysis of tumors before xenotransplantation (post FACS sorting) or after xenotransplantation (post transplant, PARPi). The percentage of GFP-RFP cells is indicated. l, Tumor chimerism post xenotransplantation for indicated conditions. For Data in j and l, each circle represents data from one tumor and each group represents n \u2265 7 tumors from n \u2265 6 mice. Brackets show mean \u00b1 s.e.m. Data in e-g show mean \u00b1 s.e.m. For f each group represents n \u2265 6 tumors from n \u2265 6 mice.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 2}, {"body": 26, "word": "mice", "fig": 8}, {"body": 69, "word": "cells", "fig": 2}, {"body": 22, "word": "tumors", "fig": 5}, {"body": 25, "word": "The", "fig": 4}, {"body": 46, "word": "Data", "fig": 2}, {"body": 14, "word": "PARPi", "fig": 4}, {"body": 23, "word": "For", "fig": 2}, {"body": 11, "word": "indicated", "fig": 4}, {"body": 37, "word": "HR", "fig": 1}, {"body": 29, "word": "hours", "fig": 1}, {"body": 13, "word": "generated", "fig": 2}, {"body": 11, "word": "treated", "fig": 2}, {"body": 6, "word": "group", "fig": 3}, {"body": 8, "word": "tumor", "fig": 2}, {"body": 15, "word": "repair", "fig": 1}, {"body": 7, "word": "observed", "fig": 2}, {"body": 4, "word": "Fancd2\u2212/\u2212Polq\u2212/\u2212", "fig": 3}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 11, "word": "data", "fig": 1}, {"body": 5, "word": "vivo", "fig": 2}, {"body": 10, "word": "\u03bcM", "fig": 1}, {"body": 5, "word": "measured", "fig": 2}, {"body": 2, "word": "represents", "fig": 4}, {"body": 4, "word": "either", "fig": 2}, {"body": 4, "word": "vehicle", "fig": 2}, {"body": 4, "word": "f", "fig": 2}, {"body": 7, "word": "Scr", "fig": 1}, {"body": 7, "word": "In", "fig": 1}, {"body": 3, "word": "\u03b3H2AX", "fig": 2}, {"body": 6, "word": "assay", "fig": 1}, {"body": 6, "word": "reduced", "fig": 1}, {"body": 3, "word": "mean", "fig": 2}, {"body": 2, "word": "malformations", "fig": 3}, {"body": 6, "word": "expressing", "fig": 1}, {"body": 3, "word": "embryos", "fig": 2}, {"body": 3, "word": "study", "fig": 2}, {"body": 3, "word": "s.e.m", "fig": 2}, {"body": 2, "word": "congenital", "fig": 3}, {"body": 6, "word": "e", "fig": 1}, {"body": 5, "word": "A2780", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "days", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "staining", "fig": 1}, {"body": 2, "word": "nude", "fig": 2}, {"body": 4, "word": "competition", "fig": 1}, {"body": 4, "word": "formation", "fig": 1}, {"body": 2, "word": "conditions", "fig": 2}, {"body": 4, "word": "pathways", "fig": 1}, {"body": 3, "word": "absence", "fig": 1}, {"body": 3, "word": "xenografts", "fig": 1}, {"body": 3, "word": "weeks", "fig": 1}, {"body": 3, "word": "MEFs", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "weight", "fig": 1}, {"body": 3, "word": "body", "fig": 1}, {"body": 3, "word": "GFP-RFP", "fig": 1}, {"body": 3, "word": "one", "fig": 1}, {"body": 3, "word": "percentage", "fig": 1}, {"body": 3, "word": "quantification", "fig": 1}, {"body": 1, "word": "offspring", "fig": 3}, {"body": 3, "word": "shRNAs", "fig": 1}, {"body": 1, "word": "show", "fig": 2}, {"body": 1, "word": "E13.5", "fig": 2}, {"body": 1, "word": "interbred", "fig": 2}, {"body": 1, "word": "l", "fig": 2}, {"body": 1, "word": "athymic", "fig": 2}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 1, "word": "Tumor", "fig": 2}, {"body": 2, "word": "shows", "fig": 1}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 2, "word": "g", "fig": 1}, {"body": 1, "word": "Ki67", "fig": 2}, {"body": 1, "word": "E15", "fig": 2}, {"body": 2, "word": "A2780-shFANCD2", "fig": 1}, {"body": 2, "word": "Each", "fig": 1}, {"body": 2, "word": "volumes", "fig": 1}, {"body": 2, "word": "FACS", "fig": 1}, {"body": 1, "word": "four", "fig": 1}, {"body": 1, "word": "WT", "fig": 1}, {"body": 1, "word": "xenotransplanted", "fig": 1}, {"body": 1, "word": "lethal", "fig": 1}, {"body": 1, "word": "death", "fig": 1}, {"body": 1, "word": "transduced", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "Fancd2-/-", "fig": 1}, {"body": 1, "word": "flanks", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "size", "fig": 1}, {"body": 1, "word": "Polq-/-", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 1}, {"body": 1, "word": "flow", "fig": 1}, {"body": 1, "word": "together", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f8.jpg", "caption": "POLQ is required for HR-deficient cell survival and limits the formation of RAD51 structures in HR-deficient cells a, Clonogenic formation of Fancd2-/-Polq-/- MEFs transfected with full-length POLQ cDNA constructs in the presence of increasing concentrations of PARPi. b, Chromosome breakage analysis of FANCD2-depleted cells that were first transfected with the indicated siRNA and full-length POLQ cDNA constructs refractory to siPOLQ1 and then exposed to MMC. c, DR-GFP assay in U2OS cells transfected with indicated siRNA. d, Quantification of baseline and IR-induced RAD51 foci in U2OS cells transfected with indicated siRNA. e, RAD51 recruitment to chromatin is enhanced by UV treatment. Vu423 cells (BRCA2-/-) were collected at indicated time points after UV treatment and immunoblotting performed on the cytoplasmic, nuclear and chromatin fractions. f, RAD51 recruitment to chromatin in Vu423 cells (BRCA2-/-) transfected with indicated siRNA. Histone H3 was used as a control for chromatin fractionation. All data show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 69, "word": "cells", "fig": 6}, {"body": 131, "word": "POLQ", "fig": 3}, {"body": 35, "word": "RAD51", "fig": 4}, {"body": 11, "word": "indicated", "fig": 5}, {"body": 23, "word": "treatment", "fig": 2}, {"body": 8, "word": "transfected", "fig": 5}, {"body": 17, "word": "HR-deficient", "fig": 2}, {"body": 7, "word": "siRNA", "fig": 4}, {"body": 19, "word": "performed", "fig": 1}, {"body": 14, "word": "survival", "fig": 1}, {"body": 14, "word": "PARPi", "fig": 1}, {"body": 6, "word": "UV", "fig": 2}, {"body": 6, "word": "constructs", "fig": 2}, {"body": 6, "word": "cDNA", "fig": 2}, {"body": 12, "word": "used", "fig": 1}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 11, "word": "data", "fig": 1}, {"body": 10, "word": "foci", "fig": 1}, {"body": 10, "word": "MMC", "fig": 1}, {"body": 5, "word": "full-length", "fig": 2}, {"body": 2, "word": "chromatin", "fig": 4}, {"body": 8, "word": "cell", "fig": 1}, {"body": 4, "word": "formation", "fig": 2}, {"body": 8, "word": "control", "fig": 1}, {"body": 6, "word": "assay", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 5, "word": "exposed", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "All", "fig": 1}, {"body": 3, "word": "MEFs", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "fractionation", "fig": 1}, {"body": 3, "word": "fractions", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 3, "word": "required", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 2, "word": "siPOLQ1", "fig": 1}, {"body": 2, "word": "breakage", "fig": 1}, {"body": 2, "word": "increasing", "fig": 1}, {"body": 2, "word": "DR-GFP", "fig": 1}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 2, "word": "first", "fig": 1}, {"body": 2, "word": "collected", "fig": 1}, {"body": 2, "word": "IR-induced", "fig": 1}, {"body": 1, "word": "U2OS", "fig": 2}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "Histone", "fig": 1}, {"body": 1, "word": "enhanced", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "limits", "fig": 1}, {"body": 1, "word": "H3", "fig": 1}, {"body": 1, "word": "presence", "fig": 1}, {"body": 1, "word": "structures", "fig": 1}, {"body": 1, "word": "immunoblotting", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f9.jpg", "caption": "POLQ participates in error-prone DNA repair a, End-joining reporter assay in U2OS cells transfected with indicated siRNA and/or treated with PARPi. b, End-joining reporter assay in U2OS cells transfected with indicated siRNA and POLQ cDNA constructs refractory to siPOLQ1. c, UV damage-induced POLQ foci formation in U2OS cells. POLQ foci were abolished by pre-treatment with PARPi. d, Mutation frequency was determined in damaged supF plasmid, recovered from siRNA-treated 293T cells. e, Non-synonymous mutation count in ovarian, uterine and breast TCGA. All data show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 4}, {"body": 69, "word": "cells", "fig": 4}, {"body": 31, "word": "DNA", "fig": 1}, {"body": 14, "word": "PARPi", "fig": 2}, {"body": 11, "word": "indicated", "fig": 2}, {"body": 10, "word": "foci", "fig": 2}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 15, "word": "repair", "fig": 1}, {"body": 7, "word": "siRNA", "fig": 2}, {"body": 6, "word": "assay", "fig": 2}, {"body": 11, "word": "data", "fig": 1}, {"body": 11, "word": "treated", "fig": 1}, {"body": 8, "word": "ovarian", "fig": 1}, {"body": 7, "word": "TCGA", "fig": 1}, {"body": 7, "word": "mutation", "fig": 1}, {"body": 6, "word": "cDNA", "fig": 1}, {"body": 6, "word": "constructs", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 6, "word": "UV", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "error-prone", "fig": 1}, {"body": 4, "word": "293T", "fig": 1}, {"body": 4, "word": "All", "fig": 1}, {"body": 4, "word": "formation", "fig": 1}, {"body": 4, "word": "breast", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 3, "word": "frequency", "fig": 1}, {"body": 1, "word": "U2OS", "fig": 3}, {"body": 3, "word": "uterine", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 2, "word": "participates", "fig": 1}, {"body": 2, "word": "siPOLQ1", "fig": 1}, {"body": 1, "word": "reporter", "fig": 2}, {"body": 2, "word": "count", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "damaged", "fig": 1}, {"body": 1, "word": "and/or", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "plasmid", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f10.jpg", "caption": "Model depicting the role of POLQ in DNA repair a, Mechanistic model for how POLQ limits RAD51-ssDNA filament assembly. According to this model, the ATPase domain of POLQ may prevent the assembly of RAD51 monomers into RAD51 polymers, perhaps by depleting local ATP concentrations. The RAD51 binding domains in the central region of POLQ may then sequester the RAD51 monomers, preventing filament assembly. b, I. Under physiological conditions, POLQ expression is low and its impact on repqir of DNA double-strand breaks (DSB) is limited. II. When HR deficiency occurs, POLQ is then highly expressed and channels DSB repair toward alt-EJ. III. In the case of an HR-defect, the loss of POLQ leads to cell death through the persistence of toxic RAD51 intermediates and inhibition of alt-EJ.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 7}, {"body": 35, "word": "RAD51", "fig": 5}, {"body": 31, "word": "DNA", "fig": 2}, {"body": 37, "word": "HR", "fig": 1}, {"body": 15, "word": "repair", "fig": 2}, {"body": 28, "word": "expression", "fig": 1}, {"body": 25, "word": "The", "fig": 1}, {"body": 5, "word": "assembly", "fig": 3}, {"body": 13, "word": "binding", "fig": 1}, {"body": 5, "word": "alt-EJ", "fig": 2}, {"body": 9, "word": "ATPase", "fig": 1}, {"body": 8, "word": "expressed", "fig": 1}, {"body": 8, "word": "cell", "fig": 1}, {"body": 7, "word": "inhibition", "fig": 1}, {"body": 7, "word": "In", "fig": 1}, {"body": 6, "word": "domain", "fig": 1}, {"body": 6, "word": "role", "fig": 1}, {"body": 5, "word": "RAD51-ssDNA", "fig": 1}, {"body": 5, "word": "deficiency", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 2, "word": "may", "fig": 2}, {"body": 4, "word": "ATP", "fig": 1}, {"body": 4, "word": "low", "fig": 1}, {"body": 3, "word": "loss", "fig": 1}, {"body": 3, "word": "region", "fig": 1}, {"body": 1, "word": "filament", "fig": 2}, {"body": 2, "word": "conditions", "fig": 1}, {"body": 2, "word": "toxic", "fig": 1}, {"body": 2, "word": "II", "fig": 1}, {"body": 2, "word": "concentrations", "fig": 1}, {"body": 1, "word": "death", "fig": 1}, {"body": 1, "word": "breaks", "fig": 1}, {"body": 1, "word": "prevent", "fig": 1}, {"body": 1, "word": "limits", "fig": 1}, {"body": 1, "word": "double-strand", "fig": 1}, {"body": 1, "word": "When", "fig": 1}, {"body": 1, "word": "depleting", "fig": 1}, {"body": 1, "word": "I", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f11.jpg", "caption": "POLQ is a RAD51-interacting protein that suppresses HR a, DR-GFP assay in U2OS cells transfected with indicated siRNA. b, Quantification of RAD51 foci in U2OS cells transfected with indicated siRNA. c, Endogenous RAD51 co-precipitates in vivo with purified full-length Flag-tagged POLQ from whole cell extracts. d, GST pull-down experiment with full-length Flag-tagged POLQ. (*: non-specific band). e, GST-RAD51 pull-down with in-vitro translated POLQ truncation mutants. f, GST-RAD51 pull-down with in-vitro translated POLQ versions missing indicated amino acids. g, Ponceau staining and immunoblotting of peptide arrays for the indicated POLQ motifs probed with recombinant RAD51. The POLQ amino acids spanning RAD51-interacting motifs are shown. Data in a and b represent mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 7}, {"body": 69, "word": "cells", "fig": 2}, {"body": 35, "word": "RAD51", "fig": 3}, {"body": 46, "word": "Data", "fig": 1}, {"body": 11, "word": "indicated", "fig": 4}, {"body": 37, "word": "HR", "fig": 1}, {"body": 25, "word": "The", "fig": 1}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 7, "word": "siRNA", "fig": 2}, {"body": 5, "word": "full-length", "fig": 2}, {"body": 10, "word": "foci", "fig": 1}, {"body": 5, "word": "b", "fig": 2}, {"body": 8, "word": "purified", "fig": 1}, {"body": 4, "word": "GST-RAD51", "fig": 2}, {"body": 8, "word": "protein", "fig": 1}, {"body": 8, "word": "cell", "fig": 1}, {"body": 3, "word": "motifs", "fig": 2}, {"body": 6, "word": "assay", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 5, "word": "vivo", "fig": 1}, {"body": 2, "word": "Flag-tagged", "fig": 2}, {"body": 4, "word": "staining", "fig": 1}, {"body": 2, "word": "amino", "fig": 2}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "recombinant", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "arrays", "fig": 1}, {"body": 1, "word": "pull-down", "fig": 3}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 3, "word": "peptide", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 1, "word": "acids", "fig": 2}, {"body": 1, "word": "RAD51-interacting", "fig": 2}, {"body": 1, "word": "U2OS", "fig": 2}, {"body": 2, "word": "g", "fig": 1}, {"body": 2, "word": "DR-GFP", "fig": 1}, {"body": 1, "word": "translated", "fig": 2}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "GST", "fig": 1}, {"body": 1, "word": "mutants", "fig": 1}, {"body": 1, "word": "truncation", "fig": 1}, {"body": 1, "word": "immunoblotting", "fig": 1}, {"body": 1, "word": "spanning", "fig": 1}, {"body": 1, "word": "c", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f12.jpg", "caption": "POLQ inhibits RAD51-mediated recombination a, Schematic of POLQ mutants used in complementation studies and their interaction with RAD51. b, Quantification of RAD51 foci in U2OS cells transfected with indicated siRNA and POLQ cDNA constructs refractory to siPOLQ1. c, DR-GFP assay in U2OS cells transfected with indicated siRNA and POLQ cDNA constructs refractory to siPOLQ1. d, Coomassie-stained gel of the purified POLQ fragment. e, Quantification of POLQ ATPase activity. f, Quantification of POLQ binding to ssDNA and dsDNA. g, RAD51-ssDNA nucleofilament assembly assay. h, Assessment of RAD51-dependent D-loop formation. Data in b, c, e and f represent mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 7}, {"body": 69, "word": "cells", "fig": 2}, {"body": 35, "word": "RAD51", "fig": 2}, {"body": 46, "word": "Data", "fig": 1}, {"body": 11, "word": "indicated", "fig": 2}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 7, "word": "siRNA", "fig": 2}, {"body": 13, "word": "binding", "fig": 1}, {"body": 6, "word": "cDNA", "fig": 2}, {"body": 12, "word": "used", "fig": 1}, {"body": 6, "word": "assay", "fig": 2}, {"body": 6, "word": "constructs", "fig": 2}, {"body": 6, "word": "e", "fig": 2}, {"body": 11, "word": "ssDNA", "fig": 1}, {"body": 10, "word": "activity", "fig": 1}, {"body": 5, "word": "b", "fig": 2}, {"body": 10, "word": "foci", "fig": 1}, {"body": 9, "word": "ATPase", "fig": 1}, {"body": 8, "word": "purified", "fig": 1}, {"body": 4, "word": "f", "fig": 2}, {"body": 6, "word": "gel", "fig": 1}, {"body": 6, "word": "studies", "fig": 1}, {"body": 5, "word": "RAD51-ssDNA", "fig": 1}, {"body": 5, "word": "assembly", "fig": 1}, {"body": 5, "word": "dsDNA", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 4, "word": "D-loop", "fig": 1}, {"body": 2, "word": "siPOLQ1", "fig": 2}, {"body": 4, "word": "interaction", "fig": 1}, {"body": 4, "word": "formation", "fig": 1}, {"body": 4, "word": "recombination", "fig": 1}, {"body": 3, "word": "nucleofilament", "fig": 1}, {"body": 3, "word": "complementation", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 1, "word": "U2OS", "fig": 2}, {"body": 2, "word": "DR-GFP", "fig": 1}, {"body": 2, "word": "fragment", "fig": 1}, {"body": 1, "word": "c", "fig": 2}, {"body": 2, "word": "g", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "RAD51-mediated", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "mutants", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f13.jpg", "caption": "POLQ promotes S phase progression and recovery of stalled forks a, POLQ gene expression in subtypes of cancers with HR deficiency. b, Survival assays of A2780 cells exposed to the indicated DNA-damaging agents. Immunoblot showing silencing efficiency. c, Immunoblot analyses following pulse treatments with DNA-damaging agents (*\u03b3H2AX: see methods). d, Cell cycle progression of synchronized A2780 cells. A representative cell cycle distribution. e, Fraction of cycling A2780 cells measured by EdU incorporation. f, Quantification of DNA fiber lengths. g, Percentage of stalled forks. All experiments shown in a-d were performed in two cell lines (A2780 and 293T). All data represent mean \u00b1 s.e.m. except for box plots in f that show twenty-fifth to seventy-fifth percentiles, with lines indicating the median, and whiskers indicating the smallest and largest values.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 2}, {"body": 69, "word": "cells", "fig": 3}, {"body": 37, "word": "HR", "fig": 1}, {"body": 31, "word": "DNA", "fig": 1}, {"body": 28, "word": "expression", "fig": 1}, {"body": 5, "word": "A2780", "fig": 4}, {"body": 19, "word": "performed", "fig": 1}, {"body": 8, "word": "cell", "fig": 2}, {"body": 13, "word": "gene", "fig": 1}, {"body": 12, "word": "experiments", "fig": 1}, {"body": 11, "word": "data", "fig": 1}, {"body": 11, "word": "indicated", "fig": 1}, {"body": 10, "word": "assays", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "efficiency", "fig": 1}, {"body": 4, "word": "f", "fig": 2}, {"body": 4, "word": "All", "fig": 2}, {"body": 7, "word": "values", "fig": 1}, {"body": 7, "word": "cancers", "fig": 1}, {"body": 3, "word": "forks", "fig": 2}, {"body": 6, "word": "following", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 5, "word": "exposed", "fig": 1}, {"body": 5, "word": "deficiency", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 5, "word": "measured", "fig": 1}, {"body": 2, "word": "stalled", "fig": 2}, {"body": 2, "word": "progression", "fig": 2}, {"body": 4, "word": "median", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "293T", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 2, "word": "cycle", "fig": 2}, {"body": 2, "word": "lines", "fig": 2}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 1}, {"body": 1, "word": "indicating", "fig": 2}, {"body": 1, "word": "DNA-damaging", "fig": 2}, {"body": 2, "word": "analyses", "fig": 1}, {"body": 2, "word": "g", "fig": 1}, {"body": 1, "word": "agents", "fig": 2}, {"body": 2, "word": "two", "fig": 1}, {"body": 1, "word": "Immunoblot", "fig": 2}, {"body": 2, "word": "Survival", "fig": 1}, {"body": 2, "word": "EdU", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "pulse", "fig": 1}, {"body": 1, "word": "except", "fig": 1}, {"body": 1, "word": "synchronized", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "promotes", "fig": 1}, {"body": 1, "word": "treatments", "fig": 1}, {"body": 1, "word": "phase", "fig": 1}, {"body": 1, "word": "silencing", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415602/bin/nihms651721f14.jpg", "caption": "Synthetic lethality between HR and POLQ repair pathways a, Clonogenic formation of BRCA1-deficient (MDA-MB-436) cells expressing indicated cDNA together with indicated shRNA. b, Chromosome breakage analysis of HR-deficient cells transfected with the indicated siRNA. A representative image is shown. Arrows indicate chromosomal aberrations. c, Embryos at day 14 of gestation. d, Growth of indicated xenografts in vivo. Immunoblot showing silencing efficiency. e, Relative tumor volumes (RTV) for individual mice treated in (d) after three weeks of treatment. f, Overall survival for mice treated with vehicle or PARPi. Log-rank P < 10-3. Clonogenic formation (g) and chromosome breakage analysis (h) of BRCA2-deficient cells expressing POLQ cDNA constructs refractory to siPOLQ1 and transfected with the indicated siRNA. i, Clonogenic formation of BRCA2-deficient cells transfected with the indicated siRNA. j, Model for role of POLQ in DNA repair. Data in a, b, g and i represent mean \u00b1 s.e.m. For data in d-f, each circle represents data from one tumor and each group represents n \u2265 7 tumors from n \u2265 6 mice. Brackets show mean \u00b1 s.e.m.", "co_occurrence": [{"body": 131, "word": "POLQ", "fig": 3}, {"body": 69, "word": "cells", "fig": 4}, {"body": 26, "word": "mice", "fig": 3}, {"body": 11, "word": "indicated", "fig": 6}, {"body": 46, "word": "Data", "fig": 1}, {"body": 37, "word": "HR", "fig": 1}, {"body": 31, "word": "DNA", "fig": 1}, {"body": 15, "word": "repair", "fig": 2}, {"body": 8, "word": "transfected", "fig": 3}, {"body": 12, "word": "analysis", "fig": 2}, {"body": 23, "word": "treatment", "fig": 1}, {"body": 23, "word": "For", "fig": 1}, {"body": 22, "word": "tumors", "fig": 1}, {"body": 11, "word": "treated", "fig": 2}, {"body": 11, "word": "data", "fig": 2}, {"body": 7, "word": "siRNA", "fig": 3}, {"body": 17, "word": "HR-deficient", "fig": 1}, {"body": 8, "word": "tumor", "fig": 2}, {"body": 14, "word": "survival", "fig": 1}, {"body": 14, "word": "PARPi", "fig": 1}, {"body": 6, "word": "expressing", "fig": 2}, {"body": 4, "word": "formation", "fig": 3}, {"body": 6, "word": "cDNA", "fig": 2}, {"body": 10, "word": "shRNA", "fig": 1}, {"body": 5, "word": "b", "fig": 2}, {"body": 9, "word": "three", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "efficiency", "fig": 1}, {"body": 6, "word": "group", "fig": 1}, {"body": 3, "word": "d", "fig": 2}, {"body": 3, "word": "mean", "fig": 2}, {"body": 6, "word": "constructs", "fig": 1}, {"body": 3, "word": "s.e.m", "fig": 2}, {"body": 6, "word": "role", "fig": 1}, {"body": 6, "word": "e", "fig": 1}, {"body": 5, "word": "P", "fig": 1}, {"body": 5, "word": "h", "fig": 1}, {"body": 5, "word": "vivo", "fig": 1}, {"body": 2, "word": "breakage", "fig": 2}, {"body": 2, "word": "represents", "fig": 2}, {"body": 4, "word": "shown", "fig": 1}, {"body": 2, "word": "g", "fig": 2}, {"body": 4, "word": "vehicle", "fig": 1}, {"body": 4, "word": "f", "fig": 1}, {"body": 4, "word": "pathways", "fig": 1}, {"body": 3, "word": "xenografts", "fig": 1}, {"body": 3, "word": "lethality", "fig": 1}, {"body": 3, "word": "weeks", "fig": 1}, {"body": 3, "word": "day", "fig": 1}, {"body": 3, "word": "one", "fig": 1}, {"body": 3, "word": "indicate", "fig": 1}, {"body": 2, "word": "siPOLQ1", "fig": 1}, {"body": 2, "word": "MDA-MB-436", "fig": 1}, {"body": 2, "word": "chromosomal", "fig": 1}, {"body": 2, "word": "aberrations", "fig": 1}, {"body": 2, "word": "volumes", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "RTV", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "Overall", "fig": 1}, {"body": 1, "word": "BRCA1-deficient", "fig": 1}, {"body": 1, "word": "together", "fig": 1}, {"body": 1, "word": "Immunoblot", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "Growth", "fig": 1}, {"body": 1, "word": "silencing", "fig": 1}]}], "4353233": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353233/bin/kccy-14-375-g001.jpg", "caption": "(See previous page) DAXX is phosphorylated on S564 rapidly after DNA damage. (A) HEK 293T cells were transfected with a vector expressing FLAG-DAXXWT and treated or not, as indicated, with 8 nM NCS or10 \u03bcM VP16 for 1 hour. Cells were lysed and FLAG-tagged proteins immunoprecipitated using anti-FLAG M2 beads, prior to analysis by SDS-PAGE and western blotting with antibodies against phospho-(S/T) ATM/ATR substrate, FLAG M2, phospho-Chk2 (T68) and DAXX. (B) HEK 293T cells were transfected with expression constructs encoding FLAG-tagged wild-type DAXX, single (DAXXS564A), triple or quadruple mutant as indicated and treated with 10 \u03bcM VP16 for 1 hour. Cells were lysed, immunoprecipitated using anti-FLAG M2 beads and analyzed by protein gel blotting with indicated antibodies. (C) BJ fibroblasts were exposed to 10 Gy of IR, collected at the indicated time points and subjected to western blotting analysis using specific phospho-DAXX (S564), DAXX, phospho-p53 (S15) and phospho-Chk2 (T68) antibodies. GAPDH was used as a loading control. (D) BJ fibroblasts were transfected with control (siCTRL) or DAXX siRNA and 3 d later treated or not as indicated with 10 \u03bcM VP16 for 1 hour. Immunofluorescence analysis using \u03b1-PML (red) and \u03b1-P-DAXX (S564) (green) showed that upon DNA damage DAXX is preferentially phosphorylated at PML nuclear bodies.", "co_occurrence": [{"body": 135, "word": "DAXX", "fig": 6}, {"body": 46, "word": "DNA", "fig": 2}, {"body": 28, "word": "S564", "fig": 3}, {"body": 42, "word": "cells", "fig": 2}, {"body": 15, "word": "using", "fig": 4}, {"body": 29, "word": "damage", "fig": 2}, {"body": 21, "word": "phosphorylated", "fig": 2}, {"body": 9, "word": "antibodies", "fig": 3}, {"body": 25, "word": "protein", "fig": 1}, {"body": 23, "word": "expression", "fig": 1}, {"body": 7, "word": "transfected", "fig": 3}, {"body": 6, "word": "VP16", "fig": 3}, {"body": 8, "word": "control", "fig": 2}, {"body": 3, "word": "M2", "fig": 3}, {"body": 4, "word": "BJ", "fig": 2}, {"body": 4, "word": "Cells", "fig": 2}, {"body": 7, "word": "substrate", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 3, "word": "fibroblasts", "fig": 2}, {"body": 2, "word": "\u03bcM", "fig": 3}, {"body": 3, "word": "293T", "fig": 2}, {"body": 2, "word": "blotting", "fig": 3}, {"body": 3, "word": "HEK", "fig": 2}, {"body": 2, "word": "treated", "fig": 3}, {"body": 6, "word": "siRNA", "fig": 1}, {"body": 2, "word": "analysis", "fig": 3}, {"body": 5, "word": "proteins", "fig": 1}, {"body": 5, "word": "GAPDH", "fig": 1}, {"body": 5, "word": "expressing", "fig": 1}, {"body": 5, "word": "wild-type", "fig": 1}, {"body": 5, "word": "FLAG-DAXXWT", "fig": 1}, {"body": 5, "word": "NCS", "fig": 1}, {"body": 4, "word": "rapidly", "fig": 1}, {"body": 2, "word": "beads", "fig": 2}, {"body": 4, "word": "vector", "fig": 1}, {"body": 4, "word": "specific", "fig": 1}, {"body": 4, "word": "nuclear", "fig": 1}, {"body": 4, "word": "B", "fig": 1}, {"body": 4, "word": "PML", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 4, "word": "bodies", "fig": 1}, {"body": 3, "word": "IR", "fig": 1}, {"body": 3, "word": "ATM/ATR", "fig": 1}, {"body": 3, "word": "constructs", "fig": 1}, {"body": 1, "word": "hour", "fig": 3}, {"body": 3, "word": "mutant", "fig": 1}, {"body": 3, "word": "upon", "fig": 1}, {"body": 2, "word": "showed", "fig": 1}, {"body": 2, "word": "previous", "fig": 1}, {"body": 1, "word": "FLAG-tagged", "fig": 2}, {"body": 2, "word": "DAXXS564A", "fig": 1}, {"body": 2, "word": "FLAG", "fig": 1}, {"body": 2, "word": "S15", "fig": 1}, {"body": 1, "word": "lysed", "fig": 2}, {"body": 1, "word": "anti-FLAG", "fig": 2}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "Gy", "fig": 1}, {"body": 1, "word": "exposed", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "preferentially", "fig": 1}, {"body": 1, "word": "encoding", "fig": 1}, {"body": 1, "word": "nM", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353233/bin/kccy-14-375-g002.jpg", "caption": "DAXX depletion or S564A mutation does not affect Mdm2/p53 stability or p53\u2011mediated gene expression. (A) BJ fibroblasts stably transduced with empty lentiviral pCDH vector or either pCDH-DAXXWT or pCDH-DAXXS564A were treated with 40 \u03bcM VP16 for 0, 2, 4 or 6 hours and RNA expression of the indicated p53-dependent genes was analyzed by quantitative RT\u2011PCR. Expression values were normalized to the average of 3 reference genes (\u03b2-actin, SDH and ALAS). (B) Transduced BJ fibroblast as in (A) were exposed to 40 \u03bcM VP16 for the indicated times and subjected to protein gel blotting analysis using add p53 - antibodies against DAXX, phospho-p53 (S15), p53 or p21. (C) U2OS cells transfected with pXJ41 Hdm2 (human Mdm2) together with empty FLAG-CMV, FLAG-DAXXWT or FLAG-DAXXS564A were treated with 50 \u03bcl/ml CHX alone or together with 10 \u03bcM VP16 for the specified time points. Cell were harvested and lysates separated by SDS\u2013PAGE and probed with indicated antibodies. (D) BJ fibroblasts were depleted by control siRNA (siLuc) or siRNA against Wip1 and 3 d after transfection treated with 4 nM NCS. Cells were lysed at the indicated time points after DNA damage and analyzed by western blotting using labeled antibodies. GAPDH was used as a loading control.", "co_occurrence": [{"body": 135, "word": "DAXX", "fig": 2}, {"body": 46, "word": "p53", "fig": 2}, {"body": 23, "word": "expression", "fig": 2}, {"body": 46, "word": "DNA", "fig": 1}, {"body": 42, "word": "cells", "fig": 1}, {"body": 38, "word": "Wip1", "fig": 1}, {"body": 15, "word": "using", "fig": 2}, {"body": 29, "word": "damage", "fig": 1}, {"body": 9, "word": "antibodies", "fig": 3}, {"body": 13, "word": "genes", "fig": 2}, {"body": 25, "word": "protein", "fig": 1}, {"body": 21, "word": "Mdm2", "fig": 1}, {"body": 6, "word": "VP16", "fig": 3}, {"body": 17, "word": "U2OS", "fig": 1}, {"body": 8, "word": "control", "fig": 2}, {"body": 4, "word": "BJ", "fig": 3}, {"body": 12, "word": "gene", "fig": 1}, {"body": 6, "word": "siRNA", "fig": 2}, {"body": 10, "word": "Cell", "fig": 1}, {"body": 9, "word": "stability", "fig": 1}, {"body": 9, "word": "either", "fig": 1}, {"body": 8, "word": "human", "fig": 1}, {"body": 8, "word": "p21", "fig": 1}, {"body": 8, "word": "depletion", "fig": 1}, {"body": 4, "word": "time", "fig": 2}, {"body": 7, "word": "used", "fig": 1}, {"body": 7, "word": "transfected", "fig": 1}, {"body": 3, "word": "fibroblasts", "fig": 2}, {"body": 2, "word": "\u03bcM", "fig": 3}, {"body": 6, "word": "p53-dependent", "fig": 1}, {"body": 6, "word": "hours", "fig": 1}, {"body": 2, "word": "treated", "fig": 3}, {"body": 5, "word": "GAPDH", "fig": 1}, {"body": 5, "word": "FLAG-DAXXWT", "fig": 1}, {"body": 5, "word": "NCS", "fig": 1}, {"body": 2, "word": "blotting", "fig": 2}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "vector", "fig": 1}, {"body": 4, "word": "B", "fig": 1}, {"body": 3, "word": "\u03b2-actin", "fig": 1}, {"body": 3, "word": "stably", "fig": 1}, {"body": 3, "word": "lentiviral", "fig": 1}, {"body": 3, "word": "times", "fig": 1}, {"body": 3, "word": "depleted", "fig": 1}, {"body": 2, "word": "affect", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 2}, {"body": 2, "word": "RNA", "fig": 1}, {"body": 2, "word": "ALAS", "fig": 1}, {"body": 2, "word": "S15", "fig": 1}, {"body": 1, "word": "empty", "fig": 2}, {"body": 2, "word": "Mdm2/p53", "fig": 1}, {"body": 2, "word": "transfection", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "points", "fig": 2}, {"body": 2, "word": "SDH", "fig": 1}, {"body": 1, "word": "CHX", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "S564A", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "exposed", "fig": 1}, {"body": 1, "word": "mutation", "fig": 1}, {"body": 1, "word": "harvested", "fig": 1}, {"body": 1, "word": "FLAG-DAXXS564A", "fig": 1}, {"body": 1, "word": "nM", "fig": 1}, {"body": 1, "word": "lysed", "fig": 1}, {"body": 1, "word": "Transduced", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353233/bin/kccy-14-375-g003.jpg", "caption": "DAXX deletion does not affect Mdm2/p53 stability or p53-mediated gene expression. (A) Mdm2 and p53 protein stability was examined in control U2OS cells, 2 independent DAXX+/+ clones (0\u20134, 0\u201318), 3 independent DAXX\u2212/- clones (17-7, 17-18, 17\u201342) and in 17-7 DAXX\u2212/- clone stably transduced with pCDH empty vector (EV) or pCDH-DAXXWT. Cells were collected after the treatment with 50 \u03bcl/ml CHX at the indicated time and subjected to protein gel blotting analysis using labeled antibodies. THIIF was used as a loading control. (B) DAXX+/+ (clone 0\u201318) and DAXX\u2212/- (clones 17-18) cells were exposed to 4 nM NCS for the specified time points. Lysed cells were then separated by SDS\u2013PAGE and immunoblotted with indicated antibodies. GAPDH was used as a loading control. (C) RNA expression of p53-dependent genes 8 hours after the treatment with 10 \u03bcM VP16 (expressed as fold change after VP16) in U2OS clones. RNA was analyzed by quantitative RT\u2011PCR and the expression values were normalized to the average of 3 reference genes (\u03b2-actin, SDH and ALAS). (D) U2OS cells transfected with control non-targeting siRNA and siRNA against p53 were treated with 10 \u03bcM VP16 for 8 hours and RNA expression of p53 and indicated p53-dependent genes was analyzed by quantitative RT\u2011PCR. The expression values were normalized to the average of 3 reference genes (\u03b2-actin, SDH and ALAS).", "co_occurrence": [{"body": 42, "word": "cells", "fig": 4}, {"body": 46, "word": "p53", "fig": 3}, {"body": 135, "word": "DAXX", "fig": 1}, {"body": 23, "word": "expression", "fig": 5}, {"body": 13, "word": "genes", "fig": 4}, {"body": 17, "word": "U2OS", "fig": 3}, {"body": 25, "word": "protein", "fig": 2}, {"body": 8, "word": "control", "fig": 4}, {"body": 6, "word": "clones", "fig": 4}, {"body": 21, "word": "Mdm2", "fig": 1}, {"body": 9, "word": "stability", "fig": 2}, {"body": 6, "word": "VP16", "fig": 3}, {"body": 9, "word": "antibodies", "fig": 2}, {"body": 15, "word": "using", "fig": 1}, {"body": 7, "word": "used", "fig": 2}, {"body": 6, "word": "p53-dependent", "fig": 2}, {"body": 6, "word": "hours", "fig": 2}, {"body": 12, "word": "gene", "fig": 1}, {"body": 6, "word": "siRNA", "fig": 2}, {"body": 5, "word": "treatment", "fig": 2}, {"body": 3, "word": "DAXX\u2212/-", "fig": 3}, {"body": 8, "word": "The", "fig": 1}, {"body": 4, "word": "time", "fig": 2}, {"body": 7, "word": "p53-mediated", "fig": 1}, {"body": 7, "word": "transfected", "fig": 1}, {"body": 3, "word": "\u03b2-actin", "fig": 2}, {"body": 2, "word": "RNA", "fig": 3}, {"body": 6, "word": "examined", "fig": 1}, {"body": 6, "word": "deletion", "fig": 1}, {"body": 3, "word": "independent", "fig": 2}, {"body": 3, "word": "clone", "fig": 2}, {"body": 5, "word": "GAPDH", "fig": 1}, {"body": 5, "word": "NCS", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 4, "word": "vector", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 2}, {"body": 2, "word": "ALAS", "fig": 2}, {"body": 4, "word": "B", "fig": 1}, {"body": 2, "word": "SDH", "fig": 2}, {"body": 3, "word": "stably", "fig": 1}, {"body": 2, "word": "blotting", "fig": 1}, {"body": 1, "word": "loading", "fig": 2}, {"body": 2, "word": "affect", "fig": 1}, {"body": 2, "word": "expressed", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 2}, {"body": 2, "word": "Mdm2/p53", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "CHX", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "exposed", "fig": 1}, {"body": 1, "word": "empty", "fig": 1}, {"body": 1, "word": "nM", "fig": 1}, {"body": 1, "word": "non-targeting", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353233/bin/kccy-14-375-g004.jpg", "caption": "Overview of ATM-dependent phosphorylation of DAXX at S564 after DNA damage. (A) U2OS cells were pretreated with DMSO or 10 \u03bcM ATM inhibitor KU-55933 (ATMi) for 30 min, exposed to 2 mM hydroxyurea (HU), 4 nM neocarzinostatin (NCS) or 1 \u03bcM camptothecin (CPT) for the indicated times and subjected to western blotting analysis using labeled antibodies. (B) Table showing the level of phosphorylated S564 on DAXX and the activity of ATM/ATR kinases after different types of DNA damage. (C) Sequence-based predicted modular organization of DAXX according to Escobar-Cabrera et al.54 with indicated putative ATM/ATR phosphorylation motifs at C-terminus of DAXX (S564, S707, S712 and T726). SUMO-Interaction Motif (SIM), DAXX Helix Bundle (DHB) domain, segments rich in Ser/Pro/Glu residues (SPE) and in Ser/Pro/Thr (SPT) residues.", "co_occurrence": [{"body": 135, "word": "DAXX", "fig": 5}, {"body": 47, "word": "phosphorylation", "fig": 2}, {"body": 46, "word": "DNA", "fig": 2}, {"body": 28, "word": "S564", "fig": 3}, {"body": 29, "word": "damage", "fig": 2}, {"body": 42, "word": "cells", "fig": 1}, {"body": 27, "word": "ATM", "fig": 1}, {"body": 21, "word": "phosphorylated", "fig": 1}, {"body": 17, "word": "U2OS", "fig": 1}, {"body": 15, "word": "using", "fig": 1}, {"body": 9, "word": "antibodies", "fig": 1}, {"body": 8, "word": "mM", "fig": 1}, {"body": 7, "word": "min", "fig": 1}, {"body": 6, "word": "level", "fig": 1}, {"body": 6, "word": "activity", "fig": 1}, {"body": 3, "word": "ATM/ATR", "fig": 2}, {"body": 5, "word": "inhibitor", "fig": 1}, {"body": 5, "word": "NCS", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 2}, {"body": 4, "word": "domain", "fig": 1}, {"body": 4, "word": "kinases", "fig": 1}, {"body": 4, "word": "B", "fig": 1}, {"body": 3, "word": "S712", "fig": 1}, {"body": 3, "word": "motifs", "fig": 1}, {"body": 3, "word": "according", "fig": 1}, {"body": 3, "word": "times", "fig": 1}, {"body": 3, "word": "types", "fig": 1}, {"body": 2, "word": "SIM", "fig": 1}, {"body": 2, "word": "blotting", "fig": 1}, {"body": 2, "word": "putative", "fig": 1}, {"body": 2, "word": "et", "fig": 1}, {"body": 2, "word": "different", "fig": 1}, {"body": 2, "word": "DHB", "fig": 1}, {"body": 2, "word": "ATM-dependent", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "CPT", "fig": 1}, {"body": 1, "word": "C-terminus", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "SPT", "fig": 1}, {"body": 1, "word": "SPE", "fig": 1}, {"body": 1, "word": "KU-55933", "fig": 1}, {"body": 1, "word": "S707", "fig": 1}, {"body": 1, "word": "exposed", "fig": 1}, {"body": 1, "word": "HU", "fig": 1}, {"body": 1, "word": "hydroxyurea", "fig": 1}, {"body": 1, "word": "T726", "fig": 1}, {"body": 1, "word": "camptothecin", "fig": 1}, {"body": 1, "word": "Motif", "fig": 1}, {"body": 1, "word": "nM", "fig": 1}, {"body": 1, "word": "neocarzinostatin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353233/bin/kccy-14-375-g005.jpg", "caption": "DAXX is a substrate of Wip1 phosphatase. (A) BJ fibroblasts were exposed to 10 Gy or 2 Gy of IR and lysed at the indicated time points after DNA damage. Western blotting analysis using antibodies against phospho-DAXX (S564), DAXX, Wip1 or GAPDH showed that the DAXX S564 dephosphorylation coincides with increased expression of Wip1. (B) In vitro phosphatase assay was performed with recombinant wild-type Wip1 or phosphatase-dead Wip1-D314A mutant on FLAG-DAXXWT immunopurified from transfected U2OS cells exposed to DNA damage. Samples were separated by SDS\u2013PAGE and probed with indicated antibodies. As control, phosphatase buffer without Mg2+ was used or treatment with lambda protein phosphatase (\u03bbPP). (C) Wip1 was depleted by siRNA in U2OS cells stably expressing FLAG-DAXXWT. Western blotting analysis using indicated antibodies showed that after DNA damage more phosphorylated DAXX is present in Wip1 siRNA treated cells compared to control GAPDH siRNA transfected cells.", "co_occurrence": [{"body": 135, "word": "DAXX", "fig": 4}, {"body": 38, "word": "Wip1", "fig": 6}, {"body": 42, "word": "cells", "fig": 4}, {"body": 46, "word": "DNA", "fig": 3}, {"body": 29, "word": "damage", "fig": 3}, {"body": 28, "word": "S564", "fig": 2}, {"body": 14, "word": "phosphatase", "fig": 4}, {"body": 17, "word": "U2OS", "fig": 2}, {"body": 15, "word": "using", "fig": 2}, {"body": 9, "word": "antibodies", "fig": 3}, {"body": 25, "word": "protein", "fig": 1}, {"body": 23, "word": "expression", "fig": 1}, {"body": 21, "word": "phosphorylated", "fig": 1}, {"body": 6, "word": "siRNA", "fig": 3}, {"body": 16, "word": "In", "fig": 1}, {"body": 8, "word": "control", "fig": 2}, {"body": 7, "word": "transfected", "fig": 2}, {"body": 5, "word": "GAPDH", "fig": 2}, {"body": 5, "word": "FLAG-DAXXWT", "fig": 2}, {"body": 7, "word": "substrate", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 5, "word": "expressing", "fig": 1}, {"body": 5, "word": "wild-type", "fig": 1}, {"body": 5, "word": "treatment", "fig": 1}, {"body": 5, "word": "present", "fig": 1}, {"body": 4, "word": "BJ", "fig": 1}, {"body": 2, "word": "blotting", "fig": 2}, {"body": 2, "word": "Western", "fig": 2}, {"body": 4, "word": "increased", "fig": 1}, {"body": 4, "word": "performed", "fig": 1}, {"body": 4, "word": "B", "fig": 1}, {"body": 2, "word": "showed", "fig": 2}, {"body": 4, "word": "compared", "fig": 1}, {"body": 4, "word": "buffer", "fig": 1}, {"body": 2, "word": "analysis", "fig": 2}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "stably", "fig": 1}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "fibroblasts", "fig": 1}, {"body": 3, "word": "IR", "fig": 1}, {"body": 3, "word": "vitro", "fig": 1}, {"body": 3, "word": "depleted", "fig": 1}, {"body": 3, "word": "mutant", "fig": 1}, {"body": 2, "word": "recombinant", "fig": 1}, {"body": 1, "word": "Gy", "fig": 2}, {"body": 1, "word": "exposed", "fig": 2}, {"body": 2, "word": "immunopurified", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 1, "word": "dephosphorylation", "fig": 1}, {"body": 1, "word": "Samples", "fig": 1}, {"body": 1, "word": "phosphatase-dead", "fig": 1}, {"body": 1, "word": "Wip1-D314A", "fig": 1}, {"body": 1, "word": "lysed", "fig": 1}, {"body": 1, "word": "points", "fig": 1}, {"body": 1, "word": "coincides", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353233/bin/kccy-14-375-g006.jpg", "caption": "Wip1 affects DNA damage-induced phosphorylation of endogenous DAXX. MCF7 or U2OS cells were transfected with control (siLuc) or siRNA targeting Wip1 and 3 d later exposed to 5 Gy of IR or 4 nM NCS. Cells were lysed at the indicated time points after DNA damage and analyzed by protein gel blotting with the indicated antibodies (* unspecific band). \u03b1\u2011tubulin was used as a loading control.", "co_occurrence": [{"body": 135, "word": "DAXX", "fig": 1}, {"body": 46, "word": "DNA", "fig": 2}, {"body": 38, "word": "Wip1", "fig": 2}, {"body": 47, "word": "phosphorylation", "fig": 1}, {"body": 42, "word": "cells", "fig": 1}, {"body": 29, "word": "damage", "fig": 1}, {"body": 25, "word": "protein", "fig": 1}, {"body": 17, "word": "U2OS", "fig": 1}, {"body": 8, "word": "control", "fig": 2}, {"body": 9, "word": "antibodies", "fig": 1}, {"body": 7, "word": "used", "fig": 1}, {"body": 7, "word": "transfected", "fig": 1}, {"body": 6, "word": "siRNA", "fig": 1}, {"body": 6, "word": "targeting", "fig": 1}, {"body": 6, "word": "endogenous", "fig": 1}, {"body": 5, "word": "NCS", "fig": 1}, {"body": 5, "word": "damage-induced", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 4, "word": "Cells", "fig": 1}, {"body": 3, "word": "MCF7", "fig": 1}, {"body": 3, "word": "IR", "fig": 1}, {"body": 2, "word": "blotting", "fig": 1}, {"body": 2, "word": "affects", "fig": 1}, {"body": 1, "word": "nM", "fig": 1}, {"body": 1, "word": "exposed", "fig": 1}, {"body": 1, "word": "Gy", "fig": 1}, {"body": 1, "word": "lysed", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}], "3688626": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688626/bin/pone.0067381.g001.jpg", "caption": "Electroretinographic (ERG) analysis of the super p53 mouse. (A) ERG responses from P30 wild type (left) and super p53 (right) mice to a series of stimulus intensities spanning a several log unit range presented to the dark-adapted mouse eye. Dashed vertical lines represent the time of presentation of stimulus. Amplitude of the dark-adapted, scotopic a wave (B) and b wave (C) plotted as a function of stimulus intensity. (D) Amplitude of the scotopic a wave plotted as a function of mouse age. (E) Amplitude of the scotopic b wave plotted as a function of mouse age. (F) Amplitude of the light-adapted photopic b wave plotted as a function of mouse age. Solid squares represent responses from wild type mice; filled circles represent the super p53 mouse responses. Symbols represent the average obtained from testing 6 to 12 transgenic animals; error bars represent SEM. (G) Spectral electroretinography. Recordings of maximal b wave responses to either a 400 nm flash (blue) or to a 500 nm flash (green) made from P90 wt (filled bars) or super p53 (open bars) mice. Symbols represent the average obtained from testing 6 transgenic animals; error bars represent SEM. The responses marked by \u201cwhite\u2019 represent the full photopic b wave response.", "co_occurrence": [{"body": 181, "word": "p53", "fig": 4}, {"body": 41, "word": "mouse", "fig": 6}, {"body": 58, "word": "super", "fig": 4}, {"body": 56, "word": "mice", "fig": 3}, {"body": 19, "word": "wave", "fig": 7}, {"body": 20, "word": "responses", "fig": 5}, {"body": 18, "word": "b", "fig": 5}, {"body": 26, "word": "transgenic", "fig": 2}, {"body": 12, "word": "scotopic", "fig": 3}, {"body": 33, "word": "The", "fig": 1}, {"body": 28, "word": "wt", "fig": 1}, {"body": 7, "word": "function", "fig": 4}, {"body": 13, "word": "ERG", "fig": 2}, {"body": 12, "word": "photopic", "fig": 2}, {"body": 11, "word": "type", "fig": 2}, {"body": 10, "word": "wild", "fig": 2}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 1, "word": "represent", "fig": 8}, {"body": 8, "word": "either", "fig": 1}, {"body": 7, "word": "P30", "fig": 1}, {"body": 7, "word": "response", "fig": 1}, {"body": 5, "word": "intensities", "fig": 1}, {"body": 5, "word": "lines", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "vertical", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 2, "word": "SEM", "fig": 2}, {"body": 3, "word": "blue", "fig": 1}, {"body": 3, "word": "eye", "fig": 1}, {"body": 3, "word": "range", "fig": 1}, {"body": 3, "word": "F", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 1, "word": "age", "fig": 3}, {"body": 1, "word": "dark-adapted", "fig": 2}, {"body": 1, "word": "flash", "fig": 2}, {"body": 2, "word": "presented", "fig": 1}, {"body": 2, "word": "intensity", "fig": 1}, {"body": 1, "word": "obtained", "fig": 2}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "spanning", "fig": 1}, {"body": 2, "word": "green", "fig": 1}, {"body": 2, "word": "time", "fig": 1}, {"body": 1, "word": "D", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "log", "fig": 1}, {"body": 1, "word": "made", "fig": 1}, {"body": 1, "word": "several", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688626/bin/pone.0067381.g002.jpg", "caption": "Histologic examination of super p53 retina. Light micrographs of retinal cross-sections taken from Wild Type (A&C) and Super p53 (B&D) mice. A&B present images obtained at 20X and C&D present images obtained at 40X. RPE: pigment epithelium; OS: outer segments; IS inner segments; ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer; GCL: ganglion cell layer. Bar is equal 50 \u00b5m. E. The number of nuclei in the ONL was counted along the vertical meridian at each indicated distance from the optic nerve head (ONH, 0) from inferior to superior retinal margin (n7\u20138 mice). F. The number of nuclei in the INL was counted along the vertical meridian at each indicated distance from the optic nerve head (0) from inferior to superior retinal margin (n7\u20138 mice). P values for points marked by an asterisk ranged between <0.001 and <0.05.", "co_occurrence": [{"body": 181, "word": "p53", "fig": 2}, {"body": 56, "word": "mice", "fig": 3}, {"body": 40, "word": "retinal", "fig": 3}, {"body": 33, "word": "The", "fig": 2}, {"body": 58, "word": "super", "fig": 1}, {"body": 56, "word": "retina", "fig": 1}, {"body": 22, "word": "INL", "fig": 2}, {"body": 8, "word": "layer", "fig": 5}, {"body": 18, "word": "number", "fig": 2}, {"body": 34, "word": "cell", "fig": 1}, {"body": 10, "word": "inner", "fig": 3}, {"body": 11, "word": "ONL", "fig": 2}, {"body": 6, "word": "outer", "fig": 3}, {"body": 6, "word": "nuclear", "fig": 2}, {"body": 11, "word": "\u00b5m", "fig": 1}, {"body": 5, "word": "nuclei", "fig": 2}, {"body": 4, "word": "C", "fig": 2}, {"body": 4, "word": "vertical", "fig": 2}, {"body": 4, "word": "present", "fig": 2}, {"body": 4, "word": "A", "fig": 2}, {"body": 3, "word": "meridian", "fig": 2}, {"body": 6, "word": "Super", "fig": 1}, {"body": 3, "word": "along", "fig": 2}, {"body": 3, "word": "nerve", "fig": 2}, {"body": 3, "word": "head", "fig": 2}, {"body": 3, "word": "optic", "fig": 2}, {"body": 2, "word": "segments", "fig": 2}, {"body": 4, "word": "IPL", "fig": 1}, {"body": 2, "word": "plexiform", "fig": 2}, {"body": 2, "word": "B", "fig": 2}, {"body": 2, "word": "counted", "fig": 2}, {"body": 3, "word": "OPL", "fig": 1}, {"body": 1, "word": "inferior", "fig": 2}, {"body": 1, "word": "D", "fig": 2}, {"body": 1, "word": "images", "fig": 2}, {"body": 1, "word": "superior", "fig": 2}, {"body": 1, "word": "obtained", "fig": 2}, {"body": 2, "word": "Wild", "fig": 1}, {"body": 1, "word": "Bar", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "OS", "fig": 1}, {"body": 1, "word": "Type", "fig": 1}, {"body": 1, "word": "Light", "fig": 1}, {"body": 1, "word": "GCL", "fig": 1}, {"body": 1, "word": "examination", "fig": 1}, {"body": 1, "word": "ganglion", "fig": 1}, {"body": 1, "word": "IS", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688626/bin/pone.0067381.g003.jpg", "caption": "TUNEL labeling of cross sections of P1 retina. TUNEL labeling showed increased apoptotic death in the neuroblastic layer (NBL) of P1 super p53 mice (B) when compared to wt retinas (A). TUNEL-positive cells are green; nuclei (blue) were stained with DAPI. C. Bar graphs showing the increase in the total number of apoptotic cells in a cross section of the retina of the super p53 mouse at P1. N3\u20134 sections from 4 mice of each genotype. Bars represent SEM. Scale bar50 \u00b5m. D. Immunoblot analysis of retinal extracts from super p53 and wild type mice at P1& P3. Upper blot was probed with anti-p53 antibody then stripped and reprobed with anti-actin antibody.", "co_occurrence": [{"body": 181, "word": "p53", "fig": 3}, {"body": 58, "word": "super", "fig": 3}, {"body": 56, "word": "mice", "fig": 3}, {"body": 56, "word": "retina", "fig": 2}, {"body": 51, "word": "cells", "fig": 2}, {"body": 41, "word": "mouse", "fig": 1}, {"body": 40, "word": "retinal", "fig": 1}, {"body": 14, "word": "sections", "fig": 2}, {"body": 28, "word": "wt", "fig": 1}, {"body": 18, "word": "number", "fig": 1}, {"body": 16, "word": "showed", "fig": 1}, {"body": 15, "word": "increased", "fig": 1}, {"body": 7, "word": "labeling", "fig": 2}, {"body": 12, "word": "retinas", "fig": 1}, {"body": 3, "word": "P1", "fig": 4}, {"body": 11, "word": "\u00b5m", "fig": 1}, {"body": 11, "word": "type", "fig": 1}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 5, "word": "TUNEL", "fig": 2}, {"body": 10, "word": "wild", "fig": 1}, {"body": 8, "word": "layer", "fig": 1}, {"body": 7, "word": "death", "fig": 1}, {"body": 3, "word": "apoptotic", "fig": 2}, {"body": 5, "word": "nuclei", "fig": 1}, {"body": 4, "word": "total", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "compared", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "blue", "fig": 1}, {"body": 3, "word": "NBL", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "P3", "fig": 1}, {"body": 2, "word": "SEM", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 1, "word": "cross", "fig": 2}, {"body": 2, "word": "increase", "fig": 1}, {"body": 2, "word": "TUNEL-positive", "fig": 1}, {"body": 2, "word": "Immunoblot", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 2, "word": "green", "fig": 1}, {"body": 1, "word": "antibody", "fig": 2}, {"body": 2, "word": "extracts", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "genotype", "fig": 1}, {"body": 1, "word": "Bar", "fig": 1}, {"body": 1, "word": "neuroblastic", "fig": 1}, {"body": 1, "word": "Bars", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688626/bin/pone.0067381.g004.jpg", "caption": "Pattern of expression of p53, its family members, and its regulators in HIP retinas. (A) Western blot analysis showing the levels of expression of p53 in four transgenic HIP families relative to its levels in 661W cells, a continuously dividing cone photoreceptor cell line. (B) Levels of Mdm2, Mdm4, p63 and p73 were determined in two of the HIP families. Actin served as a loading control. (C) Immunoblot demonstrating the increased levels of p21 in HIP retinas at P6\u20137.", "co_occurrence": [{"body": 181, "word": "p53", "fig": 2}, {"body": 37, "word": "HIP", "fig": 4}, {"body": 33, "word": "levels", "fig": 3}, {"body": 29, "word": "expression", "fig": 2}, {"body": 51, "word": "cells", "fig": 1}, {"body": 34, "word": "cell", "fig": 1}, {"body": 26, "word": "transgenic", "fig": 1}, {"body": 12, "word": "retinas", "fig": 2}, {"body": 21, "word": "cone", "fig": 1}, {"body": 15, "word": "Mdm2", "fig": 1}, {"body": 15, "word": "increased", "fig": 1}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 9, "word": "photoreceptor", "fig": 1}, {"body": 8, "word": "Mdm4", "fig": 1}, {"body": 6, "word": "family", "fig": 1}, {"body": 6, "word": "line", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "p63", "fig": 1}, {"body": 5, "word": "four", "fig": 1}, {"body": 5, "word": "members", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "dividing", "fig": 1}, {"body": 3, "word": "661W", "fig": 1}, {"body": 3, "word": "p73", "fig": 1}, {"body": 2, "word": "two", "fig": 1}, {"body": 2, "word": "p21", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "Immunoblot", "fig": 1}, {"body": 2, "word": "regulators", "fig": 1}, {"body": 1, "word": "Actin", "fig": 1}, {"body": 1, "word": "P6\u20137", "fig": 1}, {"body": 1, "word": "continuously", "fig": 1}, {"body": 1, "word": "served", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688626/bin/pone.0067381.g005.jpg", "caption": "Immunohistochemical localization of p53 in two of the HIP mouse lines. Retinal sections from P30 wild type (A&B), F089 (C&D) and F044 (E&F) mice were labeled using an anti-p53 antibody (red). Asterisks in D&F point to p53-expressing cells in the INL of both HIP families. OS outer segments; IS inner segments; ONL outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer. Scale bar20 \u00b5m.", "co_occurrence": [{"body": 181, "word": "p53", "fig": 1}, {"body": 37, "word": "HIP", "fig": 2}, {"body": 56, "word": "mice", "fig": 1}, {"body": 51, "word": "cells", "fig": 1}, {"body": 22, "word": "INL", "fig": 2}, {"body": 41, "word": "mouse", "fig": 1}, {"body": 8, "word": "layer", "fig": 3}, {"body": 10, "word": "inner", "fig": 2}, {"body": 6, "word": "outer", "fig": 3}, {"body": 14, "word": "sections", "fig": 1}, {"body": 13, "word": "using", "fig": 1}, {"body": 12, "word": "F044", "fig": 1}, {"body": 6, "word": "nuclear", "fig": 2}, {"body": 11, "word": "type", "fig": 1}, {"body": 11, "word": "ONL", "fig": 1}, {"body": 11, "word": "\u00b5m", "fig": 1}, {"body": 10, "word": "F089", "fig": 1}, {"body": 10, "word": "wild", "fig": 1}, {"body": 7, "word": "P30", "fig": 1}, {"body": 3, "word": "F", "fig": 2}, {"body": 5, "word": "lines", "fig": 1}, {"body": 2, "word": "segments", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 3, "word": "OPL", "fig": 1}, {"body": 3, "word": "labeled", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "plexiform", "fig": 1}, {"body": 2, "word": "Retinal", "fig": 1}, {"body": 2, "word": "two", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "D", "fig": 2}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "OS", "fig": 1}, {"body": 1, "word": "localization", "fig": 1}, {"body": 1, "word": "IS", "fig": 1}, {"body": 1, "word": "p53-expressing", "fig": 1}, {"body": 1, "word": "antibody", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688626/bin/pone.0067381.g006.jpg", "caption": "Functional and histologic analyses of the HIP F089 retina. A. Developmental electroretinographic analysis of scotopic a and b waves responses and the photopic b wave responses from the HIP F089 retinas presented as percent of wt. B. Histologic cross sections of wild type (wt) and HIP F089 retinas. Scale bar50 \u00b5m.", "co_occurrence": [{"body": 37, "word": "HIP", "fig": 3}, {"body": 56, "word": "retina", "fig": 1}, {"body": 28, "word": "wt", "fig": 2}, {"body": 20, "word": "responses", "fig": 2}, {"body": 18, "word": "b", "fig": 2}, {"body": 10, "word": "F089", "fig": 3}, {"body": 12, "word": "retinas", "fig": 2}, {"body": 19, "word": "wave", "fig": 1}, {"body": 14, "word": "sections", "fig": 1}, {"body": 12, "word": "photopic", "fig": 1}, {"body": 12, "word": "scotopic", "fig": 1}, {"body": 11, "word": "type", "fig": 1}, {"body": 11, "word": "\u00b5m", "fig": 1}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 10, "word": "wild", "fig": 1}, {"body": 2, "word": "Developmental", "fig": 1}, {"body": 2, "word": "Scale", "fig": 1}, {"body": 2, "word": "waves", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 1, "word": "cross", "fig": 1}, {"body": 1, "word": "histologic", "fig": 1}, {"body": 1, "word": "analyses", "fig": 1}]}], "4344198": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g001.jpg", "caption": "ULK1 phosphorylates p62 at S409. A.-C. In vitro p62 phosphorylation assay by ULK1 with purified MBP-p62 WT or mutant proteins. Bacterially expressed MBP-p62 was purified and then MBP tag was cleaved by Factor Xa. The purified p62 was incubated with Myc-ULK1 WT or KI mutant IPed from transfected HEK293T cells at 37\u00b0C for 30 min. Phosphorylation of p62 was examined by 32P-labeling and autoradiography or p-S409 specific antibody. A. p62 is an ULK1 substrate in vitro. Alkaline phosphatase(AP) was used to dephosphorylate p62. 32P-autoradiograph shows autophosphorylation of ULK1 and p62 phosphorylation. B. ULK1 phosphorylates p62 at Ser409 in vitro. Purified MBP-p62 WT or S409A proteins were used in ULK1 kinase assay in the presence of 32P-ATP. C. ULK1 phosphorylates Ser409 of p62. Purified MBP-62 WT proteins were incubated with Myc-ULK1 variants isolated from transfected HEK 293T cells. Immunoblotting assay with indicated antibodies, including phospho-p62 antibody against Ser409, was followed. Afterwards, the membrane probed with p-p62 antibody(S409) was incubated with alkaline phosphatase(AP) to dephosphorylate p62. Asterisks indicate nonspecific bands. D. p62 S409 is a ULK1 substrate. HEK 293T cells were transfected wit empty vector, FLAG-p62 WT or FLAG-p62 S409A together with Myc-ULK1 WT or KI. IP with anti-FLAG antibody was performed, followed by Westernblot assay with indicated antibodies.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 11}, {"body": 83, "word": "ULK1", "fig": 8}, {"body": 60, "word": "WT", "fig": 6}, {"body": 56, "word": "proteins", "fig": 3}, {"body": 52, "word": "S409", "fig": 3}, {"body": 71, "word": "phosphorylation", "fig": 2}, {"body": 39, "word": "cells", "fig": 3}, {"body": 26, "word": "antibody", "fig": 4}, {"body": 21, "word": "assay", "fig": 4}, {"body": 34, "word": "mutant", "fig": 2}, {"body": 16, "word": "transfected", "fig": 3}, {"body": 24, "word": "S409A", "fig": 2}, {"body": 15, "word": "MBP-p62", "fig": 3}, {"body": 14, "word": "incubated", "fig": 3}, {"body": 40, "word": "The", "fig": 1}, {"body": 19, "word": "FLAG-p62", "fig": 2}, {"body": 10, "word": "purified", "fig": 3}, {"body": 10, "word": "vitro", "fig": 3}, {"body": 27, "word": "performed", "fig": 1}, {"body": 13, "word": "KI", "fig": 2}, {"body": 23, "word": "p-S409", "fig": 1}, {"body": 11, "word": "followed", "fig": 2}, {"body": 11, "word": "used", "fig": 2}, {"body": 7, "word": "Myc-ULK1", "fig": 3}, {"body": 20, "word": "kinase", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 2}, {"body": 9, "word": "phosphatase", "fig": 2}, {"body": 9, "word": "indicated", "fig": 2}, {"body": 8, "word": "293T", "fig": 2}, {"body": 8, "word": "HEK", "fig": 2}, {"body": 16, "word": "In", "fig": 1}, {"body": 12, "word": "min", "fig": 1}, {"body": 11, "word": "IP", "fig": 1}, {"body": 5, "word": "substrate", "fig": 2}, {"body": 10, "word": "vector", "fig": 1}, {"body": 8, "word": "variants", "fig": 1}, {"body": 8, "word": "examined", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 6, "word": "specific", "fig": 1}, {"body": 2, "word": "Ser409", "fig": 3}, {"body": 2, "word": "phosphorylates", "fig": 3}, {"body": 5, "word": "Phosphorylation", "fig": 1}, {"body": 5, "word": "empty", "fig": 1}, {"body": 5, "word": "anti-FLAG", "fig": 1}, {"body": 5, "word": "MBP", "fig": 1}, {"body": 4, "word": "including", "fig": 1}, {"body": 2, "word": "Purified", "fig": 2}, {"body": 4, "word": "C.", "fig": 1}, {"body": 4, "word": "indicate", "fig": 1}, {"body": 4, "word": "A.", "fig": 1}, {"body": 4, "word": "together", "fig": 1}, {"body": 3, "word": "Factor", "fig": 1}, {"body": 3, "word": "alkaline", "fig": 1}, {"body": 3, "word": "32P-labeling", "fig": 1}, {"body": 3, "word": "Xa", "fig": 1}, {"body": 3, "word": "IPed", "fig": 1}, {"body": 2, "word": "p-p62", "fig": 1}, {"body": 2, "word": "expressed", "fig": 1}, {"body": 2, "word": "membrane", "fig": 1}, {"body": 2, "word": "shows", "fig": 1}, {"body": 2, "word": "37\u00b0C", "fig": 1}, {"body": 2, "word": "autoradiography", "fig": 1}, {"body": 1, "word": "AP", "fig": 2}, {"body": 2, "word": "D.", "fig": 1}, {"body": 2, "word": "HEK293T", "fig": 1}, {"body": 1, "word": "bands", "fig": 1}, {"body": 1, "word": "B.", "fig": 1}, {"body": 1, "word": "phospho-p62", "fig": 1}, {"body": 1, "word": "autophosphorylation", "fig": 1}, {"body": 1, "word": "Asterisks", "fig": 1}, {"body": 1, "word": "32P-ATP", "fig": 1}, {"body": 1, "word": "tag", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "cleaved", "fig": 1}, {"body": 1, "word": "Bacterially", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g002.jpg", "caption": "Phosphorylation of p62 at S409 is enhanced upon proteasome inhibition. A. ULK1 mediates p-S409 of p62 upon MG132 treatment. HEK 293T cells transfected with empty vector, Myc-ULK1 WT or KI were treated with MG132 and then cell lysates were analysed with indicated antibodies(Top). The ratio of p-p62 and p62 was obtained by dividing the level of p-p62 by total p62(n = 3). One sample t-test was used and data are represented as mean \u00b1 SEM(n = 3). * p < 0.05; ns, not significant(bottom). B. ULK1 is important for MG132-induced p-S409 of p62. WT and ULK1 KO MEFs were treated with MG132 and analyzed with indicated antibodies(Top). The ratio of p-p62 and p62 was obtained by dividing the level of p-p62 by total p62(n = 3). One sample t-test was used and data are represented as mean \u00b1 SEM(n = 3). * p < 0.05; ns, not significant(bottom). C. MG132 treatment but not starvation increases p-S409 levels of p62 or ULK1-p62 interaction. p62 KO MEFs stably expressing empty vector or FLAG-p62 were incubated with MG132 or starved for glucose(-glu) or amino acid(-aa). F.M. indicates full medium as a control. Subsequently, IP with anti-FLAG or-ULK1 antibodies were performed and immunoprecipitants were analyzed with indicated antibodies.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 9}, {"body": 83, "word": "ULK1", "fig": 3}, {"body": 27, "word": "MG132", "fig": 5}, {"body": 60, "word": "WT", "fig": 2}, {"body": 40, "word": "The", "fig": 2}, {"body": 23, "word": "p-S409", "fig": 3}, {"body": 52, "word": "S409", "fig": 1}, {"body": 23, "word": "treatment", "fig": 2}, {"body": 21, "word": "MEFs", "fig": 2}, {"body": 10, "word": "antibodies", "fig": 4}, {"body": 39, "word": "cells", "fig": 1}, {"body": 19, "word": "data", "fig": 2}, {"body": 36, "word": "interaction", "fig": 1}, {"body": 16, "word": "upon", "fig": 2}, {"body": 27, "word": "performed", "fig": 1}, {"body": 9, "word": "indicated", "fig": 3}, {"body": 13, "word": "KO", "fig": 2}, {"body": 11, "word": "used", "fig": 2}, {"body": 10, "word": "vector", "fig": 2}, {"body": 19, "word": "FLAG-p62", "fig": 1}, {"body": 9, "word": "sample", "fig": 2}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 8, "word": "treated", "fig": 2}, {"body": 14, "word": "incubated", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 13, "word": "KI", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 2}, {"body": 12, "word": "lysates", "fig": 1}, {"body": 11, "word": "cell", "fig": 1}, {"body": 11, "word": "IP", "fig": 1}, {"body": 5, "word": "p", "fig": 2}, {"body": 5, "word": "empty", "fig": 2}, {"body": 9, "word": "starvation", "fig": 1}, {"body": 2, "word": "p-p62", "fig": 4}, {"body": 8, "word": "stably", "fig": 1}, {"body": 4, "word": "level", "fig": 2}, {"body": 8, "word": "ULK1-p62", "fig": 1}, {"body": 8, "word": "acid", "fig": 1}, {"body": 8, "word": "293T", "fig": 1}, {"body": 4, "word": "t-test", "fig": 2}, {"body": 8, "word": "HEK", "fig": 1}, {"body": 2, "word": "n", "fig": 4}, {"body": 8, "word": "important", "fig": 1}, {"body": 7, "word": "proteasome", "fig": 1}, {"body": 7, "word": "enhanced", "fig": 1}, {"body": 7, "word": "expressing", "fig": 1}, {"body": 7, "word": "Myc-ULK1", "fig": 1}, {"body": 3, "word": "ratio", "fig": 2}, {"body": 6, "word": "inhibition", "fig": 1}, {"body": 3, "word": "mean", "fig": 2}, {"body": 6, "word": "control", "fig": 1}, {"body": 3, "word": "total", "fig": 2}, {"body": 3, "word": "SEM", "fig": 2}, {"body": 3, "word": "significant", "fig": 2}, {"body": 3, "word": "One", "fig": 2}, {"body": 5, "word": "Phosphorylation", "fig": 1}, {"body": 5, "word": "anti-FLAG", "fig": 1}, {"body": 2, "word": "obtained", "fig": 2}, {"body": 2, "word": "represented", "fig": 2}, {"body": 4, "word": "amino", "fig": 1}, {"body": 4, "word": "C.", "fig": 1}, {"body": 4, "word": "medium", "fig": 1}, {"body": 4, "word": "A.", "fig": 1}, {"body": 3, "word": "full", "fig": 1}, {"body": 3, "word": "Subsequently", "fig": 1}, {"body": 3, "word": "indicates", "fig": 1}, {"body": 3, "word": "immunoprecipitants", "fig": 1}, {"body": 2, "word": "increases", "fig": 1}, {"body": 2, "word": "mediates", "fig": 1}, {"body": 1, "word": "Top", "fig": 2}, {"body": 2, "word": "glucose", "fig": 1}, {"body": 1, "word": "B.", "fig": 1}, {"body": 1, "word": "or-ULK1", "fig": 1}, {"body": 1, "word": "starved", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g003.jpg", "caption": "Phosphorylation of p62 at S409 is enhanced upon expression of polyQ-Htt proteins. A. Expanded polyQ-mCFP induces p-S405 and p-S409 of p62 in a polyQ length dependent manner. HeLa/25Q, 65Q, 103Q\u2014mCFP cells were cultured with or without doxycycline to regulate the expression of each protein. Cellular lysates were assayed with indicated antibodies. GFP antibody was used to monitor induction of polyQ-mCFP proteins. B. The ratio for Fig. 3A was obtained by dividing the level of p-p62 by total p62(n = 3). One sample t-test and student t-test were used and data are represented as mean \u00b1 SEM(n = 3). * p < 0.05; ** p < 0.01; ns, not significant C. Shutoff of the expression of 103Q-mCFP reduces p-S405 and p-S409 of p62. Induced HeLa/103Q-mCFP cells were replenished with Doxycycline to turn off the protein expression and then were analyzed with indicated antibodies. D. p62 phosphorylation is increased in z_Q175 HD mouse model. Striatal and cortical lysates of 1, 5, 10, and 15 months old WT and Q175 mice were prepared and analyzed with indicated antibodies(n = 4). E. P-S409 localizes to and surrounds 103Q-mCFP positive inclusions. Induced HeLa/25Q-mCFP and HeLa/103Q-mCFP cells were stained with anti-p62 and p-p62(S409) and examined under confocal microscope. Scale bar = 10 \u03bcm.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 5}, {"body": 39, "word": "cells", "fig": 3}, {"body": 56, "word": "proteins", "fig": 2}, {"body": 52, "word": "S409", "fig": 2}, {"body": 49, "word": "protein", "fig": 2}, {"body": 71, "word": "phosphorylation", "fig": 1}, {"body": 60, "word": "WT", "fig": 1}, {"body": 23, "word": "p-S409", "fig": 2}, {"body": 43, "word": "Fig", "fig": 1}, {"body": 40, "word": "The", "fig": 1}, {"body": 9, "word": "expression", "fig": 4}, {"body": 10, "word": "antibodies", "fig": 3}, {"body": 9, "word": "indicated", "fig": 3}, {"body": 26, "word": "antibody", "fig": 1}, {"body": 12, "word": "lysates", "fig": 2}, {"body": 11, "word": "used", "fig": 2}, {"body": 19, "word": "data", "fig": 1}, {"body": 16, "word": "upon", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 2}, {"body": 6, "word": "p-S405", "fig": 2}, {"body": 11, "word": "B", "fig": 1}, {"body": 11, "word": "polyQ", "fig": 1}, {"body": 5, "word": "p", "fig": 2}, {"body": 9, "word": "sample", "fig": 1}, {"body": 9, "word": "mouse", "fig": 1}, {"body": 4, "word": "t-test", "fig": 2}, {"body": 8, "word": "examined", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "enhanced", "fig": 1}, {"body": 7, "word": "mice", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 3, "word": "103Q-mCFP", "fig": 2}, {"body": 6, "word": "\u03bcm", "fig": 1}, {"body": 6, "word": "induces", "fig": 1}, {"body": 2, "word": "n", "fig": 3}, {"body": 5, "word": "Phosphorylation", "fig": 1}, {"body": 5, "word": "inclusions", "fig": 1}, {"body": 2, "word": "p-p62", "fig": 2}, {"body": 4, "word": "stained", "fig": 1}, {"body": 4, "word": "increased", "fig": 1}, {"body": 4, "word": "level", "fig": 1}, {"body": 4, "word": "HD", "fig": 1}, {"body": 4, "word": "induction", "fig": 1}, {"body": 4, "word": "length", "fig": 1}, {"body": 4, "word": "C.", "fig": 1}, {"body": 3, "word": "ratio", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "SEM", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "One", "fig": 1}, {"body": 2, "word": "old", "fig": 1}, {"body": 2, "word": "3A", "fig": 1}, {"body": 2, "word": "represented", "fig": 1}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 2, "word": "months", "fig": 1}, {"body": 2, "word": "D.", "fig": 1}, {"body": 2, "word": "manner", "fig": 1}, {"body": 2, "word": "z_Q175", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 1, "word": "dependent", "fig": 1}, {"body": 1, "word": "bar", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "E.", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "Striatal", "fig": 1}, {"body": 1, "word": "doxycycline", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "cultured", "fig": 1}, {"body": 1, "word": "65Q", "fig": 1}, {"body": 1, "word": "regulate", "fig": 1}, {"body": 1, "word": "anti-p62", "fig": 1}, {"body": 1, "word": "GFP", "fig": 1}, {"body": 1, "word": "without", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g004.jpg", "caption": "Accumulation of protein aggregates induces the interaction between ULK1 and p62. A. The accumulation of ubiquitinated proteins induces ULK1-p62 interaction. WT and ULK1 KO MEFs lysates treated with or without MG132 were subjected to IP with anti-ULK1 antibody and immunoblotted with anti-ULK1 and-p62 antibodies. Asterisks indicate non-specific bands. B. ULK1-p62 interaction in a p62 stable cell line. p62 KO MEFs stably expressing FLAG-p62 or empty vector were incubated with or without MG132. IP was performed with anti-ULK1 antibody, followed by immunoblot assay using indicated antibodies. C. Co-localization of p62 and ULK1 upon MG132. p62 KO MEFs stably expressing FLAG-p62 WT were treated with MG132, fixed, stained with ULK1(green) and p62(red) antibodies, and visualized under fluorescent microscope. Line profile was used to illustrate co-localization between p62 and ULK1. Green and red lines indicate ULK1 and p62 staining profiles, respectively. Scale bar = 10 \u03bcm and 2.5 \u03bcm for zoomed images. D. ULK1-p62 interaction increases upon induction of expanded polyQ proteins. HeLa/25Q, 65Q, 103Q\u2014mCFP cells were transfected with empty vector or FLAG-p62 and were cultured with or without doxycycline to regulate the expression of each protein. Cellular lysates were used to perform IP with anti-ULK1 antibody and immunoblot assay with indicated antibodies was followed. GFP antibody was used to monitor induction of polyQ-mCFP proteins.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 8}, {"body": 83, "word": "ULK1", "fig": 6}, {"body": 56, "word": "proteins", "fig": 3}, {"body": 36, "word": "interaction", "fig": 4}, {"body": 60, "word": "WT", "fig": 2}, {"body": 27, "word": "MG132", "fig": 4}, {"body": 26, "word": "antibody", "fig": 4}, {"body": 49, "word": "protein", "fig": 2}, {"body": 21, "word": "MEFs", "fig": 3}, {"body": 19, "word": "FLAG-p62", "fig": 3}, {"body": 21, "word": "assay", "fig": 2}, {"body": 40, "word": "The", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 4}, {"body": 39, "word": "cells", "fig": 1}, {"body": 13, "word": "KO", "fig": 3}, {"body": 11, "word": "used", "fig": 3}, {"body": 11, "word": "IP", "fig": 3}, {"body": 16, "word": "upon", "fig": 2}, {"body": 27, "word": "performed", "fig": 1}, {"body": 8, "word": "ULK1-p62", "fig": 3}, {"body": 12, "word": "lysates", "fig": 2}, {"body": 23, "word": "ubiquitinated", "fig": 1}, {"body": 11, "word": "followed", "fig": 2}, {"body": 21, "word": "aggregates", "fig": 1}, {"body": 10, "word": "immunoblot", "fig": 2}, {"body": 10, "word": "vector", "fig": 2}, {"body": 19, "word": "accumulation", "fig": 1}, {"body": 9, "word": "indicated", "fig": 2}, {"body": 4, "word": "anti-ULK1", "fig": 4}, {"body": 8, "word": "stably", "fig": 2}, {"body": 16, "word": "using", "fig": 1}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 8, "word": "treated", "fig": 2}, {"body": 7, "word": "expressing", "fig": 2}, {"body": 14, "word": "incubated", "fig": 1}, {"body": 6, "word": "\u03bcm", "fig": 2}, {"body": 6, "word": "induces", "fig": 2}, {"body": 11, "word": "subjected", "fig": 1}, {"body": 11, "word": "cell", "fig": 1}, {"body": 11, "word": "polyQ", "fig": 1}, {"body": 5, "word": "empty", "fig": 2}, {"body": 9, "word": "expression", "fig": 1}, {"body": 4, "word": "induction", "fig": 2}, {"body": 4, "word": "indicate", "fig": 2}, {"body": 8, "word": "A", "fig": 1}, {"body": 5, "word": "staining", "fig": 1}, {"body": 4, "word": "stained", "fig": 1}, {"body": 4, "word": "C.", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "expanded", "fig": 1}, {"body": 1, "word": "without", "fig": 3}, {"body": 2, "word": "increases", "fig": 1}, {"body": 2, "word": "fixed", "fig": 1}, {"body": 1, "word": "red", "fig": 2}, {"body": 2, "word": "D.", "fig": 1}, {"body": 2, "word": "co-localization", "fig": 1}, {"body": 2, "word": "line", "fig": 1}, {"body": 2, "word": "lines", "fig": 1}, {"body": 1, "word": "65Q", "fig": 1}, {"body": 1, "word": "visualized", "fig": 1}, {"body": 1, "word": "immunoblotted", "fig": 1}, {"body": 1, "word": "stable", "fig": 1}, {"body": 1, "word": "bands", "fig": 1}, {"body": 1, "word": "bar", "fig": 1}, {"body": 1, "word": "B.", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "Line", "fig": 1}, {"body": 1, "word": "fluorescent", "fig": 1}, {"body": 1, "word": "non-specific", "fig": 1}, {"body": 1, "word": "doxycycline", "fig": 1}, {"body": 1, "word": "Asterisks", "fig": 1}, {"body": 1, "word": "cultured", "fig": 1}, {"body": 1, "word": "Accumulation", "fig": 1}, {"body": 1, "word": "regulate", "fig": 1}, {"body": 1, "word": "GFP", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g005.jpg", "caption": "ULK1-mediated phosphorylation of p62 at S409 enhances p62 and Ub binding affinity. A. P-S409 enhances binding between p62 and poly-Ub proteins. Cellular lysates of p62 KO MEFs stably expressing empty vector, FLAG-p62 WT, S409A, or S409E were incubated with p62 KO MEFs lysates treated with MG132 and subsequently subjected to IP using anti-FLAG antibody. Immunoblot assay with indicated antibodies was followed. B. Quantification of the results from Fig. 5A were obtained by normalizing levels of IPed Ub to FLAG blots; then S409A or S409E were normalized to WT. One sample t-test was used and data are represented as mean \u00b1 SEM(n = 3). * p < 0.05; ns, not significant C. p62 UBA S409E has an enhanced binding affinity to mono-Ub. Binding affinities of p62 UBA WT(left) or S409E(right) to mono-Ub were measured by Isothermal Titration Calorimetry(ITC). Representative ITC profiles are shown.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 7}, {"body": 60, "word": "WT", "fig": 3}, {"body": 40, "word": "S409E", "fig": 4}, {"body": 34, "word": "binding", "fig": 3}, {"body": 50, "word": "UBA", "fig": 2}, {"body": 71, "word": "phosphorylation", "fig": 1}, {"body": 56, "word": "proteins", "fig": 1}, {"body": 52, "word": "S409", "fig": 1}, {"body": 24, "word": "S409A", "fig": 2}, {"body": 23, "word": "Ub", "fig": 2}, {"body": 43, "word": "Fig", "fig": 1}, {"body": 21, "word": "MEFs", "fig": 2}, {"body": 27, "word": "MG132", "fig": 1}, {"body": 26, "word": "antibody", "fig": 1}, {"body": 13, "word": "KO", "fig": 2}, {"body": 12, "word": "lysates", "fig": 2}, {"body": 21, "word": "assay", "fig": 1}, {"body": 10, "word": "affinity", "fig": 2}, {"body": 19, "word": "FLAG-p62", "fig": 1}, {"body": 19, "word": "data", "fig": 1}, {"body": 16, "word": "using", "fig": 1}, {"body": 15, "word": "poly-Ub", "fig": 1}, {"body": 14, "word": "results", "fig": 1}, {"body": 14, "word": "incubated", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 11, "word": "subjected", "fig": 1}, {"body": 11, "word": "followed", "fig": 1}, {"body": 11, "word": "used", "fig": 1}, {"body": 11, "word": "IP", "fig": 1}, {"body": 10, "word": "vector", "fig": 1}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 9, "word": "indicated", "fig": 1}, {"body": 9, "word": "sample", "fig": 1}, {"body": 8, "word": "ULK1-mediated", "fig": 1}, {"body": 8, "word": "stably", "fig": 1}, {"body": 4, "word": "mono-Ub", "fig": 2}, {"body": 8, "word": "treated", "fig": 1}, {"body": 7, "word": "enhanced", "fig": 1}, {"body": 7, "word": "expressing", "fig": 1}, {"body": 3, "word": "enhances", "fig": 2}, {"body": 6, "word": "Calorimetry", "fig": 1}, {"body": 6, "word": "FLAG", "fig": 1}, {"body": 5, "word": "p", "fig": 1}, {"body": 5, "word": "empty", "fig": 1}, {"body": 5, "word": "anti-FLAG", "fig": 1}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "C.", "fig": 1}, {"body": 2, "word": "ITC", "fig": 2}, {"body": 4, "word": "A.", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "Isothermal", "fig": 1}, {"body": 3, "word": "SEM", "fig": 1}, {"body": 3, "word": "normalized", "fig": 1}, {"body": 3, "word": "IPed", "fig": 1}, {"body": 3, "word": "Titration", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "One", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "represented", "fig": 1}, {"body": 2, "word": "obtained", "fig": 1}, {"body": 2, "word": "n", "fig": 1}, {"body": 2, "word": "Immunoblot", "fig": 1}, {"body": 2, "word": "left", "fig": 1}, {"body": 1, "word": "5A", "fig": 1}, {"body": 1, "word": "B.", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g006.jpg", "caption": "Phosphorylation of S409 destabilizes the UBA dimer interface and regulates phosphorylation of S405. A. S409E does not influence overall folding of UBA. Overlay of 1H-15N HSQC spectra of 15N-labeled p62 UBA WT(red) and S409E(blue) in the absence of mono-ubiquitin(Ub). B. p62 UBA S409E destabilizes p62 UBA dimer. Differential Scanning Calorimetry was performed with p62 UBA WT and S409E to measure the melting temperature of p62 UBA dimer. C. Overlay of 1H-15N HSQC spectra of 15N-labeled p62 UBA WT(blue) and S409E(red) in the presence of 6-fold excess unlabeled mono-Ub. D. ULK1 phosphorylates p62 at S405 and p-Ser409 is a prerequisite for ULK1-mediated p-S405. HEK 293T cells were transfected with indicated plasmids. IP with anti-FLAG antibody was performed and Westernblot assay with indicated antibodies was followed.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 7}, {"body": 50, "word": "UBA", "fig": 8}, {"body": 40, "word": "S409E", "fig": 5}, {"body": 60, "word": "WT", "fig": 3}, {"body": 83, "word": "ULK1", "fig": 1}, {"body": 71, "word": "phosphorylation", "fig": 1}, {"body": 27, "word": "performed", "fig": 2}, {"body": 52, "word": "S409", "fig": 1}, {"body": 24, "word": "S405", "fig": 2}, {"body": 39, "word": "cells", "fig": 1}, {"body": 13, "word": "dimer", "fig": 3}, {"body": 26, "word": "antibody", "fig": 1}, {"body": 23, "word": "Ub", "fig": 1}, {"body": 21, "word": "assay", "fig": 1}, {"body": 9, "word": "indicated", "fig": 2}, {"body": 16, "word": "transfected", "fig": 1}, {"body": 8, "word": "spectra", "fig": 2}, {"body": 11, "word": "followed", "fig": 1}, {"body": 11, "word": "IP", "fig": 1}, {"body": 5, "word": "blue", "fig": 2}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 8, "word": "interface", "fig": 1}, {"body": 8, "word": "293T", "fig": 1}, {"body": 8, "word": "ULK1-mediated", "fig": 1}, {"body": 8, "word": "HEK", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "absence", "fig": 1}, {"body": 3, "word": "destabilizes", "fig": 2}, {"body": 6, "word": "Calorimetry", "fig": 1}, {"body": 6, "word": "overall", "fig": 1}, {"body": 6, "word": "p-S405", "fig": 1}, {"body": 5, "word": "temperature", "fig": 1}, {"body": 5, "word": "anti-FLAG", "fig": 1}, {"body": 5, "word": "Phosphorylation", "fig": 1}, {"body": 4, "word": "regulates", "fig": 1}, {"body": 4, "word": "C.", "fig": 1}, {"body": 4, "word": "A.", "fig": 1}, {"body": 4, "word": "mono-Ub", "fig": 1}, {"body": 2, "word": "1H-15N", "fig": 2}, {"body": 2, "word": "HSQC", "fig": 2}, {"body": 4, "word": "folding", "fig": 1}, {"body": 3, "word": "Differential", "fig": 1}, {"body": 3, "word": "Scanning", "fig": 1}, {"body": 1, "word": "15N-labeled", "fig": 2}, {"body": 1, "word": "red", "fig": 2}, {"body": 2, "word": "D.", "fig": 1}, {"body": 2, "word": "phosphorylates", "fig": 1}, {"body": 1, "word": "unlabeled", "fig": 1}, {"body": 1, "word": "plasmids", "fig": 1}, {"body": 1, "word": "6-fold", "fig": 1}, {"body": 1, "word": "excess", "fig": 1}, {"body": 1, "word": "melting", "fig": 1}, {"body": 1, "word": "B.", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g007.jpg", "caption": "Phosphorylation of p62 at S409 is required for autophagic degradation of polyubiquitinated proteins and the recruitment of autophagy proteins. A.-C. p62 p-S409 regulates autophagic degradation of ubiquitinated proteins. p62 KO MEFs stably expressing indicated constructs were treated with MG132 for 16 hr(pre), then media were switched to serum starvation(S.S.), in combination with CQ for 24 hr(post). A. p62 S409A overexpressing cells are resistant to autophagic degradation of poly-Ub proteins. Total cellular lysates were subjected to immunoblot assay with indicated antibodies. B. The level of poly-Ub proteins from Fig. 7A was normalized to actin level, and further to each own control. Student\u2019s t-test was used and data are represented as mean \u00b1 SEM(n = 4). * p < 0.05; ns, not significant C. p62 S409A is impaired in the recruitment of autophagy machinery proteins. MEFs were fixed, stained with antibodies against p62(red) and WIPI2, LC3, Rab7, or LAMP2(green), and then visualized under fluorescent microscope. Line profile was used to illustrate co-localization. Green lines indicate WIPI2, LC3, Rab7, or LAMP2 and red lines indicate p62. Scale bar = 10 \u03bcm, 5 \u03bcm for enlarged images.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 7}, {"body": 56, "word": "proteins", "fig": 6}, {"body": 38, "word": "autophagy", "fig": 2}, {"body": 24, "word": "degradation", "fig": 3}, {"body": 52, "word": "S409", "fig": 1}, {"body": 24, "word": "S409A", "fig": 2}, {"body": 43, "word": "Fig", "fig": 1}, {"body": 21, "word": "MEFs", "fig": 2}, {"body": 40, "word": "The", "fig": 1}, {"body": 39, "word": "cells", "fig": 1}, {"body": 15, "word": "poly-Ub", "fig": 2}, {"body": 27, "word": "MG132", "fig": 1}, {"body": 8, "word": "autophagic", "fig": 3}, {"body": 23, "word": "ubiquitinated", "fig": 1}, {"body": 23, "word": "p-S409", "fig": 1}, {"body": 11, "word": "used", "fig": 2}, {"body": 21, "word": "assay", "fig": 1}, {"body": 10, "word": "hr", "fig": 2}, {"body": 10, "word": "antibodies", "fig": 2}, {"body": 19, "word": "data", "fig": 1}, {"body": 9, "word": "indicated", "fig": 2}, {"body": 13, "word": "KO", "fig": 1}, {"body": 6, "word": "\u03bcm", "fig": 2}, {"body": 12, "word": "lysates", "fig": 1}, {"body": 11, "word": "subjected", "fig": 1}, {"body": 11, "word": "B", "fig": 1}, {"body": 10, "word": "immunoblot", "fig": 1}, {"body": 9, "word": "starvation", "fig": 1}, {"body": 8, "word": "stably", "fig": 1}, {"body": 4, "word": "level", "fig": 2}, {"body": 4, "word": "indicate", "fig": 2}, {"body": 8, "word": "treated", "fig": 1}, {"body": 7, "word": "cellular", "fig": 1}, {"body": 7, "word": "expressing", "fig": 1}, {"body": 7, "word": "constructs", "fig": 1}, {"body": 7, "word": "required", "fig": 1}, {"body": 3, "word": "LC3", "fig": 2}, {"body": 6, "word": "polyubiquitinated", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 5, "word": "Phosphorylation", "fig": 1}, {"body": 5, "word": "p", "fig": 1}, {"body": 5, "word": "serum", "fig": 1}, {"body": 5, "word": "machinery", "fig": 1}, {"body": 4, "word": "stained", "fig": 1}, {"body": 2, "word": "WIPI2", "fig": 2}, {"body": 2, "word": "Rab7", "fig": 2}, {"body": 4, "word": "t-test", "fig": 1}, {"body": 4, "word": "regulates", "fig": 1}, {"body": 4, "word": "C.", "fig": 1}, {"body": 4, "word": "A.", "fig": 1}, {"body": 2, "word": "lines", "fig": 2}, {"body": 2, "word": "LAMP2", "fig": 2}, {"body": 3, "word": "impaired", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "SEM", "fig": 1}, {"body": 3, "word": "normalized", "fig": 1}, {"body": 3, "word": "CQ", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 1, "word": "recruitment", "fig": 2}, {"body": 1, "word": "red", "fig": 2}, {"body": 2, "word": "represented", "fig": 1}, {"body": 2, "word": "fixed", "fig": 1}, {"body": 2, "word": "co-localization", "fig": 1}, {"body": 2, "word": "n", "fig": 1}, {"body": 2, "word": "overexpressing", "fig": 1}, {"body": 2, "word": "7A", "fig": 1}, {"body": 1, "word": "visualized", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "Line", "fig": 1}, {"body": 1, "word": "bar", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "fluorescent", "fig": 1}, {"body": 1, "word": "post", "fig": 1}, {"body": 1, "word": "pre", "fig": 1}, {"body": 1, "word": "S.S.", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g008.jpg", "caption": "Phosphorylation of p62 at S409 enhances the autophagic degradation of polyQ-Htt mutant proteins. HeLa/65Q\u2013mCFP cells were transfected with mCherry-p62 WT, S409A or S409E and treated with Rapamycin to induce autophagy. A. Cells were fixed and visualized under fluorescent confocal microscope. Scale bar = 20 \u03bcm. B. Quantifications of the results in Fig. 8A were performed by counting cell numbers containing 65Q-mCFP aggregates. Then the number of cell carrying 65Q-mCFP aggregates was normalized to the number of control cells transfected with p62 WT(left panel). Efficiency of polyQ clearance(right panel) was obtained from the ratio of control sample vs. rapamycin-treated sample. C. Cells were separated into detergent soluble and insoluble fractions and probed with indicated antibodies. D. Quantifications were performed by normalizing the intensity to that of control samples transfected with p62 WT(upper panel). Efficiency of polyQ reduction(lower panel) based on the results in Fig. 8C was obtained as described in Fig. 8B. One sample t-test and student t-test were used and data are represented as mean \u00b1 SEM(n = 4). * p < 0.05, ** p < 0.01; ns, not significant.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 3}, {"body": 60, "word": "WT", "fig": 3}, {"body": 43, "word": "Fig", "fig": 3}, {"body": 39, "word": "cells", "fig": 2}, {"body": 56, "word": "proteins", "fig": 1}, {"body": 27, "word": "performed", "fig": 2}, {"body": 52, "word": "S409", "fig": 1}, {"body": 16, "word": "transfected", "fig": 3}, {"body": 21, "word": "aggregates", "fig": 2}, {"body": 40, "word": "S409E", "fig": 1}, {"body": 38, "word": "autophagy", "fig": 1}, {"body": 34, "word": "mutant", "fig": 1}, {"body": 14, "word": "results", "fig": 2}, {"body": 9, "word": "sample", "fig": 3}, {"body": 13, "word": "65Q-mCFP", "fig": 2}, {"body": 24, "word": "degradation", "fig": 1}, {"body": 24, "word": "S409A", "fig": 1}, {"body": 11, "word": "cell", "fig": 2}, {"body": 11, "word": "polyQ", "fig": 2}, {"body": 19, "word": "data", "fig": 1}, {"body": 6, "word": "control", "fig": 3}, {"body": 6, "word": "number", "fig": 2}, {"body": 11, "word": "containing", "fig": 1}, {"body": 11, "word": "used", "fig": 1}, {"body": 5, "word": "p", "fig": 2}, {"body": 10, "word": "antibodies", "fig": 1}, {"body": 9, "word": "indicated", "fig": 1}, {"body": 4, "word": "Cells", "fig": 2}, {"body": 2, "word": "panel", "fig": 4}, {"body": 4, "word": "t-test", "fig": 2}, {"body": 8, "word": "autophagic", "fig": 1}, {"body": 8, "word": "treated", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "described", "fig": 1}, {"body": 6, "word": "\u03bcm", "fig": 1}, {"body": 6, "word": "induce", "fig": 1}, {"body": 5, "word": "samples", "fig": 1}, {"body": 5, "word": "Phosphorylation", "fig": 1}, {"body": 5, "word": "reduction", "fig": 1}, {"body": 5, "word": "mCherry-p62", "fig": 1}, {"body": 5, "word": "clearance", "fig": 1}, {"body": 4, "word": "based", "fig": 1}, {"body": 2, "word": "obtained", "fig": 2}, {"body": 4, "word": "C.", "fig": 1}, {"body": 3, "word": "ratio", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "enhances", "fig": 1}, {"body": 3, "word": "SEM", "fig": 1}, {"body": 3, "word": "lower", "fig": 1}, {"body": 3, "word": "normalized", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "One", "fig": 1}, {"body": 2, "word": "fixed", "fig": 1}, {"body": 2, "word": "right", "fig": 1}, {"body": 2, "word": "n", "fig": 1}, {"body": 2, "word": "insoluble", "fig": 1}, {"body": 2, "word": "represented", "fig": 1}, {"body": 2, "word": "8C", "fig": 1}, {"body": 2, "word": "fractions", "fig": 1}, {"body": 2, "word": "D.", "fig": 1}, {"body": 2, "word": "left", "fig": 1}, {"body": 1, "word": "visualized", "fig": 1}, {"body": 1, "word": "soluble", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "bar", "fig": 1}, {"body": 1, "word": "B.", "fig": 1}, {"body": 1, "word": "8B", "fig": 1}, {"body": 1, "word": "8A", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "upper", "fig": 1}, {"body": 1, "word": "fluorescent", "fig": 1}, {"body": 1, "word": "separated", "fig": 1}, {"body": 1, "word": "carrying", "fig": 1}, {"body": 1, "word": "numbers", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344198/bin/pgen.1004987.g009.jpg", "caption": "The working model for ULK1-mediated p-S409 and p-S405 of p62 in selective degradation of ubiquitinated proteins and polyglutamine-expanded proteins. Accumulated polyubiquitinated(poly-Ub) proteins or polyQ-expanded proteins trigger interaction of p62 with ULK1. This interaction induces ULK1-mediated p62 phosphorylation at S409 in UBA domain, which facilitates dimer to monomer transition of UBA domain, and subsequent phosphorylation at S405(mediated by either ULK1, CK2 or TBK-1). As a result, the phosphorylation of p62 at S405 and S409 leads to enhanced binding affinity of p62 to poly-Ub or polyQ-expanded proteins. The presence of ULK1 and p62 p-S405 and p-S409 in poly-Ub or polyQ-expanded protein aggregates causes the recruitment of autophagy machinery that is responsible for the degradation of poly-Ub or polyQ-Htt mutant proteins.", "co_occurrence": [{"body": 181, "word": "p62", "fig": 6}, {"body": 56, "word": "proteins", "fig": 6}, {"body": 83, "word": "ULK1", "fig": 3}, {"body": 71, "word": "phosphorylation", "fig": 3}, {"body": 52, "word": "S409", "fig": 2}, {"body": 50, "word": "UBA", "fig": 2}, {"body": 40, "word": "The", "fig": 2}, {"body": 39, "word": "domain", "fig": 2}, {"body": 36, "word": "interaction", "fig": 2}, {"body": 15, "word": "poly-Ub", "fig": 4}, {"body": 49, "word": "protein", "fig": 1}, {"body": 24, "word": "degradation", "fig": 2}, {"body": 24, "word": "S405", "fig": 2}, {"body": 23, "word": "p-S409", "fig": 2}, {"body": 38, "word": "autophagy", "fig": 1}, {"body": 34, "word": "binding", "fig": 1}, {"body": 34, "word": "mutant", "fig": 1}, {"body": 23, "word": "ubiquitinated", "fig": 1}, {"body": 21, "word": "aggregates", "fig": 1}, {"body": 8, "word": "ULK1-mediated", "fig": 2}, {"body": 13, "word": "dimer", "fig": 1}, {"body": 6, "word": "p-S405", "fig": 2}, {"body": 4, "word": "polyQ-expanded", "fig": 3}, {"body": 10, "word": "affinity", "fig": 1}, {"body": 8, "word": "selective", "fig": 1}, {"body": 7, "word": "presence", "fig": 1}, {"body": 7, "word": "enhanced", "fig": 1}, {"body": 7, "word": "model", "fig": 1}, {"body": 6, "word": "induces", "fig": 1}, {"body": 6, "word": "polyubiquitinated", "fig": 1}, {"body": 5, "word": "machinery", "fig": 1}, {"body": 4, "word": "either", "fig": 1}, {"body": 4, "word": "CK2", "fig": 1}, {"body": 4, "word": "transition", "fig": 1}, {"body": 3, "word": "TBK-1", "fig": 1}, {"body": 3, "word": "result", "fig": 1}, {"body": 3, "word": "This", "fig": 1}, {"body": 3, "word": "subsequent", "fig": 1}, {"body": 2, "word": "leads", "fig": 1}, {"body": 2, "word": "monomer", "fig": 1}, {"body": 2, "word": "responsible", "fig": 1}, {"body": 2, "word": "mediated", "fig": 1}, {"body": 1, "word": "recruitment", "fig": 1}, {"body": 1, "word": "facilitates", "fig": 1}, {"body": 1, "word": "trigger", "fig": 1}, {"body": 1, "word": "causes", "fig": 1}, {"body": 1, "word": "working", "fig": 1}]}], "2238759": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238759/bin/1471-2202-8-92-1.jpg", "caption": "BrdU-positive cells and also cells staining for the biochemical subtype markers CB, CR, GABA, TH, and NC are differentially distributed throughout the olfactory bulb. Low magnification images (10\u00d7) of sagittal sections through the olfactory bulb show positive immunoreactivity for (A) BrdU, (B) CB, (C) CR, (D) GABA, (E) TH, and (F) NC predominately within the GLL and GCL. Scale bars, 100 \u03bcm. CB, calbindin; CR, calretinin; TH, tyrosine-hydroxylase; NC, N-copine; GLL, glomerular layer; GCL, granule cell layer.", "co_occurrence": [{"body": 91, "word": "cells", "fig": 2}, {"body": 42, "word": "GLL", "fig": 2}, {"body": 27, "word": "CR", "fig": 3}, {"body": 40, "word": "GCL", "fig": 2}, {"body": 25, "word": "CB", "fig": 3}, {"body": 24, "word": "NC", "fig": 3}, {"body": 23, "word": "TH", "fig": 3}, {"body": 32, "word": "GABA", "fig": 2}, {"body": 59, "word": "BrdU", "fig": 1}, {"body": 26, "word": "layer", "fig": 2}, {"body": 23, "word": "bulb", "fig": 2}, {"body": 20, "word": "olfactory", "fig": 2}, {"body": 37, "word": "markers", "fig": 1}, {"body": 33, "word": "positive", "fig": 1}, {"body": 20, "word": "cell", "fig": 1}, {"body": 18, "word": "images", "fig": 1}, {"body": 18, "word": "sections", "fig": 1}, {"body": 14, "word": "also", "fig": 1}, {"body": 14, "word": "subtype", "fig": 1}, {"body": 13, "word": "granule", "fig": 1}, {"body": 11, "word": "glomerular", "fig": 1}, {"body": 10, "word": "within", "fig": 1}, {"body": 9, "word": "staining", "fig": 1}, {"body": 6, "word": "biochemical", "fig": 1}, {"body": 5, "word": "calretinin", "fig": 1}, {"body": 4, "word": "show", "fig": 1}, {"body": 4, "word": "N-copine", "fig": 1}, {"body": 4, "word": "throughout", "fig": 1}, {"body": 4, "word": "calbindin", "fig": 1}, {"body": 3, "word": "BrdU-positive", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "tyrosine-hydroxylase", "fig": 1}, {"body": 1, "word": "sagittal", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "differentially", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238759/bin/1471-2202-8-92-2.jpg", "caption": "Adult born neurons express CR, CB, and TH. 40\u00d7 images with arrowheads indicating double positive cells for BrdU (red) and the subtypes CR, CB, and TH (green). Scale bars, 37 \u03bcm. (A and B) BrdU co-labels with CR in the GLL (A) and the GCL (B). BrdU co-labels with CB (C) and TH (D) in the GLL. CB, calbindin; CR, calretinin; TH, tyrosine-hydroxylase; GLL, glomerular layer; GCL, granule cell layer.", "co_occurrence": [{"body": 59, "word": "BrdU", "fig": 3}, {"body": 42, "word": "GLL", "fig": 3}, {"body": 27, "word": "CR", "fig": 4}, {"body": 25, "word": "CB", "fig": 4}, {"body": 94, "word": "neurons", "fig": 1}, {"body": 23, "word": "TH", "fig": 4}, {"body": 91, "word": "cells", "fig": 1}, {"body": 40, "word": "GCL", "fig": 2}, {"body": 26, "word": "layer", "fig": 2}, {"body": 33, "word": "positive", "fig": 1}, {"body": 21, "word": "subtypes", "fig": 1}, {"body": 21, "word": "double", "fig": 1}, {"body": 20, "word": "cell", "fig": 1}, {"body": 18, "word": "images", "fig": 1}, {"body": 13, "word": "granule", "fig": 1}, {"body": 11, "word": "express", "fig": 1}, {"body": 11, "word": "glomerular", "fig": 1}, {"body": 7, "word": "green", "fig": 1}, {"body": 7, "word": "red", "fig": 1}, {"body": 5, "word": "calretinin", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 4, "word": "calbindin", "fig": 1}, {"body": 3, "word": "Adult", "fig": 1}, {"body": 2, "word": "born", "fig": 1}, {"body": 2, "word": "indicating", "fig": 1}, {"body": 1, "word": "B", "fig": 2}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "tyrosine-hydroxylase", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238759/bin/1471-2202-8-92-3.jpg", "caption": "Adult born neurons express GABA and NC. 40\u00d7 images of sagittal sections with arrowheads indicating double positive cells for BrdU (red) and the subtypes GABA and NC (green). Scale bars, 37 \u03bcm. (A and B) BrdU co-labels with GABA in the GLL (A) and the GCL (B). (C and D) BrdU co-labels with NC in the GCL (C) and TH (D) in the GLL. NC, N-copine; GLL, glomerular layer; GCL, granule cell layer.", "co_occurrence": [{"body": 59, "word": "BrdU", "fig": 3}, {"body": 42, "word": "GLL", "fig": 3}, {"body": 40, "word": "GCL", "fig": 3}, {"body": 24, "word": "NC", "fig": 4}, {"body": 32, "word": "GABA", "fig": 3}, {"body": 94, "word": "neurons", "fig": 1}, {"body": 91, "word": "cells", "fig": 1}, {"body": 26, "word": "layer", "fig": 2}, {"body": 33, "word": "positive", "fig": 1}, {"body": 23, "word": "TH", "fig": 1}, {"body": 21, "word": "subtypes", "fig": 1}, {"body": 21, "word": "double", "fig": 1}, {"body": 20, "word": "cell", "fig": 1}, {"body": 18, "word": "images", "fig": 1}, {"body": 18, "word": "sections", "fig": 1}, {"body": 13, "word": "granule", "fig": 1}, {"body": 11, "word": "express", "fig": 1}, {"body": 11, "word": "glomerular", "fig": 1}, {"body": 7, "word": "red", "fig": 1}, {"body": 7, "word": "green", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 4, "word": "N-copine", "fig": 1}, {"body": 3, "word": "Adult", "fig": 1}, {"body": 2, "word": "born", "fig": 1}, {"body": 2, "word": "indicating", "fig": 1}, {"body": 1, "word": "C", "fig": 2}, {"body": 1, "word": "B", "fig": 2}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "sagittal", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238759/bin/1471-2202-8-92-4.jpg", "caption": "The neuronal specific marker NeuN does not label all GLL neurons. 10\u00d7 images of sagittal sections shown to compare the immunofluorescent staining of NeuN (A) to that of the fluorescent Nissl stain NT (B) within the olfactory bulb. NT stains a much larger number of cells in the GLL. Scale bars, 148 \u03bcm. NeuN, neuronal nuclei; GLL, glomerular layer; NT, NeuroTrace; GCL, granule cell layer; MCL, mitral cell layer; EPL, external plexiform layer.", "co_occurrence": [{"body": 42, "word": "GLL", "fig": 3}, {"body": 26, "word": "layer", "fig": 4}, {"body": 94, "word": "neurons", "fig": 1}, {"body": 31, "word": "NT", "fig": 3}, {"body": 91, "word": "cells", "fig": 1}, {"body": 25, "word": "NeuN", "fig": 3}, {"body": 21, "word": "neuronal", "fig": 2}, {"body": 20, "word": "cell", "fig": 2}, {"body": 40, "word": "GCL", "fig": 1}, {"body": 23, "word": "bulb", "fig": 1}, {"body": 21, "word": "The", "fig": 1}, {"body": 20, "word": "olfactory", "fig": 1}, {"body": 18, "word": "images", "fig": 1}, {"body": 18, "word": "sections", "fig": 1}, {"body": 13, "word": "granule", "fig": 1}, {"body": 11, "word": "glomerular", "fig": 1}, {"body": 10, "word": "within", "fig": 1}, {"body": 10, "word": "fluorescent", "fig": 1}, {"body": 9, "word": "staining", "fig": 1}, {"body": 8, "word": "marker", "fig": 1}, {"body": 7, "word": "label", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 5, "word": "number", "fig": 1}, {"body": 5, "word": "stain", "fig": 1}, {"body": 5, "word": "NeuroTrace", "fig": 1}, {"body": 4, "word": "mitral", "fig": 1}, {"body": 4, "word": "compare", "fig": 1}, {"body": 4, "word": "nuclei", "fig": 1}, {"body": 3, "word": "MCL", "fig": 1}, {"body": 3, "word": "specific", "fig": 1}, {"body": 2, "word": "stains", "fig": 1}, {"body": 2, "word": "EPL", "fig": 1}, {"body": 2, "word": "plexiform", "fig": 1}, {"body": 2, "word": "Nissl", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "much", "fig": 1}, {"body": 2, "word": "external", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "sagittal", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238759/bin/1471-2202-8-92-5.jpg", "caption": "Adult born neurons express the neuron specific marker NT in the SVZ and proximal RMS 12 hours after the final BrdU injection. 40\u00d7 images of sagittal sections through the olfactory bulb of SVZ showing BrdU (red) and NT (green). Co-localization is seen within the SVZ (A) and the proximal RMS (B). Scale bars, 37 \u03bcm. NT, NeuroTrace; SVZ, sub-ventricular zone; RMS, rostral migratory stream, BrdU, bromodeoxyuridine.", "co_occurrence": [{"body": 59, "word": "BrdU", "fig": 3}, {"body": 94, "word": "neurons", "fig": 1}, {"body": 31, "word": "NT", "fig": 3}, {"body": 9, "word": "SVZ", "fig": 4}, {"body": 8, "word": "RMS", "fig": 3}, {"body": 23, "word": "bulb", "fig": 1}, {"body": 20, "word": "olfactory", "fig": 1}, {"body": 18, "word": "sections", "fig": 1}, {"body": 18, "word": "images", "fig": 1}, {"body": 17, "word": "injection", "fig": 1}, {"body": 11, "word": "express", "fig": 1}, {"body": 10, "word": "within", "fig": 1}, {"body": 9, "word": "final", "fig": 1}, {"body": 8, "word": "marker", "fig": 1}, {"body": 7, "word": "seen", "fig": 1}, {"body": 7, "word": "red", "fig": 1}, {"body": 7, "word": "green", "fig": 1}, {"body": 3, "word": "proximal", "fig": 2}, {"body": 5, "word": "NeuroTrace", "fig": 1}, {"body": 3, "word": "zone", "fig": 1}, {"body": 3, "word": "Adult", "fig": 1}, {"body": 3, "word": "hours", "fig": 1}, {"body": 3, "word": "specific", "fig": 1}, {"body": 2, "word": "stream", "fig": 1}, {"body": 2, "word": "migratory", "fig": 1}, {"body": 2, "word": "born", "fig": 1}, {"body": 2, "word": "bromodeoxyuridine", "fig": 1}, {"body": 2, "word": "rostral", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "Scale", "fig": 1}, {"body": 1, "word": "sagittal", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238759/bin/1471-2202-8-92-6.jpg", "caption": "The fractions of biochemical markers expressed by adult born neurons are similar to those expressed by the overall population of olfactory bulb neurons labeled with NT. The percentage of BrdU or NT positive cells that also express NC, CR, GABA, TH, and CB in the GCL (A) and GLL (B). Data for all markers are similar except for GABA, which is expressed in significantly more new neurons (BrdU+) than in the overall population (NT+). Also shown, data from confocal imaging of new GCL neurons double labeled for Calretinin, GABA and N-copein. BrdU, bromodeoxyuridine; NT, NeuroTrace; NC, N-copine; CR, calretinin; TH, tyrosine-hydroxylase; CB, calbindin; GCL, granule cell layer; GLL, glomerular layer.", "co_occurrence": [{"body": 94, "word": "neurons", "fig": 4}, {"body": 40, "word": "GCL", "fig": 3}, {"body": 59, "word": "BrdU", "fig": 2}, {"body": 32, "word": "GABA", "fig": 3}, {"body": 31, "word": "NT", "fig": 3}, {"body": 91, "word": "cells", "fig": 1}, {"body": 42, "word": "GLL", "fig": 2}, {"body": 37, "word": "markers", "fig": 2}, {"body": 27, "word": "CR", "fig": 2}, {"body": 26, "word": "layer", "fig": 2}, {"body": 26, "word": "new", "fig": 2}, {"body": 25, "word": "CB", "fig": 2}, {"body": 25, "word": "labeled", "fig": 2}, {"body": 24, "word": "NC", "fig": 2}, {"body": 23, "word": "TH", "fig": 2}, {"body": 21, "word": "The", "fig": 2}, {"body": 33, "word": "positive", "fig": 1}, {"body": 10, "word": "expressed", "fig": 3}, {"body": 14, "word": "population", "fig": 2}, {"body": 23, "word": "bulb", "fig": 1}, {"body": 21, "word": "double", "fig": 1}, {"body": 20, "word": "olfactory", "fig": 1}, {"body": 20, "word": "cell", "fig": 1}, {"body": 9, "word": "similar", "fig": 2}, {"body": 14, "word": "also", "fig": 1}, {"body": 13, "word": "granule", "fig": 1}, {"body": 11, "word": "express", "fig": 1}, {"body": 11, "word": "glomerular", "fig": 1}, {"body": 10, "word": "adult", "fig": 1}, {"body": 8, "word": "data", "fig": 1}, {"body": 8, "word": "fractions", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "biochemical", "fig": 1}, {"body": 5, "word": "NeuroTrace", "fig": 1}, {"body": 5, "word": "calretinin", "fig": 1}, {"body": 4, "word": "imaging", "fig": 1}, {"body": 4, "word": "calbindin", "fig": 1}, {"body": 4, "word": "N-copine", "fig": 1}, {"body": 3, "word": "except", "fig": 1}, {"body": 3, "word": "percentage", "fig": 1}, {"body": 3, "word": "confocal", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "born", "fig": 1}, {"body": 1, "word": "overall", "fig": 2}, {"body": 2, "word": "bromodeoxyuridine", "fig": 1}, {"body": 1, "word": "BrdU+", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "tyrosine-hydroxylase", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238759/bin/1471-2202-8-92-7.jpg", "caption": "The biochemical subtype expression of adult born neurons is dynamic from 14\u201375 days after the final BrdU injection. The percentage of BrdU cells that co-expressed NC, CR, GABA, TH, and CB in the GCL (A) and GLL (B) at 7, 14, 20, 40 and 75 days post final BrdU injection. BrdU, bromodeoxyuridine; NC, N-copine; CR, calretinin; TH, tyrosine-hydroxylase; CB, calbindin; GCL, granule cell layer; GLL, glomerular layer.", "co_occurrence": [{"body": 59, "word": "BrdU", "fig": 4}, {"body": 94, "word": "neurons", "fig": 1}, {"body": 91, "word": "cells", "fig": 1}, {"body": 42, "word": "GLL", "fig": 2}, {"body": 40, "word": "GCL", "fig": 2}, {"body": 27, "word": "CR", "fig": 2}, {"body": 26, "word": "layer", "fig": 2}, {"body": 25, "word": "CB", "fig": 2}, {"body": 24, "word": "NC", "fig": 2}, {"body": 24, "word": "days", "fig": 2}, {"body": 23, "word": "TH", "fig": 2}, {"body": 21, "word": "The", "fig": 2}, {"body": 17, "word": "injection", "fig": 2}, {"body": 32, "word": "GABA", "fig": 1}, {"body": 20, "word": "cell", "fig": 1}, {"body": 9, "word": "final", "fig": 2}, {"body": 17, "word": "expression", "fig": 1}, {"body": 14, "word": "subtype", "fig": 1}, {"body": 13, "word": "granule", "fig": 1}, {"body": 11, "word": "glomerular", "fig": 1}, {"body": 10, "word": "adult", "fig": 1}, {"body": 7, "word": "post", "fig": 1}, {"body": 6, "word": "biochemical", "fig": 1}, {"body": 5, "word": "calretinin", "fig": 1}, {"body": 4, "word": "calbindin", "fig": 1}, {"body": 4, "word": "N-copine", "fig": 1}, {"body": 3, "word": "percentage", "fig": 1}, {"body": 2, "word": "born", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "bromodeoxyuridine", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "co-expressed", "fig": 1}, {"body": 1, "word": "tyrosine-hydroxylase", "fig": 1}]}], "4729957": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729957/bin/ncomms10338-f1.jpg", "caption": "Reconstitution of Atg1PC from purified components. (a) SDS\u2013PAGE of recombinantly expressed and SEC-purified Atg1\u2013kinase complex subunits. Atg17TC and Atg17monoTC were co-expressed; Atg1\u2013Atg13, Atg1PC and Atg1monoPC were reconstituted from single components. (b) SEC elution profiles of Atg1PC (red) compared with that of Atg17TC (green) and Atg1\u2013Atg13 subcomplexes (blue). (c) Liposome sedimentation assays of Atg1 and Atg13. Lipid specificity of Atg1 and Atg13 was assessed by comparing their interaction with SUV containing 10 mol% PS ([PS]\u2193), YPL-extracts, 40 mol% PS ([PS]\u2191), 30 mol% PI, or 25 mol% PI supplemented with 2.5 mol% PI(3)P. S, supernatant; P, pellet. (d) Floatation assay of YPL-large unilamellar vesicles (LUVs) and MLVs of different sizes with Atg1PC. Atg1PC is efficiently recruited to membranes with high curvature (red box). Cartoons represent subunits and complexes.", "co_occurrence": [{"body": 56, "word": "Atg1PC", "fig": 5}, {"body": 50, "word": "Atg13", "fig": 2}, {"body": 44, "word": "Atg17TC", "fig": 2}, {"body": 44, "word": "Atg1", "fig": 2}, {"body": 15, "word": "mol", "fig": 5}, {"body": 12, "word": "PI", "fig": 3}, {"body": 15, "word": "Atg1\u2013Atg13", "fig": 2}, {"body": 27, "word": "interaction", "fig": 1}, {"body": 18, "word": "containing", "fig": 1}, {"body": 14, "word": "complex", "fig": 1}, {"body": 13, "word": "purified", "fig": 1}, {"body": 13, "word": "vesicles", "fig": 1}, {"body": 6, "word": "subunits", "fig": 2}, {"body": 11, "word": "recruited", "fig": 1}, {"body": 10, "word": "membranes", "fig": 1}, {"body": 9, "word": "expressed", "fig": 1}, {"body": 8, "word": "assay", "fig": 1}, {"body": 8, "word": "assays", "fig": 1}, {"body": 8, "word": "Atg1monoPC", "fig": 1}, {"body": 4, "word": "components", "fig": 2}, {"body": 7, "word": "reconstituted", "fig": 1}, {"body": 7, "word": "c", "fig": 1}, {"body": 7, "word": "Atg17monoTC", "fig": 1}, {"body": 6, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "curvature", "fig": 1}, {"body": 5, "word": "supplemented", "fig": 1}, {"body": 5, "word": "high", "fig": 1}, {"body": 5, "word": "Atg1\u2013kinase", "fig": 1}, {"body": 5, "word": "assessed", "fig": 1}, {"body": 4, "word": "subcomplexes", "fig": 1}, {"body": 1, "word": "PS", "fig": 4}, {"body": 3, "word": "Liposome", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "unilamellar", "fig": 1}, {"body": 3, "word": "sedimentation", "fig": 1}, {"body": 3, "word": "SEC", "fig": 1}, {"body": 3, "word": "YPL-extracts", "fig": 1}, {"body": 3, "word": "efficiently", "fig": 1}, {"body": 3, "word": "supernatant", "fig": 1}, {"body": 2, "word": "Reconstitution", "fig": 1}, {"body": 2, "word": "recombinantly", "fig": 1}, {"body": 2, "word": "specificity", "fig": 1}, {"body": 2, "word": "different", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "S", "fig": 1}, {"body": 1, "word": "MLVs", "fig": 1}, {"body": 1, "word": "co-expressed", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "complexes", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729957/bin/ncomms10338-f2.jpg", "caption": "Cytoplasmic domains of Atg9 interact with Atg17 to promote autophagy. (a) The scheme shows the topology of Atg9 in membranes (transmembrane domains, pink cylinders; membrane bilayer in grey; cD, cytoplasmic domain). The grey bar represents Atg9WT, the pink bars illustrate Atg9-variants with corresponding domain borders indicated by numbers. (b) \u03b1-myc immunoblot of co-floatation assays of Atg9-PL, containing Atg9core or its variants, with Atg17. Large unilamellar vesicles (LUVs) lacking Atg9 served as a control for unspecific membrane binding. Proteins, recombinant Atg17 and Atg9\u2013PLs used for experiments. (c) Immunoprecipitation (IP) of Atg17myc from ATG9WT, ATG9\u0394N, ATG9\u0394cD, ATG9\u0394N\u0394cD and ATG9\u0394 lysates under vegetative conditions and after 2 h of starvation. Atg9-variants contained the very N- (1\u2013280) and C-terminal (779\u2013997) unstructured regions, which were not present in Atg9core (indicated by the prefix fl), because these regions are essential for proper trafficking of Atg9 in vivo104950. Atg17 and co-immunoprecipitated Atg9-variants were detected by \u03b1-myc and \u03b1-HA immunoblots as indicated. Atg17 strongly interacts with wild-type Atg9, but not with Atg9 lacking N-, cD- or both domains. Bottom panel: total protein amounts in cell lysates. (d) Pho8\u039460 assay of vegetative (white bars) and starved (black bars) ATG9WT, ATG9\u0394N, ATG9\u0394cD, ATG9\u0394N\u0394cD and ATG9\u0394. The Pho8\u039460 activity of starved ATG9WT was set to 100% and used for normalization. Mean values\u00b1s.d. of N=3 independent experiments are shown.", "co_occurrence": [{"body": 117, "word": "Atg17", "fig": 5}, {"body": 52, "word": "Atg9", "fig": 6}, {"body": 49, "word": "The", "fig": 3}, {"body": 21, "word": "Atg9core", "fig": 2}, {"body": 33, "word": "Atg9\u2013PLs", "fig": 1}, {"body": 11, "word": "Atg9-variants", "fig": 3}, {"body": 16, "word": "membrane", "fig": 2}, {"body": 32, "word": "binding", "fig": 1}, {"body": 27, "word": "autophagy", "fig": 1}, {"body": 9, "word": "domain", "fig": 2}, {"body": 6, "word": "domains", "fig": 3}, {"body": 18, "word": "containing", "fig": 1}, {"body": 9, "word": "used", "fig": 2}, {"body": 17, "word": "activity", "fig": 1}, {"body": 16, "word": "protein", "fig": 1}, {"body": 7, "word": "lysates", "fig": 2}, {"body": 7, "word": "vegetative", "fig": 2}, {"body": 13, "word": "conditions", "fig": 1}, {"body": 13, "word": "vesicles", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 6, "word": "lacking", "fig": 2}, {"body": 12, "word": "cell", "fig": 1}, {"body": 11, "word": "strongly", "fig": 1}, {"body": 10, "word": "membranes", "fig": 1}, {"body": 10, "word": "C-terminal", "fig": 1}, {"body": 8, "word": "assay", "fig": 1}, {"body": 8, "word": "variants", "fig": 1}, {"body": 8, "word": "h", "fig": 1}, {"body": 8, "word": "corresponding", "fig": 1}, {"body": 4, "word": "N-", "fig": 2}, {"body": 8, "word": "assays", "fig": 1}, {"body": 7, "word": "recombinant", "fig": 1}, {"body": 7, "word": "cytoplasmic", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 7, "word": "c", "fig": 1}, {"body": 6, "word": "starvation", "fig": 1}, {"body": 6, "word": "promote", "fig": 1}, {"body": 2, "word": "indicated", "fig": 3}, {"body": 6, "word": "amounts", "fig": 1}, {"body": 5, "word": "Atg9-PL", "fig": 1}, {"body": 5, "word": "interact", "fig": 1}, {"body": 5, "word": "interacts", "fig": 1}, {"body": 5, "word": "co-immunoprecipitated", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 2, "word": "Pho8\u039460", "fig": 2}, {"body": 2, "word": "regions", "fig": 2}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "unilamellar", "fig": 1}, {"body": 3, "word": "set", "fig": 1}, {"body": 3, "word": "control", "fig": 1}, {"body": 3, "word": "Atg17myc", "fig": 1}, {"body": 3, "word": "co-floatation", "fig": 1}, {"body": 1, "word": "\u03b1-myc", "fig": 2}, {"body": 2, "word": "contained", "fig": 1}, {"body": 2, "word": "topology", "fig": 1}, {"body": 2, "word": "present", "fig": 1}, {"body": 1, "word": "starved", "fig": 2}, {"body": 1, "word": "detected", "fig": 1}, {"body": 1, "word": "Large", "fig": 1}, {"body": 1, "word": "Atg9WT", "fig": 1}, {"body": 1, "word": "proper", "fig": 1}, {"body": 1, "word": "Proteins", "fig": 1}, {"body": 1, "word": "wild-type", "fig": 1}, {"body": 1, "word": "borders", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}, {"body": 1, "word": "transmembrane", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729957/bin/ncomms10338-f3.jpg", "caption": "Atg9 binds the central crescent of Atg17. (a) Cartoon representation of the crystal structure of Atg17TC (pdb 4HPQ). Helix \u03b14 (orange and green) spans the entire Atg17-crescent and forms part of the dimerization domain (green). Domain borders that have been used to design Atg17-variants are indicated by numbers. The minimal Atg17-binding region of Atg31 is highlighted in red with numbers indicating corresponding domain borders. Images were prepared in PYMOL (The PyMOL Molecular Graphics System, Version 1.2r3pre, Schr\u00f6dinger, LLC). (b) SDS\u2013PAGE gel of co-floatation experiments of Atg9\u2013PLs with recombinant thioredoxin-tagged Atg17-fragments. Thioredoxin-tag lacking Atg17 (w/o Atg17) and co-floatation with large unilamellar vesicles (LUVs) lacking Atg9core served as controls. Input corresponds to 10% of total protein used for co-floatation. (c) \u03b1-myc immunoblot of co-floatation experiments of Atg17 with Atg9\u2013PLs and increasing stoichiometric ratios of Atg31\u2013Atg29. After incubating Atg9\u2013PLs with Atg17, purified Atg31\u2013Atg29 was added. Atg31\u2013Atg29 inhibits binding of Atg17 to Atg9 in vitro. (d) Quantification of Atg17 retrieved from the floating fraction in co-floatation experiments with Atg9\u2013PLs as shown in c. The intensity of the Atg17-band in the absence of Atg31\u2013Atg29 was set to one and used for normalization. Mean values\u00b1s.d. of N=3 independent experiments are shown. (e) Immunoprecipitation (IP) of Atg17myc from cell lysates after 2 h of starvation. Increasing amount of GST-Atg31160\u2013196 as indicated or 5 \u03bcg GST were added to cell lysates prior IP. Atg17 and co-immunoprecipitated Atg9 were detected by \u03b1-myc and \u03b1-HA immunoblots. (f) Quantification of Atg9HA as shown in e. The intensity of the Atg9HA-band (w/o GST-Atg31160\u2013196) was set to one and used for normalization. Mean values\u00b1s.d. of N=3 independent experiments are shown. P values were calculated using two-tailed Student's T-test (*P<0.05; **P<0.01; ***P<0.005).", "co_occurrence": [{"body": 117, "word": "Atg17", "fig": 8}, {"body": 49, "word": "The", "fig": 4}, {"body": 52, "word": "Atg9", "fig": 3}, {"body": 33, "word": "Atg9\u2013PLs", "fig": 4}, {"body": 18, "word": "Atg31\u2013Atg29", "fig": 4}, {"body": 44, "word": "Atg17TC", "fig": 1}, {"body": 9, "word": "used", "fig": 4}, {"body": 32, "word": "binding", "fig": 1}, {"body": 31, "word": "using", "fig": 1}, {"body": 6, "word": "experiments", "fig": 5}, {"body": 12, "word": "cell", "fig": 2}, {"body": 21, "word": "Atg9core", "fig": 1}, {"body": 19, "word": "vitro", "fig": 1}, {"body": 9, "word": "domain", "fig": 2}, {"body": 4, "word": "shown", "fig": 4}, {"body": 16, "word": "protein", "fig": 1}, {"body": 3, "word": "co-floatation", "fig": 5}, {"body": 7, "word": "GST-Atg31160\u2013196", "fig": 2}, {"body": 7, "word": "added", "fig": 2}, {"body": 7, "word": "lysates", "fig": 2}, {"body": 13, "word": "purified", "fig": 1}, {"body": 13, "word": "dimerization", "fig": 1}, {"body": 13, "word": "vesicles", "fig": 1}, {"body": 6, "word": "lacking", "fig": 2}, {"body": 5, "word": "one", "fig": 2}, {"body": 10, "word": "Atg31", "fig": 1}, {"body": 9, "word": "prepared", "fig": 1}, {"body": 8, "word": "h", "fig": 1}, {"body": 8, "word": "corresponding", "fig": 1}, {"body": 7, "word": "recombinant", "fig": 1}, {"body": 7, "word": "c", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 6, "word": "starvation", "fig": 1}, {"body": 3, "word": "set", "fig": 2}, {"body": 6, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 6, "word": "fraction", "fig": 1}, {"body": 6, "word": "binds", "fig": 1}, {"body": 5, "word": "indicating", "fig": 1}, {"body": 5, "word": "\u03bcg", "fig": 1}, {"body": 5, "word": "\u03b14", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 5, "word": "amount", "fig": 1}, {"body": 5, "word": "incubating", "fig": 1}, {"body": 5, "word": "co-immunoprecipitated", "fig": 1}, {"body": 4, "word": "absence", "fig": 1}, {"body": 4, "word": "region", "fig": 1}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "unilamellar", "fig": 1}, {"body": 3, "word": "crescent", "fig": 1}, {"body": 3, "word": "increasing", "fig": 1}, {"body": 3, "word": "Atg17-binding", "fig": 1}, {"body": 3, "word": "central", "fig": 1}, {"body": 3, "word": "inhibits", "fig": 1}, {"body": 3, "word": "Atg17myc", "fig": 1}, {"body": 3, "word": "structure", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 2, "word": "GST", "fig": 1}, {"body": 1, "word": "\u03b1-myc", "fig": 2}, {"body": 2, "word": "entire", "fig": 1}, {"body": 1, "word": "intensity", "fig": 2}, {"body": 2, "word": "Atg17-crescent", "fig": 1}, {"body": 2, "word": "Images", "fig": 1}, {"body": 1, "word": "borders", "fig": 2}, {"body": 2, "word": "stoichiometric", "fig": 1}, {"body": 2, "word": "Atg9HA", "fig": 1}, {"body": 1, "word": "independent", "fig": 2}, {"body": 2, "word": "calculated", "fig": 1}, {"body": 1, "word": "Molecular", "fig": 1}, {"body": 1, "word": "forms", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}, {"body": 1, "word": "large", "fig": 1}, {"body": 1, "word": "minimal", "fig": 1}, {"body": 1, "word": "ratios", "fig": 1}, {"body": 1, "word": "corresponds", "fig": 1}, {"body": 1, "word": "detected", "fig": 1}, {"body": 1, "word": "part", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "prior", "fig": 1}, {"body": 1, "word": "Atg17-variants", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729957/bin/ncomms10338-f4.jpg", "caption": "The activity of Atg17 is regulated by Atg31\u2013Atg29 and Atg1\u2013Atg13 subcomplexes in vitro and in vivo. (a) The schematic drawing illustrates the experimental set-up of floatation assays. (b) \u03b1-myc immunoblot from co-floatation experiments of Atg9\u2013PLs with recombinant myc-tagged Atg17 with and without other Atg1PC-subunits as indicated. Similar experiments with large unilamellar vesicles (LUVs) lacking Atg9core served as controls for unspecific membrane binding. Input corresponds to 10% of total protein used for co-floatation. (c) Semiquantitative analysis of immunoblots as shown in b from co-floatation experiments of Atg17myc with Atg9\u2013PLs in the presence of other subunits of Atg1PC as indicated. All Atg17myc-intensities were corrected for Atg9-intensities. The band intensity of Atg17myc (w/o other Atg1PC-subunits) was set to one and used for normalization. Mean values\u00b1s.d. of N=3 independent experiments are shown. P values were calculated using two-tailed Student's T-test (*P<0.05; **P<0.01; ***P<0.005). (d) Immunoprecipitation (IP) of Atg17myc from lysates of wildtype (WT), atg1\u0394 and atg13\u0394cells after two hours of starvation. Atg17 and co-immunoprecipitated Atg9 were detected by \u03b1-myc and \u03b1-HA immunoblots as indicated. (e) Quantification of Atg9HA as shown in d. The intensity of the Atg9HA-band in wildtype (WT), atg1\u0394, and atg13\u0394 cells were corrected for unspecific binding of Atg9HA in the control (Ctrl, cells w/o myc-tag). The WT Atg17-band intensity was set to one and used for normalization. Mean values\u00b1s.d. of N=3 independent experiments are shown. (f) Co-localization of Atg9-tandem-mCherry with Atg17-tandem-GFP in wildtype (WT) and atg13\u0394 cells under vegetative and autophagy-induced conditions. Arrowheads indicate positions of non-colocalizing Atg9-puncta. Scale bar, 2 \u03bcm. (g) Quantification of relative co-localization of Atg17-puncta with Atg9-puncta (number of co-localizing puncta per cell, normalized by number of Atg17 puncta per cell) in WT, atg1\u0394, and atg13\u0394 cells under vegetative (white bars) and autophagy-induced (black bars) conditions. Mean values\u00b1s.d. of N=3 independent experiments are shown (>200 cells per strain were examined).", "co_occurrence": [{"body": 117, "word": "Atg17", "fig": 4}, {"body": 49, "word": "The", "fig": 5}, {"body": 31, "word": "cells", "fig": 5}, {"body": 33, "word": "Atg9\u2013PLs", "fig": 2}, {"body": 32, "word": "binding", "fig": 2}, {"body": 56, "word": "Atg1PC", "fig": 1}, {"body": 52, "word": "Atg9", "fig": 1}, {"body": 6, "word": "experiments", "fig": 6}, {"body": 31, "word": "using", "fig": 1}, {"body": 9, "word": "used", "fig": 3}, {"body": 13, "word": "conditions", "fig": 2}, {"body": 12, "word": "cell", "fig": 2}, {"body": 21, "word": "Atg9core", "fig": 1}, {"body": 4, "word": "shown", "fig": 5}, {"body": 20, "word": "vivo", "fig": 1}, {"body": 19, "word": "vitro", "fig": 1}, {"body": 18, "word": "Atg31\u2013Atg29", "fig": 1}, {"body": 17, "word": "activity", "fig": 1}, {"body": 16, "word": "membrane", "fig": 1}, {"body": 16, "word": "protein", "fig": 1}, {"body": 15, "word": "Atg1\u2013Atg13", "fig": 1}, {"body": 7, "word": "vegetative", "fig": 2}, {"body": 13, "word": "vesicles", "fig": 1}, {"body": 4, "word": "atg13\u0394", "fig": 3}, {"body": 5, "word": "one", "fig": 2}, {"body": 10, "word": "two", "fig": 1}, {"body": 3, "word": "per", "fig": 3}, {"body": 3, "word": "atg1\u0394", "fig": 3}, {"body": 3, "word": "Atg17myc", "fig": 3}, {"body": 3, "word": "co-floatation", "fig": 3}, {"body": 8, "word": "assays", "fig": 1}, {"body": 7, "word": "recombinant", "fig": 1}, {"body": 7, "word": "c", "fig": 1}, {"body": 7, "word": "lysates", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 6, "word": "lacking", "fig": 1}, {"body": 3, "word": "Atg1PC-subunits", "fig": 2}, {"body": 6, "word": "starvation", "fig": 1}, {"body": 3, "word": "set", "fig": 2}, {"body": 6, "word": "presence", "fig": 1}, {"body": 2, "word": "wildtype", "fig": 3}, {"body": 2, "word": "indicated", "fig": 3}, {"body": 6, "word": "subunits", "fig": 1}, {"body": 5, "word": "g", "fig": 1}, {"body": 5, "word": "co-localization", "fig": 1}, {"body": 5, "word": "co-immunoprecipitated", "fig": 1}, {"body": 2, "word": "autophagy-induced", "fig": 2}, {"body": 4, "word": "subcomplexes", "fig": 1}, {"body": 4, "word": "floatation", "fig": 1}, {"body": 2, "word": "Atg9HA", "fig": 2}, {"body": 4, "word": "All", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "unilamellar", "fig": 1}, {"body": 1, "word": "intensity", "fig": 3}, {"body": 3, "word": "control", "fig": 1}, {"body": 3, "word": "regulated", "fig": 1}, {"body": 1, "word": "independent", "fig": 3}, {"body": 3, "word": "P", "fig": 1}, {"body": 1, "word": "\u03b1-myc", "fig": 2}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "Atg9-puncta", "fig": 2}, {"body": 1, "word": "corrected", "fig": 2}, {"body": 1, "word": "b", "fig": 2}, {"body": 2, "word": "calculated", "fig": 1}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 1, "word": "number", "fig": 2}, {"body": 2, "word": "without", "fig": 1}, {"body": 1, "word": "detected", "fig": 1}, {"body": 1, "word": "corresponds", "fig": 1}, {"body": 1, "word": "band", "fig": 1}, {"body": 1, "word": "positions", "fig": 1}, {"body": 1, "word": "large", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "Atg17-puncta", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "Co-localization", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}, {"body": 1, "word": "myc-tag", "fig": 1}, {"body": 1, "word": "strain", "fig": 1}, {"body": 1, "word": "myc-tagged", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729957/bin/ncomms10338-f5.jpg", "caption": "The dimerization domain of Atg17 regulates Atg17-function. (a) \u03b1-myc immunoblots from co-floatation experiments of Atg9\u2013PLs with recombinant myc-tagged, monomeric Atg17 (Atg17mono), Atg17monoTC and Atg1monoPC. Atg17mono is strongly inhibited by Atg31\u2013Atg29, but Atg17monoTC is not activated by Atg1\u2013Atg13. Similar experiments with large unilamellar vesicles (LUVs) lacking Atg9core served as controls. Input corresponds to 10% of total protein used for co-floatation. (b) Pho8\u039460 assay of wildtype (WT), atg17mono, and atg17\u0394 cell lysates to assess autophagic activity under vegetative (grey bars) and starvation (black bars) conditions. Mean values\u00b1s.d. of N=3 independent experiments are shown. (c) Co-localization of GFP-Atg8 with mCherry-tagged Atg17 or Atg17mono under vegetative or autophagy-induced conditions. Atg17mono is not forming puncta under autophagy-induced conditions. Consequently, autophagosomes are not being formed as apparent from the lack of Atg8-puncta. Scale bar, 2 \u03bcm.", "co_occurrence": [{"body": 117, "word": "Atg17", "fig": 3}, {"body": 49, "word": "The", "fig": 1}, {"body": 12, "word": "Atg17mono", "fig": 4}, {"body": 13, "word": "conditions", "fig": 3}, {"body": 33, "word": "Atg9\u2013PLs", "fig": 1}, {"body": 21, "word": "Atg9core", "fig": 1}, {"body": 6, "word": "experiments", "fig": 3}, {"body": 18, "word": "Atg31\u2013Atg29", "fig": 1}, {"body": 17, "word": "activity", "fig": 1}, {"body": 16, "word": "protein", "fig": 1}, {"body": 15, "word": "Atg1\u2013Atg13", "fig": 1}, {"body": 7, "word": "vegetative", "fig": 2}, {"body": 7, "word": "Atg17monoTC", "fig": 2}, {"body": 13, "word": "dimerization", "fig": 1}, {"body": 13, "word": "vesicles", "fig": 1}, {"body": 12, "word": "cell", "fig": 1}, {"body": 11, "word": "strongly", "fig": 1}, {"body": 9, "word": "domain", "fig": 1}, {"body": 9, "word": "monomeric", "fig": 1}, {"body": 9, "word": "used", "fig": 1}, {"body": 8, "word": "assay", "fig": 1}, {"body": 8, "word": "regulates", "fig": 1}, {"body": 8, "word": "Atg1monoPC", "fig": 1}, {"body": 7, "word": "recombinant", "fig": 1}, {"body": 7, "word": "c", "fig": 1}, {"body": 7, "word": "lysates", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 6, "word": "lacking", "fig": 1}, {"body": 6, "word": "starvation", "fig": 1}, {"body": 3, "word": "co-floatation", "fig": 2}, {"body": 5, "word": "Consequently", "fig": 1}, {"body": 5, "word": "inhibited", "fig": 1}, {"body": 2, "word": "autophagy-induced", "fig": 2}, {"body": 4, "word": "shown", "fig": 1}, {"body": 3, "word": "unilamellar", "fig": 1}, {"body": 3, "word": "autophagic", "fig": 1}, {"body": 2, "word": "lack", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "wildtype", "fig": 1}, {"body": 2, "word": "forming", "fig": 1}, {"body": 2, "word": "Pho8\u039460", "fig": 1}, {"body": 1, "word": "activated", "fig": 1}, {"body": 1, "word": "\u03b1-myc", "fig": 1}, {"body": 1, "word": "large", "fig": 1}, {"body": 1, "word": "Atg17-function", "fig": 1}, {"body": 1, "word": "autophagosomes", "fig": 1}, {"body": 1, "word": "corresponds", "fig": 1}, {"body": 1, "word": "Co-localization", "fig": 1}, {"body": 1, "word": "formed", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "myc-tagged", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729957/bin/ncomms10338-f6.jpg", "caption": "Atg1PC tethers Atg9\u2013PLs. (a) The hydrodynamic radius of SUVs (white bar) and Atg9\u2013PLs (black bar) obtained from DLS-experiments in the absence or presence of Atg17 and corresponding variants as illustrated by cartoons are shown. ND, not determinable (polydisperse). (b) Similar experiments shown in a were performed for Atg17 and Atg17-variants and that of corresponding Atg17TC and Atg1PC (sub)complexes. (a,b). Mean values\u00b1s.d. of N=5 experiments are shown for both a and b. P values were calculated using two-tailed Student's T-test (*P<0.05; **P<0.01; ***P<0.001). (c) The schematic drawing illustrates the experimental setup and summarizes the results obtained from DLS-experiments in a and b. (d) Cyro-electron micrographs of Atg9\u2013PLs from samples used for DLS-experiments containing Atg17, Atg17TC, Atg17mono, and Atg1PC. Atg17 tethers two and Atg1PC tethers multiple vesicles together. Scale bar, 50 nm.", "co_occurrence": [{"body": 117, "word": "Atg17", "fig": 4}, {"body": 56, "word": "Atg1PC", "fig": 4}, {"body": 33, "word": "Atg9\u2013PLs", "fig": 3}, {"body": 49, "word": "The", "fig": 2}, {"body": 44, "word": "Atg17TC", "fig": 2}, {"body": 31, "word": "using", "fig": 1}, {"body": 21, "word": "nm", "fig": 1}, {"body": 18, "word": "containing", "fig": 1}, {"body": 8, "word": "corresponding", "fig": 2}, {"body": 13, "word": "vesicles", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 12, "word": "Atg17mono", "fig": 1}, {"body": 4, "word": "shown", "fig": 3}, {"body": 10, "word": "two", "fig": 1}, {"body": 10, "word": "SUVs", "fig": 1}, {"body": 3, "word": "tethers", "fig": 3}, {"body": 9, "word": "used", "fig": 1}, {"body": 8, "word": "variants", "fig": 1}, {"body": 8, "word": "performed", "fig": 1}, {"body": 7, "word": "c", "fig": 1}, {"body": 6, "word": "presence", "fig": 1}, {"body": 4, "word": "results", "fig": 1}, {"body": 4, "word": "absence", "fig": 1}, {"body": 4, "word": "multiple", "fig": 1}, {"body": 3, "word": "samples", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 1, "word": "b", "fig": 3}, {"body": 3, "word": "together", "fig": 1}, {"body": 2, "word": "hydrodynamic", "fig": 1}, {"body": 2, "word": "polydisperse", "fig": 1}, {"body": 2, "word": "calculated", "fig": 1}, {"body": 1, "word": "radius", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "Atg17-variants", "fig": 1}, {"body": 1, "word": "complexes", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729957/bin/ncomms10338-f7.jpg", "caption": "Phosphorylation of Atg13 disassembles Atg1PC and prevents tethering. (a) SEC elution profiles of Atg17TC in the presence of Atg1\u2013Atg13 (red), Atg1\u2013Atg13SD (blue), and Atg1\u2013Atg13+ATP (green). Atg13SD and addition of ATP prevents assembly of Atg1PC. (b) \u03b1-myc immunoblot of co-floatation experiments of Atg9\u2013PLs with recombinant myc-tagged Atg17 and Atg17TC without and with Atg1\u2013Atg13 (Atg1PC) or Atg1\u2013Atg13SD (ref. 23). Similar experiments with large unilamellar vesicles (LUVs) lacking Atg9core served as controls. Input corresponds to 10% of total protein used for co-floatation. (c) The hydrodynamic radius of SUVs (white bar) and Atg9\u2013PLs (black bar) with similar samples as shown in (b) obtained from DLS-experiments. Mean values\u00b1s.d. of N=5 experiments. (d) Model for Atg1PC function, tethering of Atg9-vesicles, and its regulated assembly from and disassembly into subcomplexes. P indicates phosphorylation of Atg13 under vegetative conditions.", "co_occurrence": [{"body": 56, "word": "Atg1PC", "fig": 4}, {"body": 117, "word": "Atg17", "fig": 1}, {"body": 50, "word": "Atg13", "fig": 2}, {"body": 44, "word": "Atg17TC", "fig": 2}, {"body": 33, "word": "Atg9\u2013PLs", "fig": 2}, {"body": 49, "word": "The", "fig": 1}, {"body": 15, "word": "Atg1\u2013Atg13", "fig": 2}, {"body": 15, "word": "tethering", "fig": 2}, {"body": 23, "word": "Atg9-vesicles", "fig": 1}, {"body": 21, "word": "Atg9core", "fig": 1}, {"body": 6, "word": "experiments", "fig": 3}, {"body": 16, "word": "protein", "fig": 1}, {"body": 13, "word": "conditions", "fig": 1}, {"body": 13, "word": "vesicles", "fig": 1}, {"body": 13, "word": "similar", "fig": 1}, {"body": 10, "word": "ref", "fig": 1}, {"body": 5, "word": "assembly", "fig": 2}, {"body": 10, "word": "SUVs", "fig": 1}, {"body": 9, "word": "used", "fig": 1}, {"body": 7, "word": "recombinant", "fig": 1}, {"body": 7, "word": "c", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 7, "word": "vegetative", "fig": 1}, {"body": 6, "word": "lacking", "fig": 1}, {"body": 3, "word": "Atg1\u2013Atg13SD", "fig": 2}, {"body": 6, "word": "phosphorylation", "fig": 1}, {"body": 6, "word": "presence", "fig": 1}, {"body": 3, "word": "co-floatation", "fig": 2}, {"body": 5, "word": "function", "fig": 1}, {"body": 4, "word": "subcomplexes", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 3, "word": "samples", "fig": 1}, {"body": 3, "word": "P", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "unilamellar", "fig": 1}, {"body": 3, "word": "regulated", "fig": 1}, {"body": 3, "word": "addition", "fig": 1}, {"body": 3, "word": "SEC", "fig": 1}, {"body": 2, "word": "hydrodynamic", "fig": 1}, {"body": 1, "word": "b", "fig": 2}, {"body": 1, "word": "prevents", "fig": 2}, {"body": 2, "word": "without", "fig": 1}, {"body": 2, "word": "disassembly", "fig": 1}, {"body": 1, "word": "\u03b1-myc", "fig": 1}, {"body": 1, "word": "Atg13SD", "fig": 1}, {"body": 1, "word": "large", "fig": 1}, {"body": 1, "word": "radius", "fig": 1}, {"body": 1, "word": "corresponds", "fig": 1}, {"body": 1, "word": "ATP", "fig": 1}, {"body": 1, "word": "myc-tagged", "fig": 1}]}], "3829018": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829018/bin/jcmm0014-1520-f1.jpg", "caption": "EGF increases the expression level of Aurora-A through the activation of ERK and Akt signalling pathways in human colorectal cancer cell lines. (A) The expression of Aurora-A was enhanced by EGF treatment in a bi-phase manner. Total lysates from EGF treated A431 cells were harvested for performing the Western blot analysis to demonstrate the expression of Aurora-A. The time-points indicated the duration of EGF treatment. \u03b1-Tubulin was used as a loading control. (B) Five colorectal cancer cell lines were treated with EGF for 2 (LS174T) or 3 hrs (SW480, SW620, HT29 and HCT116), and then Western Blot analysis was performed. (C) LS174T cells were treated with EGF for various times as indicated (left) or treated with 0, 30 or 60 ng/ml EGF for 2 hrs (right). The lysates were analysed as in (B). The quantitative results are shown below. Statistic results from three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (D) Cells were pre-treated with AG1478 for 30 min., followed by treatment with EGF for 2 hrs. The expressions of Aurora-A and EGFR were analysed as in (B). (E) EGF-stimulated cells were harvested at the indicated times, and the expressions of EGFR, Aurora-A, p-Akt, Akt, p-ERK, ERK and \u03b1-tubulin were analysed. (F) Cells were pre-treated with U0126 or wortmannin for 30 min., followed by EGF treatment for 2 hrs (DMSO, vehicle control). \u03b1-Tubulin was used as the loading control. (G) The induction of Aurora-A by short-term (2 hrs) EGF treatment was inhibited by U0126. Serum-starved A431 cells were pre-treated without (lanes 2, 5) or with (lanes 3, 6) U0126 (10 \u03bcM) for 30 min. and then treated without (lanes 1, 4) or with EGF (10 nM) for 2 (lanes 2\u20133) or 24 hrs (lanes 5\u20136). Total lysates were harvested for performing the Western blotting analysis by using the indicated antibodies.", "co_occurrence": [{"body": 71, "word": "EGF", "fig": 11}, {"body": 118, "word": "Aurora-A", "fig": 6}, {"body": 65, "word": "expression", "fig": 3}, {"body": 31, "word": "The", "fig": 6}, {"body": 46, "word": "cells", "fig": 4}, {"body": 34, "word": "treatment", "fig": 5}, {"body": 14, "word": "hrs", "fig": 6}, {"body": 42, "word": "EGFR", "fig": 2}, {"body": 30, "word": "cancer", "fig": 2}, {"body": 21, "word": "ERK", "fig": 2}, {"body": 20, "word": "colorectal", "fig": 2}, {"body": 19, "word": "cell", "fig": 2}, {"body": 8, "word": "indicated", "fig": 4}, {"body": 16, "word": "Akt", "fig": 2}, {"body": 32, "word": "signalling", "fig": 1}, {"body": 6, "word": "treated", "fig": 5}, {"body": 5, "word": "lanes", "fig": 5}, {"body": 21, "word": "pathways", "fig": 1}, {"body": 6, "word": "U0126", "fig": 3}, {"body": 5, "word": "control", "fig": 3}, {"body": 5, "word": "analysis", "fig": 3}, {"body": 14, "word": "activation", "fig": 1}, {"body": 6, "word": "results", "fig": 2}, {"body": 6, "word": "LS174T", "fig": 2}, {"body": 4, "word": "lysates", "fig": 3}, {"body": 6, "word": "lines", "fig": 2}, {"body": 11, "word": "level", "fig": 1}, {"body": 5, "word": "A431", "fig": 2}, {"body": 10, "word": "performed", "fig": 1}, {"body": 5, "word": "used", "fig": 2}, {"body": 3, "word": "analysed", "fig": 3}, {"body": 3, "word": "harvested", "fig": 3}, {"body": 8, "word": "human", "fig": 1}, {"body": 8, "word": "using", "fig": 1}, {"body": 2, "word": "Western", "fig": 3}, {"body": 6, "word": "demonstrate", "fig": 1}, {"body": 2, "word": "pre-treated", "fig": 3}, {"body": 4, "word": "enhanced", "fig": 1}, {"body": 2, "word": "followed", "fig": 2}, {"body": 4, "word": "nM", "fig": 1}, {"body": 4, "word": "min", "fig": 1}, {"body": 2, "word": "without", "fig": 2}, {"body": 2, "word": "Cells", "fig": 2}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 3, "word": "increases", "fig": 1}, {"body": 3, "word": "wortmannin", "fig": 1}, {"body": 3, "word": "shown", "fig": 1}, {"body": 3, "word": "various", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "HCT116", "fig": 1}, {"body": 2, "word": "SW480", "fig": 1}, {"body": 2, "word": "time-points", "fig": 1}, {"body": 1, "word": "times", "fig": 2}, {"body": 2, "word": "bi-phase", "fig": 1}, {"body": 2, "word": "ng/ml", "fig": 1}, {"body": 2, "word": "HT29", "fig": 1}, {"body": 1, "word": "min.", "fig": 2}, {"body": 1, "word": "short-term", "fig": 1}, {"body": 1, "word": "AG1478", "fig": 1}, {"body": 1, "word": "G", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "manner", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "DMSO", "fig": 1}, {"body": 1, "word": "SW620", "fig": 1}, {"body": 1, "word": "inhibited", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829018/bin/jcmm0014-1520-f2.jpg", "caption": "Co-expression of EGFR and Aurroa-A, and activation of Akt and ERK pathways in human colorectal tissues. (A) The expression of the EGFR and Aurora-A in normal colon tissue (a and c) and colorectal cancer (b and d). Representative data are shown. The statistical result of the immunohistochemical staining of 13 human colorectal specimens is shown below. (B) The expression levels of the EGFR and Aurora-A and the activation statuses of Akt (Akt/pS473) and ERK (pERK) in human normal colon tissues (N) and colorectal cancers (Ca) were analysed by Western Blot. The statistical result is shown in right panel.", "co_occurrence": [{"body": 118, "word": "Aurora-A", "fig": 2}, {"body": 65, "word": "expression", "fig": 2}, {"body": 42, "word": "EGFR", "fig": 3}, {"body": 31, "word": "The", "fig": 4}, {"body": 20, "word": "colorectal", "fig": 4}, {"body": 21, "word": "ERK", "fig": 2}, {"body": 16, "word": "Akt", "fig": 2}, {"body": 30, "word": "cancer", "fig": 1}, {"body": 14, "word": "activation", "fig": 2}, {"body": 8, "word": "human", "fig": 3}, {"body": 12, "word": "result", "fig": 2}, {"body": 21, "word": "pathways", "fig": 1}, {"body": 12, "word": "cancers", "fig": 1}, {"body": 3, "word": "shown", "fig": 3}, {"body": 2, "word": "tissues", "fig": 2}, {"body": 4, "word": "levels", "fig": 1}, {"body": 3, "word": "analysed", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "colon", "fig": 2}, {"body": 2, "word": "Western", "fig": 1}, {"body": 1, "word": "normal", "fig": 2}, {"body": 1, "word": "statuses", "fig": 1}, {"body": 1, "word": "Co-expression", "fig": 1}, {"body": 1, "word": "specimens", "fig": 1}, {"body": 1, "word": "immunohistochemical", "fig": 1}, {"body": 1, "word": "data", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829018/bin/jcmm0014-1520-f3.jpg", "caption": "EGF does not alter the Aurora-A mRNA level in human colorectal cancer cell lines. (A) Serum-starved LS174T cells were treated with EGF for 3 hrs, and total RNA was harvested. The expression levels of Aurora-A and GAPDH mRNA were detected by RT-PCR. The lower panel, serum-starved cells were treated with EGF for different time-points, and the expression level of Aurora-A mRNA was quantified by real-time RT-PCR and normalized with RPL13A (ribosomal protein L 13A). The mean \u00b1 S.D. (error bars) was obtained from three independent experiments. (B) Neither U0126 nor wortmannin changed the expression level of Aurora A mRNA under EGF treatment. The expression of Aurora-A mRNA was analysed as in (A). (C) Cells were transiently transfected with the Aurora-A promoter-luciferase construct. After starvation, cells were treated with EGF for 0, 4, 18 and 24 hrs, and the reporter assay was performed with a dual luciferase assay kit. The mean \u00b1 S.D. was obtained from three independent experiments. (D) Serum-starved cells were pre-treated with actinomycin D for 30 min., followed by EGF for another 2 hrs. The expressions of Aurora-A and \u03b1-tubulin were analysed by Western Blot.", "co_occurrence": [{"body": 118, "word": "Aurora-A", "fig": 6}, {"body": 71, "word": "EGF", "fig": 6}, {"body": 65, "word": "expression", "fig": 4}, {"body": 38, "word": "mRNA", "fig": 5}, {"body": 31, "word": "The", "fig": 6}, {"body": 46, "word": "cells", "fig": 4}, {"body": 51, "word": "protein", "fig": 1}, {"body": 14, "word": "hrs", "fig": 3}, {"body": 18, "word": "assay", "fig": 2}, {"body": 34, "word": "treatment", "fig": 1}, {"body": 11, "word": "level", "fig": 3}, {"body": 30, "word": "cancer", "fig": 1}, {"body": 20, "word": "colorectal", "fig": 1}, {"body": 19, "word": "cell", "fig": 1}, {"body": 6, "word": "treated", "fig": 3}, {"body": 10, "word": "performed", "fig": 1}, {"body": 3, "word": "A", "fig": 3}, {"body": 8, "word": "human", "fig": 1}, {"body": 6, "word": "luciferase", "fig": 1}, {"body": 3, "word": "RT-PCR", "fig": 2}, {"body": 6, "word": "LS174T", "fig": 1}, {"body": 6, "word": "U0126", "fig": 1}, {"body": 3, "word": "analysed", "fig": 2}, {"body": 6, "word": "different", "fig": 1}, {"body": 6, "word": "lines", "fig": 1}, {"body": 5, "word": "ribosomal", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 2, "word": "experiments", "fig": 2}, {"body": 2, "word": "D", "fig": 2}, {"body": 4, "word": "another", "fig": 1}, {"body": 4, "word": "After", "fig": 1}, {"body": 4, "word": "levels", "fig": 1}, {"body": 3, "word": "detected", "fig": 1}, {"body": 3, "word": "wortmannin", "fig": 1}, {"body": 3, "word": "construct", "fig": 1}, {"body": 3, "word": "harvested", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "Cells", "fig": 1}, {"body": 1, "word": "mean", "fig": 2}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "reporter", "fig": 1}, {"body": 2, "word": "time-points", "fig": 1}, {"body": 1, "word": "obtained", "fig": 2}, {"body": 2, "word": "transfected", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 1, "word": "three", "fig": 2}, {"body": 2, "word": "RPL13A", "fig": 1}, {"body": 2, "word": "pre-treated", "fig": 1}, {"body": 1, "word": "independent", "fig": 2}, {"body": 1, "word": "Aurora", "fig": 1}, {"body": 1, "word": "serum-starved", "fig": 1}, {"body": 1, "word": "actinomycin", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "min.", "fig": 1}, {"body": 1, "word": "kit", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829018/bin/jcmm0014-1520-f4.jpg", "caption": "EGF increases the translational efficiency of Aurora-A mRNA. (A) LS174T cells were treated with EGF (10 nM) for 2 hrs and then further incubated with the translational inhibitor, cyclohexamide (CHX, 0.2 \u03bcg/ml), for additional 0, 0.5, 1, 2 and 3 hrs. The protein level of Aurora-A was measured by Western blot analysis. Relative protein levels of Aurora-A were normalized to GAPDH. And the quantitative results from three independent experiments was shown below. (B) The expression level of Cdh1 under EGF treated (+) or not (\u2013) was examined by Western blot analysis. (C) 35S-methionine labelled Aurora-A was immunoprecipitated from LS174T cell lysates by anti-Aurora-A antibodies. The immunoprecipitated product was separated by 10% SDS-PAGE and analysed by radiography. (D) Equal amounts of EGF-stimulated cell lysates were used for the ribosomal protein S6-immunoprecipitation assay. The amount of Aurora-A mRNA in the S6-IP complex was analysed by RT-PCR. Quantitative results are shown in the right panel. The mean \u00b1 S.D. was obtained from three independent experiments. (w, water control; ***, P < 0.001). (E) Amounts of Aurora A mRNA in the S6-IP complexes of SW480, HT29, HCT116 and A431 cells were analysed as described in (C). (w, water control).", "co_occurrence": [{"body": 118, "word": "Aurora-A", "fig": 5}, {"body": 71, "word": "EGF", "fig": 3}, {"body": 31, "word": "The", "fig": 5}, {"body": 51, "word": "protein", "fig": 3}, {"body": 38, "word": "mRNA", "fig": 3}, {"body": 46, "word": "cells", "fig": 2}, {"body": 65, "word": "expression", "fig": 1}, {"body": 19, "word": "cell", "fig": 2}, {"body": 19, "word": "translational", "fig": 2}, {"body": 14, "word": "hrs", "fig": 2}, {"body": 11, "word": "level", "fig": 2}, {"body": 18, "word": "assay", "fig": 1}, {"body": 6, "word": "results", "fig": 2}, {"body": 6, "word": "LS174T", "fig": 2}, {"body": 6, "word": "treated", "fig": 2}, {"body": 12, "word": "complex", "fig": 1}, {"body": 5, "word": "control", "fig": 2}, {"body": 5, "word": "analysis", "fig": 2}, {"body": 3, "word": "analysed", "fig": 3}, {"body": 9, "word": "described", "fig": 1}, {"body": 4, "word": "lysates", "fig": 2}, {"body": 6, "word": "\u03bcg/ml", "fig": 1}, {"body": 3, "word": "A", "fig": 2}, {"body": 3, "word": "shown", "fig": 2}, {"body": 6, "word": "efficiency", "fig": 1}, {"body": 5, "word": "ribosomal", "fig": 1}, {"body": 5, "word": "A431", "fig": 1}, {"body": 5, "word": "inhibitor", "fig": 1}, {"body": 5, "word": "used", "fig": 1}, {"body": 2, "word": "experiments", "fig": 2}, {"body": 2, "word": "blot", "fig": 2}, {"body": 2, "word": "Western", "fig": 2}, {"body": 2, "word": "immunoprecipitated", "fig": 2}, {"body": 4, "word": "nM", "fig": 1}, {"body": 4, "word": "levels", "fig": 1}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 3, "word": "increases", "fig": 1}, {"body": 3, "word": "anti-Aurora-A", "fig": 1}, {"body": 3, "word": "RT-PCR", "fig": 1}, {"body": 3, "word": "amount", "fig": 1}, {"body": 3, "word": "examined", "fig": 1}, {"body": 1, "word": "S6-IP", "fig": 2}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "SW480", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "incubated", "fig": 1}, {"body": 1, "word": "three", "fig": 2}, {"body": 2, "word": "HT29", "fig": 1}, {"body": 2, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "independent", "fig": 2}, {"body": 2, "word": "HCT116", "fig": 1}, {"body": 1, "word": "cyclohexamide", "fig": 1}, {"body": 1, "word": "35S-methionine", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "Aurora", "fig": 1}, {"body": 1, "word": "obtained", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "And", "fig": 1}, {"body": 1, "word": "Cdh1", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}, {"body": 1, "word": "complexes", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829018/bin/jcmm0014-1520-f5.jpg", "caption": "Activation of the ERK and Akt signalling pathways is important for EGF-increased Aurora-A overexpression. (A) In LS174T cells, the expression of Aurora-A, the activation of mTOR (p-mTOR/S2448) and its substrates, 70S6K (p-p70S6K/T389) and 4E-BP1 (p-4E-BP1/T70), were activated by EGF treatment (lanes 1\u20132). The addition of the mTOR inhibitor, rapamycin, blocked EGF effect on Aurora-A protein expression (lanes 3\u20136). (B) The amount of Aurora-A mRNA in the S6-IP complexes of U0126- or wortmannin pre-treated cells was analysed by RT-PCR as described in Fig. 4D. (C) Serum-starved cells were pre-treated with U0126 or wortmannin, followed by EGF treatment as described above. The phosphorylation status of mTOR (p-mTOR), ERK (pERK) and Akt (pAkt) was analysed. (D) The expression levels of Aurora-A and Aurora-B were analysed by the Western blot analysis in cells which are EGF-treated (+) or not (\u2013) (lanes 1\u20132). And the amount of Aurora-A or Aurora-B mRNA in the S6-IP complexes were examined (lanes 3\u20136). w: H2O negative control.", "co_occurrence": [{"body": 118, "word": "Aurora-A", "fig": 6}, {"body": 71, "word": "EGF", "fig": 3}, {"body": 65, "word": "expression", "fig": 3}, {"body": 46, "word": "cells", "fig": 4}, {"body": 31, "word": "The", "fig": 4}, {"body": 38, "word": "mRNA", "fig": 2}, {"body": 34, "word": "treatment", "fig": 2}, {"body": 51, "word": "protein", "fig": 1}, {"body": 46, "word": "Fig", "fig": 1}, {"body": 15, "word": "mTOR", "fig": 3}, {"body": 21, "word": "ERK", "fig": 2}, {"body": 16, "word": "Akt", "fig": 2}, {"body": 32, "word": "signalling", "fig": 1}, {"body": 21, "word": "pathways", "fig": 1}, {"body": 5, "word": "lanes", "fig": 4}, {"body": 9, "word": "described", "fig": 2}, {"body": 18, "word": "In", "fig": 1}, {"body": 14, "word": "activated", "fig": 1}, {"body": 14, "word": "activation", "fig": 1}, {"body": 11, "word": "addition", "fig": 1}, {"body": 3, "word": "analysed", "fig": 3}, {"body": 7, "word": "phosphorylation", "fig": 1}, {"body": 3, "word": "wortmannin", "fig": 2}, {"body": 6, "word": "LS174T", "fig": 1}, {"body": 6, "word": "U0126", "fig": 1}, {"body": 3, "word": "amount", "fig": 2}, {"body": 6, "word": "important", "fig": 1}, {"body": 3, "word": "Aurora-B", "fig": 2}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "inhibitor", "fig": 1}, {"body": 5, "word": "overexpression", "fig": 1}, {"body": 5, "word": "analysis", "fig": 1}, {"body": 4, "word": "levels", "fig": 1}, {"body": 2, "word": "pre-treated", "fig": 2}, {"body": 3, "word": "RT-PCR", "fig": 1}, {"body": 3, "word": "4E-BP1", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "examined", "fig": 1}, {"body": 3, "word": "status", "fig": 1}, {"body": 1, "word": "S6-IP", "fig": 2}, {"body": 2, "word": "blocked", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "rapamycin", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "complexes", "fig": 2}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "4D", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "And", "fig": 1}, {"body": 1, "word": "EGF-treated", "fig": 1}, {"body": 1, "word": "Activation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829018/bin/jcmm0014-1520-f6.jpg", "caption": "The exon 2 containing Aurora-A mRNA plays an important role in response to EGF treatment. (A) Schematic of Aurora-A mRNA 5\u2032-UTR isoforms, and the location of primer pairs used for identifying the expression pattern of Aurora-A 5\u2032UTR (F1 and R1) and S6-IP followed PCR (F2 and R2) are indicated. (B) The 133/147 bps and 243/257 bps 5\u2032UTRs were dominantly expressed in LS174T cells, and the expression levels of Aurora-A mRNA and its 5\u2032UTR isoforms were not changed under EGF stimulus. (C) The S6 ribosomal protein-associated Aurora-A mRNA was detected by primer pair F2/R2 located on the 5\u2032UTR as indicated in (A). (D) Equal amount of RNA from different splicing variant, 133 bps and 243 bps, were incubated with EGF-treated or untreated lysates and then performed the in vitro translation assay. (E) The constructs of pGL3-promoter contained different Aurora-A 5\u2032UTR splicing forms (243 bps and 133 bps) were transient transfected into cells, and then the reporter assays were performed. The expression level of luciferase mRNA was used for indicating the similar amount of mRNA. In the lower panel, the S6-IP assays were also conducted to exam the association of splicing form 243 bps with translational complex under EGF stimulation. (***, P < 0.001) (F) The expression pattern of Aurora-A 5\u2032UTRs in human normal colon tissues (N) and colorectal cancers (Ca). GAPDH as an internal control.", "co_occurrence": [{"body": 118, "word": "Aurora-A", "fig": 7}, {"body": 65, "word": "expression", "fig": 4}, {"body": 38, "word": "mRNA", "fig": 6}, {"body": 71, "word": "EGF", "fig": 3}, {"body": 31, "word": "The", "fig": 6}, {"body": 46, "word": "cells", "fig": 2}, {"body": 9, "word": "5\u2032UTR", "fig": 4}, {"body": 34, "word": "treatment", "fig": 1}, {"body": 11, "word": "splicing", "fig": 3}, {"body": 4, "word": "bps", "fig": 7}, {"body": 25, "word": "translation", "fig": 1}, {"body": 10, "word": "performed", "fig": 2}, {"body": 20, "word": "colorectal", "fig": 1}, {"body": 19, "word": "translational", "fig": 1}, {"body": 18, "word": "assay", "fig": 1}, {"body": 18, "word": "In", "fig": 1}, {"body": 8, "word": "indicated", "fig": 2}, {"body": 13, "word": "also", "fig": 1}, {"body": 6, "word": "different", "fig": 2}, {"body": 12, "word": "cancers", "fig": 1}, {"body": 12, "word": "complex", "fig": 1}, {"body": 11, "word": "exon", "fig": 1}, {"body": 11, "word": "level", "fig": 1}, {"body": 5, "word": "used", "fig": 2}, {"body": 9, "word": "stimulation", "fig": 1}, {"body": 8, "word": "human", "fig": 1}, {"body": 7, "word": "S6", "fig": 1}, {"body": 7, "word": "containing", "fig": 1}, {"body": 7, "word": "role", "fig": 1}, {"body": 6, "word": "luciferase", "fig": 1}, {"body": 6, "word": "stimulus", "fig": 1}, {"body": 6, "word": "LS174T", "fig": 1}, {"body": 3, "word": "amount", "fig": 2}, {"body": 3, "word": "A", "fig": 2}, {"body": 6, "word": "important", "fig": 1}, {"body": 5, "word": "ribosomal", "fig": 1}, {"body": 5, "word": "vitro", "fig": 1}, {"body": 5, "word": "RNA", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 2, "word": "isoforms", "fig": 2}, {"body": 4, "word": "levels", "fig": 1}, {"body": 4, "word": "lysates", "fig": 1}, {"body": 4, "word": "variant", "fig": 1}, {"body": 3, "word": "detected", "fig": 1}, {"body": 3, "word": "expressed", "fig": 1}, {"body": 3, "word": "dominantly", "fig": 1}, {"body": 1, "word": "S6-IP", "fig": 2}, {"body": 2, "word": "5\u2032-UTR", "fig": 1}, {"body": 2, "word": "indicating", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "association", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "plays", "fig": 1}, {"body": 1, "word": "pattern", "fig": 2}, {"body": 2, "word": "contained", "fig": 1}, {"body": 2, "word": "reporter", "fig": 1}, {"body": 2, "word": "transfected", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "incubated", "fig": 1}, {"body": 2, "word": "constructs", "fig": 1}, {"body": 2, "word": "tissues", "fig": 1}, {"body": 1, "word": "forms", "fig": 1}, {"body": 1, "word": "R2", "fig": 1}, {"body": 1, "word": "untreated", "fig": 1}, {"body": 1, "word": "colon", "fig": 1}, {"body": 1, "word": "PCR", "fig": 1}, {"body": 1, "word": "form", "fig": 1}, {"body": 1, "word": "transient", "fig": 1}, {"body": 1, "word": "F1", "fig": 1}, {"body": 1, "word": "F2", "fig": 1}, {"body": 1, "word": "R1", "fig": 1}, {"body": 1, "word": "EGF-treated", "fig": 1}, {"body": 1, "word": "normal", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}, {"body": 1, "word": "response", "fig": 1}]}], "3196493": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196493/bin/pone.0025562.g001.jpg", "caption": "Morphology of H+/K+ ATPase-positive cells from preterm infants, freshly isolated and in primary cultures. A. B. Typical freshly isolated exfoliated cells from Day-5 to Day-36. C. Epithelial cell adherent to external wall of nasogastric tube. D. Samples obtained before Day-5 were mostly made up of cellular aggregates showing damaged nuclei (left insert). Later, all preparations contained epithelial cells showing quiescent nuclei (right insert). E. Pouf5-F1-Oct-4 positive and negative cells at inoculation for primary culture (center panel), nuclei are shown on left panel and nuclei inside cytoplasm shown on right panel. F. A colony of growing epithelial cells harboring Pouf5-F1-Oct-4 biomarker of progenitor status (center panel). Nuclei inside cytoplasm shown on left panel and nuclei staining by Hoechst on right panel. White bars stand for 10 \u00b5m.", "co_occurrence": [{"body": 111, "word": "cells", "fig": 5}, {"body": 36, "word": "epithelial", "fig": 2}, {"body": 38, "word": "exfoliated", "fig": 1}, {"body": 31, "word": "infants", "fig": 1}, {"body": 6, "word": "nuclei", "fig": 5}, {"body": 26, "word": "cell", "fig": 1}, {"body": 7, "word": "shown", "fig": 3}, {"body": 20, "word": "H+/K+", "fig": 1}, {"body": 9, "word": "A", "fig": 2}, {"body": 17, "word": "preterm", "fig": 1}, {"body": 13, "word": "cellular", "fig": 1}, {"body": 13, "word": "obtained", "fig": 1}, {"body": 6, "word": "showing", "fig": 2}, {"body": 12, "word": "culture", "fig": 1}, {"body": 6, "word": "primary", "fig": 2}, {"body": 11, "word": "quiescent", "fig": 1}, {"body": 5, "word": "isolated", "fig": 2}, {"body": 5, "word": "freshly", "fig": 2}, {"body": 8, "word": "\u00b5m", "fig": 1}, {"body": 7, "word": "tube", "fig": 1}, {"body": 7, "word": "preparations", "fig": 1}, {"body": 6, "word": "status", "fig": 1}, {"body": 6, "word": "Hoechst", "fig": 1}, {"body": 5, "word": "progenitor", "fig": 1}, {"body": 5, "word": "B", "fig": 1}, {"body": 5, "word": "ATPase-positive", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 4, "word": "made", "fig": 1}, {"body": 1, "word": "right", "fig": 3}, {"body": 3, "word": "nasogastric", "fig": 1}, {"body": 3, "word": "cultures", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 1, "word": "Day-5", "fig": 2}, {"body": 2, "word": "harboring", "fig": 1}, {"body": 1, "word": "inside", "fig": 2}, {"body": 2, "word": "bars", "fig": 1}, {"body": 1, "word": "Pouf5-F1-Oct-4", "fig": 2}, {"body": 2, "word": "Typical", "fig": 1}, {"body": 2, "word": "biomarker", "fig": 1}, {"body": 1, "word": "E.", "fig": 1}, {"body": 1, "word": "contained", "fig": 1}, {"body": 1, "word": "stand", "fig": 1}, {"body": 1, "word": "Samples", "fig": 1}, {"body": 1, "word": "C.", "fig": 1}, {"body": 1, "word": "mostly", "fig": 1}, {"body": 1, "word": "external", "fig": 1}, {"body": 1, "word": "inoculation", "fig": 1}, {"body": 1, "word": "F.", "fig": 1}, {"body": 1, "word": "damaged", "fig": 1}, {"body": 1, "word": "Epithelial", "fig": 1}, {"body": 1, "word": "aggregates", "fig": 1}, {"body": 1, "word": "Later", "fig": 1}, {"body": 1, "word": "D.", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196493/bin/pone.0025562.g002.jpg", "caption": "3D-view of exfoliated epithelial cells of preterm infant showing membrane-bound labeling of H+/K+-ATPases (A, B, in green), and intact nuclei labeled by Hoechst (in blue). The cytoplasmic expression of Survivin (B, red), LC3-b (C, red) and CLOCK (D, red). White bars stand for 10 \u00b5m.", "co_occurrence": [{"body": 111, "word": "cells", "fig": 1}, {"body": 38, "word": "exfoliated", "fig": 1}, {"body": 36, "word": "epithelial", "fig": 1}, {"body": 29, "word": "The", "fig": 1}, {"body": 17, "word": "preterm", "fig": 1}, {"body": 16, "word": "labeling", "fig": 1}, {"body": 14, "word": "expression", "fig": 1}, {"body": 11, "word": "CLOCK", "fig": 1}, {"body": 5, "word": "B", "fig": 2}, {"body": 3, "word": "red", "fig": 3}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "\u00b5m", "fig": 1}, {"body": 6, "word": "infant", "fig": 1}, {"body": 6, "word": "showing", "fig": 1}, {"body": 6, "word": "Hoechst", "fig": 1}, {"body": 6, "word": "nuclei", "fig": 1}, {"body": 3, "word": "membrane-bound", "fig": 1}, {"body": 3, "word": "Survivin", "fig": 1}, {"body": 3, "word": "labeled", "fig": 1}, {"body": 2, "word": "bars", "fig": 1}, {"body": 2, "word": "cytoplasmic", "fig": 1}, {"body": 2, "word": "blue", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 1, "word": "H+/K+-ATPases", "fig": 1}, {"body": 1, "word": "green", "fig": 1}, {"body": 1, "word": "stand", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196493/bin/pone.0025562.g003.jpg", "caption": "Kinetics of exfoliation of H+/K+-ATPase-positive cells over 24-hours followed by ELISA. Four infants were sampled every 3 hours on two consecutive 24-h cycles. Infant 1(inverted triangle) and 3 (circle) had similar profiles for both cycles. Infant 3 (triangle) and 4 (diamond) were comparable for the second 24-h cycles. Note that infant 4 (diamond) was unfed but showing low level of cellular loss. White dotted arrow heads indicate acrophases and black arrow heads indicate bathyphases.", "co_occurrence": [{"body": 111, "word": "cells", "fig": 1}, {"body": 31, "word": "infants", "fig": 1}, {"body": 29, "word": "exfoliation", "fig": 1}, {"body": 9, "word": "cycles", "fig": 3}, {"body": 13, "word": "cellular", "fig": 1}, {"body": 11, "word": "hours", "fig": 1}, {"body": 11, "word": "level", "fig": 1}, {"body": 10, "word": "every", "fig": 1}, {"body": 9, "word": "ELISA", "fig": 1}, {"body": 6, "word": "infant", "fig": 1}, {"body": 6, "word": "showing", "fig": 1}, {"body": 6, "word": "loss", "fig": 1}, {"body": 4, "word": "Note", "fig": 1}, {"body": 4, "word": "sampled", "fig": 1}, {"body": 4, "word": "low", "fig": 1}, {"body": 3, "word": "two", "fig": 1}, {"body": 3, "word": "black", "fig": 1}, {"body": 3, "word": "H+/K+-ATPase-positive", "fig": 1}, {"body": 3, "word": "comparable", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 1, "word": "diamond", "fig": 2}, {"body": 2, "word": "Kinetics", "fig": 1}, {"body": 1, "word": "24-h", "fig": 2}, {"body": 2, "word": "unfed", "fig": 1}, {"body": 2, "word": "24-hours", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "second", "fig": 1}, {"body": 1, "word": "consecutive", "fig": 1}, {"body": 1, "word": "profiles", "fig": 1}, {"body": 1, "word": "Four", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196493/bin/pone.0025562.g004.jpg", "caption": "Distributions of intensity of labeling by anti-Survivin antibody of gastric cells after exfoliation (white bar) or within the gland (black bar) on hand-picked cells with a quiescent nucleus and a membrane labeling by H+/K+-ATPases-antibody. The distributions of intensities of cells within the gland were widely different at 13H00 and 01H00 (note black bar positions on A and B). The level of survivin labeling of H+/K+ ATPase-positive cells by exfoliated cells and cells within the gastric gland, were similar at 01H00 (A) and 13H00 (B).", "co_occurrence": [{"body": 111, "word": "cells", "fig": 6}, {"body": 61, "word": "gastric", "fig": 2}, {"body": 29, "word": "The", "fig": 2}, {"body": 16, "word": "gland", "fig": 3}, {"body": 16, "word": "labeling", "fig": 3}, {"body": 38, "word": "exfoliated", "fig": 1}, {"body": 29, "word": "exfoliation", "fig": 1}, {"body": 8, "word": "within", "fig": 3}, {"body": 20, "word": "H+/K+", "fig": 1}, {"body": 9, "word": "A", "fig": 2}, {"body": 14, "word": "intensity", "fig": 1}, {"body": 11, "word": "quiescent", "fig": 1}, {"body": 11, "word": "level", "fig": 1}, {"body": 5, "word": "B", "fig": 2}, {"body": 9, "word": "survivin", "fig": 1}, {"body": 4, "word": "13H00", "fig": 2}, {"body": 8, "word": "antibody", "fig": 1}, {"body": 3, "word": "black", "fig": 2}, {"body": 3, "word": "01H00", "fig": 2}, {"body": 5, "word": "ATPase-positive", "fig": 1}, {"body": 5, "word": "membrane", "fig": 1}, {"body": 4, "word": "nucleus", "fig": 1}, {"body": 3, "word": "similar", "fig": 1}, {"body": 2, "word": "different", "fig": 1}, {"body": 2, "word": "white", "fig": 1}, {"body": 1, "word": "anti-Survivin", "fig": 1}, {"body": 1, "word": "hand-picked", "fig": 1}, {"body": 1, "word": "widely", "fig": 1}, {"body": 1, "word": "intensities", "fig": 1}]}], "4080263": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080263/bin/fncel-08-00182-g0001.jpg", "caption": "MPP+ induced neurotoxicity in cortical neurons. Seven-day primary cortical neurons were treated with various concentrations of MPP+ for 24 h. (A) Cell viability following dose-dependent treatments was assayed by measuring MTT reduction by live neurons. Note that a significant reduction in neuronal viability was observed upon treatment with 10, 20, 30, and 50 \u03bcM, but not 5 \u03bcM, of MPP+. (B,C) Equal amounts of total protein from lysates of cortical neurons cultured for 24 h in the presence of 10, 20, and 30 \u03bcM MPP+ were analyzed on 12% SDS-PAGE and immunoblotted with antibodies specific for BCL-2 (B) and cleaved caspase-3 (C). To ensure equal loading, membranes were re-probed against GAPDH. Note that compared to untreated controls, primary cortical neurons treated for 24 h with MPP+ displayed a dose-dependent decrease of BCL-2 protein levels, as well as a dose-dependent increase of cleaved caspase-3 protein levels. Quantification of the results in (B,C) was performed by scanning densitometry. Bars in all the presented graphs depict mean \u00b1 s.e.m. ***P \u2264 0.001.", "co_occurrence": [{"body": 74, "word": "neurons", "fig": 5}, {"body": 51, "word": "MPP+", "fig": 5}, {"body": 42, "word": "cortical", "fig": 4}, {"body": 27, "word": "\u03bcM", "fig": 3}, {"body": 37, "word": "levels", "fig": 2}, {"body": 16, "word": "protein", "fig": 3}, {"body": 20, "word": "viability", "fig": 2}, {"body": 18, "word": "primary", "fig": 2}, {"body": 15, "word": "h", "fig": 2}, {"body": 27, "word": "neuronal", "fig": 1}, {"body": 12, "word": "treated", "fig": 2}, {"body": 19, "word": "treatment", "fig": 1}, {"body": 9, "word": "BCL-2", "fig": 2}, {"body": 7, "word": "caspase-3", "fig": 2}, {"body": 13, "word": "significant", "fig": 1}, {"body": 6, "word": "reduction", "fig": 2}, {"body": 6, "word": "cleaved", "fig": 2}, {"body": 10, "word": "observed", "fig": 1}, {"body": 3, "word": "dose-dependent", "fig": 3}, {"body": 8, "word": "displayed", "fig": 1}, {"body": 8, "word": "controls", "fig": 1}, {"body": 8, "word": "compared", "fig": 1}, {"body": 7, "word": "induced", "fig": 1}, {"body": 7, "word": "concentrations", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "MTT", "fig": 1}, {"body": 6, "word": "increase", "fig": 1}, {"body": 2, "word": "B", "fig": 3}, {"body": 6, "word": "upon", "fig": 1}, {"body": 6, "word": "well", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "untreated", "fig": 1}, {"body": 5, "word": "treatments", "fig": 1}, {"body": 5, "word": "h.", "fig": 1}, {"body": 5, "word": "To", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 4, "word": "neurotoxicity", "fig": 1}, {"body": 3, "word": "decrease", "fig": 1}, {"body": 3, "word": "various", "fig": 1}, {"body": 1, "word": "C", "fig": 3}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 2, "word": "Cell", "fig": 1}, {"body": 2, "word": "cultured", "fig": 1}, {"body": 2, "word": "live", "fig": 1}, {"body": 2, "word": "following", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "ensure", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}, {"body": 1, "word": "assayed", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080263/bin/fncel-08-00182-g0002.jpg", "caption": "Cortical neurons treated with MPP+ displayed alterations in all major intracellular signaling cascades. Seven-day primary cortical neurons were treated with 10, 20, and 30 \u03bcM MPP+ for 24 h. Equal amounts of total protein from lysates of cortical neurons were analyzed on 10% SDS-PAGE and immunoblotted with antibodies specific for phosphorylated forms of AKT (A), p38 MAPK (B), ERK1/2 (C), JNK/SAPK (D), p70S6K (E), as well as for the phosphorylated forms of p70S6K substrate S6RP (F). To ensure equal loading membranes were re-probed against AKT, p38 MAPK, ERK1/2, JNK/SAPK, p70S6K, and S6RP, respectively. Quantification of the results was performed by scanning densitometry. Bars in the graph depict mean \u00b1 s.e.m. Note that MPP+-treatment changed the phosphorylation status of all the major signaling kinases examined in a concentration dependent manner. **P \u2264 0.01, ***P \u2264 0.001.", "co_occurrence": [{"body": 74, "word": "neurons", "fig": 3}, {"body": 51, "word": "MPP+", "fig": 2}, {"body": 48, "word": "signaling", "fig": 2}, {"body": 42, "word": "cortical", "fig": 2}, {"body": 24, "word": "phosphorylated", "fig": 2}, {"body": 13, "word": "p70S6K", "fig": 3}, {"body": 33, "word": "F", "fig": 1}, {"body": 15, "word": "p38", "fig": 2}, {"body": 15, "word": "AKT", "fig": 2}, {"body": 27, "word": "\u03bcM", "fig": 1}, {"body": 12, "word": "treated", "fig": 2}, {"body": 10, "word": "major", "fig": 2}, {"body": 18, "word": "primary", "fig": 1}, {"body": 9, "word": "S6RP", "fig": 2}, {"body": 16, "word": "intracellular", "fig": 1}, {"body": 16, "word": "protein", "fig": 1}, {"body": 8, "word": "MAPK", "fig": 2}, {"body": 14, "word": "phosphorylation", "fig": 1}, {"body": 5, "word": "ERK1/2", "fig": 2}, {"body": 10, "word": "respectively", "fig": 1}, {"body": 8, "word": "displayed", "fig": 1}, {"body": 7, "word": "cascades", "fig": 1}, {"body": 7, "word": "kinases", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "status", "fig": 1}, {"body": 6, "word": "well", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "h.", "fig": 1}, {"body": 5, "word": "To", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 4, "word": "manner", "fig": 1}, {"body": 3, "word": "examined", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 3, "word": "concentration", "fig": 1}, {"body": 2, "word": "substrate", "fig": 1}, {"body": 2, "word": "alterations", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "MPP+-treatment", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "ensure", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "Cortical", "fig": 1}, {"body": 1, "word": "changed", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080263/bin/fncel-08-00182-g0003.jpg", "caption": "Neuroprotective effects of miR-7 and miR-153 against MPP+-toxicity. Six to seven days old primary cortical neurons were transduced with adenoviral particles expressing scramble miR, miR-7, miR-153, or both miR-7/153. After 24 h, transduced neurons were exposed for additional 24 h to various concentrations of MPP+. (A) Neuronal viability following MPP+-treatment was monitored by the MTT assay. Note that over-expression of miR-7 and/or miR-153 attenuated MPP+-induced cell death. (B,C) Equal amounts of total protein from lysates of transduced cortical neurons cultured for 24 h in the presence of 10 \u03bcM MPP+ were analyzed on 12% SDS-PAGE and immunoblotted with antibodies specific for BCL-2 (B) and cleaved caspase-3 (C). To ensure equal loading membranes were re-probed against GAPDH. Quantification of the results was performed by scanning densitometry. Note that compared to scramble-transduced untreated controls, only scramble-transduced cortical neurons displayed significant changes in BCL-2 and cleaved caspase-3 protein levels. Bars in all the depicted graphs correspond to mean \u00b1 s.e.m. *P \u2264 0.05, ***P \u2264 0.001.", "co_occurrence": [{"body": 74, "word": "neurons", "fig": 4}, {"body": 69, "word": "miR-7", "fig": 3}, {"body": 68, "word": "miR-153", "fig": 3}, {"body": 42, "word": "cortical", "fig": 3}, {"body": 51, "word": "MPP+", "fig": 2}, {"body": 26, "word": "transduced", "fig": 3}, {"body": 15, "word": "h", "fig": 3}, {"body": 37, "word": "levels", "fig": 1}, {"body": 16, "word": "protein", "fig": 2}, {"body": 27, "word": "\u03bcM", "fig": 1}, {"body": 20, "word": "viability", "fig": 1}, {"body": 19, "word": "and/or", "fig": 1}, {"body": 19, "word": "MPP+-induced", "fig": 1}, {"body": 18, "word": "adenoviral", "fig": 1}, {"body": 9, "word": "BCL-2", "fig": 2}, {"body": 18, "word": "primary", "fig": 1}, {"body": 17, "word": "cell", "fig": 1}, {"body": 16, "word": "miR", "fig": 1}, {"body": 15, "word": "scramble", "fig": 1}, {"body": 7, "word": "scramble-transduced", "fig": 2}, {"body": 7, "word": "caspase-3", "fig": 2}, {"body": 13, "word": "significant", "fig": 1}, {"body": 6, "word": "cleaved", "fig": 2}, {"body": 11, "word": "effects", "fig": 1}, {"body": 11, "word": "particles", "fig": 1}, {"body": 11, "word": "expressing", "fig": 1}, {"body": 10, "word": "days", "fig": 1}, {"body": 9, "word": "miR-7/153", "fig": 1}, {"body": 9, "word": "attenuated", "fig": 1}, {"body": 8, "word": "displayed", "fig": 1}, {"body": 8, "word": "death", "fig": 1}, {"body": 8, "word": "controls", "fig": 1}, {"body": 8, "word": "compared", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 7, "word": "old", "fig": 1}, {"body": 7, "word": "concentrations", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "MTT", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "untreated", "fig": 1}, {"body": 5, "word": "additional", "fig": 1}, {"body": 5, "word": "To", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 4, "word": "exposed", "fig": 1}, {"body": 2, "word": "B", "fig": 2}, {"body": 3, "word": "monitored", "fig": 1}, {"body": 3, "word": "various", "fig": 1}, {"body": 3, "word": "changes", "fig": 1}, {"body": 3, "word": "depicted", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 3, "word": "Neuronal", "fig": 1}, {"body": 1, "word": "C", "fig": 2}, {"body": 2, "word": "cultured", "fig": 1}, {"body": 2, "word": "over-expression", "fig": 1}, {"body": 2, "word": "following", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "MPP+-treatment", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "ensure", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "After", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080263/bin/fncel-08-00182-g0004.jpg", "caption": "miR-7 and miR-153 activated p70S6K signaling cascade in cortical neurons. Six to seven days old primary cortical neurons were transduced with adenoviral particles expressing scramble miR, miR-7, or miR-153 and were lysed 48 h post-transduction. (A) Equal amounts of total protein from lysates of cortical neurons were analyzed on 10% SDS-PAGE and immunoblotted with antibodies specific for phosphorylated forms of AKT, p38 MAPK, ERK1/2 SAPK/JNK. To ensure equal loading membranes were re-probed against AKT, p38 MAPK, ERK1/2, and SAPK/JNK, respectively. (B,C) Equal amounts of total protein from lysates of cortical neurons were analyzed on 10% SDS-PAGE and immunoblotted with antibodies specific for phosphorylated forms of p70S6K (B) as well as for the phosphorylated forms of p70S6K substrate, S6RP (C). To ensure equal loading, membranes were re-probed against p70S6K and S6RP, respectively. Quantification of the results was performed by scanning densitometry. Bars in the graph depict mean \u00b1 s.e.m. Note that compared to scramble-transduced controls, primary cortical neurons transduced with miR-7 or miR-153 expressing adenoviruses displayed a significant increase only in the levels of phosphorylated forms of p70S6K and S6RP. **P \u2264 0.01, ***P \u2264 0.001.", "co_occurrence": [{"body": 74, "word": "neurons", "fig": 5}, {"body": 42, "word": "cortical", "fig": 5}, {"body": 69, "word": "miR-7", "fig": 3}, {"body": 68, "word": "miR-153", "fig": 3}, {"body": 24, "word": "phosphorylated", "fig": 4}, {"body": 13, "word": "p70S6K", "fig": 5}, {"body": 26, "word": "transduced", "fig": 2}, {"body": 48, "word": "signaling", "fig": 1}, {"body": 37, "word": "levels", "fig": 1}, {"body": 18, "word": "primary", "fig": 2}, {"body": 16, "word": "protein", "fig": 2}, {"body": 15, "word": "p38", "fig": 2}, {"body": 15, "word": "AKT", "fig": 2}, {"body": 9, "word": "S6RP", "fig": 3}, {"body": 13, "word": "SAPK/JNK", "fig": 2}, {"body": 11, "word": "expressing", "fig": 2}, {"body": 10, "word": "respectively", "fig": 2}, {"body": 18, "word": "adenoviral", "fig": 1}, {"body": 16, "word": "miR", "fig": 1}, {"body": 8, "word": "MAPK", "fig": 2}, {"body": 15, "word": "h", "fig": 1}, {"body": 15, "word": "scramble", "fig": 1}, {"body": 13, "word": "significant", "fig": 1}, {"body": 11, "word": "particles", "fig": 1}, {"body": 5, "word": "ERK1/2", "fig": 2}, {"body": 10, "word": "days", "fig": 1}, {"body": 5, "word": "To", "fig": 2}, {"body": 5, "word": "antibodies", "fig": 2}, {"body": 8, "word": "controls", "fig": 1}, {"body": 8, "word": "displayed", "fig": 1}, {"body": 8, "word": "compared", "fig": 1}, {"body": 7, "word": "scramble-transduced", "fig": 1}, {"body": 7, "word": "old", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 6, "word": "increase", "fig": 1}, {"body": 3, "word": "membranes", "fig": 2}, {"body": 6, "word": "well", "fig": 1}, {"body": 5, "word": "activated", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "post-transduction", "fig": 1}, {"body": 2, "word": "B", "fig": 2}, {"body": 3, "word": "adenoviruses", "fig": 1}, {"body": 3, "word": "cascade", "fig": 1}, {"body": 1, "word": "loading", "fig": 2}, {"body": 2, "word": "substrate", "fig": 1}, {"body": 1, "word": "specific", "fig": 2}, {"body": 1, "word": "C", "fig": 2}, {"body": 1, "word": "equal", "fig": 2}, {"body": 1, "word": "ensure", "fig": 2}, {"body": 1, "word": "lysates", "fig": 2}, {"body": 1, "word": "amounts", "fig": 2}, {"body": 1, "word": "SDS-PAGE", "fig": 2}, {"body": 1, "word": "Equal", "fig": 2}, {"body": 1, "word": "lysed", "fig": 1}, {"body": 1, "word": "A", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080263/bin/fncel-08-00182-g0005.jpg", "caption": "Overexpression of miR-7 or miR-153 attenuated the effects of rapamycin in cortical neurons. (A,B) Six to seven days old primary cortical neurons were transduced with adenoviral particles expressing scramble miR, miR-7, or miR-153 and left in culture for additional 48 h. One hour before harvest, cultures were supplemented with 20 nM rapamycin. Equal amounts of total protein from lysates of cortical neurons were analyzed on 10% SDS-PAGE and immunoblotted with antibodies specific for phosphorylated forms of p70S6K, S6RP, and eEF2K. To ensure equal loading, membranes were re-probed against GAPDH. Quantification of the results was performed by scanning densitometry. Note that overexpression of miR-7, as well as that of miR-153 attenuated the effect of rapamycin on the phosphorylation of all proteins examined. (C) Six to seven days old primary cortical neurons were transduced with the same adenoviral particles and after 24 h were exposed to 20 nM of rapamycin for an additional of 24 h. Neuronal viability following 24-h treatment with rapamycin was monitored by the MTT assay. Note that overexpression of miR-7 and/or miR-153 attenuated rapamycin-induced cell death. Bars in all the presented graphs depict mean \u00b1 s.e.m. **P \u2264 0.01, ***P \u2264 0.001.", "co_occurrence": [{"body": 74, "word": "neurons", "fig": 4}, {"body": 69, "word": "miR-7", "fig": 4}, {"body": 68, "word": "miR-153", "fig": 4}, {"body": 42, "word": "cortical", "fig": 4}, {"body": 15, "word": "rapamycin", "fig": 5}, {"body": 26, "word": "transduced", "fig": 2}, {"body": 21, "word": "overexpression", "fig": 2}, {"body": 18, "word": "adenoviral", "fig": 2}, {"body": 18, "word": "primary", "fig": 2}, {"body": 9, "word": "attenuated", "fig": 3}, {"body": 24, "word": "phosphorylated", "fig": 1}, {"body": 11, "word": "particles", "fig": 2}, {"body": 20, "word": "viability", "fig": 1}, {"body": 10, "word": "days", "fig": 2}, {"body": 19, "word": "treatment", "fig": 1}, {"body": 19, "word": "and/or", "fig": 1}, {"body": 19, "word": "effect", "fig": 1}, {"body": 17, "word": "cell", "fig": 1}, {"body": 17, "word": "cultures", "fig": 1}, {"body": 16, "word": "protein", "fig": 1}, {"body": 16, "word": "miR", "fig": 1}, {"body": 15, "word": "h", "fig": 1}, {"body": 15, "word": "scramble", "fig": 1}, {"body": 14, "word": "phosphorylation", "fig": 1}, {"body": 7, "word": "old", "fig": 2}, {"body": 13, "word": "p70S6K", "fig": 1}, {"body": 11, "word": "effects", "fig": 1}, {"body": 11, "word": "expressing", "fig": 1}, {"body": 5, "word": "h.", "fig": 2}, {"body": 5, "word": "additional", "fig": 2}, {"body": 9, "word": "S6RP", "fig": 1}, {"body": 8, "word": "culture", "fig": 1}, {"body": 8, "word": "death", "fig": 1}, {"body": 4, "word": "nM", "fig": 2}, {"body": 7, "word": "eEF2K", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 7, "word": "24-h", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "MTT", "fig": 1}, {"body": 6, "word": "well", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "proteins", "fig": 1}, {"body": 5, "word": "To", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 4, "word": "exposed", "fig": 1}, {"body": 3, "word": "supplemented", "fig": 1}, {"body": 3, "word": "monitored", "fig": 1}, {"body": 3, "word": "examined", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 3, "word": "Neuronal", "fig": 1}, {"body": 3, "word": "left", "fig": 1}, {"body": 2, "word": "Overexpression", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "following", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "ensure", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "harvest", "fig": 1}, {"body": 1, "word": "hour", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}, {"body": 1, "word": "One", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080263/bin/fncel-08-00182-g0006.jpg", "caption": "miR-7 and/or miR-153 attenuated MPP+-induced neurotoxicity via upregulation of rapamycin sensitive mTOR pathway. (A,B) Six to seven days old primary cortical neurons were transduced with adenoviral particles expressing scramble miR, miR-7, miR-153, or both miR-7/153. After 24 h, transduced neurons were exposed for additional 24 h to 10 \u03bcM of MPP+. Equal amounts of total protein from lysates of transduced cortical neurons cultured for 24 h in the presence of 10 \u03bcM MPP+ were analyzed on 10% SDS-PAGE and immunoblotted with antibodies specific for phosphorylated forms of p70S6K (A) and S6RP (B). To ensure equal loading membranes were re-probed against p70S6K and S6RP, respectively. Note that overexpression of miR-7 and/or miR-153 attenuated the effect of MPP+ on the phosphorylation of all proteins examined. Quantification of the results was performed by scanning densitometry. (C) Six to seven days old cultures of primary cortical neurons were transduced as described above, and 24 h later were exposed to 20 nM of rapamycin, 10 \u03bcM of MPP+, or both. Neuronal viability was monitored 24 h post-exposure by the MTT assay. Note that in the presence of rapamycin, overexpression of miR-7 and/or miR-153 failed to protect cortical neurons against MPP+-induced cell death. Bars in all presented graphs depict mean \u00b1 s.e.m. *P < 0.05, ***P \u2264 0.001.", "co_occurrence": [{"body": 74, "word": "neurons", "fig": 5}, {"body": 69, "word": "miR-7", "fig": 4}, {"body": 68, "word": "miR-153", "fig": 4}, {"body": 51, "word": "MPP+", "fig": 4}, {"body": 42, "word": "cortical", "fig": 4}, {"body": 26, "word": "transduced", "fig": 4}, {"body": 27, "word": "\u03bcM", "fig": 3}, {"body": 15, "word": "h", "fig": 5}, {"body": 19, "word": "and/or", "fig": 3}, {"body": 15, "word": "rapamycin", "fig": 3}, {"body": 21, "word": "overexpression", "fig": 2}, {"body": 19, "word": "MPP+-induced", "fig": 2}, {"body": 18, "word": "primary", "fig": 2}, {"body": 29, "word": "mTOR", "fig": 1}, {"body": 13, "word": "p70S6K", "fig": 2}, {"body": 24, "word": "phosphorylated", "fig": 1}, {"body": 20, "word": "viability", "fig": 1}, {"body": 10, "word": "days", "fig": 2}, {"body": 19, "word": "effect", "fig": 1}, {"body": 18, "word": "adenoviral", "fig": 1}, {"body": 9, "word": "attenuated", "fig": 2}, {"body": 9, "word": "S6RP", "fig": 2}, {"body": 17, "word": "cell", "fig": 1}, {"body": 17, "word": "cultures", "fig": 1}, {"body": 16, "word": "protein", "fig": 1}, {"body": 16, "word": "miR", "fig": 1}, {"body": 15, "word": "scramble", "fig": 1}, {"body": 14, "word": "phosphorylation", "fig": 1}, {"body": 7, "word": "old", "fig": 2}, {"body": 11, "word": "particles", "fig": 1}, {"body": 11, "word": "expressing", "fig": 1}, {"body": 11, "word": "pathway", "fig": 1}, {"body": 10, "word": "respectively", "fig": 1}, {"body": 9, "word": "miR-7/153", "fig": 1}, {"body": 8, "word": "death", "fig": 1}, {"body": 4, "word": "exposed", "fig": 2}, {"body": 7, "word": "assay", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "MTT", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "proteins", "fig": 1}, {"body": 5, "word": "protect", "fig": 1}, {"body": 5, "word": "additional", "fig": 1}, {"body": 5, "word": "To", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 5, "word": "later", "fig": 1}, {"body": 4, "word": "neurotoxicity", "fig": 1}, {"body": 4, "word": "via", "fig": 1}, {"body": 2, "word": "B", "fig": 2}, {"body": 4, "word": "nM", "fig": 1}, {"body": 4, "word": "upregulation", "fig": 1}, {"body": 3, "word": "monitored", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 3, "word": "examined", "fig": 1}, {"body": 3, "word": "Neuronal", "fig": 1}, {"body": 1, "word": "A", "fig": 2}, {"body": 2, "word": "cultured", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "described", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "ensure", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}, {"body": 1, "word": "After", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080263/bin/fncel-08-00182-g0007.jpg", "caption": "Effect of miR-7 and/or mir-153 overexpression on AKT, p38, ERK-1/2, and SAPK/JNK signaling in MPP+-treated cortical neurons. Six to seven days old primary cortical neurons were transduced with adenoviral particles expressing scramble miR, miR-7, miR-153, or both miR-7/153. After 24 h, transduced neurons were exposed for additional 24 h to 10 \u03bcM of MPP+. Equal amounts of total protein from lysates of transduced cortical neurons cultured for 24 h in the presence of 10 \u03bcM MPP+ were analyzed on 10% SDS-PAGE and immunoblotted with antibodies specific for phosphorylated forms of AKT (A), p38 MAPK (B), ERK1/2 (C), and SAPK/JNK (D). To ensure equal loading membranes were re-probed against AKT, p38 MAPK, ERK1/2, and SAPK/JNK, respectively. Quantification of the results was performed by scanning densitometry. Bars in all the presented graphs depict mean \u00b1 s.e.m. Note that miR-7, miR-153, or miR-7/153 altered in an opposite way MPP+-induced changes in intracellular signaling cascades. ***P < 0.001.", "co_occurrence": [{"body": 74, "word": "neurons", "fig": 4}, {"body": 69, "word": "miR-7", "fig": 3}, {"body": 68, "word": "miR-153", "fig": 2}, {"body": 42, "word": "cortical", "fig": 3}, {"body": 51, "word": "MPP+", "fig": 2}, {"body": 48, "word": "signaling", "fig": 2}, {"body": 26, "word": "transduced", "fig": 3}, {"body": 27, "word": "\u03bcM", "fig": 2}, {"body": 15, "word": "h", "fig": 3}, {"body": 15, "word": "p38", "fig": 3}, {"body": 15, "word": "AKT", "fig": 3}, {"body": 13, "word": "SAPK/JNK", "fig": 3}, {"body": 24, "word": "phosphorylated", "fig": 1}, {"body": 21, "word": "overexpression", "fig": 1}, {"body": 19, "word": "and/or", "fig": 1}, {"body": 19, "word": "MPP+-induced", "fig": 1}, {"body": 18, "word": "adenoviral", "fig": 1}, {"body": 9, "word": "miR-7/153", "fig": 2}, {"body": 18, "word": "primary", "fig": 1}, {"body": 16, "word": "intracellular", "fig": 1}, {"body": 16, "word": "protein", "fig": 1}, {"body": 16, "word": "miR", "fig": 1}, {"body": 8, "word": "MAPK", "fig": 2}, {"body": 15, "word": "scramble", "fig": 1}, {"body": 11, "word": "particles", "fig": 1}, {"body": 11, "word": "expressing", "fig": 1}, {"body": 5, "word": "ERK1/2", "fig": 2}, {"body": 10, "word": "respectively", "fig": 1}, {"body": 10, "word": "days", "fig": 1}, {"body": 7, "word": "old", "fig": 1}, {"body": 7, "word": "cascades", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 7, "word": "MPP+-treated", "fig": 1}, {"body": 6, "word": "ERK-1/2", "fig": 1}, {"body": 5, "word": "results", "fig": 1}, {"body": 5, "word": "additional", "fig": 1}, {"body": 5, "word": "To", "fig": 1}, {"body": 5, "word": "antibodies", "fig": 1}, {"body": 4, "word": "exposed", "fig": 1}, {"body": 3, "word": "mir-153", "fig": 1}, {"body": 3, "word": "changes", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 2, "word": "cultured", "fig": 1}, {"body": 2, "word": "B", "fig": 1}, {"body": 2, "word": "altered", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "specific", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "C", "fig": 1}, {"body": 1, "word": "equal", "fig": 1}, {"body": 1, "word": "ensure", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "amounts", "fig": 1}, {"body": 1, "word": "After", "fig": 1}, {"body": 1, "word": "A", "fig": 1}, {"body": 1, "word": "Equal", "fig": 1}]}], "4525167": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525167/bin/ncomms8821-f1.jpg", "caption": "DOT1L is associated with aggressive breast cancer by promoting EMT-induced breast tumour metastasis. (a) Analysis of overall and disease-free survival according to DOT1L expression in 91 ER-negative human breast cancers using Kaplan\u2013Meier method with log-rank test. (b) The quantification of the association with DOT1L expression and invasion and metastasis in 182 human breast cancers. The P values were calculated by \u03c72-test. (c) Bright-field images of the indicated cell types for observation of changes in cell morphology after DOT1L overexpression and knockdown using lentiviruses encoding DOT1L cDNA or Tet-inducible DOT1L shRNA (shDOT1L), respectively. CON (control), empty vector; shCON, shRNA control. (d) The expression levels of epithelial and mesenchymal markers in the indicated cells were analysed using immunoblotting. (e,f) DOT1L-overexpressing MCF10A and its control cells were treated with 100 pM TGF-\u03b21 for 48 h, and subjected to immunoblotting for analysis of DOT1L expression and activity (e). The invasion (upper) and migration (lower) by the indicated cells were analysed and quantified (f). * and \u2020P<0.05 compared with CON/vehicle and CON/TGF-\u03b2, respectively (Student's t-test). (g) Analysis of invasion (left) and migration (right) by Tet-inducible DOTL-knockdown MDA-MB-231 cells. *P<0.05 versus shCON (Student's t-test). The data in f,g represent the means\u00b1s.d. of triplicate assays. (h) Effect of DOT1L on lung metastasis of breast cancer in xenografted mice. The in vivo experimental procedure was shown as a timeline (top). A representative images of histological analysis of lungs isolated from xenograft mice bearing Control (shCON) or Tet-inducible DOT1L-knockdown (shDOT1L)-MDA-MB-231 tumours (left). Arrowheads in the haematoxylin and eosin (H&E) image indicate lung metastatic nodules. To confirm DOT1L knockdown, immunohistochemical analysis of DOT1L expression was performed using lung tissues from the mice (bottom left). Data were quantified by counting the number of surface lung nodules (middle right) or assessing the incidence of lung metastasis in each group of mice (n=5; bottom right). Error bars indicate the means\u00b1s.e.m. *P<0.05 versus shCON (Student's t-test). Poisson distribution analysis was used for calculation of statistical significance of tumour incidence difference. Scale bars in c,f\u2013h, 100 \u03bcm.", "co_occurrence": [{"body": 173, "word": "DOT1L", "fig": 10}, {"body": 96, "word": "cells", "fig": 4}, {"body": 55, "word": "breast", "fig": 5}, {"body": 42, "word": "expression", "fig": 5}, {"body": 28, "word": "The", "fig": 6}, {"body": 32, "word": "using", "fig": 4}, {"body": 34, "word": "cancer", "fig": 2}, {"body": 16, "word": "mice", "fig": 4}, {"body": 15, "word": "metastasis", "fig": 4}, {"body": 29, "word": "cell", "fig": 2}, {"body": 17, "word": "invasion", "fig": 3}, {"body": 25, "word": "tumour", "fig": 2}, {"body": 12, "word": "analysis", "fig": 4}, {"body": 17, "word": "knockdown", "fig": 2}, {"body": 25, "word": "MCF10A", "fig": 1}, {"body": 12, "word": "human", "fig": 2}, {"body": 8, "word": "Tet-inducible", "fig": 3}, {"body": 4, "word": "lung", "fig": 5}, {"body": 9, "word": "migration", "fig": 2}, {"body": 17, "word": "data", "fig": 1}, {"body": 16, "word": "MDA-MB-231", "fig": 1}, {"body": 5, "word": "control", "fig": 3}, {"body": 5, "word": "indicated", "fig": 3}, {"body": 7, "word": "h", "fig": 2}, {"body": 13, "word": "b", "fig": 1}, {"body": 13, "word": "To", "fig": 1}, {"body": 12, "word": "activity", "fig": 1}, {"body": 6, "word": "cancers", "fig": 2}, {"body": 6, "word": "immunoblotting", "fig": 2}, {"body": 6, "word": "shRNA", "fig": 2}, {"body": 11, "word": "DOT1L-overexpressing", "fig": 1}, {"body": 11, "word": "vivo", "fig": 1}, {"body": 11, "word": "A", "fig": 1}, {"body": 9, "word": "associated", "fig": 1}, {"body": 9, "word": "epithelial", "fig": 1}, {"body": 3, "word": "'s", "fig": 3}, {"body": 9, "word": "overexpression", "fig": 1}, {"body": 8, "word": "aggressive", "fig": 1}, {"body": 4, "word": "versus", "fig": 2}, {"body": 4, "word": "analysed", "fig": 2}, {"body": 8, "word": "performed", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "survival", "fig": 1}, {"body": 7, "word": "vector", "fig": 1}, {"body": 6, "word": "tumours", "fig": 1}, {"body": 3, "word": "respectively", "fig": 2}, {"body": 6, "word": "metastatic", "fig": 1}, {"body": 6, "word": "xenograft", "fig": 1}, {"body": 6, "word": "\u03c72-test", "fig": 1}, {"body": 2, "word": "left", "fig": 3}, {"body": 5, "word": "association", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 4, "word": "DOT1L-knockdown", "fig": 1}, {"body": 2, "word": "nodules", "fig": 2}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "encoding", "fig": 1}, {"body": 2, "word": "indicate", "fig": 2}, {"body": 4, "word": "ER-negative", "fig": 1}, {"body": 4, "word": "assays", "fig": 1}, {"body": 4, "word": "surface", "fig": 1}, {"body": 2, "word": "quantified", "fig": 2}, {"body": 4, "word": "immunohistochemical", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "Student", "fig": 3}, {"body": 1, "word": "t-test", "fig": 3}, {"body": 3, "word": "number", "fig": 1}, {"body": 1, "word": "right", "fig": 3}, {"body": 3, "word": "EMT-induced", "fig": 1}, {"body": 1, "word": "f", "fig": 3}, {"body": 3, "word": "compared", "fig": 1}, {"body": 3, "word": "mesenchymal", "fig": 1}, {"body": 3, "word": "levels", "fig": 1}, {"body": 3, "word": "calculated", "fig": 1}, {"body": 2, "word": "promoting", "fig": 1}, {"body": 2, "word": "histological", "fig": 1}, {"body": 2, "word": "overall", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "difference", "fig": 1}, {"body": 2, "word": "upper", "fig": 1}, {"body": 1, "word": "images", "fig": 2}, {"body": 2, "word": "markers", "fig": 1}, {"body": 1, "word": "incidence", "fig": 2}, {"body": 1, "word": "g", "fig": 2}, {"body": 2, "word": "lentiviruses", "fig": 1}, {"body": 2, "word": "changes", "fig": 1}, {"body": 2, "word": "empty", "fig": 1}, {"body": 2, "word": "lungs", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 2, "word": "significance", "fig": 1}, {"body": 2, "word": "cDNA", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "disease-free", "fig": 1}, {"body": 2, "word": "lower", "fig": 1}, {"body": 1, "word": "bottom", "fig": 2}, {"body": 1, "word": "xenografted", "fig": 1}, {"body": 1, "word": "group", "fig": 1}, {"body": 1, "word": "Kaplan\u2013Meier", "fig": 1}, {"body": 1, "word": "log-rank", "fig": 1}, {"body": 1, "word": "statistical", "fig": 1}, {"body": 1, "word": "confirm", "fig": 1}, {"body": 1, "word": "method", "fig": 1}, {"body": 1, "word": "according", "fig": 1}, {"body": 1, "word": "haematoxylin", "fig": 1}, {"body": 1, "word": "experimental", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}, {"body": 1, "word": "middle", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525167/bin/ncomms8821-f2.jpg", "caption": "DOT1L is required for malignant transformation of breast epithelial cells and CSC-induced tumour initiation. (a) Lysates from stable DOT1L-expressing MCF10A and T47D cells and DOT1L siRNA (#1)-transfected MCF7 and MDA-MB-231 cells were subjected to immunoblotting for analysis of DOT1L and H3K79me2 expression (upper). The percentages of CD44+/CD24\u2212/ESA+ breast CSC cells in the indicated cell lines were measured using flow cytometry (lower). siCON, control siRNA; siDOT1L, DOT1L siRNA. *P<0.05 versus controls (Student's t-test). (b) Tumoursphere formation assay was performed to evaluate self-renewal of CSCs in stable DOT1L-overexpressing and Tet-inducible DOT1L shRNA-expressing cells. shCON, pLKO-Tet control shRNA; shDOT1L, pLKO-Tet-DOT1L shRNA. *P<0.05 versus controls (Student's t-test). (c) Cell lines were generated by sequentially infecting MCF10A wild-type cells with activated HRAS and/or pLVX-DOT1L. Lysates from the indicated cells were then subjected to immunoblotting. (d) Morphological changes in the indicated cells were evaluated by microscopy (upper left). Images of invasion and migration assays in the indicated cells (middle and lower, left). Bars indicate measurements of invasion and migration abilities (right). *P<0.05 versus CON (Student's t-test). Results in (a,b,d) are shown as means\u00b1s.d. of experiments in triplicate. (e) The indicated stable MCF10A cells were orthotopically xenografted into NOD/SCID mice and tumour formation was monitored for 3 months. Representative tumour growth curves are shown. Error bars indicate the means\u00b1s.e.m. (n=5 mice). P values for multiple comparisons were calculated via repeated measures analysis of variance (RM ANOVA) followed by LSD post hoc test. *P=0.011 and 0.023, CON versus DOT1L and HRAS, respectively; ***P<0.001, CON versus DOT1L+HRAS; \u2020\u2020\u2020P<0.001, DOT1L versus DOT1L+HRAS. (f) Representative images of H&E staining and immunohistochemistry for DOT1L and E-cadherin in the xenograft tumours from the indicated groups of mice. Scale bars in d,f, 100 \u03bcm.", "co_occurrence": [{"body": 173, "word": "DOT1L", "fig": 8}, {"body": 96, "word": "cells", "fig": 10}, {"body": 55, "word": "breast", "fig": 2}, {"body": 25, "word": "MCF10A", "fig": 3}, {"body": 25, "word": "tumour", "fig": 3}, {"body": 28, "word": "The", "fig": 2}, {"body": 16, "word": "mice", "fig": 3}, {"body": 15, "word": "siRNA", "fig": 3}, {"body": 42, "word": "expression", "fig": 1}, {"body": 18, "word": "HRAS", "fig": 2}, {"body": 17, "word": "invasion", "fig": 2}, {"body": 32, "word": "using", "fig": 1}, {"body": 5, "word": "indicated", "fig": 6}, {"body": 29, "word": "cell", "fig": 1}, {"body": 13, "word": "b", "fig": 2}, {"body": 4, "word": "versus", "fig": 6}, {"body": 24, "word": "E-cadherin", "fig": 1}, {"body": 12, "word": "analysis", "fig": 2}, {"body": 23, "word": "CSC", "fig": 1}, {"body": 10, "word": "formation", "fig": 2}, {"body": 9, "word": "migration", "fig": 2}, {"body": 16, "word": "MDA-MB-231", "fig": 1}, {"body": 5, "word": "d", "fig": 3}, {"body": 7, "word": "lines", "fig": 2}, {"body": 13, "word": "assay", "fig": 1}, {"body": 6, "word": "shRNA", "fig": 2}, {"body": 6, "word": "immunoblotting", "fig": 2}, {"body": 11, "word": "DOT1L-overexpressing", "fig": 1}, {"body": 11, "word": "CSCs", "fig": 1}, {"body": 5, "word": "control", "fig": 2}, {"body": 10, "word": "initiation", "fig": 1}, {"body": 9, "word": "growth", "fig": 1}, {"body": 9, "word": "epithelial", "fig": 1}, {"body": 3, "word": "'s", "fig": 3}, {"body": 8, "word": "Tet-inducible", "fig": 1}, {"body": 8, "word": "performed", "fig": 1}, {"body": 4, "word": "shown", "fig": 2}, {"body": 7, "word": "self-renewal", "fig": 1}, {"body": 6, "word": "abilities", "fig": 1}, {"body": 6, "word": "tumours", "fig": 1}, {"body": 6, "word": "staining", "fig": 1}, {"body": 3, "word": "controls", "fig": 2}, {"body": 6, "word": "T47D", "fig": 1}, {"body": 6, "word": "xenograft", "fig": 1}, {"body": 5, "word": "MCF7", "fig": 1}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 2, "word": "DOT1L+HRAS", "fig": 2}, {"body": 2, "word": "upper", "fig": 2}, {"body": 4, "word": "NOD/SCID", "fig": 1}, {"body": 4, "word": "Cell", "fig": 1}, {"body": 2, "word": "indicate", "fig": 2}, {"body": 4, "word": "assays", "fig": 1}, {"body": 4, "word": "CD44+/CD24\u2212/ESA+", "fig": 1}, {"body": 4, "word": "H3K79me2", "fig": 1}, {"body": 2, "word": "lower", "fig": 2}, {"body": 4, "word": "required", "fig": 1}, {"body": 2, "word": "left", "fig": 2}, {"body": 3, "word": "malignant", "fig": 1}, {"body": 3, "word": "monitored", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "via", "fig": 1}, {"body": 3, "word": "months", "fig": 1}, {"body": 1, "word": "t-test", "fig": 3}, {"body": 3, "word": "cytometry", "fig": 1}, {"body": 1, "word": "Student", "fig": 3}, {"body": 3, "word": "calculated", "fig": 1}, {"body": 3, "word": "flow", "fig": 1}, {"body": 3, "word": "shRNA-expressing", "fig": 1}, {"body": 2, "word": "activated", "fig": 1}, {"body": 2, "word": "transformation", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "and/or", "fig": 1}, {"body": 1, "word": "f", "fig": 2}, {"body": 2, "word": "evaluated", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "changes", "fig": 1}, {"body": 1, "word": "LSD", "fig": 1}, {"body": 1, "word": "xenografted", "fig": 1}, {"body": 1, "word": "evaluate", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "right", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}, {"body": 1, "word": "post", "fig": 1}, {"body": 1, "word": "orthotopically", "fig": 1}, {"body": 1, "word": "followed", "fig": 1}, {"body": 1, "word": "groups", "fig": 1}, {"body": 1, "word": "Tumoursphere", "fig": 1}, {"body": 1, "word": "wild-type", "fig": 1}, {"body": 1, "word": "repeated", "fig": 1}, {"body": 1, "word": "pLVX-DOT1L", "fig": 1}, {"body": 1, "word": "middle", "fig": 1}, {"body": 1, "word": "hoc", "fig": 1}, {"body": 1, "word": "measures", "fig": 1}, {"body": 1, "word": "generated", "fig": 1}, {"body": 1, "word": "variance", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525167/bin/ncomms8821-f3.jpg", "caption": "DOT1L increases Snail, ZEB1 and ZEB2 expression to repress E-cadherin expression and breast CSC property. (a) CDH1 mRNA levels in the indicated cell lines were analysed using qRT\u2013PCR. For transient knockdown of DOT1L, five different siRNAs against DOT1L (siDOT1L, #1\u20135) or siCON were transfected into MDA-MB-231 cells (middle). MCF10A cells expressing DOT1L wild-type (DOT1L) or DOT1L siRNA (#2)-resistant mutant (DOT1L-si MUT) were transfected with DOT1L siRNA #2 or control siRNA for 48 h, and subjected to qRT\u2013PCR for analysis of CDH1 expression (right). *P<0.05 versus controls (CON, siCON, CON/siCON) by Student's t-test. (b) Effect of DOT1L on CDH1 promoter activity. Cells were transfected with luciferase constructs of wild-type (CDH1 pro-WT) or E-box-mutant (CDH1 pro-MUT) CDH1 promoters for 24 h and the luciferase activity was measured. RLU, relative light units. *P<0.05 versus CON (Student's t-test). (c\u2013e) Effects of DOT1L on the expression of CDH1 transcriptional regulators were examined using immunoblotting (c), qRT\u2013PCR (d) and immunofluorescence staining (e). *P<0.05 versus CON or siCON (Student's t-test). Scale bars in e, 100 \u03bcm. (f) Binding by EMT-TFs to the CDH1 promoter region was analysed using ChIP\u2013qPCR. *P<0.05 versus CON (Student's t-test). (g,h) Effect of EMT-TFs on DOT1L-induced cancer stemness. Cells were transfected with siRNAs against Snail, ZEB1 and ZEB2, and the CSC population was measured using flow cytometry. The knockdown of EMT-TFs was confirmed by immunoblotting (g). The FACS results were quantified and shown as a bar graph (h). * and \u2020P<0.05 versus CON/siCON and DOT1L/siCON, respectively (Student's t-test). Error bars in a,b,d,f,h indicate the means\u00b1s.d. of experiments in triplicate.", "co_occurrence": [{"body": 173, "word": "DOT1L", "fig": 9}, {"body": 96, "word": "cells", "fig": 2}, {"body": 42, "word": "expression", "fig": 4}, {"body": 32, "word": "using", "fig": 4}, {"body": 11, "word": "CDH1", "fig": 8}, {"body": 26, "word": "EMT-TFs", "fig": 3}, {"body": 28, "word": "The", "fig": 2}, {"body": 55, "word": "breast", "fig": 1}, {"body": 23, "word": "CSC", "fig": 2}, {"body": 15, "word": "siRNA", "fig": 3}, {"body": 19, "word": "ZEB1", "fig": 2}, {"body": 18, "word": "ZEB2", "fig": 2}, {"body": 7, "word": "h", "fig": 5}, {"body": 34, "word": "cancer", "fig": 1}, {"body": 17, "word": "knockdown", "fig": 2}, {"body": 16, "word": "promoter", "fig": 2}, {"body": 15, "word": "Snail", "fig": 2}, {"body": 29, "word": "cell", "fig": 1}, {"body": 13, "word": "b", "fig": 2}, {"body": 25, "word": "MCF10A", "fig": 1}, {"body": 12, "word": "activity", "fig": 2}, {"body": 24, "word": "E-cadherin", "fig": 1}, {"body": 4, "word": "versus", "fig": 5}, {"body": 18, "word": "transcriptional", "fig": 1}, {"body": 17, "word": "For", "fig": 1}, {"body": 16, "word": "MDA-MB-231", "fig": 1}, {"body": 3, "word": "'s", "fig": 5}, {"body": 3, "word": "transfected", "fig": 4}, {"body": 4, "word": "qRT\u2013PCR", "fig": 3}, {"body": 6, "word": "immunoblotting", "fig": 2}, {"body": 12, "word": "analysis", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 10, "word": "promoters", "fig": 1}, {"body": 9, "word": "results", "fig": 1}, {"body": 4, "word": "analysed", "fig": 2}, {"body": 4, "word": "siRNAs", "fig": 2}, {"body": 7, "word": "region", "fig": 1}, {"body": 7, "word": "DOT1L-induced", "fig": 1}, {"body": 7, "word": "lines", "fig": 1}, {"body": 6, "word": "staining", "fig": 1}, {"body": 3, "word": "Cells", "fig": 2}, {"body": 6, "word": "population", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "mRNA", "fig": 1}, {"body": 1, "word": "t-test", "fig": 5}, {"body": 5, "word": "transient", "fig": 1}, {"body": 5, "word": "indicated", "fig": 1}, {"body": 5, "word": "examined", "fig": 1}, {"body": 1, "word": "Student", "fig": 5}, {"body": 5, "word": "confirmed", "fig": 1}, {"body": 2, "word": "luciferase", "fig": 2}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "regulators", "fig": 1}, {"body": 3, "word": "controls", "fig": 1}, {"body": 3, "word": "\u03bcm", "fig": 1}, {"body": 3, "word": "ChIP\u2013qPCR", "fig": 1}, {"body": 3, "word": "repress", "fig": 1}, {"body": 3, "word": "expressing", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "flow", "fig": 1}, {"body": 3, "word": "cytometry", "fig": 1}, {"body": 3, "word": "levels", "fig": 1}, {"body": 3, "word": "light", "fig": 1}, {"body": 3, "word": "FACS", "fig": 1}, {"body": 2, "word": "quantified", "fig": 1}, {"body": 2, "word": "five", "fig": 1}, {"body": 1, "word": "g", "fig": 2}, {"body": 1, "word": "wild-type", "fig": 2}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "constructs", "fig": 1}, {"body": 1, "word": "f", "fig": 2}, {"body": 2, "word": "mutant", "fig": 1}, {"body": 1, "word": "measured", "fig": 2}, {"body": 2, "word": "immunofluorescence", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "stemness", "fig": 1}, {"body": 1, "word": "increases", "fig": 1}, {"body": 1, "word": "right", "fig": 1}, {"body": 1, "word": "E-box-mutant", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "middle", "fig": 1}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "units", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525167/bin/ncomms8821-f4.jpg", "caption": "DOT1L epigenetically enhances EMT-TF expression in cooperation with histone acetyltransferases and c-Myc in the EMT-TF promoters. (a) Cells were treated with 1 \u03bcM EPZ004777 (EPZ) for 48 h and subjected to immunoblotting for analysis of Snail, ZEB1 and ZEB2 expression after inhibition of DOT1L enzymatic activity. (b) ChIP\u2013qPCR analysis showing the amount of indicated proteins recruited to the promoter regions of Snail, ZEB1 and ZEB2. Data are presented as the means\u00b1s.d (n=3). *P<0.05 versus CON (Student's t-test). (c,d) The expression levels of EMT markers and transcriptional regulators were measured using immunoblotting after treatment of DOT1L-knockdown MDA-MB-231 cells with 5 \u03bcM 5'-Aza-2'-deoxycytidine (AZA) for 72 h and 100 ng ml\u22121 Trichostatin A (TSA) for 12 h. (e) The effect of DOT1L on c-Myc expression was analysed using immunoblotting. (f) Lysates from 293T cells transfected with DOT1L and/or c-Myc cDNA constructs were immunoprecipitated using the indicated antibodies and subjected to immunoblotting. (g) In vitro pull-down assay was performed to confirm the interaction between DOT1L and c-Myc. GST-c-Myc was used to pull down DOT1L from DOT1L-transfected 293T cell lysates. c-Myc-bound DOT1L was detected by indicated antibodies. Expression levels of DOT1L in 5% input were shown as indicated. Data are representative of three independent experiments.", "co_occurrence": [{"body": 173, "word": "DOT1L", "fig": 8}, {"body": 50, "word": "c-Myc", "fig": 4}, {"body": 96, "word": "cells", "fig": 2}, {"body": 42, "word": "expression", "fig": 4}, {"body": 32, "word": "using", "fig": 3}, {"body": 28, "word": "The", "fig": 2}, {"body": 19, "word": "ZEB1", "fig": 2}, {"body": 19, "word": "EMT-TF", "fig": 2}, {"body": 18, "word": "ZEB2", "fig": 2}, {"body": 36, "word": "EMT", "fig": 1}, {"body": 15, "word": "Snail", "fig": 2}, {"body": 29, "word": "cell", "fig": 1}, {"body": 6, "word": "immunoblotting", "fig": 4}, {"body": 12, "word": "analysis", "fig": 2}, {"body": 5, "word": "indicated", "fig": 4}, {"body": 18, "word": "transcriptional", "fig": 1}, {"body": 17, "word": "In", "fig": 1}, {"body": 16, "word": "MDA-MB-231", "fig": 1}, {"body": 16, "word": "promoter", "fig": 1}, {"body": 16, "word": "ml\u22121", "fig": 1}, {"body": 7, "word": "h", "fig": 2}, {"body": 7, "word": "antibodies", "fig": 2}, {"body": 13, "word": "assay", "fig": 1}, {"body": 13, "word": "b", "fig": 1}, {"body": 12, "word": "activity", "fig": 1}, {"body": 11, "word": "A", "fig": 1}, {"body": 10, "word": "histone", "fig": 1}, {"body": 10, "word": "inhibition", "fig": 1}, {"body": 10, "word": "promoters", "fig": 1}, {"body": 8, "word": "vitro", "fig": 1}, {"body": 8, "word": "performed", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "cooperation", "fig": 1}, {"body": 7, "word": "ng", "fig": 1}, {"body": 6, "word": "treatment", "fig": 1}, {"body": 6, "word": "proteins", "fig": 1}, {"body": 6, "word": "enzymatic", "fig": 1}, {"body": 6, "word": "regions", "fig": 1}, {"body": 6, "word": "effect", "fig": 1}, {"body": 3, "word": "levels", "fig": 2}, {"body": 5, "word": "showing", "fig": 1}, {"body": 5, "word": "d", "fig": 1}, {"body": 4, "word": "DOT1L-knockdown", "fig": 1}, {"body": 4, "word": "versus", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "analysed", "fig": 1}, {"body": 4, "word": "regulators", "fig": 1}, {"body": 4, "word": "lysates", "fig": 1}, {"body": 4, "word": "h.", "fig": 1}, {"body": 4, "word": "recruited", "fig": 1}, {"body": 3, "word": "ChIP\u2013qPCR", "fig": 1}, {"body": 3, "word": "enhances", "fig": 1}, {"body": 3, "word": "immunoprecipitated", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "EPZ004777", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "'s", "fig": 1}, {"body": 2, "word": "acetyltransferases", "fig": 1}, {"body": 2, "word": "epigenetically", "fig": 1}, {"body": 2, "word": "pull-down", "fig": 1}, {"body": 2, "word": "and/or", "fig": 1}, {"body": 1, "word": "293T", "fig": 2}, {"body": 2, "word": "markers", "fig": 1}, {"body": 2, "word": "constructs", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 2, "word": "cDNA", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "detected", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "confirm", "fig": 1}, {"body": 1, "word": "g", "fig": 1}, {"body": 1, "word": "amount", "fig": 1}, {"body": 1, "word": "c-Myc-bound", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}, {"body": 1, "word": "GST-c-Myc", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525167/bin/ncomms8821-f5.jpg", "caption": "c-Myc is required for formation of DOT1L-containing transcriptional active complex and recognition of DOT1L on EMT-TFs in regulation of breast CSC activity. (a) To confirm the binding of DOT1L or c-Myc with the indicated proteins, co-immunoprecipitation assays were performed using lysates from 293T cells transfected with the indicated constructs. (b) To investigate the effect of c-Myc on DOT1L-induced EMT-TF expression, lysates from CON or DOT1L-overexpressing MCF10A cells transfected with control or c-Myc siRNA (si c-Myc) were analysed by immunoblotting. (c) Dependency of EMT-TF regulation by DOT1L on c-Myc was confirmed using ChIP\u2013qPCR assay in c-Myc siRNA-transfected MCF10A cells expressing DOT1L or its control cells. (d) The CSC population after c-Myc siRNA transfection was measured by FACS. Results in c,d are shown as means\u00b1s.d. of experiments in triplicate. * and \u2020P<0.05 versus CON/siCON and DOT1L/siCON, respectively (Student's t-test). (e) A proposed model for the regulation by DOT1L of EMT-TFs. In the absence of DOT1L, c-Myc forms a repressive complex with DNMTs and HDACs in the E-box motif of the promoter regions of Snail, ZEB1 and ZEB2 EMT-TFs, which leads to DNA methylation at the CpG island and histone deacetylation within the promoters. When DOT1L is overexpressed, c-Myc interacts directly with the DOT1L complex containing HATs and recruits them to the promoter region of EMT-TFs. This leads to dissociation of DNMTs and HDACs from the promoters and enrichment of H3K79me and H3 acetylation in the region for activation of EMT-TF transcription. The enhanced expression of EMT-TFs induces EMT-associated CSC and metastasis.", "co_occurrence": [{"body": 173, "word": "DOT1L", "fig": 8}, {"body": 50, "word": "c-Myc", "fig": 10}, {"body": 96, "word": "cells", "fig": 4}, {"body": 26, "word": "EMT-TFs", "fig": 5}, {"body": 42, "word": "expression", "fig": 2}, {"body": 23, "word": "CSC", "fig": 3}, {"body": 32, "word": "using", "fig": 2}, {"body": 19, "word": "regulation", "fig": 3}, {"body": 19, "word": "EMT-TF", "fig": 3}, {"body": 19, "word": "complex", "fig": 3}, {"body": 28, "word": "The", "fig": 2}, {"body": 55, "word": "breast", "fig": 1}, {"body": 25, "word": "MCF10A", "fig": 2}, {"body": 16, "word": "promoter", "fig": 2}, {"body": 15, "word": "siRNA", "fig": 2}, {"body": 13, "word": "To", "fig": 2}, {"body": 10, "word": "promoters", "fig": 2}, {"body": 19, "word": "ZEB1", "fig": 1}, {"body": 18, "word": "ZEB2", "fig": 1}, {"body": 18, "word": "transcriptional", "fig": 1}, {"body": 17, "word": "In", "fig": 1}, {"body": 16, "word": "transcription", "fig": 1}, {"body": 15, "word": "metastasis", "fig": 1}, {"body": 15, "word": "Snail", "fig": 1}, {"body": 7, "word": "region", "fig": 2}, {"body": 13, "word": "assay", "fig": 1}, {"body": 13, "word": "b", "fig": 1}, {"body": 12, "word": "activity", "fig": 1}, {"body": 11, "word": "DOT1L-overexpressing", "fig": 1}, {"body": 11, "word": "A", "fig": 1}, {"body": 10, "word": "histone", "fig": 1}, {"body": 5, "word": "d", "fig": 2}, {"body": 10, "word": "formation", "fig": 1}, {"body": 10, "word": "methylation", "fig": 1}, {"body": 5, "word": "control", "fig": 2}, {"body": 5, "word": "indicated", "fig": 2}, {"body": 8, "word": "activation", "fig": 1}, {"body": 8, "word": "active", "fig": 1}, {"body": 4, "word": "lysates", "fig": 2}, {"body": 8, "word": "DNA", "fig": 1}, {"body": 8, "word": "binding", "fig": 1}, {"body": 8, "word": "performed", "fig": 1}, {"body": 7, "word": "E-box", "fig": 1}, {"body": 7, "word": "DOT1L-induced", "fig": 1}, {"body": 6, "word": "proteins", "fig": 1}, {"body": 3, "word": "transfected", "fig": 2}, {"body": 6, "word": "population", "fig": 1}, {"body": 6, "word": "H3K79me", "fig": 1}, {"body": 6, "word": "regions", "fig": 1}, {"body": 6, "word": "effect", "fig": 1}, {"body": 6, "word": "immunoblotting", "fig": 1}, {"body": 5, "word": "containing", "fig": 1}, {"body": 5, "word": "H3", "fig": 1}, {"body": 5, "word": "acetylation", "fig": 1}, {"body": 5, "word": "confirmed", "fig": 1}, {"body": 5, "word": "enrichment", "fig": 1}, {"body": 4, "word": "forms", "fig": 1}, {"body": 4, "word": "versus", "fig": 1}, {"body": 4, "word": "shown", "fig": 1}, {"body": 4, "word": "analysed", "fig": 1}, {"body": 4, "word": "directly", "fig": 1}, {"body": 4, "word": "assays", "fig": 1}, {"body": 4, "word": "required", "fig": 1}, {"body": 3, "word": "induces", "fig": 1}, {"body": 3, "word": "ChIP\u2013qPCR", "fig": 1}, {"body": 3, "word": "repressive", "fig": 1}, {"body": 3, "word": "expressing", "fig": 1}, {"body": 3, "word": "This", "fig": 1}, {"body": 3, "word": "respectively", "fig": 1}, {"body": 3, "word": "within", "fig": 1}, {"body": 3, "word": "'s", "fig": 1}, {"body": 3, "word": "model", "fig": 1}, {"body": 3, "word": "FACS", "fig": 1}, {"body": 1, "word": "leads", "fig": 2}, {"body": 2, "word": "dissociation", "fig": 1}, {"body": 1, "word": "DNMTs", "fig": 2}, {"body": 2, "word": "motif", "fig": 1}, {"body": 1, "word": "HDACs", "fig": 2}, {"body": 2, "word": "constructs", "fig": 1}, {"body": 1, "word": "proposed", "fig": 1}, {"body": 1, "word": "experiments", "fig": 1}, {"body": 1, "word": "investigate", "fig": 1}, {"body": 1, "word": "recognition", "fig": 1}, {"body": 1, "word": "confirm", "fig": 1}, {"body": 1, "word": "293T", "fig": 1}, {"body": 1, "word": "EMT-associated", "fig": 1}, {"body": 1, "word": "recruits", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "absence", "fig": 1}, {"body": 1, "word": "interacts", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}]}], "4850358": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850358/bin/fx1.jpg", "caption": "", "co_occurrence": []}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850358/bin/gr1.jpg", "caption": "Absence of Roma Leads to Uncontrolled Proliferation (A) Immunofluorescence analysis of EdU incorporation in mammary gland tissue sections from WT and Roma\u2212/\u2212 mice at 5dG and 10dL, 24 hr following injection in vivo. Scale bars, 10 \u03bcm. The number of EdU+ and EdU\u2013 cells was counted and presented as an average percentage. Data are presented as the mean, and error bars represent SD (5dG: p = 9.52E\u221204, 10dL: p = 2.49E\u221205, Student\u2019s t test). (B) Protein extracts were prepared from WT and Roma\u2212/\u2212 glands at 10dL followed by immunoblot analysis of cell-cycle factors as indicated. Protein extract from 5dG WT gland was used as a proliferation control. (C) PCR and quantitative real-time PCR analysis of geminin in extracts from 10dL WT and Roma\u2212/\u2212 glands (p = 0.0002, Student\u2019s t test). (D) Immunofluorescence analysis of E-cadherin staining (green) with binucleate cells indicated (white arrows). Nuclei are stained with DAPI (blue). Scale bars, 10 \u03bcm. (E) Immunoblot analysis of cell-cycle factors in extracts of WT and Roma\u2212/\u2212 glands at 10dL. Protein extract from 5dG WT gland was used as a proliferation control. (F) Primary MECs were isolated from WT and Roma\u2212/\u2212 glands at full wean, and metaphase spreads were prepared. Karyotype analysis was carried out, and tetraploidy was determined by counting the number of chromosomes. See also Figure S1.", "co_occurrence": [{"body": 30, "word": "Roma\u2212/\u2212", "fig": 5}, {"body": 16, "word": "analysis", "fig": 6}, {"body": 43, "word": "cells", "fig": 2}, {"body": 10, "word": "WT", "fig": 7}, {"body": 65, "word": "Roma", "fig": 1}, {"body": 16, "word": "glands", "fig": 4}, {"body": 21, "word": "cell-cycle", "fig": 2}, {"body": 37, "word": "Figure", "fig": 1}, {"body": 13, "word": "proliferation", "fig": 2}, {"body": 5, "word": "10dL", "fig": 5}, {"body": 15, "word": "mammary", "fig": 1}, {"body": 5, "word": "gland", "fig": 3}, {"body": 14, "word": "The", "fig": 1}, {"body": 12, "word": "geminin", "fig": 1}, {"body": 6, "word": "used", "fig": 2}, {"body": 5, "word": "factors", "fig": 2}, {"body": 10, "word": "hr", "fig": 1}, {"body": 9, "word": "also", "fig": 1}, {"body": 4, "word": "control", "fig": 2}, {"body": 8, "word": "MECs", "fig": 1}, {"body": 2, "word": "5dG", "fig": 4}, {"body": 6, "word": "mice", "fig": 1}, {"body": 3, "word": "Immunofluorescence", "fig": 2}, {"body": 2, "word": "Protein", "fig": 3}, {"body": 6, "word": "EdU", "fig": 1}, {"body": 5, "word": "tissue", "fig": 1}, {"body": 2, "word": "PCR", "fig": 2}, {"body": 4, "word": "Immunoblot", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "full", "fig": 1}, {"body": 3, "word": "carried", "fig": 1}, {"body": 1, "word": "extracts", "fig": 3}, {"body": 3, "word": "Leads", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 2}, {"body": 2, "word": "Proliferation", "fig": 1}, {"body": 2, "word": "wean", "fig": 1}, {"body": 2, "word": "Primary", "fig": 1}, {"body": 2, "word": "followed", "fig": 1}, {"body": 2, "word": "S1", "fig": 1}, {"body": 2, "word": "Absence", "fig": 1}, {"body": 1, "word": "indicated", "fig": 2}, {"body": 1, "word": "prepared", "fig": 2}, {"body": 1, "word": "stained", "fig": 1}, {"body": 1, "word": "immunoblot", "fig": 1}, {"body": 1, "word": "Uncontrolled", "fig": 1}, {"body": 1, "word": "chromosomes", "fig": 1}, {"body": 1, "word": "tetraploidy", "fig": 1}, {"body": 1, "word": "E-cadherin", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "incorporation", "fig": 1}, {"body": 1, "word": "real-time", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "vivo", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "average", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850358/bin/gr2.jpg", "caption": "Absence of Roma Leads to Activation of the DNA Damage Response and Genomic Instability (A) Representative immunofluorescence analysis of RPA2-pT21, \u03b3H2AX, and 53BP1 foci in tissue sections from WT and Roma\u2212/\u2212 glands at 10dL. The white arrow indicates nucleolar \u03b3H2AX. Scale bars, 10 \u03bcm. The higher magnification panels on the right have been chosen to highlight the foci and are not zoomed images of the left panels. (B) Immunoblot analysis of cell-cycle checkpoint and DNA damage response in extracts from WT and Roma\u2212/\u2212 glands at 10dL. Extracts from U2OS cells treated with 5mM HU were used as a damage control. (C) PCR analysis of p21Cip1 and MDM2 and quantitative real-time PCR analysis of p21Cip1 in extracts from 10dL WT and Roma\u2212/\u2212 glands (p = 0.0007, Student\u2019s t test). (D) Representative spectral karyotypes (top) and metaphase spreads (bottom panel) prepared from MECs isolated from WT and Roma\u2212/\u2212 glands after a full natural wean. See also Figure S2.", "co_occurrence": [{"body": 30, "word": "Roma\u2212/\u2212", "fig": 4}, {"body": 37, "word": "p21Cip1", "fig": 2}, {"body": 65, "word": "Roma", "fig": 1}, {"body": 16, "word": "glands", "fig": 4}, {"body": 16, "word": "analysis", "fig": 4}, {"body": 30, "word": "DNA", "fig": 2}, {"body": 43, "word": "cells", "fig": 1}, {"body": 10, "word": "WT", "fig": 4}, {"body": 37, "word": "Figure", "fig": 1}, {"body": 14, "word": "The", "fig": 2}, {"body": 21, "word": "cell-cycle", "fig": 1}, {"body": 5, "word": "10dL", "fig": 3}, {"body": 6, "word": "foci", "fig": 2}, {"body": 6, "word": "damage", "fig": 2}, {"body": 11, "word": "checkpoint", "fig": 1}, {"body": 9, "word": "also", "fig": 1}, {"body": 8, "word": "panel", "fig": 1}, {"body": 8, "word": "MECs", "fig": 1}, {"body": 6, "word": "used", "fig": 1}, {"body": 5, "word": "tissue", "fig": 1}, {"body": 2, "word": "PCR", "fig": 2}, {"body": 4, "word": "bottom", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 4, "word": "Immunoblot", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 4, "word": "natural", "fig": 1}, {"body": 3, "word": "full", "fig": 1}, {"body": 3, "word": "Leads", "fig": 1}, {"body": 3, "word": "top", "fig": 1}, {"body": 3, "word": "response", "fig": 1}, {"body": 1, "word": "\u03b3H2AX", "fig": 2}, {"body": 2, "word": "wean", "fig": 1}, {"body": 1, "word": "extracts", "fig": 2}, {"body": 2, "word": "Absence", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 2, "word": "higher", "fig": 1}, {"body": 2, "word": "53BP1", "fig": 1}, {"body": 1, "word": "Damage", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "MDM2", "fig": 1}, {"body": 1, "word": "S2", "fig": 1}, {"body": 1, "word": "immunofluorescence", "fig": 1}, {"body": 1, "word": "Response", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "real-time", "fig": 1}, {"body": 1, "word": "highlight", "fig": 1}, {"body": 1, "word": "Activation", "fig": 1}, {"body": 1, "word": "prepared", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850358/bin/gr3.jpg", "caption": "Altered Replication Dynamics and Aneuploidy in Roma-Deficient Cells (A) Primary MEFs were isolated from WT and Roma\u2212/\u2212 embryos and cultured in vitro. DNA fibers from these cells were spread and stained with antibodies to IdU and CldU and counterstained with anti-DNA antibodies to ensure that broken fibers were not analyzed. Replication fork velocities were then measured. Data are presented as mean \u00b1 SD. (B) Interorigin distances in WT and Roma\u2212/\u2212 MEFs were measured. Data are presented as mean \u00b1 SD. (C) Protein extracts were prepared from WT and Roma\u2212/\u2212 primary MEFs followed by immunoblot analysis of markers of cell-cycle checkpoints and the DNA damage response. Extract from U2OS cells treated with 5 mM HU was used as a damage control. (D) Primary WT and Roma\u2212/\u2212 MEFs were pulsed with BrdU, and cell-cycle analysis was conducted. Percentage of cells in G1/G2/M and S phases was calculated. (E) Immunoblot analysis of cell-cycle factors. Protein extract from 5dG WT gland was used as a proliferation control. (F) EpH4 cells were transfected with a Roma-FLAG expression construct and cultured under puromycin selection. Doxycycline was used to induce Roma-FLAG expression. Protein extracts were prepared from EpH4 cells under the stated conditions followed by FLAG immunoprecipitation and immunoblot against Mcm2, Mcm3, and DNA Topoisomerase I showing association with Roma-FLAG. See also Figure S3.", "co_occurrence": [{"body": 43, "word": "cells", "fig": 5}, {"body": 30, "word": "Roma\u2212/\u2212", "fig": 4}, {"body": 30, "word": "DNA", "fig": 3}, {"body": 16, "word": "MEFs", "fig": 4}, {"body": 21, "word": "cell-cycle", "fig": 3}, {"body": 10, "word": "WT", "fig": 5}, {"body": 16, "word": "analysis", "fig": 3}, {"body": 37, "word": "Figure", "fig": 1}, {"body": 6, "word": "used", "fig": 3}, {"body": 17, "word": "S", "fig": 1}, {"body": 13, "word": "proliferation", "fig": 1}, {"body": 12, "word": "fork", "fig": 1}, {"body": 6, "word": "damage", "fig": 2}, {"body": 5, "word": "EpH4", "fig": 2}, {"body": 9, "word": "also", "fig": 1}, {"body": 3, "word": "Roma-FLAG", "fig": 3}, {"body": 8, "word": "Cells", "fig": 1}, {"body": 4, "word": "control", "fig": 2}, {"body": 7, "word": "BrdU", "fig": 1}, {"body": 2, "word": "Protein", "fig": 3}, {"body": 3, "word": "expression", "fig": 2}, {"body": 3, "word": "Replication", "fig": 2}, {"body": 5, "word": "factors", "fig": 1}, {"body": 5, "word": "gland", "fig": 1}, {"body": 2, "word": "Primary", "fig": 2}, {"body": 2, "word": "followed", "fig": 2}, {"body": 4, "word": "Immunoblot", "fig": 1}, {"body": 4, "word": "A", "fig": 1}, {"body": 3, "word": "checkpoints", "fig": 1}, {"body": 3, "word": "response", "fig": 1}, {"body": 1, "word": "immunoblot", "fig": 2}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "embryos", "fig": 1}, {"body": 1, "word": "extracts", "fig": 2}, {"body": 2, "word": "ensure", "fig": 1}, {"body": 2, "word": "vitro", "fig": 1}, {"body": 2, "word": "construct", "fig": 1}, {"body": 1, "word": "cultured", "fig": 2}, {"body": 2, "word": "5dG", "fig": 1}, {"body": 2, "word": "immunoprecipitation", "fig": 1}, {"body": 2, "word": "Topoisomerase", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 2, "word": "Mcm3", "fig": 1}, {"body": 1, "word": "fibers", "fig": 2}, {"body": 2, "word": "CldU", "fig": 1}, {"body": 2, "word": "I", "fig": 1}, {"body": 1, "word": "prepared", "fig": 2}, {"body": 2, "word": "IdU", "fig": 1}, {"body": 1, "word": "distances", "fig": 1}, {"body": 1, "word": "isolated", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}, {"body": 1, "word": "spread", "fig": 1}, {"body": 1, "word": "induce", "fig": 1}, {"body": 1, "word": "primary", "fig": 1}, {"body": 1, "word": "association", "fig": 1}, {"body": 1, "word": "velocities", "fig": 1}, {"body": 1, "word": "phases", "fig": 1}, {"body": 1, "word": "transfected", "fig": 1}, {"body": 1, "word": "markers", "fig": 1}, {"body": 1, "word": "conditions", "fig": 1}, {"body": 1, "word": "Dynamics", "fig": 1}, {"body": 1, "word": "G1/G2/M", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "stated", "fig": 1}, {"body": 1, "word": "Mcm2", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "E", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850358/bin/gr4.jpg", "caption": "Overexpression of Roma Results in S Phase Arrest (A) EpH4 cells were transfected with a Roma-FLAG expression construct and cultured under puromycin selection. Doxycycline was used to induce Roma-FLAG expression. Cell counts were monitored over the course of a week and represented in a graph. (B) Representative images of cells under the indicated conditions. (C) EpH4 cells transfected with a Roma-FLAG expression construct were treated with doxycycline at a series of time points and then released from doxycycline and pulsed with BrdU followed by flow cytometry analysis. (D) Protein extracts were prepared from EpH4 cells at conditions stated and immunoblot analysis of cell-cycle checkpoint, and DNA damage response markers was conducted. (E) RNA was extracted from EpH4 cells cultured in conditions stated followed by PCR analysis of p21Cip1. (F) EpH4 cells cultured in conditions stated were treated with p21Cip1 siRNA and pulsed with BrdU followed by cell-cycle analysis using flow cytometry. See also Figure S4.", "co_occurrence": [{"body": 43, "word": "cells", "fig": 6}, {"body": 37, "word": "p21Cip1", "fig": 2}, {"body": 65, "word": "Roma", "fig": 1}, {"body": 16, "word": "analysis", "fig": 4}, {"body": 21, "word": "cell-cycle", "fig": 2}, {"body": 37, "word": "Figure", "fig": 1}, {"body": 30, "word": "DNA", "fig": 1}, {"body": 5, "word": "EpH4", "fig": 5}, {"body": 17, "word": "S", "fig": 1}, {"body": 14, "word": "Cell", "fig": 1}, {"body": 7, "word": "BrdU", "fig": 2}, {"body": 11, "word": "checkpoint", "fig": 1}, {"body": 9, "word": "also", "fig": 1}, {"body": 3, "word": "expression", "fig": 3}, {"body": 3, "word": "Roma-FLAG", "fig": 3}, {"body": 7, "word": "RNA", "fig": 1}, {"body": 6, "word": "damage", "fig": 1}, {"body": 2, "word": "followed", "fig": 3}, {"body": 6, "word": "used", "fig": 1}, {"body": 2, "word": "doxycycline", "fig": 2}, {"body": 4, "word": "A", "fig": 1}, {"body": 1, "word": "conditions", "fig": 4}, {"body": 2, "word": "construct", "fig": 2}, {"body": 2, "word": "treated", "fig": 2}, {"body": 3, "word": "using", "fig": 1}, {"body": 1, "word": "cultured", "fig": 3}, {"body": 1, "word": "stated", "fig": 3}, {"body": 3, "word": "response", "fig": 1}, {"body": 2, "word": "Overexpression", "fig": 1}, {"body": 2, "word": "Protein", "fig": 1}, {"body": 2, "word": "PCR", "fig": 1}, {"body": 1, "word": "transfected", "fig": 2}, {"body": 2, "word": "siRNA", "fig": 1}, {"body": 2, "word": "time", "fig": 1}, {"body": 1, "word": "course", "fig": 1}, {"body": 1, "word": "immunoblot", "fig": 1}, {"body": 1, "word": "induce", "fig": 1}, {"body": 1, "word": "markers", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "released", "fig": 1}, {"body": 1, "word": "extracts", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "prepared", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}], "4974783": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig1_HTML.jpg", "caption": "CDCP1 mediates suspension growth of MDA-MB-468 cells. a Morphology of the MDA-MB-468 vector control cell line or a line stably overexpressing wild-type CDCP1. CDCP1 induces suspension growth of cell cultures. b Comparison of MDA-MB-468 cell lines expressing wild-type CDCP1, or a phospho-defective form of CDCP1 in which tyrosine residues 707, 734, and 762 have been mutated to phenylalanine ([3YF]), grown in either soft agar or collagen I gels. Note that CDCP1-dependent suspension growth requires tyrosine phosphorylation. c Immunoblot analysis showing that the MDA-MB-468 cell lines stably express CDCP1 or its mutants at similar levels, but only wild-type CDCP1 increases activating Src phosphorylation above basal levels. d Treatment of MDA-MB-468 cells with Disulfide bond Disrupting Agents (DDAs) induces parallel mobility shifts of EGFR and CDCP1 in time- and concentration-dependent manners", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 8}, {"body": 42, "word": "cell", "fig": 4}, {"body": 55, "word": "cells", "fig": 2}, {"body": 72, "word": "EGFR", "fig": 1}, {"body": 11, "word": "MDA-MB-468", "fig": 5}, {"body": 13, "word": "growth", "fig": 3}, {"body": 19, "word": "phosphorylation", "fig": 2}, {"body": 34, "word": "Src", "fig": 1}, {"body": 16, "word": "levels", "fig": 2}, {"body": 16, "word": "lines", "fig": 2}, {"body": 9, "word": "suspension", "fig": 3}, {"body": 12, "word": "tyrosine", "fig": 2}, {"body": 10, "word": "line", "fig": 2}, {"body": 12, "word": "form", "fig": 1}, {"body": 10, "word": "DDAs", "fig": 1}, {"body": 10, "word": "control", "fig": 1}, {"body": 8, "word": "either", "fig": 1}, {"body": 4, "word": "induces", "fig": 2}, {"body": 8, "word": "similar", "fig": 1}, {"body": 7, "word": "vector", "fig": 1}, {"body": 7, "word": "analysis", "fig": 1}, {"body": 3, "word": "stably", "fig": 2}, {"body": 6, "word": "mobility", "fig": 1}, {"body": 2, "word": "wild-type", "fig": 3}, {"body": 4, "word": "express", "fig": 1}, {"body": 4, "word": "expressing", "fig": 1}, {"body": 4, "word": "cultures", "fig": 1}, {"body": 3, "word": "Immunoblot", "fig": 1}, {"body": 2, "word": "Disulfide", "fig": 1}, {"body": 2, "word": "CDCP1-dependent", "fig": 1}, {"body": 2, "word": "increases", "fig": 1}, {"body": 2, "word": "gels", "fig": 1}, {"body": 2, "word": "Agents", "fig": 1}, {"body": 2, "word": "bond", "fig": 1}, {"body": 2, "word": "mediates", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "collagen", "fig": 1}, {"body": 2, "word": "Treatment", "fig": 1}, {"body": 2, "word": "I", "fig": 1}, {"body": 2, "word": "Disrupting", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "soft", "fig": 1}, {"body": 1, "word": "phenylalanine", "fig": 1}, {"body": 1, "word": "basal", "fig": 1}, {"body": 1, "word": "agar", "fig": 1}, {"body": 1, "word": "concentration-dependent", "fig": 1}, {"body": 1, "word": "overexpressing", "fig": 1}, {"body": 1, "word": "shifts", "fig": 1}, {"body": 1, "word": "grown", "fig": 1}, {"body": 1, "word": "3YF", "fig": 1}, {"body": 1, "word": "residues", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig2_HTML.jpg", "caption": "CDCP1 forms ternary complexes with EGFR and Src. a Immunoprecipitation of FLAG-tagged CDCP1 from MDA-MB-468 and BT474 cells shows that CDCP1 associates with EGFR and HER2. b CDCP1 association with EGFR, Src, and PKC\u03b4 are significantly reduced either by mutation of Tyr734 to phenylalanine, or by a 24-hour treatment with 20 \u03bcM DDA NSC624203. c DDA treatment of cells dissociates EGFR/CDCP1 complexes in a concentration-dependent manner. d EGFR and Src form ternary complexes, as indicated by sequential CDCP1 and Src co-immunoprecipitation, and complex formation is reduced by treatment of the cells for 24 hours with 20 \u03bcM DDA NSC624203. e MDA-MB-468 cells transduced with adenoviruses encoding GFP, CDCP1 or PKC\u03b4 were stimulated with either 20 \u03bcM EGF or 100 \u03bcM sodium pervanadate for 20 minutes as indicated. Cell extracts were subjected to sequential anti-FLAG (CDCP1), anti-Src immunoprecipitation. Immunoprecipitates and the corresponding crude cell lysates were analyzed by immunoblot. f Lapatinib treatment (20 \u03bcM) for 24 hours reduces EGFR association with CDCP1. Dasatinib treatment (100 nM) for 24 hours does not alter EGFR association with CDCP1, but reduces overall tyrosine phosphorylation and EGFR phosphorylation on the Src site, Tyr845. In the MDA-MB-468 cell background, complex formation is not significantly altered by stimulation with 10 ng/ml EGF for 20 minutes. g Subjection of affinity purified CDCP1-containing complexes to in vitro kinase assays demonstrated ATP-dependent increases in overall tyrosine phosphorylation, EGFR phosphorylation on Tyr845 and Src phosphorylation on Tyr416. These phosphorylation events were blocked by the addition of 100 nM dasatinib to the kinase assays, but unaffected by 20 \u03bcM lapatinib", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 9}, {"body": 72, "word": "EGFR", "fig": 8}, {"body": 55, "word": "cells", "fig": 4}, {"body": 34, "word": "Src", "fig": 6}, {"body": 36, "word": "complexes", "fig": 4}, {"body": 19, "word": "phosphorylation", "fig": 6}, {"body": 42, "word": "cell", "fig": 2}, {"body": 9, "word": "treatment", "fig": 5}, {"body": 22, "word": "EGF", "fig": 2}, {"body": 11, "word": "MDA-MB-468", "fig": 3}, {"body": 10, "word": "association", "fig": 3}, {"body": 13, "word": "complex", "fig": 2}, {"body": 12, "word": "tyrosine", "fig": 2}, {"body": 10, "word": "ternary", "fig": 2}, {"body": 8, "word": "either", "fig": 2}, {"body": 5, "word": "DDA", "fig": 3}, {"body": 6, "word": "Tyr845", "fig": 2}, {"body": 12, "word": "form", "fig": 1}, {"body": 12, "word": "associates", "fig": 1}, {"body": 11, "word": "These", "fig": 1}, {"body": 5, "word": "reduced", "fig": 2}, {"body": 9, "word": "stimulation", "fig": 1}, {"body": 9, "word": "In", "fig": 1}, {"body": 4, "word": "formation", "fig": 2}, {"body": 4, "word": "assays", "fig": 2}, {"body": 8, "word": "site", "fig": 1}, {"body": 7, "word": "encoding", "fig": 1}, {"body": 6, "word": "forms", "fig": 1}, {"body": 3, "word": "kinase", "fig": 2}, {"body": 3, "word": "PKC\u03b4", "fig": 2}, {"body": 6, "word": "HER2", "fig": 1}, {"body": 3, "word": "NSC624203", "fig": 2}, {"body": 3, "word": "indicated", "fig": 2}, {"body": 5, "word": "affinity", "fig": 1}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 2, "word": "overall", "fig": 2}, {"body": 4, "word": "CDCP1-containing", "fig": 1}, {"body": 4, "word": "lapatinib", "fig": 1}, {"body": 4, "word": "anti-FLAG", "fig": 1}, {"body": 3, "word": "immunoblot", "fig": 1}, {"body": 3, "word": "pervanadate", "fig": 1}, {"body": 1, "word": "hours", "fig": 3}, {"body": 3, "word": "addition", "fig": 1}, {"body": 3, "word": "dasatinib", "fig": 1}, {"body": 3, "word": "manner", "fig": 1}, {"body": 3, "word": "GFP", "fig": 1}, {"body": 2, "word": "blocked", "fig": 1}, {"body": 2, "word": "sodium", "fig": 1}, {"body": 2, "word": "FLAG-tagged", "fig": 1}, {"body": 2, "word": "alter", "fig": 1}, {"body": 2, "word": "increases", "fig": 1}, {"body": 1, "word": "significantly", "fig": 2}, {"body": 1, "word": "sequential", "fig": 2}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "vitro", "fig": 1}, {"body": 1, "word": "minutes", "fig": 2}, {"body": 2, "word": "stimulated", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "EGFR/CDCP1", "fig": 1}, {"body": 1, "word": "phenylalanine", "fig": 1}, {"body": 1, "word": "mutation", "fig": 1}, {"body": 1, "word": "demonstrated", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "g", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "adenoviruses", "fig": 1}, {"body": 1, "word": "Tyr416", "fig": 1}, {"body": 1, "word": "Dasatinib", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "BT474", "fig": 1}, {"body": 1, "word": "transduced", "fig": 1}, {"body": 1, "word": "Immunoprecipitation", "fig": 1}, {"body": 1, "word": "concentration-dependent", "fig": 1}, {"body": 1, "word": "immunoprecipitation", "fig": 1}, {"body": 1, "word": "unaffected", "fig": 1}, {"body": 1, "word": "Tyr734", "fig": 1}, {"body": 1, "word": "events", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig3_HTML.jpg", "caption": "CDCP1 and EGFR cooperate to induce cell detachment from the substratum and to disrupt adherens junctions. a Immunoblot analysis of T47D cell lines stably expressing the indicated combinations of EGFR, CDCP1, and the Y734F mutant CDCP1. Coexpression of wild-type CDCP1 and EGFR results in a tyrosine-phosphorylated band that comigrates with EGFR. Similar results were observed whether the cells are plated on tissue culture plastic or type I collagen. b Coexpression of CDCP1 and EGFR result in enhanced EGF-dependent EGFR phosphorylation on Tyr845. This effect was blunted if wild-type CDCP1 was replaced with the Y734F mutant. c Treatment with DDA NSC624205 (20 \u03bcM) for 24 hours induces an electrophoretic mobility shift of EGFR, but not CDCP1, in the T47D cell background. d T47D cells stably expressing EGFR and CDCP1 were treated for 24 hours with vehicle or 20 \u03bcM DDA NSC333839 and stimulated for 20 minutes with or without 10 ng/ml EGF and analyzed by immunoblot. e The indicated cell lines were plated onto tissue culture plastic and treated with or without 10 ng/ml EGF for 24 hours and photographed. f Cells grown and treated as in Fig. 3b were gently pipetted with the culture medium and the detached suspension cells, and the cells remaining attached to the plates were counted. Results were plotted as the fraction of cells that were detached in triplicate determinations. Error bars represent standard deviation (SD). g Photomicrographs of the indicated cell lines treated as in Fig. 3e, but grown on the surface of collagen I gels. Note that EGFR and CDCP1 coexpression and EGF stimulation cooperate to induce suspension growth", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 9}, {"body": 72, "word": "EGFR", "fig": 9}, {"body": 55, "word": "cells", "fig": 5}, {"body": 42, "word": "cell", "fig": 5}, {"body": 55, "word": "Fig", "fig": 2}, {"body": 22, "word": "EGF", "fig": 3}, {"body": 16, "word": "lines", "fig": 3}, {"body": 19, "word": "results", "fig": 2}, {"body": 35, "word": "The", "fig": 1}, {"body": 8, "word": "T47D", "fig": 3}, {"body": 19, "word": "phosphorylation", "fig": 1}, {"body": 9, "word": "suspension", "fig": 2}, {"body": 15, "word": "observed", "fig": 1}, {"body": 7, "word": "mutant", "fig": 2}, {"body": 13, "word": "growth", "fig": 1}, {"body": 13, "word": "junctions", "fig": 1}, {"body": 6, "word": "induce", "fig": 2}, {"body": 11, "word": "This", "fig": 1}, {"body": 5, "word": "DDA", "fig": 2}, {"body": 5, "word": "Y734F", "fig": 2}, {"body": 9, "word": "detachment", "fig": 1}, {"body": 3, "word": "culture", "fig": 3}, {"body": 9, "word": "stimulation", "fig": 1}, {"body": 3, "word": "indicated", "fig": 3}, {"body": 4, "word": "expressing", "fig": 2}, {"body": 4, "word": "cooperate", "fig": 2}, {"body": 2, "word": "treated", "fig": 4}, {"body": 8, "word": "surface", "fig": 1}, {"body": 4, "word": "without", "fig": 2}, {"body": 7, "word": "analysis", "fig": 1}, {"body": 3, "word": "stably", "fig": 2}, {"body": 6, "word": "Tyr845", "fig": 1}, {"body": 6, "word": "mobility", "fig": 1}, {"body": 6, "word": "attached", "fig": 1}, {"body": 5, "word": "disrupt", "fig": 1}, {"body": 5, "word": "enhanced", "fig": 1}, {"body": 5, "word": "coexpression", "fig": 1}, {"body": 4, "word": "adherens", "fig": 1}, {"body": 4, "word": "induces", "fig": 1}, {"body": 4, "word": "substratum", "fig": 1}, {"body": 2, "word": "collagen", "fig": 2}, {"body": 2, "word": "Coexpression", "fig": 2}, {"body": 2, "word": "wild-type", "fig": 2}, {"body": 2, "word": "plastic", "fig": 2}, {"body": 2, "word": "detached", "fig": 2}, {"body": 2, "word": "tissue", "fig": 2}, {"body": 2, "word": "I", "fig": 2}, {"body": 4, "word": "effect", "fig": 1}, {"body": 3, "word": "Similar", "fig": 1}, {"body": 1, "word": "hours", "fig": 3}, {"body": 3, "word": "NSC624205", "fig": 1}, {"body": 3, "word": "whether", "fig": 1}, {"body": 3, "word": "shift", "fig": 1}, {"body": 3, "word": "result", "fig": 1}, {"body": 3, "word": "Immunoblot", "fig": 1}, {"body": 3, "word": "immunoblot", "fig": 1}, {"body": 3, "word": "Results", "fig": 1}, {"body": 2, "word": "band", "fig": 1}, {"body": 2, "word": "gels", "fig": 1}, {"body": 2, "word": "3e", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "onto", "fig": 1}, {"body": 2, "word": "Treatment", "fig": 1}, {"body": 1, "word": "grown", "fig": 2}, {"body": 1, "word": "plated", "fig": 2}, {"body": 2, "word": "stimulated", "fig": 1}, {"body": 1, "word": "combinations", "fig": 1}, {"body": 1, "word": "remaining", "fig": 1}, {"body": 1, "word": "Cells", "fig": 1}, {"body": 1, "word": "background", "fig": 1}, {"body": 1, "word": "NSC333839", "fig": 1}, {"body": 1, "word": "3b", "fig": 1}, {"body": 1, "word": "g", "fig": 1}, {"body": 1, "word": "fraction", "fig": 1}, {"body": 1, "word": "electrophoretic", "fig": 1}, {"body": 1, "word": "minutes", "fig": 1}, {"body": 1, "word": "plates", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig4_HTML.jpg", "caption": "CDCP1, EGFR, and EGF cooperate to induce E-cadherin internalization. a T47D cells stably expressing an E-cadherin-GFP fusion protein and either EGFR, CDCP1, or EGFR + CDCP1, or the corresponding vector control line were plated on glass coverslips coated with collagen I and treated for 24 hours with or without 10 ng/ml EGF. Intracellular E-cadherin-GFP localization was imaged by confocal immunofluorescence microscopy. b The indicated T47D cell lines were stimulated with or without 20 ng/ml EGF for 24 hours and subjected to cell surface biotinylation. Biotinylated proteins (external, Ext.) were isolated by streptavidin-agarose chromatography and unbound proteins were collected as non-biotinylated proteins (internal, Int.). Protein fractions were analyzed by immunoblot. c The indicated cell lines treated as in Fig. 4b were extracted with 1 % Triton X100 and analyzed by immunoblot", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 3}, {"body": 72, "word": "EGFR", "fig": 3}, {"body": 42, "word": "cell", "fig": 3}, {"body": 38, "word": "proteins", "fig": 3}, {"body": 35, "word": "The", "fig": 2}, {"body": 22, "word": "EGF", "fig": 3}, {"body": 57, "word": "E-cadherin", "fig": 1}, {"body": 55, "word": "Fig", "fig": 1}, {"body": 55, "word": "cells", "fig": 1}, {"body": 16, "word": "lines", "fig": 2}, {"body": 28, "word": "protein", "fig": 1}, {"body": 8, "word": "T47D", "fig": 2}, {"body": 11, "word": "localization", "fig": 1}, {"body": 10, "word": "control", "fig": 1}, {"body": 10, "word": "line", "fig": 1}, {"body": 8, "word": "either", "fig": 1}, {"body": 8, "word": "surface", "fig": 1}, {"body": 4, "word": "without", "fig": 2}, {"body": 7, "word": "vector", "fig": 1}, {"body": 3, "word": "immunoblot", "fig": 2}, {"body": 6, "word": "induce", "fig": 1}, {"body": 3, "word": "indicated", "fig": 2}, {"body": 4, "word": "internalization", "fig": 1}, {"body": 4, "word": "fusion", "fig": 1}, {"body": 4, "word": "expressing", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 2}, {"body": 4, "word": "biotinylation", "fig": 1}, {"body": 2, "word": "E-cadherin-GFP", "fig": 2}, {"body": 4, "word": "cooperate", "fig": 1}, {"body": 2, "word": "treated", "fig": 2}, {"body": 3, "word": "stably", "fig": 1}, {"body": 3, "word": "Triton", "fig": 1}, {"body": 3, "word": "X100", "fig": 1}, {"body": 3, "word": "Protein", "fig": 1}, {"body": 3, "word": "isolated", "fig": 1}, {"body": 3, "word": "extracted", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}, {"body": 1, "word": "hours", "fig": 2}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "collagen", "fig": 1}, {"body": 2, "word": "stimulated", "fig": 1}, {"body": 2, "word": "I", "fig": 1}, {"body": 1, "word": "Biotinylated", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "non-biotinylated", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "streptavidin-agarose", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "external", "fig": 1}, {"body": 1, "word": "plated", "fig": 1}, {"body": 1, "word": "internal", "fig": 1}, {"body": 1, "word": "4b", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig5_HTML.jpg", "caption": "Characterization of E-cadherin/CDCP1-containing protein complexes. a MDA-MB-231 or T47D cell lines stably expressing an E-cadherin-glutathione S-transferase (E-cad-GST) fusion protein were transduced with an adenovirus encoding \u0394CDCP1-FLAG or a control adenovirus encoding GFP. Cell extracts were subjected to sequential affinity purification using anti-FLAG agarose followed by glutathione-agarose. b T47D cell extracts were immunoprecipitated with a CDCP1 antibody and the immunoprecipitates were analyzed by immunoblot with the indicated antibodies. c The indicated stable cell lines were transduced with adenoviruses encoding GFP (control) or \u0394CDCP1-FLAG and cell extracts were subjected to affinity purification with either anti-FLAG agarose or glutathione agarose. Affinity-purified proteins were analyzed by immunoblot. d HEK 293 cells were transiently transfected with the indicated tagged CDCP1 constructs and treated with the specified DDAs or vehicle. CDCP1 dimerization was monitored by TALON pulldown of His6-tagged proteins followed by purification with anti-FLAG agarose and immunoblot analysis of the sequentially affinity-purified material. e HEK 293 cells were transiently transfected with the indicated plasmid constructs and cell extracts were affinity purified sequentially using TALON resin and anti-FLAG agarose. The affinity-purified material was analyzed by immunoblot", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 3}, {"body": 42, "word": "cell", "fig": 5}, {"body": 55, "word": "cells", "fig": 2}, {"body": 38, "word": "proteins", "fig": 2}, {"body": 35, "word": "The", "fig": 2}, {"body": 28, "word": "protein", "fig": 2}, {"body": 21, "word": "using", "fig": 2}, {"body": 36, "word": "complexes", "fig": 1}, {"body": 16, "word": "lines", "fig": 2}, {"body": 7, "word": "encoding", "fig": 3}, {"body": 10, "word": "control", "fig": 2}, {"body": 8, "word": "T47D", "fig": 2}, {"body": 4, "word": "anti-FLAG", "fig": 4}, {"body": 5, "word": "affinity", "fig": 3}, {"body": 3, "word": "agarose", "fig": 5}, {"body": 5, "word": "purification", "fig": 3}, {"body": 3, "word": "immunoblot", "fig": 4}, {"body": 3, "word": "indicated", "fig": 4}, {"body": 10, "word": "DDAs", "fig": 1}, {"body": 8, "word": "either", "fig": 1}, {"body": 4, "word": "followed", "fig": 2}, {"body": 7, "word": "analysis", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 3}, {"body": 3, "word": "GFP", "fig": 2}, {"body": 5, "word": "Cell", "fig": 1}, {"body": 5, "word": "plasmid", "fig": 1}, {"body": 4, "word": "stable", "fig": 1}, {"body": 4, "word": "expressing", "fig": 1}, {"body": 4, "word": "dimerization", "fig": 1}, {"body": 2, "word": "affinity-purified", "fig": 2}, {"body": 2, "word": "transfected", "fig": 2}, {"body": 2, "word": "adenovirus", "fig": 2}, {"body": 2, "word": "constructs", "fig": 2}, {"body": 2, "word": "HEK", "fig": 2}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 4, "word": "fusion", "fig": 1}, {"body": 3, "word": "glutathione-agarose", "fig": 1}, {"body": 3, "word": "stably", "fig": 1}, {"body": 3, "word": "specified", "fig": 1}, {"body": 3, "word": "MDA-MB-231", "fig": 1}, {"body": 3, "word": "immunoprecipitates", "fig": 1}, {"body": 1, "word": "subjected", "fig": 2}, {"body": 1, "word": "transduced", "fig": 2}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "S-transferase", "fig": 1}, {"body": 1, "word": "transiently", "fig": 2}, {"body": 1, "word": "TALON", "fig": 2}, {"body": 2, "word": "treated", "fig": 1}, {"body": 1, "word": "sequentially", "fig": 2}, {"body": 1, "word": "tagged", "fig": 1}, {"body": 1, "word": "pulldown", "fig": 1}, {"body": 1, "word": "glutathione", "fig": 1}, {"body": 1, "word": "resin", "fig": 1}, {"body": 1, "word": "sequential", "fig": 1}, {"body": 1, "word": "immunoprecipitated", "fig": 1}, {"body": 1, "word": "antibody", "fig": 1}, {"body": 1, "word": "adenoviruses", "fig": 1}, {"body": 1, "word": "E-cadherin-glutathione", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig6_HTML.jpg", "caption": "Characterization of CDCP1-containing protein complexes reveals that MMP14 preferentially associates with cleaved CDCP1, while Galectin 1 only binds to full-length CDCP1. a Coomassie-stained SDS-PAGE gel of proteins affinity purified from MDA-MB-231 cells transduced with FLAG-tagged \u0394CDCP1 or CDCP1 and treated for 15 minutes with or without the tyrosine phosphatase inhibitor sodium pervanadate (100 \u03bcM) to elevate overall tyrosine phosphorylation. Protein bands were excised and identified by mass spectrometry as described in the \u201cMethods\u201d section. b Extracts from MDA-MB-231 cells transduced with the indicated adenoviral vectors were affinity purified with anti-FLAG agarose to isolate CDCP1-containing complexes and the purified material or corresponding crude lysates were analyzed by immunoblot. c Study performed as in Fig. 5b except that cells were treated for 24 hours with either vehicle, 20 \u03bcM of the matrix metalloproteinase inhibitor GM6001 or 100 nM of the Src-family kinase inhibitor dasatinib. d Silver-stained SDS-PAGE gel of proteins isolated by anti-FLAG affinity purification from MDA-MB-231 cells transduced with the indicated adenoviruses and treated for 15 minutes with or without 100 \u03bcM sodium pervanadate. A low-molecular-mass protein was observed (red arrow) that was present when full-length forms of CDCP1 were expressed, but not when cleaved forms of CDCP1 (\u0394CDCP1) were expressed. e HEK 293 cells were transiently transfected with the indicated vectors and CDCP1 or \u0394CDCP1-containing complexes were isolated with anti-FLAG agarose and analyzed by immunoblot", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 6}, {"body": 55, "word": "cells", "fig": 5}, {"body": 36, "word": "complexes", "fig": 3}, {"body": 38, "word": "proteins", "fig": 2}, {"body": 28, "word": "protein", "fig": 2}, {"body": 55, "word": "Fig", "fig": 1}, {"body": 23, "word": "\u0394CDCP1", "fig": 2}, {"body": 13, "word": "full-length", "fig": 2}, {"body": 13, "word": "cleaved", "fig": 2}, {"body": 12, "word": "tyrosine", "fig": 2}, {"body": 19, "word": "phosphorylation", "fig": 1}, {"body": 6, "word": "inhibitor", "fig": 3}, {"body": 5, "word": "affinity", "fig": 3}, {"body": 15, "word": "observed", "fig": 1}, {"body": 6, "word": "forms", "fig": 2}, {"body": 12, "word": "associates", "fig": 1}, {"body": 4, "word": "anti-FLAG", "fig": 3}, {"body": 11, "word": "MMP14", "fig": 1}, {"body": 5, "word": "expressed", "fig": 2}, {"body": 9, "word": "Galectin", "fig": 1}, {"body": 3, "word": "MDA-MB-231", "fig": 3}, {"body": 3, "word": "indicated", "fig": 3}, {"body": 9, "word": "performed", "fig": 1}, {"body": 8, "word": "either", "fig": 1}, {"body": 4, "word": "CDCP1-containing", "fig": 2}, {"body": 8, "word": "described", "fig": 1}, {"body": 4, "word": "without", "fig": 2}, {"body": 8, "word": "mass", "fig": 1}, {"body": 7, "word": "identified", "fig": 1}, {"body": 7, "word": "A", "fig": 1}, {"body": 7, "word": "present", "fig": 1}, {"body": 3, "word": "immunoblot", "fig": 2}, {"body": 3, "word": "pervanadate", "fig": 2}, {"body": 2, "word": "treated", "fig": 3}, {"body": 3, "word": "isolated", "fig": 2}, {"body": 3, "word": "agarose", "fig": 2}, {"body": 5, "word": "matrix", "fig": 1}, {"body": 5, "word": "spectrometry", "fig": 1}, {"body": 5, "word": "purification", "fig": 1}, {"body": 2, "word": "sodium", "fig": 2}, {"body": 2, "word": "gel", "fig": 2}, {"body": 2, "word": "analyzed", "fig": 2}, {"body": 4, "word": "Src-family", "fig": 1}, {"body": 3, "word": "bands", "fig": 1}, {"body": 1, "word": "transduced", "fig": 3}, {"body": 3, "word": "Protein", "fig": 1}, {"body": 3, "word": "preferentially", "fig": 1}, {"body": 3, "word": "dasatinib", "fig": 1}, {"body": 3, "word": "kinase", "fig": 1}, {"body": 3, "word": "metalloproteinase", "fig": 1}, {"body": 2, "word": "FLAG-tagged", "fig": 1}, {"body": 2, "word": "adenoviral", "fig": 1}, {"body": 2, "word": "overall", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 1, "word": "vectors", "fig": 2}, {"body": 2, "word": "transfected", "fig": 1}, {"body": 2, "word": "HEK", "fig": 1}, {"body": 1, "word": "minutes", "fig": 2}, {"body": 1, "word": "5b", "fig": 1}, {"body": 1, "word": "arrow", "fig": 1}, {"body": 1, "word": "phosphatase", "fig": 1}, {"body": 1, "word": "GM6001", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "hours", "fig": 1}, {"body": 1, "word": "lysates", "fig": 1}, {"body": 1, "word": "adenoviruses", "fig": 1}, {"body": 1, "word": "corresponding", "fig": 1}, {"body": 1, "word": "transiently", "fig": 1}, {"body": 1, "word": "binds", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig7_HTML.jpg", "caption": "CDCP1 complexes are similar between breast and pancreatic cancer cell lines and are stable in a variety of detergents. a MDA-MB-231 or T47D cells were transduced with the indicated adenoviral vectors, CDCP1-containing complexes were isolated with anti-FLAG agarose, and the presence of components of adherens and desmosomal junctions was assessed by immunoblot analysis. b This study was carried out similarly to the study in Fig. 6a, except that the pancreatic cancer cell lines AsPC1 or PANC1 were used. c AsPC1 cells were transduced with control (GFP) or \u0394CDCP1 adenoviruses, the cells were extracted with the indicated detergents, and \u0394CDCP1-associated proteins were examined by immunoblot (left panel) or total protein levels were assessed by Coomassie staining of the same samples resolved by SDS-PAGE (right panel)", "co_occurrence": [{"body": 55, "word": "cells", "fig": 3}, {"body": 146, "word": "CDCP1", "fig": 1}, {"body": 42, "word": "cell", "fig": 2}, {"body": 36, "word": "complexes", "fig": 2}, {"body": 55, "word": "Fig", "fig": 1}, {"body": 38, "word": "proteins", "fig": 1}, {"body": 17, "word": "cancer", "fig": 2}, {"body": 16, "word": "lines", "fig": 2}, {"body": 28, "word": "protein", "fig": 1}, {"body": 23, "word": "\u0394CDCP1", "fig": 1}, {"body": 16, "word": "levels", "fig": 1}, {"body": 13, "word": "junctions", "fig": 1}, {"body": 11, "word": "This", "fig": 1}, {"body": 10, "word": "control", "fig": 1}, {"body": 8, "word": "T47D", "fig": 1}, {"body": 8, "word": "breast", "fig": 1}, {"body": 8, "word": "similar", "fig": 1}, {"body": 7, "word": "analysis", "fig": 1}, {"body": 6, "word": "used", "fig": 1}, {"body": 3, "word": "indicated", "fig": 2}, {"body": 3, "word": "panel", "fig": 2}, {"body": 3, "word": "immunoblot", "fig": 2}, {"body": 3, "word": "study", "fig": 2}, {"body": 5, "word": "presence", "fig": 1}, {"body": 5, "word": "desmosomal", "fig": 1}, {"body": 5, "word": "samples", "fig": 1}, {"body": 4, "word": "CDCP1-containing", "fig": 1}, {"body": 4, "word": "stable", "fig": 1}, {"body": 4, "word": "anti-FLAG", "fig": 1}, {"body": 4, "word": "adherens", "fig": 1}, {"body": 3, "word": "6a", "fig": 1}, {"body": 3, "word": "isolated", "fig": 1}, {"body": 3, "word": "GFP", "fig": 1}, {"body": 3, "word": "MDA-MB-231", "fig": 1}, {"body": 3, "word": "agarose", "fig": 1}, {"body": 3, "word": "extracted", "fig": 1}, {"body": 3, "word": "carried", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "similarly", "fig": 1}, {"body": 2, "word": "adenoviral", "fig": 1}, {"body": 1, "word": "detergents", "fig": 2}, {"body": 1, "word": "assessed", "fig": 2}, {"body": 1, "word": "pancreatic", "fig": 2}, {"body": 1, "word": "transduced", "fig": 2}, {"body": 1, "word": "AsPC1", "fig": 2}, {"body": 1, "word": "right", "fig": 1}, {"body": 1, "word": "PANC1", "fig": 1}, {"body": 1, "word": "adenoviruses", "fig": 1}, {"body": 1, "word": "vectors", "fig": 1}, {"body": 1, "word": "examined", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig8_HTML.jpg", "caption": "Enigma/PDLIM7 as a novel CDCP1-associated protein. a MDA-MB-231 cells were transduced with the indicated recombinant adenoviruses, then treated for 15 minutes with 100 \u03bcM sodium pervanadate just before cell lysates were prepared. The various forms of CDCP1 were isolated by anti-FLAG affinity chromatography and CDCP1-associated proteins were identified by immunoblot. Note that the phospho-PKC\u03b4[Y311] antibody cross-reacts with phosphorylated Tyr707 of CDCP1 and that staining was absent when the Y707F mutant of CDCP1 was employed. b HEK 293 cells were transfected with the indicated constructs, cell lysates were immunoprecipitated with an E-cadherin antibody, and the immunoprecipitates were analyzed by immunoblot. c HEK 293 cells were transfected with the indicated constructs, cell lysates were immunoprecipitated with anti-FLAG agarose, and the immunoprecipitates were analyzed by immunoblot. d HEK 293 cells were transfected with the indicated constructs, cell lysates were immunoprecipitated with an E-cadherin antibody, and the immunoprecipitates were analyzed by immunoblot", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 3}, {"body": 55, "word": "cells", "fig": 4}, {"body": 42, "word": "cell", "fig": 4}, {"body": 57, "word": "E-cadherin", "fig": 2}, {"body": 38, "word": "proteins", "fig": 1}, {"body": 35, "word": "The", "fig": 1}, {"body": 28, "word": "protein", "fig": 1}, {"body": 7, "word": "CDCP1-associated", "fig": 2}, {"body": 3, "word": "indicated", "fig": 4}, {"body": 3, "word": "immunoblot", "fig": 4}, {"body": 3, "word": "immunoprecipitates", "fig": 3}, {"body": 4, "word": "anti-FLAG", "fig": 2}, {"body": 7, "word": "mutant", "fig": 1}, {"body": 7, "word": "identified", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 3}, {"body": 6, "word": "forms", "fig": 1}, {"body": 2, "word": "constructs", "fig": 3}, {"body": 2, "word": "HEK", "fig": 3}, {"body": 2, "word": "transfected", "fig": 3}, {"body": 5, "word": "affinity", "fig": 1}, {"body": 1, "word": "lysates", "fig": 4}, {"body": 4, "word": "prepared", "fig": 1}, {"body": 1, "word": "antibody", "fig": 3}, {"body": 3, "word": "phosphorylated", "fig": 1}, {"body": 3, "word": "pervanadate", "fig": 1}, {"body": 3, "word": "isolated", "fig": 1}, {"body": 3, "word": "MDA-MB-231", "fig": 1}, {"body": 3, "word": "agarose", "fig": 1}, {"body": 1, "word": "immunoprecipitated", "fig": 3}, {"body": 3, "word": "employed", "fig": 1}, {"body": 3, "word": "novel", "fig": 1}, {"body": 2, "word": "sodium", "fig": 1}, {"body": 2, "word": "various", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "Y707F", "fig": 1}, {"body": 2, "word": "treated", "fig": 1}, {"body": 1, "word": "transduced", "fig": 1}, {"body": 1, "word": "adenoviruses", "fig": 1}, {"body": 1, "word": "recombinant", "fig": 1}, {"body": 1, "word": "absent", "fig": 1}, {"body": 1, "word": "minutes", "fig": 1}, {"body": 1, "word": "Enigma/PDLIM7", "fig": 1}, {"body": 1, "word": "phospho-PKC\u03b4", "fig": 1}, {"body": 1, "word": "Y311", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974783/bin/13058_2016_741_Fig9_HTML.jpg", "caption": "Model for CDCP1 influences on cell-cell and substratum adhesion through a variety of mechanisms. We propose that CDCP1 participates in complexes with EGFR and Src leading to Src activation and EGFR transactivation, and that CDCP1 also participates in complexes that contain cell adhesion proteins such as cadherins and catenins. EGFR and Src have been established to reduce E-cadherin-mediated cell-cell adhesion and to induce E-cadherin internalization into cytoplasmic vesicles. Therefore, CDCP1 may abrogate cadherin adhesive function through the assembly of \u201canti-adhesive\u201d complexes", "co_occurrence": [{"body": 146, "word": "CDCP1", "fig": 4}, {"body": 72, "word": "EGFR", "fig": 3}, {"body": 36, "word": "complexes", "fig": 3}, {"body": 34, "word": "Src", "fig": 3}, {"body": 57, "word": "E-cadherin", "fig": 1}, {"body": 17, "word": "adhesion", "fig": 3}, {"body": 24, "word": "cell-cell", "fig": 2}, {"body": 42, "word": "cell", "fig": 1}, {"body": 38, "word": "proteins", "fig": 1}, {"body": 15, "word": "may", "fig": 1}, {"body": 14, "word": "also", "fig": 1}, {"body": 9, "word": "transactivation", "fig": 1}, {"body": 8, "word": "activation", "fig": 1}, {"body": 8, "word": "contain", "fig": 1}, {"body": 6, "word": "function", "fig": 1}, {"body": 6, "word": "mechanisms", "fig": 1}, {"body": 6, "word": "induce", "fig": 1}, {"body": 4, "word": "internalization", "fig": 1}, {"body": 4, "word": "substratum", "fig": 1}, {"body": 3, "word": "cytoplasmic", "fig": 1}, {"body": 3, "word": "cadherin", "fig": 1}, {"body": 2, "word": "vesicles", "fig": 1}, {"body": 2, "word": "established", "fig": 1}, {"body": 1, "word": "participates", "fig": 2}, {"body": 2, "word": "influences", "fig": 1}, {"body": 1, "word": "Therefore", "fig": 1}, {"body": 1, "word": "adhesive", "fig": 1}, {"body": 1, "word": "cadherins", "fig": 1}]}], "3727923": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727923/bin/2303fig1.jpg", "caption": "Human Argonaute2 exists in complex with Dicer, Hsp90, and the cochaperones FKBP4 and p23. (A) HeLa cells transiently transfected with pcDNA3/myc-hAgo2 (WT) or empty pcDNA3 (V) were lysed 16 h posttransfection and subjected to immunoprecipitation (IP) using Sepharose beads coated with monoclonal anti-myc antibodies (myc) or anti-VSVG (con) as a control. Total cell lysate (Input) and bound fractions were subjected to SDS\u2013PAGE and immunoblotted for hAgo2, Dicer, Hsp90, Hsp70, and cochaperones as indicated. (B) Immunoprecipitations performed as in A were treated with or without the nuclease Benzonase (nuc) for 15 min before addition of Sepharose beads. (C, D) Lysates of untransfected HeLa cells were subjected to immunoprecipitation using monoclonal antibodies against hAgo2, p23, FKBP4, or VSV-G (P5D4) as a control. Total cell lysate (Input) and unbound and bound fractions were subjected to SDS\u2013PAGE and immunoblotted for hAgo2, p23, and FKBP4 as indicated. Nonspecific band marked with an asterisk.", "co_occurrence": [{"body": 49, "word": "hAgo2", "fig": 3}, {"body": 54, "word": "Hsp90", "fig": 2}, {"body": 28, "word": "p23", "fig": 3}, {"body": 27, "word": "FKBP4", "fig": 3}, {"body": 27, "word": "cochaperones", "fig": 2}, {"body": 29, "word": "complex", "fig": 1}, {"body": 14, "word": "cells", "fig": 2}, {"body": 10, "word": "using", "fig": 2}, {"body": 8, "word": "control", "fig": 2}, {"body": 6, "word": "Dicer", "fig": 2}, {"body": 5, "word": "beads", "fig": 2}, {"body": 5, "word": "cell", "fig": 2}, {"body": 4, "word": "bound", "fig": 2}, {"body": 4, "word": "immunoprecipitation", "fig": 2}, {"body": 4, "word": "antibodies", "fig": 2}, {"body": 7, "word": "h", "fig": 1}, {"body": 3, "word": "HeLa", "fig": 2}, {"body": 3, "word": "A", "fig": 2}, {"body": 4, "word": "Hsp70", "fig": 1}, {"body": 1, "word": "subjected", "fig": 4}, {"body": 4, "word": "transiently", "fig": 1}, {"body": 2, "word": "monoclonal", "fig": 2}, {"body": 2, "word": "Sepharose", "fig": 2}, {"body": 4, "word": "performed", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "anti-myc", "fig": 1}, {"body": 3, "word": "min", "fig": 1}, {"body": 2, "word": "P5D4", "fig": 1}, {"body": 1, "word": "immunoblotted", "fig": 2}, {"body": 2, "word": "Benzonase", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 2}, {"body": 1, "word": "Input", "fig": 2}, {"body": 1, "word": "fractions", "fig": 2}, {"body": 1, "word": "lysate", "fig": 2}, {"body": 2, "word": "Argonaute2", "fig": 1}, {"body": 2, "word": "lysed", "fig": 1}, {"body": 1, "word": "band", "fig": 1}, {"body": 1, "word": "posttransfection", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727923/bin/2303fig2.jpg", "caption": "Knockdown of Hsp90 cochaperones reduces efficiency of RNAi. (A) HeLa cells were harvested 72 h after transient cotransfection with pLKO.1 vectors expressing shRNAs against hAgo2, FKBP4, Cdc37, Aha1, p23, or a nonsilencing control (nsc) as a control and a GFP-based reporter for RNAi activity (GFP-let7a) or the control (GFP-let7XX). Lysates were subjected to SDS\u2013PAGE and immunoblotted for GFP and actin as a loading control. (B) GFP expression was quantitated using Odyssey software and normalized to actin. RNAi efficiency was calculated by determining the relative GFP expression between cells expressing GFP-let7a or GFP-let7XX. The efficiency of RNAi-mediated silencing was calculated independently for each shRNA, and the pLKO.1-nsc\u2013transfected sample was set to 100%. Error bars represent SE, and n values are indicated below the axis. *p < 0.05; **p < 0.01.", "co_occurrence": [{"body": 19, "word": "RNAi", "fig": 3}, {"body": 54, "word": "Hsp90", "fig": 1}, {"body": 49, "word": "hAgo2", "fig": 1}, {"body": 8, "word": "control", "fig": 4}, {"body": 28, "word": "p23", "fig": 1}, {"body": 14, "word": "cells", "fig": 2}, {"body": 27, "word": "FKBP4", "fig": 1}, {"body": 27, "word": "cochaperones", "fig": 1}, {"body": 23, "word": "Cdc37", "fig": 1}, {"body": 7, "word": "efficiency", "fig": 3}, {"body": 19, "word": "Aha1", "fig": 1}, {"body": 17, "word": "activity", "fig": 1}, {"body": 5, "word": "GFP", "fig": 3}, {"body": 6, "word": "expression", "fig": 2}, {"body": 11, "word": "The", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 5, "word": "GFP-let7a", "fig": 2}, {"body": 9, "word": "loading", "fig": 1}, {"body": 4, "word": "GFP-let7XX", "fig": 2}, {"body": 7, "word": "h", "fig": 1}, {"body": 6, "word": "reporter", "fig": 1}, {"body": 6, "word": "silencing", "fig": 1}, {"body": 2, "word": "expressing", "fig": 2}, {"body": 3, "word": "HeLa", "fig": 1}, {"body": 3, "word": "software", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "actin", "fig": 2}, {"body": 2, "word": "pLKO.1", "fig": 1}, {"body": 2, "word": "reduces", "fig": 1}, {"body": 2, "word": "nonsilencing", "fig": 1}, {"body": 2, "word": "transient", "fig": 1}, {"body": 2, "word": "shRNA", "fig": 1}, {"body": 2, "word": "shRNAs", "fig": 1}, {"body": 1, "word": "calculated", "fig": 2}, {"body": 1, "word": "immunoblotted", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "Odyssey", "fig": 1}, {"body": 1, "word": "pLKO.1-nsc\u2013transfected", "fig": 1}, {"body": 1, "word": "set", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "determining", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 1, "word": "RNAi-mediated", "fig": 1}, {"body": 1, "word": "nsc", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "harvested", "fig": 1}, {"body": 1, "word": "sample", "fig": 1}, {"body": 1, "word": "GFP-based", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727923/bin/2303fig3.jpg", "caption": "Knockdown of Hsp90 cochaperones does not affect the level of RNAi effector proteins. (A) HeLa cells were harvested 72 h after transient cotransfection with pLKO.1 vectors expressing shRNAs against hAgo2, FKBP4, Cdc37, Aha1, p23, or a nonsilencing control (nsc) as a control. Lysates were subjected to SDS\u2013PAGE, and the levels of the RNAi effector proteins Dicer and hAgo2 were determined by immunoblot analysis. (B) Lysates from A were immunoblotted for the targeted cochaperones FKBP4, Cdc37, Aha1, and p23. (C) Signal intensities for FKBP4, Cdc37, Aha1, and p23 were quantitated for each knockdown. The bar graph indicates the average level of expression of the shRNA-targeted protein remaining 72 h posttransfection relative to the nonsilencing control.", "co_occurrence": [{"body": 49, "word": "hAgo2", "fig": 2}, {"body": 28, "word": "p23", "fig": 3}, {"body": 27, "word": "FKBP4", "fig": 3}, {"body": 23, "word": "Cdc37", "fig": 3}, {"body": 19, "word": "Aha1", "fig": 3}, {"body": 54, "word": "Hsp90", "fig": 1}, {"body": 27, "word": "cochaperones", "fig": 2}, {"body": 19, "word": "RNAi", "fig": 2}, {"body": 13, "word": "proteins", "fig": 2}, {"body": 8, "word": "control", "fig": 3}, {"body": 7, "word": "h", "fig": 2}, {"body": 14, "word": "cells", "fig": 1}, {"body": 11, "word": "The", "fig": 1}, {"body": 11, "word": "knockdown", "fig": 1}, {"body": 7, "word": "protein", "fig": 1}, {"body": 6, "word": "Dicer", "fig": 1}, {"body": 3, "word": "A", "fig": 2}, {"body": 3, "word": "level", "fig": 2}, {"body": 6, "word": "expression", "fig": 1}, {"body": 5, "word": "targeted", "fig": 1}, {"body": 2, "word": "nonsilencing", "fig": 2}, {"body": 4, "word": "levels", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "HeLa", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 1, "word": "effector", "fig": 2}, {"body": 2, "word": "analysis", "fig": 1}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "immunoblot", "fig": 1}, {"body": 2, "word": "pLKO.1", "fig": 1}, {"body": 2, "word": "shRNAs", "fig": 1}, {"body": 2, "word": "transient", "fig": 1}, {"body": 2, "word": "affect", "fig": 1}, {"body": 1, "word": "immunoblotted", "fig": 1}, {"body": 1, "word": "posttransfection", "fig": 1}, {"body": 1, "word": "subjected", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "nsc", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "harvested", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 1}, {"body": 1, "word": "intensities", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727923/bin/2303fig4.jpg", "caption": "Inability to load small RNAs increases association between hAgo2, Hsp90, and cochaperones. (A) HeLa cells transiently transfected with pcDNA3/myc-hAgo2 (WT), pcDNA3/myc-hAgo2-PAZ9 (PAZ9), pcDNA3/myc-hAgo2-H634P (H634P), or empty pcDNA3 (con) were lysed 16 h posttransfection and subjected to immunoprecipitation using Sepharose beads coated with monoclonal anti-myc antibodies (myc) or anti-VSVG (control) as a control. Total cell lysate (Input) and bound fractions were subjected to SDS\u2013PAGE and immunoblotted for hAgo2, Dicer, Hsp90, Hsp70, and cochaperones as indicated. (B) Signal intensities for Dicer, Hsp90, Hsp70, FKBP4, and p23 were quantitated and normalized to level of immunoprecipitated hAgo2. The bar graph indicates the fold change in the amount of each coimmunoprecipitated hAgo2-binding partner analyzed relative to the amount associated with wild-type hAgo2. Error bars indicate SE. *p < 0.05; **p < 0.01.", "co_occurrence": [{"body": 49, "word": "hAgo2", "fig": 4}, {"body": 54, "word": "Hsp90", "fig": 3}, {"body": 27, "word": "cochaperones", "fig": 2}, {"body": 28, "word": "p23", "fig": 1}, {"body": 27, "word": "FKBP4", "fig": 1}, {"body": 20, "word": "small", "fig": 1}, {"body": 8, "word": "control", "fig": 2}, {"body": 14, "word": "cells", "fig": 1}, {"body": 13, "word": "RNAs", "fig": 1}, {"body": 6, "word": "Dicer", "fig": 2}, {"body": 11, "word": "The", "fig": 1}, {"body": 10, "word": "using", "fig": 1}, {"body": 4, "word": "Hsp70", "fig": 2}, {"body": 7, "word": "h", "fig": 1}, {"body": 5, "word": "association", "fig": 1}, {"body": 5, "word": "beads", "fig": 1}, {"body": 5, "word": "PAZ9", "fig": 1}, {"body": 5, "word": "cell", "fig": 1}, {"body": 4, "word": "change", "fig": 1}, {"body": 4, "word": "bound", "fig": 1}, {"body": 4, "word": "transiently", "fig": 1}, {"body": 4, "word": "associated", "fig": 1}, {"body": 4, "word": "immunoprecipitation", "fig": 1}, {"body": 4, "word": "antibodies", "fig": 1}, {"body": 3, "word": "HeLa", "fig": 1}, {"body": 3, "word": "increases", "fig": 1}, {"body": 3, "word": "level", "fig": 1}, {"body": 3, "word": "H634P", "fig": 1}, {"body": 3, "word": "transfected", "fig": 1}, {"body": 3, "word": "indicate", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "anti-myc", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 1, "word": "subjected", "fig": 2}, {"body": 2, "word": "immunoprecipitated", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "wild-type", "fig": 1}, {"body": 2, "word": "monoclonal", "fig": 1}, {"body": 2, "word": "Sepharose", "fig": 1}, {"body": 2, "word": "lysed", "fig": 1}, {"body": 1, "word": "immunoblotted", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "posttransfection", "fig": 1}, {"body": 1, "word": "load", "fig": 1}, {"body": 1, "word": "Input", "fig": 1}, {"body": 1, "word": "fractions", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "coimmunoprecipitated", "fig": 1}, {"body": 1, "word": "intensities", "fig": 1}, {"body": 1, "word": "lysate", "fig": 1}, {"body": 1, "word": "SDS\u2013PAGE", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727923/bin/2303fig5.jpg", "caption": "Model of cochaperone involvement in Hsp90-mediated maturation of RISC. (A) ATP-binding to Hsp90 facilitates a conformational change in the chaperone\u2013client complex, leading to an \u201copen\u201d conformation of hAgo2. This transient intermediate is stabilized by interaction with p23, which delays the hydrolysis of ATP and release of the client. (B) Interaction with the RISC loading complex and subsequent loading of a small RNA causing a second conformational change in hAgo2. (C) PPIase activity of FKBP4 alters the cis/trans bond configuration of hAgo2, stabilizing the loaded conformation of RISC and its interaction with the guide RNA. The isomerization of peptidyl-prolyl bonds in hAgo2 triggers the coordinated exchange of p23 with Aha1. (D) Binding of Aha1 activates the ATPase activity of Hsp90. ATP hydrolysis promotes the rapid resolution of the chaperone\u2013client complex, unwinding and removal of the passenger strand, and release of the mature RISC.", "co_occurrence": [{"body": 49, "word": "hAgo2", "fig": 4}, {"body": 54, "word": "Hsp90", "fig": 2}, {"body": 29, "word": "complex", "fig": 3}, {"body": 28, "word": "p23", "fig": 2}, {"body": 19, "word": "Aha1", "fig": 2}, {"body": 9, "word": "RISC", "fig": 4}, {"body": 17, "word": "activity", "fig": 2}, {"body": 14, "word": "RNA", "fig": 2}, {"body": 27, "word": "FKBP4", "fig": 1}, {"body": 20, "word": "small", "fig": 1}, {"body": 9, "word": "ATP", "fig": 2}, {"body": 9, "word": "loading", "fig": 2}, {"body": 8, "word": "hydrolysis", "fig": 2}, {"body": 16, "word": "client", "fig": 1}, {"body": 11, "word": "maturation", "fig": 1}, {"body": 11, "word": "The", "fig": 1}, {"body": 4, "word": "interaction", "fig": 2}, {"body": 4, "word": "conformational", "fig": 2}, {"body": 4, "word": "change", "fig": 2}, {"body": 7, "word": "cochaperone", "fig": 1}, {"body": 6, "word": "resolution", "fig": 1}, {"body": 5, "word": "This", "fig": 1}, {"body": 5, "word": "ATPase", "fig": 1}, {"body": 3, "word": "strand", "fig": 1}, {"body": 3, "word": "C", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "guide", "fig": 1}, {"body": 2, "word": "loaded", "fig": 1}, {"body": 2, "word": "cis/trans", "fig": 1}, {"body": 2, "word": "peptidyl-prolyl", "fig": 1}, {"body": 1, "word": "conformation", "fig": 2}, {"body": 2, "word": "transient", "fig": 1}, {"body": 2, "word": "stabilizing", "fig": 1}, {"body": 2, "word": "mature", "fig": 1}, {"body": 1, "word": "release", "fig": 2}, {"body": 1, "word": "rapid", "fig": 1}, {"body": 1, "word": "involvement", "fig": 1}, {"body": 1, "word": "Hsp90-mediated", "fig": 1}, {"body": 1, "word": "exchange", "fig": 1}, {"body": 1, "word": "promotes", "fig": 1}, {"body": 1, "word": "subsequent", "fig": 1}, {"body": 1, "word": "coordinated", "fig": 1}, {"body": 1, "word": "isomerization", "fig": 1}, {"body": 1, "word": "PPIase", "fig": 1}, {"body": 1, "word": "configuration", "fig": 1}, {"body": 1, "word": "triggers", "fig": 1}, {"body": 1, "word": "bond", "fig": 1}]}], "4268886": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f1.jpg", "caption": "Constitutive EGFR signaling (a,b) Western blot showing EGFR levels in various cell lines, lysates prepared directly from frozen resected GBM tumor tissue (RS23, 238, 331, 334) and primary neurosphere cultures derived from GBMs (748NS and 429NS). The lower molecular weight bands identified by the EGFR antibody may be partially degraded EGFR. Cells were cultured in serum free DMEM overnight for experiments C\u2013H. The EGF concentration used was 50ng/ml. (c) Quantitative real time PCR examining IFIT1 mRNA levels in U251EGFR cells and in empty vector transfected U251V cells. In U251EGFR cells, IFIT1 level is high in the absence of EGF and diminishes in response to EGF exposure (p<0.0001). (d) The same experiment examining IFI27 mRNA shows similar results (p<0.0001). (e) U251V or U251EGFR cells were treated with EGF for 15 minutes followed by preparation of lysates and Western blot with the indicated antibodies. Densitometry was performed for pEGFR/EGFR and the values are shown. (f) An experiment examining mRNA levels of EGR1 in U251EGFR cells. In contradistinction to IFIT1 and IFI27, EGR1 is low in the absence of EGF and increase when cells are exposed to EGF (p<0.001). (g) Protein levels of IFIT1 were examined in U251EGFR cells by Western blot. There is a decrease in IFIT1 levels with the addition of EGF or when cells are exposed to Erlotinib (10\u00b5M, overnight). (h) ELISA for IFI27 levels in U251EGFR cells shows a high level of IFI27 in the absence of EGF. When EGF is added IFI27 levels are decreased. Exposing cells to Erlotinib also results in a decrease in IFI27 levels. Error bars represent the means\u00b1standard deviations of three independent experiments. Data were analyzed by 1way ANOVA followed by Tukey\u2019s multiple comparison test. (p values and asterisks: \u22640.05 (*) \u22640.01 (**), \u22640.001 (***).", "co_occurrence": [{"body": 105, "word": "cells", "fig": 10}, {"body": 230, "word": "EGFR", "fig": 4}, {"body": 67, "word": "EGF", "fig": 9}, {"body": 43, "word": "IFI27", "fig": 6}, {"body": 46, "word": "IFIT1", "fig": 5}, {"body": 29, "word": "U251EGFR", "fig": 6}, {"body": 21, "word": "levels", "fig": 8}, {"body": 36, "word": "The", "fig": 3}, {"body": 38, "word": "results", "fig": 2}, {"body": 24, "word": "absence", "fig": 3}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 19, "word": "In", "fig": 2}, {"body": 12, "word": "experiments", "fig": 2}, {"body": 24, "word": "cell", "fig": 1}, {"body": 12, "word": "Erlotinib", "fig": 2}, {"body": 24, "word": "used", "fig": 1}, {"body": 22, "word": "also", "fig": 1}, {"body": 10, "word": "high", "fig": 2}, {"body": 9, "word": "level", "fig": 2}, {"body": 17, "word": "examined", "fig": 1}, {"body": 8, "word": "followed", "fig": 2}, {"body": 16, "word": "may", "fig": 1}, {"body": 16, "word": "response", "fig": 1}, {"body": 5, "word": "blot", "fig": 3}, {"body": 5, "word": "Western", "fig": 3}, {"body": 7, "word": "exposed", "fig": 2}, {"body": 7, "word": "overnight", "fig": 2}, {"body": 13, "word": "added", "fig": 1}, {"body": 13, "word": "shown", "fig": 1}, {"body": 13, "word": "lines", "fig": 1}, {"body": 3, "word": "p", "fig": 4}, {"body": 12, "word": "GBM", "fig": 1}, {"body": 11, "word": "addition", "fig": 1}, {"body": 3, "word": "mRNA", "fig": 3}, {"body": 9, "word": "tumor", "fig": 1}, {"body": 9, "word": "low", "fig": 1}, {"body": 4, "word": "experiment", "fig": 2}, {"body": 8, "word": "concentration", "fig": 1}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 3, "word": "U251V", "fig": 2}, {"body": 6, "word": "PCR", "fig": 1}, {"body": 3, "word": "EGR1", "fig": 2}, {"body": 3, "word": "decrease", "fig": 2}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 6, "word": "Constitutive", "fig": 1}, {"body": 5, "word": "Cells", "fig": 1}, {"body": 5, "word": "vector", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "When", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 5, "word": "exposure", "fig": 1}, {"body": 4, "word": "increase", "fig": 1}, {"body": 2, "word": "lysates", "fig": 2}, {"body": 4, "word": "empty", "fig": 1}, {"body": 4, "word": "DMEM", "fig": 1}, {"body": 4, "word": "similar", "fig": 1}, {"body": 4, "word": "tissue", "fig": 1}, {"body": 4, "word": "serum", "fig": 1}, {"body": 4, "word": "GBMs", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "ELISA", "fig": 1}, {"body": 3, "word": "minutes", "fig": 1}, {"body": 3, "word": "performed", "fig": 1}, {"body": 2, "word": "real", "fig": 1}, {"body": 2, "word": "identified", "fig": 1}, {"body": 2, "word": "50ng/ml", "fig": 1}, {"body": 2, "word": "various", "fig": 1}, {"body": 1, "word": "shows", "fig": 2}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "429NS", "fig": 1}, {"body": 2, "word": "There", "fig": 1}, {"body": 2, "word": "directly", "fig": 1}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "An", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "Protein", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "resected", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "primary", "fig": 1}, {"body": 1, "word": "deviations", "fig": 1}, {"body": 1, "word": "cultures", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "frozen", "fig": 1}, {"body": 1, "word": "test", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "derived", "fig": 1}, {"body": 1, "word": "lower", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f2.jpg", "caption": "Constitutive EGFR signaling requires EGFR kinase activity but not ligand (a) Cetuximab fails to inhibit EGFR mediated induction of IFIT1 mRNA as detected by real time quantitative PCR. Cells were incubated overnight with either control IgG or Cetuximab (100ug/ml). (b) Cetuximab effectively blocks EGF induced tyrosine phosphorylation of EGFR. Cells were incubated overnight with Cetuximab or control IgG followed by exposure to EGF for 15 minutes followed by Western blot with pEGFR antibody. (c) U251 cells conditionally expressing the mutant EGFRvIII in response to tetracycline were incubated with tetracycline (or no tetracycline) for 24h followed by RNA extraction and qPCR for IFIT1. (d) Western blot showing expression of EGFRvIII in U251 cells following tetracycline exposure. EGFRvIII is truncated and migrates faster on electrophoresis gels compared to endogenous EGFRwt. (e) U251 cells were transfected with EGFRwt, a kinase inactive EGFR mutant, or empty vector followed by extraction of RNA and qPCR for IFIT1. (f) shows that expression of EGFRwt results in increased tyrosine phosphorylation of EGFR, which is further and substantially increased by EGF stimulation, while the EGFR kinase mutant fails to become tyrosine phosphorylated in response to EGF (an increase in tyrosine phosphorylation of the small amount of endogenous EGFRwt is seen). Cells were serum starved and cultured in serum free DMEM overnight for all experiments. The EGF concentration used was 50ng/ml. Error bars represent the means\u00b1standard deviations of three independent experiments. Data were analyzed by 1way ANOVA followed by Tukey\u2019s multiple comparison test. (p values and asterisks: \u22640.05 (*) \u22640.01 (**), \u22640.001 (***).", "co_occurrence": [{"body": 230, "word": "EGFR", "fig": 7}, {"body": 67, "word": "EGF", "fig": 5}, {"body": 105, "word": "cells", "fig": 3}, {"body": 46, "word": "IFIT1", "fig": 3}, {"body": 39, "word": "expression", "fig": 2}, {"body": 24, "word": "phosphorylation", "fig": 3}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 46, "word": "ligand", "fig": 1}, {"body": 11, "word": "tyrosine", "fig": 4}, {"body": 8, "word": "followed", "fig": 5}, {"body": 10, "word": "Cetuximab", "fig": 4}, {"body": 38, "word": "results", "fig": 1}, {"body": 36, "word": "The", "fig": 1}, {"body": 16, "word": "response", "fig": 2}, {"body": 31, "word": "mediated", "fig": 1}, {"body": 10, "word": "kinase", "fig": 3}, {"body": 12, "word": "increased", "fig": 2}, {"body": 12, "word": "experiments", "fig": 2}, {"body": 6, "word": "EGFRwt", "fig": 4}, {"body": 24, "word": "used", "fig": 1}, {"body": 7, "word": "overnight", "fig": 3}, {"body": 17, "word": "detected", "fig": 1}, {"body": 17, "word": "induced", "fig": 1}, {"body": 16, "word": "activity", "fig": 1}, {"body": 4, "word": "tetracycline", "fig": 4}, {"body": 5, "word": "mutant", "fig": 3}, {"body": 5, "word": "Cells", "fig": 3}, {"body": 14, "word": "induction", "fig": 1}, {"body": 6, "word": "RNA", "fig": 2}, {"body": 4, "word": "incubated", "fig": 3}, {"body": 12, "word": "compared", "fig": 1}, {"body": 5, "word": "blot", "fig": 2}, {"body": 5, "word": "Western", "fig": 2}, {"body": 5, "word": "control", "fig": 2}, {"body": 5, "word": "exposure", "fig": 2}, {"body": 3, "word": "U251", "fig": 3}, {"body": 3, "word": "EGFRvIII", "fig": 3}, {"body": 8, "word": "concentration", "fig": 1}, {"body": 4, "word": "serum", "fig": 2}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 6, "word": "PCR", "fig": 1}, {"body": 6, "word": "expressing", "fig": 1}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 6, "word": "Constitutive", "fig": 1}, {"body": 6, "word": "inhibit", "fig": 1}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 5, "word": "vector", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "phosphorylated", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 4, "word": "conditionally", "fig": 1}, {"body": 4, "word": "empty", "fig": 1}, {"body": 4, "word": "DMEM", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 4, "word": "increase", "fig": 1}, {"body": 3, "word": "inactive", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "p", "fig": 1}, {"body": 3, "word": "mRNA", "fig": 1}, {"body": 3, "word": "following", "fig": 1}, {"body": 3, "word": "minutes", "fig": 1}, {"body": 2, "word": "real", "fig": 1}, {"body": 2, "word": "either", "fig": 1}, {"body": 2, "word": "24h", "fig": 1}, {"body": 1, "word": "fails", "fig": 2}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "amount", "fig": 1}, {"body": 1, "word": "extraction", "fig": 2}, {"body": 2, "word": "50ng/ml", "fig": 1}, {"body": 1, "word": "qPCR", "fig": 2}, {"body": 2, "word": "starved", "fig": 1}, {"body": 2, "word": "quantitative", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "small", "fig": 1}, {"body": 1, "word": "become", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "pEGFR", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "stimulation", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "effectively", "fig": 1}, {"body": 1, "word": "seen", "fig": 1}, {"body": 1, "word": "test", "fig": 1}, {"body": 1, "word": "blocks", "fig": 1}, {"body": 1, "word": "deviations", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f3.jpg", "caption": "IRF3 is required for constitutive EGFR signaling (a,b) U251EGFR cells were transfected with control (scrambled) siRNA or with siRNA directed against IRF3 followed by quantitative real time PCR for IFIT1 or IFI27. The mRNA levels for both genes are decreased when IRF3 is silenced compared to control siRNA (unpaired t test, p<0.0001). (c) shows silencing of IRF3 by Western blot. In (d,e) U251EGFR cells were transfected with IRF3 siRNA (for 72h) followed by reexpression of IRF3 (or empty vector) and extraction of RNA after 48h for qPCR for IFIT1 and IFI27. (f) Western blot showing silencing of IRF3 and reexpression in silenced cells. Error bars represent the means\u00b1standard deviations of three independent experiments. Data were analyzed by 1way ANOVA followed by Tukey\u2019s multiple comparison test. (p values and asterisks: \u22640.05 (*) \u22640.01 (**), \u22640.001 (***).", "co_occurrence": [{"body": 110, "word": "IRF3", "fig": 7}, {"body": 105, "word": "cells", "fig": 3}, {"body": 230, "word": "EGFR", "fig": 1}, {"body": 46, "word": "IFIT1", "fig": 2}, {"body": 43, "word": "IFI27", "fig": 2}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 29, "word": "U251EGFR", "fig": 2}, {"body": 46, "word": "constitutive", "fig": 1}, {"body": 36, "word": "The", "fig": 1}, {"body": 32, "word": "genes", "fig": 1}, {"body": 8, "word": "siRNA", "fig": 4}, {"body": 8, "word": "followed", "fig": 3}, {"body": 21, "word": "levels", "fig": 1}, {"body": 19, "word": "In", "fig": 1}, {"body": 12, "word": "experiments", "fig": 1}, {"body": 12, "word": "compared", "fig": 1}, {"body": 5, "word": "blot", "fig": 2}, {"body": 5, "word": "Western", "fig": 2}, {"body": 5, "word": "transfected", "fig": 2}, {"body": 5, "word": "control", "fig": 2}, {"body": 3, "word": "p", "fig": 2}, {"body": 6, "word": "PCR", "fig": 1}, {"body": 6, "word": "RNA", "fig": 1}, {"body": 5, "word": "vector", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 4, "word": "empty", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 2, "word": "silencing", "fig": 2}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "mRNA", "fig": 1}, {"body": 3, "word": "required", "fig": 1}, {"body": 2, "word": "real", "fig": 1}, {"body": 1, "word": "silenced", "fig": 2}, {"body": 1, "word": "test", "fig": 2}, {"body": 2, "word": "scrambled", "fig": 1}, {"body": 2, "word": "quantitative", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "72h", "fig": 1}, {"body": 1, "word": "extraction", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "directed", "fig": 1}, {"body": 1, "word": "qPCR", "fig": 1}, {"body": 1, "word": "deviations", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f4.jpg", "caption": "Constitutive EGFR signaling activates IRF3 transcriptional activity (a) The transcriptional activity of IRF3 was examined by using a synthetic pISRE-Luc reporter in U251EGFR cells using a dual luciferase assay. The activity of IRF3 is high in U251EGFR cells compared to U251V (vector transfected cells). Addition of EGF leads to a statistically significant decrease in reporter activity. Furthermore, Erlotinib also downregulates reporter activity, indicating that the high IRF3 transcriptional activity in the absence of EGF is driven by EGFR. (b) The same experiment as A was conducted in U251EGFR cell using an IFI27-Luc reporter. (c) The EGFR induced transcriptional activity of IRF3 is not blocked by Cetuximab compared to control IgG in U251EGFR cells. (d) A kinase inactive EGFR (EGFRK-) fails to activate the pISRE-Luc reporter in U251 cells, whereas the EGFRwt efficiently activates the reporter. Data for (a\u2013d) were analyzed by 1 way ANOVA followed by Tukey\u2019s multiple comparison test. (e) A CHIP assay examining IFIT1 promoter occupancy by IRF3 in U251EGFR cells with or without EGF. IRF3 promoter binding can be detected in the absence of EGF and decreases by 6h of EGF stimulation and remains decreased 24h after EGF treatment. (f) A CHIP assay examining IFI27 promoter occupancy by IRF3 in U251EGFR cells with or without EGF. IRF3 promoter binding can be detected in the absence of EGF and decreases by 6h of EGF stimulation. Cells were serum starved and cultured in serum free DMEM overnight for all experiments. The EGF concentration used was 50ng/ml. (g) We examined the nuclear localization of EGFR, IRF3 and TBK1 in U251 cells conditionally expressing EGFR in response to tetracycline. Cells were treated with tetracycline for 24h and then exposed to EGF (50ng/ml) for the time points indicated. Error bars represent the means\u00b1standard deviations of three independent experiments. Data were analyzed by 1way ANOVA followed by Tukey\u2019s multiple comparison test. (p values and asterisks: \u22640.05 (*) \u22640.01 (**), \u22640.001 (***).", "co_occurrence": [{"body": 230, "word": "EGFR", "fig": 6}, {"body": 110, "word": "IRF3", "fig": 10}, {"body": 105, "word": "cells", "fig": 8}, {"body": 67, "word": "EGF", "fig": 11}, {"body": 36, "word": "The", "fig": 5}, {"body": 29, "word": "U251EGFR", "fig": 6}, {"body": 16, "word": "activity", "fig": 7}, {"body": 24, "word": "absence", "fig": 3}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 16, "word": "using", "fig": 3}, {"body": 12, "word": "transcriptional", "fig": 4}, {"body": 12, "word": "A", "fig": 4}, {"body": 46, "word": "IFIT1", "fig": 1}, {"body": 43, "word": "IFI27", "fig": 1}, {"body": 7, "word": "reporter", "fig": 6}, {"body": 17, "word": "detected", "fig": 2}, {"body": 17, "word": "examined", "fig": 2}, {"body": 31, "word": "We", "fig": 1}, {"body": 28, "word": "TBK1", "fig": 1}, {"body": 24, "word": "cell", "fig": 1}, {"body": 8, "word": "assay", "fig": 3}, {"body": 12, "word": "experiments", "fig": 2}, {"body": 12, "word": "compared", "fig": 2}, {"body": 24, "word": "used", "fig": 1}, {"body": 11, "word": "activates", "fig": 2}, {"body": 22, "word": "also", "fig": 1}, {"body": 10, "word": "binding", "fig": 2}, {"body": 10, "word": "high", "fig": 2}, {"body": 17, "word": "induced", "fig": 1}, {"body": 8, "word": "followed", "fig": 2}, {"body": 4, "word": "promoter", "fig": 4}, {"body": 16, "word": "response", "fig": 1}, {"body": 12, "word": "Erlotinib", "fig": 1}, {"body": 6, "word": "without", "fig": 2}, {"body": 5, "word": "Cells", "fig": 2}, {"body": 5, "word": "CHIP", "fig": 2}, {"body": 10, "word": "kinase", "fig": 1}, {"body": 5, "word": "multiple", "fig": 2}, {"body": 10, "word": "Cetuximab", "fig": 1}, {"body": 9, "word": "Addition", "fig": 1}, {"body": 8, "word": "concentration", "fig": 1}, {"body": 4, "word": "serum", "fig": 2}, {"body": 4, "word": "tetracycline", "fig": 2}, {"body": 7, "word": "exposed", "fig": 1}, {"body": 7, "word": "overnight", "fig": 1}, {"body": 6, "word": "nuclear", "fig": 1}, {"body": 6, "word": "expressing", "fig": 1}, {"body": 3, "word": "U251", "fig": 2}, {"body": 6, "word": "EGFRwt", "fig": 1}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 6, "word": "Furthermore", "fig": 1}, {"body": 6, "word": "Constitutive", "fig": 1}, {"body": 5, "word": "treatment", "fig": 1}, {"body": 5, "word": "vector", "fig": 1}, {"body": 5, "word": "conducted", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "significant", "fig": 1}, {"body": 4, "word": "blocked", "fig": 1}, {"body": 4, "word": "conditionally", "fig": 1}, {"body": 2, "word": "24h", "fig": 2}, {"body": 4, "word": "experiment", "fig": 1}, {"body": 2, "word": "50ng/ml", "fig": 2}, {"body": 4, "word": "DMEM", "fig": 1}, {"body": 4, "word": "time", "fig": 1}, {"body": 3, "word": "leads", "fig": 1}, {"body": 3, "word": "inactive", "fig": 1}, {"body": 3, "word": "U251V", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "p", "fig": 1}, {"body": 3, "word": "activate", "fig": 1}, {"body": 3, "word": "localization", "fig": 1}, {"body": 3, "word": "decrease", "fig": 1}, {"body": 3, "word": "driven", "fig": 1}, {"body": 2, "word": "luciferase", "fig": 1}, {"body": 1, "word": "decreases", "fig": 2}, {"body": 2, "word": "indicating", "fig": 1}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 1, "word": "pISRE-Luc", "fig": 2}, {"body": 2, "word": "free", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 2}, {"body": 1, "word": "stimulation", "fig": 2}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 1, "word": "test", "fig": 2}, {"body": 2, "word": "efficiently", "fig": 1}, {"body": 2, "word": "starved", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "synthetic", "fig": 1}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "points", "fig": 1}, {"body": 1, "word": "fails", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "IFI27-Luc", "fig": 1}, {"body": 1, "word": "deviations", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f5.jpg", "caption": "EGFR constitutive signaling is independent of ER stress (a) U251V cells (transfected with empty vector) and U251EGFR cells were examined for phosphorylation of EIF2\u03b1. EGF or Erlotinib were added as indicated followed by lysate preparation and Western blot with phospo-EIF2\u03b1 antibodies. Densitometry was performed to quantitate the pEIF2\u03b1 signal. Splicing of XBP-1 or level of BiP were examined by Western blot in U251EGFR cells. Splicing of XBP-1 can only be detected in EGF treated cells. BiP levels are unchanged. (b) U251EGFR cells were treated with a PERK inhibitor, GSK 2606414 (1\u00b5M) overnight followed by RNA extraction and qPCR for IFIT1. GSK 2606414 fails to prevent EGFR mediated IFIT1 induction. (c) GSK 2606414 efficiently inhibits thapsigargin (0.5\u00b5M for 6h) induced phosphorylation of EIF2\u03b1 as shown in the Western blot with phospo-EIF2\u03b1 antibodies. (d) U251EGFR cells were treated with an ATF6 inhibitor, AEBSF (300\u00b5M) overnight followed by RNA extraction and qPCR for IFIT1. AEBSF fails to prevent EGFR mediated IFIT1 induction. (e) AEBSF (300\u00b5M) efficiently inhibits thapsigargin induced ATF6 promoter activity in a reporter assay. (f) Silencing XBP-1 fails to prevent EGFR induced activation of IRF3 mediated transcriptional activity assessed using a synthetic pISRE-Luc reporter. (g) Silencing XBP-1 fails to prevent EGFR induced induction of IFIT1 in U251EGFR cells. (h) Effective silencing of XBP-1 is demonstrated in U251EGFR cells by Western blot. Error bars represent the means\u00b1standard deviations of three independent experiments. Data were analyzed by 1 way ANOVA followed by Tukey\u2019s multiple comparison test. (p values and asterisks: \u22640.05 (*) \u22640.01 (**), \u22640.001 (***).", "co_occurrence": [{"body": 230, "word": "EGFR", "fig": 5}, {"body": 105, "word": "cells", "fig": 8}, {"body": 46, "word": "IFIT1", "fig": 5}, {"body": 29, "word": "U251EGFR", "fig": 6}, {"body": 67, "word": "EGF", "fig": 2}, {"body": 110, "word": "IRF3", "fig": 1}, {"body": 31, "word": "mediated", "fig": 3}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 17, "word": "induced", "fig": 4}, {"body": 60, "word": "activation", "fig": 1}, {"body": 24, "word": "phosphorylation", "fig": 2}, {"body": 46, "word": "constitutive", "fig": 1}, {"body": 14, "word": "induction", "fig": 3}, {"body": 17, "word": "examined", "fig": 2}, {"body": 16, "word": "activity", "fig": 2}, {"body": 8, "word": "followed", "fig": 4}, {"body": 21, "word": "levels", "fig": 1}, {"body": 5, "word": "blot", "fig": 4}, {"body": 5, "word": "Western", "fig": 4}, {"body": 4, "word": "XBP-1", "fig": 5}, {"body": 17, "word": "detected", "fig": 1}, {"body": 16, "word": "using", "fig": 1}, {"body": 5, "word": "treated", "fig": 3}, {"body": 7, "word": "reporter", "fig": 2}, {"body": 7, "word": "overnight", "fig": 2}, {"body": 13, "word": "added", "fig": 1}, {"body": 13, "word": "shown", "fig": 1}, {"body": 12, "word": "experiments", "fig": 1}, {"body": 4, "word": "AEBSF", "fig": 3}, {"body": 12, "word": "ER", "fig": 1}, {"body": 6, "word": "RNA", "fig": 2}, {"body": 12, "word": "Erlotinib", "fig": 1}, {"body": 12, "word": "transcriptional", "fig": 1}, {"body": 11, "word": "stress", "fig": 1}, {"body": 5, "word": "EIF2\u03b1", "fig": 2}, {"body": 5, "word": "independent", "fig": 2}, {"body": 9, "word": "level", "fig": 1}, {"body": 8, "word": "assay", "fig": 1}, {"body": 3, "word": "inhibits", "fig": 2}, {"body": 3, "word": "inhibitor", "fig": 2}, {"body": 5, "word": "vector", "fig": 1}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 4, "word": "PERK", "fig": 1}, {"body": 1, "word": "prevent", "fig": 4}, {"body": 1, "word": "fails", "fig": 4}, {"body": 4, "word": "empty", "fig": 1}, {"body": 4, "word": "promoter", "fig": 1}, {"body": 2, "word": "efficiently", "fig": 2}, {"body": 2, "word": "antibodies", "fig": 2}, {"body": 2, "word": "thapsigargin", "fig": 2}, {"body": 2, "word": "ATF6", "fig": 2}, {"body": 1, "word": "GSK", "fig": 3}, {"body": 3, "word": "U251V", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "p", "fig": 1}, {"body": 3, "word": "performed", "fig": 1}, {"body": 1, "word": "BiP", "fig": 2}, {"body": 1, "word": "Silencing", "fig": 2}, {"body": 2, "word": "0.5\u00b5M", "fig": 1}, {"body": 1, "word": "extraction", "fig": 2}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 1, "word": "qPCR", "fig": 2}, {"body": 2, "word": "silencing", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "synthetic", "fig": 1}, {"body": 1, "word": "signal", "fig": 1}, {"body": 1, "word": "pEIF2\u03b1", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "demonstrated", "fig": 1}, {"body": 1, "word": "pISRE-Luc", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "deviations", "fig": 1}, {"body": 1, "word": "unchanged", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "lysate", "fig": 1}, {"body": 1, "word": "1\u00b5M", "fig": 1}, {"body": 1, "word": "test", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f6.jpg", "caption": "Constitutive EGFR signaling results in IRF3 and TBK1 phosphorylation (a) IRF3 is phosphorylated in U251EGFR cells in the absence of ligand. When EGF is added, (50ng/ml for 15 min) there is rapid decrease in IRF3 phosphorylation. Erlotinib also inhibits IRF3 phosphorylation. (b) TBK1 is phosphorylated in U251EGFR cells in the absence of ligand. When EGF is added, there is rapid decrease in TBK1 phosphorylation. (c) Similarly, IRF3 is phosphorylated in MDAMB468 cells and exposure to EGF or Erlotinib downregulates IRF3 phosphorylation. (d) TBK1 is phosphorylated in MDAMB468 cells and exposure to EGF or Erlotinib downregulates TBK1 phosphorylation. (e) siRNA knockdown of EGFR in MDAMB468 cells results in a loss of IRF3 phosphorylation compared to control siRNA (C). (f) Neither IRF3 nor TBK1 are tyrosine phosphorylated in EGFR overexpressing cells. We immunoprecipitated IRF3 or TBK1 in U251EGFR cells followed by Western blot with phosphotyrosine antibodies. As a positive control, we immunoprecipitated EGFR. Cells were serum starved and cultured in serum free DMEM overnight for all experiments. The EGF concentration used was 50ng/ml.", "co_occurrence": [{"body": 110, "word": "IRF3", "fig": 9}, {"body": 230, "word": "EGFR", "fig": 4}, {"body": 105, "word": "cells", "fig": 7}, {"body": 67, "word": "EGF", "fig": 5}, {"body": 28, "word": "TBK1", "fig": 7}, {"body": 24, "word": "phosphorylation", "fig": 7}, {"body": 46, "word": "ligand", "fig": 2}, {"body": 29, "word": "U251EGFR", "fig": 3}, {"body": 38, "word": "results", "fig": 2}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 24, "word": "absence", "fig": 2}, {"body": 36, "word": "The", "fig": 1}, {"body": 12, "word": "Erlotinib", "fig": 3}, {"body": 31, "word": "We", "fig": 1}, {"body": 9, "word": "MDAMB468", "fig": 3}, {"body": 13, "word": "added", "fig": 2}, {"body": 5, "word": "phosphorylated", "fig": 5}, {"body": 24, "word": "used", "fig": 1}, {"body": 22, "word": "also", "fig": 1}, {"body": 8, "word": "siRNA", "fig": 2}, {"body": 15, "word": "overexpressing", "fig": 1}, {"body": 12, "word": "experiments", "fig": 1}, {"body": 12, "word": "compared", "fig": 1}, {"body": 12, "word": "loss", "fig": 1}, {"body": 11, "word": "tyrosine", "fig": 1}, {"body": 5, "word": "control", "fig": 2}, {"body": 5, "word": "When", "fig": 2}, {"body": 5, "word": "exposure", "fig": 2}, {"body": 8, "word": "followed", "fig": 1}, {"body": 4, "word": "rapid", "fig": 2}, {"body": 4, "word": "serum", "fig": 2}, {"body": 8, "word": "concentration", "fig": 1}, {"body": 7, "word": "overnight", "fig": 1}, {"body": 3, "word": "decrease", "fig": 2}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 6, "word": "Constitutive", "fig": 1}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 5, "word": "Cells", "fig": 1}, {"body": 2, "word": "50ng/ml", "fig": 2}, {"body": 4, "word": "DMEM", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "min", "fig": 1}, {"body": 3, "word": "As", "fig": 1}, {"body": 3, "word": "inhibits", "fig": 1}, {"body": 2, "word": "Similarly", "fig": 1}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "knockdown", "fig": 1}, {"body": 2, "word": "starved", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 1, "word": "phosphotyrosine", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f7.jpg", "caption": "EGFR forms a signaling complex with IRF3 and TBK1 (a) EGFR co-immunoprecipitates with IRF3 in U251EGFR cells in the absence of EGF. When EGF is added there is a rapid loss of the EGFR-IRF3 association. (b) Similarly, the EGFR coimmunoprecipitates with TBK1 in U251EGFR cells. When EGF is added there is a rapid loss of the EGFR-TBK1 association. (c) TBK1 is associated with IRF3 in U251EGFR cells in the absence of EGF. When EGF is added to cells, there is a rapid decrease in TBK-IRF3 association. The TBK1-IRF3 association is also disrupted when Erlotinib is used suggesting that it is EGFR driven. C refers to control vehicle (PBS). (d) EGFR co-immunoprecipitates with IRF3 in MDAMB468 cells in the absence of EGF. When EGF is added there is a rapid loss of the EGFR-IRF3 association. (e) Similarly, the EGFR coimmunoprecipitates with TBK1 in MDAMB468 cells. When EGF is added there is a rapid loss of the EGFR-TBK1 association. (f) TBK1 is associated with IRF3 in MDAMB468 cells in the absence of EGF. When EGF is added to cells, there is a rapid decrease in TBK-IRF3 association. The TBK1-IRF3 association is also disrupted when Erlotinib is used suggesting that it is EGFR driven. (g) In contradistinction to IRF3 and TBK1, Shc becomes associated with the EGFR only when EGF is added to U251EGFR cells. (h) About 10% of IRF3 is associated with the EGFR. (i) About 5% of phospho-IRF3 is associated with the EGFR. (j) EGFR associates with IRF3 and TBK1 in the membrane fraction. Membrane, cytosolic or nuclear fractions were prepared from U251EGFR cells. Immunoprecipitation was conducted with IRF3 or TBK1 antibody followed by Western blot with EGFR. E-Cadherin, GAPDH and lamin blots were done to test purity of various fractions. Cells were serum starved and cultured in serum free DMEM overnight for all experiments. The EGF concentration used was 50ng/ml. (k) In vitro transcribed and translated EGFR was incubated with GST-IRF3 or GST alone followed by Western blot with EGFR. (l) shows in vitro transcribed and translated EGFR. V: empty vector.", "co_occurrence": [{"body": 230, "word": "EGFR", "fig": 15}, {"body": 105, "word": "cells", "fig": 10}, {"body": 110, "word": "IRF3", "fig": 9}, {"body": 67, "word": "EGF", "fig": 12}, {"body": 28, "word": "TBK1", "fig": 8}, {"body": 29, "word": "U251EGFR", "fig": 5}, {"body": 36, "word": "The", "fig": 3}, {"body": 24, "word": "absence", "fig": 4}, {"body": 13, "word": "added", "fig": 7}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 24, "word": "used", "fig": 3}, {"body": 12, "word": "loss", "fig": 4}, {"body": 22, "word": "also", "fig": 2}, {"body": 19, "word": "In", "fig": 2}, {"body": 4, "word": "association", "fig": 8}, {"body": 5, "word": "When", "fig": 6}, {"body": 6, "word": "associated", "fig": 5}, {"body": 9, "word": "MDAMB468", "fig": 3}, {"body": 4, "word": "rapid", "fig": 6}, {"body": 12, "word": "Erlotinib", "fig": 2}, {"body": 8, "word": "followed", "fig": 2}, {"body": 7, "word": "suggesting", "fig": 2}, {"body": 12, "word": "experiments", "fig": 1}, {"body": 5, "word": "Western", "fig": 2}, {"body": 5, "word": "blot", "fig": 2}, {"body": 9, "word": "complex", "fig": 1}, {"body": 4, "word": "vitro", "fig": 2}, {"body": 8, "word": "concentration", "fig": 1}, {"body": 4, "word": "serum", "fig": 2}, {"body": 7, "word": "Shc", "fig": 1}, {"body": 7, "word": "membrane", "fig": 1}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 7, "word": "overnight", "fig": 1}, {"body": 6, "word": "nuclear", "fig": 1}, {"body": 3, "word": "decrease", "fig": 2}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 3, "word": "EGFR-IRF3", "fig": 2}, {"body": 3, "word": "driven", "fig": 2}, {"body": 5, "word": "Cells", "fig": 1}, {"body": 5, "word": "vector", "fig": 1}, {"body": 5, "word": "done", "fig": 1}, {"body": 5, "word": "GST-IRF3", "fig": 1}, {"body": 5, "word": "conducted", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 2, "word": "Similarly", "fig": 2}, {"body": 4, "word": "forms", "fig": 1}, {"body": 2, "word": "disrupted", "fig": 2}, {"body": 4, "word": "incubated", "fig": 1}, {"body": 4, "word": "empty", "fig": 1}, {"body": 4, "word": "DMEM", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "becomes", "fig": 1}, {"body": 2, "word": "GST", "fig": 1}, {"body": 1, "word": "transcribed", "fig": 2}, {"body": 2, "word": "50ng/ml", "fig": 1}, {"body": 1, "word": "translated", "fig": 2}, {"body": 2, "word": "various", "fig": 1}, {"body": 2, "word": "PBS", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "alone", "fig": 1}, {"body": 2, "word": "Immunoprecipitation", "fig": 1}, {"body": 2, "word": "associates", "fig": 1}, {"body": 2, "word": "prepared", "fig": 1}, {"body": 2, "word": "starved", "fig": 1}, {"body": 1, "word": "E-Cadherin", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "refers", "fig": 1}, {"body": 1, "word": "fraction", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 1}, {"body": 1, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "test", "fig": 1}, {"body": 1, "word": "cytosolic", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f8.jpg", "caption": "Constitutive EGFR signaling activates the interferon pathway (a) EGFR overexpression leads to increased mRNA for IFN\u03b2 compared to vector transfected cells. Addition of EGF or Erlotinib leads to a loss of this increase in IFN\u03b2 in EGFR overexpressing cells. (b) EGFR overexpression leads to increased mRNA for IFN\u03b1 compared to vector transfected cells. Addition of EGF or Erlotinib leads to decreased IFN\u03b1 in EGFR overexpressing cells. (c) An ELISA done on supernatants from U251EGFR or vector transfected cells shows that EGFR overexpression leads to increased IFN\u03b2 at a protein level. (d) STAT1 is phosphorylated in U251EGFR cells. This phosphorylation is lost when EGF (15min) is added to cells. (e, f) U251EGFR cells were incubated with Ruxolinitib (1uM) overnight followed by extraction of RNA and qPCR for IFIT1 or IFI27. (g) U251EGFR cells were incubated with Tofacitinib (300nM) overnight followed by extraction of RNA and qPCR. Cells were serum starved and cultured in serum free DMEM overnight for all experiments. The EGF concentration used was 50ng/ml. Error bars represent the means\u00b1standard deviations of three independent experiments. Data were analyzed by 1way ANOVA followed by Tukey\u2019s multiple comparison test. (p values and asterisks: \u22640.05 (*) \u22640.01 (**), \u22640.001 (***).", "co_occurrence": [{"body": 230, "word": "EGFR", "fig": 6}, {"body": 105, "word": "cells", "fig": 9}, {"body": 67, "word": "EGF", "fig": 4}, {"body": 29, "word": "U251EGFR", "fig": 4}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 22, "word": "overexpression", "fig": 3}, {"body": 46, "word": "IFIT1", "fig": 1}, {"body": 43, "word": "IFI27", "fig": 1}, {"body": 12, "word": "increased", "fig": 3}, {"body": 36, "word": "The", "fig": 1}, {"body": 15, "word": "overexpressing", "fig": 2}, {"body": 9, "word": "IFN\u03b2", "fig": 3}, {"body": 12, "word": "experiments", "fig": 2}, {"body": 24, "word": "phosphorylation", "fig": 1}, {"body": 24, "word": "used", "fig": 1}, {"body": 8, "word": "followed", "fig": 3}, {"body": 12, "word": "Erlotinib", "fig": 2}, {"body": 12, "word": "compared", "fig": 2}, {"body": 7, "word": "overnight", "fig": 3}, {"body": 9, "word": "Addition", "fig": 2}, {"body": 3, "word": "leads", "fig": 5}, {"body": 5, "word": "vector", "fig": 3}, {"body": 5, "word": "transfected", "fig": 3}, {"body": 13, "word": "added", "fig": 1}, {"body": 12, "word": "loss", "fig": 1}, {"body": 6, "word": "RNA", "fig": 2}, {"body": 11, "word": "activates", "fig": 1}, {"body": 5, "word": "IFN\u03b1", "fig": 2}, {"body": 9, "word": "level", "fig": 1}, {"body": 9, "word": "protein", "fig": 1}, {"body": 4, "word": "incubated", "fig": 2}, {"body": 4, "word": "serum", "fig": 2}, {"body": 8, "word": "concentration", "fig": 1}, {"body": 7, "word": "interferon", "fig": 1}, {"body": 6, "word": "pathway", "fig": 1}, {"body": 3, "word": "mRNA", "fig": 2}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 6, "word": "Constitutive", "fig": 1}, {"body": 5, "word": "Cells", "fig": 1}, {"body": 5, "word": "This", "fig": 1}, {"body": 5, "word": "done", "fig": 1}, {"body": 5, "word": "STAT1", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "phosphorylated", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 4, "word": "increase", "fig": 1}, {"body": 4, "word": "DMEM", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "lost", "fig": 1}, {"body": 3, "word": "p", "fig": 1}, {"body": 3, "word": "ELISA", "fig": 1}, {"body": 2, "word": "50ng/ml", "fig": 1}, {"body": 2, "word": "1uM", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "Tofacitinib", "fig": 1}, {"body": 1, "word": "extraction", "fig": 2}, {"body": 1, "word": "qPCR", "fig": 2}, {"body": 2, "word": "300nM", "fig": 1}, {"body": 2, "word": "An", "fig": 1}, {"body": 2, "word": "starved", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "supernatants", "fig": 1}, {"body": 1, "word": "test", "fig": 1}, {"body": 1, "word": "deviations", "fig": 1}, {"body": 1, "word": "Ruxolinitib", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f9.jpg", "caption": "Ligand-activated EGFR increases sensitivity to virus and chemotherapy mediated cell death (a) U251 and U87EGFR cells were infected with Adenovirus-GFP at an MOI of 10. Cells were examined with immunofluorescence microscopy after 24h. EGF (50ng/ml) or control vehicle were added at the time of adenovirus infection. (b, c) U251EGFR or U87EGFR cells were infected with adenovirus following by an Annexin-FACS assay for detecting cell death. EGF (50ng/ml) was added at the time of infection for 24h and leads to a statistically significant increase in annexin and PI positive cells compared to cells exposed to adenovirus alone. (d) U251EGFR cells were exposed to EGF or control vehicle and temozolomide (50\u00b5M) for 24h and an Annexin-FACS assay was performed. In \u201cControl\u201d cells are treated with control vehicle (PBS). Temozolomide alone induces cell death in these cells. The cell death is strikingly amplified when cells are pretreated with EGF (p\u22640.001). (e) A similar experiment was conducted in U87EGFR cells with a similar result (p\u22640.001). Data were analyzed by 1way ANOVA followed by Tukey\u2019s Multiple Comparison test. Cells were serum starved and cultured in serum free DMEM overnight for all experiments. The EGF concentration used was 50ng/ml. Error bars represent the means\u00b1standard deviations of three independent experiments. Data were analyzed by 1way ANOVA followed by Tukey\u2019s multiple comparison test. (p values and asterisks: \u22640.05 (*) \u22640.01 (**), \u22640.001 (***).", "co_occurrence": [{"body": 105, "word": "cells", "fig": 9}, {"body": 67, "word": "EGF", "fig": 5}, {"body": 230, "word": "EGFR", "fig": 1}, {"body": 24, "word": "cell", "fig": 4}, {"body": 36, "word": "The", "fig": 2}, {"body": 21, "word": "U87EGFR", "fig": 3}, {"body": 29, "word": "U251EGFR", "fig": 2}, {"body": 8, "word": "death", "fig": 4}, {"body": 31, "word": "mediated", "fig": 1}, {"body": 13, "word": "added", "fig": 2}, {"body": 12, "word": "experiments", "fig": 2}, {"body": 24, "word": "used", "fig": 1}, {"body": 7, "word": "adenovirus", "fig": 3}, {"body": 19, "word": "In", "fig": 1}, {"body": 17, "word": "examined", "fig": 1}, {"body": 8, "word": "assay", "fig": 2}, {"body": 8, "word": "followed", "fig": 2}, {"body": 5, "word": "control", "fig": 3}, {"body": 7, "word": "exposed", "fig": 2}, {"body": 12, "word": "sensitivity", "fig": 1}, {"body": 6, "word": "infection", "fig": 2}, {"body": 12, "word": "compared", "fig": 1}, {"body": 12, "word": "A", "fig": 1}, {"body": 5, "word": "Cells", "fig": 2}, {"body": 10, "word": "temozolomide", "fig": 1}, {"body": 4, "word": "similar", "fig": 2}, {"body": 4, "word": "time", "fig": 2}, {"body": 8, "word": "concentration", "fig": 1}, {"body": 4, "word": "serum", "fig": 2}, {"body": 7, "word": "result", "fig": 1}, {"body": 7, "word": "overnight", "fig": 1}, {"body": 2, "word": "24h", "fig": 3}, {"body": 6, "word": "cultured", "fig": 1}, {"body": 3, "word": "infected", "fig": 2}, {"body": 2, "word": "50ng/ml", "fig": 3}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "chemotherapy", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 5, "word": "conducted", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "multiple", "fig": 1}, {"body": 5, "word": "significant", "fig": 1}, {"body": 4, "word": "experiment", "fig": 1}, {"body": 4, "word": "induces", "fig": 1}, {"body": 4, "word": "increase", "fig": 1}, {"body": 2, "word": "alone", "fig": 2}, {"body": 4, "word": "DMEM", "fig": 1}, {"body": 3, "word": "leads", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "p", "fig": 1}, {"body": 3, "word": "U251", "fig": 1}, {"body": 1, "word": "vehicle", "fig": 3}, {"body": 3, "word": "following", "fig": 1}, {"body": 3, "word": "performed", "fig": 1}, {"body": 3, "word": "virus", "fig": 1}, {"body": 2, "word": "statistically", "fig": 1}, {"body": 2, "word": "PBS", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "MOI", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 2}, {"body": 2, "word": "positive", "fig": 1}, {"body": 1, "word": "test", "fig": 2}, {"body": 2, "word": "starved", "fig": 1}, {"body": 1, "word": "represent", "fig": 1}, {"body": 1, "word": "Multiple", "fig": 1}, {"body": 1, "word": "microscopy", "fig": 1}, {"body": 1, "word": "Temozolomide", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "PI", "fig": 1}, {"body": 1, "word": "Error", "fig": 1}, {"body": 1, "word": "immunofluorescence", "fig": 1}, {"body": 1, "word": "deviations", "fig": 1}, {"body": 1, "word": "Adenovirus-GFP", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268886/bin/nihms641838f10.jpg", "caption": "Constitutive EGFR signaling in GBM (a, b) show EGFR levels in 27 GBM tumors by real time quantitative PCR. An arbitrary cutoff of 1 or above was considered to be EGFR overexpression and corresponded well to expression levels of EGFR on Western blot (Supplementary Fig. 17D). (c, d) show TGF\u03b1, IFIT1 and IFI27 levels in GBMs expressing a low level of TGF\u03b1 (less than 1) measured by real time quantitative PCR. (e, f) show TGF\u03b1, IFIT1 and IFI27 levels in GBM tumors expressing a high level of TGF\u03b1 measured by real time quantitative PCR.", "co_occurrence": [{"body": 230, "word": "EGFR", "fig": 4}, {"body": 46, "word": "IFIT1", "fig": 2}, {"body": 43, "word": "IFI27", "fig": 2}, {"body": 21, "word": "levels", "fig": 4}, {"body": 72, "word": "signaling", "fig": 1}, {"body": 41, "word": "Fig", "fig": 1}, {"body": 39, "word": "expression", "fig": 1}, {"body": 38, "word": "Supplementary", "fig": 1}, {"body": 12, "word": "GBM", "fig": 3}, {"body": 17, "word": "tumors", "fig": 2}, {"body": 22, "word": "overexpression", "fig": 1}, {"body": 6, "word": "PCR", "fig": 3}, {"body": 9, "word": "level", "fig": 2}, {"body": 6, "word": "expressing", "fig": 2}, {"body": 4, "word": "time", "fig": 3}, {"body": 10, "word": "high", "fig": 1}, {"body": 9, "word": "low", "fig": 1}, {"body": 8, "word": "well", "fig": 1}, {"body": 2, "word": "show", "fig": 3}, {"body": 2, "word": "real", "fig": 3}, {"body": 6, "word": "Constitutive", "fig": 1}, {"body": 2, "word": "quantitative", "fig": 3}, {"body": 5, "word": "blot", "fig": 1}, {"body": 5, "word": "Western", "fig": 1}, {"body": 4, "word": "GBMs", "fig": 1}, {"body": 1, "word": "TGF\u03b1", "fig": 4}, {"body": 3, "word": "d", "fig": 1}, {"body": 1, "word": "measured", "fig": 2}, {"body": 2, "word": "An", "fig": 1}, {"body": 1, "word": "less", "fig": 1}, {"body": 1, "word": "considered", "fig": 1}]}], "4449815": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f1.jpg", "caption": "Gnas deletion from skin epidermis induces rapid basal cell carcinoma formation in mice a, Schematic representation of the animal model used to delete Gnas exon 1 (Ex1) from the basal epidermal stem cell compartment. b, Representative pictures of WT and Gnas eKO animals 60 days after tamoxifen treatment. c, Kaplan-Meier curve of lesion-free mice. WT (Gnas+/+; n=8 mice) and heterozygous Gnas deleted mice (K14CreER Gnas+/\u2212; n=8 mice) did not develop lesions, while homozygous deleted Gnas eKO mice (K14CreER Gnas\u2212/\u2212; n=13 mice) developed lesions 20 to 40 days after tamoxifen treatment. Significance was calculated by Mantel-Cox. d, Histological analysis of WT and Gnas eKO mice. Gnas eKO skin shows basaloid cells growing in the stroma resembling micronodular and superficial BCC. e, Example of human normal and BCC skin histopathology. f, g, h, i, j, Representative pictures of the skin of WT and Gnas eKO animals stained to show expression of the stem cell marker p63 (green) and the basal progenitor marker cytokeratin 5 (CK5, red) (f); the proliferation marker Ki67 (green) and nuclei (blue) (g); CK5 (red), \u03b16 integrin (green) and nuclei (blue) (h); the hair follicle marker cytokeratin 15 (CK15, red) and nuclei (blue) (i); and the differentiation marker loricrin (red) and nuclei (blue) (j). Insert panels in each images show details at higher magnification. Location of the basal membrane is indicated with a white dotted line.", "co_occurrence": [{"body": 48, "word": "Gnas", "fig": 8}, {"body": 48, "word": "mice", "fig": 8}, {"body": 41, "word": "cell", "fig": 3}, {"body": 23, "word": "eKO", "fig": 5}, {"body": 22, "word": "skin", "fig": 4}, {"body": 41, "word": "stem", "fig": 2}, {"body": 41, "word": "cells", "fig": 1}, {"body": 10, "word": "basal", "fig": 4}, {"body": 7, "word": "marker", "fig": 5}, {"body": 17, "word": "BCC", "fig": 2}, {"body": 29, "word": "hair", "fig": 1}, {"body": 11, "word": "lesions", "fig": 2}, {"body": 5, "word": "WT", "fig": 4}, {"body": 19, "word": "follicle", "fig": 1}, {"body": 16, "word": "epidermis", "fig": 1}, {"body": 15, "word": "human", "fig": 1}, {"body": 15, "word": "expression", "fig": 1}, {"body": 14, "word": "used", "fig": 1}, {"body": 13, "word": "deletion", "fig": 1}, {"body": 12, "word": "epidermal", "fig": 1}, {"body": 6, "word": "cytokeratin", "fig": 2}, {"body": 11, "word": "analysis", "fig": 1}, {"body": 9, "word": "proliferation", "fig": 1}, {"body": 8, "word": "differentiation", "fig": 1}, {"body": 4, "word": "treatment", "fig": 2}, {"body": 8, "word": "formation", "fig": 1}, {"body": 3, "word": "tamoxifen", "fig": 2}, {"body": 6, "word": "stained", "fig": 1}, {"body": 3, "word": "K14CreER", "fig": 2}, {"body": 3, "word": "CK5", "fig": 2}, {"body": 3, "word": "days", "fig": 2}, {"body": 4, "word": "rapid", "fig": 1}, {"body": 1, "word": "red", "fig": 4}, {"body": 4, "word": "p63", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 3, "word": "developed", "fig": 1}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "CK15", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "progenitor", "fig": 1}, {"body": 3, "word": "compartment", "fig": 1}, {"body": 3, "word": "Ki67", "fig": 1}, {"body": 1, "word": "show", "fig": 2}, {"body": 2, "word": "exon", "fig": 1}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "loricrin", "fig": 1}, {"body": 2, "word": "integrin", "fig": 1}, {"body": 1, "word": "stroma", "fig": 1}, {"body": 1, "word": "superficial", "fig": 1}, {"body": 1, "word": "homozygous", "fig": 1}, {"body": 1, "word": "resembling", "fig": 1}, {"body": 1, "word": "basaloid", "fig": 1}, {"body": 1, "word": "membrane", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "\u03b16", "fig": 1}, {"body": 1, "word": "animal", "fig": 1}, {"body": 1, "word": "normal", "fig": 1}, {"body": 1, "word": "model", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f2.jpg", "caption": "Genomic analysis unveils activation of GLI and YAP transcriptional networks in Gnas eKO mice a, Gene ontology analysis of differentially regulated genes in Gnas eKO mice filtered by development terms. b, Functional analysis of transcriptional regulators shows epithelial stem cells factors upregulated in Gnas eKO mice. Generated using Ingenuity Pathway Analysis (IPA, Ingenuity\u00ae Systems) c, Heat map depicting the fold change of the expression level of Hedgehog signaling related genes in Gnas eKO vs WT mice in gene array. d, qRT\u2013PCR analysis of GLI transcription factors and the GLI-regulated genes Ptch1 and Ptch2. n=3 mice of each genotype (samples from 3 WT mice and 3 Gnas eKO mice). e, Gnas eKO mice skin qRT\u2013PCR quantification of transcriptional regulators and markers essential for hair follicle stem cell maintenance and proliferation. n=3 mice of each genotype (samples from 3 WT mice and 3 Gnas eKO mice). f, Schematic representation of skin showing the location of the GLI positive stem cell compartment in the hair follicle isthmus and secondary hair germ. g, \u03b2Gal staining for ear skin of WT Glilz and Gnas eKO Glilz mice 4 weeks following tamoxifen administration showing GLI+ cells. Arrows indicate the typical location of GLI+ stem cells. h, i, Staining (h) and quantification (i) of YAP1 expression in skin of WT and Gnas eKO animals. n=240 cells WT, 300 cells KO, from tissue samples from 3 WT mice and 3 Gnas eKO mice. j, Unsupervised hierarchical clustering using a YAP1 transcriptional signature in gene array analysis. k, l, Immunostaining (k) and quantification (l) of YAP1 expression in human normal skin and BCC. n= 3 normal and 6 BCC tissue sections. Data are presented as means\u00b1s.e.m., and significance was calculated by ANOVA and Student\u2019s t-test (NS P > 0.05; *P < 0.05; **P < 0.01; and ***P < 0.001).", "co_occurrence": [{"body": 48, "word": "mice", "fig": 14}, {"body": 48, "word": "Gnas", "fig": 10}, {"body": 23, "word": "eKO", "fig": 10}, {"body": 41, "word": "cells", "fig": 5}, {"body": 66, "word": "YAP1", "fig": 3}, {"body": 41, "word": "stem", "fig": 4}, {"body": 22, "word": "skin", "fig": 5}, {"body": 26, "word": "transcriptional", "fig": 4}, {"body": 34, "word": "GLI", "fig": 3}, {"body": 29, "word": "hair", "fig": 3}, {"body": 41, "word": "cell", "fig": 2}, {"body": 11, "word": "analysis", "fig": 5}, {"body": 15, "word": "expression", "fig": 3}, {"body": 19, "word": "follicle", "fig": 2}, {"body": 18, "word": "using", "fig": 2}, {"body": 5, "word": "WT", "fig": 7}, {"body": 17, "word": "BCC", "fig": 2}, {"body": 28, "word": "signaling", "fig": 1}, {"body": 21, "word": "activation", "fig": 1}, {"body": 8, "word": "Glilz", "fig": 2}, {"body": 15, "word": "human", "fig": 1}, {"body": 5, "word": "genes", "fig": 3}, {"body": 14, "word": "Hedgehog", "fig": 1}, {"body": 6, "word": "tissue", "fig": 2}, {"body": 5, "word": "regulators", "fig": 2}, {"body": 9, "word": "staining", "fig": 1}, {"body": 9, "word": "proliferation", "fig": 1}, {"body": 4, "word": "factors", "fig": 2}, {"body": 8, "word": "epithelial", "fig": 1}, {"body": 8, "word": "development", "fig": 1}, {"body": 6, "word": "following", "fig": 1}, {"body": 6, "word": "transcription", "fig": 1}, {"body": 5, "word": "networks", "fig": 1}, {"body": 5, "word": "\u03b2Gal", "fig": 1}, {"body": 5, "word": "Gene", "fig": 1}, {"body": 5, "word": "upregulated", "fig": 1}, {"body": 4, "word": "markers", "fig": 1}, {"body": 2, "word": "gene", "fig": 2}, {"body": 2, "word": "array", "fig": 2}, {"body": 4, "word": "positive", "fig": 1}, {"body": 4, "word": "maintenance", "fig": 1}, {"body": 2, "word": "GLI+", "fig": 2}, {"body": 3, "word": "tamoxifen", "fig": 1}, {"body": 3, "word": "ear", "fig": 1}, {"body": 1, "word": "samples", "fig": 3}, {"body": 3, "word": "weeks", "fig": 1}, {"body": 3, "word": "Analysis", "fig": 1}, {"body": 3, "word": "terms", "fig": 1}, {"body": 3, "word": "regulated", "fig": 1}, {"body": 3, "word": "compartment", "fig": 1}, {"body": 3, "word": "sections", "fig": 1}, {"body": 2, "word": "essential", "fig": 1}, {"body": 2, "word": "fold", "fig": 1}, {"body": 2, "word": "change", "fig": 1}, {"body": 2, "word": "signature", "fig": 1}, {"body": 2, "word": "clustering", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "isthmus", "fig": 1}, {"body": 2, "word": "Staining", "fig": 1}, {"body": 1, "word": "qRT\u2013PCR", "fig": 2}, {"body": 2, "word": "filtered", "fig": 1}, {"body": 1, "word": "normal", "fig": 2}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "Systems", "fig": 1}, {"body": 1, "word": "NS", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "secondary", "fig": 1}, {"body": 1, "word": "IPA", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "ontology", "fig": 1}, {"body": 1, "word": "germ", "fig": 1}, {"body": 1, "word": "YAP", "fig": 1}, {"body": 1, "word": "hierarchical", "fig": 1}, {"body": 1, "word": "KO", "fig": 1}, {"body": 1, "word": "Ingenuity\u00ae", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "Ptch2", "fig": 1}, {"body": 1, "word": "Ptch1", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f3.jpg", "caption": "Gnas eKO triggers ectopic/de novo activation of GLI and YAP1 a, b, Representative pictures of \u03b2Gal staining of tail skin whole mounts from WT Glilz and Gnas eKO Glilz mice showing GLI+ cells one day after finishing the administration of tamoxifen. Arrows indicate the location of GLI+ epithelial stem cells. In b hair follicles were removed to facilitate visualization of GLI activation at the base of the isthmus of hair follicles. c, d, Representative pictures of tail skin whole mounts from WT and Gnas eKO animals stained to show expression of YAP1 (green) and cytokeratin 15 (CK15, red), one day after finishing the administration of tamoxifen. e, Representative pictures of wells and quantification of clonogenic assays of keratinocytes isolated from WT and Gnas eKO mice two weeks after tamoxifen treatment. n=3 technical replicates, one representative experiment of three is shown. f, Quantification and representative pictures of \u03b2Gal positive keratinocyte colonies from WT Glilz and Gnas eKO Glilz mice. Cells from 2 mice of each genotype were plated in duplicate and colonies counted (cells from 2 WT mice and 2 Gnas eKO mice). g, Representative pictures of wells and quantification from clonogenic assays of keratinocytes isolated from Gnas eKO mice and transfected with the corresponding siRNAs. Graphs on the right show mRNA levels of Gli1 and Yap1 after transfection with respective siRNAs. n=3 technical replicates, one representative experiment of three is shown. Insert panels in images show details at higher magnification. Hair follicles are delineated with a white dotted line.", "co_occurrence": [{"body": 48, "word": "Gnas", "fig": 7}, {"body": 48, "word": "mice", "fig": 7}, {"body": 23, "word": "eKO", "fig": 7}, {"body": 66, "word": "YAP1", "fig": 2}, {"body": 41, "word": "cells", "fig": 3}, {"body": 34, "word": "GLI", "fig": 2}, {"body": 29, "word": "hair", "fig": 2}, {"body": 22, "word": "skin", "fig": 2}, {"body": 21, "word": "activation", "fig": 2}, {"body": 41, "word": "stem", "fig": 1}, {"body": 8, "word": "Glilz", "fig": 4}, {"body": 5, "word": "WT", "fig": 5}, {"body": 10, "word": "keratinocytes", "fig": 2}, {"body": 6, "word": "follicles", "fig": 3}, {"body": 4, "word": "one", "fig": 4}, {"body": 15, "word": "expression", "fig": 1}, {"body": 6, "word": "whole", "fig": 2}, {"body": 5, "word": "day", "fig": 2}, {"body": 5, "word": "\u03b2Gal", "fig": 2}, {"body": 5, "word": "isolated", "fig": 2}, {"body": 3, "word": "tamoxifen", "fig": 3}, {"body": 9, "word": "staining", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 8, "word": "epithelial", "fig": 1}, {"body": 7, "word": "In", "fig": 1}, {"body": 6, "word": "stained", "fig": 1}, {"body": 3, "word": "tail", "fig": 2}, {"body": 3, "word": "mounts", "fig": 2}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "cytokeratin", "fig": 1}, {"body": 4, "word": "treatment", "fig": 1}, {"body": 2, "word": "shown", "fig": 2}, {"body": 4, "word": "transfected", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 2, "word": "assays", "fig": 2}, {"body": 2, "word": "siRNAs", "fig": 2}, {"body": 2, "word": "GLI+", "fig": 2}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "weeks", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "Yap1", "fig": 1}, {"body": 3, "word": "CK15", "fig": 1}, {"body": 1, "word": "show", "fig": 3}, {"body": 3, "word": "keratinocyte", "fig": 1}, {"body": 3, "word": "Gli1", "fig": 1}, {"body": 2, "word": "base", "fig": 1}, {"body": 2, "word": "isthmus", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "corresponding", "fig": 1}, {"body": 2, "word": "triggers", "fig": 1}, {"body": 1, "word": "colonies", "fig": 2}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "Hair", "fig": 1}, {"body": 1, "word": "removed", "fig": 1}, {"body": 1, "word": "plated", "fig": 1}, {"body": 1, "word": "transfection", "fig": 1}, {"body": 1, "word": "two", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f4.jpg", "caption": "G\u03b1s-PKA restrain GLI and YAP1 transcriptional activity a, Structure of PKA bound to the active PKA inhibitor protein (PKI) peptide and amino-acid sequence of PKI and its inactive mutant PKI4A. b, Both forskolin and the G\u03b1s active mutant G\u03b1sR201C are able to activate a CRE luciferase reporter in 293 cells expressing the inactive GFP-PKI4A mutant, while GFP-PKI completely blocks this response. Data from one representative experiment of three are shown. c, d, Transcriptional activity measured by luciferase assay of GLI1 (d) and YAP1 (e) in 293 cells transfected with the indicated DNAs. GLI1 activity was measured by GAL4GLI1/UASLuc and YAP1 by GAL4TEAD/UASLuc reporters. The constitutive active mutant G\u03b1sR201C was used to mimic G\u03b1s activation and PKI was used to block PKA activity (see also Supplementary Fig. 3). n=3 independent experiments. e, Phosphorylation of GLI1 by PKA. 293 cells were transfected with the indicated DNAs and GLI1-HA. Then, cells were treated with forskolin (FSK) for 30 min and GLI1-HA was immunoprecipitated and tested with two different anti-phospho-PKA substrate motif antibodies that detect proteins containing phospho-serine/threonine residues with arginine at the \u22123 and \u22122 positions [RXX(S*/T*) and RRX(S*/T*)]. Full images of blots are shown in Supplementary Fig. 6. f, Transcriptional activity of GLI1 in NIH3T3 cells measured by GAL4GLI1/UASLuc reporters co-transfected with the indicated DNAs and treated or not with cyclopamine. n=3 independent experiments. g, h, Quantification (h) and representative pictures (i) of \u03b2Gal staining of keratinocytes from WT Glilz and Gnas eKO Glilz mice treated with the indicated drugs for 48hs. Cells isolated from WT or Gnas eKO mice were plated in triplicate, treated and positive and negative cells were counted (between 1000 and 1500 cells per condition were counted). One representative experiment of three is shown. RLU: relative luciferase units; Cy: cyclopamine; FI: forskolin+IBMX. Data are presented as means\u00b1s.e.m., and significance was calculated by ANOVA and Student\u2019s t-test (NS P > 0.05; *P < 0.05; **P < 0.01; and ***P < 0.001).", "co_occurrence": [{"body": 41, "word": "cells", "fig": 7}, {"body": 66, "word": "YAP1", "fig": 3}, {"body": 76, "word": "Fig", "fig": 2}, {"body": 35, "word": "PKA", "fig": 4}, {"body": 25, "word": "activity", "fig": 5}, {"body": 48, "word": "Gnas", "fig": 2}, {"body": 48, "word": "mice", "fig": 2}, {"body": 37, "word": "G\u03b1s", "fig": 2}, {"body": 23, "word": "eKO", "fig": 2}, {"body": 10, "word": "GLI1", "fig": 4}, {"body": 34, "word": "GLI", "fig": 1}, {"body": 14, "word": "used", "fig": 2}, {"body": 13, "word": "Supplementary", "fig": 2}, {"body": 26, "word": "transcriptional", "fig": 1}, {"body": 21, "word": "activation", "fig": 1}, {"body": 6, "word": "active", "fig": 3}, {"body": 17, "word": "The", "fig": 1}, {"body": 8, "word": "Glilz", "fig": 2}, {"body": 4, "word": "indicated", "fig": 4}, {"body": 5, "word": "PKI", "fig": 3}, {"body": 7, "word": "experiments", "fig": 2}, {"body": 7, "word": "G\u03b1sR201C", "fig": 2}, {"body": 13, "word": "GFP-PKI", "fig": 1}, {"body": 11, "word": "also", "fig": 1}, {"body": 5, "word": "cyclopamine", "fig": 2}, {"body": 5, "word": "WT", "fig": 2}, {"body": 10, "word": "keratinocytes", "fig": 1}, {"body": 10, "word": "GFP-PKI4A", "fig": 1}, {"body": 5, "word": "independent", "fig": 2}, {"body": 9, "word": "staining", "fig": 1}, {"body": 4, "word": "transfected", "fig": 2}, {"body": 2, "word": "mutant", "fig": 4}, {"body": 7, "word": "sequence", "fig": 1}, {"body": 2, "word": "luciferase", "fig": 3}, {"body": 2, "word": "shown", "fig": 3}, {"body": 6, "word": "min", "fig": 1}, {"body": 2, "word": "measured", "fig": 3}, {"body": 5, "word": "isolated", "fig": 1}, {"body": 5, "word": "\u03b2Gal", "fig": 1}, {"body": 5, "word": "expressing", "fig": 1}, {"body": 5, "word": "reporter", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 4, "word": "one", "fig": 1}, {"body": 1, "word": "treated", "fig": 4}, {"body": 3, "word": "see", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "inhibitor", "fig": 1}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "residues", "fig": 1}, {"body": 3, "word": "48hs", "fig": 1}, {"body": 2, "word": "G\u03b1s-PKA", "fig": 1}, {"body": 2, "word": "negative", "fig": 1}, {"body": 1, "word": "Transcriptional", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 1, "word": "forskolin", "fig": 2}, {"body": 2, "word": "antibodies", "fig": 1}, {"body": 2, "word": "triplicate", "fig": 1}, {"body": 2, "word": "co-transfected", "fig": 1}, {"body": 2, "word": "blocks", "fig": 1}, {"body": 2, "word": "containing", "fig": 1}, {"body": 2, "word": "NIH3T3", "fig": 1}, {"body": 2, "word": "response", "fig": 1}, {"body": 2, "word": "One", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "Both", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "activate", "fig": 1}, {"body": 1, "word": "NS", "fig": 1}, {"body": 1, "word": "CRE", "fig": 1}, {"body": 1, "word": "detect", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "block", "fig": 1}, {"body": 1, "word": "anti-phospho-PKA", "fig": 1}, {"body": 1, "word": "peptide", "fig": 1}, {"body": 1, "word": "Then", "fig": 1}, {"body": 1, "word": "plated", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "FI", "fig": 1}, {"body": 1, "word": "arginine", "fig": 1}, {"body": 1, "word": "two", "fig": 1}, {"body": 1, "word": "P", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f5.jpg", "caption": "PKA mediates cAMP-induced inactivation of YAP1 through LATS and NF2 a, Western blot analysis of YAP1 regulatory molecules in non-confluent HACAT cells treated with with cAMP raising agents, forskolin+IBMX (FI), for the indicated times. b, Representative pictures of non-confluent HACAT cells treated or not with forskolin+IBMX (FI) for 2 hs and stained to show expression of YAP1 (green) and nuclei (blue). c, d, RNA interference experiments of the indicated YAP1 regulatory molecules. Cells were transfected with indicated siRNAs for 48hs and then treated (FI) or not (C) with forskolin+IBMX for 2 hs and stained to show expression of YAP1 (c); or harvested for the indicated Western blot analysis (d). For d, the proportion of cells per field showing YAP1 localization in the nucleus or cytoplasm was quantified. n=3 independent experiments, 4 fields with 30 to 50 cells were counted per condition per experiment. Data are presented as means\u00b1s.e.m., and significance was calculated in the nucleus fraction by Student\u2019s t-test against the control of the same group (NS P > 0.05; *P < 0.05; **P < 0.01; and ***P < 0.001). Full images of blots are shown in Supplementary Fig. 6.", "co_occurrence": [{"body": 66, "word": "YAP1", "fig": 6}, {"body": 41, "word": "cells", "fig": 4}, {"body": 76, "word": "Fig", "fig": 1}, {"body": 35, "word": "PKA", "fig": 1}, {"body": 15, "word": "expression", "fig": 2}, {"body": 11, "word": "analysis", "fig": 2}, {"body": 4, "word": "indicated", "fig": 4}, {"body": 7, "word": "experiments", "fig": 2}, {"body": 13, "word": "Supplementary", "fig": 1}, {"body": 6, "word": "stained", "fig": 2}, {"body": 11, "word": "cAMP", "fig": 1}, {"body": 10, "word": "NF2", "fig": 1}, {"body": 8, "word": "LATS", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 3, "word": "HACAT", "fig": 2}, {"body": 2, "word": "per", "fig": 3}, {"body": 5, "word": "independent", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "transfected", "fig": 1}, {"body": 2, "word": "Western", "fig": 2}, {"body": 2, "word": "non-confluent", "fig": 2}, {"body": 4, "word": "inactivation", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "mediates", "fig": 1}, {"body": 3, "word": "localization", "fig": 1}, {"body": 1, "word": "FI", "fig": 3}, {"body": 1, "word": "treated", "fig": 3}, {"body": 3, "word": "Cells", "fig": 1}, {"body": 3, "word": "48hs", "fig": 1}, {"body": 1, "word": "show", "fig": 2}, {"body": 1, "word": "blot", "fig": 2}, {"body": 1, "word": "molecules", "fig": 2}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "regulatory", "fig": 2}, {"body": 2, "word": "times", "fig": 1}, {"body": 1, "word": "hs", "fig": 2}, {"body": 2, "word": "siRNAs", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "fields", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "RNA", "fig": 1}, {"body": 1, "word": "NS", "fig": 1}, {"body": 1, "word": "raising", "fig": 1}, {"body": 1, "word": "cAMP-induced", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f6.jpg", "caption": "Inactivation of PKA is sufficient to initiate basal cell carcinoma formation a, Schematic representation of the animal model used to target the inducible expression of the PKA inhibitor protein (GFP-PKI) to the basal epidermal stem cell compartment. b, Histological analysis of WT and K5rtTA Tet-GFP-PKI mice. K5rtTA Tet-GFP-PKI skin shows basaloid cells growing in the stroma resembling micronodular and superficial BCCs. c, Representative pictures of the skin of K5rtTA Tet-GFP-PKI4A and K5rtTA Tet-GFP-PKI mice stained to show expression of GFP (green), \u03b16 integrin (red) and nuclei (blue). d, e, f, Representative pictures of the skin of K5rtTA Tet-GFP-PKI animals stained to show expression of the stem cell marker p63 (green) and the basal progenitor marker cytokeratin 5 (CK5, red) (d); the hair follicle marker cytokeratin 15 (CK15, red) and nuclei (blue) (e), and the proliferation marker Ki67 (red) and nuclei (blue) (f). g, Representative picture of \u03b2Gal staining of the skin of K5rtTA tet-GFP-PKI Glilz mice showing activation of GLI. h, Representative picture of YAP1 immunohistochemistry staining of the skin of K5rtTA tet-GFP-PKI showing nuclear localization of YAP1 in skin lesions. i, qRT\u2013PCR analysis of mRNA levels of Yap1 and the YAP1-regulated gene Ctgf, and transcriptional regulators and markers essential for hair follicle stem cell maintenance and proliferation in primary cultures of keratinocytes from K5rtTA tet-GFP-PKI mice compared to cultures from WT littermates. n=3 independent cultures from 3 WT and 3 K5rtTA tet-GFP-PKI mice. Data are presented as means\u00b1s.e.m., and significance was calculated by ANOVA and Student\u2019s t-test (NS P > 0.05; *P < 0.05; **P < 0.01; and ***P < 0.001). Insert panels in images show details at higher magnification. Location of the basal membrane is indicated with a white dotted line.", "co_occurrence": [{"body": 48, "word": "mice", "fig": 5}, {"body": 41, "word": "cell", "fig": 4}, {"body": 22, "word": "skin", "fig": 6}, {"body": 66, "word": "YAP1", "fig": 2}, {"body": 41, "word": "stem", "fig": 3}, {"body": 35, "word": "PKA", "fig": 2}, {"body": 29, "word": "hair", "fig": 2}, {"body": 15, "word": "expression", "fig": 3}, {"body": 41, "word": "cells", "fig": 1}, {"body": 10, "word": "basal", "fig": 4}, {"body": 19, "word": "follicle", "fig": 2}, {"body": 34, "word": "GLI", "fig": 1}, {"body": 7, "word": "marker", "fig": 4}, {"body": 3, "word": "K5rtTA", "fig": 9}, {"body": 26, "word": "transcriptional", "fig": 1}, {"body": 11, "word": "analysis", "fig": 2}, {"body": 21, "word": "activation", "fig": 1}, {"body": 9, "word": "staining", "fig": 2}, {"body": 9, "word": "proliferation", "fig": 2}, {"body": 5, "word": "WT", "fig": 3}, {"body": 14, "word": "used", "fig": 1}, {"body": 13, "word": "GFP-PKI", "fig": 1}, {"body": 6, "word": "stained", "fig": 2}, {"body": 12, "word": "epidermal", "fig": 1}, {"body": 6, "word": "cytokeratin", "fig": 2}, {"body": 11, "word": "lesions", "fig": 1}, {"body": 10, "word": "keratinocytes", "fig": 1}, {"body": 9, "word": "levels", "fig": 1}, {"body": 8, "word": "formation", "fig": 1}, {"body": 8, "word": "Glilz", "fig": 1}, {"body": 8, "word": "sufficient", "fig": 1}, {"body": 6, "word": "mRNA", "fig": 1}, {"body": 6, "word": "GFP", "fig": 1}, {"body": 5, "word": "independent", "fig": 1}, {"body": 5, "word": "\u03b2Gal", "fig": 1}, {"body": 5, "word": "regulators", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 5, "word": "nuclear", "fig": 1}, {"body": 4, "word": "markers", "fig": 1}, {"body": 1, "word": "red", "fig": 4}, {"body": 1, "word": "tet-GFP-PKI", "fig": 4}, {"body": 4, "word": "maintenance", "fig": 1}, {"body": 4, "word": "p63", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 1, "word": "show", "fig": 3}, {"body": 3, "word": "line", "fig": 1}, {"body": 3, "word": "CK5", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "Yap1", "fig": 1}, {"body": 3, "word": "localization", "fig": 1}, {"body": 3, "word": "Ctgf", "fig": 1}, {"body": 3, "word": "CK15", "fig": 1}, {"body": 3, "word": "progenitor", "fig": 1}, {"body": 1, "word": "cultures", "fig": 3}, {"body": 3, "word": "compartment", "fig": 1}, {"body": 3, "word": "Ki67", "fig": 1}, {"body": 3, "word": "inhibitor", "fig": 1}, {"body": 2, "word": "essential", "fig": 1}, {"body": 2, "word": "gene", "fig": 1}, {"body": 2, "word": "integrin", "fig": 1}, {"body": 2, "word": "compared", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "stroma", "fig": 1}, {"body": 1, "word": "superficial", "fig": 1}, {"body": 1, "word": "**P", "fig": 1}, {"body": 1, "word": "P", "fig": 1}, {"body": 1, "word": "inducible", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "basaloid", "fig": 1}, {"body": 1, "word": "NS", "fig": 1}, {"body": 1, "word": "membrane", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "model", "fig": 1}, {"body": 1, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "\u03b16", "fig": 1}, {"body": 1, "word": "initiate", "fig": 1}, {"body": 1, "word": "primary", "fig": 1}, {"body": 1, "word": "qRT\u2013PCR", "fig": 1}, {"body": 1, "word": "target", "fig": 1}, {"body": 1, "word": "*P", "fig": 1}, {"body": 1, "word": "***P", "fig": 1}, {"body": 1, "word": "animal", "fig": 1}, {"body": 1, "word": "significance", "fig": 1}, {"body": 1, "word": "resembling", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f7.jpg", "caption": "G\u03b1s activation in the skin leads to epidermal stem cell differentiation and premature hair loss a, Schematic representation of the animal model. b, Western blot analysis of keratinocytes isolated from control (K5rtTA) and active G\u03b1s mice (K5rtTA tet-G\u03b1sR201C) treated with doxycycline (to induce transgene expression). Full images shown in Supplementary Fig. 6. c, Representative picture of control and active G\u03b1s mice 5 months after doxycycline treatment. d, Histological analysis of skin from active G\u03b1s mice showing hair follicles differentiated into keratinized cysts structures. e, f, g, representative pictures of skin stained to show expression of the hair follicle stem cell marker CD34 (green) and pan-cytokeratin (panCK, red) (e); the stem cell marker p63 (green) and the basal progenitor marker CK5 (red) (f); and the proliferation marker Ki67 (green) and nuclei (blue) (g). Insert panels in images show details at higher magnification. Location of the basal membrane is indicated with a white dotted line. h, Representative pictures of hair follicles from tail skin whole mounts in mice treated with doxycycline for 2 months. Staining shows YAP1 (green) and cytokeratin 15 (CK15, red). Details at higher magnification can be seen in Supplementary Fig. 5. Hair follicles are delineated with a white dotted line. i, j, qRT\u2013PCR analysis of the expression of Gnas and the differentiation markers cytokeratin 10 (Krt10) and loricrin (Lor) (j), Gli transcription factors (k), GLI-regulated genes Ptch1 and Ptch2 (k), hair follicle stem cell markers (Lgr5, Runx1, Nfatc1) (k), Yap1 and the YAP1-regulated gene Ctgf (k), in primary culture of keratinocytes. Data from one representative experiment of three are shown. Data are presented as means.", "co_occurrence": [{"body": 48, "word": "mice", "fig": 4}, {"body": 41, "word": "cell", "fig": 4}, {"body": 41, "word": "stem", "fig": 4}, {"body": 76, "word": "Fig", "fig": 2}, {"body": 37, "word": "G\u03b1s", "fig": 4}, {"body": 29, "word": "hair", "fig": 5}, {"body": 22, "word": "skin", "fig": 4}, {"body": 66, "word": "YAP1", "fig": 1}, {"body": 48, "word": "Gnas", "fig": 1}, {"body": 15, "word": "expression", "fig": 3}, {"body": 19, "word": "follicle", "fig": 2}, {"body": 11, "word": "analysis", "fig": 3}, {"body": 7, "word": "marker", "fig": 4}, {"body": 13, "word": "Supplementary", "fig": 2}, {"body": 21, "word": "activation", "fig": 1}, {"body": 10, "word": "keratinocytes", "fig": 2}, {"body": 10, "word": "basal", "fig": 2}, {"body": 6, "word": "follicles", "fig": 3}, {"body": 6, "word": "active", "fig": 3}, {"body": 8, "word": "differentiation", "fig": 2}, {"body": 7, "word": "control", "fig": 2}, {"body": 12, "word": "epidermal", "fig": 1}, {"body": 6, "word": "cytokeratin", "fig": 2}, {"body": 9, "word": "proliferation", "fig": 1}, {"body": 4, "word": "markers", "fig": 2}, {"body": 3, "word": "line", "fig": 2}, {"body": 6, "word": "stained", "fig": 1}, {"body": 3, "word": "K5rtTA", "fig": 2}, {"body": 3, "word": "images", "fig": 2}, {"body": 2, "word": "doxycycline", "fig": 3}, {"body": 6, "word": "transcription", "fig": 1}, {"body": 6, "word": "whole", "fig": 1}, {"body": 5, "word": "induce", "fig": 1}, {"body": 5, "word": "genes", "fig": 1}, {"body": 5, "word": "isolated", "fig": 1}, {"body": 4, "word": "treatment", "fig": 1}, {"body": 2, "word": "shown", "fig": 2}, {"body": 4, "word": "factors", "fig": 1}, {"body": 4, "word": "one", "fig": 1}, {"body": 4, "word": "p63", "fig": 1}, {"body": 4, "word": "indicated", "fig": 1}, {"body": 3, "word": "tail", "fig": 1}, {"body": 3, "word": "loss", "fig": 1}, {"body": 3, "word": "CK5", "fig": 1}, {"body": 3, "word": "mounts", "fig": 1}, {"body": 3, "word": "Yap1", "fig": 1}, {"body": 1, "word": "red", "fig": 3}, {"body": 3, "word": "Ctgf", "fig": 1}, {"body": 3, "word": "CK15", "fig": 1}, {"body": 3, "word": "progenitor", "fig": 1}, {"body": 3, "word": "Ki67", "fig": 1}, {"body": 1, "word": "show", "fig": 2}, {"body": 2, "word": "differentiated", "fig": 1}, {"body": 2, "word": "culture", "fig": 1}, {"body": 2, "word": "Staining", "fig": 1}, {"body": 2, "word": "loricrin", "fig": 1}, {"body": 2, "word": "gene", "fig": 1}, {"body": 2, "word": "structures", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "transgene", "fig": 1}, {"body": 1, "word": "treated", "fig": 2}, {"body": 1, "word": "CD34", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "Lgr5", "fig": 1}, {"body": 1, "word": "means", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "pan-cytokeratin", "fig": 1}, {"body": 1, "word": "Krt10", "fig": 1}, {"body": 1, "word": "membrane", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "Hair", "fig": 1}, {"body": 1, "word": "keratinized", "fig": 1}, {"body": 1, "word": "primary", "fig": 1}, {"body": 1, "word": "qRT\u2013PCR", "fig": 1}, {"body": 1, "word": "Nfatc1", "fig": 1}, {"body": 1, "word": "tet-G\u03b1sR201C", "fig": 1}, {"body": 1, "word": "animal", "fig": 1}, {"body": 1, "word": "Lor", "fig": 1}, {"body": 1, "word": "Ptch2", "fig": 1}, {"body": 1, "word": "Ptch1", "fig": 1}, {"body": 1, "word": "model", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449815/bin/nihms673780f8.jpg", "caption": "Model of the regulation of stem cell fate in the epidermis by G\u03b1s-PKA a, b, In contrast with the well-known tumor promoting role of the heterotrimeric G protein G\u03b1s, this study suggests that G\u03b1s and its downstream effector PKA function as part of a tumor suppressive circuitry regulating the fate of GLI+ stem cells (shown in blue in a), in part by restraining the transcriptional activity YAP1 and GLI, independently of canonical Hippo and SHH signaling (b). Disruption of this G\u03b1s-PKA signaling axis in the epidermis is sufficient to promote rapid stem cell expansion and basal cell carcinoma formation, while overactivation of this signaling pathway leads to hair follicle stem cell depletion and hair loss (a). See text for more details.", "co_occurrence": [{"body": 41, "word": "cell", "fig": 4}, {"body": 41, "word": "stem", "fig": 4}, {"body": 28, "word": "signaling", "fig": 3}, {"body": 37, "word": "G\u03b1s", "fig": 2}, {"body": 66, "word": "YAP1", "fig": 1}, {"body": 29, "word": "hair", "fig": 2}, {"body": 41, "word": "cells", "fig": 1}, {"body": 35, "word": "PKA", "fig": 1}, {"body": 34, "word": "GLI", "fig": 1}, {"body": 16, "word": "epidermis", "fig": 2}, {"body": 26, "word": "transcriptional", "fig": 1}, {"body": 25, "word": "activity", "fig": 1}, {"body": 10, "word": "tumor", "fig": 2}, {"body": 19, "word": "follicle", "fig": 1}, {"body": 11, "word": "expansion", "fig": 1}, {"body": 5, "word": "fate", "fig": 2}, {"body": 10, "word": "basal", "fig": 1}, {"body": 8, "word": "sufficient", "fig": 1}, {"body": 4, "word": "part", "fig": 2}, {"body": 8, "word": "formation", "fig": 1}, {"body": 7, "word": "Hippo", "fig": 1}, {"body": 7, "word": "downstream", "fig": 1}, {"body": 7, "word": "pathway", "fig": 1}, {"body": 7, "word": "In", "fig": 1}, {"body": 6, "word": "role", "fig": 1}, {"body": 6, "word": "function", "fig": 1}, {"body": 5, "word": "protein", "fig": 1}, {"body": 5, "word": "SHH", "fig": 1}, {"body": 4, "word": "rapid", "fig": 1}, {"body": 2, "word": "G\u03b1s-PKA", "fig": 2}, {"body": 4, "word": "suppressive", "fig": 1}, {"body": 3, "word": "contrast", "fig": 1}, {"body": 3, "word": "loss", "fig": 1}, {"body": 3, "word": "independently", "fig": 1}, {"body": 2, "word": "restraining", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "GLI+", "fig": 1}, {"body": 2, "word": "heterotrimeric", "fig": 1}, {"body": 2, "word": "axis", "fig": 1}, {"body": 2, "word": "promote", "fig": 1}, {"body": 2, "word": "study", "fig": 1}, {"body": 2, "word": "overactivation", "fig": 1}, {"body": 1, "word": "well-known", "fig": 1}, {"body": 1, "word": "depletion", "fig": 1}, {"body": 1, "word": "promoting", "fig": 1}, {"body": 1, "word": "effector", "fig": 1}]}], "4558155": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558155/bin/oncotarget-06-15332-g001.jpg", "caption": "Activation of the InAT axis is observed in colorectal CSCs (A and B) Representative immunoblots and the corresponding bar graph of the gel densitometry analyses of relative normalized expression of the InAT axis proteins including activated (phosphorylated) levels of IGF-1R, AKT, mTOR, p70S6K and 4EBP1 (normalized to total protein expression) as well as PTEN, an inhibitor of InAT axis, in HCT-116 spheroids compared to respective monolayer controls. \u03b2-actin is used as a loading control. (C) Q-PCR analyses demonstrating differential expression of IGF-1R pathway genes and CSC markers in Dual(hi) [CD133(hi)/CXCR4(hi), CSCs] compared to Dual(lo) [CD133(low)/CXCR4 (low), non-CSCs] cells. Data was normalized to GAPDH. (D and E) Representative immunoblots and the corresponding bar graph of the gel densitometry analyses show higher expression of phosphorylated IGF-1R and AKT (normalized to total protein expression) as well as substantial increase in IGF1 level in Dual(hi) HT-29 cells compared to Dual(lo) controls. GAPDH is used as a loading control. (F and H) HCT-116 and WiDR cells grown in monolayer condition were serum starved for 24 h followed by stimulation with IGF1 (100 ng/ml) for 48 hours. Representative scattered plots of flow cytometry analyses for LGR5 positive and Dual(hi) cells (CD133 positive cells depicted in blue and CXCR4 positive cells depicted in green) show increase in proportion of CSCs in IGF1 stimulated cells compared to unstimulated controls. (G and I) Colonosphere formation in HCT-116 and WiDR monolayer cells stimulated with IGF1 (100 ng/ml) compared to respective controls. Data are presented as mean \u00b1 SD (n = 3). *p < 0.05; **p < 0.005.", "co_occurrence": [{"body": 44, "word": "cells", "fig": 8}, {"body": 59, "word": "CSCs", "fig": 3}, {"body": 53, "word": "IGF-1R", "fig": 3}, {"body": 21, "word": "compared", "fig": 5}, {"body": 74, "word": "pathway", "fig": 1}, {"body": 14, "word": "expression", "fig": 5}, {"body": 15, "word": "controls", "fig": 4}, {"body": 17, "word": "axis", "fig": 3}, {"body": 10, "word": "Dual", "fig": 5}, {"body": 9, "word": "hi", "fig": 5}, {"body": 15, "word": "InAT", "fig": 3}, {"body": 13, "word": "HCT-116", "fig": 3}, {"body": 18, "word": "protein", "fig": 2}, {"body": 15, "word": "well", "fig": 2}, {"body": 26, "word": "levels", "fig": 1}, {"body": 8, "word": "monolayer", "fig": 3}, {"body": 12, "word": "increase", "fig": 2}, {"body": 8, "word": "CD133", "fig": 3}, {"body": 20, "word": "spheroids", "fig": 1}, {"body": 19, "word": "observed", "fig": 1}, {"body": 18, "word": "colorectal", "fig": 1}, {"body": 4, "word": "IGF1", "fig": 4}, {"body": 12, "word": "mTOR", "fig": 1}, {"body": 12, "word": "formation", "fig": 1}, {"body": 11, "word": "inhibitor", "fig": 1}, {"body": 11, "word": "HT-29", "fig": 1}, {"body": 5, "word": "control", "fig": 2}, {"body": 5, "word": "AKT", "fig": 2}, {"body": 5, "word": "low", "fig": 2}, {"body": 5, "word": "ng/ml", "fig": 2}, {"body": 5, "word": "used", "fig": 2}, {"body": 9, "word": "LGR5", "fig": 1}, {"body": 9, "word": "genes", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 2, "word": "analyses", "fig": 4}, {"body": 7, "word": "including", "fig": 1}, {"body": 7, "word": "CSC", "fig": 1}, {"body": 7, "word": "CXCR4", "fig": 1}, {"body": 6, "word": "activated", "fig": 1}, {"body": 3, "word": "lo", "fig": 2}, {"body": 3, "word": "total", "fig": 2}, {"body": 2, "word": "positive", "fig": 3}, {"body": 5, "word": "markers", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 2, "word": "show", "fig": 2}, {"body": 4, "word": "proportion", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 2}, {"body": 4, "word": "G", "fig": 1}, {"body": 4, "word": "hours", "fig": 1}, {"body": 2, "word": "WiDR", "fig": 2}, {"body": 4, "word": "stimulation", "fig": 1}, {"body": 3, "word": "condition", "fig": 1}, {"body": 3, "word": "level", "fig": 1}, {"body": 3, "word": "followed", "fig": 1}, {"body": 3, "word": "serum", "fig": 1}, {"body": 1, "word": "gel", "fig": 2}, {"body": 1, "word": "/CXCR4", "fig": 2}, {"body": 2, "word": "Q-PCR", "fig": 1}, {"body": 2, "word": "p70S6K", "fig": 1}, {"body": 1, "word": "phosphorylated", "fig": 2}, {"body": 2, "word": "grown", "fig": 1}, {"body": 1, "word": "respective", "fig": 2}, {"body": 1, "word": "stimulated", "fig": 2}, {"body": 1, "word": "Colonosphere", "fig": 1}, {"body": 1, "word": "4EBP1", "fig": 1}, {"body": 1, "word": "**p", "fig": 1}, {"body": 1, "word": "h", "fig": 1}, {"body": 1, "word": "proteins", "fig": 1}, {"body": 1, "word": "blue", "fig": 1}, {"body": 1, "word": "PTEN", "fig": 1}, {"body": 1, "word": "non-CSCs", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "flow", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "Activation", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 1}, {"body": 1, "word": "starved", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558155/bin/oncotarget-06-15332-g002.jpg", "caption": "Inhibition of IGR-1R, an upstream regulator of the InAT axis, suppresses colon CSCs growth and self-renewal (A) Immunoblot analyses show reduced IGF-1R expression and corresponding inhibition of 1o/2o/3o spheroid formation in different subclones of HCT-116 cells stably transfected with IGF-1R shRNA compared to scrambled controls; suggesting attenuation of CSC growth and self-renewal by IGF-1R gene knockdown. (B) Extreme limiting dilution assay shows reduced spheroid forming frequency of HCT-116 cells transfected with IGF-1R shRNA (Clone 2, IGF-1R KD) compared to scramble transfected control. (C & D) Representative immunoblots and the corresponding bar graph of the gel densitometry analyses show decreased expression of activated and total IGF-1R as well as CSC markers (CD133, CD44, and LGR5) and self-renewal factor (C-MYC) in IGF-1R KD spheroids compared to scrambled controls. (E) Dose response curve shows dose dependent inhibition of primary colonosphere formation in three out of four colon cancer cell lines treated with OSI-906, a tyrosine kinase inhibitor of IGF-1R, at an IC50 ranging from 0.75 \u03bcM \u22121.5 \u03bcM compared to vehicle treated control. (F) OSI-906 (1.5 \u03bc\u039c) inhibits 1o as well as 2o spheroid formation in HCT-116, HT-29 and WiDR colon cancer cells suggesting attenuation of CSC growth and self-renewal. (G & H) Representative immunoblots and the corresponding bar graph of the gel densitometry analyses show decreased expression of activated IGF-1R (at 15 min) as well as CSC markers (CD133, CD44, LGR5, and DCAMKL1) and self-renewal marker (C-MYC) (24 hours) in HCT-116 and HT-29 spheroids treated with OSI-906 (1.5 \u03bc\u039c) compared to vehicle treated controls. GAPDH is used as loading control for all immunoblot analyses. Data are presented as mean \u00b1 SD (n = 3). Numbers under the blot represent relative densitometry values. *p < 0.05; **p < 0.005.", "co_occurrence": [{"body": 53, "word": "IGF-1R", "fig": 9}, {"body": 44, "word": "cells", "fig": 3}, {"body": 21, "word": "compared", "fig": 5}, {"body": 32, "word": "growth", "fig": 3}, {"body": 37, "word": "inhibition", "fig": 2}, {"body": 21, "word": "OSI-906", "fig": 3}, {"body": 59, "word": "CSCs", "fig": 1}, {"body": 13, "word": "HCT-116", "fig": 4}, {"body": 23, "word": "cancer", "fig": 2}, {"body": 15, "word": "controls", "fig": 3}, {"body": 15, "word": "well", "fig": 3}, {"body": 11, "word": "treated", "fig": 4}, {"body": 14, "word": "expression", "fig": 3}, {"body": 8, "word": "self-renewal", "fig": 5}, {"body": 20, "word": "spheroids", "fig": 2}, {"body": 13, "word": "colon", "fig": 3}, {"body": 12, "word": "spheroid", "fig": 3}, {"body": 12, "word": "formation", "fig": 3}, {"body": 7, "word": "CSC", "fig": 4}, {"body": 11, "word": "vehicle", "fig": 2}, {"body": 11, "word": "HT-29", "fig": 2}, {"body": 9, "word": "LGR5", "fig": 2}, {"body": 17, "word": "axis", "fig": 1}, {"body": 8, "word": "suggesting", "fig": 2}, {"body": 8, "word": "CD133", "fig": 2}, {"body": 5, "word": "control", "fig": 3}, {"body": 15, "word": "InAT", "fig": 1}, {"body": 13, "word": "cell", "fig": 1}, {"body": 6, "word": "activated", "fig": 2}, {"body": 6, "word": "C-MYC", "fig": 2}, {"body": 11, "word": "inhibitor", "fig": 1}, {"body": 5, "word": "markers", "fig": 2}, {"body": 9, "word": "A", "fig": 1}, {"body": 2, "word": "analyses", "fig": 4}, {"body": 4, "word": "KD", "fig": 2}, {"body": 4, "word": "attenuation", "fig": 2}, {"body": 4, "word": "CD44", "fig": 2}, {"body": 4, "word": "scrambled", "fig": 2}, {"body": 7, "word": "dilution", "fig": 1}, {"body": 2, "word": "show", "fig": 3}, {"body": 6, "word": "assay", "fig": 1}, {"body": 2, "word": "transfected", "fig": 3}, {"body": 3, "word": "shRNA", "fig": 2}, {"body": 5, "word": "factor", "fig": 1}, {"body": 5, "word": "used", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "colonosphere", "fig": 1}, {"body": 4, "word": "dependent", "fig": 1}, {"body": 2, "word": "reduced", "fig": 2}, {"body": 2, "word": "shows", "fig": 2}, {"body": 4, "word": "G", "fig": 1}, {"body": 4, "word": "hours", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 2}, {"body": 4, "word": "gene", "fig": 1}, {"body": 4, "word": "knockdown", "fig": 1}, {"body": 4, "word": "limiting", "fig": 1}, {"body": 3, "word": "primary", "fig": 1}, {"body": 3, "word": "kinase", "fig": 1}, {"body": 3, "word": "total", "fig": 1}, {"body": 3, "word": "three", "fig": 1}, {"body": 3, "word": "tyrosine", "fig": 1}, {"body": 3, "word": "response", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 2, "word": "dose", "fig": 1}, {"body": 1, "word": "decreased", "fig": 2}, {"body": 2, "word": "upstream", "fig": 1}, {"body": 1, "word": "gel", "fig": 2}, {"body": 2, "word": "inhibits", "fig": 1}, {"body": 2, "word": "Extreme", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "WiDR", "fig": 1}, {"body": 2, "word": "forming", "fig": 1}, {"body": 2, "word": "regulator", "fig": 1}, {"body": 2, "word": "min", "fig": 1}, {"body": 1, "word": "stably", "fig": 1}, {"body": 1, "word": "IC50", "fig": 1}, {"body": 1, "word": "**p", "fig": 1}, {"body": 1, "word": "DCAMKL1", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "suppresses", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "marker", "fig": 1}, {"body": 1, "word": "ranging", "fig": 1}, {"body": 1, "word": "frequency", "fig": 1}, {"body": 1, "word": "Numbers", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "Inhibition", "fig": 1}, {"body": 1, "word": "lines", "fig": 1}, {"body": 1, "word": "IGR-1R", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558155/bin/oncotarget-06-15332-g003.jpg", "caption": "The mevalonate-isoprenoid biosynthesis (MIB) pathway is upregulated in colon CSCs (A). Q-PCR analyses show higher expression of several MIB pathway genes in HCT-116 and HT-29 spheroids compared to monolayer controls suggesting upregulation of MIB pathway in colorectal CSCs. Data was normalized to GAPDH. (B). Immunoblot analyses show increased expression of key MIB pathway proteins in both HCT-116 and HT-29 spheroids compared to monolayer controls. \u03b2-actin is used as loading control. Data are presented as mean \u00b1 SD (n = 3). Numbers under the blot represent relative densitometry values. *p < 0.05; **p < 0.005.", "co_occurrence": [{"body": 74, "word": "pathway", "fig": 4}, {"body": 60, "word": "MIB", "fig": 4}, {"body": 59, "word": "CSCs", "fig": 2}, {"body": 21, "word": "compared", "fig": 2}, {"body": 20, "word": "spheroids", "fig": 2}, {"body": 15, "word": "controls", "fig": 2}, {"body": 14, "word": "expression", "fig": 2}, {"body": 13, "word": "HCT-116", "fig": 2}, {"body": 11, "word": "HT-29", "fig": 2}, {"body": 18, "word": "colorectal", "fig": 1}, {"body": 16, "word": "The", "fig": 1}, {"body": 8, "word": "monolayer", "fig": 2}, {"body": 13, "word": "colon", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 9, "word": "genes", "fig": 1}, {"body": 8, "word": "suggesting", "fig": 1}, {"body": 7, "word": "several", "fig": 1}, {"body": 7, "word": "biosynthesis", "fig": 1}, {"body": 5, "word": "used", "fig": 1}, {"body": 5, "word": "increased", "fig": 1}, {"body": 5, "word": "control", "fig": 1}, {"body": 2, "word": "show", "fig": 2}, {"body": 2, "word": "analyses", "fig": 2}, {"body": 3, "word": "upregulated", "fig": 1}, {"body": 2, "word": "Q-PCR", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "**p", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "upregulation", "fig": 1}, {"body": 1, "word": "key", "fig": 1}, {"body": 1, "word": "mevalonate-isoprenoid", "fig": 1}, {"body": 1, "word": "proteins", "fig": 1}, {"body": 1, "word": "Numbers", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558155/bin/oncotarget-06-15332-g004.jpg", "caption": "The InAT axis regulates the MIB pathway in CSCs \u2018in vitro\u2019 (A) Q-PCR analyses show increased expression of MIB pathway genes in HCT-116 spheroids stimulated with IGF1 (10 ng/ml) for 6 h compared to unstimulated controls. Moreover, pretreatment with Rapamycin (3 nM) abrogates increase in MIB pathway gene expression seen with IGF-1 stimulation. Data was normalized to GAPDH. **p < 0.005 compared to vehicle treated control; \u01c2 p < 0.05 compared to IGF1 treated spheroid. (B) Immunoblots showing increased expression of select MIB pathway proteins in HCT-116 spheroids stimulated with IGF1 (10 ng/ml) for 6 hours compared to controls. GAPDH is used as loading control. (C and D) Representative immunoblots and the corresponding bar graph of the gel densitometry analyses in HCT-116 spheroids stimulated with IGF1 (10 ng/ml) show increased expression of pIGF-1R and downstream mediator pAKT and pmTOR (at 15 min) (normalized to total protein expression) as well as increased expression of cleaved form of SREBPs (transcriptionally active (at 6 hours)), compared to unstimulated controls. GAPDH is used as loading control. (E) Q-PCR analyses showing decreased expression of MIB pathway genes in IGF-1R KD, as well as HCT-116 spheroids treated with OSI-906 (1.5 \u03bc\u039c) for 24 h compared to scrambled or vehicle treated controls respectively. Data was normalized to GAPDH. (F) Immunoblot analyses show varying degree of inhibition of select MIB pathway proteins at early (6 h) and late (24 h) time points following OSI-906 (1.5 \u03bc\u039c) treatment in HCT-116 spheroids. \u03b2-actin is used as loading control. (G and H) Representative immunoblots and the corresponding bar graph of the gel densitometry analyses show decreased levels of activated form of IGF-1R as well as downstream components of InAT axis (at 15 min) (normalized to total protein expression), as well as cleaved form of SREBP2 (transcriptionally active (1 h treatment)) in OSI-906 (1.5 \u03bcM) treated HCT-116 spheroids compared to vehicle treated controls. GAPDH is used as loading control. Numbers under the blot represent relative densitometry values. Data are presented as mean \u00b1 SD (n = 3). *p < 0.05; **p < 0.005.", "co_occurrence": [{"body": 74, "word": "pathway", "fig": 6}, {"body": 60, "word": "MIB", "fig": 6}, {"body": 21, "word": "compared", "fig": 7}, {"body": 20, "word": "spheroids", "fig": 6}, {"body": 14, "word": "expression", "fig": 8}, {"body": 53, "word": "IGF-1R", "fig": 2}, {"body": 13, "word": "HCT-116", "fig": 6}, {"body": 15, "word": "controls", "fig": 5}, {"body": 11, "word": "treated", "fig": 6}, {"body": 21, "word": "OSI-906", "fig": 3}, {"body": 15, "word": "well", "fig": 4}, {"body": 59, "word": "CSCs", "fig": 1}, {"body": 20, "word": "treatment", "fig": 2}, {"body": 37, "word": "inhibition", "fig": 1}, {"body": 18, "word": "protein", "fig": 2}, {"body": 17, "word": "axis", "fig": 2}, {"body": 11, "word": "vehicle", "fig": 3}, {"body": 15, "word": "InAT", "fig": 2}, {"body": 26, "word": "levels", "fig": 1}, {"body": 5, "word": "control", "fig": 5}, {"body": 5, "word": "increased", "fig": 4}, {"body": 5, "word": "used", "fig": 4}, {"body": 9, "word": "downstream", "fig": 2}, {"body": 9, "word": "genes", "fig": 2}, {"body": 4, "word": "IGF1", "fig": 4}, {"body": 16, "word": "IGF-1", "fig": 1}, {"body": 16, "word": "The", "fig": 1}, {"body": 5, "word": "form", "fig": 3}, {"body": 5, "word": "ng/ml", "fig": 3}, {"body": 12, "word": "Moreover", "fig": 1}, {"body": 12, "word": "spheroid", "fig": 1}, {"body": 12, "word": "increase", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 5}, {"body": 2, "word": "analyses", "fig": 5}, {"body": 9, "word": "A", "fig": 1}, {"body": 2, "word": "show", "fig": 4}, {"body": 4, "word": "hours", "fig": 2}, {"body": 6, "word": "activated", "fig": 1}, {"body": 6, "word": "SREBPs", "fig": 1}, {"body": 3, "word": "total", "fig": 2}, {"body": 6, "word": "regulates", "fig": 1}, {"body": 6, "word": "following", "fig": 1}, {"body": 1, "word": "h", "fig": 5}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "time", "fig": 1}, {"body": 2, "word": "showing", "fig": 2}, {"body": 4, "word": "G", "fig": 1}, {"body": 2, "word": "active", "fig": 2}, {"body": 4, "word": "gene", "fig": 1}, {"body": 4, "word": "stimulation", "fig": 1}, {"body": 4, "word": "KD", "fig": 1}, {"body": 2, "word": "Q-PCR", "fig": 2}, {"body": 2, "word": "min", "fig": 2}, {"body": 2, "word": "cleaved", "fig": 2}, {"body": 4, "word": "scrambled", "fig": 1}, {"body": 3, "word": "\u2018in", "fig": 1}, {"body": 3, "word": "pIGF-1R", "fig": 1}, {"body": 1, "word": "stimulated", "fig": 3}, {"body": 2, "word": "represent", "fig": 1}, {"body": 1, "word": "**p", "fig": 2}, {"body": 1, "word": "decreased", "fig": 2}, {"body": 2, "word": "early", "fig": 1}, {"body": 1, "word": "transcriptionally", "fig": 2}, {"body": 1, "word": "gel", "fig": 2}, {"body": 1, "word": "proteins", "fig": 2}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 2, "word": "SREBP2", "fig": 1}, {"body": 2, "word": "pAKT", "fig": 1}, {"body": 1, "word": "mediator", "fig": 1}, {"body": 1, "word": "late", "fig": 1}, {"body": 1, "word": "pretreatment", "fig": 1}, {"body": 1, "word": "pmTOR", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "respectively", "fig": 1}, {"body": 1, "word": "vitro\u2019", "fig": 1}, {"body": 1, "word": "Numbers", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "points", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558155/bin/oncotarget-06-15332-g005.jpg", "caption": "Downregulation of the MIB pathway is required for the InAT axis inhibition mediated attenuation of CSCs growth (A): Colonosphere formation assays in HCT-116 cells treated with either OSI-906 (1.5 \u03bcM) or Rapamycin (3 nM) alone or along with various metabolites of the MIB pathway (1 \u03bcM) show near complete reversal of OSI-906 (and/or Rapamycin) mediated inhibition of spheroid formation by DMAPP and FPP (downstream of IDI-1, highlighted with green arrow) but not by MVA or IPP (upstream of IDI-1, highlighted with purple arrow), compared to vehicle treated control. *p < 0.05, **p < 0.005 compared to vehicle treated control; \u00a5 p < 0.05 compared to OSI-906 treated spheroid; \u00a5 p < 0.005 compared to Rapamycin treated spheroids. (B) Immunoblots showing reduced expression of CSC markers (CD133 and LGR5) and a self-renewal factor (C-MYC) in IGF-1R KD cells which is almost completely reversed by supplementation with FPP (10 \u03bcM) for 48 hours, strongly suggesting critical role of MIB pathway in mediating IGF-1R's effect on expression of CSC markers. Tubulin was used as loading control. (C) Schematic representation of the MIB pathway. Metabolites upstream of IDI-1 are highlighted in purple and downstream of IDI-1 are highlighted in green. Two classes of FDA-approved agents, statins and nitrosylated-bisphophonates (N-BPs), target different enzymes in the MIB pathways than that targeted by InAT axis. Numbers under the blot represent relative densitometry values. Data are presented as mean \u00b1 SD (n = 3).", "co_occurrence": [{"body": 60, "word": "MIB", "fig": 5}, {"body": 74, "word": "pathway", "fig": 4}, {"body": 53, "word": "IGF-1R", "fig": 2}, {"body": 44, "word": "cells", "fig": 2}, {"body": 21, "word": "compared", "fig": 4}, {"body": 37, "word": "inhibition", "fig": 2}, {"body": 21, "word": "OSI-906", "fig": 3}, {"body": 59, "word": "CSCs", "fig": 1}, {"body": 11, "word": "treated", "fig": 5}, {"body": 17, "word": "axis", "fig": 2}, {"body": 32, "word": "growth", "fig": 1}, {"body": 15, "word": "InAT", "fig": 2}, {"body": 14, "word": "expression", "fig": 2}, {"body": 6, "word": "IDI-1", "fig": 4}, {"body": 12, "word": "spheroid", "fig": 2}, {"body": 12, "word": "formation", "fig": 2}, {"body": 11, "word": "vehicle", "fig": 2}, {"body": 20, "word": "spheroids", "fig": 1}, {"body": 9, "word": "downstream", "fig": 2}, {"body": 8, "word": "mediated", "fig": 2}, {"body": 16, "word": "role", "fig": 1}, {"body": 5, "word": "control", "fig": 3}, {"body": 7, "word": "CSC", "fig": 2}, {"body": 13, "word": "HCT-116", "fig": 1}, {"body": 13, "word": "effect", "fig": 1}, {"body": 5, "word": "markers", "fig": 2}, {"body": 10, "word": "statins", "fig": 1}, {"body": 9, "word": "critical", "fig": 1}, {"body": 9, "word": "LGR5", "fig": 1}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "suggesting", "fig": 1}, {"body": 8, "word": "self-renewal", "fig": 1}, {"body": 8, "word": "CD133", "fig": 1}, {"body": 8, "word": "'s", "fig": 1}, {"body": 4, "word": "FPP", "fig": 2}, {"body": 6, "word": "IPP", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 3}, {"body": 6, "word": "pathways", "fig": 1}, {"body": 6, "word": "C-MYC", "fig": 1}, {"body": 6, "word": "target", "fig": 1}, {"body": 6, "word": "enzymes", "fig": 1}, {"body": 5, "word": "factor", "fig": 1}, {"body": 5, "word": "used", "fig": 1}, {"body": 5, "word": "and/or", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "MVA", "fig": 1}, {"body": 2, "word": "upstream", "fig": 2}, {"body": 4, "word": "hours", "fig": 1}, {"body": 4, "word": "reversed", "fig": 1}, {"body": 4, "word": "KD", "fig": 1}, {"body": 4, "word": "attenuation", "fig": 1}, {"body": 3, "word": "supplementation", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 2, "word": "show", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "either", "fig": 1}, {"body": 2, "word": "reduced", "fig": 1}, {"body": 2, "word": "metabolites", "fig": 1}, {"body": 2, "word": "targeted", "fig": 1}, {"body": 2, "word": "DMAPP", "fig": 1}, {"body": 2, "word": "alone", "fig": 1}, {"body": 1, "word": "Colonosphere", "fig": 1}, {"body": 1, "word": "**p", "fig": 1}, {"body": 1, "word": "strongly", "fig": 1}, {"body": 1, "word": "relative", "fig": 1}, {"body": 1, "word": "FDA-approved", "fig": 1}, {"body": 1, "word": "completely", "fig": 1}, {"body": 1, "word": "agents", "fig": 1}, {"body": 1, "word": "Downregulation", "fig": 1}, {"body": 1, "word": "classes", "fig": 1}, {"body": 1, "word": "Numbers", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "mediating", "fig": 1}, {"body": 1, "word": "different", "fig": 1}, {"body": 1, "word": "required", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558155/bin/oncotarget-06-15332-g006.jpg", "caption": "OSI-906 inhibits the MIB pathway and CSCs \u2018in vivo\u2019 (A) Change in mean tumor volume of HCT-116 xenograft in mice treated with oral gavage of OSI-906 or vehicle (control). Arrows indicate the days of OSI-906 / vehicle gavage. (B) TUNEL staining for apoptosis in HCT-116 xenografts. Arrow indicates an area of positive staining. Average number of TUNEL-positive cells per HPF (80x) shows significant induction of apoptosis in xenograft derived from mice treated with OSI-906, compared to vehicle treated controls. (C) Representative scattered plots of flow cytometry analyses show decrease in expression of CSC markers (LGR5 and CXCR4) in xenograft derived from OSI-906 treated mice, compared to vehicle treated controls. (D) Q-PCR analyses showing significant reduction in the mRNA levels of several CSC markers (CD133, LGR5 and CXCR4), self-renewal factors (C-MYC, NANOG, OCT-4) and select MIB pathway genes in OSI-906 treated mouse xenograft tissue compared to controls. Data was normalized to GAPDH. (E and F) Representative immunoblots and the corresponding bar graph of the gel densitometry analyses show decreased expression of phosphorylated IGF-1R, CSC markers (CD133, LGR5, CXCR4, and DCAMKL1), self-renewal factor (C-MYC and OCT-4) and an MIB pathway protein (IDI-1) in OSI-906 treated xenografts compared to vehicle controls. GAPDH is used as a loading control. Data are presented as mean \u00b1 SD (n = 3). *p < 0.05; **p < 0.005.", "co_occurrence": [{"body": 74, "word": "pathway", "fig": 3}, {"body": 60, "word": "MIB", "fig": 3}, {"body": 21, "word": "OSI-906", "fig": 7}, {"body": 21, "word": "compared", "fig": 4}, {"body": 11, "word": "treated", "fig": 7}, {"body": 15, "word": "controls", "fig": 4}, {"body": 59, "word": "CSCs", "fig": 1}, {"body": 11, "word": "vehicle", "fig": 5}, {"body": 53, "word": "IGF-1R", "fig": 1}, {"body": 44, "word": "cells", "fig": 1}, {"body": 14, "word": "expression", "fig": 2}, {"body": 9, "word": "LGR5", "fig": 3}, {"body": 13, "word": "HCT-116", "fig": 2}, {"body": 26, "word": "levels", "fig": 1}, {"body": 6, "word": "xenograft", "fig": 4}, {"body": 12, "word": "significant", "fig": 2}, {"body": 7, "word": "CSC", "fig": 3}, {"body": 7, "word": "CXCR4", "fig": 3}, {"body": 18, "word": "protein", "fig": 1}, {"body": 8, "word": "self-renewal", "fig": 2}, {"body": 8, "word": "CD133", "fig": 2}, {"body": 5, "word": "markers", "fig": 3}, {"body": 14, "word": "mRNA", "fig": 1}, {"body": 6, "word": "C-MYC", "fig": 2}, {"body": 5, "word": "control", "fig": 2}, {"body": 10, "word": "reduction", "fig": 1}, {"body": 9, "word": "genes", "fig": 1}, {"body": 3, "word": "mice", "fig": 3}, {"body": 9, "word": "A", "fig": 1}, {"body": 8, "word": "tumor", "fig": 1}, {"body": 8, "word": "tissue", "fig": 1}, {"body": 7, "word": "several", "fig": 1}, {"body": 3, "word": "OCT-4", "fig": 2}, {"body": 3, "word": "apoptosis", "fig": 2}, {"body": 2, "word": "analyses", "fig": 3}, {"body": 6, "word": "IDI-1", "fig": 1}, {"body": 5, "word": "factor", "fig": 1}, {"body": 5, "word": "C", "fig": 1}, {"body": 5, "word": "used", "fig": 1}, {"body": 2, "word": "show", "fig": 2}, {"body": 2, "word": "xenografts", "fig": 2}, {"body": 2, "word": "GAPDH", "fig": 2}, {"body": 4, "word": "per", "fig": 1}, {"body": 4, "word": "induction", "fig": 1}, {"body": 4, "word": "volume", "fig": 1}, {"body": 3, "word": "NANOG", "fig": 1}, {"body": 3, "word": "TUNEL-positive", "fig": 1}, {"body": 3, "word": "\u2018in", "fig": 1}, {"body": 3, "word": "number", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "vivo\u2019", "fig": 1}, {"body": 2, "word": "factors", "fig": 1}, {"body": 2, "word": "shows", "fig": 1}, {"body": 1, "word": "derived", "fig": 2}, {"body": 2, "word": "Q-PCR", "fig": 1}, {"body": 2, "word": "days", "fig": 1}, {"body": 2, "word": "inhibits", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "mouse", "fig": 1}, {"body": 2, "word": "oral", "fig": 1}, {"body": 1, "word": "**p", "fig": 1}, {"body": 1, "word": "decreased", "fig": 1}, {"body": 1, "word": "gel", "fig": 1}, {"body": 1, "word": "DCAMKL1", "fig": 1}, {"body": 1, "word": "phosphorylated", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 1}, {"body": 1, "word": "80x", "fig": 1}, {"body": 1, "word": "flow", "fig": 1}]}], "4132412": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132412/bin/BMRI2014-941486.001.jpg", "caption": "(a) Third-passaged ADSCs with a homogenous fibroblast-like morphology, (b) expression of stem cell marker, Sca-1, mesenchymal stem cell markers, CD73 and CD105, and hematopoietic cell markers, CD34 and c-Kit in the freshly isolated (ADSC P0) and third-passaged ADSCs (ADSC P3), (c) flow cytometry histograms of third-passaged ADSCs for hematopoietic (CD45 and CD11b), endothelial (CD31), and mesenchymal stem cell (CD29, and CD105) markers, and (d) expression of three germ layer markers, AFP, Pax6, and Brachyury, in the freshly isolated (ADSC P0) and third-passaged ADSCs (ADSC P3).", "co_occurrence": [{"body": 71, "word": "ADSCs", "fig": 4}, {"body": 39, "word": "expression", "fig": 2}, {"body": 19, "word": "markers", "fig": 4}, {"body": 17, "word": "stem", "fig": 3}, {"body": 10, "word": "cell", "fig": 4}, {"body": 12, "word": "third-passaged", "fig": 3}, {"body": 16, "word": "isolated", "fig": 2}, {"body": 11, "word": "freshly", "fig": 2}, {"body": 8, "word": "mesenchymal", "fig": 2}, {"body": 5, "word": "CD105", "fig": 2}, {"body": 2, "word": "ADSC", "fig": 4}, {"body": 7, "word": "three", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 7, "word": "AFP", "fig": 1}, {"body": 6, "word": "d", "fig": 1}, {"body": 3, "word": "hematopoietic", "fig": 2}, {"body": 5, "word": "c", "fig": 1}, {"body": 2, "word": "P3", "fig": 2}, {"body": 2, "word": "P0", "fig": 2}, {"body": 3, "word": "CD29", "fig": 1}, {"body": 3, "word": "marker", "fig": 1}, {"body": 3, "word": "Pax6", "fig": 1}, {"body": 3, "word": "Brachyury", "fig": 1}, {"body": 2, "word": "Third-passaged", "fig": 1}, {"body": 2, "word": "CD73", "fig": 1}, {"body": 2, "word": "CD31", "fig": 1}, {"body": 2, "word": "CD34", "fig": 1}, {"body": 2, "word": "c-Kit", "fig": 1}, {"body": 2, "word": "CD45", "fig": 1}, {"body": 2, "word": "Sca-1", "fig": 1}, {"body": 2, "word": "CD11b", "fig": 1}, {"body": 1, "word": "homogenous", "fig": 1}, {"body": 1, "word": "morphology", "fig": 1}, {"body": 1, "word": "fibroblast-like", "fig": 1}, {"body": 1, "word": "flow", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132412/bin/BMRI2014-941486.002.jpg", "caption": "(a) RT-PCR analysis of the expression of pluripotency markers in the freshly isolated (ADSC P0) and third-passaged ADSCs (ADSC P3), (b) quantitative real-time PCR analysis for the expression of OCT4, Sox2, and Nanog mRNAs in the freshly isolated (ADSC P0) and third-passaged ADSCs (ADSC P3) using \u03b2-tubulin (Tubb5) mRNA level as an internal control. P < 0.05 was considered as significant.", "co_occurrence": [{"body": 71, "word": "ADSCs", "fig": 2}, {"body": 39, "word": "expression", "fig": 2}, {"body": 16, "word": "isolated", "fig": 2}, {"body": 12, "word": "third-passaged", "fig": 2}, {"body": 11, "word": "freshly", "fig": 2}, {"body": 21, "word": "OCT4", "fig": 1}, {"body": 19, "word": "markers", "fig": 1}, {"body": 19, "word": "using", "fig": 1}, {"body": 8, "word": "analysis", "fig": 2}, {"body": 15, "word": "pluripotency", "fig": 1}, {"body": 15, "word": "Sox2", "fig": 1}, {"body": 14, "word": "Nanog", "fig": 1}, {"body": 2, "word": "ADSC", "fig": 4}, {"body": 8, "word": "mRNA", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 6, "word": "PCR", "fig": 1}, {"body": 5, "word": "RT-PCR", "fig": 1}, {"body": 4, "word": "mRNAs", "fig": 1}, {"body": 2, "word": "P3", "fig": 2}, {"body": 2, "word": "P0", "fig": 2}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "control", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "level", "fig": 1}, {"body": 1, "word": "internal", "fig": 1}, {"body": 1, "word": "considered", "fig": 1}, {"body": 1, "word": "Tubb5", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132412/bin/BMRI2014-941486.003.jpg", "caption": "(a) Immunostaining of the freshly isolated ADSCs (ADSC P0) with anti-OCT3/4 antibody, (b) propidium iodide (PI) staining of the nuclei represented in (a). (c\u2013e) Phase contrast, PI staining, and OCT3/4 immunostaining of the ADSC P0. Immunostaining was performed using a specific monoclonal antibody (sc-5279) against the OCT4A protein. Nuclear signal was detected in the ADSCs and recognized the OCT4A isoform. (f) Immunostaining of third-passaged ADSCs (ADSC P3) with anti-OCT3/4 antibody, (g) PI staining of the nuclei represented in (f).", "co_occurrence": [{"body": 71, "word": "ADSCs", "fig": 3}, {"body": 14, "word": "OCT4A", "fig": 2}, {"body": 19, "word": "using", "fig": 1}, {"body": 6, "word": "antibody", "fig": 3}, {"body": 16, "word": "isolated", "fig": 1}, {"body": 12, "word": "third-passaged", "fig": 1}, {"body": 11, "word": "protein", "fig": 1}, {"body": 11, "word": "freshly", "fig": 1}, {"body": 7, "word": "detected", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 7, "word": "performed", "fig": 1}, {"body": 2, "word": "ADSC", "fig": 3}, {"body": 5, "word": "specific", "fig": 1}, {"body": 5, "word": "monoclonal", "fig": 1}, {"body": 2, "word": "P0", "fig": 2}, {"body": 2, "word": "nuclei", "fig": 2}, {"body": 3, "word": "sc-5279", "fig": 1}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 2, "word": "isoform", "fig": 1}, {"body": 2, "word": "contrast", "fig": 1}, {"body": 2, "word": "P3", "fig": 1}, {"body": 1, "word": "f", "fig": 2}, {"body": 1, "word": "g", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132412/bin/BMRI2014-941486.004.jpg", "caption": "(a) Immunostaining of the freshly isolated ADSCs (ADSC P0) with anti-Sox2 monoclonal antibody, (b) propidium iodide (PI) staining of the nuclei represented in (a), (c) immunostaining of the third-passaged ADSCs (ADSC P3) with anti-Sox2 antibody, and (d) PI staining of the nuclei represented in (f).", "co_occurrence": [{"body": 71, "word": "ADSCs", "fig": 2}, {"body": 16, "word": "isolated", "fig": 1}, {"body": 12, "word": "third-passaged", "fig": 1}, {"body": 6, "word": "antibody", "fig": 2}, {"body": 11, "word": "freshly", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 6, "word": "d", "fig": 1}, {"body": 5, "word": "monoclonal", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 2, "word": "ADSC", "fig": 2}, {"body": 2, "word": "nuclei", "fig": 2}, {"body": 3, "word": "immunostaining", "fig": 1}, {"body": 1, "word": "anti-Sox2", "fig": 2}, {"body": 2, "word": "P3", "fig": 1}, {"body": 2, "word": "P0", "fig": 1}, {"body": 1, "word": "f", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132412/bin/BMRI2014-941486.005.jpg", "caption": "Quantitative real-time RT-PCR analysis for the expression of OCT4, Sox2, and Nanog mRNAs in the ADSCs cultured at the presence or absence of LIF; Tubb5 mRNA level was used as an internal control. P < 0.05 was considered as significant.", "co_occurrence": [{"body": 71, "word": "ADSCs", "fig": 1}, {"body": 39, "word": "expression", "fig": 1}, {"body": 21, "word": "LIF", "fig": 1}, {"body": 21, "word": "OCT4", "fig": 1}, {"body": 15, "word": "Sox2", "fig": 1}, {"body": 14, "word": "Nanog", "fig": 1}, {"body": 9, "word": "cultured", "fig": 1}, {"body": 8, "word": "mRNA", "fig": 1}, {"body": 8, "word": "analysis", "fig": 1}, {"body": 5, "word": "RT-PCR", "fig": 1}, {"body": 5, "word": "used", "fig": 1}, {"body": 4, "word": "mRNAs", "fig": 1}, {"body": 3, "word": "presence", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "absence", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "control", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "level", "fig": 1}, {"body": 1, "word": "internal", "fig": 1}, {"body": 1, "word": "Quantitative", "fig": 1}, {"body": 1, "word": "considered", "fig": 1}, {"body": 1, "word": "Tubb5", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132412/bin/BMRI2014-941486.006.jpg", "caption": "(a) The pEGFPC1-miR-302 vector, (b and c) expression of EGFP in the third-passaged ADSCs, 24 h after transfection with pEGFP-C1-miR-302 using Lipofectamine 2000.", "co_occurrence": [{"body": 71, "word": "ADSCs", "fig": 1}, {"body": 39, "word": "expression", "fig": 1}, {"body": 19, "word": "using", "fig": 1}, {"body": 12, "word": "third-passaged", "fig": 1}, {"body": 12, "word": "The", "fig": 1}, {"body": 11, "word": "transfection", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 3, "word": "pEGFPC1-miR-302", "fig": 1}, {"body": 2, "word": "Lipofectamine", "fig": 1}, {"body": 2, "word": "vector", "fig": 1}, {"body": 1, "word": "EGFP", "fig": 1}, {"body": 1, "word": "h", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132412/bin/BMRI2014-941486.007.jpg", "caption": "(a and b) Expression of EGFP in the third-passaged ADSCs, after three-day antibiotic selection, (c) western blot analysis for the expression of OCT4A protein in the transfected and control ADSCs, after 5-day antibiotic selection, and (d) quantitative real-time RT-PCR analysis for the expression of OCT4, Nanog, Sox2, and AFP mRNAs in the miR-302 group comparing to mock group, 48 hours after transfection. Tubb5 mRNA level was used as an internal control. P < 0.05 was considered as significant.", "co_occurrence": [{"body": 71, "word": "ADSCs", "fig": 2}, {"body": 39, "word": "expression", "fig": 2}, {"body": 21, "word": "OCT4", "fig": 1}, {"body": 8, "word": "analysis", "fig": 2}, {"body": 15, "word": "Sox2", "fig": 1}, {"body": 14, "word": "OCT4A", "fig": 1}, {"body": 14, "word": "Nanog", "fig": 1}, {"body": 13, "word": "miR-302", "fig": 1}, {"body": 6, "word": "group", "fig": 2}, {"body": 12, "word": "third-passaged", "fig": 1}, {"body": 11, "word": "protein", "fig": 1}, {"body": 11, "word": "transfection", "fig": 1}, {"body": 10, "word": "Expression", "fig": 1}, {"body": 9, "word": "transfected", "fig": 1}, {"body": 8, "word": "mRNA", "fig": 1}, {"body": 7, "word": "AFP", "fig": 1}, {"body": 7, "word": "b", "fig": 1}, {"body": 6, "word": "d", "fig": 1}, {"body": 5, "word": "RT-PCR", "fig": 1}, {"body": 5, "word": "mock", "fig": 1}, {"body": 5, "word": "used", "fig": 1}, {"body": 5, "word": "hours", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 2, "word": "control", "fig": 2}, {"body": 2, "word": "selection", "fig": 2}, {"body": 2, "word": "antibiotic", "fig": 2}, {"body": 4, "word": "mRNAs", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "western", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "level", "fig": 1}, {"body": 1, "word": "EGFP", "fig": 1}, {"body": 1, "word": "internal", "fig": 1}, {"body": 1, "word": "5-day", "fig": 1}, {"body": 1, "word": "considered", "fig": 1}, {"body": 1, "word": "Tubb5", "fig": 1}, {"body": 1, "word": "quantitative", "fig": 1}]}], "1310526": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-1.jpg", "caption": "Wright-Giemsa stained smears of human and mouse blood. Selected neutrophils are shown (top row, human; bottom row, mouse). Note that human neutrophils exhibit nuclear lobes frequently connected by thin strands. Mouse neutrophil nuclei are usually twisted ring-shapes, frequently exhibiting several small NE nodules. Scale bars: 10 \u03bcm.", "co_occurrence": [{"body": 25, "word": "human", "fig": 3}, {"body": 34, "word": "mouse", "fig": 2}, {"body": 16, "word": "neutrophils", "fig": 2}, {"body": 31, "word": "nuclear", "fig": 1}, {"body": 24, "word": "blood", "fig": 1}, {"body": 20, "word": "NE", "fig": 1}, {"body": 16, "word": "nuclei", "fig": 1}, {"body": 7, "word": "stained", "fig": 1}, {"body": 6, "word": "nodules", "fig": 1}, {"body": 3, "word": "frequently", "fig": 2}, {"body": 6, "word": "neutrophil", "fig": 1}, {"body": 5, "word": "exhibit", "fig": 1}, {"body": 5, "word": "shown", "fig": 1}, {"body": 3, "word": "lobes", "fig": 1}, {"body": 3, "word": "several", "fig": 1}, {"body": 2, "word": "Mouse", "fig": 1}, {"body": 2, "word": "Wright-Giemsa", "fig": 1}, {"body": 2, "word": "smears", "fig": 1}, {"body": 1, "word": "small", "fig": 1}, {"body": 1, "word": "exhibiting", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-2.jpg", "caption": "Immunostaining of human blood neutrophils with various methylated histone antibodies. Columns: DAPI (DNA stain); Cy3, antibody staining viewed by conventional epifluorescent microscopy. Abbreviations: monoMe, diMe and triMe, monomethylated, dimethylated and trimethylated lysine. Scale bar: 10 \u03bcm.", "co_occurrence": [{"body": 25, "word": "human", "fig": 1}, {"body": 24, "word": "blood", "fig": 1}, {"body": 23, "word": "staining", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 16, "word": "histone", "fig": 1}, {"body": 16, "word": "neutrophils", "fig": 1}, {"body": 14, "word": "trimethylated", "fig": 1}, {"body": 9, "word": "antibody", "fig": 1}, {"body": 8, "word": "methylated", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 4, "word": "stain", "fig": 1}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 2, "word": "Abbreviations", "fig": 1}, {"body": 2, "word": "lysine", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 2, "word": "epifluorescent", "fig": 1}, {"body": 2, "word": "conventional", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-3.jpg", "caption": "Immunoblotting of human granulocyte extracts with various methylated histone antibodies. Samples: F, normal female; M, normal male; H, HeLa. Panels: a, dimethyl H3K9; b, trimethyl H3K9; c, monomethyl H3K27; d, dimethyl H3K27; e, trimethyl H3K27; f, dimethyl H4K20; g, trimethyl H4K20.", "co_occurrence": [{"body": 36, "word": "H3K9", "fig": 2}, {"body": 20, "word": "trimethyl", "fig": 3}, {"body": 23, "word": "normal", "fig": 2}, {"body": 15, "word": "H3K27", "fig": 3}, {"body": 21, "word": "H4K20", "fig": 2}, {"body": 27, "word": "granulocyte", "fig": 1}, {"body": 25, "word": "human", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 16, "word": "histone", "fig": 1}, {"body": 13, "word": "extracts", "fig": 1}, {"body": 4, "word": "dimethyl", "fig": 3}, {"body": 8, "word": "methylated", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 5, "word": "HeLa", "fig": 1}, {"body": 5, "word": "male", "fig": 1}, {"body": 4, "word": "female", "fig": 1}, {"body": 3, "word": "Immunoblotting", "fig": 1}, {"body": 2, "word": "g", "fig": 1}, {"body": 1, "word": "monomethyl", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-4.jpg", "caption": "Immunostaining of mouse blood neutrophils with methylated histone antibodies. Columns: DAPI (DNA stain); Cy3, antibody staining viewed by conventional epifluorescent microscopy. Abbreviations: monoMe, diMe and triMe, monomethylated, dimethylated and trimethylated lysine. Scale bar: 10 \u03bcm", "co_occurrence": [{"body": 34, "word": "mouse", "fig": 1}, {"body": 24, "word": "blood", "fig": 1}, {"body": 23, "word": "staining", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 16, "word": "histone", "fig": 1}, {"body": 16, "word": "neutrophils", "fig": 1}, {"body": 14, "word": "trimethylated", "fig": 1}, {"body": 9, "word": "antibody", "fig": 1}, {"body": 8, "word": "methylated", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 4, "word": "stain", "fig": 1}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 2, "word": "Abbreviations", "fig": 1}, {"body": 2, "word": "lysine", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 2, "word": "epifluorescent", "fig": 1}, {"body": 2, "word": "conventional", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-5.jpg", "caption": "Immunostaining of mouse blood neutrophils with methylated histone antibodies: confocal sections. Top row: anti-trimethyl H3K9 (left); anti-lamin B (middle); merged images (right). Bottom two rows: anti-trimethyl H4K20 (left); anti-lamin B (middle); merged images (right). Slides were fixed in methanol. Scale bar: 10 \u03bcm", "co_occurrence": [{"body": 36, "word": "H3K9", "fig": 1}, {"body": 34, "word": "mouse", "fig": 1}, {"body": 24, "word": "blood", "fig": 1}, {"body": 21, "word": "H4K20", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 9, "word": "anti-trimethyl", "fig": 2}, {"body": 16, "word": "histone", "fig": 1}, {"body": 16, "word": "neutrophils", "fig": 1}, {"body": 7, "word": "B", "fig": 2}, {"body": 8, "word": "methylated", "fig": 1}, {"body": 3, "word": "images", "fig": 2}, {"body": 3, "word": "anti-lamin", "fig": 2}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 3, "word": "two", "fig": 1}, {"body": 3, "word": "fixed", "fig": 1}, {"body": 1, "word": "Slides", "fig": 1}, {"body": 1, "word": "methanol", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-6.jpg", "caption": "Immunostaining of undifferentiated and granulocytic MPRO cells with various histone methylation antibodies. Panels: A, undifferentiated cells; B, granulocyte cells (4 days of RA). Columns: DAPI (DNA stain); Cy3, anti-methylated histone staining; Lamin B, FITC staining. Rows: monoMe, diMe and triMe, monomethylated, dimethylated and trimethylated lysines. Scale bar: 10 \u03bcm.", "co_occurrence": [{"body": 39, "word": "cells", "fig": 3}, {"body": 23, "word": "staining", "fig": 2}, {"body": 16, "word": "histone", "fig": 2}, {"body": 28, "word": "MPRO", "fig": 1}, {"body": 27, "word": "granulocyte", "fig": 1}, {"body": 11, "word": "undifferentiated", "fig": 2}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 7, "word": "B", "fig": 2}, {"body": 14, "word": "methylation", "fig": 1}, {"body": 14, "word": "trimethylated", "fig": 1}, {"body": 12, "word": "granulocytic", "fig": 1}, {"body": 8, "word": "RA", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 5, "word": "anti-methylated", "fig": 1}, {"body": 4, "word": "stain", "fig": 1}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 2, "word": "days", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 1, "word": "lysines", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-7.jpg", "caption": "Immunoblotting of MPRO granulocyte extracts with various histone methylation antibodies. Samples: O, undifferentiated; RA differentiated granulocytes; H, HeLa. Panels: a, dimethyl H3K9; b, trimethyl H3K9; c, monomethyl H3K27; d, dimethyl H3K27; e, trimethyl H3K27; f, dimethyl H4K20; g, trimethyl H4K20.", "co_occurrence": [{"body": 36, "word": "H3K9", "fig": 2}, {"body": 20, "word": "trimethyl", "fig": 3}, {"body": 15, "word": "H3K27", "fig": 3}, {"body": 21, "word": "H4K20", "fig": 2}, {"body": 40, "word": "granulocytes", "fig": 1}, {"body": 28, "word": "MPRO", "fig": 1}, {"body": 27, "word": "granulocyte", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 16, "word": "histone", "fig": 1}, {"body": 14, "word": "methylation", "fig": 1}, {"body": 13, "word": "extracts", "fig": 1}, {"body": 4, "word": "dimethyl", "fig": 3}, {"body": 11, "word": "undifferentiated", "fig": 1}, {"body": 8, "word": "RA", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 5, "word": "HeLa", "fig": 1}, {"body": 5, "word": "differentiated", "fig": 1}, {"body": 3, "word": "Immunoblotting", "fig": 1}, {"body": 2, "word": "O", "fig": 1}, {"body": 2, "word": "g", "fig": 1}, {"body": 1, "word": "monomethyl", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-8.jpg", "caption": "Immunostaining of mouse NIH 3T3 cells with HP1 antibodies. Columns: DAPI (DNA staining); Cy3, antibody staining of HP1 viewed by conventional epifluorescent microscopy; Lamin B, FITC staining. Note the clear co-localization of HP1 staining with the DAPI-bright pericentric heterochromatin. Scale bar: 10 \u03bcm", "co_occurrence": [{"body": 49, "word": "HP1", "fig": 3}, {"body": 23, "word": "staining", "fig": 4}, {"body": 39, "word": "cells", "fig": 1}, {"body": 34, "word": "mouse", "fig": 1}, {"body": 34, "word": "heterochromatin", "fig": 1}, {"body": 19, "word": "pericentric", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 9, "word": "antibody", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 7, "word": "clear", "fig": 1}, {"body": 6, "word": "co-localization", "fig": 1}, {"body": 5, "word": "DAPI-bright", "fig": 1}, {"body": 4, "word": "3T3", "fig": 1}, {"body": 4, "word": "NIH", "fig": 1}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 2, "word": "conventional", "fig": 1}, {"body": 2, "word": "epifluorescent", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-9.jpg", "caption": "Immunostaining of human blood buffy coat with various HP1 antibodies. Columns: Cy3, antibody staining viewed by conventional epifluorescent microscopy; DAPI (DNA staining). Note that the monocytic nuclei exhibit staining with all monoclonal anti-HP1 antibodies (Chemicon); whereas, the granulocytic nuclei only reveal staining with anti-HP1 \u03b3. Anti-HP1 \u03b1, \u03b2 and \u03b3 appear to stain cytoplasmic granules. Scale bar: 10 \u03bcm.", "co_occurrence": [{"body": 23, "word": "staining", "fig": 4}, {"body": 49, "word": "HP1", "fig": 1}, {"body": 23, "word": "anti-HP1", "fig": 2}, {"body": 19, "word": "antibodies", "fig": 2}, {"body": 16, "word": "nuclei", "fig": 2}, {"body": 28, "word": "\u03b3", "fig": 1}, {"body": 27, "word": "\u03b2", "fig": 1}, {"body": 26, "word": "\u03b1", "fig": 1}, {"body": 25, "word": "human", "fig": 1}, {"body": 24, "word": "blood", "fig": 1}, {"body": 12, "word": "granulocytic", "fig": 1}, {"body": 9, "word": "antibody", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 6, "word": "buffy", "fig": 1}, {"body": 6, "word": "coat", "fig": 1}, {"body": 5, "word": "exhibit", "fig": 1}, {"body": 5, "word": "cytoplasmic", "fig": 1}, {"body": 4, "word": "stain", "fig": 1}, {"body": 4, "word": "Chemicon", "fig": 1}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 3, "word": "appear", "fig": 1}, {"body": 3, "word": "monocytic", "fig": 1}, {"body": 3, "word": "granules", "fig": 1}, {"body": 3, "word": "reveal", "fig": 1}, {"body": 2, "word": "conventional", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 2, "word": "Anti-HP1", "fig": 1}, {"body": 2, "word": "epifluorescent", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}, {"body": 2, "word": "\u03b3.", "fig": 1}, {"body": 2, "word": "whereas", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-10.jpg", "caption": "Immunoblotting of human granulocyte extracts with various HP1 antibodies. Samples: F, normal female; M, normal male; H, HeLa. Panels: a, monoclonal anti-HP1 \u03b1 (Upstate); b, monoclonal anti-HP1 \u03b2 (Chemicon); c, rabbit anti-HP1 \u03b2 (Upstate); d, monoclonal anti-HP1 \u03b3 (Chemicon). Note the trace reaction of anti-HP1 \u03b3 with the granulocyte extract (panel d).", "co_occurrence": [{"body": 23, "word": "anti-HP1", "fig": 5}, {"body": 28, "word": "\u03b3", "fig": 2}, {"body": 27, "word": "granulocyte", "fig": 2}, {"body": 27, "word": "\u03b2", "fig": 2}, {"body": 49, "word": "HP1", "fig": 1}, {"body": 23, "word": "normal", "fig": 2}, {"body": 26, "word": "\u03b1", "fig": 1}, {"body": 25, "word": "human", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 13, "word": "extracts", "fig": 1}, {"body": 5, "word": "Upstate", "fig": 2}, {"body": 4, "word": "Chemicon", "fig": 2}, {"body": 7, "word": "various", "fig": 1}, {"body": 5, "word": "HeLa", "fig": 1}, {"body": 5, "word": "male", "fig": 1}, {"body": 4, "word": "female", "fig": 1}, {"body": 4, "word": "reaction", "fig": 1}, {"body": 3, "word": "Immunoblotting", "fig": 1}, {"body": 3, "word": "panel", "fig": 1}, {"body": 2, "word": "extract", "fig": 1}, {"body": 1, "word": "trace", "fig": 1}, {"body": 1, "word": "rabbit", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-11.jpg", "caption": "Immunostaining of mouse blood buffy coat with various HP1 antibodies. Columns: DAPI (DNA staining); Cy3, antibody staining viewed by conventional epifluorescent microscopy. Note that the monocytic nuclei exhibit staining with all monoclonal anti-HP1 antibodies (Chemicon). Granulocytic nuclei only reveal staining with anti-HP1 \u03b3, which appears more concentrated at pericentric heterochromatin. Scale bar: 10 \u03bcm.", "co_occurrence": [{"body": 23, "word": "staining", "fig": 4}, {"body": 49, "word": "HP1", "fig": 1}, {"body": 23, "word": "anti-HP1", "fig": 2}, {"body": 19, "word": "antibodies", "fig": 2}, {"body": 34, "word": "mouse", "fig": 1}, {"body": 34, "word": "heterochromatin", "fig": 1}, {"body": 16, "word": "nuclei", "fig": 2}, {"body": 28, "word": "\u03b3", "fig": 1}, {"body": 24, "word": "blood", "fig": 1}, {"body": 19, "word": "pericentric", "fig": 1}, {"body": 9, "word": "antibody", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 6, "word": "buffy", "fig": 1}, {"body": 6, "word": "coat", "fig": 1}, {"body": 5, "word": "exhibit", "fig": 1}, {"body": 4, "word": "appears", "fig": 1}, {"body": 4, "word": "Chemicon", "fig": 1}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 3, "word": "monocytic", "fig": 1}, {"body": 3, "word": "reveal", "fig": 1}, {"body": 2, "word": "conventional", "fig": 1}, {"body": 2, "word": "epifluorescent", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 1, "word": "Granulocytic", "fig": 1}, {"body": 1, "word": "concentrated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-12.jpg", "caption": "Immunostaining of MPRO cells with various HP1 antibodies. Panels: A, undifferentiated; B, granulocyte forms of MPRO. Columns: FITC, antibody staining viewed by conventional epifluorescent microscopy; DAPI (DNA staining). Cells were stained with anti-HP1 \u03b1, \u03b2 and \u03b3. Note the co-localization of anti-HP1 \u03b3 with DAPI-bright pericentric heterochromatin. Panel C: confocal images demonstrating co-localization of anti-trimethylated H4K20 with anti-HP1 \u03b3 stained granulocyte pericentric heterochromatin. Scale bars: 10 \u03bcm.", "co_occurrence": [{"body": 28, "word": "\u03b3", "fig": 3}, {"body": 23, "word": "anti-HP1", "fig": 3}, {"body": 34, "word": "heterochromatin", "fig": 2}, {"body": 28, "word": "MPRO", "fig": 2}, {"body": 27, "word": "granulocyte", "fig": 2}, {"body": 49, "word": "HP1", "fig": 1}, {"body": 23, "word": "staining", "fig": 2}, {"body": 39, "word": "cells", "fig": 1}, {"body": 19, "word": "pericentric", "fig": 2}, {"body": 27, "word": "\u03b2", "fig": 1}, {"body": 26, "word": "\u03b1", "fig": 1}, {"body": 21, "word": "H4K20", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 7, "word": "stained", "fig": 2}, {"body": 6, "word": "co-localization", "fig": 2}, {"body": 11, "word": "undifferentiated", "fig": 1}, {"body": 9, "word": "antibody", "fig": 1}, {"body": 8, "word": "A", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 7, "word": "C", "fig": 1}, {"body": 7, "word": "B", "fig": 1}, {"body": 7, "word": "DNA", "fig": 1}, {"body": 6, "word": "forms", "fig": 1}, {"body": 5, "word": "DAPI-bright", "fig": 1}, {"body": 3, "word": "Immunostaining", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 2, "word": "microscopy", "fig": 1}, {"body": 2, "word": "conventional", "fig": 1}, {"body": 2, "word": "anti-trimethylated", "fig": 1}, {"body": 2, "word": "DAPI", "fig": 1}, {"body": 2, "word": "epifluorescent", "fig": 1}, {"body": 1, "word": "Cells", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310526/bin/1471-2121-6-39-13.jpg", "caption": "Immunoblotting of MPRO extracts with various HP1 antibodies. Samples: H, HeLa; O, MPRO undifferentiated cells; RA, MPRO granulocytes (differentiated 4 days). Panels: a, Coomassie blue stained membrane; b, monoclonal anti-HP1 \u03b2 (Chemicon); c, monoclonal anti-HP1 \u03b3 (Chemicon). Note that MPRO HP1 \u03b2 appears to be of higher mol wt, than that of HeLa cells. Also note the apparent reduction of the amount of MPRO HP1 \u03b3 during RA-induced differentiation.", "co_occurrence": [{"body": 49, "word": "HP1", "fig": 3}, {"body": 28, "word": "MPRO", "fig": 5}, {"body": 39, "word": "cells", "fig": 2}, {"body": 28, "word": "\u03b3", "fig": 2}, {"body": 27, "word": "\u03b2", "fig": 2}, {"body": 23, "word": "anti-HP1", "fig": 2}, {"body": 40, "word": "granulocytes", "fig": 1}, {"body": 19, "word": "antibodies", "fig": 1}, {"body": 13, "word": "extracts", "fig": 1}, {"body": 11, "word": "undifferentiated", "fig": 1}, {"body": 11, "word": "differentiation", "fig": 1}, {"body": 5, "word": "HeLa", "fig": 2}, {"body": 4, "word": "Chemicon", "fig": 2}, {"body": 8, "word": "RA", "fig": 1}, {"body": 7, "word": "stained", "fig": 1}, {"body": 7, "word": "various", "fig": 1}, {"body": 5, "word": "differentiated", "fig": 1}, {"body": 4, "word": "apparent", "fig": 1}, {"body": 4, "word": "appears", "fig": 1}, {"body": 3, "word": "Immunoblotting", "fig": 1}, {"body": 2, "word": "O", "fig": 1}, {"body": 2, "word": "days", "fig": 1}, {"body": 1, "word": "Also", "fig": 1}, {"body": 1, "word": "amount", "fig": 1}, {"body": 1, "word": "RA-induced", "fig": 1}]}], "4072523": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072523/bin/pgen.1004409.g001.jpg", "caption": "Aberrant autophagosome and autolysosome formation in spns1-mutant zebrafish. (A) Yolk opaqueness and LC3 puncta formation in spns1-mutant zebrafish embryos. For EGFP-LC3 transgenic spns1-mutant [Tg(CMV:EGFP-LC3);spns1hi891/hi891] fish siblings, bright-field and fluorescence images of wild-type (wt) control (upper) and spns1 mutant (spns1\u2212/\u2212) (lower) embryos at 84 hpf are shown. The black arrow indicates the yolk-opaqueness phenotype in the spns1 mutant. The gross expression of EGFP-LC3 at head and trunk in the spns1-mutant animal is relatively stronger than in the wt animal. Occasionally, however, a high intensity signal can be observed at the liver region in the mutant (as seen in D). Scale bar, 250 \u00b5m. (B) EGFP-LC3 punctate compartments in the liver cells of the spns1 mutant. Through high magnification (\u00d7600) confocal microscopy, intracellular EGFP-LC3 puncta were visualized in live animals at 84 hpf. Nuclei were counterstained with Hoechest 33342 (blue), and peri-nuclear EGFP-LC3 puncta were evident in the spns1 mutant, but not in wt animals. Scale bar, 10 \u00b5m. (C) Immunoblotting to detect the conversion of LC3-I to LC-II. Using an anti-LC3 antibody, both endogenous LC3 and transgenic (exogenous) EGFP-LC3 expression was detected and an increase of LC3-II conversion/accumulation was seen in the spns1 mutant compared with wt fish at 84 hpf. (D\u2013F) Identification of autophagosome and autolysosome/lysosome formation in the spns1 mutant. (D, E) LysoTracker (DND-99; red) staining of EGFP-LC3 transgenic spns1-mutant [Tg(CMV:EGFP-LC3); spns1hi891/hi891] embryos was performed at 84 hpf. At the whole animal levels (D), the EGFP-LC3 signal is relatively higher throughout in the spns1 mutant than in wild type, and a particularly strong signal can be seen in the liver, as shown in (A). In the head and trunk portions of the animals (D), a distinctive increase in the intensity of LysoTracker can be observed in the spns1 mutant. At the intracellular level (E), several small LC3 spots and largely diffuse green signal in the cells and cytosolic LysoTracker staining is seen. A number of enlarged LC3- and LysoTracker-positive yellow punctate structures can be seen in the spns1 mutant by confocal microscopy at a higher magnification (inset; enlarged from dotted square area). (F) EGFP-LC3 and mCherry-LC3 double-transgenic [Tg(EGFP-LC3:mCherry-LC3)] zebrafish were used to monitor autolysosome formation in spns1 MO-injected embryos at 84 hpf. A number of enlarged yellow LC3 puncta were detected in the spns1 morphant, while only small yellow LC3 spots can be seen in control-injected embryos. Nuclei were counterstained with 4\u2032, 6-diamidino-2-phenylindole, dihydrochloride (DAPI). Scale bar, 250 \u00b5m in (D). Scale bar, 10 \u00b5m in (E, F). Quantification of data presented in D (n = 12), E (n = 6), and F (n = 6) is shown in the right graph; the number (n) of animals is for each genotype. Three independent areas (periderm or basal epidermal cells above the eye) were selected from individual animals. (G) Transgenic expression of mCherry-Lamp1 in wt [Tg(CMV:EGFP-LC3)] and spns1-mutant [Tg(CMV:EGFP-LC3);spns1hi891/hi891] animals 84 hpf. Scale bar, 10 \u00b5m. (H) Transgenic expression of EGFP-Vector (vector), EGFP-wild-type Spns1 (spns1 WT), or EGFP-mutant Spns1 (spns1 E153K) in [Tg(CMV:mCherry-LC3);spns1hi891/hi891] animals at 84 hpf. Scale bar, 10 \u00b5m. Quantification of data presented in H is shown for ratio of yolk opaqueness phenotype (n = 48), mCherry intensity (red) (n = 6), and merge intensity of EGFP and mCherry (yellow) (n = 6) in the right graphs; the number (n) of animals is for each genotype. Three independent areas (periderm or basal epidermal cells above the eye) were selected from individual animals. Error bars represent the mean \u00b1 standard deviation (S.D.), *p<0.005; ns, not significant.", "co_occurrence": [{"body": 80, "word": "spns1", "fig": 13}, {"body": 103, "word": "animals", "fig": 9}, {"body": 40, "word": "EGFP-LC3", "fig": 14}, {"body": 63, "word": "hpf", "fig": 7}, {"body": 52, "word": "n", "fig": 8}, {"body": 30, "word": "mutant", "fig": 10}, {"body": 47, "word": "spns1-mutant", "fig": 6}, {"body": 65, "word": "A", "fig": 4}, {"body": 41, "word": "\u00b5m", "fig": 6}, {"body": 49, "word": "embryos", "fig": 5}, {"body": 39, "word": "bar", "fig": 6}, {"body": 39, "word": "Scale", "fig": 6}, {"body": 47, "word": "shown", "fig": 4}, {"body": 46, "word": "cells", "fig": 4}, {"body": 56, "word": "zebrafish", "fig": 3}, {"body": 32, "word": "number", "fig": 4}, {"body": 57, "word": "Spns1", "fig": 2}, {"body": 28, "word": "spns1hi891/hi891", "fig": 4}, {"body": 22, "word": "wt", "fig": 5}, {"body": 36, "word": "LysoTracker", "fig": 3}, {"body": 53, "word": "The", "fig": 2}, {"body": 21, "word": "LC3", "fig": 5}, {"body": 49, "word": "data", "fig": 2}, {"body": 24, "word": "expression", "fig": 4}, {"body": 22, "word": "puncta", "fig": 4}, {"body": 43, "word": "fish", "fig": 2}, {"body": 14, "word": "Tg", "fig": 6}, {"body": 36, "word": "Quantification", "fig": 2}, {"body": 14, "word": "CMV", "fig": 5}, {"body": 10, "word": "D", "fig": 6}, {"body": 27, "word": "basal", "fig": 2}, {"body": 25, "word": "presented", "fig": 2}, {"body": 8, "word": "seen", "fig": 6}, {"body": 23, "word": "staining", "fig": 2}, {"body": 23, "word": "red", "fig": 2}, {"body": 15, "word": "mCherry-LC3", "fig": 3}, {"body": 22, "word": "observed", "fig": 2}, {"body": 10, "word": "signal", "fig": 4}, {"body": 10, "word": "formation", "fig": 4}, {"body": 20, "word": "genotype", "fig": 2}, {"body": 20, "word": "right", "fig": 2}, {"body": 20, "word": "independent", "fig": 2}, {"body": 36, "word": "B", "fig": 1}, {"body": 33, "word": "In", "fig": 1}, {"body": 16, "word": "epidermal", "fig": 2}, {"body": 16, "word": "periderm", "fig": 2}, {"body": 16, "word": "phenotype", "fig": 2}, {"body": 31, "word": "yolk", "fig": 1}, {"body": 15, "word": "areas", "fig": 2}, {"body": 15, "word": "selected", "fig": 2}, {"body": 7, "word": "yellow", "fig": 4}, {"body": 14, "word": "detected", "fig": 2}, {"body": 14, "word": "individual", "fig": 2}, {"body": 7, "word": "E", "fig": 4}, {"body": 27, "word": "significant", "fig": 1}, {"body": 13, "word": "Three", "fig": 2}, {"body": 12, "word": "microscopy", "fig": 2}, {"body": 6, "word": "intensity", "fig": 4}, {"body": 12, "word": "eye", "fig": 2}, {"body": 8, "word": "enlarged", "fig": 3}, {"body": 22, "word": "wild-type", "fig": 1}, {"body": 7, "word": "transgenic", "fig": 3}, {"body": 7, "word": "animal", "fig": 3}, {"body": 20, "word": "mean", "fig": 1}, {"body": 20, "word": "*p", "fig": 1}, {"body": 20, "word": "green", "fig": 1}, {"body": 19, "word": "control", "fig": 1}, {"body": 18, "word": "C", "fig": 1}, {"body": 18, "word": "used", "fig": 1}, {"body": 18, "word": "compartments", "fig": 1}, {"body": 8, "word": "increase", "fig": 2}, {"body": 8, "word": "confocal", "fig": 2}, {"body": 15, "word": "EGFP", "fig": 1}, {"body": 14, "word": "Error", "fig": 1}, {"body": 14, "word": "bars", "fig": 1}, {"body": 14, "word": "graph", "fig": 1}, {"body": 13, "word": "represent", "fig": 1}, {"body": 6, "word": "mCherry", "fig": 2}, {"body": 6, "word": "intracellular", "fig": 2}, {"body": 4, "word": "F", "fig": 3}, {"body": 12, "word": "compared", "fig": 1}, {"body": 11, "word": "morphant", "fig": 1}, {"body": 11, "word": "ns", "fig": 1}, {"body": 5, "word": "H", "fig": 2}, {"body": 10, "word": "level", "fig": 1}, {"body": 5, "word": "opaqueness", "fig": 2}, {"body": 10, "word": "standard", "fig": 1}, {"body": 5, "word": "trunk", "fig": 2}, {"body": 9, "word": "fluorescence", "fig": 1}, {"body": 4, "word": "higher", "fig": 2}, {"body": 4, "word": "magnification", "fig": 2}, {"body": 4, "word": "autolysosome", "fig": 2}, {"body": 4, "word": "high", "fig": 2}, {"body": 8, "word": "performed", "fig": 1}, {"body": 8, "word": "MO-injected", "fig": 1}, {"body": 7, "word": "LC3-II", "fig": 1}, {"body": 7, "word": "graphs", "fig": 1}, {"body": 3, "word": "autophagosome", "fig": 2}, {"body": 3, "word": "punctate", "fig": 2}, {"body": 2, "word": "liver", "fig": 3}, {"body": 5, "word": "For", "fig": 1}, {"body": 5, "word": "however", "fig": 1}, {"body": 5, "word": "region", "fig": 1}, {"body": 5, "word": "spns1\u2212/\u2212", "fig": 1}, {"body": 5, "word": "several", "fig": 1}, {"body": 5, "word": "lower", "fig": 1}, {"body": 4, "word": "monitor", "fig": 1}, {"body": 4, "word": "LysoTracker-positive", "fig": 1}, {"body": 4, "word": "DND-99", "fig": 1}, {"body": 2, "word": "counterstained", "fig": 2}, {"body": 4, "word": "cytosolic", "fig": 1}, {"body": 4, "word": "evident", "fig": 1}, {"body": 4, "word": "levels", "fig": 1}, {"body": 4, "word": "inset", "fig": 1}, {"body": 3, "word": "visualized", "fig": 1}, {"body": 3, "word": "upper", "fig": 1}, {"body": 3, "word": "images", "fig": 1}, {"body": 3, "word": "gross", "fig": 1}, {"body": 3, "word": "whole", "fig": 1}, {"body": 3, "word": "vector", "fig": 1}, {"body": 3, "word": "live", "fig": 1}, {"body": 3, "word": "LC3-I", "fig": 1}, {"body": 3, "word": "conversion", "fig": 1}, {"body": 2, "word": "particularly", "fig": 1}, {"body": 2, "word": "deviation", "fig": 1}, {"body": 2, "word": "endogenous", "fig": 1}, {"body": 1, "word": "small", "fig": 2}, {"body": 2, "word": "strong", "fig": 1}, {"body": 1, "word": "spots", "fig": 2}, {"body": 1, "word": "head", "fig": 2}, {"body": 2, "word": "double-transgenic", "fig": 1}, {"body": 1, "word": "relatively", "fig": 2}, {"body": 2, "word": "largely", "fig": 1}, {"body": 2, "word": "antibody", "fig": 1}, {"body": 1, "word": "WT", "fig": 1}, {"body": 1, "word": "black", "fig": 1}, {"body": 1, "word": "exogenous", "fig": 1}, {"body": 1, "word": "Yolk", "fig": 1}, {"body": 1, "word": "E153K", "fig": 1}, {"body": 1, "word": "conversion/accumulation", "fig": 1}, {"body": 1, "word": "Immunoblotting", "fig": 1}, {"body": 1, "word": "Using", "fig": 1}, {"body": 1, "word": "LC3-", "fig": 1}, {"body": 1, "word": "structures", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "indicates", "fig": 1}, {"body": 1, "word": "dotted", "fig": 1}, {"body": 1, "word": "square", "fig": 1}, {"body": 1, "word": "detect", "fig": 1}, {"body": 1, "word": "throughout", "fig": 1}, {"body": 1, "word": "stronger", "fig": 1}, {"body": 1, "word": "S.D", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072523/bin/pgen.1004409.g002.jpg", "caption": "Knockdown of beclin 1 suppresses the Spns1 deficiency in zebrafish. (A) Schematic representation of the zebrafish beclin 1 (zbeclin 1) gene, its mRNA and protein products. A splice-blocking beclin 1 MO was designed to overlap the intron-exon boundary at the 5\u2032-splice junction of exon 4 in the zebrafish beclin 1 gene. To detect aberrantly spliced RNA products, two forward primers were designed for exon 3 (EX3 primer) and exon 4 (EX4 primer), and one reverse primer was designed for exon 7 (EX7 primer) within the beclin 1 gene. The zebrafish beclin 1 gene has a total of 11 exons having three unique domains [BH3 domain, coiled-coil (CCD) domain, and evolutionarily conserved (ECD) domain], and the beclin 1 MO was anticipated to disrupt the BH3 domain encoded by exon 4 and exon 5. (B) Splicing detection of zbeclin 1 mRNA by RT-PCR. Amplified PCR fragments show the intact sizes of the two amplicons for EX3-EX7 and EX4-EX7 following control (water) injection or only spns1 MO injection. Either beclin 1 MO (12 ng/embryo) injection or coinjection of spns1 MO (4 ng/embryo) and beclin 1 MO (12 ng/embryo) generated a skipping of exon 4 (beclin 1\u0394exon4). This was detected by the presence of an altered EX3-EX7 amplicon and undetectable EX4-EX7 product. The deletion of exon 4 was confirmed by sequencing. Injected embryos were harvested for total RNA isolation at 54 hpf. (C and D) Rescue of the spns1 morphant by beclin 1 knockdown. (C) The yolk opaqueness phenotype appearance in control-injected (water), spns1 MO-injected, and spns1 and beclin 1 MOs-coinjected embryos was followed through 72 hpf. At 24 hpf, opaqueness commenced from the yolk extension region, which had almost disappeared or was severely damaged (more than 95% of spns1 MO-injected animals) with an extension of opacity to the entire yolk at 48 hpf. By 72 hpf, yolk opaqueness became highly dense throughout most of the spns1 MO-injected embryos, which usually died within another 24 h. Scale bar, 250 \u00b5m. (D) Clarification of the yolk opaqueness phenotype in spns1 morphants at 72 hpf. As described in (C), more than 95% of the spns1 MO-injected embryos showed a \u2018mostly opaque\u2019 yolk at 48 hpf, and such embryos subsequently died. Animals showing a \u2018partially opaque\u2019 yolk could sometimes be recovered and subsequently survived 96 h and beyond. beclin 1 MO coinjection dramatically increased (more than 10 times) the animal numbers with the partial yolk opaque phenotype. (E) Survival curve for spns1 morphant and spns1;beclin 1-double morphant larvae (log rank test: \u03c72 = 162.5 on one degree of freedom; p<0.0001).", "co_occurrence": [{"body": 80, "word": "spns1", "fig": 11}, {"body": 53, "word": "beclin", "fig": 14}, {"body": 63, "word": "hpf", "fig": 7}, {"body": 54, "word": "MO", "fig": 7}, {"body": 31, "word": "yolk", "fig": 8}, {"body": 49, "word": "embryos", "fig": 5}, {"body": 56, "word": "zebrafish", "fig": 4}, {"body": 53, "word": "The", "fig": 3}, {"body": 65, "word": "A", "fig": 2}, {"body": 103, "word": "animals", "fig": 1}, {"body": 19, "word": "gene", "fig": 4}, {"body": 57, "word": "Spns1", "fig": 1}, {"body": 18, "word": "C", "fig": 3}, {"body": 16, "word": "phenotype", "fig": 3}, {"body": 41, "word": "\u00b5m", "fig": 1}, {"body": 39, "word": "bar", "fig": 1}, {"body": 39, "word": "Scale", "fig": 1}, {"body": 36, "word": "B", "fig": 1}, {"body": 11, "word": "morphant", "fig": 3}, {"body": 8, "word": "MO-injected", "fig": 4}, {"body": 31, "word": "knockdown", "fig": 1}, {"body": 25, "word": "deficiency", "fig": 1}, {"body": 3, "word": "exon", "fig": 8}, {"body": 5, "word": "primer", "fig": 4}, {"body": 10, "word": "D", "fig": 2}, {"body": 5, "word": "opaqueness", "fig": 4}, {"body": 19, "word": "control", "fig": 1}, {"body": 17, "word": "morphants", "fig": 1}, {"body": 16, "word": "h", "fig": 1}, {"body": 5, "word": "injection", "fig": 3}, {"body": 7, "word": "subsequently", "fig": 2}, {"body": 14, "word": "detected", "fig": 1}, {"body": 7, "word": "water", "fig": 2}, {"body": 7, "word": "two", "fig": 2}, {"body": 14, "word": "increased", "fig": 1}, {"body": 6, "word": "one", "fig": 2}, {"body": 12, "word": "followed", "fig": 1}, {"body": 4, "word": "ng/embryo", "fig": 3}, {"body": 12, "word": "protein", "fig": 1}, {"body": 9, "word": "RT-PCR", "fig": 1}, {"body": 9, "word": "presence", "fig": 1}, {"body": 3, "word": "designed", "fig": 3}, {"body": 2, "word": "domain", "fig": 4}, {"body": 4, "word": "products", "fig": 2}, {"body": 8, "word": "larvae", "fig": 1}, {"body": 4, "word": "extension", "fig": 2}, {"body": 8, "word": "showed", "fig": 1}, {"body": 8, "word": "To", "fig": 1}, {"body": 7, "word": "animal", "fig": 1}, {"body": 7, "word": "opacity", "fig": 1}, {"body": 7, "word": "E", "fig": 1}, {"body": 7, "word": "As", "fig": 1}, {"body": 7, "word": "generated", "fig": 1}, {"body": 3, "word": "zbeclin", "fig": 2}, {"body": 6, "word": "PCR", "fig": 1}, {"body": 6, "word": "This", "fig": 1}, {"body": 6, "word": "three", "fig": 1}, {"body": 3, "word": "RNA", "fig": 2}, {"body": 5, "word": "show", "fig": 1}, {"body": 5, "word": "detection", "fig": 1}, {"body": 5, "word": "region", "fig": 1}, {"body": 5, "word": "appearance", "fig": 1}, {"body": 5, "word": "confirmed", "fig": 1}, {"body": 5, "word": "primers", "fig": 1}, {"body": 4, "word": "anticipated", "fig": 1}, {"body": 2, "word": "mRNA", "fig": 2}, {"body": 4, "word": "times", "fig": 1}, {"body": 2, "word": "within", "fig": 2}, {"body": 2, "word": "total", "fig": 2}, {"body": 4, "word": "described", "fig": 1}, {"body": 3, "word": "opaque", "fig": 1}, {"body": 3, "word": "reverse", "fig": 1}, {"body": 3, "word": "forward", "fig": 1}, {"body": 2, "word": "By", "fig": 1}, {"body": 2, "word": "entire", "fig": 1}, {"body": 2, "word": "could", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "sequencing", "fig": 1}, {"body": 2, "word": "fragments", "fig": 1}, {"body": 2, "word": "p", "fig": 1}, {"body": 1, "word": "coinjection", "fig": 2}, {"body": 2, "word": "degree", "fig": 1}, {"body": 2, "word": "log", "fig": 1}, {"body": 2, "word": "rank", "fig": 1}, {"body": 2, "word": "undetectable", "fig": 1}, {"body": 2, "word": "freedom", "fig": 1}, {"body": 2, "word": "numbers", "fig": 1}, {"body": 2, "word": "conserved", "fig": 1}, {"body": 1, "word": "BH3", "fig": 2}, {"body": 2, "word": "\u03c72", "fig": 1}, {"body": 2, "word": "deletion", "fig": 1}, {"body": 2, "word": "product", "fig": 1}, {"body": 2, "word": "altered", "fig": 1}, {"body": 2, "word": "damaged", "fig": 1}, {"body": 2, "word": "evolutionarily", "fig": 1}, {"body": 1, "word": "CCD", "fig": 1}, {"body": 1, "word": "junction", "fig": 1}, {"body": 1, "word": "showing", "fig": 1}, {"body": 1, "word": "EX7", "fig": 1}, {"body": 1, "word": "EX4", "fig": 1}, {"body": 1, "word": "EX3", "fig": 1}, {"body": 1, "word": "intact", "fig": 1}, {"body": 1, "word": "detect", "fig": 1}, {"body": 1, "word": "Rescue", "fig": 1}, {"body": 1, "word": "boundary", "fig": 1}, {"body": 1, "word": "became", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "another", "fig": 1}, {"body": 1, "word": "Animals", "fig": 1}, {"body": 1, "word": "isolation", "fig": 1}, {"body": 1, "word": "following", "fig": 1}, {"body": 1, "word": "intron-exon", "fig": 1}, {"body": 1, "word": "almost", "fig": 1}, {"body": 1, "word": "beyond", "fig": 1}, {"body": 1, "word": "Injected", "fig": 1}, {"body": 1, "word": "5\u2032-splice", "fig": 1}, {"body": 1, "word": "throughout", "fig": 1}, {"body": 1, "word": "highly", "fig": 1}, {"body": 1, "word": "Amplified", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072523/bin/pgen.1004409.g003.jpg", "caption": "Knockdown of beclin 1 suppresses abnormal autolysosomal puncta formation and embryonic senescence caused by Spns1 deficiency in zebrafish. (A) Effect of beclin 1 knockdown on EGFP-LC3 puncta formation in spns1-depleted zebrafish embryos. Injection of control (water) injection, spns1 MO (4 ng/embryo) or coinjection of spns1 MO (4 ng/embryo) and beclin 1 MO (12 ng/embryo) into Tg(CMV:EGFP-LC3) fish was performed to assess whether the beclin 1 knockdown reduces or eliminates aggregated LC3 puncta induced by Spns1 depletion at 84 hpf. Scale bar, 10 \u00b5m. Quantification of data presented in panel A (n = 12) is shown in the right graph; the number (n) of animals is for each morphant or water-injected control. Three independent areas (periderm or basal epidermal cells above the eye) were selected from individual animals. (B) Effect of beclin 1 knockdown on EGFP-GABARAP as well as mCherry-LC3 puncta formation in spns1-depleted zebrafish embryos. Injection of control (water), spns1 MO or coinjection of spns1 MO and beclin 1 MO into Tg(CMV:EGFP-GABARAP;mCherry-LC3) fish was performed to evaluate whether the beclin 1 knockdown reduces or eliminates the aggregation of GFP-GABARAP puncta in comparison with those of LC3 caused by the Spns1 depletion at 84 hpf. Scale bar, 10 \u00b5m. Quantification of data presented in the top row (green; EGFP) (n = 9), middle row (red; mCherry) (n = 12), and bottom row (yellow; merge of EGFP and mCherry) (n = 9) in panel B is shown in the right graphs; the number (n) of animals is for each morphant or water-injected control. Three independent areas (periderm or basal epidermal cells above the eye) were selected from individual animals. (C) Effect of beclin 1 knockdown on embryonic senescence in spns1 morphant. By using the same injection samples [injection of control (water), spns1 MO or coinjection of spns1 MO and beclin 1 MO into Tg(CMV:EGFP-GABARAP;mCherry-LC3) fish], SA-\u03b2-gal staining was performed to assess whether the beclin 1 knockdown has any impact on the embryonic senescence caused by Spns1 depletion at 84 hpf. Representative images of individual fish by bright field (BF, live samples) and SA-\u03b2-gal (SABG) staining are shown in the upper and middle panels, respectively. Scale bar, 250 \u00b5m. Lower panels are larger magnification images of corresponding SA-\u03b2-gal samples shown in the middle panels and the fluorescence images of nuclei counterstained with DAPI. Scale bar, 10 \u00b5m. Quantification of data presented in the middle row (SABG) in panel C (n = 12) is shown in the right graph; the number (n) of animals is for each morphant or water-injected control. Error bars represent the mean \u00b1 S.D., *p<0.005.", "co_occurrence": [{"body": 80, "word": "spns1", "fig": 7}, {"body": 53, "word": "beclin", "fig": 10}, {"body": 103, "word": "animals", "fig": 5}, {"body": 54, "word": "MO", "fig": 9}, {"body": 52, "word": "n", "fig": 8}, {"body": 47, "word": "shown", "fig": 5}, {"body": 57, "word": "Spns1", "fig": 4}, {"body": 63, "word": "hpf", "fig": 3}, {"body": 31, "word": "knockdown", "fig": 6}, {"body": 43, "word": "fish", "fig": 4}, {"body": 56, "word": "zebrafish", "fig": 3}, {"body": 41, "word": "\u00b5m", "fig": 4}, {"body": 39, "word": "bar", "fig": 4}, {"body": 39, "word": "Scale", "fig": 4}, {"body": 49, "word": "senescence", "fig": 3}, {"body": 49, "word": "data", "fig": 3}, {"body": 65, "word": "A", "fig": 2}, {"body": 43, "word": "SA-\u03b2-gal", "fig": 3}, {"body": 19, "word": "control", "fig": 6}, {"body": 22, "word": "puncta", "fig": 5}, {"body": 36, "word": "Quantification", "fig": 3}, {"body": 49, "word": "embryos", "fig": 2}, {"body": 32, "word": "number", "fig": 3}, {"body": 46, "word": "cells", "fig": 2}, {"body": 40, "word": "EGFP-LC3", "fig": 2}, {"body": 25, "word": "presented", "fig": 3}, {"body": 36, "word": "B", "fig": 2}, {"body": 20, "word": "right", "fig": 3}, {"body": 19, "word": "embryonic", "fig": 3}, {"body": 18, "word": "panel", "fig": 3}, {"body": 27, "word": "basal", "fig": 2}, {"body": 23, "word": "staining", "fig": 2}, {"body": 15, "word": "depletion", "fig": 3}, {"body": 15, "word": "mCherry-LC3", "fig": 3}, {"body": 11, "word": "morphant", "fig": 4}, {"body": 21, "word": "LC3", "fig": 2}, {"body": 14, "word": "individual", "fig": 3}, {"body": 14, "word": "CMV", "fig": 3}, {"body": 14, "word": "Tg", "fig": 3}, {"body": 20, "word": "independent", "fig": 2}, {"body": 18, "word": "C", "fig": 2}, {"body": 16, "word": "epidermal", "fig": 2}, {"body": 16, "word": "periderm", "fig": 2}, {"body": 10, "word": "caused", "fig": 3}, {"body": 15, "word": "areas", "fig": 2}, {"body": 15, "word": "selected", "fig": 2}, {"body": 10, "word": "formation", "fig": 3}, {"body": 10, "word": "panels", "fig": 3}, {"body": 15, "word": "EGFP", "fig": 2}, {"body": 14, "word": "graph", "fig": 2}, {"body": 9, "word": "samples", "fig": 3}, {"body": 13, "word": "Three", "fig": 2}, {"body": 26, "word": "using", "fig": 1}, {"body": 25, "word": "deficiency", "fig": 1}, {"body": 12, "word": "eye", "fig": 2}, {"body": 6, "word": "middle", "fig": 4}, {"body": 8, "word": "performed", "fig": 3}, {"body": 23, "word": "red", "fig": 1}, {"body": 7, "word": "water", "fig": 3}, {"body": 20, "word": "autolysosomal", "fig": 1}, {"body": 20, "word": "mean", "fig": 1}, {"body": 20, "word": "*p", "fig": 1}, {"body": 20, "word": "green", "fig": 1}, {"body": 6, "word": "Effect", "fig": 3}, {"body": 18, "word": "well", "fig": 1}, {"body": 5, "word": "injection", "fig": 3}, {"body": 5, "word": "whether", "fig": 3}, {"body": 14, "word": "bars", "fig": 1}, {"body": 14, "word": "Error", "fig": 1}, {"body": 13, "word": "represent", "fig": 1}, {"body": 13, "word": "S.D.", "fig": 1}, {"body": 6, "word": "mCherry", "fig": 2}, {"body": 12, "word": "induced", "fig": 1}, {"body": 4, "word": "ng/embryo", "fig": 3}, {"body": 4, "word": "EGFP-GABARAP", "fig": 3}, {"body": 10, "word": "impact", "fig": 1}, {"body": 10, "word": "respectively", "fig": 1}, {"body": 3, "word": "images", "fig": 3}, {"body": 9, "word": "fluorescence", "fig": 1}, {"body": 7, "word": "yellow", "fig": 1}, {"body": 7, "word": "graphs", "fig": 1}, {"body": 3, "word": "SABG", "fig": 2}, {"body": 1, "word": "row", "fig": 4}, {"body": 4, "word": "magnification", "fig": 1}, {"body": 4, "word": "corresponding", "fig": 1}, {"body": 3, "word": "upper", "fig": 1}, {"body": 3, "word": "bottom", "fig": 1}, {"body": 3, "word": "live", "fig": 1}, {"body": 1, "word": "coinjection", "fig": 3}, {"body": 2, "word": "By", "fig": 1}, {"body": 1, "word": "spns1-depleted", "fig": 2}, {"body": 2, "word": "Representative", "fig": 1}, {"body": 1, "word": "assess", "fig": 2}, {"body": 2, "word": "counterstained", "fig": 1}, {"body": 2, "word": "aggregated", "fig": 1}, {"body": 1, "word": "BF", "fig": 1}, {"body": 1, "word": "bright", "fig": 1}, {"body": 1, "word": "abnormal", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "comparison", "fig": 1}, {"body": 1, "word": "field", "fig": 1}, {"body": 1, "word": "aggregation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072523/bin/pgen.1004409.g004.jpg", "caption": "p53 depletion does not suppress but rather exacerbates Spns1 deficiency. (A) Effect of p53 knockdown on embryonic senescence and autolysosome formation in spns1 morphants. The impact of transient p53 knockdown on SA-\u03b2-gal (SABG) induction, as well as on EGFP-LC3 and LysoTracker (LysoT) puncta, was determined in spns1 morphants at 84 hpf, followed by the MO (4 ng/embryo) injections. Inverse-sequence p53 MO (inv. p53 MO) was used as a negative control for the original p53 MO. Scale bar, 250 \u00b5m in the SABG images. Scale bar, 10 \u00b5m in the fluorescence images. (B) Quantification of the SA-\u03b2-gal intensities in MO-injected animals, as shown for the SABG images in (A). Quantification of data presented in the top row (SABG) in B (n = 12) is shown; the number (n) of animals is for each morphant. (C) Quantification of EGFP-LC3 and LysoTracker puncta in MO-injected animals shown in (A) (n = 9); the number (n) of animals is for each morphant. Three independent areas (periderm or basal epidermal cells above the eye) were selected from individual animals. (D) Effect of a p53 mutation on embryonic SA-\u03b2-gal activity in the spns1 mutant. The heritable impact of p53 and Spns1 on SA-\u03b2-gal induction was tested in each single gene mutant [spns1hi891/hi891 (spns1\u2212/\u2212) or tp53zdf1/zdf1 (p53m/m)] and double mutant spns1hi891/hi891;tp53zdf1/zdf1 (spns1\u2212/\u2212;p53m/m) compared with wild-type (wt) animals at 84 hpf. Scale bar, 250 \u00b5m. (E) Quantification of the SA-\u03b2-gal intensities in wt, tp53zdf1/zdf1, spns1hi891/hi891 and spns1hi891/hi891;tp53zdf1/zdf1 animals, shown in (D). Quantification of data presented in panel D (n = 12) is shown; the number (n) of animals is for each genotype. (F) Quantitative RT-PCR analyses of senescence marker and/or mediator expression as well as p53-downstream target genes in wt, tp53zdf1/zdf1, spns1hi891/hi891 and spns1hi891/hi891;tp53zdf1/zdf1 at 72 hpf. Data are mean \u00b1SD [n = 4 samples (3 embryos/sample) per genotype]. Asterisks denote significant changes compared to wt values. *p<0.05. (G) LC3 conversions in p53 and spns1-mutant animals. Protein detection for the conversion/accumulation of LC3-I to LC-II was performed in the described mutant background animals in comparison with wt fish at 84 hpf. Western blot analysis using anti-LC3 antibody shows endogenous LC3 protein levels, which can confirm an increase of the total amount of LC3 in the p53 mutant compared with wt fish. Increased LC3-II conversion/accumulation was detected in p53 and spns1 double-mutants as well as in spns1 single-mutant fish. (H) The blotting band intensities of LC3-I, LC3-II and \u03b2-actin were quantified (n = 6), and the relative ratios between LC3-II/actin and LC3-I/actin are shown in the bar graph; the number (n) of animals is for each genotype. (I) wt, tp53zdf1/zdf1, spns1hi891/hi891 and spns1hi891/hi891;tp53zdf1/zdf1 embryos injected with beclin 1 MO or control MO (12 ng/embryo) were assayed for SA-\u03b2-gal at 84 hpf. beclin 1 MO-mediated suppression of SA-\u03b2-gal in spns1hi891/hi891 animals was attenuated in the p53 mutant background. Scale bar, 250 \u00b5m. (J) Quantification of the SA-\u03b2-gal intensities shown in (I). Quantification of data presented in H (n = 12) is shown; the number (n) of animals is for each genotype with MO. Error bars represent the mean \u00b1 S.D., *p<0.005; ns, not significant.", "co_occurrence": [{"body": 121, "word": "p53", "fig": 12}, {"body": 103, "word": "animals", "fig": 13}, {"body": 52, "word": "n", "fig": 11}, {"body": 80, "word": "spns1", "fig": 5}, {"body": 54, "word": "MO", "fig": 7}, {"body": 47, "word": "shown", "fig": 8}, {"body": 43, "word": "SA-\u03b2-gal", "fig": 8}, {"body": 63, "word": "hpf", "fig": 5}, {"body": 36, "word": "Quantification", "fig": 7}, {"body": 28, "word": "spns1hi891/hi891", "fig": 9}, {"body": 39, "word": "bar", "fig": 5}, {"body": 65, "word": "A", "fig": 3}, {"body": 30, "word": "mutant", "fig": 6}, {"body": 41, "word": "\u00b5m", "fig": 4}, {"body": 32, "word": "number", "fig": 5}, {"body": 53, "word": "The", "fig": 3}, {"body": 39, "word": "Scale", "fig": 4}, {"body": 22, "word": "wt", "fig": 7}, {"body": 49, "word": "data", "fig": 3}, {"body": 43, "word": "fish", "fig": 3}, {"body": 57, "word": "Spns1", "fig": 2}, {"body": 14, "word": "tp53zdf1/zdf1", "fig": 8}, {"body": 53, "word": "beclin", "fig": 2}, {"body": 49, "word": "senescence", "fig": 2}, {"body": 40, "word": "EGFP-LC3", "fig": 2}, {"body": 20, "word": "genotype", "fig": 4}, {"body": 25, "word": "presented", "fig": 3}, {"body": 36, "word": "B", "fig": 2}, {"body": 36, "word": "LysoTracker", "fig": 2}, {"body": 21, "word": "LC3", "fig": 3}, {"body": 31, "word": "knockdown", "fig": 2}, {"body": 14, "word": "intensities", "fig": 4}, {"body": 27, "word": "significant", "fig": 2}, {"body": 18, "word": "well", "fig": 3}, {"body": 49, "word": "embryos", "fig": 1}, {"body": 24, "word": "induction", "fig": 2}, {"body": 47, "word": "spns1-mutant", "fig": 1}, {"body": 46, "word": "cells", "fig": 1}, {"body": 22, "word": "puncta", "fig": 2}, {"body": 20, "word": "mean", "fig": 2}, {"body": 20, "word": "*p", "fig": 2}, {"body": 19, "word": "embryonic", "fig": 2}, {"body": 19, "word": "control", "fig": 2}, {"body": 12, "word": "compared", "fig": 3}, {"body": 17, "word": "morphants", "fig": 2}, {"body": 32, "word": "and/or", "fig": 1}, {"body": 10, "word": "D", "fig": 3}, {"body": 27, "word": "activity", "fig": 1}, {"body": 27, "word": "basal", "fig": 1}, {"body": 26, "word": "using", "fig": 1}, {"body": 25, "word": "deficiency", "fig": 1}, {"body": 24, "word": "expression", "fig": 1}, {"body": 11, "word": "morphant", "fig": 2}, {"body": 22, "word": "wild-type", "fig": 1}, {"body": 10, "word": "impact", "fig": 2}, {"body": 20, "word": "independent", "fig": 1}, {"body": 19, "word": "gene", "fig": 1}, {"body": 18, "word": "C", "fig": 1}, {"body": 18, "word": "panel", "fig": 1}, {"body": 18, "word": "used", "fig": 1}, {"body": 16, "word": "epidermal", "fig": 1}, {"body": 16, "word": "periderm", "fig": 1}, {"body": 8, "word": "MO-injected", "fig": 2}, {"body": 15, "word": "areas", "fig": 1}, {"body": 15, "word": "selected", "fig": 1}, {"body": 15, "word": "depletion", "fig": 1}, {"body": 15, "word": "suppression", "fig": 1}, {"body": 14, "word": "graph", "fig": 1}, {"body": 14, "word": "detected", "fig": 1}, {"body": 14, "word": "bars", "fig": 1}, {"body": 14, "word": "individual", "fig": 1}, {"body": 7, "word": "LC3-II", "fig": 2}, {"body": 14, "word": "Error", "fig": 1}, {"body": 13, "word": "represent", "fig": 1}, {"body": 13, "word": "Three", "fig": 1}, {"body": 13, "word": "S.D.", "fig": 1}, {"body": 3, "word": "SABG", "fig": 4}, {"body": 12, "word": "followed", "fig": 1}, {"body": 12, "word": "eye", "fig": 1}, {"body": 6, "word": "Effect", "fig": 2}, {"body": 12, "word": "protein", "fig": 1}, {"body": 11, "word": "ns", "fig": 1}, {"body": 5, "word": "H", "fig": 2}, {"body": 10, "word": "formation", "fig": 1}, {"body": 5, "word": "spns1\u2212/\u2212", "fig": 2}, {"body": 10, "word": "determined", "fig": 1}, {"body": 9, "word": "RT-PCR", "fig": 1}, {"body": 9, "word": "samples", "fig": 1}, {"body": 3, "word": "images", "fig": 3}, {"body": 9, "word": "analyses", "fig": 1}, {"body": 9, "word": "analysis", "fig": 1}, {"body": 9, "word": "fluorescence", "fig": 1}, {"body": 8, "word": "increase", "fig": 1}, {"body": 4, "word": "background", "fig": 2}, {"body": 8, "word": "mutation", "fig": 1}, {"body": 8, "word": "genes", "fig": 1}, {"body": 4, "word": "ng/embryo", "fig": 2}, {"body": 8, "word": "performed", "fig": 1}, {"body": 4, "word": "I", "fig": 2}, {"body": 7, "word": "values", "fig": 1}, {"body": 7, "word": "injected", "fig": 1}, {"body": 7, "word": "E", "fig": 1}, {"body": 7, "word": "changes", "fig": 1}, {"body": 6, "word": "per", "fig": 1}, {"body": 3, "word": "LC3-I", "fig": 2}, {"body": 6, "word": "suppress", "fig": 1}, {"body": 6, "word": "target", "fig": 1}, {"body": 6, "word": "double", "fig": 1}, {"body": 6, "word": "rather", "fig": 1}, {"body": 5, "word": "detection", "fig": 1}, {"body": 5, "word": "injections", "fig": 1}, {"body": 5, "word": "attenuated", "fig": 1}, {"body": 5, "word": "Data", "fig": 1}, {"body": 4, "word": "marker", "fig": 1}, {"body": 4, "word": "embryos/sample", "fig": 1}, {"body": 4, "word": "Asterisks", "fig": 1}, {"body": 4, "word": "F", "fig": 1}, {"body": 4, "word": "transient", "fig": 1}, {"body": 4, "word": "autolysosome", "fig": 1}, {"body": 4, "word": "denote", "fig": 1}, {"body": 4, "word": "described", "fig": 1}, {"body": 4, "word": "levels", "fig": 1}, {"body": 3, "word": "quantified", "fig": 1}, {"body": 3, "word": "inv", "fig": 1}, {"body": 3, "word": "tested", "fig": 1}, {"body": 2, "word": "\u03b2-actin", "fig": 1}, {"body": 2, "word": "MO-mediated", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 2, "word": "p53-downstream", "fig": 1}, {"body": 2, "word": "exacerbates", "fig": 1}, {"body": 2, "word": "shows", "fig": 1}, {"body": 2, "word": "antibody", "fig": 1}, {"body": 1, "word": "conversion/accumulation", "fig": 2}, {"body": 2, "word": "Quantitative", "fig": 1}, {"body": 2, "word": "endogenous", "fig": 1}, {"body": 1, "word": "row", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "Inverse-sequence", "fig": 1}, {"body": 1, "word": "Protein", "fig": 1}, {"body": 1, "word": "Increased", "fig": 1}, {"body": 1, "word": "amount", "fig": 1}, {"body": 1, "word": "top", "fig": 1}, {"body": 1, "word": "mediator", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "single", "fig": 1}, {"body": 1, "word": "assayed", "fig": 1}, {"body": 1, "word": "comparison", "fig": 1}, {"body": 1, "word": "original", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072523/bin/pgen.1004409.g005.jpg", "caption": "Acidity-dependent lysosomal biogenesis is rate limiting in spns1-mutant zebrafish. (A) Effect of bafilomycin A1 (BafA) on the yolk opaque phenotype (BF; bright field) and embryonic senescence (SABG; SA-\u03b2-gal) in the spns1 mutant in the presence or absence of p53 at 48 hpf. Normal wild-type (spns1+/+;p53+/+), tp53zdf1/zdf1 (p53m/m), spns1hi891/hi891 (spns1\u2212/\u2212) and spns1hi891/hi891;tp53zdf1/zdf1 (spns1\u2212/\u2212;p53m/m) embryos at 36 hpf were incubated with BafA (200 nM) for 12 h, and stained with LysoTracker at 48 hpf, followed by SA-\u03b2-gal staining at 60 hpf. Scale bar, 250 \u00b5m. (B) Quantification of the SA-\u03b2-gal intensities shown in (A). Quantification of data presented in panel A (n = 12) is shown; the number (n) of animals is for each genotype with DMSO or BafA. (C) Gross morphology, EGFP-LC3 and LysoTracker intensities in wild-type (wt) and spns1-mutant animals treated with BafA shown at 48 hpf (12 h treatment starting at 36 hpf). Scale bar, 250 \u00b5m. (D) Quantification of the EGFP-LC3 and LysoTracker fluorescence intensities shown in (C). Quantification of data presented in the middle and bottom rows (green; EGFP, red; mCherry) in panel C (n = 12) is shown; the number (n) of animals is for each genotype with DMSO or BafA. (E) Intracellular autolysosome formation and lysosomal biogenesis in the BafA-treated spns1 mutant. The samples analyzed in (C) were observed by using confocal microscopy at high magnification (\u00d7600). Scale bar, 10 \u00b5m. (F) Quantification of the EGFP-LC3 and LysoTracker fluorescence intensities shown in (E). Quantification of data presented for EGFP (green) and mCherry (red) signals in panel E (n = 6) is shown; the number (n) of animals is for each genotype with DMSO or BafA. Three independent areas (periderm or basal epidermal cells above the eye) were selected from individual animals. (G) Insufficient intracellular acidity constituent in the spns1 mutants. Using two different acidic-sensitive probes, LysoSensor 189 and neutral-sensitive LysoSensor 153 (green), in combination with LysoTracker (red), wt and spns1-mutant animals showed detectable signals when stained at 72 hpf. In spns1-mutant animals, autolysosomal and/or lysosomal compartments were more prominently detectable by LysoSensor 153 than by LysoSensor 189, at the cellular level with enhanced signal intensity of these enlarged compartments. In stark contrast, the cellular compartments in wt fish treated with pepstatin A and E-64-d (P/E) (12 h treatment from 60 hpf through 72 hpf) were more prominently detectable by LysoSensor 189 than by LysoSensor 153 under the identical LysoTracker staining conditions. Of note, these autolysosomal and lysosomal compartments in spns1 mutants, as well as in wt animals treated with pepstatin A and E-64-d, may still retain some weak (higher pH) and strong (lower pH) acidity, respectively, as short-term BafA treatment (for 1 h between 71 and 72 hpf) can abolish the acidic compartments stained by both LysoSensor and LysoTracker (Figure S17C and D). Scale bar, 10 \u00b5m. (H) Quantification of the LysoSensor (189 and 153) and LysoTracker fluorescence intensities shown in (G). Quantification of data presented for LysoSensor (green) and LysoTracker (red) signals in panel G (n = 6) is shown; the number (n) of animals is for each genotype with DMSO or pepstatin A and E-64-d (P/E). Three independent areas (periderm or basal epidermal cells above the eye) were selected from individual animals. Error bars represent the mean \u00b1 S.D., *p<0.005; ns, not significant.", "co_occurrence": [{"body": 103, "word": "animals", "fig": 10}, {"body": 63, "word": "hpf", "fig": 10}, {"body": 47, "word": "shown", "fig": 9}, {"body": 52, "word": "n", "fig": 8}, {"body": 65, "word": "A", "fig": 6}, {"body": 36, "word": "LysoTracker", "fig": 9}, {"body": 80, "word": "spns1", "fig": 4}, {"body": 36, "word": "Quantification", "fig": 8}, {"body": 31, "word": "LysoSensor", "fig": 9}, {"body": 31, "word": "BafA", "fig": 7}, {"body": 49, "word": "data", "fig": 4}, {"body": 47, "word": "spns1-mutant", "fig": 4}, {"body": 44, "word": "lysosomal", "fig": 4}, {"body": 41, "word": "\u00b5m", "fig": 4}, {"body": 39, "word": "bar", "fig": 4}, {"body": 39, "word": "Scale", "fig": 4}, {"body": 43, "word": "treatment", "fig": 3}, {"body": 43, "word": "SA-\u03b2-gal", "fig": 3}, {"body": 32, "word": "number", "fig": 4}, {"body": 121, "word": "p53", "fig": 1}, {"body": 40, "word": "EGFP-LC3", "fig": 3}, {"body": 110, "word": "Figure", "fig": 1}, {"body": 25, "word": "presented", "fig": 4}, {"body": 23, "word": "red", "fig": 4}, {"body": 46, "word": "cells", "fig": 2}, {"body": 18, "word": "compartments", "fig": 5}, {"body": 22, "word": "wt", "fig": 4}, {"body": 42, "word": "mutants", "fig": 2}, {"body": 20, "word": "genotype", "fig": 4}, {"body": 20, "word": "green", "fig": 4}, {"body": 18, "word": "C", "fig": 4}, {"body": 18, "word": "panel", "fig": 4}, {"body": 14, "word": "intensities", "fig": 5}, {"body": 23, "word": "signals", "fig": 3}, {"body": 33, "word": "In", "fig": 2}, {"body": 16, "word": "h", "fig": 4}, {"body": 30, "word": "mutant", "fig": 2}, {"body": 56, "word": "zebrafish", "fig": 1}, {"body": 28, "word": "spns1hi891/hi891", "fig": 2}, {"body": 27, "word": "basal", "fig": 2}, {"body": 53, "word": "The", "fig": 1}, {"body": 17, "word": "E-64-d", "fig": 3}, {"body": 17, "word": "pepstatin", "fig": 3}, {"body": 49, "word": "senescence", "fig": 1}, {"body": 49, "word": "embryos", "fig": 1}, {"body": 23, "word": "staining", "fig": 2}, {"body": 22, "word": "wild-type", "fig": 2}, {"body": 43, "word": "fish", "fig": 1}, {"body": 20, "word": "autolysosomal", "fig": 2}, {"body": 20, "word": "independent", "fig": 2}, {"body": 36, "word": "B", "fig": 1}, {"body": 11, "word": "detectable", "fig": 3}, {"body": 32, "word": "and/or", "fig": 1}, {"body": 16, "word": "epidermal", "fig": 2}, {"body": 16, "word": "periderm", "fig": 2}, {"body": 8, "word": "DMSO", "fig": 4}, {"body": 31, "word": "yolk", "fig": 1}, {"body": 15, "word": "cellular", "fig": 2}, {"body": 15, "word": "areas", "fig": 2}, {"body": 15, "word": "pH", "fig": 2}, {"body": 15, "word": "selected", "fig": 2}, {"body": 15, "word": "EGFP", "fig": 2}, {"body": 14, "word": "P/E", "fig": 2}, {"body": 14, "word": "biogenesis", "fig": 2}, {"body": 14, "word": "individual", "fig": 2}, {"body": 14, "word": "tp53zdf1/zdf1", "fig": 2}, {"body": 9, "word": "stained", "fig": 3}, {"body": 27, "word": "significant", "fig": 1}, {"body": 9, "word": "fluorescence", "fig": 3}, {"body": 13, "word": "Three", "fig": 2}, {"body": 26, "word": "using", "fig": 1}, {"body": 12, "word": "eye", "fig": 2}, {"body": 22, "word": "observed", "fig": 1}, {"body": 7, "word": "E", "fig": 3}, {"body": 21, "word": "may", "fig": 1}, {"body": 10, "word": "D", "fig": 2}, {"body": 20, "word": "mean", "fig": 1}, {"body": 20, "word": "*p", "fig": 1}, {"body": 19, "word": "embryonic", "fig": 1}, {"body": 6, "word": "treated", "fig": 3}, {"body": 18, "word": "well", "fig": 1}, {"body": 16, "word": "phenotype", "fig": 1}, {"body": 14, "word": "bars", "fig": 1}, {"body": 14, "word": "acidic", "fig": 1}, {"body": 14, "word": "Error", "fig": 1}, {"body": 7, "word": "acidity", "fig": 2}, {"body": 13, "word": "represent", "fig": 1}, {"body": 13, "word": "S.D.", "fig": 1}, {"body": 12, "word": "absence", "fig": 1}, {"body": 6, "word": "mCherry", "fig": 2}, {"body": 12, "word": "microscopy", "fig": 1}, {"body": 12, "word": "conditions", "fig": 1}, {"body": 12, "word": "followed", "fig": 1}, {"body": 11, "word": "ns", "fig": 1}, {"body": 10, "word": "signal", "fig": 1}, {"body": 10, "word": "level", "fig": 1}, {"body": 10, "word": "contrast", "fig": 1}, {"body": 10, "word": "still", "fig": 1}, {"body": 10, "word": "respectively", "fig": 1}, {"body": 10, "word": "formation", "fig": 1}, {"body": 5, "word": "spns1\u2212/\u2212", "fig": 2}, {"body": 10, "word": "probes", "fig": 1}, {"body": 9, "word": "samples", "fig": 1}, {"body": 9, "word": "presence", "fig": 1}, {"body": 8, "word": "showed", "fig": 1}, {"body": 8, "word": "confocal", "fig": 1}, {"body": 8, "word": "enlarged", "fig": 1}, {"body": 7, "word": "incubated", "fig": 1}, {"body": 7, "word": "two", "fig": 1}, {"body": 3, "word": "prominently", "fig": 2}, {"body": 6, "word": "enhanced", "fig": 1}, {"body": 6, "word": "intracellular", "fig": 1}, {"body": 6, "word": "Effect", "fig": 1}, {"body": 6, "word": "intensity", "fig": 1}, {"body": 6, "word": "middle", "fig": 1}, {"body": 5, "word": "nM", "fig": 1}, {"body": 5, "word": "H", "fig": 1}, {"body": 5, "word": "lower", "fig": 1}, {"body": 4, "word": "Of", "fig": 1}, {"body": 4, "word": "retain", "fig": 1}, {"body": 4, "word": "rows", "fig": 1}, {"body": 4, "word": "magnification", "fig": 1}, {"body": 4, "word": "F", "fig": 1}, {"body": 4, "word": "autolysosome", "fig": 1}, {"body": 4, "word": "high", "fig": 1}, {"body": 4, "word": "spns1+/+", "fig": 1}, {"body": 4, "word": "BafA-treated", "fig": 1}, {"body": 4, "word": "higher", "fig": 1}, {"body": 3, "word": "morphology", "fig": 1}, {"body": 3, "word": "note", "fig": 1}, {"body": 3, "word": "combination", "fig": 1}, {"body": 3, "word": "short-term", "fig": 1}, {"body": 3, "word": "opaque", "fig": 1}, {"body": 3, "word": "SABG", "fig": 1}, {"body": 3, "word": "different", "fig": 1}, {"body": 3, "word": "bottom", "fig": 1}, {"body": 2, "word": "weak", "fig": 1}, {"body": 2, "word": "strong", "fig": 1}, {"body": 2, "word": "Acidity-dependent", "fig": 1}, {"body": 2, "word": "Gross", "fig": 1}, {"body": 2, "word": "A1", "fig": 1}, {"body": 2, "word": "starting", "fig": 1}, {"body": 1, "word": "BF", "fig": 1}, {"body": 1, "word": "bright", "fig": 1}, {"body": 1, "word": "Using", "fig": 1}, {"body": 1, "word": "identical", "fig": 1}, {"body": 1, "word": "p53+/+", "fig": 1}, {"body": 1, "word": "rate", "fig": 1}, {"body": 1, "word": "analyzed", "fig": 1}, {"body": 1, "word": "S17C", "fig": 1}, {"body": 1, "word": "Intracellular", "fig": 1}, {"body": 1, "word": "stark", "fig": 1}, {"body": 1, "word": "abolish", "fig": 1}, {"body": 1, "word": "field", "fig": 1}, {"body": 1, "word": "bafilomycin", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072523/bin/pgen.1004409.g006.jpg", "caption": "Schematic model for Spns1 function under the control of the network module of autophagy-senescence signaling cascades differentially regulated through Beclin 1 and p53. (A) Beclin 1 is essential for the early stage of autophagy and its depletion suppresses the Spns1 defect by blocking the \u2018autophagic process\u2019 and its progression. BafA can decelerate \u2018lysosomal biogenesis\u2019, which subsequently presumably prevents autophagosome-lysosome fusion, through the inhibition of the v-ATPase, and contributes to amelioration of the Spns1 defect at least temporarily. Basal p53 activity may suppress the intersection between the \u2018autophagic progress\u2019 and \u2018lysosomal biogenesis\u2019 where the Beclin 1 depletion was not sufficient, but the v-ATPase inhibition was still effective enough, to compete with the p53 loss to suppress the Spns1 deficiency. By switching the basal p53 state to the activated version with UV irradiation, p53 can promote autophagy. Spns1 might be a gatekeeper of autolysosomal maturation followed by lysosomal biogenesis. It remains unknown how p53 can mechanistically be linked to the lysosomal \u2018efflux\u2019 function of Spns1 as well as the lysosomal \u2018influx\u2019 function of v-ATPase, and further investigations will be required to explore this connection. (B) Roles of Spns1, p53 and Beclin 1 in senescence equilibrium. Loss of Spns1 leads to an imbalance in homeostasis and increased senescence. This effect can be ameliorated by concurrent knockdown of Beclin 1. p53 has a comparatively less dramatic impact on Spns1-loss-induced embryonic senescence. When in the \u201cbasal\u201d state, p53 helps retain equilibrium. When p53 is \u201cactivated\u201d by UV irradiation, a modest increase in senescence is observed. The higher level of senescence is seen during loss of Spns1 in the absence of basal p53 or in the presence of activated p53. During loss/knockdown of all three genes (spns1, p53 and beclin 1), a state of moderate senescence is observed. An increase in senescence is accompanied by a p53-dependent decrease in cellular proliferation.", "co_occurrence": [{"body": 121, "word": "p53", "fig": 13}, {"body": 57, "word": "Spns1", "fig": 9}, {"body": 49, "word": "senescence", "fig": 7}, {"body": 44, "word": "lysosomal", "fig": 3}, {"body": 20, "word": "Beclin", "fig": 5}, {"body": 49, "word": "autophagy", "fig": 2}, {"body": 80, "word": "spns1", "fig": 1}, {"body": 39, "word": "UV", "fig": 2}, {"body": 65, "word": "A", "fig": 1}, {"body": 27, "word": "basal", "fig": 2}, {"body": 53, "word": "beclin", "fig": 1}, {"body": 53, "word": "The", "fig": 1}, {"body": 22, "word": "observed", "fig": 2}, {"body": 36, "word": "B", "fig": 1}, {"body": 31, "word": "knockdown", "fig": 1}, {"body": 31, "word": "BafA", "fig": 1}, {"body": 15, "word": "depletion", "fig": 2}, {"body": 9, "word": "v-ATPase", "fig": 3}, {"body": 27, "word": "activity", "fig": 1}, {"body": 25, "word": "deficiency", "fig": 1}, {"body": 7, "word": "function", "fig": 3}, {"body": 21, "word": "may", "fig": 1}, {"body": 20, "word": "autolysosomal", "fig": 1}, {"body": 19, "word": "embryonic", "fig": 1}, {"body": 19, "word": "control", "fig": 1}, {"body": 9, "word": "loss", "fig": 2}, {"body": 18, "word": "well", "fig": 1}, {"body": 8, "word": "inhibition", "fig": 2}, {"body": 8, "word": "increase", "fig": 2}, {"body": 16, "word": "effect", "fig": 1}, {"body": 15, "word": "cellular", "fig": 1}, {"body": 5, "word": "state", "fig": 3}, {"body": 14, "word": "biogenesis", "fig": 1}, {"body": 14, "word": "increased", "fig": 1}, {"body": 7, "word": "defect", "fig": 2}, {"body": 12, "word": "absence", "fig": 1}, {"body": 6, "word": "irradiation", "fig": 2}, {"body": 12, "word": "followed", "fig": 1}, {"body": 6, "word": "suppress", "fig": 2}, {"body": 10, "word": "still", "fig": 1}, {"body": 10, "word": "impact", "fig": 1}, {"body": 10, "word": "progression", "fig": 1}, {"body": 10, "word": "level", "fig": 1}, {"body": 9, "word": "presence", "fig": 1}, {"body": 4, "word": "activated", "fig": 2}, {"body": 8, "word": "fusion", "fig": 1}, {"body": 8, "word": "model", "fig": 1}, {"body": 8, "word": "genes", "fig": 1}, {"body": 8, "word": "stage", "fig": 1}, {"body": 8, "word": "seen", "fig": 1}, {"body": 7, "word": "early", "fig": 1}, {"body": 7, "word": "remains", "fig": 1}, {"body": 7, "word": "It", "fig": 1}, {"body": 7, "word": "subsequently", "fig": 1}, {"body": 6, "word": "This", "fig": 1}, {"body": 6, "word": "three", "fig": 1}, {"body": 5, "word": "homeostasis", "fig": 1}, {"body": 5, "word": "might", "fig": 1}, {"body": 4, "word": "maturation", "fig": 1}, {"body": 4, "word": "retain", "fig": 1}, {"body": 4, "word": "presumably", "fig": 1}, {"body": 4, "word": "linked", "fig": 1}, {"body": 4, "word": "higher", "fig": 1}, {"body": 3, "word": "leads", "fig": 1}, {"body": 3, "word": "autophagosome-lysosome", "fig": 1}, {"body": 3, "word": "decrease", "fig": 1}, {"body": 3, "word": "promote", "fig": 1}, {"body": 3, "word": "concurrent", "fig": 1}, {"body": 3, "word": "effective", "fig": 1}, {"body": 2, "word": "differentially", "fig": 1}, {"body": 2, "word": "less", "fig": 1}, {"body": 2, "word": "accompanied", "fig": 1}, {"body": 2, "word": "essential", "fig": 1}, {"body": 2, "word": "proliferation", "fig": 1}, {"body": 2, "word": "enough", "fig": 1}, {"body": 1, "word": "When", "fig": 2}, {"body": 2, "word": "regulated", "fig": 1}, {"body": 2, "word": "least", "fig": 1}, {"body": 2, "word": "blocking", "fig": 1}, {"body": 2, "word": "By", "fig": 1}, {"body": 2, "word": "\u201cbasal\u201d", "fig": 1}, {"body": 2, "word": "required", "fig": 1}, {"body": 1, "word": "ameliorated", "fig": 1}, {"body": 1, "word": "temporarily", "fig": 1}, {"body": 1, "word": "p53-dependent", "fig": 1}, {"body": 1, "word": "version", "fig": 1}, {"body": 1, "word": "During", "fig": 1}, {"body": 1, "word": "explore", "fig": 1}, {"body": 1, "word": "Spns1-loss-induced", "fig": 1}, {"body": 1, "word": "unknown", "fig": 1}, {"body": 1, "word": "imbalance", "fig": 1}, {"body": 1, "word": "Loss", "fig": 1}, {"body": 1, "word": "\u201cactivated\u201d", "fig": 1}]}], "4723263": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723263/bin/pone.0147503.g001.jpg", "caption": "PAD3 is the most highly expressed PAD isoform in mouse mammary epithelial CID-9 cells. PAD3 mRNA levels are significantly higher in CID-9 cells compared to all other PAD isoforms. Total RNA was extracted from CID-9 cells, reverse transcribed, and resulting cDNA examined by qPCR with intron spanning primers specific for PAD1, PAD2, PAD3, PAD4 or GAPDH as the reference gene control. All data values were normalized to PAD1 to yield fold change, and data are expressed as means \u00b1 SEM. Means were separated using Tukey\u2019s test ANOVA and letters indicate significant differences (P< 0.05).", "co_occurrence": [{"body": 114, "word": "PAD3", "fig": 3}, {"body": 79, "word": "cells", "fig": 3}, {"body": 51, "word": "CID-9", "fig": 3}, {"body": 68, "word": "mammary", "fig": 1}, {"body": 30, "word": "PAD", "fig": 2}, {"body": 13, "word": "expressed", "fig": 2}, {"body": 22, "word": "mouse", "fig": 1}, {"body": 22, "word": "gene", "fig": 1}, {"body": 9, "word": "data", "fig": 2}, {"body": 18, "word": "using", "fig": 1}, {"body": 17, "word": "examined", "fig": 1}, {"body": 15, "word": "levels", "fig": 1}, {"body": 7, "word": "PAD1", "fig": 2}, {"body": 12, "word": "significantly", "fig": 1}, {"body": 12, "word": "control", "fig": 1}, {"body": 12, "word": "mRNA", "fig": 1}, {"body": 9, "word": "P", "fig": 1}, {"body": 9, "word": "epithelial", "fig": 1}, {"body": 8, "word": "isoforms", "fig": 1}, {"body": 8, "word": "All", "fig": 1}, {"body": 8, "word": "specific", "fig": 1}, {"body": 6, "word": "fold", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "resulting", "fig": 1}, {"body": 5, "word": "PAD2", "fig": 1}, {"body": 5, "word": "GAPDH", "fig": 1}, {"body": 5, "word": "highly", "fig": 1}, {"body": 5, "word": "PAD4", "fig": 1}, {"body": 5, "word": "values", "fig": 1}, {"body": 4, "word": "qPCR", "fig": 1}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 4, "word": "SEM", "fig": 1}, {"body": 4, "word": "higher", "fig": 1}, {"body": 4, "word": "separated", "fig": 1}, {"body": 4, "word": "means", "fig": 1}, {"body": 4, "word": "primers", "fig": 1}, {"body": 4, "word": "Means", "fig": 1}, {"body": 4, "word": "RNA", "fig": 1}, {"body": 3, "word": "reference", "fig": 1}, {"body": 3, "word": "ANOVA", "fig": 1}, {"body": 3, "word": "spanning", "fig": 1}, {"body": 3, "word": "isoform", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "normalized", "fig": 1}, {"body": 3, "word": "Tukey\u2019s", "fig": 1}, {"body": 3, "word": "intron", "fig": 1}, {"body": 2, "word": "letters", "fig": 1}, {"body": 2, "word": "indicate", "fig": 1}, {"body": 2, "word": "transcribed", "fig": 1}, {"body": 2, "word": "test", "fig": 1}, {"body": 2, "word": "differences", "fig": 1}, {"body": 2, "word": "reverse", "fig": 1}, {"body": 2, "word": "yield", "fig": 1}, {"body": 2, "word": "Total", "fig": 1}, {"body": 1, "word": "extracted", "fig": 1}, {"body": 1, "word": "change", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723263/bin/pone.0147503.g002.jpg", "caption": "Inhibition of PAD3 decreases the level of citrullinated proteins in CID-9 cells. CID-9 cells were treated with vehicle or 50 \u03bcM Cl4-amidine overnight. The following morning cells were lysed and equal concentrations of protein lysates examined by western blot following the AMC protocol. The positive control is in vitro citrullinated bulk histones.", "co_occurrence": [{"body": 79, "word": "cells", "fig": 3}, {"body": 114, "word": "PAD3", "fig": 1}, {"body": 51, "word": "CID-9", "fig": 2}, {"body": 27, "word": "The", "fig": 2}, {"body": 17, "word": "citrullinated", "fig": 2}, {"body": 23, "word": "proteins", "fig": 1}, {"body": 18, "word": "protein", "fig": 1}, {"body": 17, "word": "examined", "fig": 1}, {"body": 15, "word": "lysates", "fig": 1}, {"body": 7, "word": "following", "fig": 2}, {"body": 14, "word": "treated", "fig": 1}, {"body": 12, "word": "vehicle", "fig": 1}, {"body": 12, "word": "control", "fig": 1}, {"body": 11, "word": "overnight", "fig": 1}, {"body": 11, "word": "equal", "fig": 1}, {"body": 11, "word": "Cl4-amidine", "fig": 1}, {"body": 8, "word": "protocol", "fig": 1}, {"body": 8, "word": "western", "fig": 1}, {"body": 7, "word": "\u03bcM", "fig": 1}, {"body": 5, "word": "lysed", "fig": 1}, {"body": 5, "word": "AMC", "fig": 1}, {"body": 5, "word": "concentrations", "fig": 1}, {"body": 4, "word": "morning", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "level", "fig": 1}, {"body": 2, "word": "Inhibition", "fig": 1}, {"body": 2, "word": "histones", "fig": 1}, {"body": 1, "word": "vitro", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "decreases", "fig": 1}, {"body": 1, "word": "bulk", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723263/bin/pone.0147503.g003.jpg", "caption": "Prolactin stimulation of CID-9 cells increases PAD3 mRNA and protein expression. Equal numbers of CID-9 cells were grown in phenol red free media with charcoal-stripped FBS overnight. The following morning cells were treated with vehicle or 5 \u03bcg/mL of prolactin for 24 or 48 hours. (A) Prolactin treatment significantly increases PAD3 mRNA. Total RNA was extracted from CID-9 cells, reverse transcribed, and resulting cDNA examined by qPCR with intron spanning primers specific for PAD3 or GAPDH as the reference gene control. All data values were normalized to vehicle treated control and data are presented as means \u00b1 SEM. Means were separated using SNK ANOVA and * indicates significant difference (P<0.05). (B) Prolactin treatment increases PAD3 protein levels. The top panel shows a representative western blot, while the graph in the bottom panel represents the quantification of western blots using BioRad Image Lab 4.0 (n = 4, P<0.05). Protein concentrations of cell lysates were determined by BCA assay and equal amounts loaded and examined by western blot. Membranes were probed with a rabbit anti-PAD3 antibody or with anti-\u03b2-actin as a loading control. The positive control was generated by overexpressing human PAD3 in CID-9 cells.", "co_occurrence": [{"body": 114, "word": "PAD3", "fig": 5}, {"body": 79, "word": "cells", "fig": 5}, {"body": 51, "word": "CID-9", "fig": 4}, {"body": 27, "word": "The", "fig": 3}, {"body": 65, "word": "expression", "fig": 1}, {"body": 61, "word": "prolactin", "fig": 1}, {"body": 12, "word": "control", "fig": 4}, {"body": 18, "word": "using", "fig": 2}, {"body": 18, "word": "protein", "fig": 2}, {"body": 17, "word": "examined", "fig": 2}, {"body": 14, "word": "treated", "fig": 2}, {"body": 12, "word": "treatment", "fig": 2}, {"body": 12, "word": "mRNA", "fig": 2}, {"body": 8, "word": "western", "fig": 3}, {"body": 12, "word": "vehicle", "fig": 2}, {"body": 22, "word": "gene", "fig": 1}, {"body": 7, "word": "increases", "fig": 3}, {"body": 21, "word": "hours", "fig": 1}, {"body": 9, "word": "P", "fig": 2}, {"body": 6, "word": "Prolactin", "fig": 3}, {"body": 9, "word": "data", "fig": 2}, {"body": 16, "word": "human", "fig": 1}, {"body": 16, "word": "cell", "fig": 1}, {"body": 15, "word": "lysates", "fig": 1}, {"body": 15, "word": "levels", "fig": 1}, {"body": 15, "word": "antibody", "fig": 1}, {"body": 12, "word": "significantly", "fig": 1}, {"body": 11, "word": "equal", "fig": 1}, {"body": 11, "word": "overnight", "fig": 1}, {"body": 10, "word": "blots", "fig": 1}, {"body": 9, "word": "\u03bcg/mL", "fig": 1}, {"body": 8, "word": "specific", "fig": 1}, {"body": 8, "word": "indicates", "fig": 1}, {"body": 8, "word": "All", "fig": 1}, {"body": 7, "word": "stimulation", "fig": 1}, {"body": 7, "word": "following", "fig": 1}, {"body": 3, "word": "blot", "fig": 2}, {"body": 6, "word": "resulting", "fig": 1}, {"body": 6, "word": "anti-PAD3", "fig": 1}, {"body": 5, "word": "GAPDH", "fig": 1}, {"body": 5, "word": "concentrations", "fig": 1}, {"body": 5, "word": "values", "fig": 1}, {"body": 4, "word": "Means", "fig": 1}, {"body": 4, "word": "means", "fig": 1}, {"body": 4, "word": "morning", "fig": 1}, {"body": 4, "word": "loading", "fig": 1}, {"body": 4, "word": "RNA", "fig": 1}, {"body": 4, "word": "SEM", "fig": 1}, {"body": 4, "word": "separated", "fig": 1}, {"body": 4, "word": "rabbit", "fig": 1}, {"body": 4, "word": "qPCR", "fig": 1}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 4, "word": "primers", "fig": 1}, {"body": 3, "word": "ANOVA", "fig": 1}, {"body": 3, "word": "intron", "fig": 1}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "reference", "fig": 1}, {"body": 3, "word": "shows", "fig": 1}, {"body": 3, "word": "normalized", "fig": 1}, {"body": 3, "word": "FBS", "fig": 1}, {"body": 3, "word": "spanning", "fig": 1}, {"body": 3, "word": "grown", "fig": 1}, {"body": 3, "word": "probed", "fig": 1}, {"body": 3, "word": "Equal", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "transcribed", "fig": 1}, {"body": 2, "word": "Membranes", "fig": 1}, {"body": 2, "word": "anti-\u03b2-actin", "fig": 1}, {"body": 2, "word": "reverse", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "Total", "fig": 1}, {"body": 1, "word": "SNK", "fig": 1}, {"body": 1, "word": "Protein", "fig": 1}, {"body": 1, "word": "bottom", "fig": 1}, {"body": 1, "word": "red", "fig": 1}, {"body": 1, "word": "free", "fig": 1}, {"body": 1, "word": "BCA", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "quantification", "fig": 1}, {"body": 1, "word": "numbers", "fig": 1}, {"body": 1, "word": "extracted", "fig": 1}, {"body": 1, "word": "phenol", "fig": 1}, {"body": 1, "word": "generated", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723263/bin/pone.0147503.g004.jpg", "caption": "Prolactin stimulates the JAK2/STAT5 signaling pathway to upregulate PAD3 expression in CID-9 cells. (A) JAK2 mediates prolactin induced PAD3 upregulation. CID-9 cells were pre-treated for 4 hours with DMSO or 3 \u03bcM JAK2 inhibitor (SD-1029). Following pre-treatment, cells were stimulated with vehicle or 5 \u03bcg/mL of prolactin for 48 hours. After the first 24 hours, cells received fresh inhibitor. Protein concentrations of cell lysates were determined by BCA assay and equal amounts examined by western blot. Membranes were probed with anti-PAD3, p-JAK2, total JAK2 antibodies or with anti-\u03b2-actin as a loading control. (B) STAT5 mediates prolactin induced PAD3 upregulation. CID-9 cells were infected overnight with 10 MOI of an adenovirus expressing GFP (Ad-GFP) or an adenovirus expressing a dominant-negative form of STAT5 (Ad-DN-STAT5) as indicated. The following morning cells were treated with vehicle or 5 \u03bcg/mL of prolactin for 24 or 48 hours. Protein concentrations of cell lysates were determined by BCA assay and equal amounts examined by western blot. Membranes were probed with anti-PAD3, GFP, p-STAT5, total STAT5 or \u03b2-actin antibodies.", "co_occurrence": [{"body": 79, "word": "cells", "fig": 6}, {"body": 114, "word": "PAD3", "fig": 3}, {"body": 61, "word": "prolactin", "fig": 4}, {"body": 51, "word": "CID-9", "fig": 3}, {"body": 21, "word": "hours", "fig": 4}, {"body": 65, "word": "expression", "fig": 1}, {"body": 16, "word": "JAK2", "fig": 3}, {"body": 14, "word": "STAT5", "fig": 3}, {"body": 17, "word": "examined", "fig": 2}, {"body": 16, "word": "cell", "fig": 2}, {"body": 15, "word": "lysates", "fig": 2}, {"body": 27, "word": "The", "fig": 1}, {"body": 12, "word": "vehicle", "fig": 2}, {"body": 12, "word": "inhibitor", "fig": 2}, {"body": 11, "word": "equal", "fig": 2}, {"body": 9, "word": "\u03bcg/mL", "fig": 2}, {"body": 9, "word": "induced", "fig": 2}, {"body": 8, "word": "western", "fig": 2}, {"body": 14, "word": "treated", "fig": 1}, {"body": 6, "word": "anti-PAD3", "fig": 2}, {"body": 12, "word": "control", "fig": 1}, {"body": 11, "word": "first", "fig": 1}, {"body": 11, "word": "overnight", "fig": 1}, {"body": 11, "word": "signaling", "fig": 1}, {"body": 5, "word": "concentrations", "fig": 2}, {"body": 10, "word": "pathway", "fig": 1}, {"body": 9, "word": "Following", "fig": 1}, {"body": 4, "word": "adenovirus", "fig": 2}, {"body": 7, "word": "\u03bcM", "fig": 1}, {"body": 7, "word": "following", "fig": 1}, {"body": 3, "word": "blot", "fig": 2}, {"body": 3, "word": "assay", "fig": 2}, {"body": 6, "word": "JAK2/STAT5", "fig": 1}, {"body": 6, "word": "Prolactin", "fig": 1}, {"body": 3, "word": "total", "fig": 2}, {"body": 3, "word": "probed", "fig": 2}, {"body": 3, "word": "antibodies", "fig": 2}, {"body": 4, "word": "morning", "fig": 1}, {"body": 2, "word": "expressing", "fig": 2}, {"body": 4, "word": "Ad-DN-STAT5", "fig": 1}, {"body": 4, "word": "loading", "fig": 1}, {"body": 2, "word": "Membranes", "fig": 2}, {"body": 4, "word": "After", "fig": 1}, {"body": 2, "word": "GFP", "fig": 2}, {"body": 3, "word": "SD-1029", "fig": 1}, {"body": 3, "word": "p-JAK2", "fig": 1}, {"body": 3, "word": "infected", "fig": 1}, {"body": 3, "word": "stimulates", "fig": 1}, {"body": 3, "word": "Ad-GFP", "fig": 1}, {"body": 3, "word": "DMSO", "fig": 1}, {"body": 1, "word": "Protein", "fig": 2}, {"body": 2, "word": "anti-\u03b2-actin", "fig": 1}, {"body": 2, "word": "MOI", "fig": 1}, {"body": 1, "word": "BCA", "fig": 2}, {"body": 2, "word": "form", "fig": 1}, {"body": 2, "word": "pre-treated", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "dominant-negative", "fig": 1}, {"body": 1, "word": "p-STAT5", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "stimulated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723263/bin/pone.0147503.g005.jpg", "caption": "The human PAD3 gene promoter is prolactin responsive in CID-9 cells -276/+41 and -94/+41 base pairs of the human PAD3 gene promoter were cloned from genomic DNA and fused to the cDNA of luciferase. CID-9 cells were transfected overnight with hPAD3\u2013276/+41-Luc, hPAD3\u201394/+41-Luc, pGL3 empty, and CMV-\u03b2-galactosidase. The next morning cells were treated with vehicle or 5 \u03bcg/mL of prolactin for 24 hours. Cellular lysates were assayed for luciferase and \u03b2-galactosidase activity. Luciferase values were corrected for \u03b2-galactosidase activity, and data are expressed as adjusted light units (top panel A) or fold change in adjusted luciferase activity (bottom panel B). The inset figure in top panel A illustrates that the hPAD3\u201394/+41-Luc construct has significant transcriptional activity compared to the pGL3 empty. Values represent the mean \u00b1 SEM. Means were separated using Student\u2019s T-Test with * designating significant differences with treatment (P<0.05).", "co_occurrence": [{"body": 79, "word": "cells", "fig": 3}, {"body": 114, "word": "PAD3", "fig": 2}, {"body": 61, "word": "prolactin", "fig": 2}, {"body": 51, "word": "CID-9", "fig": 2}, {"body": 27, "word": "The", "fig": 3}, {"body": 20, "word": "activity", "fig": 4}, {"body": 22, "word": "gene", "fig": 2}, {"body": 16, "word": "human", "fig": 2}, {"body": 15, "word": "promoter", "fig": 2}, {"body": 21, "word": "hours", "fig": 1}, {"body": 6, "word": "luciferase", "fig": 3}, {"body": 18, "word": "using", "fig": 1}, {"body": 15, "word": "lysates", "fig": 1}, {"body": 14, "word": "treated", "fig": 1}, {"body": 13, "word": "expressed", "fig": 1}, {"body": 12, "word": "treatment", "fig": 1}, {"body": 12, "word": "vehicle", "fig": 1}, {"body": 11, "word": "overnight", "fig": 1}, {"body": 9, "word": "\u03bcg/mL", "fig": 1}, {"body": 9, "word": "P", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 8, "word": "next", "fig": 1}, {"body": 6, "word": "fold", "fig": 1}, {"body": 3, "word": "\u03b2-galactosidase", "fig": 2}, {"body": 6, "word": "DNA", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 3, "word": "significant", "fig": 2}, {"body": 5, "word": "transfected", "fig": 1}, {"body": 5, "word": "values", "fig": 1}, {"body": 4, "word": "Means", "fig": 1}, {"body": 2, "word": "pGL3", "fig": 2}, {"body": 4, "word": "morning", "fig": 1}, {"body": 4, "word": "SEM", "fig": 1}, {"body": 2, "word": "empty", "fig": 2}, {"body": 4, "word": "separated", "fig": 1}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 2, "word": "A", "fig": 2}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "construct", "fig": 1}, {"body": 3, "word": "transcriptional", "fig": 1}, {"body": 2, "word": "responsive", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 2, "word": "genomic", "fig": 1}, {"body": 2, "word": "base", "fig": 1}, {"body": 1, "word": "adjusted", "fig": 2}, {"body": 2, "word": "differences", "fig": 1}, {"body": 2, "word": "T-Test", "fig": 1}, {"body": 1, "word": "bottom", "fig": 1}, {"body": 1, "word": "fused", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "pairs", "fig": 1}, {"body": 1, "word": "CMV-\u03b2-galactosidase", "fig": 1}, {"body": 1, "word": "cloned", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 1}, {"body": 1, "word": "Values", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723263/bin/pone.0147503.g006.jpg", "caption": "PAD3 expression in mouse mammary secretory cells initiates during late pregnancy and is highest during lactation. (A) PAD3 expression is first detected at P18 and increases from L2 through L9. Mouse mammary tissue from pregnancy day 12 (a, b), day 18 (c, d), lactation day 2 (e, f), and day 9 (g, h) was harvested, fixed in 10% neutral buffered formalin, embedded in paraffin and sectioned. 5 \u03bcm mammary tissue sections were subject to a standard IHC protocol using a rabbit anti-PAD3 antibody or an equal amount of non-specific rabbit IgG as a control. Images were taken with 20 and 40X objectives, and DAB staining represents PAD3 expression. (B) PAD3 mRNA and protein expression increases two-fold between L2 and L9. Total RNA was extracted from L2 and L9 mouse mammary glands, reverse transcribed, and resulting cDNA examined by qPCR with intron spanning primers specific for PAD3 or EE2F as the reference gene control. Data values were normalized to L2 to yield fold change, and data are expressed as means \u00b1 SEM. L2 and 9 mammary glands were homogenized in RIPA buffer and equal concentrations subject to western blot. The positive control was generated by overexpressing PAD3 in CID-9 cells. Western blots were quantified using BioRad Image Lab 4.0. Data values were normalized to L2 to yield fold change, and data are expressed as means \u00b1 SEM. Means were separated using Student\u2019s T-test and * indicates a significant difference (P< 0.05).", "co_occurrence": [{"body": 114, "word": "PAD3", "fig": 6}, {"body": 68, "word": "mammary", "fig": 5}, {"body": 65, "word": "expression", "fig": 4}, {"body": 79, "word": "cells", "fig": 2}, {"body": 13, "word": "L2", "fig": 6}, {"body": 23, "word": "L9", "fig": 3}, {"body": 18, "word": "using", "fig": 3}, {"body": 51, "word": "CID-9", "fig": 1}, {"body": 22, "word": "lactation", "fig": 2}, {"body": 22, "word": "mouse", "fig": 2}, {"body": 12, "word": "control", "fig": 3}, {"body": 8, "word": "day", "fig": 4}, {"body": 27, "word": "The", "fig": 1}, {"body": 13, "word": "expressed", "fig": 2}, {"body": 13, "word": "glands", "fig": 2}, {"body": 12, "word": "pregnancy", "fig": 2}, {"body": 11, "word": "equal", "fig": 2}, {"body": 22, "word": "gene", "fig": 1}, {"body": 9, "word": "tissue", "fig": 2}, {"body": 18, "word": "protein", "fig": 1}, {"body": 9, "word": "data", "fig": 2}, {"body": 17, "word": "examined", "fig": 1}, {"body": 15, "word": "antibody", "fig": 1}, {"body": 7, "word": "increases", "fig": 2}, {"body": 13, "word": "secretory", "fig": 1}, {"body": 6, "word": "fold", "fig": 2}, {"body": 12, "word": "mRNA", "fig": 1}, {"body": 11, "word": "first", "fig": 1}, {"body": 10, "word": "blots", "fig": 1}, {"body": 5, "word": "values", "fig": 2}, {"body": 9, "word": "P", "fig": 1}, {"body": 8, "word": "protocol", "fig": 1}, {"body": 4, "word": "means", "fig": 2}, {"body": 8, "word": "specific", "fig": 1}, {"body": 4, "word": "SEM", "fig": 2}, {"body": 4, "word": "rabbit", "fig": 2}, {"body": 8, "word": "indicates", "fig": 1}, {"body": 8, "word": "western", "fig": 1}, {"body": 7, "word": "IHC", "fig": 1}, {"body": 7, "word": "buffer", "fig": 1}, {"body": 6, "word": "resulting", "fig": 1}, {"body": 6, "word": "anti-PAD3", "fig": 1}, {"body": 3, "word": "normalized", "fig": 2}, {"body": 6, "word": "highest", "fig": 1}, {"body": 5, "word": "IgG", "fig": 1}, {"body": 5, "word": "detected", "fig": 1}, {"body": 5, "word": "concentrations", "fig": 1}, {"body": 4, "word": "Means", "fig": 1}, {"body": 2, "word": "yield", "fig": 2}, {"body": 2, "word": "subject", "fig": 2}, {"body": 4, "word": "P18", "fig": 1}, {"body": 4, "word": "non-specific", "fig": 1}, {"body": 4, "word": "RNA", "fig": 1}, {"body": 4, "word": "separated", "fig": 1}, {"body": 4, "word": "initiates", "fig": 1}, {"body": 4, "word": "qPCR", "fig": 1}, {"body": 4, "word": "cDNA", "fig": 1}, {"body": 4, "word": "primers", "fig": 1}, {"body": 3, "word": "blot", "fig": 1}, {"body": 3, "word": "intron", "fig": 1}, {"body": 3, "word": "Mouse", "fig": 1}, {"body": 3, "word": "reference", "fig": 1}, {"body": 3, "word": "RIPA", "fig": 1}, {"body": 3, "word": "spanning", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "late", "fig": 1}, {"body": 2, "word": "transcribed", "fig": 1}, {"body": 1, "word": "Data", "fig": 2}, {"body": 2, "word": "h", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 1, "word": "change", "fig": 2}, {"body": 2, "word": "reverse", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "Total", "fig": 1}, {"body": 1, "word": "Western", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "40X", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "fixed", "fig": 1}, {"body": 1, "word": "standard", "fig": 1}, {"body": 1, "word": "buffered", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "neutral", "fig": 1}, {"body": 1, "word": "homogenized", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "DAB", "fig": 1}, {"body": 1, "word": "extracted", "fig": 1}, {"body": 1, "word": "generated", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723263/bin/pone.0147503.g007.jpg", "caption": "Citrullinated proteins are present in the lactating mammary gland and are citrullinated, in part, by PAD3. Mammary glands were collected on L2 and 9, homogenized and sonicated in modified RIPA buffer. (A) Citrullinated proteins are present in L2 and L9 mammary glands. Equal concentrations of protein lysates were examined by western blot following the AMC protocol. The positive control is in vitro citrullinated bulk histones. (B) Citrullinated histone tail arginine residues 2, 8, and 17 are present in L2 and L9 mammary glands. Equal concentrations of protein lysates were examined by western blot using an anti-citrullinated histone H3 arginine 2, 8, and 17 antibody. (C) Citrullinated proteins are detected in L2 and L9 mammary tissue. Mouse mammary tissue from lactation day 2 (a, b, c), and day 9 (d, e, f) was harvested, fixed in 10% neutral buffered formalin, embedded in paraffin and sectioned. 5 \u03bcm mammary tissue sections were subject to a standard IHC protocol using a rabbit anti-citrulline antibody or an equal amount of non-specific rabbit IgG as a control. Images were taken with 20 and 40X objectives, and DAB staining represents citrullinated proteins. (D) Cl4-amidine decreases PAD3 activity in L9 mammary gland lysates. Equal concentrations of L9 mammary gland lysates were incubated with 100 \u03bcM Cl4-amidine for 15 minutes then subject to COLDER PAD activity assay. Values represent the mean \u00b1 SEM. Means were separated using Student\u2019s T-Test with * designating significant differences with treatment (P<0.05).", "co_occurrence": [{"body": 68, "word": "mammary", "fig": 8}, {"body": 114, "word": "PAD3", "fig": 2}, {"body": 23, "word": "L9", "fig": 5}, {"body": 23, "word": "proteins", "fig": 4}, {"body": 26, "word": "gland", "fig": 3}, {"body": 15, "word": "lysates", "fig": 4}, {"body": 18, "word": "using", "fig": 3}, {"body": 13, "word": "L2", "fig": 4}, {"body": 17, "word": "citrullinated", "fig": 3}, {"body": 20, "word": "activity", "fig": 2}, {"body": 13, "word": "glands", "fig": 3}, {"body": 18, "word": "protein", "fig": 2}, {"body": 17, "word": "examined", "fig": 2}, {"body": 30, "word": "PAD", "fig": 1}, {"body": 15, "word": "antibody", "fig": 2}, {"body": 9, "word": "tissue", "fig": 3}, {"body": 27, "word": "The", "fig": 1}, {"body": 12, "word": "control", "fig": 2}, {"body": 22, "word": "lactation", "fig": 1}, {"body": 11, "word": "Cl4-amidine", "fig": 2}, {"body": 8, "word": "protocol", "fig": 2}, {"body": 8, "word": "day", "fig": 2}, {"body": 4, "word": "Citrullinated", "fig": 4}, {"body": 8, "word": "western", "fig": 2}, {"body": 5, "word": "concentrations", "fig": 3}, {"body": 12, "word": "treatment", "fig": 1}, {"body": 11, "word": "equal", "fig": 1}, {"body": 10, "word": "lactating", "fig": 1}, {"body": 10, "word": "incubated", "fig": 1}, {"body": 5, "word": "arginine", "fig": 2}, {"body": 9, "word": "P", "fig": 1}, {"body": 3, "word": "Equal", "fig": 3}, {"body": 4, "word": "histone", "fig": 2}, {"body": 4, "word": "rabbit", "fig": 2}, {"body": 7, "word": "IHC", "fig": 1}, {"body": 7, "word": "\u03bcM", "fig": 1}, {"body": 7, "word": "following", "fig": 1}, {"body": 7, "word": "buffer", "fig": 1}, {"body": 3, "word": "blot", "fig": 2}, {"body": 2, "word": "present", "fig": 3}, {"body": 5, "word": "detected", "fig": 1}, {"body": 5, "word": "AMC", "fig": 1}, {"body": 5, "word": "IgG", "fig": 1}, {"body": 5, "word": "minutes", "fig": 1}, {"body": 4, "word": "Means", "fig": 1}, {"body": 2, "word": "subject", "fig": 2}, {"body": 4, "word": "non-specific", "fig": 1}, {"body": 4, "word": "SEM", "fig": 1}, {"body": 4, "word": "separated", "fig": 1}, {"body": 3, "word": "assay", "fig": 1}, {"body": 3, "word": "Mouse", "fig": 1}, {"body": 3, "word": "mean", "fig": 1}, {"body": 3, "word": "H3", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "collected", "fig": 1}, {"body": 3, "word": "modified", "fig": 1}, {"body": 3, "word": "RIPA", "fig": 1}, {"body": 3, "word": "residues", "fig": 1}, {"body": 2, "word": "Student\u2019s", "fig": 1}, {"body": 2, "word": "histones", "fig": 1}, {"body": 2, "word": "sonicated", "fig": 1}, {"body": 2, "word": "T-Test", "fig": 1}, {"body": 2, "word": "anti-citrulline", "fig": 1}, {"body": 2, "word": "COLDER", "fig": 1}, {"body": 2, "word": "differences", "fig": 1}, {"body": 2, "word": "harvested", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "decreases", "fig": 1}, {"body": 1, "word": "40X", "fig": 1}, {"body": 1, "word": "d", "fig": 1}, {"body": 1, "word": "fixed", "fig": 1}, {"body": 1, "word": "standard", "fig": 1}, {"body": 1, "word": "Values", "fig": 1}, {"body": 1, "word": "buffered", "fig": 1}, {"body": 1, "word": "vitro", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "bulk", "fig": 1}, {"body": 1, "word": "neutral", "fig": 1}, {"body": 1, "word": "part", "fig": 1}, {"body": 1, "word": "homogenized", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "f", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "DAB", "fig": 1}, {"body": 1, "word": "anti-citrullinated", "fig": 1}, {"body": 1, "word": "e", "fig": 1}]}], "3928559": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928559/bin/emss-55145-f0001.jpg", "caption": "HIV-1 CPSF6 binding mutant CA N74D is restricted in MDM due to induction of Type-I IFN (a) Replication of WT HIV-1 or CA mutant N74D in MDM. (b) IFN-\u03b2 levels in supernatants from (a). (c-d) Replication of HIV-1 CA N74D or WT HIV-1 with IFNAR2 or control antibody (cAb). (e) Replication of WT or WT plus CA N74D. Mean data and regression lines for biological replicates are shown in c-e. P values (2-way ANOVA) are given for (c-d) IFNAR2 blockade and (e) co-infection with CA mutant N74D. (f) Infection of MDM by HIV-1 measured at 48h (g) GAPDH normalized IP10 RNA levels expressed as fold change over untreated cells after infection with WT or HIV-1 mutants (Mean of 3 technical replicates \u00b1SEM, f-g).", "co_occurrence": [{"body": 104, "word": "HIV-1", "fig": 6}, {"body": 45, "word": "CA", "fig": 5}, {"body": 39, "word": "WT", "fig": 5}, {"body": 52, "word": "MDM", "fig": 3}, {"body": 28, "word": "N74D", "fig": 5}, {"body": 25, "word": "mutant", "fig": 3}, {"body": 45, "word": "infection", "fig": 1}, {"body": 36, "word": "cells", "fig": 1}, {"body": 35, "word": "CPSF6", "fig": 1}, {"body": 14, "word": "IFNAR2", "fig": 2}, {"body": 13, "word": "replicates", "fig": 2}, {"body": 25, "word": "IFN-\u03b2", "fig": 1}, {"body": 22, "word": "control", "fig": 1}, {"body": 11, "word": "levels", "fig": 2}, {"body": 20, "word": "antibody", "fig": 1}, {"body": 19, "word": "data", "fig": 1}, {"body": 16, "word": "IFN", "fig": 1}, {"body": 5, "word": "Replication", "fig": 3}, {"body": 15, "word": "mutants", "fig": 1}, {"body": 13, "word": "measured", "fig": 1}, {"body": 13, "word": "RNA", "fig": 1}, {"body": 12, "word": "b", "fig": 1}, {"body": 11, "word": "biological", "fig": 1}, {"body": 5, "word": "Mean", "fig": 2}, {"body": 5, "word": "e", "fig": 2}, {"body": 9, "word": "expressed", "fig": 1}, {"body": 8, "word": "shown", "fig": 1}, {"body": 8, "word": "fold", "fig": 1}, {"body": 8, "word": "lines", "fig": 1}, {"body": 6, "word": "induction", "fig": 1}, {"body": 6, "word": "normalized", "fig": 1}, {"body": 6, "word": "P", "fig": 1}, {"body": 6, "word": "g", "fig": 1}, {"body": 5, "word": "GAPDH", "fig": 1}, {"body": 5, "word": "Infection", "fig": 1}, {"body": 5, "word": "cAb", "fig": 1}, {"body": 5, "word": "IP10", "fig": 1}, {"body": 5, "word": "blockade", "fig": 1}, {"body": 5, "word": "f", "fig": 1}, {"body": 4, "word": "regression", "fig": 1}, {"body": 4, "word": "due", "fig": 1}, {"body": 4, "word": "values", "fig": 1}, {"body": 4, "word": "ANOVA", "fig": 1}, {"body": 4, "word": "change", "fig": 1}, {"body": 2, "word": "supernatants", "fig": 1}, {"body": 2, "word": "2-way", "fig": 1}, {"body": 2, "word": "technical", "fig": 1}, {"body": 1, "word": "48h", "fig": 1}, {"body": 1, "word": "binding", "fig": 1}, {"body": 1, "word": "\u00b1SEM", "fig": 1}, {"body": 1, "word": "untreated", "fig": 1}, {"body": 1, "word": "given", "fig": 1}, {"body": 1, "word": "plus", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928559/bin/emss-55145-f0002.jpg", "caption": "HIV-1 elicits a Type-1 IFN response that restricts replication in CPSF6 depleted MDM (a) Protocol schema. (b) CPSF6/actin detected at time of infection (c). HIV-1 replication in MDM expressing shRNA targeting CPSF6 or control shRNA (d) IFN-\u03b2 levels in supernatants from (c). (e-f) Infection of CPSF6 depleted or MDM expressing control shRNA with IFNAR2 or control antibody (cAb). P values (2-way ANOVA) are given for the effect of (e) CPSF6 depletion or (f) control shRNA on biological replicates. (g) IFN-\u03b2 produced from shRNA expressing MDM or IFN-\u03b2 treated MDM. (h) Infection of MDM by HIV-1 measured at 48h on CPSF6 depleted or control shRNA expressing MDM (Mean of 3 technical replicates \u00b1SEM).", "co_occurrence": [{"body": 52, "word": "MDM", "fig": 7}, {"body": 104, "word": "HIV-1", "fig": 3}, {"body": 35, "word": "CPSF6", "fig": 5}, {"body": 22, "word": "control", "fig": 5}, {"body": 15, "word": "shRNA", "fig": 6}, {"body": 25, "word": "IFN-\u03b2", "fig": 3}, {"body": 45, "word": "infection", "fig": 1}, {"body": 9, "word": "expressing", "fig": 4}, {"body": 17, "word": "replication", "fig": 2}, {"body": 13, "word": "replicates", "fig": 2}, {"body": 11, "word": "c", "fig": 2}, {"body": 20, "word": "antibody", "fig": 1}, {"body": 16, "word": "IFN", "fig": 1}, {"body": 5, "word": "depleted", "fig": 3}, {"body": 15, "word": "h", "fig": 1}, {"body": 15, "word": "time", "fig": 1}, {"body": 14, "word": "IFNAR2", "fig": 1}, {"body": 13, "word": "measured", "fig": 1}, {"body": 12, "word": "b", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 11, "word": "biological", "fig": 1}, {"body": 5, "word": "Infection", "fig": 2}, {"body": 10, "word": "depletion", "fig": 1}, {"body": 10, "word": "d", "fig": 1}, {"body": 6, "word": "effect", "fig": 1}, {"body": 6, "word": "g", "fig": 1}, {"body": 6, "word": "P", "fig": 1}, {"body": 6, "word": "detected", "fig": 1}, {"body": 5, "word": "Mean", "fig": 1}, {"body": 5, "word": "cAb", "fig": 1}, {"body": 5, "word": "e", "fig": 1}, {"body": 5, "word": "response", "fig": 1}, {"body": 5, "word": "f", "fig": 1}, {"body": 4, "word": "ANOVA", "fig": 1}, {"body": 4, "word": "values", "fig": 1}, {"body": 3, "word": "treated", "fig": 1}, {"body": 3, "word": "produced", "fig": 1}, {"body": 2, "word": "supernatants", "fig": 1}, {"body": 2, "word": "targeting", "fig": 1}, {"body": 2, "word": "2-way", "fig": 1}, {"body": 2, "word": "technical", "fig": 1}, {"body": 1, "word": "48h", "fig": 1}, {"body": 1, "word": "given", "fig": 1}, {"body": 1, "word": "\u00b1SEM", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928559/bin/emss-55145-f0003.jpg", "caption": "HIV-1 CypA binding mutant CA P90A is restricted in MDM due to induction of Type-I IFN (a) Replication of WT HIV-1 or CA mutant P90A in MDM. (b) IFN-\u03b2 levels in supernatants from (a). (c) Replication of HIV-1 CA P90A with IFNAR2 or control antibody (cAb). (d) as in Figure 1d. (e) Replication of WT or WT plus CA P90A. Mean data and regression lines are shown for biological replicates in c-e. P values (2-way ANOVA) are given for (c-d) IFNAR2 blockade and (e) co-infection with CA mutant P90A. (f) Infection of MDM by HIV-1 measured at 48h (g) GAPDH normalized IP10 RNA levels expressed as fold change over untreated cells after infection with WT or HIV-1 mutants (Mean of 3 technical replicates \u00b1SEM, f-g).", "co_occurrence": [{"body": 104, "word": "HIV-1", "fig": 5}, {"body": 45, "word": "CA", "fig": 5}, {"body": 39, "word": "WT", "fig": 4}, {"body": 52, "word": "MDM", "fig": 3}, {"body": 21, "word": "P90A", "fig": 5}, {"body": 25, "word": "mutant", "fig": 3}, {"body": 45, "word": "infection", "fig": 1}, {"body": 36, "word": "cells", "fig": 1}, {"body": 14, "word": "IFNAR2", "fig": 2}, {"body": 13, "word": "replicates", "fig": 2}, {"body": 25, "word": "IFN-\u03b2", "fig": 1}, {"body": 22, "word": "control", "fig": 1}, {"body": 11, "word": "levels", "fig": 2}, {"body": 20, "word": "antibody", "fig": 1}, {"body": 19, "word": "data", "fig": 1}, {"body": 16, "word": "IFN", "fig": 1}, {"body": 5, "word": "Replication", "fig": 3}, {"body": 15, "word": "mutants", "fig": 1}, {"body": 13, "word": "measured", "fig": 1}, {"body": 13, "word": "RNA", "fig": 1}, {"body": 12, "word": "CypA", "fig": 1}, {"body": 12, "word": "b", "fig": 1}, {"body": 11, "word": "c", "fig": 1}, {"body": 11, "word": "biological", "fig": 1}, {"body": 5, "word": "Mean", "fig": 2}, {"body": 5, "word": "e", "fig": 2}, {"body": 10, "word": "d", "fig": 1}, {"body": 9, "word": "expressed", "fig": 1}, {"body": 9, "word": "Figure", "fig": 1}, {"body": 8, "word": "shown", "fig": 1}, {"body": 8, "word": "fold", "fig": 1}, {"body": 8, "word": "lines", "fig": 1}, {"body": 6, "word": "g", "fig": 1}, {"body": 6, "word": "induction", "fig": 1}, {"body": 6, "word": "normalized", "fig": 1}, {"body": 6, "word": "P", "fig": 1}, {"body": 5, "word": "GAPDH", "fig": 1}, {"body": 5, "word": "Infection", "fig": 1}, {"body": 5, "word": "cAb", "fig": 1}, {"body": 5, "word": "IP10", "fig": 1}, {"body": 5, "word": "blockade", "fig": 1}, {"body": 5, "word": "f", "fig": 1}, {"body": 4, "word": "regression", "fig": 1}, {"body": 4, "word": "due", "fig": 1}, {"body": 4, "word": "values", "fig": 1}, {"body": 4, "word": "ANOVA", "fig": 1}, {"body": 4, "word": "change", "fig": 1}, {"body": 2, "word": "supernatants", "fig": 1}, {"body": 2, "word": "2-way", "fig": 1}, {"body": 2, "word": "technical", "fig": 1}, {"body": 1, "word": "48h", "fig": 1}, {"body": 1, "word": "binding", "fig": 1}, {"body": 1, "word": "\u00b1SEM", "fig": 1}, {"body": 1, "word": "untreated", "fig": 1}, {"body": 1, "word": "given", "fig": 1}, {"body": 1, "word": "plus", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928559/bin/emss-55145-f0004.jpg", "caption": "NF\u03baB/IRF3 are activated by mutant HIV-1 and SmBz-CsA treatment causes WT HIV-1 to trigger innate responses (a, b) Mean (\u00b1SEM) nuclear:cytoplasmic ratios for NF\u03baB or IRF3 in infected MDM (p<0.05, 2-way ANOVA). (c) Infection at 48h \u00b1IKK inhibitor. (d, e) SmBz-CsA (green) complexed with CypA (gray), Cs (yellow) and calcineurin (orange/blue). (f) Replication of HIV-1 in MDM \u00b1SmBz-CsA (g) IFN-\u03b2 levels from (f). (h) MDM infected with WT HIV-1 plus SmBz-CsA and IFNAR2 antibody or cAb (mean data and regression lines). P value (2-way ANOVA) is given for IFNAR2 blockade of biological replicates. (i) Infection of MDM by WT HIV-1 \u00b1SmBz-CsA at 48h (Mean of 3 technical replicates \u00b1SEM).", "co_occurrence": [{"body": 104, "word": "HIV-1", "fig": 5}, {"body": 52, "word": "MDM", "fig": 4}, {"body": 39, "word": "WT", "fig": 3}, {"body": 35, "word": "infected", "fig": 2}, {"body": 10, "word": "SmBz-CsA", "fig": 3}, {"body": 14, "word": "IFNAR2", "fig": 2}, {"body": 13, "word": "replicates", "fig": 2}, {"body": 25, "word": "mutant", "fig": 1}, {"body": 25, "word": "IFN-\u03b2", "fig": 1}, {"body": 21, "word": "innate", "fig": 1}, {"body": 20, "word": "antibody", "fig": 1}, {"body": 19, "word": "data", "fig": 1}, {"body": 17, "word": "nuclear", "fig": 1}, {"body": 15, "word": "h", "fig": 1}, {"body": 12, "word": "CypA", "fig": 1}, {"body": 12, "word": "b", "fig": 1}, {"body": 11, "word": "levels", "fig": 1}, {"body": 11, "word": "c", "fig": 1}, {"body": 11, "word": "biological", "fig": 1}, {"body": 10, "word": "d", "fig": 1}, {"body": 5, "word": "Infection", "fig": 2}, {"body": 5, "word": "Mean", "fig": 2}, {"body": 5, "word": "f", "fig": 2}, {"body": 4, "word": "ANOVA", "fig": 2}, {"body": 8, "word": "IRF3", "fig": 1}, {"body": 8, "word": "lines", "fig": 1}, {"body": 6, "word": "trigger", "fig": 1}, {"body": 6, "word": "mean", "fig": 1}, {"body": 6, "word": "responses", "fig": 1}, {"body": 6, "word": "P", "fig": 1}, {"body": 6, "word": "g", "fig": 1}, {"body": 5, "word": "cAb", "fig": 1}, {"body": 5, "word": "blockade", "fig": 1}, {"body": 5, "word": "e", "fig": 1}, {"body": 5, "word": "Replication", "fig": 1}, {"body": 4, "word": "regression", "fig": 1}, {"body": 2, "word": "2-way", "fig": 2}, {"body": 4, "word": "cytoplasmic", "fig": 1}, {"body": 3, "word": "activated", "fig": 1}, {"body": 3, "word": "treatment", "fig": 1}, {"body": 3, "word": "Cs", "fig": 1}, {"body": 3, "word": "inhibitor", "fig": 1}, {"body": 2, "word": "technical", "fig": 1}, {"body": 1, "word": "48h", "fig": 2}, {"body": 1, "word": "\u00b1SEM", "fig": 2}, {"body": 2, "word": "ratios", "fig": 1}, {"body": 2, "word": "green", "fig": 1}, {"body": 2, "word": "NF\u03baB", "fig": 1}, {"body": 1, "word": "given", "fig": 1}, {"body": 1, "word": "plus", "fig": 1}, {"body": 1, "word": "calcineurin", "fig": 1}]}], "3517545": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517545/bin/pone.0050557.g001.jpg", "caption": "Subcellular localization of alpha arrestins. Vasopressin receptor 2 HA-V2R-V5-stably transfected HEK293T cells were transiently transfected with expression constructs of alpha arrestins with C-terminal fusions of fluorescent protein mCherry. Unstimulated or 1 uM arginine vasopressin (AVP)-stimulated (15 m) cells were fixed, and epifluorescence images were captured using an AxioVision confocal microscope.", "co_occurrence": [{"body": 53, "word": "cells", "fig": 2}, {"body": 17, "word": "arrestins", "fig": 2}, {"body": 13, "word": "alpha", "fig": 2}, {"body": 25, "word": "receptor", "fig": 1}, {"body": 24, "word": "m", "fig": 1}, {"body": 23, "word": "protein", "fig": 1}, {"body": 21, "word": "expression", "fig": 1}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 14, "word": "localization", "fig": 1}, {"body": 13, "word": "transiently", "fig": 1}, {"body": 11, "word": "uM", "fig": 1}, {"body": 11, "word": "using", "fig": 1}, {"body": 7, "word": "AVP", "fig": 1}, {"body": 7, "word": "fluorescent", "fig": 1}, {"body": 6, "word": "C-terminal", "fig": 1}, {"body": 5, "word": "constructs", "fig": 1}, {"body": 4, "word": "mCherry", "fig": 1}, {"body": 4, "word": "HEK293T", "fig": 1}, {"body": 4, "word": "confocal", "fig": 1}, {"body": 2, "word": "vasopressin", "fig": 1}, {"body": 1, "word": "Subcellular", "fig": 1}, {"body": 1, "word": "fusions", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "AxioVision", "fig": 1}, {"body": 1, "word": "Unstimulated", "fig": 1}, {"body": 1, "word": "arginine", "fig": 1}, {"body": 1, "word": "Vasopressin", "fig": 1}, {"body": 1, "word": "fixed", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517545/bin/pone.0050557.g002.jpg", "caption": "Subcellular colocalization and coIP of alpha arrestins with activated GPCR, clathrin, and endosome markers. (A) Subcellular colocalization of alpha-arrestin-mCherry in receptor HA-b2AR permanent cell lines. HEK-293T cells stably expressing HA-b2AR were transiently cotransfected with ARRDC3-mCherry construct. 24 h after transfection, cells were serum-starved for 2 h, treated or not with 1 uM isoproterenol (Iso) ligand for 30 m, and then washed, and fixed and permeabilized. HA-b2AR was stained with rabbit anti-HA antibodies followed by incubation with Alexa Fluor 488-conjugated goat anti-rabbit secondary antibody. Epifluorescence images were captured using AxioVision or Zeiss 510 META confocal microscope (receptor, green; aArr, red). (B) Co-immunoprecipitation of aArr ARRDC3 with b2AR, clathrin and Hrs. HEK-293T cells were transiently cotransfected with HA-b2AR-V5 plus either empty vector, pBSR-ARRDC3-GFP, or pBSR-ARRDC3 PY motif mutant construct respectively. After 24 h incubation, cells were serum-starved for 2 h and treated or not with 1 uM Iso for 30 m. The cells were lysed, and lysates were immunoprecipitated (IP) and analyzed by western blot (WB). (C) Co-immunoprecipitation of aArr ARRDC4 with V2R, clathrin, and Hrs. HEK-293T cells were transiently cotransfected with HA-V2R-V5 plus either empty vector, pcDNA3-ARRDC4-Flag, or pcDNA3-ARRDC4 PY motif mutant construct respectively. After 24 h incubation, cells were serum-starved for 2 h and treated or not with 1 uM AVP for 30 m. The cells were lysed, the lysates were immunoprecipitated (IP), and analyzed as above. (D, E) Histograms of B and C from three independent experiments including the mean (+/\u2212 S.D.) and p-values calculated by paired, two-tailed t-tests on signal from untreated and ligand-treated samples versus their respective vector control are denoted by thin lines and treated vs. untreated samples are denoted by bold lines (***, p<0.001; **, p<0.01; *p<0.05). (F) Subcellular colocalization of alpha-arrestin-mCherry with early (Rab5) and late (Rab7) endosomal markers in HA-V2R-V5 permanent cells. HA-V2R-V5 permanent cells were transiently co-transfected with ARRDC3- or ARRDC4-mCherry construct with Rab5- or Rab7-GFP construct. After 24 h, transfected cells were serum-starved, treated or not with 1 uM AVP for 30 m, and fixed with 4% paraformaldehyde. Epifluorescence images were captured using AxioVision confocal microscope (aArr, red; Rab, green).", "co_occurrence": [{"body": 53, "word": "cells", "fig": 11}, {"body": 67, "word": "aArr", "fig": 4}, {"body": 60, "word": "PY", "fig": 2}, {"body": 8, "word": "h", "fig": 7}, {"body": 13, "word": "transiently", "fig": 4}, {"body": 26, "word": "The", "fig": 2}, {"body": 50, "word": "ARRDC3", "fig": 1}, {"body": 25, "word": "receptor", "fig": 2}, {"body": 24, "word": "m", "fig": 2}, {"body": 11, "word": "uM", "fig": 4}, {"body": 13, "word": "colocalization", "fig": 3}, {"body": 13, "word": "vector", "fig": 3}, {"body": 16, "word": "IP", "fig": 2}, {"body": 30, "word": "b2AR", "fig": 1}, {"body": 13, "word": "plus", "fig": 2}, {"body": 26, "word": "coIP", "fig": 1}, {"body": 13, "word": "mutant", "fig": 2}, {"body": 5, "word": "treated", "fig": 5}, {"body": 11, "word": "using", "fig": 2}, {"body": 11, "word": "respectively", "fig": 2}, {"body": 22, "word": "V2R", "fig": 1}, {"body": 21, "word": "ligand", "fig": 1}, {"body": 5, "word": "serum-starved", "fig": 4}, {"body": 19, "word": "activated", "fig": 1}, {"body": 19, "word": "ARRDC4", "fig": 1}, {"body": 17, "word": "arrestins", "fig": 1}, {"body": 17, "word": "cell", "fig": 1}, {"body": 8, "word": "m.", "fig": 2}, {"body": 5, "word": "HEK-293T", "fig": 3}, {"body": 3, "word": "construct", "fig": 5}, {"body": 15, "word": "western", "fig": 1}, {"body": 5, "word": "After", "fig": 3}, {"body": 5, "word": "cotransfected", "fig": 3}, {"body": 7, "word": "either", "fig": 2}, {"body": 7, "word": "AVP", "fig": 2}, {"body": 13, "word": "alpha", "fig": 1}, {"body": 4, "word": "incubation", "fig": 3}, {"body": 6, "word": "motif", "fig": 2}, {"body": 11, "word": "including", "fig": 1}, {"body": 11, "word": "co-transfected", "fig": 1}, {"body": 5, "word": "empty", "fig": 2}, {"body": 3, "word": "HA-V2R-V5", "fig": 3}, {"body": 3, "word": "clathrin", "fig": 3}, {"body": 3, "word": "lines", "fig": 3}, {"body": 4, "word": "C", "fig": 2}, {"body": 4, "word": "confocal", "fig": 2}, {"body": 8, "word": "transfected", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 3, "word": "Hrs", "fig": 2}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 6, "word": "followed", "fig": 1}, {"body": 3, "word": "p", "fig": 2}, {"body": 2, "word": "HA-b2AR", "fig": 3}, {"body": 3, "word": "analyzed", "fig": 2}, {"body": 3, "word": "B", "fig": 2}, {"body": 3, "word": "lysed", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 3, "word": "Iso", "fig": 2}, {"body": 2, "word": "markers", "fig": 2}, {"body": 2, "word": "red", "fig": 2}, {"body": 2, "word": "immunoprecipitated", "fig": 2}, {"body": 2, "word": "lysates", "fig": 2}, {"body": 4, "word": "early", "fig": 1}, {"body": 3, "word": "antibody", "fig": 1}, {"body": 1, "word": "Subcellular", "fig": 3}, {"body": 1, "word": "permanent", "fig": 3}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "HA-b2AR-V5", "fig": 1}, {"body": 3, "word": "transfection", "fig": 1}, {"body": 2, "word": "WB", "fig": 1}, {"body": 1, "word": "AxioVision", "fig": 2}, {"body": 2, "word": "secondary", "fig": 1}, {"body": 2, "word": "anti-rabbit", "fig": 1}, {"body": 1, "word": "fixed", "fig": 2}, {"body": 2, "word": "signal", "fig": 1}, {"body": 2, "word": "endosome", "fig": 1}, {"body": 1, "word": "images", "fig": 2}, {"body": 2, "word": "expressing", "fig": 1}, {"body": 2, "word": "ARRDC4-mCherry", "fig": 1}, {"body": 2, "word": "ARRDC3-", "fig": 1}, {"body": 2, "word": "late", "fig": 1}, {"body": 2, "word": "pcDNA3-ARRDC4-Flag", "fig": 1}, {"body": 2, "word": "endosomal", "fig": 1}, {"body": 2, "word": "thin", "fig": 1}, {"body": 2, "word": "isoproterenol", "fig": 1}, {"body": 1, "word": "green", "fig": 2}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "pBSR-ARRDC3", "fig": 1}, {"body": 1, "word": "t-tests", "fig": 1}, {"body": 1, "word": "Zeiss", "fig": 1}, {"body": 1, "word": "paraformaldehyde", "fig": 1}, {"body": 1, "word": "Rab5-", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "META", "fig": 1}, {"body": 1, "word": "washed", "fig": 1}, {"body": 1, "word": "Rab5", "fig": 1}, {"body": 1, "word": "Rab7", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "pBSR-ARRDC3-GFP", "fig": 1}, {"body": 1, "word": "permeabilized", "fig": 1}, {"body": 1, "word": "p-values", "fig": 1}, {"body": 1, "word": "S.D", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "paired", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "respective", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "pcDNA3-ARRDC4", "fig": 1}, {"body": 1, "word": "antibodies", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517545/bin/pone.0050557.g003.jpg", "caption": "Time course analysis of ligand-stimulated aArrs. (A) HEK-293T cells were transiently cotransfected with HA-b2AR-V5 plus pBSR-ARRDC3-Flag, or HA-V2R-V5 plus pcDNA3-ARRDC4-Flag respectively. After 24 h incubation, cells were serum-starved and treated with 1 uM Iso or AVP for 1, 5, 15, 30, and 60 m. The cells were lysed, and lysates were immunoprecipitated (IP) and analyzed by western blot (WB). Note ARRDC4-Flag protein appears as two bands; we believe this is also the case for ARRDC4-mCherry (Fig. 2C), but that is less evident due to the large size of the fusion protein. The basis of this is not yet determined. (B, C) The histogram of A with mean (+/\u2212 S.D.) and p-values calculated by comparing levels of ligand-treated samples with respective vector controls (paired, two-tailed t-tests from three independent experiments; ***, p<0.001; **, p<0.01; *p<0.05).", "co_occurrence": [{"body": 53, "word": "cells", "fig": 3}, {"body": 26, "word": "The", "fig": 3}, {"body": 65, "word": "aArrs", "fig": 1}, {"body": 46, "word": "Fig", "fig": 1}, {"body": 23, "word": "protein", "fig": 2}, {"body": 13, "word": "plus", "fig": 2}, {"body": 26, "word": "two", "fig": 1}, {"body": 24, "word": "also", "fig": 1}, {"body": 24, "word": "levels", "fig": 1}, {"body": 16, "word": "IP", "fig": 1}, {"body": 15, "word": "western", "fig": 1}, {"body": 15, "word": "analysis", "fig": 1}, {"body": 13, "word": "vector", "fig": 1}, {"body": 13, "word": "transiently", "fig": 1}, {"body": 6, "word": "A", "fig": 2}, {"body": 11, "word": "respectively", "fig": 1}, {"body": 11, "word": "uM", "fig": 1}, {"body": 9, "word": "course", "fig": 1}, {"body": 8, "word": "h", "fig": 1}, {"body": 8, "word": "m.", "fig": 1}, {"body": 7, "word": "AVP", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 3, "word": "p", "fig": 2}, {"body": 5, "word": "HEK-293T", "fig": 1}, {"body": 5, "word": "serum-starved", "fig": 1}, {"body": 5, "word": "ligand-stimulated", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 5, "word": "After", "fig": 1}, {"body": 5, "word": "cotransfected", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 4, "word": "bands", "fig": 1}, {"body": 4, "word": "C", "fig": 1}, {"body": 4, "word": "size", "fig": 1}, {"body": 4, "word": "incubation", "fig": 1}, {"body": 3, "word": "HA-V2R-V5", "fig": 1}, {"body": 3, "word": "HA-b2AR-V5", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "due", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "determined", "fig": 1}, {"body": 3, "word": "lysed", "fig": 1}, {"body": 3, "word": "pBSR-ARRDC3-Flag", "fig": 1}, {"body": 3, "word": "Iso", "fig": 1}, {"body": 2, "word": "WB", "fig": 1}, {"body": 2, "word": "immunoprecipitated", "fig": 1}, {"body": 2, "word": "ARRDC4-mCherry", "fig": 1}, {"body": 2, "word": "lysates", "fig": 1}, {"body": 2, "word": "pcDNA3-ARRDC4-Flag", "fig": 1}, {"body": 1, "word": "yet", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "t-tests", "fig": 1}, {"body": 1, "word": "fusion", "fig": 1}, {"body": 1, "word": "Note", "fig": 1}, {"body": 1, "word": "large", "fig": 1}, {"body": 1, "word": "mean", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "appears", "fig": 1}, {"body": 1, "word": "p-values", "fig": 1}, {"body": 1, "word": "S.D", "fig": 1}, {"body": 1, "word": "Time", "fig": 1}, {"body": 1, "word": "case", "fig": 1}, {"body": 1, "word": "paired", "fig": 1}, {"body": 1, "word": "*p", "fig": 1}, {"body": 1, "word": "respective", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517545/bin/pone.0050557.g004.jpg", "caption": "Recruitment and activation of Nedd4 E3 ligases by alpha arrestins. (A) Interactions of PY motif-containing alpha arrestin tails and WW region fragments demonstrated by yeast two-hybrid analysis. Bait plasmid (pDEST32-ARRDC1 or -ARRDC3) which contain two sets of PY motifs and prey plasmid (pDEST22-ITCH, -WWP2, -SAV1, -PLEKHA5, -Nedd4L, or -MAGI-2) which contain 1\u20134 sets of WW domains were transformed into competent yeast strain MaV203. pEXP32/Krev1 plus pEXP22/RalGDS-wt was included as strong positive control, pEXP32/Krev1 plus pEXP22/RALGDS-m1 weak positive control, pEXP32/Krev1 plus pEXP22/RALGDS-m2 and empty bait vector pDEST32 plus empty prey vector pDEST22 negative controls. Positive clones growing on SD/-Trp/-Leu/-His/-Ura plates are selected and the activity of lacZ reporter gene is examined with colony-lift filter assay by X-gal. (B) Subcellular colocalization of alpha-arrestin-mCherry and Nedd4 in HA-b2AR permanent cell lines. HA-b2AR permanent cells were transiently co-transfected with ARRDC3 -mCherry and pBJ-Nedd4-myc constructs. After 24 h, transfected cells were serum-starved, treated with 1 uM Iso for 30 m, and fixed. Nedd4 was stained with mouse monoclonal anti-myc antibody followed by incubation with Alexa Fluor 488-conjugated goat anti-mouse second antibody. Confocal epifluorescence images were obtained (aArr, red; Nedd4, green). (C) Co-immunoprecipitation of alpha arestin ARRDC3 and Nedd4 family E3 ubiquitin ligases with overexpressed b2AR. Empty vector, pBSR-ARRDC3-Flag, or pBSR-ARRDC3-Flag PY motif mutant construct was cotransfected respectively with pcDNA3-HA-b2AR-V5. After 24 h incubation, cells were serum-starved and treated or not with 1 uM Iso for 5 m. The transfected cells were lysed, lysates were immunoprecipitated (IP), and analyzed by western blot (WB). (D) Co-immunoprecipitation of aArr ARRDC4 and Nedd4 family E3 ubiquitin ligases with overexpressed V2R, unstimulated or 5 m post 1 uM AVP stimulation. (E, F) Histograms of C and D from three different experiments; p-values were calculated by comparing levels of ligand-treated or non-treated samples with their respective vector control (p value levels and thin/bold lines used as in Fig. 2).", "co_occurrence": [{"body": 53, "word": "cells", "fig": 4}, {"body": 60, "word": "PY", "fig": 3}, {"body": 30, "word": "Nedd4", "fig": 6}, {"body": 67, "word": "aArr", "fig": 2}, {"body": 50, "word": "ARRDC3", "fig": 2}, {"body": 21, "word": "E3", "fig": 3}, {"body": 27, "word": "WW", "fig": 2}, {"body": 27, "word": "family", "fig": 2}, {"body": 13, "word": "vector", "fig": 4}, {"body": 13, "word": "plus", "fig": 4}, {"body": 24, "word": "m", "fig": 2}, {"body": 24, "word": "levels", "fig": 2}, {"body": 46, "word": "Fig", "fig": 1}, {"body": 22, "word": "ubiquitin", "fig": 2}, {"body": 13, "word": "alpha", "fig": 3}, {"body": 33, "word": "motifs", "fig": 1}, {"body": 11, "word": "uM", "fig": 3}, {"body": 30, "word": "b2AR", "fig": 1}, {"body": 26, "word": "two", "fig": 1}, {"body": 26, "word": "The", "fig": 1}, {"body": 23, "word": "domains", "fig": 1}, {"body": 11, "word": "yeast", "fig": 2}, {"body": 22, "word": "V2R", "fig": 1}, {"body": 22, "word": "arrestin", "fig": 1}, {"body": 7, "word": "control", "fig": 3}, {"body": 19, "word": "ARRDC4", "fig": 1}, {"body": 6, "word": "ligases", "fig": 3}, {"body": 17, "word": "arrestins", "fig": 1}, {"body": 17, "word": "activation", "fig": 1}, {"body": 17, "word": "cell", "fig": 1}, {"body": 17, "word": "gene", "fig": 1}, {"body": 8, "word": "h", "fig": 2}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 16, "word": "IP", "fig": 1}, {"body": 15, "word": "western", "fig": 1}, {"body": 15, "word": "analysis", "fig": 1}, {"body": 7, "word": "overexpressed", "fig": 2}, {"body": 7, "word": "positive", "fig": 2}, {"body": 13, "word": "colocalization", "fig": 1}, {"body": 13, "word": "transiently", "fig": 1}, {"body": 13, "word": "mutant", "fig": 1}, {"body": 11, "word": "respectively", "fig": 1}, {"body": 11, "word": "co-transfected", "fig": 1}, {"body": 11, "word": "mouse", "fig": 1}, {"body": 11, "word": "used", "fig": 1}, {"body": 5, "word": "serum-starved", "fig": 2}, {"body": 5, "word": "empty", "fig": 2}, {"body": 5, "word": "treated", "fig": 2}, {"body": 5, "word": "After", "fig": 2}, {"body": 9, "word": "stimulation", "fig": 1}, {"body": 4, "word": "C", "fig": 2}, {"body": 8, "word": "m.", "fig": 1}, {"body": 4, "word": "incubation", "fig": 2}, {"body": 8, "word": "unstimulated", "fig": 1}, {"body": 7, "word": "assay", "fig": 1}, {"body": 7, "word": "three", "fig": 1}, {"body": 7, "word": "AVP", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 6, "word": "followed", "fig": 1}, {"body": 3, "word": "D", "fig": 2}, {"body": 6, "word": "tails", "fig": 1}, {"body": 6, "word": "strong", "fig": 1}, {"body": 3, "word": "antibody", "fig": 2}, {"body": 3, "word": "prey", "fig": 2}, {"body": 6, "word": "motif", "fig": 1}, {"body": 6, "word": "strain", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 3, "word": "pBSR-ARRDC3-Flag", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 3, "word": "Iso", "fig": 2}, {"body": 3, "word": "lines", "fig": 2}, {"body": 5, "word": "constructs", "fig": 1}, {"body": 5, "word": "cotransfected", "fig": 1}, {"body": 4, "word": "controls", "fig": 1}, {"body": 4, "word": "fragments", "fig": 1}, {"body": 2, "word": "HA-b2AR", "fig": 2}, {"body": 4, "word": "post", "fig": 1}, {"body": 3, "word": "p", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "negative", "fig": 1}, {"body": 3, "word": "construct", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "lysed", "fig": 1}, {"body": 3, "word": "included", "fig": 1}, {"body": 2, "word": "bait", "fig": 1}, {"body": 2, "word": "WB", "fig": 1}, {"body": 1, "word": "permanent", "fig": 2}, {"body": 2, "word": "transformed", "fig": 1}, {"body": 2, "word": "anti-mouse", "fig": 1}, {"body": 2, "word": "selected", "fig": 1}, {"body": 1, "word": "contain", "fig": 2}, {"body": 2, "word": "immunoprecipitated", "fig": 1}, {"body": 2, "word": "lysates", "fig": 1}, {"body": 2, "word": "two-hybrid", "fig": 1}, {"body": 2, "word": "red", "fig": 1}, {"body": 2, "word": "clones", "fig": 1}, {"body": 1, "word": "plasmid", "fig": 2}, {"body": 2, "word": "examined", "fig": 1}, {"body": 2, "word": "pDEST22", "fig": 1}, {"body": 2, "word": "pDEST32", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "MaV203", "fig": 1}, {"body": 1, "word": "lacZ", "fig": 1}, {"body": 1, "word": "demonstrated", "fig": 1}, {"body": 1, "word": "SD/-Trp/-Leu/-His/-Ura", "fig": 1}, {"body": 1, "word": "activity", "fig": 1}, {"body": 1, "word": "fixed", "fig": 1}, {"body": 1, "word": "second", "fig": 1}, {"body": 1, "word": "images", "fig": 1}, {"body": 1, "word": "weak", "fig": 1}, {"body": 1, "word": "competent", "fig": 1}, {"body": 1, "word": "filter", "fig": 1}, {"body": 1, "word": "Subcellular", "fig": 1}, {"body": 1, "word": "p-values", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "reporter", "fig": 1}, {"body": 1, "word": "growing", "fig": 1}, {"body": 1, "word": "Positive", "fig": 1}, {"body": 1, "word": "respective", "fig": 1}, {"body": 1, "word": "colony-lift", "fig": 1}, {"body": 1, "word": "plates", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517545/bin/pone.0050557.g005.jpg", "caption": "Biology of alpha arrestins. (A) Ubiquitination effect of alpha arrestins on GPCR. Empty vector, pBSR-ARRDC3-Flag, or pBSR-ARRDC3-Flag PY motif mutant construct was cotransfected with pcDNA3-HA-b2AR-V5. After 24 h incubation, cells were serum-starved for 2 h and treated or not with 1 uM Iso for 30 m. The transfected cells were lysed, and lysates were immunoprecipitated (IP) and analyzed by western blot (WB). The same experiment was performed with ARRDC4 and V2R (1 uM AVP treatment for 30 m). (B) The mean values (+/\u2212 S.D.) of three independent experiments are included in the histogram (p value levels and lines used as in Fig. 2). (C.) Effects of siRNA-mediated ADDRC3 knockdown on b2AR ubiquitination and ITCH expression. Scrambled siRNA, and ARRDC3 siRNAs #1 and #2 were cotransfected with HA-b2AR-V5 construct. After 48 h incubation, cells were serum-starved for 2 h and treated with 1 uM Isoproterenol Iso for 30 m. The transfected cells were lysed, and the lysates were immunoprecipitated (IP) and analyzed by western blot (WB). (D) Histograms of mean (+/\u2212 S.D.) and p-values calculated from three different experiments by paired, two-tailed t-tests comparing ligand-stimulated cells transfected with ARRDC3 siRNA versus with control siRNA (p value levels used as in Fig. 2).", "co_occurrence": [{"body": 53, "word": "cells", "fig": 5}, {"body": 26, "word": "The", "fig": 4}, {"body": 50, "word": "ARRDC3", "fig": 2}, {"body": 46, "word": "Fig", "fig": 2}, {"body": 60, "word": "PY", "fig": 1}, {"body": 24, "word": "levels", "fig": 2}, {"body": 40, "word": "ubiquitination", "fig": 1}, {"body": 17, "word": "arrestins", "fig": 2}, {"body": 11, "word": "uM", "fig": 3}, {"body": 8, "word": "h", "fig": 4}, {"body": 16, "word": "IP", "fig": 2}, {"body": 30, "word": "b2AR", "fig": 1}, {"body": 15, "word": "western", "fig": 2}, {"body": 13, "word": "alpha", "fig": 2}, {"body": 8, "word": "transfected", "fig": 3}, {"body": 24, "word": "m", "fig": 1}, {"body": 22, "word": "V2R", "fig": 1}, {"body": 11, "word": "used", "fig": 2}, {"body": 21, "word": "expression", "fig": 1}, {"body": 19, "word": "ARRDC4", "fig": 1}, {"body": 8, "word": "m.", "fig": 2}, {"body": 7, "word": "three", "fig": 2}, {"body": 13, "word": "vector", "fig": 1}, {"body": 13, "word": "mutant", "fig": 1}, {"body": 6, "word": "experiments", "fig": 2}, {"body": 5, "word": "serum-starved", "fig": 2}, {"body": 5, "word": "treated", "fig": 2}, {"body": 5, "word": "After", "fig": 2}, {"body": 5, "word": "cotransfected", "fig": 2}, {"body": 9, "word": "ITCH", "fig": 1}, {"body": 3, "word": "siRNA", "fig": 3}, {"body": 4, "word": "incubation", "fig": 2}, {"body": 7, "word": "AVP", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 3, "word": "p", "fig": 2}, {"body": 3, "word": "analyzed", "fig": 2}, {"body": 3, "word": "construct", "fig": 2}, {"body": 6, "word": "motif", "fig": 1}, {"body": 6, "word": "performed", "fig": 1}, {"body": 3, "word": "lysed", "fig": 2}, {"body": 6, "word": "different", "fig": 1}, {"body": 3, "word": "pBSR-ARRDC3-Flag", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 3, "word": "Iso", "fig": 2}, {"body": 5, "word": "ligand-stimulated", "fig": 1}, {"body": 5, "word": "knockdown", "fig": 1}, {"body": 5, "word": "effect", "fig": 1}, {"body": 2, "word": "WB", "fig": 2}, {"body": 2, "word": "immunoprecipitated", "fig": 2}, {"body": 2, "word": "lysates", "fig": 2}, {"body": 3, "word": "HA-b2AR-V5", "fig": 1}, {"body": 3, "word": "included", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "lines", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 1, "word": "blot", "fig": 2}, {"body": 1, "word": "mean", "fig": 2}, {"body": 2, "word": "C.", "fig": 1}, {"body": 2, "word": "treatment", "fig": 1}, {"body": 1, "word": "S.D", "fig": 2}, {"body": 1, "word": "Effects", "fig": 1}, {"body": 1, "word": "t-tests", "fig": 1}, {"body": 1, "word": "Isoproterenol", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "p-values", "fig": 1}, {"body": 1, "word": "paired", "fig": 1}, {"body": 1, "word": "siRNAs", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517545/bin/pone.0050557.g006.jpg", "caption": "Hetero-association of alpha and beta arrestins. (A) Subcellular colocalization of alpha and beta arrestins in HA-b2AR and HA-V2R-V5 permanent cell lines. HA-b2AR and HA-V2R-V5 permanent cells were transiently co-transfected with either ARRDC3- or ARRDC4-mCherry construct plus pArrb2-EGFP. After 24 h, transfected cells were serum-starved for 2 h, treated or not with 1 uM ligand for 30 m, and then washed and fixed with 4% paraformaldehyde. Fluorescent confocal images were captured (aArr, red; ARRB2, green). (B) Subcellular colocalization of mutant alpha- and beta-arrestin in ligand treated V2R permanent cell line. HA-V2R-V5 permanent cells were transiently co-transfected with either ARRDC3- or ARRDC4-mCherry PY mutant construct plus pArrb2-EGFP. After 24 h, transfected cells were serum-starved for 2 h, treated with 1 uM AMP for 30 m, and then washed and fixed. Fluorescent confocal images were captured (aArr, red; ARRB2, green). (C) Co-immunoprecipitation of wild type aArrs and bArrs. HEK-293Tcells were co-transfected either with empty vector, or pBSR-ARRDC3-Flag, or pcDNA3-ARRDC4-Flag plus pcDNA3-HA-b2AR or pcDND3-HA-V2R-V5. After 24 h incubation, cells were serum-starved and treated or not with 1 uM ligand for 5 m. The cells were lysed, and lysates were immunoprecipitated and analyzed by western blot. (D) Co-immunoprecipitation of wild type or mutant aArrs and bArrs. HEK-293T cells were co-transfected either with empty vector, pBSR-ARRDC3-Flag, or pBSR-ARRDC3-Flag PY mutant, plus pcDNA3-HA-b2AR. Protein levels of ARRB1/2 and aArrs were detected by western blot. (E) The same concept as in D was done with ARRDC4 plus HA-V2R-V5. P-values were calculated by paired, two-tailed t-tests (p values and thin/bold lines used as in Fig. 2).", "co_occurrence": [{"body": 53, "word": "cells", "fig": 7}, {"body": 65, "word": "aArrs", "fig": 3}, {"body": 67, "word": "aArr", "fig": 2}, {"body": 60, "word": "PY", "fig": 2}, {"body": 33, "word": "bArrs", "fig": 2}, {"body": 13, "word": "plus", "fig": 5}, {"body": 21, "word": "ligand", "fig": 3}, {"body": 13, "word": "mutant", "fig": 4}, {"body": 26, "word": "The", "fig": 2}, {"body": 24, "word": "m", "fig": 2}, {"body": 46, "word": "Fig", "fig": 1}, {"body": 11, "word": "co-transfected", "fig": 4}, {"body": 8, "word": "h", "fig": 5}, {"body": 17, "word": "arrestins", "fig": 2}, {"body": 17, "word": "cell", "fig": 2}, {"body": 11, "word": "uM", "fig": 3}, {"body": 15, "word": "western", "fig": 2}, {"body": 7, "word": "either", "fig": 4}, {"body": 13, "word": "colocalization", "fig": 2}, {"body": 13, "word": "vector", "fig": 2}, {"body": 13, "word": "ARRB2", "fig": 2}, {"body": 13, "word": "transiently", "fig": 2}, {"body": 13, "word": "alpha", "fig": 2}, {"body": 24, "word": "levels", "fig": 1}, {"body": 22, "word": "V2R", "fig": 1}, {"body": 5, "word": "treated", "fig": 4}, {"body": 19, "word": "ARRDC4", "fig": 1}, {"body": 8, "word": "transfected", "fig": 2}, {"body": 5, "word": "serum-starved", "fig": 3}, {"body": 5, "word": "After", "fig": 3}, {"body": 7, "word": "beta", "fig": 2}, {"body": 3, "word": "HA-V2R-V5", "fig": 4}, {"body": 11, "word": "used", "fig": 1}, {"body": 5, "word": "empty", "fig": 2}, {"body": 3, "word": "pBSR-ARRDC3-Flag", "fig": 3}, {"body": 4, "word": "confocal", "fig": 2}, {"body": 8, "word": "m.", "fig": 1}, {"body": 4, "word": "type", "fig": 2}, {"body": 4, "word": "wild", "fig": 2}, {"body": 6, "word": "detected", "fig": 1}, {"body": 3, "word": "D", "fig": 2}, {"body": 3, "word": "construct", "fig": 2}, {"body": 3, "word": "lines", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "HEK-293T", "fig": 1}, {"body": 5, "word": "Protein", "fig": 1}, {"body": 1, "word": "permanent", "fig": 4}, {"body": 2, "word": "red", "fig": 2}, {"body": 2, "word": "HA-b2AR", "fig": 2}, {"body": 4, "word": "C", "fig": 1}, {"body": 2, "word": "ARRDC4-mCherry", "fig": 2}, {"body": 2, "word": "ARRDC3-", "fig": 2}, {"body": 4, "word": "incubation", "fig": 1}, {"body": 4, "word": "line", "fig": 1}, {"body": 4, "word": "ARRB1/2", "fig": 1}, {"body": 3, "word": "p", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 3, "word": "B", "fig": 1}, {"body": 3, "word": "lysed", "fig": 1}, {"body": 1, "word": "blot", "fig": 2}, {"body": 1, "word": "fixed", "fig": 2}, {"body": 1, "word": "images", "fig": 2}, {"body": 1, "word": "washed", "fig": 2}, {"body": 2, "word": "immunoprecipitated", "fig": 1}, {"body": 2, "word": "lysates", "fig": 1}, {"body": 1, "word": "Subcellular", "fig": 2}, {"body": 2, "word": "pcDNA3-ARRDC4-Flag", "fig": 1}, {"body": 1, "word": "green", "fig": 2}, {"body": 1, "word": "t-tests", "fig": 1}, {"body": 1, "word": "paraformaldehyde", "fig": 1}, {"body": 1, "word": "done", "fig": 1}, {"body": 1, "word": "two-tailed", "fig": 1}, {"body": 1, "word": "paired", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517545/bin/pone.0050557.g007.jpg", "caption": "Model of integrated alpha and beta arrestin roles in membrane protein transport in mammals. In the case of 7TMRs, receptor activation results in heterotrimeric G protein signaling through second messenger systems. This is instantly followed by receptor phosphorylation by GRK, which results in beta arrestin binding (arresting further G protein binding/signaling). Our findings suggest that alpha and beta arrestins heteroassociate and have coordinated functions. Among the biological functions that could be regulated by integrated alpha/beta arrestin functions are endocytic trafficking of cell surface cargoes (recycling or lysosomal degradation), kinase signaling (e.g., metabolism, cell growth, survival/apoptosis) and cytoskeletal dynamics. Alpha and beta arrestins could have a yin yang relationship with both antagonistic (e.g., inactivating and activating, respectively) and cooperative properties depending on context. We envision that arrestins are dynamic adaptors that can integrate internal and external information to mediate programmed ends (i.e., programs created through evolutionary processes). This is largely achieved through reversible posttranslational modifications, such as phosphorylation (not shown) and ubiqutination, and their effects on protein-protein interactions.", "co_occurrence": [{"body": 23, "word": "protein", "fig": 3}, {"body": 22, "word": "arrestin", "fig": 3}, {"body": 17, "word": "arrestins", "fig": 3}, {"body": 25, "word": "receptor", "fig": 2}, {"body": 34, "word": "We", "fig": 1}, {"body": 17, "word": "cell", "fig": 2}, {"body": 16, "word": "This", "fig": 2}, {"body": 7, "word": "beta", "fig": 4}, {"body": 13, "word": "alpha", "fig": 2}, {"body": 24, "word": "trafficking", "fig": 1}, {"body": 11, "word": "signaling", "fig": 2}, {"body": 10, "word": "results", "fig": 2}, {"body": 10, "word": "could", "fig": 2}, {"body": 19, "word": "shown", "fig": 1}, {"body": 19, "word": "membrane", "fig": 1}, {"body": 9, "word": "phosphorylation", "fig": 2}, {"body": 18, "word": "interactions", "fig": 1}, {"body": 17, "word": "activation", "fig": 1}, {"body": 15, "word": "effects", "fig": 1}, {"body": 14, "word": "endocytic", "fig": 1}, {"body": 13, "word": "findings", "fig": 1}, {"body": 13, "word": "In", "fig": 1}, {"body": 4, "word": "functions", "fig": 3}, {"body": 11, "word": "respectively", "fig": 1}, {"body": 10, "word": "degradation", "fig": 1}, {"body": 9, "word": "regulated", "fig": 1}, {"body": 9, "word": "lysosomal", "fig": 1}, {"body": 9, "word": "roles", "fig": 1}, {"body": 8, "word": "modifications", "fig": 1}, {"body": 8, "word": "Our", "fig": 1}, {"body": 8, "word": "surface", "fig": 1}, {"body": 8, "word": "suggest", "fig": 1}, {"body": 7, "word": "7TMRs", "fig": 1}, {"body": 6, "word": "followed", "fig": 1}, {"body": 6, "word": "posttranslational", "fig": 1}, {"body": 3, "word": "e.g.", "fig": 2}, {"body": 5, "word": "mammals", "fig": 1}, {"body": 5, "word": "binding", "fig": 1}, {"body": 4, "word": "heteroassociate", "fig": 1}, {"body": 2, "word": "G", "fig": 2}, {"body": 4, "word": "mediate", "fig": 1}, {"body": 4, "word": "metabolism", "fig": 1}, {"body": 4, "word": "Alpha", "fig": 1}, {"body": 3, "word": "kinase", "fig": 1}, {"body": 3, "word": "biological", "fig": 1}, {"body": 3, "word": "context", "fig": 1}, {"body": 2, "word": "growth", "fig": 1}, {"body": 2, "word": "transport", "fig": 1}, {"body": 1, "word": "integrated", "fig": 2}, {"body": 2, "word": "properties", "fig": 1}, {"body": 2, "word": "adaptors", "fig": 1}, {"body": 1, "word": "evolutionary", "fig": 1}, {"body": 1, "word": "dynamic", "fig": 1}, {"body": 1, "word": "cooperative", "fig": 1}, {"body": 1, "word": "activating", "fig": 1}, {"body": 1, "word": "coordinated", "fig": 1}, {"body": 1, "word": "second", "fig": 1}, {"body": 1, "word": "created", "fig": 1}, {"body": 1, "word": "alpha/beta", "fig": 1}, {"body": 1, "word": "cytoskeletal", "fig": 1}, {"body": 1, "word": "i.e.", "fig": 1}, {"body": 1, "word": "yin", "fig": 1}, {"body": 1, "word": "relationship", "fig": 1}, {"body": 1, "word": "case", "fig": 1}, {"body": 1, "word": "antagonistic", "fig": 1}, {"body": 1, "word": "information", "fig": 1}, {"body": 1, "word": "yang", "fig": 1}]}], "4669703": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669703/bin/cddis2015124f1.jpg", "caption": "Identification of mesothelioma cell lines sensitive versus resistant to PI3K/mTOR inhibition. IC50 of 19 MPM cell lines: ACC-Meso-1, SPC212, MSTO-211H, ZL34, ZL55, NCI-H2452, ZL5, NCI-H226, SPC111, NCI-H2052, Mero-25, Mero-95, SDM103T2, ACC-Meso-4, Mero-82, ONE58, Mero-14, Mero-84 and Mero-83 and Q-Q Plot normality test at 250 nM after 72 h treated with (a) NVP-BEZ235 and (b) GDC-0980", "co_occurrence": [{"body": 78, "word": "cell", "fig": 2}, {"body": 46, "word": "lines", "fig": 2}, {"body": 34, "word": "PI3K/mTOR", "fig": 1}, {"body": 33, "word": "GDC-0980", "fig": 1}, {"body": 26, "word": "inhibition", "fig": 1}, {"body": 26, "word": "Mero-82", "fig": 1}, {"body": 26, "word": "resistant", "fig": 1}, {"body": 24, "word": "sensitive", "fig": 1}, {"body": 24, "word": "NVP-BEZ235", "fig": 1}, {"body": 21, "word": "SPC212", "fig": 1}, {"body": 17, "word": "MPM", "fig": 1}, {"body": 16, "word": "h", "fig": 1}, {"body": 11, "word": "mesothelioma", "fig": 1}, {"body": 10, "word": "IC50", "fig": 1}, {"body": 8, "word": "test", "fig": 1}, {"body": 7, "word": "nM", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 4, "word": "Plot", "fig": 1}, {"body": 4, "word": "Mero-25", "fig": 1}, {"body": 3, "word": "Q-Q", "fig": 1}, {"body": 3, "word": "versus", "fig": 1}, {"body": 3, "word": "NCI-H2452", "fig": 1}, {"body": 2, "word": "ZL34", "fig": 1}, {"body": 2, "word": "MSTO-211H", "fig": 1}, {"body": 2, "word": "Mero-83", "fig": 1}, {"body": 2, "word": "ACC-Meso-1", "fig": 1}, {"body": 2, "word": "ACC-Meso-4", "fig": 1}, {"body": 2, "word": "ONE58", "fig": 1}, {"body": 1, "word": "SPC111", "fig": 1}, {"body": 1, "word": "Mero-95", "fig": 1}, {"body": 1, "word": "ZL55", "fig": 1}, {"body": 1, "word": "normality", "fig": 1}, {"body": 1, "word": "NCI-H226", "fig": 1}, {"body": 1, "word": "Mero-84", "fig": 1}, {"body": 1, "word": "SDM103T2", "fig": 1}, {"body": 1, "word": "ZL5", "fig": 1}, {"body": 1, "word": "NCI-H2052", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669703/bin/cddis2015124f2.jpg", "caption": "Decrease of PI3K/mTOR signaling is accompanied by G1 arrest, which is more pronounced in sensitive cell lines. (a) Protein lysates of sensitive cell lines SPC212, ZL34 and Mero-25 and resistant cell lines Mero-83, Mero-82 and ONE58 were analyzed by western blotting against PI3K/mTOR activity markers: phospho-AKT (Thr308), phospho-AKT (Ser473), AKT, phospho-S6, S6, phospho-4E-BP1, 4E-BP1, and Actin. Each cell line was serum-starved for 16 h and treated as indicated for 4 h with 1000 \u03bcg/ml IGF-1, 0.5 \u03bcM NVP-BEZ235, 0.5 \u03bcM GDC-0980 or treated for 72 h with increasing concentrations of NVP-BEZ235 or GDC-0980 as indicated. (b) Cell cycle profile of sensitive cell line SPC212 and resistant line Mero-82 treated with 0.2 \u03bcM NVP-BEZ235 or 0.5 \u03bcM GDC-0980 for 72 h. Data are presented as means\u00b1S.D. from \u22653 independent experiments. Significance was determined by Student's t-test (***P<0.005, **P<0.01 and *P<0.05; NS, not significant)", "co_occurrence": [{"body": 78, "word": "cell", "fig": 5}, {"body": 46, "word": "lines", "fig": 3}, {"body": 33, "word": "GDC-0980", "fig": 3}, {"body": 24, "word": "NVP-BEZ235", "fig": 3}, {"body": 24, "word": "sensitive", "fig": 3}, {"body": 34, "word": "PI3K/mTOR", "fig": 2}, {"body": 26, "word": "Mero-82", "fig": 2}, {"body": 26, "word": "resistant", "fig": 2}, {"body": 16, "word": "h", "fig": 3}, {"body": 15, "word": "line", "fig": 3}, {"body": 21, "word": "SPC212", "fig": 2}, {"body": 7, "word": "treated", "fig": 3}, {"body": 10, "word": "activity", "fig": 1}, {"body": 10, "word": "significant", "fig": 1}, {"body": 9, "word": "Cell", "fig": 1}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 6, "word": "h.", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 1}, {"body": 6, "word": "AKT", "fig": 1}, {"body": 5, "word": "\u03bcg/ml", "fig": 1}, {"body": 5, "word": "'s", "fig": 1}, {"body": 1, "word": "\u03bcM", "fig": 4}, {"body": 4, "word": "S6", "fig": 1}, {"body": 4, "word": "Mero-25", "fig": 1}, {"body": 4, "word": "cycle", "fig": 1}, {"body": 3, "word": "4E-BP1", "fig": 1}, {"body": 3, "word": "markers", "fig": 1}, {"body": 2, "word": "ZL34", "fig": 1}, {"body": 2, "word": "Protein", "fig": 1}, {"body": 2, "word": "Mero-83", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 1, "word": "indicated", "fig": 2}, {"body": 2, "word": "Thr308", "fig": 1}, {"body": 2, "word": "ONE58", "fig": 1}, {"body": 2, "word": "Ser473", "fig": 1}, {"body": 1, "word": "blotting", "fig": 1}, {"body": 1, "word": "G1", "fig": 1}, {"body": 1, "word": "arrest", "fig": 1}, {"body": 1, "word": "Student", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "pronounced", "fig": 1}, {"body": 1, "word": "increasing", "fig": 1}, {"body": 1, "word": "concentrations", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "profile", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "western", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669703/bin/cddis2015124f3.jpg", "caption": "Mesothelioma cells exhibit a high level of autophagy, which is increased upon inhibition of PI3K/mTOR signaling. (a) Anti-P62 and -LC3BI/II and -Actin western blots of protein lysates of sensitive cell line SPC212 and resistant cell line Mero-82 treated for 72 h with increasing concentrations of NVP-BEZ235 or GDC-0980 as indicated. (b) Anti-LC3BI/II and -Actin western blots of mesothelial cell line SDM104 and MPM cell lines SPC111, SPC212, NCI-H226, NCI-H2052, NCI-H2452, Mero-14, Mero-25, Mero-82, Mero-83, Mero-84, Mero-95, ACC-Meso-1, ACC-Meso-4, MSTO-211H and ONE58 left with serum or serum-starved for 16 h. In the lower panel, protein level quantification of LC3BII normalized against Actin is represented for the cell lines described above with standard culture conditions", "co_occurrence": [{"body": 78, "word": "cell", "fig": 5}, {"body": 46, "word": "lines", "fig": 2}, {"body": 53, "word": "cells", "fig": 1}, {"body": 26, "word": "Mero-82", "fig": 2}, {"body": 15, "word": "line", "fig": 3}, {"body": 21, "word": "SPC212", "fig": 2}, {"body": 34, "word": "PI3K/mTOR", "fig": 1}, {"body": 33, "word": "GDC-0980", "fig": 1}, {"body": 27, "word": "autophagy", "fig": 1}, {"body": 26, "word": "inhibition", "fig": 1}, {"body": 26, "word": "resistant", "fig": 1}, {"body": 24, "word": "NVP-BEZ235", "fig": 1}, {"body": 24, "word": "sensitive", "fig": 1}, {"body": 10, "word": "protein", "fig": 2}, {"body": 17, "word": "In", "fig": 1}, {"body": 17, "word": "MPM", "fig": 1}, {"body": 16, "word": "h", "fig": 1}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 6, "word": "h.", "fig": 1}, {"body": 6, "word": "increased", "fig": 1}, {"body": 3, "word": "level", "fig": 2}, {"body": 5, "word": "high", "fig": 1}, {"body": 4, "word": "Mero-25", "fig": 1}, {"body": 4, "word": "conditions", "fig": 1}, {"body": 4, "word": "serum", "fig": 1}, {"body": 3, "word": "described", "fig": 1}, {"body": 3, "word": "SDM104", "fig": 1}, {"body": 3, "word": "NCI-H2452", "fig": 1}, {"body": 3, "word": "culture", "fig": 1}, {"body": 2, "word": "Mero-83", "fig": 1}, {"body": 2, "word": "panel", "fig": 1}, {"body": 2, "word": "MSTO-211H", "fig": 1}, {"body": 2, "word": "ACC-Meso-1", "fig": 1}, {"body": 2, "word": "upon", "fig": 1}, {"body": 2, "word": "ACC-Meso-4", "fig": 1}, {"body": 2, "word": "ONE58", "fig": 1}, {"body": 2, "word": "mesothelial", "fig": 1}, {"body": 1, "word": "western", "fig": 2}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "SPC111", "fig": 1}, {"body": 1, "word": "Mero-95", "fig": 1}, {"body": 1, "word": "Mero-84", "fig": 1}, {"body": 1, "word": "NCI-H226", "fig": 1}, {"body": 1, "word": "increasing", "fig": 1}, {"body": 1, "word": "NCI-H2052", "fig": 1}, {"body": 1, "word": "concentrations", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669703/bin/cddis2015124f4.jpg", "caption": "Inhibition of autophagy with CQ sensitizes mesothelioma cell lines to PI3K/mTOR inhibitors. (a) Anti-P62, L-C3BI/II and Actin western blots of protein lysates of sensitive cell line SPC212 and resistant cell line Mero-82 treated with 20 \u03bcM CQ, 0.5 \u03bcM GDC-0980 or in combination for 24, 48 and 72 h. (b) Light micrographs of SPC212 and Mero-82 treated with 0.2 \u03bcM NVP-BEZ235, 0.5 \u03bcM GDC-0980 alone or in combination with 20 \u03bcM CQ for 96 h. Scale bar represents 25 \u03bcm. (c) Quantification of the percentage of ATP content of SPC212 cells and Mero-82 cell treated with 0.2 \u03bcM NVP-BEZ235, 0.5 \u03bcM GDC-0980 alone or in combination with 20 \u03bcM CQ for 96 h. Data are presented as means\u00b1S.D. from \u22653 independent experiments. Significance was determined by analysis of variance test (***P<0.005, **P<0.01 and *P<0.05; NS, not significant)", "co_occurrence": [{"body": 78, "word": "cell", "fig": 4}, {"body": 25, "word": "CQ", "fig": 4}, {"body": 33, "word": "GDC-0980", "fig": 3}, {"body": 26, "word": "Mero-82", "fig": 3}, {"body": 21, "word": "SPC212", "fig": 3}, {"body": 53, "word": "cells", "fig": 1}, {"body": 24, "word": "NVP-BEZ235", "fig": 2}, {"body": 46, "word": "lines", "fig": 1}, {"body": 13, "word": "combination", "fig": 3}, {"body": 34, "word": "PI3K/mTOR", "fig": 1}, {"body": 30, "word": "inhibitors", "fig": 1}, {"body": 15, "word": "line", "fig": 2}, {"body": 27, "word": "autophagy", "fig": 1}, {"body": 26, "word": "resistant", "fig": 1}, {"body": 24, "word": "sensitive", "fig": 1}, {"body": 7, "word": "treated", "fig": 3}, {"body": 10, "word": "alone", "fig": 2}, {"body": 6, "word": "h.", "fig": 3}, {"body": 11, "word": "mesothelioma", "fig": 1}, {"body": 10, "word": "ATP", "fig": 1}, {"body": 10, "word": "protein", "fig": 1}, {"body": 10, "word": "significant", "fig": 1}, {"body": 1, "word": "\u03bcM", "fig": 8}, {"body": 8, "word": "test", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "sensitizes", "fig": 1}, {"body": 3, "word": "content", "fig": 1}, {"body": 2, "word": "\u03bcm", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "Inhibition", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 1}, {"body": 1, "word": "western", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "micrographs", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669703/bin/cddis2015124f5.jpg", "caption": "Autophagy is necessary for mesothelioma cell growth. SPC212 and Mero-82 cell lines were stable transduced with virus particles carrying Mir30- Sh-Atg5 or Mir30-Sh-Ctrl. (a) Atg5 gene silencing was confirmed by anti-ATG5 western blotting. (b) Anti-P62, -LC3BI/II and -Actin of SPC212 and Mero-82 Sh-Atg5 and Sh-Ctrl untreated or treated with 20 \u03bcM CQ for 4 h. (c) Fold cell growth of SPC212 and Mero-82 Sh-Atg5 and Sh-Ctrl for 3 days. Data are presented as means\u00b1S.D. from three independent experiments. Significance was determined by Mann\u2013Whitney U-test (*P<0.05)", "co_occurrence": [{"body": 78, "word": "cell", "fig": 3}, {"body": 26, "word": "Mero-82", "fig": 3}, {"body": 21, "word": "SPC212", "fig": 3}, {"body": 46, "word": "lines", "fig": 1}, {"body": 18, "word": "growth", "fig": 2}, {"body": 25, "word": "CQ", "fig": 1}, {"body": 11, "word": "mesothelioma", "fig": 1}, {"body": 7, "word": "Atg5", "fig": 1}, {"body": 7, "word": "treated", "fig": 1}, {"body": 6, "word": "days", "fig": 1}, {"body": 6, "word": "h.", "fig": 1}, {"body": 4, "word": "gene", "fig": 1}, {"body": 3, "word": "Autophagy", "fig": 1}, {"body": 3, "word": "silencing", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "confirmed", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "transduced", "fig": 1}, {"body": 1, "word": "untreated", "fig": 1}, {"body": 1, "word": "U-test", "fig": 1}, {"body": 1, "word": "blotting", "fig": 1}, {"body": 1, "word": "particles", "fig": 1}, {"body": 1, "word": "anti-ATG5", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "Mann\u2013Whitney", "fig": 1}, {"body": 1, "word": "western", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "\u03bcM", "fig": 1}, {"body": 1, "word": "three", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669703/bin/cddis2015124f6.jpg", "caption": "Inhibition of autophagy with CQ combined with inhibition of PI3K/mTOR signaling induces caspase-independent cell death. (a) SPC212 and Mero-82 cell lines were treated as indicated with 0.2 \u03bcM NVP-BEZ235, 0.5 \u03bcM GDC-0980, 20 \u03bcM CQ, 20 \u03bcM ZVAD-FMK or 50 \u03bcM Nec-1 for 96 h. Cell death was assessed by GFP-Annexin V/PI staining and flow cytometry. Data are presented as means\u00b1S.D. from three independent experiments. Significance was determined by analysis of variance test (***P<0.005, **P<0.01 and *P<0.05; NS, not significant). (b) Anti- PARP, -Caspase 3 and -Actin western blots of SPC212 and Mero-82 treated as indicated with 0.2 \u03bcM NVP-BEZ235, 0.5 \u03bcM GDC-0980 and 20 \u03bcM CQ. SV40 immortalized wt MEFs treated for 15 h with 3 \u03bcg/ml Etoposide were used as control for apoptosis. (c) Anti-XIAP (asterisk (*) represents unspecific band), -RIP1 and -Actin western blots of protein lysates of SPC212 and Mero-82 treated as indicated with 0.2 \u03bcM NVP-BEZ235, 0.5 \u03bcM GDC-0980 and 20 \u03bcM CQ for 72 and 96 h", "co_occurrence": [{"body": 78, "word": "cell", "fig": 2}, {"body": 25, "word": "CQ", "fig": 4}, {"body": 33, "word": "GDC-0980", "fig": 3}, {"body": 26, "word": "Mero-82", "fig": 3}, {"body": 24, "word": "NVP-BEZ235", "fig": 3}, {"body": 21, "word": "SPC212", "fig": 3}, {"body": 46, "word": "lines", "fig": 1}, {"body": 21, "word": "death", "fig": 2}, {"body": 34, "word": "PI3K/mTOR", "fig": 1}, {"body": 16, "word": "h", "fig": 2}, {"body": 7, "word": "treated", "fig": 4}, {"body": 27, "word": "autophagy", "fig": 1}, {"body": 26, "word": "inhibition", "fig": 1}, {"body": 1, "word": "\u03bcM", "fig": 11}, {"body": 10, "word": "protein", "fig": 1}, {"body": 10, "word": "used", "fig": 1}, {"body": 10, "word": "significant", "fig": 1}, {"body": 9, "word": "Cell", "fig": 1}, {"body": 8, "word": "combined", "fig": 1}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 8, "word": "test", "fig": 1}, {"body": 6, "word": "apoptosis", "fig": 1}, {"body": 6, "word": "h.", "fig": 1}, {"body": 5, "word": "Nec-1", "fig": 1}, {"body": 5, "word": "\u03bcg/ml", "fig": 1}, {"body": 4, "word": "staining", "fig": 1}, {"body": 4, "word": "control", "fig": 1}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 1, "word": "indicated", "fig": 3}, {"body": 3, "word": "assessed", "fig": 1}, {"body": 3, "word": "flow", "fig": 1}, {"body": 2, "word": "PARP", "fig": 1}, {"body": 2, "word": "V/PI", "fig": 1}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 2, "word": "GFP-Annexin", "fig": 1}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "Inhibition", "fig": 1}, {"body": 1, "word": "western", "fig": 2}, {"body": 1, "word": "immortalized", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "SV40", "fig": 1}, {"body": 1, "word": "three", "fig": 1}, {"body": 1, "word": "cytometry", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669703/bin/cddis2015124f7.jpg", "caption": "Inhibition of autophagy with CQ combined with inhibition of PI3K/mTOR signaling induces spheroid cell death. (a) Representative light micrographs of SPC212 and Mero-82 spheroids treated as indicated with 1 \u03bcM NVP-BEZ235, 1 \u03bcM GDC-0980 and 20 \u03bcM CQ for 6 days. (b) Fold increase volume (growth) of spheroids shown in panel (a). (c) Viability is presented as the percentage of ATP content in SPC212 and Mero-82 spheroids treated as described in panel (a). Data are presented as means\u00b1S.D. from \u22653 independent experiments. Significance was determined by analysis of variance test (***P<0.005 and *P<0.05; NS, not significant)", "co_occurrence": [{"body": 78, "word": "cell", "fig": 1}, {"body": 26, "word": "Mero-82", "fig": 2}, {"body": 25, "word": "CQ", "fig": 2}, {"body": 21, "word": "SPC212", "fig": 2}, {"body": 34, "word": "PI3K/mTOR", "fig": 1}, {"body": 33, "word": "GDC-0980", "fig": 1}, {"body": 10, "word": "spheroids", "fig": 3}, {"body": 27, "word": "autophagy", "fig": 1}, {"body": 26, "word": "inhibition", "fig": 1}, {"body": 24, "word": "NVP-BEZ235", "fig": 1}, {"body": 21, "word": "death", "fig": 1}, {"body": 18, "word": "growth", "fig": 1}, {"body": 7, "word": "treated", "fig": 2}, {"body": 12, "word": "shown", "fig": 1}, {"body": 10, "word": "ATP", "fig": 1}, {"body": 10, "word": "significant", "fig": 1}, {"body": 8, "word": "test", "fig": 1}, {"body": 8, "word": "combined", "fig": 1}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 6, "word": "days", "fig": 1}, {"body": 5, "word": "spheroid", "fig": 1}, {"body": 5, "word": "increase", "fig": 1}, {"body": 4, "word": "volume", "fig": 1}, {"body": 2, "word": "panel", "fig": 2}, {"body": 4, "word": "analysis", "fig": 1}, {"body": 3, "word": "described", "fig": 1}, {"body": 3, "word": "content", "fig": 1}, {"body": 1, "word": "\u03bcM", "fig": 3}, {"body": 2, "word": "determined", "fig": 1}, {"body": 2, "word": "Viability", "fig": 1}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "Inhibition", "fig": 1}, {"body": 2, "word": "c", "fig": 1}, {"body": 1, "word": "presented", "fig": 2}, {"body": 2, "word": "light", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "micrographs", "fig": 1}]}], "4657330": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g1.jpg", "caption": "Rac1 augments the canonical Wnt pathway. Testing the effect of Rac1 on Wnt stimulation of LEF-1/TCF dependent promoter activity. (A) (left panel) HEK293T cells were co-transfected with plasmids encoding TOPflash/FOPflash reporters and GFP, Rac1-WT-GFP or Rac1-Q61L-GFP. At 48 h post-transfection, cells were treated with LiCl (40 mM) for 6 h to stimulate the Wnt pathway, then lysed and analyzed for LEF-1/TCF-dependent transcription by measuring luciferase activity (see Materials and Methods). Each sample was corrected for transfection efficiency by normalizing samples against GFP expression, and promoter activity displayed as a TOPflash/FOPflash (pOT/pOF) ratio. The transient expression of Rac1-WT (wild-type) and Rac1-Q61L (constitutively active) increased the positive effect of LiCl on TOPflash activity. Experiments were performed three times. Error bars represent standard deviations and statistically significant values are indicated (*P<0.01, **P<0.001, ***P<0.0001). The right-hand panel shows a western blot of total lysates from HEK293 cells treated for \u00b16 h with 40 mM LiCl, and confirms induction of endogenous \u03b2-catenin. LEF-1 and actin (loading control) were also stained. (B) Rac1 expression up-regulates Wnt target genes. HEK293T cells were transfected with GFP or Rac1-WT-GFP and treated with Wnt3a conditioned media (6 h). Changes in mRNA levels for \u03b2-catenin and the Wnt target genes c-myc, Axin 2, cyclin D1 and LEF-1 were determined by real-time PCR and normalized to GAPDH. Overexpression of Rac1-WT-GFP stimulated Wnt-driven gene expression by up to \u223c70%. Results are presented as means\u00b1s.d. for two independent experiments. Differences between GFP alone and Rac1-WT-GFP were statistically significant where indicated. Unt, untreated.", "co_occurrence": [{"body": 99, "word": "Rac1", "fig": 3}, {"body": 54, "word": "Wnt", "fig": 5}, {"body": 59, "word": "cells", "fig": 4}, {"body": 107, "word": "\u03b2-catenin", "fig": 2}, {"body": 18, "word": "h", "fig": 4}, {"body": 33, "word": "LEF-1", "fig": 2}, {"body": 14, "word": "expression", "fig": 4}, {"body": 28, "word": "The", "fig": 2}, {"body": 17, "word": "LiCl", "fig": 3}, {"body": 10, "word": "activity", "fig": 4}, {"body": 28, "word": "active", "fig": 1}, {"body": 7, "word": "GFP", "fig": 4}, {"body": 11, "word": "pathway", "fig": 2}, {"body": 8, "word": "target", "fig": 2}, {"body": 8, "word": "effect", "fig": 2}, {"body": 5, "word": "treated", "fig": 3}, {"body": 13, "word": "levels", "fig": 1}, {"body": 3, "word": "Rac1-WT-GFP", "fig": 4}, {"body": 11, "word": "transfected", "fig": 1}, {"body": 5, "word": "genes", "fig": 2}, {"body": 10, "word": "wild-type", "fig": 1}, {"body": 10, "word": "endogenous", "fig": 1}, {"body": 5, "word": "significant", "fig": 2}, {"body": 5, "word": "HEK293T", "fig": 2}, {"body": 10, "word": "media", "fig": 1}, {"body": 9, "word": "three", "fig": 1}, {"body": 9, "word": "constitutively", "fig": 1}, {"body": 8, "word": "increased", "fig": 1}, {"body": 8, "word": "also", "fig": 1}, {"body": 7, "word": "gene", "fig": 1}, {"body": 7, "word": "total", "fig": 1}, {"body": 7, "word": "Wnt3a", "fig": 1}, {"body": 7, "word": "transcription", "fig": 1}, {"body": 6, "word": "luciferase", "fig": 1}, {"body": 6, "word": "see", "fig": 1}, {"body": 6, "word": "canonical", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 3, "word": "panel", "fig": 2}, {"body": 6, "word": "two", "fig": 1}, {"body": 6, "word": "performed", "fig": 1}, {"body": 5, "word": "displayed", "fig": 1}, {"body": 5, "word": "Rac1-WT", "fig": 1}, {"body": 5, "word": "stimulate", "fig": 1}, {"body": 5, "word": "alone", "fig": 1}, {"body": 5, "word": "transfection", "fig": 1}, {"body": 5, "word": "c-myc", "fig": 1}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 4, "word": "induction", "fig": 1}, {"body": 4, "word": "analyzed", "fig": 1}, {"body": 4, "word": "stimulation", "fig": 1}, {"body": 2, "word": "mM", "fig": 2}, {"body": 4, "word": "conditioned", "fig": 1}, {"body": 4, "word": "D1", "fig": 1}, {"body": 3, "word": "Rac1-Q61L", "fig": 1}, {"body": 3, "word": "ratio", "fig": 1}, {"body": 3, "word": "TOPflash", "fig": 1}, {"body": 3, "word": "cyclin", "fig": 1}, {"body": 3, "word": "PCR", "fig": 1}, {"body": 3, "word": "plasmids", "fig": 1}, {"body": 3, "word": "Axin", "fig": 1}, {"body": 3, "word": "times", "fig": 1}, {"body": 3, "word": "lysates", "fig": 1}, {"body": 3, "word": "HEK293", "fig": 1}, {"body": 3, "word": "co-transfected", "fig": 1}, {"body": 3, "word": "sample", "fig": 1}, {"body": 2, "word": "real-time", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "actin", "fig": 1}, {"body": 2, "word": "samples", "fig": 1}, {"body": 2, "word": "Overexpression", "fig": 1}, {"body": 2, "word": "untreated", "fig": 1}, {"body": 1, "word": "TOPflash/FOPflash", "fig": 2}, {"body": 2, "word": "GAPDH", "fig": 1}, {"body": 1, "word": "statistically", "fig": 2}, {"body": 2, "word": "mRNA", "fig": 1}, {"body": 2, "word": "encoding", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 1, "word": "indicated", "fig": 2}, {"body": 2, "word": "lysed", "fig": 1}, {"body": 2, "word": "post-transfection", "fig": 1}, {"body": 2, "word": "stimulated", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "LEF-1/TCF", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "Wnt-driven", "fig": 1}, {"body": 1, "word": "Rac1-Q61L-GFP", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "normalized", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "Each", "fig": 1}, {"body": 1, "word": "Differences", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "transient", "fig": 1}, {"body": 1, "word": "western", "fig": 1}, {"body": 1, "word": "determined", "fig": 1}, {"body": 1, "word": "values", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "Results", "fig": 1}, {"body": 1, "word": "At", "fig": 1}, {"body": 1, "word": "left", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g2.jpg", "caption": "Blocking Rac1 activity or expression does not alter \u03b2-catenin nuclear localization. (A) Two likely mechanisms by which Rac1 can stimulate Wnt/\u03b2-catenin gene transactivation are shown: (i) Rac1-mediated phosphorylation of \u03b2-catenin drives nuclear import and accumulation of \u03b2-catenin (Wu et al., 2008; Phelps et al., 2009), and (ii) unphosphorylated \u03b2-catenin can enter the nucleus (1) and Rac1-mediated phosphorylation of \u03b2-catenin stabilizes its interaction with LEF-1 to drive transactivation (2). (B) To test the first model, different cell lines were treated for 6 h with 50 \u00b5M NSC23766 (Rac1 inhibitor) in the absence and presence of 40 mM LiCl. Cells were then fixed and stained for \u03b2-catenin, then analyzed by immunofluorescence microscopy. Representative cell images are shown. Two hundred cells were scored for nuclear localization of \u03b2-catenin and the data are plotted as means\u00b1s.d. from two independent experiments. The Rac1 inhibitor had no significant effect. (C) SW480 cells were treated with NSC23766 (50 \u00b5M) for 6 or 24 h, after which cells were lysed and \u03b2-catenin protein levels analyzed by western blotting. Blots were probed for anti-\u03b2-catenin, \u03b2-tubulin (cytoplasmic loading control; cyto) and Topoisomerase II (Topo II, nuclear loading control; nuc). (D) Rac1 knockdown did not affect \u03b2-catenin distribution. SW480 cells were transfected with Rac1 or control siRNAs for 72 h. Cells were then lysed and subjected to western blotting. Blots were probed for anti-Rac1, \u03b2-catenin, \u03b2-tubulin and Topo II. (E) p\u03b2-catenin-WT-GFP and p\u03b2-catenin-S605A-GFP were expressed in NIH3T3 cells and compared for nuclear import by FRAP. Nuclear fluorescence was bleached and recovery measured over 300 s (see cell images and recovery curve). (F) Analysis of the first 30 s post-bleach revealed that the S605A mutation did not inhibit nuclear import of \u03b2-catenin.", "co_occurrence": [{"body": 107, "word": "\u03b2-catenin", "fig": 11}, {"body": 99, "word": "Rac1", "fig": 6}, {"body": 58, "word": "nuclear", "fig": 6}, {"body": 59, "word": "cells", "fig": 5}, {"body": 85, "word": "al.", "fig": 2}, {"body": 85, "word": "et", "fig": 2}, {"body": 28, "word": "cell", "fig": 3}, {"body": 18, "word": "h", "fig": 2}, {"body": 33, "word": "LEF-1", "fig": 1}, {"body": 28, "word": "The", "fig": 1}, {"body": 9, "word": "import", "fig": 3}, {"body": 13, "word": "SW480", "fig": 2}, {"body": 26, "word": "distribution", "fig": 1}, {"body": 11, "word": "localization", "fig": 2}, {"body": 21, "word": "nucleus", "fig": 1}, {"body": 10, "word": "Cells", "fig": 2}, {"body": 6, "word": "control", "fig": 3}, {"body": 17, "word": "LiCl", "fig": 1}, {"body": 8, "word": "first", "fig": 2}, {"body": 8, "word": "NSC23766", "fig": 2}, {"body": 7, "word": "phosphorylation", "fig": 2}, {"body": 14, "word": "interaction", "fig": 1}, {"body": 14, "word": "expression", "fig": 1}, {"body": 7, "word": "transactivation", "fig": 2}, {"body": 13, "word": "Wu", "fig": 1}, {"body": 13, "word": "levels", "fig": 1}, {"body": 12, "word": "S605A", "fig": 1}, {"body": 6, "word": "shown", "fig": 2}, {"body": 6, "word": "inhibitor", "fig": 2}, {"body": 12, "word": "data", "fig": 1}, {"body": 11, "word": "transfected", "fig": 1}, {"body": 11, "word": "To", "fig": 1}, {"body": 10, "word": "activity", "fig": 1}, {"body": 10, "word": "accumulation", "fig": 1}, {"body": 5, "word": "treated", "fig": 2}, {"body": 9, "word": "microscopy", "fig": 1}, {"body": 8, "word": "mutation", "fig": 1}, {"body": 4, "word": "\u00b5M", "fig": 2}, {"body": 4, "word": "images", "fig": 2}, {"body": 4, "word": "analyzed", "fig": 2}, {"body": 8, "word": "presence", "fig": 1}, {"body": 8, "word": "effect", "fig": 1}, {"body": 8, "word": "lines", "fig": 1}, {"body": 7, "word": "affect", "fig": 1}, {"body": 7, "word": "gene", "fig": 1}, {"body": 6, "word": "fixed", "fig": 1}, {"body": 6, "word": "two", "fig": 1}, {"body": 6, "word": "absence", "fig": 1}, {"body": 3, "word": "Rac1-mediated", "fig": 2}, {"body": 6, "word": "see", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 3, "word": "recovery", "fig": 2}, {"body": 2, "word": "II", "fig": 3}, {"body": 5, "word": "protein", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "different", "fig": 1}, {"body": 5, "word": "Phelps", "fig": 1}, {"body": 5, "word": "significant", "fig": 1}, {"body": 5, "word": "stimulate", "fig": 1}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 2, "word": "\u03b2-tubulin", "fig": 2}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 4, "word": "cytoplasmic", "fig": 1}, {"body": 4, "word": "revealed", "fig": 1}, {"body": 4, "word": "anti-\u03b2-catenin", "fig": 1}, {"body": 2, "word": "lysed", "fig": 2}, {"body": 3, "word": "Wnt/\u03b2-catenin", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "h.", "fig": 1}, {"body": 3, "word": "fluorescence", "fig": 1}, {"body": 1, "word": "blotting", "fig": 2}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "FRAP", "fig": 1}, {"body": 2, "word": "scored", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "loading", "fig": 2}, {"body": 2, "word": "mM", "fig": 1}, {"body": 1, "word": "western", "fig": 2}, {"body": 2, "word": "Topoisomerase", "fig": 1}, {"body": 2, "word": "siRNAs", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "drives", "fig": 1}, {"body": 2, "word": "model", "fig": 1}, {"body": 1, "word": "post-bleach", "fig": 1}, {"body": 1, "word": "alter", "fig": 1}, {"body": 1, "word": "likely", "fig": 1}, {"body": 1, "word": "inhibit", "fig": 1}, {"body": 1, "word": "p\u03b2-catenin-S605A-GFP", "fig": 1}, {"body": 1, "word": "mechanisms", "fig": 1}, {"body": 1, "word": "measured", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "stabilizes", "fig": 1}, {"body": 1, "word": "anti-Rac1", "fig": 1}, {"body": 1, "word": "Nuclear", "fig": 1}, {"body": 1, "word": "ii", "fig": 1}, {"body": 1, "word": "test", "fig": 1}, {"body": 1, "word": "p\u03b2-catenin-WT-GFP", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "NIH3T3", "fig": 1}, {"body": 1, "word": "curve", "fig": 1}, {"body": 1, "word": "drive", "fig": 1}, {"body": 1, "word": "bleached", "fig": 1}, {"body": 1, "word": "plotted", "fig": 1}, {"body": 1, "word": "enter", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g3.jpg", "caption": "Overexpression of Rac1 does not affect nuclear localization of endogenous \u03b2-catenin in HCT116, SW480 or NIH 3T3 cells. (A) HCT116 and SW480 colorectal cancer cells were transfected with plasmids for GFP-tagged WT (wild-type), T17N (dominant negative) or Q61L (constitutively active) Rac1. Immunostaining with \u03b2-catenin antibody and microscopy of cells revealed that endogenous \u03b2-catenin (red) remains nuclear/cytoplasmic (N/C) in distribution regardless of Rac1-GFP (green) localization. The cytoplasmic (C) and nuclear (N) distribution of \u03b2-catenin is shown in the bar graphs (C>N, N/C, N>C) for each Rac1 construct. (B) Next, a dominant negative mutant form of Rac1 (T17N) was tested for its ability to block \u03b2-catenin nuclear accumulation in Wnt-stimulated HCT116 and NIH 3T3 cells. Cells were transfected with pRac1-WT-GFP or pRac1-T17N-GFP, treated with 40 mM LiCl or Wnt3a conditioned media for 6 h and then stained for GFP (green), \u03b2-catenin (red) and DNA (blue). Typical microscopy images of transfected HCT116 cells are shown. Column graph displays the cellular distribution (N>C) of endogenous \u03b2-catenin in Rac1-WT or T17N transfected cells in the absence and presence of LiCl/Wnt3a in HCT116 and NIH 3T3 cells.", "co_occurrence": [{"body": 107, "word": "\u03b2-catenin", "fig": 7}, {"body": 59, "word": "cells", "fig": 7}, {"body": 99, "word": "Rac1", "fig": 4}, {"body": 58, "word": "nuclear", "fig": 3}, {"body": 26, "word": "distribution", "fig": 3}, {"body": 10, "word": "HCT116", "fig": 5}, {"body": 11, "word": "transfected", "fig": 4}, {"body": 13, "word": "NIH", "fig": 3}, {"body": 13, "word": "3T3", "fig": 3}, {"body": 10, "word": "endogenous", "fig": 3}, {"body": 28, "word": "active", "fig": 1}, {"body": 28, "word": "The", "fig": 1}, {"body": 13, "word": "SW480", "fig": 2}, {"body": 11, "word": "localization", "fig": 2}, {"body": 7, "word": "T17N", "fig": 3}, {"body": 18, "word": "h", "fig": 1}, {"body": 9, "word": "microscopy", "fig": 2}, {"body": 9, "word": "negative", "fig": 2}, {"body": 17, "word": "LiCl", "fig": 1}, {"body": 8, "word": "dominant", "fig": 2}, {"body": 6, "word": "shown", "fig": 2}, {"body": 11, "word": "form", "fig": 1}, {"body": 10, "word": "Cells", "fig": 1}, {"body": 5, "word": "red", "fig": 2}, {"body": 10, "word": "accumulation", "fig": 1}, {"body": 10, "word": "cancer", "fig": 1}, {"body": 10, "word": "wild-type", "fig": 1}, {"body": 10, "word": "media", "fig": 1}, {"body": 9, "word": "mutant", "fig": 1}, {"body": 9, "word": "constitutively", "fig": 1}, {"body": 2, "word": "C", "fig": 4}, {"body": 8, "word": "presence", "fig": 1}, {"body": 7, "word": "affect", "fig": 1}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 7, "word": "Wnt3a", "fig": 1}, {"body": 7, "word": "GFP", "fig": 1}, {"body": 6, "word": "absence", "fig": 1}, {"body": 6, "word": "Q61L", "fig": 1}, {"body": 6, "word": "colorectal", "fig": 1}, {"body": 5, "word": "WT", "fig": 1}, {"body": 5, "word": "Rac1-WT", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 4, "word": "cytoplasmic", "fig": 1}, {"body": 4, "word": "ability", "fig": 1}, {"body": 4, "word": "tested", "fig": 1}, {"body": 4, "word": "conditioned", "fig": 1}, {"body": 4, "word": "images", "fig": 1}, {"body": 4, "word": "revealed", "fig": 1}, {"body": 3, "word": "GFP-tagged", "fig": 1}, {"body": 3, "word": "cellular", "fig": 1}, {"body": 3, "word": "Next", "fig": 1}, {"body": 3, "word": "plasmids", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "Overexpression", "fig": 1}, {"body": 2, "word": "nuclear/cytoplasmic", "fig": 1}, {"body": 2, "word": "block", "fig": 1}, {"body": 2, "word": "DNA", "fig": 1}, {"body": 2, "word": "mM", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "green", "fig": 2}, {"body": 1, "word": "Rac1-GFP", "fig": 1}, {"body": 1, "word": "graph", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "displays", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g4.jpg", "caption": "Activation of Rac1 causes Rac1\u2013\u03b2-catenin complexes to move from the plasma membrane to the nucleus. (A) Left panel: IP of endogenous \u03b2-catenin detects association with Rac1 in HEK293 cell lysate; right panel: schematic diagram illustrates the steps involved with the Duolink in situ PLA. The process consists of primary antibodies and PLA probes binding to the target proteins (e.g. \u03b2-catenin and Rac1), hybridization and ligation followed by rolling circle amplification. (B) HEK293T cells were stained with primary antibodies for either endogenous total Rac1 or active Rac1 (GTP) and \u03b2-catenin, processed for detection of Rac1\u2013\u03b2-catenin complexes by PLA technique and imaged using confocal microscopy (see Materials and Methods). Each red dot represents a single interaction between Rac1 and \u03b2-catenin. Nuclei were stained with Hoechst (blue) and \u03b2-catenin cellular staining is shown in green. Column graph displays the fluorescence intensity of the PLA red dots at the adherens junctions (AJ), nucleus (nuc) or cytosol (cyto) for Rac1(total)\u2013\u03b2-catenin and Rac1(GTP)\u2013\u03b2-catenin complexes. There was a significant increase in active Rac1\u2013\u03b2-catenin complexes in the nucleus, compared with total Rac1\u2013\u03b2-catenin complexes, correlating with a reduction in complexes at the adherens junctions. Control images can be found in Fig. S2A. (C) HEK293T and NIH 3T3 cells were transfected with plasmids for GFP-tagged WT (wild-type), T17N or Q61L Rac1 before being stained with anti-GFP and anti-\u03b2-catenin antibodies to detect interactions between Rac1 and \u03b2-catenin using the PLA. Cells were then stained for \u03b2-catenin (green) and DNA (blue), and the PLA-positive red dots each represent an amplified Rac1-GFP/\u03b2-catenin interaction complex. For the controls, only one primary antibody (\u03b2-catenin or GFP) was added to each well (Fig. S2B). The dot plot represents the number of positive nuclear PLA signals per cell for both the single antibody controls (GFP pAb or \u03b2-catenin mAb) or both antibodies for each Rac1 construct. The dot plot is representative of two independent experiments each containing 50 cells scored from z-stack confocal microscopy images. (D) Schematic diagram illustrating Rac1\u2013\u03b2-catenin complex cellular distribution. When Rac1 is predominantly in its inactive form, Rac1(GDP)\u2013\u03b2-catenin complexes are strongly located at the membrane and adherens junctions. Alternatively, when Rac1 is active, Rac1(GTP)\u2013\u03b2-catenin complexes displayed a more nuclear-cytoplasmic distribution pattern.", "co_occurrence": [{"body": 99, "word": "Rac1", "fig": 15}, {"body": 107, "word": "\u03b2-catenin", "fig": 9}, {"body": 33, "word": "complexes", "fig": 8}, {"body": 59, "word": "cells", "fig": 3}, {"body": 26, "word": "Rac1\u2013\u03b2-catenin", "fig": 5}, {"body": 64, "word": "Fig", "fig": 2}, {"body": 15, "word": "PLA", "fig": 6}, {"body": 28, "word": "active", "fig": 3}, {"body": 28, "word": "The", "fig": 3}, {"body": 16, "word": "antibodies", "fig": 4}, {"body": 21, "word": "nucleus", "fig": 3}, {"body": 58, "word": "nuclear", "fig": 1}, {"body": 28, "word": "cell", "fig": 2}, {"body": 26, "word": "distribution", "fig": 2}, {"body": 24, "word": "using", "fig": 2}, {"body": 14, "word": "interaction", "fig": 2}, {"body": 14, "word": "complex", "fig": 2}, {"body": 12, "word": "membrane", "fig": 2}, {"body": 7, "word": "total", "fig": 3}, {"body": 10, "word": "endogenous", "fig": 2}, {"body": 9, "word": "microscopy", "fig": 2}, {"body": 8, "word": "confocal", "fig": 2}, {"body": 5, "word": "red", "fig": 3}, {"body": 7, "word": "antibody", "fig": 2}, {"body": 7, "word": "GFP", "fig": 2}, {"body": 13, "word": "NIH", "fig": 1}, {"body": 13, "word": "3T3", "fig": 1}, {"body": 4, "word": "primary", "fig": 3}, {"body": 11, "word": "transfected", "fig": 1}, {"body": 11, "word": "form", "fig": 1}, {"body": 11, "word": "binding", "fig": 1}, {"body": 10, "word": "Cells", "fig": 1}, {"body": 10, "word": "wild-type", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 2}, {"body": 9, "word": "increase", "fig": 1}, {"body": 9, "word": "interactions", "fig": 1}, {"body": 4, "word": "images", "fig": 2}, {"body": 2, "word": "stained", "fig": 4}, {"body": 8, "word": "target", "fig": 1}, {"body": 7, "word": "T17N", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 3, "word": "cellular", "fig": 2}, {"body": 6, "word": "see", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 3, "word": "panel", "fig": 2}, {"body": 6, "word": "Duolink", "fig": 1}, {"body": 6, "word": "Q61L", "fig": 1}, {"body": 6, "word": "reduction", "fig": 1}, {"body": 3, "word": "dots", "fig": 2}, {"body": 6, "word": "compared", "fig": 1}, {"body": 6, "word": "two", "fig": 1}, {"body": 5, "word": "displayed", "fig": 1}, {"body": 5, "word": "WT", "fig": 1}, {"body": 5, "word": "plasma", "fig": 1}, {"body": 5, "word": "IP", "fig": 1}, {"body": 5, "word": "significant", "fig": 1}, {"body": 2, "word": "controls", "fig": 2}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "anti-\u03b2-catenin", "fig": 1}, {"body": 4, "word": "added", "fig": 1}, {"body": 4, "word": "inactive", "fig": 1}, {"body": 1, "word": "adherens", "fig": 3}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "GFP-tagged", "fig": 1}, {"body": 3, "word": "proteins", "fig": 1}, {"body": 3, "word": "found", "fig": 1}, {"body": 3, "word": "imaged", "fig": 1}, {"body": 3, "word": "plasmids", "fig": 1}, {"body": 3, "word": "HEK293", "fig": 1}, {"body": 3, "word": "ligation", "fig": 1}, {"body": 1, "word": "GTP", "fig": 3}, {"body": 1, "word": "junctions", "fig": 3}, {"body": 3, "word": "nuclear-cytoplasmic", "fig": 1}, {"body": 3, "word": "located", "fig": 1}, {"body": 3, "word": "fluorescence", "fig": 1}, {"body": 2, "word": "cytosol", "fig": 1}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "causes", "fig": 1}, {"body": 2, "word": "scored", "fig": 1}, {"body": 2, "word": "detect", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "When", "fig": 1}, {"body": 2, "word": "positive", "fig": 1}, {"body": 2, "word": "mAb", "fig": 1}, {"body": 2, "word": "DNA", "fig": 1}, {"body": 1, "word": "single", "fig": 2}, {"body": 2, "word": "situ", "fig": 1}, {"body": 2, "word": "Activation", "fig": 1}, {"body": 2, "word": "predominantly", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "containing", "fig": 1}, {"body": 2, "word": "probes", "fig": 1}, {"body": 1, "word": "green", "fig": 2}, {"body": 2, "word": "pattern", "fig": 1}, {"body": 1, "word": "amplified", "fig": 1}, {"body": 1, "word": "amplification", "fig": 1}, {"body": 1, "word": "circle", "fig": 1}, {"body": 1, "word": "association", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "z-stack", "fig": 1}, {"body": 1, "word": "steps", "fig": 1}, {"body": 1, "word": "anti-GFP", "fig": 1}, {"body": 1, "word": "strongly", "fig": 1}, {"body": 1, "word": "right", "fig": 1}, {"body": 1, "word": "detection", "fig": 1}, {"body": 1, "word": "displays", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "Each", "fig": 1}, {"body": 1, "word": "e.g", "fig": 1}, {"body": 1, "word": "graph", "fig": 1}, {"body": 1, "word": "There", "fig": 1}, {"body": 1, "word": "one", "fig": 1}, {"body": 1, "word": "pAb", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "GDP", "fig": 1}, {"body": 1, "word": "lysate", "fig": 1}, {"body": 1, "word": "S2B", "fig": 1}, {"body": 1, "word": "S2A", "fig": 1}, {"body": 1, "word": "Hoechst", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g5.jpg", "caption": "The Wnt agonist LiCl stimulates formation of endogenous active Rac1\u2013\u03b2-catenin complexes in the cytoplasm and nucleus. In situ PLA in HEK293T and NIH 3T3 cells after Wnt stimulation with LiCl. (A) Cells were treated with 40 mM LiCl for 6 h and antibodies against active Rac1 and \u03b2-catenin were used to detect active Rac1\u2013\u03b2-catenin complexes. The primary antibodies Rac1-GTP and \u03b2-catenin were used alone as controls (top two rows). Cells were counterstained with anti-\u03b2-catenin (green) and Hoechst (blue). (B) Positive PLA signals (red dots) were counted from z-stack confocal images and the number of dots in the nuclei of cells is presented in the dot plots for each cell line. Fifty nuclei per experiment were counted over two independent experiments and a representative plot is displayed. Unt, untreated.", "co_occurrence": [{"body": 107, "word": "\u03b2-catenin", "fig": 2}, {"body": 59, "word": "cells", "fig": 2}, {"body": 54, "word": "Wnt", "fig": 2}, {"body": 99, "word": "Rac1", "fig": 1}, {"body": 28, "word": "active", "fig": 3}, {"body": 33, "word": "complexes", "fig": 2}, {"body": 28, "word": "The", "fig": 2}, {"body": 26, "word": "Rac1\u2013\u03b2-catenin", "fig": 2}, {"body": 17, "word": "LiCl", "fig": 3}, {"body": 16, "word": "antibodies", "fig": 2}, {"body": 15, "word": "PLA", "fig": 2}, {"body": 28, "word": "cell", "fig": 1}, {"body": 14, "word": "used", "fig": 2}, {"body": 21, "word": "nucleus", "fig": 1}, {"body": 10, "word": "Cells", "fig": 2}, {"body": 18, "word": "h", "fig": 1}, {"body": 13, "word": "NIH", "fig": 1}, {"body": 13, "word": "3T3", "fig": 1}, {"body": 6, "word": "two", "fig": 2}, {"body": 12, "word": "In", "fig": 1}, {"body": 6, "word": "nuclei", "fig": 2}, {"body": 10, "word": "endogenous", "fig": 1}, {"body": 9, "word": "formation", "fig": 1}, {"body": 8, "word": "confocal", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 3, "word": "dots", "fig": 2}, {"body": 6, "word": "cytoplasm", "fig": 1}, {"body": 5, "word": "displayed", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "alone", "fig": 1}, {"body": 5, "word": "treated", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 1}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 4, "word": "images", "fig": 1}, {"body": 4, "word": "primary", "fig": 1}, {"body": 4, "word": "anti-\u03b2-catenin", "fig": 1}, {"body": 4, "word": "stimulation", "fig": 1}, {"body": 4, "word": "stimulates", "fig": 1}, {"body": 3, "word": "agonist", "fig": 1}, {"body": 2, "word": "controls", "fig": 1}, {"body": 2, "word": "untreated", "fig": 1}, {"body": 2, "word": "detect", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "experiment", "fig": 1}, {"body": 2, "word": "mM", "fig": 1}, {"body": 2, "word": "situ", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 1, "word": "z-stack", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "Positive", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "counterstained", "fig": 1}, {"body": 1, "word": "Hoechst", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g6.jpg", "caption": "Rac1 stimulates the formation of endogenous \u03b2-catenin\u2013LEF-1 complexes. (A) HEK293T cells were stained with primary antibodies and processed for detection of interactions between endogenous \u03b2-catenin and LEF-1 using the proximity ligation assay (PLA) Duolink. As shown in the cell images, cells were either transfected with Rac1 constructs (WT, T17N or Q61L) or treated with Wnt3a conditioned media, 40 mM LiCl, 50 \u00b5M NSC23766 or 50 \u00b5M NSC23766+Wnt3a for 6 h before being fixed and subjected to Duolink assay. The assay was performed using both anti-\u03b2-catenin and anti-LEF-1 antibodies (see Materials and Methods for details). For the control wells, only one primary antibody (\u03b2-catenin or LEF-1) was added. Cells were then stained for \u03b2-catenin (green) and the PLA-positive red dots detected each represent an amplified \u03b2-catenin/LEF-1 interaction complex. (B) The PLA signals were counted and the number of dots in the nucleus per cell from single slice confocal images is presented in the plot. One hundred nuclei from two independent experiments were scored. (C) GFP, GFP-\u03b2-catenin and HA-tagged LEF1 were transiently expressed in HEK293 cells and total lysates used for IP by anti-HA antibody. The IP shows detection of LEF-1\u2013\u03b2-catenin complexes in cells untreated or treated for 6 h with drug. (D) Summary diagram showing that the interaction between \u03b2-catenin and LEF-1 is stimulated in the presence of Wnt and active Rac1, and inhibited in the presence of inactive Rac1.", "co_occurrence": [{"body": 107, "word": "\u03b2-catenin", "fig": 4}, {"body": 99, "word": "Rac1", "fig": 4}, {"body": 59, "word": "cells", "fig": 4}, {"body": 33, "word": "LEF-1", "fig": 3}, {"body": 28, "word": "The", "fig": 3}, {"body": 33, "word": "complexes", "fig": 2}, {"body": 28, "word": "cell", "fig": 2}, {"body": 54, "word": "Wnt", "fig": 1}, {"body": 24, "word": "using", "fig": 2}, {"body": 18, "word": "h", "fig": 2}, {"body": 16, "word": "antibodies", "fig": 2}, {"body": 10, "word": "assay", "fig": 3}, {"body": 15, "word": "PLA", "fig": 2}, {"body": 28, "word": "active", "fig": 1}, {"body": 14, "word": "interaction", "fig": 2}, {"body": 21, "word": "nucleus", "fig": 1}, {"body": 10, "word": "endogenous", "fig": 2}, {"body": 17, "word": "LiCl", "fig": 1}, {"body": 8, "word": "presence", "fig": 2}, {"body": 14, "word": "used", "fig": 1}, {"body": 7, "word": "antibody", "fig": 2}, {"body": 14, "word": "complex", "fig": 1}, {"body": 6, "word": "Duolink", "fig": 2}, {"body": 11, "word": "transfected", "fig": 1}, {"body": 10, "word": "Cells", "fig": 1}, {"body": 10, "word": "\u03b2-catenin\u2013LEF-1", "fig": 1}, {"body": 5, "word": "IP", "fig": 2}, {"body": 5, "word": "treated", "fig": 2}, {"body": 10, "word": "media", "fig": 1}, {"body": 10, "word": "constructs", "fig": 1}, {"body": 9, "word": "interactions", "fig": 1}, {"body": 9, "word": "formation", "fig": 1}, {"body": 4, "word": "images", "fig": 2}, {"body": 8, "word": "confocal", "fig": 1}, {"body": 4, "word": "primary", "fig": 2}, {"body": 8, "word": "NSC23766", "fig": 1}, {"body": 4, "word": "\u00b5M", "fig": 2}, {"body": 7, "word": "total", "fig": 1}, {"body": 7, "word": "Wnt3a", "fig": 1}, {"body": 7, "word": "GFP", "fig": 1}, {"body": 7, "word": "T17N", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 6, "word": "fixed", "fig": 1}, {"body": 6, "word": "nuclei", "fig": 1}, {"body": 6, "word": "see", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 6, "word": "control", "fig": 1}, {"body": 6, "word": "Q61L", "fig": 1}, {"body": 3, "word": "dots", "fig": 2}, {"body": 6, "word": "performed", "fig": 1}, {"body": 6, "word": "two", "fig": 1}, {"body": 5, "word": "WT", "fig": 1}, {"body": 5, "word": "expressed", "fig": 1}, {"body": 5, "word": "red", "fig": 1}, {"body": 5, "word": "HEK293T", "fig": 1}, {"body": 4, "word": "proximity", "fig": 1}, {"body": 4, "word": "anti-HA", "fig": 1}, {"body": 4, "word": "subjected", "fig": 1}, {"body": 2, "word": "stained", "fig": 2}, {"body": 4, "word": "detected", "fig": 1}, {"body": 4, "word": "For", "fig": 1}, {"body": 4, "word": "drug", "fig": 1}, {"body": 4, "word": "anti-\u03b2-catenin", "fig": 1}, {"body": 4, "word": "experiments", "fig": 1}, {"body": 4, "word": "conditioned", "fig": 1}, {"body": 4, "word": "stimulates", "fig": 1}, {"body": 4, "word": "added", "fig": 1}, {"body": 4, "word": "inactive", "fig": 1}, {"body": 4, "word": "As", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "lysates", "fig": 1}, {"body": 3, "word": "HEK293", "fig": 1}, {"body": 3, "word": "ligation", "fig": 1}, {"body": 3, "word": "transiently", "fig": 1}, {"body": 2, "word": "untreated", "fig": 1}, {"body": 2, "word": "scored", "fig": 1}, {"body": 1, "word": "detection", "fig": 2}, {"body": 2, "word": "per", "fig": 1}, {"body": 2, "word": "C", "fig": 1}, {"body": 2, "word": "mM", "fig": 1}, {"body": 2, "word": "LEF-1\u2013\u03b2-catenin", "fig": 1}, {"body": 2, "word": "stimulated", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "One", "fig": 1}, {"body": 2, "word": "inhibited", "fig": 1}, {"body": 1, "word": "amplified", "fig": 1}, {"body": 1, "word": "Methods", "fig": 1}, {"body": 1, "word": "presented", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "NSC23766+Wnt3a", "fig": 1}, {"body": 1, "word": "Materials", "fig": 1}, {"body": 1, "word": "one", "fig": 1}, {"body": 1, "word": "anti-LEF-1", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "single", "fig": 1}, {"body": 1, "word": "details", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "wells", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g7.jpg", "caption": "Mutation of the Rac1-regulated phosphorylation sites of \u03b2-catenin reduce its binding to LEF-1. Overexpression of pHA-LEF-1 anchors \u03b2-catenin to chromatin and stabilizes it in the nucleus of NIH 3T3 cells (Henderson et al., 2002). (A) We used this ability of LEF-1 to anchor \u03b2-catenin in the nucleus to first compare LEF-1 binding efficiency of wild-type and Rac1-regulatory site mutants (S191 and S605) of \u03b2-catenin. NIH 3T3 cells were co-transfected with plasmids encoding myc-tagged WT, S191A or S605A \u03b2-catenin and pHA-LEF-1 before being fixed and stained for \u03b1-myc (green: \u03b2-catenin), \u03b1-HA (red: LEF-1) and DNA (blue: Hoechst dye,). LEF-1 is seen to drag WT-\u03b2-catenin into the nuclei of cells more efficiently than it does for \u03b2-catenin-S191A and S605A mutants. (B) Cells were scored for nuclear>cytoplasmic staining of ectopic \u03b2-catenin in the LEF-1-transfected cells. (C) NIH 3T3 cells were co-transfected with myc-tagged \u03b2-catenin constructs (WT, S191A or S605A) and pHA-LEF-1 and subjected to PLA. \u03b1-myc and \u03b1-HA antibodies were used to detect the interaction between \u03b2-catenin and LEF-1. A significant reduction in nuclear interactions between the \u03b2-catenin mutants (S191A and S605A) and LEF-1-HA can be seen. (D) A dot plot shows the number of nuclear interactions between \u03b2-catenin and LEF-1 counted per cell. One hundred nuclei over two independent experiments were scored from z-stack confocal microscopy images and a representative graph is shown. (E) pLEF-1-HA was co-transfected with p\u03b2-catenin-myc constructs (WT, S191A or S605A) in NIH 3T3 cells. Cell lysates were subjected to immunoprecipitation using HA mAb or isotype control IgG antibody. The blot was probed with anti-HA and myc antibodies and shows a reduction in \u03b2-catenin-phosphorylation mutant binding to LEF-1 compared with WT-\u03b2-catenin. (F) Column graph showing significant reduction in \u03b2-catenin mutant band intensity compared with wild-type analyzed by densitometry over three independent experiments. (G) Schematic diagram showing the phosphorylation of \u03b2-catenin at S605 (Rac1 mediated) increases the interaction between \u03b2-catenin and LEF-1.", "co_occurrence": [{"body": 107, "word": "\u03b2-catenin", "fig": 14}, {"body": 59, "word": "cells", "fig": 6}, {"body": 33, "word": "LEF-1", "fig": 9}, {"body": 58, "word": "nuclear", "fig": 3}, {"body": 99, "word": "Rac1", "fig": 1}, {"body": 85, "word": "al.", "fig": 1}, {"body": 85, "word": "et", "fig": 1}, {"body": 12, "word": "S605A", "fig": 5}, {"body": 13, "word": "NIH", "fig": 4}, {"body": 13, "word": "3T3", "fig": 4}, {"body": 21, "word": "nucleus", "fig": 2}, {"body": 11, "word": "binding", "fig": 3}, {"body": 8, "word": "S191A", "fig": 4}, {"body": 16, "word": "antibodies", "fig": 2}, {"body": 28, "word": "cell", "fig": 1}, {"body": 14, "word": "interaction", "fig": 2}, {"body": 14, "word": "used", "fig": 2}, {"body": 28, "word": "The", "fig": 1}, {"body": 14, "word": "S605", "fig": 2}, {"body": 24, "word": "using", "fig": 1}, {"body": 8, "word": "mutants", "fig": 3}, {"body": 10, "word": "wild-type", "fig": 2}, {"body": 10, "word": "constructs", "fig": 2}, {"body": 9, "word": "interactions", "fig": 2}, {"body": 6, "word": "reduction", "fig": 3}, {"body": 9, "word": "mutant", "fig": 2}, {"body": 5, "word": "WT", "fig": 3}, {"body": 15, "word": "PLA", "fig": 1}, {"body": 7, "word": "phosphorylation", "fig": 2}, {"body": 6, "word": "compared", "fig": 2}, {"body": 6, "word": "nuclei", "fig": 2}, {"body": 10, "word": "Cells", "fig": 1}, {"body": 10, "word": "S191", "fig": 1}, {"body": 5, "word": "significant", "fig": 2}, {"body": 9, "word": "We", "fig": 1}, {"body": 9, "word": "microscopy", "fig": 1}, {"body": 9, "word": "three", "fig": 1}, {"body": 3, "word": "co-transfected", "fig": 3}, {"body": 4, "word": "subjected", "fig": 2}, {"body": 4, "word": "experiments", "fig": 2}, {"body": 8, "word": "confocal", "fig": 1}, {"body": 8, "word": "first", "fig": 1}, {"body": 4, "word": "myc-tagged", "fig": 2}, {"body": 7, "word": "sites", "fig": 1}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 6, "word": "fixed", "fig": 1}, {"body": 6, "word": "shown", "fig": 1}, {"body": 3, "word": "WT-\u03b2-catenin", "fig": 2}, {"body": 6, "word": "control", "fig": 1}, {"body": 6, "word": "number", "fig": 1}, {"body": 6, "word": "two", "fig": 1}, {"body": 3, "word": "seen", "fig": 2}, {"body": 2, "word": "A", "fig": 3}, {"body": 5, "word": "red", "fig": 1}, {"body": 4, "word": "anti-HA", "fig": 1}, {"body": 4, "word": "ectopic", "fig": 1}, {"body": 2, "word": "scored", "fig": 2}, {"body": 4, "word": "cytoplasmic", "fig": 1}, {"body": 4, "word": "images", "fig": 1}, {"body": 4, "word": "HA", "fig": 1}, {"body": 4, "word": "ability", "fig": 1}, {"body": 4, "word": "analyzed", "fig": 1}, {"body": 3, "word": "D", "fig": 1}, {"body": 3, "word": "plasmids", "fig": 1}, {"body": 3, "word": "lysates", "fig": 1}, {"body": 3, "word": "immunoprecipitation", "fig": 1}, {"body": 1, "word": "pHA-LEF-1", "fig": 3}, {"body": 2, "word": "staining", "fig": 1}, {"body": 2, "word": "Henderson", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "Overexpression", "fig": 1}, {"body": 2, "word": "detect", "fig": 1}, {"body": 2, "word": "per", "fig": 1}, {"body": 1, "word": "shows", "fig": 2}, {"body": 2, "word": "C", "fig": 1}, {"body": 1, "word": "graph", "fig": 2}, {"body": 2, "word": "encoding", "fig": 1}, {"body": 2, "word": "mAb", "fig": 1}, {"body": 2, "word": "DNA", "fig": 1}, {"body": 2, "word": "site", "fig": 1}, {"body": 2, "word": "myc", "fig": 1}, {"body": 2, "word": "One", "fig": 1}, {"body": 1, "word": "IgG", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "chromatin", "fig": 1}, {"body": 1, "word": "z-stack", "fig": 1}, {"body": 1, "word": "reduce", "fig": 1}, {"body": 1, "word": "Cell", "fig": 1}, {"body": 1, "word": "Mutation", "fig": 1}, {"body": 1, "word": "Rac1-regulated", "fig": 1}, {"body": 1, "word": "B", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "stabilizes", "fig": 1}, {"body": 1, "word": "compare", "fig": 1}, {"body": 1, "word": "E", "fig": 1}, {"body": 1, "word": "Hoechst", "fig": 1}, {"body": 1, "word": "Rac1-regulatory", "fig": 1}, {"body": 1, "word": "green", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657330/bin/joces-128-167742-g8.jpg", "caption": "Rac1 activation and Wnt synergistically enhance \u03b2-catenin transactivation in the canonical Wnt pathway. In Wnt stimulated cells or in cancer when there are mutations in key pathway components (*Axin, APC, \u03b2-catenin) \u03b2-catenin is driven into the nuclei of cells to transactivate Wnt target genes in co-operation with LEF-1/TCF transcription factors. In addition to Wnt, active Rac1 augments the transcription of Wnt target genes through the following steps: (1) loss of \u03b2-catenin membrane retention after Rac1 activation; (2) increased nuclear localization of active Rac1\u2013\u03b2-catenin complexes; (3) phosphorylation of \u03b2-catenin at S191 and S605 by JNK2, leading to (4) increased binding of phosphorylated \u03b2-catenin to the transcription factor LEF-1 and enhanced transactivation. It is possible that phosphorylation of \u03b2-catenin at S191 and S605 could occur in either nucleus or cytoplasm.", "co_occurrence": [{"body": 107, "word": "\u03b2-catenin", "fig": 7}, {"body": 54, "word": "Wnt", "fig": 6}, {"body": 99, "word": "Rac1", "fig": 3}, {"body": 59, "word": "cells", "fig": 2}, {"body": 58, "word": "nuclear", "fig": 1}, {"body": 28, "word": "active", "fig": 2}, {"body": 17, "word": "activation", "fig": 2}, {"body": 33, "word": "complexes", "fig": 1}, {"body": 33, "word": "LEF-1", "fig": 1}, {"body": 14, "word": "S605", "fig": 2}, {"body": 26, "word": "Rac1\u2013\u03b2-catenin", "fig": 1}, {"body": 12, "word": "In", "fig": 2}, {"body": 11, "word": "pathway", "fig": 2}, {"body": 7, "word": "transcription", "fig": 3}, {"body": 21, "word": "nucleus", "fig": 1}, {"body": 10, "word": "S191", "fig": 2}, {"body": 8, "word": "increased", "fig": 2}, {"body": 8, "word": "target", "fig": 2}, {"body": 7, "word": "transactivation", "fig": 2}, {"body": 7, "word": "phosphorylation", "fig": 2}, {"body": 12, "word": "membrane", "fig": 1}, {"body": 11, "word": "binding", "fig": 1}, {"body": 11, "word": "localization", "fig": 1}, {"body": 10, "word": "cancer", "fig": 1}, {"body": 5, "word": "genes", "fig": 2}, {"body": 6, "word": "cytoplasm", "fig": 1}, {"body": 6, "word": "canonical", "fig": 1}, {"body": 6, "word": "nuclei", "fig": 1}, {"body": 5, "word": "mutations", "fig": 1}, {"body": 5, "word": "APC", "fig": 1}, {"body": 5, "word": "leading", "fig": 1}, {"body": 4, "word": "JNK2", "fig": 1}, {"body": 4, "word": "factor", "fig": 1}, {"body": 4, "word": "following", "fig": 1}, {"body": 3, "word": "key", "fig": 1}, {"body": 3, "word": "phosphorylated", "fig": 1}, {"body": 3, "word": "addition", "fig": 1}, {"body": 2, "word": "stimulated", "fig": 1}, {"body": 2, "word": "loss", "fig": 1}, {"body": 1, "word": "enhanced", "fig": 1}, {"body": 1, "word": "It", "fig": 1}, {"body": 1, "word": "factors", "fig": 1}, {"body": 1, "word": "could", "fig": 1}, {"body": 1, "word": "possible", "fig": 1}, {"body": 1, "word": "LEF-1/TCF", "fig": 1}, {"body": 1, "word": "retention", "fig": 1}, {"body": 1, "word": "steps", "fig": 1}, {"body": 1, "word": "either", "fig": 1}, {"body": 1, "word": "enhance", "fig": 1}]}], "4147360": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147360/bin/BMRI2014-309385.001.jpg", "caption": "Phenotype caused by pax1b knockdown. In order to analyze the function of pax1b during embryogenesis, we injected pax1b-specific morpholinos into fertilized eggs to block production of functional Pax1b protein. (a) Embryo injected with 5 ng control morpholino. ((b)-(c)) The phenotypes of pax1b morphants caused by 2 ng or 5 ng injection doses. ((d)\u2013(g)) The phenotypes caused by coinjection of 200 ng pax1b or gfp mRNA with 5 ng pax1b MO or control MO. pax1b mRNA could partially rescue the defective fin bud phenotype of the pax1b morphant (g); gfp mRNA failed to rescue defective fin bud phenotype of the pax1b morphant (e). (h) Statistical analysis of phenotypes caused by coinjection of different mRNAs with 5 ng pax1b MO. 150 embryos were calculated. The amount of mRNA injected for every embryo is as follows: 200 ng gfp mRNA, 200 ng pax1b mRNA, 200 ng pax1a mRNA, 150 ng amphioxus pax1/9 mRNA, and 200 ng zebrafish pax9 mRNA. All embryos were observed at 24 hpf. zpax1b: zebrafish pax1b, zpax1a: zebrafish pax1a, zpax9: zebrafish pax9. hpf: hours post-fertilization. gfp: green fluorescence protein. ctr: control.", "co_occurrence": [{"body": 56, "word": "pax1b", "fig": 11}, {"body": 29, "word": "zebrafish", "fig": 4}, {"body": 9, "word": "mRNA", "fig": 9}, {"body": 5, "word": "ng", "fig": 11}, {"body": 18, "word": "The", "fig": 3}, {"body": 14, "word": "MO", "fig": 3}, {"body": 21, "word": "pax9", "fig": 2}, {"body": 18, "word": "fin", "fig": 2}, {"body": 13, "word": "bud", "fig": 2}, {"body": 24, "word": "morphants", "fig": 1}, {"body": 12, "word": "embryos", "fig": 2}, {"body": 7, "word": "control", "fig": 3}, {"body": 5, "word": "caused", "fig": 4}, {"body": 6, "word": "phenotypes", "fig": 3}, {"body": 17, "word": "Pax1b", "fig": 1}, {"body": 5, "word": "injected", "fig": 3}, {"body": 15, "word": "In", "fig": 1}, {"body": 6, "word": "rescue", "fig": 2}, {"body": 6, "word": "hpf", "fig": 2}, {"body": 5, "word": "protein", "fig": 2}, {"body": 9, "word": "different", "fig": 1}, {"body": 8, "word": "could", "fig": 1}, {"body": 7, "word": "knockdown", "fig": 1}, {"body": 3, "word": "pax1a", "fig": 2}, {"body": 3, "word": "phenotype", "fig": 2}, {"body": 5, "word": "b", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 1, "word": "gfp", "fig": 4}, {"body": 4, "word": "function", "fig": 1}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "h", "fig": 1}, {"body": 3, "word": "pax1/9", "fig": 1}, {"body": 3, "word": "All", "fig": 1}, {"body": 3, "word": "analysis", "fig": 1}, {"body": 3, "word": "morpholino", "fig": 1}, {"body": 2, "word": "mRNAs", "fig": 1}, {"body": 1, "word": "g", "fig": 2}, {"body": 1, "word": "coinjection", "fig": 2}, {"body": 2, "word": "amphioxus", "fig": 1}, {"body": 1, "word": "Embryo", "fig": 1}, {"body": 1, "word": "morpholinos", "fig": 1}, {"body": 1, "word": "follows", "fig": 1}, {"body": 1, "word": "observed", "fig": 1}, {"body": 1, "word": "hours", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "block", "fig": 1}, {"body": 1, "word": "embryo", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "partially", "fig": 1}, {"body": 1, "word": "eggs", "fig": 1}, {"body": 1, "word": "fertilized", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}, {"body": 1, "word": "order", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147360/bin/BMRI2014-309385.002.jpg", "caption": "Fin bud and tail defects caused by injection of pax1b MO and/or zebrafish pax9 MO. (a) Fin bud and axis defects caused by injection of 5 ng pax1b MO. (b) Tail defect caused by injection of 5 ng zebrafish pax9 MO. (c) Fin bud and tail defects caused by coinjection of 2.5 ng pax1b MO and 2.5 ng zebrafish pax9 MO. (d) Statistics of phenotype ratios. White columns indicate the ratio of fin bud defect; shaded columns indicate the ratio of kinky tail. (e) Statistical analysis of phenotypes caused by coinjection of different mRNAs with 5 ng zebrafish pax9 MO. The amount of mRNA injected for every embryo is as follows: 200 ng gfp mRNA, 200 ng pax1b mRNA, 200 ng pax1a mRNA, and 200 ng zebrafish pax9 mRNA. All embryos were observed at 36 hpf.", "co_occurrence": [{"body": 56, "word": "pax1b", "fig": 4}, {"body": 29, "word": "zebrafish", "fig": 5}, {"body": 21, "word": "pax9", "fig": 5}, {"body": 14, "word": "MO", "fig": 7}, {"body": 13, "word": "bud", "fig": 4}, {"body": 9, "word": "mRNA", "fig": 5}, {"body": 5, "word": "ng", "fig": 9}, {"body": 10, "word": "defects", "fig": 3}, {"body": 5, "word": "caused", "fig": 5}, {"body": 18, "word": "The", "fig": 1}, {"body": 18, "word": "fin", "fig": 1}, {"body": 12, "word": "embryos", "fig": 1}, {"body": 9, "word": "different", "fig": 1}, {"body": 3, "word": "tail", "fig": 3}, {"body": 6, "word": "phenotypes", "fig": 1}, {"body": 6, "word": "hpf", "fig": 1}, {"body": 5, "word": "axis", "fig": 1}, {"body": 5, "word": "injected", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 2, "word": "defect", "fig": 2}, {"body": 3, "word": "All", "fig": 1}, {"body": 1, "word": "Fin", "fig": 3}, {"body": 3, "word": "phenotype", "fig": 1}, {"body": 3, "word": "pax1a", "fig": 1}, {"body": 1, "word": "injection", "fig": 3}, {"body": 3, "word": "d", "fig": 1}, {"body": 3, "word": "analysis", "fig": 1}, {"body": 2, "word": "mRNAs", "fig": 1}, {"body": 1, "word": "coinjection", "fig": 2}, {"body": 1, "word": "ratio", "fig": 2}, {"body": 1, "word": "observed", "fig": 1}, {"body": 1, "word": "Tail", "fig": 1}, {"body": 1, "word": "gfp", "fig": 1}, {"body": 1, "word": "e", "fig": 1}, {"body": 1, "word": "embryo", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}, {"body": 1, "word": "follows", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147360/bin/BMRI2014-309385.003.jpg", "caption": "Fin bud defects caused by pax1b knockdown. ((a)\u2013(d)) Dorsal view of the region near the fin bud with orientation of head towards the top. (a) Control embryos. ((b)-(c)) pax1b morphants. (d) Rescue embryos: coinjection with 5 ng pax1b MO and 200 ng pax1b mRNA. (e) Statistical analysis of fin bud defects caused by injection of control MO or pax1b MO. Total numbers of injected embryos are labeled. ((f)\u2013(m)) Expression pattern of erm and pea3 in control embryos, pax1b morphants, and coinjected embryos. Numbers of defective embryos and total numbers of stained embryos are labeled in the bottoms. The embryonic stage is 72 hpf in panels (a)\u2013(e) and 32 hpf in panels (f)\u2013(m). All the embryos are viewed from the dorsal side with head towards the top.", "co_occurrence": [{"body": 56, "word": "pax1b", "fig": 6}, {"body": 12, "word": "embryos", "fig": 8}, {"body": 24, "word": "morphants", "fig": 2}, {"body": 14, "word": "MO", "fig": 3}, {"body": 13, "word": "bud", "fig": 3}, {"body": 18, "word": "fin", "fig": 2}, {"body": 10, "word": "defects", "fig": 2}, {"body": 18, "word": "The", "fig": 1}, {"body": 7, "word": "control", "fig": 2}, {"body": 6, "word": "hpf", "fig": 2}, {"body": 5, "word": "caused", "fig": 2}, {"body": 5, "word": "ng", "fig": 2}, {"body": 9, "word": "mRNA", "fig": 1}, {"body": 7, "word": "knockdown", "fig": 1}, {"body": 3, "word": "d", "fig": 2}, {"body": 5, "word": "injected", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 3, "word": "All", "fig": 1}, {"body": 3, "word": "embryonic", "fig": 1}, {"body": 3, "word": "analysis", "fig": 1}, {"body": 1, "word": "numbers", "fig": 2}, {"body": 2, "word": "pea3", "fig": 1}, {"body": 2, "word": "Expression", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 1, "word": "head", "fig": 2}, {"body": 2, "word": "stage", "fig": 1}, {"body": 1, "word": "e", "fig": 2}, {"body": 1, "word": "f", "fig": 2}, {"body": 1, "word": "m", "fig": 2}, {"body": 2, "word": "erm", "fig": 1}, {"body": 1, "word": "dorsal", "fig": 1}, {"body": 1, "word": "coinjection", "fig": 1}, {"body": 1, "word": "Fin", "fig": 1}, {"body": 1, "word": "injection", "fig": 1}, {"body": 1, "word": "Statistical", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147360/bin/BMRI2014-309385.004.jpg", "caption": "Molecular mechanism of sclerotome development mediated by Pax1b. (a) The relative expression level of zebrafish collagen type II (col2a1) monitored by qPCR. (b) Sclerotome differentiation analyzed by molecular markers Uncx4.1 and Noggin3 by Western blot. (c) The relative expression level of zebrafish aggrecan monitored by qPCR. The fold change for each group was determined using the delta-delta Ct method. Quantified mRNA levels were normalized to \u03b2-actin and are presented relative to control embryos. 50 embryos at the 48 hpf stage were used in each group, performed in triplicate.", "co_occurrence": [{"body": 29, "word": "zebrafish", "fig": 2}, {"body": 18, "word": "The", "fig": 3}, {"body": 12, "word": "embryos", "fig": 2}, {"body": 12, "word": "expression", "fig": 2}, {"body": 17, "word": "Pax1b", "fig": 1}, {"body": 12, "word": "development", "fig": 1}, {"body": 9, "word": "differentiation", "fig": 1}, {"body": 9, "word": "mRNA", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "control", "fig": 1}, {"body": 7, "word": "using", "fig": 1}, {"body": 3, "word": "level", "fig": 2}, {"body": 6, "word": "hpf", "fig": 1}, {"body": 5, "word": "Noggin3", "fig": 1}, {"body": 5, "word": "Uncx4.1", "fig": 1}, {"body": 5, "word": "sclerotome", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "Western", "fig": 1}, {"body": 2, "word": "group", "fig": 2}, {"body": 1, "word": "relative", "fig": 3}, {"body": 3, "word": "col2a1", "fig": 1}, {"body": 3, "word": "determined", "fig": 1}, {"body": 1, "word": "qPCR", "fig": 2}, {"body": 2, "word": "markers", "fig": 1}, {"body": 2, "word": "performed", "fig": 1}, {"body": 2, "word": "mechanism", "fig": 1}, {"body": 2, "word": "molecular", "fig": 1}, {"body": 2, "word": "levels", "fig": 1}, {"body": 2, "word": "normalized", "fig": 1}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 2, "word": "stage", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 1, "word": "\u03b2-actin", "fig": 1}, {"body": 1, "word": "collagen", "fig": 1}, {"body": 1, "word": "fold", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "Quantified", "fig": 1}, {"body": 1, "word": "mediated", "fig": 1}, {"body": 1, "word": "delta-delta", "fig": 1}, {"body": 1, "word": "type", "fig": 1}, {"body": 1, "word": "method", "fig": 1}, {"body": 1, "word": "aggrecan", "fig": 1}, {"body": 1, "word": "II", "fig": 1}, {"body": 1, "word": "change", "fig": 1}, {"body": 1, "word": "Ct", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147360/bin/BMRI2014-309385.005.jpg", "caption": "Forced expression of Pax1 decreases cell death potential on physiological stress. U2OS cells were exposed to 80 J/m2 UV (a) or 2.5 \u03bcM doxorubicin (b) for 8 h. Hoechst-positive cells were counted and subjected to statistical analysis using Student's t-tests. All pax1b DNA induction was mediated by the IRES-TOMATO lentivirus system. Data are presented as means \u00b1 SE from three independent experiments. \u2217P < 0.05, compared with vector.", "co_occurrence": [{"body": 56, "word": "pax1b", "fig": 1}, {"body": 25, "word": "cell", "fig": 1}, {"body": 9, "word": "cells", "fig": 2}, {"body": 16, "word": "Pax1", "fig": 1}, {"body": 14, "word": "death", "fig": 1}, {"body": 12, "word": "expression", "fig": 1}, {"body": 7, "word": "using", "fig": 1}, {"body": 7, "word": "stress", "fig": 1}, {"body": 5, "word": "DNA", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 4, "word": "U2OS", "fig": 1}, {"body": 3, "word": "All", "fig": 1}, {"body": 3, "word": "analysis", "fig": 1}, {"body": 2, "word": "experiments", "fig": 1}, {"body": 2, "word": "doxorubicin", "fig": 1}, {"body": 2, "word": "means", "fig": 1}, {"body": 2, "word": "system", "fig": 1}, {"body": 2, "word": "presented", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "UV", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 1, "word": "Forced", "fig": 1}, {"body": 1, "word": "exposed", "fig": 1}, {"body": 1, "word": "lentivirus", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "IRES-TOMATO", "fig": 1}, {"body": 1, "word": "physiological", "fig": 1}, {"body": 1, "word": "induction", "fig": 1}, {"body": 1, "word": "independent", "fig": 1}, {"body": 1, "word": "'s", "fig": 1}, {"body": 1, "word": "J/m2", "fig": 1}, {"body": 1, "word": "compared", "fig": 1}, {"body": 1, "word": "mediated", "fig": 1}, {"body": 1, "word": "vector", "fig": 1}, {"body": 1, "word": "SE", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147360/bin/BMRI2014-309385.006.jpg", "caption": "The interaction between PAX1 and FOXO1. (a) FOXO1 is a new PAX1-interacting protein. HEK293FT cells were transfected with Myc-tagged FOXO1 and Flag-tagged PAX1 cloned from human cDNA. Cells were harvested for immunoprecipitation with anti-Flag affinity resin and immunoblotted with the indicated antibodies. (b) The interaction of Pax1 and FOXO1 was conserved. Myc-tagged FOXO1 was immunoprecipitated by Flag-tagged Pax1b or mouse Pax1. (c) PAX9 did not interact with FOXO1 in HEK293FT cells. zPax1b: zebrafish Pax1b; mPax1: mouse Pax1. TCL: total cell lysate. IP: immunoprecipitation.", "co_occurrence": [{"body": 21, "word": "FOXO1", "fig": 6}, {"body": 16, "word": "Pax1", "fig": 3}, {"body": 18, "word": "The", "fig": 2}, {"body": 17, "word": "Pax1b", "fig": 2}, {"body": 15, "word": "PAX1", "fig": 2}, {"body": 29, "word": "zebrafish", "fig": 1}, {"body": 25, "word": "cell", "fig": 1}, {"body": 9, "word": "cells", "fig": 2}, {"body": 7, "word": "interaction", "fig": 2}, {"body": 6, "word": "mouse", "fig": 2}, {"body": 5, "word": "protein", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "b", "fig": 1}, {"body": 2, "word": "immunoprecipitation", "fig": 2}, {"body": 3, "word": "indicated", "fig": 1}, {"body": 3, "word": "PAX9", "fig": 1}, {"body": 3, "word": "cDNA", "fig": 1}, {"body": 3, "word": "antibodies", "fig": 1}, {"body": 2, "word": "human", "fig": 1}, {"body": 2, "word": "total", "fig": 1}, {"body": 1, "word": "HEK293FT", "fig": 2}, {"body": 2, "word": "conserved", "fig": 1}, {"body": 1, "word": "anti-Flag", "fig": 1}, {"body": 1, "word": "affinity", "fig": 1}, {"body": 1, "word": "new", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147360/bin/BMRI2014-309385.007.jpg", "caption": "The interaction between PAX1 and FOXO1 is enhanced under hypoxia stress. (a) Colocalization of PAX1 and FOXO1 in HeLa cells. Myc-FOXO1 is distributed in the cytoplasm and nucleus while Flag-PAX1 is located in the nucleus only. The colocalization of PAX1 and FOXO1 was increased after treatment with 20 \u03bcM CoCl2 for 14 h. Myc-FOXO1 was cotransfected with Flag-PAX1 into HeLa cells. 36 h after transfection, cells were subjected to immunostaining using anti-Myc antibody, anti-Flag antibody, and DAPI and observed by microscopy. ((b)-(c)) 2 \u03bcg Flag-tagged PAX1 and/or 0.5 \u03bcg Myc-tagged FOXO1 were transfected into HEK293FT cells, respectively. Semiendogenous Co-IP revealed that the interaction of PAX1 and FOXO1 was strengthened when stimulated with CoCl2 and the enhancement occurred in a dose-dependent manner.", "co_occurrence": [{"body": 21, "word": "FOXO1", "fig": 5}, {"body": 15, "word": "PAX1", "fig": 5}, {"body": 18, "word": "The", "fig": 2}, {"body": 9, "word": "cells", "fig": 4}, {"body": 7, "word": "interaction", "fig": 2}, {"body": 5, "word": "antibody", "fig": 2}, {"body": 4, "word": "\u03bcg", "fig": 2}, {"body": 7, "word": "using", "fig": 1}, {"body": 7, "word": "stress", "fig": 1}, {"body": 6, "word": "hypoxia", "fig": 1}, {"body": 3, "word": "nucleus", "fig": 2}, {"body": 5, "word": "b", "fig": 1}, {"body": 5, "word": "c", "fig": 1}, {"body": 5, "word": "respectively", "fig": 1}, {"body": 2, "word": "HeLa", "fig": 2}, {"body": 2, "word": "CoCl2", "fig": 2}, {"body": 3, "word": "enhanced", "fig": 1}, {"body": 3, "word": "treatment", "fig": 1}, {"body": 3, "word": "transfection", "fig": 1}, {"body": 3, "word": "revealed", "fig": 1}, {"body": 3, "word": "h", "fig": 1}, {"body": 2, "word": "cytoplasm", "fig": 1}, {"body": 2, "word": "dose-dependent", "fig": 1}, {"body": 2, "word": "increased", "fig": 1}, {"body": 2, "word": "\u03bcM", "fig": 1}, {"body": 2, "word": "manner", "fig": 1}, {"body": 1, "word": "strengthened", "fig": 1}, {"body": 1, "word": "stimulated", "fig": 1}, {"body": 1, "word": "observed", "fig": 1}, {"body": 1, "word": "anti-Flag", "fig": 1}, {"body": 1, "word": "distributed", "fig": 1}, {"body": 1, "word": "located", "fig": 1}, {"body": 1, "word": "h.", "fig": 1}, {"body": 1, "word": "HEK293FT", "fig": 1}, {"body": 1, "word": "colocalization", "fig": 1}, {"body": 1, "word": "DAPI", "fig": 1}]}], "4382927": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382927/bin/40478_2015_201_Fig1_HTML.jpg", "caption": "HDAC2 mRNA and protein is differentially expressed in clinical medulloblastoma samples. a scatter plot of mRNA expression of HDAC1, 2 and 3, as measured by gene expression profiling. Only HDAC2 is elevated in in the subgroups with poor prognosis (SHH, Group 3 and Group 4), but not in the subgroup with good prognosis (WNT) or normal cerebellum. b HDAC2 protein expression is detected by immunohistochemistry (IHC) (brown staining) in the majority of medulloblastoma tumor samples. Both positive (sample 1, molecular subgroup: group 3) and negative (sample 2, molecular subgroup: SHH) examples are shown. No HDAC2 protein expression is detected by IHC in normal cerebellum in the two samples analyzed (depicted region: molecular layer of the hemisphere). Scale bar size: 50 \u03bcm. c Semiquantitative analysis of HDAC2 IHC reveals higher expression of HDAC2 protein in SHH, Group3 and Group4 compared to WNT and normal cerebellum. cb: cerebellum.", "co_occurrence": [{"body": 33, "word": "HDAC2", "fig": 6}, {"body": 27, "word": "expression", "fig": 5}, {"body": 32, "word": "Group", "fig": 2}, {"body": 12, "word": "protein", "fig": 4}, {"body": 14, "word": "SHH", "fig": 3}, {"body": 12, "word": "molecular", "fig": 3}, {"body": 6, "word": "cerebellum", "fig": 4}, {"body": 8, "word": "subgroup", "fig": 3}, {"body": 22, "word": "clinical", "fig": 1}, {"body": 7, "word": "IHC", "fig": 3}, {"body": 10, "word": "WNT", "fig": 2}, {"body": 6, "word": "normal", "fig": 3}, {"body": 8, "word": "mRNA", "fig": 2}, {"body": 5, "word": "samples", "fig": 3}, {"body": 6, "word": "prognosis", "fig": 2}, {"body": 12, "word": "subgroups", "fig": 1}, {"body": 11, "word": "HDAC1", "fig": 1}, {"body": 10, "word": "shown", "fig": 1}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 4, "word": "medulloblastoma", "fig": 2}, {"body": 8, "word": "tumor", "fig": 1}, {"body": 7, "word": "staining", "fig": 1}, {"body": 7, "word": "poor", "fig": 1}, {"body": 6, "word": "group", "fig": 1}, {"body": 6, "word": "expressed", "fig": 1}, {"body": 6, "word": "No", "fig": 1}, {"body": 6, "word": "compared", "fig": 1}, {"body": 5, "word": "higher", "fig": 1}, {"body": 4, "word": "gene", "fig": 1}, {"body": 4, "word": "measured", "fig": 1}, {"body": 3, "word": "positive", "fig": 1}, {"body": 3, "word": "Group4", "fig": 1}, {"body": 3, "word": "Group3", "fig": 1}, {"body": 1, "word": "detected", "fig": 2}, {"body": 2, "word": "analyzed", "fig": 1}, {"body": 1, "word": "sample", "fig": 2}, {"body": 1, "word": "good", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "differentially", "fig": 1}, {"body": 1, "word": "reveals", "fig": 1}, {"body": 1, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "two", "fig": 1}, {"body": 1, "word": "Both", "fig": 1}, {"body": 1, "word": "elevated", "fig": 1}, {"body": 1, "word": "majority", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382927/bin/40478_2015_201_Fig2_HTML.jpg", "caption": "MYC amplified medulloblastoma cell lines show differential expression of class I HDACs HDAC1, 2 and 3. a gene expression as measured by quantitative RT-real time PCR shows differential expression of HDAC1, 2 and 3 in medulloblastoma cell lines with high MYC expression, with HDAC2 showing a significant difference between MYC amplified and MYC non-amplified cell lines (* = p < 0.05, one way ANOVA test). b protein detection by western blot detects higher cMYC and HDAC2 protein in cells with MYC amplification. c correlation of HDAC2 and MYC mRNA expression as measured by gene expression profiling in n = 42 primary Group 3 MB tumors (Pearson product-moment correlation coefficient, two tailed p-test). Bars depict mean and standard error of three independent experiments.", "co_occurrence": [{"body": 39, "word": "MYC", "fig": 6}, {"body": 27, "word": "expression", "fig": 6}, {"body": 37, "word": "cell", "fig": 3}, {"body": 33, "word": "HDAC2", "fig": 3}, {"body": 52, "word": "MB", "fig": 1}, {"body": 46, "word": "class", "fig": 1}, {"body": 15, "word": "lines", "fig": 3}, {"body": 20, "word": "amplified", "fig": 2}, {"body": 32, "word": "Group", "fig": 1}, {"body": 29, "word": "cells", "fig": 1}, {"body": 25, "word": "HDACs", "fig": 1}, {"body": 12, "word": "protein", "fig": 2}, {"body": 24, "word": "I", "fig": 1}, {"body": 11, "word": "HDAC1", "fig": 2}, {"body": 16, "word": "tumors", "fig": 1}, {"body": 8, "word": "mRNA", "fig": 1}, {"body": 8, "word": "high", "fig": 1}, {"body": 8, "word": "amplification", "fig": 1}, {"body": 4, "word": "measured", "fig": 2}, {"body": 4, "word": "differential", "fig": 2}, {"body": 4, "word": "medulloblastoma", "fig": 2}, {"body": 4, "word": "gene", "fig": 2}, {"body": 6, "word": "primary", "fig": 1}, {"body": 6, "word": "non-amplified", "fig": 1}, {"body": 3, "word": "correlation", "fig": 2}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 5, "word": "higher", "fig": 1}, {"body": 5, "word": "cMYC", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 2, "word": "PCR", "fig": 1}, {"body": 2, "word": "blot", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "showing", "fig": 1}, {"body": 2, "word": "difference", "fig": 1}, {"body": 2, "word": "n", "fig": 1}, {"body": 2, "word": "quantitative", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "show", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "test", "fig": 1}, {"body": 1, "word": "shows", "fig": 1}, {"body": 1, "word": "western", "fig": 1}, {"body": 1, "word": "detection", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "two", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382927/bin/40478_2015_201_Fig3_HTML.jpg", "caption": "HDAC inhibitors MAZ1863 and MAZ1866 are highly selective and potently inhibit class IIa activity. Both MAZ1863 (top) and MAZ1866 (bottom) significantly inhibit intracellular class IIa HDAC activity compared to DMSO control, as measured by class IIa HDAC specific substrate turnover in a cell-based biochemical HDAC activity assay after treatment of MED8A MB cells with the compounds at indicated concentrations for 1 h. Class I/IIb HDAC activity is not inhibited by MAZ1863 or MAZ1866, while vorinostat significantly inhibits class I/IIb HDAC activity, as expected. Bars depict mean and standard error of three independent experiments, significant differences compared to DMSO control are indicated: * = p < 0.05, ** = p < 0.01, *** = p < 0.001 (unpaired t-test).", "co_occurrence": [{"body": 46, "word": "activity", "fig": 5}, {"body": 37, "word": "HDAC", "fig": 6}, {"body": 46, "word": "class", "fig": 4}, {"body": 22, "word": "IIa", "fig": 3}, {"body": 52, "word": "MB", "fig": 1}, {"body": 29, "word": "cells", "fig": 1}, {"body": 7, "word": "MAZ1863", "fig": 3}, {"body": 7, "word": "MAZ1866", "fig": 3}, {"body": 19, "word": "vorinostat", "fig": 1}, {"body": 13, "word": "treatment", "fig": 1}, {"body": 6, "word": "compared", "fig": 2}, {"body": 9, "word": "concentrations", "fig": 1}, {"body": 8, "word": "inhibitors", "fig": 1}, {"body": 7, "word": "specific", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 3, "word": "I/IIb", "fig": 2}, {"body": 5, "word": "MED8A", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "assay", "fig": 1}, {"body": 5, "word": "selective", "fig": 1}, {"body": 2, "word": "control", "fig": 2}, {"body": 2, "word": "significantly", "fig": 2}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 4, "word": "highly", "fig": 1}, {"body": 4, "word": "intracellular", "fig": 1}, {"body": 4, "word": "measured", "fig": 1}, {"body": 2, "word": "inhibit", "fig": 2}, {"body": 2, "word": "DMSO", "fig": 2}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "substrate", "fig": 1}, {"body": 3, "word": "compounds", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "cell-based", "fig": 1}, {"body": 1, "word": "potently", "fig": 1}, {"body": 1, "word": "Class", "fig": 1}, {"body": 1, "word": "expected", "fig": 1}, {"body": 1, "word": "Both", "fig": 1}, {"body": 1, "word": "inhibited", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "unpaired", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382927/bin/40478_2015_201_Fig4_HTML.jpg", "caption": "Class I/IIb- but not class IIa-HDAC inhibitors potently inhibit metabolic activity of MYC amplified medulloblastoma (MB) cells in vitro. a The metabolic activity of MYC amplified medullobastoma cells HD-MB03, MED8A, D458 (yellow) is potently inhibited by class I/IIb HDACi vorinostat and HDAC1,2,3 selective MS275, but not by class IIa HDACi MAZ1863 and MAZ1866, each after 72 h of treatment. The metabolic activity of MYC non-amplified MB cells UW228-2, DAOY, ONS76 (red) is inhibited only at very high concentrations. b EC50 values of vorinostat and MS-275 are significantly lower for MYC amplified cell lines, and are close to (MS-275) or below (vorinostat) published plasma concentrations clinically achievable in patients (dashed lines).", "co_occurrence": [{"body": 39, "word": "MYC", "fig": 4}, {"body": 46, "word": "class", "fig": 3}, {"body": 46, "word": "activity", "fig": 3}, {"body": 52, "word": "MB", "fig": 2}, {"body": 29, "word": "cells", "fig": 3}, {"body": 20, "word": "amplified", "fig": 3}, {"body": 19, "word": "vorinostat", "fig": 3}, {"body": 19, "word": "The", "fig": 2}, {"body": 37, "word": "cell", "fig": 1}, {"body": 10, "word": "metabolic", "fig": 3}, {"body": 15, "word": "lines", "fig": 2}, {"body": 15, "word": "MS-275", "fig": 2}, {"body": 14, "word": "HDACi", "fig": 2}, {"body": 22, "word": "IIa", "fig": 1}, {"body": 9, "word": "concentrations", "fig": 2}, {"body": 17, "word": "h", "fig": 1}, {"body": 13, "word": "treatment", "fig": 1}, {"body": 11, "word": "patients", "fig": 1}, {"body": 9, "word": "vitro", "fig": 1}, {"body": 8, "word": "high", "fig": 1}, {"body": 8, "word": "inhibitors", "fig": 1}, {"body": 7, "word": "MAZ1863", "fig": 1}, {"body": 7, "word": "MAZ1866", "fig": 1}, {"body": 6, "word": "non-amplified", "fig": 1}, {"body": 5, "word": "MED8A", "fig": 1}, {"body": 5, "word": "selective", "fig": 1}, {"body": 4, "word": "HD-MB03", "fig": 1}, {"body": 4, "word": "medulloblastoma", "fig": 1}, {"body": 3, "word": "I/IIb", "fig": 1}, {"body": 3, "word": "plasma", "fig": 1}, {"body": 3, "word": "clinically", "fig": 1}, {"body": 3, "word": "D458", "fig": 1}, {"body": 2, "word": "achievable", "fig": 1}, {"body": 2, "word": "significantly", "fig": 1}, {"body": 1, "word": "potently", "fig": 2}, {"body": 2, "word": "UW228-2", "fig": 1}, {"body": 2, "word": "lower", "fig": 1}, {"body": 2, "word": "inhibit", "fig": 1}, {"body": 1, "word": "inhibited", "fig": 2}, {"body": 2, "word": "EC50", "fig": 1}, {"body": 1, "word": "DAOY", "fig": 1}, {"body": 1, "word": "ONS76", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "Class", "fig": 1}, {"body": 1, "word": "published", "fig": 1}, {"body": 1, "word": "values", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382927/bin/40478_2015_201_Fig5_HTML.jpg", "caption": "Class I HDAC inhibitors potently inhibit cell growth of MYC amplified medulloblastoma (MB) cells in vitro. Bars and error bars depict mean and standard error of numbers of viable cells a and cell viability (number of viable cells/number of total cells) b after 72 h of treatment, as determined by trypan blue staining. Class I selective HDAC inhibitors vorinostat (top) and MS-275 (bottom) potently inhibit cell growth of MYC amplified MB cells (MED8A and HD-MB03), while cell growth of MYC non amplified MB cells (UW228-2) is reduced only at higher concentrations. Bars depict mean and standard error of three independent experiments, significant differences between cell lines are indicated: * = p < 0.05, ** = p < 0.01, *** = p < 0.001 (unpaired t-test). ampl: amplified", "co_occurrence": [{"body": 37, "word": "cell", "fig": 5}, {"body": 52, "word": "MB", "fig": 3}, {"body": 29, "word": "cells", "fig": 5}, {"body": 39, "word": "MYC", "fig": 3}, {"body": 20, "word": "amplified", "fig": 4}, {"body": 37, "word": "HDAC", "fig": 2}, {"body": 24, "word": "I", "fig": 2}, {"body": 19, "word": "vorinostat", "fig": 1}, {"body": 17, "word": "h", "fig": 1}, {"body": 8, "word": "inhibitors", "fig": 2}, {"body": 15, "word": "MS-275", "fig": 1}, {"body": 15, "word": "lines", "fig": 1}, {"body": 13, "word": "treatment", "fig": 1}, {"body": 9, "word": "vitro", "fig": 1}, {"body": 9, "word": "concentrations", "fig": 1}, {"body": 7, "word": "staining", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 2, "word": "growth", "fig": 3}, {"body": 5, "word": "MED8A", "fig": 1}, {"body": 5, "word": "higher", "fig": 1}, {"body": 5, "word": "selective", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "reduced", "fig": 1}, {"body": 4, "word": "bars", "fig": 1}, {"body": 4, "word": "HD-MB03", "fig": 1}, {"body": 4, "word": "number", "fig": 1}, {"body": 2, "word": "inhibit", "fig": 2}, {"body": 4, "word": "medulloblastoma", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 2, "word": "mean", "fig": 2}, {"body": 3, "word": "viability", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 1, "word": "potently", "fig": 2}, {"body": 1, "word": "Class", "fig": 2}, {"body": 2, "word": "UW228-2", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "viable", "fig": 2}, {"body": 1, "word": "blue", "fig": 1}, {"body": 1, "word": "trypan", "fig": 1}, {"body": 1, "word": "unpaired", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382927/bin/40478_2015_201_Fig6_HTML.jpg", "caption": "siRNA-mediated knockdown of HDAC2 induces acetylation of histone 4, caspase 3-like activity and sub-G0/G1 fraction, and reduces cell number of MYC amplified MB cells. a siRNA-mediated knockdown reduces HDAC2 protein and induces acetylation of histone 4 (H4) in MYC amplified cells MED8A and HD-MB03 72 h after transfection, as determined by western blot. HDAC2 ratio: HDAC2/beta-actin ratio, quantification of HDAC2 protein relative to untreated. Of note: The upper band in the beta-actin labeled blot of HD-MB03 cells is the signal from the HDAC2 detection, which was performed before the beta-actin detection. b-d siRNA-mediated knockdown induces caspase 3-like activity (72 h after transfection) and Sub-G0/G1 fraction (96 h after transfection), and reduces the number of viable cells (96 h after transfection) in MYC amplified cells MED8A and HD-MB03, as measured by caspase 3-like activity assay b, Nicoletti staining and flow cytometric analysis c, and trypan blue staining d, respectively. Bars depict mean and standard error of three independent experiments, significant differences are indicated: * = p < 0.05 (one way ANOVA test).", "co_occurrence": [{"body": 33, "word": "HDAC2", "fig": 5}, {"body": 29, "word": "cells", "fig": 5}, {"body": 46, "word": "activity", "fig": 3}, {"body": 39, "word": "MYC", "fig": 3}, {"body": 17, "word": "h", "fig": 4}, {"body": 20, "word": "amplified", "fig": 3}, {"body": 52, "word": "MB", "fig": 1}, {"body": 37, "word": "cell", "fig": 1}, {"body": 12, "word": "protein", "fig": 2}, {"body": 19, "word": "The", "fig": 1}, {"body": 7, "word": "staining", "fig": 2}, {"body": 7, "word": "histone", "fig": 2}, {"body": 4, "word": "knockdown", "fig": 3}, {"body": 4, "word": "HD-MB03", "fig": 3}, {"body": 11, "word": "performed", "fig": 1}, {"body": 5, "word": "MED8A", "fig": 2}, {"body": 10, "word": "analysis", "fig": 1}, {"body": 3, "word": "siRNA-mediated", "fig": 3}, {"body": 4, "word": "number", "fig": 2}, {"body": 4, "word": "fraction", "fig": 2}, {"body": 7, "word": "H4", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 2, "word": "induces", "fig": 3}, {"body": 5, "word": "assay", "fig": 1}, {"body": 5, "word": "three", "fig": 1}, {"body": 2, "word": "blot", "fig": 2}, {"body": 2, "word": "acetylation", "fig": 2}, {"body": 4, "word": "determined", "fig": 1}, {"body": 1, "word": "transfection", "fig": 4}, {"body": 4, "word": "measured", "fig": 1}, {"body": 1, "word": "3-like", "fig": 3}, {"body": 1, "word": "reduces", "fig": 3}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "relative", "fig": 1}, {"body": 2, "word": "respectively", "fig": 1}, {"body": 1, "word": "detection", "fig": 2}, {"body": 2, "word": "indicated", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "ANOVA", "fig": 1}, {"body": 1, "word": "signal", "fig": 1}, {"body": 1, "word": "upper", "fig": 1}, {"body": 1, "word": "blue", "fig": 1}, {"body": 1, "word": "viable", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "western", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "trypan", "fig": 1}, {"body": 1, "word": "test", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382927/bin/40478_2015_201_Fig7_HTML.jpg", "caption": "In vitro simulation of clinical pharmacokinetics uncovers crucial hurdles of in vivo HDAC treatment. a reduction of class I HDAC activity after in vitro treatment of MED8A cells with vorinostat or MS-275 measured at times indicated after washout of HDACi as determined by HDAC activity assay. HDAC activity is strongly reduced immediately upon vorinostat treatment, however immediately returns to normal after a 90 min incubation period followed by washout. HDAC activity is reduced in a time-dependent manner upon treatment with MS275, and returns to normal approx. 24 h after a 90 min incubation period followed by washout. b Incubation with vorinostat induces immediate and strong acetylation of histone 4 (acH4), which is quickly reduced after a 90 min incubation period followed by washout. Incubation with MS275 induces acetylation of histone 4 (H4) in a time dependent manner, which is stable even after a 90 min incubation period followed by washout. Actin served as loading control. c Incubation for 72 h with vorinostat or MS-275 induces strong reduction of metabolic activity, but this effect is nullified if metabolic activity is measured after 72 h with an incubation period of 90 min followed by washout once every 24 h. Bars depict mean and standard error of three independent experiments, significant differences are indicated: * = p < 0.05 (unpaired t-test).", "co_occurrence": [{"body": 46, "word": "activity", "fig": 6}, {"body": 37, "word": "HDAC", "fig": 5}, {"body": 17, "word": "washout", "fig": 6}, {"body": 19, "word": "vorinostat", "fig": 4}, {"body": 13, "word": "treatment", "fig": 4}, {"body": 17, "word": "h", "fig": 3}, {"body": 46, "word": "class", "fig": 1}, {"body": 15, "word": "MS-275", "fig": 2}, {"body": 29, "word": "cells", "fig": 1}, {"body": 5, "word": "incubation", "fig": 5}, {"body": 24, "word": "I", "fig": 1}, {"body": 22, "word": "clinical", "fig": 1}, {"body": 10, "word": "metabolic", "fig": 2}, {"body": 4, "word": "min", "fig": 5}, {"body": 9, "word": "vitro", "fig": 2}, {"body": 5, "word": "reduced", "fig": 3}, {"body": 15, "word": "effect", "fig": 1}, {"body": 7, "word": "histone", "fig": 2}, {"body": 14, "word": "HDACi", "fig": 1}, {"body": 13, "word": "In", "fig": 1}, {"body": 6, "word": "strong", "fig": 2}, {"body": 6, "word": "normal", "fig": 2}, {"body": 5, "word": "reduction", "fig": 2}, {"body": 5, "word": "manner", "fig": 2}, {"body": 4, "word": "measured", "fig": 2}, {"body": 7, "word": "H4", "fig": 1}, {"body": 6, "word": "experiments", "fig": 1}, {"body": 3, "word": "immediately", "fig": 2}, {"body": 2, "word": "induces", "fig": 3}, {"body": 5, "word": "assay", "fig": 1}, {"body": 1, "word": "followed", "fig": 5}, {"body": 5, "word": "three", "fig": 1}, {"body": 5, "word": "MED8A", "fig": 1}, {"body": 2, "word": "acetylation", "fig": 2}, {"body": 4, "word": "vivo", "fig": 1}, {"body": 4, "word": "determined", "fig": 1}, {"body": 4, "word": "strongly", "fig": 1}, {"body": 2, "word": "indicated", "fig": 2}, {"body": 3, "word": "however", "fig": 1}, {"body": 3, "word": "time", "fig": 1}, {"body": 3, "word": "immediate", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 2, "word": "dependent", "fig": 1}, {"body": 2, "word": "mean", "fig": 1}, {"body": 2, "word": "control", "fig": 1}, {"body": 2, "word": "independent", "fig": 1}, {"body": 1, "word": "served", "fig": 1}, {"body": 1, "word": "uncovers", "fig": 1}, {"body": 1, "word": "even", "fig": 1}, {"body": 1, "word": "c", "fig": 1}, {"body": 1, "word": "times", "fig": 1}, {"body": 1, "word": "time-dependent", "fig": 1}, {"body": 1, "word": "t-test", "fig": 1}, {"body": 1, "word": "b", "fig": 1}, {"body": 1, "word": "unpaired", "fig": 1}, {"body": 1, "word": "pharmacokinetics", "fig": 1}]}], "3661508": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661508/bin/pone.0065105.g001.jpg", "caption": "P190B overexpression in the developing mammary epithelium is associated with stromal alterations. A. Representative images of H&E stained control and p190B overexpressing TEBs with quantification of stromal thickness demonstrating increased thickness of the stroma at the neck (blue arrows) (p = 0.04) and tip (black arrows) (p = 0.005) regions of p190B overexpressing TEBs compared to control TEBs (n = 5 mice/genotype with at least 5 TEBs analyzed per animal). Magnification = 200X. B. Representative images of Masson's Trichrome staining (collagen, blue) and the corresponding quantification demonstrating increased collagen deposition around p190B overexpressing TEBs (n = 5 mice/genotype with at least 3 TEBs analyzed per animal), *p = 0.003. C. Representative images of LOX immunofluorescence (red), corresponding quantification, and an immunoblot of LOX on lysates from control and p190B overexpressing whole glands showing increased LOX expression in p190B overexpressing glands (immunofluorescence: n = 4\u20135 mice/genotype with at least 4 TEBs per animal; immunoblot: equal amounts of protein pooled from n = 5 mice/genotype), *p = 0.05. D. Representative images of Ki67 immunohistochemistry with corresponding quantification of stromal cell proliferation (arrows indicate positive cells in the stroma) and cell number with respect to area demonstrates no significant difference in proliferation between control and p190B overexpressing TEBs (n = 5 mice/genotype with at least 3 TEBs per animal) as well as no difference between the number of stromal cells per stromal area (n = 4 mice/genotype with at least 3 TEBs per animal). Magnification for panels B-D = 400X and all size bars = 20 \u00b5m.", "co_occurrence": [{"body": 74, "word": "p190B", "fig": 6}, {"body": 51, "word": "overexpressing", "fig": 6}, {"body": 17, "word": "TEBs", "fig": 10}, {"body": 39, "word": "control", "fig": 4}, {"body": 35, "word": "increased", "fig": 3}, {"body": 21, "word": "stromal", "fig": 5}, {"body": 11, "word": "per", "fig": 6}, {"body": 50, "word": "mammary", "fig": 1}, {"body": 23, "word": "glands", "fig": 2}, {"body": 21, "word": "cells", "fig": 2}, {"body": 24, "word": "expression", "fig": 1}, {"body": 10, "word": "stroma", "fig": 2}, {"body": 18, "word": "protein", "fig": 1}, {"body": 18, "word": "deposition", "fig": 1}, {"body": 6, "word": "LOX", "fig": 3}, {"body": 17, "word": "compared", "fig": 1}, {"body": 8, "word": "cell", "fig": 2}, {"body": 8, "word": "collagen", "fig": 2}, {"body": 7, "word": "proliferation", "fig": 2}, {"body": 13, "word": "epithelium", "fig": 1}, {"body": 6, "word": "analyzed", "fig": 2}, {"body": 3, "word": "quantification", "fig": 4}, {"body": 12, "word": "overexpression", "fig": 1}, {"body": 9, "word": "lysates", "fig": 1}, {"body": 4, "word": "number", "fig": 2}, {"body": 8, "word": "'s", "fig": 1}, {"body": 7, "word": "associated", "fig": 1}, {"body": 6, "word": "pooled", "fig": 1}, {"body": 1, "word": "mice/genotype", "fig": 6}, {"body": 6, "word": "developing", "fig": 1}, {"body": 1, "word": "least", "fig": 5}, {"body": 5, "word": "well", "fig": 1}, {"body": 4, "word": "\u00b5m", "fig": 1}, {"body": 2, "word": "p", "fig": 2}, {"body": 1, "word": "images", "fig": 4}, {"body": 2, "word": "thickness", "fig": 2}, {"body": 2, "word": "area", "fig": 2}, {"body": 4, "word": "positive", "fig": 1}, {"body": 4, "word": "Ki67", "fig": 1}, {"body": 2, "word": "immunofluorescence", "fig": 2}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "P190B", "fig": 1}, {"body": 3, "word": "Masson", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "indicate", "fig": 1}, {"body": 3, "word": "A", "fig": 1}, {"body": 3, "word": "neck", "fig": 1}, {"body": 2, "word": "stained", "fig": 1}, {"body": 2, "word": "H", "fig": 1}, {"body": 2, "word": "alterations", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "Trichrome", "fig": 1}, {"body": 2, "word": "tip", "fig": 1}, {"body": 2, "word": "regions", "fig": 1}, {"body": 1, "word": "demonstrating", "fig": 2}, {"body": 2, "word": "whole", "fig": 1}, {"body": 1, "word": "bars", "fig": 1}, {"body": 1, "word": "immunohistochemistry", "fig": 1}, {"body": 1, "word": "respect", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661508/bin/pone.0065105.g002.jpg", "caption": "P190B overexpression is confined to the epithelium in p190B overexpressing mammary glands. A. Luciferase assay showing that luciferase activity is only detected in the p190B organoids indicating that transgene expression is confined to the epithelial cell compartment of p190B overexpressing mammary glands (n = 5 mice/genotype pooled). B. Immunoblot with corresponding densitometry demonstrating approximately a 2-fold increase in p190B expression in p190B organoids compared to control organoids and no significant difference in p190B levels between fibroblasts from control and p190B overexpressing glands. E-cadherin and keratin 14 (K14), an epithelial cell and myoepithelial cell marker, respectively, and fibroblast specific protein 1 (FSP1) and vimentin, mesenchymal markers, demonstrate the efficacy of the method used to separate organoids and fibroblasts (n = 5 mice/genotype pooled). C. Immunostaining of the fibroblast population for \u03b1 smooth muscle actin (\u03b1SMA) and K14 and the corresponding quantification of K14 positive cells confirming very little myoepithelial contamination of the isolated fibroblasts (n>500 cells/genotype).", "co_occurrence": [{"body": 74, "word": "p190B", "fig": 7}, {"body": 84, "word": "fibroblasts", "fig": 3}, {"body": 51, "word": "overexpressing", "fig": 3}, {"body": 50, "word": "mammary", "fig": 2}, {"body": 39, "word": "control", "fig": 2}, {"body": 23, "word": "glands", "fig": 3}, {"body": 32, "word": "fibroblast", "fig": 2}, {"body": 24, "word": "expression", "fig": 2}, {"body": 9, "word": "organoids", "fig": 4}, {"body": 14, "word": "epithelial", "fig": 2}, {"body": 8, "word": "cell", "fig": 3}, {"body": 22, "word": "isolated", "fig": 1}, {"body": 21, "word": "cells", "fig": 1}, {"body": 18, "word": "protein", "fig": 1}, {"body": 17, "word": "compared", "fig": 1}, {"body": 16, "word": "levels", "fig": 1}, {"body": 15, "word": "activity", "fig": 1}, {"body": 15, "word": "used", "fig": 1}, {"body": 13, "word": "epithelium", "fig": 1}, {"body": 6, "word": "pooled", "fig": 2}, {"body": 4, "word": "K14", "fig": 3}, {"body": 12, "word": "overexpression", "fig": 1}, {"body": 11, "word": "increase", "fig": 1}, {"body": 4, "word": "myoepithelial", "fig": 2}, {"body": 8, "word": "transgene", "fig": 1}, {"body": 7, "word": "detected", "fig": 1}, {"body": 4, "word": "luciferase", "fig": 1}, {"body": 4, "word": "assay", "fig": 1}, {"body": 4, "word": "\u03b1SMA", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 4, "word": "demonstrate", "fig": 1}, {"body": 3, "word": "actin", "fig": 1}, {"body": 3, "word": "2-fold", "fig": 1}, {"body": 3, "word": "P190B", "fig": 1}, {"body": 3, "word": "marker", "fig": 1}, {"body": 3, "word": "smooth", "fig": 1}, {"body": 3, "word": "quantification", "fig": 1}, {"body": 3, "word": "significant", "fig": 1}, {"body": 3, "word": "muscle", "fig": 1}, {"body": 2, "word": "\u03b1", "fig": 1}, {"body": 2, "word": "specific", "fig": 1}, {"body": 2, "word": "E-cadherin", "fig": 1}, {"body": 2, "word": "markers", "fig": 1}, {"body": 1, "word": "mice/genotype", "fig": 2}, {"body": 2, "word": "vimentin", "fig": 1}, {"body": 2, "word": "respectively", "fig": 1}, {"body": 2, "word": "contamination", "fig": 1}, {"body": 2, "word": "compartment", "fig": 1}, {"body": 1, "word": "indicating", "fig": 1}, {"body": 1, "word": "demonstrating", "fig": 1}, {"body": 1, "word": "little", "fig": 1}, {"body": 1, "word": "population", "fig": 1}, {"body": 1, "word": "Luciferase", "fig": 1}, {"body": 1, "word": "separate", "fig": 1}, {"body": 1, "word": "FSP1", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661508/bin/pone.0065105.g003.jpg", "caption": "P190B-associated fibroblasts display elevated ECM production that depends on TGF-\u03b2 signaling. A. qRT-PCR Super Array for ECM proteins showing increased collagen (Col1a1, Col3a1, Col6a1), fibronectin (Fn1), and laminin alpha 1 (Lama1) mRNA expression in fibroblasts associated with p190B overexpressing MECs (n = 5 mice/genotype pooled) compared to fibroblasts associated with control MECs. B. Immunoblot of conditioned medium (CM) from CTL and p190B-associated fibroblasts showing increased secretion of collagen, fibronectin, laminin, and CTGF by p190B-associated fibroblasts. Values to the right of the blots represent fold change with respect to control CM and were normalized to ponceau loading control (CM from n = 3 mice/genotype pooled). C. Immunoblots performed on fibroblasts isolated from control and p190B overexpressing glands showing increased pSMAD2, pERK1/2, \u03b1SMA, and pMLC in p190B-associated fibroblasts. Values to the right of the blots represent fold change with respect to control fibroblasts and were normalized to \u03b2-tubulin (n = 5 mice/genotype pooled). D. qRT-PCR on fibroblasts isolated from control and p190B overexpressing glands and treated with DMSO or 5 \u00b5M SB431542 (SB) showing that TGF\u03b2 receptor inhibition blocks the increased expression of Col1a1, Lama1, and Ctgf mRNA in the p190B-associated fibroblasts (n = 4 mice/genotype pooled), *p\u22640.001 (p190B vs. control), #p\u22640.04 (p190B vs. p190B+SB). E. Immunoblot of lysates prepared from fibroblasts isolated from control and p190B overexpressing glands and treated in culture with DMSO or 5 \u00b5M SB431542 demonstrating that SB431542 effectively blocks TGF\u03b2 signaling through SMAD2. Values were normalized to \u03b2-tubulin (n = 4 mice/genotyped pooled).", "co_occurrence": [{"body": 84, "word": "fibroblasts", "fig": 11}, {"body": 74, "word": "p190B", "fig": 6}, {"body": 39, "word": "control", "fig": 8}, {"body": 51, "word": "overexpressing", "fig": 4}, {"body": 35, "word": "increased", "fig": 4}, {"body": 28, "word": "p190B-associated", "fig": 4}, {"body": 40, "word": "MECs", "fig": 2}, {"body": 37, "word": "ECM", "fig": 2}, {"body": 23, "word": "glands", "fig": 3}, {"body": 22, "word": "isolated", "fig": 3}, {"body": 26, "word": "signaling", "fig": 2}, {"body": 24, "word": "expression", "fig": 2}, {"body": 35, "word": "TGF-\u03b2", "fig": 1}, {"body": 11, "word": "CM", "fig": 3}, {"body": 6, "word": "pooled", "fig": 5}, {"body": 13, "word": "mRNA", "fig": 2}, {"body": 12, "word": "qRT-PCR", "fig": 2}, {"body": 11, "word": "Col1a1", "fig": 2}, {"body": 7, "word": "SB431542", "fig": 3}, {"body": 17, "word": "compared", "fig": 1}, {"body": 8, "word": "collagen", "fig": 2}, {"body": 8, "word": "treated", "fig": 2}, {"body": 7, "word": "Lama1", "fig": 2}, {"body": 7, "word": "associated", "fig": 2}, {"body": 6, "word": "DMSO", "fig": 2}, {"body": 11, "word": "production", "fig": 1}, {"body": 11, "word": "elevated", "fig": 1}, {"body": 5, "word": "represent", "fig": 2}, {"body": 10, "word": "conditioned", "fig": 1}, {"body": 9, "word": "lysates", "fig": 1}, {"body": 3, "word": "normalized", "fig": 3}, {"body": 6, "word": "Fn1", "fig": 1}, {"body": 6, "word": "culture", "fig": 1}, {"body": 3, "word": "laminin", "fig": 2}, {"body": 6, "word": "SMAD2", "fig": 1}, {"body": 3, "word": "fibronectin", "fig": 2}, {"body": 5, "word": "Super", "fig": 1}, {"body": 5, "word": "secretion", "fig": 1}, {"body": 5, "word": "medium", "fig": 1}, {"body": 5, "word": "Array", "fig": 1}, {"body": 1, "word": "mice/genotype", "fig": 4}, {"body": 2, "word": "change", "fig": 2}, {"body": 4, "word": "\u03b1SMA", "fig": 1}, {"body": 4, "word": "Ctgf", "fig": 1}, {"body": 2, "word": "vs.", "fig": 2}, {"body": 2, "word": "\u03b2-tubulin", "fig": 2}, {"body": 2, "word": "fold", "fig": 2}, {"body": 4, "word": "display", "fig": 1}, {"body": 3, "word": "receptor", "fig": 1}, {"body": 3, "word": "CTGF", "fig": 1}, {"body": 3, "word": "prepared", "fig": 1}, {"body": 1, "word": "blots", "fig": 2}, {"body": 1, "word": "\u00b5M", "fig": 2}, {"body": 1, "word": "respect", "fig": 2}, {"body": 1, "word": "TGF\u03b2", "fig": 2}, {"body": 2, "word": "effectively", "fig": 1}, {"body": 2, "word": "alpha", "fig": 1}, {"body": 1, "word": "ponceau", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "Col3a1", "fig": 1}, {"body": 1, "word": "Immunoblots", "fig": 1}, {"body": 1, "word": "inhibition", "fig": 1}, {"body": 1, "word": "proteins", "fig": 1}, {"body": 1, "word": "CTL", "fig": 1}, {"body": 1, "word": "pSMAD2", "fig": 1}, {"body": 1, "word": "demonstrating", "fig": 1}, {"body": 1, "word": "Col6a1", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661508/bin/pone.0065105.g004.jpg", "caption": "Paracrine signals from p190B overexpressing MECs upregulate TGF-\u03b2 dependent ECM mRNA expression in fibroblasts. A. Representative immunoblot of MEC CM showing increased levels of active TGF-\u03b2. The value to the right of the blot represents fold change with respect to control MEC CM and is normalized to ponceau loading control. (CM from n = 4 mice/genotype pooled). B. A schematic representing the contraction assay is shown. Quantification of contraction assay on CTL and p190B overexpressing MECs demonstrating increased contractility of p190B overexpressing MECs compared to control MECs. Data represents the average of 3 independent experiments, *p = 0.006. C. qRT-PCR on wildtype fibroblasts treated with CM from CTL or p190B overexpressing MECs showing that p190B CM induces increased gene expression of Col1a1, Fn1, and Lama1 in wildtype fibroblasts (CM from n = 4 mice/genotype pooled). D. Immunoblot on wildtype fibroblasts treated with CTL or p190B CM demonstrating that CM from p190B overexpressing MECs increased SMAD2 phosphorylation in wildtype fibroblasts compared to CM from CTL MECs. The value to the right of the blot represents fold change with respect to treatment with CTL CM and is normalized to \u03b2-tubulin (wildtype fibroblasts treated with CM from n = 4 mice/genotype pooled). E. qRT-PCR on wildtype fibroblasts that were co-cultured with CTL or p190B overexpressing MECs showing that co-culture with p190B overexpressing MECs increased gene expression of Col1a1 in wildtype fibroblasts compared to co-culture with CTL MECs. Additionally, treatment of co-cultures with 5 \u00b5M SB431542 prevents the increased Col1a1 mRNA expression in wildtype fibroblasts co-cultured with p190B overexpressing MECs. Data represent the average of 3 independent experiments with MECs from n = 3\u20134 mice/genotype pooled per experiment, *p = 0.01. F. Immunoblot on wildtype fibroblasts that were co-cultured with CTL or p190B overexpressing MECs demonstrating that co-culture with p190B overexpressing MECs increased SMAD2 phosphorylation in wildtype fibroblasts. Value to the right of the blot represents fold change with respect to wildtype fibroblasts co-cultured with CTL MECs and is normalized to \u03b2-tubulin (wildtype fibroblasts in co-culture with n = 4 mice/genotype pooled).", "co_occurrence": [{"body": 84, "word": "fibroblasts", "fig": 13}, {"body": 74, "word": "p190B", "fig": 12}, {"body": 40, "word": "MECs", "fig": 15}, {"body": 51, "word": "overexpressing", "fig": 10}, {"body": 35, "word": "increased", "fig": 7}, {"body": 11, "word": "CM", "fig": 11}, {"body": 39, "word": "control", "fig": 3}, {"body": 24, "word": "expression", "fig": 4}, {"body": 7, "word": "wildtype", "fig": 12}, {"body": 35, "word": "TGF-\u03b2", "fig": 2}, {"body": 31, "word": "The", "fig": 2}, {"body": 17, "word": "compared", "fig": 3}, {"body": 37, "word": "ECM", "fig": 1}, {"body": 9, "word": "co-culture", "fig": 4}, {"body": 11, "word": "Col1a1", "fig": 3}, {"body": 6, "word": "pooled", "fig": 5}, {"body": 14, "word": "experiments", "fig": 2}, {"body": 13, "word": "mRNA", "fig": 2}, {"body": 12, "word": "qRT-PCR", "fig": 2}, {"body": 8, "word": "treated", "fig": 3}, {"body": 9, "word": "MEC", "fig": 2}, {"body": 4, "word": "co-cultured", "fig": 4}, {"body": 16, "word": "levels", "fig": 1}, {"body": 7, "word": "gene", "fig": 2}, {"body": 6, "word": "treatment", "fig": 2}, {"body": 6, "word": "SMAD2", "fig": 2}, {"body": 11, "word": "per", "fig": 1}, {"body": 3, "word": "blot", "fig": 3}, {"body": 9, "word": "shown", "fig": 1}, {"body": 3, "word": "normalized", "fig": 3}, {"body": 1, "word": "CTL", "fig": 9}, {"body": 4, "word": "assay", "fig": 2}, {"body": 4, "word": "phosphorylation", "fig": 2}, {"body": 8, "word": "contractility", "fig": 1}, {"body": 7, "word": "Lama1", "fig": 1}, {"body": 7, "word": "SB431542", "fig": 1}, {"body": 6, "word": "signals", "fig": 1}, {"body": 6, "word": "Fn1", "fig": 1}, {"body": 2, "word": "fold", "fig": 3}, {"body": 2, "word": "change", "fig": 3}, {"body": 3, "word": "Data", "fig": 2}, {"body": 3, "word": "A", "fig": 2}, {"body": 3, "word": "independent", "fig": 2}, {"body": 5, "word": "represent", "fig": 1}, {"body": 1, "word": "mice/genotype", "fig": 5}, {"body": 5, "word": "active", "fig": 1}, {"body": 4, "word": "dependent", "fig": 1}, {"body": 2, "word": "contraction", "fig": 2}, {"body": 2, "word": "\u03b2-tubulin", "fig": 2}, {"body": 2, "word": "average", "fig": 2}, {"body": 1, "word": "respect", "fig": 3}, {"body": 1, "word": "demonstrating", "fig": 3}, {"body": 2, "word": "induces", "fig": 1}, {"body": 2, "word": "experiment", "fig": 1}, {"body": 2, "word": "co-cultures", "fig": 1}, {"body": 1, "word": "ponceau", "fig": 1}, {"body": 1, "word": "\u00b5M", "fig": 1}, {"body": 1, "word": "loading", "fig": 1}, {"body": 1, "word": "Paracrine", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 1}]}], "3861503": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g001.jpg", "caption": "Body and muscle wet weights. A) Bodyweight measurements of all animals were taken immediately prior to the start of the one-week pretreatment period (Start), prior to suspension (0), following hindlimb suspension (HS), and again following the reloading period recovery in cage control (n=12), vehicle-treated (n=12) or resveratrol-treated (n=12) animals. B. Plantaris muscle wet weights were obtained following HS or R. * P<0.05 vs. cage control.", "co_occurrence": [{"body": 131, "word": "animals", "fig": 2}, {"body": 92, "word": "muscle", "fig": 2}, {"body": 78, "word": "suspension", "fig": 2}, {"body": 31, "word": "following", "fig": 3}, {"body": 43, "word": "control", "fig": 2}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 32, "word": "cage", "fig": 2}, {"body": 25, "word": "period", "fig": 2}, {"body": 15, "word": "reloading", "fig": 1}, {"body": 4, "word": "n=12", "fig": 3}, {"body": 4, "word": "prior", "fig": 2}, {"body": 8, "word": "obtained", "fig": 1}, {"body": 3, "word": "wet", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 3, "word": "weights", "fig": 2}, {"body": 5, "word": "vehicle-treated", "fig": 1}, {"body": 4, "word": "immediately", "fig": 1}, {"body": 3, "word": "taken", "fig": 1}, {"body": 2, "word": "Start", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "resveratrol-treated", "fig": 1}, {"body": 2, "word": "vs.", "fig": 1}, {"body": 1, "word": "Body", "fig": 1}, {"body": 1, "word": "pretreatment", "fig": 1}, {"body": 1, "word": "measurements", "fig": 1}, {"body": 1, "word": "one-week", "fig": 1}, {"body": 1, "word": "Plantaris", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g002.jpg", "caption": "Plantaris muscle twitch characteristics. Muscle twitch contractile properties including CT and \u00bd RT were analyzed in the plantaris muscles of both the hindlimb suspension (A) and recovery (B) groups. Each data point represents the average of three measures. * P<0.05 vs. cage control; \u2020 P<0.05 vehicle vs. resveratrol.", "co_occurrence": [{"body": 157, "word": "resveratrol", "fig": 1}, {"body": 92, "word": "muscle", "fig": 1}, {"body": 78, "word": "suspension", "fig": 1}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 63, "word": "vehicle", "fig": 1}, {"body": 43, "word": "control", "fig": 1}, {"body": 43, "word": "muscles", "fig": 1}, {"body": 34, "word": "plantaris", "fig": 1}, {"body": 34, "word": "groups", "fig": 1}, {"body": 32, "word": "cage", "fig": 1}, {"body": 7, "word": "twitch", "fig": 2}, {"body": 9, "word": "RT", "fig": 1}, {"body": 9, "word": "Muscle", "fig": 1}, {"body": 9, "word": "data", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "characteristics", "fig": 1}, {"body": 5, "word": "contractile", "fig": 1}, {"body": 4, "word": "point", "fig": 1}, {"body": 2, "word": "P", "fig": 2}, {"body": 2, "word": "vs.", "fig": 2}, {"body": 4, "word": "CT", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 2, "word": "properties", "fig": 1}, {"body": 1, "word": "including", "fig": 1}, {"body": 1, "word": "measures", "fig": 1}, {"body": 1, "word": "average", "fig": 1}, {"body": 1, "word": "Plantaris", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g003.jpg", "caption": "Force-frequency relationship. A force-frequency curve was plotted for both the hindlimb suspension (A) and recovery (B) groups. Each force-frequency measurement was made three times with a minimum of 5 minutes rest between each contraction, and the average of the three trials was recorded for each animal. * P<0.05 vehicle and resveratrol vs. cage control; \u2020 P<0.05 vehicle vs. resveratrol.", "co_occurrence": [{"body": 157, "word": "resveratrol", "fig": 2}, {"body": 63, "word": "vehicle", "fig": 2}, {"body": 78, "word": "suspension", "fig": 1}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 43, "word": "control", "fig": 1}, {"body": 34, "word": "groups", "fig": 1}, {"body": 32, "word": "cage", "fig": 1}, {"body": 6, "word": "A", "fig": 2}, {"body": 9, "word": "minutes", "fig": 1}, {"body": 7, "word": "contraction", "fig": 1}, {"body": 3, "word": "force-frequency", "fig": 2}, {"body": 2, "word": "vs.", "fig": 2}, {"body": 2, "word": "P", "fig": 2}, {"body": 4, "word": "curve", "fig": 1}, {"body": 2, "word": "rest", "fig": 1}, {"body": 2, "word": "animal", "fig": 1}, {"body": 2, "word": "made", "fig": 1}, {"body": 1, "word": "recorded", "fig": 1}, {"body": 1, "word": "average", "fig": 1}, {"body": 1, "word": "Force-frequency", "fig": 1}, {"body": 1, "word": "plotted", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g004.jpg", "caption": "Fatigue index. Plantaris muscle fatigability was expressed as a fatigue index, and calculated as the percent of the initial force ( average of the first three contractions, divided by the force at the end of the fatigue protocol (an average of the force generated in the final three contractions) in a series of 128 consecutive contractions. * P<0.05 vs. cage control; \u2020 P<0.05 vehicle vs. resveratrol.", "co_occurrence": [{"body": 157, "word": "resveratrol", "fig": 1}, {"body": 92, "word": "muscle", "fig": 1}, {"body": 63, "word": "vehicle", "fig": 1}, {"body": 22, "word": "fatigue", "fig": 2}, {"body": 43, "word": "control", "fig": 1}, {"body": 16, "word": "index", "fig": 2}, {"body": 32, "word": "cage", "fig": 1}, {"body": 7, "word": "force", "fig": 3}, {"body": 4, "word": "contractions", "fig": 3}, {"body": 7, "word": "expressed", "fig": 1}, {"body": 5, "word": "end", "fig": 1}, {"body": 4, "word": "protocol", "fig": 1}, {"body": 2, "word": "P", "fig": 2}, {"body": 2, "word": "vs.", "fig": 2}, {"body": 4, "word": "calculated", "fig": 1}, {"body": 3, "word": "first", "fig": 1}, {"body": 1, "word": "average", "fig": 2}, {"body": 1, "word": "series", "fig": 1}, {"body": 1, "word": "percent", "fig": 1}, {"body": 1, "word": "fatigability", "fig": 1}, {"body": 1, "word": "generated", "fig": 1}, {"body": 1, "word": "Plantaris", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g005.jpg", "caption": "Resveratrol-induced metabolic signaling in the plantaris muscle. A. Western blots were conducted for plantaris muscles after hindlimb suspension or following recovery from hindlimb suspension. The protein content was measured in total plantaris muscle homogenates via immunoblotting. Total muscle protein lysates were separated on a 4-12% gradient polyacrylamide gel by routine SDS-PAGE. The proteins were electroblotted to nitrocellulose membranes and the signals were developed by chemiluminescence. The proteins included phosphorylated (activated) AMPK, total AMPK, PGC1\u03b1, and Sirt1. GAPDH was used as an internal loading control. Con, control; Veh, vehicle-treated; Res, resveratrol treated. B-E. The digital images of the western blots were quantified as optical density x band area using ImageJ software and normalized to GAPDH, which was used as the loading control for each lane. The data include: B, total AMPK; C. phosphorylated AMPK (pAMPK); D. PGC1\u03b1; and E. Sirt1. The data are expressed as the protein signal to the GAPDH signal and are reported as mean \u00b1 SEM in arbitrary units. A minimum of three western blots were completed for each protein, and the data were averaged for each animal. F. Sirt1 enzyme activity was determined fluorometrically in plantaris muscle homogenates. Data are expressed as arbitrary fluorescent units (AFU)/\u00b5g protein. * P<0.05 vs. cage control; \u2020P<0.05 vehicle vs. resveratrol.", "co_occurrence": [{"body": 92, "word": "muscle", "fig": 4}, {"body": 55, "word": "The", "fig": 6}, {"body": 157, "word": "resveratrol", "fig": 2}, {"body": 43, "word": "control", "fig": 4}, {"body": 78, "word": "suspension", "fig": 2}, {"body": 34, "word": "plantaris", "fig": 4}, {"body": 68, "word": "hindlimb", "fig": 2}, {"body": 24, "word": "protein", "fig": 5}, {"body": 82, "word": "treated", "fig": 1}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 63, "word": "vehicle", "fig": 1}, {"body": 43, "word": "muscles", "fig": 1}, {"body": 13, "word": "Sirt1", "fig": 3}, {"body": 32, "word": "cage", "fig": 1}, {"body": 31, "word": "following", "fig": 1}, {"body": 9, "word": "data", "fig": 3}, {"body": 6, "word": "total", "fig": 3}, {"body": 8, "word": "proteins", "fig": 2}, {"body": 8, "word": "used", "fig": 2}, {"body": 15, "word": "using", "fig": 1}, {"body": 7, "word": "expressed", "fig": 2}, {"body": 6, "word": "PGC1\u03b1", "fig": 2}, {"body": 3, "word": "AMPK", "fig": 4}, {"body": 12, "word": "signaling", "fig": 1}, {"body": 6, "word": "A", "fig": 2}, {"body": 10, "word": "mean", "fig": 1}, {"body": 8, "word": "determined", "fig": 1}, {"body": 8, "word": "activity", "fig": 1}, {"body": 3, "word": "loading", "fig": 2}, {"body": 2, "word": "blots", "fig": 3}, {"body": 2, "word": "GAPDH", "fig": 3}, {"body": 3, "word": "units", "fig": 2}, {"body": 5, "word": "vehicle-treated", "fig": 1}, {"body": 5, "word": "reported", "fig": 1}, {"body": 5, "word": "fluorescent", "fig": 1}, {"body": 5, "word": "area", "fig": 1}, {"body": 2, "word": "arbitrary", "fig": 2}, {"body": 2, "word": "vs.", "fig": 2}, {"body": 2, "word": "homogenates", "fig": 2}, {"body": 2, "word": "western", "fig": 2}, {"body": 3, "word": "normalized", "fig": 1}, {"body": 3, "word": "pAMPK", "fig": 1}, {"body": 3, "word": "software", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 3, "word": "measured", "fig": 1}, {"body": 2, "word": "signals", "fig": 1}, {"body": 2, "word": "Western", "fig": 1}, {"body": 2, "word": "animal", "fig": 1}, {"body": 2, "word": "gel", "fig": 1}, {"body": 1, "word": "signal", "fig": 2}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "content", "fig": 1}, {"body": 2, "word": "via", "fig": 1}, {"body": 2, "word": "included", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 1, "word": "developed", "fig": 1}, {"body": 1, "word": "activated", "fig": 1}, {"body": 1, "word": "density", "fig": 1}, {"body": 1, "word": "enzyme", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "band", "fig": 1}, {"body": 1, "word": "polyacrylamide", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "metabolic", "fig": 1}, {"body": 1, "word": "nitrocellulose", "fig": 1}, {"body": 1, "word": "gradient", "fig": 1}, {"body": 1, "word": "routine", "fig": 1}, {"body": 1, "word": "ImageJ", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "separated", "fig": 1}, {"body": 1, "word": "optical", "fig": 1}, {"body": 1, "word": "Data", "fig": 1}, {"body": 1, "word": "averaged", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g006.jpg", "caption": "Muscle fiber immunocytochemistry. Frozen tissue cross sections were incubated overnight at 4\u00b0C with antibodies directed against the basal lamina (red) and myosin heavy chain I, IIA, or IIB (green). The sections were counterstained with DAPI (blue) to identify the nuclei. Digital images were taken with a confocal microscope. This figure provides a representative example of a section stained for type I myosin heavy chain that was used to measure fiber type composition and CSA analyses for this fiber type in both the hindlimb suspension and recovery groups. Green fibers are positive for type I myosin heavy chains. Scale bars represent 50 \u00b5m. * P<0.05 vs. cage control; \u2020 P<0.05 vehicle vs. resveratrol.", "co_occurrence": [{"body": 52, "word": "type", "fig": 4}, {"body": 157, "word": "resveratrol", "fig": 1}, {"body": 35, "word": "fiber", "fig": 3}, {"body": 78, "word": "suspension", "fig": 1}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 63, "word": "vehicle", "fig": 1}, {"body": 55, "word": "The", "fig": 1}, {"body": 16, "word": "I", "fig": 3}, {"body": 43, "word": "control", "fig": 1}, {"body": 38, "word": "fibers", "fig": 1}, {"body": 34, "word": "groups", "fig": 1}, {"body": 32, "word": "cage", "fig": 1}, {"body": 13, "word": "sections", "fig": 2}, {"body": 20, "word": "This", "fig": 1}, {"body": 6, "word": "myosin", "fig": 3}, {"body": 16, "word": "CSA", "fig": 1}, {"body": 5, "word": "heavy", "fig": 3}, {"body": 15, "word": "nuclei", "fig": 1}, {"body": 14, "word": "IIB", "fig": 1}, {"body": 12, "word": "incubated", "fig": 1}, {"body": 12, "word": "tissue", "fig": 1}, {"body": 11, "word": "IIA", "fig": 1}, {"body": 5, "word": "chain", "fig": 2}, {"body": 9, "word": "Muscle", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 6, "word": "microscope", "fig": 1}, {"body": 6, "word": "antibodies", "fig": 1}, {"body": 5, "word": "cross", "fig": 1}, {"body": 5, "word": "overnight", "fig": 1}, {"body": 2, "word": "P", "fig": 2}, {"body": 4, "word": "4\u00b0C", "fig": 1}, {"body": 4, "word": "lamina", "fig": 1}, {"body": 4, "word": "analyses", "fig": 1}, {"body": 2, "word": "vs.", "fig": 2}, {"body": 3, "word": "DAPI", "fig": 1}, {"body": 3, "word": "Frozen", "fig": 1}, {"body": 3, "word": "confocal", "fig": 1}, {"body": 3, "word": "taken", "fig": 1}, {"body": 3, "word": "basal", "fig": 1}, {"body": 3, "word": "directed", "fig": 1}, {"body": 3, "word": "composition", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "section", "fig": 1}, {"body": 2, "word": "provides", "fig": 1}, {"body": 1, "word": "identify", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}, {"body": 1, "word": "example", "fig": 1}, {"body": 1, "word": "Digital", "fig": 1}, {"body": 1, "word": "immunocytochemistry", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g007.jpg", "caption": "Muscle fiber myosin heavy chain composition and morphology. Immunocytochemical stained plantaris muscle fibers for myosin heavy chains, from control, vehicle-treated and resveratrol-treated rats were analyzed for their myosin heavy chain fiber composition in both the hindlimb suspension (A) and recovery (B) groups. * P<0.05 vs. cage control.", "co_occurrence": [{"body": 92, "word": "muscle", "fig": 1}, {"body": 43, "word": "control", "fig": 2}, {"body": 78, "word": "suspension", "fig": 1}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 35, "word": "fiber", "fig": 2}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 38, "word": "fibers", "fig": 1}, {"body": 34, "word": "plantaris", "fig": 1}, {"body": 34, "word": "groups", "fig": 1}, {"body": 32, "word": "cage", "fig": 1}, {"body": 6, "word": "myosin", "fig": 3}, {"body": 5, "word": "heavy", "fig": 3}, {"body": 11, "word": "rats", "fig": 1}, {"body": 5, "word": "chain", "fig": 2}, {"body": 9, "word": "Muscle", "fig": 1}, {"body": 3, "word": "composition", "fig": 2}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "vehicle-treated", "fig": 1}, {"body": 3, "word": "analyzed", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "resveratrol-treated", "fig": 1}, {"body": 2, "word": "vs.", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g008.jpg", "caption": "Muscle fiber cross sectional area. Mean fiber cross sectional area (CSA) measurements were obtained from a minimum of 500 fibers in each muscle for plantaris muscle fibers that expressed type I, IIA, or IIB myosin heavy chains in hindlimb suspension (A) and recovery (B) groups. Four images from non-overlapping regions of each tissue cross-section stained for individual MyHC fibers were used for muscle fiber CSA measures. All images were taken with a Zeiss LSM 510 Meta confocal microscope at a magnification of 20X. Mean fiber CSA of respective fiber types was determined by planimetry. * P<0.05 vs. cage control.", "co_occurrence": [{"body": 92, "word": "muscle", "fig": 3}, {"body": 35, "word": "fiber", "fig": 5}, {"body": 38, "word": "fibers", "fig": 3}, {"body": 78, "word": "suspension", "fig": 1}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 52, "word": "type", "fig": 1}, {"body": 16, "word": "CSA", "fig": 3}, {"body": 43, "word": "control", "fig": 1}, {"body": 34, "word": "groups", "fig": 1}, {"body": 34, "word": "plantaris", "fig": 1}, {"body": 32, "word": "cage", "fig": 1}, {"body": 17, "word": "MyHC", "fig": 1}, {"body": 16, "word": "I", "fig": 1}, {"body": 14, "word": "IIB", "fig": 1}, {"body": 12, "word": "tissue", "fig": 1}, {"body": 11, "word": "IIA", "fig": 1}, {"body": 5, "word": "cross", "fig": 2}, {"body": 5, "word": "area", "fig": 2}, {"body": 9, "word": "Muscle", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 8, "word": "determined", "fig": 1}, {"body": 8, "word": "obtained", "fig": 1}, {"body": 7, "word": "respective", "fig": 1}, {"body": 7, "word": "expressed", "fig": 1}, {"body": 6, "word": "microscope", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 6, "word": "myosin", "fig": 1}, {"body": 6, "word": "Zeiss", "fig": 1}, {"body": 5, "word": "heavy", "fig": 1}, {"body": 5, "word": "All", "fig": 1}, {"body": 2, "word": "images", "fig": 2}, {"body": 4, "word": "types", "fig": 1}, {"body": 2, "word": "Mean", "fig": 2}, {"body": 4, "word": "individual", "fig": 1}, {"body": 3, "word": "20X", "fig": 1}, {"body": 3, "word": "LSM", "fig": 1}, {"body": 3, "word": "regions", "fig": 1}, {"body": 3, "word": "Meta", "fig": 1}, {"body": 3, "word": "taken", "fig": 1}, {"body": 3, "word": "non-overlapping", "fig": 1}, {"body": 3, "word": "confocal", "fig": 1}, {"body": 1, "word": "sectional", "fig": 2}, {"body": 2, "word": "vs.", "fig": 1}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "planimetry", "fig": 1}, {"body": 1, "word": "cross-section", "fig": 1}, {"body": 1, "word": "measurements", "fig": 1}, {"body": 1, "word": "magnification", "fig": 1}, {"body": 1, "word": "measures", "fig": 1}, {"body": 1, "word": "Four", "fig": 1}, {"body": 1, "word": "stained", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g009.jpg", "caption": "Proliferation of satellite cells. In order to analyze satellite cell proliferation during the reloading period, a time-released BrdU pellet was inserted into the recovery animals at the point that they were released from suspension. BrdU is a thymidine analogue and it was incorporated into muscle nuclei (satellite cells) that divided. A. A representative section from the plantaris of a resveratrol-treated animal that was reloaded for 14 days following 14 days of hindlimb suspension. The tissue was stained with DAPI to identify all of the nuclei, an anti-BrdU antibody to identify nuclei that had proliferated, and an anti-laminin antibody to identify the basal lamina. The overlay shows the three fluorescent images superimposed. The expanded insert shows examples of BrdU positive nuclei that are co-localized to the DAPI stained myonuclei over the basal lamina (white arrows). Other examples of non-specific (green) staining not on nuclei are evident, but they were not included in the quantification of BrdU positive nuclei. B. BrdU incorporation in muscle nuclei (i.e., proliferated satellite cells) is expressed as the number of BrdU-positive nuclei per one hundred myonuclei. * P<0.05 vs. cage control.", "co_occurrence": [{"body": 92, "word": "muscle", "fig": 2}, {"body": 55, "word": "The", "fig": 3}, {"body": 78, "word": "suspension", "fig": 2}, {"body": 131, "word": "animals", "fig": 1}, {"body": 15, "word": "nuclei", "fig": 8}, {"body": 72, "word": "recovery", "fig": 1}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 9, "word": "BrdU", "fig": 5}, {"body": 43, "word": "control", "fig": 1}, {"body": 10, "word": "satellite", "fig": 4}, {"body": 34, "word": "plantaris", "fig": 1}, {"body": 32, "word": "cage", "fig": 1}, {"body": 31, "word": "following", "fig": 1}, {"body": 9, "word": "cells", "fig": 3}, {"body": 25, "word": "period", "fig": 1}, {"body": 19, "word": "In", "fig": 1}, {"body": 8, "word": "days", "fig": 2}, {"body": 15, "word": "reloading", "fig": 1}, {"body": 7, "word": "antibody", "fig": 2}, {"body": 12, "word": "tissue", "fig": 1}, {"body": 6, "word": "A", "fig": 2}, {"body": 9, "word": "cell", "fig": 1}, {"body": 9, "word": "proliferation", "fig": 1}, {"body": 4, "word": "lamina", "fig": 2}, {"body": 4, "word": "myonuclei", "fig": 2}, {"body": 7, "word": "expressed", "fig": 1}, {"body": 7, "word": "order", "fig": 1}, {"body": 3, "word": "DAPI", "fig": 2}, {"body": 3, "word": "basal", "fig": 2}, {"body": 5, "word": "fluorescent", "fig": 1}, {"body": 5, "word": "one", "fig": 1}, {"body": 4, "word": "point", "fig": 1}, {"body": 1, "word": "identify", "fig": 3}, {"body": 3, "word": "per", "fig": 1}, {"body": 3, "word": "pellet", "fig": 1}, {"body": 3, "word": "incorporation", "fig": 1}, {"body": 3, "word": "reloaded", "fig": 1}, {"body": 2, "word": "i.e.", "fig": 1}, {"body": 1, "word": "stained", "fig": 2}, {"body": 2, "word": "P", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "section", "fig": 1}, {"body": 2, "word": "vs.", "fig": 1}, {"body": 1, "word": "positive", "fig": 2}, {"body": 2, "word": "resveratrol-treated", "fig": 1}, {"body": 2, "word": "animal", "fig": 1}, {"body": 2, "word": "included", "fig": 1}, {"body": 1, "word": "proliferated", "fig": 2}, {"body": 1, "word": "number", "fig": 1}, {"body": 1, "word": "thymidine", "fig": 1}, {"body": 1, "word": "incorporated", "fig": 1}, {"body": 1, "word": "white", "fig": 1}, {"body": 1, "word": "analyze", "fig": 1}, {"body": 1, "word": "released", "fig": 1}, {"body": 1, "word": "representative", "fig": 1}, {"body": 1, "word": "BrdU-positive", "fig": 1}, {"body": 1, "word": "inserted", "fig": 1}, {"body": 1, "word": "anti-BrdU", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g010.jpg", "caption": "Apoptotic signaling proteins in plantaris muscles. Plantaris muscle samples were homogenized and total muscle lysates were separated on a 4-12% gradient polyacrylamide gel by routine SDS-PAGE. The proteins were electroblotted to nitrocellulose membranes and the signals were developed by chemiluminescence. A. Representative western blots of apoptotic proteins. Bax, Bcl-xL, Bcl-2, cleaved caspase 3 (CC-3), cleaved caspase 9 (CC-9) and GAPDH. The digital images were quantified as optical density x band area using ImageJ software and normalized to GAPDH, which was used as the loading control for each lane. The data are expressed as the protein signal to the GAPDH signal and are reported as mean \u00b1 SEM in arbitrary units. The western blots were run a minimum of three times for each protein, and the data were averaged for each animal\u2019s data point. These data include: Bax (B) Bcl-2 (C), Bcl-xL (D), cleaved caspase 3 (E), and cleaved caspase 9 (F). * P<0.05 vs. cage control; \u2020 P<0.05 vehicle vs. resveratrol.", "co_occurrence": [{"body": 55, "word": "The", "fig": 4}, {"body": 92, "word": "muscle", "fig": 2}, {"body": 157, "word": "resveratrol", "fig": 1}, {"body": 43, "word": "control", "fig": 2}, {"body": 63, "word": "vehicle", "fig": 1}, {"body": 15, "word": "caspase", "fig": 4}, {"body": 15, "word": "cleaved", "fig": 4}, {"body": 24, "word": "protein", "fig": 2}, {"body": 43, "word": "muscles", "fig": 1}, {"body": 9, "word": "data", "fig": 4}, {"body": 34, "word": "plantaris", "fig": 1}, {"body": 32, "word": "cage", "fig": 1}, {"body": 8, "word": "proteins", "fig": 3}, {"body": 15, "word": "using", "fig": 1}, {"body": 15, "word": "apoptotic", "fig": 1}, {"body": 7, "word": "Bax", "fig": 2}, {"body": 6, "word": "Bcl-2", "fig": 2}, {"body": 12, "word": "signaling", "fig": 1}, {"body": 5, "word": "Bcl-xL", "fig": 2}, {"body": 10, "word": "mean", "fig": 1}, {"body": 8, "word": "used", "fig": 1}, {"body": 7, "word": "expressed", "fig": 1}, {"body": 2, "word": "GAPDH", "fig": 3}, {"body": 6, "word": "total", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "reported", "fig": 1}, {"body": 5, "word": "area", "fig": 1}, {"body": 4, "word": "samples", "fig": 1}, {"body": 2, "word": "blots", "fig": 2}, {"body": 2, "word": "vs.", "fig": 2}, {"body": 4, "word": "point", "fig": 1}, {"body": 2, "word": "western", "fig": 2}, {"body": 4, "word": "These", "fig": 1}, {"body": 2, "word": "P", "fig": 2}, {"body": 3, "word": "loading", "fig": 1}, {"body": 3, "word": "software", "fig": 1}, {"body": 3, "word": "normalized", "fig": 1}, {"body": 3, "word": "units", "fig": 1}, {"body": 3, "word": "membranes", "fig": 1}, {"body": 2, "word": "signals", "fig": 1}, {"body": 2, "word": "gel", "fig": 1}, {"body": 1, "word": "signal", "fig": 2}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "arbitrary", "fig": 1}, {"body": 2, "word": "homogenized", "fig": 1}, {"body": 1, "word": "developed", "fig": 1}, {"body": 1, "word": "density", "fig": 1}, {"body": 1, "word": "quantified", "fig": 1}, {"body": 1, "word": "band", "fig": 1}, {"body": 1, "word": "polyacrylamide", "fig": 1}, {"body": 1, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "nitrocellulose", "fig": 1}, {"body": 1, "word": "gradient", "fig": 1}, {"body": 1, "word": "routine", "fig": 1}, {"body": 1, "word": "ImageJ", "fig": 1}, {"body": 1, "word": "animal\u2019s", "fig": 1}, {"body": 1, "word": "Apoptotic", "fig": 1}, {"body": 1, "word": "SEM", "fig": 1}, {"body": 1, "word": "separated", "fig": 1}, {"body": 1, "word": "optical", "fig": 1}, {"body": 1, "word": "averaged", "fig": 1}, {"body": 1, "word": "Plantaris", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861503/bin/pone.0083518.g011.jpg", "caption": "Immunocytochemical evidence for apoptotic nuclei in reloaded muscles. DNA fragmentation was assessed with TUNEL staining (green) as an indication of nuclei committed to apoptosis in the plantaris muscles from animals. The basal lamina of the muscle fibers was incubated in an anti-lamina antibody (red) to identify nuclei adjacent to or inside the basal lamina of the fibers. Representative tissue cross sections are shown for animals in the hindlimb suspension (A) and recovery (B) groups. C. Quantification of the TUNEL positive nuclei that were located at or below the basal lamina of the muscle fibers in the recovery or cage control animals. *P<0.05 vs. cage control.", "co_occurrence": [{"body": 131, "word": "animals", "fig": 3}, {"body": 92, "word": "muscle", "fig": 2}, {"body": 72, "word": "recovery", "fig": 2}, {"body": 38, "word": "fibers", "fig": 3}, {"body": 43, "word": "control", "fig": 2}, {"body": 43, "word": "muscles", "fig": 2}, {"body": 78, "word": "suspension", "fig": 1}, {"body": 68, "word": "hindlimb", "fig": 1}, {"body": 32, "word": "cage", "fig": 2}, {"body": 15, "word": "nuclei", "fig": 4}, {"body": 55, "word": "The", "fig": 1}, {"body": 34, "word": "groups", "fig": 1}, {"body": 34, "word": "plantaris", "fig": 1}, {"body": 15, "word": "apoptotic", "fig": 1}, {"body": 7, "word": "TUNEL", "fig": 2}, {"body": 13, "word": "sections", "fig": 1}, {"body": 12, "word": "incubated", "fig": 1}, {"body": 12, "word": "shown", "fig": 1}, {"body": 4, "word": "lamina", "fig": 3}, {"body": 12, "word": "tissue", "fig": 1}, {"body": 3, "word": "basal", "fig": 3}, {"body": 7, "word": "apoptosis", "fig": 1}, {"body": 7, "word": "antibody", "fig": 1}, {"body": 6, "word": "A", "fig": 1}, {"body": 5, "word": "cross", "fig": 1}, {"body": 3, "word": "reloaded", "fig": 1}, {"body": 2, "word": "evidence", "fig": 1}, {"body": 2, "word": "anti-lamina", "fig": 1}, {"body": 2, "word": "assessed", "fig": 1}, {"body": 2, "word": "vs.", "fig": 1}, {"body": 1, "word": "adjacent", "fig": 1}, {"body": 1, "word": "DNA", "fig": 1}, {"body": 1, "word": "Quantification", "fig": 1}, {"body": 1, "word": "positive", "fig": 1}, {"body": 1, "word": "identify", "fig": 1}]}], "4991853": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991853/bin/gr1.jpg", "caption": "(A) HNF1\u03b2 protein expression levels in CCC cell lines OVISE, JHOC5, JHOC7, JHOC9, SKOV3 and a negative control HGSOC cell line, PEO1; (B) Data is the mean (n = 3, three biological replicates) and SEM. Expression levels were normalised to the housekeeping protein GAPDH. The expression levels observed with JHOC5 (P < 0.005, \u2217\u2217\u2217) and OVISE (P < 0.05, \u2217) cells were significantly higher than PEO1.", "co_occurrence": [{"body": 53, "word": "HNF1\u03b2", "fig": 1}, {"body": 24, "word": "cell", "fig": 2}, {"body": 19, "word": "protein", "fig": 2}, {"body": 30, "word": "The", "fig": 1}, {"body": 27, "word": "cells", "fig": 1}, {"body": 8, "word": "PEO1", "fig": 2}, {"body": 8, "word": "expression", "fig": 2}, {"body": 5, "word": "levels", "fig": 3}, {"body": 13, "word": "CCC", "fig": 1}, {"body": 13, "word": "lines", "fig": 1}, {"body": 8, "word": "control", "fig": 1}, {"body": 6, "word": "line", "fig": 1}, {"body": 5, "word": "observed", "fig": 1}, {"body": 2, "word": "OVISE", "fig": 2}, {"body": 2, "word": "P", "fig": 2}, {"body": 2, "word": "JHOC5", "fig": 2}, {"body": 3, "word": "negative", "fig": 1}, {"body": 3, "word": "JHOC7", "fig": 1}, {"body": 3, "word": "HGSOC", "fig": 1}, {"body": 2, "word": "Data", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "JHOC9", "fig": 1}, {"body": 2, "word": "SKOV3", "fig": 1}, {"body": 2, "word": "three", "fig": 1}, {"body": 1, "word": "higher", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991853/bin/gr2.jpg", "caption": "eGFP imaging of PEO1 transduced lines with (a) eGFP-HNF1\u03b2 (Lv103) showed primarily nuclear localisation of the GFP signal, whereas cells transduced with eGFP (Lv105) alone (b) showed both nuclear and cytoplasmic localisation. In cells transduced with eGFP-HNF1\u03b2 (Lv103) in which the seven-residue NLS had been deleted (c, Mutant 8) the eGFP signal was mislocalized to the cytoplasm. The scale bar represents 80 \u03bcm. Images were taken on a Leica tandem confocal microscope using 20\u00d7, 40\u00d7 and 60\u00d7 objectives.", "co_occurrence": [{"body": 27, "word": "cells", "fig": 2}, {"body": 34, "word": "using", "fig": 1}, {"body": 31, "word": "NLS", "fig": 1}, {"body": 15, "word": "nuclear", "fig": 2}, {"body": 30, "word": "The", "fig": 1}, {"body": 9, "word": "transduced", "fig": 3}, {"body": 7, "word": "eGFP", "fig": 3}, {"body": 13, "word": "lines", "fig": 1}, {"body": 5, "word": "eGFP-HNF1\u03b2", "fig": 2}, {"body": 5, "word": "localisation", "fig": 2}, {"body": 5, "word": "Lv103", "fig": 2}, {"body": 8, "word": "PEO1", "fig": 1}, {"body": 6, "word": "Lv105", "fig": 1}, {"body": 3, "word": "showed", "fig": 2}, {"body": 5, "word": "primarily", "fig": 1}, {"body": 5, "word": "In", "fig": 1}, {"body": 5, "word": "GFP", "fig": 1}, {"body": 4, "word": "cytoplasm", "fig": 1}, {"body": 1, "word": "signal", "fig": 2}, {"body": 2, "word": "whereas", "fig": 1}, {"body": 2, "word": "Mutant", "fig": 1}, {"body": 2, "word": "imaging", "fig": 1}, {"body": 1, "word": "mislocalized", "fig": 1}, {"body": 1, "word": "tandem", "fig": 1}, {"body": 1, "word": "cytoplasmic", "fig": 1}, {"body": 1, "word": "deleted", "fig": 1}, {"body": 1, "word": "seven-residue", "fig": 1}, {"body": 1, "word": "confocal", "fig": 1}, {"body": 1, "word": "microscope", "fig": 1}, {"body": 1, "word": "Leica", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991853/bin/gr3.jpg", "caption": "(A) Stable complex formation between \u0394IBB mouse Importin-\u03b11 (50 kDa) and HNF1\u03b2 (27 kDa) during size exclusion chromatography. Fractions were analysed by Coomassie stained SDS-PAGE (\u2217 marks the peak for the complex); (B) GST pull-down with liberated HNF1\u03b2 showing pull-downs using different \u0394IBB mouse Importin-\u03b1 isoforms (red \u2217).", "co_occurrence": [{"body": 53, "word": "HNF1\u03b2", "fig": 2}, {"body": 34, "word": "using", "fig": 1}, {"body": 23, "word": "Importin-\u03b1", "fig": 1}, {"body": 6, "word": "complex", "fig": 2}, {"body": 9, "word": "isoforms", "fig": 1}, {"body": 6, "word": "different", "fig": 1}, {"body": 5, "word": "pull-down", "fig": 1}, {"body": 2, "word": "kDa", "fig": 2}, {"body": 4, "word": "chromatography", "fig": 1}, {"body": 4, "word": "Importin-\u03b11", "fig": 1}, {"body": 3, "word": "stained", "fig": 1}, {"body": 2, "word": "GST", "fig": 1}, {"body": 1, "word": "mouse", "fig": 2}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "analysed", "fig": 1}, {"body": 2, "word": "SDS-PAGE", "fig": 1}, {"body": 1, "word": "size", "fig": 1}, {"body": 1, "word": "Fractions", "fig": 1}, {"body": 1, "word": "exclusion", "fig": 1}, {"body": 1, "word": "pull-downs", "fig": 1}, {"body": 1, "word": "Coomassie", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991853/bin/gr4.jpg", "caption": "(A) ITC titration for the binding of the HNF1\u03b2 NLS peptide to \u0394IBB mImportin-\u03b11. Fitting the data (with \u03c72/DoF = 2.9 \u00d7 104) gave a Kd of 13.6 \u00b1 1.5 nM for 0.94 \u00b1 0.13 sites, \u0394H = \u22127.2 \u00b1 1.6 kcal/mol, \u0394S = \u22121.7 cal/mol/deg. (B) In pull-down assays, GST-HNF1\u03b2 bound only the E mutant of \u0394IBB Xenopus Importin-\u03b11 (that impairs NLS binding at the minor site) Mr 50 kD, but not the D mutant (that impairs binding at the major site) or ED double mutant (see Giesecke and Stewart, 2010).", "co_occurrence": [{"body": 31, "word": "NLS", "fig": 2}, {"body": 53, "word": "HNF1\u03b2", "fig": 1}, {"body": 12, "word": "binding", "fig": 3}, {"body": 16, "word": "site", "fig": 2}, {"body": 5, "word": "mutant", "fig": 3}, {"body": 15, "word": "peptide", "fig": 1}, {"body": 8, "word": "bound", "fig": 1}, {"body": 8, "word": "major", "fig": 1}, {"body": 7, "word": "minor", "fig": 1}, {"body": 5, "word": "data", "fig": 1}, {"body": 5, "word": "pull-down", "fig": 1}, {"body": 5, "word": "In", "fig": 1}, {"body": 4, "word": "Importin-\u03b11", "fig": 1}, {"body": 4, "word": "Stewart", "fig": 1}, {"body": 3, "word": "mImportin-\u03b11", "fig": 1}, {"body": 3, "word": "ITC", "fig": 1}, {"body": 2, "word": "E", "fig": 1}, {"body": 2, "word": "D", "fig": 1}, {"body": 2, "word": "sites", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "Kd", "fig": 1}, {"body": 2, "word": "ED", "fig": 1}, {"body": 2, "word": "titration", "fig": 1}, {"body": 1, "word": "nM", "fig": 1}, {"body": 1, "word": "Giesecke", "fig": 1}, {"body": 1, "word": "gave", "fig": 1}, {"body": 1, "word": "assays", "fig": 1}, {"body": 1, "word": "Xenopus", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991853/bin/gr5.jpg", "caption": "(A) Overview of the 2.4 \u00c5 crystal structure of the \u0394IBB mouse Importin-\u03b11:HNF1\u03b2NLS complex. Two copies of the NLS peptide were observed where one was bound in the major site (blue) and another in the minor site (yellow). Each ARM repeat of mouse Importin-\u03b11 has been labelled with alternating colours. (B) Final 2Fo-Fc electron density map around NLS peptide in major and minor binding sites on mouse Importin-\u03b11 contoured at 1\u03c3.", "co_occurrence": [{"body": 31, "word": "NLS", "fig": 2}, {"body": 16, "word": "site", "fig": 2}, {"body": 15, "word": "peptide", "fig": 2}, {"body": 8, "word": "major", "fig": 2}, {"body": 7, "word": "minor", "fig": 2}, {"body": 12, "word": "binding", "fig": 1}, {"body": 4, "word": "Importin-\u03b11", "fig": 3}, {"body": 8, "word": "bound", "fig": 1}, {"body": 7, "word": "structure", "fig": 1}, {"body": 6, "word": "complex", "fig": 1}, {"body": 5, "word": "observed", "fig": 1}, {"body": 4, "word": "density", "fig": 1}, {"body": 4, "word": "HNF1\u03b2NLS", "fig": 1}, {"body": 1, "word": "mouse", "fig": 3}, {"body": 3, "word": "crystal", "fig": 1}, {"body": 2, "word": "sites", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "\u00c5", "fig": 1}, {"body": 1, "word": "one", "fig": 1}, {"body": 1, "word": "blue", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991853/bin/gr6.jpg", "caption": "Schematic illustration of the interactions of the HNF1\u03b2NLS peptide in the major (A) and minor (B) sites on \u0394IBB mouse Importin-\u03b11.", "co_occurrence": [{"body": 15, "word": "peptide", "fig": 1}, {"body": 8, "word": "major", "fig": 1}, {"body": 7, "word": "minor", "fig": 1}, {"body": 4, "word": "HNF1\u03b2NLS", "fig": 1}, {"body": 4, "word": "Importin-\u03b11", "fig": 1}, {"body": 3, "word": "interactions", "fig": 1}, {"body": 2, "word": "A", "fig": 1}, {"body": 2, "word": "sites", "fig": 1}, {"body": 1, "word": "mouse", "fig": 1}]}], "4951302": [{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g001.jpg", "caption": "MTA1 promotes the Pten loss-driven prostate tumorigenesis and cancer progression (A) Comparison of H & E and IHC of MTA1, p-Akt and PTEN in the prostates from 10-month-old Pten+/f mice and Cre-negative normal prostate (NP) controls. Scale bars, 100 \u03bcm. (B) Immunoblots of MTA1, PTEN, p-Akt, Akt, AR, c-Myc, CyclinD1, TGF\u03b21, Notch2, Ets2, and Hsp90 and (C) qRT-PCR analysis of MTA1, Akt1, c-Myc, Ets2 and Hsp90 mRNA levels in the prostate tissues from 10-month-old Pten+/f mice compared to NP controls. (D) Comparison of H & E, MTA1, and p-Akt staining in the prostate tissues from 10-week-old Ptenf/f mice and NP controls. Scale bars, 100 \u03bcm. (E) Immunoblots of MTA1, p-Akt, Akt, AR, NF-\u03baB (p65), IL-1\u03b2, Hsp90, E-cadherin (E-cad) and Vimentin in the prostate tissues from Ptenf/f mice compared to NP controls, isolated at the ages mentioned. Hsp70 was used as a loading control. qRT-PCR data represent the mean \u00b1 SEM (n = 3), *p < 0.05 (two-tailed, two-sample t-test).", "co_occurrence": [{"body": 117, "word": "MTA1", "fig": 6}, {"body": 62, "word": "prostate", "fig": 5}, {"body": 48, "word": "mice", "fig": 4}, {"body": 26, "word": "Pten+/f", "fig": 2}, {"body": 16, "word": "tissues", "fig": 3}, {"body": 24, "word": "PTEN", "fig": 2}, {"body": 47, "word": "cancer", "fig": 1}, {"body": 20, "word": "Ptenf/f", "fig": 2}, {"body": 32, "word": "levels", "fig": 1}, {"body": 16, "word": "Akt", "fig": 2}, {"body": 10, "word": "Hsp90", "fig": 3}, {"body": 14, "word": "AR", "fig": 2}, {"body": 26, "word": "analysis", "fig": 1}, {"body": 20, "word": "prostates", "fig": 1}, {"body": 10, "word": "c-Myc", "fig": 2}, {"body": 19, "word": "Pten", "fig": 1}, {"body": 4, "word": "p-Akt", "fig": 4}, {"body": 14, "word": "progression", "fig": 1}, {"body": 7, "word": "Ets2", "fig": 2}, {"body": 13, "word": "IHC", "fig": 1}, {"body": 13, "word": "mRNA", "fig": 1}, {"body": 11, "word": "used", "fig": 1}, {"body": 10, "word": "control", "fig": 1}, {"body": 5, "word": "compared", "fig": 2}, {"body": 10, "word": "data", "fig": 1}, {"body": 3, "word": "E", "fig": 3}, {"body": 2, "word": "controls", "fig": 4}, {"body": 2, "word": "NP", "fig": 4}, {"body": 8, "word": "IL-1\u03b2", "fig": 1}, {"body": 7, "word": "normal", "fig": 1}, {"body": 3, "word": "H", "fig": 2}, {"body": 6, "word": "Notch2", "fig": 1}, {"body": 6, "word": "n", "fig": 1}, {"body": 5, "word": "loss-driven", "fig": 1}, {"body": 5, "word": "Akt1", "fig": 1}, {"body": 5, "word": "E-cadherin", "fig": 1}, {"body": 5, "word": "tumorigenesis", "fig": 1}, {"body": 4, "word": "Vimentin", "fig": 1}, {"body": 2, "word": "qRT-PCR", "fig": 2}, {"body": 4, "word": "p65", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "CyclinD1", "fig": 1}, {"body": 3, "word": "NF-\u03baB", "fig": 1}, {"body": 3, "word": "promotes", "fig": 1}, {"body": 3, "word": "Cre-negative", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 1, "word": "10-month-old", "fig": 2}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "ages", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 2, "word": "TGF\u03b21", "fig": 1}, {"body": 1, "word": "Hsp70", "fig": 1}, {"body": 1, "word": "two-sample", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g002.jpg", "caption": "MTA1 directly regulates key molecular drivers of tumor promotion (A) Immunoblots of MTA1, NF-\u03baB (p65), IL-1\u03b2, Hsp90, E-cadherin (E-cad), Vimentin, c-Myc, Cyclin D1, Notch2, and Ets2 in LNCaP (left) and DU145 (right) cells expressing (EV) and silenced for MTA1 (shMTA1). (B) qRT-PCR of MTA1, Ets2, Akt1, Notch2, c-Myc, Cyclin D1 and Hsp90 mRNA levels in LNCaP (top) and DU145 (bottom) EV and shMTA1 cells. (C) Immunoblot of MTA1, p-Akt and Akt in LNCaP EV and shMTA1 cells. (D) Immunoblot of p-Akt, Akt, c-Myc and MTA1 and (E) qRT-PCR of MTA1 mRNA levels in PC3M cells treated with vehicle (DMSO) and LY (LY294002). (F) Proposed mechanism involved in Pten loss-induced upregulation of MTA1, exhibiting the MTA1-Akt and MTA1-c-Myc feed-forward signaling loops (blue arrows), putative Akt-MTA1 link (dotted arrow). \u03b2-actin was used as a loading control. qRT-PCR data represent the mean \u00b1 SEM (n = 3), *p < 0.05; **p < 0.01 (two-tailed, two-sample t-test).", "co_occurrence": [{"body": 117, "word": "MTA1", "fig": 8}, {"body": 17, "word": "cells", "fig": 4}, {"body": 32, "word": "levels", "fig": 2}, {"body": 16, "word": "Akt", "fig": 2}, {"body": 10, "word": "c-Myc", "fig": 3}, {"body": 13, "word": "mRNA", "fig": 2}, {"body": 10, "word": "Hsp90", "fig": 2}, {"body": 19, "word": "Pten", "fig": 1}, {"body": 7, "word": "Ets2", "fig": 2}, {"body": 12, "word": "tumor", "fig": 1}, {"body": 4, "word": "LNCaP", "fig": 3}, {"body": 6, "word": "Notch2", "fig": 2}, {"body": 11, "word": "used", "fig": 1}, {"body": 10, "word": "control", "fig": 1}, {"body": 10, "word": "data", "fig": 1}, {"body": 9, "word": "upregulation", "fig": 1}, {"body": 4, "word": "p-Akt", "fig": 2}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 8, "word": "IL-1\u03b2", "fig": 1}, {"body": 6, "word": "bottom", "fig": 1}, {"body": 2, "word": "qRT-PCR", "fig": 3}, {"body": 6, "word": "top", "fig": 1}, {"body": 6, "word": "n", "fig": 1}, {"body": 2, "word": "shMTA1", "fig": 3}, {"body": 5, "word": "Akt1", "fig": 1}, {"body": 5, "word": "E-cadherin", "fig": 1}, {"body": 4, "word": "Vimentin", "fig": 1}, {"body": 2, "word": "D1", "fig": 2}, {"body": 4, "word": "right", "fig": 1}, {"body": 4, "word": "key", "fig": 1}, {"body": 2, "word": "DU145", "fig": 2}, {"body": 4, "word": "molecular", "fig": 1}, {"body": 4, "word": "involved", "fig": 1}, {"body": 4, "word": "treated", "fig": 1}, {"body": 4, "word": "p65", "fig": 1}, {"body": 2, "word": "Immunoblot", "fig": 2}, {"body": 2, "word": "Cyclin", "fig": 2}, {"body": 4, "word": "link", "fig": 1}, {"body": 4, "word": "left", "fig": 1}, {"body": 3, "word": "NF-\u03baB", "fig": 1}, {"body": 3, "word": "promotion", "fig": 1}, {"body": 3, "word": "vehicle", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 2, "word": "LY294002", "fig": 1}, {"body": 2, "word": "PC3M", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "loss-induced", "fig": 1}, {"body": 2, "word": "DMSO", "fig": 1}, {"body": 1, "word": "MTA1-c-Myc", "fig": 1}, {"body": 1, "word": "loops", "fig": 1}, {"body": 1, "word": "two-sample", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "MTA1-Akt", "fig": 1}, {"body": 1, "word": "feed-forward", "fig": 1}, {"body": 1, "word": "drivers", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g003.jpg", "caption": "GEO analyses for correlation of MTA1 with PTEN, AKT1 and AR GSE41967 study of human prostate tissues (n = 639) [38] was used. Scatter plot depicting (A) strong negative correlation between MTA1 and PTEN (r = \u22120.349, whole cohort), which becomes stronger with increased Gleason score (r = \u22120.299, Gleason < 7; r = \u22120.348, Gleason = 7; r = \u22120.433, Gleason > 7, p < 0.001); (B) positive MTA1 correlation with AKT1 expression (r = 0.499, whole cohort, p < 0.001); and no correlation between MTA1 and AR (r = 0.021, whole cohort. p = 0.592). p values were calculated using two-tailed one-sample z-test for a correlation coefficient.", "co_occurrence": [{"body": 117, "word": "MTA1", "fig": 4}, {"body": 62, "word": "prostate", "fig": 1}, {"body": 24, "word": "PTEN", "fig": 2}, {"body": 8, "word": "correlation", "fig": 5}, {"body": 14, "word": "AR", "fig": 2}, {"body": 23, "word": "expression", "fig": 1}, {"body": 18, "word": "using", "fig": 1}, {"body": 16, "word": "tissues", "fig": 1}, {"body": 4, "word": "p", "fig": 4}, {"body": 11, "word": "used", "fig": 1}, {"body": 10, "word": "human", "fig": 1}, {"body": 10, "word": "increased", "fig": 1}, {"body": 2, "word": "Gleason", "fig": 4}, {"body": 8, "word": "study", "fig": 1}, {"body": 6, "word": "n", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 3, "word": "GEO", "fig": 1}, {"body": 3, "word": "values", "fig": 1}, {"body": 1, "word": "AKT1", "fig": 2}, {"body": 2, "word": "GSE41967", "fig": 1}, {"body": 1, "word": "coefficient", "fig": 1}, {"body": 1, "word": "negative", "fig": 1}, {"body": 1, "word": "calculated", "fig": 1}, {"body": 1, "word": "score", "fig": 1}, {"body": 1, "word": "analyses", "fig": 1}, {"body": 1, "word": "strong", "fig": 1}, {"body": 1, "word": "stronger", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g004.jpg", "caption": "Pterostilbene reduces PIN formation in Pten+/f and blocks progression to adenocarcinoma in Ptenf/f mice (A) Gross anatomy (top) and ex vivo images (middle) of urogenital system (UGS) and dissected prostate lobes (APR, right anterior; APL, left anterior, and DLV, dorso-latero-ventral) (bottom) of the representative prostates from 10-month-old Pten+/f mice on phytoestrogen free AIN76 diet (Ctrl-Diet) and 100 mg/kg diet supplementation with pterostilbene (PTER-Diet). (B) Percentage of prostate glands from 10-month-old Pten+/f mice on Ctrl\u2212 (n = 6) and PTER-Diet (n = 7) involved in high grade mouse PIN (mPIN). p < 0.001 (Fisher's exact test). (C) Comparison of H & E prostate histology and PTEN staining in representative 10-month-old mice with NP and Pten+/f mice on Ctrl\u2212 and PTER-Diet. Scale bars, 100 \u03bcm. (D) Gross anatomy of the representative UGS from 10-week-old (top) and 33-week-old (middle) Ptenf/f mice treated with vehicle (DMSO) and 10 mg/kg bw PTER. Representative images of dissected prostate lobes of Ptenf/f mice (bottom). (E) Comparison of UGS weights of vehicle or PTER treated Ptenf/f mice, isolated at the indicated ages (n = 3/group). *p < 0.05 (two-tailed, two-sample t-test). (F) Incidence of mPIN, pre-invasive and invasive adenocarcinoma (AC) in Ptenf/f mice treated with vehicle (n = 19) and PTER (n = 18). p < 0.01 (Fisher's exact test). (G) Comparison of H & E, smooth muscle actin (SMA) and cytokeratin 8 (CK8) staining from representative 6-, 10- and 25-week-old mice with NP and vehicle or PTER treated Ptenf/f mice. Arrows indicate loss of SMA staining and CK8 positive luminal cells in the stroma of vehicle treated Ptenf/f mice as signs of invasiveness. Scale bars, 100 \u03bcm.", "co_occurrence": [{"body": 48, "word": "mice", "fig": 12}, {"body": 62, "word": "prostate", "fig": 4}, {"body": 20, "word": "Ptenf/f", "fig": 7}, {"body": 26, "word": "Pten+/f", "fig": 4}, {"body": 81, "word": "pterostilbene", "fig": 1}, {"body": 21, "word": "diet", "fig": 2}, {"body": 6, "word": "n", "fig": 5}, {"body": 24, "word": "PTEN", "fig": 1}, {"body": 12, "word": "lobes", "fig": 2}, {"body": 20, "word": "prostates", "fig": 1}, {"body": 4, "word": "treated", "fig": 5}, {"body": 9, "word": "mg/kg", "fig": 2}, {"body": 17, "word": "cells", "fig": 1}, {"body": 17, "word": "mouse", "fig": 1}, {"body": 4, "word": "PTER", "fig": 4}, {"body": 3, "word": "vehicle", "fig": 5}, {"body": 7, "word": "PIN", "fig": 2}, {"body": 14, "word": "progression", "fig": 1}, {"body": 6, "word": "bottom", "fig": 2}, {"body": 6, "word": "top", "fig": 2}, {"body": 3, "word": "staining", "fig": 3}, {"body": 3, "word": "PTER-Diet", "fig": 3}, {"body": 3, "word": "E", "fig": 3}, {"body": 8, "word": "stroma", "fig": 1}, {"body": 8, "word": "Pterostilbene", "fig": 1}, {"body": 4, "word": "p", "fig": 2}, {"body": 4, "word": "anterior", "fig": 2}, {"body": 4, "word": "adenocarcinoma", "fig": 2}, {"body": 3, "word": "H", "fig": 2}, {"body": 3, "word": "dissected", "fig": 2}, {"body": 3, "word": "'s", "fig": 2}, {"body": 2, "word": "UGS", "fig": 3}, {"body": 3, "word": "SMA", "fig": 2}, {"body": 3, "word": "middle", "fig": 2}, {"body": 3, "word": "anatomy", "fig": 2}, {"body": 5, "word": "loss", "fig": 1}, {"body": 5, "word": "bw", "fig": 1}, {"body": 5, "word": "vivo", "fig": 1}, {"body": 2, "word": "exact", "fig": 2}, {"body": 4, "word": "APL", "fig": 1}, {"body": 2, "word": "CK8", "fig": 2}, {"body": 4, "word": "right", "fig": 1}, {"body": 2, "word": "images", "fig": 2}, {"body": 4, "word": "luminal", "fig": 1}, {"body": 4, "word": "supplementation", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 2, "word": "NP", "fig": 2}, {"body": 4, "word": "involved", "fig": 1}, {"body": 4, "word": "high", "fig": 1}, {"body": 2, "word": "mPIN", "fig": 2}, {"body": 4, "word": "urogenital", "fig": 1}, {"body": 4, "word": "left", "fig": 1}, {"body": 1, "word": "10-month-old", "fig": 3}, {"body": 3, "word": "system", "fig": 1}, {"body": 3, "word": "glands", "fig": 1}, {"body": 1, "word": "Fisher", "fig": 2}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 2, "word": "APR", "fig": 1}, {"body": 2, "word": "ex", "fig": 1}, {"body": 2, "word": "free", "fig": 1}, {"body": 2, "word": "DLV", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "grade", "fig": 1}, {"body": 2, "word": "invasive", "fig": 1}, {"body": 2, "word": "pre-invasive", "fig": 1}, {"body": 1, "word": "Gross", "fig": 2}, {"body": 2, "word": "ages", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 1, "word": "test", "fig": 2}, {"body": 2, "word": "dorso-latero-ventral", "fig": 1}, {"body": 2, "word": "DMSO", "fig": 1}, {"body": 1, "word": "signs", "fig": 1}, {"body": 1, "word": "reduces", "fig": 1}, {"body": 1, "word": "Ctrl-Diet", "fig": 1}, {"body": 1, "word": "F", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "two-sample", "fig": 1}, {"body": 1, "word": "weights", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g005.jpg", "caption": "Inhibition of MTA1 and its associated signaling by pterostilbene (PTER) in Pten+/f mice (A) Immunoblots of MTA1, PTEN, p-Akt, Akt, AR, c-Myc, CyclinD1, TGF\u03b21, Notch2, Ets2, and Hsp90 of prostate tissues from representative 10-month-old Pten+/f mice on Ctrl- and PTER-Diet. Hsp70 was a loading control. (B) Comparison of MTA1, p-Akt and AR IHC staining of the prostate sections from representative 10-month-old Pten+/f mice on Ctrl- and PTER-Diet. NP, normal prostate. Scale bars, 100 \u03bcm. (C) qRT-PCR of PTEN and MTA1 mRNA levels in prostate tissues from 10-month-old Pten+/f mice on Ctrl- and PTER-Diet. Data are mean \u00b1 SEM (n = 3), *p < 0.05; **p < 0.01 (two-tailed, two-sample t-test). (D) Comparative analysis of MTA1 binding in the prostate tissues of Pten+/f mice on Ctrl- and PTER-Diet. Representative MTA1 ChIP-Seq tracks for Pten, Akt1, c-Myc, CyclinD1, Notch2, Ets2 and Hsp90 gene loci at 10 kb resolution are shown. (E) Quantitation of MTA1, p-Akt/Akt and AR expression in prostate lobes of 10 month-old Pten+/f mice on Ctrl- and PTER-Diet (see F). Data represent the mean \u00b1 SEM (n = 3), *p < 0.05; **p < 0.01 (two-tailed, two-sample t-test). (F) Immunoblots of MTA1, p-Akt, Akt and AR in the dissected prostatic lobes (APR, right anterior; APL, left anterior, and DLV, dorso-latero-ventral) from 10-month-old Pten+/f mice on Ctrl- and PTER-Diet. Hsp70 was used as a loading control.", "co_occurrence": [{"body": 117, "word": "MTA1", "fig": 8}, {"body": 62, "word": "prostate", "fig": 6}, {"body": 48, "word": "mice", "fig": 7}, {"body": 26, "word": "Pten+/f", "fig": 7}, {"body": 81, "word": "pterostilbene", "fig": 1}, {"body": 14, "word": "AR", "fig": 4}, {"body": 16, "word": "tissues", "fig": 3}, {"body": 24, "word": "PTEN", "fig": 2}, {"body": 32, "word": "levels", "fig": 1}, {"body": 16, "word": "Akt", "fig": 2}, {"body": 26, "word": "analysis", "fig": 1}, {"body": 12, "word": "lobes", "fig": 2}, {"body": 23, "word": "expression", "fig": 1}, {"body": 10, "word": "control", "fig": 2}, {"body": 10, "word": "Hsp90", "fig": 2}, {"body": 10, "word": "c-Myc", "fig": 2}, {"body": 19, "word": "Pten", "fig": 1}, {"body": 3, "word": "PTER-Diet", "fig": 6}, {"body": 7, "word": "Ets2", "fig": 2}, {"body": 13, "word": "IHC", "fig": 1}, {"body": 13, "word": "mRNA", "fig": 1}, {"body": 4, "word": "p-Akt", "fig": 3}, {"body": 6, "word": "Notch2", "fig": 2}, {"body": 6, "word": "n", "fig": 2}, {"body": 11, "word": "used", "fig": 1}, {"body": 10, "word": "ChIP-Seq", "fig": 1}, {"body": 9, "word": "gene", "fig": 1}, {"body": 9, "word": "associated", "fig": 1}, {"body": 4, "word": "anterior", "fig": 2}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 7, "word": "normal", "fig": 1}, {"body": 3, "word": "CyclinD1", "fig": 2}, {"body": 5, "word": "Akt1", "fig": 1}, {"body": 5, "word": "prostatic", "fig": 1}, {"body": 4, "word": "PTER", "fig": 1}, {"body": 4, "word": "APL", "fig": 1}, {"body": 1, "word": "10-month-old", "fig": 4}, {"body": 4, "word": "right", "fig": 1}, {"body": 2, "word": "t-test", "fig": 2}, {"body": 4, "word": "left", "fig": 1}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "dissected", "fig": 1}, {"body": 3, "word": "see", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 2, "word": "represent", "fig": 1}, {"body": 2, "word": "dorso-latero-ventral", "fig": 1}, {"body": 2, "word": "APR", "fig": 1}, {"body": 1, "word": "Hsp70", "fig": 2}, {"body": 2, "word": "shown", "fig": 1}, {"body": 1, "word": "two-sample", "fig": 2}, {"body": 2, "word": "DLV", "fig": 1}, {"body": 2, "word": "qRT-PCR", "fig": 1}, {"body": 2, "word": "NP", "fig": 1}, {"body": 1, "word": "F", "fig": 2}, {"body": 2, "word": "binding", "fig": 1}, {"body": 2, "word": "TGF\u03b21", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g006.jpg", "caption": "Inhibition of MTA1 and its associated signaling by pterostilbene (PTER) in Ptenf/f mice (A) Immunoblots of MTA1, p-Akt, Akt, AR, IL-1\u03b2, Hsp90 and E-cadherin (E-cad) in the prostate tissues of vehicle and PTER treated Ptenf/f mice, isolated at indicated ages. Hsp70 was a loading control. (B) Comparative analysis of MTA1 binding in the prostate tissues of Pten+/f mice on Ctrl- and PTER-Diet. Representative MTA1 ChIP-Seq tracks for IL-1\u03b2, E-cadherin and Vimentin gene loci at 10 kb resolution are shown. (C) Comparison of IHC staining of MTA1, p-Akt and AR in the prostate sections with carcinoma lesions from representative 10-, 25- and 33-week old vehicle or PTER treated Ptenf/f mice and NP controls. Scale bars, 100 \u03bcm. (D) Immunoblots of MTA1, p-Akt, Akt and AR in the dissected prostate lobes from vehicle or PTER-treated 10-, 15-, 20- and 25-week-old Ptenf/f mice. Hsp70 was used as a loading control. For quantitation of MTA1, p-Akt/Akt and AR expression in prostate lobes of Ptenf/f mice at different ages (n = 3/group) see Supplementary Figure S5.", "co_occurrence": [{"body": 117, "word": "MTA1", "fig": 7}, {"body": 62, "word": "prostate", "fig": 5}, {"body": 48, "word": "mice", "fig": 6}, {"body": 20, "word": "Ptenf/f", "fig": 5}, {"body": 81, "word": "pterostilbene", "fig": 1}, {"body": 81, "word": "Figure", "fig": 1}, {"body": 14, "word": "AR", "fig": 4}, {"body": 16, "word": "tissues", "fig": 2}, {"body": 16, "word": "Akt", "fig": 2}, {"body": 26, "word": "Pten+/f", "fig": 1}, {"body": 26, "word": "analysis", "fig": 1}, {"body": 12, "word": "lobes", "fig": 2}, {"body": 23, "word": "expression", "fig": 1}, {"body": 22, "word": "Supplementary", "fig": 1}, {"body": 10, "word": "control", "fig": 2}, {"body": 8, "word": "IL-1\u03b2", "fig": 2}, {"body": 13, "word": "IHC", "fig": 1}, {"body": 4, "word": "PTER", "fig": 3}, {"body": 4, "word": "p-Akt", "fig": 3}, {"body": 11, "word": "used", "fig": 1}, {"body": 5, "word": "E-cadherin", "fig": 2}, {"body": 10, "word": "ChIP-Seq", "fig": 1}, {"body": 10, "word": "Hsp90", "fig": 1}, {"body": 9, "word": "gene", "fig": 1}, {"body": 3, "word": "vehicle", "fig": 3}, {"body": 9, "word": "associated", "fig": 1}, {"body": 4, "word": "treated", "fig": 2}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 6, "word": "n", "fig": 1}, {"body": 5, "word": "For", "fig": 1}, {"body": 5, "word": "S5", "fig": 1}, {"body": 4, "word": "Vimentin", "fig": 1}, {"body": 2, "word": "ages", "fig": 2}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "dissected", "fig": 1}, {"body": 3, "word": "see", "fig": 1}, {"body": 3, "word": "PTER-Diet", "fig": 1}, {"body": 3, "word": "different", "fig": 1}, {"body": 3, "word": "lesions", "fig": 1}, {"body": 2, "word": "controls", "fig": 1}, {"body": 1, "word": "Hsp70", "fig": 2}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "NP", "fig": 1}, {"body": 2, "word": "binding", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 2, "word": "carcinoma", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 1}, {"body": 1, "word": "PTER-treated", "fig": 1}, {"body": 1, "word": "sections", "fig": 1}, {"body": 1, "word": "indicated", "fig": 1}, {"body": 1, "word": "quantitation", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g007.jpg", "caption": "Pterostilbene significantly inhibits MTA1-dependent cell proliferation and induces MTA1-targeted apoptosis in Pten+/f mice (A) Representative Ki-67 (top) and cleaved Caspase-3 (bottom) staining of prostate tissues from 10-month-old Pten+/f mice on Ctrl- and PTER-Diet. Scale bars, 100 \u03bcm (Ki-67) and 50 \u03bcm (cleaved Caspase-3). (B) Quantitation of Ki-67 (left) and cleaved Caspase-3 (right) positive cells of prostate tissues from 10-month-old Pten+/f mice on Ctrl- and PTER-Diet (n = 5/group). (C) Immunoblots of total and cleaved Caspase-3 in prostate tissues of 10-month-old Pten+/f mice on Ctrl- and PTER-Diet. (D) Immunoblots of p21 and p27 in the prostate tissues of 10-month-old Pten+/f mice compared to NP controls (left) and mice on Ctrl- and PTER-Diet (right). (E) Comparative analysis of MTA1 binding in the prostate tissues of Pten+/f mice on Ctrl- and PTER-Diet. Representative ChIP-Seq tracks for p21 and p27 gene loci at 10 kb resolution are shown. (F) Immunoblots of p21 and p27 in LNCaP (top) and DU145 (bottom) cells expressing (EV) and silenced for MTA1 (shMTA1). (G) qRT-PCR of p21 and p27 mRNA levels in cells expressing MTA1 and silenced for MTA1 (shMTA1). Data are mean \u00b1 SEM (n = 3), *p < 0.05; **p < 0.01 (two-tailed, two-sample t-test).", "co_occurrence": [{"body": 117, "word": "MTA1", "fig": 4}, {"body": 48, "word": "mice", "fig": 7}, {"body": 62, "word": "prostate", "fig": 5}, {"body": 26, "word": "Pten+/f", "fig": 6}, {"body": 16, "word": "tissues", "fig": 5}, {"body": 17, "word": "cells", "fig": 3}, {"body": 32, "word": "levels", "fig": 1}, {"body": 26, "word": "analysis", "fig": 1}, {"body": 5, "word": "p27", "fig": 4}, {"body": 4, "word": "p21", "fig": 4}, {"body": 4, "word": "cleaved", "fig": 4}, {"body": 3, "word": "PTER-Diet", "fig": 5}, {"body": 13, "word": "mRNA", "fig": 1}, {"body": 6, "word": "bottom", "fig": 2}, {"body": 6, "word": "top", "fig": 2}, {"body": 6, "word": "n", "fig": 2}, {"body": 10, "word": "cell", "fig": 1}, {"body": 10, "word": "ChIP-Seq", "fig": 1}, {"body": 9, "word": "gene", "fig": 1}, {"body": 3, "word": "Ki-67", "fig": 3}, {"body": 8, "word": "Pterostilbene", "fig": 1}, {"body": 8, "word": "apoptosis", "fig": 1}, {"body": 2, "word": "Caspase-3", "fig": 4}, {"body": 4, "word": "right", "fig": 2}, {"body": 4, "word": "left", "fig": 2}, {"body": 6, "word": "proliferation", "fig": 1}, {"body": 6, "word": "MTA1-dependent", "fig": 1}, {"body": 6, "word": "MTA1-targeted", "fig": 1}, {"body": 5, "word": "compared", "fig": 1}, {"body": 1, "word": "10-month-old", "fig": 4}, {"body": 4, "word": "LNCaP", "fig": 1}, {"body": 4, "word": "total", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 2, "word": "shMTA1", "fig": 2}, {"body": 3, "word": "staining", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 2, "word": "controls", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 2, "word": "significantly", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "qRT-PCR", "fig": 1}, {"body": 2, "word": "DU145", "fig": 1}, {"body": 2, "word": "NP", "fig": 1}, {"body": 2, "word": "binding", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "two-sample", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "F", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g008.jpg", "caption": "Pterostilbene significantly inhibits MTA1-dependent cell proliferation and angiogenesis and induces MTA1-targeted apoptosis in Ptenf/f mice (A) Representative Ki-67 (top, each panel), CD31 (middle, each panel) and VEGF-C (bottom, each panel) staining of the prostate tissues from Ptenf/f mice treated with vehicle and PTER, at indicated ages. Arrows indicate vessels. Scale bars, 100 \u03bcm. (B) Quantitation of Ki-67 (top) and CD31 (bottom) positive cells of prostate tissues from mice treated with vehicle and PTER (n = 5/group). (C) Representative images and (D) Quantitation of cleaved Caspase-3 staining at the indicated ages of vehicle and PTER treated Ptenf/f mice (n = 5/group). Scale bars, 10 \u03bcm. Data are mean \u00b1 SEM (n = 3), *p < 0.05; **p < 0.01; ***p < 0.001 (two-tailed, two-sample t-test). (E) Immunoblots of MTA1, Ac-p53, p53 and Bak in the prostate tissues from vehicle and PTER treated Ptenf/f mice, isolated at the indicated ages. NP, normal prostate. Hsp70 was used as loading controls from prostate tissues. (F) Densitometry of the Ac-p53/p53 ratio from the representative blot. (G) Comparative analysis of MTA1 binding in the prostate tissues of Pten+/f mice on Ctrl- and PTER-Diet. Representative MTA1 ChIP-Seq tracks for Vegf-c gene locus at 10 kb resolution are shown.", "co_occurrence": [{"body": 62, "word": "prostate", "fig": 6}, {"body": 117, "word": "MTA1", "fig": 3}, {"body": 48, "word": "mice", "fig": 6}, {"body": 20, "word": "Ptenf/f", "fig": 4}, {"body": 16, "word": "tissues", "fig": 5}, {"body": 26, "word": "Pten+/f", "fig": 1}, {"body": 26, "word": "analysis", "fig": 1}, {"body": 6, "word": "n", "fig": 3}, {"body": 17, "word": "cells", "fig": 1}, {"body": 4, "word": "PTER", "fig": 4}, {"body": 4, "word": "treated", "fig": 4}, {"body": 6, "word": "bottom", "fig": 2}, {"body": 6, "word": "top", "fig": 2}, {"body": 3, "word": "vehicle", "fig": 4}, {"body": 11, "word": "used", "fig": 1}, {"body": 10, "word": "cell", "fig": 1}, {"body": 10, "word": "ChIP-Seq", "fig": 1}, {"body": 9, "word": "gene", "fig": 1}, {"body": 8, "word": "Pterostilbene", "fig": 1}, {"body": 8, "word": "apoptosis", "fig": 1}, {"body": 7, "word": "VEGF-C", "fig": 1}, {"body": 7, "word": "normal", "fig": 1}, {"body": 3, "word": "CD31", "fig": 2}, {"body": 3, "word": "staining", "fig": 2}, {"body": 6, "word": "proliferation", "fig": 1}, {"body": 6, "word": "MTA1-dependent", "fig": 1}, {"body": 3, "word": "Ki-67", "fig": 2}, {"body": 2, "word": "ages", "fig": 3}, {"body": 6, "word": "MTA1-targeted", "fig": 1}, {"body": 5, "word": "angiogenesis", "fig": 1}, {"body": 4, "word": "positive", "fig": 1}, {"body": 4, "word": "p53", "fig": 1}, {"body": 4, "word": "cleaved", "fig": 1}, {"body": 3, "word": "PTER-Diet", "fig": 1}, {"body": 1, "word": "panel", "fig": 3}, {"body": 1, "word": "indicated", "fig": 3}, {"body": 3, "word": "middle", "fig": 1}, {"body": 3, "word": "E", "fig": 1}, {"body": 2, "word": "controls", "fig": 1}, {"body": 1, "word": "\u03bcm", "fig": 2}, {"body": 2, "word": "Bak", "fig": 1}, {"body": 2, "word": "significantly", "fig": 1}, {"body": 2, "word": "images", "fig": 1}, {"body": 2, "word": "shown", "fig": 1}, {"body": 2, "word": "t-test", "fig": 1}, {"body": 2, "word": "Caspase-3", "fig": 1}, {"body": 2, "word": "binding", "fig": 1}, {"body": 2, "word": "NP", "fig": 1}, {"body": 2, "word": "isolated", "fig": 1}, {"body": 1, "word": "Ac-p53", "fig": 1}, {"body": 1, "word": "Hsp70", "fig": 1}, {"body": 1, "word": "induces", "fig": 1}, {"body": 1, "word": "two-sample", "fig": 1}, {"body": 1, "word": "blot", "fig": 1}, {"body": 1, "word": "inhibits", "fig": 1}, {"body": 1, "word": "F", "fig": 1}]}, {"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951302/bin/oncotarget-07-18469-g009.jpg", "caption": "Schematic representation of MTA1-targeted effects of pterostilbene in prostate cancer Significantly increased levels of MTA1, a key upstream epigenetic regulator, promote inflammation, tumorigenesis, EMT, angiogenesis, and survival signaling and repress apoptosis. Pterostilbene (PTER) targets MTA1 and MTA1-guided molecular drivers of tumor promotion, thereby blocking the Pten loss-driven prostate tumorigenesis and cancer progression.", "co_occurrence": [{"body": 117, "word": "MTA1", "fig": 2}, {"body": 62, "word": "prostate", "fig": 2}, {"body": 47, "word": "cancer", "fig": 2}, {"body": 81, "word": "pterostilbene", "fig": 1}, {"body": 32, "word": "levels", "fig": 1}, {"body": 19, "word": "Pten", "fig": 1}, {"body": 14, "word": "progression", "fig": 1}, {"body": 12, "word": "tumor", "fig": 1}, {"body": 12, "word": "effects", "fig": 1}, {"body": 11, "word": "epigenetic", "fig": 1}, {"body": 5, "word": "tumorigenesis", "fig": 2}, {"body": 10, "word": "increased", "fig": 1}, {"body": 8, "word": "Pterostilbene", "fig": 1}, {"body": 8, "word": "apoptosis", "fig": 1}, {"body": 8, "word": "signaling", "fig": 1}, {"body": 6, "word": "MTA1-targeted", "fig": 1}, {"body": 5, "word": "loss-driven", "fig": 1}, {"body": 5, "word": "angiogenesis", "fig": 1}, {"body": 4, "word": "targets", "fig": 1}, {"body": 4, "word": "inflammation", "fig": 1}, {"body": 4, "word": "molecular", "fig": 1}, {"body": 4, "word": "key", "fig": 1}, {"body": 4, "word": "PTER", "fig": 1}, {"body": 3, "word": "upstream", "fig": 1}, {"body": 3, "word": "promotion", "fig": 1}, {"body": 2, "word": "EMT", "fig": 1}, {"body": 2, "word": "survival", "fig": 1}, {"body": 2, "word": "promote", "fig": 1}, {"body": 2, "word": "blocking", "fig": 1}, {"body": 1, "word": "drivers", "fig": 1}, {"body": 1, "word": "thereby", "fig": 1}, {"body": 1, "word": "MTA1-guided", "fig": 1}]}]}